Psyllid ID: psy3074

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-
Protein Sequence
WSSGENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Secondary Structure (PSIPRED)
cccccccccccHHHHHHHHHHHccccccccccccccccccccccccEEEcccccccccEEcccccccccccccccccccccccccccccHHHHHccccccccEEEEEccccccHHHHHHHHHHccccEEEEEEccccHHcccccccccccHHcccHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHccccHHHHcccccccEEEEEccccccccccccHHHHHHHHHHccccccEEEEEEEEEEccEEEEEEEcccccHHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEcccccccEEEEccccccccccccccccEEEEEEcccccccccccccccccEEEEEEEcccccEEEcccccccccccccccccccHHHHHHHHHHccccccEEEEEEEEEEccEEEEEEEccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEccccccccEEEccHHHcEEccccccccccccccccccEEcccEEEEccccccccEEEEEEcccccEEEEEEEEccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccccccHHHccccccccccccccccHHHHcccccccHHHHHHHHHHccccHHHcccHHHHHHHHHHHccccccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccEEHHHHHccccccccHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEcccccccHHHHHHHHHHHHHHHHcccEEcccccHHHEEEccccccccccEccccEEHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEccccccc
Coil and Loop (DISEMBL)
wssgenkatVQRQIsvssdsklldaDIAEETRVLLrnrkpprpksevflnkyatpprelkLADFglaraksvpshtyshqgdspfgkaDAYIKldqlgegsyATVFKGYSNLTNQVVALKEIRLQEEegitlwyrppdvllgsteystsldmWGVGCILIEMvtglptfpgvrEVYDQLDKIFKILgtpteetwegvsllpgynvhrdapytgnklgltfprlydipegesMASAFLQVRDAAilnpmehvhncekeggngpkngapFTAIREASLLKElkhnnivtLHDIVHTRSTLTFVFEYVHTDLSqymerhsggldhhnIRLFMFQLLRGLsychrrrilhrdvkpqnlliSEIDHHNIRLFMFQLLRGLsychrrrilhrdvkpqnLLISEIVFTNLSGVVVSTvdsgsggwwfesksninlsfhylppgapfTAIREASLLKElkhnnivtLHDIVHTRSTLTFVFEYVLFPTV
Flexible Loop (DISEMBL)
wssgenkatvqrqisvssdsklldadIAEEtrvllrnrkpprpksevflnkyatpprELKLADFGLARAKSVPshtyshqgdspFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEeegitlwyrppdVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Low Complexity Region (SEG)
WSSGENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLsgvvvstvdsgsggWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Disordered region (IsUnstruct)
***********************************************************KLADFGL*******************GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHN**************FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLF***
Disordered Region (DISOPRED)
**************SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPS*******************LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Disordered Region (DISEMBL)
*****************SDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAK************SPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Disordered Region (DISPRO)
*****NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
WSSGENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPTV
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	481	2.2.26 [Sep-21-2011]
Q3V3A1	433	Cyclin-dependent kinase 1	yes	N/A	0.232	0.258	0.675	4e-38
Q96Q40	435	Cyclin-dependent kinase 1	yes	N/A	0.232	0.257	0.666	2e-37
Q1RLU9	418	Cyclin-dependent kinase 1	no	N/A	0.232	0.267	0.701	5e-37
C0RW22	468	Cyclin-dependent kinase 1	N/A	N/A	0.232	0.239	0.675	7e-37
B6A7Q3	468	Cyclin-dependent kinase 1	no	N/A	0.232	0.239	0.675	8e-37
O35495	469	Cyclin-dependent kinase 1	no	N/A	0.232	0.238	0.675	8e-37
O94921	469	Cyclin-dependent kinase 1	no	N/A	0.232	0.238	0.675	9e-37
B0VXL7	451	Cyclin-dependent kinase 1	N/A	N/A	0.232	0.248	0.675	1e-36
B0VXE8	423	Cyclin-dependent kinase 1	no	N/A	0.232	0.264	0.675	1e-36
Q6DJM7	435	Cyclin-dependent kinase 1	N/A	N/A	0.232	0.257	0.666	2e-36

>sp|Q3V3A1|CDK15_MOUSE Cyclin-dependent kinase 15 OS=Mus musculus GN=Cdk15 PE=2 SV=2

 Score =  159 bits (402), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 91/114 (79%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDIVHT+ TLTFVFEY+HTDL+QYM +H GGL  
Sbjct: 137 EEGVPFTAIREASLLKGLKHANIVLLHDIVHTKETLTFVFEYMHTDLAQYMSQHPGGLHP 196

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           HN+RLFMFQLLRGL+Y H +R+LHRD+KPQNLL+S +    ++L  F L R  S
Sbjct: 197 HNVRLFMFQLLRGLAYIHHQRVLHRDLKPQNLLLSHLG--ELKLADFGLARAKS 248

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin.
Mus musculus (taxid: 10090)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2

>sp|Q96Q40|CDK15_HUMAN Cyclin-dependent kinase 15 OS=Homo sapiens GN=CDK15 PE=1 SV=2

 Score =  157 bits (396), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 76/114 (66%), Positives = 90/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLTFVFEY+HTDL+QYM +H GGL  
Sbjct: 139 EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMSQHPGGLHP 198

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           HN+RLFMFQLLRGL+Y H + +LHRD+KPQNLLIS +    ++L  F L R  S
Sbjct: 199 HNVRLFMFQLLRGLAYIHHQHVLHRDLKPQNLLISHLG--ELKLADFGLARAKS 250

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q1RLU9|CDK15_DANRE Cyclin-dependent kinase 15 OS=Danio rerio GN=cdk15 PE=2 SV=1

 Score =  155 bits (393), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 80/114 (70%), Positives = 90/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HTR +LTFVFEYV TDL+QYM +H GGL  
Sbjct: 120 EEGIPFTAIREASLLKGLKHANIVLLHDIIHTRESLTFVFEYVQTDLAQYMIQHPGGLHS 179

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +NIRLFMFQLLRGLSY H RRILHRD+KPQNLLIS +    ++L  F L R  S
Sbjct: 180 YNIRLFMFQLLRGLSYIHGRRILHRDLKPQNLLISYLG--ELKLADFGLARSKS 231

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin.

Danio rerio (taxid: 7955)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|C0RW22|CDK14_DASNO Cyclin-dependent kinase 14 OS=Dasypus novemcinctus GN=CDK14 PE=3 SV=1

 Score =  155 bits (392), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 170 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 229

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 230 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 281

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Dasypus novemcinctus (taxid: 9361)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|B6A7Q3|CDK14_RABIT Cyclin-dependent kinase 14 OS=Oryctolagus cuniculus GN=CDK14 PE=3 SV=1

 Score =  155 bits (391), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 170 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 229

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 230 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 281

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|O35495|CDK14_MOUSE Cyclin-dependent kinase 14 OS=Mus musculus GN=Cdk14 PE=2 SV=2

 Score =  155 bits (391), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 171 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 230

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 231 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 282

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|O94921|CDK14_HUMAN Cyclin-dependent kinase 14 OS=Homo sapiens GN=CDK14 PE=1 SV=3

 Score =  155 bits (391), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 171 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 230

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 231 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 282

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|B0VXL7|CDK14_CALMO Cyclin-dependent kinase 14 OS=Callicebus moloch GN=CDK14 PE=3 SV=1

 Score =  154 bits (390), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 153 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 212

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 213 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 264

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Callicebus moloch (taxid: 9523)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|B0VXE8|CDK14_CALJA Cyclin-dependent kinase 14 OS=Callithrix jacchus GN=CDK14 PE=3 SV=1

 Score =  154 bits (389), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 125 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 184

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 185 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 236

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.

Callithrix jacchus (taxid: 9483)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q6DJM7|CDK14_XENLA Cyclin-dependent kinase 14 OS=Xenopus laevis GN=cdk14 PE=2 SV=1

 Score =  154 bits (388), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 76/114 (66%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL+ 
Sbjct: 137 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLNP 196

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+  ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 197 ENVKLFLFQLLRGLSYIHQGHILHRDLKPQNLLIS--DTGELKLADFGLARAKS 248

Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of lrp6, leading to the activation of the Wnt signaling pathway.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
312373180	562	hypothetical protein AND_17821 [Anophele	0.478	0.409	0.475	1e-54
157108436	345	als2cr7 [Aedes aegypti] gi|108868545|gb|	0.324	0.452	0.542	1e-52
157133875	338	als2cr7 [Aedes aegypti] gi|108870657|gb|	0.316	0.449	0.552	2e-52
56199528	273	protein serine/threonine kinase [Culicoi	0.316	0.556	0.548	7e-52
170044715	462	als2cr7 [Culex quinquefasciatus] gi|1678	0.278	0.290	0.587	7e-52
195441456	584	GK20517 [Drosophila willistoni] gi|19416	0.328	0.270	0.522	3e-51
307185035	493	Serine/threonine-protein kinase PFTAIRE-	0.328	0.320	0.536	4e-51
195125515	637	GI12497 [Drosophila mojavensis] gi|19391	0.328	0.248	0.518	4e-51
332027953	476	Serine/threonine-protein kinase PFTAIRE-	0.328	0.331	0.536	5e-51
198463556	525	GA10409 [Drosophila pseudoobscura pseudo	0.291	0.266	0.561	5e-51

>gi|312373180|gb|EFR20977.1| hypothetical protein AND_17821 [Anopheles darlingi]

 Score =  220 bits (561), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 143/301 (47%), Positives = 169/301 (56%), Gaps = 71/301 (23%)

Query: 80  QGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDV 139
           +GDSPFGK++AYIKL+QLGEGSYATVFKGYSN   QV  +K             +R    
Sbjct: 81  KGDSPFGKSEAYIKLEQLGEGSYATVFKGYSNSDFQVGQIKST-----------FRSSSF 129

Query: 140 LLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR----EVYDQLDKIFKILGTPTEETWE 195
             G  +  T  D      I ++        P VR    +  D  D+  + L  P  ET  
Sbjct: 130 DNGFVDSHTDTDCLSSPVIPVDYD------PSVRRRNGDETDDDDR--QALNPPASET-S 180

Query: 196 GVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCE 255
           G+ + P        P T   + L   RL                               E
Sbjct: 181 GIVITP--------PLTNQVVALKEIRLQ------------------------------E 202

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER 315
           +EG       APFTAIREASLLKELKH+NIVTLHDIVHTR TLTFVFE+V+TDLSQYMER
Sbjct: 203 EEG-------APFTAIREASLLKELKHSNIVTLHDIVHTRETLTFVFEFVNTDLSQYMER 255

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
           H GGLDH N+RLF+FQLLRGLSYCH+RR+LHRDVKPQNLLISE+    ++L  F L R  
Sbjct: 256 HPGGLDHRNVRLFLFQLLRGLSYCHKRRVLHRDVKPQNLLISEMG--ELKLADFGLARAK 313

Query: 376 S 376
           S
Sbjct: 314 S 314

Source: Anopheles darlingi

Species: Anopheles darlingi

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157108436|ref|XP_001650227.1| als2cr7 [Aedes aegypti] gi|108868545|gb|EAT32770.1| AAEL015000-PA [Aedes aegypti]

 Score =  214 bits (544), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 115/212 (54%), Positives = 129/212 (60%), Gaps = 56/212 (26%)

Query: 28  AEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK 87
             + RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH        
Sbjct: 137 CHKRRVLHRDVKPQ--------NLLISEMGELKLADFGLARAKSVPSHTYSH-------- 180

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYS 147
                                                   E +TLWYRPPDVLLGSTEYS
Sbjct: 181 ----------------------------------------EVVTLWYRPPDVLLGSTEYS 200

Query: 148 TSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHR 207
           TSLDMWGVGCI +EM+TG+PTFPG+R+ YDQLDKIFKILGTPTEETW GV+ LPGY +H 
Sbjct: 201 TSLDMWGVGCIFVEMITGMPTFPGIRDTYDQLDKIFKILGTPTEETWPGVTHLPGYKLHM 260

Query: 208 DAPYTGNKLGLTFPRLYDIPEGESMASAFLQV 239
              +   KLGL+FPRLYDI EGE MASAFLQ+
Sbjct: 261 LGFFKSRKLGLSFPRLYDIIEGEMMASAFLQL 292

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|157133875|ref|XP_001663051.1| als2cr7 [Aedes aegypti] gi|108870657|gb|EAT34882.1| AAEL012915-PA [Aedes aegypti]

 Score =  213 bits (541), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 115/208 (55%), Positives = 128/208 (61%), Gaps = 56/208 (26%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 134 RVLHRDVKPQ--------NLLISEMGELKLADFGLARAKSVPSHTYSH------------ 173

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 174 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 197

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EM+TG+PTFPG+R+ YDQLDKIFKILGTPTEETW GV+ LPGY +H    +
Sbjct: 198 MWGVGCIFVEMITGMPTFPGIRDTYDQLDKIFKILGTPTEETWPGVTHLPGYKLHMLGFF 257

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQV 239
              KLGL+FPRLYDI EGE MASAFLQ+
Sbjct: 258 KSRKLGLSFPRLYDIIEGEMMASAFLQL 285

Source: Aedes aegypti

Species: Aedes aegypti

Genus: Aedes

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|56199528|gb|AAV84253.1| protein serine/threonine kinase [Culicoides sonorensis]

 Score =  211 bits (537), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 114/208 (54%), Positives = 127/208 (61%), Gaps = 56/208 (26%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 97  RVLHRDVKPQ--------NLLISEIGELKLADFGLARAKSVPSHTYSH------------ 136

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 137 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 160

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EM+TG+PTFPG+R+ YDQLDKIFK+LGTPTEETW GV+ LPGY  H+   Y
Sbjct: 161 MWGVGCIFVEMITGMPTFPGIRDTYDQLDKIFKMLGTPTEETWNGVTHLPGYKPHKLGFY 220

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQV 239
              KLGL+FPRLYDI EGESMA A LQ+
Sbjct: 221 RTRKLGLSFPRLYDIVEGESMAGALLQL 248

Source: Culicoides sonorensis

Species: Culicoides sonorensis

Genus: Culicoides

Family: Ceratopogonidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170044715|ref|XP_001849982.1| als2cr7 [Culex quinquefasciatus] gi|167867757|gb|EDS31140.1| als2cr7 [Culex quinquefasciatus]

 Score =  211 bits (537), Expect = 7e-52,   Method: Compositional matrix adjust.
 Identities = 107/182 (58%), Positives = 120/182 (65%), Gaps = 48/182 (26%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKSVPSHTYSH                                      
Sbjct: 278 ELKLADFGLARAKSVPSHTYSH-------------------------------------- 299

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                     E +TLWYRPPDVLLGSTEYSTSLDMWGVGCI +EM+TG+PTFPG+R+ YD
Sbjct: 300 ----------EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFVEMITGMPTFPGIRDTYD 349

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QLDKIFKILGTPTEE+W+GV+ LPGY +H    +   KLGL+FPRLYDI EGE MASAFL
Sbjct: 350 QLDKIFKILGTPTEESWQGVTHLPGYKLHMLGFFKPRKLGLSFPRLYDIIEGEMMASAFL 409

Query: 238 QV 239
           Q+
Sbjct: 410 QL 411

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195441456|ref|XP_002068525.1| GK20517 [Drosophila willistoni] gi|194164610|gb|EDW79511.1| GK20517 [Drosophila willistoni]

 Score =  209 bits (531), Expect = 3e-51,   Method: Compositional matrix adjust.
 Identities = 115/220 (52%), Positives = 131/220 (59%), Gaps = 62/220 (28%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 383 RVLHRDVKPQ--------NLLISDCGELKLADFGLARAKSVPSHTYSH------------ 422

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 423 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 446

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EMVTG+PTFPG+R+ YDQLDKIFK+LGTPTEETW+GV+  PGY  H+   Y
Sbjct: 447 MWGVGCIFVEMVTGMPTFPGIRDTYDQLDKIFKLLGTPTEETWQGVTHFPGYKPHKLGFY 506

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV 251
              KLG  FPRLYDI EGE++A+AFLQ      LNP + +
Sbjct: 507 RPRKLGHNFPRLYDIIEGETIANAFLQ------LNPEQRI 540

Source: Drosophila willistoni

Species: Drosophila willistoni

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307185035|gb|EFN71264.1| Serine/threonine-protein kinase PFTAIRE-1 [Camponotus floridanus]

 Score =  209 bits (531), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 118/220 (53%), Positives = 130/220 (59%), Gaps = 62/220 (28%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 283 RVLHRDVKPQ--------NLLISEIGELKLADFGLARAKSVPSHTYSH------------ 322

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 323 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 346

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EM+TG PTFPGVR  YDQLDKIFK+LGTPTEETW GV+ LPGY  HR   Y
Sbjct: 347 MWGVGCIFVEMLTGEPTFPGVRCTYDQLDKIFKVLGTPTEETWPGVTHLPGYKAHRLLFY 406

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV 251
              KLGL+FPRLYDI EG+SMAS+ LQ      LNP + +
Sbjct: 407 PPRKLGLSFPRLYDIAEGDSMASSLLQ------LNPDQRI 440

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|195125515|ref|XP_002007223.1| GI12497 [Drosophila mojavensis] gi|193918832|gb|EDW17699.1| GI12497 [Drosophila mojavensis]

 Score =  208 bits (530), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 114/220 (51%), Positives = 131/220 (59%), Gaps = 62/220 (28%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 436 RVLHRDVKPQ--------NLLISDCGELKLADFGLARAKSVPSHTYSH------------ 475

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 476 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 499

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EMVTG+PTFPG+R+ YDQLDKIFK+LGTPTE+TW+GV+  PGY  H+   Y
Sbjct: 500 MWGVGCIFVEMVTGMPTFPGIRDTYDQLDKIFKLLGTPTEDTWQGVTHFPGYKPHKLGFY 559

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV 251
              KLG  FPRLYDI EGE++A+AFLQ      LNP + +
Sbjct: 560 RPRKLGHNFPRLYDIIEGETIANAFLQ------LNPEQRI 593

Source: Drosophila mojavensis

Species: Drosophila mojavensis

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332027953|gb|EGI68004.1| Serine/threonine-protein kinase PFTAIRE-1 [Acromyrmex echinatior]

 Score =  208 bits (529), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 118/220 (53%), Positives = 130/220 (59%), Gaps = 62/220 (28%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP         N   +   ELKLADFGLARAKSVPSHTYSH            
Sbjct: 266 RVLHRDVKPQ--------NLLISEIGELKLADFGLARAKSVPSHTYSH------------ 305

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVLLGSTEYSTSLD
Sbjct: 306 ------------------------------------EVVTLWYRPPDVLLGSTEYSTSLD 329

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI +EM+TG PTFPGVR  YDQLDKIFK+LGTPTEETW GV+ LPGY  HR   Y
Sbjct: 330 MWGVGCIFVEMLTGEPTFPGVRCTYDQLDKIFKVLGTPTEETWPGVTHLPGYKAHRLIFY 389

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV 251
              KLGL+FPRLYDI EG+SMAS+ LQ      LNP + +
Sbjct: 390 PPRKLGLSFPRLYDIAEGDSMASSLLQ------LNPDQRI 423

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|198463556|ref|XP_001352868.2| GA10409 [Drosophila pseudoobscura pseudoobscura] gi|198151308|gb|EAL30369.2| GA10409 [Drosophila pseudoobscura pseudoobscura]

 Score =  208 bits (529), Expect = 5e-51,   Method: Compositional matrix adjust.
 Identities = 109/194 (56%), Positives = 121/194 (62%), Gaps = 54/194 (27%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKSVPSHTYSH                                      
Sbjct: 342 ELKLADFGLARAKSVPSHTYSH-------------------------------------- 363

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                     E +TLWYRPPDVLLGSTEYSTSLDMWGVGCI +EMVTG+PTFPG+R+ YD
Sbjct: 364 ----------EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFVEMVTGMPTFPGIRDTYD 413

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QLDKIFK+LGTPTEETW GV+  PGY  H+   Y   KLG  FPRLYDI EGE++A+AFL
Sbjct: 414 QLDKIFKLLGTPTEETWTGVTHFPGYKPHKLGFYRPRKLGHNFPRLYDIIEGETIANAFL 473

Query: 238 QVRDAAILNPMEHV 251
           Q      LNP E +
Sbjct: 474 Q------LNPEERI 481

Source: Drosophila pseudoobscura pseudoobscura

Species: Drosophila pseudoobscura

Genus: Drosophila

Family: Drosophilidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	481
FB|FBgn0005640	522	Eip63E "Ecdysone-induced prote	0.284	0.262	0.640	1.5e-77
UNIPROTKB|Q6DJM7	435	cdk14 "Cyclin-dependent kinase	0.232	0.257	0.666	1.8e-52
ZFIN|ZDB-GENE-080220-44	324	zgc:172096 "zgc:172096" [Danio	0.232	0.345	0.684	6.1e-52
UNIPROTKB|E1BS76	454	LOC100859608 "Uncharacterized	0.284	0.301	0.556	7.7e-52
UNIPROTKB|F1S320	423	F1S320 "Uncharacterized protei	0.284	0.323	0.556	7.7e-52
UNIPROTKB|B6A7Q3	468	CDK14 "Cyclin-dependent kinase	0.284	0.292	0.556	7.7e-52
UNIPROTKB|C0RW22	468	CDK14 "Cyclin-dependent kinase	0.284	0.292	0.556	7.7e-52
MGI|MGI:894318	469	Cdk14 "cyclin-dependent kinase	0.284	0.292	0.556	9.9e-52
UNIPROTKB|O94921	469	CDK14 "Cyclin-dependent kinase	0.284	0.292	0.556	9.9e-52
UNIPROTKB|B0VXE8	423	CDK14 "Cyclin-dependent kinase	0.284	0.323	0.556	9.9e-52

FB|FBgn0005640 Eip63E "Ecdysone-induced protein 63E" [Drosophila melanogaster (taxid:7227)]

 Score = 458 (166.3 bits), Expect = 1.5e-77, Sum P(2) = 1.5e-77
 Identities = 91/142 (64%), Positives = 111/142 (78%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + GAPFTAIREASLLKELKH+NIVTLHDIVHTR TLTFVFEYV+TDLSQYME+H GGLDH
Sbjct:   241 EEGAPFTAIREASLLKELKHSNIVTLHDIVHTRETLTFVFEYVNTDLSQYMEKHPGGLDH 300

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N+RLF+FQLLRGLSYCH+RR+LHRDVKPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   301 RNVRLFLFQLLRGLSYCHKRRVLHRDVKPQNLLIS--DCGELKLADFGLARAKSVPSHTY 358

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   359 SHEVVTLWYRPPDVLLGSTEYS 380

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS;IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS;NAS

GO:0001700 "embryonic development via the syncytial blastoderm" evidence=IMP

GO:0030332 "cyclin binding" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=ISS;IDA;NAS

GO:0007552 "metamorphosis" evidence=IMP

GO:0002009 "morphogenesis of an epithelium" evidence=IMP

GO:0002168 "instar larval development" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0020037 "heme binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0048589 "developmental growth" evidence=IMP

UNIPROTKB|Q6DJM7 cdk14 "Cyclin-dependent kinase 14" [Xenopus laevis (taxid:8355)]

 Score = 384 (140.2 bits), Expect = 1.8e-52, Sum P(2) = 1.8e-52
 Identities = 76/114 (66%), Positives = 89/114 (78%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL+ 
Sbjct:   137 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLNP 196

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
              N++LF+FQLLRGLSY H+  ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct:   197 ENVKLFLFQLLRGLSYIHQGHILHRDLKPQNLLIS--DTGELKLADFGLARAKS 248

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=ISS

ZFIN|ZDB-GENE-080220-44 zgc:172096 "zgc:172096" [Danio rerio (taxid:7955)]

 Score = 390 (142.3 bits), Expect = 6.1e-52, Sum P(2) = 6.1e-52
 Identities = 78/114 (68%), Positives = 89/114 (78%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   125 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLQP 184

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
              N+RLF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct:   185 DNVRLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 236

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|E1BS76 LOC100859608 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 388 (141.6 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   156 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 215

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   216 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 273

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   274 SNEVVTLWYRPPDVLLGSTEYS 295

GO:0005524 "ATP binding" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=IEA

UNIPROTKB|F1S320 F1S320 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 388 (141.6 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   125 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 184

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   185 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 242

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   243 SNEVVTLWYRPPDVLLGSTEYS 264

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|B6A7Q3 CDK14 "Cyclin-dependent kinase 14" [Oryctolagus cuniculus (taxid:9986)]

 Score = 388 (141.6 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   170 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 229

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   230 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 287

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   288 SNEVVTLWYRPPDVLLGSTEYS 309

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=ISS

UNIPROTKB|C0RW22 CDK14 "Cyclin-dependent kinase 14" [Dasypus novemcinctus (taxid:9361)]

 Score = 388 (141.6 bits), Expect = 7.7e-52, Sum P(2) = 7.7e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   170 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 229

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   230 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 287

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   288 SNEVVTLWYRPPDVLLGSTEYS 309

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=ISS

MGI|MGI:894318 Cdk14 "cyclin-dependent kinase 14" [Mus musculus (taxid:10090)]

 Score = 387 (141.3 bits), Expect = 9.9e-52, Sum P(2) = 9.9e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   171 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 230

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   231 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 288

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   289 SNEVVTLWYRPPDVLLGSTEYS 310

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISO

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005886 "plasma membrane" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=ISO;ISS;IDA

GO:0007049 "cell cycle" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030332 "cyclin binding" evidence=ISO

GO:0051301 "cell division" evidence=IEA

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=ISO

UNIPROTKB|O94921 CDK14 "Cyclin-dependent kinase 14" [Homo sapiens (taxid:9606)]

 Score = 387 (141.3 bits), Expect = 9.9e-52, Sum P(2) = 9.9e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   171 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 230

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   231 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 288

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   289 SNEVVTLWYRPPDVLLGSTEYS 310

GO:0005524 "ATP binding" evidence=IEA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0030332 "cyclin binding" evidence=IPI

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=IDA

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

UNIPROTKB|B0VXE8 CDK14 "Cyclin-dependent kinase 14" [Callithrix jacchus (taxid:9483)]

 Score = 387 (141.3 bits), Expect = 9.9e-52, Sum P(2) = 9.9e-52
 Identities = 79/142 (55%), Positives = 101/142 (71%)

Query:   263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct:   125 EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 184

Query:   323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH 379
              N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S   + +
Sbjct:   185 DNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKSVPSHTY 242

Query:   380 RRRILHRDVKPQNLLISEIVFT 401
                ++    +P ++L+    ++
Sbjct:   243 SNEVVTLWYRPPDVLLGSTEYS 264

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=ISS

GO:0000308 "cytoplasmic cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISS

GO:0060828 "regulation of canonical Wnt receptor signaling pathway" evidence=ISS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	481
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-66
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-63
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-50
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-43
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-43
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-43
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-42
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	9e-41
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-40
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-39
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-38
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-37
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-37
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-37
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-35
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-35
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-35
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-35
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-34
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-34
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-33
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-31
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-31
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-31
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-31
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-30
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-29
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-28
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-27
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-27
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-26
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-26
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-26
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-25
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-24
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-23
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-23
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-22
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-21
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-21
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-21
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-21
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-20
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-20
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-19
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-19
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-19
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-18
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-18
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-18
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	8e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-17
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-17
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-16
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-16
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-16
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-16
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-15
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-14
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-14
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-14
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-13
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-12
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-12
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	8e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-11
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-11
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-10
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-10
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-10
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-10
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-10
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-09
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-09
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-09
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	6e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-08
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-08
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-08
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-08
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	5e-08
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-08
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-07
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-07
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-07
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-07
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-07
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-07
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-07
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-07
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-07
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-07
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	9e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-06
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-06
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-06
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-06
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-06
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-06
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-06
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	8e-06
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-05
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-05
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-05
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-05
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-05
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-05
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-05
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-05
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-05
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-05
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-05
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-05
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-05
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-05
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-05
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-05
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-04
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-04
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-04
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-04
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-04
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-04
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-04
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-04
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-04
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-04
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-04
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-04
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-04
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-04
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-04
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	6e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.001
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.001
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.001
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	0.001
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	0.001
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.001
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.001
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.001
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	0.001
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.001
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.001
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	0.001
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.001
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	0.001
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	0.002
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	0.002
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	0.002
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	0.002
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	0.002
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	0.002
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.002
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.002
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.002
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	0.002
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	0.002
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	0.003
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	0.003
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	0.003
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	0.003
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	0.003
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	0.003
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.003
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.003
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.003
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	0.003
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.003
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	0.003
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	0.004
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	0.004
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	0.004
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.004
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	0.004
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.004
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	0.004

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  214 bits (546), Expect = 5e-66
 Identities = 90/181 (49%), Positives = 98/181 (54%), Gaps = 48/181 (26%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKSVPS TYS+                                      
Sbjct: 141 ELKLADFGLARAKSVPSKTYSN-------------------------------------- 162

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                     E +TLWYRPPDVLLGSTEYSTSLDMWGVGCI  EM TG P FPG  +V D
Sbjct: 163 ----------EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL KIF++LGTPTEETW GVS  P +  +    Y    L    PRL  IP GE +A  FL
Sbjct: 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFL 272

Query: 238 Q 238
           Q
Sbjct: 273 Q 273

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  206 bits (527), Expect = 3e-63
 Identities = 73/94 (77%), Positives = 84/94 (89%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           GAPFTAIREASLLK+LKH NIVTLHDI+HT+ TLT VFEY+ TDL QYM+   GGL  HN
Sbjct: 45  GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHN 104

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +RLF+FQLLRGL+YCH+RR+LHRD+KPQNLLISE
Sbjct: 105 VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  173 bits (439), Expect = 2e-50
 Identities = 76/114 (66%), Positives = 90/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLTFVFEY+HTDL+QYM +H GGL  
Sbjct: 43  EEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP 102

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +N+RLFMFQLLRGL+Y H + ILHRD+KPQNLLIS +    ++L  F L R  S
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  154 bits (393), Expect = 1e-43
 Identities = 74/194 (38%), Positives = 93/194 (47%), Gaps = 58/194 (29%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           R+L R+ KP      + +N+       LKLADFGLARA  +P  TY+H            
Sbjct: 118 RILHRDLKP----QNILINRDGV----LKLADFGLARAFGIPLRTYTH------------ 157

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYR P++LLGS  YST++D
Sbjct: 158 ------------------------------------EVVTLWYRAPEILLGSKHYSTAVD 181

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           +W VGCI  EM+TG P FPG  E+ DQL KIF+ILGTPTEE+W GV+ LP Y       +
Sbjct: 182 IWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK-F 239

Query: 212 TGNKLGLTFPRLYD 225
               L    PRL  
Sbjct: 240 PPKDLEKVLPRLDP 253

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  155 bits (392), Expect = 2e-43
 Identities = 77/114 (67%), Positives = 89/114 (78%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYVHTDL QYM++H GGL  
Sbjct: 43  EEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP 102

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            N++LF+FQLLRGLSY H+R ILHRD+KPQNLLIS  D   ++L  F L R  S
Sbjct: 103 ENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS--DTGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  153 bits (390), Expect = 3e-43
 Identities = 54/96 (56%), Positives = 69/96 (71%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G P TA+RE SLLKELKH NIV L D++HT   L  VFEY   DL +Y+++  G L  
Sbjct: 38  EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSP 97

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           + I+  M+QLLRGL+YCH  RILHRD+KPQN+LI+ 
Sbjct: 98  NLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR 133

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  152 bits (385), Expect = 2e-42
 Identities = 78/180 (43%), Positives = 98/180 (54%), Gaps = 48/180 (26%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKS+PS TYS                                       
Sbjct: 141 ELKLADFGLARAKSIPSQTYS--------------------------------------- 161

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                     E +TLWYRPPDVLLG+T+YS++LD+WG GCI IEM+ G P FPGV +V++
Sbjct: 162 ---------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE 212

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL+KI+ +LG PTE+TW GVS LP Y      P    +L + + RL   P+ E +AS  L
Sbjct: 213 QLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQML 272

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  150 bits (380), Expect = 8e-42
 Identities = 80/181 (44%), Positives = 99/181 (54%), Gaps = 48/181 (26%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKSVPSHTYS+                                      
Sbjct: 141 ELKLADFGLARAKSVPSHTYSN-------------------------------------- 162

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                     E +TLWYRPPDVLLGSTEYST LDMWGVGCI +EM+ G+  FPG++++ D
Sbjct: 163 ----------EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL++IF +LGTP E+TW GV  LP +   R   Y+   L   + +L  +   E +AS  L
Sbjct: 213 QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272

Query: 238 Q 238
           Q
Sbjct: 273 Q 273

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  147 bits (372), Expect = 9e-41
 Identities = 69/112 (61%), Positives = 84/112 (75%), Gaps = 2/112 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           GAP TAIRE SLLK LKH NIVTLHDI+HT   LT VFEY+ +DL QY++     +  HN
Sbjct: 45  GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHN 104

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +++FMFQLLRGLSYCH+R+ILHRD+KPQNLLI+E     ++L  F L R  S
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINE--KGELKLADFGLARAKS 154

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  145 bits (367), Expect = 6e-40
 Identities = 68/114 (59%), Positives = 87/114 (76%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+  DL QY++     ++ 
Sbjct: 44  EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM 103

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           HN++LF+FQLLRGL+YCHRR++LHRD+KPQNLLI+E     ++L  F L R  S
Sbjct: 104 HNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKS 155

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  143 bits (362), Expect = 4e-39
 Identities = 67/114 (58%), Positives = 86/114 (75%), Gaps = 2/114 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + GAP TAIRE SLLK+LKH NIVTLHDIVHT  +LT VFEY+  DL QYM+     +  
Sbjct: 44  EEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSM 103

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           HN+++F++Q+LRGL+YCHRR++LHRD+KPQNLLI+E     ++L  F L R  S
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINE--RGELKLADFGLARAKS 155

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  140 bits (355), Expect = 2e-38
 Identities = 54/94 (57%), Positives = 71/94 (75%), Gaps = 2/94 (2%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS--GGLDH 322
           G P TAIRE SL+KELKH NIV LHD++HT + L  VFEY+  DL +YM+ H   G LD 
Sbjct: 40  GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDP 99

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           + ++ F +QLL+G+++CH  R+LHRD+KPQNLLI
Sbjct: 100 NTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI 133

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (352), Expect = 8e-38
 Identities = 58/163 (35%), Positives = 78/163 (47%), Gaps = 48/163 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLAR        Y+ +  + +                           TN+V 
Sbjct: 138 VLKLADFGLAR-------PYTKRNSADY---------------------------TNRV- 162

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                       ITLWYRPP++LLG+T Y   +DMW VGCIL E+  G P F G  E+ +
Sbjct: 163 ------------ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-E 209

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTF 220
           QL+KIF++ G+PT+E W GVS LP +   +       +L   F
Sbjct: 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  139 bits (351), Expect = 1e-37
 Identities = 81/195 (41%), Positives = 95/195 (48%), Gaps = 60/195 (30%)

Query: 30  ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD 89
           E RVL R+ KP      + +NK      ELKLADFGLARA  +P +T+S           
Sbjct: 118 ENRVLHRDLKP----QNLLINKRG----ELKLADFGLARAFGIPVNTFS----------- 158

Query: 90  AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS 149
                                   N+VV             TLWYR PDVLLGS  YSTS
Sbjct: 159 ------------------------NEVV-------------TLWYRAPDVLLGSRTYSTS 181

Query: 150 LDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDA 209
           +D+W VGCI+ EM+TG P FPG     DQL KIF+I+GTPTE TW G+S LP Y      
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPG-TNNEDQLLKIFRIMGTPTESTWPGISQLPEYK--PTF 238

Query: 210 P-YTGNKLGLTFPRL 223
           P Y    L   FP  
Sbjct: 239 PRYPPQDLQQLFPHA 253

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 2e-37
 Identities = 56/110 (50%), Positives = 74/110 (67%), Gaps = 3/110 (2%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG-GLDHH 323
           G P TAIRE SLLKEL H NIV L D+VH+ + L  VFE++  DL +YM+     GLD  
Sbjct: 40  GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPP 99

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            I+ +++QLL+G++YCH  R+LHRD+KPQNLLI       ++L  F L R
Sbjct: 100 LIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID--REGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  137 bits (347), Expect = 4e-37
 Identities = 54/109 (49%), Positives = 75/109 (68%), Gaps = 2/109 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P +A+RE  LLKELKH NIV L+D++H+   LT VFEY   DL +Y +  +G +D   
Sbjct: 41  GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI 100

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           ++ FMFQLL+GL++CH   +LHRD+KPQNLLI+   +  ++L  F L R
Sbjct: 101 VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN--KNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  133 bits (335), Expect = 1e-35
 Identities = 81/194 (41%), Positives = 99/194 (51%), Gaps = 57/194 (29%)

Query: 30  ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD 89
           + ++L R+ KP      + +N+      ELKLADFGLARAKSVP+ TYS           
Sbjct: 121 KRKILHRDLKP----QNLLINEKG----ELKLADFGLARAKSVPTKTYS----------- 161

Query: 90  AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS 149
                                   N+VV             TLWYRPPDVLLGSTEYST 
Sbjct: 162 ------------------------NEVV-------------TLWYRPPDVLLGSTEYSTP 184

Query: 150 LDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDA 209
           +DMWGVGCIL EM TG P FPG   V ++L  IF++LGTPTEETW G++    +  +   
Sbjct: 185 IDMWGVGCILYEMATGRPMFPG-STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243

Query: 210 PYTGNKLGLTFPRL 223
            Y    L    PRL
Sbjct: 244 QYRAQPLINHAPRL 257

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 1e-35
 Identities = 65/172 (37%), Positives = 83/172 (48%), Gaps = 57/172 (33%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP      + +++       LKLADFGLARA  VP  TY+H            
Sbjct: 119 RVLHRDLKP----QNLLIDREGA----LKLADFGLARAFGVPVRTYTH------------ 158

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYR P++LLGS +YST +D
Sbjct: 159 ------------------------------------EVVTLWYRAPEILLGSRQYSTPVD 182

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY 203
           +W +GCI  EMV   P FPG  E+ DQL +IF+ LGTP E+ W GV+ LP Y
Sbjct: 183 IWSIGCIFAEMVNRRPLFPGDSEI-DQLFRIFRTLGTPDEDVWPGVTSLPDY 233

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  132 bits (335), Expect = 2e-35
 Identities = 74/193 (38%), Positives = 92/193 (47%), Gaps = 59/193 (30%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
            VL R+ KP      + +NK      ELKLADFGLARA  +P   YS             
Sbjct: 119 NVLHRDLKP----QNLLINKNG----ELKLADFGLARAFGIPVRCYSA------------ 158

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYRPPDVL G+  YSTS+D
Sbjct: 159 ------------------------------------EVVTLWYRPPDVLFGAKLYSTSID 182

Query: 152 MWGVGCILIEMVT-GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAP 210
           MW  GCI  E+   G P FPG  +V DQL +IF++LGTPTEE+W GVS LP Y  +   P
Sbjct: 183 MWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYP 241

Query: 211 YTGNKLGLTFPRL 223
            T + + +  P+L
Sbjct: 242 ATTSLVNVV-PKL 253

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  131 bits (331), Expect = 8e-35
 Identities = 84/207 (40%), Positives = 103/207 (49%), Gaps = 59/207 (28%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           +VL R+ KP      + +N+      ELKLADFGLARAKS+P+ TYS             
Sbjct: 124 KVLHRDLKP----QNLLINERG----ELKLADFGLARAKSIPTKTYS------------- 162

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                 N+VV             TLWYRPPD+LLGST+YST +D
Sbjct: 163 ----------------------NEVV-------------TLWYRPPDILLGSTDYSTQID 187

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI  EM TG P FPG   V +QL  IF+ILGTPTEETW G+     +  +    Y
Sbjct: 188 MWGVGCIFYEMSTGRPLFPG-STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKY 246

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQ 238
             + L    PRL    +G  + S  LQ
Sbjct: 247 RADCLHNHAPRLDS--DGAELLSKLLQ 271

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  130 bits (329), Expect = 2e-34
 Identities = 88/224 (39%), Positives = 110/224 (49%), Gaps = 62/224 (27%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           +VL R+ KP      + +N+      ELKLADFGLARAKSVP+ TYS             
Sbjct: 124 KVLHRDLKP----QNLLINERG----ELKLADFGLARAKSVPTKTYS------------- 162

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                 N+VV             TLWYRPPDVLLGS+EYST +D
Sbjct: 163 ----------------------NEVV-------------TLWYRPPDVLLGSSEYSTQID 187

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPY 211
           MWGVGCI  EM +G P FPG   V D+L  IF++LGTPTEETW G+S    +  +    Y
Sbjct: 188 MWGVGCIFFEMASGRPLFPG-STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKY 246

Query: 212 TGNKLGLTFPRLYDIPEGESMASAFLQV---RDAAILNPMEHVH 252
               L    PRL    EG  + + FLQ    +  +    M+H +
Sbjct: 247 KPQPLINHAPRLDT--EGIELLTKFLQYESKKRISAEEAMKHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  130 bits (328), Expect = 2e-34
 Identities = 58/121 (47%), Positives = 78/121 (64%), Gaps = 8/121 (6%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHH 323
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+     G+   
Sbjct: 41  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLP 100

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL-----SYC 378
            I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R       +Y 
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYT 158

Query: 379 H 379
           H
Sbjct: 159 H 159

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  126 bits (319), Expect = 4e-33
 Identities = 65/166 (39%), Positives = 78/166 (46%), Gaps = 49/166 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LK+ DFGLAR    P   Y                                   T  VV
Sbjct: 144 ILKICDFGLAREYGSPLKPY-----------------------------------TQLVV 168

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR P++LLG+ EYST++DMW VGCI  E++T  P FPG  E+ D
Sbjct: 169 -------------TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-D 214

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRL 223
           QL+KIFK+LGTPTE+ W G S LPG        Y  N+L   FP L
Sbjct: 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPAL 260

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  123 bits (309), Expect = 1e-31
 Identities = 67/172 (38%), Positives = 84/172 (48%), Gaps = 56/172 (32%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP      + +++       LKLADFGLARA  +P  T++H            
Sbjct: 122 RVLHRDLKP----QNLLIDRRTN---ALKLADFGLARAFGIPVRTFTH------------ 162

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYR P++LLGS  YST +D
Sbjct: 163 ------------------------------------EVVTLWYRAPEILLGSRHYSTPVD 186

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY 203
           +W VGCI  EMV   P FPG  E+ D+L KIF+ILGTP EETW GV+ LP Y
Sbjct: 187 IWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSLPDY 237

Length = 294

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  122 bits (308), Expect = 1e-31
 Identities = 49/116 (42%), Positives = 70/116 (60%), Gaps = 2/116 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P TA+RE  LLKEL H NI+ L D+   +  L  VFE++ TDL + ++    GL    
Sbjct: 40  GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESL 99

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR 380
           I+ +++QLL+GL++CH   ILHRD+KP+NLLI+      ++L  F L R      R
Sbjct: 100 IKSYLYQLLQGLAFCHSHGILHRDLKPENLLINT--EGVLKLADFGLARSFGSPVR 153

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  121 bits (306), Expect = 4e-31
 Identities = 58/164 (35%), Positives = 75/164 (45%), Gaps = 51/164 (31%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLAR+               FG  +                      +T+QVV
Sbjct: 140 VLKLADFGLARS---------------FGSPN--------------------RKMTHQVV 164

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++L G+  Y   +DMW VGCI  E++  +P  PG  ++ D
Sbjct: 165 -------------TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-D 210

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFP 221
           QL KIF+ LGTPTEE W GV+ LP Y   +  P+    L   FP
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFK--PFPPTPLKQIFP 252

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  120 bits (302), Expect = 8e-31
 Identities = 48/93 (51%), Positives = 66/93 (70%), Gaps = 1/93 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG-GLDHH 323
           G P TAIRE SLLKE++H NIV L D+VH+   L  VFEY+  DL ++M+       +  
Sbjct: 43  GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR 102

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            I+ +++Q+LRG++YCH  R+LHRD+KPQNLLI
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135

Length = 294

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  119 bits (301), Expect = 2e-30
 Identities = 65/180 (36%), Positives = 79/180 (43%), Gaps = 42/180 (23%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LK+ADFGLAR    P            G                          TN VV 
Sbjct: 154 LKIADFGLAR----PYDGPPPNPKGGGGGGTR--------------------KYTNLVV- 188

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ 178
                       T WYRPP++LLG   Y+T++D+WG+GC+  EM T  P   G  ++ DQ
Sbjct: 189 ------------TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQ 235

Query: 179 LDKIFKILGTPTEETWEGVSLLPGY-NVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           L  IFK+ GTPTEETW G   LPG   VH    Y    L   F +L   PEG  + S  L
Sbjct: 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT-LEERFGKLG--PEGLDLLSKLL 292

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  117 bits (296), Expect = 5e-30
 Identities = 63/172 (36%), Positives = 80/172 (46%), Gaps = 57/172 (33%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP      + ++        +KLADFGLARA  +P   Y+H            
Sbjct: 121 RVLHRDLKP----QNLLIDNKGV----IKLADFGLARAFGIPVRVYTH------------ 160

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYR P+VLLGS  YST +D
Sbjct: 161 ------------------------------------EVVTLWYRAPEVLLGSPRYSTPVD 184

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY 203
           +W +G I  EM T  P F G  E+ DQL +IF+ILGTPTE+ W GV+ LP Y
Sbjct: 185 IWSIGTIFAEMATKKPLFHGDSEI-DQLFRIFRILGTPTEDVWPGVTSLPDY 235

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  117 bits (295), Expect = 8e-30
 Identities = 51/111 (45%), Positives = 74/111 (66%), Gaps = 4/111 (3%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG--LDH 322
           G P TAIRE SLLKEL+H NIV L D++   S L  +FE++  DL +Y++    G  +D 
Sbjct: 41  GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDA 100

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             ++ +++Q+L+G+ +CH RR+LHRD+KPQNLLI   +   I+L  F L R
Sbjct: 101 ELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID--NKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  116 bits (292), Expect = 1e-29
 Identities = 36/99 (36%), Positives = 56/99 (56%), Gaps = 4/99 (4%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
             +RE  +LK+LKH NIV L+D+      L  V EY    DL   +++  G L     R 
Sbjct: 43  RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARF 101

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           ++ Q+L  L Y H + I+HRD+KP+N+L+ E    +++L
Sbjct: 102 YLRQILSALEYLHSKGIVHRDLKPENILLDE--DGHVKL 138

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  115 bits (290), Expect = 4e-29
 Identities = 64/172 (37%), Positives = 80/172 (46%), Gaps = 57/172 (33%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
           RVL R+ KP      + +N        +KLADFGLARA  VP  TY+H            
Sbjct: 120 RVLHRDLKP----QNLLINTEG----AIKLADFGLARAFGVPVRTYTH------------ 159

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                               E +TLWYR P++LLG   YST++D
Sbjct: 160 ------------------------------------EVVTLWYRAPEILLGCKYYSTAVD 183

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY 203
           +W +GCI  EMVT    FPG  E+ DQL +IF+ LGTP E  W GV+ LP Y
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSLPDY 234

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  115 bits (289), Expect = 6e-29
 Identities = 66/194 (34%), Positives = 84/194 (43%), Gaps = 59/194 (30%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LK+AD GL RA S+P  +Y+H                                       
Sbjct: 150 LKIADLGLGRAFSIPVKSYTH--------------------------------------- 170

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ 178
                    E +TLWYR P+VLLGST YST +D+W VGCI  EM    P FPG  E+  Q
Sbjct: 171 ---------EIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL-QQ 220

Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQ 238
           L  IFK+LGTPTE+ W GVS L  +  H    +    L    P L   PEG  +    L+
Sbjct: 221 LLHIFKLLGTPTEQVWPGVSKLRDW--HEFPQWKPQDLSRAVPDLS--PEGLDLLQKMLR 276

Query: 239 VRDAAILNPMEHVH 252
                  +P + + 
Sbjct: 277 ------YDPAKRIS 284

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 7e-28
 Identities = 46/122 (37%), Positives = 67/122 (54%), Gaps = 4/122 (3%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGGL 320
           K G P TAIRE  LL++L+H NIV L +IV    + ++  VFEY+  DL+  ++      
Sbjct: 38  KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKF 97

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR 380
               I+ +M QLL GL Y H   ILHRD+K  N+LI+  +   ++L  F L R  +  + 
Sbjct: 98  TESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN--NDGVLKLADFGLARPYTKRNS 155

Query: 381 RR 382
             
Sbjct: 156 AD 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 3e-27
 Identities = 39/90 (43%), Positives = 60/90 (66%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           TA+RE  +L++L+H NIV L +    +  L  VFEYV   L + +E   GGL    +R +
Sbjct: 46  TALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSY 105

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           ++QLL+ ++YCH   I+HRD+KP+N+L+SE
Sbjct: 106 IWQLLQAIAYCHSHNIIHRDIKPENILVSE 135

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 6e-27
 Identities = 55/163 (33%), Positives = 67/163 (41%), Gaps = 49/163 (30%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKLADFGLAR+   P   Y+H                                    VV 
Sbjct: 137 LKLADFGLARSFGSPVRPYTHY-----------------------------------VV- 160

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ 178
                       T WYR P++LLG   YST +D+W VGCI  E+++  P FPG  E+ DQ
Sbjct: 161 ------------TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQ 207

Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFP 221
           L KIF+ LGTP  E W   + L            G  L   FP
Sbjct: 208 LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFP 250

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  109 bits (275), Expect = 6e-27
 Identities = 45/96 (46%), Positives = 62/96 (64%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K+G  FTA+RE  LL+ELKH NI+ L D+   +S +  VFE++ TDL + ++  S  L  
Sbjct: 42  KDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTP 101

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +I+ +M   LRGL Y H   ILHRD+KP NLLI+ 
Sbjct: 102 ADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS 137

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  109 bits (275), Expect = 1e-26
 Identities = 56/159 (35%), Positives = 77/159 (48%), Gaps = 43/159 (27%)

Query: 47  VFLNKYATPPRELKLADFGLAR--AKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYAT 104
           +F+N         K+ADFGLAR       S T S              +  Q  E     
Sbjct: 150 IFINSKG----ICKIADFGLARRYGYPPYSDTLSKD------------ETMQRRE----- 188

Query: 105 VFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT 164
                  +T++VV             TLWYR P++L+G+ +Y  ++DMW VGCI  E++T
Sbjct: 189 ------EMTSKVV-------------TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Query: 165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY 203
           G P FPG  E+ DQL +IF++LGTP E+ W     LP Y
Sbjct: 230 GKPLFPGENEI-DQLGRIFELLGTPNEDNWPQAKKLPLY 267

Length = 335

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  107 bits (269), Expect = 2e-26
 Identities = 38/91 (41%), Positives = 49/91 (53%), Gaps = 2/91 (2%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
           TA RE  +L+ L H NIV L D    +  L  V EY    DL  Y+ R  G L     + 
Sbjct: 44  TARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG-GPLSEDEAKK 102

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              Q+LRGL Y H   I+HRD+KP+N+L+ E
Sbjct: 103 IALQILRGLEYLHSNGIIHRDLKPENILLDE 133

Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  108 bits (271), Expect = 2e-26
 Identities = 59/168 (35%), Positives = 74/168 (44%), Gaps = 53/168 (31%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LK+ADFGLAR   +P+                                      T +VV
Sbjct: 146 CLKIADFGLARTYGLPAKPM-----------------------------------TPKVV 170

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR P++LLG T Y+T++DMW VGCIL E++   P  PG  E+ +
Sbjct: 171 -------------TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-E 216

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYN--VHRDAPYTGNKLGLTFPRL 223
           QLD I ++LGTP E  W G S LP          PY  N L   FP L
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPY--NNLKHKFPWL 262

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (268), Expect = 4e-26
 Identities = 47/117 (40%), Positives = 65/117 (55%), Gaps = 17/117 (14%)

Query: 250 HVHNCEKEGGNGPKNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFV 301
            V   E         G P + +RE +LLK+L+   H NIV L D+ H   T     LT V
Sbjct: 33  RVPLSE--------EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV 84

Query: 302 FEYVHTDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           FE+V  DL+ Y+ +    GL    I+  M QLLRG+ + H  RI+HRD+KPQN+L++
Sbjct: 85  FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 52/145 (35%), Positives = 65/145 (44%), Gaps = 51/145 (35%)

Query: 57  RELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQV 116
            ++K+ADFGLAR        YS +                               LT+ V
Sbjct: 144 GQVKIADFGLAR-------IYSFE-----------------------------MALTSVV 167

Query: 117 VALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVY 176
           V             TLWYR P+VLL S+ Y+T +DMW VGCI  E+    P F G  E  
Sbjct: 168 V-------------TLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEA- 212

Query: 177 DQLDKIFKILGTPTEETWEGVSLLP 201
           DQLDKIF ++G P+EE W     LP
Sbjct: 213 DQLDKIFDVIGLPSEEEWPRNVSLP 237

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  105 bits (265), Expect = 1e-25
 Identities = 51/147 (34%), Positives = 67/147 (45%), Gaps = 50/147 (34%)

Query: 59  LKLADFGLARA-KSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           LK+ADFGLAR         YSHQ                                    V
Sbjct: 138 LKIADFGLARLFSEEEPRLYSHQ------------------------------------V 161

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
           A            T WYR P++L G+ +Y   +D+W VGCI  E++ G P FPG  ++ +
Sbjct: 162 A------------TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-E 208

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYN 204
           QL  +F+ LGTP EETW G++ LP YN
Sbjct: 209 QLAIVFRTLGTPNEETWPGLTSLPDYN 235

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  102 bits (258), Expect = 1e-24
 Identities = 55/179 (30%), Positives = 77/179 (43%), Gaps = 66/179 (36%)

Query: 59  LKLADFGLAR-AKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           +K+ADFGLAR  +S P +T              Y+                         
Sbjct: 138 VKIADFGLAREIRSRPPYT-------------DYVS------------------------ 160

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++LL ST YS+ +D+W +GCI+ E+ T  P FPG  E+ D
Sbjct: 161 -------------TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEI-D 206

Query: 178 QLDKIFKILGTPTEETW-EGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASA 235
           QL KI  +LGTPT++ W EG  L              +KLG  FP+       + + +A
Sbjct: 207 QLYKICSVLGTPTKQDWPEGYKLA-------------SKLGFRFPQFAPTSLHQLIPNA 252

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 1/94 (1%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
            +RE  +LK+L H NIV L+ +    + L  V EY     L   ++ + G L    I   
Sbjct: 38  LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           + Q+L GL Y H   I+HRD+KP+N+L+   +  
Sbjct: 98  LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK 131

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 99.9 bits (249), Expect = 2e-23
 Identities = 43/102 (42%), Positives = 66/102 (64%), Gaps = 10/102 (9%)

Query: 265 GAPFTAIREASLLKELKHNN-IVTLHDIVHT-----RSTLTFVFEYVHTDLSQYMERHSG 318
           G P TA+RE SLL+ L  +  IV L D+ H      + +L  VFEY+ +DL ++M+ +  
Sbjct: 42  GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGR 101

Query: 319 G----LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           G    L    I+ FM+QLL+G+++CH+  ++HRD+KPQNLL+
Sbjct: 102 GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV 143

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 99.1 bits (248), Expect = 5e-23
 Identities = 45/141 (31%), Positives = 64/141 (45%), Gaps = 46/141 (32%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           +LK+ DFGLAR                  K                        LT  VV
Sbjct: 141 DLKICDFGLARG----------VDPDEDEK----------------------GFLTEYVV 168

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++LL S+ Y+ ++D+W VGCI  E++T  P FPG R+  D
Sbjct: 169 -------------TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG-RDYID 214

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL+ I ++LGTP+EE  + ++
Sbjct: 215 QLNLIVEVLGTPSEEDLKFIT 235

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 36/101 (35%), Positives = 53/101 (52%)

Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHH 323
            G P  A+RE   L+  +H  +V L D+    S    V EY+ +DLS+ +      L   
Sbjct: 40  GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEA 99

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
            ++ +M  LL+G++Y H   I+HRD+KP NLLIS      I
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 56/161 (34%), Positives = 73/161 (45%), Gaps = 52/161 (32%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
            V+ R+ KP    S + LN        +KLADFGLAR+                      
Sbjct: 127 NVIHRDLKP----SNILLNSDCR----VKLADFGLARS---------------------- 156

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
             L +L E     V   Y       VA            T WYR P++LLGST Y+  +D
Sbjct: 157 --LSELEENPENPVLTDY-------VA------------TRWYRAPEILLGSTRYTKGVD 195

Query: 152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           MW VGCIL EM+ G P FPG     +QL+KI +++G P+ E
Sbjct: 196 MWSVGCILGEMLLGKPLFPG-TSTLNQLEKIIEVIGPPSAE 235

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 34/41 (82%), Positives = 38/41 (92%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAPFTAIREASLLK+LKH NIVTLHDI+HT+ TLT VFEY+
Sbjct: 45  GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 39/89 (43%), Positives = 62/89 (69%), Gaps = 2/89 (2%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           A+RE  +LK+L+H N+V L ++   +  L  VFE+V HT L   +E++  GLD   +R +
Sbjct: 47  AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKY 105

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           +FQ+LRG+ +CH   I+HRD+KP+N+L+S
Sbjct: 106 LFQILRGIEFCHSHNIIHRDIKPENILVS 134

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 92.8 bits (231), Expect = 4e-21
 Identities = 41/108 (37%), Positives = 69/108 (63%), Gaps = 4/108 (3%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           A+RE  +LK+LKH N+V L ++   +  L  VFEY  HT L++ +E++  G+  H I+  
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKI 105

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           ++Q L+ +++CH+   +HRDVKP+N+LI++     I+L  F   R L+
Sbjct: 106 IWQTLQAVNFCHKHNCIHRDVKPENILITK--QGQIKLCDFGFARILT 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 45/120 (37%), Positives = 65/120 (54%), Gaps = 10/120 (8%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIV--------HTRSTLTFVFEYVHTDLSQYME 314
           K+G P TA+RE  +LK+LKH N+V L D+           R ++  V  Y+  DLS  +E
Sbjct: 47  KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE 106

Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
             S  L    I+ +M QLL G++Y H   ILHRD+K  N+LI   +   +++  F L R 
Sbjct: 107 NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID--NQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 33/82 (40%), Positives = 52/82 (63%), Gaps = 8/82 (9%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE--------VYDQLDK 181
           +T+WYR P++LLG+  Y+ ++D+W +GCI  E++T  P F G             DQL++
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 182 IFKILGTPTEETWEGVSLLPGY 203
           IF++LGTPTE+ W  +  +P Y
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEY 258

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 47/121 (38%), Positives = 64/121 (52%), Gaps = 12/121 (9%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLT----------FVFEYVHTDLSQY 312
           K G P TAIRE  +L++L H NIV L +IV  +               VFEY+  DL   
Sbjct: 46  KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGL 105

Query: 313 MERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLL 372
           +E         +I+ FM QLL GL+YCH++  LHRD+K  N+L++      I+L  F L 
Sbjct: 106 LESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLA 163

Query: 373 R 373
           R
Sbjct: 164 R 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 90.4 bits (225), Expect = 6e-20
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 54/165 (32%)

Query: 33  VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI 92
           VL R+ KP    S + LN       +LK+ DFGLAR  + P H ++              
Sbjct: 127 VLHRDLKP----SNLLLNTNC----DLKICDFGLARI-ADPEHDHTGF------------ 165

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
                              LT  V              T WYR P+++L S  Y+ ++D+
Sbjct: 166 -------------------LTEYVA-------------TRWYRAPEIMLNSKGYTKAIDI 193

Query: 153 WGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGV 197
           W VGCIL EM++  P FPG ++   QL+ I  +LGTP++E    +
Sbjct: 194 WSVGCILAEMLSNRPLFPG-KDYLHQLNLILGVLGTPSQEDLNCI 237

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 89.2 bits (222), Expect = 8e-20
 Identities = 38/98 (38%), Positives = 57/98 (58%), Gaps = 4/98 (4%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVF---EYVHTDLSQYMERHSGG 319
           K G P T++RE ++L +L+H NIVT+ ++V   S L  ++   EYV  DL   ME     
Sbjct: 44  KEGFPITSLREINILLKLQHPNIVTVKEVV-VGSNLDKIYMVMEYVEHDLKSLMETMKQP 102

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                ++  M QLL G+++ H   ILHRD+K  NLL++
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 33/45 (73%), Positives = 38/45 (84%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           FGK + Y KLD+LGEGSYATV+KG S LT Q+VALKEIRL+ EEG
Sbjct: 1   FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG 45

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 2/108 (1%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           T +RE  +L+ LK  NIV L +    R  L  VFEYV  ++ + +E    G+    +R +
Sbjct: 46  TTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSY 105

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           ++QL++ + +CH+  I+HRD+KP+NLLIS  D   ++L  F   R LS
Sbjct: 106 IYQLIKAIHWCHKNDIVHRDIKPENLLISHND--VLKLCDFGFARNLS 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 6/92 (6%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNIR 326
           RE  LL+ L+H NI+ L DI+   S   F     V E + TDL + + +    L   +I+
Sbjct: 48  REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVI-KSPQPLTDDHIQ 106

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            F++Q+LRGL Y H   ++HRD+KP N+L++ 
Sbjct: 107 YFLYQILRGLKYLHSANVIHRDLKPSNILVNS 138

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 87.0 bits (216), Expect = 7e-19
 Identities = 52/147 (35%), Positives = 66/147 (44%), Gaps = 45/147 (30%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKLADFGLARA S+  +           K + Y                     TN+VV 
Sbjct: 158 LKLADFGLARAFSLSKN----------SKPNRY---------------------TNRVV- 185

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ 178
                       TLWYRPP++LLG  +Y   +DMWG GCI+ EM T  P   G  E + Q
Sbjct: 186 ------------TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-Q 232

Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNV 205
           L  I ++ G+ T E W GV  L  +  
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKK 259

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 47/150 (31%), Positives = 67/150 (44%), Gaps = 48/150 (32%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ++KLADFGLAR        Y+ +   P+                           TN+V 
Sbjct: 154 QIKLADFGLAR-------LYNSEESRPY---------------------------TNKV- 178

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                       ITLWYRPP++LLG   Y  ++D+W  GCIL E+ T  P F   +E+  
Sbjct: 179 ------------ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-A 225

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHR 207
           QL+ I ++ G+P    W  V  LP +N  +
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMK 255

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 85.2 bits (212), Expect = 1e-18
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 4/96 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDH---HNI 325
           A+ E  +LK+L H NI+  ++    +  L  V EY    DLSQ +++            I
Sbjct: 46  ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
             +  QL   L Y H R+ILHRD+KPQN+ ++    
Sbjct: 106 LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 83.8 bits (208), Expect = 3e-18
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 272 REASLLKELKHNNIVTL--HDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLF 328
           RE  +L  L+H NIV     +    ++TL    EYV    LS  +++  G L    IR +
Sbjct: 48  REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKY 106

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+L GL+Y H   I+HRD+K  N+L+  
Sbjct: 107 TRQILEGLAYLHSNGIVHRDIKGANILVDS 136

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 84.4 bits (209), Expect = 7e-18
 Identities = 48/167 (28%), Positives = 70/167 (41%), Gaps = 48/167 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELK+ DFGLAR  S              G+   ++                Y       V
Sbjct: 143 ELKICDFGLARGFSEN-----------PGENAGFMT--------------EY-------V 170

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
           A            T WYR P+++L    Y+ ++D+W VGCIL E++   P F G ++  D
Sbjct: 171 A------------TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG-KDYVD 217

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
           QL++I ++LGTP EET   +      N  R  P   N     F  ++
Sbjct: 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLP---NIPKKPFESIF 261

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 83.5 bits (206), Expect = 8e-18
 Identities = 47/124 (37%), Positives = 69/124 (55%), Gaps = 11/124 (8%)

Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           ++G P + +RE +LLK L+   H NIV L D+  T  T     +T VFE+V  DL  Y++
Sbjct: 39  EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLD 98

Query: 315 R-HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +    GL    I+  M Q LRGL + H   I+HRD+KP+N+L++      ++L  F L R
Sbjct: 99  KVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGQVKLADFGLAR 156

Query: 374 GLSY 377
             S 
Sbjct: 157 IYSC 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 8/102 (7%)

Query: 267 PFTAIREASLLKELK-------HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG 319
            F +  E   L+E+K       H NIV L ++      L FVFEY+  +L Q M+   G 
Sbjct: 35  KFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGK 94

Query: 320 -LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
                 IR  ++Q+L+GL++ H+    HRD+KP+NLL+S  +
Sbjct: 95  PFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE 136

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 48/124 (38%), Positives = 72/124 (58%), Gaps = 11/124 (8%)

Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  DL+ Y++
Sbjct: 41  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 100

Query: 315 R-HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++      I+L  F L R
Sbjct: 101 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLAR 158

Query: 374 GLSY 377
             S+
Sbjct: 159 IYSF 162

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 35/92 (38%), Positives = 53/92 (57%), Gaps = 7/92 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTL----TFVFEYVHTDLSQYMERHSGG-LDHHNIR 326
           RE  +L+  KH+NI+ + DI+            V + + +DL   +  HS   L   +IR
Sbjct: 53  RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII--HSDQPLTEEHIR 110

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            F++QLLRGL Y H   ++HRD+KP NLL++E
Sbjct: 111 YFLYQLLRGLKYIHSANVIHRDLKPSNLLVNE 142

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 6/98 (6%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           G   +A RE +LL+ELKH N+V+L ++   H   ++  +F+Y   DL Q ++ H      
Sbjct: 44  GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRV 103

Query: 323 H----NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                 ++  ++Q+L G+ Y H   +LHRD+KP N+L+
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 6e-17
 Identities = 39/113 (34%), Positives = 63/113 (55%), Gaps = 4/113 (3%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVHTDLSQYMERHSGGL 320
           ++G P +++RE +LL  L+H NIV L ++V  +   ++  V EY   DL+  ++      
Sbjct: 46  RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPF 105

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
               ++  M QLLRGL Y H   I+HRD+K  NLL++  D   +++  F L R
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT--DKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 41/144 (28%), Positives = 53/144 (36%), Gaps = 49/144 (34%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+ADFGLA+     S +                           T F G         
Sbjct: 136 VVKIADFGLAKKLLKSSSSL--------------------------TTFVG--------- 160

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WY  P+VLLG   Y   +D+W +G IL E++TG P F G   + D
Sbjct: 161 -------------TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG-ENILD 206

Query: 178 QLDKIFKILGTPTEETWEGVSLLP 201
           QL  I +ILG P E      S   
Sbjct: 207 QLQLIRRILGPPLEFDEPKWSSGS 230

Length = 260

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 39/103 (37%), Positives = 55/103 (53%), Gaps = 8/103 (7%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHT--------RSTLTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T        + +   VFE+   DL+  + 
Sbjct: 51  KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS 110

Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             +       I+  M  LL GL Y HR +ILHRD+K  N+LI+
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT 153

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 3/91 (3%)

Query: 269 TAIREASLLKELK-HNNIVTLHDIVHTRST--LTFVFEYVHTDLSQYMERHSGGLDHHNI 325
             +RE   L+ L  H NI+ L +++  R T  L  VFE +  +L + ++     L    +
Sbjct: 43  NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRV 102

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           + +M+QLL+ L + HR  I HRD+KP+N+LI
Sbjct: 103 KSYMYQLLKSLDHMHRNGIFHRDIKPENILI 133

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 38/105 (36%), Positives = 60/105 (57%), Gaps = 16/105 (15%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRS--------------TLTFVFEYVHTDLSQYMER 315
           A+RE  +++ L H+NIV +++++                  ++  V EY+ TDL+  +E+
Sbjct: 49  ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ 108

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             G L   + RLFM+QLLRGL Y H   +LHRD+KP N+ I+  D
Sbjct: 109 --GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 42/144 (29%), Positives = 54/144 (37%), Gaps = 54/144 (37%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +KLADFGLAR                           QL  G   T F G         
Sbjct: 135 HVKLADFGLAR---------------------------QLDPGEKLTTFVG--------- 158

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T  Y  P+VLLG   Y  ++D+W +G IL E++TG P FPG     D
Sbjct: 159 -------------TPEYMAPEVLLG-KGYGKAVDIWSLGVILYELLTGKPPFPG----DD 200

Query: 178 QLDKIFKILGTPTEETWEGVSLLP 201
           QL ++FK +G P          + 
Sbjct: 201 QLLELFKKIGKPKPPFPPPEWDIS 224

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 40/139 (28%), Positives = 53/139 (38%), Gaps = 48/139 (34%)

Query: 54  TPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLT 113
           +    LKL DFG ARA                                        S LT
Sbjct: 134 SESGVLKLCDFGFARALRARPA----------------------------------SPLT 159

Query: 114 NQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR 173
           + V              T WYR P++L+G T Y   +D+W +GCI+ E++ G P FPG  
Sbjct: 160 DYVA-------------TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206

Query: 174 EVYDQLDKIFKILGTPTEE 192
           ++ DQL  I K LG     
Sbjct: 207 DI-DQLYLIQKCLGPLPPS 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.9 bits (195), Expect = 2e-16
 Identities = 41/135 (30%), Positives = 52/135 (38%), Gaps = 50/135 (37%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFG  R        YS     P+     YI                         
Sbjct: 137 ILKLADFGSCRG------IYSKP---PY---TEYIS------------------------ 160

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+ LL    Y   +D+W VGC+  E+++  P FPG  E+ D
Sbjct: 161 -------------TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-D 206

Query: 178 QLDKIFKILGTPTEE 192
           Q+ KI  +LGTP  E
Sbjct: 207 QIAKIHDVLGTPDAE 221

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 28/62 (45%), Positives = 42/62 (67%), Gaps = 1/62 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG  +  DQL +I  ++GTP 
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPG-SDHIDQLKRIMNLVGTPD 236

Query: 191 EE 192
           EE
Sbjct: 237 EE 238

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 37/93 (39%), Positives = 54/93 (58%), Gaps = 6/93 (6%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  LL+ L H N++ + DI+       F     V+E + TDL Q + R S  L   + 
Sbjct: 52  LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQII-RSSQTLSDDHC 110

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           + F++QLLRGL Y H   +LHRD+KP NLL++ 
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 43/128 (33%), Positives = 66/128 (51%), Gaps = 22/128 (17%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYV-HTDLSQYMER---HSGGLDHHN 324
           + E ++L+ELKH NIV  +D +  RS  TL  V EY    DL+Q +++       ++   
Sbjct: 47  VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEF 106

Query: 325 IRLFMFQLLRGLSYCHRR-----RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH 379
           I   + QLL  L  CH R      +LHRD+KP N+ +    ++N++L  F    GL+   
Sbjct: 107 IWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDA--NNNVKLGDF----GLA--- 157

Query: 380 RRRILHRD 387
             +IL  D
Sbjct: 158 --KILGHD 163

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 58/176 (32%), Positives = 71/176 (40%), Gaps = 59/176 (33%)

Query: 26  DIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF 85
           D     RV+ R+ KP         N   T   ++KLADFGLAR        YS Q     
Sbjct: 124 DFLHSHRVVHRDLKPQ--------NILVTSSGQIKLADFGLAR-------IYSFQM---- 164

Query: 86  GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE 145
                                         VV            +TLWYR P+VLL S+ 
Sbjct: 165 --------------------------ALTSVV------------VTLWYRAPEVLLQSS- 185

Query: 146 YSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLP 201
           Y+T +D+W VGCI  EM    P F G  +V DQL KI  ++G P EE W     LP
Sbjct: 186 YATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEEDWPRDVALP 240

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 5e-16
 Identities = 38/88 (43%), Positives = 56/88 (63%), Gaps = 3/88 (3%)

Query: 272 REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           RE  LLK L+H NI++L DI +     + FV E + TDL + +   S  L+   I+ F++
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLY 115

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           Q+LRGL Y H   ++HRD+KP N+LI+E
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINE 143

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 33/41 (80%), Positives = 36/41 (87%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G PFTAIREASLLK LKH NIV LHDI+HT+ TLTFVFEY+
Sbjct: 45  GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYM 85

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 39/81 (48%), Positives = 46/81 (56%), Gaps = 2/81 (2%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +TLWYR P+VLL ST Y+T +DMW VGCI  EM    P F G  E  DQL KIF ++G P
Sbjct: 169 VTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP 226

Query: 190 TEETWEGVSLLPGYNVHRDAP 210
            E+ W     LP        P
Sbjct: 227 PEDDWPRDVTLPRGAFSPRGP 247

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 30/66 (45%), Positives = 46/66 (69%), Gaps = 1/66 (1%)

Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           E  +T WYR P++LL  +EY+T++D+W VGCI  E++   P FPG ++   QL  I ++L
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG-KDYVHQLKLITELL 225

Query: 187 GTPTEE 192
           G+P+EE
Sbjct: 226 GSPSEE 231

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 43/118 (36%), Positives = 67/118 (56%), Gaps = 6/118 (5%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++LG+T Y+T +D+W +GCI+ EM+ G P F G   V DQL +I ++LGTPTE+
Sbjct: 235 FYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPTED 293

Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGE-SMASAFLQVRDAAILNPME 249
             + ++  P Y   +        L   FP+    P+   +  S FL+      LNP+E
Sbjct: 294 QLKEMN--PNYADIKFPDVKPKDLKKVFPK--GTPDDAINFISQFLKYEPLKRLNPIE 347

Length = 440

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 53/160 (33%)

Query: 33  VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI 92
           V+ R+ KP    S + +N+      EL++ DFG+AR                        
Sbjct: 128 VIHRDLKP----SNLLVNEDC----ELRIGDFGMARG----------------------- 156

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
                     ++    +     + VA            T WYR P++LL   EY+T++DM
Sbjct: 157 ---------LSSSPTEHKYFMTEYVA------------TRWYRAPELLLSLPEYTTAIDM 195

Query: 153 WGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           W VGCI  EM+     FPG +    QL  I  +LG+P+EE
Sbjct: 196 WSVGCIFAEMLGRRQLFPG-KNYVHQLKLILSVLGSPSEE 234

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 77.9 bits (190), Expect = 2e-15
 Identities = 32/105 (30%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 262 PKNGAPFTAIREASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-- 317
            K+      +RE  +L  L H  NIV L+D      +L  V EYV    L   +++    
Sbjct: 36  SKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK 95

Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           G L        + Q+L  L Y H + I+HRD+KP+N+L+      
Sbjct: 96  GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRV 140

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 29/89 (32%), Positives = 52/89 (58%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++E  LLK LKH NIV     + T  +L  + EY     L Q +++  G      + +++
Sbjct: 47  MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYV 105

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +Q+L+GL+Y H + ++HRD+K  N+L ++
Sbjct: 106 YQVLQGLAYLHEQGVIHRDIKAANILTTK 134

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 31/82 (37%), Positives = 51/82 (62%), Gaps = 8/82 (9%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE--------VYDQLDK 181
           +T WYR P++LLG+  Y+ ++D+W +GCI  E++T  P F   +E         +DQLD+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236

Query: 182 IFKILGTPTEETWEGVSLLPGY 203
           IF ++G P ++ WE +  +P Y
Sbjct: 237 IFSVMGFPADKDWEDIRKMPEY 258

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.5 bits (185), Expect = 5e-15
 Identities = 30/83 (36%), Positives = 52/83 (62%), Gaps = 8/83 (9%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE--------VYDQLDK 181
           +T WYR P++LLG+  Y+ ++D+W +GCI  E++T  P F   +E         +DQLD+
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236

Query: 182 IFKILGTPTEETWEGVSLLPGYN 204
           IF ++G P ++ WE +  +P ++
Sbjct: 237 IFNVMGFPADKDWEDIKKMPEHS 259

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 29/58 (50%), Positives = 41/58 (70%), Gaps = 1/58 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGT 188
           T WYR P++L+G T+Y  ++D+W VGC++ EM+TG P FPG  ++ DQL  I K LG 
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGN 219

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++K+L H NIV L  +      L  V EY+   DL  ++ +H   L   ++    
Sbjct: 49  LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMA 108

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+ +G+ Y   +  +HRD+  +N L++E
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTE 137

Length = 258

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 36/92 (39%), Positives = 54/92 (58%), Gaps = 7/92 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L+  KH NI+ + DI+   S  +F     V E + TDL + ++      DH  
Sbjct: 50  TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH-- 107

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           I+ F++Q+LRGL Y H   +LHRD+KP NLL+
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 139

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           +REA ++++L H N+V L  +      L  V EY+   DL  Y+ ++   L   ++  F 
Sbjct: 49  LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA 108

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+ RG+ Y   +  +HRD+  +N L+ E
Sbjct: 109 LQIARGMEYLESKNFIHRDLAARNCLVGE 137

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.8 bits (177), Expect = 6e-14
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 3/91 (3%)

Query: 270 AIRE-ASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
              E   L +   H  I+ L+        L FV EY  + +L QY+ R  G LD    R 
Sbjct: 48  VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRF 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++L  L Y H + I+HRD+KP+N+L+ +
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDK 137

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 32/45 (71%), Positives = 38/45 (84%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           FGK + Y+KLD+LGEG+YATVFKG S LT  +VALKEIRL+ EEG
Sbjct: 1   FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG 45

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 71.9 bits (176), Expect = 9e-14
 Identities = 30/63 (47%), Positives = 44/63 (69%), Gaps = 1/63 (1%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG P F G  +  DQL +I K+ GTP
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG-HDHLDQLMEIMKVTGTP 235

Query: 190 TEE 192
           ++E
Sbjct: 236 SKE 238

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 32/45 (71%), Positives = 39/45 (86%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           FGK + YIKLD+LGEG+YATV+KG S LT+ +VALKEIRL+ EEG
Sbjct: 2   FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG 46

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 27/40 (67%), Positives = 31/40 (77%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
           G P TAIRE SL+KELKH NIV LHD++HT + L  VFEY
Sbjct: 40  GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL-F 328
           +REA ++++L H NIV L  +      L  V EY+   DL  Y+ ++       +  L F
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+ RG+ Y   +  +HRD+  +N L+ E
Sbjct: 109 ALQIARGMEYLESKNFIHRDLAARNCLVGE 138

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 33/69 (47%), Positives = 46/69 (66%), Gaps = 4/69 (5%)

Query: 131 TLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGT 188
           T WYR P+ L GS  ++Y+ ++D+W +GCI  E++TG P FPG + V  QLD I  +LGT
Sbjct: 169 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KNVVHQLDLITDLLGT 226

Query: 189 PTEETWEGV 197
           P+ ET   V
Sbjct: 227 PSPETISRV 235

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 33/41 (80%), Positives = 35/41 (85%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G PFTAIREASLLK LKH NIV LHDI+HT+ TLT VFEYV
Sbjct: 45  GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 31/41 (75%), Positives = 35/41 (85%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+
Sbjct: 46  GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 32/45 (71%), Positives = 38/45 (84%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           FGK + YIKL++LGEG+YATVFKG S LT  +VALKEIRL+ EEG
Sbjct: 2   FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG 46

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 20/99 (20%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI---- 325
             RE  +L   KH+N+++  DI+       F   YV T+L Q         D H I    
Sbjct: 46  VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS--------DLHKIIVSP 97

Query: 326 --------RLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                   ++F++Q+LRGL Y H   ILHRD+KP NLL+
Sbjct: 98  QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 69.1 bits (170), Expect = 3e-13
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 4/99 (4%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRL 327
             + E ++L  + H  IV LH    T   L  V EY    +L  ++ +  G       R 
Sbjct: 39  HTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARF 97

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  +++  L Y H   I++RD+KP+N+L+   D H I+L
Sbjct: 98  YAAEIVLALEYLHSLGIIYRDLKPENILLDA-DGH-IKL 134

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 31/41 (75%), Positives = 33/41 (80%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAP TAIRE SLLK LKH NIVTLHDI+HT   LT VFEY+
Sbjct: 45  GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 69/225 (30%), Positives = 94/225 (41%), Gaps = 73/225 (32%)

Query: 33  VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI 92
           VL R+ KP    + VF+N   T    LK+ DFGLAR   V  H YSH             
Sbjct: 135 VLHRDLKP----ANVFIN---TEDLVLKIGDFGLARI--VDPH-YSH------------- 171

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
                         KGY  L+  +V             T WYR P +LL    Y+ ++DM
Sbjct: 172 --------------KGY--LSEGLV-------------TKWYRSPRLLLSPNNYTKAIDM 202

Query: 153 WGVGCILIEMVTGLPTFPGVREVYDQLDKIFK-ILGTPTEETWEGVSLLPGYNVHRDAPY 211
           W  GCI  EM+TG P F G  E+ +Q+  I + +     E+  E ++++P   V  D   
Sbjct: 203 WAAGCIFAEMLTGKPLFAGAHEL-EQMQLILESVPVVREEDRNELLNVIP-SFVRNDGGE 260

Query: 212 TGNKLGLTFPR--LYDI-PEGESMASAFLQVRDAAIL--NPMEHV 251
                    PR  L D+ P     A  FL+     IL  NPM+ +
Sbjct: 261 ---------PRRPLRDLLPGVNPEALDFLE----QILTFNPMDRL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 32/41 (78%), Positives = 35/41 (85%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAP TAIRE SLLK+LKH NIVTLHDIVHT  +LT VFEY+
Sbjct: 46  GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 69.6 bits (171), Expect = 5e-13
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 8/93 (8%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHHNI 325
           RE  LLK + H N++ L D+    S+L        V   +  DL+  ++      DH  I
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDH--I 120

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++Q+LRGL Y H   I+HRD+KP N+ ++E
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 153

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 28/92 (30%), Positives = 50/92 (54%), Gaps = 1/92 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G  FT +RE  ++ E+KH NI+ L D+      +  V + + +DL + ++R    L    
Sbjct: 62  GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI-RLTESQ 120

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           ++  + Q+L GL+  H+   +HRD+ P N+ I
Sbjct: 121 VKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152

Length = 335

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 27/57 (47%), Positives = 39/57 (68%), Gaps = 1/57 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILG 187
           T WYR P++L+G T+Y   +D+W +GC+  E++TG P +PG  +V DQL  I K LG
Sbjct: 163 TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV-DQLYLIRKTLG 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 32/85 (37%), Positives = 46/85 (54%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE +LLKEL+H NIV           L    EYV       +  + G  +   +R F+ Q
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLI 356
           +L+GL+Y H R I+HRD+K  N+L+
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILV 139

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 32/45 (71%), Positives = 39/45 (86%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           FGKAD+Y KL++LGEGSYATV+KG S +  ++VALK IRLQEEEG
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG 45

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 45/128 (35%), Positives = 68/128 (53%), Gaps = 20/128 (15%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME---RHSGGL 320
           RE  ++K L H NI+ L D  +T           L  V E++   + +YM+   R++  L
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL 167

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLL---R 373
               ++L+ +QL R L+Y H + I HRD+KPQNLLI + + H ++L  F     LL   R
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI-DPNTHTLKLCDFGSAKNLLAGQR 226

Query: 374 GLSY-CHR 380
            +SY C R
Sbjct: 227 SVSYICSR 234

Length = 440

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 66.4 bits (163), Expect = 4e-12
 Identities = 26/41 (63%), Positives = 29/41 (70%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TA+RE SLLKELKH NIV L D++HT   L  VFEY 
Sbjct: 40  GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 272 REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
            E  +L+ LKH N+V  + + VH R  +    EY      + +  H   LD H IR++  
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTL 106

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           QLL GL+Y H   I+HRD+KP N+    +DH+ +
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIF---LDHNGV 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G ++  DQL +I K+ G P
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVP 234

Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNK-LGLTFPR 222
             E  + +      +  +  P    K     FP+
Sbjct: 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPK 268

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 42/109 (38%), Positives = 61/109 (55%), Gaps = 9/109 (8%)

Query: 272 REASLLKELK-HNNIVTLHDIVHTRST--LTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           RE   L+EL  H NIV L +++   +   +  VFEY+ TDL   + R +   D H  R  
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVI-RANILEDVH-KRYI 112

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQLLRGLS 376
           M+QLL+ L Y H   ++HRD+KP N+L+ S+     ++L  F L R LS
Sbjct: 113 MYQLLKALKYIHSGNVIHRDLKPSNILLNSDC---RVKLADFGLARSLS 158

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 25/41 (60%), Positives = 30/41 (73%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D+VH+ + L  VFE++
Sbjct: 40  GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 66.2 bits (161), Expect = 7e-12
 Identities = 29/81 (35%), Positives = 46/81 (56%), Gaps = 1/81 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 238

Query: 191 EETWEGVSLLPGYNVHRDAPY 211
            E  + +S     N  +    
Sbjct: 239 AELLKKISSESARNYIQSLTQ 259

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 33/90 (36%), Positives = 52/90 (57%), Gaps = 6/90 (6%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  LL+ L+H +IV +  I+   S   F     VFE + +DL Q ++ +      H+ 
Sbjct: 47  LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHH- 105

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
           + F++QLLR L Y H   + HRD+KP+N+L
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNIL 135

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 34/95 (35%), Positives = 52/95 (54%), Gaps = 8/95 (8%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK +KH N++ L D+     +L        V  ++ TDL + M+     L   
Sbjct: 61  AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK--LSED 118

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            I+  ++Q+L+GL Y H   I+HRD+KP NL ++E
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE +LLK ++H N++ L D+  +  +         V  Y+ TDL + M      L   
Sbjct: 61  AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP---LSED 117

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            ++  ++Q+L GL Y H   I+HRD+KP NL ++E
Sbjct: 118 KVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNE 152

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 27/68 (39%), Positives = 45/68 (66%), Gaps = 1/68 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++ G   FPG  +  DQL +I +++GTP+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG-NDYIDQLKRIMEVVGTPS 236

Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 237 PEVLKKIS 244

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 31/98 (31%), Positives = 54/98 (55%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G   T + EA LL+ + H +++ + D + + +    V  +  +DL  Y+ + S  L  
Sbjct: 97  KIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPI 156

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
               +   Q+L GL Y H +RI+HRDVK +N+ I+++D
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD 194

Length = 357

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 33/63 (52%), Positives = 42/63 (66%), Gaps = 3/63 (4%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGT-P 189
           T WYR P++LLG+  Y  ++DMW VGCIL E+  G P FPG  E+ DQL  I K+LG  P
Sbjct: 164 TRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEI-DQLFTIQKVLGPLP 221

Query: 190 TEE 192
            E+
Sbjct: 222 AEQ 224

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 29/86 (33%), Positives = 45/86 (52%), Gaps = 2/86 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           +E +LL +L+H NIV           L    E V    L++ ++++ G      IRL+  
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTR 109

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L GL Y H R  +HRD+K  N+L+
Sbjct: 110 QILLGLEYLHDRNTVHRDIKGANILV 135

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 63.7 bits (156), Expect = 3e-11
 Identities = 23/42 (54%), Positives = 30/42 (71%), Gaps = 1/42 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGIT 131
           Y KL++LGEG+Y  V+K     T ++VALK+IRL  EEEGI 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP 42

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 35/126 (27%), Positives = 63/126 (50%), Gaps = 19/126 (15%)

Query: 250 HVHNCEKEGGNGPKN---------GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTL 298
           HV+  +++ G   ++         G   +A RE +LL+ELKH N+++L  +   H    +
Sbjct: 16  HVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKV 75

Query: 299 TFVFEYVHTDLSQYMERHSGG--------LDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 350
             +F+Y   DL   ++ H           L    ++  ++Q+L G+ Y H   +LHRD+K
Sbjct: 76  WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 135

Query: 351 PQNLLI 356
           P N+L+
Sbjct: 136 PANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 24/40 (60%), Positives = 30/40 (75%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
           G P +A+RE  LLKELKH NIV L+D++H+   LT VFEY
Sbjct: 41  GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.9 bits (153), Expect = 5e-11
 Identities = 25/41 (60%), Positives = 30/41 (73%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 41  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 36/126 (28%), Positives = 62/126 (49%), Gaps = 19/126 (15%)

Query: 250 HVHNCEKEGGNGPK---------NGAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTL 298
           HV+  +++ G   K          G   +A RE +LL+ELKH N++ L  +   H+   +
Sbjct: 16  HVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75

Query: 299 TFVFEYVHTDLSQYMERHSGG--------LDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 350
             +F+Y   DL   ++ H           L    ++  ++Q+L G+ Y H   +LHRD+K
Sbjct: 76  WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLK 135

Query: 351 PQNLLI 356
           P N+L+
Sbjct: 136 PANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 64.0 bits (156), Expect = 5e-11
 Identities = 29/63 (46%), Positives = 43/63 (68%), Gaps = 2/63 (3%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG  +  DQ +KI + LGTP
Sbjct: 179 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPG-TDHIDQWNKIIEQLGTP 236

Query: 190 TEE 192
           ++E
Sbjct: 237 SDE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 26/66 (39%), Positives = 42/66 (63%), Gaps = 1/66 (1%)

Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           +E +T +YR P++L+GS  Y++++D+W VGCI  E++     F     +  QLD I  +L
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLL 221

Query: 187 GTPTEE 192
           GTP+ E
Sbjct: 222 GTPSLE 227

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 4/109 (3%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRL 327
           AI EA +L +L  + I+  ++    +  L  V EY    DL + ++   G  L    +  
Sbjct: 46  AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR 105

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           F  Q+L GL++ H ++ILHRD+K  NL +   D  N+++    + + LS
Sbjct: 106 FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD--NVKIGDLGVAKLLS 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 237

Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 268

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 2/118 (1%)

Query: 124 LQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF 183
           +     +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG  +  DQ +K+ 
Sbjct: 181 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPG-TDHIDQWNKVI 238

Query: 184 KILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + LGTP  E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 7/91 (7%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I E  ++K+ KH NIV  +D       L  V EY+     TD+   + ++   ++   I 
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDI---ITQNFVRMNEPQIA 119

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               ++L+GL Y H + ++HRD+K  N+L+S
Sbjct: 120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 22/39 (56%), Positives = 31/39 (79%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           + +L++LGEG+YATV+KG +  T ++VALKEI L  EEG
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG 40

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 25/97 (25%), Positives = 44/97 (45%), Gaps = 9/97 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIR--- 326
           ++EA ++K+L H N+V L  +      L  V EY+   DL  Y+ +              
Sbjct: 44  LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103

Query: 327 -----LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                 F  Q+ +G+ Y   ++ +HRD+  +N L+ E
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE 140

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           I E  +LK+ KH NIV  +     +  L  V E+     L   ++  +  L    I    
Sbjct: 45  INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +LL+GL Y H   I+HRD+K  N+L++ 
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTS 133

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 34/88 (38%), Positives = 44/88 (50%), Gaps = 1/88 (1%)

Query: 270 AIR-EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           A+R E   LK+L H NIV       T   L+   EYV         R  G  +   +R F
Sbjct: 54  ALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF 113

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+L GL+Y H + ILHRD+K  NLL+
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLV 141

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 30/88 (34%), Positives = 40/88 (45%), Gaps = 10/88 (11%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-----VHTDLSQYMERHSGGLDHHNIRL 327
           E  LLK L+H  IV  +  +    TL+   EY     V   L  Y     G L     R 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-----GALTETVTRK 108

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLL 355
           +  Q+L G+ Y H   I+HRD+K  N+L
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANIL 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 60.0 bits (145), Expect = 6e-10
 Identities = 26/46 (56%), Positives = 36/46 (78%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           FG A +Y+ L++LGEGSYATV+KG S +  Q+VALK I ++ EEG+
Sbjct: 1   FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV 46

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 25/41 (60%), Positives = 30/41 (73%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKE++H NIV L D+VH+   L  VFEY+
Sbjct: 43  GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83

Length = 294

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 10/94 (10%)

Query: 270 AIREASLLKELK-HNNIVTLHD--IVHTRSTLTFVFEY---VHTDLSQYMERHSGG-LDH 322
           A+RE  LL+  + H NI  L+D  IV        ++ Y   +  DL Q +   SG  L  
Sbjct: 48  ALRELKLLRHFRGHKNITCLYDMDIV-FPGNFNELYLYEELMEADLHQII--RSGQPLTD 104

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            + + F++Q+L GL Y H   +LHRD+KP NLL+
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 6e-10
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 3/98 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L E KH NIV L++     + L  + E+     L   M     GL    IR    Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           +L  L++ H  +++HRD+K  N+L++     +++L  F
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTL--DGDVKLADF 147

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 12/109 (11%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-------TDLSQYMERHSGGLDHHN 324
           RE  LLK +KH N++ L D V T +T    F  V+        DL+  ++      +H  
Sbjct: 63  RELRLLKHMKHENVIGLLD-VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH-- 119

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           ++  ++QLLRGL Y H   I+HRD+KP N+ ++E     +R+  F L R
Sbjct: 120 VQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 4/106 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           EA ++++  H +IV L  ++ T + +  V E     +L  Y++ +   LD  ++ L+ +Q
Sbjct: 57  EAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           L   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R L  
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLED 159

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 16/91 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI--RLFM 329
           RE  +L+++ H N+V  HD+      +  + E+        M+   G L+  +I    F+
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF--------MDG--GSLEGTHIADEQFL 170

Query: 330 ----FQLLRGLSYCHRRRILHRDVKPQNLLI 356
                Q+L G++Y HRR I+HRD+KP NLLI
Sbjct: 171 ADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201

Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 27/63 (42%), Positives = 41/63 (65%), Gaps = 2/63 (3%)

Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ E+V G   F G   + DQ +K+ + LGTP
Sbjct: 184 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTP 241

Query: 190 TEE 192
           + E
Sbjct: 242 SAE 244

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 58.4 bits (142), Expect = 1e-09
 Identities = 29/98 (29%), Positives = 46/98 (46%), Gaps = 1/98 (1%)

Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-VHTDLSQYMERHSGGL 320
           P        I+E S+LK+     IV  +      + L  V EY     +S  M+  +  L
Sbjct: 37  PVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL 96

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
               I   ++Q L+GL Y H  + +HRD+K  N+L++E
Sbjct: 97  TEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 27/90 (30%), Positives = 46/90 (51%), Gaps = 7/90 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD---LSQYMERHSGGLDHHNIRLF 328
           RE   L+  +   +V  +   +    ++ V EY+  D   L+  +++  G +    +   
Sbjct: 48  RELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM--DGGSLADLLKKV-GKIPEPVLAYI 104

Query: 329 MFQLLRGLSYCHR-RRILHRDVKPQNLLIS 357
             Q+L+GL Y H  R I+HRD+KP NLLI+
Sbjct: 105 ARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 25/62 (40%), Positives = 37/62 (59%), Gaps = 1/62 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T +YR P+++L   +Y   +D+W  GCI  EM+ G P FPG   V +Q   I  +LGTP 
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV-NQFSIITDLLGTPP 226

Query: 191 EE 192
           ++
Sbjct: 227 DD 228

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)

Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 53  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 112

Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 113 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 155

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 33/89 (37%), Positives = 46/89 (51%), Gaps = 2/89 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGL-DHHNIRLFM 329
           +E  LL ++KH NIVT          L  V EY    DL + + R  G L     I  + 
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF 107

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+  GL + H R+ILHRD+K QN+ +S+
Sbjct: 108 VQISLGLKHIHDRKILHRDIKSQNIFLSK 136

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 57.3 bits (139), Expect = 4e-09
 Identities = 33/106 (31%), Positives = 54/106 (50%), Gaps = 8/106 (7%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L + +   +V L+     +  L  V EY+   DL+  +E + G LD    R+++ +
Sbjct: 43  ERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAE 101

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           ++  L Y H   I+HRD+KP N+LI    H  ++L  F    GLS 
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDF----GLSK 141

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 17/39 (43%), Positives = 26/39 (66%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           Y K  +LGEG+YA V+K     T ++VA+K+I+L E + 
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE 40

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 23/41 (56%), Positives = 29/41 (70%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL+H NIV L D++   S L  +FE++
Sbjct: 41  GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 58.0 bits (140), Expect = 5e-09
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 2/96 (2%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLT-FVFEYVHTDLSQYMERHSGGLD 321
           K G   +++ EA LL+ L H  ++ L D V     LT  V     +DL  Y+      L 
Sbjct: 200 KAGWYASSVHEARLLRRLSHPAVLALLD-VRVVGGLTCLVLPKYRSDLYTYLGARLRPLG 258

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
              +     QLL  + Y H   I+HRD+K +N+L++
Sbjct: 259 LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN 294

Length = 461

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 24/155 (15%)

Query: 219 TFPRLY---DIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREAS 275
           TF R++   D       A   + + +   L   +HVHN                   E  
Sbjct: 13  TFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN-------------------EKR 53

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQLLR 334
           +LKE+ H  I+ L    H +  L  + EYV   +L  Y+ R+SG   +     +  +++ 
Sbjct: 54  VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVC 112

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            L Y H + I++RD+KP+N+L+ +  H  +  F F
Sbjct: 113 ALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGF 147

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.9 bits (140), Expect = 9e-09
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 1/90 (1%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           RE +L   L H NIV L D       L F VFEYV     + +    G L        M 
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLML 86

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           Q+L  L+  H + I+HRD+KPQN+++S+  
Sbjct: 87  QVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 6/92 (6%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG----LDHHNI 325
           ++E  LLK+L H N++         + L  V E     DLS+ M +H       +    I
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTI 108

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             +  QL   L + H +RI+HRD+KP N+ I+
Sbjct: 109 WKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 18/135 (13%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS------------- 317
           +EA L+ +L+H NIV L  +         +FEY+ H DL +++ R+S             
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 318 --GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
               LD  +      Q+  G+ Y      +HRD+  +N L+ E     +++  F L R +
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE--GLTVKISDFGLSRDI 174

Query: 376 SYCHRRRILHRDVKP 390
                 R+  + + P
Sbjct: 175 YSADYYRVQSKSLLP 189

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 21/41 (51%), Positives = 33/41 (80%), Gaps = 1/41 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ-EEEGI 130
           Y K++++GEG+Y  V+KG +  T Q+VA+K+IRL+ EEEG+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGV 42

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 3/88 (3%)

Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  V EY+ +  L  Y+++H   LDH  + L+
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILV 141

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 32/99 (32%), Positives = 42/99 (42%), Gaps = 10/99 (10%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-----VHTDLSQYMERHSGGLDHH 323
              +E  L+  L H +I+ +       S      E+     V   LS+Y     G     
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-----GAFKEA 103

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
            I  +  QLLRGLSY H  +I+HRDVK  NLLI      
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR 142

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 20/41 (48%), Positives = 31/41 (75%), Gaps = 1/41 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           Y K++++GEG+Y  V+K    LT ++VALK+IRL  E+EG+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGV 41

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHE 119

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQ---YMERHSGGLDHHNIR 326
           ++E  LLK+L H N++   D     + L  V E     DLSQ   Y ++    +    + 
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +  QL   + + H RR++HRD+KP N+ I+
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 34/110 (30%), Positives = 57/110 (51%), Gaps = 4/110 (3%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRL 327
            + +EA LL ++KH NIV   +       L  V EY    DL Q ++   G L   +  L
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103

Query: 328 FMF-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             F Q+  G+ + H +R+LHRD+K +N+ +++  +  ++L  F   R L+
Sbjct: 104 QWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ--NGKVKLGDFGSARLLT 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 7/109 (6%)

Query: 272 REASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLF 328
           RE  +L+ L H NIV    +       +L  + EY+ +  L  Y++RH   ++   + LF
Sbjct: 55  REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDH-HNIRLFMFQLLRGLS 376
             Q+ +G+ Y   +R +HRD+  +N+L   ++    +++  F L + L 
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLP 160

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 17/40 (42%), Positives = 27/40 (67%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           Y KL ++GEG+Y  V+K    LT ++VA+K+I+L+ E   
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG 40

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 2/92 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           + E  +L+EL H  +V L         +  V + +   DL +Y            ++ ++
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWI 106

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
            +++  L Y H + I+HRD+KP N+L+ E  H
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGH 138

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 53.2 bits (128), Expect = 6e-08
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 4/92 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGG---LDHHNI 325
           A+ E  +L  + H NI++  +     + L  V EY    DLS+ + +       +    I
Sbjct: 46  AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI 105

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                QLLRGL   H ++ILHRD+K  N+L+ 
Sbjct: 106 WRIFIQLLRGLQALHEQKILHRDLKSANILLV 137

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 54.0 bits (130), Expect = 7e-08
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTL-TF-----VFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L  F     V E +  +L Q ++     LDH 
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHE 118

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 151

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK + H NI++L ++   + +L        V E +  +L Q +      LDH 
Sbjct: 67  AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHE 123

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 156

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 27/91 (29%), Positives = 46/91 (50%), Gaps = 4/91 (4%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQ---YMERHSGGLDHHNIR 326
           I+E  LLK+L H N++  +      + L  V E     DLS+   + ++    +    + 
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW 109

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +  QL   L + H RR++HRD+KP N+ I+
Sbjct: 110 KYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 52.5 bits (127), Expect = 1e-07
 Identities = 21/42 (50%), Positives = 28/42 (66%), Gaps = 2/42 (4%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEY 475
           G P TAIRE  LL++L+H NIV L +IV    + ++  VFEY
Sbjct: 40  GFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 21/43 (48%), Positives = 33/43 (76%), Gaps = 1/43 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           D Y K++++GEG+Y  V+K    +TN+ +ALK+IRL QE+EG+
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGV 44

Length = 294

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 23/50 (46%), Positives = 28/50 (56%), Gaps = 2/50 (4%)

Query: 426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
           I L F     G P TA+RE  LLKEL H NI+ L D+   +  L  VFE+
Sbjct: 32  IKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 52.1 bits (126), Expect = 2e-07
 Identities = 16/37 (43%), Positives = 21/37 (56%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
             +RE  +LK+LKH NIV L+D+      L  V EY 
Sbjct: 43  RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYC 79

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 34/98 (34%), Positives = 52/98 (53%), Gaps = 13/98 (13%)

Query: 273 EASLLKELKHNNIVTLHD--IVHTRSTLTFVFEYVHT-DLSQYMER---HSGGLDHHNIR 326
           E ++++ELKH NIV   D  +      L  + E+    DLS+ +++     G ++ H I 
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 327 LFMFQLLRGLSYCHR-------RRILHRDVKPQNLLIS 357
               QLL  L+YCH         R+LHRD+KPQN+ +S
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159

Length = 1021

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 39/116 (33%), Positives = 54/116 (46%), Gaps = 21/116 (18%)

Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 304
           LNP E V                  A +EA LL +L H  IV  H     R     + EY
Sbjct: 41  LNPNETVQ-----------------ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83

Query: 305 VH-TDLSQYME--RHSGG-LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
               DL   +E  +H+G  L  + +  +  QLL G+ Y H+RRILHRD+K +N+ +
Sbjct: 84  CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 1/87 (1%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE  +LK + H  I+ L      +ST+  V      DL  Y++R SG L          +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRR 193

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISE 358
           LL  L+Y H R I+HRDVK +N+ + E
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDE 220

Length = 392

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 2/90 (2%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYME-RHSGGLDHHNIR 326
            A  E  +LK L H NI+  ++       L  V EY     L++Y++ R +  LD   I 
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            F  Q+L  L + H + ILHRD+K QN+L+
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   RS +  VFE++ H  LS Y+    G      +    
Sbjct: 47  IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVGE 135

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 30/91 (32%), Positives = 42/91 (46%), Gaps = 7/91 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIRL 327
           +E S+LKE +H NIV        R  L  V EY       D+ Q        L    I  
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAY 105

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              + L+GL+Y H    +HRD+K  N+L++E
Sbjct: 106 VCRETLKGLAYLHETGKIHRDIKGANILLTE 136

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 27/88 (30%), Positives = 40/88 (45%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++L+H N +          T   V EY     S  +E H   L    I     
Sbjct: 63  IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH 122

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H    +HRD+K  N+L++E
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 29/88 (32%), Positives = 41/88 (46%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++L+H N +          T   V EY     S  +E H   L    I     
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRDVK  N+L+SE
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 4/107 (3%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGL-DHHNIRLFM 329
           +E ++L  +KH NIV   +       L  V +Y    DL + +    G L     I  + 
Sbjct: 48  KEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            Q+   L + H R+ILHRD+K QN+ +++     I+L  F + R L+
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTK--DGTIKLGDFGIARVLN 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 23/90 (25%), Positives = 44/90 (48%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           +RE  +L +     IV  +   +    ++   EY+    L + ++   G +    +    
Sbjct: 47  LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA 106

Query: 330 FQLLRGLSYCHR-RRILHRDVKPQNLLISE 358
             +L+GL+Y H   +I+HRDVKP N+L++ 
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 37/135 (27%), Positives = 57/135 (42%), Gaps = 21/135 (15%)

Query: 224 YDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIR-EASLLKELKH 282
           YD+  G  +A+  +Q       +P              P+     +A+  E  LLK L+H
Sbjct: 22  YDVDTGRELAAKQVQ------FDP------------ESPETSKEVSALECEIQLLKNLQH 63

Query: 283 NNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
             IV  +  +      TLT   EY+     +   +  G L     R +  Q+L G+SY H
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123

Query: 341 RRRILHRDVKPQNLL 355
              I+HRD+K  N+L
Sbjct: 124 SNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 51.0 bits (123), Expect = 5e-07
 Identities = 19/40 (47%), Positives = 29/40 (72%), Gaps = 1/40 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEG 129
           Y K+ Q+GEG+Y  V+K  +  T ++VALK+IR+  E+EG
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEG 40

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 51.0 bits (123), Expect = 5e-07
 Identities = 19/37 (51%), Positives = 26/37 (70%)

Query: 439 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
           FTA+RE  LL+ELKH NI+ L D+   +S +  VFE+
Sbjct: 47  FTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 26/90 (28%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 284 NIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
            +  L+    ++  L  V EY++      + +  GGL     + ++ +++ G+   H+R 
Sbjct: 58  YVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117

Query: 344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           I+HRD+KP+NLLI +  H  ++L  F L R
Sbjct: 118 IIHRDIKPENLLIDQTGH--LKLTDFGLSR 145

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 9/109 (8%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER-HSGGLDH---HNIR 326
           ++EA+++  L H N++ L+ +V T   L  V E     L   ++R     L H     + 
Sbjct: 44  LKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAP--LGSLLDRLRKDALGHFLISTLC 100

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            +  Q+  G+ Y   +R +HRD+  +N+L++  D   +++  F L+R L
Sbjct: 101 DYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 28/88 (31%), Positives = 41/88 (46%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++LKH N +          T   V EY     S  +E H   L    I     
Sbjct: 69  IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 128

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRD+K  N+L++E
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109

Query: 330 -FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 152

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 24/94 (25%), Positives = 48/94 (51%), Gaps = 10/94 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL-- 327
           ++EA ++K+L+H+ +V L+ +      +  V EY+    L  +++   G      +RL  
Sbjct: 49  LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG----KKLRLPQ 104

Query: 328 ---FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                 Q+  G++Y   R  +HRD+  +N+L+ E
Sbjct: 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE 138

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-VHTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H N+V L+ +   +  +  V EY  +  L  Y+    G L    +    
Sbjct: 47  IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMC 106

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +   + Y      +HRD+  +N L+ E
Sbjct: 107 SDVCEAMEYLESNGFIHRDLAARNCLVGE 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 50.1 bits (120), Expect = 9e-07
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 14/99 (14%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS------GGLDHHN 324
           REA LL   +H NIV  + +         VFEY+ H DL++++  H          D   
Sbjct: 57  REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 325 IRLFMFQLLR-------GLSYCHRRRILHRDVKPQNLLI 356
             L + QLL+       G+ Y   +  +HRD+  +N L+
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 29/99 (29%), Positives = 53/99 (53%), Gaps = 4/99 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERH-SGGLDHHNIRL 327
           A+ E  +L+++    IV+L     T+  L  V   ++  DL  ++      G        
Sbjct: 40  ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF 99

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  Q++ GL + H+RRI++RD+KP+N+L+   DH N+R+
Sbjct: 100 YAAQIICGLEHLHQRRIVYRDLKPENVLLD--DHGNVRI 136

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 20/41 (48%), Positives = 32/41 (78%), Gaps = 1/41 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE-EGI 130
           Y KL+++GEG+Y TVFK  +  T+++VALK +RL ++ EG+
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV 42

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 13/40 (32%), Positives = 24/40 (60%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           Y  L++LGEGS+  V+      T ++VA+K I+ ++ +  
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD 40

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 33/114 (28%), Positives = 59/114 (51%), Gaps = 8/114 (7%)

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-VHTDLSQYME 314
           K+G   P     F A  EA+L+K+L+H  +V L+ +V T+  +  + EY  +  L  +++
Sbjct: 39  KQGSMSP---EAFLA--EANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLK 92

Query: 315 RHSGGLDHHNIRLFM-FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              G     N  + M  Q+  G+++  R+  +HRD++  N+L+SE     I  F
Sbjct: 93  TPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADF 146

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 25/94 (26%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 271 IREASLLKELKHNNIVTLHD--IVHTRSTLTFVFEYVHT----DLSQYMERHSGGLDHHN 324
           +RE  + K  K   IV  +   +  + S++    EY        + + +++  G +    
Sbjct: 47  LRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      +L+GLSY H R+I+HRD+KP N+L++ 
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 17/27 (62%), Positives = 22/27 (81%)

Query: 369 FQLLRGLSYCHRRRILHRDVKPQNLLI 395
            Q+L G++Y HRR I+HRD+KP NLLI
Sbjct: 175 RQILSGIAYLHRRHIVHRDIKPSNLLI 201

Length = 353

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 19/53 (35%), Positives = 32/53 (60%), Gaps = 3/53 (5%)

Query: 345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           +++ VK +   I E     +      +L+GLSY H R+I+HRD+KP N+L++ 
Sbjct: 91  IYKKVKKRGGRIGE---KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  LLK LKH NIV         +T++   E+V    +S  + R  G L       +  Q
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQ 110

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLI 356
           +L G++Y H   ++HRD+K  N+++
Sbjct: 111 ILDGVAYLHNNCVVHRDIKGNNVML 135

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 3/106 (2%)

Query: 265 GAPFTAIR-EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHH 323
           G  F+ I+ E  ++KE KH NIV       +R  L    EY      Q +   +G L   
Sbjct: 47  GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL 106

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            I     + L+GL+Y H +  +HRD+K  N+L++  D+ +++L  F
Sbjct: 107 QIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT--DNGDVKLADF 150

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 11/97 (11%)

Query: 273 EASLLKEL-KHNNIVTLHDI----VHT--RSTLTFVFEYVH----TDLSQYMERHSGGLD 321
           E ++L++   H NI T +              L  V E       TDL + + +    L 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              I   + + LRGL+Y H  +++HRD+K QN+L+++
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 3/92 (3%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS---GGLDHHNIR 326
             +E   + +  H N+V  +        L  V  Y+       + + S   GGLD   I 
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             + ++L+GL Y H    +HRD+K  N+L+ E
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGE 137

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 259 GNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHT-DLSQYMER 315
             G +N + +   +E ++LK L H NIV        +    L  + EYV    L  Y+ +
Sbjct: 44  ECGQQNTSGW--KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK 101

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           H   L    + LF  Q+  G++Y H +  +HRD+  +N+L+
Sbjct: 102 HKLNLAQ--LLLFAQQICEGMAYLHSQHYIHRDLAARNVLL 140

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 47.9 bits (115), Expect = 3e-06
 Identities = 19/55 (34%), Positives = 33/55 (60%), Gaps = 4/55 (7%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI 185
           T ++  P+V+ G  EY  + D+W +GC +IEM TG P +    E+ + +  ++KI
Sbjct: 166 TPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWS---ELGNPMAALYKI 216

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           E  LLK L+H+ IV  +  +       L+   EY+     +   +  G L  +  R +  
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLL 355
           Q+L+G+SY H   I+HRD+K  N+L
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 27/88 (30%), Positives = 40/88 (45%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L+ +KH N +          T   V EY     S  +E H   L    I     
Sbjct: 73  IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 132

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRD+K  N+L++E
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 48.3 bits (116), Expect = 4e-06
 Identities = 28/87 (32%), Positives = 46/87 (52%), Gaps = 2/87 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           + E  +L+ ++H  +V L+      S L  V EYV   +L  ++ R SG       R + 
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYA 107

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q++  L Y H   I++RD+KP+NLL+
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLL 134

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 4e-06
 Identities = 31/111 (27%), Positives = 41/111 (36%), Gaps = 20/111 (18%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           +KLADFGL +         +   D  +   D++  L +          K      N  V 
Sbjct: 140 IKLADFGLCKK-------MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF 169
                       T  Y  P+VL G T Y    D W +G IL EM+ G P F
Sbjct: 193 ------------TPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 9/92 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
            +E   L + +   I   +      S L  + EY       DL +      G LD   I 
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIA 101

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             + ++L GL Y H    +HRD+K  N+L+SE
Sbjct: 102 FILREVLLGLEYLHEEGKIHRDIKAANILLSE 133

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 2/87 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           LLK +KH  +V LH    T   L FV +Y++  +L  +++R    L+    R +  ++  
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 107

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
            L Y H   I++RD+KP+N+L+    H
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGH 134

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 27/94 (28%), Positives = 51/94 (54%), Gaps = 10/94 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL-- 327
           + EA+L+K L+H+ +V L+ +V     +  + EY+    L  +++   GG     + L  
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG----KVLLPK 104

Query: 328 ---FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              F  Q+  G++Y  R+  +HRD++  N+L+SE
Sbjct: 105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSE 138

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 28/87 (32%), Positives = 44/87 (50%), Gaps = 2/87 (2%)

Query: 285 IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI 344
           +V++     T+  L  V EYV       + ++ G L     R++  + +  L Y H   I
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122

Query: 345 LHRDVKPQNLLISEIDHHNIRLFMFQL 371
           +HRD+KP NLLI+ + H  I+L  F L
Sbjct: 123 VHRDLKPDNLLITSMGH--IKLTDFGL 147

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.7 bits (113), Expect = 7e-06
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 2/81 (2%)

Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++   L+Y H
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH 113

Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGH 134

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 25/53 (47%), Positives = 35/53 (66%), Gaps = 6/53 (11%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ-EEEGITLWYRPPDVL 140
           DAY KL+++GEG+Y  V+K     T ++VALK+ RL+ +EEGI     PP  L
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGI-----PPTAL 48

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 15/32 (46%), Positives = 19/32 (59%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEM 162
           T  Y  P+VLLG   YS   D+W +G IL E+
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 2/87 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           LLK LKH  +V LH    T   L FV +YV+  +L  +++R    L+    R +  ++  
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFYAAEVAS 107

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
            + Y H   I++RD+KP+N+L+    H
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGH 134

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 46.1 bits (110), Expect = 2e-05
 Identities = 16/37 (43%), Positives = 19/37 (51%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           TA RE  +L+ L H NIV L D    +  L  V EY 
Sbjct: 44  TARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYC 80

Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 1/42 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ-EEEG 129
           D +  + Q+GEG+Y  V+K     T ++VALK++RL  E+EG
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG 48

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 19/29 (65%), Positives = 22/29 (75%)

Query: 367 FMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +  QLLRGLSY H  +I+HRDVK  NLLI
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLI 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 23/98 (23%), Positives = 45/98 (45%), Gaps = 11/98 (11%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT---DLSQYME--RHSGGLDHHNI 325
           ++E+ LL  L H NI+ +  +        FV  Y +    +L  +++  R     +   +
Sbjct: 56  LQESCLLYGLSHQNILPILHVCIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 326 R-----LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                     Q+  G+SY H+R ++H+D+  +N +I E
Sbjct: 115 STQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDE 152

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.0 bits (110), Expect = 2e-05
 Identities = 19/76 (25%), Positives = 37/76 (48%), Gaps = 2/76 (2%)

Query: 281 KHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
            + N + L+  V T      + +Y+   DL   + +  G L    ++  + QL+  L+  
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-KKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 340 HRRRILHRDVKPQNLL 355
           H+  I+H D+K +N+L
Sbjct: 126 HKHNIIHNDIKLENVL 141

Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 27/87 (31%), Positives = 45/87 (51%), Gaps = 2/87 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           LLK +KH  +V LH    T   L FV ++V+  +L  +++R          R +  ++  
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS-FPEPRARFYAAEIAS 107

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
            L Y H   I++RD+KP+N+L+    H
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGH 134

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 24/81 (29%), Positives = 44/81 (54%), Gaps = 2/81 (2%)

Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L F+ + ++  DL  ++ +H G      +R +  +++ GL + H R 
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF 117

Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 118 VVYRDLKPANILLDEHGHVRI 138

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 4/97 (4%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           LLK +KH  +V LH    T   L FV +YV+  +L  +++R     +    R +  ++  
Sbjct: 49  LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRA-RFYAAEIAS 107

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
            L Y H   I++RD+KP+N+L+    H  + L  F L
Sbjct: 108 ALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 27/90 (30%), Positives = 48/90 (53%), Gaps = 2/90 (2%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGL-DHHNIRL 327
           A+ E  +L  L+H NI+  ++     +TL    EY +   L   + R  G L +   +  
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW 105

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           ++FQ++  +SY H+  ILHRD+K  N+ ++
Sbjct: 106 YLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 20/38 (52%), Positives = 28/38 (73%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + KL+++G+GS+  VFKG  N T QVVA+K I L+E E
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE 43

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 3/88 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHN--IRLFM 329
           E +L   LKH NIV                E V    LS  +    G L  +   I  + 
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            Q+L GL Y H  +I+HRD+K  N+L++
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 45.9 bits (107), Expect = 3e-05
 Identities = 26/63 (41%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 131 TLWYRPPDVLLGSTE--YSTSLDMWGVGCILIEMVTGLPTFPGVREV--YDQLDKIFKIL 186
           T  Y  P+VLLG +    S+S D+W +G  L E++TGLP F G +      Q  KI   L
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL 230

Query: 187 GTP 189
            TP
Sbjct: 231 PTP 233

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 44.8 bits (107), Expect = 3e-05
 Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 3/50 (6%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR--EVYDQ 178
           T  Y  P+VLLG   Y  ++D W +G +L EM+TG P F      E+Y++
Sbjct: 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEK 204

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 23/62 (37%), Positives = 33/62 (53%), Gaps = 5/62 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI---LG 187
           T+ +  P+VL G  +Y  S D+W VGC++IEM T  P +    +  + L  IFKI     
Sbjct: 171 TIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATT 228

Query: 188 TP 189
            P
Sbjct: 229 AP 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 23/79 (29%), Positives = 36/79 (45%), Gaps = 14/79 (17%)

Query: 313 MERHSGG-----------LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
           ME   GG           L   + R +M ++   +   H    +HRD+KP+N LI    H
Sbjct: 80  MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH 139

Query: 362 HNIRLFMFQLLRG-LSYCH 379
             I+L  F L +G ++Y +
Sbjct: 140 --IKLTDFGLSKGIVTYAN 156

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 19/127 (14%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMF 330
           REA+L+ E  H NIV L  +      +  +FEY+ + DL++++   S             
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQC-------- 108

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
            L    S         R      L +S  +   I     Q+  G++Y   R+ +HRD+  
Sbjct: 109 SLSHSTSSA-------RKCGLNPLPLSCTEQLCIAK---QVAAGMAYLSERKFVHRDLAT 158

Query: 391 QNLLISE 397
           +N L+ E
Sbjct: 159 RNCLVGE 165

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 36/122 (29%), Positives = 55/122 (45%), Gaps = 19/122 (15%)

Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYM---ER 315
           N P+    F   +EASL+ EL H NIV L  +V     +  +FEY++  DL +++     
Sbjct: 46  NNPQQWGEFQ--QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSP 103

Query: 316 HS-------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           HS               LDH +      Q+  G+ Y      +H+D+  +N+LI E  H 
Sbjct: 104 HSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV 163

Query: 363 NI 364
            I
Sbjct: 164 KI 165

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 23/91 (25%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRLF 328
           + EA+++K L+H+ +V LH +V T+  +  + E++    L  +++   G       +  F
Sbjct: 49  LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEI 359
             Q+  G+++  +R  +HRD++  N+L+S  
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSAS 138

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 16/42 (38%), Positives = 27/42 (64%), Gaps = 2/42 (4%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEY 475
           G   +A RE +LL+ELKH N+V+L ++   H   ++  +F+Y
Sbjct: 44  GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY 85

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 22/58 (37%), Positives = 30/58 (51%), Gaps = 6/58 (10%)

Query: 128 EGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI 185
           +G   W  P  V    T Y+   D+W +GC+++EM+TG   FP       QL  IFKI
Sbjct: 173 QGSVFWMAPEVV--KQTSYTRKADIWSLGCLVVEMLTGKHPFPDC----TQLQAIFKI 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 12/36 (33%), Positives = 24/36 (66%)

Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
             ++ ++ +++  L Y H + I+HRD+KP N+L+ E
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE 135

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 28/116 (24%), Positives = 54/116 (46%), Gaps = 8/116 (6%)

Query: 272 REASLLKELKHN---NIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRL 327
           RE +LL +L+ +   NI   +        L  + EY     +   M+  +G +    I +
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAEKYISV 105

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
            + ++L  L Y H+  ++HRD+K  N+L++     N++L  F +   L+    +R 
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTN--TGNVKLCDFGVAALLNQNSSKRS 159

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 4/100 (4%)

Query: 263 KNGAPFTA-IREASLLKELKHNNIVTLHD-IVHTRSTLTFVFEYVHT-DLSQYME-RHSG 318
           KN A   A + EAS++ +L+H+N+V L   IV  +  L  V EY+    L  Y+  R   
Sbjct: 38  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 97

Query: 319 GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            L    +  F   +   + Y      +HRD+  +N+L+SE
Sbjct: 98  VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSE 137

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 4/99 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++    ++   H G  G +      
Sbjct: 47  ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  ++  GL   H+ RI++RD+KP+N+L+   DH +IR+
Sbjct: 107 YAAEICCGLEDLHQERIVYRDLKPENILLD--DHGHIRI 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 17/38 (44%), Positives = 25/38 (65%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           +  L+ +G+GS+  V+K     TNQVVA+K I L+E E
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE 40

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 31/116 (26%), Positives = 58/116 (50%), Gaps = 5/116 (4%)

Query: 261 GPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG 319
           GPK    F  + EA ++  + H ++V L  +  +  T+  V + + H  L  Y+  H   
Sbjct: 49  GPKANVEF--MDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDN 105

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF-MFQLLRG 374
           +    +  +  Q+ +G+ Y   RR++HRD+  +N+L+   +H  I  F + +LL G
Sbjct: 106 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 29/133 (21%), Positives = 49/133 (36%), Gaps = 53/133 (39%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +KLADFG+A+                           Q+ E S+A  FKG         
Sbjct: 140 VVKLADFGMAK---------------------------QVVEFSFAKSFKG--------- 163

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        + ++  P+V+     Y  + D+W +GC ++EM TG P +       +
Sbjct: 164 -------------SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW----SQLE 206

Query: 178 QLDKIFKILGTPT 190
            +  +FKI  +  
Sbjct: 207 GVAAVFKIGRSKE 219

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 14/34 (41%), Positives = 23/34 (67%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           I   ++Q L+GL Y H  + +HRD+K  N+L++E
Sbjct: 101 IAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (105), Expect = 6e-05
 Identities = 16/44 (36%), Positives = 25/44 (56%)

Query: 354 LLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           L   ++D   I   + ++L GL Y H    +HRD+K  N+L+SE
Sbjct: 90  LKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.0 bits (106), Expect = 6e-05
 Identities = 30/111 (27%), Positives = 52/111 (46%), Gaps = 4/111 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L E  +  +V L+     +  L FV +Y+   D+   + R          R ++ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAE 109

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
           L   +   H+   +HRD+KP N+LI ++D H I+L  F L  G  + H  +
Sbjct: 110 LTLAIESVHKMGFIHRDIKPDNILI-DLDGH-IKLTDFGLCTGFRWTHNSK 158

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 27/90 (30%), Positives = 43/90 (47%), Gaps = 6/90 (6%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYM---ERHSGGLDHHNIRLF 328
           EAS++  L+H N+V L  +V   + L  V EY+    L  Y+    R    L       F
Sbjct: 50  EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLA--QQLGF 107

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              +  G+ Y   +  +HRD+  +N+L+SE
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 44.5 bits (105), Expect = 6e-05
 Identities = 26/101 (25%), Positives = 53/101 (52%), Gaps = 6/101 (5%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQY----MERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++    +Y    ++  + G      
Sbjct: 40  AMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRA 99

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
             +  Q++ GL + H+RRI++RD+KP+N+L+   +  N+R+
Sbjct: 100 CFYTAQIISGLEHLHQRRIIYRDLKPENVLLD--NDGNVRI 138

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 17/40 (42%), Positives = 26/40 (65%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           D    LD+LG+G+Y +V+K     T   +A+KEIRL+ +E
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE 40

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 8e-05
 Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 1/41 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ-EEEGI 130
           Y +L ++GEG+Y TV+K     T + VALK++R+   EEGI
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGI 41

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 44.1 bits (105), Expect = 8e-05
 Identities = 25/88 (28%), Positives = 43/88 (48%), Gaps = 2/88 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
            E  +L+E  H  IV L+     +  +  + EY    +L   + R  G  D +  R ++ 
Sbjct: 42  SEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTIL-RDRGLFDEYTARFYIA 100

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
            ++    Y H R I++RD+KP+NLL+  
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDS 128

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 44.0 bits (104), Expect = 9e-05
 Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 2/81 (2%)

Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV E+V   DL  +M+R    L   + R +  ++   L++ H
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK-LPEEHARFYSAEISLALNFLH 113

Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGH 134

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 43.6 bits (103), Expect = 1e-04
 Identities = 20/39 (51%), Positives = 30/39 (76%), Gaps = 1/39 (2%)

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ-EEEGI 130
           K++++GEG+Y  V+K  + LT +VVALK+IRL  E EG+
Sbjct: 4   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV 42

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 20/51 (39%), Positives = 26/51 (50%), Gaps = 10/51 (19%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLT----------FVFEYV 476
           G P TAIRE  +L++L H NIV L +IV  +               VFEY+
Sbjct: 48  GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM 98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 10/43 (23%), Positives = 22/43 (51%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLW 133
           + + + LG GS+ +V+      T +++A+K + L  +    L 
Sbjct: 2   WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELE 44

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 23/78 (29%), Positives = 36/78 (46%), Gaps = 10/78 (12%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+VL G   Y  ++D W +GC+L E + G P F G    E ++ L    + L  P  
Sbjct: 164 YMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY 222

Query: 192 ETWEGVSLLPGYNVHRDA 209
           +        P +N+  +A
Sbjct: 223 DD-------PRFNLSDEA 233

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 28/77 (36%), Positives = 44/77 (57%), Gaps = 2/77 (2%)

Query: 281 KHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           KH  +  LH    T+  L FV EYV+  DL  +++R SG  D    R +  +++ GL + 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFL 112

Query: 340 HRRRILHRDVKPQNLLI 356
           H R I++RD+K  N+L+
Sbjct: 113 HERGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 16/101 (15%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-------------- 316
           REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H              
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 317 -SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             G L    +     Q+  G+ Y   +  +HRD+  +N L+
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 13/100 (13%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG----------- 319
           REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H              
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115

Query: 320 -LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            L    +     Q+  G+ Y   +  +HRD+  +N L+ E
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 27/99 (27%), Positives = 52/99 (52%), Gaps = 4/99 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYM-ERHSGGLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++  DL  ++    + G D      
Sbjct: 47  ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  ++  GL   HR RI++RD+KP+N+L+   D+ +IR+
Sbjct: 107 YAAEITCGLEDLHRERIVYRDLKPENILLD--DYGHIRI 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 24/81 (29%), Positives = 45/81 (55%), Gaps = 2/81 (2%)

Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L+F+ + ++  DL  ++ +H G      +R +  +++ GL + H R 
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF 117

Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 118 VVYRDLKPANILLDEHGHVRI 138

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 35/141 (24%), Positives = 56/141 (39%), Gaps = 21/141 (14%)

Query: 278 KELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-SGGLDHHNIRLFMFQLLRG 335
           ++L+H NI+         S L  V   + +      ++ H   GL    I   +  +L  
Sbjct: 54  RQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNA 113

Query: 336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-------RRRILH--- 385
           L Y H +  +HR VK  ++L+S             +L GL Y         R+R++H   
Sbjct: 114 LDYIHSKGFIHRSVKASHILLSGDGK--------VVLSGLRYSVSMIKHGKRQRVVHDFP 165

Query: 386 -RDVKPQNLLISEIVFTNLSG 405
              VK    L  E++  NL G
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQG 186

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 24/96 (25%), Positives = 49/96 (51%), Gaps = 10/96 (10%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYM------ERHSGGLDHHNI 325
           EAS++KE   +++V L  +V T      V E +   DL  Y+        ++ GL    +
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 326 RLFM---FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           + F+    ++  G++Y   ++ +HRD+  +N +++E
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 31/91 (34%), Positives = 45/91 (49%), Gaps = 3/91 (3%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYVHT-DLSQYMERHSGGLDHHNIRL 327
           A +EA LL +LKH NIV   +       L + V  +    DL   ++   G L   N  +
Sbjct: 46  AEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV 105

Query: 328 FMF-QLLRGLSYCHRRRILHRDVKPQNLLIS 357
             F Q+   L Y H + ILHRD+K QN+ ++
Sbjct: 106 EWFVQIAMALQYLHEKHILHRDLKTQNVFLT 136

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 2/98 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           E S+L EL H  IV +       + + F+ E+V   +L  ++ R +G   +   + +  +
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFPNDVAKFYHAE 126

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           L+    Y H + I++RD+KP+NLL+    H  +  F F
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF 164

Length = 329

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 15/43 (34%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGITL 132
           + KL+++GEG+Y  V++     + ++VALK++R+  E +GI +
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPI 51

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 2e-04
 Identities = 22/49 (44%), Positives = 29/49 (59%), Gaps = 8/49 (16%)

Query: 436 GAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYV 476
           G P + +RE +LLK+L+   H NIV L D+ H   T     LT VFE+V
Sbjct: 40  GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV 88

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 4/111 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L E  +  +V L+     +  L FV +Y+   D+   + R  G  +    R ++ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAE 109

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
           L   +   H+   +HRD+KP N+LI    H  I+L  F L  G  + H  +
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK 158

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 27/103 (26%), Positives = 52/103 (50%), Gaps = 11/103 (10%)

Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGL 320
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 40  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 98

Query: 321 DHHNIRL-----FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
               +RL        Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 99  ----LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 137

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 15/102 (14%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-------SGGLDHH 323
           REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H       +GG D  
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 324 NIRLFMFQLLR-------GLSYCHRRRILHRDVKPQNLLISE 358
             +L + Q+L        G+ Y      +HRD+  +N L+ +
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           E  LLK L H  IV  +  +      TL+   E++     +   +  G L  +  R +  
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLL 355
           Q+L G+SY H   I+HRD+K  N+L
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 27/98 (27%), Positives = 50/98 (51%), Gaps = 2/98 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           + E+ +LK  +H  + +L     T+  L FV EYV+  +L  ++ R          R + 
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV-FSEDRTRFYG 101

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            +++  L Y H  +I++RD+K +NL++ +  H  I  F
Sbjct: 102 AEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDF 139

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 25/87 (28%), Positives = 41/87 (47%), Gaps = 5/87 (5%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYM--ERHSGGLDHHNIRLFMF 330
           EA +L+ + H +I+ L            +     TDL  Y+  +R+    D   I     
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER--- 189

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +LR + Y H  RI+HRD+K +N+ I+
Sbjct: 190 SVLRAIQYLHENRIIHRDIKAENIFIN 216

Length = 391

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 26/90 (28%), Positives = 43/90 (47%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           +E  ++K+ KH+NIV        R  L    E+      Q +   +G L    I     +
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRE 114

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
            L+GL Y H +  +HRD+K  N+L+++  H
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGH 144

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 2/78 (2%)

Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           +V LH    T S L  V EYV+  DL  +M+R    L   + R +  ++   L++ H R 
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK-LPEEHARFYAAEICIALNFLHERG 116

Query: 344 ILHRDVKPQNLLISEIDH 361
           I++RD+K  N+L+    H
Sbjct: 117 IIYRDLKLDNVLLDADGH 134

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 22/95 (23%), Positives = 41/95 (43%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E+ +L+  +H  +  L     T   L FV EY +     +             R +  ++
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104

Query: 333 LRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           +  L Y H   +++RD+K +NL++ +  H  I  F
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDF 139

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 14/37 (37%), Positives = 23/37 (62%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
           Y  L +LG GS+ TV+K     T ++VA+K ++ + E
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE 37

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 12/36 (33%), Positives = 23/36 (63%)

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
            L+++G+G +  V+K     T + VA+K I+L+ +E
Sbjct: 4   ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE 39

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 26/99 (26%), Positives = 53/99 (53%), Gaps = 3/99 (3%)

Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-G 319
           P   +P + + EA ++K+L+H+ +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 40  PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRA 98

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L   N+     Q+  G++Y  R   +HRD++  N+L+ +
Sbjct: 99  LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD 137

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 17/35 (48%), Positives = 22/35 (62%)

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEI 359
           I+  M Q+L  L   H   I+HRDVKPQN++ SE 
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291

Length = 566

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 17/35 (48%), Positives = 22/35 (62%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEI 398
           I+  M Q+L  L   H   I+HRDVKPQN++ SE 
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEG 291

Length = 566

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 22/73 (30%), Positives = 36/73 (49%), Gaps = 3/73 (4%)

Query: 298 LTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           L  V EY    DL   + R+    D    + ++ +L+  +   H+   +HRD+KP+N+LI
Sbjct: 76  LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 357 SEIDHHNIRLFMF 369
               H  I+L  F
Sbjct: 136 DRTGH--IKLADF 146

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           + EA +LK+  H NIV L  +   R  +  V E V   D   ++ +    L    +  F 
Sbjct: 40  LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFA 99

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                G++Y   +  +HRD+  +N L+ E
Sbjct: 100 LDAAAGMAYLESKNCIHRDLAARNCLVGE 128

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 19/40 (47%), Positives = 29/40 (72%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + + KL+++G+GS+  VFKG  N T +VVA+K I L+E E
Sbjct: 4   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 43

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           ++E  LLK LKH NIV     + T  +L  + EY 
Sbjct: 47  MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 20/61 (32%), Positives = 32/61 (52%), Gaps = 5/61 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T ++  P+V+ G   Y    D+W VGC ++EM+T  P +      ++ +  IFKI   PT
Sbjct: 170 TPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAE----FEAMAAIFKIATQPT 224

Query: 191 E 191
            
Sbjct: 225 N 225

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 14/30 (46%), Positives = 22/30 (73%), Gaps = 1/30 (3%)

Query: 369 FQLLRGLSYCHR-RRILHRDVKPQNLLISE 397
             +L+GL+Y H   +I+HRDVKP N+L++ 
Sbjct: 107 VAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 13/34 (38%), Positives = 25/34 (73%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
            + ++ +++ G+   H+R I+HRD+KP+NLLI +
Sbjct: 99  AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQ 132

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 14/34 (41%), Positives = 25/34 (73%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           I   + + LRGL+Y H  +++HRD+K QN+L+++
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTK 148

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 15/38 (39%), Positives = 23/38 (60%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y +L+ +G G+Y  V++G    T +VVALK I L   +
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD 40

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           ++EA +LK+  H NIV L  +   +  +  V E V    L  ++ +    L    +    
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMS 99

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                G+ Y   +  +HRD+  +N L+ E
Sbjct: 100 LDAAAGMEYLESKNCIHRDLAARNCLVGE 128

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 18/38 (47%), Positives = 28/38 (73%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + KL+++G+GS+  V+KG  N T +VVA+K I L+E E
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE 43

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 23/98 (23%), Positives = 48/98 (48%), Gaps = 2/98 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EA ++  + H ++V L  I  + S +  + + +    L  Y+  H   +    +  + 
Sbjct: 57  LDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC 115

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            Q+ +G+SY   +R++HRD+  +N+L+    H  I  F
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDF 153

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 25/98 (25%), Positives = 47/98 (47%), Gaps = 2/98 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           + E+ +L+  +H  +  L     T   L FV EY +  +L  ++ R          R + 
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYG 101

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            +++  L Y H R +++RD+K +NL++ +  H  I  F
Sbjct: 102 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 139

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 11/32 (34%), Positives = 18/32 (56%)

Query: 97  LGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           LGEG + TV+      T + VA+K I+ ++  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS 32

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 22/57 (38%), Positives = 33/57 (57%), Gaps = 7/57 (12%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF-KIL 186
           T  Y  P+V+LG   +S ++D W +GCIL E + G+P F G     +  ++IF  IL
Sbjct: 164 TPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHG-----ETPEEIFQNIL 214

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 41.3 bits (97), Expect = 5e-04
 Identities = 26/103 (25%), Positives = 46/103 (44%), Gaps = 6/103 (5%)

Query: 271 IREASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNI 325
           + E +++KE L+H NIV  +        L  V + +      +    ++          I
Sbjct: 56  VSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI 115

Query: 326 RLFMFQLLRGLSYCHR-RRILHRDVKPQNLLISEIDHHNIRLF 367
                Q++  L Y H+ +RI+HRD+ P N+++ E D   I  F
Sbjct: 116 WNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 27/119 (22%), Positives = 58/119 (48%), Gaps = 7/119 (5%)

Query: 262 PKNGAPFTA--IREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHT-DLSQYMERH 316
           P++G    A   +E  +L+ L H NIV    I      + +  + E++ +  L +Y+ R+
Sbjct: 43  PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN 102

Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
              ++      +  Q+ +G+ Y   R+ +HRD+  +N+L+     H +++  F L + +
Sbjct: 103 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE--SEHQVKIGDFGLTKAI 159

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 50/187 (26%), Positives = 75/187 (40%), Gaps = 34/187 (18%)

Query: 285 IVTLHDIVHTRSTLTFVFEY-VHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV L+  + + + +  V EY +  D+   +  + G  D      ++ ++   L Y HR  
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG 124

Query: 344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILH--------RDVKPQNL-- 393
           I+HRD+KP N+LIS   H  I+L  F    GLS     R L+           KP+N   
Sbjct: 125 IIHRDLKPDNMLISNEGH--IKLTDF----GLSKVTLNRELNMMDILTTPSMAKPKNDYS 178

Query: 394 --------LISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREA 445
                   LIS + F   + V      S + G    + S    + H      P   I + 
Sbjct: 179 RTPGQVLSLISSLGFN--TPVGEKDQGSVNSGQNNGTSSVRTGTSH------PLLMINKE 230

Query: 446 SLLKELK 452
           SL   LK
Sbjct: 231 SLPMSLK 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 16/32 (50%), Positives = 21/32 (65%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRS 467
           G P TA+RE  +LK+LKH N+V L D+   R 
Sbjct: 49  GFPITALREIKILKKLKHPNVVPLIDMAVERP 80

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 20/52 (38%), Positives = 31/52 (59%), Gaps = 2/52 (3%)

Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           G LD   I   + ++L+GL Y H  + +HRD+K  N+L+SE  H  ++L  F
Sbjct: 96  GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADF 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 10/82 (12%)

Query: 285 IVTLHDIVHTRSTLTFVFEYVH-----TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           +VTLH    T + L  + +YV+     T L Q             +R+++ +++  L + 
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHL 121

Query: 340 HRRRILHRDVKPQNLLISEIDH 361
           H+  I++RD+K +N+L+    H
Sbjct: 122 HQLGIIYRDIKLENILLDSEGH 143

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 21/95 (22%), Positives = 40/95 (42%), Gaps = 9/95 (9%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNI----- 325
           RE  + ++L H N+V L  +         + EY    DL Q++       +         
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116

Query: 326 --RLFM-FQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             ++ +  Q+  G+ +    R +HRD+  +N L+S
Sbjct: 117 KQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS 151

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 41.1 bits (97), Expect = 7e-04
 Identities = 16/43 (37%), Positives = 30/43 (69%), Gaps = 1/43 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE-EGI 130
           D Y KL+++ EG+Y  V++     T ++VALK++++++E EG 
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGF 47

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 23/91 (25%), Positives = 44/91 (48%), Gaps = 8/91 (8%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN------IR 326
           E   L  L H NI+ + +I+ + +    + +    DL  +M  +    D  +       R
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM--YDEAFDWKDRPLLKQTR 270

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             M QLL  + Y H ++++HRD+K +N+ ++
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301

Length = 501

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 16/36 (44%), Positives = 23/36 (63%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           A+RE  +LK+LKH N+V L ++   +  L  VFEY 
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 41.2 bits (96), Expect = 8e-04
 Identities = 14/38 (36%), Positives = 26/38 (68%)

Query: 358 EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           E+DH  +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 122 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 36/116 (31%), Positives = 54/116 (46%), Gaps = 7/116 (6%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L    H NIV L D  +  + L  + E+     +   M      L    IR+   Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRD 387
            L  L+Y H  +I+HRD+K  N+L + +D  +I+L  F    G+S  + R I  RD
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LD-GDIKLADF----GVSAKNTRTIQRRD 161

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 18/44 (40%), Positives = 29/44 (65%), Gaps = 4/44 (9%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVF---EYV 476
           G P T++RE ++L +L+H NIVT+ ++V   S L  ++   EYV
Sbjct: 46  GFPITSLREINILLKLQHPNIVTVKEVV-VGSNLDKIYMVMEYV 88

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 14/35 (40%), Positives = 20/35 (57%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
            +RE  +LK+L H NIV L+ +    + L  V EY
Sbjct: 38  LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEY 72

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 1/42 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEG 129
             Y KL ++G+G++  VFK     T Q+VALK++ +  E+EG
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG 53

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 40.8 bits (96), Expect = 0.001
 Identities = 18/48 (37%), Positives = 26/48 (54%), Gaps = 8/48 (16%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHT--------RSTLTFVFEY 475
           G P TA+RE  +L+ LKH N+V L +I  T        + +   VFE+
Sbjct: 53  GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEF 100

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 40.3 bits (95), Expect = 0.001
 Identities = 14/37 (37%), Positives = 23/37 (62%)

Query: 360 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           D    R+++ +++  L Y H   I+HRD+KP N+LI 
Sbjct: 91  DEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID 127

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 22/74 (29%), Positives = 40/74 (54%), Gaps = 3/74 (4%)

Query: 296 STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
           + L  + EY+    +  + R +G  D   I   + ++L+GL Y H  + +HRD+K  N+L
Sbjct: 75  TKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVL 133

Query: 356 ISEIDHHNIRLFMF 369
           +SE    +++L  F
Sbjct: 134 LSE--QGDVKLADF 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.9 bits (95), Expect = 0.001
 Identities = 14/28 (50%), Positives = 25/28 (89%)

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           ++LRGLS+ H+ +++HRD+K QN+L++E
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTE 146

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.9 bits (95), Expect = 0.001
 Identities = 14/28 (50%), Positives = 25/28 (89%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLISE 397
           ++LRGLS+ H+ +++HRD+K QN+L++E
Sbjct: 119 EILRGLSHLHQHKVIHRDIKGQNVLLTE 146

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 12/104 (11%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-----VHTDLSQYMERHSGGLDHHNIRL 327
           E  +L E+ H  IV LH    T   L  + ++     + T LS+ +          +++ 
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKF 102

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++ +L   L + H   I++RD+KP+N+L+ E  H  I+L  F L
Sbjct: 103 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGL 144

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 25/97 (25%), Positives = 47/97 (48%), Gaps = 2/97 (2%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++    ++   + G  G D      
Sbjct: 47  ALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           +  +L  GL    R RI++RD+KP+N+L+ +  H  I
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRI 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 26/106 (24%), Positives = 53/106 (50%), Gaps = 5/106 (4%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFM 329
           +REAS++ +L H  IV L  +      L  V E      L +Y+++    +   +++   
Sbjct: 44  LREASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKR-REIPVSDLKELA 101

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G++Y   +  +HRD+  +N+L+  ++ H  ++  F + R L
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLL--VNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 30/108 (27%), Positives = 49/108 (45%), Gaps = 4/108 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L E  +  +V L+     +  L FV +Y+   D+   + R  G       R ++ +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAE 109

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH 379
           L   +   H+   +HRD+KP N+LI    H  I+L  F L  G  + H
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTH 155

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 32/131 (24%), Positives = 58/131 (44%), Gaps = 13/131 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERH----------SGG 319
           ++E  ++  LK  NI+ L  +  T   L  + EY+   DL+Q++ RH             
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH 379
           + +  +     Q+  G+ Y      +HRD+  +N L+ +  ++ I++  F + R L    
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK--NYTIKIADFGMSRNLYSGD 184

Query: 380 RRRILHRDVKP 390
             RI  R V P
Sbjct: 185 YYRIQGRAVLP 195

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 2/91 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
              ASL+ +L H ++V L+  V  R     V EYV    L  ++ R    +  H      
Sbjct: 49  FETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVA 107

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
            QL   L Y   ++++H +V  +N+L++   
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYG 138

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 1/86 (1%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L    H  IV L    +    L  + E+     +   M     GL    I++   Q
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLIS 357
           +L  L Y H  +I+HRD+K  N+L++
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT 144

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 20/46 (43%), Positives = 30/46 (65%)

Query: 351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           P N+   + D + I+  M Q+L GL   HR  I+HRD+KP+NLL++
Sbjct: 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343

Length = 507

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 40.0 bits (94), Expect = 0.001
 Identities = 21/96 (21%), Positives = 44/96 (45%), Gaps = 15/96 (15%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-VHTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++ +  H NI+ L  +V     +  + EY  +  L +++  + G       +  +
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG-------KFTV 105

Query: 330 FQLLR-------GLSYCHRRRILHRDVKPQNLLISE 358
            QL+        G+ Y      +HRD+  +N+L++ 
Sbjct: 106 GQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNS 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 16/42 (38%), Positives = 26/42 (61%), Gaps = 2/42 (4%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEY 475
           G P +++RE +LL  L+H NIV L ++V  +   ++  V EY
Sbjct: 48  GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 39.9 bits (94), Expect = 0.002
 Identities = 21/52 (40%), Positives = 28/52 (53%), Gaps = 2/52 (3%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI 185
           Y  P+ LL       S D+W +GCI+ +M+TG P F G  E Y    KI K+
Sbjct: 188 YVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-YLTFQKILKL 237

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 10/66 (15%)

Query: 123 RLQEEEGITLWYRPPDVLLGST--EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD 180
            +Q   G T  Y  P+V+ G     +  + D+W +GC+++EM TG   +        +LD
Sbjct: 159 EVQSLAG-TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS-------ELD 210

Query: 181 KIFKIL 186
             F+I+
Sbjct: 211 NEFQIM 216

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 39.6 bits (93), Expect = 0.002
 Identities = 10/36 (27%), Positives = 25/36 (69%)

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + +++G G++  V+   +  T +++A+KEIR+Q+ +
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND 39

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 15/35 (42%), Positives = 21/35 (60%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           +  L +LG+GSY +V+K      NQ  ALKE+ L 
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLG 36

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 20/89 (22%), Positives = 44/89 (49%), Gaps = 9/89 (10%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIRLF 328
           E  ++++ +H NIV ++        L  V E++     TD+  +       ++   I   
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATV 120

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
              +L+ LS+ H + ++HRD+K  ++L++
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLT 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 18/114 (15%)

Query: 281 KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH---------------SGGLDHHN 324
           KH NI+ L  +      L  V EY  H +L  ++                     L   +
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC 378
           +  F +Q+ RG+ +   ++ +HRD+  +N+L++E   H +++  F L R + + 
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE--DHVMKIADFGLARDIHHI 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 21/86 (24%), Positives = 42/86 (48%), Gaps = 1/86 (1%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           EAS++ +  H+NI+ L  +V        + EY+    L +Y+  H G    + +   +  
Sbjct: 56  EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLIS 357
           +  G+ Y      +HRD+  +N+L++
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 21/86 (24%), Positives = 41/86 (47%), Gaps = 1/86 (1%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQ 331
           EA  L +  H+NIV L  ++   +T+  V EY+ +  L  ++ +H G L    +   +  
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLIS 357
           L  G+ Y      +H+ +    +L++
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVN 141

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 28/100 (28%), Positives = 52/100 (52%), Gaps = 4/100 (4%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E ++L+ +KH  IV L     T   L  + EY+   +L  ++ER  G         ++ +
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSE 108

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           +   L + H++ I++RD+KP+N+L+    H  ++L  F L
Sbjct: 109 ISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGL 146

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 24/99 (24%), Positives = 51/99 (51%), Gaps = 3/99 (3%)

Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P    P   ++EA ++K+L+H+ +V L+ +V +   +  V E++    L  +++   G  
Sbjct: 40  PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKY 98

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ +
Sbjct: 99  LKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD 137

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 23/97 (23%), Positives = 46/97 (47%), Gaps = 2/97 (2%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRL 327
           A+ E  +L+++    +V L     T+  L  V   ++    ++   + G  G +      
Sbjct: 47  ALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           +  ++L GL   HR   ++RD+KP+N+L+ +  H  I
Sbjct: 107 YAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRI 143

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 17/37 (45%), Positives = 24/37 (64%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           TA+RE  +L++L+H NIV L +    +  L  VFEYV
Sbjct: 46  TALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 39.5 bits (93), Expect = 0.003
 Identities = 13/35 (37%), Positives = 20/35 (57%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           +REA ++++L H NIV L  +      L  V EY+
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 39.2 bits (92), Expect = 0.003
 Identities = 16/34 (47%), Positives = 25/34 (73%)

Query: 94  LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
           L++LGEGSY +V+K     T QVVA+K + ++E+
Sbjct: 8   LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED 41

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 17/41 (41%), Positives = 26/41 (63%)

Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           G L+   I   + ++L+GL Y H  R +HRD+K  N+L+SE
Sbjct: 96  GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 39.7 bits (92), Expect = 0.003
 Identities = 18/37 (48%), Positives = 26/37 (70%)

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           D + I+  M Q+L GL   HR  I+HRD+KP+NLL++
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT 343

Length = 507

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   +  L  V E++ +  L  Y+ +  G L   ++ L M
Sbjct: 47  IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-DMLLSM 105

Query: 330 FQ-LLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q +  G+ Y  R   +HRD+  +N L+S 
Sbjct: 106 CQDVCEGMEYLERNSFIHRDLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 26/82 (31%), Positives = 41/82 (50%), Gaps = 2/82 (2%)

Query: 281 KHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           KH  +  LH    T+  L FV EYV+  DL   ++R S   D    R +  ++   L + 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFL 112

Query: 340 HRRRILHRDVKPQNLLISEIDH 361
           HR  +++RD+K  N+L+    H
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGH 134

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 26/112 (23%), Positives = 52/112 (46%), Gaps = 24/112 (21%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYM---------------E 314
           + E +LLK++ H +++ L+        L  + EY  +  L  ++                
Sbjct: 51  LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110

Query: 315 RHSGGLDHHNIR--------LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           R+S  LD+ + R         F +Q+ RG+ Y    +++HRD+  +N+L++E
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAE 162

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 29/97 (29%), Positives = 51/97 (52%), Gaps = 13/97 (13%)

Query: 273 EASLLKELKHN-NIVTLHDIVHTRS------TLTFVFEYVH----TDLSQYMERHSGGLD 321
           E ++LK+  H+ NI T +     +S       L  V E+      TDL +  + ++  L 
Sbjct: 62  EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LK 119

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              I     ++LRGL++ H  +++HRD+K QN+L++E
Sbjct: 120 EDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 26/96 (27%), Positives = 47/96 (48%), Gaps = 10/96 (10%)

Query: 272 REASLLKELK-------HNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDH 322
           REA L+ ELK       H NIV L         +  + EY  + DL  ++ R     L  
Sbjct: 82  REA-LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL 140

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            ++  F +Q+ +G+++   +  +HRD+  +N+L++ 
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH 176

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 36/163 (22%), Positives = 59/163 (36%), Gaps = 42/163 (25%)

Query: 225 DIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIR------------ 272
           D+PEGE +  +          NP EH++      G  P   A F A R            
Sbjct: 51  DLPEGEEVPES---------NNPREHMYVLTTLVGRNPTTAA-FVATRGSDPKEKVVAKF 100

Query: 273 --------------EASLLKELKHNNIVTLHDIVHTRSTLTFVFEY-----VHTDLSQYM 313
                         E   L    H  IV   D   +   L  + EY     ++  + Q +
Sbjct: 101 VMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL 160

Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           + H      + + L  +Q++  L   H R+++HRD+K  N+ +
Sbjct: 161 KEHLP-FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202

Length = 478

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 9/90 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I E  +++E KH NIV   D       L  V EY+     TD+          +D   I 
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIA 118

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
               + L+ L + H  +++HRD+K  N+L+
Sbjct: 119 AVCRECLQALEFLHSNQVIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 13/34 (38%), Positives = 20/34 (58%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL 124
           Y   D +G G++  V+KG +  T   VA+K+I L
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISL 35

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 38.4 bits (90), Expect = 0.004
 Identities = 11/39 (28%), Positives = 23/39 (58%)

Query: 94  LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITL 132
           + ++G G+Y  V+K     T ++VA+K I+L+  +   +
Sbjct: 8   IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI 46

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 1/40 (2%)

Query: 131 TLWYRPPDVL-LGSTEYSTSLDMWGVGCILIEMVTGLPTF 169
           TL Y  P+V+  G   Y    D+W +GC ++EM TG P F
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 13/28 (46%), Positives = 24/28 (85%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLISE 397
           ++LRGL++ H  +++HRD+K QN+L++E
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTE 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 4/106 (3%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GL 320
           K      A+ E  +L+++    IV L     +++ L  V   ++    +Y   + G  GL
Sbjct: 33  KKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL 92

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +   +  +  Q+  G+ + H   I++RD+KP+N+L+   D  N RL
Sbjct: 93  EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD--DQGNCRL 136

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.004
 Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 2/91 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRLFMF 330
           E  +L  L H  + TL+    T + L  V +Y    +L + ++R  G  L     R +  
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA 110

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
           ++L  L Y H   I++RD+KP+N+L+ E  H
Sbjct: 111 EVLLALEYLHLLGIVYRDLKPENILLHESGH 141

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 38.6 bits (89), Expect = 0.004
 Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 9/90 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I E  ++KELK+ NIV   D       L  V EY+     TD+          +D   I 
Sbjct: 64  INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT-----ETCMDEAQIA 118

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
               + L+ L + H  +++HRD+K  N+L+
Sbjct: 119 AVCRECLQALEFLHANQVIHRDIKSDNVLL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	481
KOG0603|consensus	612		100.0
KOG0595|consensus	429		100.0
KOG0593|consensus	396		100.0
KOG0615|consensus	475		100.0
KOG0598|consensus	357		100.0
KOG0575|consensus	592		100.0
KOG0600|consensus	560		100.0
KOG0659|consensus	318		100.0
KOG0659|consensus	318		100.0
KOG0616|consensus	355		100.0
KOG0594|consensus	323		100.0
KOG0605|consensus	550		99.98
KOG0594|consensus	323		99.97
KOG0663|consensus	419		99.97
KOG0663|consensus	419		99.97
KOG0600|consensus	560		99.97
KOG0660|consensus	359		99.97
KOG0661|consensus	538		99.97
KOG0591|consensus	375		99.97
KOG0597|consensus	808		99.97
KOG0662|consensus	292		99.97
KOG0592|consensus	604		99.97
KOG0583|consensus	370		99.97
KOG0611|consensus	668		99.96
KOG0581|consensus	364		99.96
KOG0585|consensus	576		99.96
KOG0610|consensus	459		99.96
KOG0660|consensus	359		99.96
KOG0593|consensus	396		99.96
KOG0661|consensus	538		99.96
KOG0662|consensus	292		99.96
KOG0658|consensus	364		99.96
KOG0694|consensus	694		99.96
KOG0612|consensus	1317		99.95
KOG0598|consensus	357		99.95
KOG0605|consensus	550		99.95
KOG0608|consensus	1034		99.95
KOG0588|consensus	786		99.95
KOG0198|consensus	313		99.95
KOG0033|consensus	355		99.95
KOG0658|consensus	364		99.95
KOG0667|consensus	586		99.95
KOG0032|consensus	382		99.94
KOG0578|consensus	550		99.94
KOG0580|consensus	281		99.94
KOG0615|consensus	475		99.94
KOG0694|consensus	694		99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
KOG4236|consensus	888		99.94
KOG0690|consensus	516		99.94
KOG0582|consensus	516		99.94
KOG0599|consensus	411		99.94
KOG0581|consensus	364		99.94
KOG0666|consensus	438		99.94
KOG0192|consensus	362		99.94
KOG0665|consensus	369		99.94
KOG0574|consensus	502		99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
KOG4717|consensus	864		99.93
KOG0197|consensus	468		99.93
KOG0589|consensus	426		99.93
KOG0033|consensus	355		99.93
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.93
KOG4250|consensus	732		99.93
KOG0616|consensus	355		99.93
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.93
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.93
KOG0664|consensus	449		99.93
KOG0586|consensus	596		99.93
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.92
KOG0607|consensus	463		99.92
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.92
KOG0667|consensus	586		99.92
KOG0577|consensus	948		99.92
KOG0669|consensus	376		99.92
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
KOG1989|consensus	738		99.92
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.92
KOG0201|consensus	467		99.92
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
KOG0986|consensus	591		99.92
KOG0696|consensus	683		99.92
KOG0592|consensus	604		99.92
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.92
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.92
KOG0590|consensus	601		99.92
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.92
KOG0591|consensus	375		99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.91
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.91
PTZ00036	440	glycogen synthase kinase; Provisional	99.91
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.91
KOG0669|consensus	376		99.91
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.91
KOG0604|consensus	400		99.91
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.91
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
KOG0197|consensus	468		99.91
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.91
KOG4721|consensus	904		99.91
KOG0666|consensus	438		99.91
KOG0595|consensus	429		99.91
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.91
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.91
KOG0597|consensus	808		99.91
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.91
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.9
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.9
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.9
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.9
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.9
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.9
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.9
KOG0614|consensus	732		99.9
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.9
KOG0579|consensus	1187		99.9
KOG0578|consensus	550		99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.9
PTZ00267	478	NIMA-related protein kinase; Provisional	99.9
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.9
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.9
KOG0192|consensus	362		99.9
PHA03209	357	serine/threonine kinase US3; Provisional	99.9
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.9
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.9
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.9
KOG0575|consensus	592		99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.9
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.9
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.9
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.9
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.9
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.9
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.89
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.89
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.89
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.89
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.89
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.89
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.89
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.89
KOG4645|consensus	1509		99.89
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.89
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.89
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.89
KOG4279|consensus	1226		99.89
KOG1187|consensus	361		99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.89
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.89
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.89
KOG0604|consensus	400		99.89
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.89
KOG2345|consensus	302		99.89
KOG4721|consensus	904		99.89
PTZ00036	440	glycogen synthase kinase; Provisional	99.88
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.88
KOG0596|consensus	677		99.88
KOG1026|consensus	774		99.88
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.88
PTZ00283	496	serine/threonine protein kinase; Provisional	99.88
KOG1152|consensus	772		99.88
KOG0599|consensus	411		99.88
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.88
KOG0194|consensus	474		99.88
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.88
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.88
KOG0695|consensus	593		99.88
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.88
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.88
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.88
KOG1151|consensus	775		99.88
PTZ00284	467	protein kinase; Provisional	99.88
KOG0696|consensus	683		99.88
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.88
KOG0584|consensus	632		99.87
KOG0032|consensus	382		99.87
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.87
PHA02988	283	hypothetical protein; Provisional	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.87
KOG0690|consensus	516		99.87
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.87
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.87
KOG0193|consensus	678		99.87
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.87
KOG4257|consensus	974		99.87
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.87
KOG0588|consensus	786		99.87
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.87
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.87
KOG0983|consensus	391		99.87
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.87
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.87
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.87
KOG0196|consensus	996		99.87
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.87
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.87
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.87
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.86
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.86
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.86
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.86
PLN00009	294	cyclin-dependent kinase A; Provisional	99.86
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.86
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.86
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.86
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.86
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.86
KOG0614|consensus	732		99.86
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.86
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.86
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.86
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.86
PTZ00284	467	protein kinase; Provisional	99.86
KOG0589|consensus	426		99.86
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.86
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.86
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.86
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.86
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.86
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.86
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.86
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.86
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.86
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.86
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.85
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.85
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.85
KOG0583|consensus	370		99.85
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.85
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.85
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.85
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.85
KOG0665|consensus	369		99.85
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.85
KOG0668|consensus	338		99.85
KOG4236|consensus	888		99.85
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.85
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.85
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.85
KOG0585|consensus	576		99.85
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.85
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.85
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.85
KOG0671|consensus	415		99.85
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.85
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.85
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.85
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.85
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.85
KOG0198|consensus	313		99.85
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.85
KOG0201|consensus	467		99.85
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.85
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.85
KOG4279|consensus	1226		99.85
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.85
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.85
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.85
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.85
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.85
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.84
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.84
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.84
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.84
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.84
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.84
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.84
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.84
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.84
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.84
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.84
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.84
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.84
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.84
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.84
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.84
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.84
KOG0984|consensus	282		99.84
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.84
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.84
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.84
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.84
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.84
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.84
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.84
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.84
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.84
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.84
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.84
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.84
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.84
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.84
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.84
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.84
KOG1095|consensus	1025		99.84
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.84
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.84
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.84
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.84
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.84
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.84
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.84
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.84
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.84
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.84
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.84
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.84
KOG0608|consensus	1034		99.84
KOG0695|consensus	593		99.84
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.84
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.83
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.83
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.83
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.83
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.83
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.83
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.83
KOG0984|consensus	282		99.83
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.83
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.83
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.83
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.83
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.83
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.83
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.83
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.83
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.83
KOG0986|consensus	591		99.83
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.83
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.83
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.83
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.83
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.83
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.83
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.83
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.83
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.83
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.83
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.83
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.83
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.83
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.83
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.83
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.83
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.83
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.83
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.83
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.83
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.83
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.83
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.83
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.83
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.83
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.83
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.83
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.83
KOG1006|consensus	361		99.83
PHA02882	294	putative serine/threonine kinase; Provisional	99.83
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.83
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.83
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.83
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.83
PHA02882	294	putative serine/threonine kinase; Provisional	99.83
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.83
PHA03212	391	serine/threonine kinase US3; Provisional	99.83
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.83
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.82
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.82
KOG0610|consensus	459		99.82
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.82
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.82
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.82
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.82
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.82
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.82
KOG0603|consensus	612		99.82
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.82
KOG1026|consensus	774		99.82
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.82
KOG0612|consensus	1317		99.82
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.82
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.82
KOG1006|consensus	361		99.82
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.82
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.82
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.82
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.82
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.82
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.82
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.82
KOG0983|consensus	391		99.82
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.82
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.82
PTZ00283	496	serine/threonine protein kinase; Provisional	99.82
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.82
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.82
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.82
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.82
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.82
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.82
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.82
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.82
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.82
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.82
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.82
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.82
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.82
KOG0582|consensus	516		99.82
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.82
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.82
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.82
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.82
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.82
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.82
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.82
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.81
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.81
KOG1094|consensus	807		99.81
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.81
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.81
KOG0587|consensus	953		99.81
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.81
KOG1095|consensus	1025		99.81
KOG4717|consensus	864		99.81
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.81
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.81
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.81
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.81
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.81
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.81
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.81
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.81
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.81
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.81
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.81
KOG0607|consensus	463		99.81
KOG0670|consensus	752		99.81
KOG0574|consensus	502		99.81
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.81
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.81
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.81
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.81
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.81
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.81
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.81
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.81
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.81
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.81
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.81
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.81
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.81
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.81
KOG1035|consensus	1351		99.81
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.81
KOG0199|consensus	1039		99.81
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.81
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.81
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.8
PHA03207	392	serine/threonine kinase US3; Provisional	99.8
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.8
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.8
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.8
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.8
KOG0664|consensus	449		99.8
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.8
KOG0580|consensus	281		99.8
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.8
PTZ00267	478	NIMA-related protein kinase; Provisional	99.8
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.8
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.8
KOG4278|consensus	1157		99.8
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.8
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.8
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.8
KOG0576|consensus	829		99.8
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.8
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.8
PHA03210	501	serine/threonine kinase US3; Provisional	99.8
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.8
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.8

>KOG0603|consensus

Probab=100.00  E-value=5.8e-38  Score=321.44  Aligned_cols=372  Identities=21%  Similarity=0.290  Sum_probs=230.1

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      +...+++.++  .++|++.+|+.+|+|||+|+    +||++...    |++|+.|||+++......              
T Consensus        96 ~~~~~~~~ae--laLald~lh~l~iiyrd~k~----enilld~~----Ghi~~tdfglske~v~~~--------------  151 (612)
T KOG0603|consen   96 ELDVAFYLAE--LALALDHLHKLGIAYRDYKL----ENVLLLLE----GHIKLTDFGLSKEAVKEK--------------  151 (612)
T ss_pred             HHHHHHHHHH--HHHHHhhcchhHHHHhcccc----cceeeccc----CccccCCchhhhHhHhhh--------------
Confidence            3344455554  49999999999999999999    89999877    899999999998542110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                              +        .||                      |..|||||++.   .+..++||||+|++++||++|..|
T Consensus       152 --------~--------~cg----------------------t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~p  190 (612)
T KOG0603|consen  152 --------I--------ACG----------------------TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLP  190 (612)
T ss_pred             --------h--------ccc----------------------chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCC
Confidence                    1        144                      99999999998   378899999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHH-hCCCCcc---------------------------------------CcccccCC---C-CC-
Q psy3074         169 FPGVREVYDQLDKIFKI-LGTPTEE---------------------------------------TWEGVSLL---P-GY-  203 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~-~~~p~~~---------------------------------------~~~~~~~~---~-~~-  203 (481)
                      |.+     +....|.+. ++.|..-                                       .|.+....   + .. 
T Consensus       191 f~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp  265 (612)
T KOG0603|consen  191 FGG-----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKP  265 (612)
T ss_pred             Cch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCC
Confidence            988     333333331 1111110                                       11100000   0 00 


Q ss_pred             --CccCCCCccCCCcCcCCCCccC----CCc------chhHHH-HHHhh---------hhhhhc---CCccccccccccC
Q psy3074         204 --NVHRDAPYTGNKLGLTFPRLYD----IPE------GESMAS-AFLQV---------RDAAIL---NPMEHVHNCEKEG  258 (481)
Q Consensus       204 --~~~~~~~~~~~~~~~~~~~~~~----~~~------g~~~a~-~ll~v---------~~~~~~---~~~~~~~~~~~~~  258 (481)
                        ...++..+..+.|....|.-..    ...      +..++. .++.-         +.....   .....+..|+...
T Consensus       266 ~~~~e~~~~~fd~eft~~~P~dsp~~~~~~s~~~if~g~sfva~~il~~~~~~~~~~~y~~~~~~~~gs~s~~~~~~~~~  345 (612)
T KOG0603|consen  266 GSITERDVAQFDPEFTSQVPADSPLLSASGSDHTIFSGPSFVAPGVLEDAVTAPFTESYEFREELGEGSFSAVKYCESSP  345 (612)
T ss_pred             cccchhhhhhcCchhccCCcccCCCCCCCccccchhcCCCccChHHhhccccCCcchhhccccccCCCCccceeeeeccc
Confidence              0000000111111111111110    000      111111 11111         000000   0001111111111


Q ss_pred             CCCC-CC-CC---hhhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCC-HHHHHHHhcCCCChHHHHHHHHH
Q psy3074         259 GNGP-KN-GA---PFTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ  331 (481)
Q Consensus       259 ~~~~-~~-~~---~~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~-l~~~l~~~~~~l~~~~~~~~~~q  331 (481)
                      .... .. -+   .....+|+.++... +||||+++++.+.+..++|+|||++.|+ +.+.+... ..+. ..+..|++|
T Consensus       346 t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~  423 (612)
T KOG0603|consen  346 TDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK-PEFC-SEASQWAAE  423 (612)
T ss_pred             cccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc-chhH-HHHHHHHHH
Confidence            1100 00 00   11244577666554 5999999999999999999999999964 55555443 2233 678889999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccc-cccchhhHHHHHHHHHhhccccccCceeccccCCCccc----ccccccccCCCe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL----ISEIVFTNLSGV  406 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl-~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il----~~~~~~~~s~g~  406 (481)
                      ++.|+.|||++||+||||||+|||+ ++.++  ++++|||.++.+..--.....+..|.+|+++    +++.++.||+|+
T Consensus       424 lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGv  501 (612)
T KOG0603|consen  424 LVSAVDYLHEQGVVHRDLKPGNILLDGSAGH--LRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGV  501 (612)
T ss_pred             HHHHHHHHHhcCeeecCCChhheeecCCCCc--EEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHH
Confidence            9999999999999999999999999 56677  9999999999877543344677889999998    567778899999


Q ss_pred             eEEEeecCCCCccccccC-cccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         407 VVSTVDSGSGGWWFESKS-NINLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       407 ~~~~~~~g~~~~~~~~~~-~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ++|+|++|..||...... .+..+..+..-+ -.-+....+++..|++-+
T Consensus       502 lLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s-~~vS~~AKdLl~~LL~~d  550 (612)
T KOG0603|consen  502 LLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS-ECVSDEAKDLLQQLLQVD  550 (612)
T ss_pred             HHHHHHhCCCccccCCchHHHHHhhcCCccc-cccCHHHHHHHHHhccCC
Confidence            999999999999876443 121111111000 122234556777777765

>KOG0595|consensus

Probab=100.00  E-value=1.6e-35  Score=289.15  Aligned_cols=147  Identities=32%  Similarity=0.457  Sum_probs=128.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ...|+.||+.++|||||+++|++++++++|+|||||+ |||..++..+ +.+++..++.++.|++.||++||+++|||||
T Consensus        56 L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRD  134 (429)
T KOG0595|consen   56 LLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRD  134 (429)
T ss_pred             HHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            4579999999999999999999999999999999999 7898888765 5799999999999999999999999999999


Q ss_pred             CCCcccccccc-ch---hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         349 VKPQNLLISEI-DH---HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       349 lKp~NiLl~~~-~~---~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||+|||++.. +.   ..+|++|||+|+.++              ++.+                            ..
T Consensus       135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~--------------~~~~----------------------------a~  172 (429)
T KOG0595|consen  135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQ--------------PGSM----------------------------AE  172 (429)
T ss_pred             CCcceEEeccCCCCCCCceEEecccchhhhCC--------------chhH----------------------------HH
Confidence            99999999865 32   569999999999765              1111                            12


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..||++.||+|        +...|.||.|++||++++|..||-
T Consensus       173 tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  173 TLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             HhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            37899999999        788899999999999999985554

>KOG0593|consensus

Probab=100.00  E-value=5.2e-36  Score=281.83  Aligned_cols=152  Identities=30%  Similarity=0.519  Sum_probs=139.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..++||+++|++|+|+|+|.|.++|.....+++|+|||+-+.+..+.....+++++.++.++.|++.|+.|||++++|||
T Consensus        46 KIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHR  125 (396)
T KOG0593|consen   46 KIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHR  125 (396)
T ss_pred             HHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecc
Confidence            45889999999999999999999999999999999999999999999988899999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccccc-----cccccCCCeeEEEeecCCCCcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLISE-----IVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~~-----~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      ||||||||++..+.  +|+||||+|+.+...   -+..+.+|||++|+.++++     .+++|+-||++.||.+|.+-|.
T Consensus       126 DIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P  203 (396)
T KOG0593|consen  126 DIKPENILITQNGV--VKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP  203 (396)
T ss_pred             cCChhheEEecCCc--EEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence            99999999999888  999999999988732   2467899999999999774     4567999999999999999887


Q ss_pred             cc
Q psy3074         420 FE  421 (481)
Q Consensus       420 ~~  421 (481)
                      ..
T Consensus       204 G~  205 (396)
T KOG0593|consen  204 GR  205 (396)
T ss_pred             Cc
Confidence            65

>KOG0615|consensus

Probab=100.00  E-value=5.1e-35  Score=285.26  Aligned_cols=185  Identities=23%  Similarity=0.251  Sum_probs=152.0

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|++||++|+|||||+++++|..++..||||||++ |+|++.+.. .+.+.++..+.++.|++.|+.|||++||+|||
T Consensus       223 v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD  301 (475)
T KOG0615|consen  223 VQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD  301 (475)
T ss_pred             hHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence            4689999999999999999999999999999999999 678888876 46789999999999999999999999999999


Q ss_pred             CCCcccccccc-chhhHHHHHHHHHhhcc--ccccCceeccccCCCcccccc-------cccccCCCeeEEEeecCCCCc
Q psy3074         349 VKPQNLLISEI-DHHNIRLFMFQLLRGLS--YCHRRRILHRDVKPQNLLISE-------IVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       349 lKp~NiLl~~~-~~~~ikl~dfgla~~~~--~~~~~~i~~~d~~~~~il~~~-------~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      |||||||+..+ ....+|++|||+|+...  ........+..|-+||++.+.       .++.||.||+++.+++|.+||
T Consensus       302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF  381 (475)
T KOG0615|consen  302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF  381 (475)
T ss_pred             CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence            99999999776 44669999999999774  233445567789999999643       457799999999999999999


Q ss_pred             cccccCc------ccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         419 WFESKSN------INLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       419 ~~~~~~~------~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      .......      ..|.+.|.+|....-..+...++..|+-=+
T Consensus       382 S~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~Vd  424 (475)
T KOG0615|consen  382 SEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVD  424 (475)
T ss_pred             ccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeC
Confidence            9765322      357777777755444445566666665444

>KOG0598|consensus

Probab=100.00  E-value=2.9e-35  Score=284.77  Aligned_cols=155  Identities=24%  Similarity=0.362  Sum_probs=133.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|..||..++||+||+++..|++...+|+|+||+.| +|...|. +.+.|+|..++.|+.+|+.||+|||++|||||
T Consensus        71 ~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyR  149 (357)
T KOG0598|consen   71 HTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYR  149 (357)
T ss_pred             HHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeec
Confidence            356799999999999999999999999999999999995 5666555 46789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||||||++..|+  ++++|||+|+.....                                   |      .....+|
T Consensus       150 DlKPENILLd~~GH--i~LtDFgL~k~~~~~-----------------------------------~------~~t~tfc  186 (357)
T KOG0598|consen  150 DLKPENILLDEQGH--IKLTDFGLCKEDLKD-----------------------------------G------DATRTFC  186 (357)
T ss_pred             cCCHHHeeecCCCc--EEEeccccchhcccC-----------------------------------C------Ccccccc
Confidence            99999999999999  999999999842210                                   0      0122378


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRS  467 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~  467 (481)
                      ||+.||||        +..+||||+|+++|||++|.+||+.......-
T Consensus       187 GT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~  234 (357)
T KOG0598|consen  187 GTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMY  234 (357)
T ss_pred             CCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHH
Confidence            99999999        78889999999999999999888776654433

>KOG0575|consensus

Probab=100.00  E-value=1.7e-34  Score=294.47  Aligned_cols=150  Identities=24%  Similarity=0.350  Sum_probs=134.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      +...+|++|.+.|+|||||+++++|++.+++|||.|+|+ +++..+++ ..+.++|..+++|++||+.||.|||+.+|||
T Consensus        63 eKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiH  141 (592)
T KOG0575|consen   63 EKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIH  141 (592)
T ss_pred             HHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCcee
Confidence            446789999999999999999999999999999999999 77777766 5678999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||..|++++++-+  +||+|||||..+++.+.+                                         +..+
T Consensus       142 RDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Er-----------------------------------------k~Tl  178 (592)
T KOG0575|consen  142 RDLKLGNLFLNENMN--VKIGDFGLATQLEYDGER-----------------------------------------KKTL  178 (592)
T ss_pred             cccchhheeecCcCc--EEecccceeeeecCcccc-----------------------------------------ccee
Confidence            999999999998777  999999999887755433                                         3458


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||||.|++|        +..+|+||+||+||.|+.|.+||-.+
T Consensus       179 CGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  179 CGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             cCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            899999999        88899999999999999999776554

>KOG0600|consensus

Probab=100.00  E-value=8.2e-36  Score=297.32  Aligned_cols=154  Identities=32%  Similarity=0.499  Sum_probs=138.3

Q ss_pred             hhhHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         267 PFTAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       267 ~~~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +..+.|||.||++|+|||||+|.+...+.  ..+|||+|||+.||.-++....-.|++.+++.||.|++.||+|||.+||
T Consensus       160 ~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gv  239 (560)
T KOG0600|consen  160 PITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGV  239 (560)
T ss_pred             hHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCe
Confidence            34567999999999999999999998876  6899999999999999887755579999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhcccc----ccCceeccccCCCcccccccc-----cccCCCeeEEEeecCC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC----HRRRILHRDVKPQNLLISEIV-----FTNLSGVVVSTVDSGS  415 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~----~~~~i~~~d~~~~~il~~~~~-----~~~s~g~~~~~~~~g~  415 (481)
                      +|||||.+|||||..|.  +||+|||||+.....    -+++|++.||+|||+++++.-     +.||.||++.|+..|+
T Consensus       240 lHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk  317 (560)
T KOG0600|consen  240 LHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK  317 (560)
T ss_pred             eeccccccceEEcCCCC--EEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence            99999999999999888  999999999965533    357899999999999987655     4699999999999999


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      +.+...+
T Consensus       318 PI~~G~t  324 (560)
T KOG0600|consen  318 PILQGRT  324 (560)
T ss_pred             CCcCCcc
Confidence            9998665

>KOG0659|consensus

Probab=100.00  E-value=5.4e-35  Score=270.74  Aligned_cols=157  Identities=34%  Similarity=0.490  Sum_probs=140.7

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ++...+++||+.+|+.++|+||+.+.|+|-..+.+.||+||++.+|...++.....++..+++.|+.+++.|++|||++.
T Consensus        42 dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~  121 (318)
T KOG0659|consen   42 DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW  121 (318)
T ss_pred             cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh
Confidence            45556799999999999999999999999999999999999999999999888788999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCccccccc-----ccccCCCeeEEEeecCC
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEI-----VFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~-----~~~~s~g~~~~~~~~g~  415 (481)
                      |+||||||.|+|++++|.  +|++|||+|+.+..-+   ..++++|||++|+++++..     +++|+.||++.|++.+.
T Consensus       122 IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~  199 (318)
T KOG0659|consen  122 ILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV  199 (318)
T ss_pred             hhcccCCccceEEcCCCc--EEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC
Confidence            999999999999999998  9999999999876332   2348999999999997654     45699999999999998


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      +-|...+
T Consensus       200 P~fpG~s  206 (318)
T KOG0659|consen  200 PFFPGDS  206 (318)
T ss_pred             CCCCCCc
Confidence            8777654

>KOG0659|consensus

Probab=100.00  E-value=1.1e-33  Score=262.03  Aligned_cols=163  Identities=36%  Similarity=0.693  Sum_probs=128.9

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+++|||++.|+||||||    .|+|++++    |.+||+||||||.+..+.+.                        
T Consensus       110 ~LkGl~y~H~~~IlHRDlKP----nNLLis~~----g~lKiADFGLAr~f~~p~~~------------------------  157 (318)
T KOG0659|consen  110 TLKGLAYCHSKWILHRDLKP----NNLLISSD----GQLKIADFGLARFFGSPNRI------------------------  157 (318)
T ss_pred             HHHHHHHHHhhhhhcccCCc----cceEEcCC----CcEEeecccchhccCCCCcc------------------------
Confidence            37899999999999999999    79999887    89999999999965432211                        


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                                 .+             ..+.|.||+|||+|+|+++|+..+||||+|||++||+-|.|-|+|.+|+ +|+.
T Consensus       158 -----------~~-------------~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-dQL~  212 (318)
T KOG0659|consen  158 -----------QT-------------HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-DQLS  212 (318)
T ss_pred             -----------cc-------------cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-HHHH
Confidence                       11             1234999999999999999999999999999999999999999996665 9999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEH  250 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~  250 (481)
                      .|++.+|+|.++.||+++.++.+.-...  .+.+.+..+||...        ...+....++...||..+
T Consensus       213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~--~P~~~~~~lf~aas--------~d~ldLl~~m~~ynP~~R  272 (318)
T KOG0659|consen  213 KIFRALGTPTPDQWPEMTSLPDYVKIQQ--FPKPPLNNLFPAAS--------SDALDLLSKMLTYNPKKR  272 (318)
T ss_pred             HHHHHcCCCCcccCccccccccHHHHhc--CCCCcccccccccc--------HHHHHHHHhhhccCchhc
Confidence            9999999999999999999998865542  22233333555543        122555556666666554

>KOG0616|consensus

Probab=100.00  E-value=7.6e-34  Score=266.71  Aligned_cols=148  Identities=26%  Similarity=0.371  Sum_probs=131.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCC-HHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|..+|+.+.||++|++++.|.+.+++||||||++|+ ++.++ +..++|++..++.|+.||+.|++|||+.+|++|
T Consensus        90 H~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~L-rk~~rF~e~~arFYAAeivlAleylH~~~iiYR  168 (355)
T KOG0616|consen   90 HTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYL-RKSGRFSEPHARFYAAEIVLALEYLHSLDIIYR  168 (355)
T ss_pred             HHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHH-HhcCCCCchhHHHHHHHHHHHHHHHHhcCeeec
Confidence            3456999999999999999999999999999999999965 55555 446789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||||||+|.+|+  +|++|||+|+.+...                                            ...+|
T Consensus       169 DLKPENiLlD~~G~--iKitDFGFAK~v~~r--------------------------------------------T~TlC  202 (355)
T KOG0616|consen  169 DLKPENLLLDQNGH--IKITDFGFAKRVSGR--------------------------------------------TWTLC  202 (355)
T ss_pred             cCChHHeeeccCCc--EEEEeccceEEecCc--------------------------------------------EEEec
Confidence            99999999999999  999999999865411                                            11378


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                      |||.|++|        +..+|||++|+++|||+.|.+||+.+..
T Consensus       203 GTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  203 GTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             CCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            99999999        7788999999999999999988887754

>KOG0594|consensus

Probab=100.00  E-value=2.6e-33  Score=270.88  Aligned_cols=162  Identities=46%  Similarity=0.760  Sum_probs=133.0

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.|++|||+++|+||||||    .|||++..    |.+||+|||+||....+..+                        
T Consensus       129 ll~gl~~~H~~~IlHRDLKP----QNlLi~~~----G~lKlaDFGlAra~~ip~~~------------------------  176 (323)
T KOG0594|consen  129 LLRGLAFLHSHGILHRDLKP----QNLLISSS----GVLKLADFGLARAFSIPMRT------------------------  176 (323)
T ss_pred             HHHHHHHHHhCCeecccCCc----ceEEECCC----CcEeeeccchHHHhcCCccc------------------------
Confidence            47899999999999999999    89999985    89999999999965443321                        


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                                 .|.             .++|.||+|||+|+|++.|+..+||||+|||++||+++++.|+|..+ .+|+.
T Consensus       177 -----------yt~-------------evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~  231 (323)
T KOG0594|consen  177 -----------YTP-------------EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLF  231 (323)
T ss_pred             -----------ccc-------------cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHH
Confidence                       222             23499999999999999999999999999999999999999999766 59999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhh
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD  241 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~  241 (481)
                      +|++.+|+|+++.||.++.++.++........+..+....|...  +.+.++..++++...
T Consensus       232 ~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~--~~~~dll~~~L~y~p  290 (323)
T KOG0594|consen  232 RIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLD--PDGIELLSKLLQYDP  290 (323)
T ss_pred             HHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccC--ccHHHHHHHHhccCc
Confidence            99999999999999999999988763333333455566666655  566677766666543

>KOG0605|consensus

Probab=99.98  E-value=5.5e-33  Score=279.35  Aligned_cols=196  Identities=21%  Similarity=0.242  Sum_probs=144.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ++.|..||...++|+||+|+.+|++.+++||||||++| |...+|. ..+.|+++.++.|+.+++.|++.+|..|+||||
T Consensus       188 V~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~-~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRD  266 (550)
T KOG0605|consen  188 VRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLM-RKDTLTEDWARFYIAETVLAIESIHQLGYIHRD  266 (550)
T ss_pred             HHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHH-hcCcCchHHHHHHHHHHHHHHHHHHHcCccccc
Confidence            45699999999999999999999999999999999995 5555554 467899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecC--CCCccccc----
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSG--SGGWWFES----  422 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g--~~~~~~~~----  422 (481)
                      |||+|+|||..||  +|+.||||+.++.-.|.... ++.....+.-+.+.          ...++-  ..+....+    
T Consensus       267 IKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~-~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~  333 (550)
T KOG0605|consen  267 IKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIES-YRLDEQMQINLSEA----------KPSDFPKFNTPRSTMSRREQ  333 (550)
T ss_pred             CChhheeecCCCC--Eeeccccccchhhhhhhhhh-hcchhhhhhhhccC----------CCccccccccccchhhHHHH
Confidence            9999999999999  99999999988764332110 00000000000000          000000  01111100    


Q ss_pred             -----------cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCc--eeEEEeeeecccC
Q psy3074         423 -----------KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVLFPT  480 (481)
Q Consensus       423 -----------~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  480 (481)
                                 ....+|||.||||        +.-+||||+||+||||+-|.+||. ...|..+  ++.-|.+.|.||.
T Consensus       334 ~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~-s~tp~~T~rkI~nwr~~l~fP~  411 (550)
T KOG0605|consen  334 LQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFC-SETPQETYRKIVNWRETLKFPE  411 (550)
T ss_pred             HHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhhhccCCC
Confidence                       1236899999999        778899999999999999995555 4445444  7777888888874

>KOG0594|consensus

Probab=99.97  E-value=1.8e-32  Score=265.02  Aligned_cols=153  Identities=39%  Similarity=0.546  Sum_probs=130.5

Q ss_pred             ChhhHHHHHHHHhhcCCCC-eeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhc---CCCChHHHHHHHHHHHHH
Q psy3074         266 APFTAIREASLLKELKHNN-IVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHS---GGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       266 ~~~~~~rE~~il~~l~Hpn-IV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~  335 (481)
                      .+..++||+.+|+.|+|+| ||+|++++.+.+      .+++|+||++-+|..++....   .+++...++.+++|++.|
T Consensus        53 ~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~g  132 (323)
T KOG0594|consen   53 VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRG  132 (323)
T ss_pred             CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHH
Confidence            3456789999999999999 999999999877      899999999999999998766   468888999999999999


Q ss_pred             HHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccc---cccCceeccccCCCcccccccc-----cccCCCee
Q psy3074         336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY---CHRRRILHRDVKPQNLLISEIV-----FTNLSGVV  407 (481)
Q Consensus       336 l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~---~~~~~i~~~d~~~~~il~~~~~-----~~~s~g~~  407 (481)
                      |+|||+++|+||||||+|||+++.|.  +|++|||+|++...   .-+..+++.||+||+++++...     +.||.||+
T Consensus       133 l~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI  210 (323)
T KOG0594|consen  133 LAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI  210 (323)
T ss_pred             HHHHHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence            99999999999999999999999887  99999999998762   1245689999999999987643     34666666


Q ss_pred             EEEeecCCCCccc
Q psy3074         408 VSTVDSGSGGWWF  420 (481)
Q Consensus       408 ~~~~~~g~~~~~~  420 (481)
                      +.+|.++.+-|..
T Consensus       211 faEm~~~~~LFpG  223 (323)
T KOG0594|consen  211 FAEMFTRRPLFPG  223 (323)
T ss_pred             HHHHHhCCCCCCC
Confidence            6666666655544

>KOG0663|consensus

Probab=99.97  E-value=4e-33  Score=265.51  Aligned_cols=156  Identities=28%  Similarity=0.377  Sum_probs=136.1

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      ++.+...+||+.+|.+++|||||.+.++...  -+.+|||||||+.||...+......|....++.++.|++.|++|||.
T Consensus       116 ~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~  195 (419)
T KOG0663|consen  116 EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD  195 (419)
T ss_pred             CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh
Confidence            3445567899999999999999999998864  45799999999999999998887789999999999999999999999


Q ss_pred             CceeeccCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCccccccc-----ccccCCCeeEEEeec
Q psy3074         342 RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLISEI-----VFTNLSGVVVSTVDS  413 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~~~-----~~~~s~g~~~~~~~~  413 (481)
                      +.|+||||||+|+|++..|.  +|++|||+||.....   .++-+++-||+||+++++..     +++||.||++.+++.
T Consensus       196 ~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~  273 (419)
T KOG0663|consen  196 NWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT  273 (419)
T ss_pred             ceeEecccchhheeeccCCc--EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence            99999999999999999998  999999999988755   45779999999999997644     446788888888877


Q ss_pred             CCCCcccc
Q psy3074         414 GSGGWWFE  421 (481)
Q Consensus       414 g~~~~~~~  421 (481)
                      +.+-|...
T Consensus       274 ~kPlf~G~  281 (419)
T KOG0663|consen  274 QKPLFPGK  281 (419)
T ss_pred             cCCCCCCC
Confidence            77766554

>KOG0663|consensus

Probab=99.97  E-value=1.1e-32  Score=262.58  Aligned_cols=168  Identities=40%  Similarity=0.652  Sum_probs=136.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .|.|+.|||.+.|+||||||    +|+|++..    |.+|||||||||..+.+.                          
T Consensus       186 lL~glk~lH~~wilHRDLK~----SNLLm~~~----G~lKiaDFGLAR~ygsp~--------------------------  231 (419)
T KOG0663|consen  186 LLRGLKHLHDNWILHRDLKT----SNLLLSHK----GILKIADFGLAREYGSPL--------------------------  231 (419)
T ss_pred             HHHHHHHHhhceeEecccch----hheeeccC----CcEEecccchhhhhcCCc--------------------------
Confidence            37899999999999999999    99999987    899999999999654321                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                               ..+|..+             +|.||+|||+|+|.+.|++++|+||+|||++||++++|.|+|..+ .+|++
T Consensus       232 ---------k~~T~lV-------------VTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-~dQl~  288 (419)
T KOG0663|consen  232 ---------KPYTPLV-------------VTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-IDQLD  288 (419)
T ss_pred             ---------ccCcceE-------------EEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-HHHHH
Confidence                     2234444             399999999999999999999999999999999999999999655 59999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCcccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV  251 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~~  251 (481)
                      +|++.+|+|++..||+.+.++..+....++.+-..+...|+...-..      ..+...+.....+|..+.
T Consensus       289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse------~g~~Lln~llt~dP~kR~  353 (419)
T KOG0663|consen  289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSE------QGFDLLNKLLTYDPGKRI  353 (419)
T ss_pred             HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccch------hHHHHHHHHhccCccccc
Confidence            99999999999999999999988777777777666666666554112      234445555555665543

>KOG0600|consensus

Probab=99.97  E-value=1.6e-32  Score=273.92  Aligned_cols=146  Identities=42%  Similarity=0.739  Sum_probs=120.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+|||||.    +|||||..    |++||+||||||......                          
T Consensus       227 Ll~Gl~~cH~~gvlHRDIK~----SNiLidn~----G~LKiaDFGLAr~y~~~~--------------------------  272 (560)
T KOG0600|consen  227 LLEGLEYCHSRGVLHRDIKG----SNILIDNN----GVLKIADFGLARFYTPSG--------------------------  272 (560)
T ss_pred             HHHHHHHHhhcCeeeccccc----cceEEcCC----CCEEeccccceeeccCCC--------------------------
Confidence            58899999999999999999    99999988    899999999999532110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                              ...+|+.+|             |+||+|||+|+|.+.|+.++|+||+|||+.||++|+|.|+|.+++ +|+.
T Consensus       273 --------~~~~T~rVv-------------TLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~  330 (560)
T KOG0600|consen  273 --------SAPYTSRVV-------------TLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLH  330 (560)
T ss_pred             --------CcccccceE-------------EeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHH
Confidence                    112344443             999999999999999999999999999999999999999996655 9999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRL  223 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (481)
                      +|++.||+|.++.|+ ...++.+...+........+++.|..+
T Consensus       331 kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~  372 (560)
T KOG0600|consen  331 KIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDF  372 (560)
T ss_pred             HHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccC
Confidence            999999999999999 888886665554444445555554444

>KOG0660|consensus

Probab=99.97  E-value=7.4e-33  Score=267.20  Aligned_cols=189  Identities=32%  Similarity=0.543  Sum_probs=151.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .|.||.|+|+.+|+||||||    +|+|+|.+.    .+|||||||||.....                        ...
T Consensus       134 iLrgLKyiHSAnViHRDLKP----sNll~n~~c----~lKI~DFGLAR~~~~~------------------------~~~  181 (359)
T KOG0660|consen  134 ILRGLKYIHSANVIHRDLKP----SNLLLNADC----DLKICDFGLARYLDKF------------------------FED  181 (359)
T ss_pred             HHHhcchhhcccccccccch----hheeeccCC----CEEeccccceeecccc------------------------Ccc
Confidence            48899999999999999999    999999985    8899999999954211                        112


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ++.+                      +++.|.||+|||+++....|+.++||||+|||++|||+|++.|+| .+..+|++
T Consensus       182 ~~mT----------------------eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG-~d~v~Ql~  238 (359)
T KOG0660|consen  182 GFMT----------------------EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG-KDYVHQLQ  238 (359)
T ss_pred             cchh----------------------cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC-CchHHHHH
Confidence            2222                      234499999999999999999999999999999999999999999 56669999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCc-cCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCccccccccccCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNV-HRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGG  259 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~~~~~~~~~~  259 (481)
                      .|.+.+|+|+++....+........ ...+..++..|...||..+        ..++..+.++...+|.+++.       
T Consensus       239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~--------p~AidLlekmL~fdP~kRit-------  303 (359)
T KOG0660|consen  239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN--------PLAIDLLEKMLVFDPKKRIT-------  303 (359)
T ss_pred             HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC--------HHHHHHHHHHhccCccccCC-------
Confidence            9999999999998888875544443 4577788888999999776        23455566667777776543       


Q ss_pred             CCCCCCChhhHHHHHHHHhhcCCCCeeEEeeeeecC
Q psy3074         260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTR  295 (481)
Q Consensus       260 ~~~~~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~  295 (481)
                                      +-..|.||.+..+++.-.++
T Consensus       304 ----------------a~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  304 ----------------AEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             ----------------HHHHhcChhhhhhcCCccCC
Confidence                            33468899999988866554

>KOG0661|consensus

Probab=99.97  E-value=2.1e-33  Score=278.24  Aligned_cols=150  Identities=29%  Similarity=0.447  Sum_probs=137.2

Q ss_pred             HHHHHHHhhcC-CCCeeEEeeeeecCC-eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASLLKELK-HNNIVTLHDIVHTRS-TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~il~~l~-HpnIV~l~~~~~~~~-~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +||+..|++|+ |||||++++++.+++ .+|+|||||+.+|.++++.+...|++..++.|+.||+.||+|+|.+|+.|||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRD  135 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRD  135 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCccccc
Confidence            58999999999 999999999999988 9999999999999999998888899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcccc--ccCceeccccCCCccccccccc-----ccCCCeeEEEeecCCCCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLISEIVF-----TNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~~~~~~-----~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      +||||||+.....  |||+|||+||.+..-  -+..|-+|||++||+++...+|     .|+.||+++|+.+-.+-|.++
T Consensus       136 lKPENiLi~~~~~--iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~  213 (538)
T KOG0661|consen  136 LKPENILISGNDV--IKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA  213 (538)
T ss_pred             CChhheEecccce--eEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence            9999999986555  999999999988632  2467899999999999866655     599999999999999999877


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      +
T Consensus       214 s  214 (538)
T KOG0661|consen  214 S  214 (538)
T ss_pred             c
Confidence            6

>KOG0591|consensus

Probab=99.97  E-value=1.1e-32  Score=257.02  Aligned_cols=157  Identities=27%  Similarity=0.338  Sum_probs=131.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEee-eeecCCe-EEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         268 FTAIREASLLKELKHNNIVTLHD-IVHTRST-LTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~-~~~~~~~-~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .....|+.+|++|+|||||++++ .|.+++. ++||||||+ |||.+.+...   ...++|..++.++.|++.||..||.
T Consensus        63 q~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~  142 (375)
T KOG0591|consen   63 QDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHS  142 (375)
T ss_pred             HHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhc
Confidence            34567999999999999999998 6666665 999999998 8998888643   3569999999999999999999998


Q ss_pred             --Cc--eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         342 --RR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       342 --~~--iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                        .+  |+||||||.||+++.+|.  +|+.|||+++.+....+                                     
T Consensus       143 ~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~t-------------------------------------  183 (375)
T KOG0591|consen  143 KIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKTT-------------------------------------  183 (375)
T ss_pred             cccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchhH-------------------------------------
Confidence              44  999999999999999888  99999999997762210                                     


Q ss_pred             ccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCc
Q psy3074         418 WWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRS  467 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~  467 (481)
                      |    ....+|||+||+|        +..+|+||+||++|||-.=..||+.+..-++.
T Consensus       184 f----A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~  237 (375)
T KOG0591|consen  184 F----AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLC  237 (375)
T ss_pred             H----HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHH
Confidence            0    1126799999999        77789999999999999888899888665544

>KOG0597|consensus

Probab=99.97  E-value=6.1e-32  Score=271.94  Aligned_cols=153  Identities=29%  Similarity=0.423  Sum_probs=134.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ...+|++|++.++|||||.++++|++..++|+|.|||.|+|..++.. .+.++|+.++.++.+++.||.|||+.+|+|||
T Consensus        47 ~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd  125 (808)
T KOG0597|consen   47 NLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRD  125 (808)
T ss_pred             HHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCccccc
Confidence            46789999999999999999999999999999999999999888865 57899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      +||.|||++..+.  +|+||||+|+++....  .+                                       ...+.|
T Consensus       126 ~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t--~v---------------------------------------ltsikG  162 (808)
T KOG0597|consen  126 MKPQNILLEKGGT--LKLCDFGLARAMSTNT--SV---------------------------------------LTSIKG  162 (808)
T ss_pred             CCcceeeecCCCc--eeechhhhhhhcccCc--ee---------------------------------------eeeccC
Confidence            9999999998888  9999999999876210  00                                       123679


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHT  465 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~  465 (481)
                      ||.||+|        +..+|.||+||++|||..|.+||+...+-.
T Consensus       163 tPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~  207 (808)
T KOG0597|consen  163 TPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ  207 (808)
T ss_pred             cccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH
Confidence            9999999        555699999999999999999998765433

>KOG0662|consensus

Probab=99.97  E-value=1.9e-31  Score=234.08  Aligned_cols=156  Identities=39%  Similarity=0.678  Sum_probs=139.6

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ++.+.+++||+-+|+.++|.|||+++++...+..+.+|+|||+.+|..+....++.++.+.++.++.|++.||.|||+.+
T Consensus        42 egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn  121 (292)
T KOG0662|consen   42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN  121 (292)
T ss_pred             CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh
Confidence            45566789999999999999999999999999999999999999999999988899999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhcc---ccccCceeccccCCCcccccccc-----cccCCCeeEEEeec-C
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCHRRRILHRDVKPQNLLISEIV-----FTNLSGVVVSTVDS-G  414 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~---~~~~~~i~~~d~~~~~il~~~~~-----~~~s~g~~~~~~~~-g  414 (481)
                      ++|||+||.|+|++.+|+  +|++|||+|+++.   .|-+-.+++-+|+||.++++...     +.||.||++.++.. |
T Consensus       122 vlhrdlkpqnllin~nge--lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag  199 (292)
T KOG0662|consen  122 VLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG  199 (292)
T ss_pred             hhhccCCcceEEeccCCc--EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence            999999999999999998  9999999999887   35567789999999999976555     46999999888766 5


Q ss_pred             CCCcccc
Q psy3074         415 SGGWWFE  421 (481)
Q Consensus       415 ~~~~~~~  421 (481)
                      .+-|...
T Consensus       200 rplfpg~  206 (292)
T KOG0662|consen  200 RPLFPGN  206 (292)
T ss_pred             CCCCCCC
Confidence            5555543

>KOG0592|consensus

Probab=99.97  E-value=1.4e-30  Score=261.99  Aligned_cols=161  Identities=25%  Similarity=0.375  Sum_probs=133.5

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|-.+|.+| .||.||+|+-.|+|+..+|+|+||++ |+|++++.+. +.|++.++++|+.||+.|++|||++|||||
T Consensus       120 V~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHR  198 (604)
T KOG0592|consen  120 VTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHR  198 (604)
T ss_pred             hhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceec
Confidence            34688999999 79999999999999999999999998 8999998775 789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||||||++.+++  +||+|||.|+.+...+...- +...                           ..........++
T Consensus       199 DlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~-~~~~---------------------------~~~a~s~~~SFV  248 (604)
T KOG0592|consen  199 DLKPENILLDKDGH--IKITDFGSAKILSPSQKSQE-NPVD---------------------------PNQASSRRSSFV  248 (604)
T ss_pred             cCChhheeEcCCCc--EEEeeccccccCChhhcccc-CccC---------------------------cccccCccccee
Confidence            99999999999999  99999999998774332211 0000                           000000024589


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ||..|.+|        +..+|+|.+||+||-|+.|. |+|.+.
T Consensus       249 GTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~-PPFra~  290 (604)
T KOG0592|consen  249 GTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQ-PPFRAA  290 (604)
T ss_pred             eeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCC-CCCccc
Confidence            99999999        88889999999999999998 445443

>KOG0583|consensus

Probab=99.97  E-value=1.4e-30  Score=264.61  Aligned_cols=161  Identities=26%  Similarity=0.372  Sum_probs=130.6

Q ss_pred             HHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .||+.+++.++ ||||+++++++.....+|+|||||. |+|++.+.. .+.+.|..++.+++|++.|++|||++||+|||
T Consensus        67 ~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRD  145 (370)
T KOG0583|consen   67 KREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRD  145 (370)
T ss_pred             HHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCC
Confidence            47999999999 9999999999999999999999999 589999988 78899999999999999999999999999999


Q ss_pred             CCCcccccccc-chhhHHHHHHHHHhhcc---ccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         349 VKPQNLLISEI-DHHNIRLFMFQLLRGLS---YCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       349 lKp~NiLl~~~-~~~~ikl~dfgla~~~~---~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||||++.+ +.  +|++|||++....   ..-....++..|.+||++.+..                          
T Consensus       146 LK~ENilld~~~~~--~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~--------------------------  197 (370)
T KOG0583|consen  146 LKPENILLDGNEGN--LKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKG--------------------------  197 (370)
T ss_pred             CCHHHEEecCCCCC--EEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCC--------------------------
Confidence            99999999987 55  9999999998652   1112222333333333332210                          


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCccccccccccCce
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRST  468 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~~  468 (481)
                            .|.  +.+.|+||+|++||.|++|..||-+...+.+.+
T Consensus       198 ------~Y~--g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~  233 (370)
T KOG0583|consen  198 ------TYS--GKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR  233 (370)
T ss_pred             ------CcC--CchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence                  011  677899999999999999999888866665543

>KOG0611|consensus

Probab=99.96  E-value=1.7e-30  Score=252.45  Aligned_cols=151  Identities=24%  Similarity=0.469  Sum_probs=125.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+||++||+.|+||||+.+|++|+..+.+.|||||.. |+|.+++... +.+++..++.|++||+.|+.|||.++++||
T Consensus        99 hIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHR  177 (668)
T KOG0611|consen   99 HIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHR  177 (668)
T ss_pred             HHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceec
Confidence            46789999999999999999999999999999999998 7899988764 679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      |||.+|||+|.+++  +||+|||++....   ..+.                                       .+.+|
T Consensus       178 DLKLENILLD~N~N--iKIADFGLSNly~---~~kf---------------------------------------LqTFC  213 (668)
T KOG0611|consen  178 DLKLENILLDQNNN--IKIADFGLSNLYA---DKKF---------------------------------------LQTFC  213 (668)
T ss_pred             ccchhheeecCCCC--eeeeccchhhhhc---cccH---------------------------------------HHHhc
Confidence            99999999998877  9999999986432   1110                                       01244


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCcccccccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDIVHT  465 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~  465 (481)
                      |++.|-+|         |+-+|.|++|++||.|.||-.| |++-+|.
T Consensus       214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP-FDG~Dhk  259 (668)
T KOG0611|consen  214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP-FDGRDHK  259 (668)
T ss_pred             CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc-cCCchHH
Confidence            55555554         6667999999999999999854 5555543

>KOG0581|consensus

Probab=99.96  E-value=9.1e-31  Score=253.68  Aligned_cols=146  Identities=22%  Similarity=0.323  Sum_probs=117.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCe-EEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Ccee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRST-LTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~-~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~ii  345 (481)
                      +..||++|++.++||+||++|++|..+.. ++|+||||+ |+|..++.. .++++|..+..++.+++.||.|||+ .+||
T Consensus       123 Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~II  201 (364)
T KOG0581|consen  123 QILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKII  201 (364)
T ss_pred             HHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCee
Confidence            45689999999999999999999999995 999999999 566666554 4789999999999999999999995 9999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccc-cccCceeccccCCCcccccccc----cccCCCeeEEEeecCCCC
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY-CHRRRILHRDVKPQNLLISEIV----FTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~-~~~~~i~~~d~~~~~il~~~~~----~~~s~g~~~~~~~~g~~~  417 (481)
                      ||||||+|||+++.|+  |||||||+++.+.. .....+.|+.|++||=+-++.+    |.||+|..+.|+..|..|
T Consensus       202 HRDIKPsNlLvNskGe--VKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP  276 (364)
T KOG0581|consen  202 HRDIKPSNLLVNSKGE--VKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFP  276 (364)
T ss_pred             eccCCHHHeeeccCCC--EEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCC
Confidence            9999999999999888  99999999987653 2344566666666655544333    346666666665555544

>KOG0585|consensus

Probab=99.96  E-value=8.9e-31  Score=259.41  Aligned_cols=174  Identities=24%  Similarity=0.348  Sum_probs=130.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +...||+.||++|+|||||+|+++..++  +.+|||+|||..+-..........+++.+++.|++.++.||+|||.+|||
T Consensus       153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgii  232 (576)
T KOG0585|consen  153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGII  232 (576)
T ss_pred             HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCee
Confidence            4567899999999999999999999886  47999999999544443332222389999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|+|++++++  +||+|||++.....-..                                .|..    .....
T Consensus       233 HRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~--------------------------------~~~d----~~L~~  274 (576)
T KOG0585|consen  233 HRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSD--------------------------------EGSD----DQLSR  274 (576)
T ss_pred             ccccchhheEEcCCCc--EEeeccceeeecccCCc--------------------------------cccH----HHHhh
Confidence            9999999999999988  99999998864321100                                0000    00112


Q ss_pred             ccceeccCCC------------CCChhhhhhHHHHHHhhCCCccccccccccCceeEEEeeeecccC
Q psy3074         426 INLSFHYLPP------------GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPT  480 (481)
Q Consensus       426 ~~~t~~y~~p------------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  480 (481)
                      .+|||.+++|            +..-|+|++|+.||-|+.|..||+.+..-.+- --++-+-|.||.
T Consensus       275 tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~-~KIvn~pL~fP~  340 (576)
T KOG0585|consen  275 TVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF-DKIVNDPLEFPE  340 (576)
T ss_pred             cCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH-HHHhcCcccCCC
Confidence            4566666666            55669999999999999999999887543322 123444555553

>KOG0610|consensus

Probab=99.96  E-value=1.6e-30  Score=254.14  Aligned_cols=206  Identities=21%  Similarity=0.232  Sum_probs=151.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.-|.+||+.++||+++.||..|+.+...|++||||+ |+|..+++++. +.|++..++.|+.+++.||+|||-.|||.|
T Consensus       124 a~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYR  203 (459)
T KOG0610|consen  124 AQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYR  203 (459)
T ss_pred             HHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeec
Confidence            4559999999999999999999999999999999999 56776666554 469999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceecc-ccC-----CCcc------cccccccccCCCeeEEEeecCC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHR-DVK-----PQNL------LISEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~-d~~-----~~~i------l~~~~~~~~s~g~~~~~~~~g~  415 (481)
                      ||||||||+-++|+  |-+.||.|+....  ..+.++.. +..     +...      +.+........+-.-.....++
T Consensus       204 DLKPENILvredGH--IMLsDFDLS~~~~--~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~  279 (459)
T KOG0610|consen  204 DLKPENILVREDGH--IMLSDFDLSLRCP--VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS  279 (459)
T ss_pred             cCCcceeEEecCCc--EEeeeccccccCC--CCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence            99999999999999  8888888877542  11111111 000     0011      1100000000000000000122


Q ss_pred             CCcc-----ccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCceeEEEeeeecccC
Q psy3074         416 GGWW-----FESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLFPT  480 (481)
Q Consensus       416 ~~~~-----~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  480 (481)
                      .|-.     ......++||.+|++|        +..+|||.+|++||||++|. ++|.+-.-..+..++|-.-+.||.
T Consensus       280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~-TPFKG~~~~~Tl~NIv~~~l~Fp~  356 (459)
T KOG0610|consen  280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGT-TPFKGSNNKETLRNIVGQPLKFPE  356 (459)
T ss_pred             chhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCC-CCcCCCCchhhHHHHhcCCCcCCC
Confidence            3311     2224568999999999        88899999999999999997 777888888888899999999986

>KOG0660|consensus

Probab=99.96  E-value=5.9e-31  Score=254.05  Aligned_cols=197  Identities=24%  Similarity=0.355  Sum_probs=153.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeec-----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHT-----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~-----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .++.||+.+|+.++|+|||.+.+++..     -+.+|+|+|+|+.||.+.++.. ..+++..++.++.|++.||.|+|+.
T Consensus        66 kRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSA  144 (359)
T KOG0660|consen   66 KRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSA  144 (359)
T ss_pred             HHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcc
Confidence            357899999999999999999999976     2479999999999999988764 3499999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhcc-----ccccCceeccccCCCccccc-----ccccccCCCeeEEEee
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS-----YCHRRRILHRDVKPQNLLIS-----EIVFTNLSGVVVSTVD  412 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~-----~~~~~~i~~~d~~~~~il~~-----~~~~~~s~g~~~~~~~  412 (481)
                      +|+||||||.|+|++.+..  +|++|||+||...     .-.+..+.||||++|++++.     ..++.||.||++.+|+
T Consensus       145 nViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL  222 (359)
T KOG0660|consen  145 NVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML  222 (359)
T ss_pred             cccccccchhheeeccCCC--EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence            9999999999999998777  8999999999883     34478899999999999964     4556799999999999


Q ss_pred             cCCCCccccccCcccceeccCCCCCChhhh------hhHHHHHHhhCCCccccccccccCc
Q psy3074         413 SGSGGWWFESKSNINLSFHYLPPGAPFTAI------REASLLKELKHNNIVTLHDIVHTRS  467 (481)
Q Consensus       413 ~g~~~~~~~~~~~~~~t~~y~~p~~p~~~~------s~~~~l~~l~~~~~~~~~~~~~~~~  467 (481)
                      +|++-|.+...-.-....-...|.++.+..      ..-..+..+-.-...+|.+++|+.+
T Consensus       223 ~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~  283 (359)
T KOG0660|consen  223 TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNAN  283 (359)
T ss_pred             cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCC
Confidence            999999876521111111111121122111      1223555555555566777777665

>KOG0593|consensus

Probab=99.96  E-value=1.1e-30  Score=245.86  Aligned_cols=167  Identities=28%  Similarity=0.559  Sum_probs=129.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.|+.|||++++|||||||    +|||+...    |++||||||+||....+                          |
T Consensus       110 ~l~ai~~cHk~n~IHRDIKP----ENILit~~----gvvKLCDFGFAR~L~~p--------------------------g  155 (396)
T KOG0593|consen  110 LLKAIHFCHKNNCIHRDIKP----ENILITQN----GVVKLCDFGFARTLSAP--------------------------G  155 (396)
T ss_pred             HHHHhhhhhhcCeecccCCh----hheEEecC----CcEEeccchhhHhhcCC--------------------------c
Confidence            47899999999999999999    89999887    89999999999965322                          2


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .   .|                   +.++.|+||+|||++.|..+|+.++||||+||++.||++|.|.|||.+|+ |||-
T Consensus       156 d---~Y-------------------TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi-DQLy  212 (396)
T KOG0593|consen  156 D---NY-------------------TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI-DQLY  212 (396)
T ss_pred             c---hh-------------------hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH-HHHH
Confidence            2   11                   22445999999999999999999999999999999999999999997665 9999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCC-CccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCccccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDA-PYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      .|.+.+|...+....-.+..+.+.-.+.| +..+..++..+|.+..        ..+....+....+|.++..
T Consensus       213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~--------~~ld~~k~cL~~dP~~R~s  277 (396)
T KOG0593|consen  213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISN--------VLLDLLKKCLKMDPDDRLS  277 (396)
T ss_pred             HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchH--------HHHHHHHHHhcCCcccccc
Confidence            99999999888777766666666555444 3334556666666652        2344455555566655443

>KOG0661|consensus

Probab=99.96  E-value=1.9e-30  Score=257.39  Aligned_cols=166  Identities=31%  Similarity=0.490  Sum_probs=137.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+|+++|++|+.|||+||    +|||+...    ..+||+||||||.....                           
T Consensus       119 ilqGL~hiHk~GfFHRDlKP----ENiLi~~~----~~iKiaDFGLARev~Sk---------------------------  163 (538)
T KOG0661|consen  119 ILQGLAHIHKHGFFHRDLKP----ENILISGN----DVIKIADFGLAREVRSK---------------------------  163 (538)
T ss_pred             HHHHHHHHHhcCcccccCCh----hheEeccc----ceeEecccccccccccC---------------------------
Confidence            68899999999999999999    89999843    38999999999953210                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                                            +..++++-|+||||||+|+.+..|+.++|+||+|||++|+++-+|.|+|.++. ||+-
T Consensus       164 ----------------------pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~  220 (538)
T KOG0661|consen  164 ----------------------PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIY  220 (538)
T ss_pred             ----------------------CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHH
Confidence                                  12235566999999999999999999999999999999999999999997665 9999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCccccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      +|.+.+|+|..+.|+.-..+...--.+.|...+..+..++|.+.        ......+.++..|||.++.-
T Consensus       221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s--------~~~~~li~~ll~WDP~kRpT  284 (538)
T KOG0661|consen  221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNAS--------SEAASLIERLLAWDPDKRPT  284 (538)
T ss_pred             HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccC--------HHHHHHHHHHhcCCCccCcc
Confidence            99999999999999987655555556677777777888877754        34566677788888887653

>KOG0662|consensus

Probab=99.96  E-value=1.3e-29  Score=222.52  Aligned_cols=159  Identities=43%  Similarity=0.824  Sum_probs=130.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+|.|||+++|+||||||    .|.|+|.+    |.+||+|||+||.+..+..                         
T Consensus       110 llrgl~fchshnvlhrdlkp----qnllin~n----gelkladfglarafgipvr-------------------------  156 (292)
T KOG0662|consen  110 LLRGLGFCHSHNVLHRDLKP----QNLLINRN----GELKLADFGLARAFGIPVR-------------------------  156 (292)
T ss_pred             HHhhhhhhhhhhhhhccCCc----ceEEeccC----CcEEecccchhhhcCCceE-------------------------
Confidence            47789999999999999999    89999988    8999999999996543211                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCchhhHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGVREVYDQL  179 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~g~~~~~~~l  179 (481)
                          .      .+.+             ++|.||++|.|+.|.+-|++++|+||.|||++|+.. |+|.|+| +++.+|+
T Consensus       157 ----c------ysae-------------vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddql  212 (292)
T KOG0662|consen  157 ----C------YSAE-------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQL  212 (292)
T ss_pred             ----e------eece-------------eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHH
Confidence                1      2223             349999999999999999999999999999999986 9999999 7888999


Q ss_pred             HHHHHHhCCCCccCcccccCCCCCCccCCCCccC-CCcCcCCCCccCCCcchhHHHHHHhhh
Q psy3074         180 DKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTG-NKLGLTFPRLYDIPEGESMASAFLQVR  240 (481)
Q Consensus       180 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~g~~~a~~ll~v~  240 (481)
                      .+|++.+|+|.++.||.++.++.+...  |-++. .++..+.|.+.  ..|+++.++++.-+
T Consensus       213 krif~~lg~p~ed~wps~t~lpdyk~y--p~ypattswsqivp~ln--s~grdllqkll~cn  270 (292)
T KOG0662|consen  213 KRIFRLLGTPTEDQWPSMTKLPDYKPY--PIYPATTSWSQIVPKLN--STGRDLLQKLLKCN  270 (292)
T ss_pred             HHHHHHhCCCccccCCccccCCCCccc--CCccccchHHHHhhhhc--chhHHHHHHHhccC
Confidence            999999999999999999999877532  22222 45677788876  56777777665543

>KOG0658|consensus

Probab=99.96  E-value=1.1e-29  Score=245.81  Aligned_cols=121  Identities=33%  Similarity=0.669  Sum_probs=106.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||.|||+.||.||||||    .|+|++...   |.+||||||.|+...                           .|
T Consensus       134 lfrgl~yLh~~~IcHRDIKP----qNlLvD~~t---g~LKicDFGSAK~L~---------------------------~~  179 (364)
T KOG0658|consen  134 LFRGLAYLHSHGICHRDIKP----QNLLVDPDT---GVLKICDFGSAKVLV---------------------------KG  179 (364)
T ss_pred             HHHHHHHHHhcCcccCCCCh----heEEEcCCC---CeEEeccCCcceeec---------------------------cC
Confidence            36799999999999999999    899999775   999999999998643                           22


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .-..+|.+                      |++|||||.++|.+.|+.++||||+||+++||+-|++.|+| ++..+|+.
T Consensus       180 epniSYic----------------------SRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG-~s~~dQL~  236 (364)
T KOG0658|consen  180 EPNISYIC----------------------SRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG-DSSVDQLV  236 (364)
T ss_pred             CCceeEEE----------------------eccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC-CCHHHHHH
Confidence            22345555                      99999999999999999999999999999999999999999 56669999


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      .|++.+|+|+.+....+.
T Consensus       237 eIik~lG~Pt~e~I~~mn  254 (364)
T KOG0658|consen  237 EIIKVLGTPTREDIKSMN  254 (364)
T ss_pred             HHHHHhCCCCHHHHhhcC
Confidence            999999999998776553

>KOG0694|consensus

Probab=99.96  E-value=3.6e-30  Score=265.66  Aligned_cols=148  Identities=22%  Similarity=0.256  Sum_probs=126.7

Q ss_pred             hhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      +..+.|.+|+.... ||++++|+..|++++++|+||||+.|+.+ +...+.+.|++..++.|++.|+.||+|||++|||+
T Consensus       413 e~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIY  491 (694)
T KOG0694|consen  413 ESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIY  491 (694)
T ss_pred             HHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            45667888888776 99999999999999999999999996552 22334578999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||.+|||+|..|+  +||+|||+++..-                 .                        .....+.+
T Consensus       492 RDlKLdNiLLD~eGh--~kiADFGlcKe~m-----------------~------------------------~g~~TsTf  528 (694)
T KOG0694|consen  492 RDLKLDNLLLDTEGH--VKIADFGLCKEGM-----------------G------------------------QGDRTSTF  528 (694)
T ss_pred             eecchhheEEcccCc--EEecccccccccC-----------------C------------------------CCCccccc
Confidence            999999999999999  9999999997311                 0                        11223458


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      |||+.||+|        +..+|||++|++||||+.|..||-
T Consensus       529 CGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~  569 (694)
T KOG0694|consen  529 CGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP  569 (694)
T ss_pred             cCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence            999999999        778899999999999999986665

>KOG0612|consensus

Probab=99.95  E-value=1.2e-29  Score=272.53  Aligned_cols=176  Identities=20%  Similarity=0.208  Sum_probs=140.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      |..|..||...+.++||+++.+|+++.++|+||||++ |||..++.+.. .+++..+++|+.+|+.||.-+|+.|.||||
T Consensus       122 F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRD  200 (1317)
T KOG0612|consen  122 FREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRD  200 (1317)
T ss_pred             HHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence            4458899999999999999999999999999999998 78988888765 899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||+|||++..||  ||++|||.|-.+....    +..|+|+||-+|+|+-+-..                         
T Consensus       201 iKPDNvLld~~GH--ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~-------------------------  253 (1317)
T KOG0612|consen  201 IKPDNVLLDKSGH--IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGD-------------------------  253 (1317)
T ss_pred             CCcceeEecccCc--EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcC-------------------------
Confidence            9999999999999  9999999998765221    12233344444443322100                         


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCcccccccccc-CceeEEEeeeeccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVLFP  479 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  479 (481)
                         |+-.|   |.-+||||+|+++|||++|..|||.|...+ -++|.-.-+-+-||
T Consensus       254 ---~~g~y---G~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP  303 (1317)
T KOG0612|consen  254 ---GKGEY---GRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP  303 (1317)
T ss_pred             ---Ccccc---CCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence               00000   677899999999999999999999987654 34665556677777

>KOG0598|consensus

Probab=99.95  E-value=3.3e-29  Score=242.78  Aligned_cols=113  Identities=33%  Similarity=0.610  Sum_probs=94.9

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      +++|.  .++||.|||++|||||||||    +||||+..    |++||+|||||+..                       
T Consensus       129 fYlaE--i~lAL~~LH~~gIiyRDlKP----ENILLd~~----GHi~LtDFgL~k~~-----------------------  175 (357)
T KOG0598|consen  129 FYLAE--IVLALGYLHSKGIIYRDLKP----ENILLDEQ----GHIKLTDFGLCKED-----------------------  175 (357)
T ss_pred             HHHHH--HHHHHHHHHhCCeeeccCCH----HHeeecCC----CcEEEeccccchhc-----------------------
Confidence            44444  59999999999999999999    89999987    89999999999853                       


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                         +..|..+.++||                      |+.|||||++.+.. |+.++||||+||++|||++|.+||.+. 
T Consensus       176 ---~~~~~~t~tfcG----------------------T~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~-  228 (357)
T KOG0598|consen  176 ---LKDGDATRTFCG----------------------TPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAE-  228 (357)
T ss_pred             ---ccCCCccccccC----------------------CccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCc-
Confidence               233444556787                      99999999999886 999999999999999999999999994 


Q ss_pred             hhHHHHHHHHHHh
Q psy3074         174 EVYDQLDKIFKIL  186 (481)
Q Consensus       174 ~~~~~l~~i~~~~  186 (481)
                      +.....++|.+.-
T Consensus       229 ~~~~~~~~I~~~k  241 (357)
T KOG0598|consen  229 DVKKMYDKILKGK  241 (357)
T ss_pred             cHHHHHHHHhcCc
Confidence            4446666665543

>KOG0605|consensus

Probab=99.95  E-value=4.7e-29  Score=251.10  Aligned_cols=164  Identities=22%  Similarity=0.338  Sum_probs=109.6

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      -++||+..  ++|++.+|+.|+|||||||    +|+||+..    |++||+|||||......... ...+.....+..  
T Consensus       243 arfYiaE~--vlAI~~iH~~gyIHRDIKP----dNlLiD~~----GHiKLSDFGLs~gl~~~~~~-~~~~~~~~~~~~--  309 (550)
T KOG0605|consen  243 ARFYIAET--VLAIESIHQLGYIHRDIKP----DNLLIDAK----GHIKLSDFGLSTGLDKKHRI-ESYRLDEQMQIN--  309 (550)
T ss_pred             HHHHHHHH--HHHHHHHHHcCcccccCCh----hheeecCC----CCEeeccccccchhhhhhhh-hhhcchhhhhhh--
Confidence            35778777  9999999999999999999    89999988    99999999999654322111 110100000000  


Q ss_pred             eecccCCCCceeE--EEe-c-ccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          92 IKLDQLGEGSYAT--VFK-G-YSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        92 ~~~~~~g~g~~~~--~~~-g-~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                        +.......+..  ... . ......+.+..+......+.+|||.|||||||++.. |+..|||||+|||+||||.|.|
T Consensus       310 --~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyP  386 (550)
T KOG0605|consen  310 --LSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYP  386 (550)
T ss_pred             --hccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCC
Confidence              00001111110  000 0 011223455556666777899999999999999887 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHH---HHhCCCCcc
Q psy3074         168 TFPGVREVYDQLDKIF---KILGTPTEE  192 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~---~~~~~p~~~  192 (481)
                      ||.+. +..+..++|.   ..+..|...
T Consensus       387 PF~s~-tp~~T~rkI~nwr~~l~fP~~~  413 (550)
T KOG0605|consen  387 PFCSE-TPQETYRKIVNWRETLKFPEEV  413 (550)
T ss_pred             CCCCC-CHHHHHHHHHHHhhhccCCCcC
Confidence            99994 4445555444   445555443

>KOG0608|consensus

Probab=99.95  E-value=2.9e-28  Score=247.88  Aligned_cols=204  Identities=20%  Similarity=0.275  Sum_probs=148.5

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      .|..||..-+.++||+||..|++++.+|+||||++ ||+..+|.+ .+-|.|+.+++|+.++..|+++.|..|+||||||
T Consensus       678 AERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiK  756 (1034)
T KOG0608|consen  678 AERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIK  756 (1034)
T ss_pred             hhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence            48899999999999999999999999999999999 567776665 4779999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceecc-ccCCCcccccccccccCC-CeeEEEeecCCCC-ccccccCccc
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHR-DVKPQNLLISEIVFTNLS-GVVVSTVDSGSGG-WWFESKSNIN  427 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~-d~~~~~il~~~~~~~~s~-g~~~~~~~~g~~~-~~~~~~~~~~  427 (481)
                      |+|||||.+|+  ||+.|||||.++...|..+.... |---..-|  +....|.. +-.++.+.....- -.-...-..+
T Consensus       757 PDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSm--ep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv  832 (1034)
T KOG0608|consen  757 PDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSM--EPSPEWADISKCLKVLERRAMRQHQRILAHSLV  832 (1034)
T ss_pred             ccceEEccCCc--eeeeeccccccceeccccccccCCCccccccC--CCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence            99999999999  99999999999998876543211 00000000  00001111 0001111100000 0000012368


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCc-eeEEEeeeecccC
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRS-TLTFVFEYVLFPT  480 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  480 (481)
                      ||+.|++|        .--+|||+.|++|+||+-|.+||+.+..-+.+ ++.=|+-+|-||-
T Consensus       833 gt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~  894 (1034)
T KOG0608|consen  833 GTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPY  894 (1034)
T ss_pred             CCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccccc
Confidence            99999999        45679999999999999999777666544443 6677888888873

>KOG0588|consensus

Probab=99.95  E-value=1.1e-28  Score=253.17  Aligned_cols=156  Identities=26%  Similarity=0.379  Sum_probs=121.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..||+-||+.+.||||+++||++++..++|+|.||++ |.|++++.. .+++++..++.|++||+.|+.|||..+|+|||
T Consensus        59 IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRD  137 (786)
T KOG0588|consen   59 IEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRD  137 (786)
T ss_pred             hhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceecc
Confidence            3479999999999999999999999999999999999 678888766 47899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc--ccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS--YCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~--~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|++....  |||+|||+|.--.  .+-.......-|.+|||+.++.++                          
T Consensus       138 LKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYd--------------------------  189 (786)
T KOG0588|consen  138 LKPENLLLDVKNN--IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYD--------------------------  189 (786)
T ss_pred             CCchhhhhhcccC--EeeeccceeecccCCccccccCCCcccCCchhhcCCCCC--------------------------
Confidence            9999999998776  9999999986211  011111122223333333332221                          


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                               |.|+|+||-|++|+.|+.|.+||=+|+.
T Consensus       190 ---------G~~sDVWSCGVILfALLtG~LPFdDdNi  217 (786)
T KOG0588|consen  190 ---------GRPSDVWSCGVILFALLTGKLPFDDDNI  217 (786)
T ss_pred             ---------CCccccchhHHHHHHHHhCCCCCCCccH
Confidence                     6677888888888888888877766654

>KOG0198|consensus

Probab=99.95  E-value=3.8e-28  Score=238.37  Aligned_cols=179  Identities=22%  Similarity=0.269  Sum_probs=140.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC--eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~--~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      ...+|+++|++++|||||++++......  .++|.|||++ |+|.+++....+.+++..++.+.+||+.||.|||++|++
T Consensus        60 ~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~v  139 (313)
T KOG0198|consen   60 SLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIV  139 (313)
T ss_pred             HHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            3568999999999999999999755544  6999999999 788888887665799999999999999999999999999


Q ss_pred             eccCCCccccccc-cchhhHHHHHHHHHhhccc--c----ccCceeccccCCCcccc-c--c--cccccCCCeeEEEeec
Q psy3074         346 HRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSY--C----HRRRILHRDVKPQNLLI-S--E--IVFTNLSGVVVSTVDS  413 (481)
Q Consensus       346 HrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~--~----~~~~i~~~d~~~~~il~-~--~--~~~~~s~g~~~~~~~~  413 (481)
                      ||||||+|||++. .+.  +|++|||+++.+..  .    ......+..+.+||++. +  .  ..|.||.||++.+|.+
T Consensus       140 H~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T  217 (313)
T KOG0198|consen  140 HCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT  217 (313)
T ss_pred             ccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence            9999999999998 466  99999999997762  1    12345667788888887 2  2  5678999999999999


Q ss_pred             CCCCcccc-ccCc---ccce---eccCCCCCChhhhhhHHHHH
Q psy3074         414 GSGGWWFE-SKSN---INLS---FHYLPPGAPFTAIREASLLK  449 (481)
Q Consensus       414 g~~~~~~~-~~~~---~~~t---~~y~~p~~p~~~~s~~~~l~  449 (481)
                      |+.||... ....   -.|.   ...++...+.+++++.....
T Consensus       218 g~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~  260 (313)
T KOG0198|consen  218 GKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCF  260 (313)
T ss_pred             CCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHh
Confidence            99999862 1100   1121   22444566666666554444

>KOG0033|consensus

Probab=99.95  E-value=2.2e-29  Score=230.81  Aligned_cols=188  Identities=25%  Similarity=0.330  Sum_probs=154.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ...||++|.+.|+|||||+|++.+......|||+|++.| ++...+... ..++|..+..+++||+++|.|||.++|+||
T Consensus        56 ~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHR  134 (355)
T KOG0033|consen   56 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHR  134 (355)
T ss_pred             HHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceec
Confidence            355899999999999999999999999999999999995 566555543 468999999999999999999999999999


Q ss_pred             cCCCcccccccc-chhhHHHHHHHHHhhcccc--ccCceeccccCCCccc----ccccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEI-DHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLL----ISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il----~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      |+||+|+|+.+. ...-+|++|||+|..++.-  --..+.+..+.+|+++    ++..++.|+.|++++.++.|.+||+.
T Consensus       135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD  214 (355)
T ss_pred             cCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence            999999999653 3456999999999987711  1234566677777777    44555789999999999999999998


Q ss_pred             cccCc-----ccceeccCCCCCChhhhhhHHHHHHhhCCCcc
Q psy3074         421 ESKSN-----INLSFHYLPPGAPFTAIREASLLKELKHNNIV  457 (481)
Q Consensus       421 ~~~~~-----~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~  457 (481)
                      ++...     +.|.+.|-+|..+--..+...++..|+.-++.
T Consensus       215 ~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~  256 (355)
T KOG0033|consen  215 EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPK  256 (355)
T ss_pred             ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChh
Confidence            65432     46777777777777777888999999887743

>KOG0658|consensus

Probab=99.95  E-value=8.6e-30  Score=246.42  Aligned_cols=150  Identities=27%  Similarity=0.402  Sum_probs=129.3

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ||++||+.++|||||+|.-+|....     .+.+||||++-+|.+.++..   +..++.-.++.|+.|+.+||.|||+.|
T Consensus        66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~  145 (364)
T KOG0658|consen   66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG  145 (364)
T ss_pred             HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC
Confidence            6999999999999999999886432     46789999999999988742   456888889999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCccccc-----ccccccCCCeeEEEeecCCC
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLIS-----EIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~-----~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |+||||||.|+|+|.+ ...+|+||||.|+.+....  ...+++|-|+|||.+++     ..+|.||.||++.|+.-|.+
T Consensus       146 IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p  224 (364)
T KOG0658|consen  146 ICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP  224 (364)
T ss_pred             cccCCCChheEEEcCC-CCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence            9999999999999875 2349999999999876433  45689999999999975     44567999999999999999


Q ss_pred             Cccccc
Q psy3074         417 GWWFES  422 (481)
Q Consensus       417 ~~~~~~  422 (481)
                      -|.+.+
T Consensus       225 lFpG~s  230 (364)
T KOG0658|consen  225 LFPGDS  230 (364)
T ss_pred             ccCCCC
Confidence            998765

>KOG0667|consensus

Probab=99.95  E-value=1e-28  Score=254.60  Aligned_cols=153  Identities=25%  Similarity=0.324  Sum_probs=137.5

Q ss_pred             HHHHHHHHhhcC-CC-----CeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLKELK-HN-----NIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~~l~-Hp-----nIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.-|+.||..|+ |.     |+|+++|+|..++++|||+|++.-+|.++++... .+++...++.++.||+.||.+||+.
T Consensus       229 ~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l  308 (586)
T KOG0667|consen  229 AQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL  308 (586)
T ss_pred             HHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345999999998 42     8999999999999999999999999999998654 4699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      +|||.|||||||||.+.....||++|||+|.......-..+-.|-|++|||+++    +.+|+||+||++.||.+|.+-|
T Consensus       309 ~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf  388 (586)
T KOG0667|consen  309 GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF  388 (586)
T ss_pred             CeeeccCChhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc
Confidence            999999999999998888889999999999987755557788899999999975    5556899999999999999988


Q ss_pred             cccc
Q psy3074         419 WFES  422 (481)
Q Consensus       419 ~~~~  422 (481)
                      .+.+
T Consensus       389 pG~n  392 (586)
T KOG0667|consen  389 PGDN  392 (586)
T ss_pred             CCCC
Confidence            8765

>KOG0032|consensus

Probab=99.94  E-value=1e-27  Score=243.65  Aligned_cols=151  Identities=25%  Similarity=0.344  Sum_probs=129.5

Q ss_pred             hhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      ..+.+|++||+++. |||||.++++|++.+.+++|||+|. |.|++.+...  .+++..+..++.|++.++.|||+.||+
T Consensus        80 ~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvv  157 (382)
T KOG0032|consen   80 EDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVV  157 (382)
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence            35678999999999 9999999999999999999999999 6788888765  399999999999999999999999999


Q ss_pred             eccCCCccccccccch--hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         346 HRDVKPQNLLISEIDH--HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~--~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      ||||||||+|+.....  ..+|++|||+|.....   .                                       ...
T Consensus       158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~---------------------------------------~~~  195 (382)
T KOG0032|consen  158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---G---------------------------------------ERL  195 (382)
T ss_pred             eccCCHHHeeeccccCCCCcEEEeeCCCceEccC---C---------------------------------------ceE
Confidence            9999999999976532  4699999999875431   0                                       112


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ..++||+.|++|        +...|+||+|+++|.|++|..||+.+.
T Consensus       196 ~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  196 HTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             eeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC
Confidence            246788888888        677899999999999999998888765

>KOG0578|consensus

Probab=99.94  E-value=3.4e-28  Score=246.57  Aligned_cols=147  Identities=22%  Similarity=0.373  Sum_probs=127.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.|+.+|+..+|+|||++++.|...+.+|+||||++ |+|.+.+..  ..++|.++..++++++.||+|||.++|+|||
T Consensus       317 ilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrD  394 (550)
T KOG0578|consen  317 LLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRD  394 (550)
T ss_pred             hHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeec
Confidence            4579999999999999999999999999999999999 556665544  3599999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      ||.+|||++.+|.  +|++|||+|..+.-...+                                         -...+|
T Consensus       395 IKSDnILL~~~g~--vKltDFGFcaqi~~~~~K-----------------------------------------R~TmVG  431 (550)
T KOG0578|consen  395 IKSDNILLTMDGS--VKLTDFGFCAQISEEQSK-----------------------------------------RSTMVG  431 (550)
T ss_pred             cccceeEeccCCc--EEEeeeeeeeccccccCc-----------------------------------------cccccC
Confidence            9999999999988  999999999865522111                                         123679


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+||+|        |...|+||+|.+.-||.-|.+|+|++
T Consensus       432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE  472 (550)
T KOG0578|consen  432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE  472 (550)
T ss_pred             CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence            9999999        88889999999999999999888863

>KOG0580|consensus

Probab=99.94  E-value=2.3e-28  Score=223.72  Aligned_cols=150  Identities=23%  Similarity=0.380  Sum_probs=127.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      ....||++|.+.|+||||.++|++|.+...+|+++||.. |.++..+... ...+++..+..|+.|++.|+.|||.++||
T Consensus        67 ~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VI  146 (281)
T KOG0580|consen   67 HQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVI  146 (281)
T ss_pred             hhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcc
Confidence            346789999999999999999999999999999999998 8888888743 34599999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|+|++..+.  +|++|||.+..-. +..                                          -+.
T Consensus       147 hRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~k------------------------------------------R~t  181 (281)
T KOG0580|consen  147 HRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNK------------------------------------------RKT  181 (281)
T ss_pred             cCCCCHHHhccCCCCC--eeccCCCceeecC-CCC------------------------------------------cee
Confidence            9999999999999888  9999999764211 111                                          123


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      .|||..|++|        +...|.|++|++.||++-|.+||-..+
T Consensus       182 lcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  182 LCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             eecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence            6788888888        566799999999999999986655544

>KOG0615|consensus

Probab=99.94  E-value=8.3e-29  Score=241.93  Aligned_cols=124  Identities=29%  Similarity=0.516  Sum_probs=105.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.|+.|||++||+||||||    +|||++... .+=.+||+|||+|+.                           .|+|
T Consensus       285 ll~avkYLH~~GI~HRDiKP----eNILl~~~~-e~~llKItDFGlAK~---------------------------~g~~  332 (475)
T KOG0615|consen  285 LLTAVKYLHSQGIIHRDIKP----ENILLSNDA-EDCLLKITDFGLAKV---------------------------SGEG  332 (475)
T ss_pred             HHHHHHHHHHcCcccccCCc----ceEEeccCC-cceEEEecccchhhc---------------------------cccc
Confidence            36789999999999999999    899998763 334799999999984                           6899


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ  178 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~--~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~  178 (481)
                      +|+.++||                      ||.|.||||+.+.  ..|..++|+||+||++|.+|+|.+||.+.......
T Consensus       333 sfm~TlCG----------------------TpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl  390 (475)
T KOG0615|consen  333 SFMKTLCG----------------------TPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL  390 (475)
T ss_pred             eehhhhcC----------------------CccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence            99999999                      9999999999764  33556899999999999999999999987655556


Q ss_pred             HHHHHHHhCCCCccCccccc
Q psy3074         179 LDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       179 l~~i~~~~~~p~~~~~~~~~  198 (481)
                      .++|.++.....+..|..++
T Consensus       391 ~eQI~~G~y~f~p~~w~~Is  410 (475)
T KOG0615|consen  391 KEQILKGRYAFGPLQWDRIS  410 (475)
T ss_pred             HHHHhcCcccccChhhhhhh
Confidence            77888887777777887776

>KOG0694|consensus

Probab=99.94  E-value=1.3e-27  Score=246.91  Aligned_cols=115  Identities=30%  Similarity=0.591  Sum_probs=101.7

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      .++...+++.++||+|||++|||+||||-    +||||+..    |++||+|||||+.                      
T Consensus       468 ~rarfyaAev~l~L~fLH~~~IIYRDlKL----dNiLLD~e----Gh~kiADFGlcKe----------------------  517 (694)
T KOG0694|consen  468 PRARFYAAEVVLGLQFLHENGIIYRDLKL----DNLLLDTE----GHVKIADFGLCKE----------------------  517 (694)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCceeeecch----hheEEccc----CcEEecccccccc----------------------
Confidence            34455556689999999999999999999    89999877    9999999999994                      


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                          .++.|+.+.++||                      ||.|||||+|.+.. |+.++|||||||++||||.|++||+|
T Consensus       518 ----~m~~g~~TsTfCG----------------------Tpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  518 ----GMGQGDRTSTFCG----------------------TPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             ----cCCCCCccccccC----------------------ChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCC
Confidence                4788888899999                      99999999999887 99999999999999999999999999


Q ss_pred             chhhHHHHHHHHH
Q psy3074         172 VREVYDQLDKIFK  184 (481)
Q Consensus       172 ~~~~~~~l~~i~~  184 (481)
                      .++. +.++.|..
T Consensus       571 ddEe-e~FdsI~~  582 (694)
T KOG0694|consen  571 DDEE-EVFDSIVN  582 (694)
T ss_pred             CCHH-HHHHHHhc
Confidence            6544 77777754

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=4.7e-27  Score=233.55  Aligned_cols=153  Identities=49%  Similarity=0.742  Sum_probs=120.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.+++.++||||+++++++.+.+..|+||||+++++.+.+....+.+++..++.++.|++.||+|||+++|+||||
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl  129 (303)
T cd07869          50 AIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL  129 (303)
T ss_pred             HHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            56799999999999999999999999999999999999999988876677999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+|||+++.+.  +|++|||+++......   .....+..|.||+++.+.                             
T Consensus       130 kp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------------------------  178 (303)
T cd07869         130 KPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS-----------------------------  178 (303)
T ss_pred             CHHHEEECCCCC--EEECCCCcceeccCCCccCCCCcccCCCCChHHHcCC-----------------------------
Confidence            999999998777  9999999986432110   011112222222222110                             


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                         .   ..+..+|+||+|+++++|..|..||.
T Consensus       179 ---~---~~~~~~DiwslG~il~~l~~g~~pf~  205 (303)
T cd07869         179 ---T---EYSTCLDMWGVGCIFVEMIQGVAAFP  205 (303)
T ss_pred             ---C---CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence               0   00334699999999999999986654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG4236|consensus

Probab=99.94  E-value=6.8e-27  Score=233.68  Aligned_cols=171  Identities=22%  Similarity=0.319  Sum_probs=141.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHH-HHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYM-ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l-~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+.|++||+++.||.||.+...|++++.++.|||-+.||.+..+ ....+++++...++++.||+.||.|||.++|+|.
T Consensus       609 qlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHC  688 (888)
T KOG4236|consen  609 QLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHC  688 (888)
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeec
Confidence            356799999999999999999999999999999999999977665 4566789999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhcccc--ccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||||||||+.+.. -.++|+||||+||.+..-  ...-+.+..|-+|+++..    ...++||-|+++|..++|..||..
T Consensus       689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             cCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence            9999999997543 357999999999977633  233466778888888854    445679999999999999999985


Q ss_pred             cc-cCcccceeccCCCCCCh
Q psy3074         421 ES-KSNINLSFHYLPPGAPF  439 (481)
Q Consensus       421 ~~-~~~~~~t~~y~~p~~p~  439 (481)
                      .+ ...-.....+|.|..|.
T Consensus       769 dEdIndQIQNAaFMyPp~PW  788 (888)
T KOG4236|consen  769 DEDINDQIQNAAFMYPPNPW  788 (888)
T ss_pred             ccchhHHhhccccccCCCch
Confidence            43 22234456777776665

>KOG0690|consensus

Probab=99.94  E-value=6.4e-28  Score=229.00  Aligned_cols=148  Identities=22%  Similarity=0.359  Sum_probs=129.7

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +-|-++|+.++||++..|..+|+..+.+|+||||+.| .|+..+.+ ...++++.++.|..+|+.||.|||+++|+.|||
T Consensus       216 lTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDl  294 (516)
T KOG0690|consen  216 LTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDL  294 (516)
T ss_pred             hhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeec
Confidence            4588999999999999999999999999999999995 56655654 467999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      |.+|+|++.+|+  ||++|||+++.                 +|-.                        ....+.+|||
T Consensus       295 KLENLlLDkDGH--IKitDFGLCKE-----------------~I~~------------------------g~t~kTFCGT  331 (516)
T KOG0690|consen  295 KLENLLLDKDGH--IKITDFGLCKE-----------------EIKY------------------------GDTTKTFCGT  331 (516)
T ss_pred             hhhhheeccCCc--eEeeecccchh-----------------cccc------------------------cceeccccCC
Confidence            999999999999  99999999873                 1111                        1224468999


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      |.|++|        |...|||-+|+.||||.||++||++.-
T Consensus       332 PEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d  372 (516)
T KOG0690|consen  332 PEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD  372 (516)
T ss_pred             hhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence            999999        788899999999999999999999763

>KOG0582|consensus

Probab=99.94  E-value=5.8e-27  Score=231.05  Aligned_cols=158  Identities=22%  Similarity=0.275  Sum_probs=131.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..++|++.|+.++|||||+++.+|..+..+|+||-||. |++.+++... ..+++|..+..++++++.||.|||++|-||
T Consensus        70 ~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IH  149 (516)
T KOG0582|consen   70 ALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIH  149 (516)
T ss_pred             HHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCcee
Confidence            35689999999999999999999999999999999999 7888887653 456999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+|+.||||+++|.  ||++|||++..+..                                   .|..- .. +...+
T Consensus       150 RdvKAgnILi~~dG~--VkLadFgvsa~l~~-----------------------------------~G~R~-~~-rf~tf  190 (516)
T KOG0582|consen  150 RDVKAGNILIDSDGT--VKLADFGVSASLFD-----------------------------------SGDRQ-VT-RFNTF  190 (516)
T ss_pred             cccccccEEEcCCCc--EEEcCceeeeeecc-----------------------------------cCcee-eE-eeccc
Confidence            999999999999998  99999997654432                                   11000 00 01246


Q ss_pred             cceeccCCC----------CCChhhhhhHHHHHHhhCCCccccccccccC
Q psy3074         427 NLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTLHDIVHTR  466 (481)
Q Consensus       427 ~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~  466 (481)
                      +||+.||+|          +..+|+||+|+..-||-+|. .+|.+..|..
T Consensus       191 vgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~-aPf~k~pPmk  239 (516)
T KOG0582|consen  191 VGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGH-APFSKYPPMK  239 (516)
T ss_pred             cCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCC-CCcccCChHH
Confidence            788889888          56889999999999999997 6666665543

>KOG0599|consensus

Probab=99.94  E-value=1.6e-27  Score=221.56  Aligned_cols=151  Identities=24%  Similarity=0.367  Sum_probs=129.7

Q ss_pred             ChhhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         266 APFTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       266 ~~~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ..++.++|+.||+++. ||+|+++.|+|+++.++++|+|+|+ |.|++++... -.+++...+.+|+|+..|++|+|.++
T Consensus        65 ~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~  143 (411)
T KOG0599|consen   65 MREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARN  143 (411)
T ss_pred             HHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhh
Confidence            3467789999999986 9999999999999999999999999 8899998753 46999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++++..  ||+.|||+|..++.-.                                          ..
T Consensus       144 IVHRDLKpENILlddn~~--i~isDFGFa~~l~~Ge------------------------------------------kL  179 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMN--IKISDFGFACQLEPGE------------------------------------------KL  179 (411)
T ss_pred             hhhcccChhheeeccccc--eEEeccceeeccCCch------------------------------------------hH
Confidence            999999999999998766  9999999998765211                                          11


Q ss_pred             CcccceeccCCC--------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         424 SNINLSFHYLPP--------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       424 ~~~~~t~~y~~p--------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...||||+|++|              +.-.|.|+.|++||.|+-|.+|||+-
T Consensus       180 relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR  231 (411)
T KOG0599|consen  180 RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR  231 (411)
T ss_pred             HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence            235666666666              45569999999999999999999974

>KOG0581|consensus

Probab=99.94  E-value=1e-27  Score=232.47  Aligned_cols=112  Identities=28%  Similarity=0.505  Sum_probs=91.8

Q ss_pred             HhhhhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          12 RQISVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      +++.-.+-+.|.||.|||+ ++||||||||    +|+|+|+.    |.+||||||.++...                   
T Consensus       178 ~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP----sNlLvNsk----GeVKicDFGVS~~lv-------------------  230 (364)
T KOG0581|consen  178 PVLGKIARAVLRGLSYLHEERKIIHRDIKP----SNLLVNSK----GEVKICDFGVSGILV-------------------  230 (364)
T ss_pred             HHHHHHHHHHHHHHHHHhhccCeeeccCCH----HHeeeccC----CCEEeccccccHHhh-------------------
Confidence            3444444558999999995 9999999999    99999997    899999999998532                   


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               ++.+.+|.|                      |..|||||.+.+.. |+.++||||||+.++|+++|+.||+
T Consensus       231 ---------nS~a~tfvG----------------------T~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~  278 (364)
T KOG0581|consen  231 ---------NSIANTFVG----------------------TSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYP  278 (364)
T ss_pred             ---------hhhcccccc----------------------cccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCC
Confidence                     124456666                      99999999999987 9999999999999999999999998


Q ss_pred             Cc----hhhHHHHHHH
Q psy3074         171 GV----REVYDQLDKI  182 (481)
Q Consensus       171 g~----~~~~~~l~~i  182 (481)
                      ..    .+..++++.|
T Consensus       279 ~~~~~~~~~~~Ll~~I  294 (364)
T KOG0581|consen  279 PPNPPYLDIFELLCAI  294 (364)
T ss_pred             CcCCCCCCHHHHHHHH
Confidence            74    2344444444

>KOG0666|consensus

Probab=99.94  E-value=1.2e-27  Score=226.16  Aligned_cols=134  Identities=37%  Similarity=0.716  Sum_probs=113.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+++|||++=|+||||||    +|||+--+..+.|.+||+||||||.+..+...                    +   
T Consensus       141 il~Gv~YLH~NWvlHRDLKP----aNIlvmgdgperG~VKIaDlGlaR~~~~plkp--------------------l---  193 (438)
T KOG0666|consen  141 ILDGVHYLHSNWVLHRDLKP----ANILVMGDGPERGRVKIADLGLARLFNNPLKP--------------------L---  193 (438)
T ss_pred             HHhhhHHHhhhheeeccCCc----ceEEEeccCCccCeeEeecccHHHHhhccccc--------------------c---
Confidence            46789999999999999999    89999988888899999999999976433211                    0   


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh------
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE------  174 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~------  174 (481)
                                            ......++|.||+|||+|+|.+.|+.++|+||+|||++|||+..|.|.|..+      
T Consensus       194 ----------------------~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~  251 (438)
T KOG0666|consen  194 ----------------------ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKN  251 (438)
T ss_pred             ----------------------ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCC
Confidence                                  0111223599999999999999999999999999999999999999988632      


Q ss_pred             --hHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         175 --VYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       175 --~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                        ..+|+++|++.+|+|..+.||.+..+|.+
T Consensus       252 Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~  282 (438)
T KOG0666|consen  252 PFQHDQLDRIFEVLGTPTDKDWPDLKKMPEY  282 (438)
T ss_pred             CchHHHHHHHHHHcCCCccccchhhhhCcch
Confidence              35789999999999999999999888766

>KOG0192|consensus

Probab=99.94  E-value=7.1e-27  Score=235.69  Aligned_cols=150  Identities=25%  Similarity=0.352  Sum_probs=124.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCC-eEEEEEeccC-CCHHHHHHH-hcCCCChHHHHHHHHHHHHHHHHhhcCc-
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRS-TLTFVFEYVH-TDLSQYMER-HSGGLDHHNIRLFMFQLLRGLSYCHRRR-  343 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~-~~~iv~E~~~-g~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~ylH~~~-  343 (481)
                      .++.+|+.+|++++|||||++++++.++. .++|||||++ |+|.+++.. ....++...+..++.||+.||.|||+++ 
T Consensus        84 ~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~  163 (362)
T KOG0192|consen   84 KAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP  163 (362)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            46789999999999999999999999988 7999999999 788888877 3678999999999999999999999999 


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      ||||||||+|||++... ..+|++|||+++......                                         .+.
T Consensus       164 iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~-----------------------------------------~~~  201 (362)
T KOG0192|consen  164 IIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISK-----------------------------------------TSM  201 (362)
T ss_pred             eeecccChhhEEEcCCC-CEEEECCCccceeecccc-----------------------------------------ccc
Confidence            99999999999999876 239999999998644210                                         001


Q ss_pred             CcccceeccCCC----------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         424 SNINLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       424 ~~~~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +...||+.||||          ...+|++|+|++|.||..+.+|+-
T Consensus       202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~  247 (362)
T KOG0192|consen  202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE  247 (362)
T ss_pred             cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC
Confidence            113466666666          345699999999999999985553

>KOG0665|consensus

Probab=99.94  E-value=1.9e-27  Score=225.83  Aligned_cols=173  Identities=28%  Similarity=0.472  Sum_probs=138.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      -+.|+.+||+.||+||||||    +||+++..    +.+||+|||+|+....                            
T Consensus       127 ~~~~ik~lhs~~IihRdLkP----snivv~~~----~~lKi~dfg~ar~e~~----------------------------  170 (369)
T KOG0665|consen  127 MLCGIKHLHSAGIIHRDLKP----SNIVVNSD----CTLKILDFGLARTEDT----------------------------  170 (369)
T ss_pred             HHHHHHHHHhcceeecccCc----ccceecch----hheeeccchhhcccCc----------------------------
Confidence            47789999999999999999    99999988    5999999999984211                            


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      +        ..+|             .+++|++|+|||++.+.. |...+||||+|||+.||++|...|+| .+.++|+.
T Consensus       171 ~--------~~mt-------------pyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g-~d~idQ~~  227 (369)
T KOG0665|consen  171 D--------FMMT-------------PYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPG-KDHIDQWN  227 (369)
T ss_pred             c--------cccC-------------chhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecC-chHHHHHH
Confidence            0        1223             334599999999999987 99999999999999999999999998 67779999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCc--c--hhHHHHHHhhhhhhhcCCccccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPE--G--ESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--g--~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      +|.+.+|+|++.................+.+...++...||+..++..  +  ..-..+-....++...+|.++..
T Consensus       228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris  303 (369)
T KOG0665|consen  228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS  303 (369)
T ss_pred             HHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence            999999999999888776665555556777777888889998876533  2  22333445566778888877543

>KOG0574|consensus

Probab=99.94  E-value=9.1e-28  Score=225.79  Aligned_cols=153  Identities=20%  Similarity=0.238  Sum_probs=133.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..++|+.||++|+.|++|++|+.|.....+|||||||. |+..+.++-+...++++.+..+++..+.||+|||...-|||
T Consensus        74 EIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHR  153 (502)
T KOG0574|consen   74 EIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHR  153 (502)
T ss_pred             HHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHh
Confidence            34569999999999999999999999999999999998 89999988888899999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccC---ceeccccCCCccc----ccccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR---RILHRDVKPQNLL----ISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~---~i~~~d~~~~~il----~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      |||..|||++.+|+  .|++|||+|..+.....+   -|.+.-..+|+++    +....+.||.|+...+|.-|.+||..
T Consensus       154 DIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  154 DIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             hcccccEEEcccch--hhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence            99999999999999  999999999988755432   2445555566554    44555679999999999999999987


Q ss_pred             ccc
Q psy3074         421 ESK  423 (481)
Q Consensus       421 ~~~  423 (481)
                      ...
T Consensus       232 IHP  234 (502)
T KOG0574|consen  232 IHP  234 (502)
T ss_pred             ccc
Confidence            643

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=1.3e-26  Score=228.81  Aligned_cols=154  Identities=46%  Similarity=0.731  Sum_probs=121.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|++++++++||||+++++++.+.+..++||||++|++.+.+......+++..+..++.|++.||+|||+++|+||||
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dl  129 (288)
T cd07871          50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL  129 (288)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            45799999999999999999999999999999999999999888766556889999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+|||+++++.  +|++|||+++......   .....+..|.||+++.+                              
T Consensus       130 kp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------------------------  177 (288)
T cd07871         130 KPQNLLINEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG------------------------------  177 (288)
T ss_pred             CHHHEEECCCCC--EEECcCcceeeccCCCccccCceecccccChHHhcC------------------------------
Confidence            999999998877  9999999987543111   11111222222222211                              


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                        .   ...+.++|+||+|+++++|..|..||..
T Consensus       178 --~---~~~~~~~DiwslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         178 --S---TEYSTPIDMWGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             --C---cccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              0   0114457999999999999999866643

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4717|consensus

Probab=99.93  E-value=6.7e-27  Score=233.23  Aligned_cols=157  Identities=20%  Similarity=0.354  Sum_probs=127.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..+|++.|+.++|||||+||++..+...+|+|+|+=+ |++++++.++..++.|..++.|+.||+.|+.|||...++|||
T Consensus        64 lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRD  143 (864)
T KOG4717|consen   64 LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRD  143 (864)
T ss_pred             HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhccc
Confidence            4569999999999999999999999999999999988 799999999999999999999999999999999999999999


Q ss_pred             CCCccccc-cccchhhHHHHHHHHHhhcccccc--CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLI-SEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl-~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+.+ ...|.  +|+.|||++..+..-..  .....-.|-+|+|++++.++                         
T Consensus       144 LKPENVVFFEKlGl--VKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYD-------------------------  196 (864)
T KOG4717|consen  144 LKPENVVFFEKLGL--VKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYD-------------------------  196 (864)
T ss_pred             CCcceeEEeeecCc--eEeeeccccccCCCcchhhcccchhhccCchhhhcCccC-------------------------
Confidence            99999876 44565  99999999876552111  11122244555555553322                         


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                                .+.+|+||+|++||-|.||.+||-.-++
T Consensus       197 ----------APAVDiWSLGVILyMLVCGq~PFqeAND  224 (864)
T KOG4717|consen  197 ----------APAVDIWSLGVILYMLVCGQPPFQEAND  224 (864)
T ss_pred             ----------CcchhhhHHHHHHHHHHhCCCccccccc
Confidence                      2346999999999999999977665544

>KOG0197|consensus

Probab=99.93  E-value=8.7e-27  Score=235.58  Aligned_cols=193  Identities=21%  Similarity=0.262  Sum_probs=149.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHH-hcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMER-HSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +++.+|++||++|+|+|||+|++++..+..+|||||||+ |+|.++++. ..+.+...+...++.||++||+||.++++|
T Consensus       246 ~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~I  325 (468)
T KOG0197|consen  246 EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYI  325 (468)
T ss_pred             hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCcc
Confidence            467789999999999999999999999889999999998 999999987 445688999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc---ccc--cCceeccccCCCccc---ccccccccCCCeeEEEeec-CCC
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH--RRRILHRDVKPQNLL---ISEIVFTNLSGVVVSTVDS-GSG  416 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~---~~~--~~~i~~~d~~~~~il---~~~~~~~~s~g~~~~~~~~-g~~  416 (481)
                      ||||..+|||++++..  +|++|||+|+.+.   |..  ....--+|+.|+.+.   ++...++||+|+.++|+.+ |..
T Consensus       326 HRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~  403 (468)
T KOG0197|consen  326 HRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRV  403 (468)
T ss_pred             chhhhhhheeeccCce--EEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCC
Confidence            9999999999999887  9999999999543   222  122223456555544   4556678999999999999 999


Q ss_pred             CccccccCcc-----cceeccCCCCCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         417 GWWFESKSNI-----NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       417 ~~~~~~~~~~-----~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      |+...+....     .|-.-+-+++-|..++.+-.......-.+.|+|...
T Consensus       404 py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L  454 (468)
T KOG0197|consen  404 PYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETL  454 (468)
T ss_pred             CCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence            9886654332     233334444666666654444445555555666643

>KOG0589|consensus

Probab=99.93  E-value=5.3e-27  Score=236.29  Aligned_cols=186  Identities=24%  Similarity=0.269  Sum_probs=155.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCe-EEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRST-LTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~-~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ..+.+|+.++++++|||||.+++.|..++. ++|||+||+ |++.+.+.+.+ ..|+++.+..++.|++.|+.|||+++|
T Consensus        48 ~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~i  127 (426)
T KOG0589|consen   48 RSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRV  127 (426)
T ss_pred             HHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhh
Confidence            357889999999999999999999999887 999999999 67888888776 458999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      +|||||+.||+++.++.  ||+.|||+|+.+...   .+..+.+..|.+|+++-+    ...+.|+.||++++|+.-+.+
T Consensus       128 LHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a  205 (426)
T KOG0589|consen  128 LHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA  205 (426)
T ss_pred             hcccchhhhhhccccCc--eeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc
Confidence            99999999999999888  899999999988743   355678889999999854    455679999999999999999


Q ss_pred             ccccccCcccc--eeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         418 WWFESKSNINL--SFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       418 ~~~~~~~~~~~--t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      |...++...+.  ...-+.|-+.-+.-++-.++..|+..+
T Consensus       206 F~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~  245 (426)
T KOG0589|consen  206 FKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKN  245 (426)
T ss_pred             cCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcC
Confidence            99876544211  112245555556667777788777776

>KOG0033|consensus

Probab=99.93  E-value=8e-27  Score=214.06  Aligned_cols=122  Identities=28%  Similarity=0.432  Sum_probs=102.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .|.||+|||.++|||||+||    .|+||.+.. ....+||||||+|...                           +.|
T Consensus       119 iLeal~yCH~n~IvHRDvkP----~nllLASK~-~~A~vKL~~FGvAi~l---------------------------~~g  166 (355)
T KOG0033|consen  119 ILEALAYCHSNGIVHRDLKP----ENLLLASKA-KGAAVKLADFGLAIEV---------------------------NDG  166 (355)
T ss_pred             HHHHHHHHHhcCceeccCCh----hheeeeecc-CCCceeecccceEEEe---------------------------CCc
Confidence            47899999999999999999    899998764 3457999999999843                           333


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .   +.+|                   .+|||.|||||++...+ |+.++||||.|||+|-||.|++||.|. +..+..+
T Consensus       167 ~---~~~G-------------------~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye  222 (355)
T KOG0033|consen  167 E---AWHG-------------------FAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYE  222 (355)
T ss_pred             c---cccc-------------------ccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHH
Confidence            3   2333                   23499999999999887 999999999999999999999999994 4448889


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      +|++.-...++..|+.++
T Consensus       223 ~I~~g~yd~~~~~w~~is  240 (355)
T KOG0033|consen  223 QIKAGAYDYPSPEWDTVT  240 (355)
T ss_pred             HHhccccCCCCcccCcCC
Confidence            999988888888888887

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.93  E-value=1.8e-26  Score=237.08  Aligned_cols=189  Identities=20%  Similarity=0.283  Sum_probs=131.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|.+++.. .+.+++..++.++.|++.||+|||+.+|+||
T Consensus        47 ~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHr  125 (381)
T cd05626          47 HVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHR  125 (381)
T ss_pred             HHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            35679999999999999999999999999999999998 577777765 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceecc--ccCCC----cccccccccccCCCeeEEEeecCCCCccc-
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHR--DVKPQ----NLLISEIVFTNLSGVVVSTVDSGSGGWWF-  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~--d~~~~----~il~~~~~~~~s~g~~~~~~~~g~~~~~~-  420 (481)
                      ||||+|||++..+.  +|++|||+++.+...+.......  .++.+    ..+....... ..+.....+......... 
T Consensus       126 DlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  202 (381)
T cd05626         126 DIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC-RCGDRLKTLEQRATKQHQR  202 (381)
T ss_pred             CCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCccccccccccc-ccccccchhhccccccccc
Confidence            99999999998776  99999999886653332221110  00001    0000000000 000000000000000000 


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ......+||+.|++|        +..+|+||+|++++||+.|..||...
T Consensus       203 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         203 CLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             cccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCC
Confidence            001235799999999        55689999999999999999776543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG4250|consensus

Probab=99.93  E-value=1.7e-26  Score=239.28  Aligned_cols=154  Identities=25%  Similarity=0.288  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccC-CCHHHHHHHhc--CCCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVH-TDLSQYMERHS--GGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~-g~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      ...+|+++|++|+|||||+++++-++..      .-.+|||||. |+|...+.+..  .++++..+..++..++.||.||
T Consensus        57 ~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~L  136 (732)
T KOG4250|consen   57 RWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHL  136 (732)
T ss_pred             HHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHH
Confidence            3458999999999999999999877654      4579999999 78888887543  3699999999999999999999


Q ss_pred             hcCceeeccCCCccccc--cccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         340 HRRRILHRDVKPQNLLI--SEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl--~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |++||+||||||+||++  .++|..--|++|||.|+.++...   -+..                               
T Consensus       137 rEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S-------------------------------  182 (732)
T KOG4250|consen  137 RENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTS-------------------------------  182 (732)
T ss_pred             HHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeee-------------------------------
Confidence            99999999999999997  44466668999999999877332   1222                               


Q ss_pred             ccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         418 WWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                              +.||..|++|         +.-+|-||+|+++|+...|..||...--|
T Consensus       183 --------~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  183 --------LVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             --------ecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence                    4455555555         34457777777777777777777654444

>KOG0616|consensus

Probab=99.93  E-value=6.2e-27  Score=220.25  Aligned_cols=115  Identities=23%  Similarity=0.438  Sum_probs=97.5

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ....++..++||+|||+++||+|||||    +||||+..    |.+||+|||+|+...                      
T Consensus       146 arFYAAeivlAleylH~~~iiYRDLKP----ENiLlD~~----G~iKitDFGFAK~v~----------------------  195 (355)
T KOG0616|consen  146 ARFYAAEIVLALEYLHSLDIIYRDLKP----ENLLLDQN----GHIKITDFGFAKRVS----------------------  195 (355)
T ss_pred             HHHHHHHHHHHHHHHHhcCeeeccCCh----HHeeeccC----CcEEEEeccceEEec----------------------
Confidence            344555679999999999999999999    89999988    899999999998542                      


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             +.+.+.||                      ||.|+|||+++... |+.++|||||||++|||++|.+||.+.+
T Consensus       196 -------~rT~TlCG----------------------TPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~  245 (355)
T KOG0616|consen  196 -------GRTWTLCG----------------------TPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDN  245 (355)
T ss_pred             -------CcEEEecC----------------------CccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence                   12456677                      99999999999766 9999999999999999999999999865


Q ss_pred             hhHHHHHHHHHHhCCC
Q psy3074         174 EVYDQLDKIFKILGTP  189 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p  189 (481)
                      . +...++|.+.-...
T Consensus       246 ~-~~iY~KI~~~~v~f  260 (355)
T KOG0616|consen  246 P-IQIYEKILEGKVKF  260 (355)
T ss_pred             h-HHHHHHHHhCcccC
Confidence            4 68888888764433

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.8e-26  Score=234.01  Aligned_cols=183  Identities=20%  Similarity=0.243  Sum_probs=128.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++||||++++++|.+++.+|+|||||. |+|.+++.. .+.+++..++.++.|++.||+|||+++|+|||
T Consensus        48 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~D  126 (364)
T cd05599          48 VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRD  126 (364)
T ss_pred             HHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence            4579999999999999999999999999999999998 567777655 45699999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceecccc--CCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV--KPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~--~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||+|||++.++.  +|++|||++..+...+.........  .+.+.. .........+..   ...+... ........
T Consensus       127 lkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~-~~~~~~~~  199 (364)
T cd05599         127 IKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL-DFISKPMSSKRK---AETWKRN-RRALAYST  199 (364)
T ss_pred             CCHHHeEECCCCC--EEEeecccceecccccccccccccccccccccc-cccccccccccc---ccchhhc-cccccccc
Confidence            9999999998887  9999999998664322111000000  000000 000000000000   0000000 00001235


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|        +.++|+||+|+++++|..|..|+..
T Consensus       200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence            689999999        5678999999999999999977654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.93  E-value=2.6e-26  Score=234.33  Aligned_cols=180  Identities=16%  Similarity=0.257  Sum_probs=129.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++.+.+...+|+|||||+ |+|.+.+.. .+.+++..++.++.|++.||+|||+++|+|||
T Consensus        48 ~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrD  126 (363)
T cd05628          48 IRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRD  126 (363)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecC
Confidence            4579999999999999999999999999999999998 577777765 45799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceecc--ccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHR--DVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~--d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||+|||++.++.  +|++|||+++.+...+.......  ...+........ ..+      .....+... ........
T Consensus       127 lKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~------~~~~~~~~~-~~~~~~~~  196 (363)
T cd05628         127 IKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM-NSK------RKAETWKRN-RRQLAFST  196 (363)
T ss_pred             CCHHHeEECCCCC--EEEeeccCccccccccccccccccccccccccccccc-ccc------cccchhhhc-cccccccc
Confidence            9999999998877  99999999986542211100000  000010000000 000      000001000 00001235


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|        +.++|+||+|+++++|+.|..||..
T Consensus       197 ~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         197 VGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             cCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence            789999998        5678999999999999999977654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0664|consensus

Probab=99.93  E-value=7.3e-27  Score=217.19  Aligned_cols=121  Identities=34%  Similarity=0.626  Sum_probs=105.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+|.|||+.+|+||||||    .|+|+|++.    ++|||||||||..+...                          
T Consensus       165 ILRGLKYLHsA~ILHRDIKP----GNLLVNSNC----vLKICDFGLARvee~d~--------------------------  210 (449)
T KOG0664|consen  165 ILRGLKYLHTANILHRDIKP----GNLLVNSNC----ILKICDFGLARTWDQRD--------------------------  210 (449)
T ss_pred             HHhhhHHHhhcchhhccCCC----ccEEeccCc----eEEecccccccccchhh--------------------------
Confidence            47899999999999999999    899999996    99999999999643211                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                              ...+|.++|             |-+|+|||+++|.+.|+.++||||+|||+.|+|..+..|.. ...++|++
T Consensus       211 --------~~hMTqEVV-------------TQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA-q~PiqQL~  268 (449)
T KOG0664|consen  211 --------RLNMTHEVV-------------TQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA-AGPIEQLQ  268 (449)
T ss_pred             --------hhhhHHHHH-------------HHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc-cChHHHHH
Confidence                    234566666             99999999999999999999999999999999999999998 55669999


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      .|.+.+|+|.-+.+...
T Consensus       269 lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  269 MIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             HHHHHhCCCcHHHHHHH
Confidence            99999999998866543

>KOG0586|consensus

Probab=99.93  E-value=8.1e-26  Score=231.21  Aligned_cols=150  Identities=28%  Similarity=0.407  Sum_probs=131.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..||+++|+.|+|||||+++.+.+.+..+|+||||+. |.+.+++.++ ++..+..++.++.|++.|++|||+++|+|||
T Consensus       102 ~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrd  180 (596)
T KOG0586|consen  102 LGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRD  180 (596)
T ss_pred             HHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceeccc
Confidence            4689999999999999999999999999999999998 6788888765 5677799999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcccccc--CceeccccCCCccccccc-----ccccCCCeeEEEeecCCCCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEI-----VFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~-----~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ||.+|||++.+-.  +||+|||++..+.+.+.  .......|.+|+++.+..     ++.|+.|++++.+..|++||...
T Consensus       181 Lk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~  258 (596)
T KOG0586|consen  181 LKAENILLDENMN--IKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ  258 (596)
T ss_pred             cchhhcccccccc--eeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence            9999999997666  99999999998875542  233456788999986554     45799999999999999999966


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      .
T Consensus       259 ~  259 (596)
T KOG0586|consen  259 N  259 (596)
T ss_pred             c
Confidence            5

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.92  E-value=3.9e-26  Score=234.05  Aligned_cols=151  Identities=23%  Similarity=0.380  Sum_probs=126.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++||||+++++.|.+++.+|+|||||+ |+|.+++.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        47 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHr  125 (376)
T cd05598          47 HVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHR  125 (376)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            35679999999999999999999999999999999998 678777765 3568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc----------------------------------------------C
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR----------------------------------------------R  381 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~----------------------------------------------~  381 (481)
                      ||||+|||++.++.  +|++|||+|..+.+.+.                                              .
T Consensus       126 Dlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (376)
T cd05598         126 DIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS  203 (376)
T ss_pred             CCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence            99999999998877  99999999864432110                                              1


Q ss_pred             ceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         382 RILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       382 ~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      .+.+..|.+||++..    ...+.|+.||+++++.+|..||...+
T Consensus       204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  248 (376)
T cd05598         204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADT  248 (376)
T ss_pred             cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCC
Confidence            134456778887743    34578999999999999999998654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0607|consensus

Probab=99.92  E-value=5e-26  Score=215.83  Aligned_cols=159  Identities=16%  Similarity=0.239  Sum_probs=128.3

Q ss_pred             hhhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         267 PFTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       267 ~~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +.++.||++++.+++ |+||++|.++|+++...|+|||-|. |.++..+.++ ..|+|..+..+...|+.||.|||.+||
T Consensus       119 R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgI  197 (463)
T KOG0607|consen  119 RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGI  197 (463)
T ss_pred             HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCc
Confidence            345779999999998 9999999999999999999999998 5688887764 569999999999999999999999999


Q ss_pred             eeccCCCcccccccc-chhhHHHHHHHHHhhccccccCc-eeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         345 LHRDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRR-ILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       345 iHrDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~-i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      .||||||||||..+. ....+|||||.+..++...+.-. +.+.+                                   
T Consensus       198 AHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~-----------------------------------  242 (463)
T KOG0607|consen  198 AHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE-----------------------------------  242 (463)
T ss_pred             ccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc-----------------------------------
Confidence            999999999998654 44679999999988766443211 11111                                   


Q ss_pred             cCcccceeccCCC-------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         423 KSNINLSFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       423 ~~~~~~t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...-+|+..||+|             +..+|.||+|++||.|++|.+||...
T Consensus       243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence            1113455555665             66789999999999999999777543

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.92  E-value=2.9e-26  Score=235.59  Aligned_cols=188  Identities=20%  Similarity=0.267  Sum_probs=130.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++|||||++++.|.+.+.+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        47 ~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHr  125 (382)
T cd05625          47 HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHR  125 (382)
T ss_pred             HHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            35679999999999999999999999999999999998 577777755 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceec-ccc-CCCcccccccccccCCCeeEE---EeecCCCCcc--c
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILH-RDV-KPQNLLISEIVFTNLSGVVVS---TVDSGSGGWW--F  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~-~d~-~~~~il~~~~~~~~s~g~~~~---~~~~g~~~~~--~  420 (481)
                      ||||+|||++.++.  +|++|||+|+.+...+...... .+. ...+.-..... .....+...   ..........  .
T Consensus       126 DlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  202 (382)
T cd05625         126 DIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW-GDPANCRCGDRLKPLERRAARQHQR  202 (382)
T ss_pred             CCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccc-cccccccccccccchhhhhcccccc
Confidence            99999999998887  9999999987665433221110 000 00000000000 000000000   0000000000  0


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ......+||+.|++|        +..+|+||+|++++||+.|..||..
T Consensus       203 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~  250 (382)
T cd05625         203 CLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             ccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence            001235789999999        5668999999999999999977754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG0667|consensus

Probab=99.92  E-value=6.4e-26  Score=234.01  Aligned_cols=118  Identities=36%  Similarity=0.694  Sum_probs=100.0

Q ss_pred             cccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          20 SKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        20 ~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ..+.||.+||+.+|||.||||    +||||.....  -.|||.|||.|....                           .
T Consensus       297 Qil~~L~~L~~l~IIHcDLKP----ENILL~~~~r--~~vKVIDFGSSc~~~---------------------------q  343 (586)
T KOG0667|consen  297 QILTALLFLHELGIIHCDLKP----ENILLKDPKR--SRIKVIDFGSSCFES---------------------------Q  343 (586)
T ss_pred             HHHHHHHHHHhCCeeeccCCh----hheeeccCCc--CceeEEecccccccC---------------------------C
Confidence            478899999999999999999    8999987642  379999999997421                           1


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      +-+  +|.                      .+++|+|||||+|.+ |+.++||||||||++||++|.|.|+|.++ .+|+
T Consensus       344 ~vy--tYi----------------------QSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne-~DQl  397 (586)
T KOG0667|consen  344 RVY--TYI----------------------QSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNE-YDQL  397 (586)
T ss_pred             cce--eee----------------------eccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCH-HHHH
Confidence            112  332                      399999999999988 99999999999999999999999999554 5999


Q ss_pred             HHHHHHhCCCCccCccc
Q psy3074         180 DKIFKILGTPTEETWEG  196 (481)
Q Consensus       180 ~~i~~~~~~p~~~~~~~  196 (481)
                      ..|.+.+|.|++.....
T Consensus       398 ~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  398 ARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             HHHHHHhCCCCHHHHHh
Confidence            99999999999875443

>KOG0577|consensus

Probab=99.92  E-value=7e-27  Score=236.31  Aligned_cols=172  Identities=19%  Similarity=0.228  Sum_probs=142.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      .++|++.|++++|||+|.+.++|-.+...|+|||||-|+-.+++..+..++.+..+..++.+.+.||.|||+.+.|||||
T Consensus        73 IlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDi  152 (948)
T KOG0577|consen   73 ILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDI  152 (948)
T ss_pred             HHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhc
Confidence            45699999999999999999999999999999999999999999888889999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccc-------cccccccCCCeeEEEeecCCCCccccc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-------SEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~-------~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      |..|||+++.|.  ||++|||.|..+... ...|.+....+|++++       +..+++||.|+.+.++.-.++|+.+.+
T Consensus       153 KAGNILLse~g~--VKLaDFGSAsi~~PA-nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN  229 (948)
T KOG0577|consen  153 KAGNILLSEPGL--VKLADFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN  229 (948)
T ss_pred             cccceEecCCCe--eeeccccchhhcCch-hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch
Confidence            999999999888  999999999866533 3456777666777663       456678999999999999999976543


Q ss_pred             -cCcccceeccCCCCCChhhhhh
Q psy3074         423 -KSNINLSFHYLPPGAPFTAIRE  444 (481)
Q Consensus       423 -~~~~~~t~~y~~p~~p~~~~s~  444 (481)
                       ++..-....--+|..++.-||.
T Consensus       230 AMSALYHIAQNesPtLqs~eWS~  252 (948)
T KOG0577|consen  230 AMSALYHIAQNESPTLQSNEWSD  252 (948)
T ss_pred             HHHHHHHHHhcCCCCCCCchhHH
Confidence             2222122233456666777754

>KOG0669|consensus

Probab=99.92  E-value=9.2e-28  Score=221.00  Aligned_cols=157  Identities=31%  Similarity=0.480  Sum_probs=137.6

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeec--------CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHH
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHT--------RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~--------~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~  335 (481)
                      ++.+..++||+.+|..|+|+|++.+.+.|..        +..+|+||++|+.||.-++....-.++...++.++.++++|
T Consensus        57 eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~G  136 (376)
T KOG0669|consen   57 EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNG  136 (376)
T ss_pred             cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHH
Confidence            3455678999999999999999999998864        34699999999999999988766779999999999999999


Q ss_pred             HHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcccc-------ccCceeccccCCCccccccccc-----ccC
Q psy3074         336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC-------HRRRILHRDVKPQNLLISEIVF-----TNL  403 (481)
Q Consensus       336 l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~-------~~~~i~~~d~~~~~il~~~~~~-----~~s  403 (481)
                      |.|+|+..|+|||+||+|+||+.++.  +|++|||+++++...       -.+++++-+|.||+.++++.-+     .|.
T Consensus       137 L~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg  214 (376)
T KOG0669|consen  137 LYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG  214 (376)
T ss_pred             HHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence            99999999999999999999998888  999999999987622       2467899999999999876554     588


Q ss_pred             CCeeEEEeecCCCCccccc
Q psy3074         404 SGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       404 ~g~~~~~~~~g~~~~~~~~  422 (481)
                      .||++.+|-++++-+...+
T Consensus       215 AgCimaeMwtrspimqgnt  233 (376)
T KOG0669|consen  215 AGCIMAEMWTRSPIMQGNT  233 (376)
T ss_pred             HHHHHHHHHccCccccCCh
Confidence            8999999999999888665

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.3e-26  Score=233.90  Aligned_cols=150  Identities=21%  Similarity=0.274  Sum_probs=125.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++++.++|||||+++++|.+.+.+|+|||||+ |+|.+.+.. .+.+++..++.++.|++.||+|||+++|+|||
T Consensus        48 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrD  126 (377)
T cd05629          48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD  126 (377)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            4579999999999999999999999999999999998 678777765 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc-------------------------------------------------
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-------------------------------------------------  379 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-------------------------------------------------  379 (481)
                      |||+|||++.++.  +|++|||+++.+...+                                                 
T Consensus       127 lkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (377)
T cd05629         127 IKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLM  204 (377)
T ss_pred             CCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence            9999999998777  9999999986332100                                                 


Q ss_pred             -cCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCccccc
Q psy3074         380 -RRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       380 -~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                       ...+.+..|.+||++.    +...+.||.||+++++.+|..||....
T Consensus       205 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~  252 (377)
T cd05629         205 AYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSEN  252 (377)
T ss_pred             ccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCC
Confidence             0123556688888774    445678999999999999999997543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.4e-25  Score=231.17  Aligned_cols=148  Identities=20%  Similarity=0.258  Sum_probs=121.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+++|++++|||||+++++|......++|||++.+++...+... ..+++..++.++.|++.||.|||+++|+||||
T Consensus       130 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDi  208 (391)
T PHA03212        130 TATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDI  208 (391)
T ss_pred             hHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            35799999999999999999999999999999999999988887653 56899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      ||+|||++..+.  +|++|||+|+.........                                        ....+||
T Consensus       209 KP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~----------------------------------------~~~~~gt  246 (391)
T PHA03212        209 KAENIFINHPGD--VCLGDFGAACFPVDINANK----------------------------------------YYGWAGT  246 (391)
T ss_pred             ChHhEEEcCCCC--EEEEeCCcccccccccccc----------------------------------------cccccCc
Confidence            999999998777  9999999886322110000                                        0012345


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +.|++|        +.++|+||+|+++++|+.|..|++.
T Consensus       247 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             cCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            555555        5578999999999999999877664

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.92  E-value=3.1e-26  Score=230.71  Aligned_cols=151  Identities=21%  Similarity=0.325  Sum_probs=128.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+++.+|+|||||. |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        64 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~  142 (329)
T PTZ00263         64 HVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYR  142 (329)
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            35679999999999999999999999999999999998 577777765 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||||+|||+++++.  +|++|||+++.+.........+..|.+||++..    ...|.|++|++++++.+|..||...+
T Consensus       143 dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  219 (329)
T PTZ00263        143 DLKPENLLLDNKGH--VKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT  219 (329)
T ss_pred             CCCHHHEEECCCCC--EEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence            99999999998877  999999999866533222334556788887743    44578999999999999999997553

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=1.4e-25  Score=220.78  Aligned_cols=149  Identities=32%  Similarity=0.571  Sum_probs=120.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++||||+++++++...+..|+||||+++++...+......+++..++.++.|++.||.|||+.+++|||
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~d  125 (287)
T cd07848          46 TTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRD  125 (287)
T ss_pred             hHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            35679999999999999999999999999999999999887777766556799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+||+++.++.  +|++|||++..+.......                                        .....+
T Consensus       126 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------------------~~~~~~  163 (287)
T cd07848         126 IKPENLLISHNDV--LKLCDFGFARNLSEGSNAN----------------------------------------YTEYVA  163 (287)
T ss_pred             CCHHHEEEcCCCc--EEEeeccCccccccccccc----------------------------------------cccccc
Confidence            9999999988776  9999999987543111000                                        000123


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      |+.|++|        +..+|+||+|+++++|.+|..|+-
T Consensus       164 ~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~  202 (287)
T cd07848         164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFP  202 (287)
T ss_pred             ccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence            3334433        456799999999999999986653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1989|consensus

Probab=99.92  E-value=2.8e-26  Score=243.49  Aligned_cols=185  Identities=20%  Similarity=0.244  Sum_probs=153.6

Q ss_pred             hhHHHHHHHHhhcC-CCCeeEEeeeee-c------CCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELK-HNNIVTLHDIVH-T------RSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       268 ~~~~rE~~il~~l~-HpnIV~l~~~~~-~------~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      ..+.+|+++|+.|+ |+|||.|+|... .      .-+++|.||||. |+|.+++..+ ..+|++..+..|+.++++|+.
T Consensus        79 ~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa  158 (738)
T KOG1989|consen   79 NAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVA  158 (738)
T ss_pred             HHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHH
Confidence            35678999999999 999999999432 1      126889999999 7999998743 456999999999999999999


Q ss_pred             HhhcCc--eeeccCCCccccccccchhhHHHHHHHHHhhccccc------------cCceeccccCCCccc-------cc
Q psy3074         338 YCHRRR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH------------RRRILHRDVKPQNLL-------IS  396 (481)
Q Consensus       338 ylH~~~--iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~------------~~~i~~~d~~~~~il-------~~  396 (481)
                      +||...  |||||||-|||||+.+++  .|+||||.|...-...            -....+..|++||++       ++
T Consensus       159 ~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~  236 (738)
T KOG1989|consen  159 AMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG  236 (738)
T ss_pred             HHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence            999887  999999999999999887  9999999987432111            123567789999887       78


Q ss_pred             ccccccCCCeeEEEeecCCCCccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         397 EIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       397 ~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      |..|.|.+||.+|++++...||.......| ..-.|..|..|...-.+.+|+..|+..+
T Consensus       237 eKsDIWALGclLYkLCy~t~PFe~sg~laI-lng~Y~~P~~p~ys~~l~~LI~~mL~~n  294 (738)
T KOG1989|consen  237 EKSDIWALGCLLYKLCYFTTPFEESGKLAI-LNGNYSFPPFPNYSDRLKDLIRTMLQPN  294 (738)
T ss_pred             chhHHHHHHHHHHHHHHhCCCcCcCcceeE-EeccccCCCCccHHHHHHHHHHHHhccC
Confidence            999999999999999999999987655444 5667788877888888888888888887

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.92  E-value=3.4e-26  Score=231.55  Aligned_cols=151  Identities=17%  Similarity=0.244  Sum_probs=129.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+..|+|||||. |+|..++.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        77 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  155 (340)
T PTZ00426         77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR  155 (340)
T ss_pred             HHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            35679999999999999999999999999999999998 677777765 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||||+|||++.++.  +|++|||+++.+.........+..|.||+++.+    ...+.||.|+++++|.+|..||...+
T Consensus       156 DLkp~NILl~~~~~--ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        156 DLKPENLLLDKDGF--IKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             CCCHHHEEECCCCC--EEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence            99999999988777  999999999876543333345566888888743    45678999999999999999998654

>KOG0201|consensus

Probab=99.92  E-value=7.8e-27  Score=229.99  Aligned_cols=152  Identities=21%  Similarity=0.317  Sum_probs=129.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..+|+.+|.+++++||.++|+.|.....+|++||||.| ++.+.+.. ...+++..+..++++++.|+.|+|.++.+|||
T Consensus        58 iqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrD  136 (467)
T KOG0201|consen   58 IQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRD  136 (467)
T ss_pred             HHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceeccc
Confidence            45799999999999999999999999999999999995 56555543 34458999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      ||+.|||+...+.  +|++|||++..+.....+                                         ...++|
T Consensus       137 IKaanil~s~~g~--vkl~DfgVa~ql~~~~~r-----------------------------------------r~tfvG  173 (467)
T KOG0201|consen  137 IKAANILLSESGD--VKLADFGVAGQLTNTVKR-----------------------------------------RKTFVG  173 (467)
T ss_pred             ccccceeEeccCc--EEEEecceeeeeechhhc-----------------------------------------cccccc
Confidence            9999999998876  999999998765522111                                         123678


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccC
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTR  466 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~  466 (481)
                      |+.||+|        +..+|+||+|...+||..|. |++.+..|-+
T Consensus       174 TPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge-PP~s~~hPmr  218 (467)
T KOG0201|consen  174 TPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE-PPHSKLHPMR  218 (467)
T ss_pred             cccccchhhhccccccchhhhhhhhHHHHHHhcCC-CCCcccCcce
Confidence            9999999        67889999999999999997 8888888843

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.92  E-value=1e-25  Score=226.36  Aligned_cols=150  Identities=21%  Similarity=0.275  Sum_probs=126.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++...+.+|+||||+. |+|...+.. .+.+++..++.++.|++.||+|||+++|+|||
T Consensus        42 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD  120 (323)
T cd05571          42 TLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRD  120 (323)
T ss_pred             HHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence            4579999999999999999999999999999999998 567666654 45789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||+|||++.++.  +|++|||+++.....   ......+..|.+|+++.    +...|.|+.|++++++.+|..||...
T Consensus       121 lkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         121 LKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             CCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence            9999999998777  999999998753211   12233566788888875    34567899999999999999999754


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      +
T Consensus       199 ~  199 (323)
T cd05571         199 D  199 (323)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=4.7e-25  Score=219.75  Aligned_cols=153  Identities=44%  Similarity=0.714  Sum_probs=120.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+++++.++||||+++++++..++..++||||+++++.+.+......+++..+..++.|++.||.|||+++|+||||
T Consensus        51 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dl  130 (309)
T cd07872          51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDL  130 (309)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence            45799999999999999999999999999999999999999888766566889999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+||+++..+.  +|++|||+++.......   ....+..+.+|+++.+                              
T Consensus       131 kp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------------------------------  178 (309)
T cd07872         131 KPQNLLINERGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG------------------------------  178 (309)
T ss_pred             CHHHEEECCCCC--EEECccccceecCCCccccccccccccccCCHHHhC------------------------------
Confidence            999999998777  99999999865331110   0111112222222110                              


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                        +.   ..+.++|+|++|+++++|.+|.+|+.
T Consensus       179 --~~---~~~~~~DiwslG~il~el~tg~~pf~  206 (309)
T cd07872         179 --SS---EYSTQIDMWGVGCIFFEMASGRPLFP  206 (309)
T ss_pred             --CC---CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence              00   11346799999999999999986664

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0986|consensus

Probab=99.92  E-value=1.6e-25  Score=220.92  Aligned_cols=147  Identities=24%  Similarity=0.364  Sum_probs=124.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ++.|..||++++.++||.+-.+|++++.+|+||..|+ |||...+.... .+|+++.++.|+.+|+.||++||+.+|+.|
T Consensus       232 aLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYR  311 (591)
T KOG0986|consen  232 ALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYR  311 (591)
T ss_pred             hhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeec
Confidence            5679999999999999999999999999999999999 56655555442 379999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+|+.|+  ++|.|.|+|..+..-                                    . |     ...-+
T Consensus       312 DLKPeNILLDd~Gh--vRISDLGLAvei~~g------------------------------------~-~-----~~~rv  347 (591)
T KOG0986|consen  312 DLKPENILLDDHGH--VRISDLGLAVEIPEG------------------------------------K-P-----IRGRV  347 (591)
T ss_pred             cCChhheeeccCCC--eEeeccceEEecCCC------------------------------------C-c-----ccccc
Confidence            99999999999999  999999999755411                                    0 0     01124


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||.+||+|        +.++|||++||+||||..|.-||-.
T Consensus       348 GT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  348 GTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             CcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence            77777777        6788999999999999999977754

>KOG0696|consensus

Probab=99.92  E-value=8.1e-26  Score=220.44  Aligned_cols=148  Identities=22%  Similarity=0.308  Sum_probs=123.5

Q ss_pred             HHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       272 rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      .|-++|.... -|.+|+++..|++-+.+|+||||+. |+|...+. +-+.+.|..+..|+.+|+.||-+||++|||.|||
T Consensus       398 ~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDL  476 (683)
T KOG0696|consen  398 VEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDL  476 (683)
T ss_pred             hhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhhhhhcCCeeeeec
Confidence            3666666544 6789999999999999999999999 56665554 4578999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      |.+|||++.+|+  ||++|||+++.                 |++-                        ..+...+|||
T Consensus       477 KLDNvmLd~eGH--iKi~DFGmcKE-----------------ni~~------------------------~~TTkTFCGT  513 (683)
T KOG0696|consen  477 KLDNVMLDSEGH--IKIADFGMCKE-----------------NIFD------------------------GVTTKTFCGT  513 (683)
T ss_pred             cccceEeccCCc--eEeeecccccc-----------------cccC------------------------CcceeeecCC
Confidence            999999999999  99999999862                 2211                        1223457899


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                      +.|++|        +...|||+.|++||||+-|. |+|++.+.
T Consensus       514 PdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQ-pPFdGeDE  555 (683)
T KOG0696|consen  514 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ-PPFDGEDE  555 (683)
T ss_pred             CcccccceEEecccccchhHHHHHHHHHHHHcCC-CCCCCCCH
Confidence            999998        88899999999999999998 66666554

>KOG0592|consensus

Probab=99.92  E-value=7.8e-26  Score=227.86  Aligned_cols=137  Identities=28%  Similarity=0.376  Sum_probs=104.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++|||||||||    +||||+.+    |++||+|||-|+.+........+.-             ......
T Consensus       183 IldAleylH~~GIIHRDlKP----ENILLd~d----mhikITDFGsAK~l~~~~~~~~~~~-------------~~~~a~  241 (604)
T KOG0592|consen  183 ILDALEYLHSNGIIHRDLKP----ENILLDKD----GHIKITDFGSAKILSPSQKSQENPV-------------DPNQAS  241 (604)
T ss_pred             HHHHHHHHHhcCceeccCCh----hheeEcCC----CcEEEeeccccccCChhhccccCcc-------------Cccccc
Confidence            79999999999999999999    89999988    7999999999986542211100000             000001


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      +-...|.|                      |..|.+||+|..+. -+..+|+|+||||+|.|++|.|||.+.++. -.++
T Consensus       242 s~~~SFVG----------------------TAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFq  297 (604)
T KOG0592|consen  242 SRRSSFVG----------------------TAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQ  297 (604)
T ss_pred             Ccccceee----------------------eecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHH-HHHH
Confidence            11233444                      99999999999876 899999999999999999999999997664 7889


Q ss_pred             HHHHHhCCCCccCcccccCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                      +|...-..+++...+.+..+..
T Consensus       298 kI~~l~y~fp~~fp~~a~dLv~  319 (604)
T KOG0592|consen  298 KIQALDYEFPEGFPEDARDLIK  319 (604)
T ss_pred             HHHHhcccCCCCCCHHHHHHHH
Confidence            9998887777766665554433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.2e-26  Score=223.12  Aligned_cols=152  Identities=22%  Similarity=0.302  Sum_probs=117.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++.+.+.+|+||||+. |+|.+++.. .+.+++..+..++.|++.||.|||+++++|||
T Consensus        48 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  126 (291)
T cd05612          48 VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRD  126 (291)
T ss_pred             HHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence            5679999999999999999999999999999999998 678887765 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||+++++.  +|++|||+++.+.........+..|.||+++...                               
T Consensus       127 lkp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------------  173 (291)
T cd05612         127 LKPENILLDKEGH--IKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSK-------------------------------  173 (291)
T ss_pred             CCHHHeEECCCCC--EEEEecCcchhccCCcccccCChhhcCHHHHcCC-------------------------------
Confidence            9999999998776  9999999987543211111111222222222110                               


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                           ..+..+|+||+|+++++|..|..|+..
T Consensus       174 -----~~~~~~DiwSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         174 -----GHNKAVDWWALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             -----CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 014557888888888888888866543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.92  E-value=2.1e-25  Score=227.33  Aligned_cols=151  Identities=19%  Similarity=0.317  Sum_probs=126.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++..++||||+++++.+.+.+.+|+|||||+ |+|.+.+.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        47 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHr  125 (360)
T cd05627          47 HIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHR  125 (360)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcc
Confidence            34579999999999999999999999999999999998 567777754 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc--------------------------------------cCceeccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--------------------------------------RRRILHRDVK  389 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--------------------------------------~~~i~~~d~~  389 (481)
                      ||||+|||++.++.  +|++|||+++.+...+                                      ...+.+..|.
T Consensus       126 DLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  203 (360)
T cd05627         126 DIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI  203 (360)
T ss_pred             CCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence            99999999998877  9999999987553211                                      0123456678


Q ss_pred             CCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         390 PQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       390 ~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      |||++.+    ...+.||.||+++++.+|..||...+
T Consensus       204 APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             CHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence            8887743    34578999999999999999997654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.92  E-value=3.1e-25  Score=223.23  Aligned_cols=151  Identities=21%  Similarity=0.261  Sum_probs=129.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++.+.+..|+||||++ |+|.+++......+++..+..++.|++.||.|||+.+|+|||
T Consensus        48 ~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~D  127 (330)
T cd05601          48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD  127 (330)
T ss_pred             HHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccc
Confidence            4579999999999999999999999999999999998 688888877656799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc----------cccccccCCCeeEEEeecC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI----------SEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~----------~~~~~~~s~g~~~~~~~~g  414 (481)
                      |||+|||++.++.  +|++|||++..+....    .....+..|.|||++.          +...+.|+.|++++++.+|
T Consensus       128 lkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g  205 (330)
T cd05601         128 IKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYG  205 (330)
T ss_pred             CchHheEECCCCC--EEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccC
Confidence            9999999998877  9999999997654221    1123455688888875          3456889999999999999


Q ss_pred             CCCccccc
Q psy3074         415 SGGWWFES  422 (481)
Q Consensus       415 ~~~~~~~~  422 (481)
                      ..||...+
T Consensus       206 ~~Pf~~~~  213 (330)
T cd05601         206 RSPFHEGT  213 (330)
T ss_pred             CCCCCCCC
Confidence            99997543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0590|consensus

Probab=99.92  E-value=1e-25  Score=241.41  Aligned_cols=380  Identities=21%  Similarity=0.225  Sum_probs=233.5

Q ss_pred             ccccHHHHH-HhhhhcccCCCCCCCcchhccccCCCCC-ceeeecccccccccCCCCCcCCCCCCCCCccccceecccCC
Q psy3074          21 KLLDADIAE-ETRVLLRNRKPPRPKSEVFLNKYATPPR-ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLG   98 (481)
Q Consensus        21 ~~~~~~~lh-~~~i~hrdlkp~~~~~nill~~~~~~~g-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g   98 (481)
                      ...++.|+| +.++.||||||    +|.+++..    + .+|++|||+|.....-                         
T Consensus       132 l~s~l~~~H~~~~~~h~~ikP----~n~~l~~s----~~~l~~~df~~At~~~~~-------------------------  178 (601)
T KOG0590|consen  132 LNSGLSYLHPENGVTHRDIKP----SNSLLDES----GSALKIADFGLATAYRNK-------------------------  178 (601)
T ss_pred             hccCccccCcccccccCCCCC----ccchhccC----CCcccCCCchhhcccccc-------------------------
Confidence            367899999 99999999999    89988876    5 8999999999753210                         


Q ss_pred             CCceeEEEecccCcchhhhhhhhhhhccccCc-eeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074          99 EGSYATVFKGYSNLTNQVVALKEIRLQEEEGI-TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus        99 ~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~-t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      .|......                    ...+ ++.|+|||...+........|+||.|+++.-+++|..|+.-......
T Consensus       179 ~g~~~~~~--------------------~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~  238 (601)
T KOG0590|consen  179 NGAERSLK--------------------DRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG  238 (601)
T ss_pred             CCcceeee--------------------cccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc
Confidence            11111111                    1123 88999999999866578899999999999999999998754322212


Q ss_pred             HHHHHHHHhCCCCccCcccccCCCCCCccCCC---CccCCCcCcCCC-CccCC---------------------------
Q psy3074         178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDA---PYTGNKLGLTFP-RLYDI---------------------------  226 (481)
Q Consensus       178 ~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~---------------------------  226 (481)
                      -...+....+.+....|..++........+..   +..+.+.+.+.. .+...                           
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~~~~~~~~~n~~~~~~~~~~~~~~~~~~  318 (601)
T KOG0590|consen  239 RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSSKRNGFSKSNPCADSLTIAKSPIGFSEK  318 (601)
T ss_pred             cceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccccccccccccccccccccccCccccccc
Confidence            22222222333344444444433322222211   111111111100 00000                           


Q ss_pred             ---CcchhHHHHHHhhhhhhhcCCccccccc---cccCCCCCCCCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEE
Q psy3074         227 ---PEGESMASAFLQVRDAAILNPMEHVHNC---EKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTF  300 (481)
Q Consensus       227 ---~~g~~~a~~ll~v~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~i  300 (481)
                         ++.....++...++-+....+.+.....   .+................|.-+-..+.|||++...+.+.+....+-
T Consensus       319 y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~  398 (601)
T KOG0590|consen  319 YGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ  398 (601)
T ss_pred             cCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence               0000011111111111111111100000   0000000000001113446666777899999988888887776766


Q ss_pred             EEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcccccc
Q psy3074         301 VFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR  380 (481)
Q Consensus       301 v~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~  380 (481)
                      .||||++||+.++... +.+....+-.++.|++.|+.|+|.+||.|||+||+|+++...+.  +|++|||.+.-..+...
T Consensus       399 ~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  399 SMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCcc
Confidence            7999999887777653 46888889999999999999999999999999999999998887  99999999987776655


Q ss_pred             Cc-------eeccccCCCccccccccc-----ccCCCeeEEEeecCCCCccccccCc-----ccceeccCCCCCChhhhh
Q psy3074         381 RR-------ILHRDVKPQNLLISEIVF-----TNLSGVVVSTVDSGSGGWWFESKSN-----INLSFHYLPPGAPFTAIR  443 (481)
Q Consensus       381 ~~-------i~~~d~~~~~il~~~~~~-----~~s~g~~~~~~~~g~~~~~~~~~~~-----~~~t~~y~~p~~p~~~~s  443 (481)
                      ..       +....|.+||++.+..++     +|+.|++...|..|..||-.+....     ..+.-..-....|..+|+
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence            41       233356667766655554     5999999999999999998775432     122222222244555553


Q ss_pred             h-----HHHHHHhhCCCc
Q psy3074         444 E-----ASLLKELKHNNI  456 (481)
Q Consensus       444 ~-----~~~l~~l~~~~~  456 (481)
                      +     -.+|+.|++.++
T Consensus       556 ~lp~~~~~~~~~~l~~~P  573 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDP  573 (601)
T ss_pred             hchhhHHHHHHHHccCCh
Confidence            3     357788888773

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-25  Score=226.83  Aligned_cols=151  Identities=23%  Similarity=0.300  Sum_probs=130.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ |+|.+++.. .+.+++..++.++.|++.||.|||+++++||
T Consensus        47 ~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  125 (333)
T cd05600          47 HVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHR  125 (333)
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35679999999999999999999999999999999998 577777654 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||||+|||+++++.  +|++|||+++.........+.+..|.+|+++.+    ...+.|+.|++++++.+|..||...+
T Consensus       126 dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  202 (333)
T cd05600         126 DLKPENFLIDASGH--IKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST  202 (333)
T ss_pred             CCCHHHEEECCCCC--EEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence            99999999998877  999999999876544344456677888988754    34577999999999999999997553

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0591|consensus

Probab=99.92  E-value=6.2e-26  Score=212.05  Aligned_cols=110  Identities=30%  Similarity=0.455  Sum_probs=90.6

Q ss_pred             ccccHHHHHH--hh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceeccc
Q psy3074          21 KLLDADIAEE--TR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQ   96 (481)
Q Consensus        21 ~~~~~~~lh~--~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   96 (481)
                      .+.||..||+  .+  |+||||||    +||||+..    |++||+||||+|.++.                        
T Consensus       133 L~~AL~~cH~~~~r~~VmHRDIKP----aNIFl~~~----gvvKLGDfGL~r~l~s------------------------  180 (375)
T KOG0591|consen  133 LCRALYHCHSKIPRGTVMHRDIKP----ANIFLTAN----GVVKLGDFGLGRFLSS------------------------  180 (375)
T ss_pred             HHHHHHHHhccccccceeeccCcc----hheEEcCC----CceeeccchhHhHhcc------------------------
Confidence            4678999999  55  99999999    89999877    8999999999996542                        


Q ss_pred             CCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhH
Q psy3074          97 LGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVY  176 (481)
Q Consensus        97 ~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~  176 (481)
                        ..+|+.++.|                      ||+||+||++.++. |+.+|||||+||++|||..-++||.|. ...
T Consensus       181 --~~tfA~S~VG----------------------TPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~  234 (375)
T KOG0591|consen  181 --KTTFAHSLVG----------------------TPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGD-NLL  234 (375)
T ss_pred             --hhHHHHhhcC----------------------CCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccc-cHH
Confidence              2234555555                      99999999999887 999999999999999999999999995 554


Q ss_pred             HHHHHHHHHhCC
Q psy3074         177 DQLDKIFKILGT  188 (481)
Q Consensus       177 ~~l~~i~~~~~~  188 (481)
                      +.-++|.++-..
T Consensus       235 ~L~~KI~qgd~~  246 (375)
T KOG0591|consen  235 SLCKKIEQGDYP  246 (375)
T ss_pred             HHHHHHHcCCCC
Confidence            555666555333

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.91  E-value=7.7e-26  Score=231.58  Aligned_cols=149  Identities=19%  Similarity=0.243  Sum_probs=127.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++.+++.+|+|||||+ |+|.+++..  ..+++..++.++.|++.||+|||+++|+|||
T Consensus        90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrD  167 (370)
T cd05621          90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRD  167 (370)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            4579999999999999999999999999999999998 678877754  3588999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc--------cccccccCCCeeEEEeecCCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI--------SEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~--------~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |||+|||+++++.  +|++|||+|..+....    .....+..|.+|+++.        +...+.||.|+++++|.+|..
T Consensus       168 LKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~  245 (370)
T cd05621         168 VKPDNMLLDKHGH--LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT  245 (370)
T ss_pred             CCHHHEEECCCCC--EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence            9999999998877  9999999998664221    1234566788888874        345788999999999999999


Q ss_pred             Cccccc
Q psy3074         417 GWWFES  422 (481)
Q Consensus       417 ~~~~~~  422 (481)
                      ||...+
T Consensus       246 Pf~~~~  251 (370)
T cd05621         246 PFYADS  251 (370)
T ss_pred             CCCCCC
Confidence            997654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.91  E-value=6.1e-25  Score=220.69  Aligned_cols=148  Identities=21%  Similarity=0.332  Sum_probs=118.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||++++++|...+.+|+||||++ |+|...+.. .+.+++..++.++.|++.||.|||+++|+|||
T Consensus        42 ~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D  120 (323)
T cd05595          42 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRD  120 (323)
T ss_pred             HHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            4579999999999999999999999999999999998 567666544 45689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++........                                         .....|
T Consensus       121 lkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~-----------------------------------------~~~~~g  157 (323)
T cd05595         121 IKLENLMLDKDGH--IKITDFGLCKEGISDGAT-----------------------------------------MKTFCG  157 (323)
T ss_pred             CCHHHEEEcCCCC--EEecccHHhccccCCCCc-----------------------------------------cccccC
Confidence            9999999998777  999999998642110000                                         001224


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|        +..+|+||+|+++++|..|..|+...
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  198 (323)
T cd05595         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             CcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence            4444444        45679999999999999998776543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.91  E-value=7.4e-25  Score=229.32  Aligned_cols=154  Identities=28%  Similarity=0.410  Sum_probs=114.0

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecC--------CeEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHh
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTR--------STLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~--------~~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .+|+.+|+.++|||||+++++|...        ..+++|||||++++..++..   ....+++..++.++.|++.||.||
T Consensus       107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yL  186 (440)
T PTZ00036        107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI  186 (440)
T ss_pred             HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3699999999999999999887432        25789999999988777653   235688999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhcccccc--CceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |+++|+||||||+|||++..+ ..+|++|||+|+.+.....  ..+.++.|.+|+++.+                     
T Consensus       187 H~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~---------------------  244 (440)
T PTZ00036        187 HSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG---------------------  244 (440)
T ss_pred             HHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccCCCCcccCCCCcCccCHHHhcC---------------------
Confidence            999999999999999998543 2399999999986532110  1112222333332221                     


Q ss_pred             ccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         418 WWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                 +..   .+..+|+||+|+++++|++|.+||..
T Consensus       245 -----------~~~---~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        245 -----------ATN---YTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             -----------CCC---CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                       000   13457999999999999999866644

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.91  E-value=4.4e-25  Score=217.51  Aligned_cols=147  Identities=22%  Similarity=0.304  Sum_probs=117.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++.++|+||+++++++.+.+..++|||||+ |+|...+.... ..+++..+..++.|++.||+|||+++|+||
T Consensus        47 ~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~  126 (285)
T cd05631          47 ALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYR  126 (285)
T ss_pred             HHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            4579999999999999999999999999999999998 56766665432 358899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||++..+.....   ..                                       ...
T Consensus       127 dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~---~~---------------------------------------~~~  162 (285)
T cd05631         127 DLKPENILLDDRGH--IRISDLGLAVQIPEGET---VR---------------------------------------GRV  162 (285)
T ss_pred             CCCHHHEEECCCCC--EEEeeCCCcEEcCCCCe---ec---------------------------------------CCC
Confidence            99999999988777  99999998865321000   00                                       012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||..|++|        +..+|+||+|+++++|..|..|+..
T Consensus       163 g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  203 (285)
T cd05631         163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             CCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence            33334443        4557999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0669|consensus

Probab=99.91  E-value=3.6e-25  Score=203.99  Aligned_cols=140  Identities=39%  Similarity=0.670  Sum_probs=117.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.+|.|+|.+.|+|||+||    +|+|++.+    |.+||+|||+||.++...+.                    .+  
T Consensus       133 Lm~GL~~iHr~kilHRDmKa----aNvLIt~d----gilklADFGlar~fs~~~n~--------------------~k--  182 (376)
T KOG0669|consen  133 LMNGLYYIHRNKILHRDMKA----ANVLITKD----GILKLADFGLARAFSTSKNV--------------------VK--  182 (376)
T ss_pred             HHHHHHHHHHhhHHhhcccH----hhEEEcCC----ceEEeeccccccceeccccc--------------------CC--
Confidence            56789999999999999999    89999877    89999999999977644321                    11  


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                               ...|+.+             +|.||++||.++|.++|+.+.|+|..|||++||.++.+.|.|. ....++.
T Consensus       183 ---------prytnrv-------------vTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn-teqqql~  239 (376)
T KOG0669|consen  183 ---------PRYTNRV-------------VTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN-TEQQQLH  239 (376)
T ss_pred             ---------CCcccce-------------eeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC-hHHHHHH
Confidence                     1133333             3999999999999999999999999999999999999999994 4558999


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTG  213 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  213 (481)
                      .|...||+..++.||++..++.+.-...+|.+.
T Consensus       240 ~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~  272 (376)
T KOG0669|consen  240 LISQLCGSITKEVWPNVDNLPLYQSIELEPLPK  272 (376)
T ss_pred             HHHHHhccCCcccCCCcccchHHHhccCCCCCc
Confidence            999999999999999999988886665554433

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.5e-25  Score=225.95  Aligned_cols=151  Identities=22%  Similarity=0.261  Sum_probs=128.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|+||+++++++.+++.+|+||||+. |+|.+++......+++..++.++.|++.||+|||+++|+|||
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d  127 (331)
T cd05597          48 FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRD  127 (331)
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECC
Confidence            4569999999999999999999999999999999998 678888876556799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc---------cccccccCCCeeEEEeecCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI---------SEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~---------~~~~~~~s~g~~~~~~~~g~  415 (481)
                      |||+|||++.++.  +|++|||++..+....    .....+..|.+|+++.         +...+.|+.|++++++.+|.
T Consensus       128 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~  205 (331)
T cd05597         128 IKPDNVLLDKNGH--IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CCHHHEEECCCCC--EEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCC
Confidence            9999999988777  9999999987654211    1123456788888774         34568899999999999999


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||...+
T Consensus       206 ~Pf~~~~  212 (331)
T cd05597         206 TPFYAES  212 (331)
T ss_pred             CCCCCCC
Confidence            9997643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0604|consensus

Probab=99.91  E-value=5.5e-25  Score=207.26  Aligned_cols=186  Identities=19%  Similarity=0.223  Sum_probs=145.5

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ++||+++.-... |||||+++|+|+.    ...+.+|||.|+ |+|+..+..+. ..|+|..+..+++||+.|+.|||+.
T Consensus       101 ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~  180 (400)
T KOG0604|consen  101 ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM  180 (400)
T ss_pred             HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc
Confidence            678998876665 9999999999864    467899999999 56777776543 3599999999999999999999999


Q ss_pred             ceeeccCCCcccccccc-chhhHHHHHHHHHhhcc--ccccCceeccccCCCcccccccc----cccCCCeeEEEeecCC
Q psy3074         343 RILHRDVKPQNLLISEI-DHHNIRLFMFQLLRGLS--YCHRRRILHRDVKPQNLLISEIV----FTNLSGVVVSTVDSGS  415 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~-~~~~ikl~dfgla~~~~--~~~~~~i~~~d~~~~~il~~~~~----~~~s~g~~~~~~~~g~  415 (481)
                      +|.||||||||+|.+.. ....+|++|||+|+.-.  ........+..|.+|+++-.|.+    +.||.|++.|.++.|.
T Consensus       181 nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGy  260 (400)
T KOG0604|consen  181 NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY  260 (400)
T ss_pred             chhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCC
Confidence            99999999999998654 34679999999999655  33445567788999999976665    4699999999999999


Q ss_pred             CCccccccCc---------ccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         416 GGWWFESKSN---------INLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       416 ~~~~~~~~~~---------~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      +||.......         ..|.+.+-.|.+...+....+++..|+.-+
T Consensus       261 PPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~  309 (400)
T KOG0604|consen  261 PPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTE  309 (400)
T ss_pred             CcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCC
Confidence            9998553211         134444444444444556677788777766

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=7e-25  Score=220.87  Aligned_cols=149  Identities=26%  Similarity=0.419  Sum_probs=116.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +.+|+.+++.++||||+++++++...     ..+|+|||||.+++.+.+... ..+++..+..++.|++.||.|||+++|
T Consensus        46 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i  124 (338)
T cd07859          46 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANV  124 (338)
T ss_pred             HHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            56799999999999999999988643     358999999999998887653 468999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+|||++.++.  +|++|||+++...........                                      ..
T Consensus       125 vH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~--------------------------------------~~  164 (338)
T cd07859         125 FHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIF--------------------------------------WT  164 (338)
T ss_pred             ecCCCCHHHeEECCCCc--EEEccCccccccccccCcccc--------------------------------------cc
Confidence            99999999999998877  999999998753211100000                                      00


Q ss_pred             cccceeccCCC----------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..++|+.|++|          +...|+||+|+++++|..|..|+.
T Consensus       165 ~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~  209 (338)
T cd07859         165 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP  209 (338)
T ss_pred             CCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence            11233333333          446799999999999999986653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.91  E-value=1.8e-25  Score=228.87  Aligned_cols=181  Identities=19%  Similarity=0.228  Sum_probs=139.0

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++.+++.+|+|||||+ |+|..++..  ..+++..+..++.|++.||.|||+++|+|||
T Consensus        90 ~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD  167 (370)
T cd05596          90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRD  167 (370)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence            4569999999999999999999999999999999998 678777654  3588999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc--------cccccccCCCeeEEEeecCCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI--------SEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~--------~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |||+|||+++++.  +|++|||++..+....    ...+.+..|.||+++.        +...+.|+.|++++++.+|..
T Consensus       168 Lkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~  245 (370)
T cd05596         168 VKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  245 (370)
T ss_pred             CCHHHEEEcCCCC--EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCC
Confidence            9999999998877  9999999998654211    1233456678888764        345688999999999999999


Q ss_pred             CccccccCc----c-cceeccCCCCCChhhhhhHHHHHHhhCC
Q psy3074         417 GWWFESKSN----I-NLSFHYLPPGAPFTAIREASLLKELKHN  454 (481)
Q Consensus       417 ~~~~~~~~~----~-~~t~~y~~p~~p~~~~s~~~~l~~l~~~  454 (481)
                      ||...+...    + ........|..+.....+..++..|+..
T Consensus       246 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~  288 (370)
T cd05596         246 PFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTD  288 (370)
T ss_pred             CcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccC
Confidence            998654211    1 1111122233222334556677777654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=2e-25  Score=228.69  Aligned_cols=149  Identities=20%  Similarity=0.243  Sum_probs=127.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++.+.+.+.+|+|||||+ |+|..++..  ..+++..+..++.|++.||+|||+++|+|||
T Consensus        90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD  167 (371)
T cd05622          90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRD  167 (371)
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            4569999999999999999999999999999999998 677777654  3588999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc--------cccccccCCCeeEEEeecCCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI--------SEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~--------~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |||+|||++.++.  +|++|||+++.+....    ...+.+..|.||+++.        +...+.||.|+++++|.+|..
T Consensus       168 Lkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~  245 (371)
T cd05622         168 VKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT  245 (371)
T ss_pred             CCHHHEEECCCCC--EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence            9999999998877  9999999998664221    1234566788888874        356788999999999999999


Q ss_pred             Cccccc
Q psy3074         417 GWWFES  422 (481)
Q Consensus       417 ~~~~~~  422 (481)
                      ||...+
T Consensus       246 Pf~~~~  251 (371)
T cd05622         246 PFYADS  251 (371)
T ss_pred             CCCCCC
Confidence            998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0197|consensus

Probab=99.91  E-value=1e-25  Score=227.92  Aligned_cols=161  Identities=17%  Similarity=0.281  Sum_probs=135.0

Q ss_pred             CcchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCC
Q psy3074           4 GENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      ..+++...+.+.+|++ .-.|.+||+++++|||||.+    +||||+..    +.+||+||||||...            
T Consensus       296 ~~~~l~~~~Ll~~a~q-IaeGM~YLes~~~IHRDLAA----RNiLV~~~----~~vKIsDFGLAr~~~------------  354 (468)
T KOG0197|consen  296 EGGLLNLPQLLDFAAQ-IAEGMAYLESKNYIHRDLAA----RNILVDED----LVVKISDFGLARLIG------------  354 (468)
T ss_pred             CCCccchHHHHHHHHH-HHHHHHHHHhCCccchhhhh----hheeeccC----ceEEEcccccccccC------------
Confidence            3456677788899999 88899999999999999999    89999988    599999999999322            


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ell  163 (481)
                                     .+-+.. ..|                   ...+..|.|||++..++ |+.+||||||||+||||+
T Consensus       355 ---------------d~~Y~~-~~~-------------------~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~f  398 (468)
T KOG0197|consen  355 ---------------DDEYTA-SEG-------------------GKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELF  398 (468)
T ss_pred             ---------------CCceee-cCC-------------------CCCCceecCHHHHhhCC-cccccceeehhhhHHHHh
Confidence                           111110 001                   11278999999999887 999999999999999999


Q ss_pred             h-CCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCC
Q psy3074         164 T-GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPR  222 (481)
Q Consensus       164 t-g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (481)
                      | |+.||+++.. .+.++.+.++.+.|.|+.+|..-...|..||+..|..||+|+.+...
T Consensus       399 T~G~~py~~msn-~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~  457 (468)
T KOG0197|consen  399 TYGRVPYPGMSN-EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREV  457 (468)
T ss_pred             ccCCCCCCCCCH-HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHH
Confidence            9 9999999654 48999999999999999999999889999999999999999865443

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.91  E-value=3e-25  Score=223.47  Aligned_cols=151  Identities=23%  Similarity=0.302  Sum_probs=126.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++...+.+|+||||++ |+|...+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        41 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  119 (328)
T cd05593          41 HTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYR  119 (328)
T ss_pred             HHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence            35679999999999999999999999999999999998 567666654 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||||+|||++.++.  +|++|||+++.....   ......+..|.+|+++.    +...+.|+.|++++++.+|..||..
T Consensus       120 Dikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~  197 (328)
T cd05593         120 DLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             ccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence            99999999998777  999999998753211   11223456788888875    3456789999999999999999975


Q ss_pred             cc
Q psy3074         421 ES  422 (481)
Q Consensus       421 ~~  422 (481)
                      .+
T Consensus       198 ~~  199 (328)
T cd05593         198 QD  199 (328)
T ss_pred             CC
Confidence            53

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG4721|consensus

Probab=99.91  E-value=5.1e-25  Score=222.09  Aligned_cols=146  Identities=21%  Similarity=0.338  Sum_probs=126.7

Q ss_pred             HHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCC
Q psy3074         273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP  351 (481)
Q Consensus       273 E~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp  351 (481)
                      ++.-|++|+||||+.+.++|......|||||||. |.|...|+. ...+....+..+..+|+.||.|||...|||||||.
T Consensus       162 dIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS  240 (904)
T KOG4721|consen  162 DIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS  240 (904)
T ss_pred             hHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC
Confidence            7888999999999999999999999999999998 778777764 45688889999999999999999999999999999


Q ss_pred             ccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceec
Q psy3074         352 QNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFH  431 (481)
Q Consensus       352 ~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~  431 (481)
                      -||||+.++.  |||+|||-++.+...                                          .++..++||..
T Consensus       241 PNiLIs~~d~--VKIsDFGTS~e~~~~------------------------------------------STkMSFaGTVa  276 (904)
T KOG4721|consen  241 PNILISYDDV--VKISDFGTSKELSDK------------------------------------------STKMSFAGTVA  276 (904)
T ss_pred             CceEeeccce--EEeccccchHhhhhh------------------------------------------hhhhhhhhhHh
Confidence            9999998888  999999988765422                                          12445789999


Q ss_pred             cCCC--------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         432 YLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       432 y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                      ||+|        ...+|+||+|+.|.||+.+.| +|.|++-
T Consensus       277 WMAPEvIrnePcsEKVDIwSfGVVLWEmLT~Ei-PYkdVds  316 (904)
T KOG4721|consen  277 WMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEI-PYKDVDS  316 (904)
T ss_pred             hhCHHHhhcCCcccccceehhHHHHHHHHhcCC-Cccccch
Confidence            9999        556699999999999999995 5666653

>KOG0666|consensus

Probab=99.91  E-value=7.2e-25  Score=207.38  Aligned_cols=159  Identities=23%  Similarity=0.363  Sum_probs=136.8

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccCCCHHHHHHHhc----CCCChHHHHHHHHHHHHHHHH
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVHTDLSQYMERHS----GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~g~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      ++...++.||+.+++.++|||+|.|..+|.. +..+|+++||.+-||.+.+..+.    ..++...++.++.||+.|+.|
T Consensus        68 tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~Y  147 (438)
T KOG0666|consen   68 TGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHY  147 (438)
T ss_pred             CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHH
Confidence            5667889999999999999999999999987 77999999999999999987553    347888999999999999999


Q ss_pred             hhcCceeeccCCCcccccccc--chhhHHHHHHHHHhhcc------ccccCceeccccCCCcccccccc-----cccCCC
Q psy3074         339 CHRRRILHRDVKPQNLLISEI--DHHNIRLFMFQLLRGLS------YCHRRRILHRDVKPQNLLISEIV-----FTNLSG  405 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~--~~~~ikl~dfgla~~~~------~~~~~~i~~~d~~~~~il~~~~~-----~~~s~g  405 (481)
                      ||++=|+||||||.|||+..+  .+.++||+|+|+||.+.      |...+-+++-||++||.+++..-     +.|+-|
T Consensus       148 LH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG  227 (438)
T KOG0666|consen  148 LHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG  227 (438)
T ss_pred             HhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence            999999999999999999765  23569999999999765      33456688999999999986554     468889


Q ss_pred             eeEEEeecCCCCccccc
Q psy3074         406 VVVSTVDSGSGGWWFES  422 (481)
Q Consensus       406 ~~~~~~~~g~~~~~~~~  422 (481)
                      |+..|+++-++-|...+
T Consensus       228 CIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  228 CIFAELLTLEPLFKGRE  244 (438)
T ss_pred             HHHHHHHccCccccchh
Confidence            99999998888776543

>KOG0595|consensus

Probab=99.91  E-value=3.7e-25  Score=216.67  Aligned_cols=107  Identities=32%  Similarity=0.540  Sum_probs=89.1

Q ss_pred             cccHHHHHHhhhhcccCCCCCCCcchhccccCCCC--CceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          22 LLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPP--RELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        22 ~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~--g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ..|+++||+++||||||||    .||||.......  -.+||+|||+||.                           +..
T Consensus       119 A~alq~L~~~~IiHRDLKP----QNiLLs~~~~~~~~~~LKIADFGfAR~---------------------------L~~  167 (429)
T KOG0595|consen  119 ASALQFLHENNIIHRDLKP----QNILLSTTARNDTSPVLKIADFGFARF---------------------------LQP  167 (429)
T ss_pred             HHHHHHHHHCCeeeccCCc----ceEEeccCCCCCCCceEEecccchhhh---------------------------CCc
Confidence            4579999999999999999    899998764332  5799999999995                           456


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      |.+..+.||                      +|.||||||++... |+-|+|+||+|+|+|++++|++||... ...+.+
T Consensus       168 ~~~a~tlcG----------------------SplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~g~~Pf~a~-t~~eL~  223 (429)
T KOG0595|consen  168 GSMAETLCG----------------------SPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLTGKPPFDAE-TPKELL  223 (429)
T ss_pred             hhHHHHhhC----------------------CccccCHHHHHhcc-ccchhhHHHHHHHHHHHHhCCCCcccc-CHHHHH
Confidence            677778888                      99999999998665 999999999999999999999999873 333444


Q ss_pred             HHHH
Q psy3074         180 DKIF  183 (481)
Q Consensus       180 ~~i~  183 (481)
                      ..+.
T Consensus       224 ~~~~  227 (429)
T KOG0595|consen  224 LYIK  227 (429)
T ss_pred             HHHh
Confidence            4443

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.2e-25  Score=223.79  Aligned_cols=151  Identities=23%  Similarity=0.307  Sum_probs=129.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++..++||||+++++++.+.+.+|+||||+. |+|..++... +.+++..++.++.|++.||.|||+.|++||
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~  125 (350)
T cd05573          47 HVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHR  125 (350)
T ss_pred             HHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            35679999999999999999999999999999999998 6788877654 679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc--------------------------------cCceeccccCCCcccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--------------------------------RRRILHRDVKPQNLLI  395 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--------------------------------~~~i~~~d~~~~~il~  395 (481)
                      ||||+|||++.++.  +|++|||++..+....                                ...+.+..|.|||++.
T Consensus       126 Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (350)
T cd05573         126 DIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR  203 (350)
T ss_pred             CCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            99999999998877  9999999988654322                                1234556788888875


Q ss_pred             c----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         396 S----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       396 ~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +    ...+.|++||+++++.+|..||...+
T Consensus       204 ~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         204 GTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            4    45678999999999999999997654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.91  E-value=1.4e-24  Score=218.06  Aligned_cols=150  Identities=21%  Similarity=0.282  Sum_probs=124.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiHr  347 (481)
                      ..+|+++++.++||||+++++++..++.+|+||||++ |+|...+.. .+.+++..+..++.|++.||.|||+ .+|+||
T Consensus        42 ~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr  120 (325)
T cd05594          42 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR  120 (325)
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence            4569999999999999999999999999999999998 566666544 4568999999999999999999997 799999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||||+|||++.++.  +|++|||+++......   .....+..|.+|+++.    +...+.|+.|++++++.+|..||..
T Consensus       121 Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~  198 (325)
T cd05594         121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             CCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence            99999999998877  9999999987532111   1123455678888774    3456789999999999999999975


Q ss_pred             cc
Q psy3074         421 ES  422 (481)
Q Consensus       421 ~~  422 (481)
                      .+
T Consensus       199 ~~  200 (325)
T cd05594         199 QD  200 (325)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0597|consensus

Probab=99.91  E-value=4.2e-25  Score=222.88  Aligned_cols=129  Identities=32%  Similarity=0.503  Sum_probs=102.6

Q ss_pred             CcchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCC
Q psy3074           4 GENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      ..|++-+...-.++.+ .+.||.|||+++|+|||+||    .||||...    |.+|+||||+||..+.+.         
T Consensus        93 ~d~~lpEe~v~~~a~~-LVsaL~yLhs~rilhrd~kP----qniLl~~~----~~~KlcdFg~Ar~m~~~t---------  154 (808)
T KOG0597|consen   93 QDGKLPEEQVRAIAYD-LVSALYYLHSNRILHRDMKP----QNILLEKG----GTLKLCDFGLARAMSTNT---------  154 (808)
T ss_pred             hccCCCHHHHHHHHHH-HHHHHHHHHhcCcccccCCc----ceeeecCC----CceeechhhhhhhcccCc---------
Confidence            3456666666677777 89999999999999999999    89999877    899999999999643321         


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ell  163 (481)
                                       +.-+..+                      |||.|||||++.+.. |+..+|+||+|||+||++
T Consensus       155 -----------------~vltsik----------------------GtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~  194 (808)
T KOG0597|consen  155 -----------------SVLTSIK----------------------GTPLYMAPELVEEQP-YDHTSDLWSLGCILYELY  194 (808)
T ss_pred             -----------------eeeeecc----------------------CcccccCHHHHcCCC-ccchhhHHHHHHHHHHHh
Confidence                             1222333                      499999999999776 999999999999999999


Q ss_pred             hCCCCCCCchhhHHHHHHHHHHhCCCCc
Q psy3074         164 TGLPTFPGVREVYDQLDKIFKILGTPTE  191 (481)
Q Consensus       164 tg~~PF~g~~~~~~~l~~i~~~~~~p~~  191 (481)
                      +|+|||.. .++...+..|...-..|+.
T Consensus       195 ~G~PPF~a-~si~~Lv~~I~~d~v~~p~  221 (808)
T KOG0597|consen  195 VGQPPFYA-RSITQLVKSILKDPVKPPS  221 (808)
T ss_pred             cCCCCchH-HHHHHHHHHHhcCCCCCcc
Confidence            99999988 4565666666654444433

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.91  E-value=6.2e-25  Score=221.43  Aligned_cols=151  Identities=22%  Similarity=0.253  Sum_probs=127.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.++..++|+||+++++++.+.+..|+||||+. |+|..++......+++..+..++.|++.||+|||+++|+|||
T Consensus        48 ~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrD  127 (331)
T cd05624          48 FREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRD  127 (331)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            4568999999999999999999999999999999998 678888876556789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcccccc----CceeccccCCCcccc---------cccccccCCCeeEEEeecCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR----RRILHRDVKPQNLLI---------SEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~----~~i~~~d~~~~~il~---------~~~~~~~s~g~~~~~~~~g~  415 (481)
                      |||+|||++.++.  +|++|||+++.+.....    ....+..|.+|+++.         +...+.||.|++++++.+|.
T Consensus       128 lkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~  205 (331)
T cd05624         128 IKPDNVLLDMNGH--IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE  205 (331)
T ss_pred             CchHHEEEcCCCC--EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCC
Confidence            9999999998777  99999999876542211    123455677888764         34567899999999999999


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||...+
T Consensus       206 ~Pf~~~~  212 (331)
T cd05624         206 TPFYAES  212 (331)
T ss_pred             CCccCCC
Confidence            9997543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=4.3e-25  Score=220.65  Aligned_cols=151  Identities=23%  Similarity=0.303  Sum_probs=127.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++|||||++++++...+.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        39 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~Hr  117 (312)
T cd05585          39 HTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYR  117 (312)
T ss_pred             HHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            34579999999999999999999999999999999998 677777765 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||||+|||++.++.  +|++|||+++.....   ......+..|.|||++.+    ...+.|+.|++++++.+|..||..
T Consensus       118 Dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~  195 (312)
T cd05585         118 DLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             CCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence            99999999998877  999999998753211   112234567888888744    446789999999999999999975


Q ss_pred             cc
Q psy3074         421 ES  422 (481)
Q Consensus       421 ~~  422 (481)
                      .+
T Consensus       196 ~~  197 (312)
T cd05585         196 EN  197 (312)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=1.9e-24  Score=220.21  Aligned_cols=144  Identities=24%  Similarity=0.422  Sum_probs=114.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...+      .+|+||||+++++.+.+..   .+++..+..++.|++.||.|||++
T Consensus        66 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~  142 (359)
T cd07876          66 RAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA  142 (359)
T ss_pred             HHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567999999999999999999986543      5799999999988777643   488899999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++.  +|++|||+++.......                                          
T Consensus       143 ~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~------------------------------------------  178 (359)
T cd07876         143 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFM------------------------------------------  178 (359)
T ss_pred             CcccCCCCHHHEEECCCCC--EEEecCCCccccccCcc------------------------------------------
Confidence            9999999999999998877  99999998864321100                                          


Q ss_pred             cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .....+|+.|++|        +..+|+||+|+++++|..|.+||.
T Consensus       179 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~  223 (359)
T cd07876         179 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ  223 (359)
T ss_pred             CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence            0001233334443        446799999999999999987664

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.90  E-value=6.7e-25  Score=221.23  Aligned_cols=151  Identities=23%  Similarity=0.264  Sum_probs=129.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.++..++|+||+++++.+.+.+.+|+||||+. |+|.+++......+++..++.++.|++.||.|||+++|+|||
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrD  127 (332)
T cd05623          48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRD  127 (332)
T ss_pred             HHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            4568999999999999999999999999999999998 788888877566799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc---------cccccccCCCeeEEEeecCC
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI---------SEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~---------~~~~~~~s~g~~~~~~~~g~  415 (481)
                      |||+|||++.++.  +|++|||++..+....    .....+..|.+||++.         +...+.||+|++++++.+|.
T Consensus       128 lkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~  205 (332)
T cd05623         128 IKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE  205 (332)
T ss_pred             CCHHHEEECCCCC--EEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCC
Confidence            9999999998777  9999999997653221    1224566788888774         34567899999999999999


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||...+
T Consensus       206 ~Pf~~~~  212 (332)
T cd05623         206 TPFYAES  212 (332)
T ss_pred             CCCCCCC
Confidence            9997654

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.90  E-value=4.5e-24  Score=211.78  Aligned_cols=104  Identities=61%  Similarity=1.036  Sum_probs=96.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.+++.++||||+++++++..++..++||||+++++.+.+......+++..+..++.|++.||.|||+.+++||||
T Consensus        51 ~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dl  130 (301)
T cd07873          51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL  130 (301)
T ss_pred             HHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence            45799999999999999999999999999999999999999888776667899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+||++++++.  ++++|||++...
T Consensus       131 kp~Nil~~~~~~--~kl~dfg~~~~~  154 (301)
T cd07873         131 KPQNLLINERGE--LKLADFGLARAK  154 (301)
T ss_pred             CHHHEEECCCCc--EEECcCcchhcc
Confidence            999999998777  999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.90  E-value=2.2e-24  Score=216.63  Aligned_cols=147  Identities=21%  Similarity=0.306  Sum_probs=116.0

Q ss_pred             hHHHHHHHHhhcCCC-CeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHN-NIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~Hp-nIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|++++..++|+ +|+++++++.+.+.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||.|||+++|+|
T Consensus        46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  124 (324)
T cd05587          46 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIY  124 (324)
T ss_pred             HHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            345789999999865 58899999999999999999998 677776654 456899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+++........                                         ....
T Consensus       125 ~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-----------------------------------------~~~~  161 (324)
T cd05587         125 RDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKT-----------------------------------------TRTF  161 (324)
T ss_pred             cCCCHHHeEEcCCCC--EEEeecCcceecCCCCCc-----------------------------------------eeee
Confidence            999999999998777  999999987632110000                                         0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +||+.|++|        +..+|+||+|+++++|..|..|+.
T Consensus       162 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~  202 (324)
T cd05587         162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD  202 (324)
T ss_pred             cCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence            344444444        456799999999999999987654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.90  E-value=4.3e-24  Score=210.44  Aligned_cols=146  Identities=34%  Similarity=0.604  Sum_probs=114.4

Q ss_pred             HHHHHHHHhhc---CCCCeeEEeeeee-----cCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL---KHNNIVTLHDIVH-----TRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l---~HpnIV~l~~~~~-----~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      ..+|+.+++.+   +||||+++++++.     ....+++||||+++++.+++.... ..+++..+..++.|++.||.|||
T Consensus        48 ~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH  127 (290)
T cd07862          48 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH  127 (290)
T ss_pred             HHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45677777665   6999999999885     345699999999999988886543 35889999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +++|+||||||+|||++.++.  +|++|||+++.......                                        
T Consensus       128 ~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~----------------------------------------  165 (290)
T cd07862         128 SHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA----------------------------------------  165 (290)
T ss_pred             HCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCCcc----------------------------------------
Confidence            999999999999999998777  99999998864331100                                        


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                        .....+|+.|++|        +.++|+||+|+++++|..|.+|+.
T Consensus       166 --~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~  210 (290)
T cd07862         166 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  210 (290)
T ss_pred             --cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence              0012234444444        456799999999999999986554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.90  E-value=6.4e-24  Score=214.32  Aligned_cols=105  Identities=25%  Similarity=0.506  Sum_probs=90.3

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecC-CeEEEEEeccC-CCHHHHHHHhc----------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTR-STLTFVFEYVH-TDLSQYMERHS----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~-~~~~iv~E~~~-g~l~~~l~~~~----------------------------  317 (481)
                      .+.+|+.+|+.+ +|||||++++++... +.++++||||+ |+|.+++....                            
T Consensus        56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (338)
T cd05102          56 ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDR  135 (338)
T ss_pred             HHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhcccc
Confidence            456799999999 899999999988764 46899999998 78888776421                            


Q ss_pred             ---------------------------------CCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhH
Q psy3074         318 ---------------------------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI  364 (481)
Q Consensus       318 ---------------------------------~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~i  364 (481)
                                                       ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.  +
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~  213 (338)
T cd05102         136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--V  213 (338)
T ss_pred             ccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--E
Confidence                                             23667788899999999999999999999999999999988776  9


Q ss_pred             HHHHHHHHhhc
Q psy3074         365 RLFMFQLLRGL  375 (481)
Q Consensus       365 kl~dfgla~~~  375 (481)
                      |++|||+++.+
T Consensus       214 kl~DfG~a~~~  224 (338)
T cd05102         214 KICDFGLARDI  224 (338)
T ss_pred             EEeeccccccc
Confidence            99999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.90  E-value=1.9e-24  Score=217.72  Aligned_cols=145  Identities=25%  Similarity=0.332  Sum_probs=117.0

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|..+++.+ +||||++++++|.+.+.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        42 ~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~  120 (329)
T cd05588          42 VQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYR  120 (329)
T ss_pred             HHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            45689999888 69999999999999999999999998 577666654 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+++.......                                         .....+
T Consensus       121 dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~-----------------------------------------~~~~~~  157 (329)
T cd05588         121 DLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGD-----------------------------------------TTSTFC  157 (329)
T ss_pred             CCCHHHeEECCCCC--EEECcCccccccccCCC-----------------------------------------cccccc
Confidence            99999999998777  99999998863210000                                         000123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ||+.|++|        +..+|+|++|+++++|..|..|+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf  196 (329)
T cd05588         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCc
Confidence            45555555        45679999999999999998665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.90  E-value=2.3e-24  Score=216.55  Aligned_cols=142  Identities=20%  Similarity=0.235  Sum_probs=112.3

Q ss_pred             HHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCc
Q psy3074         274 ASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ  352 (481)
Q Consensus       274 ~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~  352 (481)
                      +.+++.++||||+++++++.+.+..|+|||||+ |+|...+.  .+.+++..+..++.|++.||.|||+++++||||||+
T Consensus        53 ~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~  130 (324)
T cd05589          53 FETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLD  130 (324)
T ss_pred             HHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHH
Confidence            344567789999999999999999999999999 56665553  356999999999999999999999999999999999


Q ss_pred             cccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceecc
Q psy3074         353 NLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHY  432 (481)
Q Consensus       353 NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y  432 (481)
                      ||++++++.  +|++|||+++.......                                         .....+|++.|
T Consensus       131 Nill~~~~~--~kL~Dfg~~~~~~~~~~-----------------------------------------~~~~~~g~~~y  167 (324)
T cd05589         131 NLLLDTEGF--VKIADFGLCKEGMGFGD-----------------------------------------RTSTFCGTPEF  167 (324)
T ss_pred             HeEECCCCc--EEeCcccCCccCCCCCC-----------------------------------------cccccccCccc
Confidence            999998877  99999998763211000                                         00112345555


Q ss_pred             CCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         433 LPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       433 ~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++|        +..+|+||+|+++++|..|..|+..
T Consensus       168 ~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~  203 (324)
T cd05589         168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             cCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence            555        4567999999999999999977643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0614|consensus

Probab=99.90  E-value=6.6e-25  Score=218.93  Aligned_cols=153  Identities=21%  Similarity=0.351  Sum_probs=134.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +..|-+||..++.|+||++|-.|.+..++|+.||-|-|+...-+.+..+.|++..+++++..+++|++|||++|||.|||
T Consensus       467 v~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDL  546 (732)
T KOG0614|consen  467 VFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDL  546 (732)
T ss_pred             HHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccC
Confidence            34599999999999999999999999999999999985544444445678999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      ||||++++..|.  +|+.|||+|+.+.                                    +|...|      .+|||
T Consensus       547 KPENllLd~~Gy--~KLVDFGFAKki~------------------------------------~g~KTw------TFcGT  582 (732)
T KOG0614|consen  547 KPENLLLDNRGY--LKLVDFGFAKKIG------------------------------------SGRKTW------TFCGT  582 (732)
T ss_pred             ChhheeeccCCc--eEEeehhhHHHhc------------------------------------cCCcee------eecCC
Confidence            999999999999  9999999998765                                    333333      27899


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCccccccccccCc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVHTRS  467 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~  467 (481)
                      +.|.+|        +..+|.|++|.+++||+.|+ |+|...+|-.+
T Consensus       583 pEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~-pPFs~~dpmkt  627 (732)
T KOG0614|consen  583 PEYVAPEIILNKGHDRAVDYWALGILIYELLTGS-PPFSGVDPMKT  627 (732)
T ss_pred             cccccchhhhccCcchhhHHHHHHHHHHHHHcCC-CCCCCCchHHH
Confidence            999999        77889999999999999998 88888888665

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.90  E-value=2.3e-24  Score=216.31  Aligned_cols=147  Identities=22%  Similarity=0.322  Sum_probs=117.7

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|..+++.+ +||||+++++++.+.+.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        42 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~  120 (320)
T cd05590          42 TMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYR  120 (320)
T ss_pred             HHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence            45688888776 69999999999999999999999998 567666654 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+++.......                                         ......
T Consensus       121 dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~-----------------------------------------~~~~~~  157 (320)
T cd05590         121 DLKLDNVLLDHEGH--CKLADFGMCKEGIFNGK-----------------------------------------TTSTFC  157 (320)
T ss_pred             CCCHHHeEECCCCc--EEEeeCCCCeecCcCCC-----------------------------------------cccccc
Confidence            99999999998877  99999998764211000                                         001123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|.+|..|+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence            55555555        4567999999999999999977643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0579|consensus

Probab=99.90  E-value=5.4e-25  Score=223.93  Aligned_cols=153  Identities=21%  Similarity=0.260  Sum_probs=123.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHH-HHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQ-YMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~-~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+-|+.||..|+||+||+|++.|...+.+||+.|||.|+-.+ .+......+.+.+++.++.|++.||.|||+++||||
T Consensus        75 DylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHR  154 (1187)
T KOG0579|consen   75 DYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHR  154 (1187)
T ss_pred             hhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhh
Confidence            4456999999999999999999999999999999999976444 445556789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      |||..|||++-+|.  |+++|||++........+    |                                     ..+.
T Consensus       155 DLKAGNiL~TldGd--irLADFGVSAKn~~t~qk----R-------------------------------------DsFI  191 (1187)
T KOG0579|consen  155 DLKAGNILLTLDGD--IRLADFGVSAKNKSTRQK----R-------------------------------------DSFI  191 (1187)
T ss_pred             hccccceEEEecCc--EeeecccccccchhHHhh----h-------------------------------------cccc
Confidence            99999999998888  999999987643321111    0                                     1134


Q ss_pred             ceeccCCC-------------CCChhhhhhHHHHHHhhCCCcccccccccc
Q psy3074         428 LSFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLHDIVHT  465 (481)
Q Consensus       428 ~t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~  465 (481)
                      |||+||+|             +..+|+||+|+.|-||..+. |+.+++.|-
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiE-PPHhelnpM  241 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIE-PPHHELNPM  241 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccC-CCccccchH
Confidence            55555555             44569999999999999998 666666553

>KOG0578|consensus

Probab=99.90  E-value=1e-24  Score=221.38  Aligned_cols=128  Identities=25%  Similarity=0.372  Sum_probs=96.9

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      .||.....+.+.||+|||.+||||||||.    +||||+..    |.+||+|||+|.......                 
T Consensus       369 ~qIA~Icre~l~aL~fLH~~gIiHrDIKS----DnILL~~~----g~vKltDFGFcaqi~~~~-----------------  423 (550)
T KOG0578|consen  369 GQIAAICREILQGLKFLHARGIIHRDIKS----DNILLTMD----GSVKLTDFGFCAQISEEQ-----------------  423 (550)
T ss_pred             HHHHHHHHHHHHHHHHHHhcceeeecccc----ceeEeccC----CcEEEeeeeeeecccccc-----------------
Confidence            34444444599999999999999999999    89999987    799999999998543211                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               .-                      ..-.+|||+|||||++.... |+.++||||||++++||+.|+|||-.
T Consensus       424 ---------~K----------------------R~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  424 ---------SK----------------------RSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             ---------Cc----------------------cccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhcCCCCccC
Confidence                     00                      11124599999999999776 99999999999999999999999987


Q ss_pred             chhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      . +....+.. +..-|+|.-..++.++
T Consensus       472 E-~PlrAlyL-Ia~ng~P~lk~~~klS  496 (550)
T KOG0578|consen  472 E-NPLRALYL-IATNGTPKLKNPEKLS  496 (550)
T ss_pred             C-ChHHHHHH-HhhcCCCCcCCccccC
Confidence            3 22233332 2345677666665555

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=4.9e-24  Score=223.39  Aligned_cols=149  Identities=21%  Similarity=0.260  Sum_probs=122.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      ..+|+++|++++|||||++++++...+..++|||++.+++..++....+.+++..+..++.|++.||.|||+++|+||||
T Consensus       207 ~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDL  286 (461)
T PHA03211        207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDI  286 (461)
T ss_pred             HHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcC
Confidence            34699999999999999999999999999999999999999988766667999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      ||+|||++..+.  +|++|||+++.+.......                                   .    ...++||
T Consensus       287 KP~NILl~~~~~--vkL~DFGla~~~~~~~~~~-----------------------------------~----~~~~~GT  325 (461)
T PHA03211        287 KTENVLVNGPED--ICLGDFGAACFARGSWSTP-----------------------------------F----HYGIAGT  325 (461)
T ss_pred             CHHHEEECCCCC--EEEcccCCceecccccccc-----------------------------------c----ccccCCC
Confidence            999999988776  9999999987543110000                                   0    0113466


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +.|++|        +..+|+||+|++|+||..+..+.|
T Consensus       326 ~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             cCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            666666        456799999999999987765444

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.90  E-value=1.8e-24  Score=215.00  Aligned_cols=126  Identities=58%  Similarity=1.057  Sum_probs=104.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+.......                         
T Consensus       112 i~~al~~lH~~~ivH~dlkp----~Nill~~~----~~~kl~Dfg~~~~~~~~~~-------------------------  158 (303)
T cd07869         112 LLRGLSYIHQRYILHRDLKP----QNLLISDT----GELKLADFGLARAKSVPSH-------------------------  158 (303)
T ss_pred             HHHHHHHHHHCCeecCCCCH----HHEEECCC----CCEEECCCCcceeccCCCc-------------------------
Confidence            78899999999999999999    89999865    7999999999974211100                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      . ..                      ...+|+.|||||++.+...|+.++||||+||++|||++|.+||.+..+..++++
T Consensus       159 ~-~~----------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  215 (303)
T cd07869         159 T-YS----------------------NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE  215 (303)
T ss_pred             c-CC----------------------CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            0 00                      012389999999998877799999999999999999999999999888888999


Q ss_pred             HHHHHhCCCCccCcccccCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                      .+...++.|....|+.....+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         216 RIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             HHHHHhCCCChhhccchhhccc
Confidence            9999999999998888765443

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.90  E-value=2.9e-24  Score=227.22  Aligned_cols=150  Identities=22%  Similarity=0.259  Sum_probs=121.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+|+.++|||||++++++...+.+|||||||+ |+|.+.+...   ...+++..+..++.|++.||.|||+++|
T Consensus       111 ~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i  190 (478)
T PTZ00267        111 YARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKM  190 (478)
T ss_pred             HHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            35679999999999999999999999999999999998 6787776532   3458899999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+|||+++.+.  +|++|||+++.+.......                                       ...
T Consensus       191 vHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~~---------------------------------------~~~  229 (478)
T PTZ00267        191 MHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLD---------------------------------------VAS  229 (478)
T ss_pred             EECCcCHHhEEECCCCc--EEEEeCcCceecCCccccc---------------------------------------ccc
Confidence            99999999999998777  9999999887543110000                                       001


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..+||+.|++|        +..+|+||+|+++++|..|..|+.
T Consensus       230 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~  272 (478)
T PTZ00267        230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK  272 (478)
T ss_pred             ccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence            23466666666        456799999999999999987764

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.90  E-value=3.3e-24  Score=215.32  Aligned_cols=147  Identities=22%  Similarity=0.308  Sum_probs=116.5

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|..++..+ +||+|+++++++.+.+.+|+||||++ |+|...+.. .+.+++..+..++.|++.||+|||+++|+||
T Consensus        47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  125 (323)
T cd05616          47 TMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYR  125 (323)
T ss_pred             HHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEec
Confidence            44577887776 48899999999999999999999998 677777654 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+++.......                                         .....+
T Consensus       126 Dlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~-----------------------------------------~~~~~~  162 (323)
T cd05616         126 DLKLDNVMLDSEGH--IKIADFGMCKENMWDGV-----------------------------------------TTKTFC  162 (323)
T ss_pred             CCCHHHeEECCCCc--EEEccCCCceecCCCCC-----------------------------------------ccccCC
Confidence            99999999998887  99999998863221000                                         000123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|+.|..|+..
T Consensus       163 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~  203 (323)
T cd05616         163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             CChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence            45555555        4567999999999999999876643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.90  E-value=3.4e-24  Score=215.00  Aligned_cols=147  Identities=24%  Similarity=0.327  Sum_probs=116.1

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|.++++.+ +||||+++++++.+++.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        42 ~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  120 (321)
T cd05591          42 TMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYR  120 (321)
T ss_pred             HHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            45688888865 79999999999999999999999998 567666654 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||++.........                                         ....+
T Consensus       121 Dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  157 (321)
T cd05591         121 DLKLDNILLDAEGH--CKLADFGMCKEGILNGVT-----------------------------------------TTTFC  157 (321)
T ss_pred             CCCHHHeEECCCCC--EEEeecccceecccCCcc-----------------------------------------ccccc
Confidence            99999999998877  999999987632100000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+-.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~  198 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence            44455554        4567999999999999999866543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0192|consensus

Probab=99.90  E-value=5.8e-25  Score=221.82  Aligned_cols=162  Identities=20%  Similarity=0.284  Sum_probs=117.0

Q ss_pred             cchhHHHHhhhhccCcccccHHHHHHhh-hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCC
Q psy3074           5 ENKATVQRQISVSSDSKLLDADIAEETR-VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~lh~~~-i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      +++....+.+.++.| ...|++|||+++ ||||||||    +|+||+...   -++||||||++|......         
T Consensus       136 ~~~l~~~~~l~~ald-iArGm~YLH~~~~iIHrDLK~----~NiLv~~~~---~~~KI~DFGlsr~~~~~~---------  198 (362)
T KOG0192|consen  136 KRKLPLKVRLRIALD-IARGMEYLHSEGPIIHRDLKS----DNILVDLKG---KTLKIADFGLSREKVISK---------  198 (362)
T ss_pred             cCCCCHHHHHHHHHH-HHHHHHHHhcCCCeeecccCh----hhEEEcCCC---CEEEECCCccceeecccc---------
Confidence            456667778899999 888999999999 99999999    899999872   299999999998532100         


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~el  162 (481)
                                      .+ +.                      ...||+.|||||++.+. ..|+.++||||||+++|||
T Consensus       199 ----------------~~-~~----------------------~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl  239 (362)
T KOG0192|consen  199 ----------------TS-MT----------------------SVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL  239 (362)
T ss_pred             ----------------cc-cc----------------------CCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence                            00 00                      11249999999999952 4599999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHH-HHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCc
Q psy3074         163 VTGLPTFPGVREVYDQLDKIF-KILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRL  223 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (481)
                      +||+.||.+... ......+. ...+.+.+...+..-...+..||...|..||+|.++...+
T Consensus       240 ~t~~~Pf~~~~~-~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l  300 (362)
T KOG0192|consen  240 LTGEIPFEDLAP-VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRL  300 (362)
T ss_pred             HHCCCCCCCCCH-HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHH
Confidence            999999999766 34344443 3344433443333222223348888888888876654433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=4.7e-24  Score=217.33  Aligned_cols=101  Identities=28%  Similarity=0.491  Sum_probs=94.7

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      .+|+.++++++|||||++++++...+..++|||++.+++..++......+++..+..++.|++.||.|||+++|+|||||
T Consensus       105 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk  184 (357)
T PHA03209        105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVK  184 (357)
T ss_pred             HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            35999999999999999999999999999999999999999987766779999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHh
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLR  373 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~  373 (481)
                      |+|||++..+.  +|++|||+++
T Consensus       185 p~Nill~~~~~--~kl~DfG~a~  205 (357)
T PHA03209        185 TENIFINDVDQ--VCIGDLGAAQ  205 (357)
T ss_pred             HHHEEECCCCC--EEEecCcccc
Confidence            99999998777  9999999886

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.90  E-value=1.3e-24  Score=217.65  Aligned_cols=149  Identities=24%  Similarity=0.324  Sum_probs=122.5

Q ss_pred             HHHHHHHhh-cCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~il~~-l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+|..++.. .+||||+++++++...+.+|+||||++ |+|...+.. .+.+++..+..++.|++.||.|||+++|+|||
T Consensus        43 ~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d  121 (316)
T cd05592          43 MVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRD  121 (316)
T ss_pred             HHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            456666664 479999999999999999999999998 567666654 45799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||+|||++.++.  +|++|||+++......   .....+..|.+|+++.+    ...+.||.|++++++.+|..||...
T Consensus       122 lkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~  199 (316)
T cd05592         122 LKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE  199 (316)
T ss_pred             CCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence            9999999998777  9999999987543211   12234567888887753    4467899999999999999999754


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      .
T Consensus       200 ~  200 (316)
T cd05592         200 D  200 (316)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=5.7e-24  Score=214.13  Aligned_cols=149  Identities=23%  Similarity=0.303  Sum_probs=122.9

Q ss_pred             HHHHHHHhhc---CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         271 IREASLLKEL---KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       271 ~rE~~il~~l---~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+|..++..+   +||||+++++.+.+.+..|+||||+. |+|...+.. .+.+++..++.++.|++.||+|||+++|+|
T Consensus        41 ~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivH  119 (330)
T cd05586          41 IGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVY  119 (330)
T ss_pred             HHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3466666665   69999999999999999999999998 567766654 467999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccc-----cccccccCCCeeEEEeecCCCCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLI-----SEIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~-----~~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      |||||+|||++.++.  +|++|||+++.....   ......+..|.+|+++.     +...+.|+.|+++++|.+|..||
T Consensus       120 rDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf  197 (330)
T cd05586         120 RDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF  197 (330)
T ss_pred             ccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCC
Confidence            999999999998777  999999998753211   11223455688888774     34467899999999999999999


Q ss_pred             cccc
Q psy3074         419 WFES  422 (481)
Q Consensus       419 ~~~~  422 (481)
                      ....
T Consensus       198 ~~~~  201 (330)
T cd05586         198 YAED  201 (330)
T ss_pred             CCCC
Confidence            7654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.90  E-value=3.4e-24  Score=215.85  Aligned_cols=145  Identities=26%  Similarity=0.348  Sum_probs=115.4

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.++.++ +|||||++++++.+.+..|+|||||+ |+|...+.. .+.+++..++.++.|++.||.|||+++|+||
T Consensus        42 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~  120 (329)
T cd05618          42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYR  120 (329)
T ss_pred             HHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            45688888776 79999999999999999999999999 567666544 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++........                                         ....+
T Consensus       121 Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~-----------------------------------------~~~~~  157 (329)
T cd05618         121 DLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDT-----------------------------------------TSTFC  157 (329)
T ss_pred             CCCHHHEEECCCCC--EEEeeCCccccccCCCCc-----------------------------------------ccccc
Confidence            99999999998877  999999988642110000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ||+.|++|        +.++|+||+|+++++|+.|..|+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf  196 (329)
T cd05618         158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             CCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCC
Confidence            44455554        45679999999999999998666

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0575|consensus

Probab=99.90  E-value=1.9e-24  Score=221.01  Aligned_cols=105  Identities=29%  Similarity=0.502  Sum_probs=86.8

Q ss_pred             cccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCCc
Q psy3074          22 LLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGS  101 (481)
Q Consensus        22 ~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~  101 (481)
                      +.|+.|||+++|||||||-    .|+||+.+.    ++||+|||||.....+                          +.
T Consensus       128 v~GlkYLH~~~IiHRDLKL----GNlfL~~~~----~VKIgDFGLAt~le~~--------------------------~E  173 (592)
T KOG0575|consen  128 VEGLKYLHSLGIIHRDLKL----GNLFLNENM----NVKIGDFGLATQLEYD--------------------------GE  173 (592)
T ss_pred             HHHHHHHHhcCceecccch----hheeecCcC----cEEecccceeeeecCc--------------------------cc
Confidence            7799999999999999999    999999885    9999999999865321                          12


Q ss_pred             eeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHHH
Q psy3074         102 YATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDK  181 (481)
Q Consensus       102 ~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~~  181 (481)
                      .-.+.||                      ||-|.||||+.+.. ++..+||||+|||+|.||.|+|||.. .++.+.+++
T Consensus       174 rk~TlCG----------------------TPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFet-k~vkety~~  229 (592)
T KOG0575|consen  174 RKKTLCG----------------------TPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFET-KTVKETYNK  229 (592)
T ss_pred             ccceecC----------------------CCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCccc-chHHHHHHH
Confidence            2345677                      99999999999654 99999999999999999999999987 344455554


Q ss_pred             HHH
Q psy3074         182 IFK  184 (481)
Q Consensus       182 i~~  184 (481)
                      |..
T Consensus       230 Ik~  232 (592)
T KOG0575|consen  230 IKL  232 (592)
T ss_pred             HHh
Confidence            443

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=3.9e-24  Score=217.52  Aligned_cols=144  Identities=24%  Similarity=0.423  Sum_probs=114.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...      ...|+||||+++++.+.+..   .+++..+..++.|++.||.|||++
T Consensus        62 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~  138 (355)
T cd07874          62 RAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA  138 (355)
T ss_pred             HHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356799999999999999999998654      35799999999988877643   488889999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++.  +|++|||+++........                                         
T Consensus       139 givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------  175 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMM-----------------------------------------  175 (355)
T ss_pred             CcccCCCChHHEEECCCCC--EEEeeCcccccCCCcccc-----------------------------------------
Confidence            9999999999999998777  999999998743211000                                         


Q ss_pred             cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                       ....+|..|++|        +..+|+||+|+++++|..|..||.
T Consensus       176 -~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  219 (355)
T cd07874         176 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_pred             -CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence             001233344444        456799999999999999987764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=8.3e-24  Score=218.25  Aligned_cols=151  Identities=26%  Similarity=0.300  Sum_probs=123.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      ..+|+.+|+.++|||||++++++......|++||++.+++..++.. .+.+++..+..++.|++.||.|||+++|+||||
T Consensus       133 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDl  211 (392)
T PHA03207        133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDV  211 (392)
T ss_pred             HHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence            3479999999999999999999999999999999999999988843 467999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      ||+|||++..+.  ++++|||+++.+........                                       .....||
T Consensus       212 kp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~---------------------------------------~~~~~gt  250 (392)
T PHA03207        212 KTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ---------------------------------------CYGWSGT  250 (392)
T ss_pred             CHHHEEEcCCCC--EEEccCccccccCccccccc---------------------------------------ccccccc
Confidence            999999998777  99999999875432110000                                       0012345


Q ss_pred             eccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         430 FHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       430 ~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      +.|++|        ...+|+|++|+++++|..|..|++...
T Consensus       251 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~  291 (392)
T PHA03207        251 LETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ  291 (392)
T ss_pred             cCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence            555555        456799999999999999998876644

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=1e-23  Score=207.42  Aligned_cols=145  Identities=33%  Similarity=0.546  Sum_probs=112.3

Q ss_pred             HHHHHHHHhhc---CCCCeeEEeeeeec-----CCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL---KHNNIVTLHDIVHT-----RSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l---~HpnIV~l~~~~~~-----~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      ..+|+.+++.+   +||||+++++++..     ...++++|||+.+++..++.... ..+++..++.++.|++.||.|||
T Consensus        46 ~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  125 (288)
T cd07863          46 TVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH  125 (288)
T ss_pred             HHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34577776665   69999999998864     34689999999999888876543 34899999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +++++||||||+||++++++.  +|++|||+++.+......                                       
T Consensus       126 ~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~~~---------------------------------------  164 (288)
T cd07863         126 ANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMAL---------------------------------------  164 (288)
T ss_pred             hCCeecCCCCHHHEEECCCCC--EEECccCccccccCcccC---------------------------------------
Confidence            999999999999999998877  999999988654311000                                       


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                         ....+|..|++|        +.++|+||+|+++++|..|.+|+
T Consensus       165 ---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f  207 (288)
T cd07863         165 ---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF  207 (288)
T ss_pred             ---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence               001123333333        45679999999999999998555

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.90  E-value=3.7e-24  Score=215.10  Aligned_cols=98  Identities=32%  Similarity=0.496  Sum_probs=87.3

Q ss_pred             HHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCc
Q psy3074         274 ASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ  352 (481)
Q Consensus       274 ~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~  352 (481)
                      ..+++.++||||+++++++...+.+|+|||||. |++...+.. .+.+++..++.++.|++.||.|||++||+||||||+
T Consensus        47 ~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~  125 (325)
T cd05602          47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE  125 (325)
T ss_pred             HHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence            345788999999999999999999999999999 567666654 456889999999999999999999999999999999


Q ss_pred             cccccccchhhHHHHHHHHHhh
Q psy3074         353 NLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       353 NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      |||++.++.  +|++|||+++.
T Consensus       126 Nili~~~~~--~kl~DfG~a~~  145 (325)
T cd05602         126 NILLDSQGH--IVLTDFGLCKE  145 (325)
T ss_pred             HeEECCCCC--EEEccCCCCcc
Confidence            999998776  99999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.90  E-value=3.6e-24  Score=215.18  Aligned_cols=148  Identities=24%  Similarity=0.312  Sum_probs=121.6

Q ss_pred             HHHH-HHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         272 REAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       272 rE~~-il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +|.. +++.++||||+++++++...+..|+||||+. |++...+.. .+.+++..+..++.|++.||.|||++||+||||
T Consensus        44 ~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dl  122 (325)
T cd05604          44 AERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDL  122 (325)
T ss_pred             HHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence            4544 5778999999999999999999999999998 566666544 457899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+|||+++++.  +|++|||+++.....   ......+..|.+|+++..    ...+.|+.|+++++|.+|..||...+
T Consensus       123 kp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (325)
T cd05604         123 KPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD  200 (325)
T ss_pred             CHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence            999999998887  999999998753211   112234556788887754    34678999999999999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.90  E-value=5.9e-24  Score=212.89  Aligned_cols=148  Identities=21%  Similarity=0.306  Sum_probs=115.9

Q ss_pred             HHHHHHHHhh-cCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~-l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|..++.. ++||||+++++++.+.+.+|+|||||. |+|...+.. .+.+++..+..++.|++.||+|||+++|+||
T Consensus        42 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr  120 (316)
T cd05620          42 TMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYR  120 (316)
T ss_pred             HHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            3457777775 489999999999999999999999998 577777654 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++........                                         ....+
T Consensus       121 Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  157 (316)
T cd05620         121 DLKLDNVMLDRDGH--IKIADFGMCKENVFGDNR-----------------------------------------ASTFC  157 (316)
T ss_pred             CCCHHHeEECCCCC--EEeCccCCCeecccCCCc-----------------------------------------eeccC
Confidence            99999999998877  999999987632110000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+..+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             CCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            44455554        44579999999999999998776543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.90  E-value=4.2e-24  Score=215.21  Aligned_cols=104  Identities=22%  Similarity=0.410  Sum_probs=93.1

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ...+|+.+++.++ ||||+++++++...+.+++|||||. |+|...+.. ...+++..+..++.|++.||.|||+++|+|
T Consensus        50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  128 (332)
T cd05614          50 HTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVY  128 (332)
T ss_pred             HHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence            3457999999995 9999999999999999999999998 577777755 356899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+|||++.++.  +|++|||+++.+
T Consensus       129 rDlkp~Nili~~~~~--~kl~DfG~~~~~  155 (332)
T cd05614         129 RDIKLENILLDSEGH--VVLTDFGLSKEF  155 (332)
T ss_pred             cCCCHHHeEECCCCC--EEEeeCcCCccc
Confidence            999999999998876  999999998754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.90  E-value=1e-23  Score=212.55  Aligned_cols=145  Identities=23%  Similarity=0.314  Sum_probs=117.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-ceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiH  346 (481)
                      .+.+|+++|++++||||+++++++...+.+++||||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +|+|
T Consensus        49 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH  127 (331)
T cd06649          49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMH  127 (331)
T ss_pred             HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence            45679999999999999999999999999999999999 577777654 35689999999999999999999986 6999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||++..+......                                           ..
T Consensus       128 ~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-------------------------------------------~~  162 (331)
T cd06649         128 RDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMAN-------------------------------------------SF  162 (331)
T ss_pred             CCCChhhEEEcCCCc--EEEccCcccccccccccc-------------------------------------------cC
Confidence            999999999998877  999999988654311000                                           01


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .+|+.|++|        +..+|+||+|+++++|..|..|+.
T Consensus       163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~  203 (331)
T cd06649         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP  203 (331)
T ss_pred             CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            233333333        456899999999999999997764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.90  E-value=4.8e-24  Score=218.38  Aligned_cols=104  Identities=33%  Similarity=0.568  Sum_probs=94.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++++...+     .+|+||||+.+++...+.. ...+++..++.++.|++.||.|||+++
T Consensus        45 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~  123 (372)
T cd07853          45 RVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG  123 (372)
T ss_pred             HHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3567999999999999999999998876     8999999999988887754 356899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ++||||||+|||++.++.  +|++|||+++..
T Consensus       124 ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~  153 (372)
T cd07853         124 ILHRDIKPGNLLVNSNCV--LKICDFGLARVE  153 (372)
T ss_pred             eeCCCCChHHEEECCCCC--EEeccccceeec
Confidence            999999999999998777  999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=5.8e-24  Score=212.94  Aligned_cols=150  Identities=21%  Similarity=0.269  Sum_probs=125.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..+|+++|++++||||+++++++.+++.+|+||||+. |+|.+.+.. ...+++..+..++.|++.||.|||+++|+|||
T Consensus        45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d  123 (318)
T cd05582          45 TKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRD  123 (318)
T ss_pred             HHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence            4569999999999999999999999999999999998 678777754 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||+||++++++.  +|++|||+++......   .....+..|.+|+++.    +...+.|+.|++++++.+|..||...
T Consensus       124 lkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         124 LKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             CCHHHeEECCCCc--EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence            9999999998777  9999999987543221   1122344577787764    34567899999999999999999754


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      +
T Consensus       202 ~  202 (318)
T cd05582         202 D  202 (318)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=1.3e-23  Score=210.00  Aligned_cols=153  Identities=24%  Similarity=0.434  Sum_probs=116.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccCCCHHHHHHHhc--------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTDLSQYMERHS--------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~g~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+++|++++||||+++++++..  ...+|++|||+.+++..++....        ..+++..++.++.|++.||.|
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  123 (317)
T cd07868          44 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY  123 (317)
T ss_pred             HHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHH
Confidence            35689999999999999999999854  45789999999999888775321        248889999999999999999


Q ss_pred             hhcCceeeccCCCcccccccc--chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         339 CHRRRILHRDVKPQNLLISEI--DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~--~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      ||+++|+||||||+|||++..  ....+|++|||+|+.+.......                                  
T Consensus       124 LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~----------------------------------  169 (317)
T cd07868         124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL----------------------------------  169 (317)
T ss_pred             HHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccc----------------------------------
Confidence            999999999999999999432  22349999999987543111000                                  


Q ss_pred             CccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         417 GWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                          .......+|+.|++|         +.++|+||+|+++++|..|.+||.
T Consensus       170 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~  217 (317)
T cd07868         170 ----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ----cccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence                000112344445555         345799999999999999986653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=6.5e-24  Score=216.71  Aligned_cols=144  Identities=23%  Similarity=0.409  Sum_probs=114.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...      ..+|+||||+++++...+..   .+++..+..++.|++.||.|||++
T Consensus        69 ~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~  145 (364)
T cd07875          69 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA  145 (364)
T ss_pred             HHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC
Confidence            356799999999999999999988643      35799999999998887743   478889999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++.  +|++|||+++........                                         
T Consensus       146 ~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~-----------------------------------------  182 (364)
T cd07875         146 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMM-----------------------------------------  182 (364)
T ss_pred             CeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCCcc-----------------------------------------
Confidence            9999999999999998777  999999998743211000                                         


Q ss_pred             cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                       ....+|..|++|        +.++|+||+|+++++|..|..||-
T Consensus       183 -~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  226 (364)
T cd07875         183 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP  226 (364)
T ss_pred             -cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence             001233344444        456899999999999999987663

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.89  E-value=3.8e-24  Score=214.54  Aligned_cols=148  Identities=25%  Similarity=0.305  Sum_probs=121.7

Q ss_pred             HHH-HHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         272 REA-SLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       272 rE~-~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +|. .+++.++|||||++++++.+.+..|+|||||+ |+|...+.. ...+++..+..++.|++.||.|||+.+|+||||
T Consensus        44 ~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dl  122 (321)
T cd05603          44 AERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL  122 (321)
T ss_pred             HHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence            344 46888999999999999999999999999998 567666654 456899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccc---cccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSY---CHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~---~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||+++.++.  +|++|||+++....   .......+..|.+|+++..    ...+.|+.|++++++.+|..||...+
T Consensus       123 kp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  200 (321)
T cd05603         123 KPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (321)
T ss_pred             CHHHeEECCCCC--EEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence            999999998877  99999999875321   1122234566888887643    45678999999999999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.89  E-value=6e-24  Score=213.44  Aligned_cols=147  Identities=22%  Similarity=0.328  Sum_probs=117.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++||||+++++.|..++..|+||||+. |+|...+.. .+.+.+..+..++.|++.||.|||+++|+|||
T Consensus        47 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~d  125 (323)
T cd05584          47 TKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRD  125 (323)
T ss_pred             HHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            4579999999999999999999999999999999998 567776654 45688899999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.......  .                                       ....+|
T Consensus       126 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~--~---------------------------------------~~~~~g  162 (323)
T cd05584         126 LKPENILLDAQGH--VKLTDFGLCKESIHEGT--V---------------------------------------THTFCG  162 (323)
T ss_pred             CCHHHeEECCCCC--EEEeeCcCCeecccCCC--c---------------------------------------ccccCC
Confidence            9999999998877  99999998763211000  0                                       001224


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|++|        +..+|+||+|+++++|++|..|+..
T Consensus       163 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~  202 (323)
T cd05584         163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             CccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence            4444444        4567999999999999999866543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.89  E-value=3.5e-24  Score=215.08  Aligned_cols=148  Identities=25%  Similarity=0.322  Sum_probs=121.6

Q ss_pred             HHHH-HHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         272 REAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       272 rE~~-il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +|.. +++.++||||+++++.+...+..|+||||+. |+|...+.. .+.+++..+..++.|++.||.|||+++|+||||
T Consensus        44 ~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~di  122 (323)
T cd05575          44 AERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDL  122 (323)
T ss_pred             HHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence            3444 5688999999999999999999999999998 567666654 457899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccccc----cccccCCCeeEEEeecCCCCccccc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLISE----IVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~~----~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+|||++.++.  +|++|||+++.....   ......+..|.+|+++.+.    ..+.|++|++++++.+|..||...+
T Consensus       123 kp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  200 (323)
T cd05575         123 KPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD  200 (323)
T ss_pred             CHHHeEECCCCc--EEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence            999999998877  999999998753211   1122345567888877543    4578999999999999999997653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.89  E-value=1.9e-23  Score=205.92  Aligned_cols=104  Identities=69%  Similarity=1.112  Sum_probs=96.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.++++++||||+++++++.+.+..++||||+.++|.+++......+++..++.++.|++.||.|||+.+++||||
T Consensus        50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl  129 (291)
T cd07844          50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL  129 (291)
T ss_pred             HHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence            45799999999999999999999999999999999999998888776667899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+||++++++.  +|++|||+++..
T Consensus       130 ~p~nil~~~~~~--~kl~dfg~~~~~  153 (291)
T cd07844         130 KPQNLLISERGE--LKLADFGLARAK  153 (291)
T ss_pred             CHHHEEEcCCCC--EEECcccccccc
Confidence            999999998877  999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=8.2e-24  Score=207.66  Aligned_cols=155  Identities=37%  Similarity=0.634  Sum_probs=120.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|++++++++||||+++++++.+.+..|+++||+++++...+....+.+++..+..++.|++.||.|||+++++||||
T Consensus        46 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl  125 (284)
T cd07839          46 ALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDL  125 (284)
T ss_pred             hhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence            45699999999999999999999999999999999999998888766667999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+||+++.++.  +|++|||+++.+.....   ....+..+.+|+++.+.                             
T Consensus       126 ~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------------------------  174 (284)
T cd07839         126 KPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA-----------------------------  174 (284)
T ss_pred             CHHHEEEcCCCc--EEECccchhhccCCCCCCcCCCccccCCcChHHHhCC-----------------------------
Confidence            999999998776  99999999875431110   01111122222221110                             


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                            ...+...|+|++|+++++|..|..|++..
T Consensus       175 ------~~~~~~~DiwslG~il~~l~tg~~p~~~~  203 (284)
T cd07839         175 ------KLYSTSIDMWSAGCIFAELANAGRPLFPG  203 (284)
T ss_pred             ------cccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence                  01134579999999999999888776643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.89  E-value=5.2e-24  Score=215.48  Aligned_cols=121  Identities=29%  Similarity=0.506  Sum_probs=98.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      +.+|+.+|+.++||||+++++++...      ...|++||++.+++...+..  ..+++..+..++.|++.||.|||+++
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~  138 (343)
T cd07878          61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG  138 (343)
T ss_pred             HHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45799999999999999999988643      45799999998888776643  46999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL  394 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il  394 (481)
                      |+||||||+|||+++++.  +|++|||+++.........+.+..|.||+++
T Consensus       139 ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~  187 (343)
T cd07878         139 IIHRDLKPSNVAVNEDCE--LRILDFGLARQADDEMTGYVATRWYRAPEIM  187 (343)
T ss_pred             eecccCChhhEEECCCCC--EEEcCCccceecCCCcCCccccccccCchHh
Confidence            999999999999998877  9999999987654322222333444444443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.89  E-value=7.7e-24  Score=213.09  Aligned_cols=145  Identities=24%  Similarity=0.311  Sum_probs=116.2

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.++.++ +||||+++++++.+.+.+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        42 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHr  120 (327)
T cd05617          42 VQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYR  120 (327)
T ss_pred             HHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            45688998888 59999999999999999999999998 567666654 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++........                                         ....+
T Consensus       121 Dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  157 (327)
T cd05617         121 DLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDT-----------------------------------------TSTFC  157 (327)
T ss_pred             CCCHHHEEEeCCCC--EEEeccccceeccCCCCc-----------------------------------------eeccc
Confidence            99999999998877  999999988632110000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf  196 (327)
T cd05617         158 GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF  196 (327)
T ss_pred             CCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCC
Confidence            44445544        45679999999999999998666

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=9.1e-24  Score=208.14  Aligned_cols=147  Identities=22%  Similarity=0.321  Sum_probs=116.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++.++||||+++++.+.+++.+++||||+. |+|...+... ...+++..+..++.|++.||.|||+.+++||
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  126 (285)
T cd05605          47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR  126 (285)
T ss_pred             HHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence            4679999999999999999999999999999999998 5676666543 2458999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||++..+.....   ..                                       ..+
T Consensus       127 dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~~---------------------------------------~~~  162 (285)
T cd05605         127 DLKPENILLDDYGH--IRISDLGLAVEIPEGET---IR---------------------------------------GRV  162 (285)
T ss_pred             CCCHHHEEECCCCC--EEEeeCCCceecCCCCc---cc---------------------------------------ccc
Confidence            99999999998776  99999998865431100   00                                       012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+..|++|        +...|+|++|+++++|..|..|+-.
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             CCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence            33333333        3457999999999999999876643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.89  E-value=9e-24  Score=212.24  Aligned_cols=147  Identities=22%  Similarity=0.301  Sum_probs=116.2

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|..+++.+. |++|+++++++.+.+.+|+||||++ |+|...+.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHr  125 (323)
T cd05615          47 TMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYR  125 (323)
T ss_pred             HHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            456888888876 5678899999999999999999998 567766654 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+++.......                                         .....+
T Consensus       126 Dikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~-----------------------------------------~~~~~~  162 (323)
T cd05615         126 DLKLDNVMLDSEGH--IKIADFGMCKEHMVDGV-----------------------------------------TTRTFC  162 (323)
T ss_pred             CCCHHHeEECCCCC--EEEeccccccccCCCCc-----------------------------------------cccCcc
Confidence            99999999998877  99999998864221000                                         000123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|+.|..|+..
T Consensus       163 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~  203 (323)
T cd05615         163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             CCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence            44455554        4567999999999999999866543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.89  E-value=1.3e-23  Score=210.35  Aligned_cols=147  Identities=20%  Similarity=0.293  Sum_probs=116.4

Q ss_pred             HHHHHHHHhh-cCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~-l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|..+++. ++||||+++++++.+.+.+|+||||++ |+|...+.. ...+++..+..++.|++.||.|||+++++||
T Consensus        42 ~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHr  120 (316)
T cd05619          42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYR  120 (316)
T ss_pred             HHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence            3457778876 589999999999999999999999998 678777754 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+++........                                         ....+
T Consensus       121 dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  157 (316)
T cd05619         121 DLKLDNILLDTDGH--IKIADFGMCKENMLGDAK-----------------------------------------TCTFC  157 (316)
T ss_pred             CCCHHHEEECCCCC--EEEccCCcceECCCCCCc-----------------------------------------eeeec
Confidence            99999999998777  999999987632100000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+..
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~  198 (316)
T cd05619         158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             CCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence            44455555        4567999999999999999977643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4645|consensus

Probab=99.89  E-value=2.6e-24  Score=234.57  Aligned_cols=147  Identities=24%  Similarity=0.302  Sum_probs=127.1

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      +|..++..++|||+|++|++-..++.++|.||||. |+|.+.+ .+.+..+|...+.|..|++.|+.|||+.||+|||+|
T Consensus      1283 eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK 1361 (1509)
T KOG4645|consen 1283 EEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIK 1361 (1509)
T ss_pred             HHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCC
Confidence            59999999999999999999999999999999999 5555554 455668899999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccc-------cCceeccccCCCcccccccc-------cccCCCeeEEEeecCCC
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCH-------RRRILHRDVKPQNLLISEIV-------FTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~-------~~~i~~~d~~~~~il~~~~~-------~~~s~g~~~~~~~~g~~  416 (481)
                      |+||+++..|.  ||..|||.|..+....       ..-+.+..|++|+++.+...       +.||.||++.||.+|+.
T Consensus      1362 ~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1362 PANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred             ccceeeecCCc--EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence            99999999887  9999999999776322       12356778888888876553       56999999999999999


Q ss_pred             Ccccc
Q psy3074         417 GWWFE  421 (481)
Q Consensus       417 ~~~~~  421 (481)
                      ||..-
T Consensus      1440 PW~~~ 1444 (1509)
T KOG4645|consen 1440 PWAEL 1444 (1509)
T ss_pred             chhhc
Confidence            99854

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.89  E-value=2e-23  Score=210.60  Aligned_cols=145  Identities=21%  Similarity=0.330  Sum_probs=117.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-ceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiH  346 (481)
                      .+.+|+++++.++|||||+++++|.+.+.+|+||||+. |+|.+++.. .+.+++..+..++.|++.||.|||+. +++|
T Consensus        49 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH  127 (333)
T cd06650          49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMH  127 (333)
T ss_pred             HHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence            35689999999999999999999999999999999998 578777765 35688999999999999999999975 7999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||++..+.......                                           .
T Consensus       128 ~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~-------------------------------------------~  162 (333)
T cd06650         128 RDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANS-------------------------------------------F  162 (333)
T ss_pred             cCCChhhEEEcCCCC--EEEeeCCcchhhhhhcccc-------------------------------------------C
Confidence            999999999998777  9999999887543110000                                           1


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .++..|++|        +..+|+|++|+++++|..|..|+.
T Consensus       163 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~  203 (333)
T cd06650         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP  203 (333)
T ss_pred             CCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            122233333        456899999999999999987764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.89  E-value=8.6e-24  Score=208.63  Aligned_cols=124  Identities=59%  Similarity=1.035  Sum_probs=102.0

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                         .
T Consensus       112 i~~aL~~LH~~~ivH~dlkp----~Nil~~~~----~~~kl~DfG~~~~~~~~~-------------------------~  158 (288)
T cd07871         112 LLRGLSYCHKRKILHRDLKP----QNLLINEK----GELKLADFGLARAKSVPT-------------------------K  158 (288)
T ss_pred             HHHHHHHHHhCCcccCCCCH----HHEEECCC----CCEEECcCcceeeccCCC-------------------------c
Confidence            68899999999999999999    89999876    799999999997421110                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ..                       ....+|+.|+|||++.+...|+.++||||+||++|||++|++||.+. +..+.+.
T Consensus       159 ~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~-~~~~~~~  214 (288)
T cd07871         159 TY-----------------------SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS-TVKEELH  214 (288)
T ss_pred             cc-----------------------cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            00                       00123889999999987667999999999999999999999999984 5558889


Q ss_pred             HHHHHhCCCCccCcccccCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~  201 (481)
                      .+.+.++.|+.+.|+.+....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         215 LIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             HHHHHhCCCChHHhhccccch
Confidence            999999999999998876543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.89  E-value=1.8e-23  Score=205.52  Aligned_cols=147  Identities=21%  Similarity=0.292  Sum_probs=117.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+|+.+++.++||||+++.+++..++..|+||||++ |+|...+..   ....+++..+..++.|++.||.|||+++|+
T Consensus        40 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  119 (280)
T cd05608          40 AMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII  119 (280)
T ss_pred             HHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4579999999999999999999999999999999998 567665533   234589999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  ++++|||++..+......                                         ...
T Consensus       120 H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~-----------------------------------------~~~  156 (280)
T cd05608         120 YRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSK-----------------------------------------TKG  156 (280)
T ss_pred             cCCCCHHHEEECCCCC--EEEeeCccceecCCCCcc-----------------------------------------ccc
Confidence            9999999999988776  999999988654311000                                         000


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..||+.|++|        +...|+||+|+++++|..|..|+.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~  198 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR  198 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            1233444444        456899999999999999987764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4279|consensus

Probab=99.89  E-value=1.5e-23  Score=215.58  Aligned_cols=149  Identities=21%  Similarity=0.317  Sum_probs=131.2

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCC--ChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGL--DHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l--~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..|+.+.++|+|.|||++.+++..++++-|.||-++ |+|..+++...+++  .|..+.+|.+||++||.|||++.|+||
T Consensus       620 hEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHR  699 (1226)
T KOG4279|consen  620 HEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHR  699 (1226)
T ss_pred             HHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeec
Confidence            359999999999999999999999999999999999 67888888888888  788999999999999999999999999


Q ss_pred             cCCCcccccccc-chhhHHHHHHHHHhhcc---ccccCceeccccCCCccc------ccccccccCCCeeEEEeecCCCC
Q psy3074         348 DVKPQNLLISEI-DHHNIRLFMFQLLRGLS---YCHRRRILHRDVKPQNLL------ISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       348 DlKp~NiLl~~~-~~~~ikl~dfgla~~~~---~~~~~~i~~~d~~~~~il------~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |||-+|+|++.- |.  +||.|||-++.+.   .+......+-.|++|+++      ++...+.||+||.+.+|.+|++|
T Consensus       700 DIKGDNVLvNTySGv--lKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP  777 (1226)
T KOG4279|consen  700 DIKGDNVLVNTYSGV--LKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP  777 (1226)
T ss_pred             cccCCcEEEeeccce--EEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence            999999999753 45  9999999999776   444556677788999988      44555679999999999999999


Q ss_pred             cccc
Q psy3074         418 WWFE  421 (481)
Q Consensus       418 ~~~~  421 (481)
                      |...
T Consensus       778 F~El  781 (1226)
T KOG4279|consen  778 FVEL  781 (1226)
T ss_pred             eeec
Confidence            9854

>KOG1187|consensus

Probab=99.89  E-value=5.8e-24  Score=215.64  Aligned_cols=151  Identities=23%  Similarity=0.258  Sum_probs=129.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-eEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCc--
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-TLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRR--  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~--  343 (481)
                      .+.+|+.+|.+++|||+|+|+++|.+.+ ..+||+||++ |+|.+.+..... .+++.....|+.+++.||+|||...  
T Consensus       117 eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~  196 (361)
T KOG1187|consen  117 EFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP  196 (361)
T ss_pred             HHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence            4788999999999999999999999998 5999999998 899999887665 7899999999999999999999753  


Q ss_pred             -eeeccCCCccccccccchhhHHHHHHHHHhhccc-cccCc---eeccccCCCccc----ccccccccCCCeeEEEeecC
Q psy3074         344 -ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY-CHRRR---ILHRDVKPQNLL----ISEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       344 -iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~-~~~~~---i~~~d~~~~~il----~~~~~~~~s~g~~~~~~~~g  414 (481)
                       ||||||||+|||+|++..  .|++|||+|+.... .....   ..+..|.+|++.    +++..|+.|+|+++.++.+|
T Consensus       197 ~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg  274 (361)
T KOG1187|consen  197 PIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG  274 (361)
T ss_pred             CEecCCCCHHHeeECCCCC--EEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence             999999999999998877  99999999975543 21111   345678888888    56677889999999999999


Q ss_pred             CCCcccc
Q psy3074         415 SGGWWFE  421 (481)
Q Consensus       415 ~~~~~~~  421 (481)
                      ..+....
T Consensus       275 r~~~d~~  281 (361)
T KOG1187|consen  275 RKAVDQS  281 (361)
T ss_pred             CcccCCC
Confidence            9877643

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=1e-23  Score=210.65  Aligned_cols=137  Identities=32%  Similarity=0.648  Sum_probs=105.7

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||+.......+.+||+|||+|+........                  
T Consensus       112 ~i~~q-i~~al~~LH~~~ivHrDlkp----~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~------------------  168 (317)
T cd07868         112 SLLYQ-ILDGIHYLHANWVLHRDLKP----ANILVMGEGPERGRVKIADMGFARLFNSPLKP------------------  168 (317)
T ss_pred             HHHHH-HHHHHHHHHhCCEEcCCCCH----HHEEEecCCCCcCcEEEeecCceeccCCCCcc------------------
Confidence            34444 67899999999999999999    89999655455689999999999853211000                  


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                           ...                      .....+|+.|||||++.+...|+.++||||+||++|||++|++||.+.++
T Consensus       169 -----~~~----------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~  221 (317)
T cd07868         169 -----LAD----------------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             -----ccc----------------------cCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcc
Confidence                 000                      00112399999999999877799999999999999999999999976532


Q ss_pred             --------hHHHHHHHHHHhCCCCccCcccccCCC
Q psy3074         175 --------VYDQLDKIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       175 --------~~~~l~~i~~~~~~p~~~~~~~~~~~~  201 (481)
                              ..+++..++..++.|....|+.....+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (317)
T cd07868         222 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP  256 (317)
T ss_pred             cccccccccHHHHHHHHHhcCCCChHHhHHHhhcc
Confidence                    246788999999999999888776543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.89  E-value=4.8e-23  Score=203.17  Aligned_cols=104  Identities=68%  Similarity=1.043  Sum_probs=94.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.+++.++|+||+++++++..++..|+||||+.+++...+......+++..+..++.|++.||.|||+.+++||||
T Consensus        50 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl  129 (291)
T cd07870          50 AIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL  129 (291)
T ss_pred             HHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            45799999999999999999999999999999999999988887665566788889999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+||+++.++.  ++++|||+++..
T Consensus       130 kp~Nil~~~~~~--~~l~Dfg~~~~~  153 (291)
T cd07870         130 KPQNLLISYLGE--LKLADFGLARAK  153 (291)
T ss_pred             ChHHEEEcCCCc--EEEecccccccc
Confidence            999999988776  999999988753

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.89  E-value=1.8e-23  Score=209.45  Aligned_cols=147  Identities=27%  Similarity=0.388  Sum_probs=116.7

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|..+++.+ +||||+++++++.+.+.+|+|||||. |+|...+.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        42 ~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~  120 (318)
T cd05570          42 TMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYR  120 (318)
T ss_pred             HHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEcc
Confidence            45688888887 69999999999999999999999998 567666654 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  +|++|||+++........                                         ....+
T Consensus       121 dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  157 (318)
T cd05570         121 DLKLDNVLLDSEGH--IKIADFGMCKEGILGGVT-----------------------------------------TSTFC  157 (318)
T ss_pred             CCCHHHeEECCCCc--EEecccCCCeecCcCCCc-----------------------------------------cccee
Confidence            99999999998877  999999987532100000                                         00112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+..
T Consensus       158 g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~  198 (318)
T cd05570         158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             cCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence            34444444        4567999999999999999977643

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.89  E-value=4.5e-23  Score=202.37  Aligned_cols=105  Identities=46%  Similarity=0.808  Sum_probs=95.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc--CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS--GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++.+++..|+||||+.+++.+++....  ..+++..+..++.|++.||.|||+.+++|
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  124 (285)
T cd07861          45 TAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLH  124 (285)
T ss_pred             HHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3557999999999999999999999999999999999998888876533  45889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+||++++++.  ++++|||++..+
T Consensus       125 ~dl~p~nil~~~~~~--~~l~dfg~~~~~  151 (285)
T cd07861         125 RDLKPQNLLIDNKGV--IKLADFGLARAF  151 (285)
T ss_pred             cCCCHHHEEEcCCCc--EEECcccceeec
Confidence            999999999998877  999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0604|consensus

Probab=99.89  E-value=4.9e-24  Score=200.91  Aligned_cols=137  Identities=27%  Similarity=0.397  Sum_probs=97.5

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +++-.|+..=+-.....|+.|||+.+|-||||||    +|+|..... ....+||+|||+|+....+             
T Consensus       156 ~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp----ENLLyt~t~-~na~lKLtDfGFAK~t~~~-------------  217 (400)
T KOG0604|consen  156 QAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP----ENLLYTTTS-PNAPLKLTDFGFAKETQEP-------------  217 (400)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh----hheeeecCC-CCcceEecccccccccCCC-------------
Confidence            3344455444444588999999999999999999    798876553 4458999999999853211             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                   ++. .+-|                      -||+|.||||+-..+ |+.++|+||+|||+|-||+|.
T Consensus       218 -------------~~L-~TPc----------------------~TPyYvaPevlg~eK-ydkscdmwSlgVimYIlLCGy  260 (400)
T KOG0604|consen  218 -------------GDL-MTPC----------------------FTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGY  260 (400)
T ss_pred             -------------ccc-cCCc----------------------ccccccCHHHhCchh-cCCCCCccchhHHHHHhhcCC
Confidence                         111 1111                      199999999987666 999999999999999999999


Q ss_pred             CCCCCchh---hHHHHHHHHHHhCCCCccCccccc
Q psy3074         167 PTFPGVRE---VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       167 ~PF~g~~~---~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      |||.+...   .-..-.+|..+...++.+.|+.+|
T Consensus       261 PPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VS  295 (400)
T KOG0604|consen  261 PPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVS  295 (400)
T ss_pred             CcccccCCccCChhHHhHhhccCccCCChhHhHHH
Confidence            99976421   112233444455556666666555

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.89  E-value=1.6e-23  Score=212.89  Aligned_cols=153  Identities=22%  Similarity=0.304  Sum_probs=112.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++|+||+++++++...+.+|+|||||.+ +|..     ....++..+..++.|++.||.|||+++|+||
T Consensus       118 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  192 (353)
T PLN00034        118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHR  192 (353)
T ss_pred             HHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            356799999999999999999999999999999999995 4432     1235677888999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||+++++.  +|++|||+++.+.....   ..+.+..|.+||++....                          
T Consensus       193 Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------------  244 (353)
T PLN00034        193 DIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL--------------------------  244 (353)
T ss_pred             CCCHHHEEEcCCCC--EEEcccccceecccccccccccccCccccCcccccccc--------------------------
Confidence            99999999998776  99999999875432110   111122222332221100                          


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                         ....  ..+..+|+|++|+++++|..|..||.
T Consensus       245 ---~~~~--~~~~~~DvwslGvil~el~~g~~pf~  274 (353)
T PLN00034        245 ---NHGA--YDGYAGDIWSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             ---ccCc--CCCcchhHHHHHHHHHHHHhCCCCCC
Confidence               0000  01246799999999999999987765

>KOG2345|consensus

Probab=99.89  E-value=4.3e-24  Score=196.63  Aligned_cols=186  Identities=17%  Similarity=0.167  Sum_probs=150.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      +.++||++..++++|||+++++++...+     ...||++.|.. |++.+.+....   ..++|.++..++.+++.||++
T Consensus        63 e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~  142 (302)
T KOG2345|consen   63 EEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEA  142 (302)
T ss_pred             HHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999877543     35999999887 88988876542   258999999999999999999


Q ss_pred             hhcCc--eeeccCCCccccccccchhhHHHHHHHHHhhccc-cc-----------cCceeccccCCCccc-------ccc
Q psy3074         339 CHRRR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY-CH-----------RRRILHRDVKPQNLL-------ISE  397 (481)
Q Consensus       339 lH~~~--iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~-~~-----------~~~i~~~d~~~~~il-------~~~  397 (481)
                      +|+..  ..||||||.|||+++.+.  +++.|||.+....- +.           ...-.+..|+||+.+       ++|
T Consensus       143 lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~e  220 (302)
T KOG2345|consen  143 LHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITE  220 (302)
T ss_pred             HhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccc
Confidence            99998  999999999999998777  99999999874431 00           112345678899888       788


Q ss_pred             cccccCCCeeEEEeecCCCCcccccc-----CcccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         398 IVFTNLSGVVVSTVDSGSGGWWFESK-----SNINLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       398 ~~~~~s~g~~~~~~~~g~~~~~~~~~-----~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..+.||+||++|.|++|..||...-.     .-.+.+..|..|..+.....+..++..|+.-+
T Consensus       221 rtDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvd  283 (302)
T KOG2345|consen  221 RTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVD  283 (302)
T ss_pred             ccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCC
Confidence            99999999999999999999985432     22456677888877667777777888887665

>KOG4721|consensus

Probab=99.89  E-value=5.5e-25  Score=221.89  Aligned_cols=145  Identities=19%  Similarity=0.252  Sum_probs=116.0

Q ss_pred             cccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          20 SKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        20 ~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ....+.+|||.++|||||||.    -|||+..+    ..|||||||-++...                           .
T Consensus       220 ~IA~GM~YLH~hKIIHRDLKS----PNiLIs~~----d~VKIsDFGTS~e~~---------------------------~  264 (904)
T KOG4721|consen  220 GIAGGMNYLHLHKIIHRDLKS----PNILISYD----DVVKISDFGTSKELS---------------------------D  264 (904)
T ss_pred             HhhhhhHHHHHhhHhhhccCC----CceEeecc----ceEEeccccchHhhh---------------------------h
Confidence            455679999999999999999    69999887    499999999998643                           2


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      -+..+.|+|                      |..|||||||...+ .++|+|||||||+|||||||..||...+.....+
T Consensus       265 ~STkMSFaG----------------------TVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw  321 (904)
T KOG4721|consen  265 KSTKMSFAG----------------------TVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW  321 (904)
T ss_pred             hhhhhhhhh----------------------hHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence            233456666                      99999999999988 9999999999999999999999997743321122


Q ss_pred             HHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCC
Q psy3074         180 DKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPR  222 (481)
Q Consensus       180 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (481)
                      -..-..+-.|-+..+|+-..+..+.||..++..+++|..+.--
T Consensus       322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H  364 (904)
T KOG4721|consen  322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH  364 (904)
T ss_pred             eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence            2222345567788888888888889999999999998876433

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.88  E-value=4.7e-24  Score=223.26  Aligned_cols=119  Identities=33%  Similarity=0.649  Sum_probs=97.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++...   +.+||+|||+|+.....                           
T Consensus       179 i~~gL~yLH~~~IiHrDLKp----~NILl~~~~---~~vkL~DFGla~~~~~~---------------------------  224 (440)
T PTZ00036        179 LCRALAYIHSKFICHRDLKP----QNLLIDPNT---HTLKLCDFGSAKNLLAG---------------------------  224 (440)
T ss_pred             HHHHHHHHHHCCEecCCcCH----HHEEEcCCC---CceeeeccccchhccCC---------------------------
Confidence            67899999999999999999    899998552   57999999999843210                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+.                      +|+.|||||++.+...|+.++||||+||++|||++|.+||.+.. ..+++.
T Consensus       225 ~~~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~-~~~~~~  281 (440)
T PTZ00036        225 QRSVSYI----------------------CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS-SVDQLV  281 (440)
T ss_pred             CCcccCC----------------------CCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-hHHHHH
Confidence            0011122                      38999999999887779999999999999999999999999854 448888


Q ss_pred             HHHHHhCCCCccCccc
Q psy3074         181 KIFKILGTPTEETWEG  196 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~  196 (481)
                      ++.+.+++|..+.+..
T Consensus       282 ~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        282 RIIQVLGTPTEDQLKE  297 (440)
T ss_pred             HHHHHhCCCCHHHHHH
Confidence            9999999998766543

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.88  E-value=3e-23  Score=228.20  Aligned_cols=167  Identities=17%  Similarity=0.258  Sum_probs=123.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh----------cCCCChHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH----------SGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~----------~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      ++.+|+++++.++|||||++++++.+.+..|++|||++ |+|.+.+...          ....+...+..++.|++.||+
T Consensus        48 rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~  127 (932)
T PRK13184         48 RFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE  127 (932)
T ss_pred             HHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998 5777776532          122455667889999999999


Q ss_pred             HhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         338 YCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       338 ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |||+++|+||||||+|||++.++.  ++++|||+++......... ...+...++....                     
T Consensus       128 yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~-~~l~~~~~~s~~s---------------------  183 (932)
T PRK13184        128 YVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDL-LDIDVDERNICYS---------------------  183 (932)
T ss_pred             HHHHCCccccCCchheEEEcCCCC--EEEEecCcceecccccccc-ccccccccccccc---------------------
Confidence            999999999999999999998877  9999999998653111000 0000000000000                     


Q ss_pred             ccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         418 WWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                       ........+||+.|++|        +..+|+||+|+++++|.+|..|+..
T Consensus       184 -~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        184 -SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             -ccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence             00011235688889888        4567999999999999999977644

>KOG0596|consensus

Probab=99.88  E-value=4.4e-23  Score=208.14  Aligned_cols=172  Identities=20%  Similarity=0.254  Sum_probs=128.2

Q ss_pred             hhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..++.|+.+|.+|+ |.+||+|+|+-..++.+||||||=+-||...|.+..+....-.++.|..|++.++.+.|..||||
T Consensus       404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVH  483 (677)
T KOG0596|consen  404 DGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVH  483 (677)
T ss_pred             HHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceee
Confidence            34678999999998 89999999999999999999998889999999876655554478899999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      .||||.|+|+-. |.  +|++|||+|.++......-+--..++..|+|.+|.+...+.+             .....   
T Consensus       484 SDLKPANFLlVk-G~--LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~-------------~~~~~---  544 (677)
T KOG0596|consen  484 SDLKPANFLLVK-GR--LKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS-------------RENGK---  544 (677)
T ss_pred             cCCCcccEEEEe-ee--EEeeeechhcccCccccceeeccccCcccccCHHHHhhcccc-------------ccCCC---
Confidence            999999999875 44  999999999988743322111123334444444433221111             00000   


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                          .-+.-+.|+|+||+||+||.|.||+ |+|.+..
T Consensus       545 ----~k~Ki~r~SDvWSLGCILYqMvYgk-tPf~~~~  576 (677)
T KOG0596|consen  545 ----SKIKISRKSDVWSLGCILYQMVYGK-TPFGQII  576 (677)
T ss_pred             ----cceeecCccchhhhhhHHHHHHhcC-CchHHHH
Confidence                0011278899999999999999999 6666554

>KOG1026|consensus

Probab=99.88  E-value=2.8e-23  Score=219.96  Aligned_cols=195  Identities=24%  Similarity=0.306  Sum_probs=151.7

Q ss_pred             ChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC-------------CCChHHHHHHHHH
Q psy3074         266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG-------------GLDHHNIRLFMFQ  331 (481)
Q Consensus       266 ~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~-------------~l~~~~~~~~~~q  331 (481)
                      ...+|.||+++|..++|||||+|+++|..++.+|+|+|||. |||.++|+.+..             .++..+...++.|
T Consensus       532 ~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~Q  611 (774)
T KOG1026|consen  532 ARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQ  611 (774)
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHH
Confidence            45678999999999999999999999999999999999998 999999986531             2677888999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc---cccc--Cc-eeccccCCCccc---cccccccc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCHR--RR-ILHRDVKPQNLL---ISEIVFTN  402 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~---~~~~--~~-i~~~d~~~~~il---~~~~~~~~  402 (481)
                      |+.||+||.++.++||||..+|.|+.+.-.  |||+|||++|.+-   |.+-  +. +--||+-|+.|+   +++..|+|
T Consensus       612 IAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVW  689 (774)
T KOG1026|consen  612 IAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVW  689 (774)
T ss_pred             HHHHHHHHHhCcccccchhhhhceeccceE--EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhh
Confidence            999999999999999999999999998777  9999999999764   3332  22 234788888888   45677899


Q ss_pred             CCCeeEEEeec-CCCCccccccCcc-----cceeccCCC-CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         403 LSGVVVSTVDS-GSGGWWFESKSNI-----NLSFHYLPP-GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       403 s~g~~~~~~~~-g~~~~~~~~~~~~-----~~t~~y~~p-~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                      ++|++++|+-+ |.-||...+...+     .|.. .-.| .-|...+++-.--..-.-.+.|+|.++-
T Consensus       690 s~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  690 SFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             hhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            99999999988 9999987765432     2333 3333 5555555544333333444446665553

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.88  E-value=5.2e-23  Score=201.88  Aligned_cols=146  Identities=21%  Similarity=0.271  Sum_probs=116.0

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|++++++++||||+++++.+.++...|+||||+. |+|...+.... ..+++..+..++.|++.||+|||+.+++||
T Consensus        40 ~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  119 (277)
T cd05607          40 ALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR  119 (277)
T ss_pred             HHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEc
Confidence            4569999999999999999999999999999999998 56766664432 358888899999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||++..+....   ...                                       ...
T Consensus       120 dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~---~~~---------------------------------------~~~  155 (277)
T cd05607         120 DMKPENVLLDDQGN--CRLSDLGLAVELKDGK---TIT---------------------------------------QRA  155 (277)
T ss_pred             cCChHhEEEcCCCC--EEEeeceeeeecCCCc---eee---------------------------------------ccC
Confidence            99999999998776  9999999876543110   000                                       011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++..|++|        +.++|+||+|+++++|..|..|+.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~  195 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK  195 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            23333333        566799999999999999997754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=2.1e-23  Score=221.36  Aligned_cols=150  Identities=20%  Similarity=0.264  Sum_probs=118.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCC--------eEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHH
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRS--------TLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~--------~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      +.+|+.++..++|+||+++++.+...+        .+++||||+. |+|.+.+...   ...+++..+..++.|++.||.
T Consensus        78 ~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~  157 (496)
T PTZ00283         78 AQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH  157 (496)
T ss_pred             HHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            457999999999999999998875432        4789999998 7888877643   245889999999999999999


Q ss_pred             HhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         338 YCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       338 ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |||+++|+||||||+|||+++++.  +|++|||+++.+........                                  
T Consensus       158 ~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~~~----------------------------------  201 (496)
T PTZ00283        158 HVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSDDV----------------------------------  201 (496)
T ss_pred             HHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccccc----------------------------------
Confidence            999999999999999999998777  99999999875431110000                                  


Q ss_pred             ccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         418 WWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                           ....+||+.|++|        +..+|+||+|+++++|..|..|+-.
T Consensus       202 -----~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        202 -----GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             -----cccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence                 0113456666666        4567999999999999999877643

>KOG1152|consensus

Probab=99.88  E-value=8.9e-24  Score=213.82  Aligned_cols=151  Identities=22%  Similarity=0.265  Sum_probs=120.9

Q ss_pred             HHHHHHhhcC---CCCeeEEeeeeecCCeEEEEEeccC-C-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         272 REASLLKELK---HNNIVTLHDIVHTRSTLTFVFEYVH-T-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       272 rE~~il~~l~---HpnIV~l~~~~~~~~~~~iv~E~~~-g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .|++||..|+   |+||+++.++|+++++.||+||--. | +|++++..+ ..++|..+..+++||+.|+++||++||+|
T Consensus       615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivh  693 (772)
T KOG1152|consen  615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVH  693 (772)
T ss_pred             hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCcee
Confidence            3999999999   9999999999999999999999765 4 788888764 56999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccc-ccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC-HRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~-~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||-||+.++.+|-  +|++|||.|.....- -.-.+.+-+|.+|+++-++.+                          
T Consensus       694 rdikdenvivd~~g~--~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y--------------------------  745 (772)
T KOG1152|consen  694 RDIKDENVIVDSNGF--VKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKY--------------------------  745 (772)
T ss_pred             cccccccEEEecCCe--EEEeeccchhhhcCCCcceeeeeccccchhhhCCCcc--------------------------
Confidence            999999999998888  999999988633210 011123334444444333211                          


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                             .  |.|-|+|.+|++||.+.+...|+|+
T Consensus       746 -------~--gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  746 -------L--GKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -------C--CCcchhhhhhheeeEEEeccCCCcC
Confidence                   1  7788999999999999888877764

>KOG0599|consensus

Probab=99.88  E-value=1.1e-23  Score=196.14  Aligned_cols=122  Identities=22%  Similarity=0.396  Sum_probs=101.6

Q ss_pred             cccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          20 SKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        20 ~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ..+.+++|||.++|+||||||    +|||++.+    ..+||+|||+|...                           ..
T Consensus       131 qlfegVeylHa~~IVHRDLKp----ENILlddn----~~i~isDFGFa~~l---------------------------~~  175 (411)
T KOG0599|consen  131 QLFEGVEYLHARNIVHRDLKP----ENILLDDN----MNIKISDFGFACQL---------------------------EP  175 (411)
T ss_pred             HHHHHHHHHHHhhhhhcccCh----hheeeccc----cceEEeccceeecc---------------------------CC
Confidence            357789999999999999999    89999988    49999999999843                           33


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG-----STEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~-----~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                      |.--.-.||                      ||.|.|||.+..     .++|+..+|+||+|||+|.||.|.+||....+
T Consensus       176 GekLrelCG----------------------TPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ  233 (411)
T KOG0599|consen  176 GEKLRELCG----------------------TPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ  233 (411)
T ss_pred             chhHHHhcC----------------------CCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence            332233344                      999999998864     56799999999999999999999999998554


Q ss_pred             hHHHHHHHHHHhCCCCccCcccccC
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVSL  199 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~~  199 (481)
                      . -.|+.|.++-..+..+.|.+++.
T Consensus       234 m-lMLR~ImeGkyqF~speWadis~  257 (411)
T KOG0599|consen  234 M-LMLRMIMEGKYQFRSPEWADISA  257 (411)
T ss_pred             H-HHHHHHHhcccccCCcchhhccc
Confidence            3 67888888888888888888873

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.88  E-value=3.1e-23  Score=212.65  Aligned_cols=105  Identities=25%  Similarity=0.447  Sum_probs=92.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------------  317 (481)
                      .+.+|+++++.+ +|+|||++++++...+.+++|||||+ |+|.+++....                             
T Consensus        87 ~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (374)
T cd05106          87 ALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKY  166 (374)
T ss_pred             HHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccc
Confidence            466899999999 89999999999999999999999998 78888775421                             


Q ss_pred             ----------------------------------------CCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCcccccc
Q psy3074         318 ----------------------------------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS  357 (481)
Q Consensus       318 ----------------------------------------~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~  357 (481)
                                                              ..+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~  246 (374)
T cd05106         167 IRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT  246 (374)
T ss_pred             ccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe
Confidence                                                    1367778899999999999999999999999999999998


Q ss_pred             ccchhhHHHHHHHHHhhc
Q psy3074         358 EIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       358 ~~~~~~ikl~dfgla~~~  375 (481)
                      +++.  +|++|||+++.+
T Consensus       247 ~~~~--~kL~DfGla~~~  262 (374)
T cd05106         247 DGRV--AKICDFGLARDI  262 (374)
T ss_pred             CCCe--EEEeeceeeeec
Confidence            8776  999999998754

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0194|consensus

Probab=99.88  E-value=5.4e-23  Score=210.96  Aligned_cols=154  Identities=23%  Similarity=0.364  Sum_probs=130.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+++|+++|++++|||||++|++...+..+++|||+|. |+|.+++.+..+.++..+...++.+.+.||+|||++++||
T Consensus       206 ~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IH  285 (474)
T KOG0194|consen  206 KEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIH  285 (474)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcc
Confidence            457889999999999999999999999999999999999 6899999887767999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc-ccccC---ceeccccCCCcc---cccccccccCCCeeEEEeec-CCCCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS-YCHRR---RILHRDVKPQNL---LISEIVFTNLSGVVVSTVDS-GSGGW  418 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~-~~~~~---~i~~~d~~~~~i---l~~~~~~~~s~g~~~~~~~~-g~~~~  418 (481)
                      |||-.+|+|++..+.  +|++|||+++.-. |....   ++-.+|+.|+-+   +++...++|++|+.++|+-. |..||
T Consensus       286 RDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py  363 (474)
T KOG0194|consen  286 RDIAARNCLYSKKGV--VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY  363 (474)
T ss_pred             hhHhHHHheecCCCe--EEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence            999999999998776  8999999998654 33322   344566654432   24555678999999999999 88898


Q ss_pred             ccccc
Q psy3074         419 WFESK  423 (481)
Q Consensus       419 ~~~~~  423 (481)
                      .....
T Consensus       364 ~g~~~  368 (474)
T KOG0194|consen  364 PGMKN  368 (474)
T ss_pred             CCCCH
Confidence            86653

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.88  E-value=7e-23  Score=199.60  Aligned_cols=104  Identities=22%  Similarity=0.376  Sum_probs=93.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++..++..++||||++ |+|.+++......+++..+..++.|++.||+|||+++++||
T Consensus        52 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~  131 (266)
T cd05064          52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK  131 (266)
T ss_pred             HHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            46689999999999999999999999999999999998 56777776655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhh
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ||||+||+++.++.  ++++|||.+..
T Consensus       132 dikp~nili~~~~~--~~l~dfg~~~~  156 (266)
T cd05064         132 GLAAHKVLVNSDLV--CKISGFRRLQE  156 (266)
T ss_pred             cccHhhEEEcCCCc--EEECCCccccc
Confidence            99999999988776  88999986543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.88  E-value=1.3e-23  Score=231.90  Aligned_cols=153  Identities=27%  Similarity=0.389  Sum_probs=124.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|+.|+|||||+++++|..  ...+|||||||+ |+|..++...   .+.+++..++.++.||+.||.|||+.
T Consensus        58 ~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~  137 (1021)
T PTZ00266         58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNL  137 (1021)
T ss_pred             HHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            35679999999999999999999854  457999999998 6888887643   24689999999999999999999984


Q ss_pred             -------ceeeccCCCcccccccc---------------chhhHHHHHHHHHhhcccc--ccCceeccccCCCcccc---
Q psy3074         343 -------RILHRDVKPQNLLISEI---------------DHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLI---  395 (481)
Q Consensus       343 -------~iiHrDlKp~NiLl~~~---------------~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~---  395 (481)
                             +|+||||||+|||++..               +...+||+|||++..+...  ....+.+..|.||+++.   
T Consensus       138 g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~  217 (1021)
T PTZ00266        138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHET  217 (1021)
T ss_pred             ccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccC
Confidence                   49999999999999642               2234899999999866422  12234566788999874   


Q ss_pred             ---cccccccCCCeeEEEeecCCCCcccc
Q psy3074         396 ---SEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       396 ---~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                         +...|.||+||+++++++|..||...
T Consensus       218 ~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        218 KSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             CCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence               34568899999999999999999743

>KOG0695|consensus

Probab=99.88  E-value=6.3e-23  Score=195.72  Aligned_cols=142  Identities=26%  Similarity=0.379  Sum_probs=120.1

Q ss_pred             HHHHHhh-cCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         273 EASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       273 E~~il~~-l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      |-.+..+ -+||++|-|+.+|+++..+++|.||++ |+|...+.+ +..++++.++.|..+|+.||.|||++|||.||||
T Consensus       300 ek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlk  378 (593)
T KOG0695|consen  300 EKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLK  378 (593)
T ss_pred             hHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecc
Confidence            4444443 369999999999999999999999999 567666655 4579999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccccee
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSF  430 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~  430 (481)
                      .+|+|++..|+  ||+.|+|+++.-            ++|                             ....+.+|||+
T Consensus       379 ldnvlldaegh--ikltdygmcke~------------l~~-----------------------------gd~tstfcgtp  415 (593)
T KOG0695|consen  379 LDNVLLDAEGH--IKLTDYGMCKEG------------LGP-----------------------------GDTTSTFCGTP  415 (593)
T ss_pred             ccceEEccCCc--eeecccchhhcC------------CCC-----------------------------CcccccccCCC
Confidence            99999999999  999999998720            110                             11234589999


Q ss_pred             ccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         431 HYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       431 ~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      .|++|        |...|||.+|++|+||..|+-||
T Consensus       416 nyiapeilrgeeygfsvdwwalgvlmfemmagrspf  451 (593)
T KOG0695|consen  416 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF  451 (593)
T ss_pred             cccchhhhcccccCceehHHHHHHHHHHHHcCCCCc
Confidence            99999        88999999999999999998665

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.88  E-value=1.1e-22  Score=200.49  Aligned_cols=147  Identities=21%  Similarity=0.305  Sum_probs=117.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.++++++|+||+.+++.+.+.+.+|+||||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+++||
T Consensus        47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~  126 (285)
T cd05630          47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYR  126 (285)
T ss_pred             HHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeC
Confidence            4579999999999999999999999999999999998 56777664432 358899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++.+.  ++++|||++........   .                                       ....
T Consensus       127 dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~---------------------------------------~~~~  162 (285)
T cd05630         127 DLKPENILLDDHGH--IRISDLGLAVHVPEGQT---I---------------------------------------KGRV  162 (285)
T ss_pred             CCCHHHEEECCCCC--EEEeeccceeecCCCcc---c---------------------------------------cCCC
Confidence            99999999998776  99999998754321000   0                                       0012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |++.|++|        +..+|+||+|+++++|..|..|+..
T Consensus       163 g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         163 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             CCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            33444444        4567999999999999999977654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.88  E-value=3.4e-23  Score=204.01  Aligned_cols=127  Identities=41%  Similarity=0.715  Sum_probs=102.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                    
T Consensus       113 ~~i~~q-i~~aL~~lH~~~iiH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~--------------------  163 (290)
T cd07862         113 KDMMFQ-LLRGLDFLHSHRVVHRDLKP----QNILVTSS----GQIKLADFGLARIYSFQ--------------------  163 (290)
T ss_pred             HHHHHH-HHHHHHHHHHCCeeeCCCCH----HHEEEcCC----CCEEEccccceEeccCC--------------------
Confidence            444555 78899999999999999999    99999876    79999999999742110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|++||.+..
T Consensus       164 -------~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         164 -------MALTSVV----------------------VTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             -------ccccccc----------------------ccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence                   0011112                      389999999998765 9999999999999999999999999854


Q ss_pred             hhHHHHHHHHHHhCCCCccCcccccCC
Q psy3074         174 EVYDQLDKIFKILGTPTEETWEGVSLL  200 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~~~~~~  200 (481)
                      + .+.+.+|.+..+.|.++.|+....+
T Consensus       214 ~-~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         214 D-VDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             H-HHHHHHHHHHhCCCChhhchhhhcc
Confidence            4 4888999999999988888765443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=1.5e-22  Score=201.96  Aligned_cols=153  Identities=24%  Similarity=0.435  Sum_probs=116.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccCCCHHHHHHHh--------cCCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTDLSQYMERH--------SGGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~g~l~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.++||||+++++++..  +..++++|||+.+++.+.+...        ...+++..+..++.|++.||.|
T Consensus        44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  123 (317)
T cd07867          44 SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY  123 (317)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999853  5688999999999988877532        1247888899999999999999


Q ss_pred             hhcCceeeccCCCcccccccc--chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         339 CHRRRILHRDVKPQNLLISEI--DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~--~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      ||+++++||||||+|||+...  ....+|++|||+++.+.......                                  
T Consensus       124 lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~----------------------------------  169 (317)
T cd07867         124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL----------------------------------  169 (317)
T ss_pred             HHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccc----------------------------------
Confidence            999999999999999999432  22349999999987543111000                                  


Q ss_pred             CccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         417 GWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                          .......+|+.|++|         +..+|+||+|+++++|..|.+||.
T Consensus       170 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~  217 (317)
T cd07867         170 ----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  217 (317)
T ss_pred             ----cccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence                000112344455555         345799999999999999986654

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.88  E-value=6.6e-23  Score=210.32  Aligned_cols=105  Identities=26%  Similarity=0.450  Sum_probs=92.4

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------------  317 (481)
                      .+.+|+++|+.+ +|||||++++++.+.+..++|||||+ |+|.+++....                             
T Consensus        84 ~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (375)
T cd05104          84 ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCD  163 (375)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccch
Confidence            466899999999 89999999999999999999999998 78888875422                             


Q ss_pred             ---------------------------------------------CCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCc
Q psy3074         318 ---------------------------------------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ  352 (481)
Q Consensus       318 ---------------------------------------------~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~  352 (481)
                                                                   ..+++..+..++.|++.||.|||+++++||||||+
T Consensus       164 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  243 (375)
T cd05104         164 SLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAAR  243 (375)
T ss_pred             hhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchh
Confidence                                                         13667788899999999999999999999999999


Q ss_pred             cccccccchhhHHHHHHHHHhhc
Q psy3074         353 NLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       353 NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||++..+.  +|++|||+++.+
T Consensus       244 Nill~~~~~--~kl~DfG~a~~~  264 (375)
T cd05104         244 NILLTHGRI--TKICDFGLARDI  264 (375)
T ss_pred             hEEEECCCc--EEEecCccceec
Confidence            999987665  999999998754

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG1151|consensus

Probab=99.88  E-value=2.1e-23  Score=205.11  Aligned_cols=185  Identities=21%  Similarity=0.265  Sum_probs=144.7

Q ss_pred             CChhhHHHHHHHHhhcCCCCeeEEeeeee-cCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-
Q psy3074         265 GAPFTAIREASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-  342 (481)
Q Consensus       265 ~~~~~~~rE~~il~~l~HpnIV~l~~~~~-~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-  342 (481)
                      .....++||-+|.+.|+||.||++||+|. +.+..|-|+|||+|+.+++..++...+++..++.++.||+.||.||.+. 
T Consensus       509 NYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEik  588 (775)
T KOG1151|consen  509 NYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIK  588 (775)
T ss_pred             hHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccC
Confidence            34456889999999999999999999997 5567899999999876666666667799999999999999999999966 


Q ss_pred             -ceeeccCCCccccccc-cchhhHHHHHHHHHhhcc---c-------cccCceeccccCCCcccc--------ccccccc
Q psy3074         343 -RILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGLS---Y-------CHRRRILHRDVKPQNLLI--------SEIVFTN  402 (481)
Q Consensus       343 -~iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~---~-------~~~~~i~~~d~~~~~il~--------~~~~~~~  402 (481)
                       .|||-||||.|||+.+ .....|||.|||+++.++   |       +.+.+..+-||-||+.|+        +..+++|
T Consensus       589 pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVW  668 (775)
T KOG1151|consen  589 PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVW  668 (775)
T ss_pred             CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeE
Confidence             5999999999999843 223459999999999876   2       235566788999999884        3467889


Q ss_pred             CCCeeEEEeecCCCCcccccc-------CcccceeccCCCCCChhhhhhHHHHH
Q psy3074         403 LSGVVVSTVDSGSGGWWFESK-------SNINLSFHYLPPGAPFTAIREASLLK  449 (481)
Q Consensus       403 s~g~~~~~~~~g~~~~~~~~~-------~~~~~t~~y~~p~~p~~~~s~~~~l~  449 (481)
                      |.|++.+.++.|..||-..-.       ..|......-.|..|........++.
T Consensus       669 SvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIR  722 (775)
T KOG1151|consen  669 SVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIR  722 (775)
T ss_pred             eeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHH
Confidence            999999999999999975421       12333344455666655444444444

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=7.5e-23  Score=215.94  Aligned_cols=142  Identities=18%  Similarity=0.329  Sum_probs=104.9

Q ss_pred             HHHHHHhhcC------CCCeeEEeeeeecC-CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cc
Q psy3074         272 REASLLKELK------HNNIVTLHDIVHTR-STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RR  343 (481)
Q Consensus       272 rE~~il~~l~------HpnIV~l~~~~~~~-~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~  343 (481)
                      +|+++++.++      |.++++++++|... .++|+|||++.+++.+++... +.+++..+..++.|++.||.|||+ .+
T Consensus       174 ~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~g  252 (467)
T PTZ00284        174 IEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELH  252 (467)
T ss_pred             HHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4555555554      45689999998765 579999999999998888654 569999999999999999999997 59


Q ss_pred             eeeccCCCccccccccch--------------hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEE
Q psy3074         344 ILHRDVKPQNLLISEIDH--------------HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVS  409 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~--------------~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~  409 (481)
                      ||||||||+|||++..+.              ..+|++|||++....                                 
T Consensus       253 IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---------------------------------  299 (467)
T PTZ00284        253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---------------------------------  299 (467)
T ss_pred             eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---------------------------------
Confidence            999999999999976542              125666666443211                                 


Q ss_pred             EeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         410 TVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       410 ~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                                 .....++||+.|++|        +..+|+||+|++++||++|.+||
T Consensus       300 -----------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        300 -----------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             -----------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                       111224455566665        44568888888888888887655

>KOG0696|consensus

Probab=99.88  E-value=3.7e-23  Score=201.99  Aligned_cols=109  Identities=27%  Similarity=0.483  Sum_probs=95.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      ...||=|||++|||.||||-    +||+|+..    |++||+|||+++.                          .+-.|
T Consensus       459 iaigLFFLh~kgIiYRDLKL----DNvmLd~e----GHiKi~DFGmcKE--------------------------ni~~~  504 (683)
T KOG0696|consen  459 IAIGLFFLHSKGIIYRDLKL----DNVMLDSE----GHIKIADFGMCKE--------------------------NIFDG  504 (683)
T ss_pred             HHHHhhhhhcCCeeeeeccc----cceEeccC----CceEeeecccccc--------------------------cccCC
Confidence            67789999999999999999    89999887    8999999999984                          24445


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ..+.++||                      ||.|+|||++.-.+ |+.++||||+||++||||.|++||.|.++. +.++
T Consensus       505 ~TTkTFCG----------------------TPdYiAPEIi~YqP-YgksvDWWa~GVLLyEmlaGQpPFdGeDE~-elF~  560 (683)
T KOG0696|consen  505 VTTKTFCG----------------------TPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQ  560 (683)
T ss_pred             cceeeecC----------------------CCcccccceEEecc-cccchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHH
Confidence            56778998                      99999999999988 999999999999999999999999996554 7888


Q ss_pred             HHHHHhC
Q psy3074         181 KIFKILG  187 (481)
Q Consensus       181 ~i~~~~~  187 (481)
                      .|.+--.
T Consensus       561 aI~ehnv  567 (683)
T KOG0696|consen  561 AIMEHNV  567 (683)
T ss_pred             HHHHccC
Confidence            8877543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.88  E-value=1.1e-22  Score=200.33  Aligned_cols=147  Identities=20%  Similarity=0.289  Sum_probs=116.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+++|+.++|+||+.+++.+..++..+++|||+. +++...+.... ..+++..+..++.|++.||.|||+.+|+||
T Consensus        47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~  126 (285)
T cd05632          47 ALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYR  126 (285)
T ss_pred             HHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            4579999999999999999999999999999999998 56766665432 358999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||++..+......                                          ....
T Consensus       127 dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~------------------------------------------~~~~  162 (285)
T cd05632         127 DLKPENILLDDYGH--IRISDLGLAVKIPEGESI------------------------------------------RGRV  162 (285)
T ss_pred             CCCHHHEEECCCCC--EEEecCCcceecCCCCcc------------------------------------------cCCC
Confidence            99999999988776  999999988643211000                                          0011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+..|++|        +..+|+||+|+++++|..|..|+..
T Consensus       163 g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             CCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            23333333        4457999999999999999877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0584|consensus

Probab=99.87  E-value=9.5e-23  Score=209.10  Aligned_cols=149  Identities=23%  Similarity=0.349  Sum_probs=130.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCe--EEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC--
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRST--LTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR--  342 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~--~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~--  342 (481)
                      +++..|+++|+.|+|||||++|+++.+...  +.+|+|++. |+|..+++++ +..+...++.|++||+.||.|||++  
T Consensus        86 eR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~P  164 (632)
T KOG0584|consen   86 ERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDP  164 (632)
T ss_pred             HHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCC
Confidence            457789999999999999999999987654  899999998 8898888776 5688999999999999999999988  


Q ss_pred             ceeeccCCCcccccccc-chhhHHHHHHHHHhhccccccCc-eeccccCCCccc---ccccccccCCCeeEEEeecCCCC
Q psy3074         343 RILHRDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRR-ILHRDVKPQNLL---ISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~-i~~~d~~~~~il---~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      .|||||||.+||+++.+ |.  |||.|.|||.-+...|... |+|..+++|++.   +.|.+++.++|..+.+|.++.-|
T Consensus       165 PIIHRDLKCDNIFinG~~G~--VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYP  242 (632)
T KOG0584|consen  165 PIIHRDLKCDNIFVNGNLGE--VKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYP  242 (632)
T ss_pred             CccccccccceEEEcCCcCc--eeecchhHHHHhhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCC
Confidence            49999999999999743 55  9999999999998887766 667777777766   66777789999999999999999


Q ss_pred             cc
Q psy3074         418 WW  419 (481)
Q Consensus       418 ~~  419 (481)
                      |.
T Consensus       243 Ys  244 (632)
T KOG0584|consen  243 YS  244 (632)
T ss_pred             hh
Confidence            87

>KOG0032|consensus

Probab=99.87  E-value=9.8e-23  Score=207.29  Aligned_cols=128  Identities=29%  Similarity=0.468  Sum_probs=103.3

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.|+.|||+.||+||||||    +|+|+.......+.+|++|||+|...                        
T Consensus       139 ~~~~~-il~av~~lH~~gvvHrDlKp----EN~L~~~~~~~~~~ik~~DFGla~~~------------------------  189 (382)
T KOG0032|consen  139 GIIRQ-ILEAVKYLHSLGVVHRDLKP----ENLLLASKDEGSGRIKLIDFGLAKFI------------------------  189 (382)
T ss_pred             HHHHH-HHHHHHHHHhCCceeccCCH----HHeeeccccCCCCcEEEeeCCCceEc------------------------
Confidence            33333 78899999999999999999    89999887666679999999999842                        


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                         +.+......+|                      |+.|+|||++.+.. |+..+||||+||++|.|++|.+||.+.++
T Consensus       190 ---~~~~~~~~~~G----------------------tp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~  243 (382)
T KOG0032|consen  190 ---KPGERLHTIVG----------------------TPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLSGVPPFWGETE  243 (382)
T ss_pred             ---cCCceEeeecC----------------------CccccCchhhcCCC-CCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence               22333444555                      99999999999766 99999999999999999999999999755


Q ss_pred             hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      . ....+|.+.-..++.+.|+.++
T Consensus       244 ~-~~~~~i~~~~~~f~~~~w~~is  266 (382)
T KOG0032|consen  244 F-EIFLAILRGDFDFTSEPWDDIS  266 (382)
T ss_pred             h-HHHHHHHcCCCCCCCCCccccC
Confidence            4 4455666666667777777765

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.87  E-value=1.4e-22  Score=201.41  Aligned_cols=106  Identities=25%  Similarity=0.451  Sum_probs=93.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------------------CCCChHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------------------GGLDHHNIRLF  328 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------------------~~l~~~~~~~~  328 (481)
                      ..+.+|+.+|++++||||+++++++.+.+..++||||+. |+|.+++....                  ..+++..+..+
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  143 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV  143 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence            356789999999999999999999999999999999998 67887775421                  13566778899


Q ss_pred             HHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       329 ~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +.|++.||.|||+.+++||||||+|||++.++.  +|++|||+++.+
T Consensus       144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~  188 (304)
T cd05096         144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNL  188 (304)
T ss_pred             HHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceec
Confidence            999999999999999999999999999998776  999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=99.87  E-value=2e-23  Score=205.74  Aligned_cols=199  Identities=14%  Similarity=0.135  Sum_probs=145.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-C
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-R  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~  342 (481)
                      .+.+|+.+|++++|||||++++++.+    ...+++|||||+ |+|.+++... +.+++.....++.|++.||.|||+ .
T Consensus        64 ~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~  142 (283)
T PHA02988         64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYT  142 (283)
T ss_pred             HHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcC
Confidence            45689999999999999999999876    457899999999 5688877653 568888999999999999999997 4


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccc------cccccccCCCeeEEEeecCCC
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI------SEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~------~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      +++||||||+|||+++++.  +|++|||+++.+.......+.+..+.||+++.      +...+.||+|++++++.+|..
T Consensus       143 ~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~  220 (283)
T PHA02988        143 NKPYKNLTSVSFLVTENYK--LKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI  220 (283)
T ss_pred             CCCCCcCChhhEEECCCCc--EEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence            8999999999999998877  99999999987654333344455677888774      345678999999999999999


Q ss_pred             CccccccCcc---cceeccCCCCCC-hhhhhhHHHHHHhhCCC---ccccccccccCceeEE
Q psy3074         417 GWWFESKSNI---NLSFHYLPPGAP-FTAIREASLLKELKHNN---IVTLHDIVHTRSTLTF  471 (481)
Q Consensus       417 ~~~~~~~~~~---~~t~~y~~p~~p-~~~~s~~~~l~~l~~~~---~~~~~~~~~~~~~~~~  471 (481)
                      ||...+...+   ....... +..| .....+..++..++..+   .|++.++...++++.+
T Consensus       221 Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        221 PFENLTTKEIYDLIINKNNS-LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCHHHHHHHHHhcCCC-CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            9986542211   1001111 1111 12234556666666543   3566666555554433

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=1.1e-22  Score=216.20  Aligned_cols=152  Identities=18%  Similarity=0.217  Sum_probs=119.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc----CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS----GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ..+.+|+.+|+.++|||||++++++...+..|++||++.+++..++....    .......++.++.|++.||.|||+++
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g  287 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK  287 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678999999999999999999999999999999999999888775422    12345667889999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+++.+.......                                        .
T Consensus       288 IiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~----------------------------------------~  325 (501)
T PHA03210        288 LIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKEREAF----------------------------------------D  325 (501)
T ss_pred             eecCCCCHHHEEECCCCC--EEEEeCCCceecCcccccc----------------------------------------c
Confidence            999999999999998777  9999999987543110000                                        0


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...+||+.|++|        +...|+||+|++++||+.+..+++.+
T Consensus       326 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        326 YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence            012344444444        45579999999999999887666643

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.87  E-value=1.3e-22  Score=197.38  Aligned_cols=103  Identities=27%  Similarity=0.446  Sum_probs=92.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++.+...+..|++|||++ ++|.+++.. .+.+++..+..++.|++.|+.|||+.+++|||
T Consensus        53 ~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  131 (267)
T cd06645          53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRD  131 (267)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            4579999999999999999999999999999999998 577776654 45799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||+||+++..+.  ++++|||++..+
T Consensus       132 lkp~nili~~~~~--~~l~dfg~~~~~  156 (267)
T cd06645         132 IKGANILLTDNGH--VKLADFGVSAQI  156 (267)
T ss_pred             CCHHHEEECCCCC--EEECcceeeeEc
Confidence            9999999988776  999999987644

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0690|consensus

Probab=99.87  E-value=2.1e-23  Score=198.41  Aligned_cols=117  Identities=26%  Similarity=0.453  Sum_probs=98.3

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ..-+..++||.|||+++||.||||-    +|+||+.+    |++||+|||||+.                          
T Consensus       272 FYGaEIvsAL~YLHs~~ivYRDlKL----ENLlLDkD----GHIKitDFGLCKE--------------------------  317 (516)
T KOG0690|consen  272 FYGAEIVSALGYLHSRNIVYRDLKL----ENLLLDKD----GHIKITDFGLCKE--------------------------  317 (516)
T ss_pred             hhhHHHHHHhhhhhhCCeeeeechh----hhheeccC----CceEeeecccchh--------------------------
Confidence            3344578999999999999999999    89999987    8999999999984                          


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                      .+..|.-+.++||                      ||.|.|||||.... |+.++|||.+||++|||+||+.||... +.
T Consensus       318 ~I~~g~t~kTFCG----------------------TPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmCGRLPFyn~-dh  373 (516)
T KOG0690|consen  318 EIKYGDTTKTFCG----------------------TPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMCGRLPFYNK-DH  373 (516)
T ss_pred             cccccceeccccC----------------------ChhhcCchhhcccc-ccceeehhhhhHHHHHHHhccCccccc-ch
Confidence            3566777788998                      99999999999876 999999999999999999999999984 44


Q ss_pred             HHHHHHHHHH-hCCCC
Q psy3074         176 YDQLDKIFKI-LGTPT  190 (481)
Q Consensus       176 ~~~l~~i~~~-~~~p~  190 (481)
                      ...++.|... +..|.
T Consensus       374 ~kLFeLIl~ed~kFPr  389 (516)
T KOG0690|consen  374 EKLFELILMEDLKFPR  389 (516)
T ss_pred             hHHHHHHHhhhccCCc
Confidence            4566666543 34443

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.87  E-value=1.9e-22  Score=200.93  Aligned_cols=105  Identities=34%  Similarity=0.630  Sum_probs=94.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|+.++++++|+||+++++++...  +.+++||||+.+++..++......+++..+..++.|++.||.|||+.+++||
T Consensus        53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (309)
T cd07845          53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHR  132 (309)
T ss_pred             hhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            45699999999999999999999765  5789999999999888887655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++.+.  +|++|||++..+.
T Consensus       133 dl~p~nil~~~~~~--~kL~dfg~~~~~~  159 (309)
T cd07845         133 DLKVSNLLLTDKGC--LKIADFGLARTYG  159 (309)
T ss_pred             CCCHHHEEECCCCC--EEECccceeeecC
Confidence            99999999998776  9999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.87  E-value=2.6e-22  Score=196.89  Aligned_cols=105  Identities=36%  Similarity=0.701  Sum_probs=95.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.++++++||||+++++++......++||||+++++...+......+++..+..++.|++.||.|||+.+++||||
T Consensus        47 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl  126 (286)
T cd07847          47 ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDV  126 (286)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence            45799999999999999999999999999999999998777666555567999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+||++++++.  ++++|||++..+.
T Consensus       127 ~p~nil~~~~~~--~~l~dfg~~~~~~  151 (286)
T cd07847         127 KPENILITKQGQ--IKLCDFGFARILT  151 (286)
T ss_pred             ChhhEEEcCCCc--EEECccccceecC
Confidence            999999998876  9999999887553

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0193|consensus

Probab=99.87  E-value=5.5e-24  Score=216.96  Aligned_cols=168  Identities=17%  Similarity=0.205  Sum_probs=131.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ++|.+|+.++++-+|.||+-+++++..+.. .||+.+|+| +|+.++......|+...++.|++||+.||.|||.++|||
T Consensus       433 qaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIH  511 (678)
T KOG0193|consen  433 QAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIH  511 (678)
T ss_pred             HHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence            357789999999999999999999998877 999999997 688888776677999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc-cCc--e--eccccCCCcccc-------cccccccCCCeeEEEeecC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRR--I--LHRDVKPQNLLI-------SEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-~~~--i--~~~d~~~~~il~-------~~~~~~~s~g~~~~~~~~g  414 (481)
                      ||||..||++.+++.  |||.||||+..-.-.. ..+  .  ..--+.+||++-       +...|+.++|++.||+++|
T Consensus       512 rDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg  589 (678)
T KOG0193|consen  512 RDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG  589 (678)
T ss_pred             hhccccceEEccCCc--EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence            999999999998766  9999999987332111 111  1  111244555553       2333457889999999999


Q ss_pred             CCCccccccCc--ccceeccCCCCCC
Q psy3074         415 SGGWWFESKSN--INLSFHYLPPGAP  438 (481)
Q Consensus       415 ~~~~~~~~~~~--~~~t~~y~~p~~p  438 (481)
                      ..||.......  ++...+|+.|...
T Consensus       590 ~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  590 ELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             cCCcCCCChhheEEEecccccCccch
Confidence            99999543333  3566778877443

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.87  E-value=1.2e-22  Score=202.68  Aligned_cols=137  Identities=32%  Similarity=0.645  Sum_probs=104.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||+.+|+||||||    +|||+.......|.+||+|||+|+.......                   
T Consensus       112 ~i~~q-i~~aL~~lH~~~ivH~Dlkp----~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~-------------------  167 (317)
T cd07867         112 SLLYQ-ILDGIHYLHANWVLHRDLKP----ANILVMGEGPERGRVKIADMGFARLFNSPLK-------------------  167 (317)
T ss_pred             HHHHH-HHHHHHHHHhCCEEcCCCCH----HHEEEccCCCCCCcEEEeeccceeccCCCcc-------------------
Confidence            33444 77899999999999999999    8999965545568999999999985321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          .....                      ....+|+.|+|||++.+...++.++||||+||++|||++|++||.+..+
T Consensus       168 ----~~~~~----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~  221 (317)
T cd07867         168 ----PLADL----------------------DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  221 (317)
T ss_pred             ----ccccc----------------------CcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccc
Confidence                00000                      0112389999999998877799999999999999999999999976432


Q ss_pred             --------hHHHHHHHHHHhCCCCccCcccccCCC
Q psy3074         175 --------VYDQLDKIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       175 --------~~~~l~~i~~~~~~p~~~~~~~~~~~~  201 (481)
                              ...++..+...++.|..+.|+.....+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (317)
T cd07867         222 DIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMP  256 (317)
T ss_pred             cccccccccHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence                    235788899999999999998776544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG4257|consensus

Probab=99.87  E-value=6.8e-23  Score=208.74  Aligned_cols=200  Identities=20%  Similarity=0.285  Sum_probs=151.1

Q ss_pred             CCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       264 ~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ....+.++.|+.+|++++|||||+|.+++.+. .+|||||+++ |.|..++...+..++...+..|+.||+.||.|||+.
T Consensus       432 ~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk  510 (974)
T KOG4257|consen  432 PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK  510 (974)
T ss_pred             hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh
Confidence            33456789999999999999999999999865 5899999999 999999999888899999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccc---cccC-ceec-cccCCCccc---ccccccccCCCeeEEEeec-
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY---CHRR-RILH-RDVKPQNLL---ISEIVFTNLSGVVVSTVDS-  413 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~---~~~~-~i~~-~d~~~~~il---~~~~~~~~s~g~~~~~~~~-  413 (481)
                      +++||||..+|||+.+..-  +|++|||++|.+++   .+.. .-+. .|+.|+.|-   ++...++|.+|+.+++++. 
T Consensus       511 rfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~l  588 (974)
T KOG4257|consen  511 RFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSL  588 (974)
T ss_pred             chhhhhhhhhheeecCcce--eeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHh
Confidence            9999999999999998887  99999999998873   2222 1111 244454444   3555678999999988776 


Q ss_pred             CCCCccccccCccccee-----ccCCCCCChhhhhhHHHHHHhhCCCccccccccccC
Q psy3074         414 GSGGWWFESKSNINLSF-----HYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTR  466 (481)
Q Consensus       414 g~~~~~~~~~~~~~~t~-----~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~  466 (481)
                      |..||.....+.+.|..     .=++|.=|...+++-.-...----+.|.|..+....
T Consensus       589 GvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~l  646 (974)
T KOG4257|consen  589 GVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAIL  646 (974)
T ss_pred             cCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence            99999988766654443     334455555444443333333333335555444433

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.87  E-value=3.8e-23  Score=211.05  Aligned_cols=119  Identities=35%  Similarity=0.634  Sum_probs=97.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                           .
T Consensus       135 i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~DfG~a~~~~~---------------------------~  179 (364)
T cd07875         135 MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAGT---------------------------S  179 (364)
T ss_pred             HHHHHHHHhhCCeecCCCCH----HHEEECCC----CcEEEEeCCCccccCC---------------------------C
Confidence            67899999999999999999    89999876    7999999999984211                           0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+                      .+|+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+ ..+.+.
T Consensus       180 ~~~~~~----------------------~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~  235 (364)
T cd07875         180 FMMTPY----------------------VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTD-HIDQWN  235 (364)
T ss_pred             CcccCC----------------------cccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCC-HHHHHH
Confidence            000111                      2389999999998765 9999999999999999999999999854 458889


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      ++.+.++.|.++.++...
T Consensus       236 ~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         236 KVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             HHHHhcCCCCHHHHHhhh
Confidence            999999999877665554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0588|consensus

Probab=99.87  E-value=6.6e-23  Score=210.80  Aligned_cols=120  Identities=22%  Similarity=0.345  Sum_probs=97.1

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      |++.++.-++.-.- .+.|++|||+.+|.||||||    +|+||+..    +.|||+|||+|..                
T Consensus       107 G~l~e~eaa~ff~Q-Ii~gv~yCH~~~icHRDLKp----ENlLLd~~----~nIKIADFGMAsL----------------  161 (786)
T KOG0588|consen  107 GPLPEREAAHFFRQ-ILDGVSYCHAFNICHRDLKP----ENLLLDVK----NNIKIADFGMASL----------------  161 (786)
T ss_pred             CCCCCHHHHHHHHH-HHHHHHHHhhhcceeccCCc----hhhhhhcc----cCEeeeccceeec----------------
Confidence            44444444444444 57789999999999999999    89999987    5799999999973                


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                 --.|..-.+.||                      +|-|.|||++.|.+..+.++||||+|||+|-||+|
T Consensus       162 -----------e~~gklLeTSCG----------------------SPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG  208 (786)
T KOG0588|consen  162 -----------EVPGKLLETSCG----------------------SPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG  208 (786)
T ss_pred             -----------ccCCccccccCC----------------------CcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence                       124566778888                      99999999999999888999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~  184 (481)
                      +.||.+ +++-..|.++.+
T Consensus       209 ~LPFdD-dNir~LLlKV~~  226 (786)
T KOG0588|consen  209 KLPFDD-DNIRVLLLKVQR  226 (786)
T ss_pred             CCCCCC-ccHHHHHHHHHc
Confidence            999996 344455555544

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.87  E-value=3.2e-22  Score=194.58  Aligned_cols=103  Identities=28%  Similarity=0.434  Sum_probs=92.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.++++++||||+++++++...+..|+||||++ ++|.+.+.. .+.+++..+..++.|++.||.|||+.+|+|||
T Consensus        53 ~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  131 (267)
T cd06646          53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRD  131 (267)
T ss_pred             HHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            4579999999999999999999999999999999998 567776654 45689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +||+||++++++.  ++++|||++..+
T Consensus       132 l~p~nill~~~~~--~~l~dfg~~~~~  156 (267)
T cd06646         132 IKGANILLTDNGD--VKLADFGVAAKI  156 (267)
T ss_pred             CCHHHEEECCCCC--EEECcCccceee
Confidence            9999999988776  999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.87  E-value=4.6e-22  Score=199.99  Aligned_cols=103  Identities=22%  Similarity=0.284  Sum_probs=91.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++.++|||||++++++..++..|+||||++ |++.+++..+ ...+++..+..++.|++.||.|||+++|+||
T Consensus        46 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~  125 (327)
T cd08227          46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR  125 (327)
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            4569999999999999999999999999999999998 6777777654 3458999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhh
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ||||+|||++.++.  +++.||+.+..
T Consensus       126 dlkp~Nil~~~~~~--~~l~~~~~~~~  150 (327)
T cd08227         126 SVKASHILISVDGK--VYLSGLRSNLS  150 (327)
T ss_pred             CCChhhEEEecCCc--EEEcccchhhc
Confidence            99999999988776  88888876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0983|consensus

Probab=99.87  E-value=1.1e-22  Score=189.59  Aligned_cols=107  Identities=23%  Similarity=0.439  Sum_probs=88.1

Q ss_pred             ccccHHHHH-HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          21 KLLDADIAE-ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        21 ~~~~~~~lh-~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      .+.||+||- ++||||||+||    +|||++..    |.+||||||++.......                         
T Consensus       200 ~v~AL~YLKeKH~viHRDvKP----SNILlDe~----GniKlCDFGIsGrlvdSk-------------------------  246 (391)
T KOG0983|consen  200 IVKALYYLKEKHGVIHRDVKP----SNILLDER----GNIKLCDFGISGRLVDSK-------------------------  246 (391)
T ss_pred             HHHHHHHHHHhcceeecccCc----cceEEccC----CCEEeecccccceeeccc-------------------------
Confidence            578999998 66999999999    99999877    899999999996542211                         


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                         +.+                     -..|++.|||||.+--  ...|+..+||||||+.++||.||+.||+|-+...+
T Consensus       247 ---Aht---------------------rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe  302 (391)
T KOG0983|consen  247 ---AHT---------------------RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE  302 (391)
T ss_pred             ---ccc---------------------cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH
Confidence               011                     1124999999999854  35699999999999999999999999999887888


Q ss_pred             HHHHHHH
Q psy3074         178 QLDKIFK  184 (481)
Q Consensus       178 ~l~~i~~  184 (481)
                      .+.+|..
T Consensus       303 ~ltkvln  309 (391)
T KOG0983|consen  303 VLTKVLN  309 (391)
T ss_pred             HHHHHHh
Confidence            8888876

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.87  E-value=4.2e-22  Score=196.68  Aligned_cols=104  Identities=26%  Similarity=0.359  Sum_probs=92.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+..++..|+||||++| ++...+......+++..+..++.|++.++.|||+.+++||
T Consensus        55 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~  134 (292)
T cd06644          55 DYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR  134 (292)
T ss_pred             HHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeec
Confidence            356799999999999999999999999999999999995 5655555555678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhh
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ||||+||+++.++.  ++++|||++..
T Consensus       135 dlkp~Nili~~~~~--~kl~dfg~~~~  159 (292)
T cd06644         135 DLKAGNVLLTLDGD--IKLADFGVSAK  159 (292)
T ss_pred             CCCcceEEEcCCCC--EEEccCcccee
Confidence            99999999987776  99999998764

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.87  E-value=2.8e-22  Score=197.95  Aligned_cols=106  Identities=35%  Similarity=0.568  Sum_probs=96.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++||||+++++++...  +..|+||||+.+++...+......+++..+..++.|++.||+|||+.+++|
T Consensus        50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H  129 (293)
T cd07843          50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILH  129 (293)
T ss_pred             hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            356799999999999999999999877  899999999999998888766566899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +||||+||++++.+.  ++++|||++..+.
T Consensus       130 ~dl~p~nili~~~~~--~~l~d~g~~~~~~  157 (293)
T cd07843         130 RDLKTSNLLLNNRGI--LKICDFGLAREYG  157 (293)
T ss_pred             ccCCHHHEEECCCCc--EEEeecCceeecc
Confidence            999999999998877  9999999887544

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.87  E-value=3.4e-22  Score=199.88  Aligned_cols=105  Identities=22%  Similarity=0.445  Sum_probs=94.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++... ..++++||+. |++.+++......+++..+..++.|++.||+|||+++|+||
T Consensus        55 ~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~  133 (316)
T cd05108          55 EILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHR  133 (316)
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence            466799999999999999999998765 5789999998 78988888766678889999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+|||+++++.  +|++|||+++.+.
T Consensus       134 dlkp~Nill~~~~~--~kl~DfG~a~~~~  160 (316)
T cd05108         134 DLAARNVLVKTPQH--VKITDFGLAKLLG  160 (316)
T ss_pred             ccchhheEecCCCc--EEEcccccccccc
Confidence            99999999988777  9999999998654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0196|consensus

Probab=99.87  E-value=1.3e-22  Score=211.58  Aligned_cols=165  Identities=21%  Similarity=0.320  Sum_probs=143.8

Q ss_pred             CCCCCCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHH
Q psy3074         260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       260 ~~~~~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .|-.++.+.+|+.|+.||.+.+||||++|-++......+.||.|||+ |.|..+|+.+.+.|+..++.-.++.|+.||.|
T Consensus       667 ~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkY  746 (996)
T KOG0196|consen  667 AGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKY  746 (996)
T ss_pred             cCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHH
Confidence            33345566778999999999999999999999999999999999998 99999999999999999999999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccc-------cCceeccccCCCccc---ccccccccCCCeeE
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-------RRRILHRDVKPQNLL---ISEIVFTNLSGVVV  408 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-------~~~i~~~d~~~~~il---~~~~~~~~s~g~~~  408 (481)
                      |.+++.+||||..+|||++++-.  +|+.|||++|.++...       ..+|--||..|+.|-   ++...++||+|+++
T Consensus       747 Lsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVm  824 (996)
T KOG0196|consen  747 LSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM  824 (996)
T ss_pred             HhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEE
Confidence            99999999999999999998877  9999999999875222       234556788888776   56777899999999


Q ss_pred             EEeec-CCCCccccccCcc
Q psy3074         409 STVDS-GSGGWWFESKSNI  426 (481)
Q Consensus       409 ~~~~~-g~~~~~~~~~~~~  426 (481)
                      +|+++ |..|||..+.+.+
T Consensus       825 WEVmSyGERPYWdmSNQdV  843 (996)
T KOG0196|consen  825 WEVMSYGERPYWDMSNQDV  843 (996)
T ss_pred             EEecccCCCcccccchHHH
Confidence            99887 9999998775543

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=2.2e-22  Score=197.28  Aligned_cols=105  Identities=28%  Similarity=0.412  Sum_probs=94.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++.+..+...|+||||++ +++..++......+++..+..++.|++.||.|||+++++|+
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~  127 (280)
T cd06611          48 DFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR  127 (280)
T ss_pred             HHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            35679999999999999999999999999999999998 57777776655679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  ++++|||++...
T Consensus       128 dl~p~nili~~~~~--~~l~d~g~~~~~  153 (280)
T cd06611         128 DLKAGNILLTLDGD--VKLADFGVSAKN  153 (280)
T ss_pred             CCChhhEEECCCCC--EEEccCccchhh
Confidence            99999999988777  999999987654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.87  E-value=2.7e-22  Score=196.85  Aligned_cols=143  Identities=18%  Similarity=0.277  Sum_probs=114.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.++++++||||+++++.+...+..++||||++++.+...    ..+++..+..++.|++.||.|||+.+++|+|
T Consensus        45 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d  120 (279)
T cd06619          45 QIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD  120 (279)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCC
Confidence            456799999999999999999999999999999999996543322    2478888999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+||+++.++.  ++++|||++..+......                                           ..++
T Consensus       121 lkp~Nill~~~~~--~~l~dfg~~~~~~~~~~~-------------------------------------------~~~~  155 (279)
T cd06619         121 VKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIAK-------------------------------------------TYVG  155 (279)
T ss_pred             CCHHHEEECCCCC--EEEeeCCcceeccccccc-------------------------------------------CCCC
Confidence            9999999998877  999999998754311000                                           0112


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |..|++|        +..+|+|++|+++++|..|..|+..
T Consensus       156 ~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             ChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence            3333333        4568999999999999999877643

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.87  E-value=3.6e-22  Score=199.03  Aligned_cols=153  Identities=21%  Similarity=0.280  Sum_probs=116.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiH  346 (481)
                      .+.+|++++++++||||+++++++.+++.+|++|||++ ++|.+++... +.+++..+..++.|++.||.|||+ .+++|
T Consensus        45 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H  123 (308)
T cd06615          45 QIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMH  123 (308)
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEE
Confidence            35679999999999999999999999999999999998 5777777653 668999999999999999999997 59999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||++..+.......                             ..|...|...+.  .
T Consensus       124 ~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~-----------------------------~~~~~~~~aPE~--~  170 (308)
T cd06615         124 RDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANS-----------------------------FVGTRSYMSPER--L  170 (308)
T ss_pred             CCCChHHEEEecCCc--EEEccCCCccccccccccc-----------------------------CCCCcCccChhH--h
Confidence            999999999998777  9999999876432110000                             001111111100  0


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .+    ...+...|+|++|+++++|..|..|+.
T Consensus       171 ~~----~~~~~~~DiwslG~~l~~l~~g~~p~~  199 (308)
T cd06615         171 QG----THYTVQSDIWSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             cC----CCCCccchHHHHHHHHHHHHhCCCCCC
Confidence            00    012456899999999999999997764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.86  E-value=6.6e-23  Score=208.85  Aligned_cols=117  Identities=35%  Similarity=0.610  Sum_probs=95.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                           
T Consensus       132 i~~~L~~LH~~~ivHrDlkp----~NIl~~~~----~~~kl~Dfg~a~~~~~~---------------------------  176 (359)
T cd07876         132 MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTACTN---------------------------  176 (359)
T ss_pred             HHHHHHHHHhCCcccCCCCH----HHEEECCC----CCEEEecCCCccccccC---------------------------
Confidence            78899999999999999999    89999876    79999999999742110                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....                      ..+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+. +..+++.
T Consensus       177 ~~~~~----------------------~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~-~~~~~~~  232 (359)
T cd07876         177 FMMTP----------------------YVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGT-DHIDQWN  232 (359)
T ss_pred             ccCCC----------------------CcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            00001                      12389999999998765 999999999999999999999999985 4457888


Q ss_pred             HHHHHhCCCCccCccc
Q psy3074         181 KIFKILGTPTEETWEG  196 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~  196 (481)
                      .+.+.++.|..+.+..
T Consensus       233 ~~~~~~~~~~~~~~~~  248 (359)
T cd07876         233 KVIEQLGTPSAEFMNR  248 (359)
T ss_pred             HHHHhcCCCcHHHHHH
Confidence            8888888887765444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.86  E-value=7.6e-22  Score=193.53  Aligned_cols=105  Identities=52%  Similarity=0.965  Sum_probs=95.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc--CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS--GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.++++++||||+++++++.+.+..++||||+++++..++....  ..+++..+..++.|++.||.|||+.+++||
T Consensus        45 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~  124 (284)
T cd07836          45 AIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR  124 (284)
T ss_pred             HHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence            457999999999999999999999999999999999999888876543  458999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  ++++|||++..+.
T Consensus       125 dl~p~ni~~~~~~~--~~l~d~g~~~~~~  151 (284)
T cd07836         125 DLKPQNLLINKRGE--LKLADFGLARAFG  151 (284)
T ss_pred             CCCHHHEEECCCCc--EEEeecchhhhhc
Confidence            99999999998777  9999999987543

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.86  E-value=1.5e-22  Score=201.72  Aligned_cols=125  Identities=58%  Similarity=1.026  Sum_probs=101.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                         
T Consensus       113 i~~aL~~lH~~~ivH~dlkp----~Nill~~~----~~~kl~Dfg~~~~~~~~~~-------------------------  159 (309)
T cd07872         113 ILRGLAYCHRRKVLHRDLKP----QNLLINER----GELKLADFGLARAKSVPTK-------------------------  159 (309)
T ss_pred             HHHHHHHHHHCCeecCCCCH----HHEEECCC----CCEEECccccceecCCCcc-------------------------
Confidence            77899999999999999999    89999876    7999999999974221100                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .. .                      ...+|+.|+|||++.+...++.++||||+||++|||++|++||.+. +..+.+.
T Consensus       160 ~~-~----------------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~-~~~~~~~  215 (309)
T cd07872         160 TY-S----------------------NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS-TVEDELH  215 (309)
T ss_pred             cc-c----------------------cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-ChHHHHH
Confidence            00 0                      0113889999999987767999999999999999999999999984 4457888


Q ss_pred             HHHHHhCCCCccCcccccCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                      .+.+.++.|..+.|+.+.....
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         216 LIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             HHHHHhCCCCHHHHhhhcchhh
Confidence            9999999999999987765433

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.86  E-value=3.5e-22  Score=203.11  Aligned_cols=144  Identities=23%  Similarity=0.411  Sum_probs=113.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||++++++|...      ...|+||||+.+++.+.+...   +++..+..++.|++.||+|||++
T Consensus        61 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~  137 (353)
T cd07850          61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA  137 (353)
T ss_pred             HHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC
Confidence            355799999999999999999998644      357999999999988877542   88999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +++||||||+||+++.++.  +|++|||+++........   .                                     
T Consensus       138 gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~---~-------------------------------------  175 (353)
T cd07850         138 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMM---T-------------------------------------  175 (353)
T ss_pred             CeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCCCC---C-------------------------------------
Confidence            9999999999999998877  999999998754311000   0                                     


Q ss_pred             cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                        ...++..|++|        +...|+|++|+++++|..|..|+-
T Consensus       176 --~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~  218 (353)
T cd07850         176 --PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP  218 (353)
T ss_pred             --CCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence              01122223333        456799999999999999987653

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.86  E-value=1e-21  Score=193.93  Aligned_cols=106  Identities=47%  Similarity=0.833  Sum_probs=92.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++||||+++++++.+.+..|+||||+++++.+.+..... .+++..+..++.|++.||+|||+++++||
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~  126 (294)
T PLN00009         47 TAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHR  126 (294)
T ss_pred             HHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            35679999999999999999999999999999999999888887765433 35788888999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++..+ ..+|++|||++..+
T Consensus       127 dl~p~nill~~~~-~~~kl~dfg~~~~~  153 (294)
T PLN00009        127 DLKPQNLLIDRRT-NALKLADFGLARAF  153 (294)
T ss_pred             CCCcceEEEECCC-CEEEEccccccccc
Confidence            9999999997533 23899999998754

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.86  E-value=1.8e-22  Score=198.10  Aligned_cols=184  Identities=19%  Similarity=0.155  Sum_probs=137.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..|+||||+++ ++...+....+.+++..+..++.|++.||.|||+.+++||
T Consensus        48 ~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~  127 (282)
T cd06643          48 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR  127 (282)
T ss_pred             HHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            356799999999999999999999999999999999984 5655555545678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccc---------cccccccCCCeeEEEeecCC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLI---------SEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~---------~~~~~~~s~g~~~~~~~~g~  415 (481)
                      ||||+||+++.++.  +|++|||++.......   .....+..|.+|+++.         +...+.|+.|++++++.+|.
T Consensus       128 dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~  205 (282)
T cd06643         128 DLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE  205 (282)
T ss_pred             CCCcccEEEccCCC--EEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC
Confidence            99999999988777  9999999987543211   1122333467777663         23577899999999999999


Q ss_pred             CCccccccCcc-----cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         416 GGWWFESKSNI-----NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       416 ~~~~~~~~~~~-----~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      +||...+....     .....-+ +.......++..++..++..+
T Consensus       206 ~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~  249 (282)
T cd06643         206 PPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSEFKDFLKKCLEKN  249 (282)
T ss_pred             CCccccCHHHHHHHHhhcCCCCC-CCccccCHHHHHHHHHHccCC
Confidence            99875432111     1111100 111111235677888888766

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=8.2e-22  Score=190.97  Aligned_cols=151  Identities=23%  Similarity=0.322  Sum_probs=117.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+++.++++|||++ +++.+.+... +.+++..+..++.|++.|+.|||+.+++||
T Consensus        50 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  128 (263)
T cd06625          50 ALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHR  128 (263)
T ss_pred             HHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            35679999999999999999999999999999999998 5677776553 568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||+++.+........                              +        .....
T Consensus       129 dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~------------------------------~--------~~~~~  168 (263)
T cd06625         129 DIKGANILRDSAGN--VKLGDFGASKRLQTICSSGT------------------------------G--------MKSVT  168 (263)
T ss_pred             CCCHHHEEEcCCCC--EEEeecccceeccccccccc------------------------------c--------ccCCC
Confidence            99999999998776  99999998865431110000                              0        00011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++..|++|        +..+|+|++|+++++|.+|..|+..
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             cCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            23333333        4667999999999999999866543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.86  E-value=1e-21  Score=190.93  Aligned_cols=150  Identities=22%  Similarity=0.290  Sum_probs=116.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|++++++++||||+++++++.+.  ..++++|||++ ++|.+++... ..+++..+..++.|++.||.|||+++++
T Consensus        50 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~  128 (265)
T cd06652          50 ALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIV  128 (265)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            356799999999999999999998763  57899999998 5787777654 4588888999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |+||||+||+++.++.  ++++|||+++.+......        ..                              ....
T Consensus       129 H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~--------~~------------------------------~~~~  168 (265)
T cd06652         129 HRDIKGANILRDSVGN--VKLGDFGASKRLQTICLS--------GT------------------------------GMKS  168 (265)
T ss_pred             cCCCCHHHEEecCCCC--EEECcCcccccccccccc--------cc------------------------------cccc
Confidence            9999999999998777  999999988754311000        00                              0001


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..++..|++|        +..+|+|++|+++++|..|..|+.
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  210 (265)
T cd06652         169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA  210 (265)
T ss_pred             CCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence            1233344444        456799999999999999997654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.86  E-value=5.3e-22  Score=197.57  Aligned_cols=156  Identities=21%  Similarity=0.243  Sum_probs=120.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||+.|++.+.+......+++..+..++.|++.||.|||+.+++|||
T Consensus        61 ~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~d  140 (307)
T cd06607          61 DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD  140 (307)
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence            35679999999999999999999999999999999999998888776666799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |+|+||++++++.  ++++|||++....... ....+..+.+|+++.+.                               
T Consensus       141 l~p~nIl~~~~~~--~kL~dfg~~~~~~~~~-~~~~~~~y~aPE~~~~~-------------------------------  186 (307)
T cd06607         141 IKAGNILLTEPGT--VKLADFGSASLVSPAN-SFVGTPYWMAPEVILAM-------------------------------  186 (307)
T ss_pred             CCcccEEECCCCC--EEEeecCcceecCCCC-CccCCccccCceeeecc-------------------------------
Confidence            9999999998777  9999999876432110 00011111222211100                               


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                        .-...+..+|+|++|+++++|..|..|++.
T Consensus       187 --~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         187 --DEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             --CCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence              000123467999999999999999977654

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.86  E-value=6e-22  Score=192.00  Aligned_cols=151  Identities=17%  Similarity=0.173  Sum_probs=117.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++..++..++||||++ |+|..++......+++..+..++.|++.||.|||+++|+||
T Consensus        45 ~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~  124 (258)
T cd05078          45 SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG  124 (258)
T ss_pred             HHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45679999999999999999999999999999999998 67888877655568899999999999999999999999999


Q ss_pred             cCCCccccccccchh------hHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         348 DVKPQNLLISEIDHH------NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       348 DlKp~NiLl~~~~~~------~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ||||+||+++.++..      .++++|||++......             +                             
T Consensus       125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-------------~-----------------------------  162 (258)
T cd05078         125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-------------E-----------------------------  162 (258)
T ss_pred             CCccceEEEecccccccCCCceEEecccccccccCCc-------------h-----------------------------
Confidence            999999999876542      2577787766432210             0                             


Q ss_pred             ccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         422 SKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       422 ~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                         ...++..|++|         +..+|+||+|+++++|..|..+++....+
T Consensus       163 ---~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~  211 (258)
T cd05078         163 ---ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS  211 (258)
T ss_pred             ---hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence               01122223333         34579999999999999996555554433

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0614|consensus

Probab=99.86  E-value=1.5e-22  Score=202.23  Aligned_cols=111  Identities=29%  Similarity=0.544  Sum_probs=97.3

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      .+..+.+.|++|||++|||.|||||    +|.+|+..    |-+||.|||+|+.                          
T Consensus       524 F~~acv~EAfeYLH~k~iIYRDLKP----ENllLd~~----Gy~KLVDFGFAKk--------------------------  569 (732)
T KOG0614|consen  524 FYVACVLEAFEYLHRKGIIYRDLKP----ENLLLDNR----GYLKLVDFGFAKK--------------------------  569 (732)
T ss_pred             hhHHHHHHHHHHHHhcCceeccCCh----hheeeccC----CceEEeehhhHHH--------------------------
Confidence            3445669999999999999999999    89999887    8999999999984                          


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                       +|.|.-+-+|||                      ||.|.|||+++... .+.++|.||+|+++||||+|.|||.|. +.
T Consensus       570 -i~~g~KTwTFcG----------------------TpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~-dp  624 (732)
T KOG0614|consen  570 -IGSGRKTWTFCG----------------------TPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGV-DP  624 (732)
T ss_pred             -hccCCceeeecC----------------------CcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCC-ch
Confidence             788888889999                      99999999999765 999999999999999999999999995 44


Q ss_pred             HHHHHHHHHH
Q psy3074         176 YDQLDKIFKI  185 (481)
Q Consensus       176 ~~~l~~i~~~  185 (481)
                      +...+.|.++
T Consensus       625 mktYn~ILkG  634 (732)
T KOG0614|consen  625 MKTYNLILKG  634 (732)
T ss_pred             HHHHHHHHhh
Confidence            4666666554

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.86  E-value=1.4e-22  Score=205.99  Aligned_cols=118  Identities=36%  Similarity=0.630  Sum_probs=96.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                           +
T Consensus       128 i~~aL~~LH~~givHrDikp----~Nill~~~----~~~kl~Dfg~~~~~~~---------------------------~  172 (355)
T cd07874         128 MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAGT---------------------------S  172 (355)
T ss_pred             HHHHHHHHHhCCcccCCCCh----HHEEECCC----CCEEEeeCcccccCCC---------------------------c
Confidence            67899999999999999999    89999876    7999999999984211                           0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+.                      +|+.|+|||++.+.. |+.++|+||+||++|||++|+.||.+. +..+.+.
T Consensus       173 ~~~~~~~----------------------~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~  228 (355)
T cd07874         173 FMMTPYV----------------------VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR-DYIDQWN  228 (355)
T ss_pred             cccCCcc----------------------ccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            0001112                      389999999998765 999999999999999999999999984 5557888


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      .+.+.++.|.++.+...
T Consensus       229 ~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         229 KVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             HHHHHhCCCCHHHHHhh
Confidence            88888998887765544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.86  E-value=5.8e-22  Score=204.82  Aligned_cols=106  Identities=25%  Similarity=0.490  Sum_probs=92.7

Q ss_pred             hhHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----------------------------
Q psy3074         268 FTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----------------------------  317 (481)
Q Consensus       268 ~~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----------------------------  317 (481)
                      +.+.+|+++|+++. |||||++++++.+.+.+|||||||+ |+|.+++....                            
T Consensus        85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (400)
T cd05105          85 QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTR  164 (400)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccccc
Confidence            35678999999996 9999999999999999999999998 78887775421                            


Q ss_pred             -------------------------------------------------------------------CCCChHHHHHHHH
Q psy3074         318 -------------------------------------------------------------------GGLDHHNIRLFMF  330 (481)
Q Consensus       318 -------------------------------------------------------------------~~l~~~~~~~~~~  330 (481)
                                                                                         ..+++..+..++.
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~  244 (400)
T cd05105         165 SYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTY  244 (400)
T ss_pred             chhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHH
Confidence                                                                               1367777889999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |++.||.|||+.+++||||||+|||+++++.  +|++|||+++.+
T Consensus       245 qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~  287 (400)
T cd05105         245 QVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDI  287 (400)
T ss_pred             HHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceec
Confidence            9999999999999999999999999988766  999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.86  E-value=7e-22  Score=196.82  Aligned_cols=151  Identities=25%  Similarity=0.413  Sum_probs=117.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhc----CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHS----GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ...+|+.+++.++||||+++++++.+.  +.+++||||+++++...+....    ..+++..+..++.|++.||.|||+.
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  127 (316)
T cd07842          48 SACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN  127 (316)
T ss_pred             HHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC
Confidence            456799999999999999999999988  8899999999988887765432    2578999999999999999999999


Q ss_pred             ceeeccCCCccccccc----cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCc
Q psy3074         343 RILHRDVKPQNLLISE----IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~----~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      +++||||||+||+++.    .+.  +|++|||+++.+.......            .                       
T Consensus       128 ~i~h~dlkp~Nil~~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~------------~-----------------------  170 (316)
T cd07842         128 WVLHRDLKPANILVMGEGPERGV--VKIGDLGLARLFNAPLKPL------------A-----------------------  170 (316)
T ss_pred             CEeeCCCCHHHEEEcCCCCccce--EEECCCccccccCCCcccc------------c-----------------------
Confidence            9999999999999987    555  9999999887653211100            0                       


Q ss_pred             cccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         419 WFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       419 ~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                         .....++++.|++|         +..+|+|++|+++++|..|..|+.
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~  217 (316)
T cd07842         171 ---DLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK  217 (316)
T ss_pred             ---ccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence               00011233334443         345799999999999999985543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.86  E-value=5.9e-22  Score=191.03  Aligned_cols=105  Identities=23%  Similarity=0.416  Sum_probs=94.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++...+..++||||+. +++.+++......+++..+..++.|++.||.|||+++++||
T Consensus        39 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  118 (252)
T cd05084          39 KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHR  118 (252)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            45679999999999999999999999999999999998 67887776655568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  +|++|||+++.+
T Consensus       119 dl~p~nil~~~~~~--~kl~dfg~~~~~  144 (252)
T cd05084         119 DLAARNCLVTEKNV--LKISDFGMSREE  144 (252)
T ss_pred             ccchheEEEcCCCc--EEECccccCccc
Confidence            99999999988776  999999988643

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PTZ00284 protein kinase; Provisional

Probab=99.86  E-value=8.9e-23  Score=215.36  Aligned_cols=120  Identities=25%  Similarity=0.427  Sum_probs=93.2

Q ss_pred             hhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCC------------CCCceeeecccccccccCCCCCcCCCC
Q psy3074          15 SVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYAT------------PPRELKLADFGLARAKSVPSHTYSHQG   81 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~------------~~g~~Kl~DFGla~~~~~~~~~~~~~~   81 (481)
                      .++.. .+.||+|||+ .|||||||||    +|||++....            ..+.+||+|||+++....         
T Consensus       235 ~i~~q-i~~aL~yLH~~~gIiHrDlKP----~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~---------  300 (467)
T PTZ00284        235 QIIFQ-TGVALDYFHTELHLMHTDLKP----ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH---------  300 (467)
T ss_pred             HHHHH-HHHHHHHHHhcCCeecCCCCH----HHEEEecCCcccccccccccCCCCceEEECCCCccccCcc---------
Confidence            34444 7889999997 5999999999    8999976421            123599999998863110         


Q ss_pred             CCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHH
Q psy3074          82 DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIE  161 (481)
Q Consensus        82 ~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~e  161 (481)
                                          ....+.                      +|+.|||||++.+.. |+.++||||+||++||
T Consensus       301 --------------------~~~~~~----------------------gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~e  337 (467)
T PTZ00284        301 --------------------SRTAIV----------------------STRHYRSPEVVLGLG-WMYSTDMWSMGCIIYE  337 (467)
T ss_pred             --------------------cccccc----------------------CCccccCcHHhhcCC-CCcHHHHHHHHHHHHH
Confidence                                001122                      399999999998775 9999999999999999


Q ss_pred             HHhCCCCCCCchhhHHHHHHHHHHhCCCCcc
Q psy3074         162 MVTGLPTFPGVREVYDQLDKIFKILGTPTEE  192 (481)
Q Consensus       162 lltg~~PF~g~~~~~~~l~~i~~~~~~p~~~  192 (481)
                      |++|++||.+.++ .+.+..+.+.++.++.+
T Consensus       338 lltG~~pf~~~~~-~~~~~~i~~~~g~~p~~  367 (467)
T PTZ00284        338 LYTGKLLYDTHDN-LEHLHLMEKTLGRLPSE  367 (467)
T ss_pred             HHhCCCCCCCCCh-HHHHHHHHHHcCCCCHH
Confidence            9999999998544 57888888888877654

>KOG0589|consensus

Probab=99.86  E-value=7.6e-23  Score=206.26  Aligned_cols=119  Identities=34%  Similarity=0.541  Sum_probs=101.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .++|++|||+++|+|||||+    +|||++.+    +.|||+|||+|+.....                          .
T Consensus       115 ~~~av~ylH~~~iLHRDlK~----~Nifltk~----~~VkLgDfGlaK~l~~~--------------------------~  160 (426)
T KOG0589|consen  115 ILLAVNYLHENRVLHRDLKC----ANIFLTKD----KKVKLGDFGLAKILNPE--------------------------D  160 (426)
T ss_pred             HHHHHHHHHhhhhhcccchh----hhhhcccc----CceeecchhhhhhcCCc--------------------------h
Confidence            58999999999999999999    89999988    57899999999964321                          1


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ++..++.|                      ||.||.||++.+.+ |+.++||||+||++|||++-+++|.+ .+....+.
T Consensus       161 ~~a~tvvG----------------------Tp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a-~~m~~Li~  216 (426)
T KOG0589|consen  161 SLASTVVG----------------------TPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKA-SNMSELIL  216 (426)
T ss_pred             hhhheecC----------------------CCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCc-cchHHHHH
Confidence            24455555                      99999999999887 99999999999999999999999999 56668889


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      +|.+....|-+..+...
T Consensus       217 ki~~~~~~Plp~~ys~e  233 (426)
T KOG0589|consen  217 KINRGLYSPLPSMYSSE  233 (426)
T ss_pred             HHhhccCCCCCccccHH
Confidence            99999988877666543

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.86  E-value=8e-22  Score=193.43  Aligned_cols=106  Identities=35%  Similarity=0.562  Sum_probs=96.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.++++++||||+++++++...+..++||||+.++|.+.+......+++..+..++.|++.||.|||+.+++|+|
T Consensus        45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  124 (286)
T cd07832          45 QALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD  124 (286)
T ss_pred             HHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            45679999999999999999999999999999999997788888876666799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||+||++++.+.  ++++|||++..+.
T Consensus       125 l~p~ni~~~~~~~--~~l~dfg~~~~~~  150 (286)
T cd07832         125 LKPANLLISADGV--LKIADFGLARLFS  150 (286)
T ss_pred             cCHHHEEEcCCCc--EEEeeeeeccccc
Confidence            9999999998776  9999999887654

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.86  E-value=9.9e-22  Score=192.99  Aligned_cols=106  Identities=41%  Similarity=0.788  Sum_probs=96.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++++.++|+||+++++++...+..+++|||+++++...+......+++..+..++.|++.||.|||+.+++|+|
T Consensus        46 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d  125 (288)
T cd07833          46 TALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD  125 (288)
T ss_pred             HHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            45679999999999999999999999999999999999887777666556799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |+|+||++++++.  +|++|||++..+.
T Consensus       126 l~~~ni~~~~~~~--~kl~d~g~~~~~~  151 (288)
T cd07833         126 IKPENILVSESGV--LKLCDFGFARALR  151 (288)
T ss_pred             CCHHHeEECCCCC--EEEEeeecccccC
Confidence            9999999998777  9999999987654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.86  E-value=1.1e-21  Score=194.58  Aligned_cols=148  Identities=21%  Similarity=0.312  Sum_probs=117.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+......|+||||++ ++|..++..  ..+++..+..++.|++.||.|||+.+++||
T Consensus        63 ~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~  140 (296)
T cd06654          63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (296)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            35679999999999999999999999999999999998 577777643  458888999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  ++++|||++..+.......  .                                       ...
T Consensus       141 dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~--~---------------------------------------~~~  177 (296)
T cd06654         141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR--S---------------------------------------TMV  177 (296)
T ss_pred             CCCHHHEEEcCCCC--EEECccccchhcccccccc--C---------------------------------------ccc
Confidence            99999999988776  9999999887543211000  0                                       011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +++.|++|        +...|+|++|+++++|..|..||...
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            22233333        35679999999999999999776543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.86  E-value=7e-22  Score=196.16  Aligned_cols=105  Identities=38%  Similarity=0.621  Sum_probs=93.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCC--------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRS--------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~--------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      +.+|+.++++++||||+++++++....        ..++||||+.+++.+.+......+++..+..++.|++.||.|||+
T Consensus        58 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~  137 (310)
T cd07865          58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR  137 (310)
T ss_pred             HHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence            457999999999999999999987654        459999999999888887655578999999999999999999999


Q ss_pred             CceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         342 RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ++++|+||||+||+++..+.  +|++|||++..+.
T Consensus       138 ~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~  170 (310)
T cd07865         138 NKILHRDMKAANILITKDGI--LKLADFGLARAFS  170 (310)
T ss_pred             CCeeccCCCHHHEEECCCCc--EEECcCCCccccc
Confidence            99999999999999998776  9999999987653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.86  E-value=8.4e-22  Score=193.38  Aligned_cols=106  Identities=51%  Similarity=0.872  Sum_probs=95.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++||||+++++++.+.+..++||||+.+++..++.... ..+++..+..++.|++.||+|||+.+++||
T Consensus        45 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~  124 (284)
T cd07860          45 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR  124 (284)
T ss_pred             HHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            3567999999999999999999999999999999999988888776533 458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|+||++++++.  +|++|||++..+.
T Consensus       125 ~l~p~nill~~~~~--~~l~dfg~~~~~~  151 (284)
T cd07860         125 DLKPQNLLINTEGA--IKLADFGLARAFG  151 (284)
T ss_pred             CCCHHHEEECCCCC--EEEeeccchhhcc
Confidence            99999999998877  9999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.86  E-value=8.6e-22  Score=190.46  Aligned_cols=105  Identities=24%  Similarity=0.425  Sum_probs=94.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++...+..+++|||++ |+|.+.+....+.+++..+..++.|++.||.|||+.+++||
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05114          45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR  124 (256)
T ss_pred             HHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            45679999999999999999999999999999999998 67888776655568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++++.  +|++|||+++.+
T Consensus       125 dl~p~ni~i~~~~~--~kl~d~g~~~~~  150 (256)
T cd05114         125 DLAARNCLVSSTGV--VKVSDFGMTRYV  150 (256)
T ss_pred             ccCcceEEEcCCCe--EEECCCCCcccc
Confidence            99999999988776  899999987643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=1.5e-21  Score=188.78  Aligned_cols=106  Identities=31%  Similarity=0.450  Sum_probs=95.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+.+|++|||++| ++..++......+++..+..++.|++.||.|||+.+++|+
T Consensus        46 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~  125 (262)
T cd06613          46 IIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHR  125 (262)
T ss_pred             HHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceec
Confidence            456799999999999999999999999999999999994 6776666554679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  ++++|||++..+.
T Consensus       126 dl~p~ni~i~~~~~--~~l~d~g~~~~~~  152 (262)
T cd06613         126 DIKGANILLTEDGD--VKLADFGVSAQLT  152 (262)
T ss_pred             CCChhhEEECCCCC--EEECccccchhhh
Confidence            99999999998777  9999999887543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.86  E-value=8.7e-22  Score=190.17  Aligned_cols=152  Identities=22%  Similarity=0.289  Sum_probs=124.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ...+|+.+++.++||||+++++.+.+.+.+|++|||++ |++.+.+.... ..+++..+..++.|++.||.|||+++++|
T Consensus        44 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H  123 (255)
T cd08219          44 DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH  123 (255)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence            34569999999999999999999999999999999998 67887776533 35789999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCccc----ccccccccCCCeeEEEeecCCCCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLL----ISEIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il----~~~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      +||||+||++++++.  ++++|||+++.+.....   ....+..+.+|+++    .+...+.|+.|++++++.+|..||.
T Consensus       124 ~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~  201 (255)
T cd08219         124 RDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQ  201 (255)
T ss_pred             CCCCcceEEECCCCc--EEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCC
Confidence            999999999988776  99999999876543211   12233346677765    3345678999999999999999997


Q ss_pred             ccc
Q psy3074         420 FES  422 (481)
Q Consensus       420 ~~~  422 (481)
                      ..+
T Consensus       202 ~~~  204 (255)
T cd08219         202 ANS  204 (255)
T ss_pred             CCC
Confidence            543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.86  E-value=7.2e-22  Score=194.92  Aligned_cols=105  Identities=27%  Similarity=0.456  Sum_probs=94.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++||||+++++++...+..|+||||++ ++|.+.+... +.+++..+..++.|++.||.|||+.+++|+
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~  125 (290)
T cd05580          47 HVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYR  125 (290)
T ss_pred             HHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            35679999999999999999999999999999999996 7787777654 568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|+||+++.++.  +|++|||+++.+.
T Consensus       126 dl~p~nili~~~~~--~kl~dfg~~~~~~  152 (290)
T cd05580         126 DLKPENLLLDSDGY--IKITDFGFAKRVK  152 (290)
T ss_pred             CCCHHHEEECCCCC--EEEeeCCCccccC
Confidence            99999999998777  9999999887543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.86  E-value=1.3e-21  Score=193.19  Aligned_cols=105  Identities=40%  Similarity=0.706  Sum_probs=91.6

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCe-----EEEEEeccCCCHHHHHHHhc----CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHS----GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~-----~~iv~E~~~g~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.+. ||||+++++++...+.     .|++|||+++++.+++....    ..+++..+..++.||+.||.|
T Consensus        46 ~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~  125 (295)
T cd07837          46 TALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH  125 (295)
T ss_pred             HHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH
Confidence            3567999999996 6999999999987665     89999999999888876532    347899999999999999999


Q ss_pred             hhcCceeeccCCCccccccc-cchhhHHHHHHHHHhhc
Q psy3074         339 CHRRRILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~  375 (481)
                      ||+++++||||||+||+++. .+.  +|++|||+++.+
T Consensus       126 LH~~~i~H~dl~~~nil~~~~~~~--~kl~dfg~~~~~  161 (295)
T cd07837         126 CHKHGVMHRDLKPQNLLVDKQKGL--LKIADLGLGRAF  161 (295)
T ss_pred             HHHCCeeecCCChHHEEEecCCCe--EEEeecccceec
Confidence            99999999999999999987 555  999999988754

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=1.6e-22  Score=198.92  Aligned_cols=151  Identities=19%  Similarity=0.283  Sum_probs=123.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHh--cCCCChHHHHHHHHHHHHHHHHhhc-Cce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERH--SGGLDHHNIRLFMFQLLRGLSYCHR-RRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~ylH~-~~i  344 (481)
                      .+.+|+.++++++||||+++++.+..++..|+|||||+| ++..++...  ...+++..+..++.|++.||.|||+ .++
T Consensus        45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i  124 (286)
T cd06622          45 QIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI  124 (286)
T ss_pred             HHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            356799999999999999999999999999999999995 676666542  2368999999999999999999996 599


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhcccc-ccCceeccccCCCcccc----------cccccccCCCeeEEEeec
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC-HRRRILHRDVKPQNLLI----------SEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~-~~~~i~~~d~~~~~il~----------~~~~~~~s~g~~~~~~~~  413 (481)
                      +||||||+||+++.++.  ++++|||++..+... ......+..+.+|+.+.          +...+.|+.|++++++.+
T Consensus       125 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~  202 (286)
T cd06622         125 IHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL  202 (286)
T ss_pred             eeCCCCHHHEEECCCCC--EEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHh
Confidence            99999999999998666  999999998765322 22223344566777663          345678999999999999


Q ss_pred             CCCCcccc
Q psy3074         414 GSGGWWFE  421 (481)
Q Consensus       414 g~~~~~~~  421 (481)
                      |..||...
T Consensus       203 g~~pf~~~  210 (286)
T cd06622         203 GRYPYPPE  210 (286)
T ss_pred             CCCCCCCc
Confidence            99998644

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.85  E-value=5.9e-22  Score=194.54  Aligned_cols=105  Identities=38%  Similarity=0.780  Sum_probs=93.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++++.++||||+++++++.+++..|+||||++++....+......+++..+..++.|++.||.|||+.+++|+|
T Consensus        46 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~  125 (286)
T cd07846          46 IAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRD  125 (286)
T ss_pred             HHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            35679999999999999999999999999999999999776665555455689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |+|+||++++++.  ++++|||++..+
T Consensus       126 l~p~ni~~~~~~~--~~l~dfg~~~~~  150 (286)
T cd07846         126 IKPENILVSQSGV--VKLCDFGFARTL  150 (286)
T ss_pred             CCHHHEEECCCCc--EEEEeeeeeeec
Confidence            9999999998776  999999988754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.85  E-value=1.7e-21  Score=189.78  Aligned_cols=104  Identities=17%  Similarity=0.295  Sum_probs=92.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC----CCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG----GLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~----~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++.+...+..|+||||++ |+|.+++.....    ..++..+..++.|++.|++|||+++
T Consensus        41 ~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  120 (269)
T cd05042          41 LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD  120 (269)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence            46789999999999999999999999999999999998 688888765432    2457778899999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      |+||||||+|||+++++.  +|++|||+++.
T Consensus       121 ivH~dlkp~Nill~~~~~--~kl~dfg~~~~  149 (269)
T cd05042         121 FIHSDLALRNCQLTADLS--VKIGDYGLALE  149 (269)
T ss_pred             EecccccHhheEecCCCc--EEEeccccccc
Confidence            999999999999998776  99999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0583|consensus

Probab=99.85  E-value=2.9e-22  Score=203.69  Aligned_cols=108  Identities=30%  Similarity=0.523  Sum_probs=88.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      ...|++|||++||+||||||    +|+||+...   +.+||+|||+++...                          +.+
T Consensus       129 lisav~y~H~~gi~HRDLK~----ENilld~~~---~~~Kl~DFG~s~~~~--------------------------~~~  175 (370)
T KOG0583|consen  129 LISAVAYCHSRGIVHRDLKP----ENILLDGNE---GNLKLSDFGLSAISP--------------------------GED  175 (370)
T ss_pred             HHHHHHHHHhCCEeeCCCCH----HHEEecCCC---CCEEEeccccccccC--------------------------CCC
Confidence            57799999999999999999    899998763   699999999998421                          344


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEY-STSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y-~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      +...++||                      |+.|+|||++.+...| +.++||||+||++|.|++|+.||.. .+.....
T Consensus       176 ~~l~t~cG----------------------sp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~  232 (370)
T KOG0583|consen  176 GLLKTFCG----------------------SPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLY  232 (370)
T ss_pred             CcccCCCC----------------------CcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHH
Confidence            55566777                      9999999999987735 5899999999999999999999988 3343555


Q ss_pred             HHHHH
Q psy3074         180 DKIFK  184 (481)
Q Consensus       180 ~~i~~  184 (481)
                      .+|.+
T Consensus       233 ~ki~~  237 (370)
T KOG0583|consen  233 RKIRK  237 (370)
T ss_pred             HHHhc
Confidence            55544

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.85  E-value=1.3e-21  Score=191.74  Aligned_cols=102  Identities=20%  Similarity=0.387  Sum_probs=89.1

Q ss_pred             HHHHH-HhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcC-ceee
Q psy3074         272 REASL-LKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRR-RILH  346 (481)
Q Consensus       272 rE~~i-l~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiH  346 (481)
                      +|+.+ ++.++||||+++++++..++..|++|||++|++.+++...   ...+++..+..++.|++.||.|||++ +++|
T Consensus        48 ~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h  127 (283)
T cd06617          48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH  127 (283)
T ss_pred             HHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence            35554 6678899999999999999999999999999887777542   24588999999999999999999997 9999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+||++++++.  +|++|||+++.+
T Consensus       128 ~dlkp~nil~~~~~~--~kl~dfg~~~~~  154 (283)
T cd06617         128 RDVKPSNVLINRNGQ--VKLCDFGISGYL  154 (283)
T ss_pred             CCCCHHHEEECCCCC--EEEeeccccccc
Confidence            999999999998776  999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.85  E-value=1.8e-21  Score=191.24  Aligned_cols=106  Identities=31%  Similarity=0.523  Sum_probs=93.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++.++||||+++++++...+..|++|||++ ++|.+++....                ..+++..+..++.|
T Consensus        53 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  132 (283)
T cd05090          53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ  132 (283)
T ss_pred             HHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHH
Confidence            45679999999999999999999999999999999998 67887775321                23678888999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ++.||.|||+++++||||||+||++++++.  +|++|||+++.+.
T Consensus       133 i~~al~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~  175 (283)
T cd05090         133 IAAGMEYLSSHFFVHKDLAARNILIGEQLH--VKISDLGLSREIY  175 (283)
T ss_pred             HHHHHHHHHhcCeehhccccceEEEcCCCc--EEecccccccccc
Confidence            999999999999999999999999998776  9999999987653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.85  E-value=2.1e-22  Score=203.73  Aligned_cols=126  Identities=34%  Similarity=0.649  Sum_probs=100.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.....                  
T Consensus       119 ~~~~i~~q-i~~aL~~LH~~~ivHrdikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~------------------  171 (343)
T cd07878         119 HVQFLIYQ-LLRGLKYIHSAGIIHRDLKP----SNVAVNED----CELRILDFGLARQADDE------------------  171 (343)
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeecccCCh----hhEEECCC----CCEEEcCCccceecCCC------------------
Confidence            33344444 78899999999999999999    89999876    79999999999842110                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                 ...+.                      +|+.|+|||++.+...|+.++||||+||++|||++|++||.+
T Consensus       172 -----------~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         172 -----------MTGYV----------------------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             -----------cCCcc----------------------ccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence                       00112                      389999999998866699999999999999999999999988


Q ss_pred             chhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      . +..+.+..+....+.|.++.+..++
T Consensus       219 ~-~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         219 N-DYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             C-CHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            4 4557888888888888776655543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.85  E-value=1.6e-21  Score=188.93  Aligned_cols=105  Identities=22%  Similarity=0.417  Sum_probs=94.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++...+..+++|||+. |++.+++......+++..+..++.|++.||.|||+.+++|+
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  124 (256)
T cd05113          45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR  124 (256)
T ss_pred             HHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            35679999999999999999999999999999999998 67888776655568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  +|++|||+++.+
T Consensus       125 dl~p~nili~~~~~--~kl~d~g~~~~~  150 (256)
T cd05113         125 DLAARNCLVDDQGC--VKVSDFGLSRYV  150 (256)
T ss_pred             ccCcceEEEcCCCC--EEECCCccceec
Confidence            99999999988776  999999987654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0665|consensus

Probab=99.85  E-value=3e-22  Score=190.57  Aligned_cols=149  Identities=24%  Similarity=0.396  Sum_probs=131.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .++.||..++..++|+||++++.+|.-..      ..|+|||+|++++.+.+..   .+++..+.+++.|++.|+.|+|+
T Consensus        60 kra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs  136 (369)
T KOG0665|consen   60 KRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHS  136 (369)
T ss_pred             hhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHh
Confidence            35789999999999999999999997543      5899999999999888763   48899999999999999999999


Q ss_pred             CceeeccCCCccccccccchhhHHHHHHHHHhhcc--ccccCceeccccCCCccccc----ccccccCCCeeEEEeecCC
Q psy3074         342 RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS--YCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~--~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~  415 (481)
                      .||+||||||+||++..+..  +|+.|||+|+.-.  ...++.+++|-|++|+++++    +.++.||.||++.+|..|.
T Consensus       137 ~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~  214 (369)
T KOG0665|consen  137 AGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGT  214 (369)
T ss_pred             cceeecccCcccceecchhh--eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhce
Confidence            99999999999999998776  9999999999544  45788999999999999965    5667899999999999999


Q ss_pred             CCcccc
Q psy3074         416 GGWWFE  421 (481)
Q Consensus       416 ~~~~~~  421 (481)
                      .-|.+.
T Consensus       215 Vlf~g~  220 (369)
T KOG0665|consen  215 VLFPGK  220 (369)
T ss_pred             EEecCc
Confidence            887643

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.85  E-value=1.5e-21  Score=193.30  Aligned_cols=106  Identities=42%  Similarity=0.700  Sum_probs=94.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC----------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS----------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~----------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      ...+|+++++.++||||+++++++.+..          .+|++|||+++++...+......+++..+..++.|++.||.|
T Consensus        52 ~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  131 (302)
T cd07864          52 TAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNY  131 (302)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            3457999999999999999999987655          799999999998888877655578999999999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+.+|+||||||+||++++.+.  +|++|||++..+.
T Consensus       132 LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~  167 (302)
T cd07864         132 CHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYN  167 (302)
T ss_pred             HHhCCeecCCCCHHHEEECCCCc--EEeCccccccccc
Confidence            99999999999999999998777  9999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0668|consensus

Probab=99.85  E-value=2e-22  Score=183.53  Aligned_cols=146  Identities=29%  Similarity=0.489  Sum_probs=113.2

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCC--eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~--~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..||+.||..|. ||||++|+++..++.  ...+++||++...+..+-   ..++...++.++.|++.||.|||++||+|
T Consensus        79 IkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImH  155 (338)
T KOG0668|consen   79 IKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMH  155 (338)
T ss_pred             HHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence            568999999998 999999999998864  567999999854333332   24788889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCccccccccc-----ccCCCeeEEEeecCCCCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVF-----TNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~-----~~s~g~~~~~~~~g~~~~~  419 (481)
                      ||+||.|++++. ...+++++|+|+|.....-.  .-++.+|.+|.|+.+++=..+     .||+||++..|.+.+-||.
T Consensus       156 RDVKPhNvmIdh-~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  156 RDVKPHNVMIDH-ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             ccCCcceeeech-hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence            999999999986 45579999999998543221  235778899999999765443     3555555555555555544

>KOG4236|consensus

Probab=99.85  E-value=5.4e-23  Score=205.91  Aligned_cols=136  Identities=29%  Similarity=0.466  Sum_probs=106.2

Q ss_pred             CCcchhHHHH-hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCC
Q psy3074           3 SGENKATVQR-QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG   81 (481)
Q Consensus         3 ~~~~~~~~~~-~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~   81 (481)
                      |..|.+.+.- ++.+..  .|.||.|||-++|+|.||||    +||||++. ++=-++||||||+||.            
T Consensus       656 sEkgRL~er~TkFlvtQ--IL~ALr~LH~knIvHCDLKP----ENVLLas~-~~FPQvKlCDFGfARi------------  716 (888)
T KOG4236|consen  656 SEKGRLPERITKFLVTQ--ILVALRYLHFKNIVHCDLKP----ENVLLASA-SPFPQVKLCDFGFARI------------  716 (888)
T ss_pred             hhcccchHHHHHHHHHH--HHHHHHHhhhcceeeccCCc----hheeeccC-CCCCceeeccccceee------------
Confidence            4444444432 333333  48899999999999999999    89999876 3335899999999994            


Q ss_pred             CCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHH
Q psy3074          82 DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIE  161 (481)
Q Consensus        82 ~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~e  161 (481)
                                     +|+.+|.....|                      ||.|.|||||.... |+.+.|+||+|||+|.
T Consensus       717 ---------------IgEksFRrsVVG----------------------TPAYLaPEVLrnkG-yNrSLDMWSVGVIiYV  758 (888)
T KOG4236|consen  717 ---------------IGEKSFRRSVVG----------------------TPAYLAPEVLRNKG-YNRSLDMWSVGVIIYV  758 (888)
T ss_pred             ---------------cchhhhhhhhcC----------------------CccccCHHHHhhcc-ccccccceeeeEEEEE
Confidence                           688888777666                      99999999998765 9999999999999999


Q ss_pred             HHhCCCCCCCchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         162 MVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       162 lltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      -|+|..||....|+.+|++   ..--..+++.|..++
T Consensus       759 sLSGTFPFNEdEdIndQIQ---NAaFMyPp~PW~eis  792 (888)
T KOG4236|consen  759 SLSGTFPFNEDEDINDQIQ---NAAFMYPPNPWSEIS  792 (888)
T ss_pred             EecccccCCCccchhHHhh---ccccccCCCchhhcC
Confidence            9999999988777777766   233334455565555

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.85  E-value=1.5e-21  Score=197.40  Aligned_cols=106  Identities=26%  Similarity=0.505  Sum_probs=90.5

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhc----------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHS----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~----------------------------  317 (481)
                      .+.+|+.+++++ +|+||+++++++.. ...++++|||++ |+|.+++....                            
T Consensus        56 ~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (337)
T cd05054          56 ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDS  135 (337)
T ss_pred             HHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccccc
Confidence            356799999999 79999999998865 457899999998 67877765321                            


Q ss_pred             --------------------------------CCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHH
Q psy3074         318 --------------------------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIR  365 (481)
Q Consensus       318 --------------------------------~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ik  365 (481)
                                                      ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.  ++
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vk  213 (337)
T cd05054         136 VSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VK  213 (337)
T ss_pred             CCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EE
Confidence                                            24678889999999999999999999999999999999998776  99


Q ss_pred             HHHHHHHhhcc
Q psy3074         366 LFMFQLLRGLS  376 (481)
Q Consensus       366 l~dfgla~~~~  376 (481)
                      ++|||+++.+.
T Consensus       214 L~DfG~a~~~~  224 (337)
T cd05054         214 ICDFGLARDIY  224 (337)
T ss_pred             Eeccccchhcc
Confidence            99999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.85  E-value=1.3e-21  Score=191.83  Aligned_cols=105  Identities=29%  Similarity=0.499  Sum_probs=93.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQL  332 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~qi  332 (481)
                      .+.+|+.+++.++||||+++++++......|++|||++ |+|.+++....               ..+++..+..++.|+
T Consensus        54 ~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l  133 (283)
T cd05048          54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI  133 (283)
T ss_pred             HHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHH
Confidence            45689999999999999999999999999999999998 68888886532               347788889999999


Q ss_pred             HHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         333 LRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       333 ~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +.||.|||+.+++||||||+||++++++.  ++++|||+++.+
T Consensus       134 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~  174 (283)
T cd05048         134 AAGMEYLSSHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDI  174 (283)
T ss_pred             HHHHHHHHhCCeeccccccceEEEcCCCc--EEECCCcceeec
Confidence            99999999999999999999999998776  999999998743

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.85  E-value=1.9e-21  Score=190.32  Aligned_cols=103  Identities=35%  Similarity=0.653  Sum_probs=93.2

Q ss_pred             HHHHHHHhhcC-CCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         271 IREASLLKELK-HNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       271 ~rE~~il~~l~-HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+|+.+++++. ||||+++++++.+.  +.+++||||+.|++.+.+......+++..+..++.|++.||.|||+.+++||
T Consensus        45 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~  124 (282)
T cd07831          45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR  124 (282)
T ss_pred             HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            46888898886 99999999999987  8999999999999998887655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++. +.  +|++|||+++.+.
T Consensus       125 dl~p~ni~l~~-~~--~kl~dfg~~~~~~  150 (282)
T cd07831         125 DIKPENILIKD-DI--LKLADFGSCRGIY  150 (282)
T ss_pred             ccCHHHEEEcC-CC--eEEEecccccccc
Confidence            99999999998 55  9999999987553

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0585|consensus

Probab=99.85  E-value=5.7e-22  Score=197.09  Aligned_cols=113  Identities=25%  Similarity=0.359  Sum_probs=88.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+++|+|||.+|||||||||    +|+||+..    |++||+|||.+..+.....                       +|
T Consensus       219 vv~GLEYLH~QgiiHRDIKP----sNLLl~~~----g~VKIsDFGVs~~~~~~~~-----------------------~~  267 (576)
T KOG0585|consen  219 VVLGLEYLHYQGIIHRDIKP----SNLLLSSD----GTVKISDFGVSNEFPQGSD-----------------------EG  267 (576)
T ss_pred             HHHHHHHHHhcCeeccccch----hheEEcCC----CcEEeeccceeeecccCCc-----------------------cc
Confidence            78999999999999999999    99999987    8999999999975421100                       00


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG---STEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~---~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      +        +.           .. ...+|||.|||||.+.+   ....+.+.||||+||++|.|+-|+.||-+. ..++
T Consensus       268 ~--------d~-----------~L-~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~-~~~~  326 (576)
T KOG0585|consen  268 S--------DD-----------QL-SRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD-FELE  326 (576)
T ss_pred             c--------HH-----------HH-hhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc-hHHH
Confidence            0        00           00 01356999999999988   334677999999999999999999999994 4457


Q ss_pred             HHHHHHHH
Q psy3074         178 QLDKIFKI  185 (481)
Q Consensus       178 ~l~~i~~~  185 (481)
                      ..++|+..
T Consensus       327 l~~KIvn~  334 (576)
T KOG0585|consen  327 LFDKIVND  334 (576)
T ss_pred             HHHHHhcC
Confidence            88888764

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.85  E-value=1.9e-21  Score=187.83  Aligned_cols=105  Identities=28%  Similarity=0.463  Sum_probs=94.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|++++++++|+||+++++++.+.+.++++||||+ ++|.+.+... ...+++..+..++.|++.|+.|||+.+++|
T Consensus        45 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  124 (256)
T cd08221          45 DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH  124 (256)
T ss_pred             HHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            45679999999999999999999999999999999998 6888888764 345889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +||||+||++++++.  +|++|||++...
T Consensus       125 ~dl~p~ni~~~~~~~--~kl~d~~~~~~~  151 (256)
T cd08221         125 RDIKTLNIFLTKAGL--IKLGDFGISKIL  151 (256)
T ss_pred             cCCChHhEEEeCCCC--EEECcCcceEEc
Confidence            999999999998777  999999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.85  E-value=1.4e-21  Score=189.95  Aligned_cols=150  Identities=25%  Similarity=0.342  Sum_probs=117.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++||||+++++++.+.+..+++|||++ |++..++...   ...+++..+..++.|++.||.|||++++
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  127 (267)
T cd08228          48 DCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV  127 (267)
T ss_pred             HHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            35679999999999999999999999999999999999 5777666432   2347888999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +|+||||+||+++.++.  ++++|||++..+.......  +                                       
T Consensus       128 ~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~--~---------------------------------------  164 (267)
T cd08228         128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAA--H---------------------------------------  164 (267)
T ss_pred             eCCCCCHHHEEEcCCCC--EEECccccceeccchhHHH--h---------------------------------------
Confidence            99999999999988776  9999999887543111000  0                                       


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...+++.|++|        +..+|+|++|+++++|..|..|++.+
T Consensus       165 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence            01122223333        45579999999999999999777654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.85  E-value=1.5e-21  Score=190.03  Aligned_cols=106  Identities=24%  Similarity=0.420  Sum_probs=95.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++...+..|++|||++ ++|.+++....+.+++..+..++.|++.|+.|||+++++||
T Consensus        51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~  130 (267)
T cd05066          51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR  130 (267)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeh
Confidence            45679999999999999999999999999999999998 57888887665678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  ++++|||++..+.
T Consensus       131 dlkp~nili~~~~~--~~l~dfg~~~~~~  157 (267)
T cd05066         131 DLAARNILVNSNLV--CKVSDFGLSRVLE  157 (267)
T ss_pred             hhchhcEEECCCCe--EEeCCCCcccccc
Confidence            99999999988776  9999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0671|consensus

Probab=99.85  E-value=9.2e-22  Score=191.27  Aligned_cols=155  Identities=17%  Similarity=0.284  Sum_probs=132.8

Q ss_pred             hhHHHHHHHHhhcCC--C----CeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         268 FTAIREASLLKELKH--N----NIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       268 ~~~~rE~~il~~l~H--p----nIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      ++++-|+++|+++.+  |    .+|.+.++|.-.+++|||+|.+..++.+++...+ ..++...++.+..|++.++.|||
T Consensus       130 eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh  209 (415)
T KOG0671|consen  130 EAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH  209 (415)
T ss_pred             hHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH
Confidence            345669999999952  2    4899999999999999999999989999997633 35889999999999999999999


Q ss_pred             cCceeeccCCCccccccccc------------------hhhHHHHHHHHHhhccccccCceeccccCCCccccc----cc
Q psy3074         341 RRRILHRDVKPQNLLISEID------------------HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EI  398 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~------------------~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~  398 (481)
                      +.+++|-||||||||+.+..                  ...|+++|||.|..-...|+.-+-||-|++|||+++    ..
T Consensus       210 ~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~p  289 (415)
T KOG0671|consen  210 DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQP  289 (415)
T ss_pred             hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCc
Confidence            99999999999999984321                  124889999999987777777788999999999974    66


Q ss_pred             ccccCCCeeEEEeecCCCCccccc
Q psy3074         399 VFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       399 ~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ++.||.||++.|+.+|..-|...+
T Consensus       290 CDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  290 CDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             cCceeeeeEEEEeeccceecccCC
Confidence            788999999999999999887654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.85  E-value=4.9e-22  Score=194.74  Aligned_cols=154  Identities=17%  Similarity=0.143  Sum_probs=122.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|..++....+.+++..+..++.|++.||+|||+++|+|
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH  140 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH  140 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            356779999999999999999999999999999999999 5666666555567899999999999999999999999999


Q ss_pred             ccCCCccccccccc-----hhhHHHHHHHHHhhccccccCceeccccCCCcccc-----cccccccCCCeeEEEee-cCC
Q psy3074         347 RDVKPQNLLISEID-----HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-----SEIVFTNLSGVVVSTVD-SGS  415 (481)
Q Consensus       347 rDlKp~NiLl~~~~-----~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~-----~~~~~~~s~g~~~~~~~-~g~  415 (481)
                      |||||+|||++..+     ...+|+.|||++....... ....+..+.+|+.+.     +...+.|++|++++++. .|.
T Consensus       141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~  219 (274)
T cd05076         141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE  219 (274)
T ss_pred             CCCCcccEEEeccCcccCccceeeecCCcccccccccc-ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999997543     2247999999886543222 222334566777653     34567899999999884 688


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||...+
T Consensus       220 ~p~~~~~  226 (274)
T cd05076         220 VPLKERT  226 (274)
T ss_pred             CCccccC
Confidence            8887543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1.4e-21  Score=195.18  Aligned_cols=176  Identities=23%  Similarity=0.256  Sum_probs=125.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++||||+++++.+......|++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+++|
T Consensus        47 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  126 (316)
T cd05574          47 RVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY  126 (316)
T ss_pred             HHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            35679999999999999999999999999999999998 57877776532 45899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      +||||+||+++.++.  +++.|||++..........  .....    ..........     ........+ ........
T Consensus       127 ~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~--~~~~~----~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~  192 (316)
T cd05574         127 RDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPV--SKALR----KGSRRSSVNS-----IPSETFSEE-PSFRSNSF  192 (316)
T ss_pred             cCCChHHeEEcCCCC--EEEeecchhhccccccccc--ccccc----cccccccccc-----cchhhhccc-ccCCCCCC
Confidence            999999999998776  9999999987654211100  00000    0000000000     000000000 00011234


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      .||..|++|        ...+|+||+|+++++|.+|..|+
T Consensus       193 ~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         193 VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             cCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            678888888        44679999999999999999665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.85  E-value=3.4e-21  Score=191.59  Aligned_cols=163  Identities=23%  Similarity=0.367  Sum_probs=120.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++.+..++.+++||||++ ++|.+++.. .+.+++..+..++.|++.||.|||+.+++|||
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d  126 (305)
T cd05609          48 VFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRD  126 (305)
T ss_pred             HHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            4579999999999999999999999999999999998 567777654 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+||++++.+.  ++++|||+++.................           . ..           .+   ......+
T Consensus       127 l~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~-----------~-~~-----------~~---~~~~~~~  178 (305)
T cd05609         127 LKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEK-----------D-TR-----------EF---LDKQVCG  178 (305)
T ss_pred             CchHHEEECCCCC--EEEeeCCCccccCcCcccccccccccc-----------c-hh-----------hc---cccCCcc
Confidence            9999999998777  999999987632110000000000000           0 00           00   0001223


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +..|++|        +.++|+|++|+++++|..|..|+..+
T Consensus       179 ~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             CccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            4445554        56689999999999999999887643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.85  E-value=1.6e-21  Score=190.03  Aligned_cols=157  Identities=20%  Similarity=0.231  Sum_probs=114.9

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecC------CeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTR------STLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~------~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      ..+|+.+++++ +||||+++++.+...      ..+|++|||+. |++..++.... ..+++..+..++.|++.|+.|||
T Consensus        49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH  128 (272)
T cd06637          49 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH  128 (272)
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45799999998 699999999998753      46899999998 57877776533 35889999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccC---ceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR---RILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~---~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      +++++||||||+||++++++.  ++++|||++..+......   ...+..|.||+++....                   
T Consensus       129 ~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-------------------  187 (272)
T cd06637         129 QHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE-------------------  187 (272)
T ss_pred             HCCCccCCCCHHHEEECCCCC--EEEccCCCceecccccccCCcccccccccCHhHhcccc-------------------
Confidence            999999999999999998776  999999998754321110   00111122222221100                   


Q ss_pred             ccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         418 WWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                  ......+.++|+|++|+++++|.+|..|+.
T Consensus       188 ------------~~~~~~~~~~Dv~slGv~l~el~~g~~p~~  217 (272)
T cd06637         188 ------------NPDATYDFKSDLWSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             ------------CcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence                        000011346899999999999999986653

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.85  E-value=5.4e-22  Score=191.97  Aligned_cols=151  Identities=21%  Similarity=0.224  Sum_probs=122.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++...+..|+||||++ ++|.+++....+.+++..+..++.|++.|+.|||+.+++||
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  124 (256)
T cd05059          45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR  124 (256)
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35679999999999999999999999999999999998 67888887655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc----CceeccccCCCccccc----ccccccCCCeeEEEeec-CCCCc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR----RRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDS-GSGGW  418 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~----~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~-g~~~~  418 (481)
                      ||||+||++++++.  +|++|||+++.+.....    .......+.||+++..    ...+.|++|++++++.+ |..||
T Consensus       125 dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  202 (256)
T cd05059         125 DLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY  202 (256)
T ss_pred             cccHhhEEECCCCc--EEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCC
Confidence            99999999998777  99999999875431110    0011123566766543    34567888999999888 78888


Q ss_pred             ccc
Q psy3074         419 WFE  421 (481)
Q Consensus       419 ~~~  421 (481)
                      ...
T Consensus       203 ~~~  205 (256)
T cd05059         203 ERF  205 (256)
T ss_pred             CCC
Confidence            644

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0198|consensus

Probab=99.85  E-value=3e-22  Score=196.74  Aligned_cols=99  Identities=26%  Similarity=0.457  Sum_probs=77.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||.|||++|||||||||    +|||++..   .|.+||+|||+|+.... ...                      ..
T Consensus       126 iL~GL~ylHs~g~vH~DiK~----~NiLl~~~---~~~~KlaDFG~a~~~~~-~~~----------------------~~  175 (313)
T KOG0198|consen  126 ILEGLAYLHSKGIVHCDIKP----ANILLDPS---NGDVKLADFGLAKKLES-KGT----------------------KS  175 (313)
T ss_pred             HHHHHHHHHhCCEeccCccc----ceEEEeCC---CCeEEeccCcccccccc-ccc----------------------cc
Confidence            68999999999999999999    89999873   27999999999985431 000                      00


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                      .....+.                      +|+.|||||++.....-+.++||||+||++.||+||.+||..
T Consensus       176 ~~~~~~~----------------------Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  176 DSELSVQ----------------------GTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccc----------------------CCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            0111223                      499999999999633233599999999999999999999976

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.85  E-value=2e-21  Score=187.23  Aligned_cols=106  Identities=29%  Similarity=0.489  Sum_probs=94.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++...+..|+||||++ ++|.+++... ...+++..+..++.|++.||.|||+.+++|
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h  124 (256)
T cd08529          45 EAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILH  124 (256)
T ss_pred             HHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45679999999999999999999999999999999998 6788877664 346888899999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +||||+||++++++.  ++++|||+++.+.
T Consensus       125 ~dl~~~nili~~~~~--~~l~df~~~~~~~  152 (256)
T cd08529         125 RDIKSLNLFLDAYDN--VKIGDLGVAKLLS  152 (256)
T ss_pred             CCCCcceEEEeCCCC--EEEcccccceecc
Confidence            999999999998776  9999999887543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0201|consensus

Probab=99.85  E-value=3.9e-22  Score=196.93  Aligned_cols=105  Identities=28%  Similarity=0.463  Sum_probs=86.1

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ...+|.++-...+.|++|||+.+.||||||+    +||||...    |.+||+|||+|.......               
T Consensus       109 ~E~~i~~ilre~l~~l~ylH~~~kiHrDIKa----anil~s~~----g~vkl~DfgVa~ql~~~~---------------  165 (467)
T KOG0201|consen  109 DEFEIAVILREVLKGLDYLHSEKKIHRDIKA----ANILLSES----GDVKLADFGVAGQLTNTV---------------  165 (467)
T ss_pred             ccceeeeehHHHHHHhhhhhhcceecccccc----cceeEecc----CcEEEEecceeeeeechh---------------
Confidence            3455666666789999999999999999999    89999877    899999999997432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 ....++.|                      ||+||||||+.+. .|+.++||||||++.+||++|.||+
T Consensus       166 -----------~rr~tfvG----------------------TPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~  211 (467)
T KOG0201|consen  166 -----------KRRKTFVG----------------------TPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPH  211 (467)
T ss_pred             -----------hccccccc----------------------cccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCC
Confidence                       11123344                      9999999999954 5999999999999999999999999


Q ss_pred             CC
Q psy3074         170 PG  171 (481)
Q Consensus       170 ~g  171 (481)
                      ..
T Consensus       212 s~  213 (467)
T KOG0201|consen  212 SK  213 (467)
T ss_pred             cc
Confidence            76

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.85  E-value=2.6e-21  Score=193.68  Aligned_cols=156  Identities=21%  Similarity=0.246  Sum_probs=119.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++++.++|||+|++++++.+.+..++||||+.|++.+.+......+++..+..++.|++.|+.|||+.+++|||
T Consensus        71 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~d  150 (317)
T cd06635          71 DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD  150 (317)
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            35679999999999999999999999999999999999998888776666789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |+|+||+++.++.  ++++|||++....... ....+..|.+|+++...                               
T Consensus       151 L~p~Nil~~~~~~--~kl~dfg~~~~~~~~~-~~~~~~~y~aPE~~~~~-------------------------------  196 (317)
T cd06635         151 IKAGNILLTEPGQ--VKLADFGSASIASPAN-SFVGTPYWMAPEVILAM-------------------------------  196 (317)
T ss_pred             CCcccEEECCCCC--EEEecCCCccccCCcc-cccCCccccChhhhhcC-------------------------------
Confidence            9999999988776  9999999875432110 00011111222211100                               


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                        ..-..+..+|+|++|+++++|..|..|++.
T Consensus       197 --~~~~~~~~~Dv~slGvil~el~~g~~p~~~  226 (317)
T cd06635         197 --DEGQYDGKVDVWSLGITCIELAERKPPLFN  226 (317)
T ss_pred             --CCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence              000013457999999999999999876654

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.85  E-value=3.3e-21  Score=191.10  Aligned_cols=147  Identities=23%  Similarity=0.340  Sum_probs=117.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..|+|+||+. +++..++..  ..+++..+..++.|++.|+.|||+.+++|+
T Consensus        62 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~  139 (296)
T cd06655          62 LIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHR  139 (296)
T ss_pred             HHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            35679999999999999999999999999999999998 566666543  358999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  ++++|||++..+.......                                         ....
T Consensus       140 dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~-----------------------------------------~~~~  176 (296)
T cd06655         140 DIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKR-----------------------------------------STMV  176 (296)
T ss_pred             CCCHHHEEECCCCC--EEEccCccchhcccccccC-----------------------------------------CCcC
Confidence            99999999988776  9999999887543211000                                         0011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +++.|++|        +..+|+|++|+++++|..|..|+..
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            23333333        3568999999999999999866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4279|consensus

Probab=99.85  E-value=2.5e-22  Score=206.51  Aligned_cols=105  Identities=30%  Similarity=0.588  Sum_probs=89.2

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      -|...+.-.|.+|.|||++.|||||||-    +|+|+|...   |++||+|||-++..                      
T Consensus       676 tm~fYtkQILeGLkYLHen~IVHRDIKG----DNVLvNTyS---GvlKISDFGTsKRL----------------------  726 (1226)
T KOG4279|consen  676 TMNFYTKQILEGLKYLHENKIVHRDIKG----DNVLVNTYS---GVLKISDFGTSKRL----------------------  726 (1226)
T ss_pred             HHHHHHHHHHHHhhhhhhcceeeccccC----CcEEEeecc---ceEEecccccchhh----------------------
Confidence            3445555578999999999999999999    899999886   99999999999853                      


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG-STEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~-~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                          -|-.-.+.+|.|                      |..|||||++-. .++|+.++|||||||++.||.||+|||..
T Consensus       727 ----AginP~TETFTG----------------------TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E  780 (1226)
T KOG4279|consen  727 ----AGINPCTETFTG----------------------TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE  780 (1226)
T ss_pred             ----ccCCcccccccc----------------------chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence                244445667777                      999999999964 57899999999999999999999999954


Q ss_pred             c
Q psy3074         172 V  172 (481)
Q Consensus       172 ~  172 (481)
                      .
T Consensus       781 l  781 (1226)
T KOG4279|consen  781 L  781 (1226)
T ss_pred             c
Confidence            3

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.85  E-value=2.9e-22  Score=193.43  Aligned_cols=152  Identities=26%  Similarity=0.382  Sum_probs=118.0

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      .+|+.++++++||||+++++++.+....+++||++.+ ++.+++. ....+++..+..++.|++.||.+||+.+++|+||
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~di  124 (260)
T PF00069_consen   46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDI  124 (260)
T ss_dssp             HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSB
T ss_pred             hhhhhcccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccc
Confidence            4599999999999999999999999999999999996 8888887 3456899999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcc---ccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLS---YCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~---~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||+||++++++.  ++++|||++..+.   ........+..+.|||++-                               
T Consensus       125 kp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------------------------------  171 (260)
T PF00069_consen  125 KPENILLDENGE--VKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQ-------------------------------  171 (260)
T ss_dssp             SGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHT-------------------------------
T ss_pred             cccccccccccc--ccccccccccccccccccccccccccccccccccc-------------------------------
Confidence            999999998777  8999999886431   1111111222233333221                               


Q ss_pred             cceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                          .-...+...|+|++|+++++|..|..|+..
T Consensus       172 ----~~~~~~~~~Di~slG~il~~l~~~~~p~~~  201 (260)
T PF00069_consen  172 ----QGKKYTRKSDIWSLGIILYELLTGKLPFEE  201 (260)
T ss_dssp             ----TTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred             ----cccccccccccccccccccccccccccccc
Confidence                001125567999999999999998865554

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.85  E-value=1.8e-21  Score=193.24  Aligned_cols=157  Identities=30%  Similarity=0.449  Sum_probs=119.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC--------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR--------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~--------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      +.+|+++++.++||||+++++.+.+.        ..+++||||+.+++...+......+++..+..++.|++.||.|||+
T Consensus        54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~  133 (311)
T cd07866          54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE  133 (311)
T ss_pred             HHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            46799999999999999999987543        3579999999998888877655679999999999999999999999


Q ss_pred             CceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         342 RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ++++||||||+||++++++.  ++++|||+++...........     +.                    ......    
T Consensus       134 ~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~-----~~--------------------~~~~~~----  182 (311)
T cd07866         134 NHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKG-----GG--------------------GGGTRK----  182 (311)
T ss_pred             CCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCccccc-----CC--------------------cccccc----
Confidence            99999999999999998877  999999998765422110000     00                    000000    


Q ss_pred             ccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         422 SKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       422 ~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                       .....+++.|++|         +...|+|++|+++++|..|.+|+
T Consensus       183 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~  227 (311)
T cd07866         183 -YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL  227 (311)
T ss_pred             -cccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence             0112344555555         34579999999999999998554

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.85  E-value=3.2e-21  Score=190.14  Aligned_cols=105  Identities=28%  Similarity=0.479  Sum_probs=94.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------------CCCChHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------------GGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------------~~l~~~~~~~~~~qi~~~  335 (481)
                      .+.+|+.++++++||||+++++++...+..+++|||++ ++|.+++....            ..+++..+..++.|++.|
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~a  132 (288)
T cd05093          53 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG  132 (288)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998 67888876432            248899999999999999


Q ss_pred             HHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       336 l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |+|||+++++||||||+||++++++.  +|++|||+++.+
T Consensus       133 L~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~  170 (288)
T cd05093         133 MVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDV  170 (288)
T ss_pred             HHHHHhCCeeecccCcceEEEccCCc--EEeccCCccccc
Confidence            99999999999999999999998777  999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.85  E-value=2.4e-22  Score=205.83  Aligned_cols=120  Identities=33%  Similarity=0.601  Sum_probs=97.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......                         .
T Consensus       112 i~~aL~~LH~~~ivH~dlkp----~Nili~~~----~~~kL~Dfg~a~~~~~~~-------------------------~  158 (372)
T cd07853         112 ILRGLKYLHSAGILHRDIKP----GNLLVNSN----CVLKICDFGLARVEEPDE-------------------------S  158 (372)
T ss_pred             HHHHHHHHHhCCeeCCCCCh----HHEEECCC----CCEEeccccceeecccCc-------------------------c
Confidence            78899999999999999999    89999876    799999999998432100                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ...                      ....+|+.|+|||++.+...|+.++||||+||++|||++|++||.+. +..++++
T Consensus       159 ~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~  215 (372)
T cd07853         159 KHM----------------------TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ-SPIQQLD  215 (372)
T ss_pred             ccC----------------------CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCC-CHHHHHH
Confidence            000                      01123889999999998777999999999999999999999999985 4458899


Q ss_pred             HHHHHhCCCCccCccc
Q psy3074         181 KIFKILGTPTEETWEG  196 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~  196 (481)
                      .|.+.++.|+.+.+..
T Consensus       216 ~i~~~~g~~~~~~~~~  231 (372)
T cd07853         216 LITDLLGTPSLEAMRS  231 (372)
T ss_pred             HHHHHcCCCCHHHHHH
Confidence            9999999998765543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.85  E-value=2.3e-22  Score=202.01  Aligned_cols=100  Identities=27%  Similarity=0.493  Sum_probs=81.0

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...                       
T Consensus        99 ~~~~q-i~~~L~~lH~~~ivHrDlkp----~NIll~~~----~~~kl~DfG~a~~~~-----------------------  146 (323)
T cd05571          99 FYGAE-IVSALGYLHSCDVVYRDLKL----ENLMLDKD----GHIKITDFGLCKEGI-----------------------  146 (323)
T ss_pred             HHHHH-HHHHHHHHHhCCeEeCCCCH----HHEEECCC----CCEEEeeCCCCcccc-----------------------
Confidence            33344 78899999999999999999    89999876    799999999997421                       


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                         ..+.....++|                      |+.|||||++.+.. |+.++||||+||++|||++|+.||.+.
T Consensus       147 ---~~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         147 ---SDGATMKTFCG----------------------TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             ---cCCCcccceec----------------------CccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCC
Confidence               11111112333                      99999999998765 999999999999999999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.84  E-value=2.9e-21  Score=188.20  Aligned_cols=105  Identities=21%  Similarity=0.392  Sum_probs=94.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+....++||||++ |+|.+++....+.+++..+..++.|++.|+.|||+++++||
T Consensus        51 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~  130 (269)
T cd05065          51 DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHR  130 (269)
T ss_pred             HHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            45679999999999999999999999999999999998 57777776655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  +|++|||++..+
T Consensus       131 dl~p~nili~~~~~--~kl~dfg~~~~~  156 (269)
T cd05065         131 DLAARNILVNSNLV--CKVSDFGLSRFL  156 (269)
T ss_pred             ccChheEEEcCCCc--EEECCCcccccc
Confidence            99999999987766  999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.84  E-value=7.8e-21  Score=184.81  Aligned_cols=106  Identities=22%  Similarity=0.417  Sum_probs=97.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..+++|||++ ++|.+++....+.+++..+..++.|++.|+.|||+++++|+
T Consensus        51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  130 (266)
T cd05033          51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR  130 (266)
T ss_pred             HHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            46679999999999999999999999999999999998 57888887766678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  ++++|||+++.+.
T Consensus       131 di~p~nili~~~~~--~~l~dfg~~~~~~  157 (266)
T cd05033         131 DLAARNILVNSNLV--CKVSDFGLSRRLE  157 (266)
T ss_pred             CCCcceEEEcCCCC--EEECccchhhccc
Confidence            99999999998777  9999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.84  E-value=2.5e-22  Score=201.67  Aligned_cols=117  Identities=23%  Similarity=0.411  Sum_probs=89.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus       100 ~~~~~~~~~q-i~~aL~~LH~~~ivHrDlkp----~Nill~~~----~~~kL~DfG~~~~~~~~----------------  154 (323)
T cd05616         100 EPHAVFYAAE-IAIGLFFLHSKGIIYRDLKL----DNVMLDSE----GHIKIADFGMCKENMWD----------------  154 (323)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCEEecCCCH----HHeEECCC----CcEEEccCCCceecCCC----------------
Confidence            3334445555 78899999999999999999    89999876    79999999999742110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                +......+                      +|+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       155 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf  201 (323)
T cd05616         155 ----------GVTTKTFC----------------------GTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPF  201 (323)
T ss_pred             ----------CCccccCC----------------------CChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCC
Confidence                      00011122                      399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFKI  185 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~  185 (481)
                      .+.+. .+.+..|...
T Consensus       202 ~~~~~-~~~~~~i~~~  216 (323)
T cd05616         202 EGEDE-DELFQSIMEH  216 (323)
T ss_pred             CCCCH-HHHHHHHHhC
Confidence            88543 3555555543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.84  E-value=2.9e-21  Score=187.65  Aligned_cols=106  Identities=22%  Similarity=0.432  Sum_probs=94.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++||||+++++++...+..+++|||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H  127 (263)
T cd05052          48 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH  127 (263)
T ss_pred             HHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            35679999999999999999999999999999999998 67888776533 35888889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  +|++|||++..+.
T Consensus       128 ~dlkp~nil~~~~~~--~kl~df~~~~~~~  155 (263)
T cd05052         128 RDLAARNCLVGENHL--VKVADFGLSRLMT  155 (263)
T ss_pred             cccCcceEEEcCCCc--EEeCCCccccccc
Confidence            999999999988776  9999999987543

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.84  E-value=3.8e-21  Score=190.56  Aligned_cols=104  Identities=25%  Similarity=0.439  Sum_probs=92.2

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+++++++ +||||+++++++...+..|++|||++ |+|.+++....               ..+++..+..++.|
T Consensus        48 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  127 (297)
T cd05089          48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD  127 (297)
T ss_pred             HHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHH
Confidence            466799999999 79999999999999999999999998 78888876432               24778899999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ++.|++|||+.+++||||||+|||+++++.  +|++|||++..
T Consensus       128 i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~  168 (297)
T cd05089         128 VATGMQYLSEKQFIHRDLAARNVLVGENLA--SKIADFGLSRG  168 (297)
T ss_pred             HHHHHHHHHHCCcccCcCCcceEEECCCCe--EEECCcCCCcc
Confidence            999999999999999999999999988766  89999998764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.84  E-value=1.5e-21  Score=196.82  Aligned_cols=103  Identities=37%  Similarity=0.704  Sum_probs=91.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+|+.+|+.++||||+++++++..    ...+++||||+.|++.+++... +.+++..+..++.|++.||.|||+.+++
T Consensus        51 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~iv  129 (334)
T cd07855          51 TLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVI  129 (334)
T ss_pred             HHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4579999999999999999998863    3578999999999888877543 4589999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||||+||++++++.  +|++|||++..+
T Consensus       130 H~dlkp~Nil~~~~~~--~kl~dfg~~~~~  157 (334)
T cd07855         130 HRDLKPSNLLVNEDCE--LRIGDFGMARGL  157 (334)
T ss_pred             cCCCCHHHEEEcCCCc--EEecccccceee
Confidence            9999999999998877  999999988754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.84  E-value=5e-21  Score=187.94  Aligned_cols=104  Identities=21%  Similarity=0.350  Sum_probs=91.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.. ...++++||++ |+|.+++....+.+++..+..++.|++.||.|||+++++||
T Consensus        55 ~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~  133 (279)
T cd05111          55 EITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR  133 (279)
T ss_pred             HHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            34568889999999999999998754 45788999998 88999887766678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++++.  +|++|||+++.+
T Consensus       134 dlkp~nili~~~~~--~kl~Dfg~~~~~  159 (279)
T cd05111         134 NLAARNILLKSDSI--VQIADFGVADLL  159 (279)
T ss_pred             ccCcceEEEcCCCc--EEEcCCccceec
Confidence            99999999988766  999999998754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.84  E-value=3.2e-21  Score=191.77  Aligned_cols=104  Identities=26%  Similarity=0.468  Sum_probs=92.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.++.++ +||||+++++++.+.+..|+||||++ |+|.+++....               ..+++..+..++.|
T Consensus        53 ~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  132 (303)
T cd05088          53 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD  132 (303)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHH
Confidence            456799999999 89999999999999999999999998 67888876432               24788899999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ++.|++|||+++++||||||+|||+++++.  +|++|||++..
T Consensus       133 i~~al~~LH~~gi~H~dlkp~Nili~~~~~--~kl~dfg~~~~  173 (303)
T cd05088         133 VARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRG  173 (303)
T ss_pred             HHHHHHHHHhCCccccccchheEEecCCCc--EEeCccccCcc
Confidence            999999999999999999999999988776  99999998753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.84  E-value=1.7e-21  Score=196.59  Aligned_cols=147  Identities=29%  Similarity=0.466  Sum_probs=114.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +.+|+.++++++||||+++++++...     ..+|++|||+.+++...+..  ..+++..+..++.|++.||.|||+.++
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~i  127 (336)
T cd07849          50 TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANV  127 (336)
T ss_pred             HHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            45799999999999999999987654     35899999999988877643  468999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++..+.  +|++|||+++..........                                      ...
T Consensus       128 vH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~--------------------------------------~~~  167 (336)
T cd07849         128 LHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTG--------------------------------------FLT  167 (336)
T ss_pred             eccCCCHHHEEECCCCC--EEECcccceeeccccccccC--------------------------------------CcC
Confidence            99999999999998777  99999998875431110000                                      000


Q ss_pred             cccceeccCCC---------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         425 NINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       425 ~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ...++..|++|         +..+|+||+|+++++|..|..|+
T Consensus       168 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f  210 (336)
T cd07849         168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF  210 (336)
T ss_pred             CcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            01233333333         44579999999999999998655

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.84  E-value=3.3e-21  Score=191.16  Aligned_cols=146  Identities=21%  Similarity=0.315  Sum_probs=116.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++.+...+..|+||||++ +++.+++..  ..+++..+..++.|++.||.|||+.+++|||
T Consensus        63 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~d  140 (297)
T cd06656          63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRD  140 (297)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            5679999999999999999999999999999999998 567776643  4588889999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+||+++.++.  ++++|||++..+.......  .                                       ...+
T Consensus       141 L~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~--~---------------------------------------~~~~  177 (297)
T cd06656         141 IKSDNILLGMDGS--VKLTDFGFCAQITPEQSKR--S---------------------------------------TMVG  177 (297)
T ss_pred             CCHHHEEECCCCC--EEECcCccceEccCCccCc--C---------------------------------------cccC
Confidence            9999999988776  9999999886543111000  0                                       0112


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++.|++|        +...|+|++|+++++|..|..|+..
T Consensus       178 ~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             CccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            2223333        4567999999999999999866643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.84  E-value=2.1e-21  Score=191.49  Aligned_cols=135  Identities=53%  Similarity=0.986  Sum_probs=107.9

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.+ .+.||.|||+++|+||||||    +|||++..    |.+||+|||+|+........                   
T Consensus       108 ~~~q-i~~~L~~lH~~~i~H~dlkp----~Nil~~~~----~~~~l~Dfg~~~~~~~~~~~-------------------  159 (291)
T cd07870         108 FMFQ-LLRGLAYIHGQHILHRDLKP----QNLLISYL----GELKLADFGLARAKSIPSQT-------------------  159 (291)
T ss_pred             HHHH-HHHHHHHHHhCCcccCCCCh----HHEEEcCC----CcEEEeccccccccCCCCCC-------------------
Confidence            4444 78899999999999999999    89999765    79999999999743211000                   


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                             ..                      ...+++.|+|||++.+...++.++|+||+||++|||++|.+||.+..+.
T Consensus       160 -------~~----------------------~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~  210 (291)
T cd07870         160 -------YS----------------------SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV  210 (291)
T ss_pred             -------CC----------------------CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence                   00                      0112888999999987666899999999999999999999999988877


Q ss_pred             HHHHHHHHHHhCCCCccCcccccCCCCCCccC
Q psy3074         176 YDQLDKIFKILGTPTEETWEGVSLLPGYNVHR  207 (481)
Q Consensus       176 ~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~  207 (481)
                      .+++.++....+.|.+..++....++.+....
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         211 FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             HHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            88899998889999888888877666554433

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.84  E-value=4e-21  Score=186.21  Aligned_cols=106  Identities=26%  Similarity=0.474  Sum_probs=94.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++|+||+++++.+.+.+..+++|||+. |++.+++.... ..+++..+..++.|++.||.|||+.+++|
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H  126 (261)
T cd05072          47 AFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH  126 (261)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            45679999999999999999999999999999999998 68888876543 45788889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||+++.++.  +++.|||++..+.
T Consensus       127 ~dl~p~nili~~~~~--~~l~dfg~~~~~~  154 (261)
T cd05072         127 RDLRAANVLVSESLM--CKIADFGLARVIE  154 (261)
T ss_pred             cccchhhEEecCCCc--EEECCCccceecC
Confidence            999999999998776  8999999987543

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.84  E-value=5.2e-21  Score=187.89  Aligned_cols=103  Identities=27%  Similarity=0.494  Sum_probs=90.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+++++.++||||+++++++...  ..++++|||+. |++.+++..  ..+++..+..++.|++.||.|||+++++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~  129 (283)
T cd05080          52 GWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYI  129 (283)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            456899999999999999999987653  46899999998 677777754  3589999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||||+||++++++.  ++++|||+++.+
T Consensus       130 H~dlkp~Nili~~~~~--~~l~dfg~~~~~  157 (283)
T cd05080         130 HRDLAARNVLLDNDRL--VKIGDFGLAKAV  157 (283)
T ss_pred             ccccChheEEEcCCCc--EEEeeccccccc
Confidence            9999999999988766  999999998754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.84  E-value=5.4e-21  Score=185.80  Aligned_cols=153  Identities=27%  Similarity=0.418  Sum_probs=119.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++...+..+++|||++ ++|..++... +.+++..+..++.|++.||+|||+.+++||
T Consensus        52 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~  130 (267)
T cd06628          52 ALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHR  130 (267)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            45679999999999999999999999999999999998 5677777553 568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||+++.+........    .   +                     +       ......
T Consensus       131 di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~----~---~---------------------~-------~~~~~~  173 (267)
T cd06628         131 DIKGANILVDNKGG--IKISDFGISKKLEANSLSTK----T---N---------------------G-------ARPSLQ  173 (267)
T ss_pred             cCCHHHEEEcCCCC--EEecccCCCcccccccccCC----c---c---------------------c-------cccccC
Confidence            99999999988776  99999999876542110000    0   0                     0       000122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++..|++|        +..+|+|++|+++++|..|..|+.
T Consensus       174 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~  213 (267)
T cd06628         174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP  213 (267)
T ss_pred             CCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence            33444444        346799999999999999986654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.84  E-value=9.6e-21  Score=183.93  Aligned_cols=153  Identities=23%  Similarity=0.332  Sum_probs=119.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++|+||+++++++.+.+..+++|||++ ++|.+++... +.+++..+..++.|++.||+|||+.+++|+
T Consensus        48 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  126 (265)
T cd06631          48 KLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHR  126 (265)
T ss_pred             HHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            35679999999999999999999999999999999998 5777777543 568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||++..+.........+.       .                            .....
T Consensus       127 dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~-------~----------------------------~~~~~  169 (265)
T cd06631         127 DIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSN-------M----------------------------LKSMH  169 (265)
T ss_pred             CcCHHhEEECCCCe--EEeccchhhHhhhhccccccccc-------c----------------------------ccccC
Confidence            99999999998777  99999999886532111000000       0                            00012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++..|++|        +...|+|++|+++++|..|..|+.
T Consensus       170 ~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~  209 (265)
T cd06631         170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA  209 (265)
T ss_pred             CCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccc
Confidence            33344444        456899999999999999997664

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.84  E-value=2.3e-21  Score=191.70  Aligned_cols=106  Identities=43%  Similarity=0.685  Sum_probs=95.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|++++++++|+||+++++++.+.+..++||||+.|+|.+++......+++..+..++.|++.||.|||+++++|+|
T Consensus        48 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d  127 (298)
T cd07841          48 TALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRD  127 (298)
T ss_pred             HHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecC
Confidence            35579999999999999999999999999999999998888888765443689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||+||+++.++.  ++++|||+++...
T Consensus       128 l~p~nill~~~~~--~~l~dfg~~~~~~  153 (298)
T cd07841         128 LKPNNLLIASDGV--LKLADFGLARSFG  153 (298)
T ss_pred             CChhhEEEcCCCC--EEEccceeeeecc
Confidence            9999999998776  9999999987554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.84  E-value=3.2e-21  Score=188.96  Aligned_cols=106  Identities=41%  Similarity=0.660  Sum_probs=96.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++|||++++++++.+.  +..++||||+++++..++......+++..+..++.|++.||.|||+.+++|
T Consensus        44 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h  123 (287)
T cd07840          44 TAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILH  123 (287)
T ss_pred             HHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            456799999999999999999999988  899999999999988888765457899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +||||+||++++++.  ++++|||++..+.
T Consensus       124 ~dl~p~nil~~~~~~--~~l~d~g~~~~~~  151 (287)
T cd07840         124 RDIKGSNILINNDGV--LKLADFGLARPYT  151 (287)
T ss_pred             ccCcHHHeEEcCCCC--EEEccccceeecc
Confidence            999999999998877  9999999887554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0984|consensus

Probab=99.84  E-value=5.3e-22  Score=178.38  Aligned_cols=107  Identities=22%  Similarity=0.356  Sum_probs=86.5

Q ss_pred             ccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          21 KLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        21 ~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      .+.|+.|||+ .+|||||+||    +|||+|..    |++|+||||++..+..                           
T Consensus       157 vv~al~~L~~kL~vIHRDvKP----sNiLIn~~----GqVKiCDFGIsG~L~d---------------------------  201 (282)
T KOG0984|consen  157 VVHALEFLHSKLSVIHRDVKP----SNILINYD----GQVKICDFGISGYLVD---------------------------  201 (282)
T ss_pred             HHHHHHHHHHHhhhhhccCCc----ceEEEccC----CcEEEcccccceeehh---------------------------
Confidence            6789999995 4999999999    99999988    8999999999964321                           


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCchhhH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG---STEYSTSLDMWGVGCILIEMVTGLPTFPGVREVY  176 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~---~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~  176 (481)
                       |.+.+                     ...|+-.|||||.+..   ..+|+.++||||+|+.+.||.+++.||+.-....
T Consensus       202 -SiAkt---------------------~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF  259 (282)
T KOG0984|consen  202 -SIAKT---------------------MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF  259 (282)
T ss_pred             -hhHHH---------------------HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence             11111                     1123778999999865   3469999999999999999999999999877777


Q ss_pred             HHHHHHHH
Q psy3074         177 DQLDKIFK  184 (481)
Q Consensus       177 ~~l~~i~~  184 (481)
                      +||.++.+
T Consensus       260 ~qLkqvVe  267 (282)
T KOG0984|consen  260 QQLKQVVE  267 (282)
T ss_pred             HHHHHHhc
Confidence            88877654

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.84  E-value=5.3e-22  Score=199.36  Aligned_cols=116  Identities=25%  Similarity=0.481  Sum_probs=88.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                 
T Consensus       100 ~~~~~~~~~q-i~~al~~lH~~~ivH~dlkp----~Nill~~~----~~~kL~Dfg~~~~~~~-----------------  153 (324)
T cd05587         100 EPHAVFYAAE-IAIGLFFLHSKGIIYRDLKL----DNVMLDAE----GHIKIADFGMCKENIF-----------------  153 (324)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeEecCCCH----HHeEEcCC----CCEEEeecCcceecCC-----------------
Confidence            3334444454 78899999999999999999    89999876    7999999999973210                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .+......+|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||
T Consensus       154 ---------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf  201 (324)
T cd05587         154 ---------GGKTTRTFCG----------------------TPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPF  201 (324)
T ss_pred             ---------CCCceeeecC----------------------CccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCC
Confidence                     0011112233                      99999999998766 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFK  184 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~  184 (481)
                      .+.+. .+.+..+..
T Consensus       202 ~~~~~-~~~~~~i~~  215 (324)
T cd05587         202 DGEDE-DELFQSIME  215 (324)
T ss_pred             CCCCH-HHHHHHHHc
Confidence            87533 345555543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.84  E-value=6.6e-22  Score=191.49  Aligned_cols=197  Identities=16%  Similarity=0.170  Sum_probs=141.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.. +..++||||++ |+|.+++.. ...+++..+..++.|++.||.|+|+++++||
T Consensus        42 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~  119 (257)
T cd05116          42 ELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHR  119 (257)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            46679999999999999999998764 46789999999 668777754 3568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc------CceeccccCCCcccc----cccccccCCCeeEEEeec-CCC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR------RRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSG  416 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~------~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~  416 (481)
                      ||||+||++++++.  +|++|||+++.+.....      .......+.+|+.+-    +...+.||+|++++++.+ |..
T Consensus       120 dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~  197 (257)
T cd05116         120 DLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK  197 (257)
T ss_pred             ccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence            99999999998766  99999999987643221      111123456666553    235677999999999997 999


Q ss_pred             CccccccCc----c-cceeccCCCCCChhhhhhHHHHHHhhCCCccccccccccCcee
Q psy3074         417 GWWFESKSN----I-NLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTL  469 (481)
Q Consensus       417 ~~~~~~~~~----~-~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~~~  469 (481)
                      ||.......    + .+...-.++..|.+.+++...+......+.|.+.++...+.+.
T Consensus       198 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         198 PYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            987543211    1 1111122334555555444444443445567777776655543

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.84  E-value=6.4e-21  Score=184.96  Aligned_cols=150  Identities=25%  Similarity=0.338  Sum_probs=118.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.++++++|+||+++++++.+.+..+++|||++ |+|..++...   ...+++..+..++.|++.|+.|||+.++
T Consensus        48 ~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  127 (267)
T cd08224          48 DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRI  127 (267)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            45679999999999999999999999999999999998 6788777542   2347889999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++.++.  ++++|||++..+.......  .                                       
T Consensus       128 ~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~--~---------------------------------------  164 (267)
T cd08224         128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAA--H---------------------------------------  164 (267)
T ss_pred             ecCCcChhhEEECCCCc--EEEeccceeeeccCCCccc--c---------------------------------------
Confidence            99999999999998776  9999999876543110000  0                                       


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...+++.|++|        ..++|+|++|+++++|..|..|+..+
T Consensus       165 ~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             eecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence            00112222222        34679999999999999998776544

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.84  E-value=1.6e-21  Score=189.78  Aligned_cols=152  Identities=18%  Similarity=0.121  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++..+...+++|||++ |.+..++......+++..+..++.|++.||+|||+++|+||
T Consensus        50 ~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  129 (262)
T cd05077          50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHG  129 (262)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence            45678999999999999999999999999999999999 55666665555668999999999999999999999999999


Q ss_pred             cCCCccccccccch-----hhHHHHHHHHHhhccccccCceeccccCCCcccc-----cccccccCCCeeEEEee-cCCC
Q psy3074         348 DVKPQNLLISEIDH-----HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-----SEIVFTNLSGVVVSTVD-SGSG  416 (481)
Q Consensus       348 DlKp~NiLl~~~~~-----~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~-----~~~~~~~s~g~~~~~~~-~g~~  416 (481)
                      ||||+|||++.++.     ..+++.|||++..+... ...+.+..+.+|+++.     +...+.|++|++++++. .|..
T Consensus       130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~  208 (262)
T cd05077         130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI  208 (262)
T ss_pred             CCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            99999999976442     13789999988754322 1222334467777664     23457899999999987 4787


Q ss_pred             Ccccc
Q psy3074         417 GWWFE  421 (481)
Q Consensus       417 ~~~~~  421 (481)
                      |+...
T Consensus       209 p~~~~  213 (262)
T cd05077         209 PLKDK  213 (262)
T ss_pred             CCCCc
Confidence            77643

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.84  E-value=7.2e-21  Score=185.19  Aligned_cols=149  Identities=23%  Similarity=0.306  Sum_probs=115.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.++++++||||+++++++.+  ...++++|||++ ++|.+.+... +.+++.....++.|++.||.|||+.+++
T Consensus        50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~  128 (266)
T cd06651          50 ALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIV  128 (266)
T ss_pred             HHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35679999999999999999999875  367899999998 5787777653 4588899999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  ++++|||+++.+.........                                      ...
T Consensus       129 H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~--------------------------------------~~~  168 (266)
T cd06651         129 HRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTG--------------------------------------IRS  168 (266)
T ss_pred             eCCCCHHHEEECCCCC--EEEccCCCccccccccccCCc--------------------------------------ccc
Confidence            9999999999988776  999999998765421100000                                      000


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ..++..|++|        +..+|+|++|+++++|..|..|+
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf  209 (266)
T cd06651         169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW  209 (266)
T ss_pred             CCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence            1233334444        34579999999999999998664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.84  E-value=3.3e-21  Score=194.47  Aligned_cols=149  Identities=30%  Similarity=0.473  Sum_probs=116.1

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecC--CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTR--STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~--~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+|+.+++++ +||||+++++++...  ...|+||||++++|...+...  .+++.....++.|++.||.|||+.+++|
T Consensus        53 ~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H  130 (337)
T cd07852          53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIH  130 (337)
T ss_pred             hhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            45699999999 999999999998653  468999999999988877653  6788888999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||+++.++.  +|++|||++..+.......        .+                            ......
T Consensus       131 ~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~--------~~----------------------------~~~~~~  172 (337)
T cd07852         131 RDLKPSNILLNSDCR--VKLADFGLARSLSELEENP--------EN----------------------------PVLTDY  172 (337)
T ss_pred             CCCCHHHEEEcCCCc--EEEeeccchhccccccccc--------cC----------------------------cchhcc
Confidence            999999999998887  9999999988654221100        00                            000001


Q ss_pred             cceeccCCC---------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         427 NLSFHYLPP---------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      .+++.|++|         +..+|+|++|+++++|.+|..|+
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf  213 (337)
T cd07852         173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF  213 (337)
T ss_pred             cccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC
Confidence            233334444         34579999999999999998665

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.84  E-value=4.8e-21  Score=188.37  Aligned_cols=106  Identities=22%  Similarity=0.484  Sum_probs=94.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+++++.++||||+++++++.+.  ...++||||++ ++|.+++......+++..+..++.|++.||.|||+++++
T Consensus        52 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~  131 (284)
T cd05079          52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYV  131 (284)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            456899999999999999999998875  57899999998 678888766545688999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||||+||+++.++.  ++++|||+++.+.
T Consensus       132 H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~  160 (284)
T cd05079         132 HRDLAARNVLVESEHQ--VKIGDFGLTKAIE  160 (284)
T ss_pred             ecccchheEEEcCCCC--EEECCCccccccc
Confidence            9999999999988776  9999999987653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.84  E-value=3.6e-21  Score=187.00  Aligned_cols=150  Identities=25%  Similarity=0.336  Sum_probs=118.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++||||+++++++..++..+++|||++ ++|.+++...   ...+++..+..++.|++.||.|||++++
T Consensus        48 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  127 (267)
T cd08229          48 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV  127 (267)
T ss_pred             HHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45679999999999999999999999999999999998 5777776532   2457899999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +|+||||+||+++.++.  ++++|||++..+......  .+.                                      
T Consensus       128 ~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~--~~~--------------------------------------  165 (267)
T cd08229         128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTA--AHS--------------------------------------  165 (267)
T ss_pred             ecCCCCHHHEEEcCCCC--EEECcchhhhccccCCcc--ccc--------------------------------------
Confidence            99999999999988776  999999998754321100  000                                      


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                       ..++..|++|        ...+|+|++|+++++|..|..|+..+
T Consensus       166 -~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             -ccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence             0122222222        34579999999999999998776543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.84  E-value=1e-21  Score=189.86  Aligned_cols=151  Identities=21%  Similarity=0.288  Sum_probs=122.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeee-ecCCeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIV-HTRSTLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~-~~~~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.++++++|+|++++++++ ...+..+++|||++ ++|.+++..... .+++..+..++.|++.||.|||+++++
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  124 (256)
T cd05082          45 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV  124 (256)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            456799999999999999999975 45567999999998 688888765433 378889999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccc----cccccCCCeeEEEeec-CCCCccc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE----IVFTNLSGVVVSTVDS-GSGGWWF  420 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~----~~~~~s~g~~~~~~~~-g~~~~~~  420 (481)
                      ||||||+||++++++.  +|++|||+++..............|.||+++...    ..+.|++|++++++.+ |..||..
T Consensus       125 H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         125 HRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             ccccchheEEEcCCCc--EEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999998777  9999999988654333222233457777776433    4567899999999986 8888865


Q ss_pred             c
Q psy3074         421 E  421 (481)
Q Consensus       421 ~  421 (481)
                      .
T Consensus       203 ~  203 (256)
T cd05082         203 I  203 (256)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.84  E-value=3.5e-21  Score=188.90  Aligned_cols=105  Identities=51%  Similarity=0.878  Sum_probs=94.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++.+.+..|++|||+++++..++.... ..+++..+..++.|++.||.|||+++++||
T Consensus        44 ~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~  123 (283)
T cd07835          44 TAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHR  123 (283)
T ss_pred             HHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            3567999999999999999999999999999999999988888876543 358999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+|+||++++++.  ++++|||++..+
T Consensus       124 dl~p~nil~~~~~~--~~l~df~~~~~~  149 (283)
T cd07835         124 DLKPQNLLIDREGA--LKLADFGLARAF  149 (283)
T ss_pred             CCCHHHEEEcCCCc--EEEeeccccccc
Confidence            99999999998776  999999998654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.84  E-value=7.1e-21  Score=185.52  Aligned_cols=104  Identities=18%  Similarity=0.293  Sum_probs=91.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.++++++||||+++++++.+....++||||++ |+|.+++....    ...++..+..++.|++.|+.|||+.+
T Consensus        41 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (269)
T cd05087          41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN  120 (269)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            45679999999999999999999999999999999998 67888776432    23556778889999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ++||||||+||+++..+.  +|++|||++..
T Consensus       121 i~H~dlkp~nil~~~~~~--~kL~dfg~~~~  149 (269)
T cd05087         121 FIHSDLALRNCLLTADLT--VKIGDYGLSHN  149 (269)
T ss_pred             EeccccCcceEEEcCCCc--EEECCcccccc
Confidence            999999999999988766  99999998864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.84  E-value=5.2e-21  Score=191.24  Aligned_cols=103  Identities=29%  Similarity=0.463  Sum_probs=94.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++++.++|||++++++++.+.+..|+||||+.|++...+......+++..+..++.|++.|+.|||+.+++|+|
T Consensus        67 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~d  146 (313)
T cd06633          67 DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD  146 (313)
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            35579999999999999999999999999999999999998888877666789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHh
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLR  373 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~  373 (481)
                      |||+||+++.++.  +|++|||++.
T Consensus       147 l~p~nili~~~~~--~kL~dfg~~~  169 (313)
T cd06633         147 IKAGNILLTEPGQ--VKLADFGSAS  169 (313)
T ss_pred             CChhhEEECCCCC--EEEeecCCCc
Confidence            9999999988776  9999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.84  E-value=5.9e-21  Score=185.59  Aligned_cols=105  Identities=25%  Similarity=0.413  Sum_probs=91.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++||||+++++.+.. +..|+||||++ |++.+++.... ..+++..+..++.|++.||.|+|+.+++|
T Consensus        47 ~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H  125 (262)
T cd05071          47 AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH  125 (262)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45679999999999999999998754 56899999998 68888886543 34788899999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  ++++|||.++.+.
T Consensus       126 ~dl~p~Nill~~~~~--~~L~dfg~~~~~~  153 (262)
T cd05071         126 RDLRAANILVGENLV--CKVADFGLARLIE  153 (262)
T ss_pred             cccCcccEEEcCCCc--EEeccCCceeecc
Confidence            999999999998776  9999999887543

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.84  E-value=1.4e-21  Score=192.29  Aligned_cols=124  Identities=38%  Similarity=0.639  Sum_probs=94.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||+.+|+||||||    +|||++..    |.+||+|||+|+......                   
T Consensus       103 ~~~~~q-i~~~L~~lH~~~i~H~dlkp----~Nill~~~----~~~kl~Dfg~~~~~~~~~-------------------  154 (287)
T cd07848         103 RSYIYQ-LIKAIHWCHKNDIVHRDIKP----ENLLISHN----DVLKLCDFGFARNLSEGS-------------------  154 (287)
T ss_pred             HHHHHH-HHHHHHHHHHCCeecCCCCH----HHEEEcCC----CcEEEeeccCcccccccc-------------------
Confidence            334444 78899999999999999999    89999765    799999999998432100                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                            ......+.                      +|+.|+|||++.+.. ++.++|+||+||++|||++|++||++.+
T Consensus       155 ------~~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~  205 (287)
T cd07848         155 ------NANYTEYV----------------------ATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGES  205 (287)
T ss_pred             ------cccccccc----------------------cccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence                  00000112                      389999999998766 9999999999999999999999999854


Q ss_pred             hhHHHHHHHHHHhCCCCccCcc
Q psy3074         174 EVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      . .+.+..+.+..+..+.+.+.
T Consensus       206 ~-~~~~~~~~~~~~~~~~~~~~  226 (287)
T cd07848         206 E-IDQLFTIQKVLGPLPAEQMK  226 (287)
T ss_pred             H-HHHHHHHHHhhCCCCHHHHH
Confidence            3 35666666666666555444

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.84  E-value=4.2e-21  Score=187.87  Aligned_cols=106  Identities=26%  Similarity=0.449  Sum_probs=94.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-------------CCCChHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-------------GGLDHHNIRLFMFQLL  333 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-------------~~l~~~~~~~~~~qi~  333 (481)
                      ..+.+|+++|+.++||||+++++++......+++|||++ ++|.+++....             ..+++..+..++.|++
T Consensus        53 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  132 (280)
T cd05049          53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA  132 (280)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHH
Confidence            356789999999999999999999999999999999998 67888876432             2367888999999999


Q ss_pred             HHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         334 RGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       334 ~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .|+.|+|+++++||||||+||+++.++.  +|++|||+++.+
T Consensus       133 ~~l~~lH~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~  172 (280)
T cd05049         133 SGMVYLASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDV  172 (280)
T ss_pred             HHHHHHhhCCeeccccccceEEEcCCCe--EEECCcccceec
Confidence            9999999999999999999999998877  999999988643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.84  E-value=9.3e-21  Score=184.19  Aligned_cols=150  Identities=22%  Similarity=0.315  Sum_probs=116.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.++++++||||+++++.+.+.  ...+++|||++ ++|.+.+... +.+++..+..++.|++.||.|||+++++
T Consensus        50 ~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~  128 (264)
T cd06653          50 ALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIV  128 (264)
T ss_pred             HHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            456799999999999999999998764  46899999998 5677777643 4588999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |+||||+||+++.++.  ++++|||+++.+.......        .                              ....
T Consensus       129 H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~--------~------------------------------~~~~  168 (264)
T cd06653         129 HRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSG--------T------------------------------GIKS  168 (264)
T ss_pred             cCCCCHHHEEEcCCCC--EEECccccccccccccccC--------c------------------------------cccc
Confidence            9999999999988776  9999999987643210000        0                              0001


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..++..|++|        +..+|+|++|+++++|..|..|+.
T Consensus       169 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  210 (264)
T cd06653         169 VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA  210 (264)
T ss_pred             cCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            1233334333        456799999999999999986654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1095|consensus

Probab=99.84  E-value=1.4e-21  Score=213.90  Aligned_cols=168  Identities=21%  Similarity=0.319  Sum_probs=137.1

Q ss_pred             ccccCCCCCCCCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh------cCCCChHHHH
Q psy3074         254 CEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH------SGGLDHHNIR  326 (481)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~------~~~l~~~~~~  326 (481)
                      +++......+.+....+++|+.+|+.++|||||++.+++-+....+|++|||+ |||..+++..      ...++..++.
T Consensus       726 aiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl  805 (1025)
T KOG1095|consen  726 AVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLL  805 (1025)
T ss_pred             EEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHH
Confidence            34444444555566789999999999999999999999999999999999998 8999999876      5678999999


Q ss_pred             HHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc---ccc-cCc-eeccccCCCcccc----cc
Q psy3074         327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCH-RRR-ILHRDVKPQNLLI----SE  397 (481)
Q Consensus       327 ~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~---~~~-~~~-i~~~d~~~~~il~----~~  397 (481)
                      .++.+|+.|+.||+++++|||||..+|+|++....  +|++|||+|+.+.   |.. ... ..---..|||.+.    ++
T Consensus       806 ~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~--VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFts  883 (1025)
T KOG1095|consen  806 AFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV--VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTS  883 (1025)
T ss_pred             HHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc--EEEcccchhHhhhhchheeccCccccceecCCHHHHhhccccc
Confidence            99999999999999999999999999999998755  9999999999553   222 111 2211234666664    55


Q ss_pred             cccccCCCeeEEEeec-CCCCcccccc
Q psy3074         398 IVFTNLSGVVVSTVDS-GSGGWWFESK  423 (481)
Q Consensus       398 ~~~~~s~g~~~~~~~~-g~~~~~~~~~  423 (481)
                      .-++||+|+.++|+.+ |..||...+.
T Consensus       884 kSDvWsFGVllWEifslG~~PY~~~~n  910 (1025)
T KOG1095|consen  884 KSDVWSFGVLLWEIFSLGATPYPSRSN  910 (1025)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCcch
Confidence            6678999999999998 9999987654

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.84  E-value=4.8e-21  Score=197.94  Aligned_cols=105  Identities=26%  Similarity=0.470  Sum_probs=91.3

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------------
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------------  317 (481)
                      .+.+|+.+|.++. |||||++++++..++.+++|||||+ |+|.+++....                             
T Consensus        86 ~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (401)
T cd05107          86 ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRK  165 (401)
T ss_pred             HHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccc
Confidence            4668999999998 9999999999999999999999998 78888875431                             


Q ss_pred             --------------------------------------------------------------------CCCChHHHHHHH
Q psy3074         318 --------------------------------------------------------------------GGLDHHNIRLFM  329 (481)
Q Consensus       318 --------------------------------------------------------------------~~l~~~~~~~~~  329 (481)
                                                                                          ..++...+..++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  245 (401)
T cd05107         166 SHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFS  245 (401)
T ss_pred             cchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHH
Confidence                                                                                124566678899


Q ss_pred             HHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       330 ~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .|++.||.|||+.+++||||||+|||+++.+.  +|++|||+++.+
T Consensus       246 ~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~--~kL~DfGla~~~  289 (401)
T cd05107         246 YQVANGMEFLASKNCVHRDLAARNVLICEGKL--VKICDFGLARDI  289 (401)
T ss_pred             HHHHHHHHHHhcCCcCcccCCcceEEEeCCCE--EEEEecCcceec
Confidence            99999999999999999999999999988766  999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.84  E-value=3.6e-21  Score=189.22  Aligned_cols=146  Identities=19%  Similarity=0.322  Sum_probs=116.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiH  346 (481)
                      .+.+|+++++.++||||+++++.+...+..++||||++ +++...+.. .+.+++..+..++.|++.||.|||+ .+++|
T Consensus        49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H  127 (284)
T cd06620          49 QILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMH  127 (284)
T ss_pred             HHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeec
Confidence            45679999999999999999999999999999999999 456655544 4568999999999999999999996 68999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||++++++.  ++++|||++..+......                                           ..
T Consensus       128 ~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~~~~-------------------------------------------~~  162 (284)
T cd06620         128 RDIKPSNILVNSRGQ--IKLCDFGVSGELINSIAD-------------------------------------------TF  162 (284)
T ss_pred             cCCCHHHEEECCCCc--EEEccCCcccchhhhccC-------------------------------------------cc
Confidence            999999999988776  999999987643211000                                           01


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +++..|++|        +.++|+|++|+++++|..|..|+..
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF  204 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            122223222        5578999999999999999877653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.84  E-value=4.2e-21  Score=185.93  Aligned_cols=104  Identities=20%  Similarity=0.343  Sum_probs=94.0

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++.... ..+++..+..++.|++.|+.|||+++++||
T Consensus        49 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~  128 (261)
T cd05148          49 FQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR  128 (261)
T ss_pred             HHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            4579999999999999999999999999999999998 68888886543 358889999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++++.  +|++|||++..+
T Consensus       129 dl~~~nilv~~~~~--~kl~d~g~~~~~  154 (261)
T cd05148         129 DLAARNILVGEDLV--CKVADFGLARLI  154 (261)
T ss_pred             ccCcceEEEcCCce--EEEccccchhhc
Confidence            99999999998777  999999998754

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.84  E-value=1.9e-21  Score=187.87  Aligned_cols=152  Identities=18%  Similarity=0.186  Sum_probs=122.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.. ...++||||++ |+|.+++......+++..+..++.|++.||.|||+++++|
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H  124 (259)
T cd05037          46 LAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH  124 (259)
T ss_pred             HHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence            456789999999999999999999988 77899999998 6777777665547899999999999999999999999999


Q ss_pred             ccCCCccccccccchh-----hHHHHHHHHHhhccccccCceeccccCCCcccccc------cccccCCCeeEEEeec-C
Q psy3074         347 RDVKPQNLLISEIDHH-----NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE------IVFTNLSGVVVSTVDS-G  414 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~-----~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~------~~~~~s~g~~~~~~~~-g  414 (481)
                      |||||+||+++..+..     .+|++|||++..+.. .........+.+|+++...      ..+.|++|++++++.+ |
T Consensus       125 ~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~  203 (259)
T cd05037         125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG  203 (259)
T ss_pred             ccCccceEEEecCccccCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCC
Confidence            9999999999876621     499999999887543 1122233456777776443      4667899999999888 5


Q ss_pred             CCCcccc
Q psy3074         415 SGGWWFE  421 (481)
Q Consensus       415 ~~~~~~~  421 (481)
                      ..||...
T Consensus       204 ~~p~~~~  210 (259)
T cd05037         204 EEPLSTL  210 (259)
T ss_pred             CCCcccC
Confidence            6666544

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.84  E-value=4.1e-21  Score=194.58  Aligned_cols=152  Identities=25%  Similarity=0.445  Sum_probs=113.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|+.++||||+++++++....      ..++||||+.+++...+..  ..+++..+..++.|++.||.|||+.
T Consensus        60 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~  137 (343)
T cd07880          60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA  137 (343)
T ss_pred             HHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3567999999999999999999997654      4589999998778776653  4689999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+||++++.+.  ++++|||++..+.........+..+.+|+.+.+                          
T Consensus       138 gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------  189 (343)
T cd07880         138 GIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDSEMTGYVVTRWYRAPEVILN--------------------------  189 (343)
T ss_pred             CeecCCCCHHHEEEcCCCC--EEEeecccccccccCccccccCCcccCHHHHhC--------------------------
Confidence            9999999999999998776  999999988754321111111112222222110                          


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                               ....+...|+|++|+++++|..|..|+-
T Consensus       190 ---------~~~~~~~~Di~slG~ll~~l~~g~~pf~  217 (343)
T cd07880         190 ---------WMHYTQTVDIWSVGCIMAEMLTGKPLFK  217 (343)
T ss_pred             ---------CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                     0112445788999999999988886553

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.84  E-value=4e-21  Score=190.58  Aligned_cols=147  Identities=17%  Similarity=0.314  Sum_probs=116.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..|++|||++ +++...+..  ..+++..+..++.|++.||.|||+++++||
T Consensus        64 ~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  141 (297)
T cd06659          64 LLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHR  141 (297)
T ss_pred             HHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            35679999999999999999999999999999999998 566665533  458999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+.......  .                                       ...
T Consensus       142 dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~--~---------------------------------------~~~  178 (297)
T cd06659         142 DIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKR--K---------------------------------------SLV  178 (297)
T ss_pred             CCCHHHeEEccCCc--EEEeechhHhhcccccccc--c---------------------------------------cee
Confidence            99999999998877  9999999987543111000  0                                       011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++..|++|        +...|+|++|+++++|..|..|++.
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  219 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS  219 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22222222        4568999999999999999877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.84  E-value=6.8e-21  Score=186.58  Aligned_cols=107  Identities=20%  Similarity=0.380  Sum_probs=93.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++|+||+++++++.+.+..+++|||+. ++|.+++....      ..+++..+..++.||+.|++|||+
T Consensus        55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  134 (277)
T cd05036          55 DFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE  134 (277)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999997 67888876543      247888999999999999999999


Q ss_pred             CceeeccCCCccccccccc-hhhHHHHHHHHHhhc
Q psy3074         342 RRILHRDVKPQNLLISEID-HHNIRLFMFQLLRGL  375 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~-~~~ikl~dfgla~~~  375 (481)
                      ++++||||||+||+++..+ ...+|++|||+++.+
T Consensus       135 ~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036         135 NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             CCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence            9999999999999998654 235899999998765

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.84  E-value=1e-21  Score=197.78  Aligned_cols=133  Identities=34%  Similarity=0.581  Sum_probs=100.5

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                
T Consensus       103 ~~~~~i~~q-i~~aL~~LH~~~ivH~dlkp----~NIll~~~----~~~kL~Dfg~~~~~~~~~----------------  157 (338)
T cd07859         103 EHHQFFLYQ-LLRALKYIHTANVFHRDLKP----KNILANAD----CKLKICDFGLARVAFNDT----------------  157 (338)
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeecCCCCH----HHeEECCC----CcEEEccCcccccccccc----------------
Confidence            333444444 78899999999999999999    89999876    799999999998421100                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                             .......                      ...+|+.|+|||++.+. ..|+.++||||+||++|||++|++||
T Consensus       158 -------~~~~~~~----------------------~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf  208 (338)
T cd07859         158 -------PTAIFWT----------------------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF  208 (338)
T ss_pred             -------Ccccccc----------------------CCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC
Confidence                   0000000                      12249999999998762 45899999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      .+. +...++..+....+.|+++.+..+.
T Consensus       209 ~~~-~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         209 PGK-NVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CCC-ChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            985 4457788888888988877665543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.84  E-value=4.5e-21  Score=188.61  Aligned_cols=124  Identities=41%  Similarity=0.707  Sum_probs=98.8

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.......                   
T Consensus       112 ~~~~q-i~~al~~lH~~~ivH~dikp----~Nili~~~----~~~kl~dfg~~~~~~~~~~-------------------  163 (288)
T cd07863         112 DLMRQ-FLRGLDFLHANCIVHRDLKP----ENILVTSG----GQVKLADFGLARIYSCQMA-------------------  163 (288)
T ss_pred             HHHHH-HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEECccCccccccCccc-------------------
Confidence            33444 78899999999999999999    89999876    7999999999974321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                              .                      ....+|+.|+|||++.+.. ++.++||||+||++|||++|++||.+..+
T Consensus       164 --------~----------------------~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~  212 (288)
T cd07863         164 --------L----------------------TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE  212 (288)
T ss_pred             --------C----------------------CCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence                    0                      0012388999999998765 99999999999999999999999988544


Q ss_pred             hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                       .+.+.++....+.|....|+...
T Consensus       213 -~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         213 -ADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             -HHHHHHHHHHhCCCChhhCcccc
Confidence             47888899988888887777543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.84  E-value=1.3e-21  Score=191.81  Aligned_cols=193  Identities=17%  Similarity=0.215  Sum_probs=137.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++... ..+++|||++ |++.+.+....+.+++..+..++.|++.||.|||+++++||
T Consensus        55 ~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~  133 (279)
T cd05109          55 EILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHR  133 (279)
T ss_pred             HHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            456799999999999999999998754 5789999998 78888887656678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc-----CceeccccCCCcccc----cccccccCCCeeEEEeec-CCCC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR-----RRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGG  417 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~-----~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~  417 (481)
                      ||||+|||+++++.  +|++|||+++.+.....     ....+..+.+|+.+.    +...+.|++|++++++.+ |..|
T Consensus       134 dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         134 DLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccccceEEEcCCCc--EEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            99999999987776  99999999986642211     111223466777664    334578999999999887 8888


Q ss_pred             ccccccCccccee--ccCCCCCChhhhhhHHHHHHhhCCC---ccccccccc
Q psy3074         418 WWFESKSNINLSF--HYLPPGAPFTAIREASLLKELKHNN---IVTLHDIVH  464 (481)
Q Consensus       418 ~~~~~~~~~~~t~--~y~~p~~p~~~~s~~~~l~~l~~~~---~~~~~~~~~  464 (481)
                      |.......+....  ....+..+....++..++..++..+   .|.+.++..
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         212 YDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8643221111000  0111112222345556666666543   355555543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.84  E-value=1.7e-21  Score=198.96  Aligned_cols=147  Identities=22%  Similarity=0.332  Sum_probs=88.8

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........            ..+.
T Consensus       103 ~~~~~~q-i~~aL~~lH~~givHrDlKp----~NILi~~~----~~vkL~DFGla~~~~~~~~~------------~~~~  161 (363)
T cd05628         103 TQFYIAE-TVLAIDSIHQLGFIHRDIKP----DNLLLDSK----GHVKLSDFGLCTGLKKAHRT------------EFYR  161 (363)
T ss_pred             HHHHHHH-HHHHHHHHHhCCeEecCCCH----HHeEECCC----CCEEEeeccCcccccccccc------------cccc
Confidence            3334444 68899999999999999999    89999865    79999999999854211100            0000


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                      .........+...... .......+...........++|+.|||||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       162 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         162 NLNHSLPSDFTFQNMN-SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccc-cccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence            0000000000000000 00000000000000011234699999999998765 999999999999999999999999874


Q ss_pred             hhhHHHHHHHH
Q psy3074         173 REVYDQLDKIF  183 (481)
Q Consensus       173 ~~~~~~l~~i~  183 (481)
                      + ..+.+.+|.
T Consensus       240 ~-~~~~~~~i~  249 (363)
T cd05628         240 T-PQETYKKVM  249 (363)
T ss_pred             C-HHHHHHHHH
Confidence            3 234444444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.84  E-value=8.2e-21  Score=186.03  Aligned_cols=105  Identities=27%  Similarity=0.433  Sum_probs=94.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++.++||||+++++++...+..|+||||++ ++|.+.+.... ..+++..+..++.|++.||.|||+.+++||
T Consensus        40 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~  119 (277)
T cd05577          40 ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR  119 (277)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            4579999999999999999999999999999999998 67877776543 258999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|+||++++++.  ++++|||++..+.
T Consensus       120 di~p~Nil~~~~~~--~~l~dfg~~~~~~  146 (277)
T cd05577         120 DLKPENVLLDDHGN--VRISDLGLAVELK  146 (277)
T ss_pred             CCCHHHEEECCCCC--EEEccCcchhhhc
Confidence            99999999998776  9999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0608|consensus

Probab=99.84  E-value=1.8e-21  Score=198.61  Aligned_cols=141  Identities=25%  Similarity=0.363  Sum_probs=93.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeeccccccccc--CCCCCcCCCCCCCCCcc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKS--VPSHTYSHQGDSPFGKA   88 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~--~~~~~~~~~~~~~~~~~   88 (481)
                      +-.+||+.=  -+|+++.|..|+|||||||    +|||++.+    |+|||+|||||.++.  .++. |...|+  +...
T Consensus       730 LARFYIAEl--tcAiesVHkmGFIHRDiKP----DNILIDrd----GHIKLTDFGLCTGfRWTHdsk-YYq~gd--H~Rq  796 (1034)
T KOG0608|consen  730 LARFYIAEL--TCAIESVHKMGFIHRDIKP----DNILIDRD----GHIKLTDFGLCTGFRWTHDSK-YYQEGD--HHRQ  796 (1034)
T ss_pred             HHHHHHHHH--HHHHHHHHhccceecccCc----cceEEccC----Cceeeeeccccccceeccccc-cccCCC--cccc
Confidence            445677654  7899999999999999999    89999988    899999999998653  2111 111110  0111


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhh-hhh-hccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALK-EIR-LQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k-~~~-~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                      +.+..-.+.+..+-.       ...=+.-|++ ..+ ..+.-+||+-|+|||||.... |+..|||||.|||||||+.|+
T Consensus       797 DSmep~~e~~d~~~~-------lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  797 DSMEPSPEWADISKC-------LKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             ccCCCchhhcccccc-------chHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhhCC
Confidence            111111111111100       0000111111 111 356778999999999999765 999999999999999999999


Q ss_pred             CCCCCc
Q psy3074         167 PTFPGV  172 (481)
Q Consensus       167 ~PF~g~  172 (481)
                      +||...
T Consensus       869 ~pf~~~  874 (1034)
T KOG0608|consen  869 PPFLAD  874 (1034)
T ss_pred             CCccCC
Confidence            999753

>KOG0695|consensus

Probab=99.84  E-value=1.7e-21  Score=186.00  Aligned_cols=100  Identities=30%  Similarity=0.577  Sum_probs=91.8

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      .+..|....+||.|||++|||.||||-    +|+|++..    |++||+|.|+++.                        
T Consensus       353 arfys~ei~lal~flh~rgiiyrdlkl----dnvlldae----ghikltdygmcke------------------------  400 (593)
T KOG0695|consen  353 ARFYSAEICLALNFLHERGIIYRDLKL----DNVLLDAE----GHIKLTDYGMCKE------------------------  400 (593)
T ss_pred             hhhhhHHHHHHHHHHhhcCeeeeeccc----cceEEccC----Cceeecccchhhc------------------------
Confidence            355667789999999999999999999    89999877    8999999999984                        


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                        .++.|..+.+|||                      ||-|.|||+|.|.. |+.++|||++||+++||+.|+.||.
T Consensus       401 --~l~~gd~tstfcg----------------------tpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfd  452 (593)
T KOG0695|consen  401 --GLGPGDTTSTFCG----------------------TPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFD  452 (593)
T ss_pred             --CCCCCcccccccC----------------------CCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcc
Confidence              4788888899999                      99999999999887 9999999999999999999999995

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.84  E-value=7.6e-21  Score=186.72  Aligned_cols=106  Identities=31%  Similarity=0.596  Sum_probs=93.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+++++.++||||+++++++..  ...+++||||++ |+|.+++......+++..+..++.|++.||.|||+++++
T Consensus        51 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~  130 (284)
T cd05081          51 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV  130 (284)
T ss_pred             HHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            35679999999999999999998754  357899999998 688888866555689999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||||+||++++++.  +|++|||+++.+.
T Consensus       131 H~dlkp~nili~~~~~--~~l~dfg~~~~~~  159 (284)
T cd05081         131 HRDLATRNILVESENR--VKIGDFGLTKVLP  159 (284)
T ss_pred             eccCCHhhEEECCCCe--EEECCCccccccc
Confidence            9999999999988776  8999999988653

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.83  E-value=2.5e-21  Score=191.62  Aligned_cols=147  Identities=19%  Similarity=0.349  Sum_probs=115.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..|+||||+++ ++..++..  +.+++..+..++.|++.||.|||+++++||
T Consensus        65 ~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~  142 (292)
T cd06658          65 LLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHR  142 (292)
T ss_pred             HHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            356799999999999999999999999999999999985 56555532  458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||++++++.  ++++|||++..+.......  .                                       ...
T Consensus       143 dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~--~---------------------------------------~~~  179 (292)
T cd06658         143 DIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKR--K---------------------------------------SLV  179 (292)
T ss_pred             CCCHHHEEEcCCCC--EEEccCcchhhcccccccC--c---------------------------------------eee
Confidence            99999999988776  9999999987543111000  0                                       011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++..|++|        +...|+||+|+++++|..|..|+..
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~  220 (292)
T cd06658         180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22223333        4567999999999999999877653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.83  E-value=4.3e-21  Score=186.46  Aligned_cols=152  Identities=23%  Similarity=0.363  Sum_probs=117.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||+. ++|.+++.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        49 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~  127 (268)
T cd06630          49 ALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHR  127 (268)
T ss_pred             HHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            46689999999999999999999999999999999999 567776654 4568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++..+ ..++++|||++..+......    .+                             .+    .....
T Consensus       128 ~i~~~nil~~~~~-~~~~l~dfg~~~~~~~~~~~----~~-----------------------------~~----~~~~~  169 (268)
T cd06630         128 DVKGANLLIDSTG-QRLRIADFGAAARLAAKGTG----AG-----------------------------EF----QGQLL  169 (268)
T ss_pred             CCCHHHEEEcCCC-CEEEEccccccccccccccc----CC-----------------------------cc----ccccc
Confidence            9999999997653 23899999998755421000    00                             00    00012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++..|++|        +...|+|++|+++++|..|..|+-
T Consensus       170 ~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~  209 (268)
T cd06630         170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN  209 (268)
T ss_pred             cccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            23333333        345799999999999999986654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.83  E-value=8.6e-22  Score=197.24  Aligned_cols=113  Identities=28%  Similarity=0.482  Sum_probs=86.3

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+.....                 
T Consensus        96 ~~~~~~~~q-i~~al~~LH~~~ivH~dlkp----~Nill~~~----~~~kL~Dfg~a~~~~~~-----------------  149 (316)
T cd05592          96 ARARFYAAE-IICGLQFLHKKGIIYRDLKL----DNVLLDKD----GHIKIADFGMCKENMNG-----------------  149 (316)
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCEEeCCCCH----HHeEECCC----CCEEEccCcCCeECCCC-----------------
Confidence            333444444 78899999999999999999    89999876    79999999999742110                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               .......+                      +|+.|||||++.+.. |+.++||||+||++|||++|+.||.
T Consensus       150 ---------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~  197 (316)
T cd05592         150 ---------EGKASTFC----------------------GTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFH  197 (316)
T ss_pred             ---------CCcccccc----------------------CCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCC
Confidence                     00111122                      399999999998765 9999999999999999999999999


Q ss_pred             CchhhHHHHHHH
Q psy3074         171 GVREVYDQLDKI  182 (481)
Q Consensus       171 g~~~~~~~l~~i  182 (481)
                      +.+. .+.+..+
T Consensus       198 ~~~~-~~~~~~i  208 (316)
T cd05592         198 GEDE-DELFDSI  208 (316)
T ss_pred             CCCH-HHHHHHH
Confidence            8543 2444444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.83  E-value=7.4e-22  Score=198.31  Aligned_cols=118  Identities=28%  Similarity=0.524  Sum_probs=89.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++...                
T Consensus        98 l~~~~~~~~~~q-i~~al~~lH~~~ivHrdlkp----~Nill~~~----~~~kL~Dfg~~~~~~----------------  152 (324)
T cd05589          98 FSEPRAVFYAAC-VVLGLQYLHENKIVYRDLKL----DNLLLDTE----GFVKIADFGLCKEGM----------------  152 (324)
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCeEecCCCH----HHeEECCC----CcEEeCcccCCccCC----------------
Confidence            334444445555 78899999999999999999    89999876    799999999987321                


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                +.+.....+.|                      |+.|||||++.+.. ++.++|+||+||++|||++|++
T Consensus       153 ----------~~~~~~~~~~g----------------------~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~G~~  199 (324)
T cd05589         153 ----------GFGDRTSTFCG----------------------TPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGES  199 (324)
T ss_pred             ----------CCCCccccccc----------------------CccccCHhHhcCCC-CCcccchhhHHHHHHHHHhCCC
Confidence                      11111112233                      89999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHH
Q psy3074         168 TFPGVREVYDQLDKIFK  184 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~  184 (481)
                      ||.+.+ ..+.+..+..
T Consensus       200 pf~~~~-~~~~~~~i~~  215 (324)
T cd05589         200 PFPGDD-EEEVFDSIVN  215 (324)
T ss_pred             CCCCCC-HHHHHHHHHh
Confidence            998853 3345555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.83  E-value=8.3e-21  Score=187.91  Aligned_cols=106  Identities=25%  Similarity=0.453  Sum_probs=93.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----------CCCChHHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----------GGLDHHNIRLFMFQLLRGL  336 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----------~~l~~~~~~~~~~qi~~~l  336 (481)
                      ..+.+|+.+++.++|+||+++++++...+..+++|||+. |+|.+++....          ..+++..+..++.|++.|+
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al  143 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM  143 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence            457789999999999999999999999999999999998 68888776532          1356778999999999999


Q ss_pred             HHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       337 ~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .|||+.+++||||||+||++++++.  ++++|||+++.+
T Consensus       144 ~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~  180 (296)
T cd05095         144 KYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNL  180 (296)
T ss_pred             HHHHHCCeecccCChheEEEcCCCC--EEeccCcccccc
Confidence            9999999999999999999987766  999999998754

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.83  E-value=7.4e-21  Score=186.74  Aligned_cols=143  Identities=22%  Similarity=0.322  Sum_probs=111.3

Q ss_pred             HHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCC
Q psy3074         273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP  351 (481)
Q Consensus       273 E~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp  351 (481)
                      .+++++...||||+++++.+.+.+..|+||||+. |+|...+.. .+.+++..++.++.|++.||.|||+.+++||||||
T Consensus        47 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p  125 (278)
T cd05606          47 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKP  125 (278)
T ss_pred             HHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCH
Confidence            3455666789999999999999999999999998 556665544 45789999999999999999999999999999999


Q ss_pred             ccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceec
Q psy3074         352 QNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFH  431 (481)
Q Consensus       352 ~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~  431 (481)
                      +||+++.++.  ++++|||++..+......                                           ...|+..
T Consensus       126 ~nili~~~~~--~kl~dfg~~~~~~~~~~~-------------------------------------------~~~~~~~  160 (278)
T cd05606         126 ANILLDEHGH--VRISDLGLACDFSKKKPH-------------------------------------------ASVGTHG  160 (278)
T ss_pred             HHEEECCCCC--EEEccCcCccccCccCCc-------------------------------------------CcCCCcC
Confidence            9999998776  999999988643211000                                           0012222


Q ss_pred             cCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         432 YLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       432 y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |++|         +...|+|++|+++++|..|..|+...
T Consensus       161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence            3222         44579999999999999998776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.83  E-value=7.1e-22  Score=198.52  Aligned_cols=109  Identities=27%  Similarity=0.500  Sum_probs=84.5

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                      
T Consensus       101 ~~~q-i~~~L~~lH~~giiHrDlkp----~Nili~~~----~~~kl~DfG~a~~~~~~----------------------  149 (325)
T cd05602         101 YAAE-IASALGYLHSLNIVYRDLKP----ENILLDSQ----GHIVLTDFGLCKENIEH----------------------  149 (325)
T ss_pred             HHHH-HHHHHHHHHHCCeEecCCCH----HHeEECCC----CCEEEccCCCCcccccC----------------------
Confidence            4444 78899999999999999999    89999865    79999999999742110                      


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                          ......++|                      |+.|||||++.+.. |+.++||||+||++|||++|.+||.+.+. 
T Consensus       150 ----~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~-  201 (325)
T cd05602         150 ----NGTTSTFCG----------------------TPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNT-  201 (325)
T ss_pred             ----CCCcccccC----------------------CccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCH-
Confidence                001112223                      99999999998765 99999999999999999999999987433 


Q ss_pred             HHHHHHHH
Q psy3074         176 YDQLDKIF  183 (481)
Q Consensus       176 ~~~l~~i~  183 (481)
                      .+.+..+.
T Consensus       202 ~~~~~~i~  209 (325)
T cd05602         202 AEMYDNIL  209 (325)
T ss_pred             HHHHHHHH
Confidence            34444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0984|consensus

Probab=99.83  E-value=1.8e-21  Score=175.00  Aligned_cols=149  Identities=13%  Similarity=0.204  Sum_probs=115.9

Q ss_pred             HHHHHHHHhh-cCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHH---HhcCCCChHHHHHHHHHHHHHHHHhhcC-ce
Q psy3074         270 AIREASLLKE-LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME---RHSGGLDHHNIRLFMFQLLRGLSYCHRR-RI  344 (481)
Q Consensus       270 ~~rE~~il~~-l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~---~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~i  344 (481)
                      .++|+.+..+ ...|++|.+|+.+.+...+||.||.|+-++..+..   .+.+..+|..+-+++..++.||.|||++ .+
T Consensus        91 ~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~v  170 (282)
T KOG0984|consen   91 LLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSV  170 (282)
T ss_pred             HHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhh
Confidence            3457766554 45899999999999999999999999988776654   3456689999999999999999999976 89


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccC--ceeccccCCCcccccccc--------cccCCCeeEEEeecC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR--RILHRDVKPQNLLISEIV--------FTNLSGVVVSTVDSG  414 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~--~i~~~d~~~~~il~~~~~--------~~~s~g~~~~~~~~g  414 (481)
                      ||||+||+|||++.+|+  +|+||||++..+......  ......|.+|+.+-++..        +.||.|+.+.|+.++
T Consensus       171 IHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l  248 (282)
T KOG0984|consen  171 IHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL  248 (282)
T ss_pred             hhccCCcceEEEccCCc--EEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence            99999999999999998  999999998866533222  233456777777654432        347777777777777


Q ss_pred             CCCccc
Q psy3074         415 SGGWWF  420 (481)
Q Consensus       415 ~~~~~~  420 (481)
                      ..||..
T Consensus       249 r~PY~~  254 (282)
T KOG0984|consen  249 RFPYES  254 (282)
T ss_pred             cccccc
Confidence            766653

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=7.1e-21  Score=185.93  Aligned_cols=145  Identities=21%  Similarity=0.266  Sum_probs=117.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++++.++||||+++++++.+....|+|+||++ +++.+.+...  .+++..+..++.|++.|+.|||+++++|+|
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~d  123 (274)
T cd06609          46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRD  123 (274)
T ss_pred             HHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            4579999999999999999999999999999999998 5777776543  689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |+|+||++++++.  ++++|||+++.+.......                                         ....+
T Consensus       124 l~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~-----------------------------------------~~~~~  160 (274)
T cd06609         124 IKAANILLSEEGD--VKLADFGVSGQLTSTMSKR-----------------------------------------NTFVG  160 (274)
T ss_pred             CCHHHEEECCCCC--EEEcccccceeeccccccc-----------------------------------------ccccC
Confidence            9999999998777  9999999987654221000                                         00112


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++.|++|        ...+|+|++|+++++|.+|..|+.
T Consensus       161 ~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~  199 (274)
T cd06609         161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLS  199 (274)
T ss_pred             CccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            2233333        456899999999999999986653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.83  E-value=1e-20  Score=182.68  Aligned_cols=148  Identities=23%  Similarity=0.288  Sum_probs=115.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.++++++|+|++++++.+.. ...+|++|||++ +++.+.+.... ..+++..+..++.|++.|+.+||+++++
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~  124 (257)
T cd08223          45 AAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL  124 (257)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35679999999999999999998864 457899999998 67877776533 3588999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  ++++|||++..+......  ..                                       .
T Consensus       125 H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~--~~---------------------------------------~  161 (257)
T cd08223         125 HRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM--AS---------------------------------------T  161 (257)
T ss_pred             ccCCCchhEEEecCCc--EEEecccceEEecccCCc--cc---------------------------------------c
Confidence            9999999999988776  999999998754311000  00                                       0


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..+++.|++|        +...|+|++|+++++|..|..|+.
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~  203 (257)
T cd08223         162 LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN  203 (257)
T ss_pred             ccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence            1122333333        456799999999999999986654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.83  E-value=1.3e-20  Score=184.12  Aligned_cols=105  Identities=22%  Similarity=0.394  Sum_probs=93.9

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC--------CCChHHHHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG--------GLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~y  338 (481)
                      ..+.+|++++++++||||+++++++.+.+..|+||||++ |+|.+++.....        .+++..+..++.|++.||.|
T Consensus        53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~  132 (275)
T cd05046          53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH  132 (275)
T ss_pred             HHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999999999999998 688888765431        58899999999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ||+.+++||||||+||+++..+.  +++.|||++..
T Consensus       133 LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~  166 (275)
T cd05046         133 LSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKD  166 (275)
T ss_pred             hhhcCcccCcCccceEEEeCCCc--EEEcccccccc
Confidence            99999999999999999988776  88999998764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=8.2e-21  Score=184.13  Aligned_cols=106  Identities=22%  Similarity=0.395  Sum_probs=95.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++||||+++++++...+..|++|||+. ++|.+++.... ..+++..+..++.|++.|+.|||+.+++|
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  126 (261)
T cd05068          47 DFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIH  126 (261)
T ss_pred             HHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            35679999999999999999999999999999999996 78888876543 35889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  ++++|||++..+.
T Consensus       127 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~  154 (261)
T cd05068         127 RDLAARNVLVGENNI--CKVADFGLARVIK  154 (261)
T ss_pred             ccCCcceEEEcCCCC--EEECCcceEEEcc
Confidence            999999999998877  9999999887654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.83  E-value=9.2e-21  Score=186.22  Aligned_cols=98  Identities=27%  Similarity=0.463  Sum_probs=85.5

Q ss_pred             HHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCcc
Q psy3074         275 SLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQN  353 (481)
Q Consensus       275 ~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~N  353 (481)
                      +++...+||||+.+++.+..++..++||||++ |+|...+.. .+.+++..+..++.|++.||+|||+.+++||||||+|
T Consensus        49 ~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~N  127 (279)
T cd05633          49 SLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPAN  127 (279)
T ss_pred             HHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHH
Confidence            34445579999999999999999999999999 567666654 3569999999999999999999999999999999999


Q ss_pred             ccccccchhhHHHHHHHHHhhc
Q psy3074         354 LLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       354 iLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+++++.  ++++|||++...
T Consensus       128 il~~~~~~--~~l~dfg~~~~~  147 (279)
T cd05633         128 ILLDEHGH--VRISDLGLACDF  147 (279)
T ss_pred             EEECCCCC--EEEccCCcceec
Confidence            99998776  999999988643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.83  E-value=1.2e-20  Score=186.62  Aligned_cols=106  Identities=24%  Similarity=0.443  Sum_probs=92.8

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------CCCChHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------GGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~~  335 (481)
                      ..+.+|++++++++||||+++++++...+..++||||+. ++|.+++....           ..+++..+..++.|++.|
T Consensus        62 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  141 (295)
T cd05097          62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG  141 (295)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence            356789999999999999999999999999999999998 67877775421           135777888999999999


Q ss_pred             HHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       336 l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |.|||+.+++||||||+||++++++.  +|++|||++..+
T Consensus       142 l~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~  179 (295)
T cd05097         142 MKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNL  179 (295)
T ss_pred             HHHHHhcCeeccccChhhEEEcCCCc--EEeccccccccc
Confidence            99999999999999999999988776  999999998754

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.83  E-value=5.4e-21  Score=187.67  Aligned_cols=106  Identities=22%  Similarity=0.435  Sum_probs=92.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---------------cCCCChHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---------------SGGLDHHNIRLFMFQL  332 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---------------~~~l~~~~~~~~~~qi  332 (481)
                      .+.+|+.+++.++|||||++++++.+.+..++++||+. +++..++...               ...+++..+..++.|+
T Consensus        54 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql  133 (283)
T cd05091          54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQI  133 (283)
T ss_pred             HHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence            45679999999999999999999999999999999998 6777776432               1247778889999999


Q ss_pred             HHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         333 LRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       333 ~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +.||.|+|+++++||||||+||++++++.  +|++|||+++.+.
T Consensus       134 ~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~  175 (283)
T cd05091         134 AAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVY  175 (283)
T ss_pred             HHHHHHHHHcCccccccchhheEecCCCc--eEecccccccccc
Confidence            99999999999999999999999987766  9999999987653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.83  E-value=9.2e-22  Score=197.40  Aligned_cols=114  Identities=26%  Similarity=0.427  Sum_probs=86.6

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+++....                  
T Consensus        96 ~~~~~~~~q-l~~~L~~lH~~~ivH~dlkp----~NIli~~~----~~~kL~DfG~~~~~~~------------------  148 (320)
T cd05590          96 ARARFYAAE-ITSALMFLHDKGIIYRDLKL----DNVLLDHE----GHCKLADFGMCKEGIF------------------  148 (320)
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeEeCCCCH----HHeEECCC----CcEEEeeCCCCeecCc------------------
Confidence            333444444 78899999999999999999    89999876    7999999999974211                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                              .+.......                      +|+.|||||++.+.. |+.++||||+||++|||++|++||.
T Consensus       149 --------~~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~  197 (320)
T cd05590         149 --------NGKTTSTFC----------------------GTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLCGHAPFE  197 (320)
T ss_pred             --------CCCcccccc----------------------cCccccCHHHHcCCC-CCCccchhhhHHHHHHHhhCCCCCC
Confidence                    011111122                      399999999998765 9999999999999999999999998


Q ss_pred             CchhhHHHHHHHH
Q psy3074         171 GVREVYDQLDKIF  183 (481)
Q Consensus       171 g~~~~~~~l~~i~  183 (481)
                      +.+. .+.+..+.
T Consensus       198 ~~~~-~~~~~~i~  209 (320)
T cd05590         198 AENE-DDLFEAIL  209 (320)
T ss_pred             CCCH-HHHHHHHh
Confidence            8533 24444443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.8e-22  Score=196.71  Aligned_cols=105  Identities=30%  Similarity=0.519  Sum_probs=82.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus        92 ~~~~~~~~~q-i~~~l~~lH~~~i~HrDlkp----~Nili~~~----~~~kl~Dfg~~~~~~~~----------------  146 (312)
T cd05585          92 LSRARFYTAE-LLCALENLHKFNVIYRDLKP----ENILLDYQ----GHIALCDFGLCKLNMKD----------------  146 (312)
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeEeCCCCH----HHeEECCC----CcEEEEECcccccCccC----------------
Confidence            3333444444 78899999999999999999    89999866    79999999999742110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......++                      +|+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       147 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf  193 (312)
T cd05585         147 ----------DDKTNTFC----------------------GTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPF  193 (312)
T ss_pred             ----------CCcccccc----------------------CCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCc
Confidence                      00111122                      399999999998765 999999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       194 ~~~  196 (312)
T cd05585         194 YDE  196 (312)
T ss_pred             CCC
Confidence            874

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0986|consensus

Probab=99.83  E-value=2.2e-21  Score=191.88  Aligned_cols=105  Identities=25%  Similarity=0.419  Sum_probs=86.8

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .++|.+-.++- ..++|+.||..+||.|||||    +||||+..    |+++|+|+|||........+            
T Consensus       285 ~e~ra~FYAAE-i~cGLehlH~~~iVYRDLKP----eNILLDd~----GhvRISDLGLAvei~~g~~~------------  343 (591)
T KOG0986|consen  285 DEQRARFYAAE-IICGLEHLHRRRIVYRDLKP----ENILLDDH----GHVRISDLGLAVEIPEGKPI------------  343 (591)
T ss_pred             chHHHHHHHHH-HHhhHHHHHhcceeeccCCh----hheeeccC----CCeEeeccceEEecCCCCcc------------
Confidence            34444444444 89999999999999999999    89999988    89999999999854322111            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                                           ...+||..||||||+.+.. |+.++||||+||++|||+.|+.|
T Consensus       344 -------------------------------------~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sP  385 (591)
T KOG0986|consen  344 -------------------------------------RGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSP  385 (591)
T ss_pred             -------------------------------------ccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCc
Confidence                                                 1124599999999999988 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |...
T Consensus       386 Fr~~  389 (591)
T KOG0986|consen  386 FRQR  389 (591)
T ss_pred             hhhh
Confidence            9764

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.83  E-value=5.4e-22  Score=200.86  Aligned_cols=107  Identities=24%  Similarity=0.438  Sum_probs=84.3

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                       
T Consensus       136 ~~~q-i~~aL~~LH~~~ivHrDLkp----~NILl~~~----~~ikL~DFG~a~~~~~-----------------------  183 (340)
T PTZ00426        136 YAAQ-IVLIFEYLQSLNIVYRDLKP----ENLLLDKD----GFIKMTDFGFAKVVDT-----------------------  183 (340)
T ss_pred             HHHH-HHHHHHHHHHCCeEccCCCH----HHEEECCC----CCEEEecCCCCeecCC-----------------------
Confidence            3444 67899999999999999999    89999765    7999999999974210                       


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                          .  .....|                      |+.|||||++.+.. ++.++||||+||++|||++|.+||.+.+. 
T Consensus       184 ----~--~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~-  233 (340)
T PTZ00426        184 ----R--TYTLCG----------------------TPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEP-  233 (340)
T ss_pred             ----C--cceecC----------------------ChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCH-
Confidence                0  011233                      89999999998765 89999999999999999999999988533 


Q ss_pred             HHHHHHHHH
Q psy3074         176 YDQLDKIFK  184 (481)
Q Consensus       176 ~~~l~~i~~  184 (481)
                      ....+.+.+
T Consensus       234 ~~~~~~i~~  242 (340)
T PTZ00426        234 LLIYQKILE  242 (340)
T ss_pred             HHHHHHHhc
Confidence            244444443

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.83  E-value=4.7e-21  Score=188.26  Aligned_cols=151  Identities=18%  Similarity=0.225  Sum_probs=120.6

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeee-----cCCeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHh
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVH-----TRSTLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~-----~~~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      +.+|+.+++.+ +||||+++++++.     ..+..++||||++ ++|.+++..   ....+++..+..++.|++.||.||
T Consensus        61 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  140 (286)
T cd06638          61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL  140 (286)
T ss_pred             HHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH
Confidence            45699999999 6999999999873     4467999999998 567776643   224588889999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccc---------cccccccCCCee
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLI---------SEIVFTNLSGVV  407 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~---------~~~~~~~s~g~~  407 (481)
                      |+.+++||||||+||++++.+.  ++++|||++..+....   .....+..|.+|+++.         +...+.|+.|++
T Consensus       141 H~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi  218 (286)
T cd06638         141 HVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT  218 (286)
T ss_pred             HhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence            9999999999999999998777  9999999987654211   1123344577787763         345678999999


Q ss_pred             EEEeecCCCCccccc
Q psy3074         408 VSTVDSGSGGWWFES  422 (481)
Q Consensus       408 ~~~~~~g~~~~~~~~  422 (481)
                      ++++.+|..||....
T Consensus       219 ~~el~~g~~p~~~~~  233 (286)
T cd06638         219 AIELGDGDPPLADLH  233 (286)
T ss_pred             HHHHhcCCCCCCCCc
Confidence            999999999987543

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.83  E-value=1e-20  Score=184.19  Aligned_cols=106  Identities=21%  Similarity=0.394  Sum_probs=90.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCe------EEEEEeccC-CCHHHHHHHhc-----CCCChHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVH-TDLSQYMERHS-----GGLDHHNIRLFMFQLLRGL  336 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~------~~iv~E~~~-g~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l  336 (481)
                      .+.+|+.+++.++||||+++++++.....      .+++|||+. |++...+....     ..+++..+..++.|++.||
T Consensus        47 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL  126 (273)
T cd05035          47 EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM  126 (273)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHH
Confidence            46789999999999999999998865543      799999998 67777764431     3578889999999999999


Q ss_pred             HHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       337 ~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      .|||+++++||||||+||++++++.  +|++|||+++.+.
T Consensus       127 ~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~  164 (273)
T cd05035         127 EYLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIY  164 (273)
T ss_pred             HHHHhCCeeccccchheEEECCCCe--EEECCccceeecc
Confidence            9999999999999999999988766  9999999987553

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.83  E-value=1.3e-20  Score=187.52  Aligned_cols=105  Identities=26%  Similarity=0.514  Sum_probs=93.3

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++.+ +||||+++++++...+..|+||||+. |+|.+++....               ..++...+..++.|
T Consensus        69 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  148 (307)
T cd05098          69 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQ  148 (307)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence            466799999999 79999999999999999999999998 68888886532               23778889999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ++.||+|||+++++||||||+||+++.++.  +|++|||+++.+
T Consensus       149 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~  190 (307)
T cd05098         149 VARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI  190 (307)
T ss_pred             HHHHHHHHHHCCcccccccHHheEEcCCCc--EEECCCcccccc
Confidence            999999999999999999999999998776  999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=8.7e-22  Score=194.70  Aligned_cols=112  Identities=23%  Similarity=0.428  Sum_probs=86.5

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++....                  
T Consensus       101 ~~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~NIli~~~----~~~kl~Dfg~~~~~~~------------------  153 (291)
T cd05612         101 STGLFYASE-IVCALEYLHSKEIVYRDLKP----ENILLDKE----GHIKLTDFGFAKKLRD------------------  153 (291)
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeeecCCCH----HHeEECCC----CCEEEEecCcchhccC------------------
Confidence            333445555 78899999999999999999    89999765    7999999999974211                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               +.  ....                      +|+.|+|||++.+.. ++.++||||+||++|||++|+.||.
T Consensus       154 ---------~~--~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~  199 (291)
T cd05612         154 ---------RT--WTLC----------------------GTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFF  199 (291)
T ss_pred             ---------Cc--cccc----------------------CChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence                     00  0112                      389999999998765 8999999999999999999999998


Q ss_pred             CchhhHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFK  184 (481)
Q Consensus       171 g~~~~~~~l~~i~~  184 (481)
                      +.+ ..+..+.+..
T Consensus       200 ~~~-~~~~~~~i~~  212 (291)
T cd05612         200 DDN-PFGIYEKILA  212 (291)
T ss_pred             CCC-HHHHHHHHHh
Confidence            853 3344444443

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.83  E-value=1e-21  Score=197.24  Aligned_cols=118  Identities=25%  Similarity=0.437  Sum_probs=89.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....              
T Consensus        98 l~~~~~~~i~~q-i~~al~~lH~~~ivHrDikp----~Nill~~~----~~ikL~Dfg~~~~~~~~--------------  154 (323)
T cd05615          98 FKEPQAVFYAAE-ISVGLFFLHRRGIIYRDLKL----DNVMLDSE----GHIKIADFGMCKEHMVD--------------  154 (323)
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeeccCCCH----HHeEECCC----CCEEEeccccccccCCC--------------
Confidence            334444555555 78899999999999999999    89999876    79999999999742110              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                  +.......                      +|+.|||||++.+.. ++.++|+||+||++|||++|++
T Consensus       155 ------------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~  199 (323)
T cd05615         155 ------------GVTTRTFC----------------------GTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQP  199 (323)
T ss_pred             ------------CccccCcc----------------------CCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCC
Confidence                        00011112                      389999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHH
Q psy3074         168 TFPGVREVYDQLDKIFK  184 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~  184 (481)
                      ||.+.+. ...+..+..
T Consensus       200 pf~~~~~-~~~~~~i~~  215 (323)
T cd05615         200 PFDGEDE-DELFQSIME  215 (323)
T ss_pred             CCCCCCH-HHHHHHHHh
Confidence            9988533 344555544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.83  E-value=9.7e-21  Score=185.91  Aligned_cols=105  Identities=28%  Similarity=0.460  Sum_probs=93.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc--------------CCCChHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS--------------GGLDHHNIRLFMFQLL  333 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~--------------~~l~~~~~~~~~~qi~  333 (481)
                      .+.+|+++++.++|+||+++++++...+..+++|||++ |+|.+++....              ..+++..+..++.|++
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~  132 (280)
T cd05092          53 DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA  132 (280)
T ss_pred             HHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998 67888876542              2478888999999999


Q ss_pred             HHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         334 RGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       334 ~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .|+.|||+.+++||||||+||++++++.  +|++|||+++.+
T Consensus       133 ~al~~LH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~  172 (280)
T cd05092         133 SGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDI  172 (280)
T ss_pred             HHHHHHHHCCeecccccHhhEEEcCCCC--EEECCCCceeEc
Confidence            9999999999999999999999988766  999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.83  E-value=8.7e-21  Score=184.54  Aligned_cols=106  Identities=24%  Similarity=0.426  Sum_probs=95.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++.+++.+.+..|+||||++ ++|..++....+.+++..+..++.|++.|++|||+.+++||
T Consensus        52 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~  131 (268)
T cd05063          52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHR  131 (268)
T ss_pred             HHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            35679999999999999999999999999999999998 57877776655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  +|++|||++..+.
T Consensus       132 dlkp~Nili~~~~~--~kl~dfg~~~~~~  158 (268)
T cd05063         132 DLAARNILVNSNLE--CKVSDFGLSRVLE  158 (268)
T ss_pred             ccchhhEEEcCCCc--EEECCCccceecc
Confidence            99999999988766  9999999886543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.83  E-value=1e-21  Score=197.18  Aligned_cols=106  Identities=29%  Similarity=0.573  Sum_probs=83.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+++....                          .+
T Consensus       109 i~~~l~~lH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~--------------------------~~  154 (323)
T cd05584         109 ISLALEHLHQQGIIYRDLKP----ENILLDAQ----GHVKLTDFGLCKESIH--------------------------EG  154 (323)
T ss_pred             HHHHHHHHHHCCeecCCCCH----HHeEECCC----CCEEEeeCcCCeeccc--------------------------CC
Confidence            67899999999999999999    89999866    7999999999974211                          11


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|++||.+.+. ...+.
T Consensus       155 ~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~-~~~~~  210 (323)
T cd05584         155 TVTHTFC----------------------GTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENR-KKTID  210 (323)
T ss_pred             CcccccC----------------------CCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCH-HHHHH
Confidence            1111122                      399999999998765 89999999999999999999999988533 34455


Q ss_pred             HHHH
Q psy3074         181 KIFK  184 (481)
Q Consensus       181 ~i~~  184 (481)
                      .+..
T Consensus       211 ~~~~  214 (323)
T cd05584         211 KILK  214 (323)
T ss_pred             HHHc
Confidence            5543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.83  E-value=6.7e-21  Score=189.93  Aligned_cols=105  Identities=30%  Similarity=0.426  Sum_probs=95.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++++.++|+|++++++++...+..++||||+.|++...+......+++..+..++.|++.|+.|||+.+++|||
T Consensus        61 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~d  140 (308)
T cd06634          61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD  140 (308)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            35579999999999999999999999999999999999988887766566789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||+||+++.++.  ++++|||++..+
T Consensus       141 l~p~nil~~~~~~--~kl~dfg~~~~~  165 (308)
T cd06634         141 VKAGNILLSEPGL--VKLGDFGSASIM  165 (308)
T ss_pred             CCHHhEEECCCCc--EEECCcccceee
Confidence            9999999988776  999999987643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.83  E-value=8.7e-22  Score=197.52  Aligned_cols=115  Identities=28%  Similarity=0.453  Sum_probs=88.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +.....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                 
T Consensus        95 ~~~~~~~~~q-i~~aL~~LH~~~ivHrDikp----~Nill~~~----~~~kL~Dfg~~~~~~~-----------------  148 (321)
T cd05591          95 EPRSRFYAAE-VTLALMFLHRHGVIYRDLKL----DNILLDAE----GHCKLADFGMCKEGIL-----------------  148 (321)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeeccCCCH----HHeEECCC----CCEEEeecccceeccc-----------------
Confidence            3344445555 78899999999999999999    89999876    7999999999974211                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .+.....+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||
T Consensus       149 ---------~~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf  196 (321)
T cd05591         149 ---------NGVTTTTFC----------------------GTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPF  196 (321)
T ss_pred             ---------CCccccccc----------------------cCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCC
Confidence                     001111122                      389999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIF  183 (481)
Q Consensus       170 ~g~~~~~~~l~~i~  183 (481)
                      .+.++ .+.+..+.
T Consensus       197 ~~~~~-~~~~~~i~  209 (321)
T cd05591         197 EADNE-DDLFESIL  209 (321)
T ss_pred             CCCCH-HHHHHHHH
Confidence            88543 34555544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.83  E-value=1.3e-20  Score=184.18  Aligned_cols=106  Identities=23%  Similarity=0.406  Sum_probs=93.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.++||||+++++++......++||||++ |+|.+++....         ..+++..+..++.|++.||.|
T Consensus        55 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  134 (277)
T cd05032          55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY  134 (277)
T ss_pred             HHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999999999999998 78888876432         235677889999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+.+++||||||+||++++++.  +|++|||+++.+.
T Consensus       135 lH~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~  170 (277)
T cd05032         135 LAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIY  170 (277)
T ss_pred             HHhCCccccccChheEEEcCCCC--EEECCcccchhhc
Confidence            99999999999999999998877  9999999987654

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.83  E-value=1.3e-21  Score=189.37  Aligned_cols=151  Identities=21%  Similarity=0.312  Sum_probs=124.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++||||+++++.+...+..++||||+. ++|...+... ..+++..+..++.|++.||.|||+++++|+
T Consensus        46 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~  124 (258)
T cd05578          46 NVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHR  124 (258)
T ss_pred             HHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            45679999999999999999999999999999999998 5777777654 578999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccc----cccccccCCCeeEEEeecCCCCcccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ||||+||++++++.  ++++|||++.......  .....+..+.+|+++.    +...+.|+.|++++++.+|..||...
T Consensus       125 dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  202 (258)
T cd05578         125 DIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH  202 (258)
T ss_pred             CCCHHHeEEcCCCC--EEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence            99999999998877  9999999887654221  1112233455666654    44567799999999999999998865


Q ss_pred             c
Q psy3074         422 S  422 (481)
Q Consensus       422 ~  422 (481)
                      +
T Consensus       203 ~  203 (258)
T cd05578         203 S  203 (258)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.83  E-value=3.7e-21  Score=189.53  Aligned_cols=105  Identities=27%  Similarity=0.497  Sum_probs=83.3

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+....                 
T Consensus       101 ~~~~~~~~~q-i~~~l~~lH~~~iiH~dikp----~Nill~~~----~~~kl~Dfg~~~~~~~-----------------  154 (285)
T cd05631         101 EQRAIFYAAE-LCCGLEDLQRERIVYRDLKP----ENILLDDR----GHIRISDLGLAVQIPE-----------------  154 (285)
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCEEeCCCCH----HHEEECCC----CCEEEeeCCCcEEcCC-----------------
Confidence            3344445555 78899999999999999999    89999865    7999999999974211                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                +.....                      ..+|+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       155 ----------~~~~~~----------------------~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf  201 (285)
T cd05631         155 ----------GETVRG----------------------RVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPF  201 (285)
T ss_pred             ----------CCeecC----------------------CCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCC
Confidence                      000001                      12389999999998765 999999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+..
T Consensus       202 ~~~~  205 (285)
T cd05631         202 RKRK  205 (285)
T ss_pred             CCCC
Confidence            8753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.83  E-value=1.6e-20  Score=180.96  Aligned_cols=106  Identities=29%  Similarity=0.453  Sum_probs=96.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++.+.+....|+++||+. ++|.+.+......+++..+..++.|++.|+.|||+.+++|+
T Consensus        44 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~  123 (256)
T cd06612          44 EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHR  123 (256)
T ss_pred             HHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            45679999999999999999999999999999999999 57877776655678999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|+||++++++.  ++++|||++..+.
T Consensus       124 dl~~~ni~~~~~~~--~~l~dfg~~~~~~  150 (256)
T cd06612         124 DIKAGNILLNEEGQ--AKLADFGVSGQLT  150 (256)
T ss_pred             CCCcceEEECCCCc--EEEcccccchhcc
Confidence            99999999998877  9999999987654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.83  E-value=9.9e-21  Score=184.44  Aligned_cols=106  Identities=20%  Similarity=0.372  Sum_probs=89.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccC-CCHHHHHHHh-----cCCCChHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVH-TDLSQYMERH-----SGGLDHHNIRLFMFQLLRGL  336 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~-g~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l  336 (481)
                      .+.+|+.+++.++||||+++++.+...      ...+++|||+. |++..++...     ...+++..+..++.|++.||
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  125 (272)
T cd05075          46 DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM  125 (272)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHH
Confidence            466799999999999999999976432      25789999998 6777776432     23478899999999999999


Q ss_pred             HHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       337 ~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      .|||+++|+||||||+|||+++++.  +|++|||+++.+.
T Consensus       126 ~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~  163 (272)
T cd05075         126 EYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIY  163 (272)
T ss_pred             HHHHHCCeeccccchhheEEcCCCC--EEECCCCcccccC
Confidence            9999999999999999999988777  9999999987653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.83  E-value=3.2e-22  Score=201.42  Aligned_cols=106  Identities=25%  Similarity=0.471  Sum_probs=83.9

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ..+...++.. .+.|++|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus        95 ~~~~~~~~~q-il~al~~LH~~~ivHrDlkp----~Nili~~~----~~~kl~Dfg~a~~~~~~----------------  149 (330)
T cd05586          95 EDRAKFYIAE-LVLALEHLHKYDIVYRDLKP----ENILLDAT----GHIALCDFGLSKANLTD----------------  149 (330)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeEeccCCH----HHeEECCC----CCEEEecCCcCcCCCCC----------------
Confidence            3333444444 78899999999999999999    89999876    79999999999742110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......++                      +|+.|||||++.+...|+.++||||+||++|||++|..||
T Consensus       150 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf  197 (330)
T cd05586         150 ----------NKTTNTFC----------------------GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF  197 (330)
T ss_pred             ----------CCCccCcc----------------------CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCC
Confidence                      00111122                      3999999999987777999999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       198 ~~~  200 (330)
T cd05586         198 YAE  200 (330)
T ss_pred             CCC
Confidence            874

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.83  E-value=1.6e-20  Score=189.18  Aligned_cols=103  Identities=39%  Similarity=0.651  Sum_probs=90.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||++++++|.. ....|++|||+.+++...+..  ..+++..+..++.|++.||.|||+.+++||
T Consensus        55 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~  132 (328)
T cd07856          55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHR  132 (328)
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            34579999999999999999999875 567999999998888777653  457888899999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++.+.  ++++|||++...
T Consensus       133 dl~p~Nili~~~~~--~~l~dfg~~~~~  158 (328)
T cd07856         133 DLKPSNILINENCD--LKICDFGLARIQ  158 (328)
T ss_pred             CCCHHHEeECCCCC--EEeCcccccccc
Confidence            99999999988776  999999988754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.83  E-value=5.8e-21  Score=187.43  Aligned_cols=141  Identities=47%  Similarity=0.781  Sum_probs=109.6

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++........++.. .+.||.|||+++|+||||||    +||+++..    +.+||+|||+++......           
T Consensus        94 ~~~~~~~~~~~~~q-i~~al~~LH~~~i~H~dl~~----~nil~~~~----~~~~l~dfg~~~~~~~~~-----------  153 (284)
T cd07839          94 GDIDPEIVKSFMFQ-LLKGLAFCHSHNVLHRDLKP----QNLLINKN----GELKLADFGLARAFGIPV-----------  153 (284)
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHHCCEecCCCCH----HHEEEcCC----CcEEECccchhhccCCCC-----------
Confidence            34444555566666 88999999999999999999    89999876    799999999997432110           


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                    ..+                       ....+++.|+|||++.+...++.++|+||+||++|||++|
T Consensus       154 --------------~~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg  196 (284)
T cd07839         154 --------------RCY-----------------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA  196 (284)
T ss_pred             --------------CCc-----------------------CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence                          000                       0012388999999998877789999999999999999998


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      ..||....+..++++.+.+.++.++...|+.....+..
T Consensus       197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         197 GRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            88765556667889999999999998888877655444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.83  E-value=7.9e-22  Score=198.62  Aligned_cols=102  Identities=25%  Similarity=0.491  Sum_probs=82.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                           .
T Consensus       127 i~~aL~~LH~~~ivH~dlkp----~NIll~~~----~~~kl~Dfg~~~~~~~---------------------------~  171 (329)
T PTZ00263        127 LVLAFEYLHSKDIIYRDLKP----ENLLLDNK----GHVKVTDFGFAKKVPD---------------------------R  171 (329)
T ss_pred             HHHHHHHHHHCCeeecCCCH----HHEEECCC----CCEEEeeccCceEcCC---------------------------C
Confidence            67899999999999999999    89999876    7999999999974211                           0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .  ....|                      |+.|+|||++.+.. ++.++||||+||++|||++|++||.+.+ ..+...
T Consensus       172 ~--~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~-~~~~~~  225 (329)
T PTZ00263        172 T--FTLCG----------------------TPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDT-PFRIYE  225 (329)
T ss_pred             c--ceecC----------------------ChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCC-HHHHHH
Confidence            0  11233                      89999999998765 8999999999999999999999998743 234444


Q ss_pred             HHH
Q psy3074         181 KIF  183 (481)
Q Consensus       181 ~i~  183 (481)
                      .+.
T Consensus       226 ~i~  228 (329)
T PTZ00263        226 KIL  228 (329)
T ss_pred             HHh
Confidence            443

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.83  E-value=2.8e-20  Score=181.39  Aligned_cols=105  Identities=16%  Similarity=0.269  Sum_probs=92.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ..+.+|+.+++.++||||+++++.+.+....|+||||++ |+|.+++....   ...++..+..++.|++.||.|||+.+
T Consensus        40 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  119 (268)
T cd05086          40 NEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN  119 (268)
T ss_pred             HHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            357789999999999999999999999999999999999 68888876532   23566677889999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ++||||||+|||++.++.  ++++|||++..
T Consensus       120 i~H~dikp~nil~~~~~~--~~l~Dfg~~~~  148 (268)
T cd05086         120 FLHSDLALRNCFLTSDLT--VKVGDYGIGPS  148 (268)
T ss_pred             eeccCCccceEEEcCCcc--EEecccccccc
Confidence            999999999999988777  99999998753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=1.5e-20  Score=181.72  Aligned_cols=106  Identities=26%  Similarity=0.412  Sum_probs=95.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++|+||+++++++.+.+..++||||++ +++.+++..... .+++..+..++.|++.|+.|||+.+++|
T Consensus        46 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H  125 (256)
T cd05039          46 AFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH  125 (256)
T ss_pred             HHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            45679999999999999999999999999999999998 688888765432 5889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||+++.++.  ++++|||+++...
T Consensus       126 ~di~p~Nili~~~~~--~~l~d~g~~~~~~  153 (256)
T cd05039         126 RDLAARNVLVSEDLV--AKVSDFGLAKEAS  153 (256)
T ss_pred             hhcccceEEEeCCCC--EEEcccccccccc
Confidence            999999999988776  9999999987653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.83  E-value=8e-21  Score=191.86  Aligned_cols=103  Identities=37%  Similarity=0.675  Sum_probs=91.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +.+|+.+++.++||||+++++++...     ...|++|||+.+++.+.+.. .+.+++..+..++.|++.||.|||++++
T Consensus        51 ~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i  129 (337)
T cd07858          51 TLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANV  129 (337)
T ss_pred             HHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            45799999999999999999988654     35899999999998887765 3569999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +||||||+||+++.++.  +|++|||++...
T Consensus       130 ~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~  158 (337)
T cd07858         130 LHRDLKPSNLLLNANCD--LKICDFGLARTT  158 (337)
T ss_pred             ecCCCCHHHEEEcCCCC--EEECcCcccccc
Confidence            99999999999988776  999999988754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.83  E-value=1.9e-20  Score=184.85  Aligned_cols=106  Identities=25%  Similarity=0.460  Sum_probs=94.6

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----------CCCChHHHHHHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----------GGLDHHNIRLFMFQLLRGL  336 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----------~~l~~~~~~~~~~qi~~~l  336 (481)
                      ..+.+|++++++++||||+++++++...+..+++||++. ++|..++....          ..+++..+..++.|++.||
T Consensus        64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al  143 (296)
T cd05051          64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM  143 (296)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence            456789999999999999999999999999999999998 67888776543          1588999999999999999


Q ss_pred             HHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       337 ~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .|||+.+++||||||+||+++.++.  ++++|||+++.+
T Consensus       144 ~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~  180 (296)
T cd05051         144 RYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNL  180 (296)
T ss_pred             HHHHHcCccccccchhceeecCCCc--eEEccccceeec
Confidence            9999999999999999999998766  999999988654

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.83  E-value=1e-20  Score=191.86  Aligned_cols=102  Identities=32%  Similarity=0.596  Sum_probs=89.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      +.+|+.++++++||||+++++++...      ...|++++++.+++.+.+..  ..+++..+..++.|++.||.|||+++
T Consensus        63 ~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~  140 (345)
T cd07877          63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD  140 (345)
T ss_pred             HHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45799999999999999999988643      35789999998888776653  35899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ++||||||+||++++++.  +|++|||+++..
T Consensus       141 ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~  170 (345)
T cd07877         141 IIHRDLKPSNLAVNEDCE--LKILDFGLARHT  170 (345)
T ss_pred             eeecCCChHHEEEcCCCC--EEEecccccccc
Confidence            999999999999998877  999999988754

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.83  E-value=1.3e-20  Score=186.09  Aligned_cols=105  Identities=28%  Similarity=0.481  Sum_probs=93.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQL  332 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~qi  332 (481)
                      .+.+|+++++.++||||+++++++...+..++||||++ ++|.+++....               +.+++..+..++.|+
T Consensus        53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  132 (291)
T cd05094          53 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI  132 (291)
T ss_pred             HHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHH
Confidence            46689999999999999999999999999999999998 78888876532               237888999999999


Q ss_pred             HHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         333 LRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       333 ~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +.|+.|||+++++||||||+||+++.++.  ++++|||++...
T Consensus       133 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~  173 (291)
T cd05094         133 ASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDV  173 (291)
T ss_pred             HHHHHHHHhCCeeecccCcceEEEccCCc--EEECCCCccccc
Confidence            99999999999999999999999998776  999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.83  E-value=1.7e-20  Score=188.62  Aligned_cols=104  Identities=25%  Similarity=0.341  Sum_probs=91.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||++++++|..++..++||||+. +++.+++.... ..+++..+..++.|++.||+|||+.+++|
T Consensus        45 ~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH  124 (328)
T cd08226          45 ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIH  124 (328)
T ss_pred             HHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            35679999999999999999999999999999999999 57777776532 35889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      |||||+||+++.++.  +++.||+.+..
T Consensus       125 rDlkp~Nill~~~~~--~~~~~~~~~~~  150 (328)
T cd08226         125 RNIKASHILISGDGL--VSLSGLSHLYS  150 (328)
T ss_pred             CCCCHHHEEEeCCCc--EEEechHHHhh
Confidence            999999999988776  88899876543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.83  E-value=1.6e-20  Score=182.78  Aligned_cols=105  Identities=29%  Similarity=0.419  Sum_probs=92.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCC--ChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGL--DHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l--~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++|+||+++++++...+..+++|||++ ++|...+......+  ++..+..++.|++.|+.|||+++++
T Consensus        51 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~  130 (268)
T cd06624          51 PLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV  130 (268)
T ss_pred             HHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            35679999999999999999999999999999999998 67888877654455  7888889999999999999999999


Q ss_pred             eccCCCccccccc-cchhhHHHHHHHHHhhc
Q psy3074         346 HRDVKPQNLLISE-IDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       346 HrDlKp~NiLl~~-~~~~~ikl~dfgla~~~  375 (481)
                      ||||||+||+++. .+.  ++++|||++..+
T Consensus       131 h~dl~p~nil~~~~~~~--~~l~dfg~~~~~  159 (268)
T cd06624         131 HRDIKGDNVLVNTYSGV--VKISDFGTSKRL  159 (268)
T ss_pred             ecCCCHHHEEEcCCCCe--EEEecchhheec
Confidence            9999999999975 344  999999988654

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG1006|consensus

Probab=99.83  E-value=3.7e-22  Score=185.53  Aligned_cols=150  Identities=17%  Similarity=0.201  Sum_probs=118.5

Q ss_pred             HHHHHH-HHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHH----HhcCCCChHHHHHHHHHHHHHHHHhhc-Cc
Q psy3074         270 AIREAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME----RHSGGLDHHNIRLFMFQLLRGLSYCHR-RR  343 (481)
Q Consensus       270 ~~rE~~-il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~----~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~  343 (481)
                      +++|.. +++.-+-||||++|+++-.++..||.||+|+-++..+..    .+...++|..+..+....+.||.||-. ..
T Consensus       109 ll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk  188 (361)
T KOG1006|consen  109 LLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK  188 (361)
T ss_pred             HHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh
Confidence            344555 445556899999999999999999999999977655543    234579999999999999999999984 58


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccc--cccCceeccccCCCcccccccc------cccCCCeeEEEeecCC
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY--CHRRRILHRDVKPQNLLISEIV------FTNLSGVVVSTVDSGS  415 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~--~~~~~i~~~d~~~~~il~~~~~------~~~s~g~~~~~~~~g~  415 (481)
                      |||||+||+|||++..|.  +|+||||++..+..  ..+.-...|.|.+|+=+.+..-      ++||.|+.++|+.+|.
T Consensus       189 iIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~  266 (361)
T KOG1006|consen  189 IIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGN  266 (361)
T ss_pred             hhhccCChhheEEecCCC--EeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCC
Confidence            999999999999999888  99999999987652  2233455666666665543322      4699999999999999


Q ss_pred             CCcccc
Q psy3074         416 GGWWFE  421 (481)
Q Consensus       416 ~~~~~~  421 (481)
                      .||...
T Consensus       267 fPyr~w  272 (361)
T KOG1006|consen  267 FPYRKW  272 (361)
T ss_pred             CCcchH
Confidence            998744

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.83  E-value=2.2e-21  Score=192.16  Aligned_cols=106  Identities=15%  Similarity=0.206  Sum_probs=80.9

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.. .+.|++|||+++|+||||||    +|||++..    +.+||+|||+|+...........                
T Consensus       131 i~~q-i~~~l~~lH~~~iiHrDiKp----~Nill~~~----~~~~l~DFGla~~~~~~~~~~~~----------------  185 (294)
T PHA02882        131 IMKD-MLTTLEYIHEHGISHGDIKP----ENIMVDGN----NRGYIIDYGIASHFIIHGKHIEY----------------  185 (294)
T ss_pred             HHHH-HHHHHHHHHhCCeecCCCCH----HHEEEcCC----CcEEEEEcCCceeeccCCccccc----------------
Confidence            3444 78899999999999999999    89999765    68999999999854221100000                


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                         .......                      ..+|+.|+|||+..+.. |+.++||||+||++|||++|.+||.+.
T Consensus       186 ---~~~~~~~----------------------~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        186 ---SKEQKDL----------------------HRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             ---ccccccc----------------------cCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence               0000011                      12499999999988766 999999999999999999999999876

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.83  E-value=1.3e-20  Score=182.57  Aligned_cols=105  Identities=25%  Similarity=0.440  Sum_probs=91.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ++.+|+.++++++||||+++++++. .+..|++|||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+++|
T Consensus        47 ~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  125 (260)
T cd05070          47 SFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH  125 (260)
T ss_pred             HHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4668999999999999999999885 456899999998 67888776532 34889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  ++++|||++..+.
T Consensus       126 ~di~p~Nili~~~~~--~~l~dfg~~~~~~  153 (260)
T cd05070         126 RDLRSANILVGDGLV--CKIADFGLARLIE  153 (260)
T ss_pred             CCCccceEEEeCCce--EEeCCceeeeecc
Confidence            999999999998766  9999999987543

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.83  E-value=3.8e-21  Score=188.30  Aligned_cols=145  Identities=21%  Similarity=0.298  Sum_probs=115.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+..++..|+||||++ +++.+.+..  +.+++..+..++.|++.|+.|||+++++|+
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~  125 (277)
T cd06642          48 DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHR  125 (277)
T ss_pred             HHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeecc
Confidence            35679999999999999999999999999999999999 567666643  468899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||+|+||++++++.  +++.|||++..+......         .+                                ...
T Consensus       126 dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~---------~~--------------------------------~~~  162 (277)
T cd06642         126 DIKAANVLLSEQGD--VKLADFGVAGQLTDTQIK---------RN--------------------------------TFV  162 (277)
T ss_pred             CCChheEEEeCCCC--EEEccccccccccCcchh---------hh--------------------------------ccc
Confidence            99999999988777  999999988754311100         00                                011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ++..|++|        ...+|.|++|+++++|..|..|+
T Consensus       163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             CcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence            22223332        45689999999999999998664

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.83  E-value=2.1e-21  Score=194.49  Aligned_cols=103  Identities=27%  Similarity=0.505  Sum_probs=81.9

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++....                    
T Consensus        98 ~~~~~~q-i~~~l~~lH~~~ivHrDlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~--------------------  148 (316)
T cd05620          98 ATFYAAE-IVCGLQFLHSKGIIYRDLKL----DNVMLDRD----GHIKIADFGMCKENVF--------------------  148 (316)
T ss_pred             HHHHHHH-HHHHHHHHHHCCeEecCCCH----HHeEECCC----CCEEeCccCCCeeccc--------------------
Confidence            3334444 78899999999999999999    89999876    7999999999973210                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                           +. .....++                      +|+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.
T Consensus       149 -----~~-~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~  199 (316)
T cd05620         149 -----GD-NRASTFC----------------------GTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGD  199 (316)
T ss_pred             -----CC-CceeccC----------------------CCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCC
Confidence                 00 0111222                      399999999998765 999999999999999999999999875


Q ss_pred             h
Q psy3074         173 R  173 (481)
Q Consensus       173 ~  173 (481)
                      +
T Consensus       200 ~  200 (316)
T cd05620         200 D  200 (316)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.83  E-value=2.8e-20  Score=182.34  Aligned_cols=105  Identities=23%  Similarity=0.465  Sum_probs=95.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.. ...+++|||+. |++.+.+......+++..+..++.|++.|++|||+++++||
T Consensus        55 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T cd05057          55 EILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR  133 (279)
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence            46689999999999999999999987 78999999998 78888887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||++++++.  +|++|||+++.+.
T Consensus       134 di~p~nil~~~~~~--~kL~dfg~~~~~~  160 (279)
T cd05057         134 DLAARNVLVKTPQH--VKITDFGLAKLLD  160 (279)
T ss_pred             ccCcceEEEcCCCe--EEECCCccccccc
Confidence            99999999988776  9999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.83  E-value=1.7e-20  Score=185.89  Aligned_cols=151  Identities=13%  Similarity=0.108  Sum_probs=112.0

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ++...+..+.|+||+++++.+....    ..+++||++..++...+... ...++..+..++.|++.||.|||+++++||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            4556677789999999998776543    45788998887776665543 346788899999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++..+.  ++++|||+|+.+...... .   .                              +.........
T Consensus       151 DiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~-~---~------------------------------~~~~~~~~~~  194 (294)
T PHA02882        151 DIKPENIMVDGNNR--GYIIDYGIASHFIIHGKH-I---E------------------------------YSKEQKDLHR  194 (294)
T ss_pred             CCCHHHEEEcCCCc--EEEEEcCCceeeccCCcc-c---c------------------------------cccccccccC
Confidence            99999999987766  899999998765321100 0   0                              0000011234


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+-
T Consensus       195 gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~  234 (294)
T PHA02882        195 GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWK  234 (294)
T ss_pred             CCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            66666666        556799999999999999986653

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.83  E-value=2.7e-20  Score=183.46  Aligned_cols=105  Identities=19%  Similarity=0.358  Sum_probs=91.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||+. |+|.+++....         ..++...+..++.|++.||.|
T Consensus        55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  134 (288)
T cd05061          55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY  134 (288)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            45679999999999999999999999999999999998 78888886532         123456788899999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+++++||||||+||++++++.  ++++|||+++.+
T Consensus       135 lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~  169 (288)
T cd05061         135 LNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDI  169 (288)
T ss_pred             HHhCCCcCCCCChheEEEcCCCc--EEECcCCccccc
Confidence            99999999999999999998776  999999988754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.83  E-value=5.6e-21  Score=197.06  Aligned_cols=124  Identities=23%  Similarity=0.330  Sum_probs=94.4

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      .+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                   
T Consensus       184 ~~~i~~q-i~~aL~ylH~~~IvHrDiKP----~NIll~~~----~~vkL~DFG~a~~~~~~-------------------  235 (391)
T PHA03212        184 ILAIERS-VLRAIQYLHENRIIHRDIKA----ENIFINHP----GDVCLGDFGAACFPVDI-------------------  235 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhCCcccCCCCh----HhEEEcCC----CCEEEEeCCcccccccc-------------------
Confidence            3444444 78899999999999999999    89999866    79999999999732110                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                           .. .....+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|..||.+.
T Consensus       236 -----~~-~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        236 -----NA-NKYYGWA----------------------GTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             -----cc-ccccccc----------------------CccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence                 00 0001122                      399999999998765 999999999999999999999887543


Q ss_pred             ------hhhHHHHHHHHHHhCCCCccC
Q psy3074         173 ------REVYDQLDKIFKILGTPTEET  193 (481)
Q Consensus       173 ------~~~~~~l~~i~~~~~~p~~~~  193 (481)
                            .+...++..+++.++.++.+.
T Consensus       287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        287 DGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             ccccccCchhHHHHHHHHHhcCChhhc
Confidence                  234467888888888776543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.83  E-value=2e-20  Score=188.63  Aligned_cols=105  Identities=28%  Similarity=0.523  Sum_probs=95.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++||||+++++++...+..+++|||+.|++.+.+.. ...+++..+..++.|++.||.|||+.+++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            46789999999999999999999999999999999999999888765 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||+||+++.++.  ++++|||++..+.
T Consensus       145 l~~~nill~~~~~--~kl~dfg~~~~~~  170 (335)
T PTZ00024        145 LSPANIFINSKGI--CKIADFGLARRYG  170 (335)
T ss_pred             ccHHHeEECCCCC--EEECCccceeecc
Confidence            9999999998776  9999999887543

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.82  E-value=9.4e-22  Score=198.05  Aligned_cols=102  Identities=25%  Similarity=0.429  Sum_probs=81.4

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+.....                   
T Consensus        97 ~~~~~~q-i~~aL~~LH~~~ivHrDikp----~NIll~~~----~~~kL~DfG~~~~~~~~-------------------  148 (328)
T cd05593          97 TRFYGAE-IVSALDYLHSGKIVYRDLKL----ENLMLDKD----GHIKITDFGLCKEGITD-------------------  148 (328)
T ss_pred             HHHHHHH-HHHHHHHHHhCCeEecccCH----HHeEECCC----CcEEEecCcCCccCCCc-------------------
Confidence            3344444 78899999999999999999    89999866    79999999999742110                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             ......++                      +|+.|+|||++.+.. ++.++||||+||++|||++|+.||.+.
T Consensus       149 -------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         149 -------AATMKTFC----------------------GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             -------cccccccc----------------------CCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCC
Confidence                   00011122                      399999999998765 999999999999999999999999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.82  E-value=1.5e-21  Score=196.20  Aligned_cols=105  Identities=26%  Similarity=0.433  Sum_probs=82.8

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus        94 ~~~~~~~~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~Dfg~~~~~~~~----------------  148 (323)
T cd05595          94 EERARFYGAE-IVSALEYLHSRDVVYRDIKL----ENLMLDKD----GHIKITDFGLCKEGISD----------------  148 (323)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeEecCCCH----HHEEEcCC----CCEEecccHHhccccCC----------------
Confidence            3444445555 78899999999999999999    89999876    79999999999742110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......+.                      +|+.|||||++.+.. ++.++|+||+||++|||++|+.||
T Consensus       149 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         149 ----------GATMKTFC----------------------GTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             ----------CCcccccc----------------------CCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCC
Confidence                      00001122                      389999999998765 999999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       196 ~~~  198 (323)
T cd05595         196 YNQ  198 (323)
T ss_pred             CCC
Confidence            874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0610|consensus

Probab=99.82  E-value=6.9e-21  Score=186.89  Aligned_cols=156  Identities=21%  Similarity=0.270  Sum_probs=98.4

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      +....+..++||+|||-.|||.|||||    +||||..+    |+|-|+||-|+..... ..+..... ++......-..
T Consensus       181 aRFYaAEvl~ALEYLHmlGivYRDLKP----ENILvred----GHIMLsDFDLS~~~~~-~Pt~~~s~-~~~~~~~~~~~  250 (459)
T KOG0610|consen  181 ARFYAAEVLLALEYLHMLGIVYRDLKP----ENILVRED----GHIMLSDFDLSLRCPV-SPTLVKSS-SPRSSGSQPSC  250 (459)
T ss_pred             HHHHHHHHHHHHHHHHhhceeeccCCc----ceeEEecC----CcEEeeeccccccCCC-CCeeeccC-CCCCCCCCccc
Confidence            445555579999999999999999999    89999987    8999999999976521 11111100 00000000000


Q ss_pred             cccCCCCceeE-EEeccc----------CcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHH
Q psy3074          94 LDQLGEGSYAT-VFKGYS----------NLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        94 ~~~~g~g~~~~-~~~g~~----------~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~el  162 (481)
                      .. ...+.|.. ......          ....+.+|--.-...+.-|||-.|.|||++.|.. .+.++|||+||+.+|||
T Consensus       251 ~~-~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEm  328 (459)
T KOG0610|consen  251 RS-RQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEM  328 (459)
T ss_pred             cc-ccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHH
Confidence            00 00011100 000000          0111222222333456778899999999999876 99999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHH
Q psy3074         163 VTGLPTFPGVREVYDQLDKI  182 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i  182 (481)
                      |-|..||.|.+.. +.+..|
T Consensus       329 LyG~TPFKG~~~~-~Tl~NI  347 (459)
T KOG0610|consen  329 LYGTTPFKGSNNK-ETLRNI  347 (459)
T ss_pred             HhCCCCcCCCCch-hhHHHH
Confidence            9999999997555 344433

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.82  E-value=1.9e-20  Score=181.60  Aligned_cols=105  Identities=23%  Similarity=0.416  Sum_probs=91.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++|||++++++++. .+..+++|||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+++|
T Consensus        47 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H  125 (260)
T cd05069          47 AFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH  125 (260)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence            4567999999999999999999875 456899999998 58888886543 34788889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  ++++|||+++.+.
T Consensus       126 ~dl~~~Nill~~~~~--~~l~dfg~~~~~~  153 (260)
T cd05069         126 RDLRAANILVGDNLV--CKIADFGLARLIE  153 (260)
T ss_pred             cccCcceEEEcCCCe--EEECCCccceEcc
Confidence            999999999998776  9999999887543

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.82  E-value=2.4e-21  Score=195.57  Aligned_cols=106  Identities=26%  Similarity=0.519  Sum_probs=81.2

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......                 
T Consensus       175 ~~~~~~~q-i~~aL~~LH~~~ivHrDiKp----~Nil~~~~----~~~kl~DfG~a~~~~~~~-----------------  228 (338)
T cd05102         175 DLICYSFQ-VARGMEFLASRKCIHRDLAA----RNILLSEN----NVVKICDFGLARDIYKDP-----------------  228 (338)
T ss_pred             HHHHHHHH-HHHHHHHHHHCCEECCCCcc----ceEEEcCC----CcEEEeecccccccccCc-----------------
Confidence            33444444 78899999999999999999    89999765    799999999998431100                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               .+  ...+                  ...+|+.|||||++.+.. |+.++||||+||++|||++ |.+||+
T Consensus       229 ---------~~--~~~~------------------~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~  278 (338)
T cd05102         229 ---------DY--VRKG------------------SARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYP  278 (338)
T ss_pred             ---------ch--hccc------------------CCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCC
Confidence                     00  0000                  011267899999998765 9999999999999999997 999998


Q ss_pred             Cch
Q psy3074         171 GVR  173 (481)
Q Consensus       171 g~~  173 (481)
                      +..
T Consensus       279 ~~~  281 (338)
T cd05102         279 GVQ  281 (338)
T ss_pred             CCC
Confidence            854

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.82  E-value=4e-20  Score=180.32  Aligned_cols=104  Identities=31%  Similarity=0.482  Sum_probs=93.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++...+..++||||+. ++|.+.+... +.+++..+..++.|++.||.|||+++++||
T Consensus        54 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~  132 (272)
T cd06629          54 ALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHR  132 (272)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeec
Confidence            35679999999999999999999999999999999998 6777777654 568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++++.  ++++|||+++..
T Consensus       133 dl~~~nil~~~~~~--~~l~d~~~~~~~  158 (272)
T cd06629         133 DLKADNLLVDADGI--CKISDFGISKKS  158 (272)
T ss_pred             CCChhhEEEcCCCe--EEEeeccccccc
Confidence            99999999998776  999999988654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.82  E-value=1.3e-21  Score=196.43  Aligned_cols=113  Identities=26%  Similarity=0.448  Sum_probs=85.9

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.....                  
T Consensus        97 ~~~~~~~q-i~~~l~~lH~~givH~dikp----~NIll~~~----~~~kl~Dfg~~~~~~~~------------------  149 (323)
T cd05575          97 RARFYAAE-IASALGYLHSLNIIYRDLKP----ENILLDSQ----GHVVLTDFGLCKEGIEH------------------  149 (323)
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeEeCCCCH----HHeEECCC----CcEEEeccCCCcccccC------------------
Confidence            33344455 78899999999999999999    89999876    79999999999742110                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                              .......+                      +|+.|||||++.+.. |+.++||||+||++|||++|.+||.+
T Consensus       150 --------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~  198 (323)
T cd05575         150 --------SKTTSTFC----------------------GTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             --------CCcccccc----------------------CChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCC
Confidence                    00011122                      399999999998765 99999999999999999999999987


Q ss_pred             chhhHHHHHHHH
Q psy3074         172 VREVYDQLDKIF  183 (481)
Q Consensus       172 ~~~~~~~l~~i~  183 (481)
                      . +..+..+.+.
T Consensus       199 ~-~~~~~~~~i~  209 (323)
T cd05575         199 R-DTAEMYDNIL  209 (323)
T ss_pred             C-CHHHHHHHHH
Confidence            4 3334444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.82  E-value=2.3e-20  Score=185.46  Aligned_cols=106  Identities=24%  Similarity=0.500  Sum_probs=93.4

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++.+ +||||+++++++...+..|++|||+. |+|.+++....               ..++...+..++.|
T Consensus        66 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  145 (304)
T cd05101          66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ  145 (304)
T ss_pred             HHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHH
Confidence            466899999999 79999999999999999999999998 68888876532               23667788899999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ++.||.|||+++++||||||+||++++++.  +|++|||+++.+.
T Consensus       146 i~~al~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~  188 (304)
T cd05101         146 VARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVN  188 (304)
T ss_pred             HHHHHHHHHHCCeeecccccceEEEcCCCc--EEECCCccceecc
Confidence            999999999999999999999999988776  9999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.82  E-value=1.3e-20  Score=184.60  Aligned_cols=104  Identities=23%  Similarity=0.415  Sum_probs=93.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+.+.+..|+||||++ |+|.+.+..  +.+++..+..++.|++.|+.|||+.+++|+
T Consensus        48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~  125 (277)
T cd06640          48 DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHR  125 (277)
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCc
Confidence            35579999999999999999999999999999999998 577777653  468899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|+||+++.++.  ++++|||++..+.
T Consensus       126 dl~p~Nil~~~~~~--~~l~dfg~~~~~~  152 (277)
T cd06640         126 DIKAANVLLSEQGD--VKLADFGVAGQLT  152 (277)
T ss_pred             CCChhhEEEcCCCC--EEEcccccceecc
Confidence            99999999998776  9999999887543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0603|consensus

Probab=99.82  E-value=4.2e-21  Score=197.78  Aligned_cols=98  Identities=31%  Similarity=0.482  Sum_probs=79.1

Q ss_pred             CcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCC
Q psy3074          19 DSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLG   98 (481)
Q Consensus        19 ~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g   98 (481)
                      ...+.|++|||++|||||||||    +|||+.   ...|++||+|||.++....                          
T Consensus       422 ~~lv~Av~~LH~~gvvhRDLkp----~NIL~~---~~~g~lrltyFG~a~~~~~--------------------------  468 (612)
T KOG0603|consen  422 AELVSAVDYLHEQGVVHRDLKP----GNILLD---GSAGHLRLTYFGFWSELER--------------------------  468 (612)
T ss_pred             HHHHHHHHHHHhcCeeecCCCh----hheeec---CCCCcEEEEEechhhhCch--------------------------
Confidence            3478899999999999999999    899995   2238999999999985311                          


Q ss_pred             CCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          99 EGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        99 ~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                        +    ++     +              ...|..|.|||++... .|+.+|||||+|+++||||+|+.||......
T Consensus       469 --~----~~-----t--------------p~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~  519 (612)
T KOG0603|consen  469 --S----CD-----T--------------PALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG  519 (612)
T ss_pred             --h----hc-----c--------------cchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence              0    00     0              0128899999999955 4999999999999999999999999875443

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.82  E-value=7.8e-21  Score=188.57  Aligned_cols=123  Identities=59%  Similarity=1.030  Sum_probs=100.0

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    +.+||+|||+++.......                         
T Consensus       113 i~~aL~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~dfg~~~~~~~~~~-------------------------  159 (301)
T cd07873         113 LLRGLNYCHRRKVLHRDLKP----QNLLINER----GELKLADFGLARAKSIPTK-------------------------  159 (301)
T ss_pred             HHHHHHHHHhCCeeCCCCCH----HHEEECCC----CcEEECcCcchhccCCCCC-------------------------
Confidence            78899999999999999999    89999876    7999999999974221100                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ..                       ....+++.|+|||++.+...++.++||||+||++|||++|++||.+. +..+++.
T Consensus       160 ~~-----------------------~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~-~~~~~~~  215 (301)
T cd07873         160 TY-----------------------SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS-TVEEQLH  215 (301)
T ss_pred             cc-----------------------cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            00                       00113889999999988777999999999999999999999999984 4557888


Q ss_pred             HHHHHhCCCCccCcccccCC
Q psy3074         181 KIFKILGTPTEETWEGVSLL  200 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~  200 (481)
                      .+.+.++.|....|+.....
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         216 FIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             HHHHHcCCCChhhchhhhcc
Confidence            89999999999888876443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG1026|consensus

Probab=99.82  E-value=1.2e-21  Score=207.53  Aligned_cols=161  Identities=15%  Similarity=0.271  Sum_probs=131.4

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      +++...+.++||+- ...+.+||-++.+|||||..    +|+|++...    .|||+||||+|..-..            
T Consensus       598 ~~L~~~q~L~iA~Q-IAaGM~YLs~~~FVHRDLAT----RNCLVge~l----~VKIsDfGLsRdiYss------------  656 (774)
T KOG1026|consen  598 PPLSTSQFLHIATQ-IAAGMEYLSSHHFVHRDLAT----RNCLVGENL----VVKISDFGLSRDIYSS------------  656 (774)
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHhCcccccchhh----hhceeccce----EEEecccccchhhhhh------------
Confidence            44667777888877 88899999999999999999    899999985    9999999999953100            


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-  164 (481)
                          .|                  ++..+            ..-.+.+||+||.|+.++ |+++|||||+||+|||+++ 
T Consensus       657 ----DY------------------Yk~~~------------~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsy  701 (774)
T KOG1026|consen  657 ----DY------------------YKVRG------------NTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSY  701 (774)
T ss_pred             ----hh------------------hcccC------------CceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhcc
Confidence                01                  11111            111388999999999887 9999999999999999999 


Q ss_pred             CCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCc
Q psy3074         165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRL  223 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  223 (481)
                      |+.|+.|..+. +.++.|-..---+.++.+|..-+-.|..||...|.+|++|.++...+
T Consensus       702 G~QPy~glSn~-EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L  759 (774)
T KOG1026|consen  702 GKQPYYGLSNQ-EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRL  759 (774)
T ss_pred             ccCcccccchH-HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            99999996543 77777777767899999999988899999999999999987764443

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.82  E-value=1.9e-21  Score=195.07  Aligned_cols=101  Identities=27%  Similarity=0.475  Sum_probs=81.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                   
T Consensus        99 ~~~~~q-i~~~L~~lH~~~ivH~Dlkp----~NIll~~~----~~~kl~Dfg~~~~~~~~~-------------------  150 (321)
T cd05603          99 RFYAAE-VASAIGYLHSLNIIYRDLKP----ENILLDSQ----GHVVLTDFGLCKEGVEPE-------------------  150 (321)
T ss_pred             HHHHHH-HHHHHHHHHHCCeEeccCCH----HHeEECCC----CCEEEccCCCCccCCCCC-------------------
Confidence            334444 78899999999999999999    89999876    799999999997421100                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             .....+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.
T Consensus       151 -------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         151 -------ETTSTFC----------------------GTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             -------Ccccccc----------------------CCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCC
Confidence                   0011122                      389999999998765 999999999999999999999999884

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0612|consensus

Probab=99.82  E-value=3.6e-21  Score=207.84  Aligned_cols=116  Identities=30%  Similarity=0.436  Sum_probs=89.6

Q ss_pred             cCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccC
Q psy3074          18 SDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQL   97 (481)
Q Consensus        18 ~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (481)
                      .+..++||+.+|+.|.|||||||    +||||+..    |++||+|||.|-....                         
T Consensus       181 ~aEiVlAldslH~mgyVHRDiKP----DNvLld~~----GHikLADFGsClkm~~-------------------------  227 (1317)
T KOG0612|consen  181 TAEIVLALDSLHSMGYVHRDIKP----DNVLLDKS----GHIKLADFGSCLKMDA-------------------------  227 (1317)
T ss_pred             HHHHHHHHHHHHhccceeccCCc----ceeEeccc----CcEeeccchhHHhcCC-------------------------
Confidence            33459999999999999999999    89999988    8999999999864211                         


Q ss_pred             CCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          98 GEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS----TEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        98 g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~----~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                       .|   +|.+                  +..||||.|.+||+|...    ..|+..|||||+||++||||.|..||... 
T Consensus       228 -dG---~V~s------------------~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-  284 (1317)
T KOG0612|consen  228 -DG---TVRS------------------SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-  284 (1317)
T ss_pred             -CC---cEEe------------------ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-
Confidence             12   2222                  123569999999999742    34999999999999999999999999873 


Q ss_pred             hhHHHHHHHHH---HhCCC
Q psy3074         174 EVYDQLDKIFK---ILGTP  189 (481)
Q Consensus       174 ~~~~~l~~i~~---~~~~p  189 (481)
                      ...+...+|..   .+..|
T Consensus       285 slveTY~KIm~hk~~l~FP  303 (1317)
T KOG0612|consen  285 SLVETYGKIMNHKESLSFP  303 (1317)
T ss_pred             HHHHHHHHHhchhhhcCCC
Confidence            34455555543   35555

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.82  E-value=8.8e-21  Score=183.82  Aligned_cols=151  Identities=21%  Similarity=0.269  Sum_probs=124.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc--CCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS--GGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++|+||+++++.+...+..|++||+++ +++.+.+....  ..+++..+..++.|++.||.|||+++++
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~  124 (267)
T cd06610          45 ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI  124 (267)
T ss_pred             HHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35679999999999999999999999999999999998 56777776532  4588999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccC-------ceeccccCCCcccccc-----cccccCCCeeEEEeec
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR-------RILHRDVKPQNLLISE-----IVFTNLSGVVVSTVDS  413 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~-------~i~~~d~~~~~il~~~-----~~~~~s~g~~~~~~~~  413 (481)
                      ||||||+||++++++.  ++++|||++..+......       ...+..+.+|+++...     ..+.|++|++++++.+
T Consensus       125 h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~  202 (267)
T cd06610         125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT  202 (267)
T ss_pred             cCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence            9999999999998776  999999999876643211       1233456677765433     4577999999999999


Q ss_pred             CCCCcccc
Q psy3074         414 GSGGWWFE  421 (481)
Q Consensus       414 g~~~~~~~  421 (481)
                      |..||...
T Consensus       203 g~~p~~~~  210 (267)
T cd06610         203 GAAPYSKY  210 (267)
T ss_pred             CCCCcccc
Confidence            99998654

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.82  E-value=1.5e-20  Score=184.35  Aligned_cols=157  Identities=20%  Similarity=0.212  Sum_probs=114.1

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeec------CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHT------RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~------~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      +.+|+.+++++ +||||+++++++..      .+..|++|||+. |++..++.... ..+++..+..++.|++.|+.|||
T Consensus        59 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  138 (282)
T cd06636          59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH  138 (282)
T ss_pred             HHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45688889888 69999999999853      467899999998 57877776533 34788889999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccC---ceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR---RILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~---~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      +.+++||||||+||++++++.  ++++|||++..+......   ...+..|.||+.+..+.                   
T Consensus       139 ~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-------------------  197 (282)
T cd06636         139 AHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE-------------------  197 (282)
T ss_pred             HCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccccCCCcccccccccCHhhcCccc-------------------
Confidence            999999999999999998777  999999998765421110   01111122222221100                   


Q ss_pred             ccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         418 WWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                  ......+..+|+|++|+++++|..|..|+.
T Consensus       198 ------------~~~~~~~~~~DvwslG~~l~el~~g~~p~~  227 (282)
T cd06636         198 ------------NPDATYDYRSDIWSLGITAIEMAEGAPPLC  227 (282)
T ss_pred             ------------CcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence                        000011335799999999999999986654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG1006|consensus

Probab=99.82  E-value=1.3e-21  Score=181.98  Aligned_cols=107  Identities=26%  Similarity=0.433  Sum_probs=88.0

Q ss_pred             ccccHHHHH-HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          21 KLLDADIAE-ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        21 ~~~~~~~lh-~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      .+.||+||- +.+|||||+||    +||||+..    |.+||||||++..+.                            
T Consensus       176 tV~AL~yLK~~lkiIHRDvKP----SNILldr~----G~vKLCDFGIcGqLv----------------------------  219 (361)
T KOG1006|consen  176 TVDALDYLKEELKIIHRDVKP----SNILLDRH----GDVKLCDFGICGQLV----------------------------  219 (361)
T ss_pred             ehhHHHHHHHHhhhhhccCCh----hheEEecC----CCEeeecccchHhHH----------------------------
Confidence            578999998 66999999999    99999987    899999999996432                            


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCchhhHHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE-YSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ  178 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~-y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~  178 (481)
                      +|++.                     +...|+..|||||.+.-+.. |+.+||+||+|+++||+.||..|+.+=+++.+|
T Consensus       220 ~SiAk---------------------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq  278 (361)
T KOG1006|consen  220 DSIAK---------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ  278 (361)
T ss_pred             HHHHh---------------------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH
Confidence            12211                     12335899999999976554 999999999999999999999999988777788


Q ss_pred             HHHHHH
Q psy3074         179 LDKIFK  184 (481)
Q Consensus       179 l~~i~~  184 (481)
                      +..+..
T Consensus       279 l~~Vv~  284 (361)
T KOG1006|consen  279 LCQVVI  284 (361)
T ss_pred             HHHHHc
Confidence            776643

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.82  E-value=1.9e-21  Score=195.92  Aligned_cols=97  Identities=23%  Similarity=0.442  Sum_probs=79.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                         .
T Consensus       114 i~~~l~~lH~~~ivHrDlkp----~Nili~~~----~~~kl~DfG~~~~~~~~~-------------------------~  160 (332)
T cd05614         114 IILALEHLHKLGIVYRDIKL----ENILLDSE----GHVVLTDFGLSKEFLSEE-------------------------K  160 (332)
T ss_pred             HHHHHHHHHHCCcEecCCCH----HHeEECCC----CCEEEeeCcCCccccccC-------------------------C
Confidence            78899999999999999999    89999876    799999999998432110                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                      .....+.|                      |+.|||||++.+...++.++||||+||++|||++|..||.+.
T Consensus       161 ~~~~~~~g----------------------t~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         161 ERTYSFCG----------------------TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             CccccccC----------------------CccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            01112233                      999999999987766899999999999999999999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.82  E-value=4.7e-21  Score=185.02  Aligned_cols=151  Identities=23%  Similarity=0.264  Sum_probs=122.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ++.+|+.+++.++||||+++++.+...+..++||||+. +++.+.+.... ..+++..+..++.|++.|+.|||+++++|
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  124 (256)
T cd08218          45 ESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH  124 (256)
T ss_pred             HHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            45679999999999999999999999999999999998 57887776533 35788899999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      +||+|+||+++.++.  ++++|||++..+....   .....+..+.||+++.+    ...+.|++|++++++.+|..||.
T Consensus       125 ~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~  202 (256)
T cd08218         125 RDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE  202 (256)
T ss_pred             CCCCHHHEEEcCCCC--EEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence            999999999988776  9999999987654221   11122334566766543    33567999999999999999986


Q ss_pred             cc
Q psy3074         420 FE  421 (481)
Q Consensus       420 ~~  421 (481)
                      ..
T Consensus       203 ~~  204 (256)
T cd08218         203 AG  204 (256)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.82  E-value=3.7e-20  Score=182.56  Aligned_cols=105  Identities=27%  Similarity=0.430  Sum_probs=89.7

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecC-----CeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHh
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTR-----STLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~-----~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      ..+|+.+++++ +||||+++++++...     +..|+||||++ |+|.+++..   ....+++..+..++.|++.||.||
T Consensus        65 ~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  144 (291)
T cd06639          65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL  144 (291)
T ss_pred             HHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            44688999998 799999999998753     36899999998 577776643   234688999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |+.+++||||||+||++++++.  +|++|||++..+.
T Consensus       145 H~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~  179 (291)
T cd06639         145 HNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLT  179 (291)
T ss_pred             HhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcc
Confidence            9999999999999999988776  9999999987654

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.82  E-value=2.2e-20  Score=183.13  Aligned_cols=104  Identities=44%  Similarity=0.716  Sum_probs=90.5

Q ss_pred             HHHHHHHHhhc---CCCCeeEEeeeeecCCe-----EEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL---KHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l---~HpnIV~l~~~~~~~~~-----~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      +.+|+.+++++   +||||+++++++.+.+.     .+++|||+.+++.+++.... ..+++..+..++.|++.||.|||
T Consensus        45 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH  124 (287)
T cd07838          45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH  124 (287)
T ss_pred             HHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34577777666   59999999999988776     99999999998888776543 35899999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +.+++|+||+|+||+++.++.  +|++|||++..+
T Consensus       125 ~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~  157 (287)
T cd07838         125 SHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIY  157 (287)
T ss_pred             HCCeeeccCChhhEEEccCCC--EEEeccCcceec
Confidence            999999999999999998866  999999988654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.82  E-value=2.8e-20  Score=182.17  Aligned_cols=105  Identities=20%  Similarity=0.367  Sum_probs=92.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC---------CCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG---------GLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~---------~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.++||||+++++++......++||||++ |+|.+++.....         .++...+..++.|++.|+.|
T Consensus        55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  134 (277)
T cd05062          55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY  134 (277)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999999999999998 678887765321         24667788899999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+.+++||||||+||++++++.  ++++|||+++.+
T Consensus       135 lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~  169 (277)
T cd05062         135 LNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI  169 (277)
T ss_pred             HHHCCcccCCcchheEEEcCCCC--EEECCCCCcccc
Confidence            99999999999999999998776  999999988754

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.82  E-value=1.2e-21  Score=196.85  Aligned_cols=115  Identities=26%  Similarity=0.447  Sum_probs=87.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +.....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus        95 ~~~~~~~~~q-i~~al~~lH~~givH~Dlkp----~NIll~~~----~~~kL~DfG~~~~~~~~----------------  149 (325)
T cd05604          95 EPRARFYAAE-IASALGYLHSINIVYRDLKP----ENILLDSQ----GHVVLTDFGLCKEGIAQ----------------  149 (325)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeeecCCCH----HHeEECCC----CCEEEeecCCcccCCCC----------------
Confidence            3334444444 78899999999999999999    89999876    79999999999742100                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......+.                      +|+.|||||++.+.. |+.++||||+||++|||++|.+||
T Consensus       150 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf  196 (325)
T cd05604         150 ----------SDTTTTFC----------------------GTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPF  196 (325)
T ss_pred             ----------CCCccccc----------------------CChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCC
Confidence                      00011122                      399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIF  183 (481)
Q Consensus       170 ~g~~~~~~~l~~i~  183 (481)
                      .+. +..+.++.+.
T Consensus       197 ~~~-~~~~~~~~~~  209 (325)
T cd05604         197 YCR-DVAEMYDNIL  209 (325)
T ss_pred             CCC-CHHHHHHHHH
Confidence            874 3334444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.82  E-value=1.9e-20  Score=184.19  Aligned_cols=155  Identities=15%  Similarity=0.158  Sum_probs=114.1

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHH---H-hcCCCChHHHHHHHHHHHHHHHHhhc-Cc
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME---R-HSGGLDHHNIRLFMFQLLRGLSYCHR-RR  343 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~---~-~~~~l~~~~~~~~~~qi~~~l~ylH~-~~  343 (481)
                      +.+|+.++.++. ||||+++++++..++..+++|||+.+++..+..   . ....+++..+..++.|++.||+|||+ .+
T Consensus        49 ~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~  128 (288)
T cd06616          49 LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK  128 (288)
T ss_pred             HHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            567999999996 999999999999999999999999876554432   1 23568999999999999999999997 49


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhcccccc--CceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ++||||||+||++++.+.  ++++|||+++.+.....  ....+..+.+|+++..                         
T Consensus       129 i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------------------------  181 (288)
T cd06616         129 IIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP-------------------------  181 (288)
T ss_pred             eeccCCCHHHEEEccCCc--EEEeecchhHHhccCCccccccCccCccCHHHhcc-------------------------
Confidence            999999999999988776  99999999975431110  0001111111111110                         


Q ss_pred             ccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         422 SKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       422 ~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                             .. ...++..+|+|++|+++++|..|.+|+-
T Consensus       182 -------~~-~~~~~~~~Di~slG~il~el~~g~~p~~  211 (288)
T cd06616         182 -------SA-RDGYDVRSDVWSLGITLYEVATGKFPYP  211 (288)
T ss_pred             -------cc-ccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence                   00 1122456799999999999999987753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983|consensus

Probab=99.82  E-value=2.3e-21  Score=180.84  Aligned_cols=150  Identities=17%  Similarity=0.222  Sum_probs=123.5

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceeec
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiHr  347 (481)
                      .++.+.++...+ .|.||+.+++|..+..++|.||.|..-...++++-.+.++|..+-.+...++.||.||-+ .+||||
T Consensus       137 ILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHR  216 (391)
T KOG0983|consen  137 ILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHR  216 (391)
T ss_pred             HHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeec
Confidence            445666665554 899999999999999999999999866666666667789999999999999999999985 489999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc--ccccCceeccccCCCcccccc-------cccccCCCeeEEEeecCCCCc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS--YCHRRRILHRDVKPQNLLISE-------IVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~--~~~~~~i~~~d~~~~~il~~~-------~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      |+||+|||+|+.|.  ||+||||++..+-  -.|++......|.+|+=+-++       ..++||+|+.++++.+|..||
T Consensus       217 DvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy  294 (391)
T KOG0983|consen  217 DVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY  294 (391)
T ss_pred             ccCccceEEccCCC--EEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence            99999999999888  9999999998775  345666666666666655433       224699999999999999999


Q ss_pred             ccc
Q psy3074         419 WFE  421 (481)
Q Consensus       419 ~~~  421 (481)
                      ...
T Consensus       295 ~~c  297 (391)
T KOG0983|consen  295 KGC  297 (391)
T ss_pred             CCC
Confidence            864

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.82  E-value=1.6e-20  Score=190.25  Aligned_cols=105  Identities=25%  Similarity=0.496  Sum_probs=88.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecC-CeEEEEEeccC-CCHHHHHHHhc----------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTR-STLTFVFEYVH-TDLSQYMERHS----------------------------  317 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~-~~~~iv~E~~~-g~l~~~l~~~~----------------------------  317 (481)
                      .+.+|+.+|.++ +|||||++++++... ..++++||||+ |+|.+++....                            
T Consensus        56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  135 (343)
T cd05103          56 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLK  135 (343)
T ss_pred             HHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhh
Confidence            466899999999 689999999988654 56899999998 67887775421                            


Q ss_pred             --------------------------------------CCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCcccccccc
Q psy3074         318 --------------------------------------GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEI  359 (481)
Q Consensus       318 --------------------------------------~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~  359 (481)
                                                            ..++...+..++.|++.||.|||+++++||||||+||+++++
T Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  215 (343)
T cd05103         136 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN  215 (343)
T ss_pred             hhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC
Confidence                                                  125667778899999999999999999999999999999887


Q ss_pred             chhhHHHHHHHHHhhc
Q psy3074         360 DHHNIRLFMFQLLRGL  375 (481)
Q Consensus       360 ~~~~ikl~dfgla~~~  375 (481)
                      +.  +|++|||++..+
T Consensus       216 ~~--~kl~dfg~~~~~  229 (343)
T cd05103         216 NV--VKICDFGLARDI  229 (343)
T ss_pred             Cc--EEEEeccccccc
Confidence            76  999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.82  E-value=4.6e-20  Score=184.30  Aligned_cols=106  Identities=28%  Similarity=0.547  Sum_probs=93.5

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++++ +||||+++++++...+..|++|||+. |+|.+++....               ..++...+..++.|
T Consensus        63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  142 (314)
T cd05099          63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ  142 (314)
T ss_pred             HHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence            456799999999 59999999999999999999999998 68888876532               24778888999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ++.||.|||+++++||||||+||++++++.  +|++|||+++.+.
T Consensus       143 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~  185 (314)
T cd05099         143 VARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVH  185 (314)
T ss_pred             HHHHHHHHHHCCeeeccccceeEEEcCCCc--EEEcccccccccc
Confidence            999999999999999999999999988776  9999999997653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.2e-21  Score=205.94  Aligned_cols=111  Identities=23%  Similarity=0.362  Sum_probs=85.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    +.+||+|||+++......                        ..
T Consensus       152 ll~aL~~lH~~~IiHrDLKP----~NILl~~~----~~vkL~DFGls~~~~~~~------------------------~~  199 (496)
T PTZ00283        152 VLLAVHHVHSKHMIHRDIKS----ANILLCSN----GLVKLGDFGFSKMYAATV------------------------SD  199 (496)
T ss_pred             HHHHHHHHHhCCEecCCCCH----HHEEEeCC----CCEEEEecccCeeccccc------------------------cc
Confidence            68899999999999999999    99999876    799999999998532110                        00


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ..+..++                      +|+.|||||++.+.. |+.++||||+||++|||++|+.||.+. +..+.+.
T Consensus       200 ~~~~~~~----------------------Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~-~~~~~~~  255 (496)
T PTZ00283        200 DVGRTFC----------------------GTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGE-NMEEVMH  255 (496)
T ss_pred             ccccccc----------------------CCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCC-CHHHHHH
Confidence            1111223                      399999999998765 999999999999999999999999874 3334555


Q ss_pred             HHHHHhC
Q psy3074         181 KIFKILG  187 (481)
Q Consensus       181 ~i~~~~~  187 (481)
                      .+.....
T Consensus       256 ~~~~~~~  262 (496)
T PTZ00283        256 KTLAGRY  262 (496)
T ss_pred             HHhcCCC
Confidence            5544333

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.82  E-value=2.1e-20  Score=184.29  Aligned_cols=104  Identities=21%  Similarity=0.413  Sum_probs=92.9

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++++ +|+||+++++.+..+...|+||||++ ++|.+.+... ..+++..+..++.|++.||.|||+.+++|
T Consensus        50 ~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H  128 (290)
T cd05613          50 HTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIY  128 (290)
T ss_pred             HHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456799999999 59999999999999999999999999 6787777653 56889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+|||++.++.  +|++|||+++.+
T Consensus       129 ~dl~p~nil~~~~~~--~kl~dfg~~~~~  155 (290)
T cd05613         129 RDIKLENILLDSNGH--VVLTDFGLSKEF  155 (290)
T ss_pred             cCCCHHHeEECCCCC--EEEeeCccceec
Confidence            999999999998776  999999988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.82  E-value=4e-20  Score=178.86  Aligned_cols=104  Identities=24%  Similarity=0.459  Sum_probs=92.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++|||||++++++.. +..+++|||+. |+|.+++... ..+++..+..++.|++.||.|||..+++||
T Consensus        42 ~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~  119 (257)
T cd05060          42 EFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHR  119 (257)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            45679999999999999999998764 46899999998 6788888654 368999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++.++.  +|++|||+++.+.
T Consensus       120 di~p~nili~~~~~--~kl~df~~~~~~~  146 (257)
T cd05060         120 DLAARNVLLVNRHQ--AKISDFGMSRALG  146 (257)
T ss_pred             CcccceEEEcCCCc--EEeccccccceee
Confidence            99999999998777  9999999987654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.82  E-value=2.2e-20  Score=180.40  Aligned_cols=103  Identities=22%  Similarity=0.437  Sum_probs=90.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++... ..+++|||+. ++|.+++..... .+++..+..++.|++.|+.|||+.+++|
T Consensus        45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H  123 (254)
T cd05083          45 AFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVH  123 (254)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456799999999999999999998764 4799999998 688888865433 4788889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      |||||+||+++.++.  +|++|||++..
T Consensus       124 ~dl~p~nili~~~~~--~kl~Dfg~~~~  149 (254)
T cd05083         124 RDLAARNILVSEDGV--AKVSDFGLARV  149 (254)
T ss_pred             cccCcceEEEcCCCc--EEECCCcccee
Confidence            999999999988776  99999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.82  E-value=1.9e-20  Score=183.40  Aligned_cols=103  Identities=25%  Similarity=0.429  Sum_probs=92.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++.+..++..|+||||++ +++...+..  +.+++..+..++.|++.|+.|||+.+++|+
T Consensus        48 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~  125 (277)
T cd06641          48 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR  125 (277)
T ss_pred             HHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecC
Confidence            35579999999999999999999999999999999998 567766643  458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  ++++|||++..+
T Consensus       126 dl~p~Ni~i~~~~~--~~l~dfg~~~~~  151 (277)
T cd06641         126 DIKAANVLLSEHGE--VKLADFGVAGQL  151 (277)
T ss_pred             CCCHHhEEECCCCC--EEEeecccceec
Confidence            99999999988776  999999988654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.82  E-value=3e-20  Score=184.78  Aligned_cols=106  Identities=23%  Similarity=0.446  Sum_probs=94.2

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ..+.+|+.+++++ +||||+++++++...+..|++|||+. |+|..++..... .+++..+..++.|++.||.|||++++
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  162 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC  162 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3467899999999 79999999999999999999999998 778888765433 38899999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +|+||||+|||++..+.  ++++|||+++.+
T Consensus       163 vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~  191 (302)
T cd05055         163 IHRDLAARNVLLTHGKI--VKICDFGLARDI  191 (302)
T ss_pred             ehhhhccceEEEcCCCe--EEECCCcccccc
Confidence            99999999999987666  999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.82  E-value=6.8e-21  Score=185.25  Aligned_cols=151  Identities=20%  Similarity=0.261  Sum_probs=120.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCC------eEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRS------TLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~------~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      .+.+|+.+++++ +|+||+++++++....      ..|+||||++ +++.+++...   ...+++..+..++.|++.||.
T Consensus        48 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~  127 (275)
T cd06608          48 EIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA  127 (275)
T ss_pred             HHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            356799999998 6999999999997644      5899999999 5677666543   356899999999999999999


Q ss_pred             HhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCccccc---------ccccccCCC
Q psy3074         338 YCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLIS---------EIVFTNLSG  405 (481)
Q Consensus       338 ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~---------~~~~~~s~g  405 (481)
                      |||+.+++|+||+|+||+++.++.  ++++|||++..+....   .....+..+.+|+++..         ...+.|+.|
T Consensus       128 ~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  205 (275)
T cd06608         128 YLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG  205 (275)
T ss_pred             HHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence            999999999999999999998776  9999999887543221   12233445677776642         345779999


Q ss_pred             eeEEEeecCCCCcccc
Q psy3074         406 VVVSTVDSGSGGWWFE  421 (481)
Q Consensus       406 ~~~~~~~~g~~~~~~~  421 (481)
                      ++++++.+|..||...
T Consensus       206 ~il~~l~~g~~p~~~~  221 (275)
T cd06608         206 ITAIELADGKPPLCDM  221 (275)
T ss_pred             HHHHHHHhCCCCcccc
Confidence            9999999999998643

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.82  E-value=5.4e-21  Score=184.74  Aligned_cols=150  Identities=26%  Similarity=0.307  Sum_probs=122.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhh---
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCH---  340 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH---  340 (481)
                      +.+|+++++.++||||+++++.+..  ....|++|||++ ++|..++...   ...+++..+..++.|++.||.|+|   
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~  125 (265)
T cd08217          46 LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS  125 (265)
T ss_pred             HHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence            4569999999999999999998754  457899999998 6788777653   356889999999999999999999   


Q ss_pred             --cCceeeccCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccc----cccccCCCeeEEEe
Q psy3074         341 --RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISE----IVFTNLSGVVVSTV  411 (481)
Q Consensus       341 --~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~----~~~~~s~g~~~~~~  411 (481)
                        +.+++|+||||+||++++++.  +|++|||++..+.....   ....+..+.||+.+...    ..+.|+.|++++++
T Consensus       126 ~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l  203 (265)
T cd08217         126 DPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL  203 (265)
T ss_pred             cccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHH
Confidence              899999999999999998776  99999999987653221   12334456777776443    35679999999999


Q ss_pred             ecCCCCcccc
Q psy3074         412 DSGSGGWWFE  421 (481)
Q Consensus       412 ~~g~~~~~~~  421 (481)
                      .+|..||...
T Consensus       204 ~~g~~p~~~~  213 (265)
T cd08217         204 CALSPPFTAR  213 (265)
T ss_pred             HHCCCcccCc
Confidence            9999998755

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.82  E-value=2.7e-20  Score=179.04  Aligned_cols=104  Identities=25%  Similarity=0.470  Sum_probs=94.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++...+..++||||++ +++..++......+++..+..++.|++.+|.|+|+++++||
T Consensus        38 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~  117 (250)
T cd05085          38 KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR  117 (250)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            35679999999999999999999999999999999998 67887776655568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhh
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      ||||+||++++++.  +|++|||++..
T Consensus       118 dl~p~nili~~~~~--~~l~d~g~~~~  142 (250)
T cd05085         118 DLAARNCLVGENNV--LKISDFGMSRQ  142 (250)
T ss_pred             ccChheEEEcCCCe--EEECCCcccee
Confidence            99999999988776  99999998864

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.82  E-value=1.2e-20  Score=185.87  Aligned_cols=131  Identities=62%  Similarity=1.015  Sum_probs=105.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||.|||+++|+||||||    +|||++..    |.+||+|||+++.......                         
T Consensus       112 l~~al~~lH~~~i~H~dl~p----~nil~~~~----~~~kl~dfg~~~~~~~~~~-------------------------  158 (291)
T cd07844         112 LLRGLAYCHQRRVLHRDLKP----QNLLISER----GELKLADFGLARAKSVPSK-------------------------  158 (291)
T ss_pred             HHHHHHHHHhCCeecccCCH----HHEEEcCC----CCEEECccccccccCCCCc-------------------------
Confidence            68899999999999999999    89999876    7999999999974211100                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      . ..                      ...++..|+|||++.+...++.++||||+||++|||++|++||.+..+..+++.
T Consensus       159 ~-~~----------------------~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~  215 (291)
T cd07844         159 T-YS----------------------NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLH  215 (291)
T ss_pred             c-cc----------------------ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHH
Confidence            0 00                      001277899999998766699999999999999999999999988776778899


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHR  207 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~  207 (481)
                      .+.+.++.|.++.|+.......+....
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         216 KIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             HHHHhcCCCChhhhhhhhhcccccccc
Confidence            999999999999998887665544333

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.82  E-value=1.3e-20  Score=182.64  Aligned_cols=155  Identities=19%  Similarity=0.285  Sum_probs=120.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiH  346 (481)
                      .+.+|+++++.++||||+++++.+...+..+++|||++ ++|.+++......+++..+..++.|++.|+.|+|+ .+++|
T Consensus        45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H  124 (265)
T cd06605          45 QILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIH  124 (265)
T ss_pred             HHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeec
Confidence            45679999999999999999999999999999999999 67888776654678999999999999999999999 99999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccC-ceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR-RILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~-~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      +||||+||++++.+.  ++++|||++..+...... ......+.||+++.                              
T Consensus       125 ~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~------------------------------  172 (265)
T cd06605         125 RDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQ------------------------------  172 (265)
T ss_pred             CCCCHHHEEECCCCC--EEEeecccchhhHHHHhhcccCChhccCHHHHc------------------------------
Confidence            999999999998776  999999988754321110 00011111121111                              


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                        ++    .++...|+|++|+++++|..|..|+...
T Consensus       173 --~~----~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         173 --GN----DYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             --CC----CCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence              00    2245679999999999999998776543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.82  E-value=5.8e-21  Score=184.51  Aligned_cols=150  Identities=22%  Similarity=0.327  Sum_probs=122.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++||||+++++.+.+ ...+++|||++ |+|.+.+.... ..+++..+..++.|++.||+|||+.+++|
T Consensus        42 ~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H  120 (257)
T cd05040          42 DFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIH  120 (257)
T ss_pred             HHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            46679999999999999999999988 89999999998 78888887654 46889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc------CceeccccCCCcccc----cccccccCCCeeEEEeec-CC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR------RRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GS  415 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~------~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~  415 (481)
                      |||||+||+++.++.  +|++|||+++.+.....      .......|.||+.+.    +...+.|++|++++++.+ |.
T Consensus       121 ~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~  198 (257)
T cd05040         121 RDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE  198 (257)
T ss_pred             cccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCC
Confidence            999999999998876  99999999986643111      111223456676553    334577899999999987 99


Q ss_pred             CCcccc
Q psy3074         416 GGWWFE  421 (481)
Q Consensus       416 ~~~~~~  421 (481)
                      .||...
T Consensus       199 ~p~~~~  204 (257)
T cd05040         199 EPWAGL  204 (257)
T ss_pred             CCCCCC
Confidence            988543

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.82  E-value=3.6e-20  Score=179.49  Aligned_cols=105  Identities=25%  Similarity=0.447  Sum_probs=91.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++. .+..+++|||+. +++.+.+.... ..+++..+..++.|++.||+|||+.+++|
T Consensus        47 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H  125 (260)
T cd05067          47 AFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH  125 (260)
T ss_pred             HHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence            4567999999999999999999874 457899999998 67888776543 35788889999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||||+||++++++.  ++++|||++....
T Consensus       126 ~dl~p~ni~i~~~~~--~~l~dfg~~~~~~  153 (260)
T cd05067         126 RDLRAANILVSETLC--CKIADFGLARLIE  153 (260)
T ss_pred             ccccHHhEEEcCCCC--EEEccCcceeecC
Confidence            999999999998777  9999999886543

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.82  E-value=5.4e-21  Score=195.82  Aligned_cols=108  Identities=29%  Similarity=0.389  Sum_probs=83.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+......                        . 
T Consensus       151 il~aL~~LH~~~IvHrDLKp----~NILl~~~----~~~kL~DFG~a~~~~~~~------------------------~-  197 (370)
T cd05621         151 VVLALDAIHSMGLIHRDVKP----DNMLLDKH----GHLKLADFGTCMKMDETG------------------------M-  197 (370)
T ss_pred             HHHHHHHHHHCCeEecCCCH----HHEEECCC----CCEEEEecccceecccCC------------------------c-
Confidence            78899999999999999999    89999866    799999999998432100                        0 


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST---EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~---~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      ......                      .+|+.|||||++.+..   .|+.++||||+||++|||++|++||.+.+ ...
T Consensus       198 ~~~~~~----------------------~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~-~~~  254 (370)
T cd05621         198 VRCDTA----------------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS-LVG  254 (370)
T ss_pred             eecccC----------------------CCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC-HHH
Confidence            000111                      2399999999997642   38899999999999999999999998853 334


Q ss_pred             HHHHHHH
Q psy3074         178 QLDKIFK  184 (481)
Q Consensus       178 ~l~~i~~  184 (481)
                      .+.+|..
T Consensus       255 ~~~~i~~  261 (370)
T cd05621         255 TYSKIMD  261 (370)
T ss_pred             HHHHHHh
Confidence            5555543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0582|consensus

Probab=99.82  E-value=6.7e-21  Score=188.42  Aligned_cols=109  Identities=21%  Similarity=0.320  Sum_probs=84.6

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      -|...-...|.||+|||.+|-||||||+    .|||++.+    |.|||+|||.+.....                    
T Consensus       127 ~Ia~iLre~LkaL~YLH~~G~IHRdvKA----gnILi~~d----G~VkLadFgvsa~l~~--------------------  178 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQNGHIHRDVKA----GNILIDSD----GTVKLADFGVSASLFD--------------------  178 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhcCceeccccc----ccEEEcCC----CcEEEcCceeeeeecc--------------------
Confidence            3444455678899999999999999999    99999988    8999999999864321                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcc-ccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDV-LLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEv-l~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                            .|. ..++.                . +..++|++|||||| .+...+|+.|+||||||++..||.+|..||..
T Consensus       179 ------~G~-R~~~r----------------f-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k  234 (516)
T KOG0582|consen  179 ------SGD-RQVTR----------------F-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK  234 (516)
T ss_pred             ------cCc-eeeEe----------------e-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence                  111 11111                0 11234999999999 55567799999999999999999999999976


Q ss_pred             ch
Q psy3074         172 VR  173 (481)
Q Consensus       172 ~~  173 (481)
                      ..
T Consensus       235 ~p  236 (516)
T KOG0582|consen  235 YP  236 (516)
T ss_pred             CC
Confidence            43

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.82  E-value=1.7e-20  Score=189.95  Aligned_cols=104  Identities=39%  Similarity=0.700  Sum_probs=88.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--------------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--------------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLR  334 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--------------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~  334 (481)
                      .+.+|+++++.++||||+++++++...              ...|+||||+++++...+..  +.+++..++.++.|++.
T Consensus        48 ~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~  125 (342)
T cd07854          48 HALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLR  125 (342)
T ss_pred             HHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHH
Confidence            355799999999999999999877654              35899999999988777653  46899999999999999


Q ss_pred             HHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         335 GLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       335 ~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||.|||+.+++||||||+||+++..+ ..+|++|||+++.+
T Consensus       126 aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~  165 (342)
T cd07854         126 GLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIV  165 (342)
T ss_pred             HHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceec
Confidence            99999999999999999999997533 23899999988654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.82  E-value=1.2e-20  Score=184.63  Aligned_cols=106  Identities=43%  Similarity=0.768  Sum_probs=97.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ...+|+++++.++||||+++++++.+++..+++|||+++++.+.+......+++..+..++.|++.||.|||+.+++|+|
T Consensus        44 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~d  123 (283)
T cd05118          44 TALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRD  123 (283)
T ss_pred             HHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence            45679999999999999999999999999999999999999988877666789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||+||++++++.  ++++|||.+..+.
T Consensus       124 l~p~nili~~~~~--~~l~df~~~~~~~  149 (283)
T cd05118         124 LKPENLLINTEGV--LKLADFGLARSFG  149 (283)
T ss_pred             cCHHHEEECCCCc--EEEeeeeeeEecC
Confidence            9999999998777  9999999886543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.82  E-value=2.8e-20  Score=184.06  Aligned_cols=103  Identities=26%  Similarity=0.408  Sum_probs=92.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+...+..|+|+||++ +++.+++..  ..+++..+..++.|++.|+.|||+++++||
T Consensus        62 ~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~  139 (293)
T cd06647          62 LIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  139 (293)
T ss_pred             HHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            35679999999999999999999999999999999998 677777654  357888899999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  ++++|||++..+
T Consensus       140 dL~p~Nili~~~~~--~kL~dfg~~~~~  165 (293)
T cd06647         140 DIKSDNILLGMDGS--VKLTDFGFCAQI  165 (293)
T ss_pred             cCCHHHEEEcCCCC--EEEccCcceecc
Confidence            99999999988776  999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.82  E-value=6.5e-21  Score=195.27  Aligned_cols=107  Identities=29%  Similarity=0.381  Sum_probs=82.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                        . 
T Consensus       151 i~~aL~~LH~~~ivHrDLkp----~NIll~~~----~~ikL~DfG~a~~~~~~~------------------------~-  197 (371)
T cd05622         151 VVLALDAIHSMGFIHRDVKP----DNMLLDKS----GHLKLADFGTCMKMNKEG------------------------M-  197 (371)
T ss_pred             HHHHHHHHHHCCEEeCCCCH----HHEEECCC----CCEEEEeCCceeEcCcCC------------------------c-
Confidence            68899999999999999999    89999865    799999999997431100                        0 


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST---EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~---~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      ......                      .+|+.|||||++.+..   .|+.++||||+||++|||++|++||.+.+ ...
T Consensus       198 ~~~~~~----------------------~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~  254 (371)
T cd05622         198 VRCDTA----------------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVG  254 (371)
T ss_pred             ccccCc----------------------ccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC-HHH
Confidence            000111                      2399999999997643   38899999999999999999999998843 334


Q ss_pred             HHHHHH
Q psy3074         178 QLDKIF  183 (481)
Q Consensus       178 ~l~~i~  183 (481)
                      .+..|.
T Consensus       255 ~~~~i~  260 (371)
T cd05622         255 TYSKIM  260 (371)
T ss_pred             HHHHHH
Confidence            455544

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.82  E-value=4.6e-20  Score=183.35  Aligned_cols=105  Identities=24%  Similarity=0.464  Sum_probs=92.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+... ..++++||++ |++.+.+......+++..+..++.|++.||.|||+++|+||
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  133 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR  133 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            356799999999999999999998764 4678999998 78888887665568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++.++.  +|++|||+++.+.
T Consensus       134 dikp~Nill~~~~~--~kL~Dfg~~~~~~  160 (303)
T cd05110         134 DLAARNVLVKSPNH--VKITDFGLARLLE  160 (303)
T ss_pred             ccccceeeecCCCc--eEEcccccccccc
Confidence            99999999987766  9999999997654

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.82  E-value=1.2e-21  Score=196.93  Aligned_cols=103  Identities=28%  Similarity=0.497  Sum_probs=81.6

Q ss_pred             HhhhhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          12 RQISVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ....++.. .+.||+|||+ +||+||||||    +|||++..    |.+||+|||+|+....                  
T Consensus        96 ~~~~~~~q-i~~aL~~lH~~~~ivHrDikp----~NIll~~~----~~~kL~Dfg~~~~~~~------------------  148 (325)
T cd05594          96 RARFYGAE-IVSALDYLHSEKNVVYRDLKL----ENLMLDKD----GHIKITDFGLCKEGIK------------------  148 (325)
T ss_pred             HHHHHHHH-HHHHHHHHHhcCCEEecCCCC----CeEEECCC----CCEEEecCCCCeecCC------------------
Confidence            33344444 7889999997 7999999999    89999876    7999999999974211                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                              .+.....+.|                      |+.|||||++.+.. |+.++||||+||++|||++|+.||.
T Consensus       149 --------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~  197 (325)
T cd05594         149 --------DGATMKTFCG----------------------TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFY  197 (325)
T ss_pred             --------CCcccccccC----------------------CcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCC
Confidence                    1111112223                      99999999998765 9999999999999999999999998


Q ss_pred             Cc
Q psy3074         171 GV  172 (481)
Q Consensus       171 g~  172 (481)
                      +.
T Consensus       198 ~~  199 (325)
T cd05594         198 NQ  199 (325)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.82  E-value=3e-20  Score=179.13  Aligned_cols=107  Identities=32%  Similarity=0.474  Sum_probs=92.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++||||+++++.+...+..++||||++ ++|.+++.... ..+++..+..++.|++.|+.|||+++++|
T Consensus        45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h  124 (256)
T cd08220          45 AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILH  124 (256)
T ss_pred             HHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            45679999999999999999999999999999999998 57888876543 34888999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +||||+||++++.+. .+|++|||++..+.
T Consensus       125 ~dl~~~nil~~~~~~-~~~l~d~~~~~~~~  153 (256)
T cd08220         125 RDLKTQNILLDKHKM-VVKIGDFGISKILS  153 (256)
T ss_pred             CCCCHHHEEEcCCCC-EEEEccCCCceecC
Confidence            999999999975432 37899999887543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.81  E-value=6.8e-21  Score=184.69  Aligned_cols=153  Identities=18%  Similarity=0.223  Sum_probs=122.2

Q ss_pred             ChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       266 ~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ....+.+|+.++++++||||+++++++.. +..++||||++ |+|.+++......+++..+..++.|++.||.|||++++
T Consensus        38 ~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  116 (257)
T cd05115          38 VRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF  116 (257)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCe
Confidence            34567899999999999999999998864 57899999998 67888877656678999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCc------eeccccCCCcccc----cccccccCCCeeEEEeec-
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR------ILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-  413 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~------i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-  413 (481)
                      +||||||+||+++.++.  +|++|||+++.+.......      .....+.+|+.+.    +...+.|++|++++++.+ 
T Consensus       117 ~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~  194 (257)
T cd05115         117 VHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSY  194 (257)
T ss_pred             eecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcC
Confidence            99999999999988766  9999999988654322110      0012355666553    335677999999999885 


Q ss_pred             CCCCcccc
Q psy3074         414 GSGGWWFE  421 (481)
Q Consensus       414 g~~~~~~~  421 (481)
                      |..||...
T Consensus       195 g~~p~~~~  202 (257)
T cd05115         195 GQKPYKKM  202 (257)
T ss_pred             CCCCcCcC
Confidence            89998654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.81  E-value=7.2e-21  Score=195.59  Aligned_cols=140  Identities=26%  Similarity=0.375  Sum_probs=82.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCC-cCCCCCCCCCccccceecccCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHT-YSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+........ ....+....  .+........+.
T Consensus       110 i~~al~~lH~~~ivHrDlKp----~NILl~~~----g~~kL~DFGla~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  179 (382)
T cd05625         110 LTCAVESVHKMGFIHRDIKP----DNILIDRD----GHIKLTDFGLCTGFRWTHDSKYYQSGDHVR--QDSMDFSNEWGD  179 (382)
T ss_pred             HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEEeECCCCccccccccccccccccccc--cccccccccccc
Confidence            67899999999999999999    89999876    79999999999743211000 000000000  000000000000


Q ss_pred             CceeEEEecccCcch--hhhhhhhh-hhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074         100 GSYATVFKGYSNLTN--QVVALKEI-RLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus       100 g~~~~~~~g~~~~~~--~~~~~k~~-~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                        .....++. ..+.  ...+.... ......++|+.|||||++.+.. |+.++||||+||++|||++|++||.+.+.
T Consensus       180 --~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~  253 (382)
T cd05625         180 --PANCRCGD-RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             --cccccccc-cccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence              00000000 0000  00000000 0112235699999999998765 99999999999999999999999988543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>KOG1094|consensus

Probab=99.81  E-value=1.1e-20  Score=191.73  Aligned_cols=121  Identities=25%  Similarity=0.333  Sum_probs=103.8

Q ss_pred             ccccCCCCCCCCChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCC-ChHHHHHHHHH
Q psy3074         254 CEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGL-DHHNIRLFMFQ  331 (481)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l-~~~~~~~~~~q  331 (481)
                      +.+....+.....+.++.+|+++|.+|+|||||+|.++|..++.++++|||++ |+|.+++..+.-.. .......++.|
T Consensus       566 AVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tq  645 (807)
T KOG1094|consen  566 AVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQ  645 (807)
T ss_pred             EEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHH
Confidence            33344444445567789999999999999999999999999999999999999 99999998874333 44556779999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |+.||+||.+.+++|||+.+.|+|++.+.+  +|++|||++|.+-
T Consensus       646 iasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~ly  688 (807)
T KOG1094|consen  646 IASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccc
Confidence            999999999999999999999999997777  9999999998653

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.81  E-value=6e-21  Score=191.19  Aligned_cols=103  Identities=27%  Similarity=0.530  Sum_probs=81.9

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+....                    
T Consensus        98 ~~~~~~q-i~~al~~LH~~~ivHrdikp----~Nil~~~~----~~~kl~Dfg~~~~~~~--------------------  148 (316)
T cd05619          98 ATFYAAE-IICGLQFLHSKGIVYRDLKL----DNILLDTD----GHIKIADFGMCKENML--------------------  148 (316)
T ss_pred             HHHHHHH-HHHHHHHHHhCCeEeCCCCH----HHEEECCC----CCEEEccCCcceECCC--------------------
Confidence            3344444 78899999999999999999    89999876    7999999999974211                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                           +. .......                      +|+.|||||++.+.. |+.++|+||+||++|||++|..||.+.
T Consensus       149 -----~~-~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~  199 (316)
T cd05619         149 -----GD-AKTCTFC----------------------GTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGH  199 (316)
T ss_pred             -----CC-Cceeeec----------------------CCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence                 00 0011122                      389999999998765 999999999999999999999999874


Q ss_pred             h
Q psy3074         173 R  173 (481)
Q Consensus       173 ~  173 (481)
                      +
T Consensus       200 ~  200 (316)
T cd05619         200 D  200 (316)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.81  E-value=4.7e-20  Score=178.04  Aligned_cols=105  Identities=25%  Similarity=0.485  Sum_probs=93.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++||||+++++++......+++|||+. ++|.+.+....+.+++..+..++.|++.|+.|||+.+++||
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~  124 (256)
T cd05112          45 DFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR  124 (256)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35679999999999999999999999999999999998 56777776655668899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  ++++|||+++..
T Consensus       125 dl~p~ni~i~~~~~--~~l~d~g~~~~~  150 (256)
T cd05112         125 DLAARNCLVGENQV--VKVSDFGMTRFV  150 (256)
T ss_pred             ccccceEEEcCCCe--EEECCCcceeec
Confidence            99999999987776  999999987643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0587|consensus

Probab=99.81  E-value=1.9e-20  Score=197.95  Aligned_cols=154  Identities=22%  Similarity=0.321  Sum_probs=122.9

Q ss_pred             HHHHHHhhcC-CCCeeEEeeeeec-----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         272 REASLLKELK-HNNIVTLHDIVHT-----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       272 rE~~il~~l~-HpnIV~l~~~~~~-----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      -|..||+.+. |||++.++++|..     ++.+|+|||||. |+..+++.... ..+.|..+.++++.++.|+.+||...
T Consensus        64 ~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk  143 (953)
T KOG0587|consen   64 LEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK  143 (953)
T ss_pred             HHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc
Confidence            4777888764 9999999999964     468999999999 55666655433 45899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      +||||+|-.|||++.++.  +|++|||++..+.....++                                         
T Consensus       144 viHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~grR-----------------------------------------  180 (953)
T KOG0587|consen  144 VIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTVGRR-----------------------------------------  180 (953)
T ss_pred             eeeecccCceEEEeccCc--EEEeeeeeeeeeecccccc-----------------------------------------
Confidence            999999999999998888  9999999998766332111                                         


Q ss_pred             CcccceeccCCC-------------CCChhhhhhHHHHHHhhCCCccccccccccCcee
Q psy3074         424 SNINLSFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTL  469 (481)
Q Consensus       424 ~~~~~t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~~~~~~  469 (481)
                      ...+||+.||+|             +..+|.||+|+..-||--|. |++.|+-|.+..+
T Consensus       181 nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~-PPl~DmHPmraLF  238 (953)
T KOG0587|consen  181 NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA-PPLCDMHPMRALF  238 (953)
T ss_pred             cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC-CCccCcchhhhhc
Confidence            013456666666             55679999999999999998 7777877766543

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.81  E-value=4.7e-20  Score=181.67  Aligned_cols=102  Identities=21%  Similarity=0.429  Sum_probs=92.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++||||+++++++...+..++++||+. ++|.+.+..  +.+++..+..++.|++.||.|||+++++|||
T Consensus        63 ~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~d  140 (285)
T cd06648          63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRD  140 (285)
T ss_pred             HHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            5679999999999999999999999999999999998 577777655  5688999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||+||+++.++.  ++++|||++..+
T Consensus       141 l~p~Nil~~~~~~--~~l~d~g~~~~~  165 (285)
T cd06648         141 IKSDSILLTSDGR--VKLSDFGFCAQV  165 (285)
T ss_pred             CChhhEEEcCCCc--EEEcccccchhh
Confidence            9999999998776  999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG1095|consensus

Probab=99.81  E-value=3.7e-21  Score=210.73  Aligned_cols=161  Identities=16%  Similarity=0.276  Sum_probs=128.2

Q ss_pred             cchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074           5 ENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      ...++.++=+.++.| ...+-+||+++++|||||.+    +|+||...    ..+||+||||||.....           
T Consensus       796 ~~~L~~~dLl~~a~d-vA~G~~YLe~~~fvHRDLAa----RNCLL~~~----r~VKIaDFGlArDiy~~-----------  855 (1025)
T KOG1095|consen  796 PSNLSMRDLLAFALD-VAKGMNYLESKHFVHRDLAA----RNCLLDER----RVVKIADFGLARDIYDK-----------  855 (1025)
T ss_pred             CCCCCHHHHHHHHHH-HhhhhHHHHhCCCcCcchhh----hheeeccc----CcEEEcccchhHhhhhc-----------
Confidence            345667777888999 88899999999999999999    89999987    69999999999942110           


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt  164 (481)
                                      .+       +...++            .-.+..|||||.+.... |+.++|||||||++||++|
T Consensus       856 ----------------~y-------yr~~~~------------a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifs  899 (1025)
T KOG1095|consen  856 ----------------DY-------YRKHGE------------AMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFS  899 (1025)
T ss_pred             ----------------hh-------eeccCc------------cccceecCCHHHHhhcc-cccccchhhhHHHHHHHHh
Confidence                            00       011111            11278999999999865 9999999999999999999


Q ss_pred             -CCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCC
Q psy3074         165 -GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPR  222 (481)
Q Consensus       165 -g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (481)
                       |.+||++.++. +.+.-..+.-+.+++..+|+.-.-.+..||+..|..|++|..+...
T Consensus       900 lG~~PY~~~~n~-~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q  957 (1025)
T KOG1095|consen  900 LGATPYPSRSNF-EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQ  957 (1025)
T ss_pred             CCCCCCCCcchH-HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhh
Confidence             99999996554 5555556666888888999888888889999999999998766553

>KOG4717|consensus

Probab=99.81  E-value=4.6e-21  Score=191.74  Aligned_cols=113  Identities=27%  Similarity=0.463  Sum_probs=93.9

Q ss_pred             cccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCCc
Q psy3074          22 LLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGS  101 (481)
Q Consensus        22 ~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~  101 (481)
                      +.|++|||+..||||||||    +|+.+....   |.+||+|||++..+.                           .|.
T Consensus       128 ~~AI~YCHqLHVVHRDLKP----ENVVFFEKl---GlVKLTDFGFSNkf~---------------------------PG~  173 (864)
T KOG4717|consen  128 VHAISYCHQLHVVHRDLKP----ENVVFFEKL---GLVKLTDFGFSNKFQ---------------------------PGK  173 (864)
T ss_pred             HHHHHHHhhhhhhcccCCc----ceeEEeeec---CceEeeeccccccCC---------------------------Ccc
Confidence            7899999999999999999    899887765   999999999997543                           333


Q ss_pred             eeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHHH
Q psy3074         102 YATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDK  181 (481)
Q Consensus       102 ~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~~  181 (481)
                      --+++||                      +..|-|||+|+|......++||||+|||+|-|+||++||...+|. +.|..
T Consensus       174 kL~TsCG----------------------SLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-ETLTm  230 (864)
T KOG4717|consen  174 KLTTSCG----------------------SLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-ETLTM  230 (864)
T ss_pred             hhhcccc----------------------hhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-hhhhh
Confidence            3456677                      999999999999885667899999999999999999999876554 77777


Q ss_pred             HHHHhCCCCc
Q psy3074         182 IFKILGTPTE  191 (481)
Q Consensus       182 i~~~~~~p~~  191 (481)
                      |..+-.+-+.
T Consensus       231 ImDCKYtvPs  240 (864)
T KOG4717|consen  231 IMDCKYTVPS  240 (864)
T ss_pred             hhcccccCch
Confidence            7776554443

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=1.8e-21  Score=196.23  Aligned_cols=107  Identities=27%  Similarity=0.531  Sum_probs=83.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                      
T Consensus       105 ~~~~q-i~~~l~~lH~~~ivH~dlkp----~Nil~~~~----~~~kL~Dfg~a~~~~~----------------------  153 (333)
T cd05600         105 FYMAE-MFEAVDALHELGYIHRDLKP----ENFLIDAS----GHIKLTDFGLSKGIVT----------------------  153 (333)
T ss_pred             HHHHH-HHHHHHHHHHCCccccCCCH----HHEEECCC----CCEEEEeCcCCccccc----------------------
Confidence            34444 78899999999999999999    89999866    7999999999974211                      


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                             .....                      .+|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.+ 
T Consensus       154 -------~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~-  202 (333)
T cd05600         154 -------YANSV----------------------VGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLCGFPPFSGST-  202 (333)
T ss_pred             -------ccCCc----------------------ccCccccChhHhcCCC-CCCccceecchHHHhhhhhCCCCCCCCC-
Confidence                   00111                      2389999999998774 9999999999999999999999998743 


Q ss_pred             hHHHHHHHH
Q psy3074         175 VYDQLDKIF  183 (481)
Q Consensus       175 ~~~~l~~i~  183 (481)
                      ..+.+..+.
T Consensus       203 ~~~~~~~i~  211 (333)
T cd05600         203 PNETWENLK  211 (333)
T ss_pred             HHHHHHHHH
Confidence            224444443

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.81  E-value=1.4e-20  Score=190.70  Aligned_cols=151  Identities=24%  Similarity=0.424  Sum_probs=115.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCe------EEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~------~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      +.+|+.+++.++||||+++++++...+.      .++|+||+.++|.+++..  ..+++..+..++.|++.||.|||+.+
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g  138 (343)
T cd07851          61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG  138 (343)
T ss_pred             HHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4579999999999999999998876654      899999998888887764  46899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      ++||||||+||++++++.  ++++|||++............+..|.+|+++.                            
T Consensus       139 i~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~----------------------------  188 (343)
T cd07851         139 IIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDEMTGYVATRWYRAPEIML----------------------------  188 (343)
T ss_pred             eecCCCCHHHeEECCCCC--EEEccccccccccccccCCcccccccCHHHHh----------------------------
Confidence            999999999999998776  99999999875432111111111122222111                            


Q ss_pred             CcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         424 SNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       424 ~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                             ....++.++|+|++|+++++|..|..|+-
T Consensus       189 -------~~~~~~~~~DvwslGv~l~elltg~~pf~  217 (343)
T cd07851         189 -------NWMHYNQTVDIWSVGCIMAELLTGKTLFP  217 (343)
T ss_pred             -------CCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence                   01123556788888888888888886653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.81  E-value=4.2e-20  Score=178.85  Aligned_cols=106  Identities=24%  Similarity=0.421  Sum_probs=94.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++......+++|||++ ++|.+++.... ..++...+..++.|++.|+.|||+++++|
T Consensus        47 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h  126 (261)
T cd05034          47 AFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH  126 (261)
T ss_pred             HHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            45679999999999999999999999899999999998 67888876543 35889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      +||||+||++++++.  ++++|||++..+.
T Consensus       127 ~di~p~nili~~~~~--~~l~d~g~~~~~~  154 (261)
T cd05034         127 RDLAARNILVGENLV--CKIADFGLARLIE  154 (261)
T ss_pred             CCcchheEEEcCCCC--EEECccccceecc
Confidence            999999999998877  9999999887543

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.81  E-value=3.1e-20  Score=181.54  Aligned_cols=102  Identities=25%  Similarity=0.449  Sum_probs=90.7

Q ss_pred             HHHHHHHHhhcC---CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         270 AIREASLLKELK---HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       270 ~~rE~~il~~l~---HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+|+.+++.++   |||++++++++......|++|||++ ++|.+++..  +.+++..+..++.|++.||.|||+.+++
T Consensus        46 ~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~  123 (277)
T cd06917          46 IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVI  123 (277)
T ss_pred             HHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            457899999987   9999999999999999999999998 567766643  4688999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |+||+|+||++++.+.  ++++|||++..+
T Consensus       124 H~dl~p~ni~i~~~~~--~~l~dfg~~~~~  151 (277)
T cd06917         124 HRDIKAANILVTNTGN--VKLCDFGVAALL  151 (277)
T ss_pred             cCCcCHHHEEEcCCCC--EEEccCCceeec
Confidence            9999999999998776  999999988654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.81  E-value=1.8e-20  Score=184.97  Aligned_cols=151  Identities=21%  Similarity=0.338  Sum_probs=122.3

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---------------cCCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---------------SGGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---------------~~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++++ +||||+++++++...+..+++|||+. |+|..++...               ...+++..+..++.|
T Consensus        61 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  140 (293)
T cd05053          61 DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ  140 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence            456899999999 79999999999999999999999998 6888887542               235788889999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcccccc-----CceeccccCCCccccc----cccccc
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR-----RRILHRDVKPQNLLIS----EIVFTN  402 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~-----~~i~~~d~~~~~il~~----~~~~~~  402 (481)
                      ++.||.|||+.+++||||||+||+++.++.  +|++|||+++.+.....     .......|.||+.+..    ...+.|
T Consensus       141 i~~al~~LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~  218 (293)
T cd05053         141 VARGMEFLASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW  218 (293)
T ss_pred             HHHHHHHHHHCCccccccceeeEEEcCCCe--EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccccee
Confidence            999999999999999999999999988776  99999999986542211     1111224667776543    345789


Q ss_pred             CCCeeEEEeec-CCCCcccc
Q psy3074         403 LSGVVVSTVDS-GSGGWWFE  421 (481)
Q Consensus       403 s~g~~~~~~~~-g~~~~~~~  421 (481)
                      ++|++++++.+ |..||...
T Consensus       219 slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         219 SFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             ehhhHHHHHhcCCCCCCCCC
Confidence            99999999886 88888654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.81  E-value=1.9e-20  Score=189.49  Aligned_cols=102  Identities=34%  Similarity=0.623  Sum_probs=88.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++....      ..|+||||+..++....   ...+++..+..++.|++.||.|||+.
T Consensus        60 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~  136 (342)
T cd07879          60 RAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSA  136 (342)
T ss_pred             HHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3567999999999999999999987543      46999999987766543   23589999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +++||||||+||+++.++.  +|++|||+++..
T Consensus       137 ~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~  167 (342)
T cd07879         137 GIIHRDLKPGNLAVNEDCE--LKILDFGLARHA  167 (342)
T ss_pred             CcccCCCCHHHEEECCCCC--EEEeeCCCCcCC
Confidence            9999999999999998776  999999988654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.81  E-value=1.8e-20  Score=188.38  Aligned_cols=105  Identities=36%  Similarity=0.669  Sum_probs=94.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++++...+     .+|++|||+.+++.+.+... ..+++..+..++.|++.||.|||+.+
T Consensus        45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~l~~~~~~~i~~~l~~~l~~LH~~g  123 (330)
T cd07834          45 RILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSP-QPLTDDHIQYFLYQILRGLKYLHSAN  123 (330)
T ss_pred             hHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3567999999999999999999998875     79999999998888877653 47899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ++||||||+||+++.++.  ++++|||++....
T Consensus       124 i~H~dlkp~nili~~~~~--~~L~dfg~~~~~~  154 (330)
T cd07834         124 VIHRDLKPSNILVNSNCD--LKICDFGLARGVD  154 (330)
T ss_pred             eecCCCCHHHEEEcCCCC--EEEcccCceEeec
Confidence            999999999999998876  9999999988654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.81  E-value=5.8e-20  Score=185.30  Aligned_cols=107  Identities=24%  Similarity=0.480  Sum_probs=93.3

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHH
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMF  330 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~  330 (481)
                      ..+.+|+.+++++ +||||+++++++...+.++++|||+. |+|.+++....               ..++...+..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY  141 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            3467899999999 79999999999999999999999998 68888876532               2366777888999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |++.||.|||+++++||||||+||+++.++.  +|++|||+++.+.
T Consensus       142 qi~~al~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~  185 (334)
T cd05100         142 QVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVH  185 (334)
T ss_pred             HHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCcccceecc
Confidence            9999999999999999999999999988776  9999999987543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.81  E-value=5.2e-21  Score=191.71  Aligned_cols=107  Identities=27%  Similarity=0.501  Sum_probs=84.4

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+++....                
T Consensus        94 ~~~~~~~~~~q-i~~~l~~LH~~~ivH~dlkp----~Nill~~~----~~~kl~Dfg~~~~~~~----------------  148 (318)
T cd05570          94 DEPRARFYAAE-IVLGLQFLHERGIIYRDLKL----DNVLLDSE----GHIKIADFGMCKEGIL----------------  148 (318)
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeEccCCCH----HHeEECCC----CcEEecccCCCeecCc----------------
Confidence            33444445555 78899999999999999999    89999876    7999999999974211                


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                .+......+|                      |+.|+|||++.+.. |+.++|+||+||++|||++|+.|
T Consensus       149 ----------~~~~~~~~~g----------------------~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~p  195 (318)
T cd05570         149 ----------GGVTTSTFCG----------------------TPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSP  195 (318)
T ss_pred             ----------CCCcccceec----------------------CccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCC
Confidence                      0011112233                      89999999998765 99999999999999999999999


Q ss_pred             CCCch
Q psy3074         169 FPGVR  173 (481)
Q Consensus       169 F~g~~  173 (481)
                      |.+.+
T Consensus       196 f~~~~  200 (318)
T cd05570         196 FEGDD  200 (318)
T ss_pred             CCCCC
Confidence            98753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.81  E-value=4.1e-20  Score=186.24  Aligned_cols=150  Identities=29%  Similarity=0.409  Sum_probs=115.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeec----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHT----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++++ +||||+++++.+..    ...+|++||++.++|...+.. ...+++..++.++.|++.||.|||+++
T Consensus        47 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g  125 (332)
T cd07857          47 RALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN  125 (332)
T ss_pred             HHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356799999999 59999999987542    246899999999998888764 356899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      ++||||||+||++++++.  +|++|||+++.+......         .+                            ...
T Consensus       126 ivH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~---------~~----------------------------~~~  166 (332)
T cd07857         126 VLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGE---------NA----------------------------GFM  166 (332)
T ss_pred             cccCCCCHHHeEEcCCCC--EEeCcCCCceeccccccc---------cc----------------------------ccc
Confidence            999999999999998777  999999988754311100         00                            000


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ....+|..|++|         +...|+|++|+++++|..|.+|+
T Consensus       167 ~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf  210 (332)
T cd07857         167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF  210 (332)
T ss_pred             cCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC
Confidence            012344444444         34579999999999999998654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.81  E-value=4.3e-20  Score=180.25  Aligned_cols=131  Identities=21%  Similarity=0.326  Sum_probs=107.0

Q ss_pred             CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCcccccccc
Q psy3074         281 KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEI  359 (481)
Q Consensus       281 ~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~  359 (481)
                      +||||+++++.|..++..|+||||++ |+|.+++... ..+++..+..++.|++.|+.|||+.+++||||||+||+++..
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA  145 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCC
Confidence            69999999999999999999999998 6888887654 478999999999999999999999999999999999999877


Q ss_pred             c-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCC---
Q psy3074         360 D-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP---  435 (481)
Q Consensus       360 ~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p---  435 (481)
                      + .  ++++|||++..+.....                                             ..++..|++|   
T Consensus       146 ~~~--~~l~dfg~~~~~~~~~~---------------------------------------------~~~~~~y~aPE~~  178 (267)
T PHA03390        146 KDR--IYLCDYGLCKIIGTPSC---------------------------------------------YDGTLDYFSPEKI  178 (267)
T ss_pred             CCe--EEEecCccceecCCCcc---------------------------------------------CCCCCcccChhhh
Confidence            6 5  99999998865431100                                             0112222222   


Q ss_pred             -----CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         436 -----GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       436 -----~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                           ..++|+||+|+++++|..|..|+.
T Consensus       179 ~~~~~~~~~DvwslG~il~~l~~g~~p~~  207 (267)
T PHA03390        179 KGHNYDVSFDWWAVGVLTYELLTGKHPFK  207 (267)
T ss_pred             cCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence                 446799999999999999997664

>KOG0607|consensus

Probab=99.81  E-value=2.4e-20  Score=177.38  Aligned_cols=132  Identities=21%  Similarity=0.329  Sum_probs=94.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      ..+||+|||.+||.||||||    +|||-... +.-..+|||||-|+.........      |+                
T Consensus       185 ia~aLdFlH~kgIAHRDlKP----ENiLC~~p-n~vsPvKiCDfDLgSg~k~~~~~------sp----------------  237 (463)
T KOG0607|consen  185 IASALDFLHTKGIAHRDLKP----ENILCESP-NKVSPVKICDFDLGSGIKLNNDC------SP----------------  237 (463)
T ss_pred             HHHHHHHHhhcCcccccCCc----cceeecCC-CCcCceeeeccccccccccCCCC------CC----------------
Confidence            67899999999999999999    89986543 33347899999998753221110      00                


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCchh--
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL----GSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE--  174 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~----~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~--  174 (481)
                                ..|.+.         ...+|+..||||||+.    ....|+..+|.||+|||+|.||+|.+||.|.-.  
T Consensus       238 ----------astP~L---------~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  238 ----------ASTPEL---------LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             ----------CCCccc---------cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence                      000000         0123488999999874    245699999999999999999999999987511  


Q ss_pred             ------------hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 ------------VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ------------~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                                  ....+..|-++-..++...|-.++
T Consensus       299 CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS  334 (463)
T KOG0607|consen  299 CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHIS  334 (463)
T ss_pred             CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhh
Confidence                        223567777777788888887776

>KOG0670|consensus

Probab=99.81  E-value=8e-21  Score=190.39  Aligned_cols=153  Identities=20%  Similarity=0.282  Sum_probs=132.8

Q ss_pred             HHHHHHHhhcCC------CCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         271 IREASLLKELKH------NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       271 ~rE~~il~~l~H------pnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ++|++||++|+.      -|+++|+-.|...+++|||+|-+.-+|...+.+...  +|....++.|+.|+..||..|-..
T Consensus       476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c  555 (752)
T KOG0670|consen  476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC  555 (752)
T ss_pred             hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc
Confidence            469999999972      379999999999999999999999999999887543  477888999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccc-cCceeccccCCCccccccccc----ccCCCeeEEEeecCCCC
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISEIVF----TNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-~~~i~~~d~~~~~il~~~~~~----~~s~g~~~~~~~~g~~~  417 (481)
                      ||+|.||||+|||+++. ...+|+||||.|....... +++.+.|-|.+|+|+++-.++    .||.||.+|++.+|..-
T Consensus       556 ~vlHaDIKPDNiLVNE~-k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  556 GVLHADIKPDNILVNES-KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             CeeecccCccceEeccC-cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence            99999999999999864 4469999999998776443 567788999999999876664    69999999999999999


Q ss_pred             ccccccC
Q psy3074         418 WWFESKS  424 (481)
Q Consensus       418 ~~~~~~~  424 (481)
                      |...+..
T Consensus       635 FpG~TNN  641 (752)
T KOG0670|consen  635 FPGRTNN  641 (752)
T ss_pred             cCCCCcH
Confidence            9877543

>KOG0574|consensus

Probab=99.81  E-value=3.7e-21  Score=181.42  Aligned_cols=106  Identities=25%  Similarity=0.397  Sum_probs=86.2

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      -..+.|+..-.+-|.+|+|||-.+-||||||+    .|||||..    |+.||+|||.|..+...               
T Consensus       126 L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKA----GNILLNT~----G~AKLADFGVAGQLTDT---------------  182 (502)
T KOG0574|consen  126 LSEQEISAVLRDTLKGLQYLHDLKKIHRDIKA----GNILLNTD----GIAKLADFGVAGQLTDT---------------  182 (502)
T ss_pred             ccHHHHHHHHHHHHhHHHHHHHHHHHHhhccc----ccEEEccc----chhhhhhccccchhhhh---------------
Confidence            34455666666689999999999999999999    89999987    89999999999632110               


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                                       ..+.+-..|||.||||||+..-. |++++||||+|++..||..|+||
T Consensus       183 ---------------------------------MAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PP  228 (502)
T KOG0574|consen  183 ---------------------------------MAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPP  228 (502)
T ss_pred             ---------------------------------HHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCC
Confidence                                             01122234599999999998655 99999999999999999999999


Q ss_pred             CCC
Q psy3074         169 FPG  171 (481)
Q Consensus       169 F~g  171 (481)
                      |..
T Consensus       229 YsD  231 (502)
T KOG0574|consen  229 YSD  231 (502)
T ss_pred             ccc
Confidence            965

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.81  E-value=3.4e-20  Score=181.54  Aligned_cols=151  Identities=22%  Similarity=0.296  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++..  ....+++|||++ +++.+++......+++..+..++.|++.||+|||+.+++
T Consensus        52 ~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~  131 (284)
T cd05038          52 DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYI  131 (284)
T ss_pred             HHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            46789999999999999999999887  568999999998 688888876655689999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccC------ceeccccCCCccccc----ccccccCCCeeEEEeecCC
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR------RILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~------~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~  415 (481)
                      ||||||+||+++.++.  ++++|||++..+......      ......+.+|+.+..    ...+.|++|++++++.+|.
T Consensus       132 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~  209 (284)
T cd05038         132 HRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG  209 (284)
T ss_pred             cCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccC
Confidence            9999999999998766  999999999876521111      111122455665533    3456799999999999999


Q ss_pred             CCcccc
Q psy3074         416 GGWWFE  421 (481)
Q Consensus       416 ~~~~~~  421 (481)
                      .|+...
T Consensus       210 ~p~~~~  215 (284)
T cd05038         210 DPSQSP  215 (284)
T ss_pred             CCcccc
Confidence            887643

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.81  E-value=5.4e-20  Score=181.25  Aligned_cols=105  Identities=28%  Similarity=0.481  Sum_probs=90.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+++++.++||||++++++|.+  .+.+|+||||++ ++|.+++..   ....+++..+..++.|++.||.|||+.
T Consensus        45 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~  124 (287)
T cd06621          45 QILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR  124 (287)
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35679999999999999999998865  347899999998 577666543   234588899999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +++|+||+|+||++++++.  ++++|||++..+
T Consensus       125 ~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~  155 (287)
T cd06621         125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGEL  155 (287)
T ss_pred             CcccCCCCHHHEEEecCCe--EEEeeccccccc
Confidence            9999999999999988776  999999987643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.81  E-value=8.4e-20  Score=177.95  Aligned_cols=105  Identities=29%  Similarity=0.505  Sum_probs=93.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+ +..|+||||++ |++.+++......+++..+..++.|++.||.|+|+.+++||
T Consensus        53 ~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~  131 (270)
T cd05056          53 KFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR  131 (270)
T ss_pred             HHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            46679999999999999999998876 45789999998 78888887655568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++..+.  ++++|||+++.+.
T Consensus       132 dl~p~nili~~~~~--~~l~d~g~~~~~~  158 (270)
T cd05056         132 DIAARNVLVSSPDC--VKLGDFGLSRYLE  158 (270)
T ss_pred             ccChheEEEecCCC--eEEccCceeeecc
Confidence            99999999998776  9999999887543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.81  E-value=3.5e-20  Score=183.44  Aligned_cols=103  Identities=19%  Similarity=0.408  Sum_probs=91.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|+||+++++.+...+..+++|||+++ ++.+.+.  .+.+++..+..++.|++.|+.|||+.+++|+
T Consensus        63 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~  140 (292)
T cd06657          63 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHR  140 (292)
T ss_pred             HHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            356799999999999999999999999999999999985 5655543  2458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||++++++.  ++++|||++..+
T Consensus       141 dl~p~Nilv~~~~~--~~l~dfg~~~~~  166 (292)
T cd06657         141 DIKSDSILLTHDGR--VKLSDFGFCAQV  166 (292)
T ss_pred             CCCHHHEEECCCCC--EEEcccccceec
Confidence            99999999998776  999999987644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.81  E-value=1.2e-20  Score=181.91  Aligned_cols=150  Identities=23%  Similarity=0.314  Sum_probs=121.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++.+....+++|||++ +++.+++... +.+++..+..++.|++.|+.|||+.+++|+
T Consensus        48 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  126 (258)
T cd06632          48 QLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR  126 (258)
T ss_pred             HHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            35679999999999999999999999999999999998 5777776553 458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCccccc-----ccccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLIS-----EIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~-----~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||+|+||+++.++.  +|++|||++..+....  .....+..+.+|+.+..     ...+.|+.|++++++.+|..||..
T Consensus       127 dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         127 DIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             CCCHHHEEECCCCC--EEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            99999999988776  9999999887654221  11122334556665533     346778899999999999999864


Q ss_pred             c
Q psy3074         421 E  421 (481)
Q Consensus       421 ~  421 (481)
                      .
T Consensus       205 ~  205 (258)
T cd06632         205 L  205 (258)
T ss_pred             C
Confidence            4

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.81  E-value=2e-20  Score=190.20  Aligned_cols=119  Identities=36%  Similarity=0.665  Sum_probs=96.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+++....                           .
T Consensus       127 l~~aL~~LH~~gi~H~dlkp----~Nil~~~~----~~~kL~Dfg~~~~~~~---------------------------~  171 (353)
T cd07850         127 MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAGT---------------------------S  171 (353)
T ss_pred             HHHHHHHHHhCCeeeCCCCH----HHEEECCC----CCEEEccCccceeCCC---------------------------C
Confidence            67899999999999999999    89999876    7999999999974211                           0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ......                      .+|+.|+|||++.+.. ++.++|+||+||++|+|++|+.||.+. +..+++.
T Consensus       172 ~~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~-~~~~~~~  227 (353)
T cd07850         172 FMMTPY----------------------VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGT-DHIDQWN  227 (353)
T ss_pred             CCCCCC----------------------cccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCC-CHHHHHH
Confidence            000111                      1388899999998765 999999999999999999999999985 4457888


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      ++...++.|+++......
T Consensus       228 ~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         228 KIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             HHHHhcCCCCHHHHHHhh
Confidence            999999998876555443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.81  E-value=6.1e-21  Score=192.01  Aligned_cols=104  Identities=25%  Similarity=0.483  Sum_probs=82.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.|++|||++||+||||||    +|||++..    |.+||+|||+|+....                 
T Consensus        95 ~~~~~~~~~q-i~~al~~lH~~~ivHrDlkp----~Nili~~~----~~~kl~Dfg~~~~~~~-----------------  148 (327)
T cd05617          95 EEHARFYAAE-ICIALNFLHERGIIYRDLKL----DNVLLDAD----GHIKLTDYGMCKEGLG-----------------  148 (327)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeeccCCCH----HHEEEeCC----CCEEEeccccceeccC-----------------
Confidence            3333445555 78899999999999999999    89999876    7999999999973211                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .+.....++|                      |+.|+|||++.+.. |+.++||||+||++|||++|.+||
T Consensus       149 ---------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf  196 (327)
T cd05617         149 ---------PGDTTSTFCG----------------------TPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPF  196 (327)
T ss_pred             ---------CCCceecccC----------------------CcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCC
Confidence                     1111112233                      99999999998765 999999999999999999999999


Q ss_pred             CC
Q psy3074         170 PG  171 (481)
Q Consensus       170 ~g  171 (481)
                      ..
T Consensus       197 ~~  198 (327)
T cd05617         197 DI  198 (327)
T ss_pred             Cc
Confidence            64

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.81  E-value=5.8e-21  Score=192.34  Aligned_cols=107  Identities=27%  Similarity=0.490  Sum_probs=84.2

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........++.. .+.|++|||++||+||||||    +|||++..    |.+||+|||+|+...               
T Consensus        92 ~l~~~~~~~~~~q-i~~~l~~lH~~~ivH~dlkp----~Nili~~~----~~~kL~Dfg~~~~~~---------------  147 (329)
T cd05588          92 KLPEEHARFYSAE-ISLALNFLHERGIIYRDLKL----DNVLLDAE----GHIKLTDYGMCKEGI---------------  147 (329)
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHCCeEecCCCH----HHeEECCC----CCEEECcCccccccc---------------
Confidence            3444444455555 78899999999999999999    89999876    799999999997321               


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                 ..+.....++|                      |+.|+|||++.+.. |+.++|+||+||++|||++|+
T Consensus       148 -----------~~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~  193 (329)
T cd05588         148 -----------RPGDTTSTFCG----------------------TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGR  193 (329)
T ss_pred             -----------cCCCccccccC----------------------CccccCHHHHcCCC-CCCccceechHHHHHHHHHCC
Confidence                       11111112333                      99999999998765 999999999999999999999


Q ss_pred             CCCCC
Q psy3074         167 PTFPG  171 (481)
Q Consensus       167 ~PF~g  171 (481)
                      .||..
T Consensus       194 ~Pf~~  198 (329)
T cd05588         194 SPFDI  198 (329)
T ss_pred             CCccc
Confidence            99963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.81  E-value=4.4e-20  Score=182.75  Aligned_cols=157  Identities=16%  Similarity=0.172  Sum_probs=115.4

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceeec
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiHr  347 (481)
                      ..+|+.++.++. ||||+++++++.+....|++|||+.+.+..++....+.+++..+..++.|++.||.|||+ .+++||
T Consensus        60 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~  139 (296)
T cd06618          60 ILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHR  139 (296)
T ss_pred             HHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecC
Confidence            345776666665 999999999999999999999999988877776656678999999999999999999997 599999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCce--eccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI--LHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i--~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||+|+||++++++.  +|++|||++..+........  .+..+.+|+.+.+                             
T Consensus       140 dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------------------------  188 (296)
T cd06618         140 DVKPSNILLDASGN--VKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDP-----------------------------  188 (296)
T ss_pred             CCcHHHEEEcCCCC--EEECccccchhccCCCcccCCCCCccccCHhhcCC-----------------------------
Confidence            99999999988776  99999998875432111100  0001111111100                             


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                         ....-..+..+|+||+|+++++|..|..|+..
T Consensus       189 ---~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         189 ---PDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             ---CCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence               00000113467999999999999999977643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.81  E-value=8.2e-20  Score=175.98  Aligned_cols=106  Identities=27%  Similarity=0.513  Sum_probs=96.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh--------cCCCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH--------SGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~--------~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .+.+|+.+++.++|+||+++++++.+....+++|||++ ++|.+++...        ...+++..+..++.|++.||.||
T Consensus        42 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l  121 (262)
T cd00192          42 DFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL  121 (262)
T ss_pred             HHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            45679999999999999999999999999999999996 7888888765        36789999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |+++++||||||+||++++++.  ++++|||.+..+.
T Consensus       122 H~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~  156 (262)
T cd00192         122 ASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVY  156 (262)
T ss_pred             HcCCcccCccCcceEEECCCCc--EEEcccccccccc
Confidence            9999999999999999998876  9999999887654

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.81  E-value=4.9e-20  Score=178.67  Aligned_cols=105  Identities=26%  Similarity=0.450  Sum_probs=94.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++.+.+++..|++|||++ ++|.+++.+. ..+++..+..++.|++.||.|+|+++++|+
T Consensus        39 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~  117 (262)
T cd05572          39 HIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYR  117 (262)
T ss_pred             HHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccC
Confidence            35679999999999999999999999999999999998 6788877653 458899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++.++.  ++++|||++..+.
T Consensus       118 dl~~~nilv~~~~~--~~l~df~~~~~~~  144 (262)
T cd05572         118 DLKPENLLLDSNGY--VKLVDFGFAKKLK  144 (262)
T ss_pred             CCCHHHEEEcCCCC--EEEeeCCcccccC
Confidence            99999999998776  9999999887654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.81  E-value=2.6e-20  Score=185.46  Aligned_cols=135  Identities=40%  Similarity=0.713  Sum_probs=106.1

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      .+....++.. .+.|++|||++|++||||||    +||+++..    |.+||+|||+++.......              
T Consensus       107 ~~~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~nil~~~~----~~~kL~dfg~~~~~~~~~~--------------  163 (309)
T cd07845         107 ESQVKCLMLQ-LLRGLQYLHENFIIHRDLKV----SNLLLTDK----GCLKIADFGLARTYGLPAK--------------  163 (309)
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEECccceeeecCCccC--------------
Confidence            3333445555 78899999999999999999    89999876    7999999999985321100              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 ..                       +....++.|+|||++.+...++.++|+||+||++|||++|++||
T Consensus       164 -----------~~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f  209 (309)
T cd07845         164 -----------PM-----------------------TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL  209 (309)
T ss_pred             -----------CC-----------------------CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence                       00                       00112788999999987666999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCCC
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                      .+. +..+++..+...++.|....|+.....+.
T Consensus       210 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         210 PGK-SEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCC-CHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            985 45588999999999998888887655543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.81  E-value=2.1e-20  Score=192.17  Aligned_cols=141  Identities=24%  Similarity=0.331  Sum_probs=82.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+++................. ..............
T Consensus       110 i~~aL~~LH~~givHrDlKp----~Nili~~~----~~~kL~DFGl~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  180 (381)
T cd05626         110 LTLAIESVHKMGFIHRDIKP----DNILIDLD----GHIKLTDFGLCTGFRWTHNSKYYQKGSHI-RQDSMEPSDLWDDV  180 (381)
T ss_pred             HHHHHHHHHhCCeeecCCcH----HHEEECCC----CCEEEeeCcCCcccccccccccccccccc-cccccCcccccccc
Confidence            68899999999999999999    89999865    79999999999754211100000000000 00000000000000


Q ss_pred             ---ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074         101 ---SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus       101 ---~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                         ..+.......   ...............++|+.|||||++.+.. |+.++||||+||++|||++|.+||.+.+.
T Consensus       181 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~  253 (381)
T cd05626         181 SNCRCGDRLKTLE---QRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPFLAPTP  253 (381)
T ss_pred             cccccccccchhh---ccccccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence               0000000000   0000000000011234699999999998765 99999999999999999999999987543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.81  E-value=1.2e-19  Score=178.97  Aligned_cols=105  Identities=24%  Similarity=0.488  Sum_probs=92.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------CCCChHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------GGLDHHN  324 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------~~l~~~~  324 (481)
                      .+.+|+.+++.++||||+++++.+...+..+++|||+. |+|.+++....                       ..+++..
T Consensus        49 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  128 (290)
T cd05045          49 DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD  128 (290)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHH
Confidence            46689999999999999999999999999999999998 67877765321                       2367888


Q ss_pred             HHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       325 ~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +..++.|++.||.|||+.+++||||||+||++++++.  +|++|||+++.+
T Consensus       129 ~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~  177 (290)
T cd05045         129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDV  177 (290)
T ss_pred             HHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc--EEeccccccccc
Confidence            8999999999999999999999999999999988776  999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1035|consensus

Probab=99.81  E-value=1.7e-19  Score=196.29  Aligned_cols=134  Identities=20%  Similarity=0.249  Sum_probs=94.9

Q ss_pred             eEEEEEeccCCCHHHHHHHhcCCC-ChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         297 TLTFVFEYVHTDLSQYMERHSGGL-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       297 ~~~iv~E~~~g~l~~~l~~~~~~l-~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .+||=||||+.++.+.+...+... ......++++||++||.|+|++|+|||||||.||++++...  |||.|||+|..+
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~  747 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDL  747 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhh
Confidence            468889999977666666544433 46788999999999999999999999999999999998777  999999999864


Q ss_pred             cccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCC-----------CCChhhhhh
Q psy3074         376 SYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP-----------GAPFTAIRE  444 (481)
Q Consensus       376 ~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p-----------~~p~~~~s~  444 (481)
                      .-.+... . -+..+.+                  ...|.   .....+..+||.-|.+|           ....|.+|+
T Consensus       748 ~~~~~~~-d-~~~~~~~------------------~~~g~---~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSL  804 (1351)
T KOG1035|consen  748 KENLESI-D-QDLSFST------------------NRAGS---NDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSL  804 (1351)
T ss_pred             hhhhhhH-h-hccCccc------------------cccCC---CCcccccccceeeeecHHHhcccccccccchhhhHHH
Confidence            4211000 0 0000000                  00010   01123346799999999           334599999


Q ss_pred             HHHHHHhhCCC
Q psy3074         445 ASLLKELKHNN  455 (481)
Q Consensus       445 ~~~l~~l~~~~  455 (481)
                      |++++||.|+.
T Consensus       805 GIVlFEM~yPF  815 (1351)
T KOG1035|consen  805 GIVLFEMLYPF  815 (1351)
T ss_pred             HHHHHHHhccC
Confidence            99999999984

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.81  E-value=1.6e-19  Score=175.65  Aligned_cols=107  Identities=23%  Similarity=0.390  Sum_probs=93.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++||||+++++++.+.+..+++|||++ ++|.+++....      ..+++..+..++.|++.|+.|||+
T Consensus        45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~  124 (269)
T cd05044          45 EFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ  124 (269)
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh
Confidence            46689999999999999999999999999999999998 68888876421      237788899999999999999999


Q ss_pred             CceeeccCCCccccccccc---hhhHHHHHHHHHhhc
Q psy3074         342 RRILHRDVKPQNLLISEID---HHNIRLFMFQLLRGL  375 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~---~~~ikl~dfgla~~~  375 (481)
                      .+++|+||||+||++++++   ...++++|||+++.+
T Consensus       125 ~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~  161 (269)
T cd05044         125 MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI  161 (269)
T ss_pred             CCcccCCCChheEEEecCCCCCCcceEECCccccccc
Confidence            9999999999999998765   124999999988754

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0199|consensus

Probab=99.81  E-value=8.4e-21  Score=195.79  Aligned_cols=155  Identities=21%  Similarity=0.316  Sum_probs=128.9

Q ss_pred             ChhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHH-hcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMER-HSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       266 ~~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~-~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ...+++||+.+|-+|+|||+|+||++..+ ..+.||||+|+ |+|++.|.+ ....|....+..|+.||+.||.||.+++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            44578999999999999999999999988 67899999999 899999987 4456888889999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceecc-------ccCCCccc---ccccccccCCCeeEEEeec
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHR-------DVKPQNLL---ISEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~-------d~~~~~il---~~~~~~~~s~g~~~~~~~~  413 (481)
                      +|||||...|+|+.+...  |||+||||.|++......+++..       |..|+.+-   ++...++|++|+.++||.+
T Consensus       233 lvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt  310 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLASPRT--VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT  310 (1039)
T ss_pred             hhhhhhhhhhheecccce--eeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence            999999999999987555  99999999999875444444333       33333222   5566678999999999998


Q ss_pred             -CCCCcccccc
Q psy3074         414 -GSGGWWFESK  423 (481)
Q Consensus       414 -g~~~~~~~~~  423 (481)
                       |.-||...+.
T Consensus       311 yGEePW~G~~g  321 (1039)
T KOG0199|consen  311 YGEEPWVGCRG  321 (1039)
T ss_pred             cCCCCCCCCCH
Confidence             8899986653

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.81  E-value=6.5e-21  Score=192.03  Aligned_cols=103  Identities=27%  Similarity=0.509  Sum_probs=81.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+....                 
T Consensus        95 ~~~~~~i~~q-i~~~l~~lH~~~ivH~Dikp----~Nili~~~----~~~kL~DfG~~~~~~~-----------------  148 (329)
T cd05618          95 EEHARFYSAE-ISLALNYLHERGIIYRDLKL----DNVLLDSE----GHIKLTDYGMCKEGLR-----------------  148 (329)
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeeeCCCCH----HHEEECCC----CCEEEeeCCccccccC-----------------
Confidence            3333445555 78899999999999999999    89999876    7999999999974211                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .+.....+.|                      |+.|+|||++.+.. |+.++||||+||++|||++|+.||
T Consensus       149 ---------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf  196 (329)
T cd05618         149 ---------PGDTTSTFCG----------------------TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPF  196 (329)
T ss_pred             ---------CCCccccccC----------------------CccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCC
Confidence                     0111111233                      99999999998765 999999999999999999999999


Q ss_pred             C
Q psy3074         170 P  170 (481)
Q Consensus       170 ~  170 (481)
                      .
T Consensus       197 ~  197 (329)
T cd05618         197 D  197 (329)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.81  E-value=2.6e-20  Score=180.68  Aligned_cols=184  Identities=16%  Similarity=0.213  Sum_probs=133.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++|+||+++++.+.. ...+++|||++ +++.+++.... ..++...+..++.|++.||.|+|+.+++|
T Consensus        47 ~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H  125 (260)
T cd05073          47 AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH  125 (260)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            46689999999999999999999988 77899999998 68888886543 34677888999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc----CceeccccCCCcccc----cccccccCCCeeEEEeec-CCCC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR----RRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGG  417 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~----~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~  417 (481)
                      |||||+||+++..+.  +|++|||++..+.....    .......|.+|+++.    +...+.|+.|++++++.+ |..|
T Consensus       126 ~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p  203 (260)
T cd05073         126 RDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP  203 (260)
T ss_pred             cccCcceEEEcCCCc--EEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCC
Confidence            999999999988776  99999999876542211    111123466777663    334567999999999997 8888


Q ss_pred             ccccccCcccc--eeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         418 WWFESKSNINL--SFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       418 ~~~~~~~~~~~--t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      |...+......  .-.+..+..+.....+..++..+.+.+
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  243 (260)
T cd05073         204 YPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNR  243 (260)
T ss_pred             CCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccC
Confidence            87543211110  011222222223334556666776654

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.80  E-value=1e-20  Score=192.94  Aligned_cols=137  Identities=21%  Similarity=0.332  Sum_probs=85.2

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........ ...+.....++..+..
T Consensus       104 ~~~~~q-i~~~L~~lH~~givHrDLkp----~NIli~~~----~~vkL~DfG~~~~~~~~~~~-~~~~~~~~~~~~~~~~  173 (360)
T cd05627         104 QFYIAE-TVLAIDAIHQLGFIHRDIKP----DNLLLDAK----GHVKLSDFGLCTGLKKAHRT-EFYRNLTHNPPSDFSF  173 (360)
T ss_pred             HHHHHH-HHHHHHHHHHCCeEccCCCH----HHEEECCC----CCEEEeeccCCccccccccc-ccccccccCCcccccc
Confidence            334444 68899999999999999999    89999765    79999999999854221100 0000000000000000


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                      .. ..           .......+...........++|+.|||||++.+.. |+.++||||+||++|||++|++||.+..
T Consensus       174 ~~-~~-----------~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~  240 (360)
T cd05627         174 QN-MN-----------SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSET  240 (360)
T ss_pred             cc-cc-----------cccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCC
Confidence            00 00           00000000000000111234699999999998765 9999999999999999999999998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.80  E-value=2.8e-20  Score=192.03  Aligned_cols=128  Identities=23%  Similarity=0.327  Sum_probs=97.0

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........            
T Consensus       183 ~~~~~~~i~~q-l~~aL~~LH~~givHrDlkp----~Nill~~~----~~~~l~DfG~a~~~~~~~~~------------  241 (392)
T PHA03207        183 PLEQAITIQRR-LLEALAYLHGRGIIHRDVKT----ENIFLDEP----ENAVLGDFGAACKLDAHPDT------------  241 (392)
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCccccCCCH----HHEEEcCC----CCEEEccCccccccCccccc------------
Confidence            33444455555 78899999999999999999    89999876    79999999999743211000            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                  .....+                      .+|+.|+|||++.+.. |+.++||||+||++|||++|+.|
T Consensus       242 ------------~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~p  286 (392)
T PHA03207        242 ------------PQCYGW----------------------SGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVT  286 (392)
T ss_pred             ------------cccccc----------------------ccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence                        000011                      2499999999998766 99999999999999999999999


Q ss_pred             CCCc--hhhHHHHHHHHHHhCCCCcc
Q psy3074         169 FPGV--REVYDQLDKIFKILGTPTEE  192 (481)
Q Consensus       169 F~g~--~~~~~~l~~i~~~~~~p~~~  192 (481)
                      |.+.  .....++..+.+.++..+.+
T Consensus       287 f~~~~~~~~~~~l~~i~~~~~~~~~~  312 (392)
T PHA03207        287 LFGKQVKSSSSQLRSIIRCMQVHPLE  312 (392)
T ss_pred             CCCCCCCCcHHHHHHHHHHhccCccc
Confidence            9875  23456788888887765544

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.80  E-value=1.8e-21  Score=189.23  Aligned_cols=152  Identities=22%  Similarity=0.312  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      ..+.+|++++++++||||+++++++...+..++|||||+ |+|.+++... ...+++.....++.|++.||.|||+++++
T Consensus        46 ~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~ii  125 (259)
T PF07714_consen   46 EEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNII  125 (259)
T ss_dssp             HHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             eeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            356789999999999999999999998888999999998 7899998876 45689999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc-----ccccCceeccccCCCccc----ccccccccCCCeeEEEeec-CC
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS-----YCHRRRILHRDVKPQNLL----ISEIVFTNLSGVVVSTVDS-GS  415 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~-----~~~~~~i~~~d~~~~~il----~~~~~~~~s~g~~~~~~~~-g~  415 (481)
                      |++|+++||++++++.  +|++|||++....     ...........+.||+.+    .+...|+|++|++++++.+ |.
T Consensus       126 H~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~  203 (259)
T PF07714_consen  126 HGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGK  203 (259)
T ss_dssp             EST-SGGGEEEETTTE--EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSS
T ss_pred             cccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999998776  9999999998662     111222333455577666    3445567999999999999 67


Q ss_pred             CCcccc
Q psy3074         416 GGWWFE  421 (481)
Q Consensus       416 ~~~~~~  421 (481)
                      .||...
T Consensus       204 ~p~~~~  209 (259)
T PF07714_consen  204 FPFSDY  209 (259)
T ss_dssp             GTTTTS
T ss_pred             cccccc
Confidence            887654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=1.4e-20  Score=193.04  Aligned_cols=147  Identities=18%  Similarity=0.259  Sum_probs=85.9

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....................    ...  .+
T Consensus       110 l~~aL~~LH~~givHrDlkp----~NIll~~~----~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~----~~~--~~  175 (377)
T cd05629         110 CVLAIEAVHKLGFIHRDIKP----DNILIDRG----GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK----NRI--DN  175 (377)
T ss_pred             HHHHHHHHHhCCeeccCCCH----HHEEECCC----CCEEEeecccccccccccccccccccccccccc----ccc--cc
Confidence            68899999999999999999    89999865    799999999997432111000000000000000    000  00


Q ss_pred             ceeEEEec--ccCcch---hhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074         101 SYATVFKG--YSNLTN---QVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus       101 ~~~~~~~g--~~~~~~---~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                      ........  ....+.   ..+....-......++|+.|||||++.+.. |+.++||||+||++|||++|.+||.+... 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~-  253 (377)
T cd05629         176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENS-  253 (377)
T ss_pred             ccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhcCCCCCCCCCH-
Confidence            00000000  000000   000000000111235699999999998765 99999999999999999999999987533 


Q ss_pred             HHHHHHHH
Q psy3074         176 YDQLDKIF  183 (481)
Q Consensus       176 ~~~l~~i~  183 (481)
                      .+.+..+.
T Consensus       254 ~~~~~~i~  261 (377)
T cd05629         254 HETYRKII  261 (377)
T ss_pred             HHHHHHHH
Confidence            34455444

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.80  E-value=7.4e-20  Score=180.18  Aligned_cols=105  Identities=29%  Similarity=0.476  Sum_probs=92.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------------CCCChHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------------GGLDHHNIR  326 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------------~~l~~~~~~  326 (481)
                      .+.+|+.+++.++||||+++++++.+.+..+++|||++ |+|.+++....                     ..+++..+.
T Consensus        54 ~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  133 (288)
T cd05050          54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL  133 (288)
T ss_pred             HHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence            46679999999999999999999999999999999998 68888876432                     136777889


Q ss_pred             HHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       327 ~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      .++.|++.||.|||+++++||||||+||++++++.  ++++|||+++.+
T Consensus       134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~  180 (288)
T cd05050         134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNI  180 (288)
T ss_pred             HHHHHHHHHHHHHHhCCeecccccHhheEecCCCc--eEECccccceec
Confidence            99999999999999999999999999999988776  999999988654

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.80  E-value=1.7e-20  Score=192.05  Aligned_cols=107  Identities=29%  Similarity=0.370  Sum_probs=82.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                        . 
T Consensus       151 i~~aL~~LH~~~ivHrDLkp----~NILl~~~----~~~kL~DfG~~~~~~~~~------------------------~-  197 (370)
T cd05596         151 VVLALDAIHSMGFIHRDVKP----DNMLLDKS----GHLKLADFGTCMKMDANG------------------------M-  197 (370)
T ss_pred             HHHHHHHHHHCCeeccCCCH----HHEEEcCC----CCEEEEeccceeeccCCC------------------------c-
Confidence            78899999999999999999    89999876    799999999997431100                        0 


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST---EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~---~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      ......                      .+|+.|||||++.+..   .++.++||||+||++|||++|++||.+.+. ..
T Consensus       198 ~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~  254 (370)
T cd05596         198 VRCDTA----------------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VG  254 (370)
T ss_pred             ccCCCC----------------------CCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HH
Confidence            000011                      2399999999997642   488999999999999999999999998533 34


Q ss_pred             HHHHHH
Q psy3074         178 QLDKIF  183 (481)
Q Consensus       178 ~l~~i~  183 (481)
                      .+.+|.
T Consensus       255 ~~~~i~  260 (370)
T cd05596         255 TYSKIM  260 (370)
T ss_pred             HHHHHH
Confidence            445443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0664|consensus

Probab=99.80  E-value=1.9e-21  Score=181.18  Aligned_cols=128  Identities=28%  Similarity=0.535  Sum_probs=109.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.||+.+|...+|.|+....|..+-.+     ++|.++|++..||...+.. ...++.+.++-++.||+.||.|||+.+
T Consensus        98 rvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~  176 (449)
T KOG0664|consen   98 RVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTAN  176 (449)
T ss_pred             HHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcc
Confidence            4668999999999999999999887654     5889999999998887765 346899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLISEIV  399 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~~~~~  399 (481)
                      |+||||||.|+|++++..  +|+||||+||.-+...    +..+++..|++|+++++..-
T Consensus       177 ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRh  234 (449)
T KOG0664|consen  177 ILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARR  234 (449)
T ss_pred             hhhccCCCccEEeccCce--EEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchh
Confidence            999999999999998776  9999999999665322    34577889999999987544

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.80  E-value=9.1e-21  Score=186.04  Aligned_cols=148  Identities=16%  Similarity=0.285  Sum_probs=99.1

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+++.....                     
T Consensus       128 ~~~~q-l~~aL~~lH~~gi~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~---------------------  177 (283)
T cd05091         128 HIVTQ-IAAGMEFLSSHHVVHKDLAT----RNVLVFDK----LNVKISDLGLFREVYAA---------------------  177 (283)
T ss_pred             HHHHH-HHHHHHHHHHcCccccccch----hheEecCC----CceEecccccccccccc---------------------
Confidence            34444 67899999999999999999    89999865    68999999999843211                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCch
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGVR  173 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~g~~  173 (481)
                            ... ...+                  ....++.|+|||++.+.. ++.++||||+||++|||++ |.+||.+..
T Consensus       178 ------~~~-~~~~------------------~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         178 ------DYY-KLMG------------------NSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             ------hhe-eecc------------------CccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence                  000 0000                  011277899999998766 9999999999999999998 899998743


Q ss_pred             hhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         174 EVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      . .+.++.+......|.+...+..-......|+...|..|+++.++
T Consensus       232 ~-~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i  276 (283)
T cd05091         232 N-QDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDI  276 (283)
T ss_pred             H-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence            3 34455554443333222222221122235666666666665443

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0580|consensus

Probab=99.80  E-value=1.1e-20  Score=173.56  Aligned_cols=108  Identities=28%  Similarity=0.440  Sum_probs=89.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      ...||.|||.++||||||||    +|+|++..    |.+||+|||-+-..                            ..
T Consensus       133 ~A~Al~y~h~k~VIhRdiKp----enlLlg~~----~~lkiAdfGwsV~~----------------------------p~  176 (281)
T KOG0580|consen  133 LANALLYCHLKRVIHRDIKP----ENLLLGSA----GELKIADFGWSVHA----------------------------PS  176 (281)
T ss_pred             HHHHHHHhccCCcccCCCCH----HHhccCCC----CCeeccCCCceeec----------------------------CC
Confidence            36789999999999999999    89999988    79999999988521                            12


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      +...+.||                      |..|.+||+..+.. ++..+|+||+|++.||++.|.+||.+.. ..+..+
T Consensus       177 ~kR~tlcg----------------------t~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYk  232 (281)
T KOG0580|consen  177 NKRKTLCG----------------------TLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYK  232 (281)
T ss_pred             CCceeeec----------------------ccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHH
Confidence            23456677                      99999999999876 9999999999999999999999999854 446677


Q ss_pred             HHHHHhCC
Q psy3074         181 KIFKILGT  188 (481)
Q Consensus       181 ~i~~~~~~  188 (481)
                      +|.+.-..
T Consensus       233 rI~k~~~~  240 (281)
T KOG0580|consen  233 RIRKVDLK  240 (281)
T ss_pred             HHHHcccc
Confidence            77665433

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.80  E-value=1.4e-19  Score=174.26  Aligned_cols=105  Identities=23%  Similarity=0.417  Sum_probs=94.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+....++||||+. +++.+++......+++..+..++.|++.|+.|||+++++||
T Consensus        38 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~  117 (251)
T cd05041          38 KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHR  117 (251)
T ss_pred             HHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehh
Confidence            45679999999999999999999999999999999998 56877776655568888999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  ++++|||++...
T Consensus       118 di~p~nili~~~~~--~~l~d~g~~~~~  143 (251)
T cd05041         118 DLAARNCLVGENNV--LKISDFGMSREE  143 (251)
T ss_pred             hcCcceEEEcCCCc--EEEeeccccccc
Confidence            99999999988776  999999988754

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.80  E-value=8.8e-21  Score=200.67  Aligned_cols=109  Identities=27%  Similarity=0.428  Sum_probs=84.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+......                        ..
T Consensus       178 i~~aL~~lH~~~ivHrDlkp----~NIll~~~----~~~kL~DFgla~~~~~~~------------------------~~  225 (478)
T PTZ00267        178 IVLALDEVHSRKMMHRDLKS----ANIFLMPT----GIIKLGDFGFSKQYSDSV------------------------SL  225 (478)
T ss_pred             HHHHHHHHHhCCEEECCcCH----HhEEECCC----CcEEEEeCcCceecCCcc------------------------cc
Confidence            67899999999999999999    89999865    799999999998532100                        00


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....++                      +|+.|||||++.+.. |+.++||||+||++|||++|+.||.+.+. .+.+.
T Consensus       226 ~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-~~~~~  281 (478)
T PTZ00267        226 DVASSFC----------------------GTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQ-REIMQ  281 (478)
T ss_pred             ccccccC----------------------CCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHH
Confidence            0111222                      399999999998765 99999999999999999999999987433 34455


Q ss_pred             HHHHH
Q psy3074         181 KIFKI  185 (481)
Q Consensus       181 ~i~~~  185 (481)
                      .+...
T Consensus       282 ~~~~~  286 (478)
T PTZ00267        282 QVLYG  286 (478)
T ss_pred             HHHhC
Confidence            55443

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.80  E-value=9.7e-20  Score=181.59  Aligned_cols=105  Identities=22%  Similarity=0.318  Sum_probs=93.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++.+.+..+++|||++ |++.+++... ...+++..+..++.|++.||.|||+++|+|
T Consensus        45 ~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH  124 (314)
T cd08216          45 LLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH  124 (314)
T ss_pred             HHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            45679999999999999999999999999999999999 6677777653 345889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+||+++.++.  +|++|||.+..+
T Consensus       125 ~dlk~~Nili~~~~~--~kl~d~~~~~~~  151 (314)
T cd08216         125 RSVKASHILLSGDGK--VVLSGLRYSVSM  151 (314)
T ss_pred             CCCCcceEEEecCCc--eEEecCccceee
Confidence            999999999998777  999999987654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.80  E-value=5.5e-20  Score=179.52  Aligned_cols=166  Identities=23%  Similarity=0.318  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++ ||||+++++++...+..+++||++. ++|.+.+... +.+++..+..++.|++.||.|||+.+++|
T Consensus        47 ~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H  125 (280)
T cd05581          47 YVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIH  125 (280)
T ss_pred             HHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            3567999999999 9999999999999999999999996 7788877654 46999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      +||||+||+++.++.  ++++|||++..+...........+...                     +.....-........
T Consensus       126 ~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~  182 (280)
T cd05581         126 RDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATN---------------------IDSQIEKNRRRFASF  182 (280)
T ss_pred             cCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCcc---------------------ccccccccccccccc
Confidence            999999999998777  999999988755422110000000000                     000000000011123


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      .++..|++|        ....|.|++|++++++..|..|+
T Consensus       183 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  222 (280)
T cd05581         183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF  222 (280)
T ss_pred             cCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence            455556655        44579999999999999998654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4278|consensus

Probab=99.80  E-value=1.7e-20  Score=191.08  Aligned_cols=157  Identities=20%  Similarity=0.288  Sum_probs=125.3

Q ss_pred             hhhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCC-CChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         267 PFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGG-LDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       267 ~~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~-l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.++.|+.+|+.++|||+|+|+++|..+...|||+|||. |+|+++++..... ++.-.+.+.+.||..||+||..+++
T Consensus       307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF  386 (1157)
T KOG4278|consen  307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF  386 (1157)
T ss_pred             HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh
Confidence            3568889999999999999999999999999999999998 9999999876554 4555566777899999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhcc---ccccCc--eeccccCCCcccc---cccccccCCCeeEEEeec-CC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS---YCHRRR--ILHRDVKPQNLLI---SEIVFTNLSGVVVSTVDS-GS  415 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~---~~~~~~--i~~~d~~~~~il~---~~~~~~~s~g~~~~~~~~-g~  415 (481)
                      |||||...|.|+.++..  +|++|||++|.+.   |...-+  .--.|..|+.+-+   .-..++|.+|+.++++.+ |.
T Consensus       387 IHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGM  464 (1157)
T KOG4278|consen  387 IHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGM  464 (1157)
T ss_pred             hhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCC
Confidence            99999999999988766  9999999999876   322111  1112444443332   334467999999999988 99


Q ss_pred             CCccccccCc
Q psy3074         416 GGWWFESKSN  425 (481)
Q Consensus       416 ~~~~~~~~~~  425 (481)
                      .||.....+.
T Consensus       465 sPYPGidlSq  474 (1157)
T KOG4278|consen  465 SPYPGIDLSQ  474 (1157)
T ss_pred             CCCCCccHHH
Confidence            9998765443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.80  E-value=1e-19  Score=180.66  Aligned_cols=145  Identities=39%  Similarity=0.698  Sum_probs=105.7

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+++..........             
T Consensus       116 ~~~~i~~~-l~~al~~lH~~~i~H~dl~p----~nil~~~~----~~~~l~dfg~~~~~~~~~~~~~-------------  173 (311)
T cd07866         116 QIKCYMLQ-LLEGINYLHENHILHRDIKA----ANILIDNQ----GILKIADFGLARPYDGPPPNPK-------------  173 (311)
T ss_pred             HHHHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEECcCccchhccCCCcccc-------------
Confidence            33344444 78899999999999999999    99999876    7999999999985422110000             


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                           .+.+...                   ...+...+++.|+|||++.+...++.++||||+||++|||++|++||.+
T Consensus       174 -----~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         174 -----GGGGGGT-------------------RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             -----cCCcccc-------------------cccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence                 0000000                   0001122388999999998776799999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      .++ .+.++.+....+.|.+..|+....++..
T Consensus       230 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (311)
T cd07866         230 KSD-IDQLHLIFKLCGTPTEETWPGWRSLPGC  260 (311)
T ss_pred             CCH-HHHHHHHHHHhCCCChhhchhhhhcccc
Confidence            544 4788889999998888877765544443

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.80  E-value=7.5e-20  Score=178.53  Aligned_cols=106  Identities=25%  Similarity=0.446  Sum_probs=93.7

Q ss_pred             hhhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHH
Q psy3074         267 PFTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFM  329 (481)
Q Consensus       267 ~~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~  329 (481)
                      ...+.+|+.+++++ +||||+++++++...+..|++|||++ |+|.+++....               ..+++..+..++
T Consensus        39 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  118 (270)
T cd05047          39 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA  118 (270)
T ss_pred             HHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHH
Confidence            34677899999999 79999999999999999999999998 78888876432               237788999999


Q ss_pred             HHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhh
Q psy3074         330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       330 ~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      .|++.|++|||+.+++||||||+||++++++.  +|++|||++..
T Consensus       119 ~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl~~~  161 (270)
T cd05047         119 ADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRG  161 (270)
T ss_pred             HHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCCccc
Confidence            99999999999999999999999999998776  99999998753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.80  E-value=5.3e-20  Score=179.97  Aligned_cols=106  Identities=53%  Similarity=0.877  Sum_probs=96.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ...+|+.+++.++|+||+++++++.+.+..++||||+++++.+++......+++..+..++.|++.||.|||+++++|||
T Consensus        44 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~  123 (282)
T cd07829          44 TALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRD  123 (282)
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            34579999999999999999999999999999999999999998887645799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |+|+||++++++.  ++++|||+++...
T Consensus       124 l~~~ni~~~~~~~--~~l~d~g~~~~~~  149 (282)
T cd07829         124 LKPQNILINRDGV--LKLADFGLARAFG  149 (282)
T ss_pred             CChheEEEcCCCC--EEEecCCcccccC
Confidence            9999999998777  9999999887654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0576|consensus

Probab=99.80  E-value=2.1e-20  Score=192.38  Aligned_cols=274  Identities=20%  Similarity=0.187  Sum_probs=174.2

Q ss_pred             cchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074           5 ENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      -|.+.+.|..+++ .+.+.++.|||+.|-+|||||-    .|||++..    |.+|++|||.+....             
T Consensus       106 Tgplselqiayvc-Retl~gl~ylhs~gk~hRdiKG----anilltd~----gDvklaDfgvsaqit-------------  163 (829)
T KOG0576|consen  106 TGPLSELQIAYVC-RETLQGLKYLHSQGKIHRDIKG----ANILLTDE----GDVKLADFGVSAQIT-------------  163 (829)
T ss_pred             cccchhHHHHHHH-hhhhccchhhhcCCcccccccc----cceeeccc----CceeecccCchhhhh-------------
Confidence            4556665555554 4589999999999999999999    89999887    899999999986321             


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHH
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~el  162 (481)
                                    .                     -+.+...-.||++||||||-.-  ...|+..||+|++|+...|+
T Consensus       164 --------------a---------------------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel  208 (829)
T KOG0576|consen  164 --------------A---------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL  208 (829)
T ss_pred             --------------h---------------------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence                          0                     0112223345999999998642  33499999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhh
Q psy3074         163 VTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDA  242 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~  242 (481)
                      -..++|.... ..+..+..+-+....|+  ..+                               ...+.......+++.+
T Consensus       209 ~eLqpplfdl-hpmr~l~LmTkS~~qpp--~lk-------------------------------Dk~kws~~fh~fvK~a  254 (829)
T KOG0576|consen  209 GELQPPLFDL-HPMRALFLMTKSGFQPP--TLK-------------------------------DKTKWSEFFHNFVKGA  254 (829)
T ss_pred             hhcCCccccc-chHHHHHHhhccCCCCC--ccc-------------------------------CCccchHHHHHHHHHH
Confidence            9988886431 11222222222111111  000                               0111222223333333


Q ss_pred             hhcCCccccccccccCCCCCCCCChhhHHHHHHHHhhcCCCC-eeEEeeeeecCCeEEEEEeccCCC--HHHHHHHhcCC
Q psy3074         243 AILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNN-IVTLHDIVHTRSTLTFVFEYVHTD--LSQYMERHSGG  319 (481)
Q Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rE~~il~~l~Hpn-IV~l~~~~~~~~~~~iv~E~~~g~--l~~~l~~~~~~  319 (481)
                      ...+|.++... ++... -+--.......-++++|.+++||| .|..++.++.++..+++|++|.++  ....+....-.
T Consensus       255 ltknpKkRpta-eklL~-h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~  332 (829)
T KOG0576|consen  255 LTKNPKKRPTA-EKLLQ-HPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIA  332 (829)
T ss_pred             hcCCCccCCCh-hhhee-ceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHh
Confidence            33444332211 11111 000011134556899999999999 888888888899999999999854  11111111112


Q ss_pred             CChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcccc
Q psy3074         320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC  378 (481)
Q Consensus       320 l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~  378 (481)
                      +.+-......+.-+.+++++|+..-+|||    ||+..+ +.  .|..+|++...+...
T Consensus       333 ~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~--~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  333 LEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EE--VKLLDFAVPPQLTRT  384 (829)
T ss_pred             hhhhhhhhhhhhhcccccccccccccCcc----cccccc-cc--cccccccCCcccCcc
Confidence            34444556667777889999988778998    888776 33  788999998887744

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.80  E-value=2.9e-20  Score=180.03  Aligned_cols=145  Identities=23%  Similarity=0.334  Sum_probs=116.1

Q ss_pred             HHH-HHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         273 EAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       273 E~~-il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      |.. +....+||||+++++++...+..|++|||++ ++|..++.. .+.+++..+..++.|++.||.|||+.+++|+||+
T Consensus        46 e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~  124 (260)
T cd05611          46 ERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIK  124 (260)
T ss_pred             HHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            443 3445689999999999999999999999998 567776654 3568999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCcccc
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |+||++++.+.  ++++|||+++..... ........+.+|+.+..    ...+.|+.|++++++.+|..||...
T Consensus       125 p~nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         125 PENLLIDQTGH--LKLTDFGLSRNGLEN-KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             HHHeEECCCCc--EEEeecccceecccc-ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence            99999998776  999999998764431 11122345667776543    3467799999999999999998654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.80  E-value=1.7e-20  Score=181.61  Aligned_cols=150  Identities=27%  Similarity=0.363  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|+||+++++.+...+..++|+||++ ++|.+.+.. ...+++..+..++.|++.||.|||+.+++|+
T Consensus        45 ~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~  123 (264)
T cd06626          45 EIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHR  123 (264)
T ss_pred             HHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            45679999999999999999999999999999999998 567776654 3458889999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccC-------ceeccccCCCccccc-------ccccccCCCeeEEEeec
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR-------RILHRDVKPQNLLIS-------EIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~-------~i~~~d~~~~~il~~-------~~~~~~s~g~~~~~~~~  413 (481)
                      ||+|+||++++.+.  +|++|||++..+......       ......+.||+++..       ...+.|++|++++++.+
T Consensus       124 dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~  201 (264)
T cd06626         124 DIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT  201 (264)
T ss_pred             CCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence            99999999998776  999999998866422111       111234566666543       33567888888888888


Q ss_pred             CCCCcccc
Q psy3074         414 GSGGWWFE  421 (481)
Q Consensus       414 g~~~~~~~  421 (481)
                      |..||...
T Consensus       202 g~~pf~~~  209 (264)
T cd06626         202 GKRPWSEL  209 (264)
T ss_pred             CCCCccCC
Confidence            88888543

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.80  E-value=1.5e-20  Score=199.86  Aligned_cols=119  Identities=24%  Similarity=0.335  Sum_probs=89.5

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.. .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+.......                    
T Consensus       272 i~~q-l~~aL~yLH~~gIiHrDLKP----~NILl~~~----~~vkL~DFGla~~~~~~~~--------------------  322 (501)
T PHA03210        272 IMKQ-LLCAVEYIHDKKLIHRDIKL----ENIFLNCD----GKIVLGDFGTAMPFEKERE--------------------  322 (501)
T ss_pred             HHHH-HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEEEeCCCceecCcccc--------------------
Confidence            4444 78899999999999999999    89999876    7999999999985321100                    


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC-CCCCc-h
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP-TFPGV-R  173 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~-PF~g~-~  173 (481)
                           .....+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|.. ||.+. .
T Consensus       323 -----~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~  374 (501)
T PHA03210        323 -----AFDYGWV----------------------GTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGG  374 (501)
T ss_pred             -----ccccccc----------------------CCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence                 0001122                      399999999998765 9999999999999999999875 45432 3


Q ss_pred             hhHHHHHHHHHHhCCCCc
Q psy3074         174 EVYDQLDKIFKILGTPTE  191 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~  191 (481)
                      ....++.++++.++.+..
T Consensus       375 ~~~~~~~~~~~~~~~~~~  392 (501)
T PHA03210        375 KPGKQLLKIIDSLSVCDE  392 (501)
T ss_pred             CHHHHHHHHHHhcccChh
Confidence            445677777777665543

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.80  E-value=7.4e-20  Score=179.31  Aligned_cols=105  Identities=23%  Similarity=0.444  Sum_probs=91.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhc-------CCCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHS-------GGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~-------~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .+.+|+.+++.++||||+++++++.. +...++++||+. |++..++....       ..+++..+..++.|++.||+||
T Consensus        54 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  133 (280)
T cd05043          54 LLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYL  133 (280)
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999998765 578899999998 78888776532       3488999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |+.+++||||||+||++++++.  +|++|||+++.+
T Consensus       134 H~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~  167 (280)
T cd05043         134 HKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDL  167 (280)
T ss_pred             HHCCEeecccCHhhEEEcCCCc--EEECCCCCcccc
Confidence            9999999999999999988766  999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.80  E-value=2.1e-19  Score=176.72  Aligned_cols=106  Identities=28%  Similarity=0.462  Sum_probs=95.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++|+||+++++.+...+..|+++||++ ++|.+++......+++..+..++.|++.||.|||+.|++|+
T Consensus        61 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~  140 (286)
T cd06614          61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR  140 (286)
T ss_pred             HHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            35679999999999999999999999999999999999 68888887654478999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+||+++.++.  ++++|||++..+.
T Consensus       141 dl~p~ni~i~~~~~--~~l~d~~~~~~~~  167 (286)
T cd06614         141 DIKSDNILLSKDGS--VKLADFGFAAQLT  167 (286)
T ss_pred             CCChhhEEEcCCCC--EEECccchhhhhc
Confidence            99999999998777  9999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	481
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-33
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-27
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		7e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-27
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-25
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-25
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-25
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-25
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-25
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-25
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-25
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-25
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-25
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		8e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-24
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-24
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-24
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-24
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-24
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-24
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-24
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-07
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-24
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-24
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-24
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-24
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-24
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		8e-24
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-24
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		8e-24
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-24
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-07
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-24
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-24
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-24
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		8e-24
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-24
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		8e-24
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		8e-24
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-24
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-24
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-23
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-23
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-23
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-23
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-23
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-23
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-23
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-23
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-22
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-16
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-16
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-15
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-14
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-14
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		9e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-14
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-14
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		7e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		9e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-10
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-13
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-13
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-12
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		3e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-12
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		7e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-11
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-11
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-10
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		6e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-10
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		8e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-10
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		7e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-10
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		9e-04
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		6e-10
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-10
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-10
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-10
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-10
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		8e-10
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		9e-10
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-10
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-09
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-09
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-09
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-09
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-09
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-09
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-09
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-09
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-09
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-09
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-09
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-09
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		9e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-09
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-09
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-09
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-09
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		5e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		7e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		4e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-08
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-05
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		3e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-05
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		9e-06
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-06
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		9e-06
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		4e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		4e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		4e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-05
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		6e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-07
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-07
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-07
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-07
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-07
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-07
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-07
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-07
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		6e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-07
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-07
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-07
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-07
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-07
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-07
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-07
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		9e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-07
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		9e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-06
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-06
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		9e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-05
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-05
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-05
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-05
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-05
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-05
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		6e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		7e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		8e-05
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-04
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-04
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-04
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-04
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-04
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-04
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-04
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-04
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-04
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-04
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-04
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-04
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-04
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-04
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-04
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-04
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-04
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-04
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-04
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-04
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-04
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-04
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-04
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-04
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-04
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-04
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-04
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-04
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-04
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-04
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		3e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-04
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-04
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-04
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		6e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		8e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-04

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  140 bits (354), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 67/114 (58%), Positives = 87/114 (76%), Gaps = 2/114 (1%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+  DL QY++     ++ 
Sbjct: 40  EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINM 99
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           HN++LF+FQLLRGL+YCHR+++LHRD+KPQNLLI+E     ++L  F L R  S
Sbjct: 100 HNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE--RGELKLADFGLARAKS 151

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 31/41 (75%), Positives = 35/41 (85%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+
Sbjct: 42  GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 58/140 (41%), Positives = 87/140 (62%), Gaps = 5/140 (3%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+   DL +Y +  +G LD   
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI 102
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY---CHRR 381
           ++ F+FQLL+GL +CH R +LHRD+KPQNLLI+   +  ++L  F L R       C+  
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLANFGLARAFGIPVRCYSA 160
Query: 382 RILHRDVKPQNLLISEIVFT 401
            ++    +P ++L    +++
Sbjct: 161 EVVTLWYRPPDVLFGAKLYS 180

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 24/41 (58%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+ 
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 58/140 (41%), Positives = 87/140 (62%), Gaps = 5/140 (3%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+   DL +Y +  +G LD   
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI 102
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY---CHRR 381
           ++ F+FQLL+GL +CH R +LHRD+KPQNLLI+   +  ++L  F L R       C+  
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR--NGELKLADFGLARAFGIPVRCYSA 160
Query: 382 RILHRDVKPQNLLISEIVFT 401
            ++    +P ++L    +++
Sbjct: 161 EVVTLWYRPPDVLFGAKLYS 180

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 24/41 (58%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+ 
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 61/137 (44%), Positives = 87/137 (63%), Gaps = 7/137 (5%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 304
           LN    V+   KE     + G P TAIRE SL+KELKH NIV L+D++HT + LT VFE+
Sbjct: 25  LNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF 84
Query: 305 VHTDLSQYMERHS-----GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEI 359
           +  DL +YM+  +      GL+ + ++ F +QLL+GL++CH  +ILHRD+KPQNLLI++ 
Sbjct: 85  MDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK- 143
Query: 360 DHHNIRLFMFQLLRGLS 376
               ++L  F L R   
Sbjct: 144 -RGQLKLGDFGLARAFG 159

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 26/41 (63%), Positives = 33/41 (80%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SL+KELKH NIV L+D++HT + LT VFE++
Sbjct: 45  GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/175 (38%), Positives = 86/175 (49%), Gaps = 57/175 (32%)
Query: 30  ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD 89
           + RVL R+ KP      + +N+      ELK+ADFGLARA  +P   Y+H          
Sbjct: 118 DRRVLHRDLKP----QNLLINREG----ELKIADFGLARAFGIPVRKYTH---------- 159
Query: 90  AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS 149
                                                 E +TLWYR PDVL+GS +YST+
Sbjct: 160 --------------------------------------EVVTLWYRAPDVLMGSKKYSTT 181
Query: 150 LDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYN 204
           +D+W VGCI  EMV G P FPGV E  DQL +IF+ILGTP  + W  V+ LP Y+
Sbjct: 182 IDIWSVGCIFAEMVNGAPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPKYD 235

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 54/117 (46%), Positives = 77/117 (65%), Gaps = 2/117 (1%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++  DL + ++   GGL+   
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT 101
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR 381
            + F+ QLL G++YCH RR+LHRD+KPQNLLI+      +++  F L R      R+
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRK 156

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 24/41 (58%), Positives = 32/41 (78%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 57/125 (45%), Positives = 81/125 (64%), Gaps = 7/125 (5%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG 319
           +    G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++  DL + ++ +  G
Sbjct: 56  DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG 115
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL---- 375
           L    I+++++QLLRG+++CH+ RILHRD+KPQNLLI+      ++L  F L R      
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPV 173
Query: 376 -SYCH 379
            SY H
Sbjct: 174 RSYTH 178

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 31/41 (75%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/175 (38%), Positives = 86/175 (49%), Gaps = 57/175 (32%)
Query: 30  ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD 89
           + RVL R+ KP      + +N+      ELK+ADFGLARA  +P   Y+H          
Sbjct: 118 DRRVLHRDLKP----QNLLINREG----ELKIADFGLARAFGIPVRKYTH---------- 159
Query: 90  AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS 149
                                                 E +TLWYR PDVL+GS +YST+
Sbjct: 160 --------------------------------------EVVTLWYRAPDVLMGSKKYSTT 181
Query: 150 LDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYN 204
           +D+W VGCI  EMV G P FPGV E  DQL +IF+ILGTP  + W  V+ LP Y+
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPKYD 235

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 54/117 (46%), Positives = 77/117 (65%), Gaps = 2/117 (1%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++  DL + ++   GGL+   
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT 101
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR 381
            + F+ QLL G++YCH RR+LHRD+KPQNLLI+      +++  F L R      R+
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRK 156

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 24/41 (58%), Positives = 32/41 (78%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 57/125 (45%), Positives = 81/125 (64%), Gaps = 7/125 (5%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG 319
           +    G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++  DL + ++ +  G
Sbjct: 56  DAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTG 115
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL---- 375
           L    I+++++QLLRG+++CH+ RILHRD+KPQNLLI+      ++L  F L R      
Sbjct: 116 LQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS--DGALKLADFGLARAFGIPV 173
Query: 376 -SYCH 379
            SY H
Sbjct: 174 RSYTH 178

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 31/41 (75%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 67/175 (38%), Positives = 86/175 (49%), Gaps = 57/175 (32%)
Query: 30  ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD 89
           + RVL R+ KP      + +N+      ELK+ADFGLARA  +P   Y+H          
Sbjct: 118 DRRVLHRDLKP----QNLLINREG----ELKIADFGLARAFGIPVRKYTH---------- 159
Query: 90  AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS 149
                                                 E +TLWYR PDVL+GS +YST+
Sbjct: 160 --------------------------------------EIVTLWYRAPDVLMGSKKYSTT 181
Query: 150 LDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYN 204
           +D+W VGCI  EMV G P FPGV E  DQL +IF+ILGTP  + W  V+ LP Y+
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPKYD 235

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 54/117 (46%), Positives = 77/117 (65%), Gaps = 2/117 (1%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++  DL + ++   GGL+   
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVT 101
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR 381
            + F+ QLL G++YCH RR+LHRD+KPQNLLI+      +++  F L R      R+
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR--EGELKIADFGLARAFGIPVRK 156

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 24/41 (58%), Positives = 32/41 (78%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 57/113 (50%), Positives = 76/113 (67%), Gaps = 3/113 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
             I+ ++FQLL+GLS+CH  R+LHRD+KPQNLLI+      I+L  F L R  
Sbjct: 103 PLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAF 153

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/113 (49%), Positives = 76/113 (67%), Gaps = 3/113 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R  
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAF 153

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 104
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 156

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 86

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 109
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 110 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 161

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 51  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 91

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 50  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 109
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 110 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 161

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 51  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 91

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/113 (49%), Positives = 76/113 (67%), Gaps = 3/113 (2%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHH 323
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+   
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLP 103
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 154

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/113 (49%), Positives = 76/113 (67%), Gaps = 3/113 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R  
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAF 153

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 157

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 87

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 104
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 156

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 86

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 157

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 87

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 106
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 107 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 158

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 48  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 88

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 154

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 103
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 155

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 85

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/113 (49%), Positives = 76/113 (67%), Gaps = 3/113 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R  
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAF 153

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 103
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 155

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 85

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 154

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 154

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 154

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 103
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 155

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 85

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 47  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 106
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 107 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 158

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 48  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 88

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 57/114 (50%), Positives = 75/114 (65%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE+VH DL  +M+  +  G+  
Sbjct: 42  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPL 101
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 153

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/41 (63%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE+V
Sbjct: 43  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV 83

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 75/114 (65%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL  +M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 157

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 87

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/114 (48%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 45  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 104
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KP+NLLI+      I+L  F L R   
Sbjct: 105 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT--EGAIKLADFGLARAFG 156

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 86

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 55/114 (48%), Positives = 76/114 (66%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+  
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL 103
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KP+NLLI+      I+L  F L R   
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT--EGAIKLADFGLARAFG 155

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 85

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 55/113 (48%), Positives = 75/113 (66%), Gaps = 3/113 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL  +M+  +  G+  
Sbjct: 43  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPL 102
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
             I+ ++FQLL+GL++CH  R+LHRD+KP+NLLI+      I+L  F L R  
Sbjct: 103 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT--EGAIKLADFGLARAF 153

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 56/114 (49%), Positives = 75/114 (65%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE+V  DL ++M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 157

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/41 (63%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE+V
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV 87

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 55/114 (48%), Positives = 74/114 (64%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++  DL  +M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 157

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 87

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 55/113 (48%), Positives = 74/113 (65%), Gaps = 3/113 (2%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHH 323
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++  DL  +M+  +  G+   
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLP 105
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+      I+L  F L R   
Sbjct: 106 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT--EGAIKLADFGLARAFG 156

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 46  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 86

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/114 (47%), Positives = 75/114 (65%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++  DL ++M+  +  G+  
Sbjct: 46  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL 105
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KP+NLLI+      I+L  F L R   
Sbjct: 106 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT--EGAIKLADFGLARAFG 157

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 47  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 87

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 54/114 (47%), Positives = 75/114 (65%), Gaps = 3/114 (2%)
Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDH 322
            G P TAIRE SLLKEL H NIV L D++HT + L  VFE++  DL ++M+  +  G+  
Sbjct: 44  EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPL 103
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I+ ++FQLL+GL++CH  R+LHRD+KP+NLLI+      I+L  F L R   
Sbjct: 104 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINT--EGAIKLADFGLARAFG 155

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 25/41 (60%), Positives = 30/41 (73%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 45  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 85

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 47/98 (47%), Positives = 67/98 (68%), Gaps = 1/98 (1%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G P TAIRE SLLKEL+H NI+ L  ++H    L  +FEY   DL +YM+++   +  
Sbjct: 73  EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSM 131
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             I+ F++QL+ G+++CH RR LHRD+KPQNLL+S  D
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSD 169

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 22/41 (53%), Positives = 27/41 (65%)
Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL+H NI+ L  ++H    L  +FEY 
Sbjct: 75  GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 67/152 (44%), Gaps = 49/152 (32%)
Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKLADFGLA++   P+  Y HQ                                      
Sbjct: 151 LKLADFGLAKSFGSPNRAYXHQV------------------------------------- 173
Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ 178
                      +T WYR P++L G+  Y   +DMW VGCIL E++  +P  PG  ++ DQ
Sbjct: 174 -----------VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQ 221
Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNVHRDAP 210
           L +IF+ LGTPTEE W  +  LP Y   +  P
Sbjct: 222 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 253

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 41/96 (42%), Positives = 61/96 (63%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K+G   TA+RE  LL+EL H NI+ L D    +S ++ VF+++ TDL   ++ +S  L  
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 111
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +I+ +M   L+GL Y H+  ILHRD+KP NLL+ E
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 147

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/124 (38%), Positives = 72/124 (58%), Gaps = 11/124 (8%)
Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  DL+ Y++
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 110
Query: 315 R-HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++      I+L  F L R
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLAR 168
Query: 374 GLSY 377
             S+
Sbjct: 169 IYSF 172

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/124 (38%), Positives = 72/124 (58%), Gaps = 11/124 (8%)
Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  DL+ Y++
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 110
Query: 315 R-HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++      I+L  F L R
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLAR 168
Query: 374 GLSY 377
             S+
Sbjct: 169 IYSF 172

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/124 (38%), Positives = 72/124 (58%), Gaps = 11/124 (8%)
Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  DL+ Y++
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 110
Query: 315 R-HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++      I+L  F L R
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS--SGQIKLADFGLAR 168
Query: 374 GLSY 377
             S+
Sbjct: 169 IYSF 172

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 58/89 (65%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
           A+RE  LLK+L+H N+V L ++   +     VFE+V   +   +E    GLD+  ++ ++
Sbjct: 71  AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL 130
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           FQ++ G+ +CH   I+HRD+KP+N+L+S+
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQ 159

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 66/121 (54%), Gaps = 14/121 (11%)
Query: 97  LGEGSYATVFK----GYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
           +GEG      K    G++ L N    LK +   +   +T WYR P++LLG+  Y+ ++D+
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS--PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 219
Query: 153 WGVGCILIEMVTGLPTFPGVREV--------YDQLDKIFKILGTPTEETWEGVSLLPGYN 204
           W +GCI  E++T  P F   +E         +DQLD+IF ++G P ++ WE +  +P ++
Sbjct: 220 WAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279
Query: 205 V 205
Sbjct: 280 T 280

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 54/102 (52%), Gaps = 10/102 (9%)
Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGG--- 319
           G   +A RE +LL+ELKH N+++L  +   H    +  +F+Y   DL   ++ H      
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119
Query: 320 -----LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                L    ++  ++Q+L G+ Y H   +LHRD+KP N+L+
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 161

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 2/107 (1%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
           A+RE  +LK+LKH N+V L ++   +  L  VFEY    +   ++R+  G+  H ++   
Sbjct: 49  ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT 108
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +Q L+ +++CH+   +HRDVKP+N+LI++  H  I+L  F   R L+
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITK--HSVIKLCDFGFARLLT 153

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/127 (37%), Positives = 71/127 (55%), Gaps = 12/127 (9%)
Query: 260 NGPKNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQ 311
           NG + G P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V  DL  
Sbjct: 41  NG-EEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT 99
Query: 312 YMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQ 370
           Y+++    GL    I+  M Q LRGL + H   I+HRD+KP+N+L++      ++L  F 
Sbjct: 100 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFG 157
Query: 371 LLRGLSY 377
           L R  SY
Sbjct: 158 LARIYSY 164

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/127 (37%), Positives = 71/127 (55%), Gaps = 12/127 (9%)
Query: 260 NGPKNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQ 311
           NG + G P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V  DL  
Sbjct: 41  NG-EEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT 99
Query: 312 YMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQ 370
           Y+++    GL    I+  M Q LRGL + H   I+HRD+KP+N+L++      ++L  F 
Sbjct: 100 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFG 157
Query: 371 LLRGLSY 377
           L R  SY
Sbjct: 158 LARIYSY 164

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/127 (37%), Positives = 71/127 (55%), Gaps = 12/127 (9%)
Query: 260 NGPKNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQ 311
           NG + G P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V  DL  
Sbjct: 41  NG-EEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT 99
Query: 312 YMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQ 370
           Y+++    GL    I+  M Q LRGL + H   I+HRD+KP+N+L++      ++L  F 
Sbjct: 100 YLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFG 157
Query: 371 LLRGLSY 377
           L R  SY
Sbjct: 158 LARIYSY 164

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 176

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 195 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 253
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 254 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 307

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 70  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 128
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 129 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 184

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 132 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 163

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 180 VSYICSR 186

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 257
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 258 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 311

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 132
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 188

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 167

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 188 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 246
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 247 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 300

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 121
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 122 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 177

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 125 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 156

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 180 VSYICSR 186

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 64/117 (54%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D+V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 176

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 199 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 257
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 258 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 311

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 132
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 188

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 136 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 167

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 176

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 206 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 264
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 265 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 318

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 81  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 139
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 140 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 195

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 143 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 174

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 191 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 249
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 250 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 303

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 124
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 125 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 180

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 128 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 159

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 200 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 258
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 259 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 312

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 75  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 133
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 134 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 192
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 193 VSYICSR 199

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 137 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 168

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 215 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 273
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 274 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 327

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 90  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 148
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 149 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 207
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 208 VSYICSR 214

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 152 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 183

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 279
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 280 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 333

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/117 (35%), Positives = 63/117 (53%), Gaps = 16/117 (13%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 154
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 210

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 192 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 250
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 251 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 304

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 67  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 125
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 126 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 184
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 185 VSYICSR 191

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 129 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 160

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 279
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 280 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 333

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 154
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 214 VSYICSR 220

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 223 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 281
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 282 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 335

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 98  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 156
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 157 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 215
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 216 VSYICSR 222

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 160 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 191

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 225 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 283
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 284 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 337

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 100 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 158
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 159 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 217
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 218 VSYICSR 224

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 162 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 193

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 65/117 (55%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 266 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 324
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y   +      +     F R    PE  ++ S  L+    A L P+E
Sbjct: 325 QIREMN--PNYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 378

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 141 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 199
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 200 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 258
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 259 VSYICSR 265

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 203 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 234

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y          +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFAFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/127 (35%), Positives = 68/127 (53%), Gaps = 20/127 (15%)
Query: 272 REASLLKELKHNNIVTLH----------DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLD 321
           RE  ++++L H NIV L           D V+    L +V E V+  ++++  R    L 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYR-VARHYSRAKQTLP 120
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG--- 374
              ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG   
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRGEPN 179
Query: 375 LSY-CHR 380
           +SY C R
Sbjct: 180 VSYICSR 186

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 6/111 (5%)
Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           E   T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  IL
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGIL 264
Query: 187 GTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           G+P++E    +  +   N  +  P   +K  + + +L+  P+ +S A   L
Sbjct: 265 GSPSQEDLNCIINMKARNYLQSLP---SKTKVAWAKLF--PKSDSKALDLL 310

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 22/151 (14%)
Query: 216 LGLTFPRLYDIPEGE--SMASAFLQVRDAAI----LNPMEHVHNCEKEGGNGPKNGAPFT 269
           +G  + +L  I EG    ++SA+  VR   +    ++P EH   C++             
Sbjct: 41  VGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQR------------- 87
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQ---YMERHSGGLDHHNIR 326
            +RE  +L   +H N++ + DI+   +       Y+  DL +   Y    S  L + +I 
Sbjct: 88  TLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHIC 147
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            F++Q+LRGL Y H   +LHRD+KP NLLI+
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLIN 178

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/117 (35%), Positives = 64/117 (54%), Gaps = 4/117 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTRE 245
Query: 193 TWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPME 249
               ++  P Y          +     F R    PE  ++ S  L+    A L P+E
Sbjct: 246 QIREMN--PNYTEFAFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEYTPTARLTPLE 299

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 61/116 (52%), Gaps = 14/116 (12%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDL---SQYMERHSGGLDH 322
           RE  ++++L H NIV L    ++         L  V +YV   +   +++  R    L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPV 121
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF----QLLRG 374
             ++L+M+QL R L+Y H   I HRD+KPQNLL+ + D   ++L  F    QL+RG
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL-DPDTAVLKLCDFGSAKQLVRG 176

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 18/32 (56%), Positives = 25/32 (78%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 124 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 155

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 67/120 (55%), Gaps = 11/120 (9%)
Query: 267 PFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSG 318
           P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V  DL  Y+++   
Sbjct: 55  PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPP 114
Query: 319 -GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
            GL    I+  M Q LRGL + H   I+HRD+KP+N+L++      ++L  F L R  SY
Sbjct: 115 PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS--GGTVKLADFGLARIYSY 172

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/111 (37%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           E   T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  IL
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGIL 248
Query: 187 GTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           G+P++E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 GSPSQEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 60  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 107 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 42/111 (37%), Positives = 61/111 (54%), Gaps = 6/111 (5%)
Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           E   T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  IL
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGIL 249
Query: 187 GTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           G+P++E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 250 GSPSQEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 295

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 61  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 107
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 108 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 163

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 252
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 253 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 60  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 107 IVQDLMETDLYKLLKCQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 252
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 253 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 60  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 107 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 248
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 290

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 56  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 158

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 250
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 251 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 292

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 58  ISPFEHQTYCQR-------------TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVY 104
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 105 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 160

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 253
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 254 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 295

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 61  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 107
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 108 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 163

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 252
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 253 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 60  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 107 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 254
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 255 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 296

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 62  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 108
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 109 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 164

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 245
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 246 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 287

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 53  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 99
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 100 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 155

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 252
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 253 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 60  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 107 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 248
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 290

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 56  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 158

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 250
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 251 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 292

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 26/153 (16%)
Query: 216 LGLTFPRLYDIPEGE--SMASAFLQVRDAAI----LNPMEHVHNCEKEGGNGPKNGAPFT 269
           +G  +  L  I EG    + SA+  V    +    ++P EH   C++             
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------- 69
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +      +  V + + TDL + ++      DH  
Sbjct: 70  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH-- 127
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 160

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 246
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 247 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 288

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 54  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 100
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 101 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 156

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 252
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 253 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 294

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 53/93 (56%), Gaps = 7/93 (7%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +      +  V + + TDL + ++      DH  
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH-- 129
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 162

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 248
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 QEDLNXIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 290

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 56  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 158

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 248
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 QEDLNXIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 290

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 56  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 158

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 256
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 257 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 298

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 64  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 110
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 111 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 166

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 248
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 249 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 290

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 56  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 102
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 103 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 158

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 268
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 269 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 310

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 216 LGLTFPRLYDIPEGE--SMASAFLQVRDAAI----LNPMEHVHNCEKEGGNGPKNGAPFT 269
           +G  +  L  I EG    + SA+  V    +    ++P EH   C++             
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------- 87
Query: 270 AIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVH---TDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   T   +  V+   H    DL + ++      DH  
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDH-- 145
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 178

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 60/107 (56%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 268
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 269 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 310

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 26/153 (16%)
Query: 216 LGLTFPRLYDIPEGE--SMASAFLQVRDAAI----LNPMEHVHNCEKEGGNGPKNGAPFT 269
           +G  +  L  I EG    + SA+  V    +    ++P EH   C++             
Sbjct: 41  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------- 87
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +      +  V + + TDL + ++      DH  
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH-- 145
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 178

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 33/70 (47%), Positives = 48/70 (68%), Gaps = 2/70 (2%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P+
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPS 250
Query: 191 EETWE-GVSL 199
           +E    G++L
Sbjct: 251 QEDLNCGINL 260

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 26/153 (16%)
Query: 216 LGLTFPRLYDIPEGE--SMASAFLQVRDAAI----LNPMEHVHNCEKEGGNGPKNGAPFT 269
           +G  +  L  I EG    + SA+  V    +    ++P EH   C++             
Sbjct: 23  VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR------------- 69
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +      +  V + + TDL + ++      DH  
Sbjct: 70  TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH-- 127
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 160

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 30/67 (44%), Positives = 45/67 (67%), Gaps = 1/67 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P++LLGST+Y+  +DMW +GCIL E++ G P FPG     +QL++I  ++  P+
Sbjct: 193 TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG-SSTMNQLERIIGVIDFPS 251
Query: 191 EETWEGV 197
            E  E +
Sbjct: 252 NEDVESI 258

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 65/115 (56%), Gaps = 9/115 (7%)
Query: 272 REASLLKELK-HNNIVTLHDIVHTRST--LTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           RE  +L EL  H NIV L +++   +   +  VF+Y+ TDL   +   +  L+  + +  
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQYV 114
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           ++QL++ + Y H   +LHRD+KP N+L++   H  +++  F L R  S+ + RR+
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSR--SFVNIRRV 165

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 41/107 (38%), Positives = 59/107 (55%), Gaps = 6/107 (5%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P 
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPE 246
Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           +E    +  L   N     P+   K  + + RL+  P  +S A   L
Sbjct: 247 QEDLNCIINLKARNYLLSLPH---KNKVPWNRLF--PNADSKALDLL 288

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 36/118 (30%), Positives = 61/118 (51%), Gaps = 20/118 (16%)
Query: 245 LNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST-----LT 299
           ++P EH   C++              +RE  +L   +H NI+ ++DI+   +      + 
Sbjct: 54  ISPFEHQTYCQR-------------TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 100
Query: 300 FVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            V + + TDL + ++      DH  I  F++Q+LRGL Y H   +LHRD+KP NLL++
Sbjct: 101 IVQDLMETDLYKLLKTQHLSNDH--ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 156

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 60/100 (60%), Gaps = 3/100 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S L+ L+H +I+ L+D++ ++  +  V EY   +L  Y+ +    +     R F  Q
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQ 121
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++  + YCHR +I+HRD+KP+NLL+ E  H N+++  F L
Sbjct: 122 IISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 159

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 60/100 (60%), Gaps = 3/100 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S L+ L+H +I+ L+D++ ++  +  V EY   +L  Y+ +    +     R F  Q
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQ 115
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++  + YCHR +I+HRD+KP+NLL+ E  H N+++  F L
Sbjct: 116 IISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 153

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 60/100 (60%), Gaps = 3/100 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S L+ L+H +I+ L+D++ ++  +  V EY   +L  Y+ +    +     R F  Q
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQ 120
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++  + YCHR +I+HRD+KP+NLL+ E  H N+++  F L
Sbjct: 121 IISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 158

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 60/100 (60%), Gaps = 3/100 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S L+ L+H +I+ L+D++ ++  +  V EY   +L  Y+ +    +     R F  Q
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDK-MSEQEARRFFQQ 111
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++  + YCHR +I+HRD+KP+NLL+ E  H N+++  F L
Sbjct: 112 IISAVEYCHRHKIVHRDLKPENLLLDE--HLNVKIADFGL 149

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 68/114 (59%), Gaps = 13/114 (11%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF--------VFEYVHTDLSQYMERHSGGLDH 322
           +RE  +LK  KH+NI+ + DI+  R T+ +        V + + +DL Q +   S  L  
Sbjct: 102 LRELKILKHFKHDNIIAIKDIL--RPTVPYGEFKSVYVVLDLMESDLHQIIH-SSQPLTL 158
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            ++R F++QLLRGL Y H  +++HRD+KP NLL++E  +  +++  F + RGL 
Sbjct: 159 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCELKIGDFGMARGLC 210

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/114 (35%), Positives = 68/114 (59%), Gaps = 13/114 (11%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF--------VFEYVHTDLSQYMERHSGGLDH 322
           +RE  +LK  KH+NI+ + DI+  R T+ +        V + + +DL Q +   S  L  
Sbjct: 101 LRELKILKHFKHDNIIAIKDIL--RPTVPYGEFKSVYVVLDLMESDLHQIIH-SSQPLTL 157
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            ++R F++QLLRGL Y H  +++HRD+KP NLL++E  +  +++  F + RGL 
Sbjct: 158 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE--NCELKIGDFGMARGLC 209

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 51/75 (68%), Gaps = 3/75 (4%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T Y+T++D+W  GC++ E++ G P FPG   + DQL +I K+LGTP+ E
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSRE 264
Query: 193 TWEGVSLLPGYNVHR 207
             + ++  P Y  H+
Sbjct: 265 QIKTMN--PNYMEHK 277

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHSGGLDHHN- 324
           RE  +++ +KH N+V L    ++         L  V EYV   + +   RH   L     
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR-ASRHYAKLKQTMP 139
Query: 325 ---IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
              I+L+M+QLLR L+Y H   I HRD+KPQNLL+
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 20/32 (62%), Positives = 26/32 (81%)
Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           I+L+M+QLLR L+Y H   I HRD+KPQNLL+
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 61/105 (58%), Gaps = 16/105 (15%)
Query: 270 AIREASLLKELKHNNIVTLHDIVH-TRSTLT-------------FVFEYVHTDLSQYMER 315
           A+RE  +++ L H+NIV + +I+  + S LT              V EY+ TDL+  +E+
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             G L   + RLFM+QLLRGL Y H   +LHRD+KP NL I+  D
Sbjct: 115 --GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++   DL+  + 
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLS 116
Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+      ++L  F L R 
Sbjct: 117 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARA 174
Query: 375 LSYC-------HRRRILHRDVKPQNLLISE 397
            S         +  R++    +P  LL+ E
Sbjct: 175 FSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++   DL+  + 
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 116
Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+      ++L  F L R 
Sbjct: 117 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARA 174
Query: 375 LSYC-------HRRRILHRDVKPQNLLISE 397
            S         +  R++    +P  LL+ E
Sbjct: 175 FSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 28/60 (46%), Positives = 45/60 (75%), Gaps = 1/60 (1%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++LG+TEY+ S+D+W +GC+  E++ G P F G   + DQL +I +I+GTPT+E
Sbjct: 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKE 264

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 2/127 (1%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE  ++K L H NI+ L D  +T             D ++   +++G  +HH   +    
Sbjct: 49  RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 332 LLRGLSYC--HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
             + L+    +    LH+ +K        I  + I ++++QL R + + H   I HRD+K
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 390 PQNLLIS 396
           PQNLL++
Sbjct: 169 PQNLLVN 175

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++   DL+  + 
Sbjct: 57  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 116
Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+      ++L  F L R 
Sbjct: 117 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARA 174
Query: 375 LSYC-------HRRRILHRDVKPQNLLISE 397
            S         +  R++    +P  LL+ E
Sbjct: 175 FSLAKNSQPNRYXNRVVTLWYRPPELLLGE 204

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 17/150 (11%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++   DL+  + 
Sbjct: 56  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 115
Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+      ++L  F L R 
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARA 173
Query: 375 LSYC-------HRRRILHRDVKPQNLLISE 397
            S         +  R++    +P  LL+ E
Sbjct: 174 FSLAKNSQPNRYXNRVVTLWYRPPELLLGE 203

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/100 (36%), Positives = 59/100 (59%), Gaps = 3/100 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S LK L+H +I+ L+D++ T + +  V EY   +L  Y+       +    R F  Q
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQ-Q 116
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           ++  + YCHR +I+HRD+KP+NLL+   D+ N+++  F L
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLD--DNLNVKIADFGL 154

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 45/68 (66%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L +  Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP- 189
           T WYR P+V+L S +YS ++D+W  GCIL E+    P FPG R+   QL  IF I+GTP 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPH 243
Query: 190 TEETWEGVSLLPGYNVHRDAP-YTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPM 248
           ++     +         +  P Y    L   FPR+   P+G  +    L    A  +   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN--PKGIDLLQRMLVFDPAKRITAK 301
Query: 249 E----------HVHNCEKEGGNGPKNGAPFTAIREASLLKELK 281
           E          H  N E EG   P +   F   +EA   K+LK
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLK 344

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  +LK  KH NI+T+ +I    S   F     + E + TDL + +       DH  I
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH--I 114
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           + F++Q LR +   H   ++HRD+KP NLLI+
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/167 (32%), Positives = 74/167 (44%), Gaps = 15/167 (8%)
Query: 127 EEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           E   T WYR P+V+L S +YS ++D+W  GCIL E+    P FPG R+   QL  IF I+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGII 239
Query: 187 GTP-TEETWEGVSLLPGYNVHRDAP-YTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAI 244
           GTP ++     +         +  P Y    L   FPR+   P+G  +    L    A  
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN--PKGIDLLQRMLVFDPAKR 297
Query: 245 LNPME----------HVHNCEKEGGNGPKNGAPFTAIREASLLKELK 281
           +   E          H  N E EG   P +   F   +EA   K+LK
Sbjct: 298 ITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLK 344

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 50/92 (54%), Gaps = 7/92 (7%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  +LK  KH NI+T+ +I    S   F     + E + TDL + +       DH  I
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH--I 114
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           + F++Q LR +   H   ++HRD+KP NLLI+
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP- 189
           T WYR P+V+L S +YS ++D+W  GCIL E+    P FPG R+   QL  IF I+GTP 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRHQLLLIFGIIGTPH 243
Query: 190 TEETWEGVSLLPGYNVHRDAP-YTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPM 248
           ++     +         +  P Y    L   FPR+   P+G  +    L    A  +   
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVN--PKGIDLLQRMLVFDPAKRITAK 301
Query: 249 E----------HVHNCEKEGGNGPKNGAPFTAIREASLLKELK 281
           E          H  N E EG   P +   F   +EA   K+LK
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLK 344

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 7/93 (7%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +LK  KH NI+T+ +I    S   F     + E + TDL + +       DH  
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH-- 113
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           I+ F++Q LR +   H   ++HRD+KP NLLI+
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN 146

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 249
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 250 AELLKKIS 257

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 124 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 166

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 249
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 250 AELLKKIS 257

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 263 KNGAPFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DL 309
           K   PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL
Sbjct: 60  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 119
Query: 310 SQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 120 NNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 166

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 239
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 240 AELLKKIS 247

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 263 KNGAPFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DL 309
           K   PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL
Sbjct: 54  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 310 SQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 NNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 248
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 249 AELLKKIS 256

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 263 KNGAPFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DL 309
           K   PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL
Sbjct: 59  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 118
Query: 310 SQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 119 NNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 165

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 253
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 254 AELLKKIS 261

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 68  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 127
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 128 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 170

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 250
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 251 AELLKKIS 258

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 124
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 125 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 248
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 249 AELLKKIS 256

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 122
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 123 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DXELKILDFGLAR 178

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 248
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 249 AELLKKIS 256

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 122
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 123 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DXELKILDFGLAR 178

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KXQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 239
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 240 AELLKKIS 247

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 KCAKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 239
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 240 AELLKKIS 247

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 118 KXQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DXELKILDFGLAR 173

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 266
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 267 AELLKKIS 274

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 81  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 140
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 141 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 183

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 250
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 251 AELLKKIS 258

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 124
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 125 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 250
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 251 AELLKKIS 258

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 124
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 125 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 263
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 264 AELLKKIS 271

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 138 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 180

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 263 KNGAPFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DL 309
           K   PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL
Sbjct: 54  KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 113
Query: 310 SQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 NNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 248
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 249 AELLKKIS 256

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 63  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 122
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 123 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 165

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 249
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 250 AELLKKIS 257

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 124 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DSELKILDFGLAR 179

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 242
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 243 AELLKKIS 250

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 57  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 116
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 117 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 159

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 250
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 251 AELLKKIS 258

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 65  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 124
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 125 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 245
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 246 AELLKKIS 253

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 119
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 120 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 162

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 239
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 240 AELLKKIS 247

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 54  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 113
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 114 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 156

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 240
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 241 AELLKKIS 248

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 55  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 114
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 115 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 157

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 262
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 263 AELLKKIS 270

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 136
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 137 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 179

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 245
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 246 AELLKKIS 253

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 119
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 120 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DSELKILDFGLAR 175

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 254
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 255 AELLKKIS 262

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 69  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 128
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 129 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DXELKILDFGLAR 184

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 263
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 264 AELLKKIS 271

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 138 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 180

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 41/120 (34%), Positives = 62/120 (51%), Gaps = 17/120 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 118 KSQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE--DSELKILDFGLCR 173

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 249
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 250 AELLKKIS 257

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 64  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 123
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 124 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 166

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 254
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 255 AELLKKIS 262

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 69  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 128
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 129 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 171

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 241
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 242 AELLKKIS 249

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 56  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 115
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 116 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 158

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 240
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 241 AELLKKIS 248

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 55  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 114
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 115 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 157

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 245
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 246 AELLKKIS 253

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 119
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 120 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 162

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 255
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 256 AELLKKIS 263

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/109 (35%), Positives = 57/109 (52%), Gaps = 15/109 (13%)
Query: 263 KNGAPFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DL 309
           K   PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL
Sbjct: 66  KLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 125
Query: 310 SQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 126 NNIVKCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 172

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 243
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 244 AELLKKIS 251

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 58  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 117
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 118 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 160

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 266
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 267 AELLKKIS 274

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 81  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 140
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 141 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 183

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 245
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 246 AELLKKIS 253

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 60  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 119
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 120 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 162

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 255
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 256 AELLKKIS 263

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 70  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 129
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 130 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 172

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 263
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 264 AELLKKIS 271

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 78  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 137
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 138 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 180

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 255
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 256 AELLKKIS 263

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVHT-----DLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    RS   F   Y+ T     DL+  +
Sbjct: 70  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 129
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 130 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 172

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + DQL  I +++GTP 
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPG 262
Query: 191 EETWEGVS 198
            E  + +S
Sbjct: 263 AELLKKIS 270

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+     +L        V   +  DL+  +
Sbjct: 77  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV 136
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 137 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 179

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++ G   FPG  +  DQL +I +++GTP+
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG-SDYIDQLKRIMEVVGTPS 241
Query: 191 EETWEGVS 198
            E    +S
Sbjct: 242 PEVLAKIS 249

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 10/108 (9%)
Query: 272 REASLLKELKHNNIVTLHDI------VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI 325
           RE  LLK LKH N++ L D+      +   S +  V   +  DL+  ++     L   ++
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHV 125
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +  ++QLLRGL Y H   I+HRD+KP N+ ++E     +R+  F L R
Sbjct: 126 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DCELRILDFGLAR 171

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++ G   FPG  +  DQL +I +++GTP+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG-SDYIDQLKRIMEVVGTPS 249
Query: 191 EETWEGVS 198
            E    +S
Sbjct: 250 PEVLAKIS 257

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 58/108 (53%), Gaps = 10/108 (9%)
Query: 272 REASLLKELKHNNIVTLHDI------VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI 325
           RE  LLK LKH N++ L D+      +   S +  V   +  DL+  ++  S  L   ++
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--SQALSDEHV 133
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +  ++QLLRGL Y H   I+HRD+KP N+ ++E     +R+  F L R
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DSELRILDFGLAR 179

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 27/68 (39%), Positives = 44/68 (64%), Gaps = 1/68 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++ G   FPG  +  DQL +I +++GTP+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPG-SDYIDQLKRIMEVVGTPS 249
Query: 191 EETWEGVS 198
            E    +S
Sbjct: 250 PEVLAKIS 257

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 10/108 (9%)
Query: 272 REASLLKELKHNNIVTLHDI------VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI 325
           RE  LLK LKH N++ L D+      +   S +  V   +  DL+  ++     L   ++
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVK--CQALSDEHV 133
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +  ++QLLRGL Y H   I+HRD+KP N+ ++E     +R+  F L R
Sbjct: 134 QFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNE--DSELRILDFGLAR 179

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 29/63 (46%), Positives = 41/63 (65%), Gaps = 1/63 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G   + DQL +I K+ GTP
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTP 245
Query: 190 TEE 192
             E
Sbjct: 246 PAE 248

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 59/110 (53%), Gaps = 10/110 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+     TL        V  ++ TDL + M+    G D  
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR- 129
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            I+  ++Q+L+GL Y H   I+HRD+KP NL ++E     +++  F L R
Sbjct: 130 -IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE--DCELKILDFGLAR 176

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 31/57 (54%), Positives = 41/57 (71%), Gaps = 2/57 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +YR P+VLLG   Y  ++DMW +GCIL+EM TG P F G  EV DQ++KI ++LG P
Sbjct: 223 FYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIP 277

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 31/57 (54%), Positives = 41/57 (71%), Gaps = 2/57 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +YR P+VLLG   Y  ++DMW +GCIL+EM TG P F G  EV DQ++KI ++LG P
Sbjct: 223 FYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 31/57 (54%), Positives = 41/57 (71%), Gaps = 2/57 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +YR P+VLLG   Y  ++DMW +GCIL+EM TG P F G  EV DQ++KI ++LG P
Sbjct: 204 FYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEV-DQMNKIVEVLGIP 258

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 52/94 (55%), Gaps = 2/94 (2%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G ++  DQL +I K+ G P
Sbjct: 185 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVP 243
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNK-LGLTFPR 222
             E  + ++     +  +  P T  K     FPR
Sbjct: 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR 277

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+    S+L        V  ++ TDL + M          
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            I+  ++Q+L+GL Y H   ++HRD+KP NL ++E
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 28/63 (44%), Positives = 41/63 (65%), Gaps = 1/63 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G ++  DQL +I K+ G P
Sbjct: 203 VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLDQLTQILKVTGVP 261
Query: 190 TEE 192
             E
Sbjct: 262 GTE 264

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+    S+L        V  ++ TDL + M          
Sbjct: 88  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGME---FSEE 144
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            I+  ++Q+L+GL Y H   ++HRD+KP NL ++E
Sbjct: 145 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 179

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 16/137 (11%)
Query: 250 HVHNCEKEGGNGPKNGAPFTAIR----------EASLLKELKHNNIVTLHDIVHTRSTLT 299
            VH CE E   G K  A     R          E S++ +L H N++ L+D   +++ + 
Sbjct: 104 QVHKCE-ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIV 162
Query: 300 FVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            V EYV  D  +  +R    S  L   +  LFM Q+  G+ + H+  ILH D+KP+N+L 
Sbjct: 163 LVMEYV--DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILC 220
Query: 357 SEIDHHNIRLFMFQLLR 373
              D   I++  F L R
Sbjct: 221 VNRDAKQIKIIDFGLAR 237

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE     +L H NIV++ D+         V EY+    LS+Y+E H G L       F  
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTN 118
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L G+ + H  RI+HRD+KPQN+LI    +  +++F F + + LS
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDS--NKTLKIFDFGIAKALS 162

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 84/224 (37%), Gaps = 60/224 (26%)
Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           +K+ DFGLAR    P +  S    SP        + D +        F    NL  Q+  
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISP--------REDDMN----LVTFPHTKNLKRQLTG 242
Query: 119 LKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL-----------P 167
                      +T WYR P+++L    Y+ ++D+W +GCI  E++  +           P
Sbjct: 243 ---------HVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293
Query: 168 TFPG-------------------VREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRD 208
            FPG                    R   DQL+ IF ILGTP+EE  E +         R 
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353
Query: 209 APY-TGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHV 251
            P   G  L   FP         S A A   ++   + NP + +
Sbjct: 354 FPKREGTDLAERFP--------ASSADAIHLLKRMLVFNPNKRI 389

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 8/112 (7%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE ++L  L H+++V + DIV  +    F     V E   +D  +   R    L   +I
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTELHI 158
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           +  ++ LL G+ Y H   ILHRD+KP N L+++    ++++  F L R + Y
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ--DCSVKVCDFGLARTVDY 208

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 61/104 (58%), Gaps = 9/104 (8%)
Query: 272 REASLLKELKHN-NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRL 327
           RE  +L+ L+   NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR 
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRF 135
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           +M+++L+ L YCH   I+HRDVKP N++I   +H  +RL  + L
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 60/106 (56%), Gaps = 4/106 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE   LK  +H +I+ L+ ++ T S +  V EYV   +L  Y+ + +G LD    R    
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQ 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L G+ YCHR  ++HRD+KP+N+L+    H N ++  F L   +S
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADFGLSNMMS 167

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/118 (33%), Positives = 57/118 (48%), Gaps = 2/118 (1%)
Query: 124 LQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF 183
           + E E +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ 
Sbjct: 181 MMEPEVVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG-RDYIDQWNKVI 238
Query: 184 KILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + LGTP  E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 62/125 (49%), Gaps = 13/125 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR--GLSYCHRR 381
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R  G S+    
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--SDCTLKILDFGLARTAGTSFMMEP 184
Query: 382 RILHR 386
            ++ R
Sbjct: 185 EVVTR 189

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 56/114 (49%), Gaps = 2/114 (1%)
Query: 128 EGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILG 187
           E +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LG
Sbjct: 185 EVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLG 242
Query: 188 TPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           TP  E  + +       V     Y G      FP +    + E  A    Q RD
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARD 296

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 62/125 (49%), Gaps = 13/125 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR--GLSYCHRR 381
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R  G S+    
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--SDCTLKILDFGLARTAGTSFMMTP 184
Query: 382 RILHR 386
            ++ R
Sbjct: 185 EVVTR 189

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 282
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 313

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 164
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS--DXTLKILDFGLAR 174

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 225 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 282
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 283 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 313

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 164
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DCTLKILDFGLAR 212

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 188 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 245
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 276

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 127
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 245
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 246 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 276

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 127
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 245 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 275

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS--DXTLKILDFGLAR 174

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 25/59 (42%), Positives = 40/59 (67%), Gaps = 1/59 (1%)
Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG   + +QL +I ++ GTP
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHI-NQLQQIMRLTGTP 271

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 15/105 (14%)
Query: 267 PFTAI-------REASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYM 313
           PF +I       RE  LLK +KH N++ L D+    ++L        V   +  DL+  +
Sbjct: 87  PFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIV 146
Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +      DH  ++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 147 KCQKLTDDH--VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 189

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 186 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 243
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 244 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 274

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 69  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 125
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 126 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 158

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 237
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 268

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 119
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +   ++Q+L G+ + H   I+HRD+KP N+++ 
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 153

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 180 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 237
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 268

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQME---LDHE 119
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 120 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKS--DXTLKILDFGLAR 167

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 238
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 239 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 269

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 120
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +   ++Q+L G+ + H   I+HRD+KP N+++ 
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 154

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/95 (38%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTP 238
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
             E  + +       V     Y     GLTFP+L+
Sbjct: 239 CPEFMKKLQPTVRNYVENRPKYA----GLTFPKLF 269

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHE 120
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            +   ++Q+L G+ + H   I+HRD+KP N+++ 
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK 154

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 2/96 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           K G      RE  +   L+H NI+ +++  H R  +  + E+    +L + +++H G  D
Sbjct: 55  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFD 113
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                 FM +L   L YCH R+++HRD+KP+NLL+ 
Sbjct: 114 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 149

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 41/73 (56%), Gaps = 8/73 (10%)
Query: 332 LLRGLSYCH-RRRI-LHRDVKPQNLLISEIDHHN------IRLFMFQLLRGLSYCHRRRI 383
           +LR  +Y H R+RI L  +  P+  L  E+  H          FM +L   L YCH R++
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 136
Query: 384 LHRDVKPQNLLIS 396
           +HRD+KP+NLL+ 
Sbjct: 137 IHRDIKPENLLMG 149

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 2/96 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           K G      RE  +   L+H NI+ +++  H R  +  + E+    +L + +++H G  D
Sbjct: 54  KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFD 112
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                 FM +L   L YCH R+++HRD+KP+NLL+ 
Sbjct: 113 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMG 148

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/73 (38%), Positives = 41/73 (56%), Gaps = 8/73 (10%)
Query: 332 LLRGLSYCH-RRRI-LHRDVKPQNLLISEIDHHN------IRLFMFQLLRGLSYCHRRRI 383
           +LR  +Y H R+RI L  +  P+  L  E+  H          FM +L   L YCH R++
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKV 135
Query: 384 LHRDVKPQNLLIS 396
           +HRD+KP+NLL+ 
Sbjct: 136 IHRDIKPENLLMG 148

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  + EY    ++  Y+  H G +     R    
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR 121
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++RI+HRD+K +NLL+    +  I  F F
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  + EY    ++  Y+  H G +     R    
Sbjct: 60  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR 118
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++RI+HRD+K +NLL+    +  I  F F
Sbjct: 119 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 157

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 48  FLNKYATPPRELKLADFGLARAKS---VPSHTYSHQGDSP----FGKADAYIKLDQLGEG 100
           +  + A PP  +K+  F L R+     +PS    H+   P      +AD  +KL   G  
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILI 160
                 K  S     V  +           + +YR P+++ G+  Y+T++D+W VGCI  
Sbjct: 180 ------KKLSPSEPNVAYI----------CSRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223
Query: 161 EMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTF 220
           EM+ G P F G      QL +I ++LG P+ E    ++       H D     +K G+ +
Sbjct: 224 EMMLGEPIFRGDNSA-GQLHEIVRVLGCPSREVLRKLN-----PSHTDVDLYNSK-GIPW 276
Query: 221 PRLY------DIPEGESMASAFLQVRDAAILNPME 249
             ++      D  E   + SA LQ      + P E
Sbjct: 277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 48/105 (45%), Gaps = 17/105 (16%)
Query: 272 REASLLKELK---HNNIVTLHDIVHTRST-------LTFVFEYV----HTDLSQYMERHS 317
           RE  ++++L    H NIV L    +T          L  V EYV    H     Y  R  
Sbjct: 65  RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 318 GGLDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEID 360
                  I++F+FQL+R +   H     + HRD+KP N+L++E D
Sbjct: 125 AP-PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEAD 168

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/91 (41%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N+LI   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVLIDH-EHRKLRLIDWGL 178

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N+LI 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVLID 165

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DATLKILDFGLAR 174

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS--DATLKILDFGLAR 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVK--SDATLKILDFGLAR 174

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 98  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 153
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 154 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 183

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 129 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 170

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 7/129 (5%)
Query: 261 GPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDLSQYMERHSGG 319
             KN    T +RE  LLK+L H NI+ L +I+   S+   V E Y   +L   + +    
Sbjct: 59  SAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRF 118
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQLLRGLSYC 378
            +H   R+   Q+  G++Y H+  I+HRD+KP+N+L+ S+    +I++  F    GLS C
Sbjct: 119 SEHDAARIIK-QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF----GLSTC 173
Query: 379 HRRRILHRD 387
            ++    +D
Sbjct: 174 FQQNTKMKD 182

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/118 (33%), Positives = 56/118 (47%), Gaps = 2/118 (1%)
Query: 124 LQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF 183
           + E E +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ 
Sbjct: 181 MMEPEVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVCHKILFPG-RDYIDQWNKVI 238
Query: 184 KILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + LGTP     + +       V     Y G      FP +    + E       Q RD
Sbjct: 239 EQLGTPCPAFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/125 (27%), Positives = 62/125 (49%), Gaps = 13/125 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR--GLSYCHRR 381
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R  G S+    
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--SDCTLKILDFGLARTAGTSFMMEP 184
Query: 382 RILHR 386
            ++ R
Sbjct: 185 EVVTR 189

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 147
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 148 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 177

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 146
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 147 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 176

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 122 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 163

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 147
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 148 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 177

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 123 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 18/42 (42%), Positives = 29/42 (69%)
Query: 355 LISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           L   +  ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 124 LYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 27/35 (77%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 131 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 189 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 246
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
             E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 247 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 298

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 72  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 128
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 129 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 161

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
             E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/91 (40%), Positives = 54/91 (59%), Gaps = 8/91 (8%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+TL DIV      T   VFE+V+ TD  Q  +     L  ++IR +M+++L+ L YCH
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLRQ----TLTDYDIRFYMYEILKALDYCH 148
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
              I+HRDVKP N++I   +H  +RL  + L
Sbjct: 149 SMGIMHRDVKPHNVMIDH-EHRKLRLIDWGL 178

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 27/35 (77%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR +M+++L+ L YCH   I+HRDVKP N++I 
Sbjct: 131 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 165

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 188 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 245
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
             E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 127
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 181 VTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG-RDYIDQWNKVIEQLGTP 238
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
             E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 239 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 290

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 64  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 120
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 153

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y+ ++D+W VGCI+ E+V G   F G   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E    +       V     Y G K    FP      E E       Q RD
Sbjct: 245 SAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARD 296

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK + H NI++L ++   + TL        V E +  +L Q +      LDH 
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 159

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP
Sbjct: 192 VTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMVCHKILFPG-RDYIDQWNKVIEQLGTP 249
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
             E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 250 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 301

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 75  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 131
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
            +   ++Q+L G+ + H   I+HRD+KP N+++
Sbjct: 132 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 164

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 68/128 (53%), Gaps = 7/128 (5%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDLSQYMERHSGGL 320
            KN    T +RE  LLK+L H NI+ L +I+   S+   V E Y   +L   + +     
Sbjct: 60  AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQLLRGLSYCH 379
           +H   R+   Q+  G++Y H+  I+HRD+KP+N+L+ S+    +I++  F    GLS C 
Sbjct: 120 EHDAARIIK-QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF----GLSTCF 174
Query: 380 RRRILHRD 387
           ++    +D
Sbjct: 175 QQNTKMKD 182

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 68/128 (53%), Gaps = 7/128 (5%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDLSQYMERHSGGL 320
            KN    T +RE  LLK+L H NI+ L +I+   S+   V E Y   +L   + +     
Sbjct: 60  AKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS 119
Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQLLRGLSYCH 379
           +H   R+   Q+  G++Y H+  I+HRD+KP+N+L+ S+    +I++  F    GLS C 
Sbjct: 120 EHDAARIIK-QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF----GLSTCF 174
Query: 380 RRRILHRD 387
           ++    +D
Sbjct: 175 QQNTKMKD 182

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 59/97 (60%), Gaps = 4/97 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE ++L+E++H NI+TLHDI   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 135
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            Q+L G+ Y H +RI H D+KP+N+++ + +  N R+
Sbjct: 136 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 172

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 2/87 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 121
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
           Q++  + YCH++ I+HRD+K +NLL+ 
Sbjct: 122 QIVSAVQYCHQKYIVHRDLKAENLLLD 148

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 59/97 (60%), Gaps = 4/97 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE ++L+E++H NI+TLHDI   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 64  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            Q+L G+ Y H +RI H D+KP+N+++ + +  N R+
Sbjct: 122 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 158

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 59/97 (60%), Gaps = 4/97 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE ++L+E++H NI+TLHDI   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            Q+L G+ Y H +RI H D+KP+N+++ + +  N R+
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 2/99 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 62  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GRMKEKEARAKFR 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 121 QIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGF 159

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 2/87 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  V EY    ++  Y+  H G +     R    
Sbjct: 55  REVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAH-GWMKEKEARAKFR 113
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
           Q++  + YCH++ I+HRD+K +NLL+ 
Sbjct: 114 QIVSAVQYCHQKFIVHRDLKAENLLLD 140

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 61/204 (29%)
Query: 22  LLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG 81
           LL  +   E+ ++ R+ KP    +   LN+  +    +K+ DFGLAR       T + + 
Sbjct: 139 LLGENFIHESGIIHRDLKP----ANCLLNQDCS----VKVCDFGLAR-------TINSEK 183
Query: 82  DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL 141
           D+          ++ L E           NL  Q+ +           +T WYR P+++L
Sbjct: 184 DTNI--------VNDLEENEEPGPHN--KNLKKQLTS---------HVVTRWYRAPELIL 224
Query: 142 GSTEYSTSLDMWGVGCILIEMVTGL-----------PTFPG-----------VREVY--- 176
               Y+ S+D+W  GCI  E++  L           P FPG            ++V+   
Sbjct: 225 LQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 177 --DQLDKIFKILGTPTEETWEGVS 198
             DQL+ IF I+GTPTE+  + ++
Sbjct: 285 NRDQLNIIFNIIGTPTEDDLKNIN 308

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE ++L  LK + I+ L+D++     L F     V E   +DL +  +      + H I
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEH-I 131
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  ++ LL G ++ H   I+HRD+KP N L+++
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQ 164

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 41/60 (68%), Gaps = 2/60 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+V+LG+  Y   +DMW +GCIL E++TG P  PG  E  DQL  + ++LG P+++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQK 321

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYMERHS-GGLDH 322
           A  E  +L+ L+  +     +++H     TF       FE +  +L + ++++   G   
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
             +R F   +L+ L   H+ RI+H D+KP+N+L+ +     I++  F
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 41/60 (68%), Gaps = 2/60 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+V+LG+  Y   +DMW +GCIL E++TG P  PG  E  DQL  + ++LG P+++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPSQK 321

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYMERHS-GGLDH 322
           A  E  +L+ L+  +     +++H     TF       FE +  +L + ++++   G   
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
             +R F   +L+ L   H+ RI+H D+KP+N+L+ +     I++  F
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 53/86 (61%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H+N++TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 49/86 (56%), Gaps = 10/86 (11%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+ L D V      T   VFEY++ TD  Q  +     L   +IR +M++LL+ L YCH
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI----LTDFDIRFYMYELLKALDYCH 149
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRL 366
            + I+HRDVKP N++   IDH   +L
Sbjct: 150 SKGIMHRDVKPHNVM---IDHQQKKL 172

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 18/34 (52%), Positives = 27/34 (79%)
Query: 363 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +IR +M++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 133 DIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 166

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE   LK  +H +I+ L+ ++ T +    V EYV   +L  Y+ +H G ++    R    
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQ 118
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L  + YCHR  ++HRD+KP+N+L+    H N ++  F L   +S
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADFGLSNMMS 162

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE   LK  +H +I+ L+ ++ T +    V EYV   +L  Y+ +H G ++    R    
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQ 118
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L  + YCHR  ++HRD+KP+N+L+    H N ++  F L   +S
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADFGLSNMMS 162

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 53/86 (61%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H+N++TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 35/86 (40%), Positives = 49/86 (56%), Gaps = 10/86 (11%)
Query: 284 NIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NI+ L D V      T   VFEY++ TD  Q  +     L   +IR +M++LL+ L YCH
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTDFKQLYQI----LTDFDIRFYMYELLKALDYCH 154
Query: 341 RRRILHRDVKPQNLLISEIDHHNIRL 366
            + I+HRDVKP N++   IDH   +L
Sbjct: 155 SKGIMHRDVKPHNVM---IDHQQKKL 177

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 18/34 (52%), Positives = 27/34 (79%)
Query: 363 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +IR +M++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 138 DIRFYMYELLKALDYCHSKGIMHRDVKPHNVMID 171

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 53/86 (61%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H+N++TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/60 (45%), Positives = 40/60 (66%), Gaps = 2/60 (3%)
Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+V+LG+  Y   +DMW +GCIL E++TG P  PG  E  DQL  + ++LG P ++
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEG-DQLACMIELLGMPXQK 321

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/107 (24%), Positives = 52/107 (48%), Gaps = 7/107 (6%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYMERHS-GGLDH 322
           A  E  +L+ L+  +     +++H     TF       FE +  +L + ++++   G   
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
             +R F   +L+ L   H+ RI+H D+KP+N+L+ +     I++  F
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 53/86 (61%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H+N++TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 53/86 (61%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H+N++TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 133
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 178

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 167

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 74  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 133
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 134 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 178

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 128 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 167

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 51/100 (51%), Gaps = 2/100 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
            RE  + K L H NIV L +++ T  TL  V EY    ++  Y+  H G       R   
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAH-GRXKEKEARAKF 119
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            Q++  + YCH++ I+HRD+K +NLL+    +  I  F F
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGF 159

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           K G      RE  +   L+H NI+ L+   H  + +  + EY    ++ + +++ S   D
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FD 111
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                 ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 2/106 (1%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           K G      RE  +   L+H NI+ L+   H  + +  + EY    ++ + +++ S   D
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK-FD 111
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                 ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD--LSQYMERHSGGLDHHNIRLFMF 330
           E SLLK L H NI+ L D+   +     V E+        Q + RH    D  +    M 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMK 153
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDH-HNIRLFMFQL 371
           Q+L G+ Y H+  I+HRD+KP+N+L+   +   NI++  F L
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 4/90 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLS-QYMERHSGGLDHHNIRL-- 327
           REAS+   LKH +IV L +   +   L  VFE++   DL  + ++R   G  +       
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           +M Q+L  L YCH   I+HRDVKP+N+L++
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPENVLLA 164

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 28/41 (68%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+ 
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 145

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 52/86 (60%), Gaps = 2/86 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE S+L+++ H NI+TLHD+   R+ +  + E V   +L  ++ +    L       F+ 
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIK 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G++Y H ++I H D+KP+N+++
Sbjct: 123 QILDGVNYLHTKKIAHFDLKPENIML 148

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 52  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 111
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 156

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 106 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 145

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 65  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 124
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 125 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 158

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 119 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 158

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 112
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 107 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 146

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 67  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 126
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILV 154

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILV 178

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 112
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 107 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 146

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 50  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 109
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 110 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 154

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 104 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 143

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 108
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VG I+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 11/110 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVK--SDATLKILDFGLAR 174

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILV 147

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 108
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 49  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 108
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 117
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVE 146

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 50  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 109
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 110 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANF 154

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 104 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 143

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VG I+ EM+ G   FPG   + DQ +K+ + LGTP
Sbjct: 187 VTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHI-DQWNKVIEQLGTP 244
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E  + +       V     Y G      FP +    + E       Q RD
Sbjct: 245 SPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 13/125 (10%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +LSQ ++     LDH 
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQME---LDHE 126
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR--GLSYCHRR 381
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R  G S+    
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVK--SDATLKILDFGLARTAGTSFMMTP 184
Query: 382 RILHR 386
            ++ R
Sbjct: 185 YVVTR 189

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 65  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 124
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVE 153

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILV 147

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 47  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 106
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 107 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 151

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 101 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 140

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE 148

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 66  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 125
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVE 154

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 122
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE 151

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANF 155

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 118
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVE 147

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 108 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 141

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/118 (36%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 271 IREASLLKELKHNNIVTLHD--IVHTRSTLTFVFEYVH-TDLSQYMERHSGG---LDHHN 324
           + E +LL+ELKH NIV  +D  I  T +TL  V EY    DL+  + + +     LD   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 325 IRLFMFQLLRGLSYCHRRR-----ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           +   M QL   L  CHRR      +LHRD+KP N+ +      N++L  F L R L++
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNH 168

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 53  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 112
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 113 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 146

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 107 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 146

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/118 (36%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 271 IREASLLKELKHNNIVTLHD--IVHTRSTLTFVFEYVH-TDLSQYMERHSGG---LDHHN 324
           + E +LL+ELKH NIV  +D  I  T +TL  V EY    DL+  + + +     LD   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 325 IRLFMFQLLRGLSYCHRRR-----ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           +   M QL   L  CHRR      +LHRD+KP N+ +      N++L  F L R L++
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNH 168

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 64  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 123
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVE 152

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/88 (30%), Positives = 51/88 (57%), Gaps = 3/88 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             Q+ +G+ Y   +R +HRD+  +N+L+
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILV 165

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/95 (29%), Positives = 45/95 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 45  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 104
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                ++ +L   LSYCH +R++HRD+KP+NLL+ 
Sbjct: 105 QRTATYITELANALSYCHSKRVIHRDIKPENLLLG 139

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 17/41 (41%), Positives = 28/41 (68%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+ 
Sbjct: 99  LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 139

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 51  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 110
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 111 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 105 LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 144

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVE 166

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/118 (36%), Positives = 61/118 (51%), Gaps = 13/118 (11%)
Query: 271 IREASLLKELKHNNIVTLHD--IVHTRSTLTFVFEYVH-TDLSQYMERHSGG---LDHHN 324
           + E +LL+ELKH NIV  +D  I  T +TL  V EY    DL+  + + +     LD   
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 325 IRLFMFQLLRGLSYCHRRR-----ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           +   M QL   L  CHRR      +LHRD+KP N+ +      N++L  F L R L++
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD--GKQNVKLGDFGLARILNH 168

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 58/204 (28%)
Query: 22  LLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG 81
           LL      E+ ++ R+ KP    +   LN+  +    +K+ DFGLAR  +          
Sbjct: 141 LLGEKFIHESGIIHRDLKP----ANCLLNQDCS----VKICDFGLARTIN---------- 182
Query: 82  DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL 141
                  D +I  D   +           NL  Q+ +           +T WYR P+++L
Sbjct: 183 ----SDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTS---------HVVTRWYRAPELIL 229
Query: 142 GSTEYSTSLDMWGVGCILIEMVTGL-----------PTFPG-----------VREVY--- 176
               Y+ S+D+W  GCI  E++  +           P FPG            ++V+   
Sbjct: 230 LQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLFPGSSCFPLSPDHNSKKVHEKS 289
Query: 177 --DQLDKIFKILGTPTEETWEGVS 198
             DQL+ IF ++GTP EE  + ++
Sbjct: 290 NRDQLNIIFNVIGTPPEEDLKCIT 313

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 8/111 (7%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE ++L  LK + I+ LHD++     L F     V E   +DL +  +      + H +
Sbjct: 75  LREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQH-V 133
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +  ++ LL G  + H   I+HRD+KP N L+++    ++++  F L R ++
Sbjct: 134 KTILYNLLLGEKFIHESGIIHRDLKPANCLLNQ--DCSVKICDFGLARTIN 182

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 2/112 (1%)
Query: 130 ITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTP 189
           +T +YR P+V+LG   Y  ++D+W VGCI+ E+V G   F G   + DQ +K+ + LGTP
Sbjct: 185 VTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHI-DQWNKVIEQLGTP 242
Query: 190 TEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
           + E    +       V     Y G      FP      E E       Q RD
Sbjct: 243 SAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARD 294

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 11/113 (9%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK + H NI++L ++   + TL        V E +  +L Q +      LDH 
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHME---LDHE 124
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            +   ++Q+L G+ + H   I+HRD+KP N+++       +++  F L R  S
Sbjct: 125 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK--SDCTLKILDFGLARTAS 175

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 52/89 (58%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + E++ +  L +Y+++H   +DH  +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQY 122
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE 151

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y++ H+  +DH  +  +
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQY 122
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HRD+  +N+L+ 
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVE 151

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 52  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE 111
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 145

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 27/40 (67%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S  D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 106 LSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 145

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 52  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE 111
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
                ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 112 QRTATYITELANALSYCHSKRVIHRDIKPENLLL 145

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 17/40 (42%), Positives = 27/40 (67%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S  D      ++ +L   LSYCH +R++HRD+KP+NLL+
Sbjct: 106 LSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 145

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/105 (27%), Positives = 47/105 (44%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 48  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE 107
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH ++++HRD+KP+NLL+       I  F
Sbjct: 108 QRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADF 152

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 16/40 (40%), Positives = 28/40 (70%)
Query: 356 ISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 395
           +S+ D      ++ +L   LSYCH ++++HRD+KP+NLL+
Sbjct: 102 LSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLL 141

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 89  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 144
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 145 SQGIMHRDVKPHNVMID 161

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 31/43 (72%)
Query: 354 LLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +L   +  ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 119 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 161

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 163
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 164 SQGIMHRDVKPHNVMID 180

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 31/43 (72%)
Query: 354 LLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +L   +  ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 138 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 180

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 143
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 144 SQGIMHRDVKPHNVMID 160

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 126 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 31/43 (72%)
Query: 354 LLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +L   +  ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 117 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 125 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 125 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 125 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 125 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 88  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 143
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 144 SQGIMHRDVKPHNVMID 160

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 18/43 (41%), Positives = 31/43 (72%)
Query: 354 LLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           +L   +  ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 118 VLYPTLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 160

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/77 (41%), Positives = 47/77 (61%), Gaps = 7/77 (9%)
Query: 284 NIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           NIV L DIV  +   T + +FEYV+ TD           L  ++IR ++++LL+ L YCH
Sbjct: 87  NIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP----TLTDYDIRYYIYELLKALDYCH 142
Query: 341 RRRILHRDVKPQNLLIS 357
            + I+HRDVKP N++I 
Sbjct: 143 SQGIMHRDVKPHNVMID 159

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 17/35 (48%), Positives = 28/35 (80%)
Query: 362 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 396
           ++IR ++++LL+ L YCH + I+HRDVKP N++I 
Sbjct: 125 YDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 159

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIML 146

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 119
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIML 146

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 5/113 (4%)
Query: 258 GGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVHTDLSQYMER 315
           GG     G      +E ++LK+L H N+V L +++       L  VFE V+      ME 
Sbjct: 71  GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ--GPVMEV 128
Query: 316 HS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            +   L     R +   L++G+ Y H ++I+HRD+KP NLL+ E  H  I  F
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 15/33 (45%), Positives = 24/33 (72%)
Query: 365 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           R +   L++G+ Y H ++I+HRD+KP NLL+ E
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 26/89 (29%), Positives = 51/89 (57%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           RE  +LK L+H+NIV    + ++  R  L  + EY+ +  L  Y+++H   +DH  +  +
Sbjct: 61  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 120
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+ +G+ Y   +R +HR++  +N+L+ 
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVE 149

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 44/81 (54%), Gaps = 4/81 (4%)
Query: 278 KELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMFQLLRG 335
           + L+H NIV   +++ T + L  + EY      +  ER  ++G       R F  QLL G
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASG--GELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 336 LSYCHRRRILHRDVKPQNLLI 356
           +SYCH  +I HRD+K +N L+
Sbjct: 129 VSYCHSMQICHRDLKLENTLL 149

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 53/87 (60%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYM-ERHSGGLDHHNIRLFM 329
           RE S+LKE++H N++TLH++   ++ +  + E V   +L  ++ E+ S  L       F+
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES--LTEEEATEFL 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G+ Y H  +I H D+KP+N+++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 5/104 (4%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDL-SQYMERHSGGLDHHNIRLF 328
           +RE  LLK+L H NI+ L++    +     V E Y   +L  + + R        +    
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARI 155
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
           + Q+L G++Y H+ +I+HRD+KP+NLL+ S+    NIR+  F L
Sbjct: 156 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 199

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME----RHSGGLDHHNIR 326
           +RE  LLK+L H NI+ L++    +     V E V+T    + E    +    +D   I 
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE-VYTGGELFDEIISRKRFSEVDAARI- 154
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
             + Q+L G++Y H+ +I+HRD+KP+NLL+ S+    NIR+  F L
Sbjct: 155 --IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 198

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME----RHSGGLDHHNIR 326
           +RE  LLK+L H NI+ L++    +     V E V+T    + E    +    +D   I 
Sbjct: 80  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE-VYTGGELFDEIISRKRFSEVDAARI- 137
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
             + Q+L G++Y H+ +I+HRD+KP+NLL+ S+    NIR+  F L
Sbjct: 138 --IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 181

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 5/111 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTD-LSQYMERH 316
           +GP     F   RE  +LK L  + IV    + +   R +L  V EY+ +  L  +++RH
Sbjct: 63  SGPDQQRDFQ--REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 120
Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              LD   + L+  Q+ +G+ Y   RR +HRD+  +N+L+    H  I  F
Sbjct: 121 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + ++L+H NIV LHD +   S    VF+ V       D+    E +S     H I+
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQ 112
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  ++YCH   I+HR++KP+NLL++
Sbjct: 113 ----QILESIAYCHSNGIVHRNLKPENLLLA 139

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 5/111 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTD-LSQYMERH 316
           +GP     F   RE  +LK L  + IV    + +   R +L  V EY+ +  L  +++RH
Sbjct: 50  SGPDQQRDFQ--REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 107
Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              LD   + L+  Q+ +G+ Y   RR +HRD+  +N+L+    H  I  F
Sbjct: 108 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 158

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 59/106 (55%), Gaps = 9/106 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME----RHSGGLDHHNIR 326
           +RE  LLK+L H NI+ L++    +     V E V+T    + E    +    +D   I 
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGE-VYTGGELFDEIISRKRFSEVDAARI- 131
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
             + Q+L G++Y H+ +I+HRD+KP+NLL+ S+    NIR+  F L
Sbjct: 132 --IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 55/111 (49%), Gaps = 5/111 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTD-LSQYMERH 316
           +GP     F   RE  +LK L  + IV    + +   R +L  V EY+ +  L  +++RH
Sbjct: 51  SGPDQQRDFQ--REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH 108
Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              LD   + L+  Q+ +G+ Y   RR +HRD+  +N+L+    H  I  F
Sbjct: 109 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 159

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLS-QYMERHSGGLDHHNIRL-- 327
           REAS+   LKH +IV L +   +   L  VFE++   DL  + ++R   G  +       
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 136
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           +M Q+L  L YCH   I+HRDVKP  +L++
Sbjct: 137 YMRQILEALRYCHDNNIIHRDVKPHCVLLA 166

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + ++L+H NIV LHD +   S    VF+ V       D+    E +S     H I+
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQ 111
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  ++YCH   I+HR++KP+NLL++
Sbjct: 112 ----QILESIAYCHSNGIVHRNLKPENLLLA 138

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 51/91 (56%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + ++L+H NIV LHD +   S    VF+ V       D+    E +S     H I+
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQ 112
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  ++YCH   I+HR++KP+NLL++
Sbjct: 113 ----QILESIAYCHSNGIVHRNLKPENLLLA 139

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLS-QYMERHSGGLDHHNIRL-- 327
           REAS+   LKH +IV L +   +   L  VFE++   DL  + ++R   G  +       
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           +M Q+L  L YCH   I+HRDVKP  +L++
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLA 164

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 7/108 (6%)
Query: 271 IREASLLKELKHNNIVTLHDI-VH----TRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  LL    H NI+ L DI VH        L  V E + TDL+Q +      +   +I
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           + FM+ +L GL   H   ++HRD+ P N+L++  D+++I +  F L R
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLA--DNNDITICDFNLAR 182

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 57/108 (52%), Gaps = 7/108 (6%)
Query: 271 IREASLLKELKHNNIVTLHDI-VH----TRSTLTFVFEYVHTDLSQYMERHSGGLDHHNI 325
           +RE  LL    H NI+ L DI VH        L  V E + TDL+Q +      +   +I
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           + FM+ +L GL   H   ++HRD+ P N+L++  D+++I +  F L R
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLA--DNNDITICDFNLAR 182

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTD-LSQYMERH 316
           +GP     F   RE  +LK L  + IV    + +   R  L  V EY+ +  L  +++RH
Sbjct: 47  SGPDQQRDFQ--REIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRH 104
Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              LD   + L+  Q+ +G+ Y   RR +HRD+  +N+L+    H  I  F
Sbjct: 105 RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 155

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 53/90 (58%), Gaps = 8/90 (8%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYM---ERHSGGLDHHNIRL 327
           REA + ++L+H NIV LHD +   S    VF+ V   +L + +   E +S     H I+ 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ- 135
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
              Q+L  ++YCH   I+HR++KP+NLL++
Sbjct: 136 ---QILESIAYCHSNGIVHRNLKPENLLLA 162

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           RE    + L+H NIV   +++ T + L  V EY      +  ER  ++G       R F 
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            QL+ G+SYCH  ++ HRD+K +N L+
Sbjct: 122 QQLISGVSYCHAMQVCHRDLKLENTLL 148

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 4/88 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           RE    + L+H NIV   +++ T + L  V EY      +  ER  ++G       R F 
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            QL+ G+SYCH  ++ HRD+K +N L+ 
Sbjct: 122 QQLISGVSYCHAMQVCHRDLKLENTLLD 149

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           RE    + L+H NIV   +++ T + L  V EY      +  ER  ++G       R F 
Sbjct: 63  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 120
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            QL+ G+SYCH  ++ HRD+K +N L+
Sbjct: 121 QQLISGVSYCHAMQVCHRDLKLENTLL 147

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           RE    + L+H NIV   +++ T + L  V EY      +  ER  ++G       R F 
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            QL+ G+SYCH  ++ HRD+K +N L+
Sbjct: 122 QQLISGVSYCHAMQVCHRDLKLENTLL 148

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME----RHSGGLDHHNIR 326
           +RE  LLK+L H NI  L++    +     V E V+T    + E    +    +D   I 
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGE-VYTGGELFDEIISRKRFSEVDAARI- 131
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
             + Q+L G++Y H+ +I+HRD+KP+NLL+ S+    NIR+  F L
Sbjct: 132 --IRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL 175

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 47/85 (55%), Gaps = 4/85 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD--LSQYMERHSGGLDHHNIRLFMF 330
           E ++LK++KH NIVTL DI  + +    V + V       + +ER  G     +  L + 
Sbjct: 56  EIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQ 113
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLL 355
           Q+L  + Y H   I+HRD+KP+NLL
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLL 138

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 78  ENKVPYVT-RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 135
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 136 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 181

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 159 IHRDLKPENILLNE 172

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 130
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 131 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 154 IHRDLKPENILLNE 167

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 74  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 131
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 132 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 177

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 155 IHRDLKPENILLNE 168

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y  + +L +Y+ R  G  D
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 130
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 131 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 154 IHRDLKPENILLNE 167

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 74  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 131
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 132 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 177

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 100 FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 155 IHRDLKPENILLNE 168

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 130
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 131 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 154 IHRDLKPENILLNE 167

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y  + +L +Y+ R  G  D
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 130
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 131 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 154 IHRDLKPENILLNE 167

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 71  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 128
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 152 IHRDLKPENILLNE 165

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y  + +L +Y+ R  G  D
Sbjct: 76  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 133
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 134 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 179

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 102 FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 157 IHRDLKPENILLNE 170

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 51  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 108
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 109 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 154

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 71  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 128
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 152 IHRDLKPENILLNE 165

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 71  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 128
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 152 IHRDLKPENILLNE 165

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++L+H N +          T   V EY     S  +E H   L    I     
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRDVK  N+L+SE
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSE 189

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 71  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 128
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 129 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 174

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 152 IHRDLKPENILLNE 165

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 50  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 107
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 108 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 153

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 130
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 131 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 99  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 154 IHRDLKPENILLNE 167

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 49  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 106
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 107 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 48  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 105
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 106 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 151

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 55  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 112
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 113 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 158

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 70  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 127
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 128 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 173

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 37/74 (50%), Gaps = 9/74 (12%)
Query: 328 FMFQ----LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
           F FQ    L  GLSY     +L    K     I   D    R +  +++  L Y H + I
Sbjct: 96  FTFQDDEKLYFGLSYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 384 LHRDVKPQNLLISE 397
           +HRD+KP+N+L++E
Sbjct: 151 IHRDLKPENILLNE 164

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 1/105 (0%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           +N  P+   RE  ++  L H   V L+        L F   Y          R  G  D 
Sbjct: 73  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDE 131
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
              R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 132 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 176

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLD 321
           +N  P+   RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D
Sbjct: 70  ENKVPYVT-RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFD 127
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
               R +  +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 128 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 173

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 41/88 (46%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++L+H N +          T   V EY     S  +E H   L    I     
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRDVK  N+L+SE
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSE 150

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 49/92 (53%), Gaps = 9/92 (9%)
Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHTDLSQYM----ERHSGGLDHHNI 325
           +E  LL+ L+H N++ L D+++   +  +  V EY    + + +    E+       H  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHG- 113
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             +  QL+ GL Y H + I+H+D+KP NLL++
Sbjct: 114 --YFCQLIDGLEYLHSQGIVHKDIKPGNLLLT 143

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 104
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 162
Query: 385 HR 386
           ++
Sbjct: 163 NK 164

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/122 (29%), Positives = 58/122 (47%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  + K L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 47  CPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 105
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 163
Query: 385 HR 386
           ++
Sbjct: 164 NK 165

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/87 (27%), Positives = 46/87 (52%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           + EA ++K L H +IV L  I+    T   +  Y + +L  Y+ER+   L    + L+  
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
           Q+ + ++Y      +HRD+  +N+L++
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVA 159

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + + LKH+NIV LHD +        VF+ V       D+    E +S     H I+
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA-REYYSEADASHCIQ 110
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  + +CH+  ++HRD+KP+NLL++
Sbjct: 111 ----QILEAVLHCHQMGVVHRDLKPENLLLA 137

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/87 (27%), Positives = 46/87 (52%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           + EA ++K L H +IV L  I+    T   +  Y + +L  Y+ER+   L    + L+  
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
           Q+ + ++Y      +HRD+  +N+L++
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVA 147

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 2/92 (2%)
Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
           K G      RE  +   L H NI+ L++  + R  +  + EY    +L + +++ S   D
Sbjct: 63  KEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQK-SCTFD 121
Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQN 353
                  M +L   L YCH ++++HRD+KP+N
Sbjct: 122 EQRTATIMEELADALMYCHGKKVIHRDIKPEN 153

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 24/87 (27%), Positives = 46/87 (52%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           + EA ++K L H +IV L  I+    T   +  Y + +L  Y+ER+   L    + L+  
Sbjct: 57  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 116
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLIS 357
           Q+ + ++Y      +HRD+  +N+L++
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVA 143

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/136 (23%), Positives = 59/136 (43%), Gaps = 10/136 (7%)
Query: 251 VHNC-EKEGG--------NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFV 301
           VH C EK  G        N P     +T   E S++ +L H  ++ LHD    +  +  +
Sbjct: 67  VHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126
Query: 302 FEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
            E++   +L   +      +    +  +M Q   GL + H   I+H D+KP+N++     
Sbjct: 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK 186
Query: 361 HHNIRLFMFQLLRGLS 376
             ++++  F L   L+
Sbjct: 187 ASSVKIIDFGLATKLN 202

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 51/90 (56%), Gaps = 8/90 (8%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYM---ERHSGGLDHHNIRL 327
           REA + + LKH NIV LHD +        VF+ V   +L + +   E +S     H I+ 
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQ- 110
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
              Q+L  +++CH   I+HRD+KP+NLL++
Sbjct: 111 ---QILESVNHCHLNGIVHRDLKPENLLLA 137

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMF 330
           E ++L+++KH NIV L DI  + + L  V + V     +  +R    G     +    + 
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSG--GELFDRIVEKGFYTEKDASTLIR 127
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
           Q+L  + Y HR  I+HRD+KP+NLL    D  +
Sbjct: 128 QVLDAVYYLHRMGIVHRDLKPENLLYYSQDEES 160

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + + LKH NIV LHD +        VF+ V       D+    E +S     H I+
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA-REYYSEADASHCIQ 110
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  +++CH   I+HRD+KP+NLL++
Sbjct: 111 ----QILESVNHCHLNGIVHRDLKPENLLLA 137

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/90 (28%), Positives = 51/90 (56%), Gaps = 2/90 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRLF 328
           + EA+L+K L+H+ +V L+ +V     +  + EY+    L  +++   GG +    +  F
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 115
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G++Y  R+  +HRD++  N+L+SE
Sbjct: 116 SAQIAEGMAYIERKNYIHRDLRAANVLVSE 145

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 4/82 (4%)
Query: 278 KELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMFQLLRG 335
           + L+H NIV   +++ T + L  V EY      +  ER  ++G       R F  QL+ G
Sbjct: 70  RSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISG 127
Query: 336 LSYCHRRRILHRDVKPQNLLIS 357
           +SY H  ++ HRD+K +N L+ 
Sbjct: 128 VSYAHAMQVAHRDLKLENTLLD 149

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMF 330
           E ++L ++KH NIV L DI  +   L  + + V     +  +R    G     +    +F
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIF 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
           Q+L  + Y H   I+HRD+KP+NLL   +D  +
Sbjct: 124 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMF 330
           E ++L ++KH NIV L DI  +   L  + + V     +  +R    G     +    +F
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIF 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
           Q+L  + Y H   I+HRD+KP+NLL   +D  +
Sbjct: 124 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMF 330
           E ++L ++KH NIV L DI  +   L  + + V     +  +R    G     +    +F
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIF 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
           Q+L  + Y H   I+HRD+KP+NLL   +D  +
Sbjct: 124 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 4/93 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMF 330
           E ++L ++KH NIV L DI  +   L  + + V     +  +R    G     +    +F
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSG--GELFDRIVEKGFYTERDASRLIF 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
           Q+L  + Y H   I+HRD+KP+NLL   +D  +
Sbjct: 124 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 156

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 110 LDVCEGMAYLEEASVIHRDLAARNCLVGE 138

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/89 (32%), Positives = 46/89 (51%), Gaps = 2/89 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE ++L  +KH NIV   +      +L  V +Y    DL + +    G L   +  L  F
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 331 -QLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+   L + H R+ILHRD+K QN+ +++
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTK 160

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + + LKH NIV LHD +        +F+ V       D+    E +S     H I+
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQ 128
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
               Q+L  + +CH+  ++HRD+KP+NLL+ S++    ++L  F L
Sbjct: 129 ----QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGL 170

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLS---QYMERHSGGLDHHNI 325
            I+E  LLK+L H N++  +      + L  V E     DLS   ++ ++    +    +
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             +  QL   L + H RR++HRD+KP N+ I+
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 170

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 25/90 (27%), Positives = 51/90 (56%), Gaps = 2/90 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRLF 328
           + EA+L+K L+H+ +V L+ +V     +  + E++    L  +++   GG +    +  F
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDF 114
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G++Y  R+  +HRD++  N+L+SE
Sbjct: 115 SAQIAEGMAYIERKNYIHRDLRAANVLVSE 144

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 9/109 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG----LDHHNIR 326
           +RE +++K L+H NIV     V     L+ V EY+    S Y   H  G    LD     
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKSGAREQLDERRRL 140
Query: 327 LFMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
              + + +G++Y H R   I+HRD+K  NLL+ +   + +++  F L R
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDK--KYTVKVCDFGLSR 187

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 57/122 (46%), Gaps = 4/122 (3%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHN 324
            P    +E  +   L H N+V  +      +      EY    +L   +E   G +   +
Sbjct: 48  CPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPD 106
Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+ E D  N+++  F L     Y +R R+L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD--NLKISDFGLATVFRYNNRERLL 164
Query: 385 HR 386
           ++
Sbjct: 165 NK 166

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 53  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 112
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 113 LDVCEGMAYLEEACVIHRDLAARNCLVGE 141

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 110 LDVCEGMAYLEEACVIHRDLAARNCLVGE 138

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 129
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 130 LDVCEGMAYLEEACVIHRDLAARNCLVGE 158

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGE 136

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 2/87 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDLSQYMERHSGGLDHHNIRLFM 329
           + E ++LK L H NI+ L+D    +     V E Y   +L   +  H    +  +  + +
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVII 142
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
            Q+L G++Y H+  I+HRD+KP+NLL+
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLL 169

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 11/131 (8%)
Query: 234 SAFLQVRDAAILNPMEHVHNCEKEGGNGP------KNGAPFTAIR-EASLLKELKHNNIV 286
           S F +V           V+ C+++G   P      K       +R E  +L  L H NI+
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNII 111
Query: 287 TLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMFQLLRGLSYCHRRRI 344
            L +I  T + ++ V E V     +  +R    G     +    + Q+L  ++Y H   I
Sbjct: 112 KLKEIFETPTEISLVLELVTG--GELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 345 LHRDVKPQNLL 355
           +HRD+KP+NLL
Sbjct: 170 VHRDLKPENLL 180

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           RE  +L+++  H +I+TL D   + S +  VF+ +   +L  Y+      L     R  M
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-LSEKETRSIM 206
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH 379
             LL  +S+ H   I+HRD+KP+N+L+   D+  IRL  F    G S CH
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLD--DNMQIRLSDF----GFS-CH 249

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 2/87 (2%)
Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           LLK +KH  +V LH    T   L FV +Y++  +L  +++R    L+    R +  ++  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 150
Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
            L Y H   I++RD+KP+N+L+    H
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGH 177

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 13/116 (11%)
Query: 251 VHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEY 304
           +  C +E    PKN   +    E  ++K+L H N+V+  ++      L          EY
Sbjct: 44  IKQCRQE--LSPKNRERWCL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 305 VHT-DLSQYMER--HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               DL +Y+ +  +  GL    IR  +  +   L Y H  RI+HRD+KP+N+++ 
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 155

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/116 (27%), Positives = 54/116 (46%), Gaps = 13/116 (11%)
Query: 251 VHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEY 304
           +  C +E    PKN   +    E  ++K+L H N+V+  ++      L          EY
Sbjct: 45  IKQCRQE--LSPKNRERWCL--EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 100
Query: 305 VHT-DLSQYMER--HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               DL +Y+ +  +  GL    IR  +  +   L Y H  RI+HRD+KP+N+++ 
Sbjct: 101 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQ 156

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 56/110 (50%), Gaps = 3/110 (2%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +  +LKH +I+ L++     + +  V E  H  ++++Y++        +  R FM Q
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR 381
           ++ G+ Y H   ILHRD+   NLL++   + NI++  F L   L   H +
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADFGLATQLKMPHEK 168

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 54/109 (49%), Gaps = 9/109 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG----LDHHNIR 326
           +RE +++K L+H NIV     V     L+ V EY+    S Y   H  G    LD     
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG-SLYRLLHKSGAREQLDERRRL 140
Query: 327 LFMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
              + + +G++Y H R   I+HR++K  NLL+ +   + +++  F L R
Sbjct: 141 SMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK--KYTVKVCDFGLSR 187

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 11/106 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + + LKH NIV LHD +        +F+ V       D+    E +S     H I+
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA-REYYSEADASHCIQ 117
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLI-SEIDHHNIRLFMFQL 371
               Q+L  + +CH+  ++HR++KP+NLL+ S++    ++L  F L
Sbjct: 118 ----QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/104 (22%), Positives = 50/104 (48%), Gaps = 1/104 (0%)
Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRL 327
           T  +E   +  L+H  +V LHD     + +  ++E++   +L + +      +       
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 259
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           +M Q+ +GL + H    +H D+KP+N++ +    + ++L  F L
Sbjct: 260 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 303

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 157

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 59  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 117
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 165

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 56/115 (48%), Gaps = 8/115 (6%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT--DLSQYMERHSGGLDHHNIRLFMF 330
           E ++L  ++H NI+ + DI   +     V E   +  DL  +++RH   LD         
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFR 137
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILH 385
           QL+  + Y   + I+HRD+K +N++I+E     I+L  F      +Y  R ++ +
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDFG---SAAYLERGKLFY 187

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 53/98 (54%), Gaps = 3/98 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-G 319
           P   +P + + EA ++K+LKH+ +V L+ +V +   +  V EY++   L  +++   G  
Sbjct: 43  PGTMSPESFLEEAQIMKKLKHDKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRA 101
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           L   N+     Q+  G++Y  R   +HRD++  N+L+ 
Sbjct: 102 LKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG 139

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSG 318
            GPK    F  + EA ++  + H ++V L  +  +  T+  V + + H  L +Y+  H  
Sbjct: 79  TGPKANVEF--MDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKD 135
Query: 319 GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF-MFQLLRG 374
            +    +  +  Q+ +G+ Y   RR++HRD+  +N+L+   +H  I  F + +LL G
Sbjct: 136 NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 192

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 57  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 163

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 157

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/86 (32%), Positives = 47/86 (54%), Gaps = 4/86 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDL-SQYMERHSGGLDHHNIRLFMF 330
           E ++LK+L H NI+ L++    +     V E Y   +L  + + R        +  + M 
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMK 128
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLI 356
           Q+L G +Y H+  I+HRD+KP+NLL+
Sbjct: 129 QVLSGTTYLHKHNIVHRDLKPENLLL 154

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 60  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 118
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 166

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 56  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 114
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 162

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 61  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 119
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 167

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++   L+Y H
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH 170
Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGH 191

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 57  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 115
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 163

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 53  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 111
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 159

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++   L+Y H
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH 138
Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGH 159

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 157

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 52  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 110
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 158

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 109
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 157

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 10/91 (10%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-----HTDLSQYMERHSGGLDHHNIR 326
           REA + + LKH NIV LHD +        VF+ V       D+    E +S     H I 
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVA-REYYSEADASHCIH 137
Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
               Q+L  +++ H+  I+HRD+KP+NLL++
Sbjct: 138 ----QILESVNHIHQHDIVHRDLKPENLLLA 164

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 59/117 (50%), Gaps = 5/117 (4%)
Query: 260 NGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSG 318
            GPK    F  + EA ++  + H ++V L  +  +  T+  V + + H  L +Y+  H  
Sbjct: 56  TGPKANVEF--MDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKD 112
Query: 319 GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF-MFQLLRG 374
            +    +  +  Q+ +G+ Y   RR++HRD+  +N+L+   +H  I  F + +LL G
Sbjct: 113 NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 169

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++   L+Y H
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH 127
Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGH 148

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/81 (35%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 282 HNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH 340
           H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++   L+Y H
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEISLALNYLH 123
Query: 341 RRRILHRDVKPQNLLISEIDH 361
            R I++RD+K  N+L+    H
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGH 144

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 285 IVTLHDIVHTRSTLTFVFEYVHTD--LSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR 342
           ++ LH++    S +  + EY       S  +   +  +  +++   + Q+L G+ Y H+ 
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 343 RILHRDVKPQNLLISEI-DHHNIRLFMFQLLRGLSY-CHRRRIL 384
            I+H D+KPQN+L+S I    +I++  F + R + + C  R I+
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 48/88 (54%), Gaps = 4/88 (4%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFE-YVHTDL-SQYMERHSGGLDHHNIRLF 328
           + E ++LK+L H NI+ L++    +     V E Y   +L  + + R        +  + 
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVI 109
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLI 356
           M Q+L G +Y H+  I+HRD+KP+NLL+
Sbjct: 110 MKQVLSGTTYLHKHNIVHRDLKPENLLL 137

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/104 (22%), Positives = 50/104 (48%), Gaps = 1/104 (0%)
Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRL 327
           T  +E   +  L+H  +V LHD     + +  ++E++   +L + +      +       
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 153
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           +M Q+ +GL + H    +H D+KP+N++ +    + ++L  F L
Sbjct: 154 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 197

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 46  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 104
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HRD++  N+L+S  D  + ++  F L R
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLAR 152

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 12/119 (10%)
Query: 259 GNGPKNGAPFTAIREASLLKELK-------HNNIVTLHDIVHTRSTLTFVFEYVHT-DLS 310
           G G  +      +REA+L KE+        H NI+ L D   T +    VF+ +   +L 
Sbjct: 41  GGGSFSAEEVQELREATL-KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 99
Query: 311 QYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            Y+      L     R  M  LL  +   H+  I+HRD+KP+N+L+   D  NI+L  F
Sbjct: 100 DYLTEKVT-LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMNIKLTDF 155

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 272 REASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLF 328
           +E  +L+ L H +I+           ++L  V EYV    L  Y+ RHS GL    + LF
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA--QLLLF 139
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G++Y H +  +HRD+  +N+L+ 
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLD 168

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/120 (25%), Positives = 55/120 (45%), Gaps = 10/120 (8%)
Query: 260 NGPKNGAPFTAIR-EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--- 315
           N  ++  P   I  E  +LK L H NI+ + ++      +  V E       + +ER   
Sbjct: 56  NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG--GELLERIVS 113
Query: 316 ---HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN-IRLFMFQL 371
                  L    +   M Q++  L+Y H + ++H+D+KP+N+L  +   H+ I++  F L
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L+F+ + ++  DL  ++ +H G     ++R +  +++ GL + H R 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 313 VVYRDLKPANILLDEHGHVRI 333

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L+F+ + ++  DL  ++ +H G     ++R +  +++ GL + H R 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 313 VVYRDLKPANILLDEHGHVRI 333

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L+F+ + ++  DL  ++ +H G     ++R +  +++ GL + H R 
Sbjct: 253 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF 311
Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 312 VVYRDLKPANILLDEHGHVRI 332

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 46/81 (56%), Gaps = 2/81 (2%)
Query: 285 IVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR 343
           IV +    HT   L+F+ + ++  DL  ++ +H G     ++R +  +++ GL + H R 
Sbjct: 254 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF 312
Query: 344 ILHRDVKPQNLLISEIDHHNI 364
           +++RD+KP N+L+ E  H  I
Sbjct: 313 VVYRDLKPANILLDEHGHVRI 333

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++    ++   H G  G        
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  ++  GL   HR RI++RD+KP+N+L+   DH +IR+
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLD--DHGHIRI 327

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 4/99 (4%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSG--GLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++    ++   H G  G        
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290
Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  ++  GL   HR RI++RD+KP+N+L+   DH +IR+
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLD--DHGHIRI 327

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           +E  ++K L H NI+ L++     + +  V E       +  ER  H       +    M
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG--GELFERVVHKRVFRESDAARIM 112
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLL 355
             +L  ++YCH+  + HRD+KP+N L
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFL 138

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 12/119 (10%)
Query: 259 GNGPKNGAPFTAIREASLLKELK-------HNNIVTLHDIVHTRSTLTFVFEYVHT-DLS 310
           G G  +      +REA+L KE+        H NI+ L D   T +    VF+ +   +L 
Sbjct: 54  GGGSFSAEEVQELREATL-KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112
Query: 311 QYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            Y+      L     R  M  LL  +   H+  I+HRD+KP+N+L+   D  NI+L  F
Sbjct: 113 DYLTEKVT-LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMNIKLTDF 168

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 1/89 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  V E++ H  LS Y+    G      +    
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGE 139

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 55/119 (46%), Gaps = 12/119 (10%)
Query: 259 GNGPKNGAPFTAIREASLLKELK-------HNNIVTLHDIVHTRSTLTFVFEYVHT-DLS 310
           G G  +      +REA+L KE+        H NI+ L D   T +    VF+ +   +L 
Sbjct: 54  GGGSFSAEEVQELREATL-KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112
Query: 311 QYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            Y+      L     R  M  LL  +   H+  I+HRD+KP+N+L+   D  NI+L  F
Sbjct: 113 DYLTEKVT-LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD--DDMNIKLTDF 168

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFM 329
           +E  ++K L H NI+ L++     + +  V E       +  ER  H       +    M
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG--GELFERVVHKRVFRESDAARIM 129
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLI 356
             +L  ++YCH+  + HRD+KP+N L 
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLF 156

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/105 (26%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         V EY+ + +L  Y+   +       + L+M
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYM 135
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHVVKVADFGLSR 178

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 51/105 (48%), Gaps = 1/105 (0%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           +E S+L   +H NI+ LH+   +   L  +FE++   D+ + +   +  L+   I  ++ 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
           Q+   L + H   I H D++P+N++        I++  F   R L
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 5/148 (3%)
Query: 220 FPRLYDIPEGESMASAFLQVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKE 279
           F  L  I +G       +Q  D   +  M++++  +    N  +N       +E  +++ 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRN-----VFKELQIMQG 71
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           L+H  +V L         +  V + +     +Y  + +       ++LF+ +L+  L Y 
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 340 HRRRILHRDVKPQNLLISEIDHHNIRLF 367
             +RI+HRD+KP N+L+ E  H +I  F
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDF 159

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           +QL   L+Y   +R +HRD+  +N+L+S  D
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATD 148

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 42  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIXIVTEYMSKGSLLDFLKGETGKY 100
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 101 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 139

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           G LD   I   + ++L+GL Y H  + +HRD+K  N+L+SE  H  ++L  F +   L+ 
Sbjct: 119 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTD 176
Query: 378 CHRRR 382
              +R
Sbjct: 177 TQIKR 181

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQY----MERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++    +Y    ++  + G      
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
             +  Q++ GL + H+R I++RD+KP+N+L+   D  N+R+
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--DDGNVRI 330

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQY----MERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++    +Y    ++  + G      
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
             +  Q++ GL + H+R I++RD+KP+N+L+   D  N+R+
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--DDGNVRI 330

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQY----MERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++    +Y    ++  + G      
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
             +  Q++ GL + H+R I++RD+KP+N+L+   D  N+R+
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--DDGNVRI 330

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/99 (27%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P N +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 219 PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 277
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 278 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 316

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/101 (25%), Positives = 52/101 (51%), Gaps = 6/101 (5%)
Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQY----MERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++    +Y    ++  + G      
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291
Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
             +  Q++ GL + H+R I++RD+KP+N+L+   D  N+R+
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD--DDGNVRI 330

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 160

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           G LD   I   + ++L+GL Y H  + +HRD+K  N+L+SE  H  ++L  F +   L+ 
Sbjct: 114 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTD 171
Query: 378 CHRRR 382
              +R
Sbjct: 172 TQIKR 176

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSATD--CVKLGDFGLSR 539

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY++   L  +++  +G  
Sbjct: 49  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKY 107
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGE 146

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT----DLSQYM----ERHSGGLDH 322
           ++E   + +  H NIV+ +     +  L  V + +      D+ +++    E  SG LD 
Sbjct: 56  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 115
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             I   + ++L GL Y H+   +HRDVK  N+L+ E
Sbjct: 116 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 151

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGL--DHHNIRLF 328
            E +L K LKH NIV           +    E V    LS  +    G L  +   I  +
Sbjct: 54  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 113
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+L GL Y H  +I+HRD+K  N+LI+
Sbjct: 114 TKQILEGLKYLHDNQIVHRDIKGDNVLIN 142

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY++   L  +++  +G  
Sbjct: 49  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGSLLDFLKGETGKY 107
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 108 LRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGE 146

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/108 (24%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R ++
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMT 167

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNE 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           G LD   I   + ++L+GL Y H  + +HRD+K  N+L+SE  H  ++L  F +   L+ 
Sbjct: 99  GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTD 156
Query: 378 CHRRR 382
              +R
Sbjct: 157 TQIKR 161

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNE 156

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 60/110 (54%), Gaps = 5/110 (4%)
Query: 266 APFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSG-GLDHH 323
           +P   + EA+L+K+L+H  +V L+ +V T+  +  + EY+    L  +++  SG  L  +
Sbjct: 47  SPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTIN 105
Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            +     Q+  G+++   R  +HR+++  N+L+S  D  + ++  F L R
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVS--DTLSCKIADFGLAR 153

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT----DLSQYM----ERHSGGLDH 322
           ++E   + +  H NIV+ +     +  L  V + +      D+ +++    E  SG LD 
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             I   + ++L GL Y H+   +HRDVK  N+L+ E
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/65 (33%), Positives = 36/65 (55%), Gaps = 2/65 (3%)
Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSY 377
           G LD   I   + ++L+GL Y H  + +HRD+K  N+L+SE  H  ++L  F +   L+ 
Sbjct: 99  GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE--HGEVKLADFGVAGQLTD 156
Query: 378 CHRRR 382
              +R
Sbjct: 157 TQIKR 161

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 41/89 (46%), Gaps = 3/89 (3%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGL--DHHNIRLF 328
            E +L K LKH NIV           +    E V    LS  +    G L  +   I  +
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+L GL Y H  +I+HRD+K  N+LI+
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLIN 156

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNE 174

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 171

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 121
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 122 QLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 162

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 122 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 165

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 171

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 164

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 146
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 147 QLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 187

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNE 152

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNE 152

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 45  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY 103
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 104 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 142

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 3/77 (3%)
Query: 282 HNNIVTLHDIVHTRSTLTFVFE--YVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           H  ++ L D   T+     V E      DL  Y+    G L     R F  Q++  + +C
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 340 HRRRILHRDVKPQNLLI 356
           H R ++HRD+K +N+LI
Sbjct: 156 HSRGVVHRDIKDENILI 172

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 52/103 (50%), Gaps = 2/103 (1%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 120
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 121 QLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 161

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 156

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 160

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/86 (26%), Positives = 39/86 (45%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQL 332
           E S+ + L H ++V  H        +  V E         + +    L     R ++ Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 333 LRGLSYCHRRRILHRDVKPQNLLISE 358
           + G  Y HR R++HRD+K  NL ++E
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNE 150

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 157

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 164

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 159

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           +QL   L+Y   +R +HRD+  +N+L+S  D
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSND 148

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/91 (26%), Positives = 50/91 (54%), Gaps = 2/91 (2%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           +QL   L+Y   +R +HRD+  +N+L+S  D
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSND 148

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 159

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/111 (24%), Positives = 54/111 (48%), Gaps = 3/111 (2%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           +E ++L +   + +   +      S L  + EY+    +  + R +G  D   I   + +
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKE 128
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
           +L+GL Y H  + +HRD+K  N+L+SE    +++L  F +   L+    +R
Sbjct: 129 ILKGLDYLHSEKKIHRDIKAANVLLSE--QGDVKLADFGVAGQLTDTQIKR 177

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L    H NIV L D  +  + L  + E+     +   M      L    I++   Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRD 387
            L  L+Y H  +I+HRD+K  N+L + +D  +I+L  F    G+S  + R I  RD
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFT-LD-GDIKLADF----GVSAKNTRXIQRRD 193

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L    H NIV L D  +  + L  + E+     +   M      L    I++   Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRD 387
            L  L+Y H  +I+HRD+K  N+L + +D  +I+L  F    G+S  + R I  RD
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFT-LD-GDIKLADF----GVSAKNTRXIQRRD 193

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L    H NIV L D  +  + L  + E+     +   M      L    I++   Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRD 387
            L  L+Y H  +I+HRD+K  N+L + +D  +I+L  F    G+S  + R I  RD
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFT-LD-GDIKLADF----GVSAKNTRTIQRRD 193

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/90 (24%), Positives = 46/90 (51%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAY 118
Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           QL   L+Y   +R +HRD+  +N+L+S  D
Sbjct: 119 QLSTALAYLESKRFVHRDIAARNVLVSSND 148

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 164

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 301 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY 359
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 360 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 398

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 161

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 122 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 165

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLF 328
           +E  +L+ L H +I+        +   +L  V EYV    L  Y+ RHS GL    + LF
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLA--QLLLF 122
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G++Y H +  +HR++  +N+L+ 
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLD 151

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGCLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 161

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 7/99 (7%)
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN---IRLFMFQLLRGL 336
           L+  N V     V  +STL    EY     + Y   HS  L+       RLF  Q+L  L
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENG-TLYDLIHSENLNQQRDEYWRLFR-QILEAL 129
Query: 337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
           SY H + I+HRD+KP N+ I E    N+++  F L + +
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGLAKNV 166

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 56/104 (53%), Gaps = 4/104 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +QL   L+Y   +R +HRD+  +N+L+S  D   ++L  F L R
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSR 539

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117
Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
            Q+  G+ Y   +R +HRD+  +NLL++  D   +++  F L+R L
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRAL 161

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 218 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY 276
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLF 328
           +E  +L+ L H +I+        +   +L  V EYV    L  Y+ RHS GL    + LF
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLA--QLLLF 122
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G++Y H +  +HR++  +N+L+ 
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLD 151

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 163

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 218 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKY 276
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/108 (24%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R ++
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMT 167

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 49/99 (49%), Gaps = 7/99 (7%)
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN---IRLFMFQLLRGL 336
           L+  N V     V  +STL    EY   + + Y   HS  L+       RLF  Q+L  L
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCE-NRTLYDLIHSENLNQQRDEYWRLFR-QILEAL 129
Query: 337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
           SY H + I+HRD+KP N+ I E    N+++  F L + +
Sbjct: 130 SYIHSQGIIHRDLKPMNIFIDE--SRNVKIGDFGLAKNV 166

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/108 (24%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R ++
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMT 162

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/108 (24%), Positives = 58/108 (53%), Gaps = 4/108 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R ++
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMT 162

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 164

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 161

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  
Sbjct: 218 PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGSLLDFLKGETGKY 276
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 277 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 315

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 56/105 (53%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +    +  + L+M
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 129
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 130 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 172

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-------SGGLDHH 323
           REA LL  L+H +IV    +      L  VFEY+ H DL++++  H       +GG D  
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 324 NIRLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
              L + QLL        G+ Y      +HRD+  +N L+ +
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG----------- 319
           REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H              
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPT 123
Query: 320 -LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            L    +     Q+  G+ Y   +  +HRD+  +N L+ E
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 16/102 (15%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS------------- 317
           REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H              
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 318 --GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             G L    +     Q+  G+ Y   +  +HRD+  +N L+ 
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 167

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 43  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 101
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 102 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 140

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 41  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 99
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 100 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 138

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 157

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 159

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 159

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDH-HNIRLF 328
           + EA+++K L+H+ +V LH +V T+  +  + E++    L  +++   G       +  F
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 116
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G+++  +R  +HRD++  N+L+S
Sbjct: 117 SAQIAEGMAFIEQRNYIHRDLRAANILVS 145

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 4/105 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +       + L+M
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 330 F-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSR 157

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 35/83 (42%)
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           L    IV L+  V     +    E +       + +  G L       ++ Q L GL Y 
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 201
Query: 340 HRRRILHRDVKPQNLLISEIDHH 362
           H RRILH DVK  N+L+S    H
Sbjct: 202 HSRRILHGDVKADNVLLSSDGSH 224

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 259 GNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMER 315
           G GP+  + +   RE  +L+ L H +IV        +   ++  V EYV    L  Y+ R
Sbjct: 48  GCGPQLRSGWQ--REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR 105
Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           H  GL    + LF  Q+  G++Y H +  +HR +  +N+L+ 
Sbjct: 106 HCVGLA--QLLLFAQQICEGMAYLHAQHYIHRALAARNVLLD 145

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/83 (31%), Positives = 35/83 (42%)
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC 339
           L    IV L+  V     +    E +       + +  G L       ++ Q L GL Y 
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL 182
Query: 340 HRRRILHRDVKPQNLLISEIDHH 362
           H RRILH DVK  N+L+S    H
Sbjct: 183 HSRRILHGDVKADNVLLSSDGSH 205

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 259 GNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMER 315
           G GP+  + +   RE  +L+ L H +IV        +   ++  V EYV    L  Y+ R
Sbjct: 49  GCGPQLRSGWQ--REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR 106
Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
           H  GL    + LF  Q+  G++Y H +  +HR +  +N+L+ 
Sbjct: 107 HCVGLA--QLLLFAQQICEGMAYLHAQHYIHRALAARNVLLD 146

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-------SGGLDHH 323
           REA LL  L+H +IV    +      L  VFEY+ H DL++++  H       +GG D  
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 122
Query: 324 NIRLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
              L + QLL        G+ Y      +HRD+  +N L+ +
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 164

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH-------SGGLDHH 323
           REA LL  L+H +IV    +      L  VFEY+ H DL++++  H       +GG D  
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 128
Query: 324 NIRLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
              L + QLL        G+ Y      +HRD+  +N L+ +
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 170

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGCLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 51/100 (51%), Gaps = 4/100 (4%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L ++ H  +V LH    T   L  + +++   DL   + +        +++ ++ +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM-FTEEDVKFYLAE 138
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQL 371
           L  GL + H   I++RD+KP+N+L+ E  H  I+L  F L
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGL 176

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDH-HNIRLF 328
           + EA+++K L+H+ +V LH +V T+  +  + E++    L  +++   G       +  F
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G+++  +R  +HRD++  N+L+S
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVS 318

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/89 (25%), Positives = 50/89 (56%), Gaps = 3/89 (3%)
Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDH-HNIRLF 328
           + EA+++K L+H+ +V LH +V T+  +  + E++    L  +++   G       +  F
Sbjct: 225 LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 283
Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
             Q+  G+++  +R  +HRD++  N+L+S
Sbjct: 284 SAQIAEGMAFIEQRNYIHRDLRAANILVS 312

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/99 (26%), Positives = 50/99 (50%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD+   N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGE 149

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E ++L+E+KH  IV L     T   L  + EY+   +L   +ER  G         ++ +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAE 129
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +   L + H++ I++RD+KP+N++++   H  ++L  F L +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK 169

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 25/99 (25%), Positives = 51/99 (51%), Gaps = 3/99 (3%)
Query: 262 PKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG- 319
           P   +P   ++EA ++K+++H  +V L+ +V +   +  V EY+    L  +++   G  
Sbjct: 52  PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKY 110
Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    +     Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 111 LRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 149

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 54/102 (52%), Gaps = 4/102 (3%)
Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E ++L+E+KH  IV L     T   L  + EY+   +L   +ER  G         ++ +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAE 129
Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           +   L + H++ I++RD+KP+N++++   H  ++L  F L +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCK 169

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/119 (21%), Positives = 58/119 (48%), Gaps = 7/119 (5%)
Query: 262 PKNGAPFTA--IREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHT-DLSQYMERH 316
           P++G    A   +E  +L+ L H NIV    I      + +  + E++ +  L +Y+ ++
Sbjct: 60  PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
              ++      +  Q+ +G+ Y   R+ +HRD+  +N+L+     H +++  F L + +
Sbjct: 120 KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE--SEHQVKIGDFGLTKAI 176

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/74 (28%), Positives = 42/74 (56%), Gaps = 3/74 (4%)
Query: 309 LSQYMERHSGGLDHHNIRLFMF-QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           L Q++E+  G      + L +F Q+ +G+ Y H ++++HRD+KP N+ +  +D   +++ 
Sbjct: 121 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFL--VDTKQVKIG 178
Query: 368 MFQLLRGLSYCHRR 381
            F L+  L    +R
Sbjct: 179 DFGLVTSLKNDGKR 192

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 31/100 (31%), Positives = 49/100 (49%), Gaps = 4/100 (4%)
Query: 263 KNGAPFTA-IREASLLKELKHNNIVTLHD-IVHTRSTLTFVFEYV-HTDLSQYM-ERHSG 318
           KN A   A + EAS++ +L+H+N+V L   IV  +  L  V EY+    L  Y+  R   
Sbjct: 44  KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 103
Query: 319 GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            L    +  F   +   + Y      +HRD+  +N+L+SE
Sbjct: 104 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 143

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 7/99 (7%)
Query: 280 LKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN---IRLFMFQLLRGL 336
           L+  N V     V  +STL    EY   + + Y   HS  L+       RLF  Q+L  L
Sbjct: 72  LERRNFVKPXTAVKKKSTLFIQXEYCE-NRTLYDLIHSENLNQQRDEYWRLFR-QILEAL 129
Query: 337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL 375
           SY H + I+HR++KP N+ I E    N+++  F L + +
Sbjct: 130 SYIHSQGIIHRNLKPXNIFIDE--SRNVKIGDFGLAKNV 166

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	481
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-52
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-50
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	5e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-51
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-50
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-16
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	7e-51
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-51
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-51
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-48
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-16
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-13
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-50
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-49
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-16
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-13
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-50
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-49
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-13
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-49
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-48
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-46
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-48
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-48
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-14
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-48
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-45
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-12
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-46
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-38
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-10
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-42
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-11
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-44
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-42
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-12
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-42
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-36
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-32
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-31
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-06
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-29
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-26
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-04
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-29
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-07
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-28
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-05
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-27
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-26
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-26
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-25
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-25
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-24
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-24
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-24
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-22
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-24
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-07
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-06
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-23
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-20
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-07
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-23
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-23
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-23
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-07
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-22
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-19
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-07
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-19
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-06
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-06
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-04
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-04
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-20
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-04
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-20
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	9e-20
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-06
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-04
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-19
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-05
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-04
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-04
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-19
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-06
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-05
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-19
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-07
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-06
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-04
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-04
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-04
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-04
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-04
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-04
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-04
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-04
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-04
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-05
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-04
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-17
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-05
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-06
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-04
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-04
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-16
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-04
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-04
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-04
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-04
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-04
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-16
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-04
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-04
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-04
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-15
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-04
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-04
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-15
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-04
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-05
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-15
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-10
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-14
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-04
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-12
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-14
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-07
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	8e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-14
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-04
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-13
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	9e-06
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-04
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-12
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-04
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-12
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-04
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-04
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-07
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-08
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-12
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-12
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	9e-12
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-04
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-07
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-11
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-11
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-11
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-11
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-05
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-11
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-11
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-11
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-11
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-06
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-10
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-10
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-06
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-10
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-07
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-05
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-10
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-08
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-10
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-07
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-10
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-06
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-05
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-10
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-07
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-04
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-09
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-09
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-09
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-06
3fme_A	290	Dual specificity mitogen-activated protein kinase;	7e-06
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-09
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-09
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-06
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-09
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-06
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-06
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-09
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-09
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-06
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-06
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	8e-09
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-09
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-08
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-08
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-08
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-07
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-07
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-04
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-07
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-07
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-07
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-05
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-07
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-07
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-05
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	4e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-07
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-07
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	6e-07
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-07
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	6e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-07
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-07
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-06
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-06
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-06
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-05
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-06
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-06
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-06
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-06
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-04
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	9e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-04
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-05
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-05
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-04
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-04
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-05
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-05
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-04
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-04
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-04
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-04
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-04
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-04
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-04
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-04

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  177 bits (452), Expect = 5e-52
 Identities = 75/181 (41%), Positives = 89/181 (49%), Gaps = 51/181 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLADFGLARAKS+P+ TY                                    N+VV
Sbjct: 138 ELKLADFGLARAKSIPTKTY-----------------------------------DNEVV 162

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYRPPD+LLGST+YST +DMWGVGCI  EM TG P FPG     +
Sbjct: 163 -------------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-E 208

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL  IF+ILGTPTEETW G+     +  +    Y    L    PRL    +G  + +  L
Sbjct: 209 QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLD--SDGADLLTKLL 266

Query: 238 Q 238
           Q
Sbjct: 267 Q 267

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  174 bits (443), Expect = 1e-50
 Identities = 62/94 (65%), Positives = 79/94 (84%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
           GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+  DL QY++     ++ HN
Sbjct: 42  GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN 101

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           ++LF+FQLLRGL+YCHR+++LHRD+KPQNLLI+E
Sbjct: 102 VKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 31/41 (75%), Positives = 35/41 (85%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           GAP TAIRE SLLK+LKH NIVTLHDI+HT  +LT VFEY+
Sbjct: 42  GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 29/42 (69%), Positives = 36/42 (85%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           + YIKLD+LGEG+YATV+KG S LT+ +VALKEIRL+ EEG 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA 43

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  175 bits (445), Expect = 3e-51
 Identities = 65/181 (35%), Positives = 79/181 (43%), Gaps = 51/181 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLARA  +P  +Y                                   T++VV
Sbjct: 157 ALKLADFGLARAFGIPVRSY-----------------------------------THEVV 181

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR PDVL+GS +YSTS+D+W +GCI  EM+TG P FPGV +  D
Sbjct: 182 -------------TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-D 227

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL KIF ILGTP    W  V  LP +       +         P      EG  + S  L
Sbjct: 228 QLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC--QEGIDLLSNML 285

Query: 238 Q 238
            
Sbjct: 286 C 286

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  172 bits (439), Expect = 3e-50
 Identities = 50/96 (52%), Positives = 71/96 (73%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++  DL + ++ +  GL  
Sbjct: 59  DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQD 118

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             I+++++QLLRG+++CH+ RILHRD+KPQNLLI+ 
Sbjct: 119 SQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS 154

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 25/41 (60%), Positives = 31/41 (75%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV+L D++H+   LT VFE++
Sbjct: 61  GIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.8 bits (164), Expect = 2e-12
 Identities = 22/57 (38%), Positives = 34/57 (59%), Gaps = 2/57 (3%)

Query: 75  HTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           H+   +     G  + Y KL+++GEG+Y  V+K   +   ++VALK IRL  E+EGI
Sbjct: 7   HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI 62

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  173 bits (442), Expect = 7e-51
 Identities = 50/96 (52%), Positives = 69/96 (71%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++  DL + ++   GGL+ 
Sbjct: 40  DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES 99

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              + F+ QLL G++YCH RR+LHRD+KPQNLLI+ 
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  173 bits (441), Expect = 9e-51
 Identities = 65/181 (35%), Positives = 83/181 (45%), Gaps = 52/181 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELK+ADFGLARA  +P   Y+H+                                   +V
Sbjct: 138 ELKIADFGLARAFGIPVRKYTHE-----------------------------------IV 162

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR PDVL+GS +YST++D+W VGCI  EMV G P FPGV E  D
Sbjct: 163 -------------TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-D 208

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL +IF+ILGTP  + W  V+ LP Y+ +    Y           L     G  + S  L
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFT-VYEPLPWESFLKGLD--ESGIDLLSKML 265

Query: 238 Q 238
           +
Sbjct: 266 K 266

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 79.5 bits (197), Expect = 1e-16
 Identities = 24/41 (58%), Positives = 32/41 (78%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++
Sbjct: 42  GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           + Y  L+++GEG+Y  V+K  +N   +  ALK+IRL +E+EGI
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGI 43

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  173 bits (441), Expect = 9e-51
 Identities = 51/96 (53%), Positives = 68/96 (70%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+   DL +Y +  +G LD 
Sbjct: 41  DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP 100

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             ++ F+FQLL+GL +CH R +LHRD+KPQNLLI+ 
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  166 bits (422), Expect = 5e-48
 Identities = 65/182 (35%), Positives = 81/182 (44%), Gaps = 53/182 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELKLA+FGLARA  +P   Y                                   + +VV
Sbjct: 139 ELKLANFGLARAFGIPVRCY-----------------------------------SAEVV 163

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGVREVY 176
                        TLWYRPPDVL G+  YSTS+DMW  GCI  E+   G P FPG     
Sbjct: 164 -------------TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD- 209

Query: 177 DQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAF 236
           DQL +IF++LGTPTEE W  ++ LP Y  +   P T   L    P+L     G  +    
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT-TSLVNVVPKLN--ATGRDLLQNL 266

Query: 237 LQ 238
           L+
Sbjct: 267 LK 268

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 24/41 (58%), Positives = 30/41 (73%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+ 
Sbjct: 43  GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 68.7 bits (169), Expect = 5e-13
 Identities = 20/43 (46%), Positives = 32/43 (74%), Gaps = 1/43 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
             Y KL+++GEG+Y TVFK  +  T+++VALK +RL  ++EG+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV 44

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  169 bits (431), Expect = 3e-49
 Identities = 51/97 (52%), Positives = 70/97 (72%), Gaps = 1/97 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLD 321
             G P TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+  +  G+ 
Sbjct: 42  TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP 101

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              I+ ++FQLL+GL++CH  R+LHRD+KPQNLLI+ 
Sbjct: 102 LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 138

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 25/41 (60%), Positives = 30/41 (73%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 44  GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 84

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 68.7 bits (169), Expect = 5e-13
 Identities = 20/43 (46%), Positives = 32/43 (74%), Gaps = 1/43 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           + + K++++GEG+Y  V+K  + LT +VVALK+IRL  E EG+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGV 45

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  173 bits (440), Expect = 4e-50
 Identities = 66/208 (31%), Positives = 92/208 (44%), Gaps = 56/208 (26%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPR-ELKLADFGLARAKSVPSHTYSHQGDSPFGKADA 90
           R L R+ KP      + L+         LK+ DFGLARA  +P   +             
Sbjct: 152 RCLHRDLKP----QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF------------- 194

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSL 150
                                 T++++             TLWYRPP++LLGS  YSTS+
Sbjct: 195 ----------------------THEII-------------TLWYRPPEILLGSRHYSTSV 219

Query: 151 DMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAP 210
           D+W + CI  EM+   P FPG  E+ DQL KIF++LG P + TW GV+ LP +       
Sbjct: 220 DIWSIACIWAEMLMKTPLFPGDSEI-DQLFKIFEVLGLPDDTTWPGVTALPDWKQSF-PK 277

Query: 211 YTGNKLGLTFPRLYDIPEGESMASAFLQ 238
           + G  L      L D  EG  + +A L+
Sbjct: 278 FRGKTLKRVLGALLD-DEGLDLLTAMLE 304

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  169 bits (431), Expect = 7e-49
 Identities = 47/101 (46%), Positives = 67/101 (66%), Gaps = 1/101 (0%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           + G P TAIRE SLLKEL+H NI+ L  ++H    L  +FEY   DL +YM+++   +  
Sbjct: 73  EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-PDVSM 131

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
             I+ F++QL+ G+++CH RR LHRD+KPQNLL+S  D   
Sbjct: 132 RVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASE 172

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 22/41 (53%), Positives = 27/41 (65%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SLLKEL+H NI+ L  ++H    L  +FEY 
Sbjct: 75  GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 1/67 (1%)

Query: 65  GLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL 124
           G   A++    + S          D Y ++ +LGEG+Y  V+K    +TN+ VA+K IRL
Sbjct: 10  GTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL 69

Query: 125 -QEEEGI 130
             EEEG+
Sbjct: 70  EHEEEGV 76

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  171 bits (437), Expect = 1e-49
 Identities = 54/181 (29%), Positives = 74/181 (40%), Gaps = 53/181 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLA++   P+  Y+HQ                                   VV
Sbjct: 150 VLKLADFGLAKSFGSPNRAYTHQ-----------------------------------VV 174

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++L G+  Y   +DMW VGCIL E++  +P  PG  ++ D
Sbjct: 175 -------------TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-D 220

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL +IF+ LGTPTEE W  +  LP Y   +   + G  L   F       +   +     
Sbjct: 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTFK--SFPGIPLHHIFSAAG--DDLLDLIQGLF 276

Query: 238 Q 238
            
Sbjct: 277 L 277

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  169 bits (430), Expect = 2e-48
 Identities = 41/96 (42%), Positives = 61/96 (63%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K+G   TA+RE  LL+EL H NI+ L D    +S ++ VF+++ TDL   ++ +S  L  
Sbjct: 52  KDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP 111

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +I+ +M   L+GL Y H+  ILHRD+KP NLL+ E
Sbjct: 112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 147

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 17/41 (41%), Positives = 26/41 (63%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G   TA+RE  LL+EL H NI+ L D    +S ++ VF+++
Sbjct: 54  GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 23/48 (47%), Positives = 33/48 (68%), Gaps = 4/48 (8%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL----QEEEGI 130
           +A  Y KLD LGEG +ATV+K     TNQ+VA+K+I+L    + ++GI
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI 55

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  169 bits (430), Expect = 9e-49
 Identities = 33/96 (34%), Positives = 58/96 (60%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
                  A+RE  LLK+L+H N+V L ++   +     VFE+V   +   +E    GLD+
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDY 123

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             ++ ++FQ++ G+ +CH   I+HRD+KP+N+L+S+
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQ 159

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  163 bits (414), Expect = 2e-46
 Identities = 43/182 (23%), Positives = 64/182 (35%), Gaps = 52/182 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +KL DFG AR  + P   Y                                    ++V 
Sbjct: 162 VVKLCDFGFARTLAAPGEVY-----------------------------------DDEVA 186

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++L+G  +Y  ++D+W +GC++ EM  G P FPG  ++ D
Sbjct: 187 -------------TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI-D 232

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYT-GNKLGLTFPRLYDIPEGESMASAF 236
           QL  I   LG       E  +  P +   R         L   +P+L        +A   
Sbjct: 233 QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS--EVVIDLAKKC 290

Query: 237 LQ 238
           L 
Sbjct: 291 LH 292

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 15/42 (35%), Positives = 23/42 (54%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
                 A+RE  LLK+L+H N+V L ++   +     VFE+V
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.9 bits (172), Expect = 2e-13
 Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 1/50 (2%)

Query: 82  DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           +  F   + Y  L  +GEGSY  V K  +  T ++VA+K+     +++ +
Sbjct: 18  NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV 67

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  168 bits (428), Expect = 1e-48
 Identities = 61/184 (33%), Positives = 77/184 (41%), Gaps = 53/184 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           +LKL DFGLARA  +P +T+                                   +++VV
Sbjct: 146 QLKLGDFGLARAFGIPVNTF-----------------------------------SSEVV 170

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR PDVL+GS  YSTS+D+W  GCIL EM+TG P FPG  +  +
Sbjct: 171 -------------TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-E 216

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDI---PEGESMAS 234
           QL  IF I+GTP E  W  V+ LP YN +         L                     
Sbjct: 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNI-QQRPPRDLRQVLQPHTKEPLDGNLMDFLH 275

Query: 235 AFLQ 238
             LQ
Sbjct: 276 GLLQ 279

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  166 bits (423), Expect = 7e-48
 Identities = 52/99 (52%), Positives = 74/99 (74%), Gaps = 5/99 (5%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-----GG 319
           G P TAIRE SL+KELKH NIV L+D++HT + LT VFE++  DL +YM+  +      G
Sbjct: 45  GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRG 104

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L+ + ++ F +QLL+GL++CH  +ILHRD+KPQNLLI++
Sbjct: 105 LELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.3 bits (199), Expect = 8e-17
 Identities = 26/41 (63%), Positives = 33/41 (80%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           G P TAIRE SL+KELKH NIV L+D++HT + LT VFE++
Sbjct: 45  GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 73.8 bits (182), Expect = 1e-14
 Identities = 20/44 (45%), Positives = 30/44 (68%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
            +  + +L++LG G+YATV+KG +  T   VALKE++L  EEG 
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT 46

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  166 bits (424), Expect = 4e-48
 Identities = 32/96 (33%), Positives = 57/96 (59%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
                  A+RE  +LK+LKH N+V L ++   +  L  VFEY    +   ++R+  G+  
Sbjct: 42  DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPE 101

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           H ++   +Q L+ +++CH+   +HRDVKP+N+LI++
Sbjct: 102 HLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  160 bits (407), Expect = 2e-45
 Identities = 43/167 (25%), Positives = 66/167 (39%), Gaps = 50/167 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +KL DFG AR  + PS  Y                                    ++V 
Sbjct: 140 VIKLCDFGFARLLTGPSDYY-----------------------------------DDEVA 164

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++L+G T+Y   +D+W +GC+  E+++G+P +PG  +V D
Sbjct: 165 -------------TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV-D 210

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRD-APYTGNKLGLTFPRL 223
           QL  I K LG       +  S    ++  +   P     L L FP +
Sbjct: 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI 257

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.5 bits (184), Expect = 5e-15
 Identities = 17/42 (40%), Positives = 24/42 (57%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           P     A+RE  +LK+LKH N+V L ++   +  L  VFEY 
Sbjct: 43  PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 65.3 bits (160), Expect = 7e-12
 Identities = 16/43 (37%), Positives = 27/43 (62%), Gaps = 1/43 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           + Y K+ ++GEGSY  VFK  +  T Q+VA+K+    +++  I
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI 45

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  164 bits (417), Expect = 1e-46
 Identities = 51/181 (28%), Positives = 68/181 (37%), Gaps = 45/181 (24%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLARA S+  ++  ++                                TN+VV
Sbjct: 162 VLKLADFGLARAFSLAKNSQPNR-------------------------------YTNRVV 190

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYRPP++LLG  +Y   +D+WG GCI+ EM T  P   G  E   
Sbjct: 191 -------------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-H 236

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL  I ++ G+ T E W  V     Y           K+          P    +    L
Sbjct: 237 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296

Query: 238 Q 238
            
Sbjct: 297 V 297

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  142 bits (361), Expect = 1e-38
 Identities = 38/103 (36%), Positives = 56/103 (54%), Gaps = 8/103 (7%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++   DL+  + 
Sbjct: 56  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 115

Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+
Sbjct: 116 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 17/49 (34%), Positives = 28/49 (57%), Gaps = 8/49 (16%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIVHTRST--------LTFVFEYV 476
           G P TA+RE  +L+ LKH N+V L +I  T+++        +  VF++ 
Sbjct: 58  GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 106

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 17/45 (37%), Positives = 27/45 (60%), Gaps = 1/45 (2%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEGI 130
           +   Y KL ++G+G++  VFK     T Q VALK++ +  E+EG 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  156 bits (397), Expect = 5e-44
 Identities = 52/181 (28%), Positives = 68/181 (37%), Gaps = 56/181 (30%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ++KLADFGLAR  S                                         T+ VV
Sbjct: 158 QIKLADFGLARIYSFQ-MAL-----------------------------------TSVVV 181

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR P+VLL S+ Y+T +D+W VGCI  EM    P F G  +V D
Sbjct: 182 -------------TLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDV-D 226

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL KI  ++G P EE W     LP    H     +   +      +     G+ +    L
Sbjct: 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHS---KSAQPIEKFVTDID--ELGKDLLLKCL 281

Query: 238 Q 238
            
Sbjct: 282 T 282

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  152 bits (387), Expect = 1e-42
 Identities = 42/105 (40%), Positives = 64/105 (60%), Gaps = 9/105 (8%)

Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYME 314
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  DL+ Y++
Sbjct: 51  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 110

Query: 315 RHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++ 
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS 155

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 19/49 (38%), Positives = 27/49 (55%), Gaps = 8/49 (16%)

Query: 436 GAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYV 476
           G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V
Sbjct: 53  GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 2/44 (4%)

Query: 89  DAYIKLDQLGEGSYATVFKGYS-NLTNQVVALKEIRL-QEEEGI 130
             Y  + ++GEG+Y  VFK        + VALK +R+   EEG+
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM 54

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  155 bits (394), Expect = 8e-44
 Identities = 55/181 (30%), Positives = 65/181 (35%), Gaps = 56/181 (30%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +KLADFGLAR  S                                         T  VV
Sbjct: 158 TVKLADFGLARIYSYQ-MAL-----------------------------------TPVVV 181

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYR P+VLL ST Y+T +DMW VGCI  EM    P F G  E  D
Sbjct: 182 -------------TLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEA-D 226

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL KIF ++G P E+ W     LP        P     +    P +     G  +    L
Sbjct: 227 QLGKIFDLIGLPPEDDWPRDVSLPRGAFP---PRGPRPVQSVVPEME--ESGAQLLLEML 281

Query: 238 Q 238
            
Sbjct: 282 T 282

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  150 bits (382), Expect = 5e-42
 Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 13/112 (11%)

Query: 255 EKEGGNGPKNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVH 306
              G      G P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V 
Sbjct: 47  GGGG----GGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD 102

Query: 307 TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
            DL  Y+++    GL    I+  M Q LRGL + H   I+HRD+KP+N+L++
Sbjct: 103 QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT 154

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 67.2 bits (165), Expect = 1e-12
 Identities = 14/50 (28%), Positives = 22/50 (44%), Gaps = 1/50 (2%)

Query: 81  GDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL-QEEEG 129
           G         Y  + ++G G+Y TV+K     +   VALK +R+     G
Sbjct: 1   GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGG 50

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 19/51 (37%), Positives = 28/51 (54%), Gaps = 8/51 (15%)

Query: 434 PPGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYV 476
             G P + +RE +LL+ L+   H N+V L D+  T  T     +T VFE+V
Sbjct: 51  GGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV 101

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  153 bits (387), Expect = 6e-42
 Identities = 40/155 (25%), Positives = 65/155 (41%), Gaps = 53/155 (34%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+AD G AR  + P    +                                 L   VV
Sbjct: 170 RVKIADMGFARLFNSPLKPLAD--------------------------------LDPVVV 197

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV-- 175
                        T WYR P++LLG+  Y+ ++D+W +GCI  E++T  P F   +E   
Sbjct: 198 -------------TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIK 244

Query: 176 ------YDQLDKIFKILGTPTEETWEGVSLLPGYN 204
                 +DQLD+IF ++G P ++ WE +  +P ++
Sbjct: 245 TSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHS 279

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  137 bits (347), Expect = 3e-36
 Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 10/114 (8%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYVHTDLSQYMERHSGG- 319
             G   +A RE +LL+ELKH N+++L  +   H    +  +F+Y   DL   ++ H    
Sbjct: 58  GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASK 117

Query: 320 -------LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
                  L    ++  ++Q+L G+ Y H   +LHRD+KP N+L+        R+
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 15/43 (34%), Positives = 25/43 (58%), Gaps = 2/43 (4%)

Query: 436 GAPFTAIREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYV 476
           G   +A RE +LL+ELKH N+++L  +   H    +  +F+Y 
Sbjct: 60  GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 102

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  125 bits (316), Expect = 5e-32
 Identities = 39/150 (26%), Positives = 63/150 (42%), Gaps = 52/150 (34%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKL DFG A+   +                  YI                         
Sbjct: 180 VLKLIDFGSAKI-LIAGEPNVS-----------YI------------------------- 202

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        + +YR P+++ G+T Y+T++D+W  GC++ E++ G P FPG   + D
Sbjct: 203 ------------CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-D 249

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHR 207
           QL +I K+LGTP+ E  + ++  P Y  H+
Sbjct: 250 QLVEIIKVLGTPSREQIKTMN--PNYMEHK 277

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  123 bits (310), Expect = 3e-31
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 9/94 (9%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHS---GGLDH 322
           RE  +++ +KH N+V L    ++         L  V EYV   + +    ++     +  
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             I+L+M+QLLR L+Y H   I HRD+KPQNLL+
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 11/48 (22%), Positives = 23/48 (47%), Gaps = 1/48 (2%)

Query: 81  GDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           G +   +  AY     +G GS+  VF+     +++ VA+K++   +  
Sbjct: 32  GKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF 78

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 6/40 (15%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYV 476
           RE  +++ +KH N+V L    ++         L  V EYV
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  117 bits (295), Expect = 2e-29
 Identities = 39/167 (23%), Positives = 58/167 (34%), Gaps = 52/167 (31%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKL DFG A+    PS                YI                         
Sbjct: 170 TLKLCDFGSAKK-LSPSEPNVA-----------YI------------------------- 192

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        + +YR P+++ G+  Y+T++D+W VGCI  EM+ G P F G      
Sbjct: 193 ------------CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-G 239

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLY 224
           QL +I ++LG P+ E    ++  P +         G      F    
Sbjct: 240 QLHEIVRVLGCPSREVLRKLN--PSHTDVDLYNSKGIPWSNVFSDHS 284

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  106 bits (268), Expect = 9e-26
 Identities = 32/110 (29%), Positives = 49/110 (44%), Gaps = 15/110 (13%)

Query: 267 PFTAIREASLLKELK---HNNIVTLHDIVHTRST-------LTFVFEYVHTDLSQYMERH 316
           P    RE  ++++L    H NIV L    +T          L  V EYV   L +    +
Sbjct: 60  PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119

Query: 317 SGG---LDHHNIRLFMFQLLRGLSYCHRR--RILHRDVKPQNLLISEIDH 361
                      I++F+FQL+R +   H     + HRD+KP N+L++E D 
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG 169

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 10/37 (27%), Positives = 17/37 (45%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL 124
            D +      G+G++ TV  G    T   VA+K++  
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ 58

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  117 bits (295), Expect = 5e-29
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 9/94 (9%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHSGG---LDH 322
           RE  ++++L H NIV L    ++         L  V +YV   + +    +S     L  
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI 356
             ++L+M+QL R L+Y H   I HRD+KPQNLL+
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  117 bits (294), Expect = 7e-29
 Identities = 42/150 (28%), Positives = 62/150 (41%), Gaps = 52/150 (34%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKL DFG A+   V                  YI                         
Sbjct: 195 VLKLCDFGSAKQ-LVRGEPNVS-----------YI------------------------- 217

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        + +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG   V D
Sbjct: 218 ------------CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-D 264

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHR 207
           QL +I K+LGTPT E    ++  P Y   +
Sbjct: 265 QLVEIIKVLGTPTREQIREMN--PNYTEFK 292

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 16/88 (18%), Positives = 32/88 (36%), Gaps = 1/88 (1%)

Query: 41  PRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP-FGKADAYIKLDQLGE 99
           PR  S     K    P           +  S  +   +  G  P   +  +Y     +G 
Sbjct: 5   PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64

Query: 100 GSYATVFKGYSNLTNQVVALKEIRLQEE 127
           GS+  V++     + ++VA+K++   + 
Sbjct: 65  GSFGVVYQAKLCDSGELVAIKKVLQDKR 92

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 6/40 (15%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYV 476
           RE  ++++L H NIV L    ++         L  V +YV
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  112 bits (282), Expect = 8e-28
 Identities = 41/109 (37%), Positives = 61/109 (55%), Gaps = 9/109 (8%)

Query: 270 AIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYV-HTDLSQYMERHSGGLDHHNI 325
             RE  +L+ L+   NI+TL DIV      T   VFE+V +TD  Q  +  +   D+  I
Sbjct: 77  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYD-I 132

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
           R +M+++L+ L YCH   I+HRDVKP N++I   +H  +RL  + L   
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEF 180

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  108 bits (271), Expect = 2e-26
 Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 58/164 (35%)

Query: 32  RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY 91
            ++ R+ KP      V ++      R+L+L D+GLA     P   Y+ +           
Sbjct: 150 GIMHRDVKP----HNVMIDH---EHRKLRLIDWGLAEF-YHPGQEYNVR----------- 190

Query: 92  IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD 151
                                    VA            + +++ P++L+    Y  SLD
Sbjct: 191 -------------------------VA------------SRYFKGPELLVDYQMYDYSLD 213

Query: 152 MWGVGCILIEMVTG-LPTFPGVREVYDQLDKIFKILGTPTEETW 194
           MW +GC+L  M+    P F G  + YDQL +I K+LGT     +
Sbjct: 214 MWSLGCMLASMIFRKEPFFHG-HDNYDQLVRIAKVLGTEDLYDY 256

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 13/46 (28%), Positives = 26/46 (56%)

Query: 85  FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           +G  D Y  + +LG G Y+ VF+  +   N+ V +K ++  +++ I
Sbjct: 32  WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 77

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 16/39 (41%), Positives = 21/39 (53%), Gaps = 3/39 (7%)

Query: 441 AIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYV 476
             RE  +L+ L+   NI+TL DIV      T   VFE+V
Sbjct: 77  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  112 bits (282), Expect = 2e-27
 Identities = 41/141 (29%), Positives = 66/141 (46%), Gaps = 28/141 (19%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+ADFGL+R+        ++   S     + +     +              LT+ V 
Sbjct: 147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI--------------LTDYVA 192

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P++LLGST+Y+  +DMW +GCIL E++ G P FPG     +
Sbjct: 193 -------------TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG-SSTMN 238

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL++I  ++  P+ E  E + 
Sbjct: 239 QLERIIGVIDFPSNEDVESIQ 259

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 29/92 (31%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 270 AIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYVHTDLSQYMERHSGGLDHHNIR 326
             RE  +L EL  H NIV L +++   +   +  VF+Y+ TDL   +   +  L+  + +
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI--RANILEPVHKQ 112

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             ++QL++ + Y H   +LHRD+KP N+L++ 
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA 144

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  109 bits (275), Expect = 2e-26
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 50/141 (35%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKL DFG A+   +PS                YI                         
Sbjct: 180 TLKLCDFGSAKK-LIPSEPSVA-----------YI------------------------- 202

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        + +YR P+++LG+TEY+ S+D+W +GC+  E++ G P F G   + D
Sbjct: 203 ------------CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI-D 249

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL +I +I+GTPT+E    ++
Sbjct: 250 QLVRIIQIMGTPTKEQMIRMN 270

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 45/136 (33%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRST------------------------------- 297
              RE  ++K L H NI+ L D  +T                                  
Sbjct: 46  YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIV 105

Query: 298 -------LTFVFEYVHTDLSQYMERHSGG-----LDHHNIRLFMFQLLRGLSYCHRRRIL 345
                  L  + EYV   L + ++          ++   I ++++QL R + + H   I 
Sbjct: 106 NPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNL--ISIYIYQLFRAVGFIHSLGIC 163

Query: 346 HRDVKPQNLLISEIDH 361
           HRD+KPQNLL++  D+
Sbjct: 164 HRDIKPQNLLVNSKDN 179

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 9/34 (26%), Positives = 16/34 (47%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL 124
           Y     LG GS+  V + +   + +  ALK++  
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ 42

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  110 bits (277), Expect = 2e-26
 Identities = 46/171 (26%), Positives = 64/171 (37%), Gaps = 51/171 (29%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+ DFGLAR    P +  S    SP       +                   LT  VV
Sbjct: 194 SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK--------RQLTGHVV 245

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL----------- 166
                        T WYR P+++L    Y+ ++D+W +GCI  E++  +           
Sbjct: 246 -------------TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRG 292

Query: 167 PTFPG-------------------VREVYDQLDKIFKILGTPTEETWEGVS 198
           P FPG                    R   DQL+ IF ILGTP+EE  E + 
Sbjct: 293 PLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALE 343

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  108 bits (271), Expect = 1e-25
 Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 6/95 (6%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHH 323
             +RE ++L  L H+++V + DIV  +    F     V E   +D  +   R    L   
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLF-RTPVYLTEL 156

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +I+  ++ LL G+ Y H   ILHRD+KP N L+++
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 12/41 (29%), Positives = 20/41 (48%), Gaps = 5/41 (12%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEY 475
             +RE ++L  L H+++V + DIV  +    F     V E 
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  103 bits (259), Expect = 8e-25
 Identities = 35/141 (24%), Positives = 49/141 (34%), Gaps = 46/141 (32%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LK+ DFGLAR          H                                L+  +V
Sbjct: 159 VLKIGDFGLARIMD------PHYSHKGH--------------------------LSEGLV 186

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P +LL    Y+ ++DMW  GCI  EM+TG   F G     +
Sbjct: 187 -------------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG-AHELE 232

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           Q+  I + +    EE  + + 
Sbjct: 233 QMQLILESIPVVHEEDRQELL 253

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 16/105 (15%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT--------------FVFEYVHTDLSQYMER 315
           A+RE  +++ L H+NIV + +I+    +                 V EY+ TDL+  +  
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL-- 112

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             G L   + RLFM+QLLRGL Y H   +LHRD+KP NL I+  D
Sbjct: 113 EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  103 bits (259), Expect = 2e-24
 Identities = 41/135 (30%), Positives = 55/135 (40%), Gaps = 39/135 (28%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           +LK+ DFGLAR     +   S                               S +   V 
Sbjct: 150 DLKVCDFGLARIIDESAADNSEPTGQQ-------------------------SGMVEFVA 184

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+V+L S +YS ++D+W  GCIL E+    P FPG R+   
Sbjct: 185 -------------TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG-RDYRH 230

Query: 178 QLDKIFKILGTPTEE 192
           QL  IF I+GTP  +
Sbjct: 231 QLLLIFGIIGTPHSD 245

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +LK  KH NI+T+ +I    S   F     + E + TDL + +   +  L   +
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDH 113

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           I+ F++Q LR +   H   ++HRD+KP NLLI+ 
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS 147

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  103 bits (258), Expect = 3e-24
 Identities = 43/141 (30%), Positives = 60/141 (42%), Gaps = 46/141 (32%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           +LK+ DFGLAR              + F                          LT  V 
Sbjct: 166 DLKICDFGLARVAD------PDHDHTGF--------------------------LTEYVA 193

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   D
Sbjct: 194 -------------TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLD 239

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL+ I  ILG+P++E    + 
Sbjct: 240 QLNHILGILGSPSQEDLNCII 260

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 7/94 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +         V + + TDL + +   +  L + +
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLL--KTQHLSNDH 129

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           I  F++Q+LRGL Y H   +LHRD+KP NLL++ 
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  102 bits (256), Expect = 4e-24
 Identities = 31/141 (21%), Positives = 51/141 (36%), Gaps = 50/141 (35%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ++ + DF LAR  +  +                                    N T+ V 
Sbjct: 172 DITICDFNLAREDTADA------------------------------------NKTHYVT 195

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                          WYR P++++    ++  +DMW  GC++ EM      F G    Y+
Sbjct: 196 -------------HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG-STFYN 241

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL+KI +++GTP  E     S
Sbjct: 242 QLNKIVEVVGTPKIEDVVMFS 262

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 95.8 bits (239), Expect = 8e-22
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  LL    H NI+ L DI              V E + TDL+Q +      +   +
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           I+ FM+ +L GL   H   ++HRD+ P N+L+++
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  101 bits (253), Expect = 5e-24
 Identities = 22/90 (24%), Positives = 45/90 (50%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNN--IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
             E + L +L+ ++  I+ L+D   T   +  V E  + DL+ ++++    +D    + +
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSY 132

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              +L  +   H+  I+H D+KP N LI +
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD 162

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 30/150 (20%), Positives = 42/150 (28%), Gaps = 58/150 (38%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKL DFG+A    +   T S   DS  G                                
Sbjct: 165 LKLIDFGIANQ--MQPDTTSVVKDSQVG-------------------------------- 190

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILIEMVTGLPT 168
                       T+ Y PP+ +             ++ S   D+W +GCIL  M  G   
Sbjct: 191 ------------TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

Query: 169 FPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           F  +     +L  I  I      E  +   
Sbjct: 239 FQQIINQISKLHAI--IDPNHEIEFPDIPE 266

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 1/36 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           Y  L Q+G G  + VF+   N   Q+ A+K + L+E
Sbjct: 30  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEE 64

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  100 bits (252), Expect = 2e-23
 Identities = 42/141 (29%), Positives = 57/141 (40%), Gaps = 52/141 (36%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELK+ DFGLAR                                         S +T  VV
Sbjct: 166 ELKILDFGLARQAD--------------------------------------SEMTGYVV 187

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G  +  D
Sbjct: 188 -------------TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG-SDHLD 233

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL +I K+ GTP  E  + + 
Sbjct: 234 QLKEIMKVTGTPPAEFVQRLQ 254

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 8/95 (8%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+     TL        V  ++ TDL + M      L   
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGED 128

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            I+  ++Q+L+GL Y H   I+HRD+KP NL ++E
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  100 bits (250), Expect = 2e-23
 Identities = 22/90 (24%), Positives = 45/90 (50%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNN--IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
             E + L +L+ ++  I+ L+D   T   +  V E  + DL+ ++++    +D    + +
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSY 113

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              +L  +   H+  I+H D+KP N LI +
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD 143

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 30/150 (20%), Positives = 42/150 (28%), Gaps = 58/150 (38%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKL DFG+A    +   T S   DS  G                                
Sbjct: 146 LKLIDFGIANQ--MQPDTTSVVKDSQVG-------------------------------- 171

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILIEMVTGLPT 168
                       T+ Y PP+ +             ++ S   D+W +GCIL  M  G   
Sbjct: 172 ------------TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

Query: 169 FPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           F  +     +L  I  I      E  +   
Sbjct: 220 FQQIINQISKLHAI--IDPNHEIEFPDIPE 247

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 13/36 (36%), Positives = 20/36 (55%), Gaps = 1/36 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           Y  L Q+G G  + VF+   N   Q+ A+K + L+E
Sbjct: 11  YSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEE 45

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (250), Expect = 3e-23
 Identities = 40/141 (28%), Positives = 58/141 (41%), Gaps = 52/141 (36%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELK+ DFGLAR                                         + +T  VV
Sbjct: 164 ELKILDFGLARHAD--------------------------------------AEMTGYVV 185

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G ++  D
Sbjct: 186 -------------TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG-KDYLD 231

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL +I K+ G P  E  + ++
Sbjct: 232 QLTQILKVTGVPGTEFVQKLN 252

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+    S+L        V  ++ TDL + M          
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK---FSEE 126

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            I+  ++Q+L+GL Y H   ++HRD+KP NL ++E
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 99.3 bits (248), Expect = 5e-23
 Identities = 39/141 (27%), Positives = 58/141 (41%), Gaps = 52/141 (36%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           ELK+ DFGLAR  +                                        +T  V 
Sbjct: 170 ELKILDFGLARHTA--------------------------------------DEMTGYVA 191

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG  +  D
Sbjct: 192 -------------TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHID 237

Query: 178 QLDKIFKILGTPTEETWEGVS 198
           QL  I +++GTP  E  + +S
Sbjct: 238 QLKLILRLVGTPGAELLKKIS 258

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 8/95 (8%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
             RE  LLK +KH N++ L D+     +L        V   +  DL+  +      L   
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV--KCQKLTDD 132

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +++  ++Q+LRGL Y H   I+HRD+KP NL ++E
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 98.7 bits (246), Expect = 9e-23
 Identities = 22/89 (24%), Positives = 45/89 (50%), Gaps = 3/89 (3%)

Query: 272 REASLLKELKHNN--IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            E + L +L+ ++  I+ L+D   T   +  V E  + DL+ ++++    +D    + + 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYW 161

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +L  +   H+  I+H D+KP N LI +
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIVD 190

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 5/88 (5%)

Query: 39  KPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLG 98
             PR              + +   D G            S   +    K   Y  L Q+G
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLG----TDDDDKASSSANECISVKGRIYSILKQIG 65

Query: 99  EGSYATVFKGYSNLTNQVVALKEIRLQE 126
            G  + VF+   N   Q+ A+K + L+E
Sbjct: 66  SGGSSKVFQVL-NEKKQIYAIKYVNLEE 92

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 29/150 (19%), Positives = 41/150 (27%), Gaps = 58/150 (38%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
           LKL DFG+A    +   T S   DS  G                                
Sbjct: 193 LKLIDFGIANQ--MQPDTTSVVKDSQVG-------------------------------- 218

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILIEMVTGLPT 168
                        + Y PP+ +             ++ S   D+W +GCIL  M  G   
Sbjct: 219 ------------AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

Query: 169 FPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           F  +     +L  I  I      E  +   
Sbjct: 267 FQQIINQISKLHAI--IDPNHEIEFPDIPE 294

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 98.7 bits (246), Expect = 1e-22
 Identities = 43/168 (25%), Positives = 65/168 (38%), Gaps = 53/168 (31%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+ DFGLAR  +    T          +   + K  +               LT+ VV
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLK-------------KQLTSHVV 213

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL----------- 166
                        T WYR P+++L    Y+ S+D+W  GCI  E++  L           
Sbjct: 214 -------------TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 167 PTFPG----------------VREVYDQLDKIFKILGTPTEETWEGVS 198
           P FPG                 +   DQL+ IF I+GTPTE+  + ++
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN 308

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF-----VFEYVHTDLSQYMERHSGGLDHHN 324
            +RE ++L  LK + I+ L+D++     L F     V E   +DL +   +    L   +
Sbjct: 72  ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF-KTPIFLTEEH 130

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           I+  ++ LL G ++ H   I+HRD+KP N L+++
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ 164

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 97.6 bits (243), Expect = 5e-22
 Identities = 45/166 (27%), Positives = 65/166 (39%), Gaps = 59/166 (35%)

Query: 33  VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI 92
           ++ R+ KP    S + +         LK+ DFGLAR            G S         
Sbjct: 185 IIHRDLKP----SNIVVKSDC----TLKILDFGLAR----------TAGTSFM------- 219

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
                              +T  VV             T +YR P+V+L    Y  ++D+
Sbjct: 220 -------------------MTPYVV-------------TRYYRAPEVIL-GMGYKENVDI 246

Query: 153 WGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           W VGCI+ EMV     FPG R+  DQ +K+ + LGTP  E  + + 
Sbjct: 247 WSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTPCPEFMKKLQ 291

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 89.1 bits (221), Expect = 3e-19
 Identities = 29/95 (30%), Positives = 51/95 (53%), Gaps = 9/95 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++     LDH 
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHE 164

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +   ++Q+L G+ + H   I+HRD+KP N+++  
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 95.5 bits (238), Expect = 8e-22
 Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 4/99 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRL 327
           + RE ++L  +KH NIV   +      +L  V +Y    DL + +    G       I  
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  Q+   L + H R+ILHRD+K QN+ +++     ++L
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTK--DGTVQL 166

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 12/54 (22%), Positives = 22/54 (40%)

Query: 73  PSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
            S       +  F   + Y++L ++GEGS+       S    +   +KEI +  
Sbjct: 8   SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 26/140 (18%), Positives = 42/140 (30%), Gaps = 57/140 (40%)

Query: 47  VFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVF 106
           +FL K  T    ++L DFG+AR  +                               A   
Sbjct: 156 IFLTKDGT----VQLGDFGIARVLN--------------------------STVELARAC 185

Query: 107 KGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL 166
            G                      T +Y  P++      Y+   D+W +GC+L E+ T  
Sbjct: 186 IG----------------------TPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLK 222

Query: 167 PTFPGVREVYDQLDKIFKIL 186
             F          + + KI+
Sbjct: 223 HAFEA----GSMKNLVLKII 238

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.8 bits (236), Expect = 2e-21
 Identities = 45/166 (27%), Positives = 66/166 (39%), Gaps = 59/166 (35%)

Query: 33  VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI 92
           ++ R+ KP    S + +         LK+ DFGLAR            G S         
Sbjct: 148 IIHRDLKP----SNIVVKSDC----TLKILDFGLAR----------TAGTSFM------- 182

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDM 152
                              +T  VV             T +YR P+V+LG   Y  ++D+
Sbjct: 183 -------------------MTPYVV-------------TRYYRAPEVILGM-GYKENVDI 209

Query: 153 WGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           W VGCI+ EM+ G   FPG  +  DQ +K+ + LGTP  E  + + 
Sbjct: 210 WSVGCIMGEMIKGGVLFPG-TDHIDQWNKVIEQLGTPCPEFMKKLQ 254

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI+ L ++   + +L        V E +  +L Q ++     LDH 
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHE 127

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +   ++Q+L G+ + H   I+HRD+KP N+++  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 162

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 30/106 (28%), Positives = 55/106 (51%), Gaps = 7/106 (6%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
            E  +  +LKH +I+ L++     + +  V E  H  ++++Y++        +  R FM 
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q++ G+ Y H   ILHRD+   NLL++   + NI++  F    GL+
Sbjct: 120 QIITGMLYLHSHGILHRDLTLSNLLLTR--NMNIKIADF----GLA 159

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 29/111 (26%), Positives = 43/111 (38%), Gaps = 16/111 (14%)

Query: 270 AIREASLLKELKHNNIVTLHD-------------IVHTRSTLTFVFEYVHT-DLSQYMER 315
            + E  LL  L H  +V  +               V  +STL    EY     L   +  
Sbjct: 49  ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS 108

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            +             Q+L  LSY H + I+HRD+KP N+ I E    N+++
Sbjct: 109 ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE--SRNVKI 157

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 23/141 (16%), Positives = 39/141 (27%), Gaps = 37/141 (26%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            +K+ DFGLA+                          +  G     T   G         
Sbjct: 154 NVKIGDFGLAKNVHRSLDILKLDSQ------------NLPGSSDNLTSAIG--------- 192

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        T  Y   +VL G+  Y+  +DM+ +G I  EM+    T      +  
Sbjct: 193 -------------TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNIL- 238

Query: 178 QLDKIFKILGTPTEETWEGVS 198
              K+  +      +  +   
Sbjct: 239 --KKLRSVSIEFPPDFDDNKM 257

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 12/38 (31%), Positives = 24/38 (63%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + ++  LG+G++  V K  + L ++  A+K+IR  EE+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK 45

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 37/105 (35%), Positives = 61/105 (58%), Gaps = 7/105 (6%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S LK L+H +I+ L+D++ T + +  V EY   +L  Y+      +     R F  Q
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQ 116

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           ++  + YCHR +I+HRD+KP+NLL+ +  + N+++  F    GLS
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDD--NLNVKIADF----GLS 155

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 16/39 (41%), Positives = 24/39 (61%), Gaps = 3/39 (7%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV---LF 478
           RE S LK L+H +I+ L+D++ T + +  V EY    LF
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELF 96

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 89.6 bits (223), Expect = 4e-20
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 2/88 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
            E S+ + L H ++V  H        +  V E      L +  +R    L     R ++ 
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLR 122

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           Q++ G  Y HR R++HRD+K  NL ++E
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNE 150

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 91.4 bits (227), Expect = 5e-20
 Identities = 28/94 (29%), Positives = 42/94 (44%), Gaps = 1/94 (1%)

Query: 270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           A RE  LL+E  +H N++        R       E     L +Y+E+             
Sbjct: 64  ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITL 123

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           + Q   GL++ H   I+HRD+KP N+LIS  + H
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAH 157

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 40.5 bits (95), Expect = 9e-04
 Identities = 11/59 (18%), Positives = 25/59 (42%), Gaps = 9/59 (15%)

Query: 131 TLWYRPPDVLLGSTE--YSTSLDMWGVGCILIEMVT-GLPTFPGVREVYDQLDKIFKIL 186
           T  +  P++L    +   + ++D++  GC+   +++ G   F         L +   IL
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF------GKSLQRQANIL 241

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 28/118 (23%), Positives = 49/118 (41%), Gaps = 10/118 (8%)

Query: 272 REASLLKELKHN--NIVTLHDIVHTRSTLTFVFEYVHT--DLSQYMERHSGGLDHHNIRL 327
            E  LLK++      ++ L D      +   + E      DL  ++    G L     R 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARS 153

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILH 385
           F +Q+L  + +CH   +LHRD+K +N+LI   +   ++L  F    G     +  +  
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDF----GSGALLKDTVYT 206

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
            E S+ + L H ++V  H        +  V E      L +  +R    L     R ++ 
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLR 148

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q++ G  Y HR R++HRD+K  NL ++E     +++  F    GL+
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNE--DLEVKIGDF----GLA 188

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 88.9 bits (221), Expect = 9e-20
 Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 1/90 (1%)

Query: 270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
            + E    +++ +H   V L         L    E     L Q+ E     L    +  +
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGY 162

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +   L  L++ H + ++H DVKP N+ +  
Sbjct: 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGP 192

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 5/88 (5%)

Query: 38  RKPPRPKSEVFLNK-YATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQ 96
                    ++    +   PR      F    ++++ S  Y       F +   + +L +
Sbjct: 9   SGVDLGTENLYFQSMHQLQPRR---VSFRGEASETLQSPGYDPSRPESFFQQS-FQRLSR 64

Query: 97  LGEGSYATVFKGYSNLTNQVVALKEIRL 124
           LG GSY  VFK  S    ++ A+K    
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMS 92

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 22/123 (17%), Positives = 35/123 (28%), Gaps = 55/123 (44%)

Query: 47  VFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVF 106
           +FL          KL DFGL                             +LG      V 
Sbjct: 188 IFLGPRGR----CKLGDFGLLV---------------------------ELGTAGAGEVQ 216

Query: 107 KGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL 166
           +G                         Y  P++L GS  Y T+ D++ +G  ++E+   +
Sbjct: 217 EG----------------------DPRYMAPELLQGS--YGTAADVFSLGLTILEVACNM 252

Query: 167 PTF 169
              
Sbjct: 253 ELP 255

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 5/100 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF--VFEYVHT-DLSQYMERH--SGGLDHHNIR 326
           RE  +LK+L H NIV L  I    +T     + E+     L   +E    + GL      
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           + +  ++ G+++     I+HR++KP N++    +      
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 11/35 (31%), Positives = 18/35 (51%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR 123
             ++  D LG+G+ A VF+G    T  + A+K   
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN 43

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 22/135 (16%), Positives = 35/135 (25%), Gaps = 56/135 (41%)

Query: 59  LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVA 118
            KL DFG AR                           +L +        G          
Sbjct: 155 YKLTDFGAAR---------------------------ELEDDEQFVSLYG---------- 177

Query: 119 LKEIRLQEEEGITLWYRPPDVLLGST-------EYSTSLDMWGVGCILIEMVTGLPTFPG 171
                       T  Y  PD+   +        +Y  ++D+W +G       TG   F  
Sbjct: 178 ------------TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

Query: 172 VREVYDQLDKIFKIL 186
                   + ++KI+
Sbjct: 226 FEGPRRNKEVMYKII 240

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE   LK  +H +I+ L+ ++ T +    V EYV   +L  Y+ +H G ++    R    
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQ 118

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L  + YCHR  ++HRD+KP+N+L+    H N ++  F    GLS
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADF----GLS 158

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 12/34 (35%), Positives = 19/34 (55%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           RE   LK  +H +I+ L+ ++ T +    V EYV
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYV 93

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 4/93 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHS---GGLDHHNI 325
            I+E  LLK+L H N++  +      + L  V E     DLS+ ++        +    +
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV 138

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  QL   L + H RR++HRD+KP N+ I+ 
Sbjct: 139 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITA 171

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 11/62 (17%), Positives = 27/62 (43%), Gaps = 2/62 (3%)

Query: 65  GLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRL 124
           G    +  P    + + D  +     +    ++G G ++ V++    L    VALK++++
Sbjct: 10  GPPVPQFQPQK--ALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67

Query: 125 QE 126
            +
Sbjct: 68  FD 69

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 43.8 bits (104), Expect = 6e-05
 Identities = 27/140 (19%), Positives = 40/140 (28%), Gaps = 55/140 (39%)

Query: 47  VFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVF 106
           VF+         +KL D GL R  S                           + + A   
Sbjct: 167 VFITATGV----VKLGDLGLGRFFS--------------------------SKTTAAHSL 196

Query: 107 KGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL 166
            G                      T +Y  P+ +  +  Y+   D+W +GC+L EM    
Sbjct: 197 VG----------------------TPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQ 233

Query: 167 PTFPGVREVYDQLDKIFKIL 186
             F G +     L    KI 
Sbjct: 234 SPFYGDKMNLYSL--CKKIE 251

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 27/115 (23%), Positives = 47/115 (40%), Gaps = 20/115 (17%)

Query: 270 AIREASLLKELKHNNIVTLHD----------------IVHTRSTLTFVFEYVHT-DLSQY 312
           A RE   L +L H NIV  +                        L    E+     L Q+
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 313 MERHSGG-LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +E+  G  LD         Q+ +G+ Y H +++++RD+KP N+ +   D   +++
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV--DTKQVKI 163

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 7/38 (18%), Positives = 19/38 (50%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + +++ +G G +  VFK    +  +   +K ++   E+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEK 50

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 23/136 (16%), Positives = 39/136 (28%), Gaps = 54/136 (39%)

Query: 47  VFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVF 106
           +FL       +++K+ DFGL                              L      T  
Sbjct: 153 IFLVDT----KQVKIGDFGLVT---------------------------SLKNDGKRTRS 181

Query: 107 KGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL 166
           KG                      TL Y  P+ +    +Y   +D++ +G IL E++   
Sbjct: 182 KG----------------------TLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVC 218

Query: 167 PTFPGVREVYDQLDKI 182
            T     + +  L   
Sbjct: 219 DTAFETSKFFTDLRDG 234

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 87.4 bits (217), Expect = 3e-19
 Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++K L H NIV L +++ T  TL  + EY    ++  Y+  H G +     R    
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFR 121

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q++  + YCH++RI+HRD+K +NLL+      NI++  F    G S
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDA--DMNIKIADF----GFS 161

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 14/34 (41%), Positives = 20/34 (58%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           RE  ++K L H NIV L +++ T  TL  + EY 
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           +E  + K L H N+V  +      +      EY    +L   +E    G+   + + F  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH 112

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           QL+ G+ Y H   I HRD+KP+NLL+ E    N+++  F    GL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDF----GLA 152

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 10/40 (25%), Positives = 15/40 (37%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           +E  + K L H N+V  +      +      EY     LF
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 26/105 (24%), Positives = 38/105 (36%), Gaps = 10/105 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF----VFEYVHT-DLSQYMERHS---GGLD 321
           A REA + +   H NI+ L                +  +     L   +ER       L 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
              I   +  + RGL   H +   HRD+KP N+L+   D     L
Sbjct: 133 EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG--DEGQPVL 175

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 14/65 (21%), Positives = 22/65 (33%), Gaps = 10/65 (15%)

Query: 74  SHTYSHQGDSPFGKADA----------YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR 123
           SH + H                     Y+ + +LGEG ++ V            ALK I 
Sbjct: 4   SHHHHHHSSGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL 63

Query: 124 LQEEE 128
             E++
Sbjct: 64  CHEQQ 68

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 6/106 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMF 330
           RE    + L+H NIV   +++ T + L  + EY    +L + +    G       R F  
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQ 123

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           QLL G+SYCH  +I HRD+K +N L+       +++  F    G S
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF----GYS 165

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 40.8 bits (96), Expect = 7e-04
 Identities = 11/34 (32%), Positives = 18/34 (52%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           RE    + L+H NIV   +++ T + L  + EY 
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 88.2 bits (218), Expect = 9e-19
 Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 9/102 (8%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHT-DLSQYMERH--SGGLDH 322
            E  ++K+L H N+V+  ++      L          EY    DL +Y+ +     GL  
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
             IR  +  +   L Y H  RI+HRD+KP+N+++       I
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLI 162

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 9/37 (24%), Positives = 18/37 (48%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
             +   ++LG G +  V +     T + VA+K+ R +
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE 50

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           +E  + K L H N+V  +      +      EY    +L   +E    G+   + + F  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFH 112

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           QL+ G+ Y H   I HRD+KP+NLL+ E    N+++  F    GL+
Sbjct: 113 QLMAGVVYLHGIGITHRDIKPENLLLDE--RDNLKISDF----GLA 152

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 10/40 (25%), Positives = 15/40 (37%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           +E  + K L H N+V  +      +      EY     LF
Sbjct: 54  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 29/106 (27%), Positives = 52/106 (49%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  +   L+H NI+ L+   H  + +  + EY     + + + +     D      ++ 
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYIT 116

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +L   LSYCH +R++HRD+KP+NLL+       +++  F    G S
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGS--AGELKIADF----GWS 156

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 5/100 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF--VFEYVHT-DLSQYMERH--SGGLDHHNIR 326
           RE  +LK+L H NIV L  I    +T     + E+     L   +E    + GL      
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL 115

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           + +  ++ G+++     I+HR++KP N++    +      
Sbjct: 116 IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 11/35 (31%), Positives = 18/35 (51%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR 123
             ++  D LG+G+ A VF+G    T  + A+K   
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFN 43

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 21/104 (20%), Positives = 46/104 (44%), Gaps = 11/104 (10%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E  ++ ++K+   +T   I+     +  ++EY+                + ++  +   
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 324 NIRLFMFQLLRGLSYCHRRR-ILHRDVKPQNLLISEIDHHNIRL 366
            I+  +  +L   SY H  + I HRDVKP N+L+ +  +  ++L
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK--NGRVKL 193

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 6/34 (17%), Positives = 17/34 (50%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
            E  ++ ++K+   +T   I+     +  ++EY+
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 36/143 (25%), Positives = 64/143 (44%), Gaps = 12/143 (8%)

Query: 238 QVRDAAILNPMEHVHNCEKEGGNGPKNGAPFTAI-REASLLKELKHNNIVTLHDIVH--T 294
           ++   A               G   +   P   + +E ++LK+L H N+V L +++    
Sbjct: 50  KLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPN 109

Query: 295 RSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQN 353
              L  VFE V+   + +        L     R +   L++G+ Y H ++I+HRD+KP N
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167

Query: 354 LLISEIDHHNIRLFMFQLLRGLS 376
           LL+ E    +I++  F    G+S
Sbjct: 168 LLVGE--DGHIKIADF----GVS 184

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 13/36 (36%), Positives = 21/36 (58%), Gaps = 2/36 (5%)

Query: 443 REASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYV 476
           +E ++LK+L H N+V L +++       L  VFE V
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELV 120

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.3 bits (209), Expect = 3e-18
 Identities = 30/111 (27%), Positives = 47/111 (42%), Gaps = 12/111 (10%)

Query: 272 REASLLKEL----KHNNIVTLHDIVHTRSTLTFVFEYVHT--DLSQYMERHSGGLDHHNI 325
            E +LL ++     H  ++ L D   T+     V E      DL  Y+    G L     
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPS 141

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           R F  Q++  + +CH R ++HRD+K +N+LI        +L  F    G  
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-RRGCAKLIDF----GSG 187

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  +   L+H NI+ +++  H R  +  + E+    +L + +++H G  D      FM 
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFME 121

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           +L   L YCH R+++HRD+KP+NLL+       +++  F    G S
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGY--KGELKIADF----GWS 161

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 85.2 bits (211), Expect = 4e-18
 Identities = 26/98 (26%), Positives = 45/98 (45%), Gaps = 7/98 (7%)

Query: 270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS------GGLDH 322
           A+ E  LL E   H N++  +    T   L    E  + +L   +E  +           
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           +N    + Q+  G+++ H  +I+HRD+KPQN+L+S   
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 85.6 bits (212), Expect = 5e-18
 Identities = 39/106 (36%), Positives = 60/106 (56%), Gaps = 8/106 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE   LK  +H +I+ L+ ++ T S +  V EYV   +L  Y+ ++ G LD    R    
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQ 123

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           Q+L G+ YCHR  ++HRD+KP+N+L+    H N ++  F    GLS
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDA--HMNAKIADF----GLS 163

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 13/34 (38%), Positives = 20/34 (58%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           RE   LK  +H +I+ L+ ++ T S +  V EYV
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYV 98

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 32/117 (27%), Positives = 57/117 (48%), Gaps = 10/117 (8%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT--DLSQYMERHSGGLDHHNIRLFM 329
            E ++L  ++H NI+ + DI   +     V E   +  DL  +++RH   LD        
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIF 136

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS-YCHRRRILH 385
            QL+  + Y   + I+HRD+K +N++I+E     I+L  F    G + Y  R ++ +
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAE--DFTIKLIDF----GSAAYLERGKLFY 187

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 13/108 (12%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF--VFEYV-HTDLSQYMERHSGG---LDHH 323
            + E +LL+ELKH NIV  +D +  R+  T   V EY    DL+  + + +     LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 324 NIRLFMFQLLRGLSYCHRRR-----ILHRDVKPQNLLISEIDHHNIRL 366
            +   M QL   L  CHRR      +LHRD+KP N+ +      N++L
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKL 157

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 45.7 bits (109), Expect = 1e-05
 Identities = 10/40 (25%), Positives = 17/40 (42%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           +A+ Y  L  +G GSY    K       +++  KE+    
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS 43

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 32/156 (20%), Positives = 48/156 (30%), Gaps = 58/156 (37%)

Query: 44  KSE-VFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSY 102
           K   VFL+        +KL DFGLAR  +                           + S+
Sbjct: 143 KPANVFLDGKQN----VKLGDFGLARILN--------------------------HDTSF 172

Query: 103 ATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEM 162
           A  F G                      T +Y  P+ +     Y+   D+W +GC+L E+
Sbjct: 173 AKTFVG----------------------TPYYMSPEQMNR-MSYNEKSDIWSLGCLLYEL 209

Query: 163 VTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS 198
              +P F      + Q +   KI            S
Sbjct: 210 CALMPPFTA----FSQKELAGKIREGKFRRIPYRYS 241

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 28/88 (31%), Positives = 37/88 (42%), Gaps = 2/88 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
            E      L    IV L+  V     +    E +    L Q + +  G L       ++ 
Sbjct: 99  EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLG 157

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           Q L GL Y H RRILH DVK  N+L+S 
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSS 185

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 9/38 (23%), Positives = 17/38 (44%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
                ++G GS+  V +     T    A+K++RL+   
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR 97

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 13/64 (20%), Positives = 25/64 (39%), Gaps = 7/64 (10%)

Query: 137 PDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL--GTPTEETW 194
           P+V++G       +D+W   C+++ M+ G   +      Y +     KI     P  E  
Sbjct: 225 PEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQ----YFRGPLCLKIASEPPPIREIP 279

Query: 195 EGVS 198
              +
Sbjct: 280 PSCA 283

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 26/110 (23%), Positives = 52/110 (47%), Gaps = 13/110 (11%)

Query: 272 REASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYV---HTDLSQYMERHSGGLDHHNIR 326
           +E  LL+ L+H N++ L D+++   +  +  V EY      ++   +             
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE--KRFPVCQAH 112

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            +  QL+ GL Y H + I+H+D+KP NLL++      +++       G++
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTT--GGTLKISAL----GVA 156

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 5/94 (5%)

Query: 270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHS---GGLDHHN 324
           A+RE      L +H+++V           +    EY +   L+  +  +           
Sbjct: 57  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           ++  + Q+ RGL Y H   ++H D+KP N+ IS 
Sbjct: 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISR 150

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 9/37 (24%), Positives = 19/37 (51%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
           + +L+++G G + +VFK    L   + A+K  +    
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA 49

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 82.1 bits (203), Expect = 4e-17
 Identities = 31/114 (27%), Positives = 53/114 (46%), Gaps = 21/114 (18%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH---------TDLSQYMERHSGGLDH 322
            E S++ +L H N++ L+D   +++ +  V EYV           +     E        
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL------- 187

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            +  LFM Q+  G+ + H+  ILH D+KP+N+L    D   I++  F    GL+
Sbjct: 188 -DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF----GLA 236

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 13/40 (32%), Positives = 23/40 (57%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
            E S++ +L H N++ L+D   +++ +  V EYV    LF
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.7 bits (200), Expect = 6e-17
 Identities = 26/114 (22%), Positives = 48/114 (42%), Gaps = 21/114 (18%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH---------TDLSQYMERHSGGLDH 322
           +E S+L   +H NI+ LH+   +   L  +FE++          T   +  ER       
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER------- 102

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             I  ++ Q+   L + H   I H D++P+N++        I++  F    G +
Sbjct: 103 -EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF----GQA 151

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 12/40 (30%), Positives = 22/40 (55%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           +E S+L   +H NI+ LH+   +   L  +FE++    +F
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 82.2 bits (203), Expect = 7e-17
 Identities = 23/114 (20%), Positives = 50/114 (43%), Gaps = 21/114 (18%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH---------TDLSQYMERHSGGLDH 322
           +E   +  L+H  +V LHD     + +  ++E++           + ++  E        
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED------- 255

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
                +M Q+ +GL + H    +H D+KP+N++ +    + ++L  F    GL+
Sbjct: 256 -EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF----GLT 304

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 41.4 bits (97), Expect = 6e-04
 Identities = 10/40 (25%), Positives = 20/40 (50%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           +E   +  L+H  +V LHD     + +  ++E++    LF
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELF 242

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 2/88 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           RE     +L H NIV++ D+         V EY+    LS+Y+E H G L       F  
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTN 118

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           Q+L G+ + H  RI+HRD+KPQN+LI  
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDS 146

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 30/92 (32%), Positives = 41/92 (44%), Gaps = 3/92 (3%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHN--IRLF 328
            E +L K LKH NIV           +    E V    LS  +    G L  +   I  +
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             Q+L GL Y H  +I+HRD+K  N+LI+   
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYS 159

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 11/44 (25%), Positives = 19/44 (43%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           + D       LG+G+Y  V+ G        +A+KEI  ++    
Sbjct: 20  EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS 63

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 26/103 (25%), Positives = 51/103 (49%), Gaps = 16/103 (15%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE S+L+++ H+N++TLHD+   R+ +  + E V                E         
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-------- 115

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
               F+ Q+L G++Y H ++I H D+KP+N+++ + +     +
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 15/40 (37%), Positives = 26/40 (65%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           RE S+L+++ H+N++TLHD+   R+ +  + E V    LF
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 27/103 (26%), Positives = 50/103 (48%), Gaps = 16/103 (15%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE S+L+++ H NI+TLHD+   R+ +  + E V                E         
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEE-------- 115

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
               F+ Q+L G++Y H ++I H D+KP+N+++ + +     +
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 25/40 (62%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           RE S+L+++ H NI+TLHD+   R+ +  + E V    LF
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 30/126 (23%), Positives = 45/126 (35%), Gaps = 1/126 (0%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
            E  L+K+L H NI  L+++      +  V E  H   L   +               + 
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
             +     C+   I       +  L        I   M Q+   L Y H + I HRD+KP
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196

Query: 391 QNLLIS 396
           +N L S
Sbjct: 197 ENFLFS 202

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 27/146 (18%), Positives = 41/146 (28%), Gaps = 54/146 (36%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
           E+KL DFGL++                             GE    T   G         
Sbjct: 208 EIKLVDFGLSK----------------------EFYKLNNGEYYGMTTKAG--------- 236

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTE-YSTSLDMWGVGCILIEMVTGLPTFPGVREVY 176
                        T ++  P+VL  + E Y    D W  G +L  ++ G   FPG     
Sbjct: 237 -------------TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG----- 278

Query: 177 DQLDKIF-KIL-GTPT--EETWEGVS 198
                   ++L          +  +S
Sbjct: 279 VNDADTISQVLNKKLCFENPNYNVLS 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 23/114 (20%), Positives = 48/114 (42%), Gaps = 21/114 (18%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH---------TDLSQYMERHSGGLDH 322
            E S++ +L H  ++ LHD    +  +  + E++           +  +  E        
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA------- 149

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             +  +M Q   GL + H   I+H D+KP+N++       ++++  F    GL+
Sbjct: 150 -EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF----GLA 198

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 10/40 (25%), Positives = 20/40 (50%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
            E S++ +L H  ++ LHD    +  +  + E++    LF
Sbjct: 97  NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELF 136

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 32/115 (27%), Positives = 57/115 (49%), Gaps = 22/115 (19%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE ++L+E++H NI+TLHDI   ++ +  + E V          +     E         
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-------- 108

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS--EIDHHNIRLFMFQLLRGLS 376
               F+ Q+L G+ Y H +RI H D+KP+N+++    + +  I+L  F    G++
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF----GIA 159

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 40.6 bits (96), Expect = 7e-04
 Identities = 16/40 (40%), Positives = 26/40 (65%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           RE ++L+E++H NI+TLHDI   ++ +  + E V    LF
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 11/100 (11%)

Query: 271 IREASLLKELKHNNIVTLH----DIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNI 325
             EA +LK L+H NIV  +      V  +  +  V E + +  L  Y++R    +    +
Sbjct: 73  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVL 131

Query: 326 RLFMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHN 363
           R +  Q+L+GL + H R   I+HRD+K  N+    I    
Sbjct: 132 RSWCRQILKGLQFLHTRTPPIIHRDLKCDNIF---ITGPT 168

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 40.8 bits (96), Expect = 5e-04
 Identities = 15/45 (33%), Positives = 25/45 (55%), Gaps = 4/45 (8%)

Query: 83  SPFGKADAYIKLDQ-LGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           S  G+   ++K D  +G GS+ TV+KG    T   VA  E++ ++
Sbjct: 22  SNDGR---FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 63

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 36/118 (30%), Positives = 52/118 (44%), Gaps = 25/118 (21%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV------------HTDLSQYMERHSGG 319
           REAS+   LKH +IV L +   +   L  VFE++                  Y E  +  
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA-- 132

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQN-LLISEIDHHNIRLFMFQLLRGLS 376
                   +M Q+L  L YCH   I+HRDVKP   LL S+ +   ++L  F    G++
Sbjct: 133 ------SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF----GVA 180

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 15/40 (37%), Positives = 21/40 (52%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           REAS+   LKH +IV L +   +   L  VFE++    L 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC 114

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           REA + ++L+H NIV LHD +   S    VF+ V              Y E  +      
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------ 107

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                + Q+L  ++YCH   I+HR++KP+NLL
Sbjct: 108 --SHCIQQILESIAYCHSNGIVHRNLKPENLL 137

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           REA + ++L+H NIV LHD +   S    VF+ V    LF
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 93

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 30/115 (26%), Positives = 55/115 (47%), Gaps = 22/115 (19%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE S+LKE++H N++TLH++   ++ +  + E V          +     E         
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE-------- 114

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS--EIDHHNIRLFMFQLLRGLS 376
               F+ Q+L G+ Y H  +I H D+KP+N+++    +    I++  F    GL+
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF----GLA 165

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 15/40 (37%), Positives = 26/40 (65%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           RE S+LKE++H N++TLH++   ++ +  + E V    LF
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 2/91 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMF 330
           REA     L+  ++V +HD       L      ++  DL+  + R  G L        + 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVR 141

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
           Q+   L   H     HRDVKP+N+L+S  D 
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDF 172

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 24/90 (26%), Positives = 44/90 (48%), Gaps = 3/90 (3%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
            E  +LK+L H  I+ + +          V E +   +L   +  +   L     +L+ +
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFY 246

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           Q+L  + Y H   I+HRD+KP+N+L+S  +
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQE 276

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 30/92 (32%), Positives = 45/92 (48%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           REA + ++L+H NIV LHD +   S    VF+ V              Y E  +      
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADA------ 130

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                + Q+L  ++YCH   I+HR++KP+NLL
Sbjct: 131 --SHCIQQILESIAYCHSNGIVHRNLKPENLL 160

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           REA + ++L+H NIV LHD +   S    VF+ V    LF
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 24/128 (18%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            +RE   L +L+H  IV   +           +   +T            L    I++  
Sbjct: 50  VMREVKALAKLEHPGIVRYFN----------AWLEKNTTEKLQPSSPKVYL---YIQM-- 94

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
                    C +   L   +  +  +  E +         Q+   + + H + ++HRD+K
Sbjct: 95  -------QLCRKEN-LKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLK 145

Query: 390 PQNLLISE 397
           P N+  + 
Sbjct: 146 PSNIFFTM 153

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 11/40 (27%), Positives = 19/40 (47%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
             +  +  LG G +  VF+  + + +   A+K IRL   E
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE 44

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 74.6 bits (183), Expect = 8e-15
 Identities = 14/92 (15%), Positives = 32/92 (34%), Gaps = 5/92 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH----SGGLDHHNIR 326
           +    LK    +  +  +     ++    V E   +  L   +  +       +    + 
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            F  ++L  +   H   I+H D+KP N ++  
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 6/92 (6%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTF----VFEYVH-TDLSQYMERHSGGLDHHNIR 326
           REA     L H  IV ++D     +        V EYV    L   +    G +      
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAI 119

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +    + L++ H+  I+HRDVKP N++IS 
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISA 151

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 24/117 (20%)

Query: 272 REASLLKELKHN-NIVTLHDIVHTRSTLTFVFEY----------VHTDLSQYMERHSGGL 320
            E ++L+  K    ++ LH++    S +  + EY          +        E      
Sbjct: 77  HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN----- 131

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQN-LLISEIDHHNIRLFMFQLLRGLS 376
              ++   + Q+L G+ Y H+  I+H D+KPQN LL S     +I++  F    G+S
Sbjct: 132 ---DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF----GMS 181

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 29/60 (48%), Positives = 39/60 (65%), Gaps = 2/60 (3%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+VLLG   Y  ++DMW +GCIL+EM TG P F G     DQ++KI ++LG P   
Sbjct: 223 FYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSG-ANEVDQMNKIVEVLGIPPAH 280

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 28/115 (24%), Positives = 49/115 (42%), Gaps = 11/115 (9%)

Query: 263 KNGAPFT--AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYME 314
           KN   F   A  E  LL+ +  ++    + IVH +    F      VFE +  +L   + 
Sbjct: 88  KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLR 147

Query: 315 RHSG-GLDHHNIRLFMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHNIRL 366
             +  G+  +  R F  Q+   L +       I+H D+KP+N+L+       I++
Sbjct: 148 NTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E ++LK++KH NIVTL DI  + +    V + V          +   Y E+ +      
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------ 108

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
              L + Q+L  + Y H   I+HRD+KP+NLL
Sbjct: 109 --SLVIQQVLSAVKYLHENGIVHRDLKPENLL 138

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 40.6 bits (96), Expect = 7e-04
 Identities = 16/40 (40%), Positives = 23/40 (57%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
            E ++LK++KH NIVTL DI  + +    V + V    LF
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELF 94

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 17/97 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E  +LK+L H  I+ + +          V E +             +  E         
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATC------ 116

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
             +L+ +Q+L  + Y H   I+HRD+KP+N+L+S  +
Sbjct: 117 --KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE 151

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           +E  ++K L H NI+ L++     + +  V E                + E  +      
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDA------ 108

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                M  +L  ++YCH+  + HRD+KP+N L
Sbjct: 109 --ARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           REA + + LKH NIV LHD +        +F+ V              Y E  +      
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--- 115

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                + Q+L  + +CH+  ++HR++KP+NLL
Sbjct: 116 -----IQQILEAVLHCHQMGVVHRNLKPENLL 142

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 16/40 (40%), Positives = 21/40 (52%), Gaps = 4/40 (10%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV----LF 478
           REA + + LKH NIV LHD +        +F+ V    LF
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF 98

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 26/62 (41%), Positives = 41/62 (66%), Gaps = 2/62 (3%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           + +YR P+V+LG   Y   +DMW +GCIL E++TG P  PG  +  DQL  + ++LG P+
Sbjct: 262 SRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPG-EDEGDQLACMIELLGMPS 319

Query: 191 EE 192
           ++
Sbjct: 320 QK 321

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 26/113 (23%), Positives = 55/113 (48%), Gaps = 9/113 (7%)

Query: 263 KNGAPFT--AIREASLLKELKHN------NIVTLHDIVHTRSTLTFVFEYVHTDLSQYME 314
           +N   F   A  E  +L+ L+        N++ + +    R+ +   FE +  +L + ++
Sbjct: 131 RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIK 190

Query: 315 RHSG-GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           ++   G     +R F   +L+ L   H+ RI+H D+KP+N+L+ +     I++
Sbjct: 191 KNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKV 243

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 7/92 (7%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I E  +L    H  IV L    +    L  + E+        +   M     GL    I+
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQ 120

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +   Q+L  L++ H +RI+HRD+K  N+L++ 
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 11/45 (24%), Positives = 23/45 (51%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITL 132
            + +  + +LG+G++  V+K  +  T  + A K I  + EE +  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED 62

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 4/90 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLF 328
            +     L  +    +  + D+VHTR+    V E++    L +  +              
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD---TSPSPVGAIRA 134

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           M  L       HR  +      P  + +S 
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSI 164

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 71.5 bits (176), Expect = 5e-14
 Identities = 27/92 (29%), Positives = 45/92 (48%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE  LLK+L H NI+ L +I+   S+   V E               ++ E  +  +   
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--- 126

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                + Q+  G++Y H+  I+HRD+KP+N+L
Sbjct: 127 -----IKQVFSGITYMHKHNIVHRDLKPENIL 153

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 19/59 (32%), Positives = 28/59 (47%), Gaps = 2/59 (3%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           YR P+V+L    +  S DMW  GC+L E+ TG   F    E  + L  +  I+    + 
Sbjct: 225 YRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRT-HEHMEHLAMMESIIQPIPKN 281

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 28/119 (23%), Positives = 58/119 (48%), Gaps = 6/119 (5%)

Query: 270 AIREASLLKELKH-----NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHH 323
           A  EA +LK++++     NNIV  H        +  +FE +   L + + R++  G    
Sbjct: 78  AKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIE 137

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
           +I+L+  ++L+ L+Y  +  + H D+KP+N+L+ +       + + ++  G      R 
Sbjct: 138 DIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 16/65 (24%), Positives = 31/65 (47%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK 423
           I+L+  ++L+ L+Y  +  + H D+KP+N+L+ +  F      V    D      +    
Sbjct: 139 IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 424 SNINL 428
           + I L
Sbjct: 199 TGIKL 203

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 16/92 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E  +L  L H NI+ L +I  T + ++ V E V          +   Y ER +      
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDA------ 150

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                + Q+L  ++Y H   I+HRD+KP+NLL
Sbjct: 151 --ADAVKQILEAVAYLHENGIVHRDLKPENLL 180

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 72.0 bits (177), Expect = 6e-14
 Identities = 21/59 (35%), Positives = 29/59 (49%), Gaps = 2/59 (3%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           YRPP+V+L    ++   D+W +GCIL E   G   F    E  + L  + KILG     
Sbjct: 205 YRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQT-HENREHLVMMEKILGPIPSH 261

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 20/102 (19%), Positives = 44/102 (43%), Gaps = 7/102 (6%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYMERHS-GGLDH 322
           A  E ++LK++K  +       V       F       FE +  +  ++++ ++      
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
            ++R   +QL   L + H  ++ H D+KP+N+L    +   +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETL 164

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 11/34 (32%), Positives = 19/34 (55%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           +R   +QL   L + H  ++ H D+KP+N+L   
Sbjct: 125 VRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 21/59 (35%), Positives = 31/59 (52%), Gaps = 2/59 (3%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           YR P+V+L    +S   D+W +GCILIE   G   FP   +  + L  + +ILG   + 
Sbjct: 200 YRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPT-HDSKEHLAMMERILGPLPKH 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 19/99 (19%), Positives = 42/99 (42%), Gaps = 7/99 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTF------VFEYVHTDLSQYMERHS-GGLDH 322
           A  E  +L+ L   +  +    V              VFE +      +++ +       
Sbjct: 58  ARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRL 117

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
            +IR   +Q+ + +++ H  ++ H D+KP+N+L  + D+
Sbjct: 118 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDY 156

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 10/34 (29%), Positives = 22/34 (64%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           IR   +Q+ + +++ H  ++ H D+KP+N+L  +
Sbjct: 120 IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 71.7 bits (176), Expect = 8e-14
 Identities = 29/88 (32%), Positives = 41/88 (46%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I+E   L++L+H N +          T   V EY     S  +E H   L    I     
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
             L+GL+Y H   ++HRDVK  N+L+SE
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSE 189

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 9/41 (21%), Positives = 21/41 (51%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
              +  L ++G GS+  V+       ++VVA+K++    ++
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ 93

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 70.7 bits (174), Expect = 9e-14
 Identities = 28/123 (22%), Positives = 48/123 (39%), Gaps = 35/123 (28%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
            E  +LK L H NI+ + ++      +  V E              GG       L    
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC-----------EGG------ELL--- 108

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ 391
                      RI+    + + L  SE     +   M Q++  L+Y H + ++H+D+KP+
Sbjct: 109 ----------ERIVSAQARGKAL--SEGY---VAELMKQMMNALAYFHSQHVVHKDLKPE 153

Query: 392 NLL 394
           N+L
Sbjct: 154 NIL 156

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 24/95 (25%), Positives = 46/95 (48%), Gaps = 9/95 (9%)

Query: 270 AIREASLLKELKHNNIVTLHDIV----HTRSTLTF-VFEYVH-TDLSQYMERHSGGLDHH 323
           A+ E   L E+ H +IV + + V         + + V EYV    L +   +    L   
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVA 182

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
               ++ ++L  LSY H   +++ D+KP+N++++E
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 15/110 (13%)

Query: 270 AIREASLLKELK-HNNIVTLHD-------IVHTRSTLTFVFEYVHT-DLSQYMERHS--G 318
            I+E   +K+L  H NIV              T      +   +    L +++++    G
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 319 GLDHHNIRLFMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHNIRL 366
            L    +    +Q  R + + HR++  I+HRD+K +NLL+S  +   I+L
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS--NQGTIKL 179

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 11/38 (28%), Positives = 17/38 (44%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
                 L EG +A V++     + +  ALK +   EEE
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE 67

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 23/92 (25%), Positives = 43/92 (46%), Gaps = 7/92 (7%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I+E S++++    ++V  +      + L  V EY      +D+   +   +  L    I 
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIA 128

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +   L+GL Y H  R +HRD+K  N+L++ 
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNT 160

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 14/40 (35%), Positives = 27/40 (67%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + +  L++LGEGSY +V+K     T Q+VA+K++ ++ + 
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL 68

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 17/96 (17%)

Query: 272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDH 322
           +E  +L+++  H NI+ L D   T +    VF+ +         T+     E+ +     
Sbjct: 72  KEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET----- 126

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              R  M  LL  +   H+  I+HRD+KP+N+L+ +
Sbjct: 127 ---RKIMRALLEVICALHKLNIVHRDLKPENILLDD 159

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 27/96 (28%), Positives = 48/96 (50%), Gaps = 17/96 (17%)

Query: 272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDH 322
           RE  +L+++  H +I+TL D   + S +  VF+ +         T+     E+ +     
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKET----- 202

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              R  M  LL  +S+ H   I+HRD+KP+N+L+ +
Sbjct: 203 ---RSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 23/92 (25%), Positives = 35/92 (38%), Gaps = 6/92 (6%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
             E  + K   H NIV         + L  V  ++      DL         G++   I 
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT--HFMDGMNELAIA 131

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  +L+ L Y H    +HR VK  ++LIS 
Sbjct: 132 YILQGVLKALDYIHHMGYVHRSVKASHILISV 163

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 10/65 (15%)

Query: 74  SHTYSHQGDSPFGK--------ADAYIKLDQLGEG--SYATVFKGYSNLTNQVVALKEIR 123
           +H + H  ++ + +           Y  L  +G+G     TV       T + V ++ I 
Sbjct: 2   AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61

Query: 124 LQEEE 128
           L+   
Sbjct: 62  LEACS 66

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 35/140 (25%), Positives = 59/140 (42%), Gaps = 31/140 (22%)

Query: 272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDH 322
           +E + LK  + H NIV LH++ H +     V E ++             + E  +  +  
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-- 111

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL-ISEIDHHNIRLFMFQLLRGLSYCHRR 381
                 M +L+  +S+ H   ++HRD+KP+NLL   E D+  I++  F    G +     
Sbjct: 112 ------MRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF----GFA----- 156

Query: 382 RILHRDVKPQNLLISEIVFT 401
               R   P N  +    FT
Sbjct: 157 ----RLKPPDNQPLKTPCFT 172

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 16/94 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE  LLK+L H NI+ L +I+   S+   V E               ++ E  +  +   
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--- 126

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                + Q+  G++Y H+  I+HRD+KP+N+L+ 
Sbjct: 127 -----IKQVFSGITYMHKHNIVHRDLKPENILLE 155

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 26/94 (27%), Positives = 44/94 (46%), Gaps = 16/94 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E ++LK L H NI+ L+D    +     V E               ++ E  +  +   
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI--- 141

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                + Q+L G++Y H+  I+HRD+KP+NLL+ 
Sbjct: 142 -----IKQVLSGVTYLHKHNIVHRDLKPENLLLE 170

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 22/68 (32%), Positives = 32/68 (47%), Gaps = 3/68 (4%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T +Y  P+VL     Y    D+W +G IL  ++ G P F G  +  + L K+ K   T  
Sbjct: 201 TAYYIAPEVLRKK--YDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYTFD 257

Query: 191 EETWEGVS 198
              W+ VS
Sbjct: 258 SPEWKNVS 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 1/88 (1%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           +E  +++ L+H N++    +++    L F+ EY+    L   ++             F  
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAK 115

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
            +  G++Y H   I+HRD+   N L+ E
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRE 143

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 16/94 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
           RE  LLK+L H NI+ L++    +     V E               ++ E  +  +   
Sbjct: 75  REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--- 131

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                + Q+L G++Y H+ +I+HRD+KP+NLL+ 
Sbjct: 132 -----IRQVLSGITYMHKNKIVHRDLKPENLLLE 160

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 23/72 (31%), Positives = 32/72 (44%), Gaps = 11/72 (15%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF-KIL-GT 188
           T +Y  P+VL G+  Y    D+W  G IL  +++G P F G          I  K+  G 
Sbjct: 191 TAYYIAPEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNG-----ANEYDILKKVEKGK 243

Query: 189 PT--EETWEGVS 198
            T     W+ VS
Sbjct: 244 YTFELPQWKKVS 255

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 29/136 (21%), Positives = 58/136 (42%), Gaps = 31/136 (22%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHHNIRL 327
           LL+  +H NI+TL D+      +  V E +              + ER +  +       
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV------- 121

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH--NIRLFMFQLLRGLSYCHRRRILH 385
            +F + + + Y H + ++HRD+KP N+L  +   +  +IR+  F    G +         
Sbjct: 122 -LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF----GFA--------- 167

Query: 386 RDVKPQNLLISEIVFT 401
           + ++ +N L+    +T
Sbjct: 168 KQLRAENGLLMTPCYT 183

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 22/149 (14%), Positives = 42/149 (28%), Gaps = 21/149 (14%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            +RE   L +L+H  IV   +         +  E     L                   +
Sbjct: 51  VMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110

Query: 330 -FQLLRGLSYCHRRRILHRDVKPQNLLI--------------------SEIDHHNIRLFM 368
             + +   S  +    L        L I                     + +H       
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 369 FQLLRGLSYCHRRRILHRDVKPQNLLISE 397
            Q+   + + H + ++HRD+KP N+  + 
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTM 199

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 40.6 bits (95), Expect = 7e-04
 Identities = 10/38 (26%), Positives = 19/38 (50%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           +  +  +G G +  VF+  + + +   A+K IRL   E
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE 45

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 24/92 (26%), Positives = 43/92 (46%), Gaps = 9/92 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
            +E ++L +     +   +      + L  + EY+      DL +      G LD   I 
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIA 122

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             + ++L+GL Y H  + +HRD+K  N+L+SE
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSE 154

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 19/41 (46%), Positives = 29/41 (70%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
            + + KL+++G+GS+  VFKG  N T +VVA+K I L+E E
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE 61

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 16/94 (17%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--------TDLSQYMERHSGGLDHH 323
            E SLLK L H NI+ L D+   +     V E+           +  ++ E  +  +   
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI--- 151

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS 357
                M Q+L G+ Y H+  I+HRD+KP+N+L+ 
Sbjct: 152 -----MKQILSGICYLHKHNIVHRDIKPENILLE 180

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 18/64 (28%), Positives = 31/64 (48%), Gaps = 6/64 (9%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG-----VREVYDQLDKIFKILGT 188
           YR P+VLLG+  +    D+W   C++ E++TG   F         +  D + +I ++LG 
Sbjct: 201 YRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

Query: 189 PTEE 192
               
Sbjct: 260 LPSY 263

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 32/122 (26%), Positives = 52/122 (42%), Gaps = 19/122 (15%)

Query: 263 KNGAPFT--AIREASLLKELK-----------HNNIVTLHDI-VHTRSTLT---FVFEYV 305
           +    +T  A  E  LL+ +             N+I+ L D   H          VFE +
Sbjct: 53  RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL 112

Query: 306 HTDLSQYMER-HSGGLDHHNIRLFMFQLLRGLSYCHRR-RILHRDVKPQNLLISEIDHHN 363
             +L   +++    G+    ++    QLL GL Y HRR  I+H D+KP+N+L+  +D   
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172

Query: 364 IR 365
             
Sbjct: 173 NL 174

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 20/91 (21%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            +E  +L+ L H NIV    I      + +  + E++    L +Y+ ++   ++      
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  Q+ +G+ Y   R+ +HRD+  +N+L+  
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVES 161

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 21/88 (23%), Positives = 39/88 (44%), Gaps = 2/88 (2%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMF 330
            E  +L++ +H NI+       T   L  V ++   + L  ++       +   +     
Sbjct: 69  NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISE 358
           Q  RG+ Y H + I+HRD+K  N+ + E
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHE 155

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 23/94 (24%), Positives = 43/94 (45%), Gaps = 5/94 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE  ++  L H NIV L+ ++H    +  V E+V   DL   +   +  +        M 
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129

Query: 331 QLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHH 362
            +  G+ Y   +   I+HRD++  N+ +  +D +
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDEN 163

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 16/56 (28%), Positives = 26/56 (46%), Gaps = 7/56 (12%)

Query: 81  GDSPFGKADAY-IKLDQL------GEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           G S F K+    +  +++      G+G +  V KG       VVA+K + L + EG
Sbjct: 4   GGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEG 59

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            RE  +LK L+H+NIV    +     R  L  + EY+ +  L  Y+++H   +DH  +  
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  Q+ +G+ Y   +R +HRD+  +N+L+  
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVEN 149

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 26/96 (27%), Positives = 43/96 (44%), Gaps = 8/96 (8%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY--------VHTDLSQYMERHSGGLDH 322
           ++E   + +  H NIV+ +     +  L  V +         +   +    E  SG LD 
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             I   + ++L GL Y H+   +HRDVK  N+L+ E
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 12/41 (29%), Positives = 20/41 (48%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
            D Y   + +G G+ A V   Y     + VA+K I L++ +
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ 54

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            RE  +LK L+H+NIV    +     R  L  + EY+ +  L  Y+++H   +DH  +  
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  Q+ +G+ Y   +R +HRD+  +N+L+  
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVEN 180

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 23/96 (23%), Positives = 38/96 (39%), Gaps = 23/96 (23%)

Query: 272 REASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG--LDH------ 322
           RE  +L + + H N++ L +          VFE +            GG  L H      
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKM-----------RGGSILSHIHKRRH 107

Query: 323 ---HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
                  + +  +   L + H + I HRD+KP+N+L
Sbjct: 108 FNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL 143

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 12/91 (13%), Positives = 23/91 (25%), Gaps = 8/91 (8%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTF--VFEYVHTDLSQYMER------HSGGLDHHNIRL 327
            +          L       +   +  +      DL              G      + +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              QL+R  +    + ++H    P NL I  
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMP 229

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 14/126 (11%), Positives = 28/126 (22%), Gaps = 7/126 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
                   L   +     D       L             + +   G  D+      +  
Sbjct: 111 EATFAAARLLGESPEEARDRRRL---LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ 391
               +        L      +           + +   QL+R  +    + ++H    P 
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDE----GILALHILTAQLIRLAANLQSKGLVHGHFTPD 223

Query: 392 NLLISE 397
           NL I  
Sbjct: 224 NLFIMP 229

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 129 GITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTF----PGVREVYDQLDKIF 183
            + + Y P + L  S   ++ +L+ W +G  +  +      F    PG++  + +     
Sbjct: 252 SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311

Query: 184 KILGTPTEETWEGVS 198
               +    +   + 
Sbjct: 312 PGTDSLAFGSCTPLP 326

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 26/92 (28%), Positives = 43/92 (46%), Gaps = 6/92 (6%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
            +EA L   LKH NI+ L  +      L  V E+     L++ +      +    +  + 
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWA 111

Query: 330 FQLLRGLSYCHRRR---ILHRDVKPQNLLISE 358
            Q+ RG++Y H      I+HRD+K  N+LI +
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQ 143

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            RE  +LK L  + IV    + +   R +L  V EY+    L  +++RH   LD   + L
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +  Q+ +G+ Y   RR +HRD+  +N+L+  
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVES 162

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 20/94 (21%), Positives = 40/94 (42%), Gaps = 4/94 (4%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMF 330
           RE    ++ +H N+V       +   L  +        L   +      LD +  R    
Sbjct: 78  REVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           ++++G+ Y H + ILH+D+K +N+     D+  +
Sbjct: 138 EIVKGMGYLHAKGILHKDLKSKNVF---YDNGKV 168

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 62.7 bits (153), Expect = 5e-11
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 5/92 (5%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGG--LDHHNIRLF 328
           RE +++K L+H NIV     V     L+ V EY+    L + + +      LD       
Sbjct: 83  REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSM 142

Query: 329 MFQLLRGLSYCHRRR--ILHRDVKPQNLLISE 358
            + + +G++Y H R   I+HR++K  NLL+ +
Sbjct: 143 AYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDK 174

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 9/92 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
           I E  +++E K+ NIV   D       L  V EY+     TD+          +D   I 
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIA 119

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
               + L+ L + H  +++HRD+K  N+L+  
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 11/38 (28%), Positives = 24/38 (63%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y + +++G+G+  TV+      T Q VA++++ LQ++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
                 +  L H +IV L  +    S+L  V +Y+    L  ++ +H G L    +  + 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+ +G+ Y     ++HR++  +N+L+  
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKS 150

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 23/89 (25%), Positives = 49/89 (55%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +QL   L+Y   +R +HRD+  +N+L+S 
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSS 526

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 23/89 (25%), Positives = 49/89 (55%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA  +++  H +IV L  ++ T + +  + E     +L  +++     LD  ++ L+ 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           +QL   L+Y   +R +HRD+  +N+L+S 
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSS 151

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 26/91 (28%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 271 IREASLLKELKHNNIVTLHDIV--HTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            +E  +L+ L H +I+           ++L  V EYV    L  Y+ RHS  +    + L
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLL 138

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           F  Q+  G++Y H +  +HRD+  +N+L+  
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 21/99 (21%), Positives = 35/99 (35%), Gaps = 23/99 (23%)

Query: 272 REASLLKEL-KHNNIVTLHDI----VHTRSTLTFVFEY----------VHTDLSQYMERH 316
           +E     +     +IV + D+     H +  L  + E                  + ER 
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129

Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
           +  +        M  +   + + H   I HRDVKP+NLL
Sbjct: 130 AAEI--------MRDIGTAIQFLHSHNIAHRDVKPENLL 160

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 21/101 (20%), Positives = 46/101 (45%), Gaps = 4/101 (3%)

Query: 259 GNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS 317
              PK       + EA ++  + + ++  L  I    ST+  + + +    L  Y+  H 
Sbjct: 55  ATSPKANKEI--LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHK 111

Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +    +  +  Q+ +G++Y   RR++HRD+  +N+L+  
Sbjct: 112 DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 19/92 (20%), Positives = 43/92 (46%), Gaps = 9/92 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH----TDLSQYMERHSGGLDHHNIR 326
             E  ++++ +H N+V ++        L  + E++     TD+          L+   I 
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV-----SQVRLNEEQIA 144

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                +L+ L+Y H + ++HRD+K  ++L++ 
Sbjct: 145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTL 176

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 10/42 (23%), Positives = 20/42 (47%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITL 132
                ++GEGS   V       + + VA+K + L++++   L
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL 88

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 8/98 (8%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYM--ERHSGGLDHHNIRL 327
           I E   L  + H NIV L+      + +  V EY     L   +            +   
Sbjct: 49  IVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 328 FMFQLLRGLSYCHRRR---ILHRDVKPQNLLISEIDHH 362
           +  Q  +G++Y H  +   ++HRD+KP NLL+      
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTV 144

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 13/99 (13%)

Query: 271 IREASLLKEL-KHNNIVTLHD------IVHTRSTLTFVFEYVH----TDLSQYMERHSGG 319
            +E ++LK+   H NI T +              L  V E+      TDL          
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNT 125

Query: 320 LDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L    I     ++LRGLS+ H+ +++HRD+K QN+L++E
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 164

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 50.1 bits (120), Expect = 7e-07
 Identities = 12/41 (29%), Positives = 23/41 (56%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           A  +  ++ +G G+Y  V+KG    T Q+ A+K + +  +E
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 15/34 (44%), Positives = 26/34 (76%)

Query: 364 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
           I     ++LRGLS+ H+ +++HRD+K QN+L++E
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 164

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 14/98 (14%), Positives = 36/98 (36%), Gaps = 11/98 (11%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYME------RHSGGL 320
           R       +K      +  +          +  F++  + ++L  + E           L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208

Query: 321 DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            HH       Q++R L+  H   ++H  ++P ++++ +
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 246

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 16/126 (12%), Positives = 36/126 (28%), Gaps = 6/126 (4%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
            E   L+ L+   I            +            + +       D   +  F   
Sbjct: 127 EEVLRLRLLRG--IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLY 184

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQ 391
                +      +L         L     HH       Q++R L+  H   ++H  ++P 
Sbjct: 185 PRMQSNLQTFGEVLLSHSSTHKSL----VHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240

Query: 392 NLLISE 397
           ++++ +
Sbjct: 241 DIVLDQ 246

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 16/104 (15%), Positives = 37/104 (35%), Gaps = 8/104 (7%)

Query: 272 REASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHT-DLSQYMERHSGG-LDHHNIRL 327
            E   L+   H N++ +     +      T +  ++    L   +   +   +D      
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115

Query: 328 FMFQLLRGLSYCHRRR--ILHRDVKPQNLLISEIDHHNIRLFMF 369
           F   + RG+++ H     I    +  ++++I E      R+ M 
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDE--DMTARISMA 157

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 60.1 bits (146), Expect = 5e-10
 Identities = 26/102 (25%), Positives = 35/102 (34%), Gaps = 29/102 (28%)

Query: 272 REASLLKEL-KHNNIVTLHDI----VHTRSTLTFVFEYVHTDLSQYMERHSGG--LDH-- 322
           RE  L     +  +IV + D+       R  L  V E +            GG       
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL-----------DGGELFSRIQ 151

Query: 323 -HNIRLF--------MFQLLRGLSYCHRRRILHRDVKPQNLL 355
               + F        M  +   + Y H   I HRDVKP+NLL
Sbjct: 152 DRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 17/184 (9%)

Query: 269 TAIREASLLKELKHNN--------IVTLHDIVHTRST----LTFVFEYVHTDLSQYMER- 315
           TA+ E  LLK +++++        +V L D           +  VFE +   L +++ + 
Sbjct: 79  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKS 138

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRR-RILHRDVKPQNLLISEIDHHNIRLFMFQLL-- 372
           +  GL    ++  + Q+L+GL Y H + RI+H D+KP+N+L+S  + +  RL        
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198

Query: 373 -RGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFH 431
             G        +        N L++ +   N   + V   D G+  W  +  +    +  
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ 258

Query: 432 YLPP 435
           Y   
Sbjct: 259 YRSL 262

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.1 bits (122), Expect = 4e-07
 Identities = 20/70 (28%), Positives = 30/70 (42%), Gaps = 6/70 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDK-----IFKI 185
           T  YR  +VL+GS  Y+T  D+W   C+  E+ TG   F          D+     I ++
Sbjct: 256 TRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314

Query: 186 LGTPTEETWE 195
           LG    +   
Sbjct: 315 LGKVPRKLIV 324

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 20/90 (22%), Positives = 38/90 (42%), Gaps = 2/90 (2%)

Query: 271 IREAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
           + +   +LK      IV       T + +    E + T   +  +R  G +    +    
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130

Query: 330 FQLLRGLSYCH-RRRILHRDVKPQNLLISE 358
             +++ L Y   +  ++HRDVKP N+L+ E
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDE 160

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 10/42 (23%), Positives = 21/42 (50%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + +    L ++G G+   V+K     T  V+A+K++R    +
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 14/54 (25%), Positives = 24/54 (44%), Gaps = 4/54 (7%)

Query: 345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISE 397
             +  K     I E     +      +++ L Y   +  ++HRDVKP N+L+ E
Sbjct: 110 AEKLKKRMQGPIPE---RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 17/104 (16%), Positives = 43/104 (41%), Gaps = 10/104 (9%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLT--FVFEYVHTDLSQYME------RHSGGLDH 322
           I    L+K+ +   ++ +         L+  F++  + ++L  + E           L H
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           H       Q++R L+  H   ++H  ++P ++++ +     + L
Sbjct: 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ--RGGVFL 247

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 8/34 (23%), Positives = 21/34 (61%), Gaps = 1/34 (2%)

Query: 365 RLFMF-QLLRGLSYCHRRRILHRDVKPQNLLISE 397
           RL +  Q++R L+  H   ++H  ++P ++++ +
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQ 241

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 9/64 (14%), Positives = 20/64 (31%), Gaps = 11/64 (17%)

Query: 131 TLWYRPPDVL----------LGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD 180
           +  + PP++              T  + S D W +G ++  +                 +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSE 323

Query: 181 KIFK 184
            IF+
Sbjct: 324 WIFR 327

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 19/89 (21%), Positives = 44/89 (49%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EA ++  + + ++  L  I    ST+  + + +    L  Y+  H   +    +  + 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+ +G++Y   RR++HRD+  +N+L+  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKT 152

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 22/89 (24%), Positives = 40/89 (44%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           ++EA +LK+  H NIV L  +   +  +  V E V   D   ++      L    +   +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                G+ Y   +  +HRD+  +N L++E
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTE 248

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 25/99 (25%), Positives = 35/99 (35%), Gaps = 23/99 (23%)

Query: 272 REASLLKEL-KHNNIVTLHDI----VHTRSTLTFVFEY----------VHTDLSQYMERH 316
           RE  L     +  +IV + D+       R  L  V E                  + ER 
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 317 SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL 355
           +  +        M  +   + Y H   I HRDVKP+NLL
Sbjct: 119 ASEI--------MKSIGEAIQYLHSINIAHRDVKPENLL 149

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V     +  V E      L   + +H G      +  + 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+  G+ Y   +R +HRD+  +NLL++ 
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLAT 156

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 57.6 bits (140), Expect = 2e-09
 Identities = 23/89 (25%), Positives = 45/89 (50%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EA ++K L H +IV L  I+        + E   + +L  Y+ER+   L    + L+ 
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+ + ++Y      +HRD+  +N+L++ 
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVAS 148

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 16/91 (17%), Positives = 39/91 (42%), Gaps = 1/91 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
              AS++ +L H ++V  + +         V E+V    L  Y++++   ++        
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
            QL   + +     ++H +V  +N+L+   +
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREE 150

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 15/87 (17%), Positives = 35/87 (40%), Gaps = 4/87 (4%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT---DLSQYMERHSGGLDHHNIRLFMFQL 332
            ++ +     VT +  +     +    E + T      + +      +    +      +
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 333 LRGLSYCH-RRRILHRDVKPQNLLISE 358
           ++ L + H +  ++HRDVKP N+LI+ 
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINA 145

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 14/42 (33%), Positives = 21/42 (50%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           KAD    + +LG G+Y  V K     + Q++A+K IR     
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS 46

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 14/54 (25%), Positives = 27/54 (50%), Gaps = 4/54 (7%)

Query: 345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISE 397
            ++ V  +   I E     +      +++ L + H +  ++HRDVKP N+LI+ 
Sbjct: 95  FYKQVIDKGQTIPE---DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 145

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 23/104 (22%), Positives = 46/104 (44%), Gaps = 5/104 (4%)

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYME 314
           K   N P        + EA+++++L +  IV +  I     +   V E      L++Y+ 
Sbjct: 53  KNEANDPALKDEL--LAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL- 108

Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           + +  +   NI   + Q+  G+ Y      +HRD+  +N+L+  
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 12/94 (12%), Positives = 30/94 (31%), Gaps = 6/94 (6%)

Query: 271 IREAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEY----VHTDLSQYMERHSGGLDHHNI 325
           + +   +++      IV  +  +          E                    +    +
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127

Query: 326 RLFMFQLLRGLSYCHR-RRILHRDVKPQNLLISE 358
                  ++ L++     +I+HRD+KP N+L+  
Sbjct: 128 GKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 13/42 (30%), Positives = 23/42 (54%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
            A+    L ++G G+Y +V K     + Q++A+K IR   +E
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE 61

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 23/90 (25%), Positives = 46/90 (51%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTD-LSQYMERHSGGLDHHNIRLFM 329
           IRE  +L E     IV  +   ++   ++   E++    L Q +++  G +    +    
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVS 137

Query: 330 FQLLRGLSYCH-RRRILHRDVKPQNLLISE 358
             +++GL+Y   + +I+HRDVKP N+L++ 
Sbjct: 138 IAVIKGLTYLREKHKIMHRDVKPSNILVNS 167

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 14/42 (33%), Positives = 22/42 (52%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           K D + K+ +LG G+   VFK     +  V+A K I L+ + 
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 12/35 (34%), Positives = 23/35 (65%), Gaps = 1/35 (2%)

Query: 364 IRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISE 397
           +      +++GL+Y   + +I+HRDVKP N+L++ 
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 167

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 56.4 bits (137), Expect = 4e-09
 Identities = 19/89 (21%), Positives = 41/89 (46%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
            +EA  + +L H  +V  + +      +  V EY+ +  L  Y+  H  GL+   +    
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           + +  G+++    + +HRD+  +N L+  
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDR 139

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  V E++ H  LS Y+    G      +    
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGE 139

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 20/89 (22%), Positives = 40/89 (44%), Gaps = 2/89 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           +REA ++ +L +  IV L  +      L  V E      L +++      +   N+   +
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q+  G+ Y   +  +HRD+  +N+L+  
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVN 145

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 56.2 bits (136), Expect = 8e-09
 Identities = 21/89 (23%), Positives = 40/89 (44%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++ +  H NI+ L  +V        V EY+ +  L  ++  H G      +   +
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G+ Y      +HRD+  +N+L+  
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDS 186

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 55.7 bits (135), Expect = 8e-09
 Identities = 18/89 (20%), Positives = 39/89 (43%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++  L H  +V L+ +   +  +  + EY+ +  L  Y+           +    
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +   + Y   ++ LHRD+  +N L+++
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVND 155

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 24/90 (26%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           +RE  L++ L H N++ L  I+     L   +  Y+ H DL Q++          ++  F
Sbjct: 70  LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+ RG+ Y   ++ +HRD+  +N ++ E
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDE 159

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 20/101 (19%), Positives = 42/101 (41%), Gaps = 4/101 (3%)

Query: 259 GNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS 317
           G    +      +REA ++ +L +  IV L  +      L  V E      L +++    
Sbjct: 374 GTEKADTEEM--MREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR 430

Query: 318 GGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +   N+   + Q+  G+ Y   +  +HR++  +N+L+  
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 17/89 (19%), Positives = 42/89 (47%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EA ++ +  H+NI+ L  ++     +  + EY+ +  L +++    G      +   +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G+ Y      +HRD+  +N+L++ 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNS 182

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 21/89 (23%), Positives = 42/89 (47%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++ +  H NI+ L  +V     +  V EY+ +  L  ++ +H        +   +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G+ Y      +HRD+  +N+LI+ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINS 182

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 20/90 (22%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRLF 328
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +   +    +   
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+   + Y  ++  +HRD+  +N L+ E
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGE 146

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 3e-08
 Identities = 82/551 (14%), Positives = 156/551 (28%), Gaps = 180/551 (32%)

Query: 13  QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPR-----ELKLADFGLA 67
            I        +   +  E R  L N      K  V         R     +L+ A   L 
Sbjct: 97  PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV--------SRLQPYLKLRQALLELR 148

Query: 68  RAKSVPSHTYSHQGDSPFGK----ADA---------------YIKL------DQLGEGSY 102
            AK+V        G    GK     D                ++ L      + + E   
Sbjct: 149 PAKNVLID-----GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203

Query: 103 ATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSL----DMW----- 153
             +++   N T++      I+L+         R    LL S  Y   L    ++      
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR----LLKSKPYENCLLVLLNVQNAKAW 259

Query: 154 ---GVGC-ILI-----EMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYN 204
               + C IL+     ++   L          D            T +  E  SLL    
Sbjct: 260 NAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL------TPD--EVKSLL---- 307

Query: 205 VHRDAPYTGNKLGLTFPRLYDIPEGE---------SMASAFLQVRDAAILNPMEHVHNCE 255
                 Y   +         D+P  E         S+ +  ++    A  +  +HV NC+
Sbjct: 308 ----LKYLDCRPQ-------DLPR-EVLTTNPRRLSIIAESIR-DGLATWDNWKHV-NCD 353

Query: 256 KEGGNGPKNGAPFTAIREASL--LK--ELKHNNIVTLHDIVHTRSTLTFVFEYVHTDL-S 310
           K            T I E+SL  L+  E +         +         VF      + +
Sbjct: 354 K-----------LTTIIESSLNVLEPAEYRKM----FDRL--------SVFPP-SAHIPT 389

Query: 311 QYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQ 370
             +      +   ++ + + +        H+  ++ +  K   + I      +I L +  
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNK-------LHKYSLVEKQPKESTISI-----PSIYLELKV 437

Query: 371 LLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF---------- 420
            L      H R I+     P+          +   ++   +D     +++          
Sbjct: 438 KLENEYALH-RSIVDHYNIPKTF--------DSDDLIPPYLD----QYFYSHIGHHLKNI 484

Query: 421 ------ESKSNINLSFHYL-----PPGAPFTAIRE-ASLLKELK-HNNIVTLHDIVHTR- 466
                      + L F +L          + A     + L++LK +   +  +D  + R 
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERL 544

Query: 467 --STLTFVFEY 475
             + L F+ + 
Sbjct: 545 VNAILDFLPKI 555

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.7 bits (128), Expect = 9e-08
 Identities = 64/426 (15%), Positives = 126/426 (29%), Gaps = 125/426 (29%)

Query: 75  HTYSHQGDSPFGKAD-AYIKLDQLGEGSYATVF--KGYSNLTNQVVALKEIR--LQEEEG 129
           H + H  D   G+    Y  +  + E ++   F  K   ++   +++ +EI   +  ++ 
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDA 60

Query: 130 ITLWYRPPDVLLGSTE------YSTSLDM---WGVGCILIEMVTGLPTFP-GVREVY-DQ 178
           ++   R    LL   E          L +   +     L+  +      P  +  +Y +Q
Sbjct: 61  VSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF-----LMSPIKTEQRQPSMMTRMYIEQ 115

Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQ 238
            D++           +    +   YNV R  PY   +  L                  L+
Sbjct: 116 RDRL-----------YNDNQVFAKYNVSRLQPYLKLRQAL------------------LE 146

Query: 239 VRDAA--ILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKE-------LKHNNIVTLH 289
           +R A   +++ +          G+G K            +  +       L   N  +  
Sbjct: 147 LRPAKNVLIDGV---------LGSG-KTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196

Query: 290 DIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV 349
            ++     L +  +   T  S +           NI+L +  +   L     RR+L    
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSS---------NIKLRIHSIQAEL-----RRLLKSKP 242

Query: 350 KPQNLLISEIDH----HNIRLFMFQLLRGLSYCHRRRIL--HRDVKPQNLLISEIVFTNL 403
               LL+  + +         F          C   +IL   R  +         V   L
Sbjct: 243 YENCLLV--LLNVQNAKAWNAFNLS-------C---KILLTTRFKQ---------VTDFL 281

Query: 404 SGVVVSTVDSGSGGWWF---ESKS----NINLSFHYLPP----GAPFTAIREASLLKELK 452
           S    + +            E KS     ++     LP       P   +   S++ E  
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPR-RL---SIIAESI 337

Query: 453 HNNIVT 458
            + + T
Sbjct: 338 RDGLAT 343

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 53.4 bits (129), Expect = 4e-08
 Identities = 20/90 (22%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIV-HTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++K+  H N+++L  I   +  +   V  Y+ H DL  ++   +      ++  F
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+ +G+ Y   ++ +HRD+  +N ++ E
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDE 163

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 19/90 (21%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRLF 328
           ++EA+++KE+KH N+V L  +         + E++ + +L  Y+   +   +    +   
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+   + Y  ++  +HR++  +N L+ E
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGE 353

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 2/92 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
            +E  +++ L+H  +V L         +  V + +   DL  ++++ +       ++LF+
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFI 121

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
            +L+  L Y   +RI+HRD+KP N+L+ E  H
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGH 153

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 25/90 (27%), Positives = 53/90 (58%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRLF 328
           + EA+L+K+L+H  +V L+ +V T+  +  + EY+ +  L  +++  SG  L  + +   
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G+++   R  +HRD++  N+L+S+
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSD 144

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 28/92 (30%), Positives = 45/92 (48%), Gaps = 2/92 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFM 329
            RE  ++  L H   V L+        L F   Y    +L +Y+ R  G  D    R + 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYT 136

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
            +++  L Y H + I+HRD+KP+N+L++E  H
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMH 168

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 41.4 bits (98), Expect = 3e-04
 Identities = 18/54 (33%), Positives = 26/54 (48%), Gaps = 7/54 (12%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF-KIL 186
           Y  P++L        S D+W +GCI+ ++V GLP F            IF KI+
Sbjct: 198 YVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRA-----GNEYLIFQKII 245

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 3/95 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L       I TLH      + L  V +Y    DL   + +    L     R ++ +
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           ++  +   H+   +HRD+KP N+L+    H  IRL
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRL 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 23/90 (25%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRLF 328
           + EA+++K L+H+ +V LH +V T+  +  + E++    L  +++   G       +  F
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G+++  +R  +HRD++  N+L+S 
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSA 319

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 23/92 (25%), Positives = 42/92 (45%), Gaps = 5/92 (5%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF--VFEYV-HTDLSQYMERHSGG-LDHHNIR 326
           + EAS++ +L+H+N+V L  ++          V EY+    L  Y+       L    + 
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 292

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            F   +   + Y      +HRD+  +N+L+SE
Sbjct: 293 KFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 324

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 25/115 (21%), Positives = 47/115 (40%), Gaps = 14/115 (12%)

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIV------HTRSTLTFVFEYV-HTD 308
           K       +   F  +REA+ +KE  H ++  L  +               +  ++ H D
Sbjct: 60  KADIIASSDIEEF--LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117

Query: 309 LSQYMERHSGGLDHHNIRL-----FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           L  ++     G +  N+ L     FM  +  G+ Y   R  +HRD+  +N +++E
Sbjct: 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 24/91 (26%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIV-HTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRL 327
           + EAS++ +L+H+N+V L  ++   +  L  V EY+    L  Y+       L    +  
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           F   +   + Y      +HRD+  +N+L+SE
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 152

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 52.1 bits (125), Expect = 2e-07
 Identities = 26/102 (25%), Positives = 52/102 (50%), Gaps = 8/102 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLS---QYMERHSGGLDHHNI 325
           A+ E  +L ++    IV+L     T++ L  V   ++  D+      ++  + G      
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH-NIRL 366
             +  Q++ GL + H+R I++RD+KP+N+L   +D   N+R+
Sbjct: 292 IFYTAQIVSGLEHLHQRNIIYRDLKPENVL---LDDDGNVRI 330

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 16/74 (21%), Positives = 30/74 (40%), Gaps = 7/74 (9%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF-KILGT---- 188
           +  P++LLG  EY  S+D + +G  L EM+     F    E  +   ++  ++L      
Sbjct: 355 FMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLEQAVTY 412

Query: 189 PTEETWEGVSLLPG 202
           P + +         
Sbjct: 413 PDKFSPASKDFCEA 426

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 19/90 (21%), Positives = 43/90 (47%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++K+  H N+++L  I          V  Y+ H DL  ++   +      ++  F
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+ +G+ +   ++ +HRD+  +N ++ E
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDE 227

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 21/102 (20%), Positives = 37/102 (36%), Gaps = 9/102 (8%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EA ++ +  H NIV    +         + E +   DL  ++ R +         L M
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-RETRPRPSQPSSLAM 139

Query: 330 FQLL-------RGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
             LL        G  Y      +HRD+  +N L++      +
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 24/90 (26%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSG-GLDHHNIRLF 328
           ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  L    +   
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGE 315

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  ++       +V L         L  V EY+   DL   M      +     R +  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 176

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           ++  L   H    +HRDVKP N+L+ +  H  ++L
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKL 209

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 26/99 (26%), Positives = 49/99 (49%), Gaps = 4/99 (4%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERH-SGGLDHHNIRL 327
           A+ E  +L+++    +V+L     T+  L  V   ++  DL  ++      G        
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           +  ++  GL   HR RI++RD+KP+N+L+ +  H  IR+
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRI 327

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 44.4 bits (105), Expect = 6e-05
 Identities = 16/57 (28%), Positives = 28/57 (49%), Gaps = 3/57 (5%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIF-KILGTP 189
           Y  P+V+     Y+ S D W +GC+L EM+ G   F   R+   + +++   +   P
Sbjct: 351 YMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVP 405

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 15/100 (15%)

Query: 272 REASLLKELKHNNIVTL----HDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIR 326
            E      L+H NI+      +    T + L  V +Y     L  Y+ R++  +    + 
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMI 142

Query: 327 LFMFQLLRGLSYCH--------RRRILHRDVKPQNLLISE 358
                   GL++ H        +  I HRD+K +N+L+ +
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 182

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 3/95 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L       I  LH      + L  V EY    DL   + +    +     R ++ +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
           ++  +   HR   +HRD+KP N+L+    H  IRL
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRL 203

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 23/114 (20%), Positives = 45/114 (39%), Gaps = 13/114 (11%)

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIV-----HTRSTLTFVFEYV-HTDL 309
           K   +  +    F  + EA+ +K+  H N++ L  +              +  ++ + DL
Sbjct: 71  KLDNSSQREIEEF--LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128

Query: 310 SQYMERHSGGLDHHNIRL-----FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Y+          +I L     FM  +  G+ Y   R  LHRD+  +N ++ +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 24/90 (26%), Positives = 49/90 (54%), Gaps = 3/90 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSG-GLDHHNIRLF 328
           ++EA ++K+L+H  +V L+ +V +   +  V EY+    L  +++  +G  L    +   
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+  G++Y  R   +HRD++  N+L+ E
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGE 398

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 50.3 bits (121), Expect = 6e-07
 Identities = 27/128 (21%), Positives = 57/128 (44%), Gaps = 17/128 (13%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + E ++LK++ H +++ L+        L  + EY  +  L  ++ R S  +    +    
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFL-RESRKVGPGYLGSGG 132

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
            +    L +   R +   D      LIS         F +Q+ +G+ Y    +++HRD+ 
Sbjct: 133 SRNSSSLDHPDERALTMGD------LIS---------FAWQISQGMQYLAEMKLVHRDLA 177

Query: 390 PQNLLISE 397
            +N+L++E
Sbjct: 178 ARNILVAE 185

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 19/98 (19%), Positives = 45/98 (45%), Gaps = 10/98 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL-- 327
           + EAS++KE   +++V L  +V        + E +   DL  Y+      + ++ +    
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135

Query: 328 -------FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
                     ++  G++Y +  + +HRD+  +N +++E
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 23/103 (22%), Positives = 40/103 (38%), Gaps = 11/103 (10%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + EA ++ +  H NIV    +   +S   F + E +   DL  ++ R +         L 
Sbjct: 122 LMEALIISKFNHQNIVRCIGVS-LQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLA 179

Query: 329 MFQLL-------RGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           M  LL        G  Y      +HRD+  +N L++      +
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L+ +    +V L       S L  V EYV   ++  ++ R  G     + R +  Q
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-RRIGRFSEPHARFYAAQ 149

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLI 356
           ++    Y H   +++RD+KP+NLLI
Sbjct: 150 IVLTFEYLHSLDLIYRDLKPENLLI 174

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 15/100 (15%)

Query: 272 REASLLKELKHNNIVTL----HDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIR 326
            E      L+H NI+          H+ + L  +  Y     L  Y++  +  LD  +  
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCL 108

Query: 327 LFMFQLLRGLSYCHRRR--------ILHRDVKPQNLLISE 358
             +  +  GL++ H           I HRD+K +N+L+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 20/100 (20%), Positives = 41/100 (41%), Gaps = 15/100 (15%)

Query: 272 REASLLKELKHNNIVTL----HDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIR 326
            E      ++H NI+           + + L  + +Y     L  Y++  +  LD  ++ 
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSML 137

Query: 327 LFMFQLLRGLSYCH--------RRRILHRDVKPQNLLISE 358
              +  + GL + H        +  I HRD+K +N+L+ +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 26/94 (27%), Positives = 52/94 (55%), Gaps = 6/94 (6%)

Query: 275 SLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLL 333
           SL+       IV +    HT   L+F+ + ++  DL  ++ +H G     ++R +  +++
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEII 302

Query: 334 RGLSYCHRRRILHRDVKPQNLLISEIDHH-NIRL 366
            GL + H R +++RD+KP N+L   +D H ++R+
Sbjct: 303 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRI 333

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 44.1 bits (104), Expect = 9e-05
 Identities = 13/39 (33%), Positives = 21/39 (53%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF 169
           T  Y  P+VL     Y +S D + +GC+L +++ G   F
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 16/104 (15%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNI---- 325
            REA LL  L+H +IV  + +      L  VFEY+ H DL++++  H             
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 326 ----RLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
                L + Q+L        G+ Y   +  +HRD+  +N L+  
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA 168

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 47.6 bits (114), Expect = 4e-06
 Identities = 24/107 (22%), Positives = 44/107 (41%), Gaps = 19/107 (17%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQY---------------- 312
           + E  +L  L  H NIV L            + EY  + DL  +                
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 313 -MERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            ME     LD  ++  F +Q+ +G+++   +  +HRD+  +N+L++ 
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 22/102 (21%), Positives = 39/102 (38%), Gaps = 17/102 (16%)

Query: 272 REASLLKELKHNNIVTL-----HDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNI 325
           +    +  ++H+NI              R     V EY  +  L +Y+  H+   D  + 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSS 113

Query: 326 RLFMFQLLRGLSYCH---------RRRILHRDVKPQNLLISE 358
                 + RGL+Y H         +  I HRD+  +N+L+  
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 47.5 bits (114), Expect = 5e-06
 Identities = 18/85 (21%), Positives = 40/85 (47%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L  + H  I+ +         +  + +Y+   +L   + R S    +   + +  +
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFPNPVAKFYAAE 114

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLI 356
           +   L Y H + I++RD+KP+N+L+
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILL 139

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 32/103 (31%), Positives = 47/103 (45%), Gaps = 15/103 (14%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHS-------GGLDH 322
            REA LL  L+H +IV    +      L  VFEY+ H DL++++  H        GG D 
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 323 HNIRLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
               L + QLL        G+ Y      +HRD+  +N L+ +
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 21/106 (19%), Positives = 42/106 (39%), Gaps = 17/106 (16%)

Query: 268 FTAIREASLLKELKHNNIVTL--HDIVHTRSTLTF--VFEYV-HTDLSQYMERHSGGLDH 322
           +    E   L  +KH NI+     +   T   +    +  +     LS +++ +   +  
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSW 120

Query: 323 HNIRLFMFQLLRGLSYCH----------RRRILHRDVKPQNLLISE 358
           + +      + RGL+Y H          +  I HRD+K +N+L+  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 46.8 bits (110), Expect = 8e-06
 Identities = 14/69 (20%), Positives = 25/69 (36%), Gaps = 4/69 (5%)

Query: 298 LTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILHRDVKPQNLLI 356
           +   FE+   DL Q   +          +  + QL   L+      R  HRD+   N+L+
Sbjct: 139 IVLEFEFGGIDLEQMRTKL---SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 357 SEIDHHNIR 365
            +     + 
Sbjct: 196 KKTSLKKLH 204

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 43.7 bits (102), Expect = 7e-05
 Identities = 21/157 (13%), Positives = 44/157 (28%), Gaps = 20/157 (12%)

Query: 251 VHNCEKEGGNGPKNGAPFTAIREASLLKEL---------KHNNIVTLHDIVHTRSTLTFV 301
           +     +  NG         + E  + KEL         +    + L+ +   + +   +
Sbjct: 51  IAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPL 110

Query: 302 FEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
                     +     G  +         QL   L +      L +     +        
Sbjct: 111 LLKAW----DHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLS------SL 160

Query: 362 HNIRLFMFQLLRGLSYCHRR-RILHRDVKPQNLLISE 397
              +  + QL   L+      R  HRD+   N+L+ +
Sbjct: 161 ATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 40.6 bits (94), Expect = 7e-04
 Identities = 9/42 (21%), Positives = 24/42 (57%), Gaps = 2/42 (4%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           +   + +++GEG +  VF+  ++  +  VA+K I ++  + +
Sbjct: 20  EKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLV 59

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 46.4 bits (111), Expect = 9e-06
 Identities = 24/105 (22%), Positives = 43/105 (40%), Gaps = 18/105 (17%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTF-VFEYV-HTDLSQYMERHSGGLDHHNI--- 325
             EA L   L+H N+V L  +V T+      +F Y  H DL +++   S   D  +    
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVV-TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 326 -----RLFMFQLL-------RGLSYCHRRRILHRDVKPQNLLISE 358
                 L     +        G+ Y     ++H+D+  +N+L+ +
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 163

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 18/90 (20%), Positives = 38/90 (42%), Gaps = 4/90 (4%)

Query: 301 VFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID 360
           + +   +DL +  E ++       +     ++L  L Y H    +H D+K  NLL++  +
Sbjct: 130 IMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189

Query: 361 HHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
              + L  +    GL+Y +    +H+    
Sbjct: 190 PDQVYLVDY----GLAYRYCPEGVHKAYAA 215

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 10/26 (38%), Positives = 15/26 (57%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L  L Y H    +H D+K  NLL+
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLL 185

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 28/130 (21%), Positives = 51/130 (39%), Gaps = 27/130 (20%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFV-FEYV-HTDLSQYMERHSGGLDHHNIRL 327
           + E  +L  +  H N+V L            V  E+    +LS Y               
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTY--------------- 122

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRD 387
                LR      R   +   V P++L    +   ++  + FQ+ +G+ +   R+ +HRD
Sbjct: 123 -----LRS----KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173

Query: 388 VKPQNLLISE 397
           +  +N+L+SE
Sbjct: 174 LAARNILLSE 183

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 11/61 (18%), Positives = 23/61 (37%), Gaps = 4/61 (6%)

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
           +LL  L + H    +H +V  +N+ +   D   + L  +    G ++ +     H     
Sbjct: 167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGY----GFAFRYCPSGKHVAYVE 222

Query: 391 Q 391
            
Sbjct: 223 G 223

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 27/129 (20%), Positives = 51/129 (39%), Gaps = 26/129 (20%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           I E  ++K + KH NI+ L         L  + EY    +L +Y                
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY---------------- 165

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
               L+      R   L     P +    ++   ++    +Q+ RG+ Y   ++ +HRD+
Sbjct: 166 ----LQA----RRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217

Query: 389 KPQNLLISE 397
             +N+L++E
Sbjct: 218 AARNVLVTE 226

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 26/129 (20%), Positives = 50/129 (38%), Gaps = 26/129 (20%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++K + KH NI+ L         L  + EY    +L +Y                
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY---------------- 131

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
               LR      R   +        +   ++   ++    +QL RG+ Y   ++ +HRD+
Sbjct: 132 ----LR----ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183

Query: 389 KPQNLLISE 397
             +N+L++E
Sbjct: 184 AARNVLVTE 192

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 2/87 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFMFQLLR 334
           L    K   +  LH    T   L FV EYV   DL  ++++  G     +   +  ++  
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAI 453

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
           GL +   + I++RD+K  N+++    H
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH 480

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+++     Y  S+D W  G +L EM+ G   F G    E++  +  +   +  P  
Sbjct: 508 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKS 564

Query: 192 ETWEGVSLLPG 202
            + E V++  G
Sbjct: 565 MSKEAVAICKG 575

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 22/129 (17%), Positives = 50/129 (38%), Gaps = 19/129 (14%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++ +L  H NIV L         +  +FEY  + DL  Y+               
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK------------ 143

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
                R           ++    +   ++ +   ++  F +Q+ +G+ +   +  +HRD+
Sbjct: 144 -----REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198

Query: 389 KPQNLLISE 397
             +N+L++ 
Sbjct: 199 AARNVLVTH 207

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 26/129 (20%), Positives = 50/129 (38%), Gaps = 26/129 (20%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++K + KH NI+ L         L  + EY    +L +Y                
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY---------------- 177

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
               LR      R   +        +   ++   ++    +QL RG+ Y   ++ +HRD+
Sbjct: 178 ----LRA----RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229

Query: 389 KPQNLLISE 397
             +N+L++E
Sbjct: 230 AARNVLVTE 238

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 4/60 (6%)

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
           ++L  L Y H    +H D+K  NLL+   +   + L  +    GLSY +     H+  + 
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY----GLSYRYCPNGNHKQYQE 214

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 10/26 (38%), Positives = 15/26 (57%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLI 395
           ++L  L Y H    +H D+K  NLL+
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLL 184

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 44.5 bits (106), Expect = 5e-05
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
             +   H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++  
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL 121

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            L+Y H R I++RD+K  N+L+    H  I+L
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGH--IKL 151

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 17/128 (13%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
            REA+L+ E  + NIV L  +      +  +FEY+ + DL++++   S            
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL----- 152

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
                          L    +  +     +          Q+  G++Y   R+ +HRD+ 
Sbjct: 153 -----------SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201

Query: 390 PQNLLISE 397
            +N L+ E
Sbjct: 202 TRNCLVGE 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 30/148 (20%), Positives = 47/148 (31%), Gaps = 10/148 (6%)

Query: 244 ILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKH-NNIVTLHDIVHTRSTLTFVF 302
           I    E     E      P          E+ + K ++    I T+            V 
Sbjct: 31  IAAGEEVAIKLECVKTKHP------QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84

Query: 303 EYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           E +   L       S       + L   Q++  + Y H +  +HRDVKP N L+      
Sbjct: 85  ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKG 144

Query: 363 N-IRLFMFQLLRGLSYCHRRRILHRDVK 389
           N + +  F L +   Y   R   H   +
Sbjct: 145 NLVYIIDFGLAKK--YRDARTHQHIPYR 170

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 2/82 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
             +   H  +V LH    T S L FV EYV+  DL  +M+R    L   + R +  ++  
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISL 164

Query: 335 GLSYCHRRRILHRDVKPQNLLI 356
            L+Y H R I++RD+K  N+L+
Sbjct: 165 ALNYLHERGIIYRDLKLDNVLL 186

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 43.7 bits (104), Expect = 7e-05
 Identities = 22/85 (25%), Positives = 42/85 (49%), Gaps = 2/85 (2%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQ 331
           E+ +L+  +H  +  L     T   L FV EY +  +L  ++ R          R +  +
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAE 113

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLI 356
           ++  L Y H R +++RD+K +NL++
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLML 138

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+VL    +Y  ++D WG+G ++ EM+ G   F       +++ +  + + +  P  
Sbjct: 171 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRFPRT 227

Query: 192 ETWEGVSLLPG 202
            + E  SLL G
Sbjct: 228 LSPEAKSLLAG 238

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 43.8 bits (104), Expect = 8e-05
 Identities = 24/129 (18%), Positives = 48/129 (37%), Gaps = 28/129 (21%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++  L +H NIV L         +  + EY  + DL  +                
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNF---------------- 140

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
               LR      R+  +        +  S     ++  F  Q+ +G+++   +  +HRDV
Sbjct: 141 ----LR------RKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190

Query: 389 KPQNLLISE 397
             +N+L++ 
Sbjct: 191 AARNVLLTN 199

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           L     H  +  L     T   L FV E+V+  DL  ++++ S   D    R +  +++ 
Sbjct: 77  LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIIS 135

Query: 335 GLSYCHRRRILHRDVKPQNLLISEIDH 361
            L + H + I++RD+K  N+L+    H
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGH 162

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 15/71 (21%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P++L     Y  ++D W +G +L EM+ G   F      ++++ +  +   +  PT 
Sbjct: 190 YIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--LNDEVVYPTW 246

Query: 192 ETWEGVSLLPG 202
              +   +L  
Sbjct: 247 LHEDATGILKS 257

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 43.4 bits (103), Expect = 1e-04
 Identities = 20/82 (24%), Positives = 40/82 (48%), Gaps = 2/82 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLR 334
           L    +H  +  +     T+  L FV EY++  DL  +++      D      +  +++ 
Sbjct: 71  LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIIL 129

Query: 335 GLSYCHRRRILHRDVKPQNLLI 356
           GL + H + I++RD+K  N+L+
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILL 151

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 41.4 bits (98), Expect = 4e-04
 Identities = 21/71 (29%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P++LLG  +Y+ S+D W  G +L EM+ G   F G    E++  +         P  
Sbjct: 184 YIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNPFYPRW 240

Query: 192 ETWEGVSLLPG 202
              E   LL  
Sbjct: 241 LEKEAKDLLVK 251

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 24/147 (16%), Positives = 46/147 (31%), Gaps = 8/147 (5%)

Query: 244 ILNPMEHVHNCEKEGGNGPKNGAPFTAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVF 302
           I    E     E      P        + E+ + + L+    I  +            V 
Sbjct: 29  IQTNEEVAIKLENVKTKHP------QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82

Query: 303 EYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH 362
           + +   L       S  L    + +   Q++  + + H +  LHRD+KP N L+      
Sbjct: 83  DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142

Query: 363 NIRLFMFQLLRGLSYCHRRRILHRDVK 389
           N ++++        Y       H   +
Sbjct: 143 N-QVYIIDFGLAKKYRDTSTHQHIPYR 168

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 14/56 (25%), Positives = 27/56 (48%), Gaps = 4/56 (7%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN 425
           Q++  + + H +  LHRD+KP N L+      N     V  +D G    + ++ ++
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAKKYRDTSTH 162

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 28/129 (21%), Positives = 45/129 (34%), Gaps = 26/129 (20%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
             E  +L +L  H NI+ L      R  L    EY  H +L  +                
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF---------------- 116

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
               LR      R           N   S +    +  F   + RG+ Y  +++ +HRD+
Sbjct: 117 ----LRK----SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 168

Query: 389 KPQNLLISE 397
             +N+L+ E
Sbjct: 169 AARNILVGE 177

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 19/71 (26%), Positives = 35/71 (49%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+VL    +Y  ++D WG+G ++ EM+ G   F      ++++ +  + + +  P  
Sbjct: 315 YLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEEIRFPRT 371

Query: 192 ETWEGVSLLPG 202
              E  SLL G
Sbjct: 372 LGPEAKSLLSG 382

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 22/91 (24%), Positives = 43/91 (47%), Gaps = 3/91 (3%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQ 331
           E  +L+  +H  +  L     T   L FV EY +  +L  ++ R          R +  +
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAE 256

Query: 332 LLRGLSYCHRRR-ILHRDVKPQNLLISEIDH 361
           ++  L Y H  + +++RD+K +NL++ +  H
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGH 287

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 2/82 (2%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLR 334
           L    K   +  LH    T   L FV EYV+  DL  ++++  G     +   +  ++  
Sbjct: 74  LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAI 132

Query: 335 GLSYCHRRRILHRDVKPQNLLI 356
           GL +   + I++RD+K  N+++
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVML 154

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 18/71 (25%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+++     Y  S+D W  G +L EM+ G   F G    E++  +  +   +  P  
Sbjct: 187 YIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--MEHNVAYPKS 243

Query: 192 ETWEGVSLLPG 202
            + E V++  G
Sbjct: 244 MSKEAVAICKG 254

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 22/92 (23%)

Query: 276 LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG-LDHHNIRLFMF---- 330
           LLK +KH  +V LH    T   L FV +Y+           +GG L +H  R   F    
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYI-----------NGGELFYHLQRERCFLEPR 140

Query: 331 ------QLLRGLSYCHRRRILHRDVKPQNLLI 356
                 ++   L Y H   I++RD+KP+N+L+
Sbjct: 141 ARFYAAEIASALGYLHSLNIVYRDLKPENILL 172

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 24/71 (33%), Positives = 33/71 (46%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+VL     Y  ++D W +G +L EM+ GLP F      E+YD +  + K L     
Sbjct: 205 YLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--LNKPLQLKPN 261

Query: 192 ETWEGVSLLPG 202
            T     LL G
Sbjct: 262 ITNSARHLLEG 272

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 13/58 (22%), Positives = 25/58 (43%)

Query: 308 DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIR 365
            L    +          + +   QL+  + Y H + +++RDVKP+N LI    +   +
Sbjct: 90  SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQ 147

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 12/26 (46%), Positives = 19/26 (73%)

Query: 370 QLLRGLSYCHRRRILHRDVKPQNLLI 395
           QL+  + Y H + +++RDVKP+N LI
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLI 138

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 25/95 (26%), Positives = 40/95 (42%), Gaps = 22/95 (23%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG-LDHHNIRLFMF- 330
           E  +L E+ H  IV LH    T   L  + +++            GG L     +  MF 
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL-----------RGGDLFTRLSKEVMFT 124

Query: 331 ---------QLLRGLSYCHRRRILHRDVKPQNLLI 356
                    +L   L + H   I++RD+KP+N+L+
Sbjct: 125 EEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 40.6 bits (96), Expect = 8e-04
 Identities = 21/71 (29%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P+V+     ++ S D W  G ++ EM+TG   F G   +E    +  +   LG P  
Sbjct: 192 YMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI--LKAKLGMPQF 248

Query: 192 ETWEGVSLLPG 202
            + E  SLL  
Sbjct: 249 LSPEAQSLLRM 259

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 26/95 (27%), Positives = 45/95 (47%), Gaps = 22/95 (23%)

Query: 273 EASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG-LDHHNIRLFMF- 330
           E ++L+E+KH  IV L     T   L  + EY+           SGG L     R  +F 
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYL-----------SGGELFMQLEREGIFM 119

Query: 331 ---------QLLRGLSYCHRRRILHRDVKPQNLLI 356
                    ++   L + H++ I++RD+KP+N+++
Sbjct: 120 EDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 41.0 bits (97), Expect = 6e-04
 Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 5/71 (7%)

Query: 134 YRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG--VREVYDQLDKIFKILGTPTE 191
           Y  P++L+  + ++ ++D W +G ++ +M+TG P F G   ++  D++  +   L  P  
Sbjct: 187 YMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI--LKCKLNLPPY 243

Query: 192 ETWEGVSLLPG 202
            T E   LL  
Sbjct: 244 LTQEARDLLKK 254

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 12/59 (20%), Positives = 25/59 (42%)

Query: 308 DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL 366
            L   ++          + +   Q+L  +   H + +++RD+KP N LI   +  N  +
Sbjct: 91  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANM 149

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 27/156 (17%), Positives = 53/156 (33%), Gaps = 29/156 (18%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFV-FEYV-HTDLSQYMERHSGGLDHHNIRL 327
           + E  +L  +  H N+V L            V  E+    +LS Y+         +  + 
Sbjct: 73  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKG 132

Query: 328 FMF------------QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRL--------- 366
             F             L R L      +        +   +S+++               
Sbjct: 133 ARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTL 192

Query: 367 -----FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
                + FQ+ +G+ +   R+ +HRD+  +N+L+SE
Sbjct: 193 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	481
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.98
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.98
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.96
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	99.95
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	99.95
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	99.95
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	99.95
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	99.95
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.95
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	99.95
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.95
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.95
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.95
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.94
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.94
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.94
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.94
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.94
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.94
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.94
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.94
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.94
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.94
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.94
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.94
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.94
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.94
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.94
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.94
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.93
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.93
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.93
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.93
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.93
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.93
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.93
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.93
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.93
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.93
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.93
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.93
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.92
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.92
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.92
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.92
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.92
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.92
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.92
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.92
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.92
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.92
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.92
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.92
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.92
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.92
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.92
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.92
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.92
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.92
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.92
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.92
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.92
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.92
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.92
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.92
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.92
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.92
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.92
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.92
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.92
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.92
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.92
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.92
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.91
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.91
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.91
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.91
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.91
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.91
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.91
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.91
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.91
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.91
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.91
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.91
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.91
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.91
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.91
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.91
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.91
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.91
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.91
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.91
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.91
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.91
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.91
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.91
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.91
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.91
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.91
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.91
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.91
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.91
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.9
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.9
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.9
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.9
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.9
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.9
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.9
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.9
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.9
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.9
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.9
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.9
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.9
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.9
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.9
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.9
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.9
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.9
3bhy_A	283	Death-associated protein kinase 3; death associate	99.9
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.9
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.9
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.9
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.9
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.9
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.9
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.9
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.9
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.9
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.9
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.9
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.9
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.9
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.9
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.9
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.9
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.9
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.9
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.9
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.9
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.9
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.9
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.89
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.89
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.89
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.89
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.89
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.89
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.89
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.89
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.89
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.89
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.89
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.89
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.89
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.89
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.89
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.89
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.89
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.89
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.89
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.89
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.89
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.89
3niz_A	311	Rhodanese family protein; structural genomics, str	99.89
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.89
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.89
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.89
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.89
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.89
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.89
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.89
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.89
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.89
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.89
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.89
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.89
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.89
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.89
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.89
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.89
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.89
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.89
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.89
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.89
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.89
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.89
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.89
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.89
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.88
3uqc_A	286	Probable conserved transmembrane protein; structur	99.88
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.88
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.88
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.88
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.88
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.88
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.88
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.88
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.88
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.88
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.88
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.88
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.88
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.88
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.88
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.88
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.88
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.88
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.88
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.88
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.87
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.87
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.87
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.87
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.87
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.87
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.87
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.87
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.87
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.87
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.87
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.87
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.87
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.87
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.86
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.86
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.86
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.86
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.86
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.86
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.86
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.86
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.86
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.86
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.86
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.86
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.86
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.86
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.85
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.85
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.85
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.85
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.85
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.85
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.85
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.85
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.85
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.85
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.85
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.84
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.84
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.84
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.84
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.84
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.84
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.84
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.84
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.84
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.84
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.84
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.84
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.84
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.84
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.84
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.84
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.83
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.83
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.83
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.83
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.83
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.83
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.83
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.83
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.83
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.83
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.83
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.83
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.83
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.83
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.83
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.83
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.83
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.83
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.83
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.83
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.83
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.83
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.83
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.83
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.82
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.82
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.82
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.82
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.82
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.82
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.82
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.82
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.82
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.82
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.82
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.82
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.82
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.82
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.82
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.82
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.82
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.82
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.82
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.82
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.82
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.82
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.81
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.81
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.81
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.81
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.81
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.81
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.81
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.81
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.81
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.81
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.81
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.81
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.81
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.81
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.81
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.81
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.81
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.81
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.81
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.8
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.8
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.8
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.8
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.8
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.8
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.8
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.8
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.8
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.8
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.8
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.8
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.8
3bhy_A	283	Death-associated protein kinase 3; death associate	99.8
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.8
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.8
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.8
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.8
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.8
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.8
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.8
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.8
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.8
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.8
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.8
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.8
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.8
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.79
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.79
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.79
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.79
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.79
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.79
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.79
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.79
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.79
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.79
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.79
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.79
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.79
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.79
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.79
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.79
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.79
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.78
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.78
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.78
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.78
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.78
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.78
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.78
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.78
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.78
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.78
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.78
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.78
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.78
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.78
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.78
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.78
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.78
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.78
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.78
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.78
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.78
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.77
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.77
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.77
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.77
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.77
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.77
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.77
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.77
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.77
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.77
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.77
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.77
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.77
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.77
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.77
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.76
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.76
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.76
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.76
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.76
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.76
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.76
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.76
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.76
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.76
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.76
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.76
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.76
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.76
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.75
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.75
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.75
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.75
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.75
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.73
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.73
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.72
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.72
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.7
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.67
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.67

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3e-38  Score=312.34  Aligned_cols=151  Identities=23%  Similarity=0.350  Sum_probs=129.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++|+|||||+++++|++++.+|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||+++|+||
T Consensus        78 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHR  156 (311)
T 4aw0_A           78 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHR  156 (311)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            46789999999999999999999999999999999999 6888888754 679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+......                                       .....++
T Consensus       157 DlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~---------------------------------------~~~~~~~  195 (311)
T 4aw0_A          157 DLKPENILLNEDMH--IQITDFGTAKVLSPESKQ---------------------------------------ARANSFV  195 (311)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECCTTTTC---------------------------------------CCBCCCC
T ss_pred             CCCHHHeEEcCCCC--EEEEEcCCceecCCCCCc---------------------------------------ccccCcc
Confidence            99999999998887  999999999754311000                                       0012367


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.||+|        +.++|+||+|+++|+|++|..||..+
T Consensus       196 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             SCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            88888888        66789999999999999999777544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=9e-38  Score=313.40  Aligned_cols=148  Identities=16%  Similarity=0.311  Sum_probs=126.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++|||||+++++|.+++.+|||||||+ |+|.+++..  +.+++..++.++.||+.||+|||+++||||
T Consensus       117 ~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHR  194 (346)
T 4fih_A          117 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR  194 (346)
T ss_dssp             GGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35689999999999999999999999999999999999 567777654  569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.....                                         .....+
T Consensus       195 DlKp~NILl~~~g~--vKl~DFGla~~~~~~~~-----------------------------------------~~~~~~  231 (346)
T 4fih_A          195 DIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP-----------------------------------------RRKSLV  231 (346)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECCSSSC-----------------------------------------CBCCCC
T ss_pred             cCCHHHEEECCCCC--EEEecCcCceecCCCCC-----------------------------------------cccccc
Confidence            99999999998887  99999999875431100                                         011356


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.||+|        +.++|+||+|+++|||++|..||..+
T Consensus       232 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  273 (346)
T 4fih_A          232 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  273 (346)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            77888887        67789999999999999999777654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-37  Score=315.86  Aligned_cols=148  Identities=16%  Similarity=0.311  Sum_probs=126.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.|+|||||+++++|.+++.+|||||||+ |+|.+++..  +.+++..++.++.||+.||+|||++|||||
T Consensus       194 ~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHR  271 (423)
T 4fie_A          194 LLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHR  271 (423)
T ss_dssp             GHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            46789999999999999999999999999999999999 567777653  569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +||+|||+|+.+.....                                         ....++
T Consensus       272 DiKp~NILl~~~g~--vKl~DFGla~~~~~~~~-----------------------------------------~~~~~~  308 (423)
T 4fie_A          272 DIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP-----------------------------------------RRKSLV  308 (423)
T ss_dssp             CCSTTTEEECTTCC--EEECCCTTCEECCSSCC-----------------------------------------CBCCCE
T ss_pred             cCCHHHEEEcCCCC--EEEecCccceECCCCCc-----------------------------------------cccccc
Confidence            99999999998887  99999999875431100                                         011256


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.||+|        +.++|+||+|+++|||++|..||..+
T Consensus       309 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~  350 (423)
T 4fie_A          309 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE  350 (423)
T ss_dssp             ECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            77777777        67789999999999999999777654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.8e-37  Score=301.05  Aligned_cols=148  Identities=26%  Similarity=0.448  Sum_probs=121.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+++|+.++|||||++++++.+++.+|||||||+|+|.+.+... +.+++..++.++.|++.||+|||+++|+|||
T Consensus        59 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRD  137 (275)
T 3hyh_A           59 RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRD  137 (275)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            467899999999999999999999999999999999999999988764 6799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||+++++.  +|++|||+|+.......                                          ....+|
T Consensus       138 iKP~NILl~~~~~--vkl~DFGla~~~~~~~~------------------------------------------~~~~~G  173 (275)
T 3hyh_A          138 LKPENLLLDEHLN--VKIADFGLSNIMTDGNF------------------------------------------LKTSCG  173 (275)
T ss_dssp             CCTTTEEECTTCC--EEECCSSCC--------------------------------------------------------
T ss_pred             CChHHeEECCCCC--EEEeecCCCeecCCCCc------------------------------------------cCCeeE
Confidence            9999999998877  99999999875331100                                          112457


Q ss_pred             eeccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|+||         +.++|+||+|+++|+|++|..||..+
T Consensus       174 T~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          174 SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             -CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence            7777777         34679999999999999999777543

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.5e-37  Score=312.21  Aligned_cols=150  Identities=24%  Similarity=0.295  Sum_probs=124.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.||+++|++|+|||||+++++|++++.+|||||||+ |+|.+++.... ..+++..++.++.||+.||+|||+++|+|
T Consensus        69 ~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiH  148 (350)
T 4b9d_A           69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILH  148 (350)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred             HHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            46789999999999999999999999999999999998 68999887654 34789999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +||+|||+|+.+.....                                         .....
T Consensus       149 RDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~-----------------------------------------~~~~~  185 (350)
T 4b9d_A          149 RDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVE-----------------------------------------LARAC  185 (350)
T ss_dssp             TTCCGGGEEECTTCC--EEECSTTEESCCCHHHH-----------------------------------------HHHHH
T ss_pred             ccCCHHHEEECCCCC--EEEcccccceeecCCcc-----------------------------------------ccccc
Confidence            999999999998887  99999999976542100                                         00124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.||+|        +.++|+||+|+++|||++|..||..+
T Consensus       186 ~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             HSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            566666666        45679999999999999998776543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.5e-36  Score=300.15  Aligned_cols=151  Identities=23%  Similarity=0.233  Sum_probs=124.2

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      +|+.+|+.|+|||||+++++|.+++.+|||||||+ |+|.+++... +.+++..++.++.|++.||+|||+++|||||||
T Consensus        99 ~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK  177 (336)
T 4g3f_A           99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVK  177 (336)
T ss_dssp             HHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred             HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence            59999999999999999999999999999999999 6888888654 679999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccccee
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSF  430 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~  430 (481)
                      |+|||++.++. ++|++|||+|+.+.......                                    .......++||+
T Consensus       178 p~NILl~~~g~-~vKl~DFGla~~~~~~~~~~------------------------------------~~~~~~~~~GT~  220 (336)
T 4g3f_A          178 ADNVLLSSDGS-RAALCDFGHALCLQPDGLGK------------------------------------SLLTGDYIPGTE  220 (336)
T ss_dssp             GGGEEECTTSC-CEEECCCTTCEEC------------------------------------------------CCCCCCG
T ss_pred             HHHEEEeCCCC-EEEEeeCCCCeEccCCCccc------------------------------------ceecCCccccCc
Confidence            99999987751 39999999998654211000                                    000112357888


Q ss_pred             ccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         431 HYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       431 ~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .||+|        +.++|+||+|+++|||++|..||..
T Consensus       221 ~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~  258 (336)
T 4g3f_A          221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ  258 (336)
T ss_dssp             GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             cccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence            88888        6677999999999999999977654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-36  Score=299.48  Aligned_cols=148  Identities=22%  Similarity=0.321  Sum_probs=121.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++|++++|||||+++++|++++.+|||||||+ |+|.+++.+. +.+++..++.++.|++.||+|||+++|+|||
T Consensus        73 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD  151 (304)
T 3ubd_A           73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRD  151 (304)
T ss_dssp             -----CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred             HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence            4579999999999999999999999999999999999 6788888654 6799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+|+.+....                                         ......+|
T Consensus       152 lKp~NILl~~~g~--vKl~DFGla~~~~~~~-----------------------------------------~~~~~~~G  188 (304)
T 3ubd_A          152 LKPENILLDEEGH--IKLTDFGLSKESIDHE-----------------------------------------KKAYSFCG  188 (304)
T ss_dssp             CCGGGEEECTTSC--EEEESSEEEEC----------------------------------------------CCCCSCCC
T ss_pred             CCHHHeEEcCCCC--EEecccccceeccCCC-----------------------------------------cccccccc
Confidence            9999999998887  9999999987432110                                         00112568


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.||+|        +.++|+||+|+++|||++|..||...
T Consensus       189 T~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence            8888888        66789999999999999999776543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.6e-35  Score=288.39  Aligned_cols=146  Identities=22%  Similarity=0.318  Sum_probs=121.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++|++|+|||||+++++|.+    ++.+|||||||+ |+|.+++.+ .+.+++..++.++.||+.||+|||+++
T Consensus        71 ~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~  149 (290)
T 3fpq_A           71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            46789999999999999999999975    356899999999 678888865 467999999999999999999999998


Q ss_pred             --eeeccCCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         344 --ILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       344 --iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                        |+||||||+|||++. ++.  +|++|||+|+......                                         
T Consensus       150 ~~IiHRDlKp~NILl~~~~g~--vKl~DFGla~~~~~~~-----------------------------------------  186 (290)
T 3fpq_A          150 PPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRASF-----------------------------------------  186 (290)
T ss_dssp             SCCCCCCCCGGGEEESSTTSC--EEECCTTGGGGCCTTS-----------------------------------------
T ss_pred             CCEEecccChhheeEECCCCC--EEEEeCcCCEeCCCCc-----------------------------------------
Confidence              999999999999974 566  9999999996322100                                         


Q ss_pred             cccCcccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                        ....+||+.||||       +.++|+||+|++++||++|..||..
T Consensus       187 --~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          187 --AKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             --BEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --cCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence              0114566677776       6778999999999999999977643

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-35  Score=300.37  Aligned_cols=152  Identities=28%  Similarity=0.469  Sum_probs=123.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec------CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT------RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~------~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .++||+++|+.|+|||||++++++..      .+.+|||||||+|+|.+.+.. .+.+++..++.++.||+.||.|||++
T Consensus        99 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~  177 (398)
T 4b99_A           99 RTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSA  177 (398)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            46689999999999999999998764      367999999999999888865 46799999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||||||+|||++.++.  +|++|||+|+.+......                                     ....
T Consensus       178 ~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~-------------------------------------~~~~  218 (398)
T 4b99_A          178 QVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAE-------------------------------------HQYF  218 (398)
T ss_dssp             TCBCCCCCGGGEEECTTCC--EEECCCTTCBCC--------------------------------------------CCC
T ss_pred             cCcCCCcCccccccCCCCC--EEEeecceeeecccCccc-------------------------------------cccc
Confidence            9999999999999998887  999999999765311000                                     0000


Q ss_pred             cCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         423 KSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       423 ~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ....+||+.|++|         +.++|+||+|++++||++|.+||..
T Consensus       219 ~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             CCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             cccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence            1224577777776         4567999999999999999977643

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.1e-35  Score=287.14  Aligned_cols=151  Identities=23%  Similarity=0.360  Sum_probs=125.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------------CCCChHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------------GGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------------~~l~~~~~~~~~~qi~~~  335 (481)
                      .+.+|+++|++++|||||++++++.+++.+|||||||+ |+|.+++....            ..+++..+..++.||+.|
T Consensus        61 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g  140 (299)
T 4asz_A           61 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG  140 (299)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998 78999887532            358999999999999999


Q ss_pred             HHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCC
Q psy3074         336 LSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       336 l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~  415 (481)
                      |.|||+++|+||||||+|||+++++.  +|++|||+|+.+.......                                 
T Consensus       141 l~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~---------------------------------  185 (299)
T 4asz_A          141 MVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYR---------------------------------  185 (299)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCEE---------------------------------
T ss_pred             HHHHHhCCcccCccCHhhEEECCCCc--EEECCcccceecCCCCcee---------------------------------
Confidence            99999999999999999999998877  9999999998654211000                                 


Q ss_pred             CCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         416 GGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       416 ~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                            .....+||+.||+|        +.++|+||+|++|+||++ |..|+..
T Consensus       186 ------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          186 ------VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             ------ETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ------ecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence                  01123467777777        567799999999999997 7866543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-34  Score=284.41  Aligned_cols=149  Identities=18%  Similarity=0.245  Sum_probs=121.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.+ +.+|||||||+ |+|.+++....+.+++..+..++.||+.||+|||+++||||
T Consensus        78 ~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR  156 (307)
T 3omv_A           78 AFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR  156 (307)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            46789999999999999999998764 56899999999 78999887777789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.......                                       .....+
T Consensus       157 DlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~---------------------------------------~~~~~~  195 (307)
T 3omv_A          157 DMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQ---------------------------------------QVEQPT  195 (307)
T ss_dssp             CCCSSSEEEETTEE--EEECCCSSCBC---------------------------------------------------CC
T ss_pred             ccCHHHEEECCCCc--EEEeeccCceecccCCcce---------------------------------------eecccc
Confidence            99999999998877  9999999987543111000                                       011245


Q ss_pred             ceeccCCC-----------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP-----------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p-----------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ||+.||+|           +..+|+||+|++|+||++|..||.
T Consensus       196 GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~  238 (307)
T 3omv_A          196 GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS  238 (307)
T ss_dssp             CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC
Confidence            77777777           225799999999999999997664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-34  Score=284.61  Aligned_cols=155  Identities=17%  Similarity=0.278  Sum_probs=112.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------------eEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------------TLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLL  333 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------------~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~  333 (481)
                      .+.||+++|++|+|||||+++++|.+.+            .+|||||||+ |+|.+++.....  ..++..++.++.|++
T Consensus        49 ~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~  128 (299)
T 4g31_A           49 KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIA  128 (299)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHH
Confidence            4678999999999999999999997544            4799999998 678888865321  234556889999999


Q ss_pred             HHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeec
Q psy3074         334 RGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       334 ~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~  413 (481)
                      .||+|||+++|+||||||+|||++.++.  +|++|||+|+.+..........                           .
T Consensus       129 ~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~~~~~~~~~~---------------------------~  179 (299)
T 4g31_A          129 EAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVL---------------------------T  179 (299)
T ss_dssp             HHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC-----------------------------------------
T ss_pred             HHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecCCCccccccc---------------------------c
Confidence            9999999999999999999999998887  9999999998765322111000                           0


Q ss_pred             CCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCC
Q psy3074         414 GSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHN  454 (481)
Q Consensus       414 g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~  454 (481)
                      ...  ........+||+.||||        +.++|+||+|++++||+++
T Consensus       180 ~~~--~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~P  226 (299)
T 4g31_A          180 PMP--AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP  226 (299)
T ss_dssp             --------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHSC
T ss_pred             ccc--cccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHccC
Confidence            000  00112236799999999        6778999999999999973

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.98  E-value=5e-34  Score=285.60  Aligned_cols=151  Identities=23%  Similarity=0.351  Sum_probs=119.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc--------------CCCChHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS--------------GGLDHHNIRLFMFQLL  333 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~--------------~~l~~~~~~~~~~qi~  333 (481)
                      .+.+|+++|++++|||||+++++|.+.+.+|||||||+ |+|.+++....              +.+++..+..++.||+
T Consensus        89 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia  168 (329)
T 4aoj_A           89 DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA  168 (329)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999999 78988886532              3589999999999999


Q ss_pred             HHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeec
Q psy3074         334 RGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       334 ~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~  413 (481)
                      .||.|||+++||||||||+|||+++++.  +|++|||+|+.+........                              
T Consensus       169 ~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~------------------------------  216 (329)
T 4aoj_A          169 AGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRV------------------------------  216 (329)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC-------------------------------------------
T ss_pred             HHHHHHhcCCeecccccHhhEEECCCCc--EEEcccccceeccCCCccee------------------------------
Confidence            9999999999999999999999998877  99999999986542111000                              


Q ss_pred             CCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         414 GSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       414 g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                               ....+||+.||+|        +..+|+||+|++|+||++ |..|+..
T Consensus       217 ---------~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          217 ---------GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             ------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             ---------cCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence                     0123467777777        556799999999999997 8866643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.98  E-value=1.5e-33  Score=279.60  Aligned_cols=151  Identities=19%  Similarity=0.299  Sum_probs=125.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---------------cCCCChHHHHHHHHH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---------------SGGLDHHNIRLFMFQ  331 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---------------~~~l~~~~~~~~~~q  331 (481)
                      +.+.+|+.+|++++|||||++++++.+++.++||||||+ |+|.+++...               ...+++..+..++.|
T Consensus        74 ~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  153 (308)
T 4gt4_A           74 EEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ  153 (308)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHH
Confidence            467899999999999999999999999999999999998 7899988643               235889999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      |+.||+|||+++||||||||+|||+++++.  +|++|||+|+.+.......                             
T Consensus       154 ia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~Ki~DFGlar~~~~~~~~~-----------------------------  202 (308)
T 4gt4_A          154 IAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYK-----------------------------  202 (308)
T ss_dssp             HHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCSCCBCGGGGGGCBC-----------------------------
T ss_pred             HHHHHHHHHhCCCCCCCccccceEECCCCC--EEECCcccceeccCCCcee-----------------------------
Confidence            999999999999999999999999998877  9999999987653211000                             


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                .....+||+.||+|        +..+|+||+|++|+||.+ |..|+.
T Consensus       203 ----------~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~  249 (308)
T 4gt4_A          203 ----------LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC  249 (308)
T ss_dssp             ----------SSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             ----------EecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCC
Confidence                      01124577778877        566799999999999997 775543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=1.9e-33  Score=302.02  Aligned_cols=144  Identities=22%  Similarity=0.315  Sum_probs=123.9

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      +++.+++.++|||||+++++|++++.+|||||||+ |+|..++.+ .+.+++..++.|+.||+.||+|||++||||||||
T Consensus       241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK  319 (689)
T 3v5w_A          241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  319 (689)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence            45778888899999999999999999999999999 678888765 4679999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccccee
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSF  430 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~  430 (481)
                      |+|||++.+++  +||+|||+|+.+...                                           .....+||+
T Consensus       320 PeNILld~~G~--vKL~DFGlA~~~~~~-------------------------------------------~~~t~~GTp  354 (689)
T 3v5w_A          320 PANILLDEHGH--VRISDLGLACDFSKK-------------------------------------------KPHASVGTH  354 (689)
T ss_dssp             GGGEEECTTSC--EEECCCTTCEECSSC-------------------------------------------CCCSCCSCG
T ss_pred             hHHeEEeCCCC--EEecccceeeecCCC-------------------------------------------CCCCccCCc
Confidence            99999999888  999999998643210                                           011256888


Q ss_pred             ccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         431 HYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       431 ~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      .||+|         +.++|+||+|++||||++|..||..+
T Consensus       355 ~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             CccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            88888         55679999999999999999777654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=5.2e-33  Score=281.87  Aligned_cols=175  Identities=15%  Similarity=0.197  Sum_probs=125.4

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++|+.+ +|||||+++++|.+++++|||||||+ |+|.+.+    +.+++..++.++.|++.||+|||++||+|
T Consensus        65 ~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiH  140 (361)
T 4f9c_A           65 RIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVH  140 (361)
T ss_dssp             HHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            356899999998 69999999999999999999999998 6787776    34999999999999999999999999999


Q ss_pred             ccCCCcccccccc-chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||++.+ +.  +|++|||+|+.........   .++...... .+...  ...+   ......    ......
T Consensus       141 RDiKPeNiLl~~~~~~--~kl~DFGla~~~~~~~~~~---~~~~~~~~~-~~~~~--~~~~---~~~~~~----~~~~~~  205 (361)
T 4f9c_A          141 RDVKPSNFLYNRRLKK--YALVDFGLAQGTHDTKIEL---LKFVQSEAQ-QERCS--QNKC---SICLSR----RQQVAP  205 (361)
T ss_dssp             SCCSGGGEEEETTTTE--EEECCCTTCEECTTCSCGG---GGGC------------------------------------
T ss_pred             CcCCHHHeEEeCCCCe--EEECcCCCCcccCCccccc---ccccccccc-ccccc--cccc---cccccc----cccccc
Confidence            9999999999765 45  9999999998654221100   000000000 00000  0000   000000    011234


Q ss_pred             ccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         426 INLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       426 ~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      .+||+.|+||         +.+.|+||+|++++||++|..||+...
T Consensus       206 ~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          206 RAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            6899999999         455699999999999999998887543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=3.9e-33  Score=299.17  Aligned_cols=151  Identities=19%  Similarity=0.277  Sum_probs=126.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|+.|+|||||+++++|.+++.+|||||||+ |+|.+++....+.+++..++.++.||+.||.|||+++|+||
T Consensus       200 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR  279 (573)
T 3uto_A          200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  279 (573)
T ss_dssp             HHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            35689999999999999999999999999999999998 68988887666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++......+|++|||+|+.+.....                                          ....+
T Consensus       280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~------------------------------------------~~~~~  317 (573)
T 3uto_A          280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS------------------------------------------VKVTT  317 (573)
T ss_dssp             CCCGGGEEESSSSCCCEEECCCSSCEECCTTSE------------------------------------------EEEEC
T ss_pred             cCChhhccccCCCCCCEEEeeccceeEccCCCc------------------------------------------eeeeE
Confidence            999999999866444599999999875431100                                          01135


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +.++|+||+|+++|+|++|..||...
T Consensus       318 GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~  359 (573)
T 3uto_A          318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE  359 (573)
T ss_dssp             SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             ECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence            66777776        45679999999999999998776543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=6.3e-32  Score=272.65  Aligned_cols=150  Identities=21%  Similarity=0.347  Sum_probs=122.5

Q ss_pred             hHHHHHHHHhhcCC-CCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHH
Q psy3074         269 TAIREASLLKELKH-NNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMF  330 (481)
Q Consensus       269 ~~~rE~~il~~l~H-pnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~  330 (481)
                      .+.+|+.+|++++| ||||+++++|.+ .+.+|||||||+ |+|.+++....               ..+++..+..++.
T Consensus       113 ~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  192 (353)
T 4ase_A          113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF  192 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHH
Confidence            46789999999976 899999999866 457999999999 78999987532               3478999999999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEE
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVST  410 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~  410 (481)
                      ||+.||+|||+++||||||||+|||+++++.  +|++|||+|+.+......                             
T Consensus       193 qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vKi~DFGlar~~~~~~~~-----------------------------  241 (353)
T 4ase_A          193 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDY-----------------------------  241 (353)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTS-----------------------------
T ss_pred             HHHHHHHhHhhCCeecCccCccceeeCCCCC--EEECcchhhhhcccCCCc-----------------------------
Confidence            9999999999999999999999999998877  999999999855311100                             


Q ss_pred             eecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         411 VDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       411 ~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                ......+||+.||+|        +..+|+||+|++|+||.. |..|+.
T Consensus       242 ----------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          242 ----------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             ----------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ----------eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence                      001124577788888        667799999999999996 875553

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.96  E-value=5.1e-31  Score=270.31  Aligned_cols=183  Identities=26%  Similarity=0.439  Sum_probs=127.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+..-..+... .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+.......            
T Consensus       155 l~~~~~~~~~~q-il~al~ylH~~~iiHRDlKP----~NIl~~~~----~~~Ki~DFGla~~~~~~~~------------  213 (398)
T 4b99_A          155 LTLEHVRYFLYQ-LLRGLKYMHSAQVIHRDLKP----SNLLVNEN----CELKIGDFGMARGLCTSPA------------  213 (398)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----CCEEECCCTTCBCC-----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCcCcCCCcCc----cccccCCC----CCEEEeecceeeecccCcc------------
Confidence            333333344444 78999999999999999999    89999876    7999999999985421100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                ........+                      +||++|||||++.+...|+.++||||+|||+|||++|++
T Consensus       214 ----------~~~~~~~~~----------------------~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~  261 (398)
T 4b99_A          214 ----------EHQYFMTEY----------------------VATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ  261 (398)
T ss_dssp             ------------CCCCCSS----------------------CCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSC
T ss_pred             ----------ccccccccc----------------------eeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCC
Confidence                      001111122                      349999999999998878999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCc-cCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNV-HRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILN  246 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~  246 (481)
                      ||.|. +..+++..|.+..++|+...|........... ...++..+..+...++.++  +      .....+.++...+
T Consensus       262 pF~g~-~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~------~~~dLl~~mL~~d  332 (398)
T 4b99_A          262 LFPGK-NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGAD--R------QALSLLGRMLRFE  332 (398)
T ss_dssp             SSCCS-SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCC--H------HHHHHHHHHSCSS
T ss_pred             CCCCC-CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCC--H------HHHHHHHHHCcCC
Confidence            99995 45599999999999999988877654433322 2334444444555555443  1      2344566677777


Q ss_pred             Cccccc
Q psy3074         247 PMEHVH  252 (481)
Q Consensus       247 ~~~~~~  252 (481)
                      |.++..
T Consensus       333 P~~R~t  338 (398)
T 4b99_A          333 PSARIS  338 (398)
T ss_dssp             TTTSCC
T ss_pred             hhHCcC
Confidence            776653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.96  E-value=5.7e-31  Score=260.80  Aligned_cols=101  Identities=22%  Similarity=0.267  Sum_probs=89.6

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC----
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR----  342 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~----  342 (481)
                      +|+.++.+++|||||++++++.+++    .+|||||||+ |+|.+++..  ..++++.+..++.|++.||+|||++    
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~  123 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGT  123 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhc
Confidence            4777778899999999999998654    6899999999 788888865  4589999999999999999999987    


Q ss_pred             ----ceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         343 ----RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       343 ----~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                          +|+||||||+|||+++++.  +|++|||+|+...
T Consensus       124 ~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~  159 (303)
T 3hmm_A          124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHD  159 (303)
T ss_dssp             TCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEEE
T ss_pred             cCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcccc
Confidence                8999999999999998887  9999999987544

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=99.95  E-value=1.3e-29  Score=254.16  Aligned_cols=118  Identities=22%  Similarity=0.392  Sum_probs=92.2

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+..-..++.. .+.||+|||++|||||||||    +||||+.+    |.+||+|||+|+.....              
T Consensus       167 l~e~~~~~~~~q-i~~aL~ylH~~~IiHRDlKp----~NILl~~~----g~vKl~DFGla~~~~~~--------------  223 (346)
T 4fih_A          167 MNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS----DSILLTHD----GRVKLSDFGFCAQVSKE--------------  223 (346)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECCSS--------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCcccccCCH----HHEEECCC----CCEEEecCcCceecCCC--------------
Confidence            334444444444 78999999999999999999    89999876    89999999999853211              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                  +.....++|                      |++|||||++.+.. |+.++||||+||++|||++|++
T Consensus       224 ------------~~~~~~~~G----------------------Tp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~  268 (346)
T 4fih_A          224 ------------VPRRKSLVG----------------------TPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEP  268 (346)
T ss_dssp             ------------SCCBCCCCS----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ------------CCccccccc----------------------CcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence                        111223344                      99999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHH
Q psy3074         168 TFPGVREVYDQLDKIFK  184 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~  184 (481)
                      ||.+.+ ..+.+..|..
T Consensus       269 PF~~~~-~~~~~~~i~~  284 (346)
T 4fih_A          269 PYFNEP-PLKAMKMIRD  284 (346)
T ss_dssp             TTTTSC-HHHHHHHHHH
T ss_pred             CCCCcC-HHHHHHHHHc
Confidence            999853 4466666654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=99.95  E-value=6.5e-30  Score=252.69  Aligned_cols=109  Identities=28%  Similarity=0.519  Sum_probs=89.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++|||||||||    +||||+.+    |.+||+|||+|+.....                        +..
T Consensus       141 i~~al~ylH~~~IiHRDlKP----eNILl~~~----g~vKl~DFGla~~~~~~------------------------~~~  188 (311)
T 4aw0_A          141 IVSALEYLHGKGIIHRDLKP----ENILLNED----MHIQITDFGTAKVLSPE------------------------SKQ  188 (311)
T ss_dssp             HHHHHHHHHHTTEECSCCSG----GGEEECTT----SCEEECCCTTCEECCTT------------------------TTC
T ss_pred             HHHHHHHHHHCCCccCCCCH----HHeEEcCC----CCEEEEEcCCceecCCC------------------------CCc
Confidence            78999999999999999999    89999876    79999999999854211                        111


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ....+++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.+. +..+.+.
T Consensus       189 ~~~~~~~G----------------------Tp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~  244 (311)
T 4aw0_A          189 ARANSFVG----------------------TAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFA  244 (311)
T ss_dssp             CCBCCCCS----------------------CGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHH
T ss_pred             ccccCccc----------------------CcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            12233445                      99999999998766 999999999999999999999999985 4446677


Q ss_pred             HHHHH
Q psy3074         181 KIFKI  185 (481)
Q Consensus       181 ~i~~~  185 (481)
                      +|.+.
T Consensus       245 ~i~~~  249 (311)
T 4aw0_A          245 KIIKL  249 (311)
T ss_dssp             HHHHT
T ss_pred             HHHcC
Confidence            77654

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=99.95  E-value=5.5e-30  Score=252.88  Aligned_cols=118  Identities=26%  Similarity=0.417  Sum_probs=91.3

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +..-..+... .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+.....                
T Consensus       125 e~~~~~~~~q-i~~aL~ylH~~~IiHRDlKp----~NILl~~~----g~vKl~DFGla~~~~~~----------------  179 (304)
T 3ubd_A          125 EEDVKFYLAE-LALALDHLHSLGIIYRDLKP----ENILLDEE----GHIKLTDFGLSKESIDH----------------  179 (304)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSSCCG----GGEEECTT----SCEEEESSEEEEC--------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCCcCCCCCH----HHeEEcCC----CCEEecccccceeccCC----------------
Confidence            3333344444 78899999999999999999    89999876    79999999999853211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       180 ----------~~~~~~~~G----------------------T~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF  226 (304)
T 3ubd_A          180 ----------EKKAYSFCG----------------------TVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPF  226 (304)
T ss_dssp             -----------CCCCSCCC----------------------CGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ----------Ccccccccc----------------------CcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCC
Confidence                      011112334                      99999999998776 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHh
Q psy3074         170 PGVREVYDQLDKIFKIL  186 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~  186 (481)
                      .+. +..+.+.+|.+..
T Consensus       227 ~~~-~~~~~~~~i~~~~  242 (304)
T 3ubd_A          227 QGK-DRKETMTMILKAK  242 (304)
T ss_dssp             CCS-SHHHHHHHHHHCC
T ss_pred             CCc-CHHHHHHHHHcCC
Confidence            985 4446777776643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=99.95  E-value=1.9e-29  Score=245.65  Aligned_cols=120  Identities=22%  Similarity=0.395  Sum_probs=87.8

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++..+..-..+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...              
T Consensus       107 ~~l~e~~~~~~~~q-i~~al~ylH~~~IiHRDiKP----~NILl~~~----~~vkl~DFGla~~~~--------------  163 (275)
T 3hyh_A          107 DKMSEQEARRFFQQ-IISAVEYCHRHKIVHRDLKP----ENLLLDEH----LNVKIADFGLSNIMT--------------  163 (275)
T ss_dssp             CSCCHHHHHHHHHH-HHHHHHHHHHTTCCCCCCCT----TTEEECTT----CCEEECCSSCC------------------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHHCCcccccCCh----HHeEECCC----CCEEEeecCCCeecC--------------
Confidence            34444444455555 78999999999999999999    89999876    799999999998422              


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                   .+....+.+|                      |+.|||||++.+...++.++||||+||++|||++|
T Consensus       164 -------------~~~~~~~~~G----------------------T~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg  208 (275)
T 3hyh_A          164 -------------DGNFLKTSCG----------------------SPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR  208 (275)
T ss_dssp             ----------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred             -------------CCCccCCeeE----------------------CcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence                         1122223344                      99999999999887567899999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~  184 (481)
                      ++||.+. +..+.++.|..
T Consensus       209 ~~PF~~~-~~~~~~~~i~~  226 (275)
T 3hyh_A          209 RLPFDDE-SIPVLFKNISN  226 (275)
T ss_dssp             SCSSCCS-SHHHHHHHHHH
T ss_pred             CCCCCCC-CHHHHHHHHHc
Confidence            9999984 33355555554

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=99.95  E-value=5.8e-29  Score=255.52  Aligned_cols=118  Identities=23%  Similarity=0.404  Sum_probs=92.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+..-..++.. .+.||+|||++|||||||||    +||||+.+    |.+||+|||+|+....               
T Consensus       244 l~e~~~~~~~~q-il~aL~ylH~~~IiHRDiKp----~NILl~~~----g~vKl~DFGla~~~~~---------------  299 (423)
T 4fie_A          244 MNEEQIAAVCLA-VLQALSVLHAQGVIHRDIKS----DSILLTHD----GRVKLSDFGFCAQVSK---------------  299 (423)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCST----TTEEECTT----CCEEECCCTTCEECCS---------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeecccCCH----HHEEEcCC----CCEEEecCccceECCC---------------
Confidence            334444445554 88999999999999999999    89999876    8999999999985321               


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                 .+.....++|                      |++|||||++.+.. |+.++||||+||++|||++|++
T Consensus       300 -----------~~~~~~~~~G----------------------Tp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~  345 (423)
T 4fie_A          300 -----------EVPRRKSLVG----------------------TPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEP  345 (423)
T ss_dssp             -----------SCCCBCCCEE----------------------CTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------CCcccccccc----------------------CcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence                       1112223445                      99999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHH
Q psy3074         168 TFPGVREVYDQLDKIFK  184 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~  184 (481)
                      ||.+.+ ..+.+..|..
T Consensus       346 PF~~~~-~~~~~~~i~~  361 (423)
T 4fie_A          346 PYFNEP-PLKAMKMIRD  361 (423)
T ss_dssp             TTTTSC-HHHHHHHHHH
T ss_pred             CCCCcC-HHHHHHHHHc
Confidence            999853 3466666544

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.95  E-value=5.1e-29  Score=249.06  Aligned_cols=123  Identities=20%  Similarity=0.274  Sum_probs=89.3

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCC-ceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPR-ELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g-~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      +..+..-..+... .+.||+|||+++||||||||    +||||+.+    | .+||+|||+|+......           
T Consensus       146 ~l~e~~~~~~~~q-i~~aL~ylH~~~IiHRDlKp----~NILl~~~----g~~vKl~DFGla~~~~~~~-----------  205 (336)
T 4g3f_A          146 CLPEDRALYYLGQ-ALEGLEYLHTRRILHGDVKA----DNVLLSSD----GSRAALCDFGHALCLQPDG-----------  205 (336)
T ss_dssp             SCCHHHHHHHHHH-HHHHHHHHHTTTEECSCCCG----GGEEECTT----SCCEEECCCTTCEEC---------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHCCceecccCH----HHEEEeCC----CCEEEEeeCCCCeEccCCC-----------
Confidence            3444444455555 78999999999999999999    89999876    5 69999999998542110           


Q ss_pred             CccccceecccCCCCc-eeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh
Q psy3074          86 GKADAYIKLDQLGEGS-YATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~-~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt  164 (481)
                                 .+... .+..+                      +||+.|||||++.+.. |+.++||||+||++|||++
T Consensus       206 -----------~~~~~~~~~~~----------------------~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemlt  251 (336)
T 4g3f_A          206 -----------LGKSLLTGDYI----------------------PGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN  251 (336)
T ss_dssp             -------------------CCC----------------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             -----------cccceecCCcc----------------------ccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHH
Confidence                       00000 01112                      3499999999999866 9999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHHH
Q psy3074         165 GLPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~  184 (481)
                      |++||.+.+. .+.+.+|..
T Consensus       252 G~~Pf~~~~~-~~~~~~i~~  270 (336)
T 4g3f_A          252 GCHPWTQYFR-GPLCLKIAS  270 (336)
T ss_dssp             SSCSSTTTCC-SCCHHHHHH
T ss_pred             CcCCCCCCCH-HHHHHHHHc
Confidence            9999988533 234444443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=99.95  E-value=7.1e-30  Score=256.46  Aligned_cols=115  Identities=24%  Similarity=0.366  Sum_probs=90.8

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..+... .+.||+|||++|||||||||    +||||+.+    |.+||+|||+|+.....                    
T Consensus       128 ~~~~~q-i~~aL~ylH~~~IiHRDlKp----~NILl~~~----g~vKl~DFGla~~~~~~--------------------  178 (350)
T 4b9d_A          128 LDWFVQ-ICLALKHVHDRKILHRDIKS----QNIFLTKD----GTVQLGDFGIARVLNST--------------------  178 (350)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCEETTCCG----GGEEECTT----CCEEECSTTEESCCCHH--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCeeeccCCH----HHEEECCC----CCEEEcccccceeecCC--------------------
Confidence            334444 78899999999999999999    89999876    89999999999842100                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                            .....                      ..+||+.|||||++.+.. |+.++||||+||++|||++|++||.+. 
T Consensus       179 ------~~~~~----------------------~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~-  228 (350)
T 4b9d_A          179 ------VELAR----------------------ACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAG-  228 (350)
T ss_dssp             ------HHHHH----------------------HHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred             ------ccccc----------------------ccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCc-
Confidence                  00011                      123599999999998865 999999999999999999999999985 


Q ss_pred             hhHHHHHHHHHHhC
Q psy3074         174 EVYDQLDKIFKILG  187 (481)
Q Consensus       174 ~~~~~l~~i~~~~~  187 (481)
                      +..+.+.+|.....
T Consensus       229 ~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          229 SMKNLVLKIISGSF  242 (350)
T ss_dssp             SHHHHHHHHHHTCC
T ss_pred             CHHHHHHHHHcCCC
Confidence            44467777766543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.95  E-value=2e-29  Score=249.89  Aligned_cols=156  Identities=14%  Similarity=0.227  Sum_probs=116.4

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      .+.....+.++.+ ...|++|||+++||||||||    +||||+..    +.+||+|||+||........          
T Consensus       141 ~l~~~~~~~i~~q-ia~gl~yLH~~~iiHRDLK~----~NILl~~~----~~~Ki~DFGlar~~~~~~~~----------  201 (308)
T 4gt4_A          141 ALEPPDFVHLVAQ-IAAGMEYLSSHHVVHKDLAT----RNVLVYDK----LNVKISDLGLFREVYAADYY----------  201 (308)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCSCCBCGGGGGGCB----------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCCCCCCccc----cceEECCC----CCEEECCcccceeccCCCce----------
Confidence            3455566777777 88999999999999999999    89999987    79999999999853211000          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                    .                      ..+...+|+.|||||++.+.. |+.++|||||||++|||+| |
T Consensus       202 --------------~----------------------~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g  244 (308)
T 4gt4_A          202 --------------K----------------------LLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYG  244 (308)
T ss_dssp             --------------C----------------------SSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred             --------------e----------------------EecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCC
Confidence                          0                      001123499999999999776 9999999999999999998 8


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      ++||.+.+. .+.+..|......|.++.++..-......||...|..||++.++
T Consensus       245 ~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei  297 (308)
T 4gt4_A          245 LQPYCGYSN-QDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI  297 (308)
T ss_dssp             CCTTTTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCH-HHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            999998643 36666666665566665555433334456787777777776553

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.95  E-value=4.2e-29  Score=247.06  Aligned_cols=130  Identities=21%  Similarity=0.306  Sum_probs=94.2

Q ss_pred             cchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074           5 ENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      +++......+.++.+ .+.||+|||+++||||||||    +||||+..    +.+||+|||+|+......          
T Consensus       126 ~~~l~~~~~~~i~~q-ia~gL~yLH~~~IiHRDlKp----~NILl~~~----~~~Ki~DFGla~~~~~~~----------  186 (307)
T 3omv_A          126 ETKFQMFQLIDIARQ-TAQGMDYLHAKNIIHRDMKS----NNIFLHEG----LTVKIGDFGLATVKSRWS----------  186 (307)
T ss_dssp             CCCCCHHHHHHHHHH-HHHHHHHHHHTTCBCSCCCS----SSEEEETT----EEEEECCCSSCBC---------------
T ss_pred             CCCCCHHHHHHHHHH-HHHHHHHHHHCCccCCccCH----HHEEECCC----CcEEEeeccCceecccCC----------
Confidence            345556666677777 88999999999999999999    89999876    799999999998532110          


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC--CCCCCccchhhHHHHHHHH
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~--~~y~~~~DvWS~G~il~el  162 (481)
                                    ........+                      ||+.|||||++.+.  ..|+.++|||||||++|||
T Consensus       187 --------------~~~~~~~~~----------------------GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~El  230 (307)
T 3omv_A          187 --------------GSQQVEQPT----------------------GSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL  230 (307)
T ss_dssp             ---------------------CC----------------------CCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHH
T ss_pred             --------------cceeecccc----------------------cCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHH
Confidence                          000111223                      49999999999753  3499999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHHHHhCCC
Q psy3074         163 VTGLPTFPGVREVYDQLDKIFKILGTP  189 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~~~~~~p  189 (481)
                      +||++||.+.+........+.+....|
T Consensus       231 ltg~~Pf~~~~~~~~~~~~~~~~~~~p  257 (307)
T 3omv_A          231 MTGELPYSHINNRDQIIFMVGRGYASP  257 (307)
T ss_dssp             HHSSCTTTTCCCHHHHHHHHHTTCCCC
T ss_pred             HHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence            999999998655433333333333444

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.95  E-value=1.3e-28  Score=255.97  Aligned_cols=150  Identities=21%  Similarity=0.261  Sum_probs=124.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|||||+++++|.+.+.+|+|||||+ |+|.+++....+.+++..++.++.|++.||.|||+++|+|||
T Consensus       121 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrD  200 (437)
T 4aw2_A          121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD  200 (437)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence            5679999999999999999999999999999999997 688888877567899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+|+.+......                                        .....+|
T Consensus       201 LKp~NILl~~~g~--vkL~DFGla~~~~~~~~~----------------------------------------~~~~~~G  238 (437)
T 4aw2_A          201 IKPDNILMDMNGH--IRLADFGSCLKLMEDGTV----------------------------------------QSSVAVG  238 (437)
T ss_dssp             CSGGGEEECTTSC--EEECCCTTCEECCTTSCE----------------------------------------ECCSCCS
T ss_pred             cCHHHeeEcCCCC--EEEcchhhhhhcccCCCc----------------------------------------ccccccC
Confidence            9999999998887  999999998654311000                                        0011345


Q ss_pred             eeccCCC-------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|             +.++|+||+|++++||++|..||...
T Consensus       239 T~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             CGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            5555555             34679999999999999999777543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=99.94  E-value=5.6e-29  Score=244.33  Aligned_cols=109  Identities=21%  Similarity=0.363  Sum_probs=85.9

Q ss_pred             hhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          14 ISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..++.. .+.||+|||+++  ||||||||    +||||+..   .|.+||+|||+|+..                     
T Consensus       132 ~~~~~q-i~~aL~ylH~~~~~IiHRDlKp----~NILl~~~---~g~vKl~DFGla~~~---------------------  182 (290)
T 3fpq_A          132 RSWCRQ-ILKGLQFLHTRTPPIIHRDLKC----DNIFITGP---TGSVKIGDLGLATLK---------------------  182 (290)
T ss_dssp             HHHHHH-HHHHHHHHHTSSSCCCCCCCCG----GGEEESST---TSCEEECCTTGGGGC---------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCCCEEecccCh----hheeEECC---CCCEEEEeCcCCEeC---------------------
Confidence            334444 688999999999  99999999    89999743   279999999999832                     


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                             .++.....+|                      |+.|||||++.+  .|+.++||||+||++|||+||++||.+
T Consensus       183 -------~~~~~~~~~G----------------------Tp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          183 -------RASFAKAVIG----------------------TPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             -------CTTSBEESCS----------------------SCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -------CCCccCCccc----------------------CccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence                   1223344455                      999999999875  399999999999999999999999987


Q ss_pred             chhhHHHHHHH
Q psy3074         172 VREVYDQLDKI  182 (481)
Q Consensus       172 ~~~~~~~l~~i  182 (481)
                      ..+....+..+
T Consensus       232 ~~~~~~~~~~i  242 (290)
T 3fpq_A          232 CQNAAQIYRRV  242 (290)
T ss_dssp             CSSHHHHHHHH
T ss_pred             CCcHHHHHHHH
Confidence            65543333333

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.94  E-value=2.7e-28  Score=239.27  Aligned_cols=151  Identities=40%  Similarity=0.689  Sum_probs=124.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.++++++|||||++++++.+.+..++|||||+|++...+....+.+++..++.++.|++.||.|||+++|+|||
T Consensus        47 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~d  126 (292)
T 3o0g_A           47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD  126 (292)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            46689999999999999999999999999999999999999988887777899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.+......                                         .....+
T Consensus       127 ikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~~  163 (292)
T 3o0g_A          127 LKPQNLLINRNGE--LKLANFGLARAFGIPVRC-----------------------------------------YSAEVV  163 (292)
T ss_dssp             CSGGGEEECTTSC--EEECCCTTCEECCSCCSC-----------------------------------------CCSCCS
T ss_pred             CCHHHEEEcCCCC--EEEeecccceecCCcccc-----------------------------------------ccCCcc
Confidence            9999999998877  999999988654311000                                         001123


Q ss_pred             eeccCCC---------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         429 SFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       429 t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      |+.|++|         +.++|+||+|+++++|.+|..|++...
T Consensus       164 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~  206 (292)
T 3o0g_A          164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_dssp             CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred             ccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC
Confidence            3444443         445799999999999998877776543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.94  E-value=2.9e-28  Score=244.97  Aligned_cols=149  Identities=21%  Similarity=0.333  Sum_probs=123.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++||||+++++++.+.+.+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        51 ~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  129 (337)
T 1o6l_A           51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             HHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45679999999999999999999999999999999998 577777765 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.......                                         .....+
T Consensus       130 Dlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~-----------------------------------------~~~~~~  166 (337)
T 1o6l_A          130 DIKLENLMLDKDGH--IKITDFGLCKEGISDGA-----------------------------------------TMKTFC  166 (337)
T ss_dssp             CCCGGGEEECTTSC--EEECCCTTCBCSCCTTC-----------------------------------------CBCCCE
T ss_pred             cCCHHHEEECCCCC--EEEeeccchhhcccCCC-----------------------------------------cccccc
Confidence            99999999998887  99999998863211000                                         011234


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|++|..|+...
T Consensus       167 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence            66666666        56789999999999999999777543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.94  E-value=3.4e-29  Score=252.69  Aligned_cols=156  Identities=16%  Similarity=0.253  Sum_probs=111.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ++..+.+.++.+ .+.|++|||+++||||||||    +||||+..    +.+||+|||+||.......            
T Consensus       182 l~~~~~~~~~~q-ia~gl~yLH~~~iiHRDLK~----~NILl~~~----~~vKi~DFGlar~~~~~~~------------  240 (353)
T 4ase_A          182 LTLEHLICYSFQ-VAKGMEFLASRKCIHRDLAA----RNILLSEK----NVVKICDFGLARDIYKDPD------------  240 (353)
T ss_dssp             BCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCGGGSCTTTCTT------------
T ss_pred             CCHHHHHHHHHH-HHHHHHhHhhCCeecCccCc----cceeeCCC----CCEEECcchhhhhcccCCC------------
Confidence            445556666666 78999999999999999999    89999887    7999999999985321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                  .......+                      +|+.|||||++.+.. |+.++|||||||++|||+| |+
T Consensus       241 ------------~~~~~~~~----------------------gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~  285 (353)
T 4ase_A          241 ------------YVRKGDAR----------------------LPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGA  285 (353)
T ss_dssp             ------------SEEETTEE----------------------ECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSC
T ss_pred             ------------ceeecccc----------------------ccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCC
Confidence                        00001122                      399999999999776 9999999999999999998 99


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      +||++.+........+.+....+.++.++..-......||...|..|+++.++
T Consensus       286 ~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ei  338 (353)
T 4ase_A          286 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL  338 (353)
T ss_dssp             CSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence            99998654434445555554444444443322222345777777777776543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.94  E-value=3.1e-28  Score=249.82  Aligned_cols=147  Identities=26%  Similarity=0.337  Sum_probs=122.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|..+|+++ +|||||+++++|.+.+.+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||+++|+|
T Consensus        98 ~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH  176 (396)
T 4dc2_A           98 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIY  176 (396)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            356799999887 89999999999999999999999998 577777765 467999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +|++|||+|+......                                         ......
T Consensus       177 rDLKp~NILl~~~g~--ikL~DFGla~~~~~~~-----------------------------------------~~~~~~  213 (396)
T 4dc2_A          177 RDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPG-----------------------------------------DTTSTF  213 (396)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCBCCCCTT-----------------------------------------CCBCCC
T ss_pred             ccCCHHHEEECCCCC--EEEeecceeeecccCC-----------------------------------------Cccccc
Confidence            999999999998887  9999999886311000                                         001124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +||+.|++|        +.++|+||+|+++++|++|..||.
T Consensus       214 ~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~  254 (396)
T 4dc2_A          214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  254 (396)
T ss_dssp             CBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred             cCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence            577777777        567899999999999999997774

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.94  E-value=1.9e-28  Score=248.35  Aligned_cols=145  Identities=20%  Similarity=0.302  Sum_probs=99.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++|||||||||    +|||++...   |.+||+|||+|+...........                 .+.+
T Consensus       126 ll~al~ylH~~gIiHRDiKP----eNiLl~~~~---~~~kl~DFGla~~~~~~~~~~~~-----------------~~~~  181 (361)
T 4f9c_A          126 LFKALKRIHQFGIVHRDVKP----SNFLYNRRL---KKYALVDFGLAQGTHDTKIELLK-----------------FVQS  181 (361)
T ss_dssp             HHHHHHHHHHTTEECSCCSG----GGEEEETTT---TEEEECCCTTCEECTTCSCGGGG-----------------GC--
T ss_pred             HHHHHHHHHHCCeEeCcCCH----HHeEEeCCC---CeEEECcCCCCcccCCccccccc-----------------cccc
Confidence            68899999999999999999    899998653   79999999999854321100000                 0000


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ......+   ..+............+..+||++|||||++.+...|+.++||||+|||+|||++|++||.+.++..+++.
T Consensus       182 ~~~~~~~---~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~  258 (361)
T 4f9c_A          182 EAQQERC---SQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALA  258 (361)
T ss_dssp             ---------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             ccccccc---ccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence            0000000   0000000000111122345799999999999988899999999999999999999999987778889999


Q ss_pred             HHHHHhCCCCcc
Q psy3074         181 KIFKILGTPTEE  192 (481)
Q Consensus       181 ~i~~~~~~p~~~  192 (481)
                      .|...+|+|+..
T Consensus       259 ~I~~~~G~~~~~  270 (361)
T 4f9c_A          259 QIMTIRGSRETI  270 (361)
T ss_dssp             HHHHHHCHHHHH
T ss_pred             HHHHhcCCccch
Confidence            999999977544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.94  E-value=2e-29  Score=248.81  Aligned_cols=156  Identities=14%  Similarity=0.229  Sum_probs=114.4

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ++...+.+.++.+ .+.|++|||+++||||||||    +||||+.+    +.+||+|||+|+.....             
T Consensus       124 ~l~~~~~~~i~~q-ia~gl~yLH~~~iiHRDlKp----~NILl~~~----~~~Ki~DFGla~~~~~~-------------  181 (299)
T 4asz_A          124 ELTQSQMLHIAQQ-IAAGMVYLASQHFVHRDLAT----RNCLVGEN----LLVKIGDFGMSRDVYST-------------  181 (299)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCSCHHHHTGG-------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCcccCccCH----hhEEECCC----CcEEECCcccceecCCC-------------
Confidence            4556666777777 88999999999999999999    89999887    69999999999853210             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                    .....                   .....+|+.|||||++.+.. |+.++|||||||++|||+| |
T Consensus       182 --------------~~~~~-------------------~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G  227 (299)
T 4asz_A          182 --------------DYYRV-------------------GGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYG  227 (299)
T ss_dssp             --------------GCEEE-------------------TTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred             --------------Cceee-------------------cCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCC
Confidence                          00000                   00112499999999999776 9999999999999999999 8


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      ++||.+.+. .+.+..|.+....+.++.++..-......||...|..|+++.++
T Consensus       228 ~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i  280 (299)
T 4asz_A          228 KQPWYQLSN-NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI  280 (299)
T ss_dssp             CCTTTTSCH-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            999998543 36667777665555555444332223445777777777776543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.94  E-value=2e-28  Score=245.16  Aligned_cols=147  Identities=26%  Similarity=0.447  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|+.++||||+++++++.+.+.+|+|||||+ |++.+++... +.+++..++.++.|++.||.|||+++|+||
T Consensus        60 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHr  138 (328)
T 3fe3_A           60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHR  138 (328)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence            35689999999999999999999999999999999998 6788877654 579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.....                                          ....+
T Consensus       139 Dlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~------------------------------------------~~~~~  174 (328)
T 3fe3_A          139 DLKAENLLLDADMN--IKIADFGFSNEFTVGGK------------------------------------------LDAFC  174 (328)
T ss_dssp             CCCGGGEEECTTSC--EEECSTTCCGGGSSSCG------------------------------------------GGTTS
T ss_pred             CCCHHHEEEcCCCC--EEEeeccCceecCCCCc------------------------------------------ccccc
Confidence            99999999998877  99999998865431100                                          01134


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|         +..+|+||+|+++++|++|..||-.
T Consensus       175 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          175 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             SSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence            55566665         2457999999999999999977643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=1.9e-28  Score=252.63  Aligned_cols=148  Identities=20%  Similarity=0.257  Sum_probs=123.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|||||+++++|.+.+.+|+|||||+ |+|.+++..  ..+++..++.++.|++.||+|||+++|+|||
T Consensus       116 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrD  193 (410)
T 3v8s_A          116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRD  193 (410)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence            5679999999999999999999999999999999997 678887754  4699999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.+++  +|++|||+|+.+....   .                                     ......+|
T Consensus       194 LKp~NILl~~~g~--ikL~DFG~a~~~~~~~---~-------------------------------------~~~~~~~g  231 (410)
T 3v8s_A          194 VKPDNMLLDKSGH--LKLADFGTCMKMNKEG---M-------------------------------------VRCDTAVG  231 (410)
T ss_dssp             CSGGGEEECTTSC--EEECCCTTCEECCTTS---E-------------------------------------EECCSCCS
T ss_pred             CCHHHeeECCCCC--EEEeccceeEeeccCC---c-------------------------------------ccccCCcC
Confidence            9999999998887  9999999986533110   0                                     00112456


Q ss_pred             eeccCCC------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|            +.++|+||+|+++++|++|..||..+
T Consensus       232 t~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  276 (410)
T 3v8s_A          232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  276 (410)
T ss_dssp             CGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC
Confidence            7777776            24679999999999999999777644

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.94  E-value=6.3e-29  Score=248.55  Aligned_cols=157  Identities=14%  Similarity=0.190  Sum_probs=110.1

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++....+.+.++.+ .+.|++|||+++||||||||    +||||+..    +.+||+|||+|+.......          
T Consensus       153 ~~l~~~~~~~i~~q-ia~gl~yLH~~~iiHRDLKp----~NILl~~~----~~~Ki~DFGla~~~~~~~~----------  213 (329)
T 4aoj_A          153 GPLGLGQLLAVASQ-VAAGMVYLAGLHFVHRDLAT----RNCLVGQG----LVVKIGDFGMSRDIYSTDY----------  213 (329)
T ss_dssp             CSCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEETT----TEEEECCCC--------------------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHhcCCeecccccH----hhEEECCC----CcEEEcccccceeccCCCc----------
Confidence            44566667778877 88999999999999999999    89999876    7999999999985321100          


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-  164 (481)
                                    ...+..                      ..+|+.|||||++.+.. |+.++|||||||++|||+| 
T Consensus       214 --------------~~~~~~----------------------~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~  256 (329)
T 4aoj_A          214 --------------YRVGGR----------------------TMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTY  256 (329)
T ss_dssp             ------------------------------------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             --------------ceecCc----------------------ccccccccChhhhcCCC-CCccccccchHHHHHHHHcC
Confidence                          000111                      12499999999999876 9999999999999999999 


Q ss_pred             CCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      |++||.+.+. .+.+..|.+....+.++.++..-......||...|..|+++.++
T Consensus       257 G~~Pf~~~~~-~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei  310 (329)
T 4aoj_A          257 GKQPWYQLSN-TEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV  310 (329)
T ss_dssp             SCCTTCSSCH-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             CCCCCCCCCH-HHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence            8999998643 36677776665555444444332223345777677777776543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.94  E-value=1.9e-28  Score=247.85  Aligned_cols=149  Identities=21%  Similarity=0.305  Sum_probs=122.5

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ...+|..+|+.+ +|||||++++++.+.+.+|+|||||+ |+|...+... +.+++..++.++.|++.||+|||+++|+|
T Consensus        69 ~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH  147 (353)
T 3txo_A           69 CTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIY  147 (353)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            356799999988 69999999999999999999999998 5777777654 57999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +|++|||+|+......                                         ......
T Consensus       148 rDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~-----------------------------------------~~~~~~  184 (353)
T 3txo_A          148 RDLKLDNVLLDHEGH--CKLADFGMCKEGICNG-----------------------------------------VTTATF  184 (353)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCBCSCC-------------------------------------------------
T ss_pred             cCCCHHHEEECCCCC--EEEccccceeecccCC-----------------------------------------cccccc
Confidence            999999999998887  9999999886321000                                         001124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|        +..+|+||+|+++++|++|..||...
T Consensus       185 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             -CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence            677888887        67889999999999999999776543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.94  E-value=4.5e-28  Score=247.74  Aligned_cols=146  Identities=21%  Similarity=0.344  Sum_probs=120.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++|||||+++++|.+.+.+|+|||||. |+|...+.. .+.+++..++.++.|++.||.|||++||+||
T Consensus        61 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHr  139 (384)
T 4fr4_A           61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHR  139 (384)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            46689999999999999999999999999999999998 567766654 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.....                                          ....+
T Consensus       140 Dlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~------------------------------------------~~~~~  175 (384)
T 4fr4_A          140 DMKPDNILLDEHGH--VHITDFNIAAMLPRETQ------------------------------------------ITTMA  175 (384)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECCTTCC------------------------------------------BCCCC
T ss_pred             cCcHHHeEECCCCC--EEEeccceeeeccCCCc------------------------------------------eeccC
Confidence            99999999998887  99999999875431100                                          01123


Q ss_pred             ceeccCCC-----------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP-----------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p-----------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ||+.|++|           +..+|+||+|+++++|++|..||.
T Consensus       176 gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~  218 (384)
T 4fr4_A          176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH  218 (384)
T ss_dssp             SCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence            44444444           446799999999999999997775

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=2.6e-28  Score=251.75  Aligned_cols=150  Identities=22%  Similarity=0.254  Sum_probs=124.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|..++..++|||||+++++|.+.+.+|+|||||+ |+|.+++......+++..++.++.|++.||+|||+++|+|||
T Consensus       108 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrD  187 (412)
T 2vd5_A          108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRD  187 (412)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            5679999999999999999999999999999999997 788888877656799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.+++  +|++|||+|+.+......                                        .....+|
T Consensus       188 LKp~NILld~~g~--vkL~DFGla~~~~~~~~~----------------------------------------~~~~~~G  225 (412)
T 2vd5_A          188 IKPDNILLDRCGH--IRLADFGSCLKLRADGTV----------------------------------------RSLVAVG  225 (412)
T ss_dssp             CSGGGEEECTTSC--EEECCCTTCEECCTTSCE----------------------------------------ECSSCCS
T ss_pred             cCHHHeeecCCCC--EEEeechhheeccCCCcc----------------------------------------ccceecc
Confidence            9999999998887  999999998754311100                                        0011234


Q ss_pred             eeccCCC---------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP---------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p---------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|               +..+|+||+|++++||++|..||..+
T Consensus       226 t~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  273 (412)
T 2vd5_A          226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD  273 (412)
T ss_dssp             CGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC
Confidence            5555554               34579999999999999999777554

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.94  E-value=6.5e-28  Score=240.39  Aligned_cols=146  Identities=16%  Similarity=0.301  Sum_probs=122.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|.+++.. .+.+++..++.++.|++.||.|||+++|+||
T Consensus        52 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  130 (318)
T 1fot_A           52 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYR  130 (318)
T ss_dssp             HHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            45679999999999999999999999999999999998 578887765 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.....                                            ..+
T Consensus       131 Dlkp~NIll~~~g~--~kL~Dfg~a~~~~~~~~--------------------------------------------~~~  164 (318)
T 1fot_A          131 DLKPENILLDKNGH--IKITDFGFAKYVPDVTY--------------------------------------------TLC  164 (318)
T ss_dssp             CCCGGGEEECTTSC--EEECCCSSCEECSSCBC--------------------------------------------CCC
T ss_pred             CCChheEEEcCCCC--EEEeecCcceecCCccc--------------------------------------------ccc
Confidence            99999999998887  99999998864331111                                            123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|++|..|+...
T Consensus       165 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             SCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence            45555555        56789999999999999998776543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.94  E-value=9.6e-28  Score=241.89  Aligned_cols=146  Identities=26%  Similarity=0.342  Sum_probs=121.6

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+++++ +|||||++++++.+.+.+|+|||||+ |+|...+... +.+++..++.++.|++.||+|||+++|+||
T Consensus        56 ~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr  134 (345)
T 3a8x_A           56 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYR  134 (345)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            55799999987 89999999999999999999999998 5787777653 579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.+++  +|++|||+|+.......                                         .....+
T Consensus       135 Dlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~-----------------------------------------~~~~~~  171 (345)
T 3a8x_A          135 DLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD-----------------------------------------TTSTFC  171 (345)
T ss_dssp             CCCGGGEEECTTSC--EEECCGGGCBCSCCTTC-----------------------------------------CBCCCC
T ss_pred             CCCHHHEEECCCCC--EEEEeccccccccCCCC-----------------------------------------cccccC
Confidence            99999999998887  99999998863211000                                         011245


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ||+.|++|        +..+|+||+|+++++|++|..||.
T Consensus       172 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  211 (345)
T 3a8x_A          172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD  211 (345)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence            66666666        567899999999999999997764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.94  E-value=9e-28  Score=243.62  Aligned_cols=151  Identities=26%  Similarity=0.411  Sum_probs=123.6

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|+.++|||||++++++.+.+.+|+|||||+ |+|.+++.. .+.+++..+..++.|++.||.|||++||+|
T Consensus        60 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH  138 (361)
T 2yab_A           60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (361)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            356789999999999999999999999999999999997 678887754 457999999999999999999999999999


Q ss_pred             ccCCCccccccccch--hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEIDH--HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~~--~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+|||++..+.  ..+|++|||++..+....                                          ...
T Consensus       139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~------------------------------------------~~~  176 (361)
T 2yab_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV------------------------------------------EFK  176 (361)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC------------------------------------------CCC
T ss_pred             CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC------------------------------------------ccc
Confidence            999999999976652  248999999876433110                                          001


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ..+||+.|++|        +.++|+||+|+++++|++|..||..+
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             cCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            13456666666        55689999999999999999777553

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.94  E-value=5.6e-28  Score=242.73  Aligned_cols=151  Identities=26%  Similarity=0.415  Sum_probs=124.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++|||||++++++.+++.+++||||+.|++.+.+... +.+++..++.++.|++.||.|||+++|+|||
T Consensus        55 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~D  133 (336)
T 3h4j_B           55 RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRD  133 (336)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            466899999999999999999999999999999999999999988764 5699999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||++..+.....                                          ....+|
T Consensus       134 lkp~NIll~~~~~--~kl~DFG~s~~~~~~~~------------------------------------------~~~~~g  169 (336)
T 3h4j_B          134 LKPENLLLDDNLN--VKIADFGLSNIMTDGNF------------------------------------------LKTSCG  169 (336)
T ss_dssp             CSTTTEEECTTCC--EEECCSSCTBTTTTSBT------------------------------------------TCCCTT
T ss_pred             CchhhEEEcCCCC--EEEEEeccceeccCCcc------------------------------------------cccccC
Confidence            9999999998777  99999998864331100                                          001224


Q ss_pred             eeccCCC---------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         429 SFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       429 t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                      |+.|++|         +..+|+||+|+++++|++|..||-....+
T Consensus       170 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~  214 (336)
T 3h4j_B          170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP  214 (336)
T ss_dssp             STTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred             CcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence            4444444         34579999999999999999777654433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.94  E-value=1.8e-27  Score=234.52  Aligned_cols=147  Identities=21%  Similarity=0.309  Sum_probs=121.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++...+..|+|||||+ |+|.+++..  ..+++..+..++.|++.||.|||+++|+||
T Consensus        63 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (297)
T 3fxz_A           63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (297)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Confidence            35679999999999999999999999999999999997 678777765  369999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||++..+......                                         ....+
T Consensus       141 Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  177 (297)
T 3fxz_A          141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQSK-----------------------------------------RSTMV  177 (297)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECCSTTCC-----------------------------------------BCCCC
T ss_pred             CCCHHHEEECCCCC--EEEeeCCCceecCCcccc-----------------------------------------cCCcc
Confidence            99999999998877  999999987644311100                                         01133


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +.++|+||+|+++++|+.|..|+..
T Consensus       178 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  218 (297)
T 3fxz_A          178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (297)
T ss_dssp             SCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            55556655        5677999999999999999977644

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=1.2e-27  Score=234.28  Aligned_cols=155  Identities=35%  Similarity=0.581  Sum_probs=123.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++||||+++++.+.+....+.+++..+..++.|++.||.|||+++|+||
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  124 (288)
T 1ob3_A           45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (288)
T ss_dssp             HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             hhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            34678999999999999999999999999999999999999999888766789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||++.++.  +|++|||+++.+....   .....+..|.|||++.+.                           
T Consensus       125 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---------------------------  175 (288)
T 1ob3_A          125 DLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS---------------------------  175 (288)
T ss_dssp             CCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTC---------------------------
T ss_pred             CCCHHHEEEcCCCC--EEEeECccccccCccccccccccccccccCchheeCC---------------------------
Confidence            99999999998877  9999999998654211   011122223333322110                           


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                           .   ..+.++|+||+|+++++|..|..|+.
T Consensus       176 -----~---~~~~~~DiwslG~il~~l~~g~~pf~  202 (288)
T 1ob3_A          176 -----K---KYSTTIDIWSVGCIFAEMVNGTPLFP  202 (288)
T ss_dssp             -----C---SCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -----C---CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                 0   01456799999999999999986653

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.94  E-value=9.8e-28  Score=241.85  Aligned_cols=148  Identities=20%  Similarity=0.287  Sum_probs=122.5

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ...+|..+++.+ +|||||++++++.+.+.+|+|||||+ |+|..++... +.+++..++.++.|++.||+|||+++|+|
T Consensus        63 ~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH  141 (345)
T 1xjd_A           63 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVY  141 (345)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            356799999887 89999999999999999999999998 5788777653 57999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +|++|||+|+.......                                         .....
T Consensus       142 rDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~-----------------------------------------~~~~~  178 (345)
T 1xjd_A          142 RDLKLDNILLDKDGH--IKIADFGMCKENMLGDA-----------------------------------------KTNTF  178 (345)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC-----------------------------------------CBCCC
T ss_pred             CCCChhhEEECCCCC--EEEeEChhhhhcccCCC-----------------------------------------cccCC
Confidence            999999999998887  99999998863211000                                         01124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|        +..+|+||+|+++++|++|..|+..
T Consensus       179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (345)
T 1xjd_A          179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  220 (345)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence            566677766        5667999999999999999977654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.94  E-value=1e-27  Score=242.21  Aligned_cols=146  Identities=21%  Similarity=0.301  Sum_probs=122.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++||||+++++++.+.+.+|+|||||+ |+|.+++... +.+++..++.++.|++.||+|||+++|+||
T Consensus        87 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHr  165 (350)
T 1rdq_E           87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            46689999999999999999999999999999999998 6788887654 569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.....                                            ..+
T Consensus       166 Dlkp~NIll~~~g~--~kL~DFg~a~~~~~~~~--------------------------------------------~~~  199 (350)
T 1rdq_E          166 DLKPENLLIDQQGY--IQVTDFGFAKRVKGRTW--------------------------------------------TLC  199 (350)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECSSCBC--------------------------------------------CCE
T ss_pred             cCccceEEECCCCC--EEEcccccceeccCCcc--------------------------------------------ccc
Confidence            99999999998887  99999998875432111                                            134


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+|++|+++++|++|..|+..+
T Consensus       200 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             ECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence            55555555        45679999999999999998776543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.94  E-value=1.9e-27  Score=236.42  Aligned_cols=154  Identities=37%  Similarity=0.621  Sum_probs=121.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-----CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-----GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++|||||++++++.+++.+|+|||||+|+|.+++....     ..+++..++.++.|++.||.|||+++
T Consensus        49 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~  128 (317)
T 2pmi_A           49 TAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK  128 (317)
T ss_dssp             HHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4668999999999999999999999999999999999999999887543     35889999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      |+||||||+|||++.++.  +|++|||+++.+....   .....+..|.|||++.+.                       
T Consensus       129 ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----------------------  183 (317)
T 2pmi_A          129 ILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS-----------------------  183 (317)
T ss_dssp             EECCCCCGGGEEECTTCC--EEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC-----------------------
T ss_pred             eeeCCCChHHeEEcCCCC--EEECcCccceecCCCcccCCCCcccccccCchHhhCC-----------------------
Confidence            999999999999998877  9999999887543110   011112222222222110                       


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                  ...+.++|+|++|+++++|..|..||.
T Consensus       184 ------------~~~~~~~DiwslG~il~el~~g~~pf~  210 (317)
T 2pmi_A          184 ------------RTYSTSIDIWSCGCILAEMITGKPLFP  210 (317)
T ss_dssp             ------------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                        001446799999999999999986664

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=1e-27  Score=237.91  Aligned_cols=107  Identities=49%  Similarity=0.845  Sum_probs=99.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+.+|+.+++.++|||||++++++.+++.+++|||||+|++.+.+......+++..+..++.|++.||.|||+++|+||
T Consensus        64 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  143 (311)
T 3niz_A           64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHR  143 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            34678999999999999999999999999999999999999999988766779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+|||++.++.  +|++|||+++.+.
T Consensus       144 Dikp~NIl~~~~~~--~kl~Dfg~a~~~~  170 (311)
T 3niz_A          144 DLKPQNLLINSDGA--LKLADFGLARAFG  170 (311)
T ss_dssp             CCCGGGEEECTTCC--EEECCCTTCEETT
T ss_pred             CCchHhEEECCCCC--EEEccCcCceecC
Confidence            99999999998877  9999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=8.6e-28  Score=239.71  Aligned_cols=150  Identities=21%  Similarity=0.336  Sum_probs=122.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++|||||++++++.+.+.+++|||||+ |+|.+.+......+++..+..++.|++.||.|||+++|+|||
T Consensus        48 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~D  127 (321)
T 1tki_A           48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD  127 (321)
T ss_dssp             HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCC
Confidence            5679999999999999999999999999999999998 578888866555799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++......+|++|||+++.+.....   .                                       ....|
T Consensus       128 lkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~---------------------------------------~~~~g  165 (321)
T 1tki_A          128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---F---------------------------------------RLLFT  165 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTTCE---E---------------------------------------EEEES
T ss_pred             CCHHHEEEccCCCCCEEEEECCCCeECCCCCc---c---------------------------------------ccccC
Confidence            99999999874344599999998865431100   0                                       01234


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|        +..+|+||+|+++++|++|..|+...
T Consensus       166 t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  206 (321)
T 1tki_A          166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence            4455554        45679999999999999998777543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=1.5e-27  Score=249.34  Aligned_cols=169  Identities=23%  Similarity=0.357  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+|+.++|||||++++++..     ...+|+||||++|+|...+.. ...+++..++.++.||+.||.|||+++
T Consensus        98 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~  176 (458)
T 3rp9_A           98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG  176 (458)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            45689999999999999999999943     357999999999999888865 456999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+|+.+.......... ...+.           ...  .....++.........
T Consensus       177 iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~~~-~~~~~-----------~~~--~~~~~~~~~~~~~~~~  240 (458)
T 3rp9_A          177 ILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQL-PISPR-----------EDD--MNLVTFPHTKNLKRQL  240 (458)
T ss_dssp             CBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCCCCC-C------------------------------------
T ss_pred             cCCCCCChhhEEECCCCC--EeecccccchhccCcccccccc-ccCcc-----------ccc--cccccccccccccccc
Confidence            999999999999998877  9999999998765322111000 00000           000  0000111111111122


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCC
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHN  454 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~  454 (481)
                      ...+||+.|++|         +..+|+||+|++++||+.|
T Consensus       241 ~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          241 TGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             ----CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            346788999988         4567999999999999983

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.93  E-value=1.6e-27  Score=241.03  Aligned_cols=149  Identities=21%  Similarity=0.294  Sum_probs=123.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|..+|+.+ +||||+++++++.+.+.+|+|||||+ |+|.+.+... +.+++..++.++.|++.||+|||++||+|
T Consensus        66 ~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH  144 (353)
T 2i0e_A           66 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIY  144 (353)
T ss_dssp             HHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            456799999987 79999999999999999999999998 5788777654 56999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +|++|||+|+......                                         ......
T Consensus       145 rDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~-----------------------------------------~~~~~~  181 (353)
T 2i0e_A          145 RDLKLDNVMLDSEGH--IKIADFGMCKENIWDG-----------------------------------------VTTKTF  181 (353)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCBCCCCTT-----------------------------------------CCBCCC
T ss_pred             ccCCHHHEEEcCCCc--EEEEeCCcccccccCC-----------------------------------------cccccc
Confidence            999999999998887  9999999886321100                                         001124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|        +..+|+|++|++++||+.|..|+...
T Consensus       182 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          182 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             CSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence            567777777        56679999999999999999776543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.93  E-value=1.8e-27  Score=242.38  Aligned_cols=147  Identities=25%  Similarity=0.335  Sum_probs=117.6

Q ss_pred             HHHHHH-HhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASL-LKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~i-l~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+|..+ ++.++|||||+++++|.+.+.+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||+++|+|||
T Consensus        86 ~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrD  164 (373)
T 2r5t_A           86 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRD  164 (373)
T ss_dssp             -----CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence            346665 577899999999999999999999999998 577777765 45799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.+++  +|++|||+++.......                                         .....+|
T Consensus       165 lkp~NIll~~~g~--ikL~DFG~a~~~~~~~~-----------------------------------------~~~~~~g  201 (373)
T 2r5t_A          165 LKPENILLDSQGH--IVLTDFGLCKENIEHNS-----------------------------------------TTSTFCG  201 (373)
T ss_dssp             CCGGGEEECTTSC--EEECCCCBCGGGBCCCC-----------------------------------------CCCSBSC
T ss_pred             CCHHHEEECCCCC--EEEeeCccccccccCCC-----------------------------------------ccccccC
Confidence            9999999998887  99999998864221000                                         0112456


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|        +..+|+|++|++++||+.|..||...
T Consensus       202 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          202 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             CCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence            6677766        56689999999999999999777543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.93  E-value=4.3e-27  Score=238.40  Aligned_cols=152  Identities=12%  Similarity=0.123  Sum_probs=121.3

Q ss_pred             hHHHHHHHHhhcC---CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh----cCCCChHHHHHHHHHHHHHHHHhh
Q psy3074         269 TAIREASLLKELK---HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH----SGGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       269 ~~~rE~~il~~l~---HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      .+.+|+++++.++   |+||+++++++...+..|+|||||+ |+|.+++...    ...+++..+..++.|++.||+|||
T Consensus       110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH  189 (365)
T 3e7e_A          110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH  189 (365)
T ss_dssp             HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence            3456777777777   9999999999999999999999998 7888888652    356999999999999999999999


Q ss_pred             cCceeeccCCCccccccc-----------cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEE
Q psy3074         341 RRRILHRDVKPQNLLISE-----------IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVS  409 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~-----------~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~  409 (481)
                      +++|+||||||+|||++.           .+.  +|++|||+|+.+.........                         
T Consensus       190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~--~kl~DFG~a~~~~~~~~~~~~-------------------------  242 (365)
T 3e7e_A          190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG--LALIDLGQSIDMKLFPKGTIF-------------------------  242 (365)
T ss_dssp             TTTEECCCCSGGGEEECGGGTCC------CTT--EEECCCTTCEEGGGSCTTEEE-------------------------
T ss_pred             hCCeecCCCCHHHEEecccccCccccccccCC--EEEeeCchhhhhhccCCCcee-------------------------
Confidence            999999999999999987           444  999999998754422111111                         


Q ss_pred             EeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         410 TVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       410 ~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                                    ...+||+.|++|        +..+|+||+|+++++|++|..|+...
T Consensus       243 --------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          243 --------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             --------------CCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred             --------------eeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence                          112355555555        55679999999999999999777654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.93  E-value=2e-27  Score=246.73  Aligned_cols=168  Identities=21%  Similarity=0.339  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+|+.++|||||++++++...     +.+|+||||++|+|.+.+.. ...+++..++.++.|++.||.|||+++
T Consensus        71 ~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g  149 (432)
T 3n9x_A           71 RILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG  149 (432)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            466899999999999999999999876     57999999999999988865 356999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+|+.+.......... +.....  ..                ...........
T Consensus       150 ivHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~-~~~~~~--~~----------------~~~~~~~~~~~  208 (432)
T 3n9x_A          150 IIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVN-DLEENE--EP----------------GPHNKNLKKQL  208 (432)
T ss_dssp             EECCCCCGGGEEECTTCC--EEECCCTTCEEC------------------------------------------------
T ss_pred             CCCCCCCHHHeEECCCCC--EEEccCCCcccccccccccccc-cccccc--cc----------------cccccchhccc
Confidence            999999999999998877  9999999998654221111000 000000  00                00000000011


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ...+||+.|++|         +..+|+||+|++++||+.|..|+
T Consensus       209 ~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          209 TSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             --CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            234577777777         45679999999999999854433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=2.6e-27  Score=242.15  Aligned_cols=167  Identities=25%  Similarity=0.383  Sum_probs=123.6

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCC--eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~--~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+|+.+. |||||++++++...+  .+|+|||||+|+|...+..  +.+++..+..++.|++.||.|||++||+
T Consensus        54 ~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iv  131 (388)
T 3oz6_A           54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLL  131 (388)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3567999999998 999999999997544  7999999999999888865  4699999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||++.++.  +|++|||+|+.+.......        .+.-......       .......     ......
T Consensus       132 HrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~--------~~~~~~~~~~-------~~~~~~~-----~~~~~~  189 (388)
T 3oz6_A          132 HRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVT--------NNIPLSINEN-------TENFDDD-----QPILTD  189 (388)
T ss_dssp             CCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCC--------CCGGGCCC---------------------------
T ss_pred             eCCCCHHHeEEcCCCC--EEecCCccccccccccccc--------cccccccccc-------ccccccc-----cccccC
Confidence            9999999999998877  9999999998654221100        0000000000       0000000     001223


Q ss_pred             ccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .+||+.|++|         +..+|+||+|+++++|++|..||.
T Consensus       190 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            5688888887         445799999999999999986664

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.93  E-value=2.3e-27  Score=240.71  Aligned_cols=150  Identities=25%  Similarity=0.358  Sum_probs=121.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+..|+|||||. |+|.+.+.. ...+++..+..++.|++.||.|||+++|+||
T Consensus        74 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~  152 (362)
T 2bdw_A           74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHR  152 (362)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            35679999999999999999999999999999999998 578777754 3568999999999999999999999999999


Q ss_pred             cCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+|||++..+. ..+|++|||++..+.....                                          ....
T Consensus       153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~------------------------------------------~~~~  190 (362)
T 2bdw_A          153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA------------------------------------------WHGF  190 (362)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS------------------------------------------CCCS
T ss_pred             cCchHHEEEecCCCCCCEEEeecCcceEecCCcc------------------------------------------cccC
Confidence            99999999986532 3589999998864331100                                          0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|        +.++|+||+|+++++|++|..||...
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             CSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            345555555        55689999999999999999777543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.93  E-value=5.6e-27  Score=231.84  Aligned_cols=163  Identities=18%  Similarity=0.248  Sum_probs=126.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+||
T Consensus        53 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  132 (310)
T 3s95_A           53 TFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHR  132 (310)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence            45689999999999999999999999999999999998 58888887766779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+...............                          + ........+
T Consensus       133 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~--------------------------~-~~~~~~~~~  183 (310)
T 3s95_A          133 DLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKK--------------------------P-DRKKRYTVV  183 (310)
T ss_dssp             CCSTTSEEECTTSC--EEECCCTTCEECC-----------------------------------------------CCCC
T ss_pred             CCCcCeEEECCCCC--EEEeecccceecccccccccccccccc--------------------------c-ccccccccC
Confidence            99999999998777  999999998754422111000000000                          0 000112356


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+|++|+++++|..|..|+..
T Consensus       184 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             SCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             CCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            78888887        5678999999999999999855543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.93  E-value=3.3e-27  Score=252.06  Aligned_cols=149  Identities=21%  Similarity=0.289  Sum_probs=123.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|+.++|||||++++++.+.+.+|+|||||+ |+|...+.... ..+++..++.++.||+.||+|||+++|+|
T Consensus       230 ~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvH  309 (576)
T 2acx_A          230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY  309 (576)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            45689999999999999999999999999999999998 67877776532 34999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +|++|||+|+.+.....                                          ....
T Consensus       310 rDLKPeNILld~~g~--vKL~DFGla~~~~~~~~------------------------------------------~~~~  345 (576)
T 2acx_A          310 RDLKPENILLDDHGH--IRISDLGLAVHVPEGQT------------------------------------------IKGR  345 (576)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCEECCTTCC------------------------------------------EECC
T ss_pred             cCCchheEEEeCCCC--eEEEecccceecccCcc------------------------------------------cccc
Confidence            999999999998887  99999999864321100                                          0013


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|        +..+|+||+|+++++|++|..||...
T Consensus       346 ~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             CSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred             CCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence            466666666        56679999999999999999776543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=8.5e-27  Score=234.73  Aligned_cols=152  Identities=31%  Similarity=0.516  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--------CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--------RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--------~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      .+.+|+.+++.++||||+++++++.+        .+.+|+|||||+|++...+......+++..++.++.|++.||.|||
T Consensus        62 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH  141 (351)
T 3mi9_A           62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH  141 (351)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999987        4468999999999999988877677999999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ++||+||||||+|||++.++.  +|++|||+|+.+........                                     
T Consensus       142 ~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~-------------------------------------  182 (351)
T 3mi9_A          142 RNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQP-------------------------------------  182 (351)
T ss_dssp             HTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSSSC-------------------------------------
T ss_pred             HCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccccc-------------------------------------
Confidence            999999999999999998877  99999999875442111000                                     


Q ss_pred             cccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .......||+.|++|         +.++|+||+|+++++|+.|..|+.
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  230 (351)
T 3mi9_A          183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  230 (351)
T ss_dssp             CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence            000112345555554         456799999999999999986654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.93  E-value=7.7e-27  Score=233.17  Aligned_cols=151  Identities=25%  Similarity=0.417  Sum_probs=122.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|+.++|||||++++++.+.+..++|||||+ |+|.+++.. .+.+++..+..++.|++.||.|||+++|+|
T Consensus        59 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH  137 (326)
T 2y0a_A           59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAH  137 (326)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEc
Confidence            356789999999999999999999999999999999998 678887754 456999999999999999999999999999


Q ss_pred             ccCCCccccccccc--hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEID--HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~--~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+|||++..+  ...+|++|||+++.+.....                                          ..
T Consensus       138 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------------~~  175 (326)
T 2y0a_A          138 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE------------------------------------------FK  175 (326)
T ss_dssp             CCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC------------------------------------------CC
T ss_pred             CCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc------------------------------------------cc
Confidence            99999999998765  12489999998865431100                                          00


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ..+||+.|++|        +..+|+||+|+++++|++|..|+..+
T Consensus       176 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  220 (326)
T 2y0a_A          176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  220 (326)
T ss_dssp             CCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             cccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            12344455554        45689999999999999999777543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.93  E-value=1.6e-27  Score=241.72  Aligned_cols=153  Identities=23%  Similarity=0.353  Sum_probs=123.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|.+.+.. .+.+++..++.++.|++.||.|||++||+||
T Consensus        62 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~  140 (361)
T 3uc3_A           62 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHR  140 (361)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            45689999999999999999999999999999999998 678777765 3579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccc--cccCceeccccCCCccccccc-----ccccCCCeeEEEeecCCCCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSY--CHRRRILHRDVKPQNLLISEI-----VFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~--~~~~~i~~~d~~~~~il~~~~-----~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||||+|||++..+..++|++|||+++....  .....+.+..|.||+++....     .+.||.|++++++.+|..||..
T Consensus       141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred             CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence            999999999877666799999999874332  223345677899999885433     5779999999999999999976


Q ss_pred             cc
Q psy3074         421 ES  422 (481)
Q Consensus       421 ~~  422 (481)
                      ..
T Consensus       221 ~~  222 (361)
T 3uc3_A          221 PE  222 (361)
T ss_dssp             --
T ss_pred             Cc
Confidence            43

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.93  E-value=7.4e-27  Score=233.29  Aligned_cols=157  Identities=15%  Similarity=0.201  Sum_probs=127.0

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.+ +||||+++++++.+.+..++||||+.++|.+++....+.+++..+..++.|++.||.|||+++|+|||
T Consensus        51 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrD  130 (330)
T 2izr_A           51 LHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD  130 (330)
T ss_dssp             HHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            56799999999 99999999999999999999999998889998887667899999999999999999999999999999


Q ss_pred             CCCccccccccchh---hHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLISEIDHH---NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~~~~~~---~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||++.++..   .+|++|||+++.+.......                                  .........
T Consensus       131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~----------------------------------~~~~~~~~~  176 (330)
T 2izr_A          131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKK----------------------------------HIPYREHKS  176 (330)
T ss_dssp             CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCC----------------------------------BCCCCCCCC
T ss_pred             CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCc----------------------------------cccccccCC
Confidence            99999999876542   28999999987543211000                                  000001123


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .+||+.|++|        +..+|+||+|+++++|++|..|+..
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~  219 (330)
T 2izr_A          177 LTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG  219 (330)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence            5577778777        4567999999999999999977654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=1.4e-26  Score=228.80  Aligned_cols=148  Identities=32%  Similarity=0.543  Sum_probs=118.8

Q ss_pred             hHHHHHHHHhhcC---CCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKELK---HNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l~---HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      ...+|+.+++.++   ||||+++++++....     .+++||||+.|+|.+++..... .+++..+..++.|++.||.||
T Consensus        57 ~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l  136 (308)
T 3g33_A           57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL  136 (308)
T ss_dssp             HHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4557888877765   999999999998755     5899999999999998876543 389999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      |+++|+||||||+|||++.++.  +|++|||+++.+......                                      
T Consensus       137 H~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~--------------------------------------  176 (308)
T 3g33_A          137 HANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMAL--------------------------------------  176 (308)
T ss_dssp             HHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTTCCCS--------------------------------------
T ss_pred             HHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCCCccc--------------------------------------
Confidence            9999999999999999998877  999999988754311100                                      


Q ss_pred             ccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         420 FESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       420 ~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                          ...+||+.|++|        +.++|+||+|+++++|..|..|+..
T Consensus       177 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          177 ----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             ----GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred             ----CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence                012344445544        5678999999999999999866643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.93  E-value=8.4e-27  Score=238.32  Aligned_cols=156  Identities=19%  Similarity=0.198  Sum_probs=122.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|.+++... ...+++..+..++.|++.||.|||+++|+|
T Consensus        72 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  151 (389)
T 3gni_B           72 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVH  151 (389)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            35679999999999999999999999999999999998 6788877654 256999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||++..+.........                                  ........
T Consensus       152 rDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~----------------------------------~~~~~~~~  195 (389)
T 3gni_B          152 RSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRV----------------------------------VHDFPKYS  195 (389)
T ss_dssp             CCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSC----------------------------------BCCCCTTC
T ss_pred             CCCCHHHEEEcCCCC--EEEcccccceeeccccccccc----------------------------------cccccccc
Confidence            999999999998877  999999987643311100000                                  00000112


Q ss_pred             cceeccCCC----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|          +.++|+||+|+++++|..|..|+..
T Consensus       196 ~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  239 (389)
T ss_dssp             TTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            355556555          4467999999999999999966643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.93  E-value=6.3e-27  Score=236.29  Aligned_cols=151  Identities=26%  Similarity=0.374  Sum_probs=121.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|.+.+....   ..+++..+..++.|++.||.|||+++|
T Consensus        72 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  151 (351)
T 3c0i_A           72 DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI  151 (351)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            46789999999999999999999999999999999999 67877765432   348999999999999999999999999


Q ss_pred             eeccCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         345 LHRDVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      +||||||+|||++..+. ..+|++|||+++.+.....  .                                       .
T Consensus       152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~---------------------------------------~  190 (351)
T 3c0i_A          152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--V---------------------------------------A  190 (351)
T ss_dssp             ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--B---------------------------------------C
T ss_pred             eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--e---------------------------------------e
Confidence            99999999999976542 3489999998865431100  0                                       0


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+||+.|++|        +.++|+||+|+++++|++|..|+..
T Consensus       191 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            012355556555        5667999999999999999977754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.93  E-value=4.2e-27  Score=231.48  Aligned_cols=149  Identities=28%  Similarity=0.416  Sum_probs=120.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+.+..|+|||||+ |+|.+++... +.+++..+..++.|++.||.|||+++|+||
T Consensus        57 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  135 (294)
T 4eqm_A           57 RFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHR  135 (294)
T ss_dssp             HHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            45689999999999999999999999999999999998 5788877654 579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+......                                        .....+
T Consensus       136 Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~----------------------------------------~~~~~~  173 (294)
T 4eqm_A          136 DIKPQNILIDSNKT--LKIFDFGIAKALSETSLT----------------------------------------QTNHVL  173 (294)
T ss_dssp             CCCGGGEEECTTSC--EEECCCSSSTTC----------------------------------------------------
T ss_pred             CCCHHHEEECCCCC--EEEEeCCCcccccccccc----------------------------------------ccCccc
Confidence            99999999998877  999999988754311000                                        001123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +.++|+||+|+++++|++|..|+-.
T Consensus       174 gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             -CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             cCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            55555555        5668999999999999999977643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.93  E-value=2.1e-27  Score=243.06  Aligned_cols=149  Identities=18%  Similarity=0.274  Sum_probs=121.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++|||||++++++.+.+.+++|||||. |+|.+.+......+++..+..++.|++.||.|||+++|+|||
T Consensus        95 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD  174 (387)
T 1kob_A           95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD  174 (387)
T ss_dssp             HHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            5679999999999999999999999999999999998 678888766555799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++..+...+|++|||+++.+.....   .                                       ...+|
T Consensus       175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~---------------------------------------~~~~g  212 (387)
T 1kob_A          175 IKPENIMCETKKASSVKIIDFGLATKLNPDEI---V---------------------------------------KVTTA  212 (387)
T ss_dssp             CCGGGEEESSTTCCCEEECCCTTCEECCTTSC---E---------------------------------------EEECS
T ss_pred             cchHHeEEecCCCCceEEEecccceecCCCcc---e---------------------------------------eeecc
Confidence            99999999865445599999998875431100   0                                       00124


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|++|        +..+|+||+|+++++|++|..|+..
T Consensus       213 t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          213 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             SGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence            4444444        4557999999999999999877654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.93  E-value=6.9e-27  Score=248.59  Aligned_cols=150  Identities=19%  Similarity=0.269  Sum_probs=124.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+|+.++|||||+++++|.+.+.+|+|||||+ |+|...+...   ...+++..++.++.||+.||.|||+++|
T Consensus       231 ~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gI  310 (543)
T 3c4z_A          231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI  310 (543)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCC
Confidence            46689999999999999999999999999999999998 6787777653   2369999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+|||++.+++  +|++|||+++.+......                                         ..
T Consensus       311 vHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~~~-----------------------------------------~~  347 (543)
T 3c4z_A          311 IYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQTK-----------------------------------------TK  347 (543)
T ss_dssp             ECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCC-----------------------------------------BC
T ss_pred             cccCCChHHEEEeCCCC--EEEeecceeeeccCCCcc-----------------------------------------cc
Confidence            99999999999998887  999999998754311000                                         01


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ..+||+.|++|        +..+|+||+|++++||++|..||...
T Consensus       348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred             cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence            13456666666        56679999999999999999777653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=1.4e-27  Score=250.15  Aligned_cols=150  Identities=22%  Similarity=0.397  Sum_probs=114.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|+.++|||||++++++...      ..+|+|||||++++.+.+.   ..+++..++.++.|++.||.|||++
T Consensus       107 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~  183 (464)
T 3ttj_A          107 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA  183 (464)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456899999999999999999999654      4679999999998887764   3489999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhcccc--ccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +|+||||||+|||++.++.  +|++|||+|+.....  ....+.++.|.+||++.+..                      
T Consensus       184 ~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------  239 (464)
T 3ttj_A          184 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG----------------------  239 (464)
T ss_dssp             TCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC----CCCTTCCHHHHTTCC----------------------
T ss_pred             CcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCC----------------------
Confidence            9999999999999998877  999999998754321  11223333444444332210                      


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                    .+.+.|+||+|+++++|+.|..||-
T Consensus       240 --------------~~~~~DiwSlG~il~ell~g~~pF~  264 (464)
T 3ttj_A          240 --------------YKENVDIWSVGCIMGEMVRHKILFP  264 (464)
T ss_dssp             --------------CCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             --------------CCHHHHHHHHHHHHHHHHhCCCCCC
Confidence                          1456789999999999998886653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.93  E-value=8.4e-27  Score=235.24  Aligned_cols=156  Identities=21%  Similarity=0.236  Sum_probs=122.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+|+.++|||||++++++.+.+..|+|||||.|++.+.+......+++..+..++.|++.||.|||+++|+|||
T Consensus       100 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D  179 (348)
T 1u5q_A          100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD  179 (348)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence            45689999999999999999999999999999999999999998877677899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.+.... ....+..|.||+++....                              
T Consensus       180 lkp~NIll~~~~~--~kL~DfG~a~~~~~~~-~~~gt~~y~aPE~~~~~~------------------------------  226 (348)
T 1u5q_A          180 VKAGNILLSEPGL--VKLGDFGSASIMAPAN-SFVGTPYWMAPEVILAMD------------------------------  226 (348)
T ss_dssp             CSGGGEEEETTTE--EEECCCTTCBSSSSBC-CCCSCGGGCCHHHHHTTS------------------------------
T ss_pred             CCHHHEEECCCCC--EEEeeccCceecCCCC-cccCCcceeCHhhhcccc------------------------------
Confidence            9999999998776  9999999886543111 111222222332221100                              


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                         --..+..+|+||+|+++++|..|..|+..
T Consensus       227 ---~~~~~~~~DiwslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          227 ---EGQYDGKVDVWSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             ---SCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ---CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence               00013457999999999999999877654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=2.6e-27  Score=236.15  Aligned_cols=152  Identities=42%  Similarity=0.703  Sum_probs=119.3

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP  351 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp  351 (481)
                      +|+.+++.++||||+++++++.+.+..++|||||+|++.+++......+++..++.++.|++.||.|||+++|+||||||
T Consensus        49 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp  128 (324)
T 3mtl_A           49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP  128 (324)
T ss_dssp             CCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCG
T ss_pred             HHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCH
Confidence            59999999999999999999999999999999999999999887767799999999999999999999999999999999


Q ss_pred             ccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         352 QNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       352 ~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      +|||++.++.  +|++|||+++......   ...+.+..|.||+++.+.                               
T Consensus       129 ~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------------------------------  175 (324)
T 3mtl_A          129 QNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS-------------------------------  175 (324)
T ss_dssp             GGEEECTTCC--EEECSSSEEECC------------CGGGCCHHHHTTC-------------------------------
T ss_pred             HHEEECCCCC--EEEccCcccccccCCccccccccCcccccChhhhcCC-------------------------------
Confidence            9999998877  9999999886433111   011112222222222110                               


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                          ...+.++|+||+|+++++|.+|..|+..
T Consensus       176 ----~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          176 ----TDYSTQIDMWGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             ----CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ----CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                0014457999999999999999866643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.93  E-value=1.2e-27  Score=249.08  Aligned_cols=186  Identities=21%  Similarity=0.275  Sum_probs=144.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++|||||++++++.+.+..|+|||||. |+|.+.+... +.+++..+..++.|++.||.|||+++|+||
T Consensus        56 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHr  134 (444)
T 3soa_A           56 KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHR  134 (444)
T ss_dssp             HHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35689999999999999999999999999999999998 5787777653 569999999999999999999999999999


Q ss_pred             cCCCcccccccc-chhhHHHHHHHHHhhccccc---cCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCcc
Q psy3074         348 DVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       348 DlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      ||||+|||++.. ....+|++|||+|+.+....   .....+..|.|||++..    ...|.||.|++++++.+|..||.
T Consensus       135 DlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~  214 (444)
T 3soa_A          135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW  214 (444)
T ss_dssp             CCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence            999999999853 22459999999997655321   22345677888888744    45577999999999999999997


Q ss_pred             ccccCc-----ccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         420 FESKSN-----INLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       420 ~~~~~~-----~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..+...     ..+.+.+..|..+.....+..++..|+..+
T Consensus       215 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  255 (444)
T 3soa_A          215 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN  255 (444)
T ss_dssp             CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSS
T ss_pred             CccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCC
Confidence            654221     122333333333333345667777777665

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.93  E-value=1.3e-26  Score=231.61  Aligned_cols=154  Identities=34%  Similarity=0.580  Sum_probs=117.3

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|+.+++.++|||||++++++.+.+.+|+|||||+|+|.+++... ..+++..++.++.|++.||.|||+++|+||||
T Consensus        80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dl  158 (329)
T 3gbz_A           80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDL  158 (329)
T ss_dssp             CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             HHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCC
Confidence            46799999999999999999999999999999999999999888764 46999999999999999999999999999999


Q ss_pred             CCccccccccc---hhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         350 KPQNLLISEID---HHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       350 Kp~NiLl~~~~---~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      ||+|||++.++   ...+|++|||+++.+....   ...+.+..|.|||++.+..                         
T Consensus       159 kp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-------------------------  213 (329)
T 3gbz_A          159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSR-------------------------  213 (329)
T ss_dssp             CGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCC-------------------------
T ss_pred             CHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCC-------------------------
Confidence            99999995432   2349999999998654211   1112233344444332100                         


Q ss_pred             CcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         424 SNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       424 ~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                ..+.++|+||+|+++++|+.|..|+.
T Consensus       214 ----------~~~~~~DiwslG~il~ell~g~~pf~  239 (329)
T 3gbz_A          214 ----------HYSTSVDIWSIACIWAEMLMKTPLFP  239 (329)
T ss_dssp             ----------CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ----------CCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence                      01345688888888888888876654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.93  E-value=1.3e-26  Score=253.49  Aligned_cols=149  Identities=21%  Similarity=0.294  Sum_probs=123.3

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|..+|..+ +||||++++++|++.+.+||||||++ |+|..++... +.+++..++.++.||+.||+|||+++|+|
T Consensus       387 ~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiH  465 (674)
T 3pfq_A          387 CTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIY  465 (674)
T ss_dssp             HHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEEC
T ss_pred             HHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            456799999987 69999999999999999999999998 5787777654 57999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.+++  +||+|||+|+.......                                         .....
T Consensus       466 rDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~-----------------------------------------~~~~~  502 (674)
T 3pfq_A          466 RDLKLDNVMLDSEGH--IKIADFGMCKENIWDGV-----------------------------------------TTKTF  502 (674)
T ss_dssp             CCCCSTTEEECSSSC--EEECCCTTCEECCCTTC-----------------------------------------CBCCC
T ss_pred             ccCChhhEEEcCCCc--EEEeecceeeccccCCc-----------------------------------------ccccc
Confidence            999999999998887  99999998863221000                                         01124


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|        +.++|+||+|++|+||+.|..||...
T Consensus       503 ~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             CSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence            566666666        56789999999999999999776543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=6.6e-27  Score=237.67  Aligned_cols=152  Identities=24%  Similarity=0.434  Sum_probs=121.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|+.++||||+++++++....      .+|+||||+.++|.+++..  ..+++..+..++.|++.||.|||++
T Consensus        70 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~  147 (367)
T 1cm8_A           70 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA  147 (367)
T ss_dssp             HHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4568999999999999999999998763      4699999998888888765  4699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||||||+|||++.++.  +|++|||+++.........+.++.|.||+++.+.                         
T Consensus       148 ~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~-------------------------  200 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSEMTGYVVTRWYRAPEVILNW-------------------------  200 (367)
T ss_dssp             TEECCCCCGGGEEECTTCC--EEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTT-------------------------
T ss_pred             CccccCcCHHHEEEcCCCC--EEEEeeecccccccccCcCcCCCCcCCHHHHhCC-------------------------
Confidence            9999999999999998877  9999999987654333333444445555444320                         


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                ...+...|+||+|+++++|+.|..||.
T Consensus       201 ----------~~~~~~~DiwslG~il~ell~g~~pf~  227 (367)
T 1cm8_A          201 ----------MRYTQTVDIWSVGCIMAEMITGKTLFK  227 (367)
T ss_dssp             ----------TCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ----------CCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence                      011456788999999999998886654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.92  E-value=1.1e-26  Score=230.45  Aligned_cols=147  Identities=20%  Similarity=0.220  Sum_probs=117.5

Q ss_pred             HHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       271 ~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      .+|+..+..+ +|||||++++++.+.+.+|+|||||.+++.+.+......+++..+..++.|++.||.|||+++|+||||
T Consensus       104 ~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  183 (311)
T 3p1a_A          104 LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDV  183 (311)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             HHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCC
Confidence            3455555554 899999999999999999999999999999998887777999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccce
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLS  429 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t  429 (481)
                      ||+|||++.++.  +|++|||++..........                                          ...||
T Consensus       184 kp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~------------------------------------------~~~gt  219 (311)
T 3p1a_A          184 KPANIFLGPRGR--CKLGDFGLLVELGTAGAGE------------------------------------------VQEGD  219 (311)
T ss_dssp             SGGGEEECGGGC--EEECCCTTCEECC------------------------------------------------CCCCC
T ss_pred             CHHHEEECCCCC--EEEccceeeeecccCCCCc------------------------------------------ccCCC
Confidence            999999988777  9999999876443111000                                          01233


Q ss_pred             eccCCC-------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         430 FHYLPP-------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       430 ~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +.|++|       +.++|+||+|+++++|.+|..+++..
T Consensus       220 ~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          220 PRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             GGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             ccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            344443       45679999999999999996565543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.92  E-value=3.4e-27  Score=235.49  Aligned_cols=148  Identities=25%  Similarity=0.409  Sum_probs=120.7

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|||||++++++.+.+..|+|||||+ |+|.+.+.. ...+++..+..++.|++.||.|||+++|+|||
T Consensus        52 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~D  130 (323)
T 3tki_A           52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD  130 (323)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence            5679999999999999999999999999999999998 477776654 34699999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.+........                                       ....+|
T Consensus       131 lkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~---------------------------------------~~~~~g  169 (323)
T 3tki_A          131 IKPENLLLDERDN--LKISDFGLATVFRYNNRERL---------------------------------------LNKMCG  169 (323)
T ss_dssp             CSGGGEEECTTCC--EEECCCTTCEECEETTEECC---------------------------------------BCSCCS
T ss_pred             cchHHEEEeCCCC--EEEEEeeccceeccCCcccc---------------------------------------cCCCcc
Confidence            9999999998777  99999998875432111000                                       011345


Q ss_pred             eeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         429 SFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       429 t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      |+.|++|         +.+.|+|++|+++++|+.|..|+.
T Consensus       170 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  209 (323)
T 3tki_A          170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD  209 (323)
T ss_dssp             CGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred             CcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence            6666666         224799999999999999997664

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.92  E-value=2.7e-27  Score=254.34  Aligned_cols=95  Identities=26%  Similarity=0.472  Sum_probs=81.3

Q ss_pred             cccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          20 SKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        20 ~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ..++||+|||++|||||||||    +||||+..    |++||+|||+|+.....                          
T Consensus       300 qIl~aL~yLH~~gIiHRDLKP----eNILld~~----G~vKL~DFGlA~~~~~~--------------------------  345 (689)
T 3v5w_A          300 EIILGLEHMHNRFVVYRDLKP----ANILLDEH----GHVRISDLGLACDFSKK--------------------------  345 (689)
T ss_dssp             HHHHHHHHHHTTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECSSC--------------------------
T ss_pred             HHHHHHHHHHHCCccccCCch----HHeEEeCC----CCEEecccceeeecCCC--------------------------
Confidence            379999999999999999999    89999876    89999999999853211                          


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                        ...+++|                      |+.|||||++.+...|+.++||||+|||+|||++|++||.+.
T Consensus       346 --~~~t~~G----------------------Tp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          346 --KPHASVG----------------------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             --CCCSCCS----------------------CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred             --CCCCccC----------------------CcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence              0112344                      999999999987666999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.92  E-value=1.8e-26  Score=247.41  Aligned_cols=133  Identities=22%  Similarity=0.335  Sum_probs=102.2

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +..+..-..+... .+.||+|||+++|+||||||    +|||++...  .|.+||+|||+|+..                
T Consensus       251 ~l~e~~~~~~~~q-i~~al~ylH~~~iiHRDlKp----~Nill~~~~--~~~vKl~DFG~a~~~----------------  307 (573)
T 3uto_A          251 KMSEDEAVEYMRQ-VCKGLCHMHENNYVHLDLKP----ENIMFTTKR--SNELKLIDFGLTAHL----------------  307 (573)
T ss_dssp             CEEHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESSSS--CCCEEECCCSSCEEC----------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHCCeeeccCCh----hhccccCCC--CCCEEEeeccceeEc----------------
Confidence            3344444444444 78999999999999999999    899997542  378999999999853                


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                 ..+....+++|                      |++|||||++.+.. |+.++||||+||++|||++|+
T Consensus       308 -----------~~~~~~~~~~G----------------------T~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~  353 (573)
T 3uto_A          308 -----------DPKQSVKVTTG----------------------TAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGL  353 (573)
T ss_dssp             -----------CTTSEEEEECS----------------------SGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSC
T ss_pred             -----------cCCCceeeeEE----------------------CccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCC
Confidence                       22333445566                      99999999999876 999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      +||.+.+. .+.+..|......++...|+.+
T Consensus       354 ~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  383 (573)
T 3uto_A          354 SPFGGEND-DETLRNVKSCDWNMDDSAFSGI  383 (573)
T ss_dssp             CSSCCSSH-HHHHHHHHTTCCCCCSGGGTTS
T ss_pred             CCCCCcCH-HHHHHHHHhCCCCCCcccccCC
Confidence            99998544 4777777665555555444443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.92  E-value=9.8e-27  Score=244.21  Aligned_cols=148  Identities=29%  Similarity=0.444  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++||||+++++++.+.+.+|+|||||+ |+|.+++.. .+.+++..++.++.|++.||.|||+++|+||
T Consensus        62 ~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  140 (476)
T 2y94_A           62 KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHR  140 (476)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcc
Confidence            45689999999999999999999999999999999997 578777754 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.....                                          ....+
T Consensus       141 DLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~------------------------------------------~~~~~  176 (476)
T 2y94_A          141 DLKPENVLLDAHMN--AKIADFGLSNMMSDGEF------------------------------------------LRTSC  176 (476)
T ss_dssp             CCSGGGEEECTTCC--EEECCCSSCEECCTTCC------------------------------------------BCCCC
T ss_pred             cccHHHEEEecCCC--eEEEeccchhhcccccc------------------------------------------ccccC
Confidence            99999999998777  99999998864331100                                          00123


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|         +..+|+||+|+++++|++|..|+..+
T Consensus       177 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          177 GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             SCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence            44455554         33579999999999999998776543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.92  E-value=5.9e-27  Score=244.09  Aligned_cols=148  Identities=20%  Similarity=0.323  Sum_probs=117.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-Cceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-RRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-~~iiHr  347 (481)
                      +.+|+.+++.++|||||++++++.+.+.+|+|||||+ |+|...+.. .+.+++..+..++.|++.||+|||+ ++|+||
T Consensus       195 ~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr  273 (446)
T 4ejn_A          195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR  273 (446)
T ss_dssp             ------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence            4569999999999999999999999999999999998 567777655 4579999999999999999999998 999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.......                                         .....+
T Consensus       274 Dlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~-----------------------------------------~~~~~~  310 (446)
T 4ejn_A          274 DLKLENLMLDKDGH--IKITDFGLCKEGIKDGA-----------------------------------------TMKTFC  310 (446)
T ss_dssp             CCCGGGEEECSSSC--EEECCCCCCCTTCC----------------------------------------------CCSS
T ss_pred             CCCHHHEEECCCCC--EEEccCCCceeccCCCc-----------------------------------------cccccc
Confidence            99999999998877  99999998763211000                                         011244


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|+.|..|+...
T Consensus       311 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             SCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence            66667766        56779999999999999999777544

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=1.3e-26  Score=233.23  Aligned_cols=106  Identities=40%  Similarity=0.657  Sum_probs=98.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||+++++...+......+++..+..++.|++.||.|||+++|+|||
T Consensus        58 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  137 (346)
T 1ua2_A           58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD  137 (346)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Confidence            46789999999999999999999999999999999999999888877666799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      |||+|||++.++.  +|++|||+++.+.
T Consensus       138 lkp~Nil~~~~~~--~kl~Dfg~a~~~~  163 (346)
T 1ua2_A          138 LKPNNLLLDENGV--LKLADFGLAKSFG  163 (346)
T ss_dssp             CCGGGEEECTTCC--EEECCCGGGSTTT
T ss_pred             CCHHHEEEcCCCC--EEEEecccceecc
Confidence            9999999998877  9999999987653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.92  E-value=1.1e-26  Score=236.74  Aligned_cols=151  Identities=26%  Similarity=0.339  Sum_probs=121.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.+.+.+++|||||+ |+|.+.+......+++..+..++.|++.||.|||+++|+||
T Consensus       132 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  211 (373)
T 2x4f_A          132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL  211 (373)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35689999999999999999999999999999999998 57888887665679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+..++...+|++|||+++.+......                                          ...+
T Consensus       212 Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~------------------------------------------~~~~  249 (373)
T 2x4f_A          212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKL------------------------------------------KVNF  249 (373)
T ss_dssp             CCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC------------------------------------------CCCC
T ss_pred             cCCHHHEEEecCCCCcEEEEeCCCceecCCcccc------------------------------------------cccc
Confidence            9999999995444445999999988654311000                                          0112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +.++|+|++|+++++|+.|..|+...
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~  291 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD  291 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence            44555555        34679999999999999998776543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.92  E-value=1.7e-26  Score=230.69  Aligned_cols=147  Identities=21%  Similarity=0.325  Sum_probs=116.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++|||||++++++.+.+.+|+|||||+ |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+|||
T Consensus        68 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~D  146 (327)
T 3a62_A           68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRD  146 (327)
T ss_dssp             ---HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEccc
Confidence            4579999999999999999999999999999999998 678777765 35689999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.......  .                                       ....+|
T Consensus       147 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~---------------------------------------~~~~~g  183 (327)
T 3a62_A          147 LKPENIMLNHQGH--VKLTDFGLCKESIHDGT--V---------------------------------------THTFCG  183 (327)
T ss_dssp             CCTTTEEECTTSC--EEECCCSCC---------------------------------------------------CTTSS
T ss_pred             CCHHHeEECCCCc--EEEEeCCcccccccCCc--c---------------------------------------ccccCC
Confidence            9999999998877  99999998764321100  0                                       011335


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|++|        +..+|+|++|+++++|++|..|+..
T Consensus       184 t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             CCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence            5555555        4567999999999999999977654

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.92  E-value=2.8e-26  Score=227.98  Aligned_cols=159  Identities=18%  Similarity=0.306  Sum_probs=118.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC----------------------------------------------------
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS----------------------------------------------------  296 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~----------------------------------------------------  296 (481)
                      .+.+|+.+|++++|||||++++++.+..                                                    
T Consensus        50 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  129 (332)
T 3qd2_B           50 KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP  129 (332)
T ss_dssp             HHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------------------------------------
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccC
Confidence            4678999999999999999999986543                                                    


Q ss_pred             -----eEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHH
Q psy3074         297 -----TLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFM  368 (481)
Q Consensus       297 -----~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~d  368 (481)
                           .+++|||||+ |+|.+++.....  ..++..+..++.|++.||.|||+++|+||||||+|||++.++.  +|++|
T Consensus       130 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~D  207 (332)
T 3qd2_B          130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGD  207 (332)
T ss_dssp             --CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECC
T ss_pred             CCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEee
Confidence                 3899999998 578888765322  2455568899999999999999999999999999999998776  99999


Q ss_pred             HHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCC--------CCChh
Q psy3074         369 FQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFT  440 (481)
Q Consensus       369 fgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~  440 (481)
                      ||+++.+.........         .                  .....  .......+||+.|++|        +.++|
T Consensus       208 fG~a~~~~~~~~~~~~---------~------------------~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  258 (332)
T 3qd2_B          208 FGLVTAMDQDEEEQTV---------L------------------TPMPA--YATHTGQVGTKLYMSPEQIHGNNYSHKVD  258 (332)
T ss_dssp             CTTCEECSCC-------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHH
T ss_pred             cCcccccccchhhccc---------c------------------ccccc--cccccccCCCcCccChHHhcCCCCcchhh
Confidence            9998765422110000         0                  00000  0011234577888877        56779


Q ss_pred             hhhhHHHHHHhhCCCccc
Q psy3074         441 AIREASLLKELKHNNIVT  458 (481)
Q Consensus       441 ~~s~~~~l~~l~~~~~~~  458 (481)
                      +||+|+++++|++|..|+
T Consensus       259 i~slG~il~el~~~~~~~  276 (332)
T 3qd2_B          259 IFSLGLILFELLYSFSTQ  276 (332)
T ss_dssp             HHHHHHHHHHHHSCCCCH
T ss_pred             HHHHHHHHHHHHHcCCCh
Confidence            999999999999997554

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.92  E-value=4.5e-26  Score=226.40  Aligned_cols=161  Identities=19%  Similarity=0.254  Sum_probs=119.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC--eEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~--~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++++.++||||+++++++...+  ..++|||||+ |+|.+++.....  .+++..+..++.|++.||.|||+++
T Consensus        53 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  132 (319)
T 4euu_A           53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG  132 (319)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3567999999999999999999998765  7899999998 688888875432  3899999999999999999999999


Q ss_pred             eeeccCCCccccc----cccchhhHHHHHHHHHhhcccccc--CceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         344 ILHRDVKPQNLLI----SEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       344 iiHrDlKp~NiLl----~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      |+||||||+|||+    +..+.  +|++|||+++.+.....  ....+..|.+|+++......                 
T Consensus       133 ivH~Dlkp~NIll~~~~~~~~~--~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----------------  193 (319)
T 4euu_A          133 IVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLR-----------------  193 (319)
T ss_dssp             EECSCCSGGGEEEEECTTSCEE--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSC-----------------
T ss_pred             EecCCCCHHHEEEeccCCCCce--EEEccCCCceecCCCCceeecccCCCccCHHHhhhcccc-----------------
Confidence            9999999999998    44444  99999999875432111  11122233333332211000                 


Q ss_pred             ccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         418 WWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                 .......+..+|+||+|+++++|+.|..||.
T Consensus       194 -----------~~~~~~~~~~~DiwslG~il~el~~g~~pf~  224 (319)
T 4euu_A          194 -----------KDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (319)
T ss_dssp             -----------CCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred             -----------ccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                       0000112467899999999999999997764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.92  E-value=2.6e-26  Score=241.79  Aligned_cols=150  Identities=24%  Similarity=0.382  Sum_probs=119.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.+.+.+|+|||||. |+|.+.+... +.+++..+..++.|++.||.|||+++|+||
T Consensus        67 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~  145 (486)
T 3mwu_A           67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (486)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            46689999999999999999999999999999999998 5787777654 579999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+|||++..+ ...+|++|||+++.+.....                                          ....
T Consensus       146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------------~~~~  183 (486)
T 3mwu_A          146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK------------------------------------------MKDR  183 (486)
T ss_dssp             CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----------------------------------------------CC
T ss_pred             cCchHHEEEecCCCCCCEEEEECCcCeECCCCCc------------------------------------------cCCC
Confidence            9999999996532 23499999998875431110                                          0011


Q ss_pred             cceeccCCC-------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      +||+.|++|       +.++|+||+|+++++|++|..|+...
T Consensus       184 ~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          184 IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             TTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            244444444       34679999999999999998776543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.92  E-value=2.4e-26  Score=229.44  Aligned_cols=152  Identities=18%  Similarity=0.251  Sum_probs=121.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++.+.+..|+|||||+ |+|.+++....+.+++..+..++.|++.||.|||+++|+||
T Consensus        96 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~  175 (325)
T 3kul_A           96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHR  175 (325)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            46789999999999999999999999999999999998 58888887666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.........                                      .....
T Consensus       176 Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~--------------------------------------~~~~~  215 (325)
T 3kul_A          176 DLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYT--------------------------------------TTGGK  215 (325)
T ss_dssp             CCSGGGEEECTTCC--EEECCCSSCEECC----CCEE--------------------------------------CC---
T ss_pred             CCCcceEEECCCCC--EEECCCCcccccccCccceee--------------------------------------ccCCC
Confidence            99999999988777  999999988754321110000                                      00112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      +|+.|++|        +..+|+||+|+++++|+. |..|+..
T Consensus       216 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~  257 (325)
T 3kul_A          216 IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN  257 (325)
T ss_dssp             CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence            34455555        456799999999999998 8866643

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.92  E-value=3.9e-26  Score=241.02  Aligned_cols=149  Identities=22%  Similarity=0.304  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++|||||++++++.+....|+|||||. |+|.+.+... ..+++..+..++.|++.||.|||+++|+||
T Consensus        82 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~  160 (494)
T 3lij_A           82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHR  160 (494)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            46689999999999999999999999999999999998 5787777654 569999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+|||++..+ ...+|++|||+|+.+.....                                          ....
T Consensus       161 Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~------------------------------------------~~~~  198 (494)
T 3lij_A          161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKK------------------------------------------MKER  198 (494)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC------------------------------------------BCCC
T ss_pred             cCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc------------------------------------------cccc
Confidence            9999999997643 23489999998864431100                                          0012


Q ss_pred             cceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|       +.++|+||+|+++++|++|..|+..
T Consensus       199 ~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~  239 (494)
T 3lij_A          199 LGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG  239 (494)
T ss_dssp             CSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence            344555554       5678999999999999999977643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.92  E-value=3e-26  Score=233.87  Aligned_cols=152  Identities=25%  Similarity=0.376  Sum_probs=115.8

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeec--------------------------------------CCeEEEEEeccCCCHHHHH
Q psy3074         272 REASLLKELKHNNIVTLHDIVHT--------------------------------------RSTLTFVFEYVHTDLSQYM  313 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~--------------------------------------~~~~~iv~E~~~g~l~~~l  313 (481)
                      +|+++|+.++|||||+++++|..                                      ...+++|||||+|+|.+.+
T Consensus        49 ~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l  128 (383)
T 3eb0_A           49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL  128 (383)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHH
T ss_pred             HHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHH
Confidence            59999999999999999999944                                      3458999999999877776


Q ss_pred             HH---hcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCcccccc-ccchhhHHHHHHHHHhhccccc--cCceeccc
Q psy3074         314 ER---HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS-EIDHHNIRLFMFQLLRGLSYCH--RRRILHRD  387 (481)
Q Consensus       314 ~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~-~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d  387 (481)
                      ..   ....+++..++.++.|++.||.|||++||+||||||+|||++ .++.  +|++|||+|+.+....  ...+.++.
T Consensus       129 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~t~~  206 (383)
T 3eb0_A          129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYICSRF  206 (383)
T ss_dssp             HHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTE--EEECCCTTCEECCTTSCCCCCCCCSS
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCc--EEEEECCCCcccCCCCCCcCcccCCC
Confidence            53   345699999999999999999999999999999999999997 4555  9999999987543211  11122223


Q ss_pred             cCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         388 VKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       388 ~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |.||+++.+.                                .   ..+.++|+||+|+++++|++|..|+..
T Consensus       207 y~aPE~~~~~--------------------------------~---~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          207 YRAPELMLGA--------------------------------T---EYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             CCCHHHHTTC--------------------------------S---SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCHHHhcCC--------------------------------C---CCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            3333332210                                0   014467999999999999999866643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.92  E-value=3.6e-27  Score=232.82  Aligned_cols=107  Identities=24%  Similarity=0.376  Sum_probs=73.8

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++|||||||||    +||||+.+    |.+||+|||+|+...........              .......
T Consensus       127 i~~al~ylH~~~IiHRDlKp----~NILl~~~----~~vKl~DFGla~~~~~~~~~~~~--------------~~~~~~~  184 (299)
T 4g31_A          127 IAEAVEFLHSKGLMHRDLKP----SNIFFTMD----DVVKVGDFGLVTAMDQDEEEQTV--------------LTPMPAY  184 (299)
T ss_dssp             HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECCCCCC---------------------------------
T ss_pred             HHHHHHHHHHCcCccccCcH----HHeEECCC----CcEEEccCccceecCCCcccccc--------------ccccccc
Confidence            67899999999999999999    89999876    79999999999864321110000              0000000


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                      ....                      ..+||+.|||||++.+.. |+.++||||+||++|||++   ||.+..+.
T Consensus       185 ~~~~----------------------~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~~~  233 (299)
T 4g31_A          185 ARHT----------------------GQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQMER  233 (299)
T ss_dssp             -----------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred             cccC----------------------CcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCccHH
Confidence            0111                      223599999999999865 9999999999999999996   88765433

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.92  E-value=4.3e-26  Score=239.93  Aligned_cols=150  Identities=24%  Similarity=0.336  Sum_probs=121.2

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|++++|||||++++++.+.+..|+|||||. |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+|
T Consensus        71 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  149 (484)
T 3nyv_A           71 ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVH  149 (484)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            346789999999999999999999999999999999998 677777765 456999999999999999999999999999


Q ss_pred             ccCCCcccccccc-chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||++.. ....+|++|||+++.+.....                                          ...
T Consensus       150 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------------~~~  187 (484)
T 3nyv_A          150 RDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK------------------------------------------MKD  187 (484)
T ss_dssp             SCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS------------------------------------------HHH
T ss_pred             CCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc------------------------------------------ccc
Confidence            9999999999532 223499999999986542110                                          001


Q ss_pred             ccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .+||+.|++|       +.++|+||+|+++++|++|..|+..
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  229 (484)
T 3nyv_A          188 KIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG  229 (484)
T ss_dssp             HTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence            2244455554       5578999999999999999976643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.92  E-value=2e-26  Score=234.23  Aligned_cols=152  Identities=24%  Similarity=0.405  Sum_probs=108.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|+.++||||+++++++...      ...|+|||++.++|.+++..  ..+++..+..++.|++.||.|||++
T Consensus        74 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~  151 (367)
T 2fst_X           74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA  151 (367)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456899999999999999999998754      56899999998888887764  5699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||||||+|||++.++.  +|++|||+++.........+.++.|.||+++.+.                         
T Consensus       152 givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~-------------------------  204 (367)
T 2fst_X          152 DIIHRDLKPSNLAVNEDCE--LKILDFGLARHTADEMTGYVATRWYRAPEIMLNW-------------------------  204 (367)
T ss_dssp             TCCCCCCCGGGEEECTTCC--EEECC---------------CCCTTCCHHHHTTC-------------------------
T ss_pred             CeeeCCCCHhhEEECCCCC--EEEeeccccccccccCCCcCcCcCccChHHHcCC-------------------------
Confidence            9999999999999998877  9999999998654333333444555555544320                         


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                ...+...|+||+|+++++|+.|..||.
T Consensus       205 ----------~~~~~~~DiwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          205 ----------MHYNQTVDIWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             ----------CSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ----------cCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                      011445788888888888888886553

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.92  E-value=2.9e-26  Score=230.74  Aligned_cols=148  Identities=20%  Similarity=0.307  Sum_probs=116.8

Q ss_pred             HHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+|++++.++ +|||||++++++.+.+.+|+|||||+ |+|.+.+.. .+.+++..+..++.|++.||.|||++||+|||
T Consensus        63 ~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrD  141 (342)
T 2qr7_A           63 TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRD  141 (342)
T ss_dssp             HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecc
Confidence            3588888888 79999999999999999999999998 578887765 45699999999999999999999999999999


Q ss_pred             CCCcccccccc-ch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         349 VKPQNLLISEI-DH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       349 lKp~NiLl~~~-~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||+|||+.+. +. ..+|++|||+++.+......                                         ....
T Consensus       142 lkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----------------------------------------~~~~  180 (342)
T 2qr7_A          142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-----------------------------------------LMTP  180 (342)
T ss_dssp             CCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC-----------------------------------------BCCS
T ss_pred             CCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc-----------------------------------------eecc
Confidence            99999998543 22 35999999988654311000                                         0112


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|        +..+|+||+|+++++|++|..||..
T Consensus       181 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             SCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence            355666666        3456899999999999998877654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.92  E-value=4.3e-26  Score=230.24  Aligned_cols=146  Identities=25%  Similarity=0.409  Sum_probs=116.6

Q ss_pred             HHHHHHHHhhcC-----CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         270 AIREASLLKELK-----HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       270 ~~rE~~il~~l~-----HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      +.+|+.+++.+.     |||||++++++...+.+|+|||||.++|.+++.... ..+++..++.++.|++.||.|||+++
T Consensus        78 ~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  157 (360)
T 3llt_A           78 AKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS  157 (360)
T ss_dssp             HHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456899999887     999999999999999999999999889999887653 35899999999999999999999999


Q ss_pred             eeeccCCCcccccccc-----------------------chhhHHHHHHHHHhhccccccCceeccccCCCccccccccc
Q psy3074         344 ILHRDVKPQNLLISEI-----------------------DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVF  400 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~-----------------------~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~  400 (481)
                      |+||||||+|||++..                       ....+|++|||+|+.......                    
T Consensus       158 ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--------------------  217 (360)
T 3llt_A          158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG--------------------  217 (360)
T ss_dssp             EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCC--------------------
T ss_pred             eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCc--------------------
Confidence            9999999999999752                       123377777777654322222                    


Q ss_pred             ccCCCeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         401 TNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       401 ~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                              ...||+.|++|        +.++|+||+|+++++|+.|..||.
T Consensus       218 ------------------------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          218 ------------------------SIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             ------------------------SCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ------------------------CccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                                    22344455554        567799999999999999986664

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.92  E-value=1e-25  Score=228.24  Aligned_cols=158  Identities=13%  Similarity=0.113  Sum_probs=124.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ...+|+..++.++|||||++++++...    ...|+|||||.++|.+++....+.+++..+..++.|++.||.|||+++|
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~i  173 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEY  173 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356788999999999999999998764    5689999999778988887766779999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+|||++......+|++|||+|+.+.......                                  .+......
T Consensus       174 iHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~----------------------------------~~~~~~~~  219 (364)
T 3op5_A          174 VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK----------------------------------AYAADPKR  219 (364)
T ss_dssp             ECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCC----------------------------------CSSCCSSC
T ss_pred             EEecCCHHHEEEecCCCCeEEEEECCcceecccCCccc----------------------------------ccccCccc
Confidence            99999999999983333449999999987544211000                                  00000112


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..+||+.|++|        +..+|+||+|+++++|++|..|+-.
T Consensus       220 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          220 CHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             CCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             ccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            24577777776        4566999999999999999977653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.92  E-value=8.7e-26  Score=225.45  Aligned_cols=150  Identities=16%  Similarity=0.264  Sum_probs=120.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.++++++|||||++++++.+.. .++++||+. |+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus        62 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  140 (327)
T 3poz_A           62 KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH  140 (327)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeC
Confidence            45678999999999999999999998765 778899998 7899988877778999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+|+.+..........                                       ..
T Consensus       141 ~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~---------------------------------------~~  179 (327)
T 3poz_A          141 RDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAE---------------------------------------GG  179 (327)
T ss_dssp             SCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC----------------------------------------------
T ss_pred             CCCChheEEECCCCC--EEEccCcceeEccCCccccccc---------------------------------------CC
Confidence            999999999988777  9999999998654221110000                                       01


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      .+|+.|++|        +..+|+||+|+++++|+. |..|+-
T Consensus       180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  221 (327)
T 3poz_A          180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence            234445554        456799999999999998 875553

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.92  E-value=5.8e-26  Score=230.64  Aligned_cols=152  Identities=17%  Similarity=0.233  Sum_probs=120.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++|||||++++++.+....|+|||||+ |+|.+++....      ..+++..+..++.|++.||.|||+
T Consensus       120 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~  199 (367)
T 3l9p_A          120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE  199 (367)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh
Confidence            46689999999999999999999999999999999997 68988887653      348899999999999999999999


Q ss_pred             CceeeccCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         342 RRILHRDVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ++|+||||||+|||++.++. ..+|++|||+|+.+........                                     
T Consensus       200 ~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~-------------------------------------  242 (367)
T 3l9p_A          200 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK-------------------------------------  242 (367)
T ss_dssp             TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTT-------------------------------------
T ss_pred             CCeeCCCCChhhEEEecCCCCceEEECCCcccccccccccccc-------------------------------------
Confidence            99999999999999985542 3489999999986542111000                                     


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                        .....+|+.|++|        +..+|+||+|+++++|++ |..|+.
T Consensus       243 --~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~  288 (367)
T 3l9p_A          243 --GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP  288 (367)
T ss_dssp             --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             --CCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence              0012244455554        456799999999999997 775553

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.92  E-value=1.7e-27  Score=242.70  Aligned_cols=180  Identities=16%  Similarity=0.154  Sum_probs=130.3

Q ss_pred             hHHHHH---HHHhhcCCCCeeEEe-------eeeecCC-----------------eEEEEEeccCCCHHHHHHHhcCCCC
Q psy3074         269 TAIREA---SLLKELKHNNIVTLH-------DIVHTRS-----------------TLTFVFEYVHTDLSQYMERHSGGLD  321 (481)
Q Consensus       269 ~~~rE~---~il~~l~HpnIV~l~-------~~~~~~~-----------------~~~iv~E~~~g~l~~~l~~~~~~l~  321 (481)
                      .+.+|+   ++|+.++|||||+++       +++.+++                 ..|+|||||+|+|.+++.... .++
T Consensus       119 ~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~  197 (377)
T 3byv_A          119 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHS  197 (377)
T ss_dssp             HHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTT
T ss_pred             HHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccc
Confidence            456799   556666899999998       6666553                 389999999999999987642 344


Q ss_pred             h-------HHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccc
Q psy3074         322 H-------HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL  394 (481)
Q Consensus       322 ~-------~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il  394 (481)
                      +       ..+..++.|++.||+|||+++|+||||||+|||++.++.  +|++|||+|+........... ..|.|||++
T Consensus       198 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFEHLVRDGARVVSSVS-RGFEPPELE  274 (377)
T ss_dssp             TTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGGGCEETTCEEECCCC-TTCCCHHHH
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEechhheecCCcccCCCC-cCccChhhh
Confidence            4       777789999999999999999999999999999998876  999999999865543333444 788899887


Q ss_pred             ccc---------------cccccCCCeeEEEeecCCCCccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         395 ISE---------------IVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       395 ~~~---------------~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ...               ..|.||+|++++++.+|..||.............-..+..|   ..+..++..|+..+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~L~~d  347 (377)
T 3byv_A          275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSCKNIP---QPVRALLEGFLRYP  347 (377)
T ss_dssp             HHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSSCCCCC---HHHHHHHHHHTCSS
T ss_pred             cccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhhccCCC---HHHHHHHHHHcCCC
Confidence            655               44679999999999999999875543221111111112333   34456677777665

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.92  E-value=5.1e-26  Score=231.37  Aligned_cols=150  Identities=21%  Similarity=0.370  Sum_probs=120.1

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+|+.+ +|||||++++++.+.+.+|+|||||+ |+|.+++....               ..+++..+..++.|
T Consensus       132 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  211 (370)
T 2psq_A          132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ  211 (370)
T ss_dssp             HHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHH
Confidence            467899999999 89999999999999999999999998 58988887643               24788899999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++|+||||||+|||++.++.  +|++|||+++.+........                            
T Consensus       212 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~----------------------------  261 (370)
T 2psq_A          212 LARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKK----------------------------  261 (370)
T ss_dssp             HHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCTTCT----------------------------
T ss_pred             HHHHHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccceec----------------------------
Confidence            999999999999999999999999998877  99999999875432110000                            


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                 .....+|+.|++|        +..+|+|++|++++||+. |..|+.
T Consensus       262 -----------~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          262 -----------TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             -----------TTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -----------ccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence                       0012234455555        445799999999999998 775543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=2.8e-26  Score=237.21  Aligned_cols=153  Identities=26%  Similarity=0.376  Sum_probs=114.4

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeec------CCeEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHT------RSTLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~------~~~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +|+++|+.++|||||+++++|..      ...+++||||+++++...+..   ....+++..++.++.|++.||.|||++
T Consensus        96 ~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~  175 (420)
T 1j1b_A           96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF  175 (420)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            59999999999999999999853      224789999999887776653   345699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhcccc--ccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +|+||||||+|||++.++ ..+|++|||+++.+...  ....+.++.|.+||++.+..                      
T Consensus       176 ~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~----------------------  232 (420)
T 1j1b_A          176 GICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT----------------------  232 (420)
T ss_dssp             TEECSCCSGGGEEEETTT-TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCS----------------------
T ss_pred             CccccCCChhhEEEeCCC-CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCC----------------------
Confidence            999999999999998543 23899999998754311  11122233333433332100                      


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                   ..+...|+|++|++++||+.|..||..
T Consensus       233 -------------~~~~~~DiwSlG~il~ell~G~~pf~~  259 (420)
T 1j1b_A          233 -------------DYTSSIDVWSAGCVLAELLLGQPIFPG  259 (420)
T ss_dssp             -------------SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------------CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence                         013457999999999999999866643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.92  E-value=3.1e-26  Score=233.44  Aligned_cols=103  Identities=23%  Similarity=0.424  Sum_probs=95.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++|++++|||||++++++.+.+.+|+|||||+ |+|.+++......+++..+..++.|++.||+|||+++++|||
T Consensus       159 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrD  238 (377)
T 3cbl_A          159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD  238 (377)
T ss_dssp             TTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcc
Confidence            4579999999999999999999999999999999998 789988887666799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhh
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRG  374 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~  374 (481)
                      |||+|||++.++.  +|++|||+++.
T Consensus       239 lkp~Nil~~~~~~--~kl~DfG~s~~  262 (377)
T 3cbl_A          239 LAARNCLVTEKNV--LKISDFGMSRE  262 (377)
T ss_dssp             CSGGGEEECTTCC--EEECCGGGCEE
T ss_pred             cCHHHEEEcCCCc--EEECcCCCcee
Confidence            9999999998777  99999998864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.92  E-value=3e-26  Score=240.02  Aligned_cols=178  Identities=28%  Similarity=0.456  Sum_probs=122.3

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...                       
T Consensus       168 ~~~~q-il~aL~~lH~~~iiHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~-----------------------  215 (464)
T 3ttj_A          168 YLLYQ-MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAG-----------------------  215 (464)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCCCCC---------------------------
T ss_pred             HHHHH-HHHHHHHHHHCCcccCCCCh----HhEEEeCC----CCEEEEEEEeeeecC-----------------------
Confidence            33444 68899999999999999999    89999876    799999999998431                       


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          .+.....+.|                      |++|+|||++.+.. |+.++||||+||++|||++|++||.|. +
T Consensus       216 ----~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~-~  267 (464)
T 3ttj_A          216 ----TSFMMTPYVV----------------------TRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR-D  267 (464)
T ss_dssp             -----CCCC----C----------------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCS-S
T ss_pred             ----CCcccCCCcc----------------------cccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCC-C
Confidence                1111222333                      99999999999875 999999999999999999999999995 5


Q ss_pred             hHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcch----hHHHHHHhhhhhhhcCCccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGE----SMASAFLQVRDAAILNPMEH  250 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~----~~a~~ll~v~~~~~~~~~~~  250 (481)
                      ..+++.+|.+.+|+|.++.+..............+......+...++.........    .-......+.++...+|.++
T Consensus       268 ~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  347 (464)
T 3ttj_A          268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR  347 (464)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhC
Confidence            56999999999999998877665422111122223333333333333332211111    12234566777888888776


Q ss_pred             cc
Q psy3074         251 VH  252 (481)
Q Consensus       251 ~~  252 (481)
                      ..
T Consensus       348 ~t  349 (464)
T 3ttj_A          348 IS  349 (464)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.92  E-value=3.9e-26  Score=232.12  Aligned_cols=144  Identities=23%  Similarity=0.405  Sum_probs=113.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...+      ..|+|||||+|++.+.+.   ..+++..+..++.|++.||.|||++
T Consensus        70 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~  146 (371)
T 2xrw_A           70 RAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA  146 (371)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHC
Confidence            3568999999999999999999998665      789999999999888774   3589999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++.  +|++|||+++.......                                          
T Consensus       147 ~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~------------------------------------------  182 (371)
T 2xrw_A          147 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFM------------------------------------------  182 (371)
T ss_dssp             TCCCSCCCGGGEEECTTSC--EEECCCCC---------------------------------------------------
T ss_pred             CeecccCCHHHEEEcCCCC--EEEEEeecccccccccc------------------------------------------
Confidence            9999999999999998877  99999999875431100                                          


Q ss_pred             cCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ....+||+.|++|        +.++|+||+|+++++|..|..||.
T Consensus       183 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~  227 (371)
T 2xrw_A          183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP  227 (371)
T ss_dssp             -------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence            0011234444444        557899999999999999987664

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=8.6e-26  Score=218.55  Aligned_cols=149  Identities=19%  Similarity=0.320  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+.+..++||||++ |+|.+++....+.+++..+..++.|++.||.|||+++++||
T Consensus        51 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (269)
T 4hcu_A           51 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  130 (269)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            46689999999999999999999999999999999998 57888887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+.......                                        .....
T Consensus       131 dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------------------~~~~~  168 (269)
T 4hcu_A          131 DLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS----------------------------------------STGTK  168 (269)
T ss_dssp             CCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHS----------------------------------------TTSTT
T ss_pred             CcchheEEEcCCCC--EEecccccccccccccccc----------------------------------------ccCcc
Confidence            99999999988776  9999999987543111000                                        00011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +|+.|++|        +.++|+||+|+++++|+. |..|+-
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~  209 (269)
T 4hcu_A          169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE  209 (269)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence            23334444        456799999999999998 775553

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.92  E-value=9e-26  Score=238.79  Aligned_cols=150  Identities=25%  Similarity=0.326  Sum_probs=122.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|+.++|||||++++++.+...+|+|||||+ |+|.+.+... +.+++..+..++.|++.||.|||+++|+|
T Consensus        91 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  169 (504)
T 3q5i_A           91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVH  169 (504)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            457789999999999999999999999999999999998 5787777654 56999999999999999999999999999


Q ss_pred             ccCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||++..+. ..+|++|||+|+.+.....                                          ...
T Consensus       170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------------~~~  207 (504)
T 3q5i_A          170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK------------------------------------------LRD  207 (504)
T ss_dssp             SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC------------------------------------------BCC
T ss_pred             CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc------------------------------------------ccc
Confidence            999999999987653 3589999998864331100                                          001


Q ss_pred             ccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .+||+.|++|       +.++|+||+|+++++|++|..|+..
T Consensus       208 ~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          208 RLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             CCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            2244445544       5678999999999999999877654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.92  E-value=4.9e-26  Score=224.87  Aligned_cols=154  Identities=29%  Similarity=0.494  Sum_probs=118.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.++++++||||+++++++.+.+..++|||||+++++..+....+.+++..+..++.|++.||.|||+++++|||
T Consensus        48 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~d  127 (311)
T 4agu_A           48 IALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRD  127 (311)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence            35679999999999999999999999999999999999776665555566799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+||+++.++.  +|++|||++..+....   .....+..|.||+++.+.                            
T Consensus       128 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------------  177 (311)
T 4agu_A          128 VKPENILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD----------------------------  177 (311)
T ss_dssp             CSGGGEEECTTSC--EEECCCTTCEECC------------GGGCCHHHHHTC----------------------------
T ss_pred             CChhhEEEcCCCC--EEEeeCCCchhccCcccccCCCcCCccccChHHHhcC----------------------------
Confidence            9999999998776  9999999886543111   011112222222222110                            


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                             ...+.++|+||+|+++++|.+|..|+.
T Consensus       178 -------~~~~~~~Di~slG~il~~l~~g~~p~~  204 (311)
T 4agu_A          178 -------TQYGPPVDVWAIGCVFAELLSGVPLWP  204 (311)
T ss_dssp             -------SCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -------CCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                   001456799999999999999986653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.92  E-value=3.8e-26  Score=234.76  Aligned_cols=150  Identities=20%  Similarity=0.247  Sum_probs=113.3

Q ss_pred             HHHHHHHHh-hcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLK-ELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~-~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.+|+.++. ..+|||||+++++|..    ...+|+|||||+ |+|.+++.... ..+++..+..++.|++.||.|||++
T Consensus       101 ~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  180 (400)
T 1nxk_A          101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI  180 (400)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            346888874 4589999999999875    668999999998 58888887543 3599999999999999999999999


Q ss_pred             ceeeccCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         343 RILHRDVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      +|+||||||+|||++..+ ...+|++|||+++.......                                         
T Consensus       181 ~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~-----------------------------------------  219 (400)
T 1nxk_A          181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-----------------------------------------  219 (400)
T ss_dssp             TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------------------------------------------
T ss_pred             CccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-----------------------------------------
Confidence            999999999999998732 23499999999874331110                                         


Q ss_pred             ccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         422 SKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       422 ~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                       ....+||+.|++|        +..+|+||+|+++++|++|..||...
T Consensus       220 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          220 -LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             -cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence             0012234444444        45679999999999999999777654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.91  E-value=6e-26  Score=235.42  Aligned_cols=154  Identities=21%  Similarity=0.324  Sum_probs=118.0

Q ss_pred             HHHHHHHHhhc------CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLKEL------KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~~l------~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.+|+.+++.+      +|+||+++++++...+.+++||||+.++|.+++.... ..+++..++.++.|++.||.|||++
T Consensus       140 ~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  219 (429)
T 3kvw_A          140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN  219 (429)
T ss_dssp             HHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            44577777776      5779999999999999999999999999999887654 3589999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++...+|++|||+|+.........+.+..|.|||++.+..                        
T Consensus       220 ~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~------------------------  275 (429)
T 3kvw_A          220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGAR------------------------  275 (429)
T ss_dssp             TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBC------------------------
T ss_pred             CeecCCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCC------------------------
Confidence            99999999999999987765689999998864332222222233333333332110                        


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                  .+.++|+||+|+++++|++|..|+.
T Consensus       276 ------------~~~~~DiwSlG~il~elltG~~pf~  300 (429)
T 3kvw_A          276 ------------YGMPIDMWSLGCILAELLTGYPLLP  300 (429)
T ss_dssp             ------------CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ------------CCchHHHHhHHHHHHHHHhCCCCCC
Confidence                        1456788888888888888875543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.91  E-value=1.1e-25  Score=218.71  Aligned_cols=147  Identities=20%  Similarity=0.301  Sum_probs=118.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++.+.+..++||||++ ++|.+.+.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  130 (277)
T 3f3z_A           52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHR  130 (277)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            46689999999999999999999999999999999998 577777765 3569999999999999999999999999999


Q ss_pred             cCCCccccc---cccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLI---SEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl---~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+||++   +.++.  +|++|||++..+.....                                          ..
T Consensus       131 dlkp~Nil~~~~~~~~~--~~l~Dfg~~~~~~~~~~------------------------------------------~~  166 (277)
T 3f3z_A          131 DLKPENFLFLTDSPDSP--LKLIDFGLAARFKPGKM------------------------------------------MR  166 (277)
T ss_dssp             CCSGGGEEESSSSTTCC--EEECCCTTCEECCTTSC------------------------------------------BC
T ss_pred             CCCHHHEEEecCCCCCc--EEEEecccceeccCccc------------------------------------------hh
Confidence            999999999   44444  99999998764331100                                          00


Q ss_pred             cccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+|+.|++|       +..+|+|++|+++++|..|..|+..
T Consensus       167 ~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             CCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC
Confidence            11234444444       5678999999999999999866643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.91  E-value=6.2e-26  Score=228.89  Aligned_cols=149  Identities=22%  Similarity=0.289  Sum_probs=111.4

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|++++||||+++++++.+.+..++||||++ |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+|||
T Consensus        95 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D  173 (349)
T 2w4o_A           95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRD  173 (349)
T ss_dssp             ----CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence            3469999999999999999999999999999999998 678777754 45689999999999999999999999999999


Q ss_pred             CCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         349 VKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       349 lKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      |||+|||++. +....+|++|||+++.+......                                          ...+
T Consensus       174 ikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~------------------------------------------~~~~  211 (349)
T 2w4o_A          174 LKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM------------------------------------------KTVC  211 (349)
T ss_dssp             CCGGGEEESSSSTTCCEEECCCC---------------------------------------------------------
T ss_pred             CCcccEEEecCCCCCCEEEccCccccccCccccc------------------------------------------cccc
Confidence            9999999975 22334999999998754311000                                          0122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|++|..|+...
T Consensus       212 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  253 (349)
T 2w4o_A          212 GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE  253 (349)
T ss_dssp             -CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred             CCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            44444444        55679999999999999998777543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.91  E-value=2.3e-25  Score=220.57  Aligned_cols=158  Identities=17%  Similarity=0.249  Sum_probs=119.9

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++++ +||||+++++++.+.+..|+|||||+ |+|.+++... +.+++..+..++.|++.||.|||+++|+|
T Consensus        56 ~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  134 (316)
T 2ac3_A           56 RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAH  134 (316)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Confidence            466899999985 79999999999999999999999998 6788887664 56999999999999999999999999999


Q ss_pred             ccCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||++.++. ..+|++|||+++.+.......                                  +........
T Consensus       135 ~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~----------------------------------~~~~~~~~~  180 (316)
T 2ac3_A          135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS----------------------------------PISTPELLT  180 (316)
T ss_dssp             CCCCGGGEEESCSSSSCSEEECCTTCCC----------------------------------------------------
T ss_pred             CCCCHHHEEEccCCCcCceEEEEccCccccccCCccc----------------------------------ccccccccc
Confidence            999999999987543 348999999876543111000                                  000000111


Q ss_pred             ccceeccCCC-------------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         426 INLSFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       426 ~~~t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      .+||+.|++|             +..+|+|++|+++++|..|..|+...
T Consensus       181 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          181 PCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             -CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred             ccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccc
Confidence            3456666665             45689999999999999999776543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=6.7e-26  Score=225.96  Aligned_cols=149  Identities=17%  Similarity=0.243  Sum_probs=118.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|||||++++++. .+..++||||+. |+|.+.+....+.+++..+..++.|++.||.|||+++|+|||
T Consensus        62 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D  140 (325)
T 3kex_A           62 VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRN  140 (325)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCc
Confidence            346999999999999999999886 456899999998 788888876656799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.+.........                                       ....+
T Consensus       141 ikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~---------------------------------------~~~~~  179 (325)
T 3kex_A          141 LAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLY---------------------------------------SEAKT  179 (325)
T ss_dssp             CSSTTEEESSSSC--EEECSCSGGGGSCCCTTCCC--------------------------------------------C
T ss_pred             cchheEEECCCCe--EEECCCCcccccCcccccccc---------------------------------------cCCCC
Confidence            9999999988777  999999999865422111000                                       01223


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      |+.|++|        +..+|+||+|+++++|+. |..|+..
T Consensus       180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  220 (325)
T 3kex_A          180 PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG  220 (325)
T ss_dssp             CTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             cccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence            4444444        456799999999999999 8766543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.91  E-value=7.2e-26  Score=226.21  Aligned_cols=155  Identities=28%  Similarity=0.525  Sum_probs=118.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++|++...+....+.+++..+..++.|++.||.|||+++++|||
T Consensus        70 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d  149 (331)
T 4aaa_A           70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRD  149 (331)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccC
Confidence            35679999999999999999999999999999999999877776666567799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+||+++.++.  +|++|||+++.+....   .....+..|.+|+++.+.                            
T Consensus       150 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------------  199 (331)
T 4aaa_A          150 IKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGD----------------------------  199 (331)
T ss_dssp             CCGGGEEECTTSC--EEECCCTTC------------CCCCCTTCCHHHHTTC----------------------------
T ss_pred             cChheEEEcCCCc--EEEEeCCCceeecCCccccCCCcCCccccCcccccCC----------------------------
Confidence            9999999998776  9999999887543211   011111222222221100                            


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                             ...+.++|+|++|+++++|.+|..|+..
T Consensus       200 -------~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          200 -------VKYGKAVDVWAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             -------TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -------CCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence                   0114567999999999999999866643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.91  E-value=1.1e-25  Score=224.37  Aligned_cols=148  Identities=16%  Similarity=0.290  Sum_probs=120.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++|||||++++++...+..++||||++ |+|.+++..  ..+++..+..++.|++.||.|||+.+|+||
T Consensus        88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  165 (321)
T 2c30_A           88 LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHR  165 (321)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45689999999999999999999999999999999998 567666543  469999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+......                                         .....
T Consensus       166 Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  202 (321)
T 2c30_A          166 DIKSDSILLTLDGR--VKLSDFGFCAQISKDVPK-----------------------------------------RKSLV  202 (321)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECCSSSCC-----------------------------------------BCCCC
T ss_pred             CCCHHHEEECCCCc--EEEeeeeeeeecccCccc-----------------------------------------ccccc
Confidence            99999999998776  999999988654311000                                         00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|+++++|..|..|+...
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~  244 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD  244 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            55555555        45679999999999999999776543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.91  E-value=5.8e-26  Score=227.81  Aligned_cols=146  Identities=23%  Similarity=0.304  Sum_probs=117.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-C-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-T-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+.+|+.++||||+++++++.+.+..++||||+. | ++..++.. ...+++..+..++.|++.||.|||+++|+||
T Consensus        76 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~  154 (335)
T 3dls_A           76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHR  154 (335)
T ss_dssp             EEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEe
Confidence            4579999999999999999999999999999999996 5 67777654 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+.....                                          ....+
T Consensus       155 Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~------------------------------------------~~~~~  190 (335)
T 3dls_A          155 DIKDENIVIAEDFT--IKLIDFGSAAYLERGKL------------------------------------------FYTFC  190 (335)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECCTTCC------------------------------------------BCEEC
T ss_pred             ccCHHHEEEcCCCc--EEEeecccceECCCCCc------------------------------------------eeccC
Confidence            99999999998776  99999998865431100                                          00123


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|         +..+|+||+|+++++|.+|..|+..
T Consensus       191 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             SCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             CCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            45555555         2345899999999999999866643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.91  E-value=8.1e-27  Score=237.01  Aligned_cols=184  Identities=11%  Similarity=0.008  Sum_probs=124.9

Q ss_pred             HHHHHHHHhhc--CCCCeeEEe-------eeeecC-----------------CeEEEEEeccCCCHHHHHHHhcCCCChH
Q psy3074         270 AIREASLLKEL--KHNNIVTLH-------DIVHTR-----------------STLTFVFEYVHTDLSQYMERHSGGLDHH  323 (481)
Q Consensus       270 ~~rE~~il~~l--~HpnIV~l~-------~~~~~~-----------------~~~~iv~E~~~g~l~~~l~~~~~~l~~~  323 (481)
                      +.+|+.+++.|  +|||||+++       +++..+                 ..+|+|||||+|+|.+++......+.+.
T Consensus       109 ~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~  188 (371)
T 3q60_A          109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR  188 (371)
T ss_dssp             HHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCC
T ss_pred             HHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchh
Confidence            34575444444  699988866       344332                 3489999999999999998765455555


Q ss_pred             HH------HHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCccccc-
Q psy3074         324 NI------RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLIS-  396 (481)
Q Consensus       324 ~~------~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~-  396 (481)
                      ..      ..++.|++.||.|||+++|+||||||+|||++.++.  +|++|||+|+...........+..|.|||++.. 
T Consensus       189 ~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~  266 (371)
T 3q60_A          189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR--LMLGDVSALWKVGTRGPASSVPVTYAPREFLNAS  266 (371)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSC--EEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCS
T ss_pred             hhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCC--EEEEecceeeecCCCccCccCCcCCcChhhccCC
Confidence            55      577799999999999999999999999999998877  999999999876544434455578899988854 


Q ss_pred             -----ccccccCCCeeEEEeecCCCCccccccCc----------ccceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         397 -----EIVFTNLSGVVVSTVDSGSGGWWFESKSN----------INLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       397 -----~~~~~~s~g~~~~~~~~g~~~~~~~~~~~----------~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                           ...|.||+|++++++.+|..||.......          ......+..|..+.....+..++..|+..+
T Consensus       267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  340 (371)
T 3q60_A          267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD  340 (371)
T ss_dssp             EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred             CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence                 34567999999999999999998663211          011112222222222345566777777765

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.91  E-value=1.3e-26  Score=227.80  Aligned_cols=184  Identities=23%  Similarity=0.315  Sum_probs=139.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ..+.+|+++|+.++||||+++++++.+  .+.+|+||||+++ ++.+++  ....+++..+..++.|++.||.|||+++|
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  158 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKI  158 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            457889999999999999999999987  5689999999984 554432  23469999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCccccc-------ccccccCCCeeEEEeecC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLIS-------EIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~~-------~~~~~~s~g~~~~~~~~g  414 (481)
                      +||||||+|||++.++.  +|++|||+++.+...   ......+..|.|||++..       ...|.|+.|++++++.+|
T Consensus       159 vH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             ECCCCCGGGEEECTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eccCCCHHHEEECCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            99999999999998877  999999999865422   223456677888988754       345789999999999999


Q ss_pred             CCCccccccCcc---cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         415 SGGWWFESKSNI---NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       415 ~~~~~~~~~~~~---~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..||........   ........|..+.....+..++..|+..+
T Consensus       237 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  280 (298)
T 2zv2_A          237 QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKN  280 (298)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSC
T ss_pred             CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcC
Confidence            999975432111   00111112222222344567777887766

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.91  E-value=9.4e-26  Score=229.69  Aligned_cols=152  Identities=18%  Similarity=0.265  Sum_probs=114.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.+.+..++|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+||
T Consensus        92 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (373)
T 2qol_A           92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHR  171 (373)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCC
Confidence            46789999999999999999999999999999999997 68988887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+++.+..........                                      ....
T Consensus       172 Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~--------------------------------------~~~~  211 (373)
T 2qol_A          172 DLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTT--------------------------------------RGGK  211 (373)
T ss_dssp             CCCGGGEEECTTCC--EEECCC----------------------------------------------------------
T ss_pred             CCCcceEEEcCCCC--EEECcCccccccccCCccceec--------------------------------------cCCC
Confidence            99999999998777  9999999997654211100000                                      0011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      +++.|++|        +..+|+||+|+++++|+. |..|+..
T Consensus       212 ~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             --CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred             cCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            23344444        446799999999999886 8866643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=7.2e-25  Score=223.44  Aligned_cols=189  Identities=22%  Similarity=0.323  Sum_probs=136.1

Q ss_pred             hHHHHHHHHhhcC--------CCCeeEEeeeee----cCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELK--------HNNIVTLHDIVH----TRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRG  335 (481)
Q Consensus       269 ~~~rE~~il~~l~--------HpnIV~l~~~~~----~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~  335 (481)
                      .+.+|+.+|+.++        |+||+++++++.    ....+|+||||+.+++.+.+.... ..+++..++.++.|++.|
T Consensus        79 ~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a  158 (397)
T 1wak_A           79 TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG  158 (397)
T ss_dssp             HHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence            3567999999986        788999999998    566899999999999888877653 569999999999999999


Q ss_pred             HHHhhcC-ceeeccCCCccccccccchhhHHHHHHHHHhhcccccc-----CceeccccCCCcccccccccccCCCeeEE
Q psy3074         336 LSYCHRR-RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR-----RRILHRDVKPQNLLISEIVFTNLSGVVVS  409 (481)
Q Consensus       336 l~ylH~~-~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~-----~~i~~~d~~~~~il~~~~~~~~s~g~~~~  409 (481)
                      |.|||++ +|+||||||+|||++.++.  ....+++.+........     ..+......+.+...............++
T Consensus       159 L~~lH~~~givHrDikp~NIll~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k  236 (397)
T 1wak_A          159 LDYLHTKCRIIHTDIKPENILLSVNEQ--YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK  236 (397)
T ss_dssp             HHHHHHTTCEECCCCSGGGEEECCCHH--HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred             HHHHHHhCCEecCCCCHHHeeEeccch--hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence            9999998 9999999999999998775  44555554433221110     00111111122222221111122335678


Q ss_pred             EeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         410 TVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       410 ~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..|+|............+||+.|++|        +.++|+||+|+++++|+.|..||.
T Consensus       237 l~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  294 (397)
T 1wak_A          237 IADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE  294 (397)
T ss_dssp             ECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence            88998877665555567899999999        667899999999999999997764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.91  E-value=2.7e-26  Score=224.06  Aligned_cols=152  Identities=20%  Similarity=0.278  Sum_probs=129.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc--ee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR--IL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~--ii  345 (481)
                      .+.+|+.+++.++||||+++++++.+..  ++||||++ |+|.+.+......+++..+..++.|++.||.|||+++  ++
T Consensus        69 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~iv  146 (287)
T 4f0f_A           69 EFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIV  146 (287)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred             HHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCee
Confidence            4678999999999999999999998776  69999998 7888888776667999999999999999999999999  99


Q ss_pred             eccCCCccccccccch---hhHHHHHHHHHhhccccccCceeccccCCCccc------ccccccccCCCeeEEEeecCCC
Q psy3074         346 HRDVKPQNLLISEIDH---HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLL------ISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~---~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il------~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      ||||||+||+++.++.   ..+|++|||+++...........+..|.||+++      .+...+.|+.|++++++.+|..
T Consensus       147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~  226 (287)
T 4f0f_A          147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG  226 (287)
T ss_dssp             CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence            9999999999976543   238999999998655444445567788899987      2345678999999999999999


Q ss_pred             Cccccc
Q psy3074         417 GWWFES  422 (481)
Q Consensus       417 ~~~~~~  422 (481)
                      ||...+
T Consensus       227 pf~~~~  232 (287)
T 4f0f_A          227 PFDEYS  232 (287)
T ss_dssp             TTTTCC
T ss_pred             CCcccc
Confidence            997543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.91  E-value=1.5e-25  Score=222.97  Aligned_cols=150  Identities=25%  Similarity=0.407  Sum_probs=121.4

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++.. .+.+++..+..++.|++.||.|||+++++|
T Consensus        60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  138 (321)
T 2a2a_A           60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAH  138 (321)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            356789999999999999999999999999999999997 678887764 456899999999999999999999999999


Q ss_pred             ccCCCccccccccch--hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEIDH--HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~~--~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+||+++.++.  ..+|++|||++..+.....                                          ..
T Consensus       139 ~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------~~  176 (321)
T 2a2a_A          139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE------------------------------------------FK  176 (321)
T ss_dssp             CCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC------------------------------------------CC
T ss_pred             CCCChHHEEEecCCCCcCCEEEccCccceecCcccc------------------------------------------cc
Confidence            999999999987652  1489999998864431100                                          00


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...||+.|++|        +..+|+||+|+++++|.+|..|+..
T Consensus       177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             CCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             ccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCC
Confidence            12244455554        4567999999999999999977654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.91  E-value=1.8e-26  Score=228.61  Aligned_cols=151  Identities=23%  Similarity=0.320  Sum_probs=115.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++|||||++++++....    ..|+|||||+ |+|.+++... +.+++..+..++.|++.||.|||+++
T Consensus        58 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~  136 (311)
T 3ork_A           58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG  136 (311)
T ss_dssp             HHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3568999999999999999999987654    3599999998 6788877653 57999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+++.+.......                                      ...
T Consensus       137 ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~--------------------------------------~~~  176 (311)
T 3ork_A          137 IIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSV--------------------------------------TQT  176 (311)
T ss_dssp             CCCCCCCGGGEEEETTSC--EEECCCSCC---------------------------------------------------
T ss_pred             CCcCCCCHHHEEEcCCCC--EEEeeccCccccccccccc--------------------------------------ccc
Confidence            999999999999988777  9999999887543211000                                      000


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ....||+.|++|        +.++|+|++|+++++|++|..|+..
T Consensus       177 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             -----CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            113355566655        4467999999999999999977643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.91  E-value=8.8e-26  Score=223.86  Aligned_cols=148  Identities=23%  Similarity=0.345  Sum_probs=114.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcCc--
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRRR--  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~~--  343 (481)
                      .+.+|+.+|++++|||||++++++.+.+..++|||||+ |+|.+++.....  .+++..+..++.|++.||.|||+++  
T Consensus        80 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~  159 (309)
T 3p86_A           80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP  159 (309)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            45689999999999999999999999999999999998 578887765321  3899999999999999999999999  


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+++........                                         .
T Consensus       160 ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~-----------------------------------------~  196 (309)
T 3p86_A          160 IVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLS-----------------------------------------S  196 (309)
T ss_dssp             CCCTTCCGGGEEECTTCC--EEECCCC-----------------------------------------------------
T ss_pred             EECCCCChhhEEEeCCCc--EEECCCCCCccccccccc-----------------------------------------c
Confidence            999999999999998777  999999998643211000                                         0


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ....||+.|++|        +.++|+||+|+++++|..|..|+.
T Consensus       197 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~  240 (309)
T 3p86_A          197 KSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG  240 (309)
T ss_dssp             -----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTT
T ss_pred             ccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            012344455554        567899999999999999986654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.91  E-value=2.3e-25  Score=218.29  Aligned_cols=157  Identities=13%  Similarity=0.134  Sum_probs=125.4

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.+ +|+||+++++++.+....++||||+.++|.+++......+++..+..++.|++.||.|||+++|+|||
T Consensus        52 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D  131 (298)
T 1csn_A           52 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD  131 (298)
T ss_dssp             HHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             HHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence            46799999999 79999999999999999999999998889999887666799999999999999999999999999999


Q ss_pred             CCCccccccccch---hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLISEIDH---HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~~~~~---~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||++.++.   ..+|++|||+++.+........                                  ........
T Consensus       132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~----------------------------------~~~~~~~~  177 (298)
T 1csn_A          132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH----------------------------------IPYREKKN  177 (298)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB----------------------------------CCCCCCCC
T ss_pred             CCHHHEEeccCCCCCCCeEEEEECcccccccccccccc----------------------------------ccccCccC
Confidence            9999999976543   3489999999875442111000                                  00001122


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..||+.|++|        +..+|+||+|+++++|..|..|+..
T Consensus       178 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  220 (298)
T 1csn_A          178 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  220 (298)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence            4566777776        4567999999999999999976654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.91  E-value=1e-25  Score=227.07  Aligned_cols=150  Identities=21%  Similarity=0.352  Sum_probs=118.1

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCC-eEEEEEeccC-CCHHHHHHHhcC---------------------------
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRS-TLTFVFEYVH-TDLSQYMERHSG---------------------------  318 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~-~~~iv~E~~~-g~l~~~l~~~~~---------------------------  318 (481)
                      .+.+|+++++++ +|||||++++++.+.+ .+++|||||+ |+|.+++.....                           
T Consensus        71 ~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (359)
T 3vhe_A           71 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK  150 (359)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------
T ss_pred             HHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhh
Confidence            467899999999 7899999999998765 4999999998 588888865432                           


Q ss_pred             --------------------------------------CCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccc
Q psy3074         319 --------------------------------------GLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEID  360 (481)
Q Consensus       319 --------------------------------------~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~  360 (481)
                                                            .+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~  230 (359)
T 3vhe_A          151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  230 (359)
T ss_dssp             ---------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             ccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC
Confidence                                                  188899999999999999999999999999999999999877


Q ss_pred             hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCC-----
Q psy3074         361 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP-----  435 (481)
Q Consensus       361 ~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p-----  435 (481)
                      .  +|++|||+++.+.......                                       ......+|+.|++|     
T Consensus       231 ~--~kl~Dfg~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~  269 (359)
T 3vhe_A          231 V--VKICDFGLARDIYKDPDYV---------------------------------------RKGDARLPLKWMAPETIFD  269 (359)
T ss_dssp             C--EEECCCGGGSCTTSCTTCE---------------------------------------EC--CEECGGGCCHHHHHH
T ss_pred             c--EEEEeccceeeecccccch---------------------------------------hccccCCCceeEChhhhcC
Confidence            6  9999999987542110000                                       00112345556665     


Q ss_pred             ---CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         436 ---GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       436 ---~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                         +..+|+||+|+++++|++ |..|+.
T Consensus       270 ~~~~~~~Di~slG~il~ellt~g~~p~~  297 (359)
T 3vhe_A          270 RVYTIQSDVWSFGVLLWEIFSLGASPYP  297 (359)
T ss_dssp             CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCCCchhhhhhHHHHHHHHHhcCCCCCC
Confidence               456799999999999997 875653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.91  E-value=2.9e-25  Score=216.29  Aligned_cols=149  Identities=17%  Similarity=0.273  Sum_probs=120.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++.+.+..++||||++ |+|.+++......+++..+..++.|++.||.|||+++++||
T Consensus        65 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  144 (283)
T 3gen_A           65 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR  144 (283)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence            46689999999999999999999999999999999997 67888887656679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+.......                                        .....
T Consensus       145 dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------------------~~~~~  182 (283)
T 3gen_A          145 DLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTS----------------------------------------SVGSK  182 (283)
T ss_dssp             SCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHS----------------------------------------TTSTT
T ss_pred             CCccceEEEcCCCC--EEEcccccccccccccccc----------------------------------------ccCCc
Confidence            99999999998777  9999999987543110000                                        00011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +|+.|++|        +...|+|++|+++++|++ |..|+.
T Consensus       183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~  223 (283)
T 3gen_A          183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE  223 (283)
T ss_dssp             SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            23334444        446799999999999997 876653

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.91  E-value=1.3e-25  Score=224.29  Aligned_cols=149  Identities=21%  Similarity=0.348  Sum_probs=112.2

Q ss_pred             HHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+|+.+++.+. |||||++++++.+....|+|||||+ |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus        52 ~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~  130 (325)
T 3kn6_A           52 TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHR  130 (325)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeec
Confidence            457999999998 9999999999999999999999998 578887765 4579999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+|||++..+ ...+|++|||+++........                                         ....
T Consensus       131 Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-----------------------------------------~~~~  169 (325)
T 3kn6_A          131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-----------------------------------------LKTP  169 (325)
T ss_dssp             CCCGGGEEEEC----CEEEECCCTTCEECCC-------------------------------------------------
T ss_pred             CCCHHHEEEecCCCcccEEEeccccceecCCCCCc-----------------------------------------cccc
Confidence            9999999997654 224999999988643211000                                         0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ++|+.|++|        +.++|+||+|+++++|++|..|+..
T Consensus       170 ~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  211 (325)
T 3kn6_A          170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS  211 (325)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred             CCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            234444444        3457999999999999999866643

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=9.7e-26  Score=231.24  Aligned_cols=152  Identities=26%  Similarity=0.376  Sum_probs=115.5

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +|+++|+.++|||||+++++|...+      .+++|||||++++...+..   ....+++..++.++.|++.||.|||++
T Consensus        81 ~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~  160 (394)
T 4e7w_A           81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI  160 (394)
T ss_dssp             HHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            6999999999999999999995433      4899999999887766543   245699999999999999999999999


Q ss_pred             ceeeccCCCcccccc-ccchhhHHHHHHHHHhhcccc--ccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcc
Q psy3074         343 RILHRDVKPQNLLIS-EIDHHNIRLFMFQLLRGLSYC--HRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~-~~~~~~ikl~dfgla~~~~~~--~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      +|+||||||+|||++ .++.  +|++|||+|+.+...  ....+.++.|.|||++.+..                     
T Consensus       161 ~ivHrDlkp~Nill~~~~~~--~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~---------------------  217 (394)
T 4e7w_A          161 GICHRDIKPQNLLLDPPSGV--LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGAT---------------------  217 (394)
T ss_dssp             TEECSCCSGGGEEEETTTTE--EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCS---------------------
T ss_pred             CccCCCCCHHHEEEcCCCCc--EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCC---------------------
Confidence            999999999999998 5666  999999998754311  11112223333333321100                     


Q ss_pred             ccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         420 FESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       420 ~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                    ..+...|+||+|+++++|++|..||..
T Consensus       218 --------------~~~~~~DiwSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          218 --------------NYTTNIDIWSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             --------------SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --------------CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                          014467999999999999999866643

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.91  E-value=2e-25  Score=216.87  Aligned_cols=149  Identities=23%  Similarity=0.362  Sum_probs=116.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++......+++..+..++.|++.||.|||+++++||
T Consensus        57 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  136 (278)
T 3cok_A           57 RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR  136 (278)
T ss_dssp             HHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            46689999999999999999999999999999999998 57888887655679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+.......                                         ....
T Consensus       137 dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~-----------------------------------------~~~~  173 (278)
T 3cok_A          137 DLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKH-----------------------------------------YTLC  173 (278)
T ss_dssp             SCCGGGEEECTTCC--EEECCCTTCEECC---------------------------------------------------
T ss_pred             CCCHHHEEEcCCCC--EEEEeecceeeccCCCCcc-----------------------------------------eecc
Confidence            99999999998777  9999999876543111000                                         0012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +|+.|++|        +..+|+|++|+++++|..|..|+-.
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  214 (278)
T 3cok_A          174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT  214 (278)
T ss_dssp             ------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            34444444        4568999999999999999866643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.91  E-value=9.4e-26  Score=220.29  Aligned_cols=151  Identities=15%  Similarity=0.184  Sum_probs=120.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus        57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  136 (289)
T 4fvq_A           57 ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIH  136 (289)
T ss_dssp             HHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeEC
Confidence            346789999999999999999999999999999999998 6898888776556999999999999999999999999999


Q ss_pred             ccCCCccccccccchhh------HHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         347 RDVKPQNLLISEIDHHN------IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~------ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      |||||+|||++.++...      +|++|||++......                                          
T Consensus       137 ~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------------------------------------------  174 (289)
T 4fvq_A          137 GNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------------------------------------------  174 (289)
T ss_dssp             CCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------------------------------------------
T ss_pred             CCcCcceEEEecCCcccccccceeeeccCcccccccCc------------------------------------------
Confidence            99999999998766422      677777766433211                                          


Q ss_pred             cccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         421 ESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                         ....+|+.|++|         +.++|+||+|+++++|..|..+++....
T Consensus       175 ---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~  223 (289)
T 4fvq_A          175 ---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD  223 (289)
T ss_dssp             ---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence               011233333333         4457999999999999997667766543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.91  E-value=2.2e-25  Score=225.90  Aligned_cols=150  Identities=27%  Similarity=0.444  Sum_probs=120.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++|+.++||||+++++++...     ...|+||||++|+|.+.+..  +.+++..+..++.|++.||.|||+++
T Consensus        71 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~  148 (364)
T 3qyz_A           71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN  148 (364)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            456899999999999999999999765     37899999999999888865  46999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+++..........                                      ..
T Consensus       149 ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~--------------------------------------~~  188 (364)
T 3qyz_A          149 VLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTG--------------------------------------FL  188 (364)
T ss_dssp             EECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCC--------------------------------------TT
T ss_pred             eecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccc--------------------------------------cc
Confidence            999999999999998777  99999999875432110000                                      00


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+||+.|++|         +.++|+||+|+++++|++|..|+-.
T Consensus       189 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  234 (364)
T 3qyz_A          189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG  234 (364)
T ss_dssp             CCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence            112345555554         4557999999999999999966643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=1.6e-25  Score=226.29  Aligned_cols=155  Identities=25%  Similarity=0.366  Sum_probs=116.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++++..     ...+|+||||++|++.+.+......+++..+..++.|++.||.|||+++
T Consensus        75 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  154 (362)
T 3pg1_A           75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG  154 (362)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence            46789999999999999999999843     3478999999999999998876667999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |+||||||+|||++.++.  +|++|||+++......  .....+..|.||+++...                        
T Consensus       155 ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------------------------  208 (362)
T 3pg1_A          155 VVHRDLHPGNILLADNND--ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQF------------------------  208 (362)
T ss_dssp             CCCCCCCGGGEEECTTCC--EEECCTTC---------------CGGGCCHHHHTTC------------------------
T ss_pred             CEecCCChHHEEEcCCCC--EEEEecCcccccccccccceecccceecCcHHhcCC------------------------
Confidence            999999999999988777  9999999987433111  111112222222222110                        


Q ss_pred             ccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         422 SKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       422 ~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                 ...+.++|+|++|+++++|+.|..|+..
T Consensus       209 -----------~~~~~~~DiwslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          209 -----------KGFTKLVDMWSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             -----------TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             -----------CCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence                       0014557999999999999999976644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.91  E-value=2.4e-25  Score=235.06  Aligned_cols=148  Identities=18%  Similarity=0.297  Sum_probs=119.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|++++|||||++++++.+.+.+|+|||||. |+|.+++.... ..+++..+..++.|++.||.|||+++|+|
T Consensus       262 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH  341 (495)
T 1opk_A          262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH  341 (495)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            46789999999999999999999999999999999998 78998887643 45889999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+++.+....  ...                                      ....
T Consensus       342 rDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~--~~~--------------------------------------~~~~  379 (495)
T 1opk_A          342 RNLAARNCLVGENHL--VKVADFGLSRLMTGDT--YTA--------------------------------------HAGA  379 (495)
T ss_dssp             SCCSGGGEEECGGGC--EEECCTTCEECCTTCC--EEC--------------------------------------CTTC
T ss_pred             CCCChhhEEECCCCc--EEEeecccceeccCCc--eee--------------------------------------cCCC
Confidence            999999999988776  9999999987542100  000                                      0001


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      .+++.|++|        +..+|+||+|++++||.. |..|+
T Consensus       380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~  420 (495)
T 1opk_A          380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  420 (495)
T ss_dssp             CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence            234445555        456799999999999998 76444

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.91  E-value=1.6e-25  Score=218.94  Aligned_cols=150  Identities=20%  Similarity=0.324  Sum_probs=117.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+++++.++||||+++++++.+.+..++|||||+ |+|.+.+...   ...+++..+..++.|++.||.|||+++|
T Consensus        66 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i  145 (285)
T 3is5_A           66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV  145 (285)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            46689999999999999999999999999999999998 5788877543   3569999999999999999999999999


Q ss_pred             eeccCCCcccccccc-chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         345 LHRDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       345 iHrDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      +||||||+||+++.. ....+|++|||++..+.....                                          .
T Consensus       146 vH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~------------------------------------------~  183 (285)
T 3is5_A          146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH------------------------------------------S  183 (285)
T ss_dssp             CCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------------------------------------------
T ss_pred             EECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc------------------------------------------C
Confidence            999999999999543 233489999998764331100                                          0


Q ss_pred             CcccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ....+|+.|++|       +.++|+|++|+++++|+.|..|+..
T Consensus       184 ~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          184 TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             ---CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence            012234444444       4567999999999999999977643

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.91  E-value=1.4e-25  Score=230.18  Aligned_cols=147  Identities=22%  Similarity=0.326  Sum_probs=116.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC--eEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~--~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++|+.++|||||++++++...+  ..++|||||+ |+|.+++.....  .+++..+..++.|++.||.|||+++
T Consensus        53 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~  132 (396)
T 4eut_A           53 VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG  132 (396)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3567999999999999999999998765  7899999998 678888765432  3899999999999999999999999


Q ss_pred             eeeccCCCccccc----cccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcc
Q psy3074         344 ILHRDVKPQNLLI----SEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       344 iiHrDlKp~NiLl----~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      |+||||||+|||+    +..+.  +|++|||+++.+.....                                       
T Consensus       133 ivH~Dlkp~NIll~~~~~~~~~--~kL~DFG~a~~~~~~~~---------------------------------------  171 (396)
T 4eut_A          133 IVHRNIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQ---------------------------------------  171 (396)
T ss_dssp             EECCCCCGGGEEEEECTTSCEE--EEECCGGGCEECCCGGG---------------------------------------
T ss_pred             EEECCcCHHHEEEeecCCCcee--EEEecCCCceEccCCCc---------------------------------------
Confidence            9999999999998    44444  99999999875431110                                       


Q ss_pred             ccccCcccceeccCCC----------------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         420 FESKSNINLSFHYLPP----------------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       420 ~~~~~~~~~t~~y~~p----------------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                         .....||+.|++|                +..+|+||+|+++++|.+|..||.
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~  224 (396)
T 4eut_A          172 ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR  224 (396)
T ss_dssp             ---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred             ---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence               0012244445544                235799999999999999997765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.91  E-value=1.7e-25  Score=222.32  Aligned_cols=152  Identities=18%  Similarity=0.273  Sum_probs=121.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++....   ..+++..+..++.|++.||.|||++++
T Consensus        81 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  160 (321)
T 2qkw_B           81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI  160 (321)
T ss_dssp             HHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCe
Confidence            46689999999999999999999999999999999998 57877765432   248899999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++.++.  +|++|||+++..........                                       ..
T Consensus       161 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~---------------------------------------~~  199 (321)
T 2qkw_B          161 IHRDVKSINILLDENFV--PKITDFGISKKGTELDQTHL---------------------------------------ST  199 (321)
T ss_dssp             ECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSCCCC---------------------------------------BC
T ss_pred             ecCCCCHHHEEECCCCC--EEEeeccccccccccccccc---------------------------------------cc
Confidence            99999999999998776  99999998864321110000                                       01


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...||+.|++|        +..+|+|++|+++++|.+|..|+...
T Consensus       200 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~  244 (321)
T 2qkw_B          200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS  244 (321)
T ss_dssp             CCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred             ccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence            12355555555        55689999999999999998776543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.91  E-value=8.9e-26  Score=235.55  Aligned_cols=153  Identities=22%  Similarity=0.270  Sum_probs=127.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-eEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-TLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+|++++|||||++++++.... .+|+|||||+ |+|.+++..... .+++..+..++.|++.||.|||+++++
T Consensus       232 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  311 (450)
T 1k9a_A          232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV  311 (450)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4678999999999999999999987654 7999999998 689998876543 378999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccc----cccccccCCCeeEEEeec-CCCCccc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGGWWF  420 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~~~~  420 (481)
                      ||||||+|||++.++.  +|++|||+++...+.......+..+.||+++.    +...|.||+|++++++.+ |..||..
T Consensus       312 HrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          312 HRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             CSCCCGGGEEECTTSC--EEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCCCCHhhEEECCCCC--EEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999998777  99999999987665544444556678888774    445577999999999998 9999986


Q ss_pred             ccc
Q psy3074         421 ESK  423 (481)
Q Consensus       421 ~~~  423 (481)
                      .+.
T Consensus       390 ~~~  392 (450)
T 1k9a_A          390 IPL  392 (450)
T ss_dssp             SCT
T ss_pred             CCH
Confidence            543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.91  E-value=2.1e-25  Score=223.28  Aligned_cols=151  Identities=23%  Similarity=0.341  Sum_probs=120.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------CCCChHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------GGLDHHN  324 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------~~l~~~~  324 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ |+|.+++....                       ..+++..
T Consensus        96 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  175 (343)
T 1luf_A           96 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE  175 (343)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHH
Confidence            46789999999999999999999999999999999998 58988887642                       4688999


Q ss_pred             HHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCC
Q psy3074         325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLS  404 (481)
Q Consensus       325 ~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~  404 (481)
                      +..++.|++.||.|||+++|+||||||+|||++.++.  +|++|||+++.+........                     
T Consensus       176 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~---------------------  232 (343)
T 1luf_A          176 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKA---------------------  232 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC----------------------
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCe--EEEeecCCCcccccCccccc---------------------
Confidence            9999999999999999999999999999999998776  99999999986542110000                     


Q ss_pred             CeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         405 GVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       405 g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                                        .....+|+.|++|        +..+|+|++|+++++|.. |..|+..
T Consensus       233 ------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          233 ------------------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             ---------------------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ------------------cCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence                              0011234444444        446799999999999997 8766543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.91  E-value=2.6e-25  Score=222.14  Aligned_cols=150  Identities=16%  Similarity=0.264  Sum_probs=116.2

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.... .+++||++. |++.+++....+.+++..+..++.|++.||.|||+++|+|
T Consensus        62 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  140 (327)
T 3lzb_A           62 KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH  140 (327)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcC
Confidence            45678999999999999999999998765 788899988 7899988877778999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+++.+..........                                       ..
T Consensus       141 ~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~~~~~---------------------------------------~~  179 (327)
T 3lzb_A          141 RDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAE---------------------------------------GG  179 (327)
T ss_dssp             SCCCGGGEEEEETTE--EEECCTTC-------------------------------------------------------
T ss_pred             CCCCHHHEEEcCCCC--EEEccCcceeEccCcccccccc---------------------------------------CC
Confidence            999999999988777  9999999987643211100000                                       01


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      .+|+.|++|        +.++|+||+|+++++|+. |..|+-
T Consensus       180 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~  221 (327)
T 3lzb_A          180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence            234445544        456799999999999998 875543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.91  E-value=1.2e-25  Score=231.28  Aligned_cols=153  Identities=24%  Similarity=0.432  Sum_probs=114.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee--cCCeEEEEEeccCCCHHHHHHHhc--------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVHTDLSQYMERHS--------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~--~~~~~~iv~E~~~g~l~~~l~~~~--------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+|+.++|||||++++++.  ....+|+||||+.|++.+.+....        ..+++..++.++.|++.||.|
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  143 (405)
T 3rgf_A           64 SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY  143 (405)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999994  467899999999999988876432        248999999999999999999


Q ss_pred             hhcCceeeccCCCcccccccc--chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         339 CHRRRILHRDVKPQNLLISEI--DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~--~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      ||+++|+||||||+|||+...  ....+|++|||+|+.+.......                                  
T Consensus       144 LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----------------------------------  189 (405)
T 3rgf_A          144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL----------------------------------  189 (405)
T ss_dssp             HHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------------------------------------------
T ss_pred             HHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCccc----------------------------------
Confidence            999999999999999999321  22349999999987543110000                                  


Q ss_pred             CccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         417 GWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                          ......+||+.|++|         +.++|+||+|+++++|+.|..||.
T Consensus       190 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  237 (405)
T 3rgf_A          190 ----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH  237 (405)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ----ccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence                000112345555554         345799999999999999996664

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.91  E-value=2.4e-25  Score=216.87  Aligned_cols=150  Identities=25%  Similarity=0.360  Sum_probs=120.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+.+..++||||+. +++.+.+... ..+++..+..++.|++.||.|||+++++||
T Consensus        51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (284)
T 3kk8_A           51 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHR  129 (284)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcC
Confidence            35679999999999999999999999999999999998 5777777654 569999999999999999999999999999


Q ss_pred             cCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+||+++.++. ..+|++|||++........                                          ....
T Consensus       130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~------------------------------------------~~~~  167 (284)
T 3kk8_A          130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA------------------------------------------WHGF  167 (284)
T ss_dssp             CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB------------------------------------------CCCS
T ss_pred             CCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc------------------------------------------ccCC
Confidence            99999999976543 3489999998754331100                                          0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      .||+.|++|        +.+.|+|++|+++++|..|..|+...
T Consensus       168 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  210 (284)
T 3kk8_A          168 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE  210 (284)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence            244445544        45689999999999999999777543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.91  E-value=3.8e-25  Score=213.72  Aligned_cols=148  Identities=16%  Similarity=0.282  Sum_probs=120.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+.+..++||||++ ++|.+++......+++..+..++.|++.||.|||+++++||
T Consensus        49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  128 (268)
T 3sxs_A           49 EFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR  128 (268)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEES
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45689999999999999999999999999999999998 67888887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..........                                        .....
T Consensus       129 dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~----------------------------------------~~~~~  166 (268)
T 3sxs_A          129 DLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS----------------------------------------SVGTK  166 (268)
T ss_dssp             SCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE----------------------------------------CCSCC
T ss_pred             CcCcceEEECCCCC--EEEccCccceecchhhhhc----------------------------------------ccCCC
Confidence            99999999998777  9999999876432110000                                        00012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      +|+.|++|        +.++|+||+|+++++|.. |..|+
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~  206 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY  206 (268)
T ss_dssp             CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred             cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence            33445554        567899999999999998 87554

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.91  E-value=4.1e-26  Score=228.73  Aligned_cols=154  Identities=24%  Similarity=0.310  Sum_probs=117.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-------------------------------
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-------------------------------  316 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-------------------------------  316 (481)
                      .+.+|+.+++.++|||||++++++.+.+..++|||||+ |+|.+.+...                               
T Consensus        74 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (345)
T 3hko_A           74 RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS  153 (345)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccc
Confidence            46789999999999999999999999999999999998 6787776311                               


Q ss_pred             --------cCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceecccc
Q psy3074         317 --------SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV  388 (481)
Q Consensus       317 --------~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~  388 (481)
                              ...+++..+..++.|++.||.|||+++|+||||||+|||++.++...+|++|||+++.+.........    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~----  229 (345)
T 3hko_A          154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY----  229 (345)
T ss_dssp             C--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-------
T ss_pred             cccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccc----
Confidence                    01135677888999999999999999999999999999998776445999999998754322110000    


Q ss_pred             CCCcccccccccccCCCeeEEEeecCCCCccccccCcccceeccCCC----------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         389 KPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPP----------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       389 ~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                                                       ......||+.|++|          +..+|+||+|+++++|.+|..|+
T Consensus       230 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  276 (345)
T 3hko_A          230 ---------------------------------GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF  276 (345)
T ss_dssp             --------------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ---------------------------------cccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence                                             00012244444444          34679999999999999999776


Q ss_pred             c
Q psy3074         459 L  459 (481)
Q Consensus       459 ~  459 (481)
                      .
T Consensus       277 ~  277 (345)
T 3hko_A          277 P  277 (345)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.91  E-value=2e-25  Score=217.17  Aligned_cols=145  Identities=23%  Similarity=0.429  Sum_probs=117.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||++ |++.+.+... ..+++..+..++.|++.||.|||+++|+||
T Consensus        55 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~  133 (279)
T 3fdn_A           55 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHR  133 (279)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEEC
T ss_pred             HHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            45689999999999999999999999999999999999 5777777654 569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++........                                           ....
T Consensus       134 dlkp~Nili~~~~~--~~l~Dfg~~~~~~~~~~-------------------------------------------~~~~  168 (279)
T 3fdn_A          134 DIKPENLLLGSAGE--LKIADFGWSVHAPSSRR-------------------------------------------TDLC  168 (279)
T ss_dssp             CCCGGGEEECTTSC--EEECSCCEESCC---------------------------------------------------C
T ss_pred             cCChHhEEEcCCCC--EEEEeccccccCCcccc-------------------------------------------cccC
Confidence            99999999998877  99999997643221100                                           0012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +|+.|++|        +...|+|++|+++++|..|..|+-
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCC
Confidence            33334443        557899999999999999986654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=4.7e-25  Score=221.07  Aligned_cols=151  Identities=21%  Similarity=0.336  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC----------------------CCChH
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG----------------------GLDHH  323 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~----------------------~l~~~  323 (481)
                      ..+.+|+.+++++ +||||+++++++...+..++|||||+ |+|.+++.....                      .+++.
T Consensus        93 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  172 (344)
T 1rjb_A           93 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE  172 (344)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHH
Confidence            3567899999999 89999999999999999999999998 689888876432                      27888


Q ss_pred             HHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccC
Q psy3074         324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNL  403 (481)
Q Consensus       324 ~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s  403 (481)
                      .+..++.|++.||.|||+++|+||||||+|||++.++.  +|++|||++..+.........                   
T Consensus       173 ~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~-------------------  231 (344)
T 1rjb_A          173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVVR-------------------  231 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEEE-------------------
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCc--EEeCCCccCcccccCccceec-------------------
Confidence            99999999999999999999999999999999998776  999999998754321110000                   


Q ss_pred             CCeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         404 SGVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       404 ~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                          ....+|+.|++|        +..+|+|++|+++++|.+ |..|+.
T Consensus       232 --------------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          232 --------------------GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             --------------------TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             --------------------cCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence                                012234445555        456799999999999997 875553

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.91  E-value=2.7e-25  Score=217.01  Aligned_cols=154  Identities=14%  Similarity=0.162  Sum_probs=110.8

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC-ceeec
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR-RILHR  347 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiHr  347 (481)
                      ++..+++.++||||+++++++.+++..++||||++|++.+++..   ....+++..+..++.|++.||.|||++ +++||
T Consensus        55 ~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~  134 (290)
T 3fme_A           55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHR  134 (290)
T ss_dssp             HHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCC
T ss_pred             HHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecC
Confidence            45566888999999999999999999999999999988777654   345799999999999999999999998 99999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccC--ceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR--RILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~--~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||+||+++.++.  +|++|||+++.+......  ...+..|.||+++..+                            
T Consensus       135 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------------  184 (290)
T 3fme_A          135 DVKPSNVLINALGQ--VKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE----------------------------  184 (290)
T ss_dssp             CCSGGGCEECTTCC--EEBCCC---------------CCCCCCSCHHHHSCC----------------------------
T ss_pred             CCCHHHEEECCCCC--EEEeecCCcccccccccccccCCCccccChhhcChh----------------------------
Confidence            99999999998776  999999998765422111  1122223333322100                            


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                          ......+.++|+|++|+++++|..|..|+-
T Consensus       185 ----~~~~~~~~~~Di~slG~il~~l~~g~~p~~  214 (290)
T 3fme_A          185 ----LNQKGYSVKSDIWSLGITMIELAILRFPYD  214 (290)
T ss_dssp             ----TTC--CCHHHHHHHHHHHHHHHHHTSCSSC
T ss_pred             ----hcCcCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence                000011346799999999999999986664

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.90  E-value=2.2e-25  Score=224.21  Aligned_cols=157  Identities=15%  Similarity=0.118  Sum_probs=124.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++||||+++++++..    ....|+|||||.++|.+++.... .+++..+..++.|++.||.|||+++|
T Consensus        94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i  172 (345)
T 2v62_A           94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEY  172 (345)
T ss_dssp             HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            45689999999999999999999987    77899999999778888776543 79999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+|||++.++...+|++|||+|+.+.......                                  .+......
T Consensus       173 vH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~----------------------------------~~~~~~~~  218 (345)
T 2v62_A          173 VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK----------------------------------QYQENPRK  218 (345)
T ss_dssp             ECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCC----------------------------------CCCCCGGG
T ss_pred             eCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccc----------------------------------cchhcccc
Confidence            99999999999988774459999999987553211000                                  00000011


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...||+.|++|        +..+|+||+|+++++|++|..|+..
T Consensus       219 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          219 GHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             CSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             ccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            24466777776        4567999999999999999977644

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.90  E-value=4.3e-25  Score=216.74  Aligned_cols=152  Identities=20%  Similarity=0.261  Sum_probs=114.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHH-------hcCCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMER-------HSGGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~-------~~~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      +.+|+.+++.++||||+++++++...+..++||||++ ++|.+++..       ..+.+++..+..++.|++.||.|||+
T Consensus        60 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  139 (303)
T 2vwi_A           60 LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK  139 (303)
T ss_dssp             ------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            4569999999999999999999999999999999997 678887764       23458999999999999999999999


Q ss_pred             CceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         342 RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      ++++||||||+||+++.++.  +|++|||++..+.......   .                                 ..
T Consensus       140 ~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~---~---------------------------------~~  181 (303)
T 2vwi_A          140 NGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDIT---R---------------------------------NK  181 (303)
T ss_dssp             TTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC---------------------------------------------
T ss_pred             CCCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCcc---c---------------------------------hh
Confidence            99999999999999998777  9999999998654211000   0                                 00


Q ss_pred             ccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         422 SKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       422 ~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ......||+.|++|         +..+|+|++|+++++|..|..|+.
T Consensus       182 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  228 (303)
T 2vwi_A          182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH  228 (303)
T ss_dssp             ------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             hhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence            00012344444444         456799999999999999986654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.90  E-value=1e-25  Score=221.03  Aligned_cols=151  Identities=23%  Similarity=0.380  Sum_probs=116.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.++++++||||+++++++..  ...+++|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+
T Consensus        57 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  136 (295)
T 3ugc_A           57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI  136 (295)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence            45689999999999999999999865  356999999997 689998877666699999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||++.++.  +|++|||+++.+.........                                      ...
T Consensus       137 H~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~--------------------------------------~~~  176 (295)
T 3ugc_A          137 HRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKV--------------------------------------KEP  176 (295)
T ss_dssp             CSCCSGGGEEEEETTE--EEECCCCSCC---------------------------------------------------C
T ss_pred             cCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeee--------------------------------------ccC
Confidence            9999999999998776  999999988754321100000                                      000


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..++..|++|        +.++|+||+|+++++|.+|..|+.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             TTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred             CCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence            1233344444        456799999999999999875543

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.90  E-value=2.6e-25  Score=221.51  Aligned_cols=148  Identities=19%  Similarity=0.215  Sum_probs=117.9

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC--
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR--  342 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~--  342 (481)
                      ..+|+.+|++++|||||++++++....    .+++|||||+ |+|.+++..  ..+++..+..++.|++.||.|||+.  
T Consensus        65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~  142 (322)
T 3soc_A           65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIP  142 (322)
T ss_dssp             HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEE
T ss_pred             HHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhcc
Confidence            346999999999999999999998744    4799999998 588888865  4599999999999999999999999  


Q ss_pred             --------ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecC
Q psy3074         343 --------RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       343 --------~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g  414 (481)
                              +|+||||||+|||++.++.  +|++|||+|+.+.......                                
T Consensus       143 ~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~~~~~~~~~~--------------------------------  188 (322)
T 3soc_A          143 GLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKSAG--------------------------------  188 (322)
T ss_dssp             EETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCEEECTTSCCC--------------------------------
T ss_pred             ccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcccccccccCcc--------------------------------
Confidence                    9999999999999998777  9999999987543211100                                


Q ss_pred             CCCccccccCcccceeccCCC-------------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         415 SGGWWFESKSNINLSFHYLPP-------------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       415 ~~~~~~~~~~~~~~t~~y~~p-------------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                             .....+||+.|++|             +.++|+||+|+++++|..|..|+..
T Consensus       189 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          189 -------DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             -------CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             -------ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence                   00113456666666             1234999999999999999866543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.90  E-value=2.5e-25  Score=224.87  Aligned_cols=147  Identities=20%  Similarity=0.326  Sum_probs=119.4

Q ss_pred             HHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       271 ~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+|+++|+.+ +||||+++++++...+..++|||||+ |+|.+++... ..+++..+..++.|++.||.|||+++|+|||
T Consensus       106 ~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D  184 (355)
T 1vzo_A          106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRD  184 (355)
T ss_dssp             CCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence            3599999999 69999999999999999999999998 5788887654 5699999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+++.+.......                                        ....+|
T Consensus       185 lkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~----------------------------------------~~~~~g  222 (355)
T 1vzo_A          185 IKLENILLDSNGH--VVLTDFGLSKEFVADETER----------------------------------------AYDFCG  222 (355)
T ss_dssp             CCGGGEEECTTSC--EEESCSSEEEECCGGGGGG----------------------------------------GCGGGS
T ss_pred             CCHHHEEECCCCc--EEEeeCCCCeecccCCCCc----------------------------------------ccCccc
Confidence            9999999998776  9999999886432110000                                        011234


Q ss_pred             eeccCCC----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|++|          +...|+|++|+++++|++|..|+..
T Consensus       223 t~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             CCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred             CcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence            5555555          3457999999999999999977653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.90  E-value=3.7e-25  Score=221.63  Aligned_cols=148  Identities=22%  Similarity=0.331  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ ++|.+++.. ...+++..+..++.|++.||.|||+++|+||
T Consensus        87 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  165 (335)
T 2owb_A           87 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHR  165 (335)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEec
Confidence            45679999999999999999999999999999999999 567776654 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+......                                         .....
T Consensus       166 dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  202 (335)
T 2owb_A          166 DLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER-----------------------------------------KKVLC  202 (335)
T ss_dssp             CCCGGGEEECTTCC--EEECCCTTCEECCSTTCC-----------------------------------------BCCCC
T ss_pred             CCCchhEEEcCCCC--EEEeeccCceecccCccc-----------------------------------------ccccC
Confidence            99999999998777  999999988754321100                                         00122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +...|+|++|+++++|..|..|+..
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             SCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence            44444444        4567999999999999999877643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.90  E-value=1.7e-25  Score=231.27  Aligned_cols=148  Identities=21%  Similarity=0.303  Sum_probs=113.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.. +..|+|||||+ |+|.+.+.. .+.+++..+..++.|++.||.|||+++|+||
T Consensus       186 ~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr  263 (419)
T 3i6u_A          186 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHR  263 (419)
T ss_dssp             CHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35689999999999999999999865 45899999998 577776654 4569999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+|||++..+ ...+|++|||+|+.+.....                                          ....
T Consensus       264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~------------------------------------------~~~~  301 (419)
T 3i6u_A          264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSL------------------------------------------MRTL  301 (419)
T ss_dssp             CCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------------------------------------------
T ss_pred             CCChHhEEEecCCCcceEEEeecccceecCCCcc------------------------------------------cccc
Confidence            9999999997543 23599999999875432110                                          0012


Q ss_pred             cceeccCCCC-----------CChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPPG-----------APFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p~-----------~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|.           .++|+||+|+++++|+.|..|+-.
T Consensus       302 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  346 (419)
T 3i6u_A          302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE  346 (419)
T ss_dssp             ---CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            3455555552           256999999999999999866643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.90  E-value=5.5e-25  Score=219.15  Aligned_cols=153  Identities=31%  Similarity=0.500  Sum_probs=114.8

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++ ||||+++++++.+  ....++||||+. +++.+.+.    .+++..+..++.|++.||.|||+++|
T Consensus        76 ~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i  151 (330)
T 3nsz_A           76 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGI  151 (330)
T ss_dssp             HHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            3567999999998 9999999999988  668999999999 56665543    38999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +||||||+|||++.++ ..+|++|||+++.+....  .....+..+.+|+++..                          
T Consensus       152 vH~Dikp~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~--------------------------  204 (330)
T 3nsz_A          152 MHRDVKPHNVMIDHEH-RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD--------------------------  204 (330)
T ss_dssp             ECCCCSGGGEEEETTT-TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT--------------------------
T ss_pred             eeCCCCHHHEEEcCCC-CEEEEEeCCCceEcCCCCccccccccccccChhhhcC--------------------------
Confidence            9999999999998654 139999999986443111  01111112222222110                          


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                               ....+..+|+||+|+++++|+.|..|++..
T Consensus       205 ---------~~~~~~~~DiwslG~il~~ll~g~~p~~~~  234 (330)
T 3nsz_A          205 ---------YQMYDYSLDMWSLGCMLASMIFRKEPFFHG  234 (330)
T ss_dssp             ---------CCCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ---------CCcCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence                     001145679999999999999999887543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.90  E-value=2e-25  Score=224.28  Aligned_cols=162  Identities=16%  Similarity=0.215  Sum_probs=118.7

Q ss_pred             hHHHHHHHHhhcCC--CCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKH--NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~H--pnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|+.++|  |||+++++++.+.+.+|+|||++.|+|.+++... +.+++..+..++.|++.||.|||+++|+|
T Consensus        53 ~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiH  131 (343)
T 3dbq_A           53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVH  131 (343)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            45689999999987  9999999999999999999998778999988764 57999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc-----CceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR-----RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~-----~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||||+|||+++ +.  +|++|||+++.+.....     ..+.+..|.||+++........                   
T Consensus       132 rDikp~NIll~~-~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-------------------  189 (343)
T 3dbq_A          132 SDLKPANFLIVD-GM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE-------------------  189 (343)
T ss_dssp             CCCCGGGEEEET-TE--EEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------------------
T ss_pred             CCCCcceEEEEC-Cc--EEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhcccccc-------------------
Confidence            999999999963 44  99999999875542211     1122333333333321000000                   


Q ss_pred             ccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         422 SKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       422 ~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                            ........+.++|+||+|+++++|++|..|+.
T Consensus       190 ------~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  221 (343)
T 3dbq_A          190 ------NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  221 (343)
T ss_dssp             -------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ------ccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence                  00000111345799999999999999997664

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.90  E-value=6.1e-25  Score=215.90  Aligned_cols=151  Identities=18%  Similarity=0.317  Sum_probs=120.8

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ..+.+|+.+++.++||||+++++++.+.  +.+++||||++ |+|.+++......+++..+..++.|++.||.|||+++|
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  147 (302)
T 4e5w_A           68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQY  147 (302)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCc
Confidence            3467899999999999999999999876  67999999998 58988887776779999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++.++.  +|++|||++..+........                                      ...
T Consensus       148 ~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~--------------------------------------~~~  187 (302)
T 4e5w_A          148 VHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYT--------------------------------------VKD  187 (302)
T ss_dssp             ECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCCEEE--------------------------------------CCC
T ss_pred             ccCCCchheEEEcCCCC--EEECcccccccccCCCccee--------------------------------------ccC
Confidence            99999999999988776  99999998875432110000                                      001


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                      ...+|..|++|        +.++|+|++|+++++|..|..|+
T Consensus       188 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             CTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             CCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCC
Confidence            12344555555        34579999999999999987653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.90  E-value=1.7e-25  Score=227.48  Aligned_cols=151  Identities=25%  Similarity=0.448  Sum_probs=115.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeE------EEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTL------TFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~------~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...+..      |+||||+.+++...+.   ..+++..+..++.|++.||.|||++
T Consensus        87 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~  163 (371)
T 4exu_A           87 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSA  163 (371)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            456899999999999999999999887655      9999999998877653   3599999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.++.  +|++|||+++.........+.+..|.||+++.+                          
T Consensus       164 ~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--------------------------  215 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAEMTGYVVTRWYRAPEVILS--------------------------  215 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCC--EEECSTTCC--------CTTCCCTTSCHHHHSC--------------------------
T ss_pred             CCcCCCcCHHHeEECCCCC--EEEEecCcccccccCcCCcccCccccCHHHhcC--------------------------
Confidence            9999999999999998877  999999988754432222222333333333221                          


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                               ....+.++|+||+|+++++|.+|..|+-
T Consensus       216 ---------~~~~~~~~DiwslG~il~el~~g~~pf~  243 (371)
T 4exu_A          216 ---------WMHYNQTVDIWSVGCIMAEMLTGKTLFK  243 (371)
T ss_dssp             ---------CSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ---------CCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence                     0112456799999999999999986664

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.90  E-value=2.3e-25  Score=228.12  Aligned_cols=163  Identities=17%  Similarity=0.236  Sum_probs=117.7

Q ss_pred             hHHHHHHHHhhcC--CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK--HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~--HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|+.++  |||||++++++...+.+|+|||++.++|.+++... ..+++..+..++.|++.||.|||+++|+|
T Consensus       100 ~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH  178 (390)
T 2zmd_A          100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVH  178 (390)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCC
T ss_pred             HHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            4568999999997  49999999999999999999997778898888764 47899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc-----cCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-----RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-----~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||||+|||+++ +.  +|++|||+++.+....     ...+.+..|.+||++.......          ..+       
T Consensus       179 rDlkp~NIll~~-~~--~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~----------~~~-------  238 (390)
T 2zmd_A          179 SDLKPANFLIVD-GM--LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR----------ENG-------  238 (390)
T ss_dssp             CCCCGGGEEESS-SC--EEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------------------
T ss_pred             cCCCHHHEEEEC-Ce--EEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccc----------ccc-------
Confidence            999999999964 44  9999999987553211     1112222333333322100000          000       


Q ss_pred             ccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         422 SKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       422 ~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                              ......+..+|+||+|+++++|++|..|+..
T Consensus       239 --------~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          239 --------KSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             -------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --------ccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence                    0000113357999999999999999977643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.90  E-value=6.2e-25  Score=215.31  Aligned_cols=148  Identities=22%  Similarity=0.331  Sum_probs=119.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||++ +++.+++.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        61 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  139 (294)
T 2rku_A           61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHR  139 (294)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35679999999999999999999999999999999999 567776654 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+......                                         .....
T Consensus       140 dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~-----------------------------------------~~~~~  176 (294)
T 2rku_A          140 DLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER-----------------------------------------KKVLC  176 (294)
T ss_dssp             CCCGGGEEECTTCC--EEECCCTTCEECCSTTCC-----------------------------------------BCCCC
T ss_pred             CCChHhEEEcCCCC--EEEEeccCceecccCccc-----------------------------------------ccccc
Confidence            99999999998777  999999988654321100                                         00112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +|+.|++|        +...|+|++|+++++|..|..|+..
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  217 (294)
T 2rku_A          177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET  217 (294)
T ss_dssp             SCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            33444444        4567999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.90  E-value=1.4e-24  Score=214.59  Aligned_cols=148  Identities=20%  Similarity=0.287  Sum_probs=121.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++| +|.+++......+++..+..++.|++.||.|||+.+++|+
T Consensus        70 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (314)
T 3com_A           70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR  149 (314)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence            456799999999999999999999999999999999984 7888887666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+......                                         .....
T Consensus       150 dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~-----------------------------------------~~~~~  186 (314)
T 3com_A          150 DIKAGNILLNTEGH--AKLADFGVAGQLTDTMAK-----------------------------------------RNTVI  186 (314)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECBTTBSC-----------------------------------------BCCCC
T ss_pred             CcCHHHEEECCCCC--EEEeecccchhhhhhccc-----------------------------------------cCccC
Confidence            99999999998777  999999988654311100                                         00112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +|+.|++|        +..+|+|++|+++++|..|..|+.
T Consensus       187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  226 (314)
T 3com_A          187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA  226 (314)
T ss_dssp             SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence            34444444        556899999999999999986654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.90  E-value=1.5e-25  Score=223.20  Aligned_cols=183  Identities=22%  Similarity=0.286  Sum_probs=124.6

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeee--------cCCeEEEEEeccCCCHHHHHHH--hcCCCChHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVH--------TRSTLTFVFEYVHTDLSQYMER--HSGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~--------~~~~~~iv~E~~~g~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      .+.+|+.+++++. ||||+++++++.        .....+++||||.|+|.+++..  ..+.+++..+..++.|++.||.
T Consensus        71 ~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~  150 (337)
T 3ll6_A           71 AIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ  150 (337)
T ss_dssp             HHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            3567999999996 999999999983        4456899999999999988865  2346999999999999999999


Q ss_pred             HhhcCc--eeeccCCCccccccccchhhHHHHHHHHHhhcccccc---------------CceeccccCCCccc------
Q psy3074         338 YCHRRR--ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---------------RRILHRDVKPQNLL------  394 (481)
Q Consensus       338 ylH~~~--iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---------------~~i~~~d~~~~~il------  394 (481)
                      |||+++  |+||||||+|||++.++.  +|++|||+++.+.....               ....+..|.+|+++      
T Consensus       151 ~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (337)
T 3ll6_A          151 HMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF  228 (337)
T ss_dssp             HHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred             HHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence            999999  999999999999998777  99999999986542211               22345568888877      


Q ss_pred             -ccccccccCCCeeEEEeecCCCCccccccCcc-cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         395 -ISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI-NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       395 -~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~-~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                       .+...+.|++|++++++.+|..||.......+ .+...  .+........+..++..|+..+
T Consensus       229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~  289 (337)
T 3ll6_A          229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYS--IPPHDTQYTVFHSLIRAMLQVN  289 (337)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHSSCCC------------CC--CCTTCCSSGGGHHHHHHHSCSS
T ss_pred             CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCccc--CCcccccchHHHHHHHHHccCC
Confidence             24456789999999999999999875533222 11111  1111112223456677776654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.90  E-value=1.6e-25  Score=218.25  Aligned_cols=181  Identities=20%  Similarity=0.285  Sum_probs=129.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++. .+..|+||||++ |+|.+++......+++..+..++.|++.||.|||+++++||
T Consensus        62 ~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  140 (281)
T 1mp8_A           62 KFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR  140 (281)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            4678999999999999999999985 457899999999 58888887665679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc----cCceeccccCCCcccc----cccccccCCCeeEEEeec-CCCCc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH----RRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGGW  418 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~----~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~~  418 (481)
                      ||||+|||++.++.  +|++|||+++.+....    .....+..|.+|+++.    +...|.||.|++++++.+ |..||
T Consensus       141 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf  218 (281)
T 1mp8_A          141 DIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  218 (281)
T ss_dssp             CCSGGGEEEEETTE--EEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             cccHHHEEECCCCC--EEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence            99999999998776  9999999998664221    1222334577888774    344577999999999986 99998


Q ss_pred             cccccCccc-----ceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         419 WFESKSNIN-----LSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       419 ~~~~~~~~~-----~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      .........     +...-.++..|   ..+..++..|+..+
T Consensus       219 ~~~~~~~~~~~i~~~~~~~~~~~~~---~~l~~li~~~l~~~  257 (281)
T 1mp8_A          219 QGVKNNDVIGRIENGERLPMPPNCP---PTLYSLMTKCWAYD  257 (281)
T ss_dssp             TTCCGGGHHHHHHTTCCCCCCTTCC---HHHHHHHHHHTCSS
T ss_pred             CcCCHHHHHHHHHcCCCCCCCCCCC---HHHHHHHHHHccCC
Confidence            755432211     11111222333   34456677777665

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.90  E-value=8.1e-25  Score=213.41  Aligned_cols=145  Identities=26%  Similarity=0.452  Sum_probs=119.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++ |+|.+.+... +.+++..+..++.|++.||.|||+++++||
T Consensus        60 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  138 (284)
T 2vgo_A           60 QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHR  138 (284)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred             HHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            46689999999999999999999999999999999998 5888887654 569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++.........                                           ...
T Consensus       139 dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-------------------------------------------~~~  173 (284)
T 2vgo_A          139 DIKPENLLMGYKGE--LKIADFGWSVHAPSLRRR-------------------------------------------TMC  173 (284)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECSSSCBC-------------------------------------------CCC
T ss_pred             CCCHHHEEEcCCCC--EEEecccccccCcccccc-------------------------------------------ccc
Confidence            99999999988777  999999987533211000                                           012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      |++.|++|        +..+|+|++|+++++|..|..|+-
T Consensus       174 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  213 (284)
T 2vgo_A          174 GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD  213 (284)
T ss_dssp             SCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence            33444444        557899999999999999986654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.90  E-value=1e-24  Score=214.27  Aligned_cols=158  Identities=22%  Similarity=0.212  Sum_probs=119.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ +++..++......+++..+..++.|++.||.|||+++++||
T Consensus        62 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  141 (302)
T 2j7t_A           62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR  141 (302)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence            46689999999999999999999999999999999998 56777776666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+||+++.++.  +|++|||++.......   .....+..|.||+++..+..                         
T Consensus       142 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-------------------------  194 (302)
T 2j7t_A          142 DLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM-------------------------  194 (302)
T ss_dssp             CCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHT-------------------------
T ss_pred             CCCHHHEEECCCCC--EEEEECCCCccccccccccccccCChhhcCCeeeccccC-------------------------
Confidence            99999999998777  9999999986432111   11122233444443321100                         


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                            .-...+..+|+|++|+++++|..|..|+.
T Consensus       195 ------~~~~~~~~~Di~slG~il~~l~~g~~p~~  223 (302)
T 2j7t_A          195 ------KDTPYDYKADIWSLGITLIEMAQIEPPHH  223 (302)
T ss_dssp             ------TSTTTTTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ------CCCCCchhhhHHHHHHHHHHHhcCCCCCc
Confidence                  00011345789999999999998885543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.90  E-value=9e-25  Score=212.65  Aligned_cols=150  Identities=25%  Similarity=0.430  Sum_probs=119.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+++++|
T Consensus        53 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  131 (283)
T 3bhy_A           53 EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAH  131 (283)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            356789999999999999999999999999999999997 678887765 356999999999999999999999999999


Q ss_pred             ccCCCccccccccc--hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEID--HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~--~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+||+++.++  ...+|++|||++..+......                                          .
T Consensus       132 ~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~------------------------------------------~  169 (283)
T 3bhy_A          132 FDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF------------------------------------------K  169 (283)
T ss_dssp             SCCSGGGEEESCSSSSSCCEEECCCTTCEECC------------------------------------------------
T ss_pred             CCCChHHEEEecCCCCCCceEEEecccceeccCCCcc------------------------------------------c
Confidence            99999999998765  224899999987643311000                                          0


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+|+.|++|        +...|+|++|+++++|..|..|+..
T Consensus       170 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence            11233444444        4567999999999999999876643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=8.5e-25  Score=220.42  Aligned_cols=147  Identities=25%  Similarity=0.330  Sum_probs=114.1

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCC-------eEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHh
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRS-------TLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~-------~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      ..+|++.++.++|||||++++++...+       .+++|||||+|++...+..   ....+++..+..++.|++.||.||
T Consensus        66 ~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  145 (360)
T 3e3p_A           66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCL  145 (360)
T ss_dssp             HHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            446888889999999999999996543       3899999999988776653   345688999999999999999999


Q ss_pred             h--cCceeeccCCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         340 H--RRRILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       340 H--~~~iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |  +++|+||||||+|||++. ++.  +|++|||+++.+......                                   
T Consensus       146 H~~~~~ivH~Dlkp~NIll~~~~~~--~kl~Dfg~a~~~~~~~~~-----------------------------------  188 (360)
T 3e3p_A          146 HLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPSEPN-----------------------------------  188 (360)
T ss_dssp             TSTTTCCBCSCCCGGGEEEETTTTE--EEECCCTTCBCCCTTSCC-----------------------------------
T ss_pred             hCCCCCeecCcCCHHHEEEeCCCCc--EEEeeCCCceecCCCCCc-----------------------------------
Confidence            9  999999999999999986 555  999999998754321110                                   


Q ss_pred             CccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         417 GWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                             ....||+.|++|         +..+|+||+|+++++|+.|..|+..
T Consensus       189 -------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          189 -------VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             -------CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence                   001233333333         4467999999999999999866644

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.90  E-value=5.8e-25  Score=219.09  Aligned_cols=154  Identities=23%  Similarity=0.348  Sum_probs=122.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee--cCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~--~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|++++++++||||+++++++.  +...+++|||||+ ++|.+++......+++..+..++.|++.||.|||+++|+
T Consensus        70 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv  149 (327)
T 3lxl_A           70 DFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCV  149 (327)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            3568999999999999999999886  4567999999997 688888877666799999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||++.++.  +|++|||+++.+........                                      ....
T Consensus       150 H~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~--------------------------------------~~~~  189 (327)
T 3lxl_A          150 HRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYV--------------------------------------VREP  189 (327)
T ss_dssp             CSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEE--------------------------------------CSSC
T ss_pred             CCCCChhhEEECCCCC--EEEcccccceecccCCccce--------------------------------------eecc
Confidence            9999999999988777  99999999875431110000                                      0001


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ..+|+.|++|        +...|+|++|+++++|+.|..|+....
T Consensus       190 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~  234 (327)
T 3lxl_A          190 GQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS  234 (327)
T ss_dssp             CCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred             CCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence            2245555555        446799999999999999987765443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.90  E-value=5.7e-25  Score=217.03  Aligned_cols=150  Identities=22%  Similarity=0.340  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC-----------------CCChHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG-----------------GLDHHNIRLFM  329 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~-----------------~l~~~~~~~~~  329 (481)
                      .+.+|+.+++++ +||||+++++++.+.+..++|||||+ |+|.+++.....                 .+++..+..++
T Consensus        72 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (313)
T 1t46_A           72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS  151 (313)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHH
Confidence            466899999999 89999999999999999999999998 589888876532                 38899999999


Q ss_pred             HHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEE
Q psy3074         330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVS  409 (481)
Q Consensus       330 ~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~  409 (481)
                      .|++.||.|||+++++||||||+||+++.++.  +|++|||+++.+........                          
T Consensus       152 ~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~--------------------------  203 (313)
T 1t46_A          152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVV--------------------------  203 (313)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEE--------------------------
T ss_pred             HHHHHHHHHHHHCCeecCCCccceEEEcCCCC--EEEcccccccccccccccee--------------------------
Confidence            99999999999999999999999999988776  99999999875432110000                          


Q ss_pred             EeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         410 TVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       410 ~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                   .....+|+.|++|        +..+|+|++|+++++|.+ |..|+.
T Consensus       204 -------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          204 -------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             -------------CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             -------------ccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         0012244455555        456799999999999998 775553

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.90  E-value=4.8e-25  Score=219.33  Aligned_cols=148  Identities=20%  Similarity=0.295  Sum_probs=121.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcC--
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRR--  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~--  342 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++....   ..+++..+..++.|++.||.|||++  
T Consensus        73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  152 (326)
T 3uim_A           73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD  152 (326)
T ss_dssp             HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36689999999999999999999999999999999998 57888876533   2388999999999999999999999  


Q ss_pred             -ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         343 -RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       343 -~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                       +|+||||||+|||++.++.  +|++|||+++.+.......                                       
T Consensus       153 ~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~---------------------------------------  191 (326)
T 3uim_A          153 PKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDTHV---------------------------------------  191 (326)
T ss_dssp             SCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSSCE---------------------------------------
T ss_pred             CCeEeCCCchhhEEECCCCC--EEeccCccccccCcccccc---------------------------------------
Confidence             9999999999999998777  9999999886543111000                                       


Q ss_pred             ccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         422 SKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       422 ~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                       .....||+.|++|        +.++|+||+|+++++|+.|..|+
T Consensus       192 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  235 (326)
T 3uim_A          192 -TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF  235 (326)
T ss_dssp             -ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred             -cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence             0112356666666        55779999999999999999776

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.90  E-value=4.5e-25  Score=221.85  Aligned_cols=157  Identities=25%  Similarity=0.385  Sum_probs=121.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC-----CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR-----STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~-----~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++++...     ...|+||||+.|+|.+.+..  +.+++..+..++.|++.||.|||+++
T Consensus        55 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~  132 (353)
T 2b9h_A           55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN  132 (353)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            356799999999999999999988754     67999999999999888765  46999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+++.+.........                           ..+.    ....
T Consensus       133 ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~---------------------------~~~~----~~~~  179 (353)
T 2b9h_A          133 VIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSE---------------------------PTGQ----QSGM  179 (353)
T ss_dssp             EECSCCCGGGEEECTTCC--EEECCCTTCEECC-----------------------------------------------
T ss_pred             eecCCCCHHHeEEcCCCc--EEEEecccccccccccccccC---------------------------cccc----ccch
Confidence            999999999999998777  999999998755421110000                           0000    0001


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+||+.|++|         +..+|+||+|+++++|..|..|+..
T Consensus       180 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             hhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            123566777766         3356999999999999999866543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.90  E-value=8.2e-25  Score=228.49  Aligned_cols=106  Identities=23%  Similarity=0.435  Sum_probs=94.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+.+|+.+|+.++|||||++++++. .+.+|+|||||. |+|.+++.... ..+++..+..++.|++.||.|||+++|+
T Consensus       228 ~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv  306 (454)
T 1qcf_A          228 EAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI  306 (454)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            35678999999999999999999987 567899999998 68988887543 3588899999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||||+|||++.++.  +|++|||+++.+.
T Consensus       307 HrDlkp~Nill~~~~~--~kl~DFG~a~~~~  335 (454)
T 1qcf_A          307 HRDLRAANILVSASLV--CKIADFGLARVIE  335 (454)
T ss_dssp             CSSCSGGGEEECTTCC--EEECSTTGGGGBC
T ss_pred             CCCCCHHHEEECCCCc--EEEeeCCCceEcC
Confidence            9999999999998777  9999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.90  E-value=1.9e-24  Score=219.25  Aligned_cols=159  Identities=25%  Similarity=0.313  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++++ +||||+++++++...+..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|
T Consensus       145 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H  223 (365)
T 2y7j_A          145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVH  223 (365)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            456899999999 79999999999999999999999998 4788777653 56999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+||+++.++.  +|++|||++..+....  .....+..|.+|+++.+....                        
T Consensus       224 ~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------------------------  277 (365)
T 2y7j_A          224 RDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE------------------------  277 (365)
T ss_dssp             SCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCT------------------------
T ss_pred             CCCCHHHEEECCCCC--EEEEecCcccccCCCcccccCCCCCCccChhhccccccc------------------------
Confidence            999999999998877  9999999887544211  011112222222222110000                        


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                            .....+..+|+||+|+++++|+.|..|+..
T Consensus       278 ------~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          278 ------THPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             ------TSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------cCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence                  000014568999999999999999977754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.90  E-value=1.2e-24  Score=209.89  Aligned_cols=105  Identities=23%  Similarity=0.414  Sum_probs=96.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++.+.+..++||||++ ++|.+++....+.+++..+..++.|++.||.|||+++++||
T Consensus        49 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  128 (267)
T 3t9t_A           49 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  128 (267)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            46789999999999999999999999999999999998 68888887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||||+||+++.++.  +|++|||++...
T Consensus       129 dl~p~Nili~~~~~--~kl~dfg~~~~~  154 (267)
T 3t9t_A          129 DLAARNCLVGENQV--IKVSDFGMTRFV  154 (267)
T ss_dssp             SCCGGGEEECGGGC--EEECCTTGGGGB
T ss_pred             CCchheEEECCCCC--EEEccccccccc
Confidence            99999999988776  999999998754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.90  E-value=1.4e-24  Score=226.88  Aligned_cols=200  Identities=29%  Similarity=0.490  Sum_probs=120.5

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +||||+..    |.+||+|||+|+..............++.  .+     
T Consensus       160 ~~~~q-i~~aL~~LH~~~iiHrDlKp----~NILl~~~----~~~kl~DFGla~~~~~~~~~~~~~~~~~~--~~-----  223 (458)
T 3rp9_A          160 TLLYN-LLVGVKYVHSAGILHRDLKP----ANCLVNQD----CSVKVCDFGLARTVDYPENGNSQLPISPR--ED-----  223 (458)
T ss_dssp             HHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----CCEEECCCTTCBCTTSCTTCCCCCC-------------
T ss_pred             HHHHH-HHHHHHHHHhCCcCCCCCCh----hhEEECCC----CCEeecccccchhccCccccccccccCcc--cc-----
Confidence            33444 78899999999999999999    89999876    79999999999865322111000000000  00     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh----------
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT----------  164 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt----------  164 (481)
                       .....++.    .         ........+..++|++|||||++.....|+.++||||+|||+|||++          
T Consensus       224 -~~~~~~~~----~---------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          224 -DMNLVTFP----H---------TKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             -----------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             -cccccccc----c---------cccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence             00000000    0         00000112234569999999998777779999999999999999998          


Q ss_pred             -CCCCCCCch-------------------hhHHHHHHHHHHhCCCCccCcccccCCCCCCcc-CCCCccCCCcCcCCCCc
Q psy3074         165 -GLPTFPGVR-------------------EVYDQLDKIFKILGTPTEETWEGVSLLPGYNVH-RDAPYTGNKLGLTFPRL  223 (481)
Q Consensus       165 -g~~PF~g~~-------------------~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  223 (481)
                       |+++|+|..                   +..+++..|++.+|+|+.+.+..+......... ..+......+...++..
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             888998853                   236889999999999998877665432111111 12222233344444433


Q ss_pred             cCCCcchhHHHHHHhhhhhhhcCCccccc
Q psy3074         224 YDIPEGESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       224 ~~~~~g~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      .        ......+.++...+|.++..
T Consensus       370 s--------~~~~dLl~~mL~~dP~~R~t  390 (458)
T 3rp9_A          370 S--------ADAIHLLKRMLVFNPNKRIT  390 (458)
T ss_dssp             C--------HHHHHHHHHHSCSSTTTSCC
T ss_pred             C--------HHHHHHHHHHhccCccccCC
Confidence            2        22345666777777777653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.90  E-value=8.9e-25  Score=213.23  Aligned_cols=148  Identities=18%  Similarity=0.303  Sum_probs=118.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|
T Consensus        55 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H  134 (288)
T 3kfa_A           55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH  134 (288)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccC
Confidence            45689999999999999999999999999999999999 68888887633 35899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||+++.++.  +|++|||++.........  .                                      ....
T Consensus       135 ~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~--~--------------------------------------~~~~  172 (288)
T 3kfa_A          135 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT--A--------------------------------------HAGA  172 (288)
T ss_dssp             SCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSE--E--------------------------------------ETTE
T ss_pred             CCCCcceEEEcCCCC--EEEccCccceeccCCccc--c--------------------------------------ccCC
Confidence            999999999988776  999999998754311000  0                                      0011


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      .+|+.|++|        +.++|+|++|+++++|.+ |..|+
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~  213 (288)
T 3kfa_A          173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY  213 (288)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            233444444        456799999999999998 76444

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.90  E-value=9.7e-25  Score=212.17  Aligned_cols=147  Identities=24%  Similarity=0.411  Sum_probs=117.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeec----------------CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHH
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHT----------------RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQ  331 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~----------------~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~q  331 (481)
                      +.+|+++++.++||||+++++++..                ...+++|||||+ |+|.+++.... ..+++..+..++.|
T Consensus        51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q  130 (284)
T 2a19_B           51 AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ  130 (284)
T ss_dssp             GHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHH
Confidence            4579999999999999999998864                456899999999 58988887543 56899999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++++||||||+||+++.++.  +|++|||++..+......                              
T Consensus       131 i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~------------------------------  178 (284)
T 2a19_B          131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKR------------------------------  178 (284)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCSCC------------------------------
T ss_pred             HHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheeccccccc------------------------------
Confidence            999999999999999999999999988776  999999987654311000                              


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                  ....+|+.|++|        +..+|+|++|+++++|.++..|++.
T Consensus       179 ------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          179 ------------TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             ------------CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             ------------cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence                        001234444444        4567999999999999999866653

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.90  E-value=1e-24  Score=213.23  Aligned_cols=155  Identities=15%  Similarity=0.172  Sum_probs=120.2

Q ss_pred             HHHHHHHHhhcCCCCeeEEeee-eecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~-~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|++++..+.. +...+..++||||+.++|.+++......+++..+..++.|++.||.|||+++|+|||
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~D  130 (296)
T 4hgt_A           51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD  130 (296)
T ss_dssp             HHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence            4579999999998876655554 467788999999998899998886667799999999999999999999999999999


Q ss_pred             CCCccccc---cccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLI---SEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl---~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||+   +..+.  +|++|||+++.+.......                                ..+  ......
T Consensus       131 lkp~NIl~~~~~~~~~--~kL~Dfg~a~~~~~~~~~~--------------------------------~~~--~~~~~~  174 (296)
T 4hgt_A          131 VKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQ--------------------------------HIP--YRENKN  174 (296)
T ss_dssp             CSGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCC--------------------------------BCC--CCCSCC
T ss_pred             CCHHHeeeeccCCCCe--EEEecCccceeccCcccCc--------------------------------cCC--CCcccc
Confidence            99999999   44444  9999999887544211100                                000  001122


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..||+.|++|        +.++|+||+|+++++|..|..|+..
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             CCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            4567777776        4467999999999999999966643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.90  E-value=9.6e-25  Score=215.51  Aligned_cols=150  Identities=18%  Similarity=0.307  Sum_probs=119.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------CCCChHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------GGLDHHN  324 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------~~l~~~~  324 (481)
                      .+.+|+.+++.++|||||++++++.+.+..++|||||+ |+|.+++....                       ..+++..
T Consensus        72 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (314)
T 2ivs_A           72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD  151 (314)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHH
T ss_pred             HHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHH
Confidence            45689999999999999999999999999999999998 78888887542                       2378899


Q ss_pred             HHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCC
Q psy3074         325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLS  404 (481)
Q Consensus       325 ~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~  404 (481)
                      +..++.|++.||.|||+++++||||||+||+++.++.  +|++|||+++.+.......                      
T Consensus       152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------  207 (314)
T 2ivs_A          152 LISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDSYV----------------------  207 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSCEE----------------------
T ss_pred             HHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCC--EEEccccccccccccccce----------------------
Confidence            9999999999999999999999999999999998776  9999999886443111000                      


Q ss_pred             CeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         405 GVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       405 g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                       ......+|+.|++|        +..+|+|++|+++++|.. |..|+.
T Consensus       208 -----------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          208 -----------------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             -----------------CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -----------------eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                             00011234445555        456799999999999998 875553

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.90  E-value=1.1e-24  Score=217.25  Aligned_cols=149  Identities=21%  Similarity=0.320  Sum_probs=119.0

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-------------cCCCChHHHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-------------SGGLDHHNIRLFMFQLL  333 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-------------~~~l~~~~~~~~~~qi~  333 (481)
                      .+.+|+.+++.+ +||||+++++++.+.+..++|||||+ |+|.+++...             ...+++..+..++.|++
T Consensus        95 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~  174 (333)
T 2i1m_A           95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA  174 (333)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHH
Confidence            467899999999 89999999999999999999999998 5888888654             23578999999999999


Q ss_pred             HHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeec
Q psy3074         334 RGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       334 ~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~  413 (481)
                      .||.|||+++|+||||||+|||++.++.  +|++|||+++.+........                              
T Consensus       175 ~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~------------------------------  222 (333)
T 2i1m_A          175 QGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFGLARDIMNDSNYIV------------------------------  222 (333)
T ss_dssp             HHHHHHHHTTEECSCCSGGGCEEEGGGE--EEBCCCGGGCCGGGCTTSEE------------------------------
T ss_pred             HHHHHHhcCCcccCCcccceEEECCCCe--EEECccccccccccccceee------------------------------
Confidence            9999999999999999999999988776  99999999875431110000                              


Q ss_pred             CCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         414 GSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       414 g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                               .....+|+.|++|        +..+|+||+|+++++|++ |..|+
T Consensus       223 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  267 (333)
T 2i1m_A          223 ---------KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY  267 (333)
T ss_dssp             ---------CSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             ---------cCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCC
Confidence                     0012234445555        456799999999999998 76444

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.90  E-value=3.4e-25  Score=223.80  Aligned_cols=153  Identities=20%  Similarity=0.270  Sum_probs=119.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-ceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ |+|.+++... +.+++..+..++.|++.||.|||++ +|+|
T Consensus        77 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H  155 (360)
T 3eqc_A           77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMH  155 (360)
T ss_dssp             HHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            45689999999999999999999999999999999998 5788877654 5699999999999999999999986 8999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc-cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||++.++.  +|++|||++..+.... .....+..|.||+++.+                             
T Consensus       156 ~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------------------------  204 (360)
T 3eqc_A          156 RDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQG-----------------------------  204 (360)
T ss_dssp             SCCSGGGEEECTTCC--EEECCCCCCHHHHHHC----CCCCTTCCHHHHTT-----------------------------
T ss_pred             CCccHHHEEECCCCC--EEEEECCCCcccccccccCCCCCCCeECHHHHcC-----------------------------
Confidence            999999999998877  9999999886543211 11111222222222210                             


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                             ...+..+|+|++|+++++|++|..|+..
T Consensus       205 -------~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          205 -------THYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             -------CCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             -------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                   0014457999999999999999977643

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.90  E-value=1.1e-24  Score=216.53  Aligned_cols=146  Identities=34%  Similarity=0.603  Sum_probs=116.8

Q ss_pred             HHHHHHHHhhc---CCCCeeEEeeeee-----cCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL---KHNNIVTLHDIVH-----TRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l---~HpnIV~l~~~~~-----~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      +.+|+.+++.+   +||||+++++++.     .....++||||++|+|.+++.... ..+++..+..++.|++.||.|||
T Consensus        58 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH  137 (326)
T 1blx_A           58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH  137 (326)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45688887776   8999999999987     566899999999999999887653 34899999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ++|++||||||+||+++.++.  +|++|||+++.+......                                       
T Consensus       138 ~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~---------------------------------------  176 (326)
T 1blx_A          138 SHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMAL---------------------------------------  176 (326)
T ss_dssp             HTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGG---------------------------------------
T ss_pred             HCCceeccCCHHHeEEcCCCC--EEEecCcccccccCCCCc---------------------------------------
Confidence            999999999999999998776  999999987644311100                                       


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                         ....+|+.|++|        +.++|+|++|+++++|.+|..|+.
T Consensus       177 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  220 (326)
T 1blx_A          177 ---TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR  220 (326)
T ss_dssp             ---CCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ---cccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence               011233334443        556899999999999999986654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.90  E-value=1.8e-25  Score=221.18  Aligned_cols=109  Identities=19%  Similarity=0.168  Sum_probs=81.7

Q ss_pred             HHHhhhhccCcccccHHHHHHh--------hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEET--------RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG   81 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~--------~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~   81 (481)
                      ....+.++.+ .+.||+|||++        +||||||||    +||||+.+    |.+||+|||+|+..........   
T Consensus        99 ~~~~~~i~~~-ia~gl~ylH~~~~~~~~~~~IiHRDlKp----~NILl~~~----~~~Ki~DFGla~~~~~~~~~~~---  166 (303)
T 3hmm_A           99 VEGMIKLALS-TASGLAHLHMEIVGTQGKPAIAHRDLKS----KNILVKKN----GTCCIADLGLAVRHDSATDTID---  166 (303)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHCCBCSTTCBCCEECSCCCG----GGEEECTT----SCEEECCCTTCEEEETTTTEES---
T ss_pred             HHHHHHHHHH-HHHHHHHHHHhhhhccCCCCEeeccCCc----ccEEECCC----CCEEEEeCCCCccccCCCCcee---
Confidence            3445556665 78899999987        999999999    89999877    7999999999985432111000   


Q ss_pred             CCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC-----CCCCccchhhHH
Q psy3074          82 DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST-----EYSTSLDMWGVG  156 (481)
Q Consensus        82 ~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~-----~y~~~~DvWS~G  156 (481)
                                         ......                      +||++|||||++.+..     .|+.++||||||
T Consensus       167 -------------------~~~~~~----------------------~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G  205 (303)
T 3hmm_A          167 -------------------IAPNHR----------------------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMG  205 (303)
T ss_dssp             -------------------CC---------------------------CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred             -------------------eecccc----------------------cccccccCHHHhcccccccCCccChhHhhhhHH
Confidence                               001112                      2499999999998653     377899999999


Q ss_pred             HHHHHHHhCCCCCCC
Q psy3074         157 CILIEMVTGLPTFPG  171 (481)
Q Consensus       157 ~il~elltg~~PF~g  171 (481)
                      |++|||+||.+||..
T Consensus       206 vvl~El~tg~~~~~~  220 (303)
T 3hmm_A          206 LVFWEIARRCSIGGI  220 (303)
T ss_dssp             HHHHHHHHTBCBTTB
T ss_pred             HHHHHHHHCCCCCCc
Confidence            999999999888754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.90  E-value=1.2e-24  Score=222.36  Aligned_cols=142  Identities=33%  Similarity=0.617  Sum_probs=101.9

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...........   .+            ....
T Consensus       118 i~~~L~~LH~~~ivHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~~~~~~~---~~------------~~~~  174 (388)
T 3oz6_A          118 LIKVIKYLHSGGLLHRDMKP----SNILLNAE----CHVKVADFGLSRSFVNIRRVTNN---IP------------LSIN  174 (388)
T ss_dssp             HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEESSSCCCCCCC---GG------------GCCC
T ss_pred             HHHHHHHHHhCCEEeCCCCH----HHeEEcCC----CCEEecCCccccccccccccccc---cc------------cccc
Confidence            68899999999999999999    89999876    79999999999864321110000   00            0000


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+..            .....+..++|++|||||++.+...|+.++||||+||++|||++|++||++. +..+++.
T Consensus       175 ~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~  241 (388)
T 3oz6_A          175 ENTENFDD------------DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS-STMNQLE  241 (388)
T ss_dssp             ---------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHH
T ss_pred             cccccccc------------ccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            00000000            0001122345999999999998777999999999999999999999999995 4558999


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      .|...++.|..+.+..+.
T Consensus       242 ~i~~~~~~p~~~~~~~~~  259 (388)
T 3oz6_A          242 RIIGVIDFPSNEDVESIQ  259 (388)
T ss_dssp             HHHHHHCCCCHHHHHTSC
T ss_pred             HHHHhcCCCCHHHHHhcc
Confidence            999999999987766543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.90  E-value=1.6e-24  Score=211.97  Aligned_cols=146  Identities=22%  Similarity=0.330  Sum_probs=115.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.+++.++||||+++++++..    ...+++||||++ |+|.+++... +.+++..+..++.|++.||.|||+++
T Consensus        71 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~  149 (290)
T 1t4h_A           71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT  149 (290)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC
Confidence            45679999999999999999998875    457999999998 5788887654 56999999999999999999999999


Q ss_pred             --eeeccCCCcccccc-ccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         344 --ILHRDVKPQNLLIS-EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       344 --iiHrDlKp~NiLl~-~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                        ++||||||+|||++ .++.  +|++|||++.........                                       
T Consensus       150 ~~i~H~dikp~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~---------------------------------------  188 (290)
T 1t4h_A          150 PPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRASFAK---------------------------------------  188 (290)
T ss_dssp             SCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTTSBE---------------------------------------
T ss_pred             CCEEECCCCHHHEEEECCCCC--EEEeeCCCcccccccccc---------------------------------------
Confidence              99999999999997 5555  999999998643211000                                       


Q ss_pred             cccCcccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                          ...||+.|++|       +.+.|+||+|+++++|..|..|+..
T Consensus       189 ----~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          189 ----AVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             ----ESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ----cccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence                01122233333       5578999999999999999877643

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.90  E-value=1.6e-24  Score=221.10  Aligned_cols=150  Identities=22%  Similarity=0.372  Sum_probs=120.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+++++.+ +|||||++++++.+.+..++|||||+ |+|.+++....               ..+++..+..++.|
T Consensus       120 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  199 (382)
T 3tt0_A          120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ  199 (382)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHH
Confidence            467899999999 89999999999999999999999998 58988887653               34899999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++|+||||||+|||++.++.  +|++|||+|+.+........                            
T Consensus       200 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~----------------------------  249 (382)
T 3tt0_A          200 VARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKK----------------------------  249 (382)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCTTCC----------------------------
T ss_pred             HHHHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCccccccccccccc----------------------------
Confidence            999999999999999999999999998876  99999998875432110000                            


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                 .....+|+.|++|        +..+|+||+|+++++|+. |..|+.
T Consensus       250 -----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          250 -----------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             -----------CTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -----------ccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence                       0012234445555        446799999999999998 775553

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.90  E-value=1e-24  Score=214.60  Aligned_cols=151  Identities=21%  Similarity=0.347  Sum_probs=118.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee--cCCeEEEEEeccCCCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVHTDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~--~~~~~~iv~E~~~g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++.  +.+..|+|||||++++.+.+... ...+++..+..++.|++.||.|||+++++
T Consensus        52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~  131 (305)
T 2wtk_C           52 NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV  131 (305)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4668999999999999999999984  45689999999998887777653 34689999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  +|++|||++..+.........                                       ..
T Consensus       132 H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~---------------------------------------~~  170 (305)
T 2wtk_C          132 HKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDTC---------------------------------------RT  170 (305)
T ss_dssp             CSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSSCEE---------------------------------------CC
T ss_pred             ecCCCcccEEEcCCCc--EEeeccccccccCcccccccc---------------------------------------cc
Confidence            9999999999998776  999999988654321111000                                       01


Q ss_pred             ccceeccCCC----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..||+.|++|          +..+|+|++|+++++|..|..|+..
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          171 SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2244555554          2357999999999999999877654

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=9.3e-25  Score=222.76  Aligned_cols=154  Identities=22%  Similarity=0.278  Sum_probs=116.3

Q ss_pred             HHHHHHHHhhcC-CC-----CeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhh--
Q psy3074         270 AIREASLLKELK-HN-----NIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCH--  340 (481)
Q Consensus       270 ~~rE~~il~~l~-Hp-----nIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH--  340 (481)
                      +.+|+.+++.++ |+     +|+++++++...+.+|+||||++|+|.+++.... +.+++..++.++.|++.||.|||  
T Consensus        97 ~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~  176 (382)
T 2vx3_A           97 AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP  176 (382)
T ss_dssp             HHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST
T ss_pred             HHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC
Confidence            456888888875 44     4999999999999999999999999999987654 46899999999999999999999  


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +.+|+||||||+|||++.++...+|++|||+|+.+.......+.+..|.|||++.+..                      
T Consensus       177 ~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~----------------------  234 (382)
T 2vx3_A          177 ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMP----------------------  234 (382)
T ss_dssp             TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCC----------------------
T ss_pred             CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCC----------------------
Confidence            5799999999999999654444599999999876543222223333344444332110                      


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                    .+.++|+||+|+++++|++|..||.
T Consensus       235 --------------~~~~~DiwSlG~il~elltg~~pf~  259 (382)
T 2vx3_A          235 --------------YDLAIDMWSLGCILVEMHTGEPLFS  259 (382)
T ss_dssp             --------------CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             --------------CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                          1445688888888888888875554

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=1.5e-24  Score=216.07  Aligned_cols=147  Identities=21%  Similarity=0.328  Sum_probs=118.0

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++++ +||||+++++++.+.+..|+||||++ |+|.+++....               ..+++..+..++.|
T Consensus        71 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  150 (327)
T 1fvr_A           71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD  150 (327)
T ss_dssp             HHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHH
Confidence            466899999999 89999999999999999999999998 68888886542               36899999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++|+||||||+||+++.++.  +|++|||+++.........                             
T Consensus       151 i~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kL~Dfg~~~~~~~~~~~~-----------------------------  199 (327)
T 1fvr_A          151 VARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKKT-----------------------------  199 (327)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC------------------------------
T ss_pred             HHHHHHHHHhCCccCCCCccceEEEcCCCe--EEEcccCcCcccccccccc-----------------------------
Confidence            999999999999999999999999988776  9999999876332111000                             


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                   ...+++.|++|        +..+|+|++|+++++|+. |..|+.
T Consensus       200 -------------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~  243 (327)
T 1fvr_A          200 -------------MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC  243 (327)
T ss_dssp             ----------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             -------------CCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCC
Confidence                         01122333333        456799999999999997 886654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.90  E-value=6.6e-25  Score=226.98  Aligned_cols=120  Identities=33%  Similarity=0.618  Sum_probs=99.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+.....                           
T Consensus       165 i~~aL~~LH~~~ivHrDlkp----~NILl~~~~---~~~kl~DFG~a~~~~~~---------------------------  210 (420)
T 1j1b_A          165 LFRSLAYIHSFGICHRDIKP----QNLLLDPDT---AVLKLCDFGSAKQLVRG---------------------------  210 (420)
T ss_dssp             HHHHHHHHHTTTEECSCCSG----GGEEEETTT---TEEEECCCTTCEECCTT---------------------------
T ss_pred             HHHHHHHHHHCCccccCCCh----hhEEEeCCC---CeEEeccchhhhhcccC---------------------------
Confidence            67899999999999999999    899998542   57899999999853211                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+                      .+|++|+|||++.+...|+.++||||+||++|||++|++||.+.+ ..+++.
T Consensus       211 ~~~~~~----------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~-~~~~l~  267 (420)
T 1j1b_A          211 EPNVSY----------------------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLV  267 (420)
T ss_dssp             CCCCSC----------------------CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH
T ss_pred             CCceee----------------------eeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Confidence            000112                      239999999999887679999999999999999999999999954 458999


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      +|++.+++|..+.+...
T Consensus       268 ~i~~~lg~p~~~~~~~~  284 (420)
T 1j1b_A          268 EIIKVLGTPTREQIREM  284 (420)
T ss_dssp             HHHHHHCSCCHHHHHHH
T ss_pred             HHHHHhCCCCHHHHHhh
Confidence            99999999998877654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.89  E-value=8.5e-25  Score=216.11  Aligned_cols=150  Identities=31%  Similarity=0.472  Sum_probs=114.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee--------------cCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH--------------TRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLR  334 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~--------------~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~  334 (481)
                      .+.+|+.+++.++||||+++++++.              +.+..|+||||++|+|.+.+..  +.+++..+..++.|++.
T Consensus        54 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~  131 (320)
T 2i6l_A           54 HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLR  131 (320)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHH
Confidence            4568999999999999999999874              4468999999999999888754  56899999999999999


Q ss_pred             HHHHhhcCceeeccCCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeec
Q psy3074         335 GLSYCHRRRILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDS  413 (481)
Q Consensus       335 ~l~ylH~~~iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~  413 (481)
                      ||.|||+++|+||||||+||+++. ++.  +|++|||+++.+........                              
T Consensus       132 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~~~------------------------------  179 (320)
T 2i6l_A          132 GLKYIHSANVLHRDLKPANLFINTEDLV--LKIGDFGLARIMDPHYSHKG------------------------------  179 (320)
T ss_dssp             HHHHHHHTTCBCCCCSGGGEEEETTTTE--EEECCCTTCBCC--------------------------------------
T ss_pred             HHHHHHhCCEecCCCCHHHEEEcCCCCe--EEEccCccccccCCCccccc------------------------------
Confidence            999999999999999999999974 334  99999998875431100000                              


Q ss_pred             CCCCccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         414 GSGGWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       414 g~~~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                              ......+|..|++|         +..+|+|++|+++++|.+|..|+..
T Consensus       180 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          180 --------HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             --------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --------ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence                    00001223333333         3457999999999999999976643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.89  E-value=1.5e-24  Score=214.72  Aligned_cols=149  Identities=22%  Similarity=0.242  Sum_probs=115.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++...+..|+||||++| +|.+++... +.+++..+..++.|++.||.|||+++|+||
T Consensus        80 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~  158 (309)
T 2h34_A           80 RMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHR  158 (309)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcC
Confidence            456799999999999999999999999999999999984 788877654 569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..........                                        .....
T Consensus       159 dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------------------~~~~~  196 (309)
T 2h34_A          159 DVKPENILVSADDF--AYLVDFGIASATTDEKLTQ----------------------------------------LGNTV  196 (309)
T ss_dssp             CCCGGGEEECTTSC--EEECSCCC--------------------------------------------------------
T ss_pred             CCChHHEEEcCCCC--EEEecCccCcccccccccc----------------------------------------ccccC
Confidence            99999999998776  9999999886543111000                                        00012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +|+.|++|        +..+|+|++|+++++|..|..|+..
T Consensus       197 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          197 GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence            33333333        4567999999999999999876644

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.89  E-value=5.8e-25  Score=228.23  Aligned_cols=107  Identities=28%  Similarity=0.337  Sum_probs=93.5

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++|+.+ +|||||++++++.+.+..|+|||||.|+|.+++......+.+..+..++.|++.||.|||+++|+|||
T Consensus        64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD  143 (432)
T 3p23_A           64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRD  143 (432)
T ss_dssp             CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCC
Confidence            35799999999 79999999999999999999999999999999887665667777889999999999999999999999


Q ss_pred             CCCccccccc---cchhhHHHHHHHHHhhcc
Q psy3074         349 VKPQNLLISE---IDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       349 lKp~NiLl~~---~~~~~ikl~dfgla~~~~  376 (481)
                      |||+|||++.   ++..++|++|||+|+.+.
T Consensus       144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          144 LKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            9999999953   344457799999987554

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.89  E-value=7.2e-25  Score=220.93  Aligned_cols=159  Identities=10%  Similarity=0.081  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcCCCCeeE---------------Eeeeeec-CCeEEEEEeccCCCHHHHHHHh-cCCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVT---------------LHDIVHT-RSTLTFVFEYVHTDLSQYMERH-SGGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~---------------l~~~~~~-~~~~~iv~E~~~g~l~~~l~~~-~~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.++++++|||||+               +++++.. .+..|+|||||.++|.+++... ...+++..+..++.|
T Consensus        88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~q  167 (352)
T 2jii_A           88 RLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACR  167 (352)
T ss_dssp             THHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHH
Confidence            3567999999999999987               5666665 6789999999977899988764 356999999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++|+||||||+|||++.++...+|++|||+++.+........                            
T Consensus       168 i~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~----------------------------  219 (352)
T 2jii_A          168 LLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA----------------------------  219 (352)
T ss_dssp             HHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCC----------------------------
T ss_pred             HHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccc----------------------------
Confidence            9999999999999999999999999987734599999999875442110000                            


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                            +.........||+.|++|        +..+|+||+|+++++|.+|..|+...
T Consensus       220 ------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          220 ------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             ------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence                  000001123466666666        45679999999999999998666543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.89  E-value=3.6e-25  Score=223.14  Aligned_cols=151  Identities=25%  Similarity=0.441  Sum_probs=114.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCe------EEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~------~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+++.++||||+++++++...+.      .|+||||+.|++...+.   ..+++..+..++.|++.||.|||++
T Consensus        69 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~  145 (353)
T 3coi_A           69 RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSA  145 (353)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            45689999999999999999999987654      49999999998876653   3589999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+||+++.++.  +|++|||+++...........+..|.||+++.+                          
T Consensus       146 ~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~--------------------------  197 (353)
T 3coi_A          146 GVVHRDLKPGNLAVNEDCE--LKILDFGLARHADAEMTGYVVTRWYRAPEVILS--------------------------  197 (353)
T ss_dssp             TCCCSSCCGGGEEECTTCC--EEECSTTCTTC--------CCSBCCSCHHHHSC--------------------------
T ss_pred             CcccCCCCHHHEeECCCCc--EEEeecccccCCCCCccccccCcCcCCHHHHhC--------------------------
Confidence            9999999999999998777  999999988754322111222223333332211                          


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                               ....+..+|+||+|+++++|..|..|+.
T Consensus       198 ---------~~~~~~~~Di~slG~il~el~~g~~pf~  225 (353)
T 3coi_A          198 ---------WMHYNQTVDIWSVGCIMAEMLTGKTLFK  225 (353)
T ss_dssp             ---------CSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred             ---------cCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                     0112456799999999999999986654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.89  E-value=1.1e-24  Score=216.33  Aligned_cols=106  Identities=22%  Similarity=0.387  Sum_probs=88.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeE------EEEEeccC-CCHHHHHHHhcC-----CCChHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTL------TFVFEYVH-TDLSQYMERHSG-----GLDHHNIRLFMFQLLRGL  336 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~------~iv~E~~~-g~l~~~l~~~~~-----~l~~~~~~~~~~qi~~~l  336 (481)
                      .+.+|++++++++||||+++++++......      ++||||+. |+|.+++.....     .+++..+..++.|++.||
T Consensus        71 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al  150 (323)
T 3qup_A           71 EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM  150 (323)
T ss_dssp             HHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHH
Confidence            467899999999999999999999877655      99999998 578888764321     488999999999999999


Q ss_pred             HHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         337 SYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       337 ~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      .|||+++|+||||||+|||++.++.  +|++|||+++.+.
T Consensus       151 ~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~~  188 (323)
T 3qup_A          151 EYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIY  188 (323)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC-----
T ss_pred             HHHHcCCcccCCCCcceEEEcCCCC--EEEeecccccccc
Confidence            9999999999999999999998776  9999999987543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.89  E-value=3e-24  Score=210.63  Aligned_cols=143  Identities=21%  Similarity=0.252  Sum_probs=111.0

Q ss_pred             HHHHHHHhh--cCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhh---
Q psy3074         271 IREASLLKE--LKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH---  340 (481)
Q Consensus       271 ~rE~~il~~--l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH---  340 (481)
                      .+|.+++..  ++||||+++++++..    ...+|+|||||+ |+|.+++..  ..+++..+..++.|++.||.|||   
T Consensus        48 ~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~  125 (301)
T 3q4u_A           48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEI  125 (301)
T ss_dssp             HHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCB
T ss_pred             HHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhh
Confidence            346666666  899999999998654    356899999998 688888743  56999999999999999999999   


Q ss_pred             -----cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCC
Q psy3074         341 -----RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       341 -----~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~  415 (481)
                           +.+|+||||||+|||++.++.  +|++|||+|+.........                                 
T Consensus       126 ~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~---------------------------------  170 (301)
T 3q4u_A          126 FGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTNQL---------------------------------  170 (301)
T ss_dssp             CSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEE---------------------------------
T ss_pred             hhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeecccccccc---------------------------------
Confidence                 999999999999999998777  9999999986433111000                                 


Q ss_pred             CCccccccCcccceeccCCC----C----------CChhhhhhHHHHHHhhCC
Q psy3074         416 GGWWFESKSNINLSFHYLPP----G----------APFTAIREASLLKELKHN  454 (481)
Q Consensus       416 ~~~~~~~~~~~~~t~~y~~p----~----------~p~~~~s~~~~l~~l~~~  454 (481)
                          .......+||+.|++|    +          .++|+||+|+++++|.+|
T Consensus       171 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          171 ----DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             ----ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ----cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhh
Confidence                0000113466666666    1          357999999999999998

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.89  E-value=2.1e-24  Score=211.29  Aligned_cols=155  Identities=15%  Similarity=0.167  Sum_probs=119.6

Q ss_pred             HHHHHHHHhhcCCCCeeEEee-eeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHD-IVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~-~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++|++++..+. ++...+..++||||+.++|.+++......+++..+..++.|++.||.|||+++|+|||
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  130 (296)
T 3uzp_A           51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD  130 (296)
T ss_dssp             HHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence            567999999999887655554 4466778999999998899999886667799999999999999999999999999999


Q ss_pred             CCCcccccc---ccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLIS---EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~---~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||++   ..+.  +|++|||+++.+........                                .++  .....
T Consensus       131 lkp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~~--------------------------------~~~--~~~~~  174 (296)
T 3uzp_A          131 VKPDNFLMGLGKKGNL--VYIIDFGLAKKYRDARTHQH--------------------------------IPY--RENKN  174 (296)
T ss_dssp             CCGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCCB--------------------------------CCC--CCSCC
T ss_pred             CCHHHeEEecCCCCCe--EEEeeCCCcccccccccccc--------------------------------ccc--ccccc
Confidence            999999995   4444  99999999875442111000                                000  01122


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..||+.|++|        +..+|+||+|+++++|.+|..|+..
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            4567777776        4467999999999999999976654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.89  E-value=6.1e-24  Score=209.75  Aligned_cols=132  Identities=39%  Similarity=0.658  Sum_probs=105.8

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       119 ~~~~~~i~~q-i~~al~~lH~~~ivH~Dlkp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~---------------  174 (308)
T 3g33_A          119 AETIKDLMRQ-FLRGLDFLHANCIVHRDLKP----ENILVTSG----GTVKLADFGLARIYSYQM---------------  174 (308)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCCT----TTEEECTT----SCEEECSCSCTTTSTTCC---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCcccCCCCH----HHEEEcCC----CCEEEeeCccccccCCCc---------------
Confidence            3333444444 78899999999999999999    89999876    799999999998432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                  ..                      ....+|+.|+|||++.+.. |+.++||||+||++|||++|++||
T Consensus       175 ------------~~----------------------~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          175 ------------AL----------------------TPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             ------------CS----------------------GGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSC
T ss_pred             ------------cc----------------------CCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCC
Confidence                        00                      0112499999999998876 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCC
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  201 (481)
                      .+.+ ..+++.++.+.++.|+...|+.....+
T Consensus       220 ~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (308)
T 3g33_A          220 CGNS-EADQLGKIFDLIGLPPEDDWPRDVSLP  250 (308)
T ss_dssp             CCSS-HHHHHHHHHHHHCCCCTTTSCSSCSSC
T ss_pred             CCCC-HHHHHHHHHHHhCCCChhhccchhhcc
Confidence            9854 458899999999999999888765544

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.89  E-value=1.1e-24  Score=213.26  Aligned_cols=150  Identities=19%  Similarity=0.288  Sum_probs=111.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||++++++. .....++|||||+ ++|.+.+......+++..+..++.|++.||.|||+++|+||
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~  144 (289)
T 3og7_A           66 AFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR  144 (289)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence            466899999999999999999955 5567899999998 67888886666679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++...........                                       ....
T Consensus       145 Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~---------------------------------------~~~~  183 (289)
T 3og7_A          145 DLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQF---------------------------------------EQLS  183 (289)
T ss_dssp             CCCGGGEEEETTTE--EEECCCC---------------------------------------------------------
T ss_pred             cCccceEEECCCCC--EEEccceeccccccccccccc---------------------------------------cccC
Confidence            99999999998776  999999998754321110000                                       0122


Q ss_pred             ceeccCCC-----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP-----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p-----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|           +.+.|+||+|+++++|.+|..|+..
T Consensus       184 gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             CCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence            34444443           3357999999999999999866643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.89  E-value=7e-25  Score=212.47  Aligned_cols=150  Identities=25%  Similarity=0.408  Sum_probs=118.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++| +|.+.+.. ...+++..+..++.|++.||.|||+++++||
T Consensus        51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  129 (276)
T 2yex_A           51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR  129 (276)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            456799999999999999999999999999999999984 77776643 3468999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+........                                       .....
T Consensus       130 dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~---------------------------------------~~~~~  168 (276)
T 2yex_A          130 DIKPENLLLDERDN--LKISDFGLATVFRYNNRERL---------------------------------------LNKMC  168 (276)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECEETTEECC---------------------------------------BCCCC
T ss_pred             CCChHHEEEccCCC--EEEeeCCCccccCCCcchhc---------------------------------------ccCCc
Confidence            99999999998777  99999998865432110000                                       00122


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|         +..+|+|++|+++++|..|..|+..
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  210 (276)
T 2yex_A          169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (276)
T ss_dssp             SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred             cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            34444444         2247999999999999999866643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.89  E-value=5.7e-25  Score=216.74  Aligned_cols=184  Identities=23%  Similarity=0.294  Sum_probs=138.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++ ++|.+.+... +.+++..+..++.|++.||.|||+++++||
T Consensus        52 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  130 (304)
T 2jam_A           52 SLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHR  130 (304)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            35679999999999999999999999999999999998 5788877654 569999999999999999999999999999


Q ss_pred             cCCCccccc---cccchhhHHHHHHHHHhhcccc-ccCceeccccCCCcccccc----cccccCCCeeEEEeecCCCCcc
Q psy3074         348 DVKPQNLLI---SEIDHHNIRLFMFQLLRGLSYC-HRRRILHRDVKPQNLLISE----IVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       348 DlKp~NiLl---~~~~~~~ikl~dfgla~~~~~~-~~~~i~~~d~~~~~il~~~----~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      ||||+||++   +..+.  +|++|||+++..... ......+..|.+|+++.+.    ..|.|+.|++++++.+|..||.
T Consensus       131 dikp~NIl~~~~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  208 (304)
T 2jam_A          131 DLKPENLLYLTPEENSK--IMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY  208 (304)
T ss_dssp             SCCGGGCEESSSSTTCC--EEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCCHHHEEEecCCCCCC--EEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            999999999   44444  999999998754321 1122345678888888543    5577999999999999999997


Q ss_pred             ccccCcc-----cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         420 FESKSNI-----NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       420 ~~~~~~~-----~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      .......     .+...+..+..+.....+..++..|+..+
T Consensus       209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  249 (304)
T 2jam_A          209 EETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKD  249 (304)
T ss_dssp             TSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSS
T ss_pred             CCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCC
Confidence            5432111     11122222211222234556677777655

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.7e-24  Score=216.79  Aligned_cols=152  Identities=16%  Similarity=0.268  Sum_probs=117.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++....+.+++..+..++.|++.||.|||+++|+||
T Consensus        92 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~  171 (333)
T 1mqb_A           92 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR  171 (333)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            46689999999999999999999999999999999998 58888887766779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+.........                                      .....
T Consensus       172 Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~--------------------------------------~~~~~  211 (333)
T 1mqb_A          172 DLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYT--------------------------------------TSGGK  211 (333)
T ss_dssp             CCCGGGEEECTTCC--EEECCCCC-------------------------------------------------------C
T ss_pred             CCChheEEECCCCc--EEECCCCcchhhccccccccc--------------------------------------cCCCC
Confidence            99999999998776  999999988754321100000                                      00011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      +|+.|++|        +..+|+|++|+++++|+. |..|+..
T Consensus       212 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~  253 (333)
T 1mqb_A          212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE  253 (333)
T ss_dssp             CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence            23344444        445799999999999987 8866643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.89  E-value=1.8e-24  Score=209.67  Aligned_cols=147  Identities=27%  Similarity=0.413  Sum_probs=116.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++ ++|.+++... +.+++..+..++.|++.||.|||+++++||
T Consensus        57 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  135 (276)
T 2h6d_A           57 KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHR  135 (276)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCC
T ss_pred             HHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            45689999999999999999999999999999999998 5888887654 568999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+......                                          ....
T Consensus       136 dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~------------------------------------------~~~~  171 (276)
T 2h6d_A          136 DLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL------------------------------------------RTSC  171 (276)
T ss_dssp             CCCGGGEEECTTSC--EEECCCCGGGCCCC--------------------------------------------------
T ss_pred             CCChhhEEECCCCC--EEEeecccccccCCCcce------------------------------------------eccc
Confidence            99999999998776  999999988754311000                                          0012


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +|+.|++|         +..+|+|++|+++++|.+|..|+-.
T Consensus       172 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          172 GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             -----CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            33334443         2347999999999999999876643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.89  E-value=1.1e-24  Score=217.47  Aligned_cols=150  Identities=21%  Similarity=0.334  Sum_probs=116.7

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.+. ||||+++++++.+.+..++|||||. |+|.+++... ...+++..+..++.|++.||.|||+++|+
T Consensus        74 ~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~giv  153 (327)
T 3lm5_A           74 EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV  153 (327)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4568999999995 6999999999999999999999998 4777766432 35689999999999999999999999999


Q ss_pred             eccCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         346 HRDVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       346 HrDlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||||+|||++... ...+|++|||+++.+.....                                          ..
T Consensus       154 H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~------------------------------------------~~  191 (327)
T 3lm5_A          154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE------------------------------------------LR  191 (327)
T ss_dssp             CSCCCGGGEEESCBTTBCCEEECCGGGCEEC-------------------------------------------------
T ss_pred             cCcCChHHEEEecCCCCCcEEEeeCccccccCCccc------------------------------------------cc
Confidence            999999999998721 23499999998865431100                                          00


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..+||+.|++|        +...|+|++|+++++|..|..|+..
T Consensus       192 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          192 EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             --CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            12344455554        4567999999999999999977643

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.89  E-value=3.6e-24  Score=209.25  Aligned_cols=149  Identities=24%  Similarity=0.383  Sum_probs=119.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++||||+++++++.+.+..++||||+. ++|.+.+... ..+++..+..++.|++.||.|||+++++||
T Consensus        67 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  145 (287)
T 2wei_A           67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR  145 (287)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            46689999999999999999999999999999999998 5787777654 569999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      ||||+||+++..+ ...+|++|||++..+......                                          ...
T Consensus       146 dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~------------------------------------------~~~  183 (287)
T 2wei_A          146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM------------------------------------------KDR  183 (287)
T ss_dssp             CCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC------------------------------------------SCH
T ss_pred             CCChhhEEEecCCCcccEEEeccCcceeecCCCcc------------------------------------------ccc
Confidence            9999999997643 335999999988754321100                                          001


Q ss_pred             cceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .+|+.|++|       +..+|+|++|+++++|..|..|+..
T Consensus       184 ~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          184 IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             HHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             cCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence            233344443       4567999999999999999877654

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.89  E-value=3.1e-24  Score=208.95  Aligned_cols=148  Identities=22%  Similarity=0.340  Sum_probs=117.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.++ ..|+||||++ ++|.+++......+++..+..++.|++.||.|||+++++||
T Consensus        59 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (281)
T 3cc6_A           59 KFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHR  137 (281)
T ss_dssp             HHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            467899999999999999999998754 5689999998 68888887766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+.......                                        .....
T Consensus       138 dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------------------~~~~~  175 (281)
T 3cc6_A          138 DIAVRNILVASPEC--VKLGDFGLSRYIEDEDYYK----------------------------------------ASVTR  175 (281)
T ss_dssp             CCSGGGEEEEETTE--EEECCCCGGGCC-------------------------------------------------CCC
T ss_pred             CCccceEEECCCCc--EEeCccCCCcccccccccc----------------------------------------cccCC
Confidence            99999999988776  9999999987543211000                                        00011


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +|+.|++|        +..+|+|++|+++++|+. |..|+.
T Consensus       176 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~  216 (281)
T 3cc6_A          176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF  216 (281)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence            33344444        445799999999999997 886664

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.89  E-value=5.9e-25  Score=217.69  Aligned_cols=105  Identities=24%  Similarity=0.358  Sum_probs=92.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee----cCCeEEEEEeccC-CCHHHHHHHh---cCCCChHHHHHHHHHHHHHHHHhh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH----TRSTLTFVFEYVH-TDLSQYMERH---SGGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~----~~~~~~iv~E~~~-g~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      .+.+|+.+++.++||||+++++++.    .....|+||||+. |+|.+++...   ...+++..+..++.|++.||.|||
T Consensus        72 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH  151 (317)
T 2buj_A           72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH  151 (317)
T ss_dssp             HHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3567999999999999999999987    3457899999999 5888887653   456999999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      +++|+||||||+||+++.++.  +|++|||++...
T Consensus       152 ~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~  184 (317)
T 2buj_A          152 AKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQA  184 (317)
T ss_dssp             HTTEECCCCCGGGEEECTTSC--EEECCCSSCEES
T ss_pred             hCCcccCCCCHHHEEEcCCCC--EEEEecCcchhc
Confidence            999999999999999988777  999999977643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.1e-24  Score=213.35  Aligned_cols=157  Identities=20%  Similarity=0.303  Sum_probs=123.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeE-EEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTL-TFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~-~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++.++||||+++++++.+.+.. +++|||+. |+|.+++......+++..+..++.|++.||.|||+++++|
T Consensus        68 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H  147 (298)
T 3pls_A           68 AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH  147 (298)
T ss_dssp             HHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            466899999999999999999999876655 99999997 7898888776667899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||+++.++.  +|++|||+++.+.......                                     .......
T Consensus       148 ~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~-------------------------------------~~~~~~~  188 (298)
T 3pls_A          148 RDLAARNCMLDESFT--VKVADFGLARDILDREYYS-------------------------------------VQQHRHA  188 (298)
T ss_dssp             SCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGC-------------------------------------SCCSSCT
T ss_pred             CCCCcceEEEcCCCc--EEeCcCCCcccccCCcccc-------------------------------------cccCcCC
Confidence            999999999998776  9999999886443110000                                     0000112


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIVH  464 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~~  464 (481)
                      .+|+.|++|        +..+|+|++|+++++|.+|..|++.+..+
T Consensus       189 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~  234 (298)
T 3pls_A          189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP  234 (298)
T ss_dssp             TCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG
T ss_pred             CCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH
Confidence            344455555        45679999999999999976677765543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.89  E-value=1.4e-24  Score=216.12  Aligned_cols=147  Identities=20%  Similarity=0.334  Sum_probs=114.9

Q ss_pred             hHHHHHHHHhhcCCCC------eeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNN------IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~Hpn------IV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++|++      |+++++++.+.+..++||||+.+++.+++.... ..+++..+..++.|++.||.|||+
T Consensus        57 ~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  136 (339)
T 1z57_A           57 AARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS  136 (339)
T ss_dssp             HHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence            3557888888887664      999999999999999999999989999887653 258899999999999999999999


Q ss_pred             CceeeccCCCccccccccc-----------------hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCC
Q psy3074         342 RRILHRDVKPQNLLISEID-----------------HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLS  404 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~-----------------~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~  404 (481)
                      ++|+||||||+|||++..+                 ...+|++|||+++......                         
T Consensus       137 ~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-------------------------  191 (339)
T 1z57_A          137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-------------------------  191 (339)
T ss_dssp             TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-------------------------
T ss_pred             CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-------------------------
Confidence            9999999999999998643                 2236666766654322111                         


Q ss_pred             CeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         405 GVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       405 g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                         ....||+.|++|        +.++|+|++|+++++|..|..|+.
T Consensus       192 -------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  235 (339)
T 1z57_A          192 -------------------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP  235 (339)
T ss_dssp             -------------------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -------------------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence                               123345555555        556799999999999999986664

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.89  E-value=3.9e-24  Score=210.56  Aligned_cols=146  Identities=20%  Similarity=0.303  Sum_probs=118.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+||||++| +|.+++..  +.+++..+..++.|++.||.|||+++++||
T Consensus        66 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  143 (303)
T 3a7i_A           66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHR  143 (303)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            466899999999999999999999999999999999984 77777643  569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+......                                         .....
T Consensus       144 dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~~~~  180 (303)
T 3a7i_A          144 DIKAANVLLSEHGE--VKLADFGVAGQLTDTQIK-----------------------------------------RNTFV  180 (303)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECBTTBCC-----------------------------------------BCCCC
T ss_pred             CCChheEEECCCCC--EEEeecccceecCccccc-----------------------------------------cCccC
Confidence            99999999988776  999999988654311100                                         00122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +|+.|++|        +..+|+|++|+++++|..|..|+.
T Consensus       181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~  220 (303)
T 3a7i_A          181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS  220 (303)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCC
Confidence            44444444        456799999999999999986653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.89  E-value=4.5e-24  Score=224.35  Aligned_cols=155  Identities=15%  Similarity=0.224  Sum_probs=121.3

Q ss_pred             HHHHHHHHhhcCC-CCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~H-pnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+++.++| ++|..+..++...+..+||||||.++|.+++......+++..+..++.||+.||.|||+++|+|||
T Consensus        49 ~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrD  128 (483)
T 3sv0_A           49 LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD  128 (483)
T ss_dssp             HHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence            4679999999997 556677777778889999999998899999887667899999999999999999999999999999


Q ss_pred             CCCcccccc---ccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLIS---EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~---~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||++   ..+.  +||+|||+++.+.......  +                              .+  ......
T Consensus       129 IKP~NILl~~~~~~~~--vkL~DFGla~~~~~~~~~~--~------------------------------~~--~~~~~~  172 (483)
T 3sv0_A          129 IKPDNFLMGLGRRANQ--VYIIDFGLAKKYRDTSTHQ--H------------------------------IP--YRENKN  172 (483)
T ss_dssp             CCGGGEEECCGGGTTC--EEECCCTTCEECBCTTTCC--B------------------------------CC--CCCCCC
T ss_pred             cCcceEEEecCCCCCe--EEEEeCCcceeccCCcccc--c------------------------------cc--cccccc
Confidence            999999994   4444  9999999987543211100  0                              00  001123


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      .+||+.|++|        +...|+|++|++|++|+.|..|+..
T Consensus       173 ~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4577777776        4466999999999999999966643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.89  E-value=4.3e-24  Score=211.68  Aligned_cols=129  Identities=50%  Similarity=0.873  Sum_probs=104.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                   
T Consensus       123 ~~~~q-i~~~l~~LH~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~a~~~~~~~~-------------------  174 (311)
T 3niz_A          123 IYLYQ-LLRGVAHCHQHRILHRDLKP----QNLLINSD----GALKLADFGLARAFGIPVR-------------------  174 (311)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEETTSCCC-------------------
T ss_pred             HHHHH-HHHHHHHHHHCCcccCCCch----HhEEECCC----CCEEEccCcCceecCCCcc-------------------
Confidence            33444 78899999999999999999    89999876    7999999999985321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                            . .                      ....+|+.|+|||++.+...|+.++||||+||++|||++|++||.+..+
T Consensus       175 ------~-~----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  225 (311)
T 3niz_A          175 ------S-Y----------------------THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD  225 (311)
T ss_dssp             --------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSST
T ss_pred             ------c-c----------------------cCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCCh
Confidence                  0 0                      0112399999999998877799999999999999999999999998644


Q ss_pred             hHHHHHHHHHHhCCCCccCcccccCCC
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~~~~  201 (481)
                       .+.+..+...++.|.+..|+....++
T Consensus       226 -~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          226 -DDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             -TTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             -HHHHHHHHHHHCCCChHHhhhhhccc
Confidence             47899999999999999998776554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.89  E-value=1.6e-24  Score=214.94  Aligned_cols=105  Identities=20%  Similarity=0.371  Sum_probs=94.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++|||||+ |+|.+++....         ..+++..+..++.|++.||.|
T Consensus        74 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  153 (322)
T 1p4o_A           74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY  153 (322)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999999999999998 68888886532         356889999999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+++|+||||||+||+++.++.  +|++|||+++.+
T Consensus       154 lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~  188 (322)
T 1p4o_A          154 LNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDI  188 (322)
T ss_dssp             HHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGG
T ss_pred             HHHCCCccCCCccceEEEcCCCe--EEECcCcccccc
Confidence            99999999999999999998776  999999988754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.89  E-value=1.1e-24  Score=226.22  Aligned_cols=197  Identities=26%  Similarity=0.460  Sum_probs=120.1

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...........             
T Consensus       131 ~~~i~~q-il~aL~~LH~~givHrDlkp----~NILl~~~----~~~kL~DFGla~~~~~~~~~~~~-------------  188 (432)
T 3n9x_A          131 IKTILYN-LLLGENFIHESGIIHRDLKP----ANCLLNQD----CSVKVCDFGLARTINSEKDTNIV-------------  188 (432)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEEC----------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCCCCCCCCH----HHeEECCC----CCEEEccCCCccccccccccccc-------------
Confidence            3344444 78999999999999999999    99999876    79999999999864321110000             


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh--------
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT--------  164 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt--------  164 (481)
                        .....+.    ..+       ..........+..++|++|+|||++.....|+.++||||+|||+|||++        
T Consensus       189 --~~~~~~~----~~~-------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          189 --NDLEENE----EPG-------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             -----------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             --ccccccc----ccc-------ccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence              0000000    000       0000000011234569999999998777779999999999999999998        


Q ss_pred             ---CCCCCCCch----------------hhHHHHHHHHHHhCCCCccCcccccCCCCCCcc-CCCCccCCCcCcCCCCcc
Q psy3074         165 ---GLPTFPGVR----------------EVYDQLDKIFKILGTPTEETWEGVSLLPGYNVH-RDAPYTGNKLGLTFPRLY  224 (481)
Q Consensus       165 ---g~~PF~g~~----------------~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  224 (481)
                         |.++|+|.+                ...+++..|++.+|+|+.+.+..+......... ..+...+..+...++.+.
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence               667777643                246899999999999998877665432211111 112222223333333332


Q ss_pred             CCCcchhHHHHHHhhhhhhhcCCccccc
Q psy3074         225 DIPEGESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       225 ~~~~g~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                              ......+.++...+|.++..
T Consensus       336 --------~~~~dLl~~mL~~dP~~R~t  355 (432)
T 3n9x_A          336 --------DDGINLLESMLKFNPNKRIT  355 (432)
T ss_dssp             --------HHHHHHHHHHSCSSTTTSCC
T ss_pred             --------HHHHHHHHHHhcCCcccCCC
Confidence                    12345566677777777653

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.89  E-value=3.8e-24  Score=213.21  Aligned_cols=152  Identities=17%  Similarity=0.234  Sum_probs=119.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc------CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS------GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ |+|.+++....      ..+++..+..++.|++.||.|||+
T Consensus        79 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~  158 (327)
T 2yfx_A           79 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE  158 (327)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence            46689999999999999999999999999999999997 68988887653      348889999999999999999999


Q ss_pred             CceeeccCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         342 RRILHRDVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ++++||||||+|||++..+ ...+|++|||+++.+........                                     
T Consensus       159 ~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~-------------------------------------  201 (327)
T 2yfx_A          159 NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK-------------------------------------  201 (327)
T ss_dssp             TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-------------------------------------------
T ss_pred             CCeecCcCCHhHEEEecCCCcceEEECcccccccccccccccc-------------------------------------
Confidence            9999999999999998543 23599999999985532110000                                     


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                        .....+|+.|++|        +..+|+|++|+++++|++ |..|+-
T Consensus       202 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  247 (327)
T 2yfx_A          202 --GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP  247 (327)
T ss_dssp             --CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             --CCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence              0012234444444        456799999999999997 775554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.89  E-value=1.2e-24  Score=216.46  Aligned_cols=157  Identities=20%  Similarity=0.254  Sum_probs=116.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++||||+++++++..++ .|+||||++ |+|.+.+.. ...+++..+..++.|++.||.|||+++++||
T Consensus        61 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~  138 (322)
T 2ycf_A           61 NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHR  138 (322)
T ss_dssp             CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             hHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            3568999999999999999999997765 899999998 578777754 4569999999999999999999999999999


Q ss_pred             cCCCccccccccc-hhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEID-HHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||++..+ ...+|++|||+++.+....  .....+..|.||+++...                           
T Consensus       139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------------------------  191 (322)
T 2ycf_A          139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV---------------------------  191 (322)
T ss_dssp             CCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT---------------------------
T ss_pred             CCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC---------------------------
Confidence            9999999998654 2358999999886543110  000112222333322110                           


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                            .....+..+|+|++|+++++|+.|..|+..
T Consensus       192 ------~~~~~~~~~Di~slG~il~~l~~g~~pf~~  221 (322)
T 2ycf_A          192 ------GTAGYNRAVDCWSLGVILFICLSGYPPFSE  221 (322)
T ss_dssp             ------TTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             ------CCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence                  000114567999999999999999866543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.8e-24  Score=218.88  Aligned_cols=156  Identities=18%  Similarity=0.318  Sum_probs=115.6

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeee-cCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVH-TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~-~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      ..+.+|+.++++++|||||++++++. .++..++|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+
T Consensus       135 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  214 (373)
T 3c1x_A          135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV  214 (373)
T ss_dssp             HHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            35678999999999999999999864 4568899999998 689998877666788999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||++.++.  +|++|||+++.+........                                     .....
T Consensus       215 HrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~-------------------------------------~~~~~  255 (373)
T 3c1x_A          215 HRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSV-------------------------------------HNKTG  255 (373)
T ss_dssp             CSCCCGGGEEECTTCC--EEECCC--------------------------------------------------------
T ss_pred             cCccchheEEECCCCC--EEEeeccccccccccccccc-------------------------------------cccCC
Confidence            9999999999998776  99999999975431100000                                     00001


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ..+|+.|++|        +..+|+||+|+++++|+.+..|+|.+.
T Consensus       256 ~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~  300 (373)
T 3c1x_A          256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  300 (373)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             CCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence            2244555555        456799999999999999545666544

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.89  E-value=1.9e-24  Score=225.60  Aligned_cols=149  Identities=21%  Similarity=0.316  Sum_probs=115.6

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+.+|+++|++++|||||++++++.+ +.+|+|||||+ |+|.+++.... ..+++..+..++.|++.||.|||+++|+
T Consensus       224 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iv  302 (452)
T 1fmk_A          224 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV  302 (452)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            356789999999999999999999876 67899999998 68998887533 4589999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||++.++.  +|++|||+++.+.......                                        ...
T Consensus       303 HrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~----------------------------------------~~~  340 (452)
T 1fmk_A          303 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA----------------------------------------RQG  340 (452)
T ss_dssp             CSCCSGGGEEECGGGC--EEECCCCTTC----------------------------------------------------
T ss_pred             CCCCChhhEEECCCCC--EEECCCccceecCCCceec----------------------------------------ccC
Confidence            9999999999988776  9999999987543110000                                        000


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      ..+++.|++|        +..+|+||+|++++||.. |..|+-
T Consensus       341 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~  383 (452)
T 1fmk_A          341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP  383 (452)
T ss_dssp             --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence            1123344444        456799999999999998 775553

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=2.4e-24  Score=218.78  Aligned_cols=123  Identities=36%  Similarity=0.632  Sum_probs=101.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                     
T Consensus       132 ~~~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~----~~~kl~Dfg~a~~~~~~---------------------  181 (367)
T 1cm8_A          132 FLVYQ-MLKGLRYIHAAGIIHRDLKP----GNLAVNED----CELKILDFGLARQADSE---------------------  181 (367)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECCSS---------------------
T ss_pred             HHHHH-HHHHHHHHHHCCccccCcCH----HHEEEcCC----CCEEEEeeecccccccc---------------------
Confidence            33334 78899999999999999999    89999876    79999999999842110                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                              ..                      ..++|++|+|||++.+...|+.++||||+||++|||++|++||.+. +
T Consensus       182 --------~~----------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~  230 (367)
T 1cm8_A          182 --------MT----------------------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS-D  230 (367)
T ss_dssp             --------CC----------------------SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS-S
T ss_pred             --------cC----------------------cCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCC-C
Confidence                    00                      1123999999999998666999999999999999999999999995 4


Q ss_pred             hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      ..+++..|.+.+++|+.+.++.+.
T Consensus       231 ~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          231 HLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHHhh
Confidence            558999999999999988766553

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.89  E-value=6.7e-24  Score=209.11  Aligned_cols=152  Identities=19%  Similarity=0.226  Sum_probs=122.2

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc--CCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS--GGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++||||++ |+|.+++....  ..+++..+..++.|++.||.|||++++
T Consensus        75 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  154 (307)
T 2nru_A           75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH  154 (307)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            346789999999999999999999999999999999997 68888876432  358999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++.++.  +|++|||+++..........                                       ..
T Consensus       155 ~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~---------------------------------------~~  193 (307)
T 2nru_A          155 IHRDIKSANILLDEAFT--AKISDFGLARASEKFAQTVM---------------------------------------TS  193 (307)
T ss_dssp             ECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSSCEE---------------------------------------CS
T ss_pred             ecCCCCHHHEEEcCCCc--EEEeeccccccccccccccc---------------------------------------cc
Confidence            99999999999998776  99999998864331110000                                       00


Q ss_pred             cccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...||+.|++|       +..+|+|++|+++++|.+|..|+-.
T Consensus       194 ~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          194 RIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             SCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             ccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCccc
Confidence            12345555555       5578999999999999999866544

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.89  E-value=3e-24  Score=210.68  Aligned_cols=156  Identities=19%  Similarity=0.330  Sum_probs=122.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeee-ecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIV-HTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~-~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++||||+++++++ ..++..++||||++ |+|.+++......+++..+..++.|++.||.|||+++++|
T Consensus        72 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H  151 (298)
T 3f66_A           72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH  151 (298)
T ss_dssp             HHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence            466899999999999999999985 55678899999998 5898888766667899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||+++.++.  +|++|||+++.+........                                     ......
T Consensus       152 ~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~-------------------------------------~~~~~~  192 (298)
T 3f66_A          152 RDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSV-------------------------------------HNKTGA  192 (298)
T ss_dssp             SCCSGGGEEECTTCC--EEECSCGGGCCCSCGGGCBC------------------------------------------C
T ss_pred             CCCchheEEECCCCC--EEECcccccccccccchhcc-------------------------------------ccccCC
Confidence            999999999998776  99999999875431110000                                     000112


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                      .+|+.|++|        +...|+|++|+++++|..|..|++.+..
T Consensus       193 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~  237 (298)
T 3f66_A          193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  237 (298)
T ss_dssp             CBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred             CCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence            345555555        4567999999999999996656665543

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.89  E-value=9.2e-25  Score=236.40  Aligned_cols=152  Identities=18%  Similarity=0.220  Sum_probs=125.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+++|++++|||||++++++.+ +.+|+|||||. |+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus       381 ~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH  459 (613)
T 2ozo_A          381 EEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH  459 (613)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEc
Confidence            457789999999999999999999986 56999999998 6788888766667999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc------CceeccccCCCcccc----cccccccCCCeeEEEeec-CC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR------RRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GS  415 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~------~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~  415 (481)
                      |||||+|||++.++.  +|++|||+++.+.....      ....+..|.+||++.    +...|.|++|++++++.+ |.
T Consensus       460 rDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~  537 (613)
T 2ozo_A          460 RNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ  537 (613)
T ss_dssp             SCCSGGGEEEEETTE--EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CcCCHHHEEEcCCCc--EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            999999999998776  99999999987642211      111223577887774    445578999999999997 99


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||....
T Consensus       538 ~Pf~~~~  544 (613)
T 2ozo_A          538 KPYKKMK  544 (613)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCC
Confidence            9998654

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.89  E-value=5.1e-24  Score=231.35  Aligned_cols=150  Identities=17%  Similarity=0.266  Sum_probs=117.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.. +..++|||||. |+|.+++.. .+.+++..+..++.||+.||.|||+++|+||
T Consensus       416 ~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr  493 (635)
T 4fl3_A          416 ELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHR  493 (635)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence            46789999999999999999999975 45899999998 678887754 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+........                                      ......
T Consensus       494 DLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~--------------------------------------~~~~~~  533 (635)
T 4fl3_A          494 DLAARNVLLVTQHY--AKISDFGLSKALRADENYYK--------------------------------------AQTHGK  533 (635)
T ss_dssp             CCSGGGEEEEETTE--EEECCTTHHHHTTC--------------------------------------------------
T ss_pred             CCChHhEEEeCCCC--EEEEEcCCccccccCccccc--------------------------------------cccCCC
Confidence            99999999998776  99999999986542110000                                      000012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      +|+.|++|        +..+|+||+|++++||+. |..|+..
T Consensus       534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            34455555        456799999999999997 8866643

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.89  E-value=2e-23  Score=202.77  Aligned_cols=164  Identities=16%  Similarity=0.128  Sum_probs=114.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+.++..+ +||||+++++++.+++..++|||||+ |+|.+++....   ..+++..+..++.|++.||.|||+++
T Consensus        56 ~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~  135 (289)
T 1x8b_A           56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS  135 (289)
T ss_dssp             HHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356799999999 89999999999999999999999998 58888886542   56899999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+||+++.++.  .+..+.....                         .........++..|+|....... .
T Consensus       136 ivH~Dikp~NIl~~~~~~--~~~~~~~~~~-------------------------~~~~~~~~~~kl~Dfg~~~~~~~-~  187 (289)
T 1x8b_A          136 LVHMDIKPSNIFISRTSI--PNAASEEGDE-------------------------DDWASNKVMFKIGDLGHVTRISS-P  187 (289)
T ss_dssp             EECSCCSGGGEEEC-----------------------------------------------CCCEEECCCTTCEETTC-S
T ss_pred             EeecCCCHHHEEEcCCCC--Cccccccccc-------------------------ccccCCceEEEEcccccccccCC-c
Confidence            999999999999986653  1111111000                         00001112234444444333222 1


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ....||+.|++|         +..+|+||+|+++++|..+.+++..
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~  233 (289)
T 1x8b_A          188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN  233 (289)
T ss_dssp             CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred             cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence            223467777777         1357999999999999999855443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.89  E-value=2.2e-24  Score=216.31  Aligned_cols=148  Identities=22%  Similarity=0.338  Sum_probs=115.7

Q ss_pred             hHHHHHHHHhhcCCCC------eeEEeeeeecCCeEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhc
Q psy3074         269 TAIREASLLKELKHNN------IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHR  341 (481)
Q Consensus       269 ~~~rE~~il~~l~Hpn------IV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~  341 (481)
                      .+.+|+.+++.++|++      ++.+++++...+..++||||+.+++.+.+.... ..+++..+..++.|++.||.|||+
T Consensus        62 ~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~  141 (355)
T 2eu9_A           62 AARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE  141 (355)
T ss_dssp             HHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            3557999999988766      999999999999999999999999988887654 468999999999999999999999


Q ss_pred             CceeeccCCCcccccccc-----------------chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCC
Q psy3074         342 RRILHRDVKPQNLLISEI-----------------DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLS  404 (481)
Q Consensus       342 ~~iiHrDlKp~NiLl~~~-----------------~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~  404 (481)
                      ++|+||||||+|||++..                 ....+|++|||+++........                       
T Consensus       142 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-----------------------  198 (355)
T 2eu9_A          142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTT-----------------------  198 (355)
T ss_dssp             TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCS-----------------------
T ss_pred             CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccC-----------------------
Confidence            999999999999999432                 1233788888876532221111                       


Q ss_pred             CeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         405 GVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       405 g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                           ..||+.|++|        +.++|+||+|+++++|..|..|+..
T Consensus       199 ---------------------~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          199 ---------------------IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             ---------------------SCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ---------------------CcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                                 2344444444        4567999999999999999866643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.89  E-value=1.7e-24  Score=212.38  Aligned_cols=184  Identities=22%  Similarity=0.328  Sum_probs=141.5

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+++++. ||||+++++++.+.+..++||||++ ++|.+++... ..+++..+..++.|++.||.|||+++++|
T Consensus        69 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  147 (298)
T 1phk_A           69 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVH  147 (298)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            4568999999996 9999999999999999999999998 6788887653 56999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccc----------cccccccCCCeeEEEeecC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLI----------SEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~----------~~~~~~~s~g~~~~~~~~g  414 (481)
                      |||||+||+++.++.  +|++|||++..+....  .....+..+.||+++.          +...+.|+.|++++++.+|
T Consensus       148 ~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g  225 (298)
T 1phk_A          148 RDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG  225 (298)
T ss_dssp             SCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCcceEEEcCCCc--EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence            999999999998877  9999999987654221  2233455678888763          3456789999999999999


Q ss_pred             CCCccccccCcc-----cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         415 SGGWWFESKSNI-----NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       415 ~~~~~~~~~~~~-----~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..||...+....     .+...+..|..+.....+..++..|+..+
T Consensus       226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  271 (298)
T 1phk_A          226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQ  271 (298)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSS
T ss_pred             CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCC
Confidence            999975432111     12222222222222335667777777665

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.89  E-value=2.8e-24  Score=214.87  Aligned_cols=150  Identities=21%  Similarity=0.375  Sum_probs=119.1

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~q  331 (481)
                      .+.+|+.+++.+ +||||+++++++.+.+.+|+||||++ |+|.+++....               ..+++..+..++.|
T Consensus        86 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q  165 (334)
T 2pvf_A           86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ  165 (334)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHH
Confidence            466899999999 89999999999999999999999998 58888887543               23888999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      ++.||.|||+++|+||||||+||+++.++.  +|++|||+++.+.......                             
T Consensus       166 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~-----------------------------  214 (334)
T 2pvf_A          166 LARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYK-----------------------------  214 (334)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSSEE-----------------------------
T ss_pred             HHHHHHHHHhCCeeCCCCccceEEEcCCCC--EEEcccccccccccccccc-----------------------------
Confidence            999999999999999999999999998777  9999999887543110000                             


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                ......+|+.|++|        +..+|+|++|+++++|.. |..|+.
T Consensus       215 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          215 ----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             ----------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ----------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence                      00011234445554        456799999999999998 775553

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.89  E-value=2.3e-24  Score=212.95  Aligned_cols=150  Identities=21%  Similarity=0.361  Sum_probs=117.5

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCC-eEEEEEeccC-CCHHHHHHHhcCC---------------CChHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRS-TLTFVFEYVH-TDLSQYMERHSGG---------------LDHHNIRLFMF  330 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~-~~~iv~E~~~-g~l~~~l~~~~~~---------------l~~~~~~~~~~  330 (481)
                      .+.+|+.+++++ +||||+++++++...+ .+++|||||+ |+|.+++......               +++..+..++.
T Consensus        76 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T 2xir_A           76 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF  155 (316)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHH
T ss_pred             HHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHH
Confidence            456899999999 6899999999987754 5999999998 5888888754322               78899999999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEE
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVST  410 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~  410 (481)
                      |++.||.|||+++|+||||||+||+++.++.  +|++|||+++.+.......                            
T Consensus       156 qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~----------------------------  205 (316)
T 2xir_A          156 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYV----------------------------  205 (316)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSE----------------------------
T ss_pred             HHHHHHHHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccce----------------------------
Confidence            9999999999999999999999999988776  9999999987543111000                            


Q ss_pred             eecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         411 VDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       411 ~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                                 ......+|+.|++|        +..+|+|++|+++++|.. |..|+.
T Consensus       206 -----------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          206 -----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             -----------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -----------eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence                       00012344455555        456799999999999997 876553

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=3.4e-24  Score=209.43  Aligned_cols=150  Identities=17%  Similarity=0.270  Sum_probs=119.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++++.++||||+++++++. .+..++||||++ ++|.+++......+++..+..++.|++.||.|||+.+++||
T Consensus        56 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  134 (287)
T 1u59_A           56 EMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR  134 (287)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            4668999999999999999999994 556999999998 57888886655679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+.......                                      .......
T Consensus       135 dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~--------------------------------------~~~~~~~  174 (287)
T 1u59_A          135 DLAARNVLLVNRHY--AKISDFGLSKALGADDSYY--------------------------------------TARSAGK  174 (287)
T ss_dssp             CCSGGGEEEEETTE--EEECCCTTCEECTTCSCEE--------------------------------------CCCCSSC
T ss_pred             CCchheEEEcCCCC--EEECcccceeeeccCccee--------------------------------------ecccccc
Confidence            99999999988776  9999999887543111000                                      0000112


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +|+.|++|        +..+|+|++|+++++|+. |..|+.
T Consensus       175 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  215 (287)
T 1u59_A          175 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  215 (287)
T ss_dssp             CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            34555555        456799999999999997 886654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.89  E-value=5e-24  Score=210.46  Aligned_cols=150  Identities=25%  Similarity=0.328  Sum_probs=112.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+.+++.++||||+++++++...+..++||||++ |+|.+++..   ....+++..+..++.|++.||.|||++++
T Consensus        78 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  157 (310)
T 2wqm_A           78 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRV  157 (310)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            45689999999999999999999999999999999998 478777754   23568999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      +||||||+||+++.++.  +|++|||+++.+......  .                                       .
T Consensus       158 ~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~--~---------------------------------------~  194 (310)
T 2wqm_A          158 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTA--A---------------------------------------H  194 (310)
T ss_dssp             CCCCCCGGGEEECTTSC--EEECCC-------------------------------------------------------
T ss_pred             eCCCCcHHHEEEcCCCC--EEEEeccceeeecCCCcc--c---------------------------------------c
Confidence            99999999999998776  999999998754311100  0                                       0


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...+++.|++|        +..+|+|++|+++++|..|..|+..+
T Consensus       195 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          195 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            01233333333        34579999999999999998776543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.89  E-value=1.9e-24  Score=211.68  Aligned_cols=158  Identities=22%  Similarity=0.254  Sum_probs=114.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec-------------CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT-------------RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLR  334 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~-------------~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~  334 (481)
                      .+.+|+.+++.++||||+++++++.+             .+..|+||||++ |+|.+++......+++..+..++.|++.
T Consensus        48 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~  127 (303)
T 1zy4_A           48 TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE  127 (303)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHH
Confidence            35679999999999999999998864             457899999998 6899888765556888899999999999


Q ss_pred             HHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecC
Q psy3074         335 GLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       335 ~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g  414 (481)
                      ||.|||+++++||||||+||+++.++.  +|++|||++..+.......                           .....
T Consensus       128 ~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~---------------------------~~~~~  178 (303)
T 1zy4_A          128 ALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDIL---------------------------KLDSQ  178 (303)
T ss_dssp             HHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC-------------------------------------
T ss_pred             HHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchh---------------------------ccccc
Confidence            999999999999999999999988777  9999999886543110000                           00000


Q ss_pred             CCCccccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCC
Q psy3074         415 SGGWWFESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       415 ~~~~~~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..+-.........||+.|++|         +..+|+|++|+++++|.++.
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~  228 (303)
T 1zy4_A          179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF  228 (303)
T ss_dssp             ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCC
T ss_pred             cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhcc
Confidence            000000011123456666666         44579999999999999843

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.89  E-value=2.3e-24  Score=219.00  Aligned_cols=127  Identities=35%  Similarity=0.633  Sum_probs=97.7

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                  
T Consensus       132 ~~~~~i~~q-i~~aL~~LH~~givH~Dlkp----~NIll~~~----~~~kL~DFG~a~~~~~------------------  184 (367)
T 2fst_X          132 DHVQFLIYQ-ILRGLKYIHSADIIHRDLKP----SNLAVNED----CELKILDFGLARHTAD------------------  184 (367)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECC---------------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeeeCCCCH----hhEEECCC----CCEEEeeccccccccc------------------
Confidence            333444444 78899999999999999999    89999876    7999999999984210                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                 ....+.                      +|++|+|||++.+...|+.++||||+||++|||++|++||+
T Consensus       185 -----------~~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  231 (367)
T 2fst_X          185 -----------EMTGYV----------------------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP  231 (367)
T ss_dssp             ---------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -----------cCCCcC----------------------cCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence                       001122                      39999999999986679999999999999999999999999


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      +. +..+++..|.+.+++|+.+.++.+.
T Consensus       232 ~~-~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          232 GT-DHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             CS-SHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             CC-CHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            95 4458999999999999988777654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.89  E-value=1.7e-23  Score=204.62  Aligned_cols=134  Identities=50%  Similarity=0.864  Sum_probs=106.1

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                 
T Consensus       101 ~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-----------------  154 (288)
T 1ob3_A          101 TAKSFLLQ-LLNGIAYCHDRRVLHRDLKP----QNLLINRE----GELKIADFGLARAFGIPV-----------------  154 (288)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECCTTHHHHHCC-------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeecCCCCH----HHEEEcCC----CCEEEeECccccccCccc-----------------
Confidence            33344444 78899999999999999999    89999876    799999999997432110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               .....                      ..+|+.|+|||++.+...|+.++||||+||++|||++|++||.+
T Consensus       155 ---------~~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          155 ---------RKYTH----------------------EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             --------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ---------ccccc----------------------ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                     00001                      12399999999998877799999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      .+ ..+++..+.+.++.|....|+.....+.+
T Consensus       204 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          204 VS-EADQLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             SS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CC-HHHHHHHHHHHHCCCChhhchhhhccccc
Confidence            54 44888899999999999999887765543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.89  E-value=1.1e-25  Score=225.45  Aligned_cols=106  Identities=19%  Similarity=0.216  Sum_probs=83.6

Q ss_pred             hhHHHHHHHHhhcC---------CCCeeEEeee-----------------eec-------------CCeEEEEEeccC-C
Q psy3074         268 FTAIREASLLKELK---------HNNIVTLHDI-----------------VHT-------------RSTLTFVFEYVH-T  307 (481)
Q Consensus       268 ~~~~rE~~il~~l~---------HpnIV~l~~~-----------------~~~-------------~~~~~iv~E~~~-g  307 (481)
                      ..+.+|+.+|+.++         |||||++.++                 |.+             .+.+|+|||||+ |
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            34668888888886         6666666554                 333             678999999998 4


Q ss_pred             CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhh-cCceeeccCCCccccccccch------------------hhHHHHH
Q psy3074         308 DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISEIDH------------------HNIRLFM  368 (481)
Q Consensus       308 ~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH-~~~iiHrDlKp~NiLl~~~~~------------------~~ikl~d  368 (481)
                      ++.+.+..  +.+++..++.++.|++.||.||| +++|+||||||+|||++.++.                  ..+|++|
T Consensus       148 ~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          148 IDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             EETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             ccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            46665533  56899999999999999999999 999999999999999987651                  1478888


Q ss_pred             HHHHhhc
Q psy3074         369 FQLLRGL  375 (481)
Q Consensus       369 fgla~~~  375 (481)
                      ||+|+.+
T Consensus       226 FG~a~~~  232 (336)
T 2vuw_A          226 YTLSRLE  232 (336)
T ss_dssp             CTTCBEE
T ss_pred             ccccEec
Confidence            8877644

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.89  E-value=3.3e-25  Score=213.83  Aligned_cols=150  Identities=13%  Similarity=0.144  Sum_probs=123.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC--CeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCc-
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR--STLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRR-  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~--~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~-  343 (481)
                      .+.+|+.++++++||||+++++++.+.  +..++||||++ |+|.+++..... .+++..+..++.|++.||.|||+++ 
T Consensus        53 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~  132 (271)
T 3kmu_A           53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP  132 (271)
T ss_dssp             HHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS
T ss_pred             HHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            466899999999999999999999887  78999999998 689888876443 4899999999999999999999999 


Q ss_pred             -eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccc-------cccccCCCeeEEEeecCC
Q psy3074         344 -ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE-------IVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       344 -iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~-------~~~~~s~g~~~~~~~~g~  415 (481)
                       ++||||||+||+++.++..+++++|||.+  ..  ......+..|.|||++.+.       ..|.|+.|++++++.+|.
T Consensus       133 ~i~H~dikp~Nil~~~~~~~~l~~~~~~~~--~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  208 (271)
T 3kmu_A          133 LIPRHALNSRSVMIDEDMTARISMADVKFS--FQ--SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE  208 (271)
T ss_dssp             CCTTCCCSGGGEEECTTSCEEEEGGGSCCT--TS--CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCS
T ss_pred             ceecCCCccceEEEcCCcceeEEeccceee--ec--ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence             99999999999999888744554454433  22  2234556778888888642       367899999999999999


Q ss_pred             CCccccc
Q psy3074         416 GGWWFES  422 (481)
Q Consensus       416 ~~~~~~~  422 (481)
                      .||...+
T Consensus       209 ~p~~~~~  215 (271)
T 3kmu_A          209 VPFADLS  215 (271)
T ss_dssp             CTTTTSC
T ss_pred             CCccccC
Confidence            9997543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.88  E-value=3.6e-24  Score=207.03  Aligned_cols=148  Identities=23%  Similarity=0.348  Sum_probs=111.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc---
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR---  343 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~---  343 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++.  .+.+++..+..++.|++.||.|||+++   
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~  128 (271)
T 3dtc_A           51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVP  128 (271)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSC
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Confidence            346789999999999999999999999999999999998 56666653  356999999999999999999999999   


Q ss_pred             eeeccCCCccccccccc------hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         344 ILHRDVKPQNLLISEID------HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~------~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      ++||||||+||+++...      ...+|++|||++..+.....                                     
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-------------------------------------  171 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK-------------------------------------  171 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----------------------------------------------
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCcccccccccc-------------------------------------
Confidence            89999999999997521      23488899988764331100                                     


Q ss_pred             ccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         418 WWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                            ....||+.|++|        +.+.|+||+|+++++|..|..|+..
T Consensus       172 ------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  216 (271)
T 3dtc_A          172 ------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG  216 (271)
T ss_dssp             ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred             ------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                  012244555554        4467999999999999999866643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.88  E-value=8.4e-24  Score=207.36  Aligned_cols=90  Identities=17%  Similarity=0.180  Sum_probs=80.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+..|+|||||+ ++|.+++..   ...+..+..++.|++.||.|||++||+||
T Consensus        77 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~  153 (286)
T 3uqc_A           77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALS  153 (286)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccC
Confidence            45679999999999999999999999999999999998 578877743   34666788999999999999999999999


Q ss_pred             cCCCccccccccch
Q psy3074         348 DVKPQNLLISEIDH  361 (481)
Q Consensus       348 DlKp~NiLl~~~~~  361 (481)
                      ||||+|||++.++.
T Consensus       154 Dikp~NIll~~~g~  167 (286)
T 3uqc_A          154 IDHPSRVRVSIDGD  167 (286)
T ss_dssp             CCSGGGEEEETTSC
T ss_pred             CCCcccEEEcCCCC
Confidence            99999999987665

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.88  E-value=3.7e-24  Score=228.15  Aligned_cols=106  Identities=25%  Similarity=0.406  Sum_probs=94.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+.+|+++|++++|||||++++++.+ +.+|||||||. |+|.+++.... ..+++..+..++.|++.||.|||+++|+
T Consensus       307 ~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  385 (535)
T 2h8h_A          307 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV  385 (535)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            346789999999999999999999876 67899999998 68999887543 4589999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||||+|||++.++.  +|++|||+++.+.
T Consensus       386 HrDlkp~NIll~~~~~--~kl~DFG~a~~~~  414 (535)
T 2h8h_A          386 HRDLRAANILVGENLV--CKVADFGLARLIE  414 (535)
T ss_dssp             CSCCSGGGEEECGGGC--EEECCTTSTTTCC
T ss_pred             CCCCCHhhEEEcCCCc--EEEcccccceecC
Confidence            9999999999988776  9999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.88  E-value=7.7e-24  Score=210.46  Aligned_cols=158  Identities=20%  Similarity=0.217  Sum_probs=116.4

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeec------CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHT------RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~------~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .+.+|+.+++++ +||||+++++++..      .+.+|+||||++ |+|.+++.... ..+++..+..++.|++.||.||
T Consensus        66 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  145 (326)
T 2x7f_A           66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL  145 (326)
T ss_dssp             HHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            456799999999 79999999999986      468999999998 58888887643 4689999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                      |+++++||||||+||+++.++.  +|++|||++..+....   .....+..|.||+++.....                 
T Consensus       146 H~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-----------------  206 (326)
T 2x7f_A          146 HQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN-----------------  206 (326)
T ss_dssp             HHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-------------CCGGGCCHHHHC---------------------
T ss_pred             HHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCccccccccCCccccChhhhccccc-----------------
Confidence            9999999999999999998777  9999999887543211   01112222333333221000                 


Q ss_pred             CccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         417 GWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                    .-...+..+|+|++|+++++|..|..|+.
T Consensus       207 --------------~~~~~~~~~Di~slG~il~~l~~g~~p~~  235 (326)
T 2x7f_A          207 --------------PDATYDFKSDLWSLGITAIEMAEGAPPLC  235 (326)
T ss_dssp             ------------------CCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred             --------------cCcCCCccchHHHHHHHHHHHHhCCCCCC
Confidence                          00012456899999999999999986654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.88  E-value=2.6e-23  Score=203.61  Aligned_cols=138  Identities=43%  Similarity=0.744  Sum_probs=109.4

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........            
T Consensus        99 ~~~~~~~~~~q-l~~~l~~lH~~~ivH~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~------------  157 (292)
T 3o0g_A           99 DPEIVKSFLFQ-LLKGLGFCHSRNVLHRDLKP----QNLLINRN----GELKLANFGLARAFGIPVRC------------  157 (292)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCSCCSC------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEEcCC----CCEEEeecccceecCCcccc------------
Confidence            33344444555 78899999999999999999    89999876    79999999999853211100            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                    .                      ....+|+.|+|||++.+...|+.++||||+||++|||++|..|
T Consensus       158 --------------~----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p  201 (292)
T 3o0g_A          158 --------------Y----------------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             --------------C----------------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             --------------c----------------------cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence                          0                      0112399999999999877799999999999999999988777


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      |....+..+++..+.+.++.|..+.|+.....+.+
T Consensus       202 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            55556777899999999999999999988766544

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.88  E-value=5.3e-24  Score=212.15  Aligned_cols=151  Identities=23%  Similarity=0.376  Sum_probs=118.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC--eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~--~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++...+  .+++||||++ ++|.+++......+++..+..++.|++.||.|||+++++
T Consensus        88 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  167 (326)
T 2w1i_A           88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI  167 (326)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            4568999999999999999999987654  7899999998 589998887666799999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  +|++|||+++.+.........                                      ...
T Consensus       168 H~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~--------------------------------------~~~  207 (326)
T 2w1i_A          168 HRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKV--------------------------------------KEP  207 (326)
T ss_dssp             CSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEEC--------------------------------------SSC
T ss_pred             ccCCCcceEEEcCCCc--EEEecCcchhhcccccccccc--------------------------------------ccC
Confidence            9999999999988776  999999988754321100000                                      000


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ..++..|++|        +..+|+||+|+++++|..|..|+.
T Consensus       208 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             CSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred             CCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence            1233344444        346799999999999999876554

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.88  E-value=7.3e-24  Score=210.51  Aligned_cols=150  Identities=21%  Similarity=0.319  Sum_probs=118.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++.+  ...+++|||||+ |+|.+++..  ..+++..+..++.|++.||.|||+++|+
T Consensus        79 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~iv  156 (318)
T 3lxp_A           79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYI  156 (318)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            45689999999999999999999987  468999999998 578887754  3599999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+||+++.++.  +|++|||++..+........                                      ....
T Consensus       157 H~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~--------------------------------------~~~~  196 (318)
T 3lxp_A          157 HRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYR--------------------------------------VRED  196 (318)
T ss_dssp             CSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEE--------------------------------------C---
T ss_pred             CCCCchheEEEcCCCC--EEECCccccccccccccccc--------------------------------------cccC
Confidence            9999999999998776  99999999875432110000                                      0001


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ..+|..|++|        +...|+|++|+++++|+.|..|+..
T Consensus       197 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             CCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence            2234445554        3457999999999999999866654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.88  E-value=5.1e-24  Score=208.61  Aligned_cols=149  Identities=17%  Similarity=0.267  Sum_probs=116.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++ ..+..++||||++ ++|.+++.. .+.+++..+..++.|++.||.|||+++++||
T Consensus        64 ~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~  141 (291)
T 1xbb_A           64 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHR  141 (291)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcC
Confidence            466899999999999999999999 5667899999998 678887765 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||++..+........                                      ......
T Consensus       142 dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~--------------------------------------~~~~~~  181 (291)
T 1xbb_A          142 DLAARNVLLVTQHY--AKISDFGLSKALRADENYYK--------------------------------------AQTHGK  181 (291)
T ss_dssp             CCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEE--------------------------------------C----C
T ss_pred             CCCcceEEEeCCCc--EEEccCCcceeeccCCCccc--------------------------------------ccccCC
Confidence            99999999998776  99999998865431110000                                      000012


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +++.|++|        +..+|+||+|+++++|.. |..|+.
T Consensus       182 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  222 (291)
T 1xbb_A          182 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  222 (291)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCC
Confidence            33445555        345799999999999998 886654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.88  E-value=2.1e-24  Score=209.63  Aligned_cols=149  Identities=32%  Similarity=0.373  Sum_probs=115.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeee--cCCeEEEEEeccC-CCHHHHHHHhc---CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVH--TRSTLTFVFEYVH-TDLSQYMERHS---GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~--~~~~~~iv~E~~~-g~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.++++++||||+++++++.  .....|+||||++ |+|.+++....   ..+++..+..++.|++.||.|||++
T Consensus        51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  130 (279)
T 2w5a_A           51 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR  130 (279)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc
Confidence            4567999999999999999999884  4678999999998 58888886532   3489999999999999999999999


Q ss_pred             c-----eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         343 R-----ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       343 ~-----iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                      +     ++||||||+||+++.++.  +|++|||+++.+.......                                   
T Consensus       131 ~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~-----------------------------------  173 (279)
T 2w5a_A          131 SDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFA-----------------------------------  173 (279)
T ss_dssp             C------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CHHH-----------------------------------
T ss_pred             cCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccccc-----------------------------------
Confidence            9     999999999999998777  9999999998654211000                                   


Q ss_pred             ccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         418 WWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                            ....+|+.|++|        +..+|+|++|+++++|..|..|+..
T Consensus       174 ------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          174 ------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             ------HHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------cccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence                  001233333333        3457999999999999999866543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.88  E-value=7.3e-24  Score=213.23  Aligned_cols=137  Identities=35%  Similarity=0.596  Sum_probs=106.9

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........              
T Consensus       124 ~~~~~i~~q-i~~~l~~LH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~a~~~~~~~~~--------------  180 (351)
T 3mi9_A          124 SEIKRVMQM-LLNGLYYIHRNKILHRDMKA----ANVLITRD----GVLKLADFGLARAFSLAKNS--------------  180 (351)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCCCSSS--------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeeCCCCCH----HHEEEcCC----CCEEEccchhcccccccccc--------------
Confidence            333444444 78899999999999999999    89999876    79999999999854321100              


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                              ....                      .....+|+.|+|||++.+...|+.++||||+||++|||++|.+||.
T Consensus       181 --------~~~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  230 (351)
T 3mi9_A          181 --------QPNR----------------------YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  230 (351)
T ss_dssp             --------SCCC----------------------CCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             --------cccc----------------------cCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence                    0000                      0012249999999999887779999999999999999999999999


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcccccCCC
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVSLLP  201 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~  201 (481)
                      +. +..+++..+.+.++.++++.|+......
T Consensus       231 ~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~  260 (351)
T 3mi9_A          231 GN-TEQHQLALISQLCGSITPEVWPNVDNYE  260 (351)
T ss_dssp             CS-SHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred             CC-ChHHHHHHHHHHhCCCChhhccccccch
Confidence            85 4458889999999999998888776443

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.88  E-value=8.1e-24  Score=206.98  Aligned_cols=149  Identities=23%  Similarity=0.340  Sum_probs=118.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++....+  .+++..+..++.|++.||.|||+++++
T Consensus        65 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  144 (295)
T 2clq_A           65 PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV  144 (295)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            45689999999999999999999999999999999997 688888876533  356888999999999999999999999


Q ss_pred             eccCCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         346 HRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       346 HrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||||+||+++. ++.  +|++|||++..+......                                         ..
T Consensus       145 H~dl~p~Nil~~~~~~~--~kl~Dfg~~~~~~~~~~~-----------------------------------------~~  181 (295)
T 2clq_A          145 HRDIKGDNVLINTYSGV--LKISDFGTSKRLAGINPC-----------------------------------------TE  181 (295)
T ss_dssp             CCCCSGGGEEEETTTCC--EEECCTTTCEESCC----------------------------------------------C
T ss_pred             ccCCChhhEEEECCCCC--EEEeecccccccCCCCCc-----------------------------------------cc
Confidence            9999999999986 555  999999987654311000                                         00


Q ss_pred             cccceeccCCC----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         425 NINLSFHYLPP----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       425 ~~~~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...||+.|++|          +...|+|++|+++++|..|..|+..
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence            12234444444          3457999999999999999877643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.88  E-value=1.3e-23  Score=215.92  Aligned_cols=138  Identities=32%  Similarity=0.632  Sum_probs=105.7

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||+....+..+.+||+|||+|+......                    
T Consensus       132 ~i~~q-i~~al~~LH~~~ivH~Dlkp----~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--------------------  186 (405)
T 3rgf_A          132 SLLYQ-ILDGIHYLHANWVLHRDLKP----ANILVMGEGPERGRVKIADMGFARLFNSPL--------------------  186 (405)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECCSSTTTTCEEECCTTCCC--------------------------
T ss_pred             HHHHH-HHHHHHHHHhCCEeCCCcCH----HHeEEecCCCCCCcEEEEECCCceecCCCC--------------------
Confidence            34444 78899999999999999999    899996554556899999999998532110                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                         .........                      .+|++|+|||++.+...|+.++||||+||++|||++|++||.+..+
T Consensus       187 ---~~~~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  241 (405)
T 3rgf_A          187 ---KPLADLDPV----------------------VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE  241 (405)
T ss_dssp             -----------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             ---cccccCCCc----------------------eecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence               000001112                      2499999999999877799999999999999999999999987543


Q ss_pred             --------hHHHHHHHHHHhCCCCccCcccccCCCC
Q psy3074         175 --------VYDQLDKIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       175 --------~~~~l~~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                              ..+++..|+..++.|+...|+.+..++.
T Consensus       242 ~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  277 (405)
T 3rgf_A          242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPE  277 (405)
T ss_dssp             -----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTT
T ss_pred             cccccccchHHHHHHHHHhhCCCChhhcchhhcCcc
Confidence                    2478999999999999999988876543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.88  E-value=6.6e-24  Score=217.56  Aligned_cols=120  Identities=33%  Similarity=0.621  Sum_probs=99.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..   .|.+||+|||+|+......                          
T Consensus       150 i~~aL~~LH~~~ivHrDlkp----~Nill~~~---~~~~kL~DFG~a~~~~~~~--------------------------  196 (394)
T 4e7w_A          150 LLRSLAYIHSIGICHRDIKP----QNLLLDPP---SGVLKLIDFGSAKILIAGE--------------------------  196 (394)
T ss_dssp             HHHHHHHHHHTTEECSCCSG----GGEEEETT---TTEEEECCCTTCEECCTTC--------------------------
T ss_pred             HHHHHHHHHHCCccCCCCCH----HHEEEcCC---CCcEEEeeCCCcccccCCC--------------------------
Confidence            68899999999999999999    89999832   2799999999998532110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                       ....+                      .+|++|+|||++.+...|+.++||||+||++|||++|++||.+. +..+++.
T Consensus       197 -~~~~~----------------------~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~l~  252 (394)
T 4e7w_A          197 -PNVSY----------------------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE-SGIDQLV  252 (394)
T ss_dssp             -CCCSS----------------------CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHH
T ss_pred             -CCccc----------------------ccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence             00111                      23999999999998777999999999999999999999999995 4458999


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      .|.+.+++|+.+.+...
T Consensus       253 ~i~~~~g~p~~~~~~~~  269 (394)
T 4e7w_A          253 EIIKVLGTPSREQIKTM  269 (394)
T ss_dssp             HHHHHHCCCCHHHHHHH
T ss_pred             HHHHHhCCCCHHHHHhh
Confidence            99999999998766544

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.88  E-value=1.5e-23  Score=208.34  Aligned_cols=126  Identities=51%  Similarity=0.934  Sum_probs=104.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........                        
T Consensus       117 i~~aL~~lH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~~~------------------------  164 (317)
T 2pmi_A          117 LLQGLAFCHENKILHRDLKP----QNLLINKR----GQLKLGDFGLARAFGIPVNT------------------------  164 (317)
T ss_dssp             HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCSSCEETTSCCCC------------------------
T ss_pred             HHHHHHHHHHCCeeeCCCCh----HHeEEcCC----CCEEECcCccceecCCCccc------------------------
Confidence            68899999999999999999    89999876    79999999999853211100                        


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                        .                      ....+|+.|+|||++.+...|+.++||||+||++|||++|++||.+.++ .+++.
T Consensus       165 --~----------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~  219 (317)
T 2pmi_A          165 --F----------------------SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLK  219 (317)
T ss_dssp             --C----------------------CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHH
T ss_pred             --C----------------------CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHH
Confidence              0                      0112399999999998876799999999999999999999999998544 48899


Q ss_pred             HHHHHhCCCCccCcccccCCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      .+.+.++.|+...|+....++.+
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~~~  242 (317)
T 2pmi_A          220 LIFDIMGTPNESLWPSVTKLPKY  242 (317)
T ss_dssp             HHHHHHCSCCTTTCGGGGGCTTC
T ss_pred             HHHHHhCCCChhHhhhhhhhhhc
Confidence            99999999999999988766544

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.88  E-value=1.2e-23  Score=209.59  Aligned_cols=123  Identities=58%  Similarity=0.980  Sum_probs=100.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                          
T Consensus       109 i~~aL~~LH~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~a~~~~~~~--------------------------  154 (324)
T 3mtl_A          109 LLRGLAYCHRQKVLHRDLKP----QNLLINER----GELKLADFGLARAKSIPT--------------------------  154 (324)
T ss_dssp             HHHHHHHHHHTTEEESSCCG----GGEEECTT----CCEEECSSSEEECC------------------------------
T ss_pred             HHHHHHHHHHCCccCCCcCH----HHEEECCC----CCEEEccCcccccccCCc--------------------------
Confidence            78899999999999999999    89999876    799999999997432110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....                      ..+|+.|+|||++.+...|+.++||||+||++|||++|++||.+. +..+++.
T Consensus       155 ~~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~  211 (324)
T 3mtl_A          155 KTYDN----------------------EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-TVEEQLH  211 (324)
T ss_dssp             ------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHH
T ss_pred             ccccc----------------------ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHH
Confidence            00001                      123999999999998777999999999999999999999999995 4558999


Q ss_pred             HHHHHhCCCCccCcccccCC
Q psy3074         181 KIFKILGTPTEETWEGVSLL  200 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~  200 (481)
                      .+.+.++.|.++.|+.....
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          212 FIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             HHHHHHCCCCTTTSTTGGGC
T ss_pred             HHHHHhCCCChHhchhhhcc
Confidence            99999999999999876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.88  E-value=2.5e-24  Score=214.36  Aligned_cols=149  Identities=14%  Similarity=0.183  Sum_probs=113.4

Q ss_pred             HHHHH-HHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHH----hcCCCChHHHHHHHHHHHHHHHHhhcC-ce
Q psy3074         271 IREAS-LLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER----HSGGLDHHNIRLFMFQLLRGLSYCHRR-RI  344 (481)
Q Consensus       271 ~rE~~-il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~----~~~~l~~~~~~~~~~qi~~~l~ylH~~-~i  344 (481)
                      .+|+. +++.++||||+++++++.+.+..++||||++|++.+++..    ....+++..+..++.|++.||.|||++ ++
T Consensus        68 ~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~i  147 (327)
T 3aln_A           68 LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI  147 (327)
T ss_dssp             HHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCE
Confidence            34555 7888999999999999999999999999999988877753    245689999999999999999999998 99


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCccc--------ccccccccCCCeeEEEeecC
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLL--------ISEIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il--------~~~~~~~~s~g~~~~~~~~g  414 (481)
                      +||||||+||+++.++.  +|++|||+++.+....  .....+..|.||+++        .+...|.|+.|++++++.+|
T Consensus       148 vH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g  225 (327)
T 3aln_A          148 IHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG  225 (327)
T ss_dssp             CCSCCCGGGEEEETTTE--EEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHS
T ss_pred             eECCCCHHHEEEcCCCC--EEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHC
Confidence            99999999999988777  9999999987654221  222456678888887        34566789999999999999


Q ss_pred             CCCcccc
Q psy3074         415 SGGWWFE  421 (481)
Q Consensus       415 ~~~~~~~  421 (481)
                      ..||...
T Consensus       226 ~~pf~~~  232 (327)
T 3aln_A          226 RFPYPKW  232 (327)
T ss_dssp             CCCSSCC
T ss_pred             CCCCCCc
Confidence            9999753

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.88  E-value=3.7e-24  Score=216.66  Aligned_cols=155  Identities=26%  Similarity=0.372  Sum_probs=114.0

Q ss_pred             HHHHHHHHhhcC-----------CCCeeEEeeeeecCC----eEEEEEeccCCCHHHHHHHhc-CCCChHHHHHHHHHHH
Q psy3074         270 AIREASLLKELK-----------HNNIVTLHDIVHTRS----TLTFVFEYVHTDLSQYMERHS-GGLDHHNIRLFMFQLL  333 (481)
Q Consensus       270 ~~rE~~il~~l~-----------HpnIV~l~~~~~~~~----~~~iv~E~~~g~l~~~l~~~~-~~l~~~~~~~~~~qi~  333 (481)
                      +.+|+.++++++           ||||+++++++...+    .+++|||++.++|.+++.... ..+++..+..++.|++
T Consensus        62 ~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~  141 (373)
T 1q8y_A           62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL  141 (373)
T ss_dssp             HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHH
Confidence            456888887776           899999999998654    799999999889999887643 4599999999999999


Q ss_pred             HHHHHhhcC-ceeeccCCCccccccccc----hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeE
Q psy3074         334 RGLSYCHRR-RILHRDVKPQNLLISEID----HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVV  408 (481)
Q Consensus       334 ~~l~ylH~~-~iiHrDlKp~NiLl~~~~----~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~  408 (481)
                      .||.|||++ +|+||||||+|||++..+    ...+|++|||+++.+.........+..|.|||++.+.           
T Consensus       142 ~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~-----------  210 (373)
T 1q8y_A          142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGA-----------  210 (373)
T ss_dssp             HHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTC-----------
T ss_pred             HHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCC-----------
Confidence            999999998 999999999999996433    2248999999886543222222222223333322110           


Q ss_pred             EEeecCCCCccccccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         409 STVDSGSGGWWFESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       409 ~~~~~g~~~~~~~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                                               ..+..+|+||+|+++++|++|..|+-.
T Consensus       211 -------------------------~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          211 -------------------------PWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             -------------------------CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             -------------------------CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                                     014557899999999999998866643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.88  E-value=9.7e-24  Score=209.93  Aligned_cols=146  Identities=25%  Similarity=0.407  Sum_probs=118.1

Q ss_pred             HHHHHHHHhhcC--CCCeeEEeeeeecCCeEEEEEeccC--CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         270 AIREASLLKELK--HNNIVTLHDIVHTRSTLTFVFEYVH--TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       270 ~~rE~~il~~l~--HpnIV~l~~~~~~~~~~~iv~E~~~--g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+|+.+++.++  ||||+++++++...+..++|||++.  ++|.+++.. .+.+++..+..++.|++.||.|||+++|+
T Consensus        93 ~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iv  171 (320)
T 3a99_A           93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVL  171 (320)
T ss_dssp             EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            446999999997  5999999999999999999999997  678888765 35799999999999999999999999999


Q ss_pred             eccCCCcccccc-ccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         346 HRDVKPQNLLIS-EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       346 HrDlKp~NiLl~-~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||||+|||++ +.+.  +|++|||+++.+.....                                           .
T Consensus       172 H~Dlkp~NIll~~~~~~--~kL~Dfg~~~~~~~~~~-------------------------------------------~  206 (320)
T 3a99_A          172 HRDIKDENILIDLNRGE--LKLIDFGSGALLKDTVY-------------------------------------------T  206 (320)
T ss_dssp             CCCCSGGGEEEETTTTE--EEECCCTTCEECCSSCB-------------------------------------------C
T ss_pred             eCCCCHHHEEEeCCCCC--EEEeeCccccccccccc-------------------------------------------c
Confidence            999999999998 4555  99999998764331100                                           0


Q ss_pred             cccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...||+.|++|         +...|+|++|+++++|..|..|+...
T Consensus       207 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            12245555555         23459999999999999998776443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=1.9e-23  Score=208.22  Aligned_cols=142  Identities=19%  Similarity=0.267  Sum_probs=110.3

Q ss_pred             HHHHHHhh--cCCCCeeEEeeeeecC----CeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC--
Q psy3074         272 REASLLKE--LKHNNIVTLHDIVHTR----STLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR--  342 (481)
Q Consensus       272 rE~~il~~--l~HpnIV~l~~~~~~~----~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~--  342 (481)
                      +|.+++..  ++||||+++++++...    ..+|+|||||+ |+|.+++..  ..+++..+..++.|++.||.|||++  
T Consensus        78 ~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~  155 (337)
T 3mdy_A           78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIF  155 (337)
T ss_dssp             HHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBC
T ss_pred             hHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhh
Confidence            45555554  4899999999999877    78999999998 588888865  4699999999999999999999998  


Q ss_pred             ------ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCC
Q psy3074         343 ------RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSG  416 (481)
Q Consensus       343 ------~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~  416 (481)
                            +|+||||||+|||++.++.  +|++|||+++.+.......                                  
T Consensus       156 ~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~----------------------------------  199 (337)
T 3mdy_A          156 STQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEV----------------------------------  199 (337)
T ss_dssp             STTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC----------------------------------------
T ss_pred             hhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccc----------------------------------
Confidence                  9999999999999998776  9999999986443111000                                  


Q ss_pred             CccccccCcccceeccCCC--------CCC------hhhhhhHHHHHHhhCC
Q psy3074         417 GWWFESKSNINLSFHYLPP--------GAP------FTAIREASLLKELKHN  454 (481)
Q Consensus       417 ~~~~~~~~~~~~t~~y~~p--------~~p------~~~~s~~~~l~~l~~~  454 (481)
                         .......+||+.|++|        ...      +|+||+|+++++|..|
T Consensus       200 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          200 ---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             ------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence               0000123466667776        122      7999999999999999

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.88  E-value=4.1e-24  Score=216.01  Aligned_cols=112  Identities=25%  Similarity=0.439  Sum_probs=87.0

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                      
T Consensus       128 ~~~~q-i~~aL~~LH~~givHrDlkp----~NILl~~~----g~ikL~DFG~a~~~~~----------------------  176 (353)
T 3txo_A          128 FYAAE-IISALMFLHDKGIIYRDLKL----DNVLLDHE----GHCKLADFGMCKEGIC----------------------  176 (353)
T ss_dssp             HHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCSCC----------------------
T ss_pred             HHHHH-HHHHHHHHHHCCCcccCCCH----HHEEECCC----CCEEEccccceeeccc----------------------
Confidence            34444 78999999999999999999    89999876    7999999999984211                      


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          .+.....++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.+.+ 
T Consensus       177 ----~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~-  228 (353)
T 3txo_A          177 ----NGVTTATFCG----------------------TPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAEN-  228 (353)
T ss_dssp             -------------C----------------------CGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             ----CCccccccCC----------------------CcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCC-
Confidence                1111223344                      99999999998765 9999999999999999999999999854 


Q ss_pred             hHHHHHHHHHH
Q psy3074         175 VYDQLDKIFKI  185 (481)
Q Consensus       175 ~~~~l~~i~~~  185 (481)
                      ..+.+.+|...
T Consensus       229 ~~~~~~~i~~~  239 (353)
T 3txo_A          229 EDDLFEAILND  239 (353)
T ss_dssp             HHHHHHHHHHC
T ss_pred             HHHHHHHHHcC
Confidence            34666666653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.88  E-value=1.1e-23  Score=204.75  Aligned_cols=104  Identities=25%  Similarity=0.451  Sum_probs=91.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++++.++||||+++++++.+ +..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++|
T Consensus        54 ~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  132 (279)
T 1qpc_A           54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH  132 (279)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            46689999999999999999999874 46899999997 68888776432 25899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||||+||++++++.  +|++|||++..+
T Consensus       133 ~dikp~Nil~~~~~~--~kl~Dfg~~~~~  159 (279)
T 1qpc_A          133 RDLRAANILVSDTLS--CKIADFGLARLI  159 (279)
T ss_dssp             SCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             cCCCHhhEEEcCCCC--EEECCCcccccc
Confidence            999999999998776  999999988654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.88  E-value=8.8e-24  Score=206.32  Aligned_cols=150  Identities=22%  Similarity=0.370  Sum_probs=119.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+++.++||||+++++++.+.+ .++||||+. |+|.+.+....+.+++..+..++.|++.||.|||+++++||
T Consensus        67 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  145 (291)
T 1u46_A           67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR  145 (291)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            4668999999999999999999998765 899999998 78988888766679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+||+++.++.  +|++|||+++.+.........                                      .....
T Consensus       146 dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~--------------------------------------~~~~~  185 (291)
T 1u46_A          146 DLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVM--------------------------------------QEHRK  185 (291)
T ss_dssp             CCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-------------------------------------------
T ss_pred             CCchheEEEcCCCC--EEEccccccccccccccchhh--------------------------------------hccCC
Confidence            99999999988776  999999988654311100000                                      00122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      +|+.|++|        +...|+|++|+++++|.. |..|+.
T Consensus       186 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~  226 (291)
T 1u46_A          186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI  226 (291)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             CCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            34445555        346799999999999998 876654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.87  E-value=1.2e-23  Score=207.99  Aligned_cols=156  Identities=18%  Similarity=0.158  Sum_probs=111.9

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-ceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiHrDlK  350 (481)
                      .+..+++.++||||+++++++.+.+..++||||+.+.+..+.....+.+++..+..++.|++.||.|||++ +++|||||
T Consensus        73 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlk  152 (318)
T 2dyl_A           73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVK  152 (318)
T ss_dssp             HHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred             HHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCC
Confidence            35567888999999999999999999999999996556555555556799999999999999999999996 99999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhcccccc--CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHR--RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~--~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |+||+++.++.  +|++|||++..+.....  ....+..|.||+++....                              
T Consensus       153 p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------------------------------  200 (318)
T 2dyl_A          153 PSNILLDERGQ--IKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD------------------------------  200 (318)
T ss_dssp             GGGEEECTTSC--EEECCCTTC--------------CCTTCCHHHHC---------------------------------
T ss_pred             HHHEEECCCCC--EEEEECCCchhccCCccccccCCCccccChhhccccc------------------------------
Confidence            99999998777  99999998865432111  111222233333221100                              


Q ss_pred             eeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                       ..-...+..+|+|++|+++++|.+|..|+..
T Consensus       201 -~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          201 -PTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             -ccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence             0000113457999999999999999866643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.87  E-value=1.4e-23  Score=207.53  Aligned_cols=152  Identities=18%  Similarity=0.194  Sum_probs=108.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHhhc---C
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYCHR---R  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~ylH~---~  342 (481)
                      .+.+|++++++++|||||++++++.+.  .++||||++ |+|.+++.....  .+++..+..++.|++.||.|||+   +
T Consensus        47 ~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~  124 (307)
T 2eva_A           47 AFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK  124 (307)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSS
T ss_pred             HHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            467899999999999999999998744  899999998 588888765432  37888899999999999999999   8


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+||+++.++. .+|++|||++..+.........+..|.|||++.+.                         
T Consensus       125 ~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-------------------------  178 (307)
T 2eva_A          125 ALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGS-------------------------  178 (307)
T ss_dssp             CCCCCCCSGGGEEEETTTT-EEEECCCCC------------CCTTSSCHHHHTCC-------------------------
T ss_pred             CeecCCCChhHEEEeCCCC-EEEEcccccccccccccccCCCCCceEChhhhCCC-------------------------
Confidence            9999999999999986543 26999999887544222222222233333322110                         


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                 ..+..+|+|++|+++++|..|..|+-
T Consensus       179 -----------~~~~~~Di~slG~il~el~~g~~p~~  204 (307)
T 2eva_A          179 -----------NYSEKCDVFSWGIILWEVITRRKPFD  204 (307)
T ss_dssp             -----------CCCTHHHHHHHHHHHHHHHHTCCTTT
T ss_pred             -----------CCCcHHHHHHHHHHHHHHHHCCCCch
Confidence                       01445788888888888888876553

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.87  E-value=1.8e-24  Score=210.22  Aligned_cols=152  Identities=22%  Similarity=0.277  Sum_probs=119.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC-CeEEEEEeccC-CCHHHHHHHhcC-CCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR-STLTFVFEYVH-TDLSQYMERHSG-GLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~-~~~~iv~E~~~-g~l~~~l~~~~~-~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .+.+|+.+++.++||||+++++++... +..++||||++ |+|.+++..... .+++..+..++.|++.||.|||+++++
T Consensus        60 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  139 (278)
T 1byg_A           60 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV  139 (278)
T ss_dssp             HHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            466899999999999999999987554 57999999998 489888875432 388999999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccc----cccccccCCCeeEEEeec-CCCCccc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGGWWF  420 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~~~~  420 (481)
                      ||||||+||+++.++.  +|++|||++............+..|.||+++.    +...+.|+.|++++++.+ |..||..
T Consensus       140 H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          140 HRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             CSCCSGGGEEECTTSC--EEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred             ccCCCcceEEEeCCCc--EEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999998776  99999999886654444444556788888774    445677999999999997 9999876


Q ss_pred             cc
Q psy3074         421 ES  422 (481)
Q Consensus       421 ~~  422 (481)
                      ..
T Consensus       218 ~~  219 (278)
T 1byg_A          218 IP  219 (278)
T ss_dssp             SC
T ss_pred             CC
Confidence            54

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.87  E-value=8.6e-24  Score=214.83  Aligned_cols=178  Identities=28%  Similarity=0.473  Sum_probs=114.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...                       
T Consensus       131 ~i~~q-i~~al~~lH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~a~~~~-----------------------  178 (371)
T 2xrw_A          131 YLLYQ-MLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAG-----------------------  178 (371)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECCCCC----------------------------
T ss_pred             HHHHH-HHHHHHHHHHCCeecccCCH----HHEEEcCC----CCEEEEEeecccccc-----------------------
Confidence            33444 78899999999999999999    89999876    799999999998421                       


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          .......+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+ 
T Consensus       179 ----~~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~-  230 (371)
T 2xrw_A          179 ----TSFMMTPYV----------------------VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTD-  230 (371)
T ss_dssp             -------------------------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             ----cccccCCce----------------------ecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCC-
Confidence                111111122                      399999999999865 9999999999999999999999999954 


Q ss_pred             hHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcch----hHHHHHHhhhhhhhcCCccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGE----SMASAFLQVRDAAILNPMEH  250 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~----~~a~~ll~v~~~~~~~~~~~  250 (481)
                      ..+++..+.+.++.|.++.+..............+......+...++....+....    .-......+.++...+|.++
T Consensus       231 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R  310 (371)
T 2xrw_A          231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR  310 (371)
T ss_dssp             HHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGS
T ss_pred             HHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhC
Confidence            45889999999999988766654321111111222233333333444433222111    11223455666777777765


Q ss_pred             cc
Q psy3074         251 VH  252 (481)
Q Consensus       251 ~~  252 (481)
                      ..
T Consensus       311 ~t  312 (371)
T 2xrw_A          311 IS  312 (371)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.87  E-value=3.8e-24  Score=229.31  Aligned_cols=122  Identities=18%  Similarity=0.183  Sum_probs=98.4

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+.+|+++|+++ .|+||+++++++++++..|||||||+| +|.+.+.. .+.+++.   .++.||+.||+|+|++|||
T Consensus       286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GII  361 (569)
T 4azs_A          286 YELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFW  361 (569)
T ss_dssp             HHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCE
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCce
Confidence            4588999999999 699999999999999999999999995 67777765 4567654   5789999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLI  395 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~  395 (481)
                      ||||||+|||+++++.  +|++|||+|+.+.....   ..+.+..|.+|+++.
T Consensus       362 HRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~  412 (569)
T 4azs_A          362 HDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA  412 (569)
T ss_dssp             ESCCCGGGEEECTTSC--EEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-
T ss_pred             eccCchHhEEECCCCC--EEEeecccCeeCCCCCccccCceechhhccHHHhC
Confidence            9999999999998887  99999999987653221   123344455555553

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.87  E-value=1.7e-23  Score=210.12  Aligned_cols=111  Identities=25%  Similarity=0.449  Sum_probs=86.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                      
T Consensus       109 ~~~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----g~vkL~DFG~a~~~~~----------------------  157 (337)
T 1o6l_A          109 FYGAE-IVSALEYLHSRDVVYRDIKL----ENLMLDKD----GHIKITDFGLCKEGIS----------------------  157 (337)
T ss_dssp             HHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCSCC----------------------
T ss_pred             HHHHH-HHHHHHHHHHCCeecCcCCH----HHEEECCC----CCEEEeeccchhhccc----------------------
Confidence            33344 78899999999999999999    89999876    7999999999984211                      


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          .+.....++|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+ 
T Consensus       158 ----~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~-  209 (337)
T 1o6l_A          158 ----DGATMKTFCG----------------------TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQD-  209 (337)
T ss_dssp             ----TTCCBCCCEE----------------------CGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             ----CCCccccccc----------------------ChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCC-
Confidence                1111122344                      99999999998765 9999999999999999999999998853 


Q ss_pred             hHHHHHHHHH
Q psy3074         175 VYDQLDKIFK  184 (481)
Q Consensus       175 ~~~~l~~i~~  184 (481)
                      ..+..+.|..
T Consensus       210 ~~~~~~~i~~  219 (337)
T 1o6l_A          210 HERLFELILM  219 (337)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHc
Confidence            3345555544

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.87  E-value=1.8e-23  Score=208.68  Aligned_cols=154  Identities=20%  Similarity=0.217  Sum_probs=114.0

Q ss_pred             HHHHHhhcCCCCeeEEeeeee-----cCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC----
Q psy3074         273 EASLLKELKHNNIVTLHDIVH-----TRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR----  342 (481)
Q Consensus       273 E~~il~~l~HpnIV~l~~~~~-----~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~----  342 (481)
                      |+..++.++||||+++++.+.     .....++|||||+ |+|.+++...  ..++..+..++.|++.||.|||+.    
T Consensus        57 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~  134 (336)
T 3g2f_A           57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRG  134 (336)
T ss_dssp             HHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCG
T ss_pred             HHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccc
Confidence            444556689999999997543     3346899999997 6888888653  468888999999999999999999    


Q ss_pred             -----ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCC
Q psy3074         343 -----RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGG  417 (481)
Q Consensus       343 -----~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~  417 (481)
                           +|+||||||+|||++.++.  +|++|||+++.+.......             .                 +.  
T Consensus       135 ~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~~~~~~~~~~-------------~-----------------~~--  180 (336)
T 3g2f_A          135 DHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGNRLVR-------------P-----------------GE--  180 (336)
T ss_dssp             GGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCEECSSSSCC------------------------------------
T ss_pred             cccccceeecccccceEEEcCCCc--EEEeeccceeecccccccC-------------c-----------------cc--
Confidence                 9999999999999998776  9999999987543211000             0                 00  


Q ss_pred             ccccccCcccceeccCCC----C-----------CChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         418 WWFESKSNINLSFHYLPP----G-----------APFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       418 ~~~~~~~~~~~t~~y~~p----~-----------~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                       ........+||+.|++|    +           ..+|+||+|+++++|+.|..|++....
T Consensus       181 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          181 -EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             -cccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence             00001123467777777    1           346999999999999999877766543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.87  E-value=1.3e-23  Score=212.40  Aligned_cols=113  Identities=24%  Similarity=0.466  Sum_probs=88.7

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                    
T Consensus       123 ~~~~~~q-i~~aL~~LH~~givHrDlkp----~NIll~~~----g~vkL~DFG~a~~~~~--------------------  173 (353)
T 2i0e_A          123 AVFYAAE-IAIGLFFLQSKGIIYRDLKL----DNVMLDSE----GHIKIADFGMCKENIW--------------------  173 (353)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCCCC--------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCEEeccCCH----HHEEEcCC----CcEEEEeCCccccccc--------------------
Confidence            3344444 78999999999999999999    89999876    7999999999984211                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                            .+.....++|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       174 ------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~  224 (353)
T 2i0e_A          174 ------DGVTTKTFCG----------------------TPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGE  224 (353)
T ss_dssp             ------TTCCBCCCCS----------------------CGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ------CCcccccccC----------------------CccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCC
Confidence                  1111122233                      99999999998765 999999999999999999999999985


Q ss_pred             hhhHHHHHHHHH
Q psy3074         173 REVYDQLDKIFK  184 (481)
Q Consensus       173 ~~~~~~l~~i~~  184 (481)
                      + ..+.+++|..
T Consensus       225 ~-~~~~~~~i~~  235 (353)
T 2i0e_A          225 D-EDELFQSIME  235 (353)
T ss_dssp             S-HHHHHHHHHH
T ss_pred             C-HHHHHHHHHh
Confidence            3 3355666655

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=6.1e-23  Score=206.38  Aligned_cols=126  Identities=42%  Similarity=0.807  Sum_probs=104.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                         
T Consensus       121 i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~~-------------------------  167 (346)
T 1ua2_A          121 TLQGLEYLHQHWILHRDLKP----NNLLLDEN----GVLKLADFGLAKSFGSPNR-------------------------  167 (346)
T ss_dssp             HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECCCGGGSTTTSCCC-------------------------
T ss_pred             HHHHHHHHHHCCEECCCCCH----HHEEEcCC----CCEEEEecccceeccCCcc-------------------------
Confidence            67899999999999999999    89999876    7999999999985321100                         


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                       ...                      ...+|+.|+|||++.+...|+.++||||+||++|||++|.+||.+.+ ..+++.
T Consensus       168 -~~~----------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~-~~~~~~  223 (346)
T 1ua2_A          168 -AYT----------------------HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-DLDQLT  223 (346)
T ss_dssp             -CCC----------------------CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHH
T ss_pred             -cCC----------------------cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC-HHHHHH
Confidence             000                      11239999999999887779999999999999999999999999854 458899


Q ss_pred             HHHHHhCCCCccCcccccCCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      .+.+..+.|..+.|+.....+.+
T Consensus       224 ~i~~~~~~~~~~~~~~~~~~~~~  246 (346)
T 1ua2_A          224 RIFETLGTPTEEQWPDMCSLPDY  246 (346)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTTC
T ss_pred             HHHHHcCCCChhhhhhhccCccc
Confidence            99999999999999887665544

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.87  E-value=1.7e-23  Score=206.97  Aligned_cols=105  Identities=21%  Similarity=0.398  Sum_probs=89.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccC-CCHHHHHHHh-----cCCCChHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVH-TDLSQYMERH-----SGGLDHHNIRLFMFQLLRGLS  337 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~-g~l~~~l~~~-----~~~l~~~~~~~~~~qi~~~l~  337 (481)
                      .+.+|+.++++++||||+++++++.+.+     ..++||||++ |+|..++...     ...+++..+..++.|++.||.
T Consensus        82 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~  161 (313)
T 3brb_A           82 EFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME  161 (313)
T ss_dssp             HHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHH
Confidence            4568999999999999999999998755     4599999998 6888887532     245899999999999999999


Q ss_pred             HhhcCceeeccCCCccccccccchhhHHHHHHHHHhhc
Q psy3074         338 YCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       338 ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      |||+++|+||||||+||+++.++.  +|++|||+++.+
T Consensus       162 ~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~  197 (313)
T 3brb_A          162 YLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKI  197 (313)
T ss_dssp             HHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC---
T ss_pred             HHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceec
Confidence            999999999999999999998776  999999988754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.87  E-value=2.8e-24  Score=215.65  Aligned_cols=153  Identities=17%  Similarity=0.267  Sum_probs=129.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCC-CHHHH------HHHh-cCCCChHHHHHHHHHHHHHHHHh
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT-DLSQY------MERH-SGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g-~l~~~------l~~~-~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      ..+.+|+.+++.++||||+++++++.+.+..|+||||++| +|.++      +... ...+++..+..++.|++.||.||
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999999999999999985 77766      4332 35689999999999999999999


Q ss_pred             hc-CceeeccCCCccccccccchhhHHHHHHHHHhhcccc-ccCceeccccCCCcccccc------cccccCCCeeEEEe
Q psy3074         340 HR-RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC-HRRRILHRDVKPQNLLISE------IVFTNLSGVVVSTV  411 (481)
Q Consensus       340 H~-~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~-~~~~i~~~d~~~~~il~~~------~~~~~s~g~~~~~~  411 (481)
                      |+ ++++||||||+||+++.++.  +|++|||++..+... ......+..|.||+++.+.      ..+.|+.|++++++
T Consensus       168 H~~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILMDKNGR--VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             HHTSCEECCCCCGGGEEECTTSC--EEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEEcCCCc--EEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence            98 99999999999999998877  999999998865422 2334556678899888654      56779999999999


Q ss_pred             ecCCCCccccc
Q psy3074         412 DSGSGGWWFES  422 (481)
Q Consensus       412 ~~g~~~~~~~~  422 (481)
                      .+|..||....
T Consensus       246 ~~g~~pf~~~~  256 (348)
T 2pml_X          246 FYNVVPFSLKI  256 (348)
T ss_dssp             HHSSCSSCCSS
T ss_pred             HhCCCCCCCCC
Confidence            99999997543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.87  E-value=1.7e-23  Score=217.25  Aligned_cols=107  Identities=28%  Similarity=0.369  Sum_probs=88.2

Q ss_pred             HHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCC------CChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG------LDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~------l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.+|+.+|+++ +|||||++++++.+.+.+|+|||||+|+|.+++......      .++..+..++.|++.||.|||++
T Consensus        55 ~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~  134 (434)
T 2rio_A           55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL  134 (434)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC
Confidence            45799999886 899999999999999999999999999999988754211      12334577999999999999999


Q ss_pred             ceeeccCCCccccccccc-----------hhhHHHHHHHHHhhcc
Q psy3074         343 RILHRDVKPQNLLISEID-----------HHNIRLFMFQLLRGLS  376 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~-----------~~~ikl~dfgla~~~~  376 (481)
                      +|+||||||+|||++..+           ...+|++|||+++.+.
T Consensus       135 ~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~  179 (434)
T 2rio_A          135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD  179 (434)
T ss_dssp             TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECC
T ss_pred             CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecC
Confidence            999999999999997643           2358999999987654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.87  E-value=3.9e-23  Score=206.59  Aligned_cols=103  Identities=23%  Similarity=0.332  Sum_probs=91.5

Q ss_pred             HHHHHHHHhh--cCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhh--
Q psy3074         270 AIREASLLKE--LKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCH--  340 (481)
Q Consensus       270 ~~rE~~il~~--l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH--  340 (481)
                      +.+|+++++.  ++||||+++++++....    .+|+||||++ |+|.+++..  ..+++..+..++.|++.||.|||  
T Consensus        81 ~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~  158 (342)
T 1b6c_B           81 WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHME  158 (342)
T ss_dssp             HHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHH
Confidence            4568888887  78999999999998876    8999999998 589888865  46899999999999999999999  


Q ss_pred             ------cCceeeccCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         341 ------RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       341 ------~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                            +.+|+||||||+|||++.++.  +|++|||+++...
T Consensus       159 ~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~  198 (342)
T 1b6c_B          159 IVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHD  198 (342)
T ss_dssp             BCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEE
T ss_pred             HhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceecc
Confidence                  899999999999999998876  9999999886543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.87  E-value=1.2e-23  Score=230.62  Aligned_cols=139  Identities=20%  Similarity=0.304  Sum_probs=108.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCe-----EEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~-----~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.++++++|||||++++++...+.     .|||||||+| +|.+.+..   .+++..+..++.|++.||.|||++
T Consensus       125 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~  201 (681)
T 2pzi_A          125 MAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI  201 (681)
T ss_dssp             HHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35679999999999999999999987665     7999999984 56655432   699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +|+||||||+|||++.+   .+|++|||+++.+... .                                          
T Consensus       202 giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~-~------------------------------------------  235 (681)
T 2pzi_A          202 GLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF-G------------------------------------------  235 (681)
T ss_dssp             TEECCCCSGGGEEECSS---CEEECCCTTCEETTCC-S------------------------------------------
T ss_pred             CCeecccChHHeEEeCC---cEEEEecccchhcccC-C------------------------------------------
Confidence            99999999999999874   4899999988643311 0                                          


Q ss_pred             cCcccceeccCCC-------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         423 KSNINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       423 ~~~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                        ...||+.|++|       +..+|+||+|+++++|..|..|+
T Consensus       236 --~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~  276 (681)
T 2pzi_A          236 --YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTR  276 (681)
T ss_dssp             --CCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEE
T ss_pred             --ccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCC
Confidence              12345555555       34568888888888888886443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.87  E-value=4.2e-23  Score=209.25  Aligned_cols=132  Identities=20%  Similarity=0.250  Sum_probs=96.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.....++.. .+.||+|||++||+||||||    +|||++........+||+|||+|+.....              
T Consensus       112 l~~~~~~~i~~q-i~~aL~~LH~~givHrDlkp----~NIll~~~~~~~~~vkl~DFG~a~~~~~~--------------  172 (361)
T 2yab_A          112 LSEEEATSFIKQ-ILDGVNYLHTKKIAHFDLKP----ENIMLLDKNIPIPHIKLIDFGLAHEIEDG--------------  172 (361)
T ss_dssp             CBHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESCTTSSSCCEEECCCSSCEECCTT--------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCcccCCCCH----HHEEEeCCCCCccCEEEEecCCceEcCCC--------------
Confidence            334444445555 78899999999999999999    89999866433348999999999853211              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                   ......+                      +|+.|+|||++.+.. |+.++||||+||++|||++|.+
T Consensus       173 -------------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~  216 (361)
T 2yab_A          173 -------------VEFKNIF----------------------GTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGAS  216 (361)
T ss_dssp             -------------CCCCCCC----------------------SCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCC
T ss_pred             -------------CccccCC----------------------CCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCC
Confidence                         1011122                      399999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      ||.+.+ ..+.+..|......++++.|+
T Consensus       217 Pf~~~~-~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          217 PFLGDT-KQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             SSCCSS-HHHHHHHHHTTCCCCCHHHHT
T ss_pred             CCCCCC-HHHHHHHHHhcCCCCCchhcc
Confidence            999854 335666666554444444333

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=9.2e-24  Score=209.11  Aligned_cols=102  Identities=21%  Similarity=0.344  Sum_probs=89.8

Q ss_pred             HHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       271 ~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      .+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++......+++..+..++.|++.||.|||+++++||||
T Consensus        77 ~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl  156 (319)
T 2y4i_B           77 KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL  156 (319)
T ss_dssp             CTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred             HHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence            458999999999999999999999999999999998 6788887665557999999999999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGL  375 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~  375 (481)
                      ||+||+++ ++.  +|++|||+++..
T Consensus       157 kp~NIl~~-~~~--~~l~Dfg~~~~~  179 (319)
T 2y4i_B          157 KSKNVFYD-NGK--VVITDFGLFSIS  179 (319)
T ss_dssp             CSTTEEEC---C--CEECCCSCCC--
T ss_pred             ChhhEEEe-CCC--EEEeecCCcccc
Confidence            99999998 344  999999987644

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.87  E-value=7.8e-24  Score=208.36  Aligned_cols=137  Identities=22%  Similarity=0.284  Sum_probs=114.3

Q ss_pred             HHHHHHHH-hhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLL-KELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il-~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.+|+.++ +.++||||+++++++..    ...+++|||||+ |+|.+++.... ..+++..+..++.|++.||.|||++
T Consensus        57 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  136 (299)
T 3m2w_A           57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI  136 (299)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            44688887 66789999999999987    678999999998 58988887653 3599999999999999999999999


Q ss_pred             ceeeccCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         343 RILHRDVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      +|+||||||+||+++..+ ...+|++|||++..+..               --.+...+.||.|++++++.+|..||...
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---------------EKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             CcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------ccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999998732 23499999998864331               12455678899999999999999999754

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.86  E-value=4.4e-23  Score=224.81  Aligned_cols=148  Identities=21%  Similarity=0.327  Sum_probs=117.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      +.+.+|+.+|++++|||||++++++. .+..|+|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  514 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH  514 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            35678999999999999999999985 456899999998 7898888766567899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+++.+.......                                        ....
T Consensus       515 rDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~~~----------------------------------------~~~~  552 (656)
T 2j0j_A          515 RDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYK----------------------------------------ASKG  552 (656)
T ss_dssp             SCCSGGGEEEEETTE--EEECCCCCCCSCCC-------------------------------------------------
T ss_pred             cccchHhEEEeCCCC--EEEEecCCCeecCCCccee----------------------------------------ccCC
Confidence            999999999998776  9999999887543111000                                        0001


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      .+|+.|++|        +..+|+||+|++++||+. |..|+
T Consensus       553 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  593 (656)
T 2j0j_A          553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF  593 (656)
T ss_dssp             -CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence            233445554        456799999999999986 76554

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.86  E-value=2.3e-23  Score=212.11  Aligned_cols=107  Identities=27%  Similarity=0.465  Sum_probs=86.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                          +
T Consensus       148 i~~aL~~LH~~givHrDlkp----~NIll~~~----g~ikL~DFG~a~~~~~~--------------------------~  193 (373)
T 2r5t_A          148 IASALGYLHSLNIVYRDLKP----ENILLDSQ----GHIVLTDFGLCKENIEH--------------------------N  193 (373)
T ss_dssp             HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCCCBCGGGBCC--------------------------C
T ss_pred             HHHHHHHHHHCCceecCCCH----HHEEECCC----CCEEEeeCccccccccC--------------------------C
Confidence            78999999999999999999    89999876    79999999999842211                          1


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....++                      +|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.+ ..+.++
T Consensus       194 ~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~  249 (373)
T 2r5t_A          194 STTSTFC----------------------GTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYD  249 (373)
T ss_dssp             CCCCSBS----------------------CCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHH
T ss_pred             Ccccccc----------------------CCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHH
Confidence            1111223                      399999999998765 9999999999999999999999998853 346666


Q ss_pred             HHHHH
Q psy3074         181 KIFKI  185 (481)
Q Consensus       181 ~i~~~  185 (481)
                      .|...
T Consensus       250 ~i~~~  254 (373)
T 2r5t_A          250 NILNK  254 (373)
T ss_dssp             HHHHS
T ss_pred             HHHhc
Confidence            66553

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.86  E-value=2.5e-23  Score=209.59  Aligned_cols=112  Identities=27%  Similarity=0.506  Sum_probs=87.6

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                    
T Consensus       121 ~~~~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----g~vkL~DFG~a~~~~~~--------------------  171 (345)
T 1xjd_A          121 TFYAAE-IILGLQFLHSKGIVYRDLKL----DNILLDKD----GHIKIADFGMCKENMLG--------------------  171 (345)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCCCCT--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCeEeCCCCh----hhEEECCC----CCEEEeEChhhhhcccC--------------------
Confidence            334444 78999999999999999999    89999876    79999999999842110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                            ......++|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+
T Consensus       172 ------~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          172 ------DAKTNTFCG----------------------TPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             ------TCCBCCCCS----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ------CCcccCCCC----------------------CcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence                  011112233                      99999999998765 9999999999999999999999999853


Q ss_pred             hhHHHHHHHHH
Q psy3074         174 EVYDQLDKIFK  184 (481)
Q Consensus       174 ~~~~~l~~i~~  184 (481)
                       ..+.+..|..
T Consensus       223 -~~~~~~~i~~  232 (345)
T 1xjd_A          223 -EEELFHSIRM  232 (345)
T ss_dssp             -HHHHHHHHHH
T ss_pred             -HHHHHHHHHh
Confidence             3355555544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.86  E-value=1.2e-23  Score=210.81  Aligned_cols=181  Identities=15%  Similarity=0.205  Sum_probs=117.0

Q ss_pred             HHHhhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         275 SLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       275 ~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      ..++.++||||+++++++..    ...+++|||||+ |+|.+++.... ..+++..+..++.|++.||.|||+++|+|||
T Consensus        74 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~d  153 (336)
T 3fhr_A           74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRD  153 (336)
T ss_dssp             HHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence            34567789999999999976    456899999998 48888887643 3599999999999999999999999999999


Q ss_pred             CCCccccccccc-hhhHHHHHHHHHhhccccc-cCceeccccCCCccccc----ccccccCCCeeEEEeecCCCCccccc
Q psy3074         349 VKPQNLLISEID-HHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLIS----EIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       349 lKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~-~~~i~~~d~~~~~il~~----~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      |||+|||++..+ ...+|++|||+++...... .....+..|.+|+++..    ...+.|+.|++++++.+|..||....
T Consensus       154 lkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  233 (336)
T 3fhr_A          154 VKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNT  233 (336)
T ss_dssp             CSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             CCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence            999999997643 3449999999987554222 23344667888888743    34567999999999999999997553


Q ss_pred             cCcc---------cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         423 KSNI---------NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       423 ~~~~---------~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ....         .+...+..+..+.....+..++..|+..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  275 (336)
T 3fhr_A          234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTD  275 (336)
T ss_dssp             -----------------CCCTTTSTTCCHHHHHHHHHHSCSS
T ss_pred             chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCC
Confidence            2211         11112222221222334566777777665

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.86  E-value=3.3e-23  Score=223.79  Aligned_cols=150  Identities=22%  Similarity=0.339  Sum_probs=118.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec------CCeEEEEEeccC-CCHHHHHHHhcC--CCChHHHHHHHHHHHHHHHHh
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT------RSTLTFVFEYVH-TDLSQYMERHSG--GLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~------~~~~~iv~E~~~-g~l~~~l~~~~~--~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .+.+|+.+++.++|||||++++++..      .+..|+|||||+ |+|.+++.....  .+++..+..++.|++.||.||
T Consensus        58 ~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yL  137 (676)
T 3qa8_A           58 RWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL  137 (676)
T ss_dssp             HHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999866      677899999997 688888765432  588999999999999999999


Q ss_pred             hcCceeeccCCCccccccccch-hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDH-HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~-~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      |+.+|+||||||+||+++.++. ..+|++|||++..+......                                     
T Consensus       138 Hs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~-------------------------------------  180 (676)
T 3qa8_A          138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC-------------------------------------  180 (676)
T ss_dssp             HHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCC-------------------------------------
T ss_pred             HHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccccc-------------------------------------
Confidence            9999999999999999986543 34789999987654311100                                     


Q ss_pred             cccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         419 WFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       419 ~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                           ....||+.|++|        +..+|+|++|+++++|.+|..|+..
T Consensus       181 -----~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          181 -----TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             -----CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                 011233334443        5578999999999999999978754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.86  E-value=1.7e-23  Score=209.25  Aligned_cols=112  Identities=21%  Similarity=0.376  Sum_probs=87.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                    
T Consensus       117 ~~~~~q-i~~al~~lH~~~ivHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~--------------------  167 (328)
T 3fe3_A          117 RSKFRQ-IVSAVQYCHQKRIVHRDLKA----ENLLLDAD----MNIKIADFGFSNEFTVG--------------------  167 (328)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECSTTCCGGGSSS--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCEeccCCCH----HHEEEcCC----CCEEEeeccCceecCCC--------------------
Confidence            334444 78899999999999999999    89999876    79999999999853211                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             ....                      ...+|++|+|||++.+...++.++||||+||++|||++|++||.+.+
T Consensus       168 -------~~~~----------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          168 -------GKLD----------------------AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             -------CGGG----------------------TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------Cccc----------------------cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence                   0001                      11249999999999988755689999999999999999999999853


Q ss_pred             hhHHHHHHHHH
Q psy3074         174 EVYDQLDKIFK  184 (481)
Q Consensus       174 ~~~~~l~~i~~  184 (481)
                       ..+....+..
T Consensus       219 -~~~~~~~i~~  228 (328)
T 3fe3_A          219 -LKELRERVLR  228 (328)
T ss_dssp             -HHHHHHHHHH
T ss_pred             -HHHHHHHHHh
Confidence             3345555544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.86  E-value=3.7e-23  Score=212.04  Aligned_cols=94  Identities=29%  Similarity=0.542  Sum_probs=79.2

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                          .+
T Consensus       162 i~~aL~~LH~~givHrDLKp----~NILl~~~----g~ikL~DFGla~~~~~--------------------------~~  207 (396)
T 4dc2_A          162 ISLALNYLHERGIIYRDLKL----DNVLLDSE----GHIKLTDYGMCKEGLR--------------------------PG  207 (396)
T ss_dssp             HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCCCC--------------------------TT
T ss_pred             HHHHHHHHHHCCEEeccCCH----HHEEECCC----CCEEEeecceeeeccc--------------------------CC
Confidence            78999999999999999999    89999876    7999999999984211                          11


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                      .....++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.+
T Consensus       208 ~~~~~~~g----------------------t~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          208 DTTSTFCG----------------------TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             CCBCCCCB----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred             CccccccC----------------------CcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            11222334                      99999999998865 99999999999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.86  E-value=6.5e-23  Score=209.14  Aligned_cols=120  Identities=33%  Similarity=0.635  Sum_probs=99.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+......                          
T Consensus       150 i~~aL~~LH~~gi~H~Dikp----~Nil~~~~~---~~~kl~Dfg~a~~~~~~~--------------------------  196 (383)
T 3eb0_A          150 LFRAVGFIHSLGICHRDIKP----QNLLVNSKD---NTLKLCDFGSAKKLIPSE--------------------------  196 (383)
T ss_dssp             HHHHHHHHHTTTEECSCCCG----GGEEEETTT---TEEEECCCTTCEECCTTS--------------------------
T ss_pred             HHHHHHHHHHCcCccCccCH----HHEEEcCCC---CcEEEEECCCCcccCCCC--------------------------
Confidence            78899999999999999999    899997432   799999999998532110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                       ....+.                      +|+.|+|||++.+...|+.++||||+||++|||++|++||.+. +..+++.
T Consensus       197 -~~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~~~~~~~  252 (383)
T 3eb0_A          197 -PSVAYI----------------------CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE-TSIDQLV  252 (383)
T ss_dssp             -CCCCCC----------------------CCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHH
T ss_pred             -CCcCcc----------------------cCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC-ChHHHHH
Confidence             011122                      3999999999998777999999999999999999999999995 4458999


Q ss_pred             HHHHHhCCCCccCcccc
Q psy3074         181 KIFKILGTPTEETWEGV  197 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~  197 (481)
                      .|.+.+++|+.+.+...
T Consensus       253 ~i~~~~g~p~~~~~~~~  269 (383)
T 3eb0_A          253 RIIQIMGTPTKEQMIRM  269 (383)
T ss_dssp             HHHHHHCCCCHHHHHHH
T ss_pred             HHHHHhCCCCHHHHHHh
Confidence            99999999988766544

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.86  E-value=1.6e-23  Score=207.04  Aligned_cols=144  Identities=26%  Similarity=0.367  Sum_probs=111.5

Q ss_pred             HHHHHHHhhc----CCCCeeEEeeeeecCCeEEEEEec-cC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         271 IREASLLKEL----KHNNIVTLHDIVHTRSTLTFVFEY-VH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       271 ~rE~~il~~l----~HpnIV~l~~~~~~~~~~~iv~E~-~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+|+.+++++    +||||+++++++.+.+..++|||+ +. ++|.+++... +.+++..+..++.|++.||.|||++++
T Consensus        82 ~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  160 (312)
T 2iwi_A           82 PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGV  160 (312)
T ss_dssp             CHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTE
T ss_pred             HHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4699999999    899999999999999999999999 55 6888887663 569999999999999999999999999


Q ss_pred             eeccCCCcccccc-ccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         345 LHRDVKPQNLLIS-EIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       345 iHrDlKp~NiLl~-~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      +||||||+||+++ .++.  +|++|||+++.+....                                           .
T Consensus       161 ~H~dlkp~Nil~~~~~~~--~kl~dfg~~~~~~~~~-------------------------------------------~  195 (312)
T 2iwi_A          161 VHRDIKDENILIDLRRGC--AKLIDFGSGALLHDEP-------------------------------------------Y  195 (312)
T ss_dssp             ECCCCSGGGEEEETTTTE--EEECCCSSCEECCSSC-------------------------------------------B
T ss_pred             eecCCChhhEEEeCCCCe--EEEEEcchhhhcccCc-------------------------------------------c
Confidence            9999999999998 5565  8999999876433110                                           0


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ....+|..|++|         +..+|+|++|+++++|..|..|+..
T Consensus       196 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            012244445554         1257999999999999999877643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.86  E-value=3e-23  Score=205.22  Aligned_cols=162  Identities=16%  Similarity=0.205  Sum_probs=116.4

Q ss_pred             hHHHHHHHHhhcC--CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK--HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~--HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.++++++  ||||+++++++...+..|+|||++.++|.+++... +.+++..+..++.|++.||.|||+++++|
T Consensus        72 ~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  150 (313)
T 3cek_A           72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVH  150 (313)
T ss_dssp             HHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            4567999999998  59999999999999999999997778999988764 56899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhcccccc-----CceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR-----RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~-----~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      |||||+|||+++ +.  +|++|||+++.+.....     ....+..|.||+++.......                    
T Consensus       151 ~dlkp~NIl~~~-~~--~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--------------------  207 (313)
T 3cek_A          151 SDLKPANFLIVD-GM--LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR--------------------  207 (313)
T ss_dssp             CCCCGGGEEEET-TE--EEECCCSSSCC--------------CCGGGCCHHHHTTCC-----------------------
T ss_pred             cCCCcccEEEEC-Ce--EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhccccc--------------------
Confidence            999999999964 44  99999999875542211     111222233333322100000                    


Q ss_pred             ccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         422 SKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       422 ~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                          . ....-...+..+|+|++|+++++|..|..|+.
T Consensus       208 ----~-~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (313)
T 3cek_A          208 ----E-NGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  240 (313)
T ss_dssp             ------------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ----c-cccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence                0 00000112346799999999999999996654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.86  E-value=2.8e-23  Score=206.84  Aligned_cols=104  Identities=25%  Similarity=0.462  Sum_probs=85.4

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                           
T Consensus       115 i~~aL~~LH~~~ivHrDlkp----~NIll~~~----g~~kL~Dfg~a~~~~~~---------------------------  159 (318)
T 1fot_A          115 VCLALEYLHSKDIIYRDLKP----ENILLDKN----GHIKITDFGFAKYVPDV---------------------------  159 (318)
T ss_dssp             HHHHHHHHHTTTEECCCCCG----GGEEECTT----SCEEECCCSSCEECSSC---------------------------
T ss_pred             HHHHHHHHHHCCccccCCCh----heEEEcCC----CCEEEeecCcceecCCc---------------------------
Confidence            78899999999999999999    89999866    79999999999842110                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                        ....+                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+ ..+.+.
T Consensus       160 --~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~  213 (318)
T 1fot_A          160 --TYTLC----------------------GTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYE  213 (318)
T ss_dssp             --BCCCC----------------------SCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHH
T ss_pred             --ccccc----------------------CCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCC-HHHHHH
Confidence              01122                      399999999998765 9999999999999999999999998853 345666


Q ss_pred             HHHHH
Q psy3074         181 KIFKI  185 (481)
Q Consensus       181 ~i~~~  185 (481)
                      +|...
T Consensus       214 ~i~~~  218 (318)
T 1fot_A          214 KILNA  218 (318)
T ss_dssp             HHHHC
T ss_pred             HHHhC
Confidence            66654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.86  E-value=3.4e-23  Score=209.04  Aligned_cols=110  Identities=21%  Similarity=0.410  Sum_probs=88.2

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                    
T Consensus       144 ~~~~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----g~~kL~DFg~a~~~~~~--------------------  194 (350)
T 1rdq_E          144 RFYAAQ-IVLTFEYLHSLDLIYRDLKP----ENLLIDQQ----GYIQVTDFGFAKRVKGR--------------------  194 (350)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECSSC--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCcccccCcc----ceEEECCC----CCEEEcccccceeccCC--------------------
Confidence            334444 78899999999999999999    89999866    79999999999843110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                               ....+|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+
T Consensus       195 ---------~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~  242 (350)
T 1rdq_E          195 ---------TWTLCG----------------------TPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQ  242 (350)
T ss_dssp             ---------BCCCEE----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---------cccccC----------------------CccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence                     011233                      99999999998765 9999999999999999999999999853


Q ss_pred             hhHHHHHHHHHH
Q psy3074         174 EVYDQLDKIFKI  185 (481)
Q Consensus       174 ~~~~~l~~i~~~  185 (481)
                       ..+.+++|...
T Consensus       243 -~~~~~~~i~~~  253 (350)
T 1rdq_E          243 -PIQIYEKIVSG  253 (350)
T ss_dssp             -HHHHHHHHHHC
T ss_pred             -HHHHHHHHHcC
Confidence             34566666654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.86  E-value=1.7e-22  Score=210.36  Aligned_cols=127  Identities=26%  Similarity=0.313  Sum_probs=95.3

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .+... .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+......                    
T Consensus       114 ~i~~q-il~aL~~lH~~givHrDlKp----~NIll~~~~-~~~~vkL~DFG~a~~~~~~~--------------------  167 (444)
T 3soa_A          114 HCIQQ-ILEAVLHCHQMGVVHRNLKP----ENLLLASKL-KGAAVKLADFGLAIEVEGEQ--------------------  167 (444)
T ss_dssp             HHHHH-HHHHHHHHHHTTCBCCCCSS----TTEEESBSS-TTCCEEECCCSSCBCCCTTC--------------------
T ss_pred             HHHHH-HHHHHHHHHHCCccccCCCH----HHEEEeccC-CCCcEEEccCceeEEecCCC--------------------
Confidence            33444 78899999999999999999    899998542 34789999999997532110                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                            ......                      .+|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.+ 
T Consensus       168 ------~~~~~~----------------------~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~-  217 (444)
T 3soa_A          168 ------QAWFGF----------------------AGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDED-  217 (444)
T ss_dssp             ------CBCCCS----------------------CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred             ------ceeecc----------------------cCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCcc-
Confidence                  000111                      2399999999998765 9999999999999999999999998854 


Q ss_pred             hHHHHHHHHHHhCCCCccCcccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      ..+.+..+......++.+.|+.+
T Consensus       218 ~~~~~~~i~~~~~~~~~~~~~~~  240 (444)
T 3soa_A          218 QHRLYQQIKAGAYDFPSPEWDTV  240 (444)
T ss_dssp             HHHHHHHHHHTCCCCCTTTTTTS
T ss_pred             HHHHHHHHHhCCCCCCccccccC
Confidence            34667777766555555555443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.86  E-value=4.2e-23  Score=225.59  Aligned_cols=114  Identities=24%  Similarity=0.464  Sum_probs=89.8

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++|||||||||    +||||+..    |.+||+|||+|+....                   
T Consensus       443 ~~~~~~~q-i~~aL~~LH~~gIiHrDLKp----~NILl~~~----g~ikL~DFGla~~~~~-------------------  494 (674)
T 3pfq_A          443 HAVFYAAE-IAIGLFFLQSKGIIYRDLKL----DNVMLDSE----GHIKIADFGMCKENIW-------------------  494 (674)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTSEECCCCCS----TTEEECSS----SCEEECCCTTCEECCC-------------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCeEeccCCh----hhEEEcCC----CcEEEeecceeecccc-------------------
Confidence            33344444 78999999999999999999    89999876    7999999999984211                   


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                             .+.....++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.+
T Consensus       495 -------~~~~~~~~~G----------------------T~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~  544 (674)
T 3pfq_A          495 -------DGVTTKTFCG----------------------TPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEG  544 (674)
T ss_dssp             -------TTCCBCCCCS----------------------CSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------CCcccccccC----------------------CCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCC
Confidence                   1111122334                      99999999998765 99999999999999999999999998


Q ss_pred             chhhHHHHHHHHH
Q psy3074         172 VREVYDQLDKIFK  184 (481)
Q Consensus       172 ~~~~~~~l~~i~~  184 (481)
                      .+ ..+.+++|..
T Consensus       545 ~~-~~~~~~~i~~  556 (674)
T 3pfq_A          545 ED-EDELFQSIME  556 (674)
T ss_dssp             SS-HHHHHHHHHS
T ss_pred             CC-HHHHHHHHHh
Confidence            53 3466666654

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.86  E-value=1.5e-22  Score=202.10  Aligned_cols=135  Identities=44%  Similarity=0.770  Sum_probs=103.9

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++... +..+.+||+|||+|+......                  
T Consensus       135 ~~i~~q-l~~~l~~LH~~~ivH~Dlkp----~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~------------------  191 (329)
T 3gbz_A          135 KSFLYQ-LINGVNFCHSRRCLHRDLKP----QNLLLSVSDASETPVLKIGDFGLARAFGIPI------------------  191 (329)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEEC-----CCEEEECCTTHHHHHC---------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCEECCCCCH----HHEEEecCCCCccceEEECcCCCccccCCcc------------------
Confidence            344444 78899999999999999999    899997553 344679999999998532110                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                              .....                      ..+|+.|+|||++.+...|+.++||||+||++|||++|++||.+.
T Consensus       192 --------~~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          192 --------RQFTH----------------------EIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             --------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------cccCC----------------------CcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence                    00001                      123999999999998777999999999999999999999999985


Q ss_pred             hhhHHHHHHHHHHhCCCCccCcccccCCCC
Q psy3074         173 REVYDQLDKIFKILGTPTEETWEGVSLLPG  202 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~  202 (481)
                      . ..+++..+.+.++.|+...|+.....+.
T Consensus       242 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (329)
T 3gbz_A          242 S-EIDQLFKIFEVLGLPDDTTWPGVTALPD  270 (329)
T ss_dssp             S-HHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             C-HHHHHHHHHHHhCCCchhhhhhhhhhhh
Confidence            4 4588999999999999999887765543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.85  E-value=8.2e-23  Score=205.79  Aligned_cols=99  Identities=28%  Similarity=0.522  Sum_probs=80.5

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                      
T Consensus       114 ~~~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----g~~kL~DFG~a~~~~~----------------------  162 (345)
T 3a8x_A          114 FYSAE-ISLALNYLHERGIIYRDLKL----DNVLLDSE----GHIKLTDYGMCKEGLR----------------------  162 (345)
T ss_dssp             HHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCGGGCBCSCC----------------------
T ss_pred             HHHHH-HHHHHHHHHHCCceecCCCH----HHEEECCC----CCEEEEeccccccccC----------------------
Confidence            33333 78899999999999999999    89999866    7999999999984211                      


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                          .+.....++|                      |+.|+|||++.+.. |+.++||||+||++|||++|++||.+
T Consensus       163 ----~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          163 ----PGDTTSTFCG----------------------TPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             ----TTCCBCCCCS----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ----CCCcccccCC----------------------CccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCC
Confidence                1111112233                      99999999998765 99999999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.85  E-value=6.2e-23  Score=207.81  Aligned_cols=129  Identities=39%  Similarity=0.692  Sum_probs=102.1

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                   
T Consensus       132 ~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~a~~~~~~~~-------------------  183 (364)
T 3qyz_A          132 YFLYQ-ILRGLKYIHSANVLHRDLKP----SNLLLNTT----CDLKICDFGLARVADPDHD-------------------  183 (364)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECCGGGC-------------------
T ss_pred             HHHHH-HHHHHHHHHHCCeecCCCCh----HhEEECCC----CCEEEEeCcceEecCCCCC-------------------
Confidence            34444 78899999999999999999    89999876    7999999999985321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                          ......                      ...+|++|+|||++.+...|+.++||||+||++|||++|++||.+. +
T Consensus       184 ----~~~~~~----------------------~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-~  236 (364)
T 3qyz_A          184 ----HTGFLT----------------------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK-H  236 (364)
T ss_dssp             ----BCCTTC----------------------CCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS-S
T ss_pred             ----cccccc----------------------ccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC-C
Confidence                000001                      1224999999999988777999999999999999999999999985 4


Q ss_pred             hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      ..+++..+...++.|+.+.+....
T Consensus       237 ~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          237 YLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             hHHHHHHHHHHhCCCCHHHHHHhh
Confidence            458999999999999887665543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.85  E-value=7.5e-23  Score=209.02  Aligned_cols=101  Identities=21%  Similarity=0.408  Sum_probs=81.3

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                     
T Consensus       118 ~~~~~q-i~~aL~~LH~~givHrDlkp----~NIll~~~----g~vkL~DFG~a~~~~~---------------------  167 (384)
T 4fr4_A          118 KLFICE-LVMALDYLQNQRIIHRDMKP----DNILLDEH----GHVHITDFNIAAMLPR---------------------  167 (384)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCT---------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCceeccCcH----HHeEECCC----CCEEEeccceeeeccC---------------------
Confidence            334444 78999999999999999999    89999876    7999999999985321                     


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~--~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                            +.....++|                      |+.|+|||++.+.  ..|+.++||||+||++|||++|++||.+
T Consensus       168 ------~~~~~~~~g----------------------t~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          168 ------ETQITTMAG----------------------TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             ------TCCBCCCCS----------------------CGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ------CCceeccCC----------------------CccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence                  111112233                      9999999999753  3599999999999999999999999985


Q ss_pred             c
Q psy3074         172 V  172 (481)
Q Consensus       172 ~  172 (481)
                      .
T Consensus       220 ~  220 (384)
T 4fr4_A          220 R  220 (384)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.85  E-value=1.1e-22  Score=209.68  Aligned_cols=109  Identities=28%  Similarity=0.373  Sum_probs=85.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                         .
T Consensus       177 i~~aL~~LH~~givHrDLKp----~NILl~~~----g~ikL~DFG~a~~~~~~~-------------------------~  223 (410)
T 3v8s_A          177 VVLALDAIHSMGFIHRDVKP----DNMLLDKS----GHLKLADFGTCMKMNKEG-------------------------M  223 (410)
T ss_dssp             HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCTTS-------------------------E
T ss_pred             HHHHHHHHHHCCeEeccCCH----HHeeECCC----CCEEEeccceeEeeccCC-------------------------c
Confidence            78899999999999999999    89999876    799999999998432100                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE---YSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~---y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                      ......                      ++|+.|||||++.+...   |+.++||||+||++|||++|++||.+. +..+
T Consensus       224 ~~~~~~----------------------~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~  280 (410)
T 3v8s_A          224 VRCDTA----------------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVG  280 (410)
T ss_dssp             EECCSC----------------------CSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS-SHHH
T ss_pred             ccccCC----------------------cCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC-Chhh
Confidence            000112                      24999999999986542   889999999999999999999999985 3446


Q ss_pred             HHHHHHHH
Q psy3074         178 QLDKIFKI  185 (481)
Q Consensus       178 ~l~~i~~~  185 (481)
                      .+.+|...
T Consensus       281 ~~~~i~~~  288 (410)
T 3v8s_A          281 TYSKIMNH  288 (410)
T ss_dssp             HHHHHHTH
T ss_pred             HHHHHHhc
Confidence            66666543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.85  E-value=1.4e-22  Score=205.06  Aligned_cols=113  Identities=17%  Similarity=0.188  Sum_probs=85.1

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhcccc-------CCCCCceeeecccccccccCCCCCcCCC
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKY-------ATPPRELKLADFGLARAKSVPSHTYSHQ   80 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~-------~~~~g~~Kl~DFGla~~~~~~~~~~~~~   80 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..       ....+.+||+|||+|+....        
T Consensus       169 l~~~~~~~i~~q-i~~~L~~lH~~~ivHrDiKp----~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--------  235 (365)
T 3e7e_A          169 MPQGLVISFAMR-MLYMIEQVHDCEIIHGDIKP----DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL--------  235 (365)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHTTTEECCCCSG----GGEEECGGGTCC------CTTEEECCCTTCEEGGG--------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHhhCCeecCCCCH----HHEEecccccCccccccccCCEEEeeCchhhhhhc--------
Confidence            333444555555 78899999999999999999    89999872       11247999999999974321        


Q ss_pred             CCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHH
Q psy3074          81 GDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILI  160 (481)
Q Consensus        81 ~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~  160 (481)
                                      ...+.....                      ..+|+.|||||++.+.. |+.++||||+||++|
T Consensus       236 ----------------~~~~~~~~~----------------------~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  276 (365)
T 3e7e_A          236 ----------------FPKGTIFTA----------------------KCETSGFQCVEMLSNKP-WNYQIDYFGVAATVY  276 (365)
T ss_dssp             ----------------SCTTEEECC----------------------SSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHH
T ss_pred             ----------------cCCCceeee----------------------ecCCCCCCChHHhcCCC-CCccccHHHHHHHHH
Confidence                            011111111                      22499999999999876 999999999999999


Q ss_pred             HHHhCCCCCCCc
Q psy3074         161 EMVTGLPTFPGV  172 (481)
Q Consensus       161 elltg~~PF~g~  172 (481)
                      ||++|++||.+.
T Consensus       277 elltg~~pf~~~  288 (365)
T 3e7e_A          277 CMLFGTYMKVKN  288 (365)
T ss_dssp             HHHHSSCCCEEE
T ss_pred             HHHhCCCccccC
Confidence            999999999643

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.85  E-value=1.5e-22  Score=210.19  Aligned_cols=112  Identities=23%  Similarity=0.401  Sum_probs=87.4

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                     
T Consensus       179 ~~~~q-i~~aL~~LH~~giiHrDLKp----~NILl~~~----g~vkL~DFGla~~~~~~---------------------  228 (437)
T 4aw2_A          179 FYLAE-MVIAIDSVHQLHYVHRDIKP----DNILMDMN----GHIRLADFGSCLKLMED---------------------  228 (437)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCTT---------------------
T ss_pred             HHHHH-HHHHHHHHHhCCeEecccCH----HHeeEcCC----CCEEEcchhhhhhcccC---------------------
Confidence            34444 78899999999999999999    89999876    79999999999753211                     


Q ss_pred             ccCCCCce-eEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          95 DQLGEGSY-ATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL----GSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        95 ~~~g~g~~-~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~----~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                           +.. ....                      ++|+.|||||++.    +...|+.++||||+||++|||++|++||
T Consensus       229 -----~~~~~~~~----------------------~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf  281 (437)
T 4aw2_A          229 -----GTVQSSVA----------------------VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF  281 (437)
T ss_dssp             -----SCEECCSC----------------------CSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -----CCcccccc----------------------cCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence                 000 0112                      2499999999997    2445999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFK  184 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~  184 (481)
                      .+. +..+.+.+|..
T Consensus       282 ~~~-~~~~~~~~i~~  295 (437)
T 4aw2_A          282 YAE-SLVETYGKIMN  295 (437)
T ss_dssp             CCS-SHHHHHHHHHT
T ss_pred             CCC-ChhHHHHhhhh
Confidence            985 34466666654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.85  E-value=1.4e-22  Score=210.07  Aligned_cols=120  Identities=30%  Similarity=0.612  Sum_probs=98.0

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCc--eeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRE--LKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      .++.. .+.||+|||+++|+||||||    +|||++..    |.  +||+|||+|+......                  
T Consensus       204 ~i~~q-i~~aL~~LH~~~ivHrDlKp----~NILl~~~----~~~~vkL~DFG~a~~~~~~~------------------  256 (429)
T 3kvw_A          204 KFAHS-ILQCLDALHKNRIIHCDLKP----ENILLKQQ----GRSGIKVIDFGSSCYEHQRV------------------  256 (429)
T ss_dssp             HHHHH-HHHHHHHHHHHTEECSCCSG----GGEEESST----TSCCEEECCCTTCEETTCCC------------------
T ss_pred             HHHHH-HHHHHHHHHHCCeecCCCCH----HHeEEccC----CCcceEEeecccceecCCcc------------------
Confidence            34444 78899999999999999999    89999876    44  9999999997421100                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                                 ..+                      .+|+.|||||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       257 -----------~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          257 -----------YTY----------------------IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             -----------CSS----------------------CSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------ccc----------------------CCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence                       011                      2399999999999876 999999999999999999999999995


Q ss_pred             hhhHHHHHHHHHHhCCCCccCccc
Q psy3074         173 REVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      + ..+++..+.+.++.|+.+.+..
T Consensus       303 ~-~~~~l~~i~~~~~~p~~~~~~~  325 (429)
T 3kvw_A          303 D-EGDQLACMIELLGMPSQKLLDA  325 (429)
T ss_dssp             S-HHHHHHHHHHHHCCCCHHHHHT
T ss_pred             C-HHHHHHHHHHHcCCCCHHHHHh
Confidence            4 4588999999999998875543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.85  E-value=3.3e-22  Score=199.18  Aligned_cols=132  Identities=17%  Similarity=0.287  Sum_probs=99.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.....++.. .+.||+|||++||+||||||    +|||++..  ..+.+||+|||+|+...                
T Consensus        99 ~~~~~~~~i~~q-i~~al~~lH~~givH~Dlkp----~NIl~~~~--~~~~~kl~Dfg~a~~~~----------------  155 (321)
T 1tki_A           99 LNEREIVSYVHQ-VCEALQFLHSHNIGHFDIRP----ENIIYQTR--RSSTIKIIEFGQARQLK----------------  155 (321)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESSS--SCCCEEECCCTTCEECC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCCCcCCCCH----HHEEEccC--CCCCEEEEECCCCeECC----------------
Confidence            334444445555 78899999999999999999    89999863  13799999999998432                


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                 .+.......|                      |+.|+|||++.+.. ++.++||||+||++|||++|.+
T Consensus       156 -----------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~  201 (321)
T 1tki_A          156 -----------PGDNFRLLFT----------------------APEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGIN  201 (321)
T ss_dssp             -----------TTCEEEEEES----------------------CGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSC
T ss_pred             -----------CCCccccccC----------------------ChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence                       1222233344                      99999999998765 8999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      ||.+..+ .+.+..+......++.+.|+.+
T Consensus       202 pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~  230 (321)
T 1tki_A          202 PFLAETN-QQIIENIMNAEYTFDEEAFKEI  230 (321)
T ss_dssp             TTCCSSH-HHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CCcCCCH-HHHHHHHHcCCCCCChhhhccC
Confidence            9998543 3667777766555555444443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.85  E-value=2.8e-22  Score=202.01  Aligned_cols=121  Identities=32%  Similarity=0.591  Sum_probs=98.9

Q ss_pred             ccccHHHHH--HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCC
Q psy3074          21 KLLDADIAE--ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLG   98 (481)
Q Consensus        21 ~~~~~~~lh--~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g   98 (481)
                      .+.||+|||  ++||+||||||    +|||++...   |.+||+|||+|+......                        
T Consensus       138 i~~al~~lH~~~~~ivH~Dlkp----~NIll~~~~---~~~kl~Dfg~a~~~~~~~------------------------  186 (360)
T 3e3p_A          138 LIRSIGCLHLPSVNVCHRDIKP----HNVLVNEAD---GTLKLCDFGSAKKLSPSE------------------------  186 (360)
T ss_dssp             HHHHHHHHTSTTTCCBCSCCCG----GGEEEETTT---TEEEECCCTTCBCCCTTS------------------------
T ss_pred             HHHHHHHHhCCCCCeecCcCCH----HHEEEeCCC---CcEEEeeCCCceecCCCC------------------------
Confidence            678899999  99999999999    899998632   799999999998532110                        


Q ss_pred             CCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHH
Q psy3074          99 EGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQ  178 (481)
Q Consensus        99 ~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~  178 (481)
                         ...                      ...+|+.|+|||++.+...|+.++||||+||++|||++|++||.+.+ ..++
T Consensus       187 ---~~~----------------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-~~~~  240 (360)
T 3e3p_A          187 ---PNV----------------------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-SAGQ  240 (360)
T ss_dssp             ---CCC----------------------STTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHH
T ss_pred             ---Ccc----------------------cccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-hHHH
Confidence               000                      11239999999999887779999999999999999999999999854 4588


Q ss_pred             HHHHHHHhCCCCccCccccc
Q psy3074         179 LDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       179 l~~i~~~~~~p~~~~~~~~~  198 (481)
                      +..+.+.++.|+.+.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3e3p_A          241 LHEIVRVLGCPSREVLRKLN  260 (360)
T ss_dssp             HHHHHHHHCCCCHHHHHHHC
T ss_pred             HHHHHHHcCCCCHHHHHhcc
Confidence            99999999999887776553

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.84  E-value=6.1e-22  Score=200.68  Aligned_cols=125  Identities=26%  Similarity=0.347  Sum_probs=92.6

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..+... .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+.....                    
T Consensus       131 ~~~~~q-i~~al~~lH~~~ivH~Dlkp----~NIll~~~~-~~~~~kl~DfG~a~~~~~~--------------------  184 (362)
T 2bdw_A          131 SHCIQQ-ILESIAYCHSNGIVHRNLKP----ENLLLASKA-KGAAVKLADFGLAIEVNDS--------------------  184 (362)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCBCCCCSG----GGEEESCSS-TTCCEEECCCTTCBCCTTC--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCeEeccCch----HHEEEecCC-CCCCEEEeecCcceEecCC--------------------
Confidence            334444 68899999999999999999    899998652 2357999999999853211                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .......                      +|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.+
T Consensus       185 -------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~  234 (362)
T 2bdw_A          185 -------EAWHGFA----------------------GTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDED  234 (362)
T ss_dssp             -------CSCCCSC----------------------SCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------cccccCC----------------------CCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence                   0001112                      399999999998765 9999999999999999999999998854


Q ss_pred             hhHHHHHHHHHHhCCCCccCcc
Q psy3074         174 EVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      . .+.+..+......++...|+
T Consensus       235 ~-~~~~~~i~~~~~~~~~~~~~  255 (362)
T 2bdw_A          235 Q-HRLYAQIKAGAYDYPSPEWD  255 (362)
T ss_dssp             H-HHHHHHHHHTCCCCCTTGGG
T ss_pred             H-HHHHHHHHhCCCCCCccccc
Confidence            3 35666666554444444443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.84  E-value=1.1e-21  Score=194.67  Aligned_cols=129  Identities=40%  Similarity=0.685  Sum_probs=103.1

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                  
T Consensus       121 ~~~~~~~q-i~~~l~~lH~~gi~H~dlkp----~Nili~~~----~~~kl~Dfg~~~~~~~~------------------  173 (326)
T 1blx_A          121 TIKDMMFQ-LLRGLDFLHSHRVVHRDLKP----QNILVTSS----GQIKLADFGLARIYSFQ------------------  173 (326)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECSCCSCCCCCGG------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCceeccCCH----HHeEEcCC----CCEEEecCcccccccCC------------------
Confidence            33444444 78899999999999999999    89999876    79999999999742110                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               ...                      ....+|+.|+|||++.+.. ++.++||||+||++|||++|++||.+
T Consensus       174 ---------~~~----------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          174 ---------MAL----------------------TSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             ---------GGG----------------------CCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ---------CCc----------------------cccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCC
Confidence                     000                      0112389999999998776 99999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccccCC
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVSLL  200 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  200 (481)
                      ..+ .+.+..+.+.++.|..+.|+.....
T Consensus       222 ~~~-~~~~~~i~~~~~~~~~~~~~~~~~~  249 (326)
T 1blx_A          222 SSD-VDQLGKILDVIGLPGEEDWPRDVAL  249 (326)
T ss_dssp             SSH-HHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             CCH-HHHHHHHHHHcCCCCcccCcccccc
Confidence            544 4788999999999998888765443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.84  E-value=1.5e-22  Score=205.58  Aligned_cols=99  Identities=15%  Similarity=0.233  Sum_probs=80.4

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      +.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                     
T Consensus       197 ~~i~~q-i~~aL~~LH~~~ivHrDikp----~NIll~~~----~~~kL~DFG~a~~~~~---------------------  246 (371)
T 3q60_A          197 HILTAQ-LIRLAANLQSKGLVHGHFTP----DNLFIMPD----GRLMLGDVSALWKVGT---------------------  246 (371)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEEETTCSG----GGEEECTT----SCEEECCGGGEEETTC---------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCCccCcCCH----HHEEECCC----CCEEEEecceeeecCC---------------------
Confidence            344444 78899999999999999999    89999876    7999999999984210                     


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                              ....                      ..+|+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.
T Consensus       247 --------~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          247 --------RGPA----------------------SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             --------EEEG----------------------GGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             --------CccC----------------------ccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                    0000                      1137999999999862 34999999999999999999999999875

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.84  E-value=3.5e-23  Score=213.51  Aligned_cols=153  Identities=15%  Similarity=0.106  Sum_probs=113.3

Q ss_pred             eEEEEEeccCCCHHHHHHHh------cCCCChHHHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHH
Q psy3074         297 TLTFVFEYVHTDLSQYMERH------SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQ  370 (481)
Q Consensus       297 ~~~iv~E~~~g~l~~~l~~~------~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfg  370 (481)
                      ..+++|+++.++|.+++...      .+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.  +|++|||
T Consensus       179 ~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~--~kL~DFG  256 (413)
T 3dzo_A          179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG--VFLTGFE  256 (413)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCGG
T ss_pred             ceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCe--EEEEecc
Confidence            57889999999998887522      233667788889999999999999999999999999999998888  9999999


Q ss_pred             HHhhccccccCceeccccCCCccc--------------ccccccccCCCeeEEEeecCCCCccccccCcccceeccCCCC
Q psy3074         371 LLRGLSYCHRRRILHRDVKPQNLL--------------ISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLPPG  436 (481)
Q Consensus       371 la~~~~~~~~~~i~~~d~~~~~il--------------~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p~  436 (481)
                      +++.........+. ..|.+||++              .+...|.||+|++++++.+|..||.............-..+.
T Consensus       257 ~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~~~  335 (413)
T 3dzo_A          257 HLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCKN  335 (413)
T ss_dssp             GCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSCCC
T ss_pred             ceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhccc
Confidence            98876644444445 788899988              334667899999999999999999765432211111111123


Q ss_pred             CChhhhhhHHHHHHhhCCC
Q psy3074         437 APFTAIREASLLKELKHNN  455 (481)
Q Consensus       437 ~p~~~~s~~~~l~~l~~~~  455 (481)
                      .|.   .+..++..|+..+
T Consensus       336 ~~~---~~~~li~~~l~~d  351 (413)
T 3dzo_A          336 IPQ---PVRALLEGFLRYP  351 (413)
T ss_dssp             CCH---HHHHHHHHHTCSS
T ss_pred             CCH---HHHHHHHHHccCC
Confidence            333   3455666666654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.84  E-value=1.4e-22  Score=202.38  Aligned_cols=112  Identities=27%  Similarity=0.496  Sum_probs=84.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                     
T Consensus       125 ~~~~q-i~~al~~lH~~~ivH~Dlkp----~Nill~~~----~~~kl~Dfg~~~~~~~~---------------------  174 (327)
T 3a62_A          125 FYLAE-ISMALGHLHQKGIIYRDLKP----ENIMLNHQ----GHVKLTDFGLCKESIHD---------------------  174 (327)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCCCCCT----TTEEECTT----SCEEECCCSCC---------------------------
T ss_pred             HHHHH-HHHHHHHHHhCCEEcccCCH----HHeEECCC----CcEEEEeCCcccccccC---------------------
Confidence            34444 78899999999999999999    89999866    79999999999742110                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                           +....                      ...+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+ 
T Consensus       175 -----~~~~~----------------------~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~-  225 (327)
T 3a62_A          175 -----GTVTH----------------------TFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN-  225 (327)
T ss_dssp             ---------C----------------------TTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSS-
T ss_pred             -----Ccccc----------------------ccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCC-
Confidence                 00000                      112499999999998765 9999999999999999999999999853 


Q ss_pred             hHHHHHHHHHH
Q psy3074         175 VYDQLDKIFKI  185 (481)
Q Consensus       175 ~~~~l~~i~~~  185 (481)
                      ..+.+..+.+.
T Consensus       226 ~~~~~~~i~~~  236 (327)
T 3a62_A          226 RKKTIDKILKC  236 (327)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHhC
Confidence            33556666554

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.84  E-value=1.8e-22  Score=210.12  Aligned_cols=112  Identities=25%  Similarity=0.407  Sum_probs=86.0

Q ss_pred             hhhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          14 ISVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ..++.. .+.||+|||+ +||+||||||    +|||++..    |.+||+|||+|+.....                   
T Consensus       251 ~~~~~q-i~~aL~~LH~~~giiHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~-------------------  302 (446)
T 4ejn_A          251 RFYGAE-IVSALDYLHSEKNVVYRDLKL----ENLMLDKD----GHIKITDFGLCKEGIKD-------------------  302 (446)
T ss_dssp             HHHHHH-HHHHHHHHHHHTCCCCCCCCG----GGEEECSS----SCEEECCCCCCCTTCC--------------------
T ss_pred             HHHHHH-HHHHHHHHhhcCCEEECCCCH----HHEEECCC----CCEEEccCCCceeccCC-------------------
Confidence            334444 7889999998 9999999999    89999876    79999999999842110                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             +.....+                      .+|+.|||||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       303 -------~~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~  352 (446)
T 4ejn_A          303 -------GATMKTF----------------------CGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQ  352 (446)
T ss_dssp             -----------CCS----------------------SSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -------Ccccccc----------------------cCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCC
Confidence                   1111112                      2499999999998766 999999999999999999999999885


Q ss_pred             hhhHHHHHHHHH
Q psy3074         173 REVYDQLDKIFK  184 (481)
Q Consensus       173 ~~~~~~l~~i~~  184 (481)
                      + ..+.+..+..
T Consensus       353 ~-~~~~~~~i~~  363 (446)
T 4ejn_A          353 D-HEKLFELILM  363 (446)
T ss_dssp             S-HHHHHHHHHH
T ss_pred             C-HHHHHHHHHh
Confidence            3 3345555544

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.84  E-value=1.8e-22  Score=205.20  Aligned_cols=118  Identities=19%  Similarity=0.386  Sum_probs=87.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........             
T Consensus       202 ~~~~~~i~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~~~~-------------  259 (370)
T 2psq_A          202 FKDLVSCTYQ-LARGMEYLASQKCIHRDLAA----RNVLVTEN----NVMKIADFGLARDINNIDYY-------------  259 (370)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCCSSCEETTCCCTT-------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeeccccch----hhEEECCC----CCEEEccccCCcccCcccce-------------
Confidence            3334445555 78899999999999999999    89999866    79999999999853211000             


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                              .                         ......+|+.|+|||++.+.. |+.++|||||||++|||++ |.+|
T Consensus       260 --------~-------------------------~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p  305 (370)
T 2psq_A          260 --------K-------------------------KTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP  305 (370)
T ss_dssp             --------C-------------------------TTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             --------e-------------------------cccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCC
Confidence                    0                         000112388999999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+.. ..+.+..+..
T Consensus       306 ~~~~~-~~~~~~~~~~  320 (370)
T 2psq_A          306 YPGIP-VEELFKLLKE  320 (370)
T ss_dssp             STTCC-GGGHHHHHHT
T ss_pred             CCCCC-HHHHHHHHhc
Confidence            98853 2234444433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.84  E-value=7.5e-22  Score=202.73  Aligned_cols=107  Identities=25%  Similarity=0.408  Sum_probs=80.7

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+....                  
T Consensus       161 ~~~~~i~~q-i~~aL~~LH~~~ivHrDlkp----~Nill~~~~-~~~~~kl~DFG~a~~~~~------------------  216 (400)
T 1nxk_A          161 REASEIMKS-IGEAIQYLHSINIAHRDVKP----ENLLYTSKR-PNAILKLTDFGFAKETTS------------------  216 (400)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESSSS-TTCCEEECCCTTCEECC-------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCccccCcCc----ceEEEecCC-CCccEEEEecccccccCC------------------
Confidence            333444444 78899999999999999999    899998631 237899999999984321                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               .......+                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||.
T Consensus       217 ---------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~  264 (400)
T 1nxk_A          217 ---------HNSLTTPC----------------------YTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFY  264 (400)
T ss_dssp             -----------------------------------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ---------CCccccCC----------------------CCCCccCHhhcCCCC-CCCcccHHHHHHHHHHHHhCCCCCC
Confidence                     01111223                      399999999997665 9999999999999999999999998


Q ss_pred             Cch
Q psy3074         171 GVR  173 (481)
Q Consensus       171 g~~  173 (481)
                      +..
T Consensus       265 ~~~  267 (400)
T 1nxk_A          265 SNH  267 (400)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.84  E-value=3.5e-22  Score=200.89  Aligned_cols=119  Identities=22%  Similarity=0.353  Sum_probs=87.6

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....+... .+.||+|||++||+||||||    +|||+.......+.+||+|||+|+.....                  
T Consensus       117 ~~~~~~~q-i~~al~~lH~~givHrDlkp----~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~------------------  173 (342)
T 2qr7_A          117 EASAVLFT-ITKTVEYLHAQGVVHRDLKP----SNILYVDESGNPESIRICDFGFAKQLRAE------------------  173 (342)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEESSSSCSGGGEEECCCTTCEECBCT------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCcEeccCCH----HHEEEecCCCCcCeEEEEECCCcccCcCC------------------
Confidence            33344444 78899999999999999999    89998655433457999999999853211                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                              +......+                      +|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+
T Consensus       174 --------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          174 --------NGLLMTPC----------------------YTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             --------TCCBCCSS----------------------CCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             --------CCceeccC----------------------CCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCC
Confidence                    00111112                      399999999998765 99999999999999999999999986


Q ss_pred             c--hhhHHHHHHHHH
Q psy3074         172 V--REVYDQLDKIFK  184 (481)
Q Consensus       172 ~--~~~~~~l~~i~~  184 (481)
                      .  .+..+.+..|..
T Consensus       223 ~~~~~~~~~~~~i~~  237 (342)
T 2qr7_A          223 GPDDTPEEILARIGS  237 (342)
T ss_dssp             STTSCHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHcc
Confidence            4  233344455544

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.84  E-value=2.8e-22  Score=213.15  Aligned_cols=106  Identities=23%  Similarity=0.391  Sum_probs=84.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +.....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       288 e~~~~~~~~q-i~~aL~~LH~~gIvHrDLKP----~NILl~~~----g~vkL~DFGla~~~~~~~---------------  343 (543)
T 3c4z_A          288 EPRAIFYTAQ-IVSGLEHLHQRNIIYRDLKP----ENVLLDDD----GNVRISDLGLAVELKAGQ---------------  343 (543)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----SCEEECCCTTCEECCTTC---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHcCCcccCCCh----HHEEEeCC----CCEEEeecceeeeccCCC---------------
Confidence            3334444444 78999999999999999999    89999876    899999999998532110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 .....++                      +|+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       344 -----------~~~~~~~----------------------GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF  389 (543)
T 3c4z_A          344 -----------TKTKGYA----------------------GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPF  389 (543)
T ss_dssp             -----------CCBCCCC----------------------SCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -----------ccccccc----------------------CCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCC
Confidence                       0011123                      399999999998765 999999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+..
T Consensus       390 ~~~~  393 (543)
T 3c4z_A          390 RARG  393 (543)
T ss_dssp             CCTT
T ss_pred             CCCc
Confidence            8753

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.84  E-value=1.4e-21  Score=199.84  Aligned_cols=125  Identities=18%  Similarity=0.285  Sum_probs=94.3

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..  ..+.+||+|||+|+...                
T Consensus       146 l~~~~~~~i~~q-i~~aL~~LH~~givHrDlkp----~NIll~~~--~~~~vkL~DFG~a~~~~----------------  202 (387)
T 1kob_A          146 MSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKP----ENIMCETK--KASSVKIIDFGLATKLN----------------  202 (387)
T ss_dssp             BCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESST--TCCCEEECCCTTCEECC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCeeecccch----HHeEEecC--CCCceEEEecccceecC----------------
Confidence            344444455555 78899999999999999999    89999743  23689999999998432                


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                 .........|                      |+.|+|||++.+.. |+.++||||+||++|||++|.+
T Consensus       203 -----------~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~  248 (387)
T 1kob_A          203 -----------PDEIVKVTTA----------------------TAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLS  248 (387)
T ss_dssp             -----------TTSCEEEECS----------------------SGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCC
T ss_pred             -----------CCcceeeecc----------------------CCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCC
Confidence                       1112223334                      99999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPT  190 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~  190 (481)
                      ||.+.++ .+.+..+......++
T Consensus       249 Pf~~~~~-~~~~~~i~~~~~~~~  270 (387)
T 1kob_A          249 PFAGEDD-LETLQNVKRCDWEFD  270 (387)
T ss_dssp             SSCCSSH-HHHHHHHHHCCCCCC
T ss_pred             CCCCCCH-HHHHHHHHhCCCCCC
Confidence            9998543 366666655443333

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.84  E-value=2.1e-22  Score=198.28  Aligned_cols=110  Identities=24%  Similarity=0.434  Sum_probs=85.2

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                   
T Consensus       119 ~~~~~q-i~~~l~~lH~~~i~H~Dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-------------------  170 (297)
T 3fxz_A          119 AAVCRE-CLQALEFLHSNQVIHRDIKS----DNILLGMD----GSVKLTDFGFCAQITPEQ-------------------  170 (297)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECCSTT-------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCceeCCCCH----HHEEECCC----CCEEEeeCCCceecCCcc-------------------
Confidence            334444 67899999999999999999    89999876    799999999997532110                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             ......                      .+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+
T Consensus       171 -------~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~  220 (297)
T 3fxz_A          171 -------SKRSTM----------------------VGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (297)
T ss_dssp             -------CCBCCC----------------------CSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             -------cccCCc----------------------cCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   000111                      2399999999998876 9999999999999999999999998854


Q ss_pred             hhHHHHHHH
Q psy3074         174 EVYDQLDKI  182 (481)
Q Consensus       174 ~~~~~l~~i  182 (481)
                      .. +.+..+
T Consensus       221 ~~-~~~~~~  228 (297)
T 3fxz_A          221 PL-RALYLI  228 (297)
T ss_dssp             HH-HHHHHH
T ss_pred             HH-HHHHHH
Confidence            33 344433

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.84  E-value=3.7e-22  Score=205.76  Aligned_cols=107  Identities=24%  Similarity=0.400  Sum_probs=84.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                          +
T Consensus       171 i~~aL~~LH~~giiHrDLKp----~NILld~~----g~vkL~DFGla~~~~~~--------------------------~  216 (412)
T 2vd5_A          171 IVMAIDSVHRLGYVHRDIKP----DNILLDRC----GHIRLADFGSCLKLRAD--------------------------G  216 (412)
T ss_dssp             HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECCTT--------------------------S
T ss_pred             HHHHHHHHHHCCeeecccCH----HHeeecCC----CCEEEeechhheeccCC--------------------------C
Confidence            78999999999999999999    89999876    79999999999853211                          0


Q ss_pred             ce-eEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074         101 SY-ATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG------STEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus       101 ~~-~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~------~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                      .. ....+                      +|+.|||||++.+      ...|+.++||||+||++|||++|++||.+.+
T Consensus       217 ~~~~~~~~----------------------Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          217 TVRSLVAV----------------------GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             CEECSSCC----------------------SCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccccceec----------------------cccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            00 01122                      4999999999983      3449999999999999999999999999853


Q ss_pred             hhHHHHHHHHH
Q psy3074         174 EVYDQLDKIFK  184 (481)
Q Consensus       174 ~~~~~l~~i~~  184 (481)
                       ..+.+.+|..
T Consensus       275 -~~~~~~~i~~  284 (412)
T 2vd5_A          275 -TAETYGKIVH  284 (412)
T ss_dssp             -HHHHHHHHHT
T ss_pred             -HHHHHHHHHh
Confidence             3355666654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.84  E-value=1.2e-21  Score=197.32  Aligned_cols=125  Identities=35%  Similarity=0.623  Sum_probs=99.6

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                  
T Consensus       127 ~~~~i~~q-i~~al~~LH~~~ivH~dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~------------------  179 (353)
T 3coi_A          127 KIQYLVYQ-MLKGLKYIHSAGVVHRDLKP----GNLAVNED----CELKILDFGLARHADAE------------------  179 (353)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSSCCG----GGEEECTT----CCEEECSTTCTTC----------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCcccCCCCH----HHEeECCC----CcEEEeecccccCCCCC------------------
Confidence            33344444 78899999999999999999    89999866    79999999999742100                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                 ....                      .+|+.|+|||++.+...++.++||||+||++|||++|++||.+
T Consensus       180 -----------~~~~----------------------~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          180 -----------MTGY----------------------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             -------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred             -----------cccc----------------------ccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                       0111                      2399999999998866699999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      . +..+++..+.+..+.|+.+.+...
T Consensus       227 ~-~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          227 K-DYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             S-CHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             C-CHHHHHHHHHHHhCCCCHHHHHHH
Confidence            5 445889999999999887655543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.84  E-value=8.5e-22  Score=195.05  Aligned_cols=100  Identities=24%  Similarity=0.356  Sum_probs=78.8

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+....                    
T Consensus       159 ~~~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIll~~~----~~~kl~DFG~a~~~~~--------------------  209 (311)
T 3p1a_A          159 VWGYLRD-TLLALAHLHSQGLVHLDVKP----ANIFLGPR----GRCKLGDFGLLVELGT--------------------  209 (311)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECGG----GCEEECCCTTCEECC---------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCEecCCCCH----HHEEECCC----CCEEEccceeeeeccc--------------------
Confidence            3344444 78899999999999999999    89999876    7999999999974321                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             ........                      +|+.|+|||++.+  .|+.++||||+||++|||++|..||.+.
T Consensus       210 -------~~~~~~~~----------------------gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~  258 (311)
T 3p1a_A          210 -------AGAGEVQE----------------------GDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG  258 (311)
T ss_dssp             ------------CCC----------------------CCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred             -------CCCCcccC----------------------CCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                   11111112                      3999999999986  4999999999999999999997777663

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.84  E-value=3.6e-22  Score=198.90  Aligned_cols=149  Identities=15%  Similarity=0.146  Sum_probs=97.3

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                
T Consensus       116 ~~~~~~~q-i~~~l~~lH~~~ivH~Dikp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~~----------------  170 (325)
T 3kex_A          116 LLLNWGVQ-IAKGMYYLEEHGMVHRNLAA----RNVLLKSP----SQVQVADFGVADLLPPDDK----------------  170 (325)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCSS----TTEEESSS----SCEEECSCSGGGGSCCCTT----------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCCCCCccch----heEEECCC----CeEEECCCCcccccCcccc----------------
Confidence            33444444 78899999999999999999    89999766    7999999999985421110                


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                              ........                      +|+.|+|||++.+.. |+.++||||+||++|||++ |+.||.
T Consensus       171 --------~~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~  219 (325)
T 3kex_A          171 --------QLLYSEAK----------------------TPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYA  219 (325)
T ss_dssp             --------CCC---------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             --------cccccCCC----------------------CcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCcc
Confidence                    00011111                      378999999998766 9999999999999999999 999998


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      +.... +....+......+.+...+..-......|+...|..|+++.
T Consensus       220 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~  265 (325)
T 3kex_A          220 GLRLA-EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFK  265 (325)
T ss_dssp             TSCTT-HHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHH
T ss_pred             ccCHH-HHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHH
Confidence            85322 33333333322222222222111112245555555555543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.83  E-value=9.9e-22  Score=198.20  Aligned_cols=125  Identities=26%  Similarity=0.335  Sum_probs=96.9

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC---------------------CCCCceeeeccccccccc
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA---------------------TPPRELKLADFGLARAKS   71 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~---------------------~~~g~~Kl~DFGla~~~~   71 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++...                     ...+.+||+|||+|+...
T Consensus       139 ~~~i~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  213 (360)
T 3llt_A          139 IKLYCIE-ILKALNYLRKMSLTHTDLKP----ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS  213 (360)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred             HHHHHHH-HHHHHHHHHHCCeeeCCCCc----ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence            3344444 78899999999999999999    899997521                     124789999999997422


Q ss_pred             CCCCCcCCCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccc
Q psy3074          72 VPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLD  151 (481)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~D  151 (481)
                      ...                             ...                      .+|+.|+|||++.+.. |+.++|
T Consensus       214 ~~~-----------------------------~~~----------------------~gt~~y~aPE~~~~~~-~~~~~D  241 (360)
T 3llt_A          214 DYH-----------------------------GSI----------------------INTRQYRAPEVILNLG-WDVSSD  241 (360)
T ss_dssp             SCC-----------------------------CSC----------------------CSCGGGCCHHHHTTCC-CCTTHH
T ss_pred             CCC-----------------------------cCc----------------------cCcccccCcHHHcCCC-CCCccc
Confidence            100                             001                      2399999999999876 999999


Q ss_pred             hhhHHHHHHHHHhCCCCCCCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         152 MWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       152 vWS~G~il~elltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      |||+||++|||++|++||.+.+ ..+.+..+....+.++...+.
T Consensus       242 iwslG~il~ell~g~~pf~~~~-~~~~~~~~~~~~~~~p~~~~~  284 (360)
T 3llt_A          242 MWSFGCVLAELYTGSLLFRTHE-HMEHLAMMESIIQPIPKNMLY  284 (360)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHHTCCCCHHHHH
T ss_pred             hHHHHHHHHHHHHCCCCCCCCc-HHHHHHHHHHhcCCCCHHHHh
Confidence            9999999999999999999854 447788888877777665443

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.83  E-value=1.1e-21  Score=195.79  Aligned_cols=124  Identities=19%  Similarity=0.248  Sum_probs=92.4

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++........+||+|||+|+......              
T Consensus       112 ~~~~~~~i~~q-i~~al~~lH~~~ivH~Dlkp----~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~--------------  172 (326)
T 2y0a_A          112 TEEEATEFLKQ-ILNGVYYLHSLQIAHFDLKP----ENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--------------  172 (326)
T ss_dssp             BHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESCSSSSSCCEEECCCTTCEECCTTS--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCeEcCCCCH----HHEEEecCCCCCCCEEEEECCCCeECCCCC--------------
Confidence            34444445555 78899999999999999999    899998764344589999999998532110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                   .....                      .+|+.|+|||++.+.. |+.++||||+||++|||++|.+|
T Consensus       173 -------------~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p  216 (326)
T 2y0a_A          173 -------------EFKNI----------------------FGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASP  216 (326)
T ss_dssp             -------------CCCCC----------------------CSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCS
T ss_pred             -------------ccccc----------------------cCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCC
Confidence                         00011                      2399999999998765 99999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHhCC
Q psy3074         169 FPGVREVYDQLDKIFKILGT  188 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~  188 (481)
                      |.+... .+.+..+......
T Consensus       217 f~~~~~-~~~~~~~~~~~~~  235 (326)
T 2y0a_A          217 FLGDTK-QETLANVSAVNYE  235 (326)
T ss_dssp             SCCSSH-HHHHHHHHHTCCC
T ss_pred             CCCCCH-HHHHHHHHhcCCC
Confidence            988533 3555555544333

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.83  E-value=3.7e-22  Score=208.36  Aligned_cols=150  Identities=19%  Similarity=0.325  Sum_probs=106.6

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+.....                 
T Consensus       284 ~~~~~~~~q-i~~~l~~LH~~~ivHrDlkp----~Nill~~~----~~~kl~DFG~a~~~~~~-----------------  337 (454)
T 1qcf_A          284 PKLIDFSAQ-IAEGMAFIEQRNYIHRDLRA----ANILVSAS----LVCKIADFGLARVIEDN-----------------  337 (454)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCSSCSG----GGEEECTT----CCEEECSTTGGGGBCCH-----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCccCCCCCH----HHEEECCC----CcEEEeeCCCceEcCCC-----------------
Confidence            334445555 78899999999999999999    89999876    79999999999843110                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF  169 (481)
                                .+                    .......+|+.|+|||++.+.. |+.++|||||||++|||++ |++||
T Consensus       338 ----------~~--------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~  386 (454)
T 1qcf_A          338 ----------EY--------------------TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPY  386 (454)
T ss_dssp             ----------HH--------------------HTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ----------ce--------------------eccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCC
Confidence                      00                    0000112378899999998765 9999999999999999999 99999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .+... .+.+..+.+....|.+..++..-......|+...|..|+++.+
T Consensus       387 ~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~  434 (454)
T 1qcf_A          387 PGMSN-PEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEY  434 (454)
T ss_dssp             TTCCH-HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence            98543 3566666666555555444432222334566666666666543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.83  E-value=4e-22  Score=209.12  Aligned_cols=120  Identities=26%  Similarity=0.406  Sum_probs=92.4

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...               
T Consensus       112 ~l~~~~~~~i~~q-i~~aL~~LH~~givHrDLkp----~NIll~~~----~~vkL~DFG~a~~~~---------------  167 (476)
T 2y94_A          112 RLDEKESRRLFQQ-ILSGVDYCHRHMVVHRDLKP----ENVLLDAH----MNAKIADFGLSNMMS---------------  167 (476)
T ss_dssp             SCCHHHHHHHHHH-HHHHHHHHHTTTEECSCCSG----GGEEECTT----CCEEECCCSSCEECC---------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHCCCCcccccH----HHEEEecC----CCeEEEeccchhhcc---------------
Confidence            3444444555555 78999999999999999999    89999876    799999999998532               


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  .+......+|                      |+.|+|||++.+...++.++||||+||++|||++|+
T Consensus       168 ------------~~~~~~~~~g----------------------t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~  213 (476)
T 2y94_A          168 ------------DGEFLRTSCG----------------------SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT  213 (476)
T ss_dssp             ------------TTCCBCCCCS----------------------CSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS
T ss_pred             ------------ccccccccCC----------------------CcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCC
Confidence                        1111112233                      999999999998775588999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~  185 (481)
                      +||.+.. ..+.+.+|...
T Consensus       214 ~Pf~~~~-~~~~~~~i~~~  231 (476)
T 2y94_A          214 LPFDDDH-VPTLFKKICDG  231 (476)
T ss_dssp             CSSCCSS-SHHHHHHHHTT
T ss_pred             CCCCCCC-HHHHHHHHhcC
Confidence            9998843 33555555544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.83  E-value=1.3e-21  Score=199.13  Aligned_cols=128  Identities=23%  Similarity=0.286  Sum_probs=95.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||+...  ..+.+||+|||+|+.....                
T Consensus       186 ~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~--~~~~~kl~DFG~a~~~~~~----------------  242 (373)
T 2x4f_A          186 ELDTILFMKQ-ICEGIRHMHQMYILHLDLKP----ENILCVNR--DAKQIKIIDFGLARRYKPR----------------  242 (373)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEEEET--TTTEEEECCCSSCEECCTT----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCcccccCCH----HHEEEecC--CCCcEEEEeCCCceecCCc----------------
Confidence            3344444444 78899999999999999999    89998532  2368999999999853211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|++||
T Consensus       243 -----------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf  288 (373)
T 2x4f_A          243 -----------EKLKVNF----------------------GTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPF  288 (373)
T ss_dssp             -----------CBCCCCC----------------------SSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -----------ccccccc----------------------CCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHhCCCCC
Confidence                       0001112                      399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      .+.++ .+.+..|......++.+.++
T Consensus       289 ~~~~~-~~~~~~i~~~~~~~~~~~~~  313 (373)
T 2x4f_A          289 LGDND-AETLNNILACRWDLEDEEFQ  313 (373)
T ss_dssp             CCSSH-HHHHHHHHHTCCCSCSGGGT
T ss_pred             CCCCH-HHHHHHHHhccCCCChhhhc
Confidence            98544 46777777765544444333

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.83  E-value=2e-22  Score=200.95  Aligned_cols=150  Identities=15%  Similarity=0.193  Sum_probs=98.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+........               
T Consensus       118 ~~~~~~~q-i~~~l~~LH~~~ivH~Dikp----~NIll~~~----~~~kl~Dfg~a~~~~~~~~~---------------  173 (327)
T 3poz_A          118 YLLNWCVQ-IAKGMNYLEDRRLVHRDLAA----RNVLVKTP----QHVKITDFGLAKLLGAEEKE---------------  173 (327)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEEET----TEEEECCTTHHHHHTTTCC----------------
T ss_pred             HHHHHHHH-HHHHHHHHhhCCeeCCCCCh----heEEECCC----CCEEEccCcceeEccCCccc---------------
Confidence            33445554 78899999999999999999    89999876    79999999999854221100               


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               .....                      ..+|+.|+|||++.+.. |+.++||||+||++|||++ |+.||.
T Consensus       174 ---------~~~~~----------------------~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~  221 (327)
T 3poz_A          174 ---------YHAEG----------------------GKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD  221 (327)
T ss_dssp             -------------------------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ---------ccccC----------------------CCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCcc
Confidence                     00000                      12388999999998765 9999999999999999999 999998


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      +.... +....+......+.+...+..-......|+...|..|+++.+
T Consensus       222 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  268 (327)
T 3poz_A          222 GIPAS-EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRE  268 (327)
T ss_dssp             TCCGG-GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred             CCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            75332 233333333333333222211111122455555555555443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.83  E-value=1.2e-21  Score=194.26  Aligned_cols=135  Identities=21%  Similarity=0.280  Sum_probs=94.4

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||+....+..+.+||+|||+|+......                
T Consensus       112 ~~~~~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~----------------  170 (319)
T 4euu_A          112 SEFLIVLRD-VVGGMNHLRENGIVHRNIKP----GNIMRVIGEDGQSVYKLTDFGAARELEDDE----------------  170 (319)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEECTTSCEEEEECCCTTCEECCTTC----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCEecCCCCH----HHEEEeccCCCCceEEEccCCCceecCCCC----------------
Confidence            333444444 78899999999999999999    899985444455789999999998532111                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC-------CCCCCCccchhhHHHHHHHHH
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG-------STEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~-------~~~y~~~~DvWS~G~il~ell  163 (481)
                                 ......                      +|+.|+|||++..       ...|+.++||||+||++|||+
T Consensus       171 -----------~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~  217 (319)
T 4euu_A          171 -----------QFVSLY----------------------GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA  217 (319)
T ss_dssp             -----------CBCCCC----------------------SCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred             -----------ceeecc----------------------cCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence                       000112                      3999999999862       345999999999999999999


Q ss_pred             hCCCCCCCchhhHHHHHHHHHHhCCCCccCcccccC
Q psy3074         164 TGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSL  199 (481)
Q Consensus       164 tg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~  199 (481)
                      +|+.||.+..........+.+.+..+++..++....
T Consensus       218 ~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  253 (319)
T 4euu_A          218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQK  253 (319)
T ss_dssp             HSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEEC
T ss_pred             hCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhc
Confidence            999999764333333333444444444445554443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.83  E-value=1.6e-21  Score=198.79  Aligned_cols=122  Identities=30%  Similarity=0.541  Sum_probs=97.0

Q ss_pred             hhccCcccccHHHHH--HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          15 SVSSDSKLLDADIAE--ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh--~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      .++.. .+.||.|||  +.||+||||||    +|||++..  ..+.+||+|||+|+......                  
T Consensus       161 ~i~~q-i~~al~~lH~~~~~ivHrDlkp----~NIll~~~--~~~~~kL~DFG~a~~~~~~~------------------  215 (382)
T 2vx3_A          161 KFAQQ-MCTALLFLATPELSIIHCDLKP----ENILLCNP--KRSAIKIVDFGSSCQLGQRI------------------  215 (382)
T ss_dssp             HHHHH-HHHHHHHHTSTTTCEECCCCSG----GGEEESST--TSCCEEECCCTTCEETTCCC------------------
T ss_pred             HHHHH-HHHHHHHhccCCCCEEcCCCCc----ccEEEecC--CCCcEEEEeccCceeccccc------------------
Confidence            34444 678999999  57999999999    89999642  23789999999998432100                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                                 ..                      ..+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       216 -----------~~----------------------~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          216 -----------YQ----------------------YIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             -----------CS----------------------SCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             -----------cc----------------------ccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                       00                      12399999999999876 999999999999999999999999985


Q ss_pred             hhhHHHHHHHHHHhCCCCccCccc
Q psy3074         173 REVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      + ..+++..|.+.++.|+...++.
T Consensus       262 ~-~~~~~~~i~~~~~~~~~~~~~~  284 (382)
T 2vx3_A          262 N-EVDQMNKIVEVLGIPPAHILDQ  284 (382)
T ss_dssp             S-HHHHHHHHHHHHCSCCHHHHTT
T ss_pred             C-HHHHHHHHHHHhCCCCHHHHHh
Confidence            4 4588999999999888765543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.83  E-value=6.4e-22  Score=198.56  Aligned_cols=102  Identities=22%  Similarity=0.397  Sum_probs=82.0

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                    
T Consensus       110 ~~~i~~q-i~~aL~~LH~~givH~Dlkp----~NIll~~~----~~~kl~DFG~s~~~~~--------------------  160 (336)
T 3h4j_B          110 GRRFFQQ-IICAIEYCHRHKIVHRDLKP----ENLLLDDN----LNVKIADFGLSNIMTD--------------------  160 (336)
T ss_dssp             HHHHHHH-HHHHHHHHHHHTCCCCCCST----TTEEECTT----CCEEECCSSCTBTTTT--------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCeEecCCch----hhEEEcCC----CCEEEEEeccceeccC--------------------
Confidence            3344444 78899999999999999999    89999866    7999999999974321                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             +......+                      +|+.|+|||++.+...++.++||||+||++|||++|+.||.+.
T Consensus       161 -------~~~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          161 -------GNFLKTSC----------------------GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             -------SBTTCCCT----------------------TSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             -------Cccccccc----------------------CCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence                   11111122                      3999999999998774588999999999999999999999764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.83  E-value=7.4e-22  Score=199.83  Aligned_cols=116  Identities=19%  Similarity=0.139  Sum_probs=85.8

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..  ..+.+||+|||+|+..........         
T Consensus       149 l~~~~~~~i~~q-i~~~l~~lH~~~iiHrDlkp----~Nill~~~--~~~~~kl~DFG~a~~~~~~~~~~~---------  212 (364)
T 3op5_A          149 FSRKTVLQLSLR-ILDILEYIHEHEYVHGDIKA----SNLLLNYK--NPDQVYLVDYGLAYRYCPEGVHKA---------  212 (364)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEEESS--CTTCEEECCCTTCEESSGGGCCCC---------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeEEecCCH----HHEEEecC--CCCeEEEEECCcceecccCCcccc---------
Confidence            344445555555 78999999999999999999    89999832  237999999999985421110000         


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                .......                      ...+|+.|||||++.+.. |+.++||||+||++|||++|+.
T Consensus       213 ----------~~~~~~~----------------------~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~  259 (364)
T 3op5_A          213 ----------YAADPKR----------------------CHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHL  259 (364)
T ss_dssp             ----------SSCCSSC----------------------CCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCC
T ss_pred             ----------cccCccc----------------------ccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCC
Confidence                      0000000                      112499999999998776 9999999999999999999999


Q ss_pred             CCCCc
Q psy3074         168 TFPGV  172 (481)
Q Consensus       168 PF~g~  172 (481)
                      ||.+.
T Consensus       260 Pf~~~  264 (364)
T 3op5_A          260 PWEDN  264 (364)
T ss_dssp             TTGGG
T ss_pred             Ccccc
Confidence            99864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.83  E-value=4.9e-22  Score=195.13  Aligned_cols=108  Identities=19%  Similarity=0.290  Sum_probs=83.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......             
T Consensus       134 ~~~~~~~~~~~q-i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-------------  191 (298)
T 2zv2_A          134 LSEDQARFYFQD-LIKGIEYLHYQKIIHRDIKP----SNLLVGED----GHIKIADFGVSNEFKGSD-------------  191 (298)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----SCEEECCCTTCEECSSSS-------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeeccCCCH----HHEEECCC----CCEEEecCCCcccccccc-------------
Confidence            334444445555 78899999999999999999    89999876    799999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCC--CCCccchhhHHHHHHHHHhC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE--YSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~--y~~~~DvWS~G~il~elltg  165 (481)
                                   .....                      ..+|+.|+|||++.+...  ++.++||||+||++|||++|
T Consensus       192 -------------~~~~~----------------------~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          192 -------------ALLSN----------------------TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             -------------CEECC----------------------CCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             -------------ccccC----------------------CcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence                         00011                      123999999999987653  47889999999999999999


Q ss_pred             CCCCCCc
Q psy3074         166 LPTFPGV  172 (481)
Q Consensus       166 ~~PF~g~  172 (481)
                      +.||.+.
T Consensus       237 ~~pf~~~  243 (298)
T 2zv2_A          237 QCPFMDE  243 (298)
T ss_dssp             SCSSCCS
T ss_pred             CCCCCCc
Confidence            9999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.83  E-value=2.3e-21  Score=191.26  Aligned_cols=122  Identities=33%  Similarity=0.664  Sum_probs=93.4

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                     
T Consensus       106 ~i~~~-l~~~l~~lH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~---------------------  155 (311)
T 4agu_A          106 SITWQ-TLQAVNFCHKHNCIHRDVKP----ENILITKH----SVIKLCDFGFARLLTGP---------------------  155 (311)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECC-----------------------
T ss_pred             HHHHH-HHHHHHHHHHCCCcCCCCCh----hhEEEcCC----CCEEEeeCCCchhccCc---------------------
Confidence            34444 67899999999999999999    89999866    79999999999743211                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                           .......                      .+|+.|+|||++.+...|+.++||||+||++|||++|++||.+..+
T Consensus       156 -----~~~~~~~----------------------~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  208 (311)
T 4agu_A          156 -----SDYYDDE----------------------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD  208 (311)
T ss_dssp             -------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             -----ccccCCC----------------------cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence                 0011111                      2399999999999877799999999999999999999999998544


Q ss_pred             hHHHHHHHHHHhCCCCccCc
Q psy3074         175 VYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~  194 (481)
                       .+.+..+.+.++.+.+...
T Consensus       209 -~~~~~~~~~~~~~~~~~~~  227 (311)
T 4agu_A          209 -VDQLYLIRKTLGDLIPRHQ  227 (311)
T ss_dssp             -HHHHHHHHHHHCSCCHHHH
T ss_pred             -HHHHHHHHHHhcccccccc
Confidence             4777778888777665433

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.83  E-value=6.5e-22  Score=211.16  Aligned_cols=105  Identities=26%  Similarity=0.476  Sum_probs=84.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +.....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...                  
T Consensus       285 e~~~~~i~~q-Il~aL~yLH~~gIvHrDLKP----eNILld~~----g~vKL~DFGla~~~~------------------  337 (576)
T 2acx_A          285 EARAVFYAAE-ICCGLEDLHRERIVYRDLKP----ENILLDDH----GHIRISDLGLAVHVP------------------  337 (576)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----SCEEECCCTTCEECC------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCEeccCCch----heEEEeCC----CCeEEEecccceecc------------------
Confidence            3334444444 78999999999999999999    89999866    799999999998432                  


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .+......+                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||
T Consensus       338 ---------~~~~~~~~~----------------------GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF  385 (576)
T 2acx_A          338 ---------EGQTIKGRV----------------------GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPF  385 (576)
T ss_dssp             ---------TTCCEECCC----------------------SCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ---------cCccccccC----------------------CCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCC
Confidence                     111111123                      399999999998765 999999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+..
T Consensus       386 ~~~~  389 (576)
T 2acx_A          386 QQRK  389 (576)
T ss_dssp             SCSS
T ss_pred             cccc
Confidence            8753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.83  E-value=2.2e-21  Score=195.46  Aligned_cols=120  Identities=24%  Similarity=0.376  Sum_probs=84.9

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++.. ...+.+||+|||+|+....                 
T Consensus       147 ~~~~~~i~~q-i~~~L~~LH~~~ivH~Dikp----~NIll~~~-~~~~~~kl~Dfg~a~~~~~-----------------  203 (349)
T 2w4o_A          147 ERDAADAVKQ-ILEAVAYLHENGIVHRDLKP----ENLLYATP-APDAPLKIADFGLSKIVEH-----------------  203 (349)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEESSS-STTCCEEECCCC------------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeEecCCCc----ccEEEecC-CCCCCEEEccCccccccCc-----------------
Confidence            3333444444 78899999999999999999    89999752 2347999999999984211                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ........                      +|+.|+|||++.+.. |+.++||||+||++|||++|..||
T Consensus       204 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf  250 (349)
T 2w4o_A          204 ----------QVLMKTVC----------------------GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPF  250 (349)
T ss_dssp             -----------------------------------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ----------cccccccc----------------------CCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCC
Confidence                      01111122                      399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFKI  185 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~  185 (481)
                      .+.......+..+...
T Consensus       251 ~~~~~~~~~~~~i~~~  266 (349)
T 2w4o_A          251 YDERGDQFMFRRILNC  266 (349)
T ss_dssp             CCTTCHHHHHHHHHTT
T ss_pred             CCCcccHHHHHHHHhC
Confidence            8765544455555543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.83  E-value=1.5e-21  Score=198.29  Aligned_cols=123  Identities=36%  Similarity=0.616  Sum_probs=98.3

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                    
T Consensus       147 ~~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIll~~~----~~~kL~Dfg~a~~~~~~--------------------  197 (371)
T 4exu_A          147 QYLVYQ-MLKGLKYIHSAGVVHRDLKP----GNLAVNED----CELKILDFGLARHADAE--------------------  197 (371)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECSTTCC--------------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCCcCCCcCH----HHeEECCC----CCEEEEecCcccccccC--------------------
Confidence            334444 78899999999999999999    89999876    79999999999742110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                               ..                      ...+|+.|+|||++.+...|+.++||||+||++|||++|++||.+. 
T Consensus       198 ---------~~----------------------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-  245 (371)
T 4exu_A          198 ---------MT----------------------GYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK-  245 (371)
T ss_dssp             ---------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred             ---------cC----------------------CcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC-
Confidence                     00                      1123999999999998666999999999999999999999999985 


Q ss_pred             hhHHHHHHHHHHhCCCCccCcccc
Q psy3074         174 EVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      +..+.+..+.+..+.|+.+.+...
T Consensus       246 ~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          246 DYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             ChHHHHHHHHHHhCCCcHHHHHHh
Confidence            455889999999999987655543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.83  E-value=5e-22  Score=200.06  Aligned_cols=121  Identities=20%  Similarity=0.367  Sum_probs=89.3

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......             
T Consensus       190 l~~~~~~~~~~q-l~~aL~~LH~~~ivH~Dikp----~NIll~~~----~~~kl~Dfg~a~~~~~~~-------------  247 (359)
T 3vhe_A          190 LTLEHLICYSFQ-VAKGMEFLASRKCIHRDLAA----RNILLSEK----NVVKICDFGLARDIYKDP-------------  247 (359)
T ss_dssp             BCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCGGGSCTTSCT-------------
T ss_pred             cCHHHHHHHHHH-HHHHHHHHHHCCcccCCCCh----hhEEEcCC----CcEEEEeccceeeecccc-------------
Confidence            334444555555 78899999999999999999    89999876    699999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                 ........                      .+|+.|+|||++.+.. |+.++||||+||++|||++ |.
T Consensus       248 -----------~~~~~~~~----------------------~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~  293 (359)
T 3vhe_A          248 -----------DYVRKGDA----------------------RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGA  293 (359)
T ss_dssp             -----------TCEEC--C----------------------EECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSC
T ss_pred             -----------cchhcccc----------------------CCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCC
Confidence                       00001111                      2388999999998765 9999999999999999998 99


Q ss_pred             CCCCCchhhHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~  184 (481)
                      +||.+..........+..
T Consensus       294 ~p~~~~~~~~~~~~~~~~  311 (359)
T 3vhe_A          294 SPYPGVKIDEEFCRRLKE  311 (359)
T ss_dssp             CSSTTCCCSHHHHHHHHH
T ss_pred             CCCCccchhHHHHHHHHc
Confidence            999986544333333333

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.83  E-value=3.5e-22  Score=202.75  Aligned_cols=152  Identities=17%  Similarity=0.265  Sum_probs=99.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..+.++.. .+.||+|||++||+||||||    +|||++... ....+||+|||+|+......                 
T Consensus       182 ~~~~i~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~~-~~~~~kL~DFG~a~~~~~~~-----------------  238 (367)
T 3l9p_A          182 DLLHVARD-IACGCQYLEENHFIHRDIAA----RNCLLTCPG-PGRVAKIGDFGMARDIYRAG-----------------  238 (367)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESCSS-TTCCEEECCCHHHHHHHHHS-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCeeCCCCCh----hhEEEecCC-CCceEEECCCcccccccccc-----------------
Confidence            33445555 78899999999999999999    899998542 12469999999998431100                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                             ...                      ......+|+.|+|||++.+.. |+.++||||+||++|||++ |.+||.
T Consensus       239 -------~~~----------------------~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~  288 (367)
T 3l9p_A          239 -------YYR----------------------KGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYP  288 (367)
T ss_dssp             -------SCT----------------------TCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             -------ccc----------------------cCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                   000                      000112388999999998765 9999999999999999998 999998


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      +... .+.+..+......+.+...+..-......|+...|..|+++.
T Consensus       289 ~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~  334 (367)
T 3l9p_A          289 SKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFA  334 (367)
T ss_dssp             TCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            8533 345555544433333322222111122245555555555543

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.83  E-value=2.4e-21  Score=193.28  Aligned_cols=125  Identities=30%  Similarity=0.581  Sum_probs=95.1

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                 
T Consensus       125 ~~~~~~~q-i~~~l~~LH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-----------------  178 (331)
T 4aaa_A          125 VVQKYLFQ-IINGIGFCHSHNIIHRDIKP----ENILVSQS----GVVKLCDFGFARTLAAPG-----------------  178 (331)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCCTTC------------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCEEccCcCh----heEEEcCC----CcEEEEeCCCceeecCCc-----------------
Confidence            33444444 78899999999999999999    89999866    799999999997432110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               .....                      ..+|+.|+|||++.+...++.++||||+||++|||++|++||.+
T Consensus       179 ---------~~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          179 ---------EVYDD----------------------EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             ------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ---------cccCC----------------------CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence                     00011                      12399999999998876799999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~  194 (481)
                      ..+ .+.+..+....+.+.+..+
T Consensus       228 ~~~-~~~~~~~~~~~~~~~~~~~  249 (331)
T 4aaa_A          228 DSD-IDQLYHIMMCLGNLIPRHQ  249 (331)
T ss_dssp             SSH-HHHHHHHHHHHCSCCHHHH
T ss_pred             CCc-HHHHHHHHHHhCCCChhhh
Confidence            644 4777888888777765543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.83  E-value=1e-21  Score=192.94  Aligned_cols=109  Identities=28%  Similarity=0.465  Sum_probs=83.2

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       110 ~~~~~~~~~q-i~~~l~~lH~~~i~H~Dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~---------------  165 (294)
T 4eqm_A          110 VDTAINFTNQ-ILDGIKHAHDMRIVHRDIKP----QNILIDSN----KTLKIFDFGIAKALSETS---------------  165 (294)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCCSSSTTC-------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCcccCCCCH----HHEEECCC----CCEEEEeCCCcccccccc---------------
Confidence            3334444444 78899999999999999999    89999866    799999999998432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ........                      +|+.|+|||++.+.. ++.++||||+||++|||++|++||
T Consensus       166 ----------~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf  212 (294)
T 4eqm_A          166 ----------LTQTNHVL----------------------GTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPF  212 (294)
T ss_dssp             -----------------------------------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ----------ccccCccc----------------------cCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCC
Confidence                      00001112                      399999999998876 899999999999999999999999


Q ss_pred             CCchhh
Q psy3074         170 PGVREV  175 (481)
Q Consensus       170 ~g~~~~  175 (481)
                      .+....
T Consensus       213 ~~~~~~  218 (294)
T 4eqm_A          213 NGETAV  218 (294)
T ss_dssp             CSSCHH
T ss_pred             CCCChH
Confidence            986544

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.83  E-value=3e-21  Score=192.51  Aligned_cols=151  Identities=24%  Similarity=0.310  Sum_probs=83.6

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++... ....+||+|||+|+.....                   
T Consensus       108 ~~~i~~q-i~~~l~~LH~~~ivH~Dlkp----~NIll~~~~-~~~~~kl~Dfg~a~~~~~~-------------------  162 (325)
T 3kn6_A          108 ASYIMRK-LVSAVSHMHDVGVVHRDLKP----ENLLFTDEN-DNLEIKIIDFGFARLKPPD-------------------  162 (325)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEEEC-----CEEEECCCTTCEECCC--------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCCeecCCCH----HHEEEecCC-CcccEEEeccccceecCCC-------------------
Confidence            3344444 78899999999999999999    899997541 1237999999999742210                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             +......+                      +|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.
T Consensus       163 -------~~~~~~~~----------------------~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          163 -------NQPLKTPC----------------------FTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             --------------------------------------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             -------CCcccccC----------------------CCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                   00011112                      399999999998765 999999999999999999999999874


Q ss_pred             hh------hHHHHHHHHHHhCCCCccCcccccCC---CCCCccCCCCccCCCcCc
Q psy3074         173 RE------VYDQLDKIFKILGTPTEETWEGVSLL---PGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       173 ~~------~~~~l~~i~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  218 (481)
                      +.      ..+.+..+......++.+.|+.++..   ....|....|..|++..+
T Consensus       213 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~e  267 (325)
T 3kn6_A          213 DRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG  267 (325)
T ss_dssp             -----CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTT
T ss_pred             ccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHH
Confidence            32      22344444444334444444333321   111344444555555443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.83  E-value=5.1e-21  Score=201.35  Aligned_cols=127  Identities=24%  Similarity=0.416  Sum_probs=94.7

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++.. ...+.+||+|||+|+.....                    
T Consensus       124 ~~i~~q-i~~al~~lH~~~ivH~Dlkp----~Nil~~~~-~~~~~~kl~Dfg~a~~~~~~--------------------  177 (486)
T 3mwu_A          124 ARIIKQ-VFSGITYMHKHNIVHRDLKP----ENILLESK-EKDCDIKIIDFGLSTCFQQN--------------------  177 (486)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEESSS-STTCCEEECSCSCTTTBCCC--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCeEeccCch----HHEEEecC-CCCCCEEEEECCcCeECCCC--------------------
Confidence            334444 78899999999999999999    89999653 23368999999999843211                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .....                      ..+|+.|+|||++.+.  |+.++||||+||++|+|++|++||.+.+
T Consensus       178 -------~~~~~----------------------~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~  226 (486)
T 3mwu_A          178 -------TKMKD----------------------RIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKN  226 (486)
T ss_dssp             -----------C----------------------CTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------CccCC----------------------CcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   00011                      1249999999999863  9999999999999999999999999854


Q ss_pred             hhHHHHHHHHHHhCCCCccCccccc
Q psy3074         174 EVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                       ..+.+..+......++.+.|+.++
T Consensus       227 -~~~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          227 -EYDILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             -HHHHHHHHHHTCCCSCSGGGGGSC
T ss_pred             -HHHHHHHHHhCCCCCCCcccCCCC
Confidence             346777777665555555555443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.83  E-value=2.6e-21  Score=195.05  Aligned_cols=118  Identities=25%  Similarity=0.376  Sum_probs=87.9

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+......                          
T Consensus       139 i~~al~~lH~~~ivHrDlkp----~NIl~~~~~-~~~~vkl~Dfg~a~~~~~~~--------------------------  187 (351)
T 3c0i_A          139 ILEALRYCHDNNIIHRDVKP----HCVLLASKE-NSAPVKLGGFGVAIQLGESG--------------------------  187 (351)
T ss_dssp             HHHHHHHHHHTTEECSCCSG----GGEEECSSS-TTCCEEECCCTTCEECCTTS--------------------------
T ss_pred             HHHHHHHHHHCCceeccCCh----HHeEEecCC-CCCcEEEecCcceeEecCCC--------------------------
Confidence            78899999999999999999    899997652 22469999999998532110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ......                      .+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+..+  +.+.
T Consensus       188 ~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~  242 (351)
T 3c0i_A          188 LVAGGR----------------------VGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFE  242 (351)
T ss_dssp             CBCCCC----------------------CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHH
T ss_pred             eeecCC----------------------cCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHH
Confidence            000111                      2399999999998765 99999999999999999999999998532  4455


Q ss_pred             HHHHHhCCCCccCc
Q psy3074         181 KIFKILGTPTEETW  194 (481)
Q Consensus       181 ~i~~~~~~p~~~~~  194 (481)
                      .+......+.+..|
T Consensus       243 ~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          243 GIIKGKYKMNPRQW  256 (351)
T ss_dssp             HHHHTCCCCCHHHH
T ss_pred             HHHcCCCCCCcccc
Confidence            55554433333333

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.83  E-value=1.4e-21  Score=195.79  Aligned_cols=130  Identities=22%  Similarity=0.305  Sum_probs=94.9

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....                 
T Consensus       129 ~~~~~~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~Dfg~a~~~~~-----------------  182 (335)
T 3dls_A          129 EPLASYIFRQ-LVSAVGYLRLKDIIHRDIKD----ENIVIAED----FTIKLIDFGSAAYLER-----------------  182 (335)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----SCEEECCCTTCEECCT-----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeEEeccCH----HHEEEcCC----CcEEEeecccceECCC-----------------
Confidence            3333445555 78899999999999999999    89999876    7999999999984321                 


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                +.......|                      |+.|+|||++.+...++.++||||+||++|||++|..||
T Consensus       183 ----------~~~~~~~~g----------------------t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf  230 (335)
T 3dls_A          183 ----------GKLFYTFCG----------------------TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF  230 (335)
T ss_dssp             ----------TCCBCEECS----------------------CGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ----------CCceeccCC----------------------CccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCch
Confidence                      111122333                      999999999998775588999999999999999999999


Q ss_pred             CCchhh-----------HHHHHHHHHHhCCCCccCcccc
Q psy3074         170 PGVREV-----------YDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       170 ~g~~~~-----------~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      .+..+.           ...+..++..+-.+++...+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~  269 (335)
T 3dls_A          231 CELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTL  269 (335)
T ss_dssp             SSGGGGTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hhHHHHHhhccCCCcccCHHHHHHHHHHccCChhhCcCH
Confidence            764321           2234445555555554444443

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.82  E-value=4.7e-22  Score=200.45  Aligned_cols=110  Identities=23%  Similarity=0.398  Sum_probs=85.5

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                   
T Consensus       156 ~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~DfG~a~~~~~~-------------------  207 (348)
T 1u5q_A          156 IAAVTHG-ALQGLAYLHSHNMIHRDVKA----GNILLSEP----GLVKLGDFGSASIMAPA-------------------  207 (348)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCBCCCCSG----GGEEEETT----TEEEECCCTTCBSSSSB-------------------
T ss_pred             HHHHHHH-HHHHHHHHHhCCeeeCCCCH----HHEEECCC----CCEEEeeccCceecCCC-------------------
Confidence            3344444 67899999999999999999    89999866    79999999999742110                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                 ..+.                      +|+.|+|||++.+  ...|+.++||||+||++|||++|++||.
T Consensus       208 -----------~~~~----------------------gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  254 (348)
T 1u5q_A          208 -----------NSFV----------------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF  254 (348)
T ss_dssp             -----------CCCC----------------------SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -----------Cccc----------------------CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                       0112                      3999999999963  3459999999999999999999999998


Q ss_pred             CchhhHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFK  184 (481)
Q Consensus       171 g~~~~~~~l~~i~~  184 (481)
                      +.+.. +.+..+..
T Consensus       255 ~~~~~-~~~~~~~~  267 (348)
T 1u5q_A          255 NMNAM-SALYHIAQ  267 (348)
T ss_dssp             TSCHH-HHHHHHHH
T ss_pred             CCChH-HHHHHHHh
Confidence            85433 44444443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.82  E-value=1.2e-21  Score=199.63  Aligned_cols=121  Identities=21%  Similarity=0.384  Sum_probs=90.3

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........          
T Consensus       187 ~l~~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~DFG~a~~~~~~~~~----------  247 (382)
T 3tt0_A          187 QLSSKDLVSCAYQ-VARGMEYLASKKCIHRDLAA----RNVLVTED----NVMKIADFGLARDIHHIDYY----------  247 (382)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECSCSCCCCSSCCCTT----------
T ss_pred             ccCHHHHHHHHHH-HHHHHHHHHhCCEecCCCCc----ceEEEcCC----CcEEEcccCccccccccccc----------
Confidence            3455555556655 78999999999999999999    89999866    79999999999853211000          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                 ..                         .....+|+.|+|||++.+.. ++.++||||+||++|||++ |
T Consensus       248 -----------~~-------------------------~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g  290 (382)
T 3tt0_A          248 -----------KK-------------------------TTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLG  290 (382)
T ss_dssp             -----------CC-------------------------CTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred             -----------cc-------------------------ccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCC
Confidence                       00                         00112388999999998765 9999999999999999999 9


Q ss_pred             CCCCCCchhhHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~  184 (481)
                      ..||.+.. ..+.++.+..
T Consensus       291 ~~p~~~~~-~~~~~~~~~~  308 (382)
T 3tt0_A          291 GSPYPGVP-VEELFKLLKE  308 (382)
T ss_dssp             CCSSTTCC-HHHHHHHHHT
T ss_pred             CCCCCCCC-HHHHHHHHHc
Confidence            99998853 3244444443

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.82  E-value=2.4e-22  Score=204.67  Aligned_cols=153  Identities=19%  Similarity=0.301  Sum_probs=102.1

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.+ .+.|++|||++||+||||||    +|||++..    |.+||+|||+|+....                
T Consensus       211 ~~~~~~~~~~q-i~~~l~~LH~~~ivHrDlkp----~Nil~~~~----~~~kl~DfG~s~~~~~----------------  265 (377)
T 3cbl_A          211 RVKTLLQMVGD-AAAGMEYLESKCCIHRDLAA----RNCLVTEK----NVLKISDFGMSREEAD----------------  265 (377)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCGGGCEECTT----------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCcCCcccCH----HHEEEcCC----CcEEECcCCCceecCC----------------
Confidence            33444455555 78899999999999999999    89999866    7999999999984211                


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                 +.+.. ..+                  ...+|+.|+|||++.+.. |+.++|||||||++|||++ |.+
T Consensus       266 -----------~~~~~-~~~------------------~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~  314 (377)
T 3cbl_A          266 -----------GVYAA-SGG------------------LRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGAS  314 (377)
T ss_dssp             -----------SEEEC-CSS------------------CCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -----------Cceee-cCC------------------CCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence                       00000 000                  011277899999998765 9999999999999999998 999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ||.+.... +....+......|.++.++..-......|+...|..|+++.+
T Consensus       315 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  364 (377)
T 3cbl_A          315 PYPNLSNQ-QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFST  364 (377)
T ss_dssp             SSTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence            99985432 333444333334444333322212233456666666666543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.82  E-value=4.1e-22  Score=198.76  Aligned_cols=153  Identities=14%  Similarity=0.193  Sum_probs=100.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......            
T Consensus       148 ~~~~~~~~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~----~~~kl~Dfg~a~~~~~~~~------------  206 (325)
T 3kul_A          148 FTIMQLVGMLRG-VGAGMRYLSDLGYVHRDLAA----RNVLVDSN----LVCKVSDFGLSRVLEDDPD------------  206 (325)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCSSCEECC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeeCCCCCc----ceEEECCC----CCEEECCCCcccccccCcc------------
Confidence            334444445555 78899999999999999999    89999765    7999999999985321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                    ......                   ...+|+.|+|||++.+.. |+.++||||+||++|||++ |.
T Consensus       207 --------------~~~~~~-------------------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~  252 (325)
T 3kul_A          207 --------------AAYTTT-------------------GGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGE  252 (325)
T ss_dssp             --------------CCEECC----------------------CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------ceeecc-------------------CCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCC
Confidence                          000000                   011378899999998765 9999999999999999999 99


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKL  216 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (481)
                      .||.+... .+.+..+......|.+..++..-......|+...|..|+++
T Consensus       253 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  301 (325)
T 3kul_A          253 RPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRF  301 (325)
T ss_dssp             CTTTTSCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcccCCH-HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCH
Confidence            99988533 35555555554444333332211111223444444444443

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.82  E-value=2.1e-21  Score=200.56  Aligned_cols=117  Identities=27%  Similarity=0.444  Sum_probs=82.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||+++|+||||||    +|||++... ..+.+||+|||+|+...                   
T Consensus       239 ~~~~~i~~q-i~~~l~~LH~~~ivHrDlkp----~NIll~~~~-~~~~~kl~DFG~a~~~~-------------------  293 (419)
T 3i6u_A          239 ATCKLYFYQ-MLLAVQYLHENGIIHRDLKP----ENVLLSSQE-EDCLIKITDFGHSKILG-------------------  293 (419)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESSSS-SSCCEEECCSSTTTSCC-------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCccccCCCh----HhEEEecCC-CcceEEEeecccceecC-------------------
Confidence            333334444 68899999999999999999    899997542 23469999999998431                   


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                              ........+|                      |+.|+|||++.+  ...|+.++||||+||++|||++|++|
T Consensus       294 --------~~~~~~~~~g----------------------t~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p  343 (419)
T 3i6u_A          294 --------ETSLMRTLCG----------------------TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP  343 (419)
T ss_dssp             -----------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             --------CCccccccCC----------------------CCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence                    1122222333                      999999999964  34589999999999999999999999


Q ss_pred             CCCchhhHHHHHHH
Q psy3074         169 FPGVREVYDQLDKI  182 (481)
Q Consensus       169 F~g~~~~~~~l~~i  182 (481)
                      |.+........+.+
T Consensus       344 f~~~~~~~~~~~~i  357 (419)
T 3i6u_A          344 FSEHRTQVSLKDQI  357 (419)
T ss_dssp             SCCCSSSCCHHHHH
T ss_pred             CCCCcchHHHHHHH
Confidence            98754432333333

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.82  E-value=4.8e-22  Score=203.46  Aligned_cols=113  Identities=23%  Similarity=0.399  Sum_probs=82.8

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||+++|+||||||    +|||++.     |.+||+|||+|+.......                   
T Consensus       159 ~i~~q-i~~aL~~lH~~~ivHrDlkp----~NIll~~-----~~~kl~DFG~a~~~~~~~~-------------------  209 (390)
T 2zmd_A          159 SYWKN-MLEAVHTIHQHGIVHSDLKP----ANFLIVD-----GMLKLIDFGIANQMQPDTT-------------------  209 (390)
T ss_dssp             HHHHH-HHHHHHHHHTTTCCCCCCCG----GGEEESS-----SCEEECCCSSSCCC------------------------
T ss_pred             HHHHH-HHHHHHHHHHCCeeecCCCH----HHEEEEC-----CeEEEEecCccccccCCCc-------------------
Confidence            34444 68899999999999999999    8999953     6899999999985321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC----------CCCCCccchhhHHHHHHHHHh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~----------~~y~~~~DvWS~G~il~ellt  164 (481)
                           ....                      ...++|+.|||||++.+.          ..|+.++||||+||++|||++
T Consensus       210 -----~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~  262 (390)
T 2zmd_A          210 -----SVVK----------------------DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  262 (390)
T ss_dssp             -------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHH
T ss_pred             -----cccC----------------------CCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHH
Confidence                 0000                      012349999999999762          359999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHH
Q psy3074         165 GLPTFPGVREVYDQLDKIF  183 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~  183 (481)
                      |++||.+..+....+..+.
T Consensus       263 G~~Pf~~~~~~~~~~~~~~  281 (390)
T 2zmd_A          263 GKTPFQQIINQISKLHAII  281 (390)
T ss_dssp             SSCTTTTCCCHHHHHHHHH
T ss_pred             CCCcchhhhHHHHHHHHHh
Confidence            9999987644444454444

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.82  E-value=1.4e-21  Score=194.89  Aligned_cols=131  Identities=21%  Similarity=0.312  Sum_probs=94.7

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++... ..|.+||+|||+|+.....               
T Consensus       129 ~~~~~~~i~~q-l~~~L~~LH~~givH~Dikp----~NIl~~~~~-~~~~~kL~Dfg~a~~~~~~---------------  187 (327)
T 3lm5_A          129 SENDVIRLIKQ-ILEGVYYLHQNNIVHLDLKP----QNILLSSIY-PLGDIKIVDFGMSRKIGHA---------------  187 (327)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEESCBT-TBCCEEECCGGGCEEC------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCeecCcCCh----HHEEEecCC-CCCcEEEeeCccccccCCc---------------
Confidence            33344444444 78999999999999999999    899998631 2378999999999843211               


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                  .......                      +|+.|+|||++.+.. |+.++||||+||++|||++|+.|
T Consensus       188 ------------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~p  232 (327)
T 3lm5_A          188 ------------CELREIM----------------------GTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSP  232 (327)
T ss_dssp             ------------------C----------------------CCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ------------ccccccc----------------------CCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence                        0011112                      399999999998765 99999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCccc
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      |.+.+. .+.+..+......++.+.++.
T Consensus       233 f~~~~~-~~~~~~i~~~~~~~~~~~~~~  259 (327)
T 3lm5_A          233 FVGEDN-QETYLNISQVNVDYSEETFSS  259 (327)
T ss_dssp             SCCSSH-HHHHHHHHHTCCCCCTTTTTT
T ss_pred             CCCCCc-hHHHHHHHhcccccCchhhcc
Confidence            988543 355566666555554444433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.82  E-value=6.7e-22  Score=195.87  Aligned_cols=108  Identities=22%  Similarity=0.308  Sum_probs=79.8

Q ss_pred             HHHHhhhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      .....+.++.. .+.||+|||++|  |+||||||    +|||++..    |.+||+|||+|+......            
T Consensus       135 ~~~~~~~i~~q-i~~aL~~LH~~~~~ivH~Dikp----~NIll~~~----~~~kL~Dfg~a~~~~~~~------------  193 (309)
T 3p86_A          135 DERRRLSMAYD-VAKGMNYLHNRNPPIVHRNLKS----PNLLVDKK----YTVKVCDFGLSRLKASTF------------  193 (309)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHTSSSCCCCTTCCG----GGEEECTT----CCEEECCCC---------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHcCCCCEECCCCCh----hhEEEeCC----CcEEECCCCCCccccccc------------
Confidence            34444455555 788999999999  99999999    89999866    799999999997421100            


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                    .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|+
T Consensus       194 --------------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~  236 (309)
T 3p86_A          194 --------------LSSKSAA----------------------GTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQ  236 (309)
T ss_dssp             --------------------------------------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCC
T ss_pred             --------------cccccCC----------------------CCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence                          0011112                      399999999998776 899999999999999999999


Q ss_pred             CCCCCchh
Q psy3074         167 PTFPGVRE  174 (481)
Q Consensus       167 ~PF~g~~~  174 (481)
                      .||.+.+.
T Consensus       237 ~Pf~~~~~  244 (309)
T 3p86_A          237 QPWGNLNP  244 (309)
T ss_dssp             CTTTTSCH
T ss_pred             CCCCCCCH
Confidence            99988543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.82  E-value=3.7e-21  Score=194.18  Aligned_cols=126  Identities=29%  Similarity=0.580  Sum_probs=96.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.....                 
T Consensus       134 ~~~~~~~~q-i~~~l~~lH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~-----------------  187 (362)
T 3pg1_A          134 QHIQYFMYH-ILLGLHVLHEAGVVHRDLHP----GNILLADN----NDITICDFNLAREDTAD-----------------  187 (362)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECCTTC------------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCcCEecCCCh----HHEEEcCC----CCEEEEecCcccccccc-----------------
Confidence            333444444 78899999999999999999    89999766    79999999999742110                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                .......                      +|+.|+|||++.+...++.++||||+||++|||++|++||.
T Consensus       188 ----------~~~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~  235 (362)
T 3pg1_A          188 ----------ANKTHYV----------------------THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR  235 (362)
T ss_dssp             ----------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ----------cccceec----------------------ccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence                      0011112                      38999999999986679999999999999999999999999


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      +. +..+.+..+.+..+.|..+.+.
T Consensus       236 ~~-~~~~~~~~i~~~~~~~~~~~~~  259 (362)
T 3pg1_A          236 GS-TFYNQLNKIVEVVGTPKIEDVV  259 (362)
T ss_dssp             CS-SHHHHHHHHHHHHCCCCHHHHH
T ss_pred             CC-CHHHHHHHHHHHcCCCChHHhh
Confidence            85 4458899999999998876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.82  E-value=4.9e-22  Score=198.34  Aligned_cols=148  Identities=15%  Similarity=0.203  Sum_probs=94.2

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                 
T Consensus       119 ~~~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIl~~~~----~~~kL~DfG~a~~~~~~~~-----------------  172 (327)
T 3lzb_A          119 LLNWCVQ-IAKGMNYLEDRRLVHRDLAA----RNVLVKTP----QHVKITDFGLAKLLGAEEK-----------------  172 (327)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEEET----TEEEECCTTC--------------------------
T ss_pred             HHHHHHH-HHHHHHHHhhCCCcCCCCCH----HHEEEcCC----CCEEEccCcceeEccCccc-----------------
Confidence            3444444 78899999999999999999    89999876    7999999999985321100                 


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPG  171 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~g  171 (481)
                                .....                   ...+|+.|+|||++.+.. |+.++||||+||++|||++ |.+||.+
T Consensus       173 ----------~~~~~-------------------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          173 ----------EYHAE-------------------GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             ------------------------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ----------ccccc-------------------CCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                      00000                   012388999999998765 9999999999999999999 9999988


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      .... +....+......|.+..++..-......|+...|..|+++.
T Consensus       223 ~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  267 (327)
T 3lzb_A          223 IPAS-EISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFR  267 (327)
T ss_dssp             CCGG-GHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHH
Confidence            5332 33333333333333333222111122234555555555543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.82  E-value=5.1e-22  Score=193.33  Aligned_cols=118  Identities=20%  Similarity=0.346  Sum_probs=80.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus       115 ~~~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~----------------  169 (281)
T 1mp8_A          115 LASLILYAYQ-LSTALAYLESKRFVHRDIAA----RNVLVSSN----DCVKLGDFGLSRYMEDS----------------  169 (281)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECC--------------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeecccccH----HHEEECCC----CCEEECccccccccCcc----------------
Confidence            3334444445 78899999999999999999    89999876    79999999999843211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 ......                    ...+|+.|+|||++.+.. |+.++||||+||++|||++ |.+|
T Consensus       170 -----------~~~~~~--------------------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          170 -----------TYYKAS--------------------KGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             ----------------------------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------cccccc--------------------cCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCC
Confidence                       000000                    011378899999998665 9999999999999999996 9999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+.... +.+..+...
T Consensus       218 f~~~~~~-~~~~~i~~~  233 (281)
T 1mp8_A          218 FQGVKNN-DVIGRIENG  233 (281)
T ss_dssp             TTTCCGG-GHHHHHHTT
T ss_pred             CCcCCHH-HHHHHHHcC
Confidence            9885432 445555443

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.82  E-value=6.3e-22  Score=206.40  Aligned_cols=146  Identities=18%  Similarity=0.218  Sum_probs=102.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.|++|||+++|+||||||    +|||++..    |.+||+|||+|+.....                 
T Consensus       289 ~~~~~~~~q-i~~~l~~LH~~~ivHrDlkp----~Nill~~~----~~~kl~DfG~a~~~~~~-----------------  342 (450)
T 1k9a_A          289 DCLLKFSLD-VCEAMEYLEGNNFVHRDLAA----RNVLVSED----NVAKVSDFGLTKEASST-----------------  342 (450)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----SCEEECCCTTCEECC-------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCeeCCCCCH----hhEEECCC----CCEEEeeCCCccccccc-----------------
Confidence            334445555 78899999999999999999    89999876    79999999999842110                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF  169 (481)
                                  ....                      .+|+.|+|||++.+.. |+.++|||||||++|||++ |+.||
T Consensus       343 ------------~~~~----------------------~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~  387 (450)
T 1k9a_A          343 ------------QDTG----------------------KLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPY  387 (450)
T ss_dssp             --------------------------------------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             ------------ccCC----------------------CCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                        0000                      1278899999998766 9999999999999999998 99999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ++... .+.+..+.+....+.+..++..-......|+...|..|+++.+
T Consensus       388 ~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~  435 (450)
T 1k9a_A          388 PRIPL-KDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQ  435 (450)
T ss_dssp             TTSCT-TTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            98533 2445555544444433333322222233566666666666543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.82  E-value=1.9e-21  Score=193.82  Aligned_cols=112  Identities=20%  Similarity=0.286  Sum_probs=85.7

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......              
T Consensus       103 ~~~~~~~i~~q-i~~aL~~LH~~givH~Dlkp----~NIll~~~----~~~kl~Dfg~a~~~~~~~--------------  159 (323)
T 3tki_A          103 PEPDAQRFFHQ-LMAGVVYLHGIGITHRDIKP----ENLLLDER----DNLKISDFGLATVFRYNN--------------  159 (323)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECEETT--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCccccccch----HHEEEeCC----CCEEEEEeeccceeccCC--------------
Confidence            33444445555 78899999999999999999    89999876    799999999997432110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                .....                      ....+|+.|+|||++.+...++.++||||+||++|||++|+.|
T Consensus       160 ----------~~~~~----------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  207 (323)
T 3tki_A          160 ----------RERLL----------------------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (323)
T ss_dssp             ----------EECCB----------------------CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----------ccccc----------------------CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence                      00000                      0122499999999999877568899999999999999999999


Q ss_pred             CCCchhh
Q psy3074         169 FPGVREV  175 (481)
Q Consensus       169 F~g~~~~  175 (481)
                      |.+..+.
T Consensus       208 f~~~~~~  214 (323)
T 3tki_A          208 WDQPSDS  214 (323)
T ss_dssp             CSSSCTT
T ss_pred             CCCCchH
Confidence            9875443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.82  E-value=1.1e-21  Score=191.42  Aligned_cols=115  Identities=20%  Similarity=0.315  Sum_probs=80.8

Q ss_pred             hhhhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          13 QISVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ...++.. .+.||+|||++ ||+||||||    +|||++..    +.+||+|||+|+.....                  
T Consensus       111 ~~~i~~q-i~~~l~~lH~~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~------------------  163 (290)
T 3fme_A          111 LGKIAVS-IVKALEHLHSKLSVIHRDVKP----SNVLINAL----GQVKMCDFGISGYLVDD------------------  163 (290)
T ss_dssp             HHHHHHH-HHHHHHHHHHHSCCCCCCCSG----GGCEECTT----CCEEBCCC---------------------------
T ss_pred             HHHHHHH-HHHHHHHHhhcCCeecCCCCH----HHEEECCC----CCEEEeecCCccccccc------------------
Confidence            3344444 78899999998 999999999    89999875    79999999999743211                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccc---cCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVL---LGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl---~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                               .......                      +|+.|+|||++   .....++.++||||+||++|||++|+.|
T Consensus       164 ---------~~~~~~~----------------------~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p  212 (290)
T 3fme_A          164 ---------VAKDIDA----------------------GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP  212 (290)
T ss_dssp             ---------------C----------------------CCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred             ---------ccccccC----------------------CCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence                     0011112                      39999999998   3445599999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+.......+..+...
T Consensus       213 ~~~~~~~~~~~~~~~~~  229 (290)
T 3fme_A          213 YDSWGTPFQQLKQVVEE  229 (290)
T ss_dssp             SCCCSCHHHHHHHHHHS
T ss_pred             ccccCchHHHHHHHhcc
Confidence            98755544555555443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.82  E-value=6.1e-21  Score=201.22  Aligned_cols=126  Identities=25%  Similarity=0.406  Sum_probs=95.8

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .+... .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+......                    
T Consensus       140 ~i~~q-i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~~-~~~~~kl~DfG~a~~~~~~~--------------------  193 (494)
T 3lij_A          140 VIIKQ-VLSGVTYLHKHNIVHRDLKP----ENLLLESKE-KDALIKIVDFGLSAVFENQK--------------------  193 (494)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECSCCSG----GGEEESCSS-TTCCEEECCCTTCEECBTTB--------------------
T ss_pred             HHHHH-HHHHHHHHHHCCceeccCCh----hhEEEeCCC-CCCcEEEEECCCCeECCCCc--------------------
Confidence            34444 78899999999999999999    899997542 23579999999998532110                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                             .....                      .+|+.|+|||++.+  .|+.++||||+||++|||++|.+||.+...
T Consensus       194 -------~~~~~----------------------~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~  242 (494)
T 3lij_A          194 -------KMKER----------------------LGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTD  242 (494)
T ss_dssp             -------CBCCC----------------------CSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             -------ccccc----------------------CCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                   00111                      23999999999874  499999999999999999999999998543


Q ss_pred             hHHHHHHHHHHhCCCCccCccccc
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                       .+.+..+......++.+.|+.++
T Consensus       243 -~~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          243 -QEILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             -HHHHHHHHHTCCCCCSGGGTTSC
T ss_pred             -HHHHHHHHhCCCCCCchhcccCC
Confidence             46777777776666666665544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.82  E-value=2.8e-21  Score=199.28  Aligned_cols=106  Identities=9%  Similarity=0.083  Sum_probs=83.9

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      +.......+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....             
T Consensus       206 ~~l~~~~~~~i~~q-i~~aL~~LH~~~iiHrDiKp----~NILl~~~----~~~kL~DFG~a~~~~~-------------  263 (413)
T 3dzo_A          206 KSLVHHARLQLTLQ-VIRLLASLHHYGLVHTYLRP----VDIVLDQR----GGVFLTGFEHLVRDGA-------------  263 (413)
T ss_dssp             HHHHHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCGGGCEETTE-------------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHhCCcccCCccc----ceEEEecC----CeEEEEeccceeecCC-------------
Confidence            33445555666555 78999999999999999999    89999877    7899999999974210             


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc---------CCCCCCCccchhhHH
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL---------GSTEYSTSLDMWGVG  156 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~---------~~~~y~~~~DvWS~G  156 (481)
                                    .     .                   ....+ +.|||||++.         ....|+.++||||+|
T Consensus       264 --------------~-----~-------------------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG  304 (413)
T 3dzo_A          264 --------------S-----A-------------------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG  304 (413)
T ss_dssp             --------------E-----E-------------------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH
T ss_pred             --------------c-----c-------------------ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH
Confidence                          0     0                   01234 7899999993         334489999999999


Q ss_pred             HHHHHHHhCCCCCCCc
Q psy3074         157 CILIEMVTGLPTFPGV  172 (481)
Q Consensus       157 ~il~elltg~~PF~g~  172 (481)
                      |++|||++|+.||.+.
T Consensus       305 vil~elltg~~Pf~~~  320 (413)
T 3dzo_A          305 LAIYWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHHHHSSCCCCTT
T ss_pred             HHHHHHHHCCCCCCCc
Confidence            9999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.82  E-value=4.1e-21  Score=192.88  Aligned_cols=131  Identities=36%  Similarity=0.597  Sum_probs=96.3

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...........              
T Consensus       115 ~~~~~q-i~~~L~~LH~~~ivH~Dlkp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~~~~~~--------------  171 (353)
T 2b9h_A          115 QYFIYQ-TLRAVKVLHGSNVIHRDLKP----SNLLINSN----CDLKVCDFGLARIIDESAADNSE--------------  171 (353)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCCTTCEECC----------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCeecCCCCH----HHeEEcCC----CcEEEEecccccccccccccccC--------------
Confidence            344444 78899999999999999999    89999866    79999999999854211100000              


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                        ..+..                      .......+|+.|+|||++.+...++.++||||+||++|||++|++||.+.+
T Consensus       172 --~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          172 --PTGQQ----------------------SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             --------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             --ccccc----------------------cchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              00000                      000112349999999999876679999999999999999999999999854


Q ss_pred             hhHHHHHHHHHHhCCCCcc
Q psy3074         174 EVYDQLDKIFKILGTPTEE  192 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~  192 (481)
                       ..+++..+....+.|...
T Consensus       228 -~~~~~~~~~~~~~~~~~~  245 (353)
T 2b9h_A          228 -YRHQLLLIFGIIGTPHSD  245 (353)
T ss_dssp             -HHHHHHHHHHHHCCCCST
T ss_pred             -cHHHHHHHHHHhCCCchh
Confidence             457788888888888643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.82  E-value=7.6e-21  Score=190.46  Aligned_cols=128  Identities=23%  Similarity=0.391  Sum_probs=97.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC---------------CCCCceeeecccccccccCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA---------------TPPRELKLADFGLARAKSVPS   74 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~---------------~~~g~~Kl~DFGla~~~~~~~   74 (481)
                      ......++.. .+.||+|||++||+||||||    +|||+....               ...+.+||+|||+|+......
T Consensus       122 ~~~~~~i~~q-i~~~L~~lH~~~ivH~Dlkp----~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~  196 (355)
T 2eu9_A          122 LPHVRHMAYQ-LCHALRFLHENQLTHTDLKP----ENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH  196 (355)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHTTTEECCCCCG----GGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCcccCCCCH----HHEEEecccccccccccccccccccCCCcEEEeecCccccccccc
Confidence            3334445555 78899999999999999999    899995321               234799999999997421100


Q ss_pred             CCcCCCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhh
Q psy3074          75 HTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWG  154 (481)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS  154 (481)
                                                   ..                      ..+|+.|+|||++.+.. |+.++||||
T Consensus       197 -----------------------------~~----------------------~~gt~~y~aPE~~~~~~-~~~~~Di~s  224 (355)
T 2eu9_A          197 -----------------------------TT----------------------IVATRHYRPPEVILELG-WAQPCDVWS  224 (355)
T ss_dssp             -----------------------------CS----------------------SCSCGGGCCHHHHTTCC-CCTHHHHHH
T ss_pred             -----------------------------cC----------------------CcCCCcccCCeeeecCC-CCCccchHH
Confidence                                         00                      12399999999998765 999999999


Q ss_pred             HHHHHHHHHhCCCCCCCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         155 VGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       155 ~G~il~elltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      +||++|||++|++||.+... .+.+..+.+.++.++...+.
T Consensus       225 lG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~p~~~~~  264 (355)
T 2eu9_A          225 IGCILFEYYRGFTLFQTHEN-REHLVMMEKILGPIPSHMIH  264 (355)
T ss_dssp             HHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCcHHHhh
Confidence            99999999999999998543 46777777888877665443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.82  E-value=7.8e-22  Score=198.04  Aligned_cols=112  Identities=24%  Similarity=0.386  Sum_probs=80.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++.     |.+||+|||+|+......                    
T Consensus       112 ~i~~q-i~~al~~lH~~~iiHrDikp----~NIll~~-----~~~kl~DFG~a~~~~~~~--------------------  161 (343)
T 3dbq_A          112 SYWKN-MLEAVHTIHQHGIVHSDLKP----ANFLIVD-----GMLKLIDFGIANQMQPDT--------------------  161 (343)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEEET-----TEEEECCCSSSCCC------------------------
T ss_pred             HHHHH-HHHHHHHHHhCCeecCCCCc----ceEEEEC-----CcEEEeecccccccCccc--------------------
Confidence            34444 78899999999999999999    8999963     689999999998532110                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC----------CCCCCCccchhhHHHHHHHHHh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG----------STEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~----------~~~y~~~~DvWS~G~il~ellt  164 (481)
                          ........                      .+|+.|+|||++.+          ...|+.++||||+||++|||++
T Consensus       162 ----~~~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~  215 (343)
T 3dbq_A          162 ----TSVVKDSQ----------------------VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY  215 (343)
T ss_dssp             ----------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred             ----ccccCCCC----------------------cCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence                00001112                      24999999999964          2458999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHH
Q psy3074         165 GLPTFPGVREVYDQLDKI  182 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i  182 (481)
                      |++||.+..+....+..+
T Consensus       216 g~~pf~~~~~~~~~~~~~  233 (343)
T 3dbq_A          216 GKTPFQQIINQISKLHAI  233 (343)
T ss_dssp             SSCTTTTCCSHHHHHHHH
T ss_pred             CCCcchhhhhHHHHHHHH
Confidence            999998754443444433

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.82  E-value=3.2e-21  Score=191.85  Aligned_cols=114  Identities=32%  Similarity=0.530  Sum_probs=91.7

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+......                          
T Consensus       139 i~~~l~~lH~~~ivH~Dikp----~Nil~~~~~---~~~kl~Dfg~a~~~~~~~--------------------------  185 (330)
T 3nsz_A          139 ILKALDYCHSMGIMHRDVKP----HNVMIDHEH---RKLRLIDWGLAEFYHPGQ--------------------------  185 (330)
T ss_dssp             HHHHHHHHHHTTEECCCCSG----GGEEEETTT---TEEEECCCTTCEECCTTC--------------------------
T ss_pred             HHHHHHHHHhCCeeeCCCCH----HHEEEcCCC---CEEEEEeCCCceEcCCCC--------------------------
Confidence            68899999999999999999    899998652   389999999997432110                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                       ....                      ..+|+.|+|||++.+...|+.++||||+||++|||++|+.||....+..+++.
T Consensus       186 -~~~~----------------------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          186 -EYNV----------------------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             -CCCS----------------------CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             -cccc----------------------ccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence             0001                      12388999999998866799999999999999999999999977666678888


Q ss_pred             HHHHHhCCCC
Q psy3074         181 KIFKILGTPT  190 (481)
Q Consensus       181 ~i~~~~~~p~  190 (481)
                      .+.+.++.+.
T Consensus       243 ~~~~~~~~~~  252 (330)
T 3nsz_A          243 RIAKVLGTED  252 (330)
T ss_dssp             HHHHHHCHHH
T ss_pred             HHHHhcCCch
Confidence            8877776543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.82  E-value=3.3e-21  Score=202.57  Aligned_cols=128  Identities=27%  Similarity=0.467  Sum_probs=95.8

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++.. ...+.+||+|||+|+......                  
T Consensus       128 ~~~i~~q-i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~-~~~~~~kl~Dfg~a~~~~~~~------------------  183 (484)
T 3nyv_A          128 AARIIRQ-VLSGITYMHKNKIVHRDLKP----ENLLLESK-SKDANIRIIDFGLSTHFEASK------------------  183 (484)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESSS-STTCCEEECCTTHHHHBCCCC------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCeeeCCCCH----HHEEEecC-CCCCcEEEEeeeeeEEccccc------------------
Confidence            3444444 78899999999999999999    89999643 234789999999998532110                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                               ..                      ....+|+.|+|||++.+  .|+.++||||+||++|||++|++||.+.
T Consensus       184 ---------~~----------------------~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          184 ---------KM----------------------KDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             ---------SH----------------------HHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ---------cc----------------------ccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence                     00                      01124999999999986  3999999999999999999999999985


Q ss_pred             hhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         173 REVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      + ..+.+..+......++.+.|+.++
T Consensus       231 ~-~~~~~~~i~~~~~~~~~~~~~~~s  255 (484)
T 3nyv_A          231 N-EYDILKKVEKGKYTFELPQWKKVS  255 (484)
T ss_dssp             S-HHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred             C-HHHHHHHHHcCCCCCCCcccccCC
Confidence            4 446777777665555555554443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.82  E-value=2.6e-21  Score=196.82  Aligned_cols=101  Identities=11%  Similarity=0.144  Sum_probs=79.7

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+...                   
T Consensus       206 ~~~~~i~~q-i~~aL~~LH~~~ivHrDikp----~NIll~~~----~~~kL~DFG~a~~~~-------------------  257 (377)
T 3byv_A          206 HARLQLTLQ-VIRLLASLHHYGLVHTYLRP----VDIVLDQR----GGVFLTGFEHLVRDG-------------------  257 (377)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCGGGCEETT-------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEEcCC----CCEEEEechhheecC-------------------
Confidence            333445555 78999999999999999999    89999866    799999999998321                   


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC----------CCCCCccchhhHHHHHH
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILI  160 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~----------~~y~~~~DvWS~G~il~  160 (481)
                              .  ..                      ....+ +.|+|||++.+.          ..|+.++||||+||++|
T Consensus       258 --------~--~~----------------------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          258 --------A--RV----------------------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             --------C--EE----------------------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             --------C--cc----------------------cCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence                    0  00                      01124 789999999876          24999999999999999


Q ss_pred             HHHhCCCCCCCc
Q psy3074         161 EMVTGLPTFPGV  172 (481)
Q Consensus       161 elltg~~PF~g~  172 (481)
                      ||++|++||.+.
T Consensus       305 elltg~~Pf~~~  316 (377)
T 3byv_A          305 WIWCADLPITKD  316 (377)
T ss_dssp             HHHHSSCCC---
T ss_pred             HHHHCCCCCccc
Confidence            999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.81  E-value=2.5e-21  Score=191.51  Aligned_cols=120  Identities=25%  Similarity=0.439  Sum_probs=85.2

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........            
T Consensus       114 ~~~~~~~~~~q-i~~~l~~lH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~~~------------  172 (311)
T 3ork_A          114 TPKRAIEVIAD-ACQALNFSHQNGIIHRDVKP----ANIMISAT----NAVKVMDFGIARAIADSGNS------------  172 (311)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEEETT----SCEEECCCSCC---------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCCCcCCCCH----HHEEEcCC----CCEEEeeccCcccccccccc------------
Confidence            33444455555 78899999999999999999    89999876    79999999999843211000            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                 .......                      .+|+.|+|||++.+.. ++.++||||+||++|||++|+.|
T Consensus       173 -----------~~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~p  218 (311)
T 3ork_A          173 -----------VTQTAAV----------------------IGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPP  218 (311)
T ss_dssp             ------------------------------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             -----------ccccccc----------------------CcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCC
Confidence                       0000111                      2499999999998775 99999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+.... +....+..
T Consensus       219 f~~~~~~-~~~~~~~~  233 (311)
T 3ork_A          219 FTGDSPV-SVAYQHVR  233 (311)
T ss_dssp             CCCSSHH-HHHHHHHH
T ss_pred             CCCCChH-HHHHHHhc
Confidence            9985433 34444433

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=7.5e-22  Score=200.89  Aligned_cols=120  Identities=21%  Similarity=0.364  Sum_probs=80.3

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......                
T Consensus       192 ~~~~~i~~q-i~~aL~~LH~~~ivHrDlkp----~NIll~~~----~~~kL~DFG~a~~~~~~~----------------  246 (373)
T 3c1x_A          192 KDLIGFGLQ-VAKGMKFLASKKFVHRDLAA----RNCMLDEK----FTVKVADFGLARDMYDKE----------------  246 (373)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCC--------------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCEecCccch----heEEECCC----CCEEEeeccccccccccc----------------
Confidence            334444444 78899999999999999999    89999866    799999999998432110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF  169 (481)
                                 .....                 ......+|+.|+|||++.+.. |+.++||||+||++|||++ |.+||
T Consensus       247 -----------~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~  297 (373)
T 3c1x_A          247 -----------FDSVH-----------------NKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPY  297 (373)
T ss_dssp             ---------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred             -----------ccccc-----------------ccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCC
Confidence                       00000                 000112388999999998765 9999999999999999999 78899


Q ss_pred             CCchhhHHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFKI  185 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~  185 (481)
                      .+.+.. +....+...
T Consensus       298 ~~~~~~-~~~~~~~~~  312 (373)
T 3c1x_A          298 PDVNTF-DITVYLLQG  312 (373)
T ss_dssp             TTSCSS-CHHHHHHTT
T ss_pred             CCCCHH-HHHHHHHcC
Confidence            875332 333344333

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.81  E-value=1.2e-21  Score=211.92  Aligned_cols=155  Identities=15%  Similarity=0.139  Sum_probs=104.7

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+.......            
T Consensus       433 l~~~~~~~i~~q-i~~~L~~LH~~~iiHrDlkp----~NILl~~~----~~vkL~DFGla~~~~~~~~------------  491 (613)
T 2ozo_A          433 IPVSNVAELLHQ-VSMGMKYLEEKNFVHRNLAA----RNVLLVNR----HYAKISDFGLSKALGADDS------------  491 (613)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECCCSTTTTCC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCEEcCcCCH----HHEEEcCC----CcEEEeeccCcccccCCCc------------
Confidence            334444555555 78899999999999999999    89999876    7999999999985321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                   .+.....                    ..+|+.|+|||++.+.. |+.++|||||||++|||++ |+
T Consensus       492 -------------~~~~~~~--------------------~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~  537 (613)
T 2ozo_A          492 -------------YYTARSA--------------------GKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQ  537 (613)
T ss_dssp             -------------------------------------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------eeeeccC--------------------CCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence                         0000000                    11278899999998665 9999999999999999998 99


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .||.+.+.. +.+..+......+.+..++..-......|+...|..|+++.+
T Consensus       538 ~Pf~~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~  588 (613)
T 2ozo_A          538 KPYKKMKGP-EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT  588 (613)
T ss_dssp             CTTTTCCSH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred             CCCCCCCHH-HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            999986443 555555554444444333322222334566666666666543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.81  E-value=5.2e-21  Score=190.78  Aligned_cols=131  Identities=15%  Similarity=0.274  Sum_probs=91.8

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++... .....+||+|||+|+........          
T Consensus       102 ~~~~~~~~i~~q-i~~~l~~LH~~~iiHrDlkp----~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~----------  166 (330)
T 2izr_A          102 FSLKTVLMIAIQ-LISRMEYVHSKNLIYRDVKP----ENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK----------  166 (330)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECCGGGTCTTSEEECCCTTCEESBCTTTC----------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCeeccCCCH----HHeeeccCCCCCCceEEEEEcccceeeecCCCC----------
Confidence            334444555555 78999999999999999999    899998763 11223999999999854221100          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  . .  ..+.                ......+|+.|+|||++.+.. |+.++||||+||++|||++|+
T Consensus       167 ------------~-~--~~~~----------------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~  214 (330)
T 2izr_A          167 ------------K-H--IPYR----------------EHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGS  214 (330)
T ss_dssp             ------------C-B--CCCC----------------CCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             ------------c-c--cccc----------------ccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCC
Confidence                        0 0  0000                001122499999999998865 999999999999999999999


Q ss_pred             CCCCCc--hhhHHHHHHHHHH
Q psy3074         167 PTFPGV--REVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~--~~~~~~l~~i~~~  185 (481)
                      .||.+.  .+..+.+..+...
T Consensus       215 ~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          215 LPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             CTTTTCCCSSHHHHHHHHHHH
T ss_pred             CCccccccccHHHHHHHHHhh
Confidence            999874  3344455555443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.81  E-value=5.2e-21  Score=186.89  Aligned_cols=116  Identities=16%  Similarity=0.241  Sum_probs=84.3

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++.. +..+.+||+|||+|+........            
T Consensus       103 ~~~~~~~i~~q-i~~~l~~LH~~~ivH~Dlkp----~NIl~~~~-~~~~~~kL~Dfg~a~~~~~~~~~------------  164 (296)
T 4hgt_A          103 SLKTVLLLADQ-MISRIEYIHSKNFIHRDVKP----DNFLMGLG-KKGNLVYIIDFGLAKKYRDARTH------------  164 (296)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECCG-GGTTCEEECCCTTCEECBCTTTC------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCeecCCCCH----HHeeeecc-CCCCeEEEecCccceeccCcccC------------
Confidence            33444445555 78899999999999999999    89999321 12378999999999854321100            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                . .  ..+.                ......+|+.|+|||++.+.. ++.++||||+||++|||++|+.|
T Consensus       165 ----------~-~--~~~~----------------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 4hgt_A          165 ----------Q-H--IPYR----------------ENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             ----------C-B--CCCC----------------CSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ----------c-c--CCCC----------------cccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCC
Confidence                      0 0  0000                001122499999999998876 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       215 f~~~  218 (296)
T 4hgt_A          215 WQGL  218 (296)
T ss_dssp             TSSC
T ss_pred             Cccc
Confidence            9874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.81  E-value=7.3e-21  Score=193.69  Aligned_cols=126  Identities=25%  Similarity=0.361  Sum_probs=96.8

Q ss_pred             HhhhhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccC-------------------------------------
Q psy3074          12 RQISVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYA-------------------------------------   53 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~-------------------------------------   53 (481)
                      ....++.. .+.||+|||++ ||+||||||    +|||++...                                     
T Consensus       147 ~~~~i~~q-i~~aL~~lH~~~givHrDikp----~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (397)
T 1wak_A          147 CVKKIIQQ-VLQGLDYLHTKCRIIHTDIKP----ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL  221 (397)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCEECCCCSG----GGEEECCCHHHHHHHHHHHC---------------------CCTTS
T ss_pred             HHHHHHHH-HHHHHHHHHHhCCEecCCCCH----HHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccc
Confidence            33444444 78899999998 999999999    899997541                                     


Q ss_pred             --------CCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhc
Q psy3074          54 --------TPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ  125 (481)
Q Consensus        54 --------~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~  125 (481)
                              .....+||+|||+|+......                                                   
T Consensus       222 ~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---------------------------------------------------  250 (397)
T 1wak_A          222 VNPLEPKNAEKLKVKIADLGNACWVHKHF---------------------------------------------------  250 (397)
T ss_dssp             CCTTSGGGGGGCCEEECCGGGCEETTBCS---------------------------------------------------
T ss_pred             ccccccccccccceEeccccccccccccC---------------------------------------------------
Confidence                    011379999999997432100                                                   


Q ss_pred             cccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh-----hHHHHHHHHHHhCCCCccCc
Q psy3074         126 EEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE-----VYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       126 ~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~-----~~~~l~~i~~~~~~p~~~~~  194 (481)
                      ....+|+.|+|||++.+.. |+.++||||+||++|||++|++||.+.+.     ..+++..+.+.++.++...+
T Consensus       251 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          251 TEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             CSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence            0112399999999999876 99999999999999999999999986432     45778888888888876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.81  E-value=1.1e-21  Score=194.66  Aligned_cols=117  Identities=16%  Similarity=0.283  Sum_probs=83.1

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                  
T Consensus       138 ~~~~i~~q-i~~al~~LH~~~ivH~Dikp----~NIli~~~----~~~kl~Dfg~a~~~~~~------------------  190 (323)
T 3qup_A          138 TLVRFMVD-IACGMEYLSSRNFIHRDLAA----RNCMLAED----MTVCVADFGLSRKIYSG------------------  190 (323)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----SCEEECCCCC-------------------------
T ss_pred             HHHHHHHH-HHHHHHHHHcCCcccCCCCc----ceEEEcCC----CCEEEeecccccccccc------------------
Confidence            33444444 78899999999999999999    89999866    79999999999843211                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               ......                   ....+|+.|+|||++.+.. |+.++||||+||++|||++ |.+||.
T Consensus       191 ---------~~~~~~-------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~  241 (323)
T 3qup_A          191 ---------DYYRQG-------------------CASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYA  241 (323)
T ss_dssp             --------------------------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ---------cccccc-------------------ccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCcc
Confidence                     000000                   0011378899999998765 9999999999999999999 999998


Q ss_pred             CchhhHHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFKI  185 (481)
Q Consensus       171 g~~~~~~~l~~i~~~  185 (481)
                      +.... +.+..+...
T Consensus       242 ~~~~~-~~~~~~~~~  255 (323)
T 3qup_A          242 GIENA-EIYNYLIGG  255 (323)
T ss_dssp             TCCGG-GHHHHHHTT
T ss_pred             ccChH-HHHHHHhcC
Confidence            85433 445544443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.81  E-value=2.2e-21  Score=192.78  Aligned_cols=126  Identities=21%  Similarity=0.251  Sum_probs=92.8

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++........+||+|||+|+......               
T Consensus       114 ~~~~~~i~~q-i~~aL~~lH~~~ivH~dikp----~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---------------  173 (321)
T 2a2a_A          114 EEEATSFIKQ-ILDGVNYLHTKKIAHFDLKP----ENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---------------  173 (321)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESCTTSSSCCEEECCCTTCEECCTTC---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeecCCCCh----HHEEEecCCCCcCCEEEccCccceecCccc---------------
Confidence            3344445555 78899999999999999999    899998763333379999999998532110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                  .....                      .+|+.|+|||++.+.. ++.++||||+||++|||++|..||
T Consensus       174 ------------~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  218 (321)
T 2a2a_A          174 ------------EFKNI----------------------FGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  218 (321)
T ss_dssp             ------------CCCCC----------------------CSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred             ------------ccccc----------------------CCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCC
Confidence                        00011                      2399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTE  191 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~  191 (481)
                      .+... .+.+..+......+++
T Consensus       219 ~~~~~-~~~~~~i~~~~~~~~~  239 (321)
T 2a2a_A          219 LGDTK-QETLANITSVSYDFDE  239 (321)
T ss_dssp             CCSSH-HHHHHHHHTTCCCCCH
T ss_pred             CCCCH-HHHHHHHHhcccccCh
Confidence            88533 3556665554444433

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.81  E-value=1e-21  Score=204.93  Aligned_cols=150  Identities=18%  Similarity=0.306  Sum_probs=102.2

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+.....                
T Consensus       279 ~~~~~~i~~q-i~~~l~~LH~~~ivHrDlkp----~Nill~~~----~~~kl~DfG~a~~~~~~----------------  333 (452)
T 1fmk_A          279 LPQLVDMAAQ-IASGMAYVERMNYVHRDLRA----ANILVGEN----LVCKVADFGLARLIEDN----------------  333 (452)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCCTTC---------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeeCCCCCh----hhEEECCC----CCEEECCCccceecCCC----------------
Confidence            3344455555 78899999999999999999    89999876    79999999999843210                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .+. ...                   ...+|+.|+|||++.+.. |+.++|||||||++|||++ |++|
T Consensus       334 -----------~~~-~~~-------------------~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P  381 (452)
T 1fmk_A          334 -----------EYT-ARQ-------------------GAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVP  381 (452)
T ss_dssp             ----------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             -----------cee-ccc-------------------CCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCC
Confidence                       000 000                   011378899999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      |.+... .+.+..+.+....|.+..++..-......|+...|..|+++.
T Consensus       382 ~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~  429 (452)
T 1fmk_A          382 YPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE  429 (452)
T ss_dssp             STTCCH-HHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence            998543 355555555545454443333222223356666666666654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.81  E-value=7.1e-22  Score=198.50  Aligned_cols=117  Identities=15%  Similarity=0.173  Sum_probs=86.1

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +......+.++.. .+.||+|||++||+||||||    +|||++...  .+.+||+|||+|+........          
T Consensus       147 ~~~~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~~--~~~~kL~Dfg~a~~~~~~~~~----------  209 (345)
T 2v62_A          147 TFKKSTVLQLGIR-MLDVLEYIHENEYVHGDIKA----ANLLLGYKN--PDQVYLADYGLSYRYCPNGNH----------  209 (345)
T ss_dssp             BCCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEESSS--TTSEEECCCTTCEESSGGGCC----------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCeeCCCcCH----HHEEEccCC--CCcEEEEeCCCceeccccccc----------
Confidence            3344455555555 78999999999999999999    899998652  248999999999854211000          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                       ..+..              .......+|+.|+|||++.+.. |+.++||||+||++|||++|+
T Consensus       210 -----------------~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~  257 (345)
T 2v62_A          210 -----------------KQYQE--------------NPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGK  257 (345)
T ss_dssp             -----------------CCCCC--------------CGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             -----------------ccchh--------------ccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCC
Confidence                             00000              0001123499999999999775 999999999999999999999


Q ss_pred             CCCCCc
Q psy3074         167 PTFPGV  172 (481)
Q Consensus       167 ~PF~g~  172 (481)
                      .||.+.
T Consensus       258 ~pf~~~  263 (345)
T 2v62_A          258 LPWEQN  263 (345)
T ss_dssp             CTTGGG
T ss_pred             CCcccc
Confidence            999764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.81  E-value=9.9e-22  Score=196.82  Aligned_cols=110  Identities=23%  Similarity=0.464  Sum_probs=84.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       171 ~~~~~~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIll~~~----~~~kL~Dfg~~~~~~~~~---------------  226 (344)
T 1rjb_A          171 FEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAA----RNVLVTHG----KVVKICDFGLARDIMSDS---------------  226 (344)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEEETTCSG----GGEEEETT----TEEEECCCGGGSCGGGCT---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCcccCCCCh----hhEEEcCC----CcEEeCCCccCcccccCc---------------
Confidence            3334445555 78899999999999999999    89999866    799999999998532110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 ..  ...+                  ...+|+.|+|||++.+.. |+.++||||+||++|||++ |.+|
T Consensus       227 -----------~~--~~~~------------------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          227 -----------NY--VVRG------------------NARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             -----------TS--EEET------------------TEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             -----------cc--eecc------------------CccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC
Confidence                       00  0000                  011388899999998765 9999999999999999998 9999


Q ss_pred             CCCchhh
Q psy3074         169 FPGVREV  175 (481)
Q Consensus       169 F~g~~~~  175 (481)
                      |.+....
T Consensus       275 ~~~~~~~  281 (344)
T 1rjb_A          275 YPGIPVD  281 (344)
T ss_dssp             STTCCCS
T ss_pred             cccCCcH
Confidence            9886443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.81  E-value=3.1e-21  Score=190.51  Aligned_cols=132  Identities=33%  Similarity=0.572  Sum_probs=97.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+.......                
T Consensus       121 ~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~~---~~~kl~Dfg~~~~~~~~~~----------------  176 (320)
T 2i6l_A          121 HARLFMYQ-LLRGLKYIHSANVLHRDLKP----ANLFINTED---LVLKIGDFGLARIMDPHYS----------------  176 (320)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCBCCCCSG----GGEEEETTT---TEEEECCCTTCBCC---------------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCEecCCCCH----HHEEEcCCC---CeEEEccCccccccCCCcc----------------
Confidence            33444444 78899999999999999999    899997432   6899999999984321000                


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                             .       .+               ......+|++|+|||++.+...++.++||||+||++|||++|++||.+
T Consensus       177 -------~-------~~---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          177 -------H-------KG---------------HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             --------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             -------c-------cc---------------ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence                   0       00               000112389999999998766799999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      ..+ .+.+..+......+..+.++..
T Consensus       228 ~~~-~~~~~~~~~~~~~~~~~~~~~~  252 (320)
T 2i6l_A          228 AHE-LEQMQLILESIPVVHEEDRQEL  252 (320)
T ss_dssp             SSH-HHHHHHHHHHSCCCCHHHHHHH
T ss_pred             CCH-HHHHHHHHHhcCCCchhhhhhh
Confidence            644 4777888877776665554443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.81  E-value=1.1e-21  Score=196.25  Aligned_cols=122  Identities=20%  Similarity=0.414  Sum_probs=90.2

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++......+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......           
T Consensus       169 ~~l~~~~~~~i~~q-i~~~l~~LH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~-----------  228 (343)
T 1luf_A          169 PPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLAT----RNCLVGEN----MVVKIADFGLSRNIYSAD-----------  228 (343)
T ss_dssp             CCCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCSCHHHHTGGG-----------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHhCCeecCCCCc----ceEEECCC----CeEEEeecCCCcccccCc-----------
Confidence            34444555556666 78999999999999999999    89999876    799999999997432100           


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-  164 (481)
                                      ....                   .....+|+.|+|||++.+.. |+.++||||+||++|||++ 
T Consensus       229 ----------------~~~~-------------------~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          229 ----------------YYKA-------------------DGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             ----------------CBC-----------------------CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             ----------------cccc-------------------cCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhc
Confidence                            0000                   00112388999999998765 9999999999999999999 


Q ss_pred             CCCCCCCchhhHHHHHHHHH
Q psy3074         165 GLPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~  184 (481)
                      |..||.+... .+.+..+..
T Consensus       273 g~~p~~~~~~-~~~~~~~~~  291 (343)
T 1luf_A          273 GLQPYYGMAH-EEVIYYVRD  291 (343)
T ss_dssp             TCCTTTTSCH-HHHHHHHHT
T ss_pred             CCCcCCCCCh-HHHHHHHhC
Confidence            9999988533 244444443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.81  E-value=1.6e-21  Score=192.26  Aligned_cols=112  Identities=24%  Similarity=0.447  Sum_probs=85.7

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......            
T Consensus       142 ~~~~~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~~------------  200 (313)
T 1t46_A          142 LDLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAA----RNILLTHG----RITKICDFGLARDIKNDSN------------  200 (313)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEETT----TEEEECCCGGGSCTTSCTT------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeecCCCcc----ceEEEcCC----CCEEEcccccccccccccc------------
Confidence            334444455555 78899999999999999999    89999866    7999999999985321110            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                    .  ...+                  ...+|+.|+|||++.+.. ++.++||||+||++|||++ |.
T Consensus       201 --------------~--~~~~------------------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~  245 (313)
T 1t46_A          201 --------------Y--VVKG------------------NARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGS  245 (313)
T ss_dssp             --------------S--EECS------------------SSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --------------c--eecc------------------CCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCC
Confidence                          0  0000                  011378899999998765 9999999999999999999 99


Q ss_pred             CCCCCchhh
Q psy3074         167 PTFPGVREV  175 (481)
Q Consensus       167 ~PF~g~~~~  175 (481)
                      +||.+....
T Consensus       246 ~p~~~~~~~  254 (313)
T 1t46_A          246 SPYPGMPVD  254 (313)
T ss_dssp             CSSTTCCSS
T ss_pred             CCCCcccch
Confidence            999886443

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.81  E-value=4.2e-21  Score=186.48  Aligned_cols=113  Identities=27%  Similarity=0.451  Sum_probs=85.9

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||++.....                  
T Consensus       109 ~~~~~~~~q-i~~~l~~LH~~~i~H~dlkp----~Nili~~~----~~~~l~Dfg~~~~~~~------------------  161 (279)
T 3fdn_A          109 QRTATYITE-LANALSYCHSKRVIHRDIKP----ENLLLGSA----GELKIADFGWSVHAPS------------------  161 (279)
T ss_dssp             HHHHHHHHH-HHHHHHHHHTTTCEECCCCG----GGEEECTT----SCEEECSCCEESCC--------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCEecccCCh----HhEEEcCC----CCEEEEeccccccCCc------------------
Confidence            333444454 78899999999999999999    89999866    7999999999863211                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|..||.
T Consensus       162 ----------~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~  208 (279)
T 3fdn_A          162 ----------SRRTDLC----------------------GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFE  208 (279)
T ss_dssp             ----------------C----------------------CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ----------ccccccC----------------------CCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCC
Confidence                      0011112                      389999999998765 8999999999999999999999998


Q ss_pred             CchhhHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFK  184 (481)
Q Consensus       171 g~~~~~~~l~~i~~  184 (481)
                      +. +..+....+..
T Consensus       209 ~~-~~~~~~~~~~~  221 (279)
T 3fdn_A          209 AN-TYQETYKRISR  221 (279)
T ss_dssp             CS-SHHHHHHHHHH
T ss_pred             CC-cHHHHHHHHHh
Confidence            74 33344555544

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.81  E-value=7.2e-21  Score=186.21  Aligned_cols=131  Identities=16%  Similarity=0.267  Sum_probs=92.4

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++... ...+.+||+|||+|+..........        
T Consensus       103 ~~~~~~~~i~~q-i~~~l~~lH~~~ivH~Dlkp----~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~--------  169 (298)
T 1csn_A          103 FSVKTVAMAAKQ-MLARVQSIHEKSLVYRDIKP----DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH--------  169 (298)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHTTTEECCCCCG----GGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB--------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCEecCCCCH----HHEEeccCCCCCCCeEEEEECcccccccccccccc--------
Confidence            344444555555 78899999999999999999    899998764 2335599999999985432110000        


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                ..       +                .......+|+.|+|||++.+.. ++.++||||+||++|||++|+
T Consensus       170 ----------~~-------~----------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~  215 (298)
T 1csn_A          170 ----------IP-------Y----------------REKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGS  215 (298)
T ss_dssp             ----------CC-------C----------------CCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             ----------cc-------c----------------cCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCC
Confidence                      00       0                0001122499999999998766 999999999999999999999


Q ss_pred             CCCCCch--hhHHHHHHHHHH
Q psy3074         167 PTFPGVR--EVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~~--~~~~~l~~i~~~  185 (481)
                      .||.+..  +....+..+...
T Consensus       216 ~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          216 LPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             CTTSSCCSCCHHHHHHHHHHH
T ss_pred             CCcchhhccccHHHHHHHHhh
Confidence            9998742  233445555444

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.81  E-value=1.3e-21  Score=206.51  Aligned_cols=152  Identities=18%  Similarity=0.267  Sum_probs=102.9

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+......              
T Consensus       316 ~~~~~~~i~~q-i~~~L~~LH~~~ivHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~~--------------  372 (495)
T 1opk_A          316 SAVVLLYMATQ-ISSAMEYLEKKNFIHRNLAA----RNCLVGEN----HLVKVADFGLSRLMTGDT--------------  372 (495)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECGG----GCEEECCTTCEECCTTCC--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCcccCCCCh----hhEEECCC----CcEEEeecccceeccCCc--------------
Confidence            33444555555 78899999999999999999    89999876    799999999998532110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                   + ....                   ...+|+.|+|||++.+.. |+.++|||||||++|||++ |.+
T Consensus       373 -------------~-~~~~-------------------~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~  418 (495)
T 1opk_A          373 -------------Y-TAHA-------------------GAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMS  418 (495)
T ss_dssp             -------------E-ECCT-------------------TCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -------------e-eecC-------------------CCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCC
Confidence                         0 0000                   011378899999998765 9999999999999999999 999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ||.+.+. .+..+.+......+.+..++..-......|+...|..|+++.+
T Consensus       419 p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e  468 (495)
T 1opk_A          419 PYPGIDL-SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE  468 (495)
T ss_dssp             SSTTCCG-GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHH
Confidence            9998532 2444444443333333333222112233466666666666544

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.81  E-value=1.4e-21  Score=212.22  Aligned_cols=150  Identities=15%  Similarity=0.175  Sum_probs=100.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......                
T Consensus       470 ~~~~i~~q-i~~~L~yLH~~~iiHrDLkp----~NILl~~~----~~~kL~DFGla~~~~~~~~----------------  524 (635)
T 4fl3_A          470 NIIELVHQ-VSMGMKYLEESNFVHRDLAA----RNVLLVTQ----HYAKISDFGLSKALRADEN----------------  524 (635)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECCTTHHHHTTC-------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCEeCCCCCh----HhEEEeCC----CCEEEEEcCCccccccCcc----------------
Confidence            33445545 78899999999999999999    89999876    7999999999985421110                


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               .....                    ....+|+.|+|||++.+.. |+.++||||+||++|||++ |+.||.
T Consensus       525 ---------~~~~~--------------------~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~  574 (635)
T 4fl3_A          525 ---------YYKAQ--------------------THGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYR  574 (635)
T ss_dssp             ---------------------------------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ---------ccccc--------------------cCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                     00000                    0011378899999998765 9999999999999999998 999999


Q ss_pred             CchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         171 GVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      +.... +....+......+.+..++..-......|+...|..|+++.
T Consensus       575 ~~~~~-~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~  620 (635)
T 4fl3_A          575 GMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFA  620 (635)
T ss_dssp             TCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             CCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence            86442 44555544444433333332222222345555555555543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.81  E-value=1.8e-20  Score=186.39  Aligned_cols=124  Identities=23%  Similarity=0.417  Sum_probs=95.3

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCC---------------CCCceeeecccccccccCCCCCcC
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYAT---------------PPRELKLADFGLARAKSVPSHTYS   78 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~---------------~~g~~Kl~DFGla~~~~~~~~~~~   78 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++....               ..+.+||+|||+|+......    
T Consensus       121 ~~~~~q-i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----  191 (339)
T 1z57_A          121 RKMAYQ-ICKSVNFLHSNKLTHTDLKP----ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH----  191 (339)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC----
T ss_pred             HHHHHH-HHHHHHHHHHCCCcCCCCCH----HHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc----
Confidence            344444 78899999999999999999    8999976321               03689999999997421100    


Q ss_pred             CCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHH
Q psy3074          79 HQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCI  158 (481)
Q Consensus        79 ~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~i  158 (481)
                                               ..                      ..+|+.|+|||++.+.. |+.++||||+||+
T Consensus       192 -------------------------~~----------------------~~gt~~y~aPE~~~~~~-~~~~~Di~slG~i  223 (339)
T 1z57_A          192 -------------------------ST----------------------LVSTRHYRAPEVILALG-WSQPCDVWSIGCI  223 (339)
T ss_dssp             -------------------------CS----------------------SCSCGGGCCHHHHTTSC-CCTHHHHHHHHHH
T ss_pred             -------------------------cc----------------------ccCCccccChHHhhCCC-CCcchhhHHHHHH
Confidence                                     00                      12399999999998765 9999999999999


Q ss_pred             HHHHHhCCCCCCCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         159 LIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       159 l~elltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      +|||++|.+||.+.+ ..+.+..+.+..+.++...+.
T Consensus       224 l~el~~g~~pf~~~~-~~~~~~~~~~~~~~~p~~~~~  259 (339)
T 1z57_A          224 LIEYYLGFTVFPTHD-SKEHLAMMERILGPLPKHMIQ  259 (339)
T ss_dssp             HHHHHHSSCSCCCSC-HHHHHHHHHHHHCSCCHHHHH
T ss_pred             HHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHh
Confidence            999999999999854 346777777777777665443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.80  E-value=2.7e-21  Score=189.10  Aligned_cols=122  Identities=22%  Similarity=0.387  Sum_probs=83.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......             
T Consensus       117 ~~~~~~~~i~~q-i~~~L~~lH~~~i~H~Dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-------------  174 (289)
T 3og7_A          117 FEMKKLIDIARQ-TARGMDYLHAKSIIHRDLKS----NNIFLHED----NTVKIGDFGLATEKSRWS-------------  174 (289)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEETT----TEEEECCCC----------------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCcccccCcc----ceEEECCC----CCEEEccceecccccccc-------------
Confidence            333444455555 78899999999999999999    89999876    799999999997432100             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHHHhC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~elltg  165 (481)
                                +. ......                      .+|+.|+|||++..  ...++.++||||+||++|||++|
T Consensus       175 ----------~~-~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  221 (289)
T 3og7_A          175 ----------GS-HQFEQL----------------------SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG  221 (289)
T ss_dssp             ------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHS
T ss_pred             ----------cc-cccccc----------------------CCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHC
Confidence                      00 000111                      23999999999972  34489999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~  184 (481)
                      +.||.+..+.......+.+
T Consensus       222 ~~p~~~~~~~~~~~~~~~~  240 (289)
T 3og7_A          222 QLPYSNINNRDQIIEMVGR  240 (289)
T ss_dssp             SCTTSSCCCHHHHHHHHHH
T ss_pred             CCCccccchHHHHHHHhcc
Confidence            9999886555334444433

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.80  E-value=9.9e-21  Score=191.38  Aligned_cols=126  Identities=25%  Similarity=0.383  Sum_probs=95.1

Q ss_pred             HhhhhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccC--CCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074          12 RQISVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYA--TPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~--~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      ....++.. .+.||+|||++ ||+||||||    +|||++...  ...+.+||+|||+|+......              
T Consensus       132 ~~~~i~~q-i~~aL~~lH~~~~ivH~Dikp----~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~--------------  192 (373)
T 1q8y_A          132 YVKQISKQ-LLLGLDYMHRRCGIIHTDIKP----ENVLMEIVDSPENLIQIKIADLGNACWYDEHY--------------  192 (373)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCEECSCCSG----GGEEEEEEETTTTEEEEEECCCTTCEETTBCC--------------
T ss_pred             HHHHHHHH-HHHHHHHHHhcCCEEecCCCh----HHeEEeccCCCcCcceEEEcccccccccCCCC--------------
Confidence            33444545 78899999998 999999999    899996543  233589999999997432100              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                                           ....+|+.|+|||++.+.. |+.++||||+||++|||++|++|
T Consensus       193 -------------------------------------~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p  234 (373)
T 1q8y_A          193 -------------------------------------TNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFL  234 (373)
T ss_dssp             -------------------------------------CSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCC
T ss_pred             -------------------------------------CCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCC
Confidence                                                 0012399999999999876 99999999999999999999999


Q ss_pred             CCCch-----hhHHHHHHHHHHhCCCCccCc
Q psy3074         169 FPGVR-----EVYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       169 F~g~~-----~~~~~l~~i~~~~~~p~~~~~  194 (481)
                      |.+..     ...+.+..+.+.++.++...+
T Consensus       235 f~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  265 (373)
T 1q8y_A          235 FEPDEGHSYTKDDDHIAQIIELLGELPSYLL  265 (373)
T ss_dssp             C---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred             CCCCcccccCChHHHHHHHHHhcCCCCHHHH
Confidence            98753     234678888888888776543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.80  E-value=4.6e-21  Score=186.46  Aligned_cols=123  Identities=27%  Similarity=0.353  Sum_probs=90.8

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+......                    
T Consensus       109 ~~~~~-i~~~l~~lH~~~i~H~dikp----~Nil~~~~~-~~~~~kl~Dfg~~~~~~~~~--------------------  162 (284)
T 3kk8_A          109 HCIQQ-ILESIAYCHSNGIVHRNLKP----ENLLLASKA-KGAAVKLADFGLAIEVNDSE--------------------  162 (284)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECSCCCG----GGEEESSSS-TTCCEEECCCTTCEECCSSC--------------------
T ss_pred             HHHHH-HHHHHHHHHHCCcCcCCCCH----HHEEEecCC-CCCcEEEeeceeeEEcccCc--------------------
Confidence            34444 78899999999999999999    899997652 23469999999997432110                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                             .....                      .+|+.|+|||++.+.. ++.++||||+||++|||++|+.||.+...
T Consensus       163 -------~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~  212 (284)
T 3kk8_A          163 -------AWHGF----------------------AGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQ  212 (284)
T ss_dssp             -------BCCCS----------------------CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             -------cccCC----------------------CCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence                   00011                      2399999999998765 99999999999999999999999988543


Q ss_pred             hHHHHHHHHHHhCCCCccCc
Q psy3074         175 VYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~  194 (481)
                       .+....+.......+...+
T Consensus       213 -~~~~~~~~~~~~~~~~~~~  231 (284)
T 3kk8_A          213 -HRLYAQIKAGAYDYPSPEW  231 (284)
T ss_dssp             -HHHHHHHHHTCCCCCTTTT
T ss_pred             -hHHHHHHHhccccCCchhh
Confidence             3555666555444443333

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=2.2e-21  Score=195.88  Aligned_cols=97  Identities=22%  Similarity=0.400  Sum_probs=76.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+......                         .
T Consensus       168 i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kl~DfG~a~~~~~~~-------------------------~  214 (355)
T 1vzo_A          168 IVLALEHLHKLGIIYRDIKL----ENILLDSN----GHVVLTDFGLSKEFVADE-------------------------T  214 (355)
T ss_dssp             HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEESCSSEEEECCGGG-------------------------G
T ss_pred             HHHHHHHHHHCCcccCCCCH----HHEEECCC----CcEEEeeCCCCeecccCC-------------------------C
Confidence            78899999999999999999    89999866    799999999998431100                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                      ..                      .....+|+.|+|||++.+. ..++.++||||+||++|||++|+.||.+.
T Consensus       215 ~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~  265 (355)
T 1vzo_A          215 ER----------------------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  265 (355)
T ss_dssp             GG----------------------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             Cc----------------------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccC
Confidence            00                      0011249999999999863 34889999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.80  E-value=1.7e-21  Score=198.20  Aligned_cols=153  Identities=14%  Similarity=0.241  Sum_probs=93.2

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......             
T Consensus       145 ~~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kl~Dfg~a~~~~~~~~-------------  202 (373)
T 2qol_A          145 TVIQLVGMLRG-IASGMKYLSDMGYVHRDLAA----RNILINSN----LVCKVSDFGLGRVLEDDPE-------------  202 (373)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCC------------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCeeCCCCCc----ceEEEcCC----CCEEECcCccccccccCCc-------------
Confidence            33444455555 78899999999999999999    89999866    7999999999985321100             


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                 ...  ...                   ...+|+.|+|||++.+.. |+.++||||+||++|||++ |+.
T Consensus       203 -----------~~~--~~~-------------------~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~  249 (373)
T 2qol_A          203 -----------AAY--TTR-------------------GGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGER  249 (373)
T ss_dssp             -------------------------------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-C
T ss_pred             -----------cce--ecc-------------------CCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCC
Confidence                       000  000                   011278899999998765 9999999999999999998 999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      ||.+... .+.+..+......|.+..++..-......|+...|..|+++.
T Consensus       250 P~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  298 (373)
T 2qol_A          250 PYWEMSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFE  298 (373)
T ss_dssp             TTTTCCH-HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCH-HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHH
Confidence            9987533 344555544444443333322111122245555555555543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.80  E-value=1.5e-20  Score=191.80  Aligned_cols=111  Identities=16%  Similarity=0.199  Sum_probs=82.8

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||++.......                   
T Consensus       131 ~~~~~q-i~~~l~~LH~~~ivHrDlkp----~NIll~~~----~~~kl~dfg~~~~~~~~~-------------------  182 (389)
T 3gni_B          131 AYILQG-VLKALDYIHHMGYVHRSVKA----SHILISVD----GKVYLSGLRSNLSMISHG-------------------  182 (389)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCGGGCEECEETT-------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEEcCC----CCEEEcccccceeecccc-------------------
Confidence            344444 78899999999999999999    89999866    799999999997432110                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             .......+               ......+|+.|+|||++.+. ..|+.++||||+||++|||++|++||.+.
T Consensus       183 -------~~~~~~~~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          183 -------QRQRVVHD---------------FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             -------EECSCBCC---------------CCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             -------cccccccc---------------ccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence                   00000000               00112348999999999874 45999999999999999999999999885


Q ss_pred             hh
Q psy3074         173 RE  174 (481)
Q Consensus       173 ~~  174 (481)
                      +.
T Consensus       241 ~~  242 (389)
T 3gni_B          241 PA  242 (389)
T ss_dssp             CS
T ss_pred             CH
Confidence            43

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.80  E-value=3.2e-21  Score=186.29  Aligned_cols=118  Identities=19%  Similarity=0.327  Sum_probs=87.9

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.....                
T Consensus       105 ~~~~~~i~~~-i~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~----------------  159 (269)
T 4hcu_A          105 AETLLGMCLD-VCEGMAYLEEACVIHRDLAA----RNCLVGEN----QVIKVSDFGMTRFVLDD----------------  159 (269)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECGG----GCEEECCTTGGGGBCCH----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeecCCcch----heEEEcCC----CCEEecccccccccccc----------------
Confidence            3334445555 78899999999999999999    89999776    69999999999843110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 ..                    .......+|+.|+|||++.+.. ++.++||||+||++|||++ |++|
T Consensus       160 -----------~~--------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p  207 (269)
T 4hcu_A          160 -----------QY--------------------TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIP  207 (269)
T ss_dssp             -----------HH--------------------HSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------cc--------------------ccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCC
Confidence                       00                    0001112378899999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+... .+.+..+...
T Consensus       208 ~~~~~~-~~~~~~~~~~  223 (269)
T 4hcu_A          208 YENRSN-SEVVEDISTG  223 (269)
T ss_dssp             TTTCCH-HHHHHHHHTT
T ss_pred             CCCCCH-HHHHHHHhcC
Confidence            988533 3445555443

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.80  E-value=1.8e-21  Score=194.07  Aligned_cols=110  Identities=25%  Similarity=0.474  Sum_probs=84.2

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......              
T Consensus       163 ~~~~~~~~~q-i~~~l~~lH~~~ivH~Dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~~--------------  219 (333)
T 2i1m_A          163 TRDLLHFSSQ-VAQGMAFLASKNCIHRDVAA----RNVLLTNG----HVAKIGDFGLARDIMNDSN--------------  219 (333)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGCEEEGG----GEEEBCCCGGGCCGGGCTT--------------
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCcccCCccc----ceEEECCC----CeEEECccccccccccccc--------------
Confidence            3334444455 78899999999999999999    89999876    7999999999985321110              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                  .  ...+                  ...+|+.|+|||++.+.. ++.++||||+||++|||++ |.+|
T Consensus       220 ------------~--~~~~------------------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  266 (333)
T 2i1m_A          220 ------------Y--IVKG------------------NARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNP  266 (333)
T ss_dssp             ------------S--EECS------------------SCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             ------------e--eecC------------------CCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCC
Confidence                        0  0000                  011378899999998765 9999999999999999998 9999


Q ss_pred             CCCchhh
Q psy3074         169 FPGVREV  175 (481)
Q Consensus       169 F~g~~~~  175 (481)
                      |.+....
T Consensus       267 ~~~~~~~  273 (333)
T 2i1m_A          267 YPGILVN  273 (333)
T ss_dssp             STTCCSS
T ss_pred             Ccccchh
Confidence            9885433

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.80  E-value=2.8e-21  Score=190.78  Aligned_cols=119  Identities=22%  Similarity=0.449  Sum_probs=87.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       147 ~~~~~~~~~q-i~~al~~lH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~---------------  202 (316)
T 2xir_A          147 LEHLICYSFQ-VAKGMEFLASRKCIHRDLAA----RNILLSEK----NVVKICDFGLARDIYKDP---------------  202 (316)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCGGGSCTTTCT---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCcccccCcc----ceEEECCC----CCEEECCCccccccccCc---------------
Confidence            3334444444 78899999999999999999    89999866    799999999998432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 ...  ..+                  ...+|+.|+|||++.+.. ++.++||||+||++|||++ |..|
T Consensus       203 -----------~~~--~~~------------------~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          203 -----------DYV--RKG------------------DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             -----------TSE--EET------------------TEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -----------cce--ecc------------------CCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCC
Confidence                       000  000                  112388999999998765 9999999999999999998 9999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+..........+..
T Consensus       251 ~~~~~~~~~~~~~~~~  266 (316)
T 2xir_A          251 YPGVKIDEEFCRRLKE  266 (316)
T ss_dssp             STTCCCSHHHHHHHHH
T ss_pred             CcccchhHHHHHHhcc
Confidence            9886444333344433

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.80  E-value=2.8e-20  Score=186.17  Aligned_cols=120  Identities=23%  Similarity=0.406  Sum_probs=87.1

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||+++|+||||||    +|||++..  ..+.+||+|||+|+.......                   
T Consensus       172 ~i~~q-i~~~l~~LH~~~ivH~Dlkp----~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~-------------------  225 (345)
T 3hko_A          172 NIMRQ-IFSALHYLHNQGICHRDIKP----ENFLFSTN--KSFEIKLVDFGLSKEFYKLNN-------------------  225 (345)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESCS--SSCCEEECCCTTCEEGGGTTC-------------------
T ss_pred             HHHHH-HHHHHHHHHHCCccccCCCh----hhEEEecC--CCceEEEeeccccccccccCc-------------------
Confidence            34444 78899999999999999999    89999754  124899999999985321100                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                         +........                      .+|+.|+|||++.+. ..|+.++||||+||++|||++|+.||.+..
T Consensus       226 ---~~~~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  280 (345)
T 3hko_A          226 ---GEYYGMTTK----------------------AGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVN  280 (345)
T ss_dssp             ---C------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ---ccccccccc----------------------CCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence               000000111                      239999999999763 459999999999999999999999999864


Q ss_pred             hhHHHHHHHHHHh
Q psy3074         174 EVYDQLDKIFKIL  186 (481)
Q Consensus       174 ~~~~~l~~i~~~~  186 (481)
                      +. +.+..+....
T Consensus       281 ~~-~~~~~~~~~~  292 (345)
T 3hko_A          281 DA-DTISQVLNKK  292 (345)
T ss_dssp             HH-HHHHHHHHCC
T ss_pred             hH-HHHHHHHhcc
Confidence            43 5555555543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.80  E-value=3.8e-21  Score=190.02  Aligned_cols=121  Identities=19%  Similarity=0.343  Sum_probs=85.8

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......            
T Consensus       144 ~~~~~~~~i~~q-i~~aL~~LH~~~ivH~dikp----~NIli~~~----~~~kl~Dfg~~~~~~~~~~------------  202 (313)
T 3brb_A          144 IPLQTLLKFMVD-IALGMEYLSNRNFLHRDLAA----RNCMLRDD----MTVCVADFGLSKKIYSGDY------------  202 (313)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHTTTCCCCCCSG----GGEEECTT----SCEEECSCSCC--------------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCcccCCCCc----ceEEEcCC----CcEEEeecCcceecccccc------------
Confidence            334444555555 78899999999999999999    89999866    7999999999984321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                  ...+..                      ..+|+.|+|||++.+.. |+.++||||+||++|||++ |.
T Consensus       203 ------------~~~~~~----------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~  247 (313)
T 3brb_A          203 ------------YRQGRI----------------------AKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGM  247 (313)
T ss_dssp             ------------------------------------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             ------------cCcccc----------------------cCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCC
Confidence                        000011                      11388999999998765 9999999999999999999 99


Q ss_pred             CCCCCchhhHHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~  185 (481)
                      +||.+.... +....+...
T Consensus       248 ~p~~~~~~~-~~~~~~~~~  265 (313)
T 3brb_A          248 TPYPGVQNH-EMYDYLLHG  265 (313)
T ss_dssp             CSSTTCCGG-GHHHHHHTT
T ss_pred             CCCccCCHH-HHHHHHHcC
Confidence            999885332 444444433

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.80  E-value=2.3e-21  Score=187.23  Aligned_cols=108  Identities=22%  Similarity=0.379  Sum_probs=80.4

Q ss_pred             HHhhhhccCcccccHHHHHHhh---hhcccCCCCCCCcchhccccCC----CCCceeeecccccccccCCCCCcCCCCCC
Q psy3074          11 QRQISVSSDSKLLDADIAEETR---VLLRNRKPPRPKSEVFLNKYAT----PPRELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~---i~hrdlkp~~~~~nill~~~~~----~~g~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      .....++.. .+.||+|||++|   |+||||||    +|||++....    ..+.+||+|||+|+......         
T Consensus       105 ~~~~~i~~~-l~~~l~~lH~~~~~~i~H~dikp----~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---------  170 (271)
T 3dtc_A          105 DILVNWAVQ-IARGMNYLHDEAIVPIIHRDLKS----SNILILQKVENGDLSNKILKITDFGLAREWHRTT---------  170 (271)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHSSSSCCCCSCCSG----GGEEESSCCSSSCCSSCCEEECCCCC-----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCCCceeecCCch----HHEEEecccccccccCcceEEccCCccccccccc---------
Confidence            333444444 788999999999   99999999    8999986422    24789999999997421100         


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ell  163 (481)
                                         .....                      +|+.|+|||++.+.. ++.++||||+||++|||+
T Consensus       171 -------------------~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~  208 (271)
T 3dtc_A          171 -------------------KMSAA----------------------GAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELL  208 (271)
T ss_dssp             ----------------------------------------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHH
T ss_pred             -------------------ccCCC----------------------CccceeCHHHhccCC-CCchhhHHHHHHHHHHHH
Confidence                               00112                      389999999998765 999999999999999999


Q ss_pred             hCCCCCCCchh
Q psy3074         164 TGLPTFPGVRE  174 (481)
Q Consensus       164 tg~~PF~g~~~  174 (481)
                      +|+.||.+.++
T Consensus       209 ~g~~p~~~~~~  219 (271)
T 3dtc_A          209 TGEVPFRGIDG  219 (271)
T ss_dssp             HCCCTTTTSCH
T ss_pred             hCCCCCCCCCH
Confidence            99999998644

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.80  E-value=5.8e-21  Score=185.62  Aligned_cols=121  Identities=21%  Similarity=0.296  Sum_probs=89.7

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +||+++......+.+||+|||+++....                  
T Consensus       108 ~~~~~~~~~-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~~~~~~~~kl~dfg~~~~~~~------------------  164 (283)
T 3bhy_A          108 DEATQFLKQ-ILDGVHYLHSKRIAHFDLKP----ENIMLLDKNVPNPRIKLIDFGIAHKIEA------------------  164 (283)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEESCSSSSSCCEEECCCTTCEECC-------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCccCCCCCh----HHEEEecCCCCCCceEEEecccceeccC------------------
Confidence            334445555 78899999999999999999    8999987644445899999999974321                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               +......                      .+|+.|+|||++.+.. ++.++||||+||++|||++|..||.
T Consensus       165 ---------~~~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~  212 (283)
T 3bhy_A          165 ---------GNEFKNI----------------------FGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFL  212 (283)
T ss_dssp             --------------------------------------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ---------CCccccc----------------------CCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCC
Confidence                     0000111                      2389999999998765 9999999999999999999999999


Q ss_pred             CchhhHHHHHHHHHHhC
Q psy3074         171 GVREVYDQLDKIFKILG  187 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~  187 (481)
                      +... .+.+..+.....
T Consensus       213 ~~~~-~~~~~~~~~~~~  228 (283)
T 3bhy_A          213 GETK-QETLTNISAVNY  228 (283)
T ss_dssp             CSSH-HHHHHHHHTTCC
T ss_pred             Ccch-HHHHHHhHhccc
Confidence            8533 345555544333

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.80  E-value=4.1e-21  Score=193.38  Aligned_cols=117  Identities=14%  Similarity=0.182  Sum_probs=87.6

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCC--ceeeecccccccccCCCCCcCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPR--ELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g--~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      ++........++.. .+.||+|||++||+||||||    +|||++..    +  .+||+|||+|+..........     
T Consensus       154 ~~l~~~~~~~i~~q-i~~~L~~LH~~~ivH~Dikp----~NIl~~~~----~~~~~kl~Dfg~a~~~~~~~~~~~-----  219 (352)
T 2jii_A          154 HVLSERSVLQVACR-LLDALEFLHENEYVHGNVTA----ENIFVDPE----DQSQVTLAGYGFAFRYCPSGKHVA-----  219 (352)
T ss_dssp             GCCCHHHHHHHHHH-HHHHHHHHHHTTCBCSCCCG----GGEEEETT----EEEEEEECCGGGCBCSSGGGCCCC-----
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHhCCccCCCCCH----HHEEEcCC----CCceEEEecCcceeeccCCCcccc-----
Confidence            34445555566666 88999999999999999999    89999865    5  899999999985421110000     


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ell  163 (481)
                                   . ....                      .....+|+.|+|||++.+.. ++.++||||+||++|||+
T Consensus       220 -------------~-~~~~----------------------~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~  262 (352)
T 2jii_A          220 -------------Y-VEGS----------------------RSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWL  262 (352)
T ss_dssp             -------------C-CTTS----------------------SCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred             -------------c-cccc----------------------cccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHH
Confidence                         0 0000                      01113499999999998765 999999999999999999


Q ss_pred             hCCCCCCCch
Q psy3074         164 TGLPTFPGVR  173 (481)
Q Consensus       164 tg~~PF~g~~  173 (481)
                      +|+.||.+..
T Consensus       263 ~g~~pf~~~~  272 (352)
T 2jii_A          263 YGFLPWTNCL  272 (352)
T ss_dssp             HSCCTTGGGT
T ss_pred             hCCCCcccCC
Confidence            9999998754

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.80  E-value=3.1e-21  Score=187.69  Aligned_cols=119  Identities=18%  Similarity=0.234  Sum_probs=86.1

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                  
T Consensus       115 ~~~~~~~-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~------------------  167 (281)
T 3cc6_A          115 LVLYSLQ-ICKAMAYLESINCVHRDIAV----RNILVASP----ECVKLGDFGLSRYIEDED------------------  167 (281)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCCCCSG----GGEEEEET----TEEEECCCCGGGCC----------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCcccCCCcc----ceEEECCC----CcEEeCccCCCccccccc------------------
Confidence            3344444 78899999999999999999    89999876    799999999998432110                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPG  171 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~g  171 (481)
                               ...                    .....+|+.|+|||++.+.. ++.++||||+||++|||++ |+.||.+
T Consensus       168 ---------~~~--------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          168 ---------YYK--------------------ASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             ----------------------------------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             ---------ccc--------------------cccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCccc
Confidence                     000                    00112378899999998665 9999999999999999998 9999986


Q ss_pred             chhhHHHHHHHHHHhCCC
Q psy3074         172 VREVYDQLDKIFKILGTP  189 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p  189 (481)
                      .... +....+......|
T Consensus       218 ~~~~-~~~~~~~~~~~~~  234 (281)
T 3cc6_A          218 LENK-DVIGVLEKGDRLP  234 (281)
T ss_dssp             SCGG-GHHHHHHHTCCCC
T ss_pred             CChH-HHHHHHhcCCCCC
Confidence            4332 3444444443333

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.80  E-value=2.2e-21  Score=187.24  Aligned_cols=118  Identities=17%  Similarity=0.287  Sum_probs=87.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus       103 ~~~~~~i~~q-i~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~~l~Dfg~~~~~~~~----------------  157 (268)
T 3sxs_A          103 PSQLLEMCYD-VCEGMAFLESHQFIHRDLAA----RNCLVDRD----LCVKVSDFGMTRYVLDD----------------  157 (268)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEEESSCSG----GGEEECTT----CCEEECCTTCEEECCTT----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeecCCcCc----ceEEECCC----CCEEEccCccceecchh----------------
Confidence            3334445555 78899999999999999999    89999866    79999999999843211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .. ....+                   ..+|+.|+|||++.+.. ++.++||||+||++|||++ |.+|
T Consensus       158 -----------~~-~~~~~-------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p  205 (268)
T 3sxs_A          158 -----------QY-VSSVG-------------------TKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMP  205 (268)
T ss_dssp             -----------CE-EECCS-------------------CCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCT
T ss_pred             -----------hh-hcccC-------------------CCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCC
Confidence                       00 00011                   11377899999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+.... +....+...
T Consensus       206 ~~~~~~~-~~~~~~~~~  221 (268)
T 3sxs_A          206 YDLYTNS-EVVLKVSQG  221 (268)
T ss_dssp             TTTSCHH-HHHHHHHTT
T ss_pred             ccccChH-HHHHHHHcC
Confidence            9875433 444444433

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.80  E-value=9.1e-21  Score=191.92  Aligned_cols=105  Identities=23%  Similarity=0.295  Sum_probs=74.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++...  .+.+||+|||+|+.....                    
T Consensus       119 ~~i~~q-l~~~L~~LH~~~ivH~Dlkp----~Nill~~~~--~~~~kl~Dfg~a~~~~~~--------------------  171 (361)
T 3uc3_A          119 RFFFQQ-LLSGVSYCHSMQICHRDLKL----ENTLLDGSP--APRLKICDFGYSKSSVLH--------------------  171 (361)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCSCCCCG----GGEEECSSS--SCCEEECCCCCC--------------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCcccCCCCH----HHEEEcCCC--CceEEEeecCcccccccc--------------------
Confidence            334444 78899999999999999999    899997542  245999999999732110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .......                      +|+.|+|||++.+...++.++||||+||++|||++|++||.+..
T Consensus       172 -------~~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          172 -------SQPKSTV----------------------GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             --------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             -------CCCCCCc----------------------CCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence                   0011112                      39999999999987734455999999999999999999998754


Q ss_pred             h
Q psy3074         174 E  174 (481)
Q Consensus       174 ~  174 (481)
                      +
T Consensus       223 ~  223 (361)
T 3uc3_A          223 E  223 (361)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.80  E-value=1.8e-20  Score=183.11  Aligned_cols=116  Identities=16%  Similarity=0.247  Sum_probs=84.6

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++.. +..+.+||+|||+|+..........          
T Consensus       103 ~~~~~~~i~~q-i~~~l~~lH~~~ivH~dlkp----~NIl~~~~-~~~~~~kl~Dfg~~~~~~~~~~~~~----------  166 (296)
T 3uzp_A          103 SLKTVLLLADQ-MISRIEYIHSKNFIHRDVKP----DNFLMGLG-KKGNLVYIIDFGLAKKYRDARTHQH----------  166 (296)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECCG-GGTTCEEECCCTTCEECBCTTTCCB----------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeeeCCCCH----HHeEEecC-CCCCeEEEeeCCCcccccccccccc----------
Confidence            34444455555 78899999999999999999    89999521 1237899999999985432110000          


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                              ..       +                .......+|+.|+|||++.+.. ++.++||||+||++|||++|+.|
T Consensus       167 --------~~-------~----------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  214 (296)
T 3uzp_A          167 --------IP-------Y----------------RENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLP  214 (296)
T ss_dssp             --------CC-------C----------------CCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             --------cc-------c----------------ccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCC
Confidence                    00       0                0001122499999999998876 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       215 f~~~  218 (296)
T 3uzp_A          215 WQGL  218 (296)
T ss_dssp             TSSC
T ss_pred             CCCc
Confidence            9874

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.80  E-value=1.5e-20  Score=185.58  Aligned_cols=119  Identities=17%  Similarity=0.293  Sum_probs=83.2

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.........            
T Consensus       107 ~~~~~~i~~q-i~~al~~lH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~~------------  165 (310)
T 3s95_A          107 WSQRVSFAKD-IASGMAYLHSMNIIHRDLNS----HNCLVREN----KNVVVADFGLARLMVDEKTQP------------  165 (310)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCST----TSEEECTT----SCEEECCCTTCEECC------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCccCCCCCc----CeEEECCC----CCEEEeecccceecccccccc------------
Confidence            3344445555 78899999999999999999    89999876    799999999998542211000            


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                             .+..+...               ..........+|+.|+|||++.+.. |+.++||||+||++|||++|..||
T Consensus       166 -------~~~~~~~~---------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~  222 (310)
T 3s95_A          166 -------EGLRSLKK---------------PDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNAD  222 (310)
T ss_dssp             ------------------------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSS
T ss_pred             -------cccccccc---------------cccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCC
Confidence                   00000000               0000011223599999999998765 999999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      ...
T Consensus       223 ~~~  225 (310)
T 3s95_A          223 PDY  225 (310)
T ss_dssp             TTT
T ss_pred             cch
Confidence            763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.80  E-value=6.1e-21  Score=186.71  Aligned_cols=124  Identities=19%  Similarity=0.286  Sum_probs=86.5

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........              
T Consensus       124 ~~~~~i~~q-i~~~l~~LH~~~i~H~dikp----~Nili~~~----~~~kl~Dfg~~~~~~~~~~~--------------  180 (298)
T 3pls_A          124 KDLISFGLQ-VARGMEYLAEQKFVHRDLAA----RNCMLDES----FTVKVADFGLARDILDREYY--------------  180 (298)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----CCEEECCTTSSCTTTTGGGG--------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCcccCCCCc----ceEEEcCC----CcEEeCcCCCcccccCCccc--------------
Confidence            333445545 78899999999999999999    89999766    79999999999843211000              


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-CCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-LPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-~~PF  169 (481)
                             .. .                      ......+|+.|+|||++.+.. ++.++||||+||++|||++| .+||
T Consensus       181 -------~~-~----------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          181 -------SV-Q----------------------QHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             -------CS-C----------------------CSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             -------cc-c----------------------cCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCC
Confidence                   00 0                      000112388999999998765 99999999999999999995 5555


Q ss_pred             CCchhhHHHHHHHHHHhCCC
Q psy3074         170 PGVREVYDQLDKIFKILGTP  189 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p  189 (481)
                      .+ .+..+....+......+
T Consensus       230 ~~-~~~~~~~~~~~~~~~~~  248 (298)
T 3pls_A          230 RH-IDPFDLTHFLAQGRRLP  248 (298)
T ss_dssp             TT-SCGGGHHHHHHTTCCCC
T ss_pred             cc-CCHHHHHHHhhcCCCCC
Confidence            55 34434444444433333

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.80  E-value=3.3e-21  Score=188.93  Aligned_cols=123  Identities=20%  Similarity=0.305  Sum_probs=87.2

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+........             
T Consensus       127 ~~~~~~i~~q-l~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~~~-------------  184 (298)
T 3f66_A          127 VKDLIGFGLQ-VAKGMKYLASKKFVHRDLAA----RNCMLDEK----FTVKVADFGLARDMYDKEYY-------------  184 (298)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----CCEEECSCGGGCCCSCGGGC-------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCccCCCCch----heEEECCC----CCEEECcccccccccccchh-------------
Confidence            3344444444 78899999999999999999    89999765    79999999999853211000             


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                               .....                      ....+|+.|+|||++.+.. ++.++||||+||++|||++ |.+|
T Consensus       185 ---------~~~~~----------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~  232 (298)
T 3f66_A          185 ---------SVHNK----------------------TGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPP  232 (298)
T ss_dssp             ---------BC---------------------------CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ---------ccccc----------------------cCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCC
Confidence                     00000                      0112388999999998765 9999999999999999999 7778


Q ss_pred             CCCchhhHHHHHHHHHHhC
Q psy3074         169 FPGVREVYDQLDKIFKILG  187 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~  187 (481)
                      |.+.+.. +....+.....
T Consensus       233 ~~~~~~~-~~~~~~~~~~~  250 (298)
T 3f66_A          233 YPDVNTF-DITVYLLQGRR  250 (298)
T ss_dssp             STTSCTT-THHHHHHTTCC
T ss_pred             CccCCHH-HHHHHHhcCCC
Confidence            8775332 44444444333

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.80  E-value=3.9e-21  Score=204.73  Aligned_cols=150  Identities=18%  Similarity=0.312  Sum_probs=104.1

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+.....                
T Consensus       362 ~~~~~~i~~q-i~~~L~~LH~~~ivHrDlkp----~NIll~~~----~~~kl~DFG~a~~~~~~----------------  416 (535)
T 2h8h_A          362 LPQLVDMAAQ-IASGMAYVERMNYVHRDLRA----ANILVGEN----LVCKVADFGLARLIEDN----------------  416 (535)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCTTSTTTCCCH----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeeCCCCCH----hhEEEcCC----CcEEEcccccceecCCC----------------
Confidence            3444555555 78899999999999999999    89999876    69999999999843110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .+                    .......+|+.|+|||++.+.. |+.++|||||||++|||++ |+.|
T Consensus       417 -----------~~--------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P  464 (535)
T 2h8h_A          417 -----------EY--------------------TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVP  464 (535)
T ss_dssp             -----------HH--------------------HTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred             -----------ce--------------------ecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence                       00                    0000112378899999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      |.+... .+.+..+.+....+.+..++..-......|+...|..|+++.
T Consensus       465 ~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  512 (535)
T 2h8h_A          465 YPGMVN-REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFE  512 (535)
T ss_dssp             STTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            998543 355555555544444443333222223356666666666544

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.80  E-value=1.3e-20  Score=182.73  Aligned_cols=124  Identities=27%  Similarity=0.384  Sum_probs=91.1

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||+... +..+.+||+|||+|+.....                   
T Consensus       108 ~~~i~~~-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~-~~~~~~~l~Dfg~~~~~~~~-------------------  162 (277)
T 3f3z_A          108 AARIMKD-VLSAVAYCHKLNVAHRDLKP----ENFLFLTD-SPDSPLKLIDFGLAARFKPG-------------------  162 (277)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESSS-STTCCEEECCCTTCEECCTT-------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCccCCCCCH----HHEEEecC-CCCCcEEEEecccceeccCc-------------------
Confidence            3444444 78899999999999999999    89999432 23478999999999743211                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                              ......                      .+|+.|+|||++.+.  ++.++||||+||++|||++|+.||.+.
T Consensus       163 --------~~~~~~----------------------~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~  210 (277)
T 3f3z_A          163 --------KMMRTK----------------------VGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAP  210 (277)
T ss_dssp             --------SCBCCC----------------------CSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             --------cchhcc----------------------CCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence                    100111                      239999999998764  899999999999999999999999885


Q ss_pred             hhhHHHHHHHHHHhCCCCccCc
Q psy3074         173 REVYDQLDKIFKILGTPTEETW  194 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p~~~~~  194 (481)
                      .+ .+.+..+.+....++...|
T Consensus       211 ~~-~~~~~~~~~~~~~~~~~~~  231 (277)
T 3f3z_A          211 TD-SEVMLKIREGTFTFPEKDW  231 (277)
T ss_dssp             SH-HHHHHHHHHCCCCCCHHHH
T ss_pred             CH-HHHHHHHHhCCCCCCchhh
Confidence            43 3556666655444444333

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.80  E-value=1.9e-20  Score=197.95  Aligned_cols=129  Identities=23%  Similarity=0.341  Sum_probs=94.9

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++... ....+||+|||+|+......                 
T Consensus       147 ~~~~i~~q-i~~~l~~lH~~~ivH~Dlkp----~Nil~~~~~-~~~~~kl~Dfg~a~~~~~~~-----------------  203 (504)
T 3q5i_A          147 DAANIMKQ-ILSGICYLHKHNIVHRDIKP----ENILLENKN-SLLNIKIVDFGLSSFFSKDY-----------------  203 (504)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEESSTT-CCSSEEECCCTTCEECCTTS-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeEeCCCcH----HHEEEecCC-CCccEEEEECCCCEEcCCCC-----------------
Confidence            33444444 78899999999999999999    899998652 12369999999998532110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                .....                      .+|+.|+|||++.+  .|+.++||||+||++|+|++|.+||.+
T Consensus       204 ----------~~~~~----------------------~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~  249 (504)
T 3q5i_A          204 ----------KLRDR----------------------LGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGG  249 (504)
T ss_dssp             ----------CBCCC----------------------CSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ----------ccccc----------------------cCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence                      00111                      23999999999874  399999999999999999999999998


Q ss_pred             chhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         172 VREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       172 ~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      .+ ..+.+..+......++.+.|+.++
T Consensus       250 ~~-~~~~~~~i~~~~~~~~~~~~~~~s  275 (504)
T 3q5i_A          250 QN-DQDIIKKVEKGKYYFDFNDWKNIS  275 (504)
T ss_dssp             SS-HHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred             CC-HHHHHHHHHcCCCCCCccccCCCC
Confidence            54 346677776655555555554443

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.80  E-value=5.7e-21  Score=185.84  Aligned_cols=123  Identities=21%  Similarity=0.367  Sum_probs=90.6

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......              
T Consensus       118 ~~~~~~~i~~q-i~~~l~~lH~~~i~H~dikp----~Nili~~~----~~~kl~Dfg~~~~~~~~~--------------  174 (283)
T 3gen_A          118 QTQQLLEMCKD-VCEAMEYLESKQFLHRDLAA----RNCLVNDQ----GVVKVSDFGLSRYVLDDE--------------  174 (283)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCSSCSG----GGEEECTT----SCEEECSTTGGGGBCCHH--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCccCCCCcc----ceEEEcCC----CCEEEccccccccccccc--------------
Confidence            34444455555 78899999999999999999    89999866    799999999998431100              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                   .                    .......+|+.|+|||++.+.. ++.++||||+||++|||++ |++
T Consensus       175 -------------~--------------------~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~  220 (283)
T 3gen_A          175 -------------Y--------------------TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKM  220 (283)
T ss_dssp             -------------H--------------------HSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCC
T ss_pred             -------------c--------------------ccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence                         0                    0000112378899999998765 9999999999999999998 999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTP  189 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p  189 (481)
                      ||.+... .+....+......+
T Consensus       221 p~~~~~~-~~~~~~~~~~~~~~  241 (283)
T 3gen_A          221 PYERFTN-SETAEHIAQGLRLY  241 (283)
T ss_dssp             TTTTSCH-HHHHHHHHTTCCCC
T ss_pred             CccccCh-hHHHHHHhcccCCC
Confidence            9988543 34555555444333

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.80  E-value=2.4e-20  Score=185.08  Aligned_cols=108  Identities=17%  Similarity=0.306  Sum_probs=84.1

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......              
T Consensus       137 ~~~~~~~i~~~-i~~~l~~lH~~~ivH~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~--------------  193 (321)
T 2qkw_B          137 SWEQRLEICIG-AARGLHYLHTRAIIHRDVKS----INILLDEN----FVPKITDFGISKKGTELD--------------  193 (321)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCCS----TTEEECTT----CCEEECCCTTCEECSSSS--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHhcCCCeecCCCCH----HHEEECCC----CCEEEeeccccccccccc--------------
Confidence            34444555555 78899999999999999999    89999765    799999999997432110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                .........                      +|+.|+|||++.+.. ++.++||||+||++|||++|+.|
T Consensus       194 ----------~~~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p  240 (321)
T 2qkw_B          194 ----------QTHLSTVVK----------------------GTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSA  240 (321)
T ss_dssp             ----------CCCCBCCCE----------------------EETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTT
T ss_pred             ----------ccccccccC----------------------CCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCc
Confidence                      000111122                      399999999998766 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       241 ~~~~  244 (321)
T 2qkw_B          241 IVQS  244 (321)
T ss_dssp             CSCS
T ss_pred             cccc
Confidence            9864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.79  E-value=1.9e-20  Score=186.31  Aligned_cols=113  Identities=24%  Similarity=0.409  Sum_probs=85.9

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......                
T Consensus       141 ~~~~~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~----~~~kl~Dfg~~~~~~~~~----------------  195 (321)
T 2c30_A          141 EQIATVCEA-VLQALAYLHAQGVIHRDIKS----DSILLTLD----GRVKLSDFGFCAQISKDV----------------  195 (321)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECCSSS----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeecCCCCH----HHEEECCC----CcEEEeeeeeeeecccCc----------------
Confidence            333444444 67899999999999999999    89999866    799999999997532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                ......                      .+|+.|+|||++.+.. |+.++||||+||++|||++|++||.
T Consensus       196 ----------~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~  242 (321)
T 2c30_A          196 ----------PKRKSL----------------------VGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYF  242 (321)
T ss_dssp             ----------CCBCCC----------------------CSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ----------cccccc----------------------cCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence                      000111                      2399999999998765 9999999999999999999999998


Q ss_pred             CchhhHHHHHHH
Q psy3074         171 GVREVYDQLDKI  182 (481)
Q Consensus       171 g~~~~~~~l~~i  182 (481)
                      +... .+.+..+
T Consensus       243 ~~~~-~~~~~~~  253 (321)
T 2c30_A          243 SDSP-VQAMKRL  253 (321)
T ss_dssp             TSCH-HHHHHHH
T ss_pred             CCCH-HHHHHHH
Confidence            7533 2444433

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=5.5e-21  Score=191.11  Aligned_cols=152  Identities=14%  Similarity=0.242  Sum_probs=96.8

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+.......             
T Consensus       145 ~~~~~~~i~~q-i~~aL~~LH~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~~-------------  202 (333)
T 1mqb_A          145 SVLQLVGMLRG-IAAGMKYLANMNYVHRDLAA----RNILVNSN----LVCKVSDFGLSRVLEDDPE-------------  202 (333)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCCCC----------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeeCCCCCh----heEEECCC----CcEEECCCCcchhhccccc-------------
Confidence            33444455555 78899999999999999999    89999865    7999999999985321100             


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                 ....  .                   ....+|+.|+|||++.+.. ++.++||||+||++|||++ |+.
T Consensus       203 -----------~~~~--~-------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~  249 (333)
T 1mqb_A          203 -----------ATYT--T-------------------SGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGER  249 (333)
T ss_dssp             ----------------------------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -----------cccc--c-------------------CCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCC
Confidence                       0000  0                   0011378899999998765 9999999999999999999 999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKL  216 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  216 (481)
                      ||.+... .+.+..+......|.+...+..-......|+...|..|+++
T Consensus       250 pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~  297 (333)
T 1mqb_A          250 PYWELSN-HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF  297 (333)
T ss_dssp             TTTTCCH-HHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCH
T ss_pred             CcccCCH-HHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCH
Confidence            9987533 34455554444444333222211112224555555555554

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.79  E-value=1.3e-20  Score=182.42  Aligned_cols=115  Identities=26%  Similarity=0.374  Sum_probs=81.8

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++....                  
T Consensus       111 ~~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~~l~dfg~~~~~~~------------------  163 (276)
T 2h6d_A          111 MEARRLFQQ-ILSAVDYCHRHMVVHRDLKP----ENVLLDAH----MNAKIADFGLSNMMSD------------------  163 (276)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHHCSSCCCCCG----GGEEECTT----SCEEECCCCGGGCCCC------------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCCccCCCCh----hhEEECCC----CCEEEeecccccccCC------------------
Confidence            334445544 78899999999999999999    89999866    7999999999974321                  


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                               +.......                      +|+.|+|||++.+...++.++|+||+||++|||++|+.||.
T Consensus       164 ---------~~~~~~~~----------------------~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~  212 (276)
T 2h6d_A          164 ---------GEFLRTSC----------------------GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD  212 (276)
T ss_dssp             --------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ---------Ccceeccc----------------------CCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence                     11111112                      38999999999987645789999999999999999999998


Q ss_pred             CchhhHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFK  184 (481)
Q Consensus       171 g~~~~~~~l~~i~~  184 (481)
                      +.. ..+.++.+..
T Consensus       213 ~~~-~~~~~~~~~~  225 (276)
T 2h6d_A          213 DEH-VPTLFKKIRG  225 (276)
T ss_dssp             CSS-HHHHHHHHHH
T ss_pred             CCc-HHHHHHHhhc
Confidence            743 3244444443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.79  E-value=3e-21  Score=189.06  Aligned_cols=108  Identities=18%  Similarity=0.357  Sum_probs=81.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+........             
T Consensus       113 ~~~~~~~~~q-i~~~l~~lH~~~ivH~Dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~~~-------------  170 (295)
T 3ugc_A          113 HIKLLQYTSQ-ICKGMEYLGTKRYIHRDLAT----RNILVENE----NRVKIGDFGLTKVLPQDKEF-------------  170 (295)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECCCCSCC---------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCcccCCCCH----hhEEEcCC----CeEEEccCcccccccCCcce-------------
Confidence            3334445555 78899999999999999999    89999876    79999999999853211000             


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                  ..                    ......+|+.|+|||++.+.. |+.++||||+||++|||++|..||
T Consensus       171 ------------~~--------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~  217 (295)
T 3ugc_A          171 ------------FK--------------------VKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKS  217 (295)
T ss_dssp             -------------------------------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             ------------ee--------------------eccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhccccc
Confidence                        00                    000112378899999998776 999999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      ...
T Consensus       218 ~~~  220 (295)
T 3ugc_A          218 KSP  220 (295)
T ss_dssp             CSH
T ss_pred             CCC
Confidence            764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.79  E-value=1.9e-20  Score=189.77  Aligned_cols=118  Identities=23%  Similarity=0.351  Sum_probs=88.5

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||+.||+||||||    +|||++..    |.+||+|||+++.....                    
T Consensus       203 ~~i~~q-i~~~L~~LH~~gi~H~Dlkp----~NIl~~~~----~~ikl~DfG~~~~~~~~--------------------  253 (365)
T 2y7j_A          203 RSIMRS-LLEAVSFLHANNIVHRDLKP----ENILLDDN----MQIRLSDFGFSCHLEPG--------------------  253 (365)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECCTT--------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEECCC----CCEEEEecCcccccCCC--------------------
Confidence            334444 78899999999999999999    89999866    79999999999753211                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-----CCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-----TEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-----~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                             .......                      +|+.|+|||++.+.     ..|+.++||||+||++|||++|.+|
T Consensus       254 -------~~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~p  304 (365)
T 2y7j_A          254 -------EKLRELC----------------------GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP  304 (365)
T ss_dssp             -------CCBCCCC----------------------SCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             -------cccccCC----------------------CCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCC
Confidence                   0001112                      39999999998742     3489999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCC
Q psy3074         169 FPGVREVYDQLDKIFKILGTPT  190 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~  190 (481)
                      |.+... ...+..+......+.
T Consensus       305 f~~~~~-~~~~~~i~~~~~~~~  325 (365)
T 2y7j_A          305 FWHRRQ-ILMLRMIMEGQYQFS  325 (365)
T ss_dssp             SCCSSH-HHHHHHHHHTCCCCC
T ss_pred             CCCCCH-HHHHHHHHhCCCCCC
Confidence            988533 355555555444333

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.79  E-value=3.5e-21  Score=189.85  Aligned_cols=110  Identities=25%  Similarity=0.458  Sum_probs=84.7

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......             
T Consensus       147 ~~~~~~~~i~~q-i~~~l~~lH~~~ivH~dikp----~NIli~~~----~~~kl~Dfg~~~~~~~~~-------------  204 (314)
T 2ivs_A          147 LTMGDLISFAWQ-ISQGMQYLAEMKLVHRDLAA----RNILVAEG----RKMKISDFGLSRDVYEED-------------  204 (314)
T ss_dssp             ECHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEETT----TEEEECCCTTCEECTTTS-------------
T ss_pred             cCHHHHHHHHHH-HHHHHHHHHHCCCcccccch----heEEEcCC----CCEEEccccccccccccc-------------
Confidence            334444555555 78899999999999999999    89999866    799999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                   ....                    .....+|+.|+|||++.+.. ++.++||||+||++|||++ |.
T Consensus       205 -------------~~~~--------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~  250 (314)
T 2ivs_A          205 -------------SYVK--------------------RSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG  250 (314)
T ss_dssp             -------------CEEC--------------------SSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------ccee--------------------ccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCC
Confidence                         0000                    00112378899999998765 9999999999999999999 99


Q ss_pred             CCCCCch
Q psy3074         167 PTFPGVR  173 (481)
Q Consensus       167 ~PF~g~~  173 (481)
                      .||.+..
T Consensus       251 ~p~~~~~  257 (314)
T 2ivs_A          251 NPYPGIP  257 (314)
T ss_dssp             CSSTTCC
T ss_pred             CCCCCCC
Confidence            9998853

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.79  E-value=1.8e-20  Score=183.68  Aligned_cols=110  Identities=21%  Similarity=0.287  Sum_probs=82.0

Q ss_pred             HHHhhhhccCcccccHHHHH--------HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAE--------ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG   81 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh--------~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~   81 (481)
                      ....+.++.. .+.||+|||        +++|+||||||    +|||++..    +.+||+|||+|+........     
T Consensus       104 ~~~~~~i~~~-i~~~l~~lH~~~~~~~~~~~ivH~Dlkp----~Nill~~~----~~~kl~Dfg~a~~~~~~~~~-----  169 (301)
T 3q4u_A          104 TVSCLRIVLS-IASGLAHLHIEIFGTQGKPAIAHRDLKS----KNILVKKN----GQCCIADLGLAVMHSQSTNQ-----  169 (301)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHSCBCSTTCBCEEECSCCCG----GGEEECTT----SCEEECCCTTCEEEETTTTE-----
T ss_pred             HHHHHHHHHH-HHHHHHHHHHhhhhccCCCCeecCCCCh----HhEEEcCC----CCEEEeeCCCeeeccccccc-----
Confidence            3344445555 788999999        99999999999    89999866    79999999999753221100     


Q ss_pred             CCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCC-----CCCccchhhHH
Q psy3074          82 DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE-----YSTSLDMWGVG  156 (481)
Q Consensus        82 ~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~-----y~~~~DvWS~G  156 (481)
                                            .. ..                .....+|+.|+|||++.+...     ++.++||||+|
T Consensus       170 ----------------------~~-~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG  210 (301)
T 3q4u_A          170 ----------------------LD-VG----------------NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG  210 (301)
T ss_dssp             ----------------------EE-CC----------------CCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH
T ss_pred             ----------------------cc-cc----------------ccccccccceeChhhhcCcCCCCcccCCchhhHHHHH
Confidence                                  00 00                001124999999999987642     45799999999


Q ss_pred             HHHHHHHhC----------CCCCCCc
Q psy3074         157 CILIEMVTG----------LPTFPGV  172 (481)
Q Consensus       157 ~il~elltg----------~~PF~g~  172 (481)
                      |++|||++|          .+||.+.
T Consensus       211 ~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          211 LVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             HHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             HHHHHHHhhhcCcccccccccccccc
Confidence            999999999          8999664

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.79  E-value=2.9e-20  Score=182.93  Aligned_cols=117  Identities=24%  Similarity=0.359  Sum_probs=87.3

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||+... +..+.+||+|||+++....                    
T Consensus       108 ~~~~~~q-i~~~l~~lH~~~i~H~dikp----~NIl~~~~-~~~~~~kl~Dfg~~~~~~~--------------------  161 (304)
T 2jam_A          108 ASLVIQQ-VLSAVKYLHENGIVHRDLKP----ENLLYLTP-EENSKIMITDFGLSKMEQN--------------------  161 (304)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCCSCCG----GGCEESSS-STTCCEEBCSCSTTCCCCC--------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCccccCCCH----HHEEEecC-CCCCCEEEccCCcceecCC--------------------
Confidence            3344444 78899999999999999999    89999421 2347899999999973210                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             +. ..                      ...+|+.|+|||++.+.. |+.++||||+||++|||++|.+||.+.
T Consensus       162 -------~~-~~----------------------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          162 -------GI-MS----------------------TACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             -------BT-TH----------------------HHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             -------Cc-cc----------------------cccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                   00 00                      011399999999998765 999999999999999999999999885


Q ss_pred             hhhHHHHHHHHHHhC
Q psy3074         173 REVYDQLDKIFKILG  187 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~  187 (481)
                      .. .+.+..+.+...
T Consensus       211 ~~-~~~~~~i~~~~~  224 (304)
T 2jam_A          211 TE-SKLFEKIKEGYY  224 (304)
T ss_dssp             CH-HHHHHHHHHCCC
T ss_pred             CH-HHHHHHHHcCCC
Confidence            33 355566655433

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.79  E-value=2.7e-21  Score=192.46  Aligned_cols=107  Identities=23%  Similarity=0.386  Sum_probs=83.2

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+++.....              
T Consensus       139 ~~~~~~~~i~~q-i~~aL~~LH~~~ivH~dlkp----~NIl~~~~----~~~kL~Dfg~~~~~~~~--------------  195 (327)
T 1fvr_A          139 LSSQQLLHFAAD-VARGMDYLSQKQFIHRDLAA----RNILVGEN----YVAKIADFGLSRGQEVY--------------  195 (327)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECGG----GCEEECCTTCEESSCEE--------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCccCCCCcc----ceEEEcCC----CeEEEcccCcCcccccc--------------
Confidence            344444555555 78899999999999999999    89999876    79999999999732100              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                   ......                      .+|+.|+|||++.+.. ++.++||||+||++|||++ |.
T Consensus       196 -------------~~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~  239 (327)
T 1fvr_A          196 -------------VKKTMG----------------------RLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGG  239 (327)
T ss_dssp             -------------CCC--------------------------CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------ccccCC----------------------CCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCC
Confidence                         000001                      1278899999998765 8999999999999999998 99


Q ss_pred             CCCCCch
Q psy3074         167 PTFPGVR  173 (481)
Q Consensus       167 ~PF~g~~  173 (481)
                      +||.+..
T Consensus       240 ~pf~~~~  246 (327)
T 1fvr_A          240 TPYCGMT  246 (327)
T ss_dssp             CTTTTCC
T ss_pred             CCCCCCc
Confidence            9998853

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.79  E-value=6.3e-21  Score=186.16  Aligned_cols=121  Identities=18%  Similarity=0.328  Sum_probs=88.8

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......            
T Consensus       107 ~~~~~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nili~~~----~~~kl~Dfg~~~~~~~~~~------------  165 (287)
T 1u59_A          107 IPVSNVAELLHQ-VSMGMKYLEEKNFVHRDLAA----RNVLLVNR----HYAKISDFGLSKALGADDS------------  165 (287)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEEET----TEEEECCCTTCEECTTCSC------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCEeeCCCch----heEEEcCC----CCEEECcccceeeeccCcc------------
Confidence            344445555555 78899999999999999999    89999876    7999999999985321110            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                    .   ...                .....+|+.|+|||++.+.. ++.++||||+||++|||++ |+
T Consensus       166 --------------~---~~~----------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~  211 (287)
T 1u59_A          166 --------------Y---YTA----------------RSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQ  211 (287)
T ss_dssp             --------------E---ECC----------------CCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSC
T ss_pred             --------------e---eec----------------cccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCC
Confidence                          0   000                00112388999999998665 9999999999999999998 99


Q ss_pred             CCCCCchhhHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~  184 (481)
                      .||.+.... +....+..
T Consensus       212 ~p~~~~~~~-~~~~~i~~  228 (287)
T 1u59_A          212 KPYKKMKGP-EVMAFIEQ  228 (287)
T ss_dssp             CTTTTCCTH-HHHHHHHT
T ss_pred             CCcccCCHH-HHHHHHhc
Confidence            999875432 34444433

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.79  E-value=8.1e-21  Score=188.26  Aligned_cols=117  Identities=16%  Similarity=0.323  Sum_probs=86.6

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                 
T Consensus       138 ~~~~~i~~q-i~~~l~~lH~~~i~H~dikp----~NIli~~~----~~~kl~Dfg~~~~~~~~-----------------  191 (322)
T 1p4o_A          138 SKMIQMAGE-IADGMAYLNANKFVHRDLAA----RNCMVAED----FTVKIGDFGMTRDIYET-----------------  191 (322)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCBCSCCSG----GGEEECTT----CCEEECCTTCCCGGGGG-----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCCccCCCcc----ceEEEcCC----CeEEECcCccccccccc-----------------
Confidence            334445555 78899999999999999999    89999866    79999999999843210                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF  169 (481)
                                ..  ..                 ......+|+.|+|||++.+.. ++.++||||+||++|||++ |.+||
T Consensus       192 ----------~~--~~-----------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~  241 (322)
T 1p4o_A          192 ----------DY--YR-----------------KGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY  241 (322)
T ss_dssp             ----------GC--EE-----------------GGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             ----------cc--cc-----------------cccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCcc
Confidence                      00  00                 000112388999999998765 9999999999999999999 89999


Q ss_pred             CCchhhHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFK  184 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~  184 (481)
                      .+... .+....+..
T Consensus       242 ~~~~~-~~~~~~~~~  255 (322)
T 1p4o_A          242 QGLSN-EQVLRFVME  255 (322)
T ss_dssp             TTSCH-HHHHHHHHT
T ss_pred             ccCCH-HHHHHHHHc
Confidence            88533 244444433

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.79  E-value=4.8e-21  Score=196.28  Aligned_cols=135  Identities=21%  Similarity=0.269  Sum_probs=94.5

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||+....+..+.+||+|||+|+.....                
T Consensus       111 ~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~~~~~~~~kL~DFG~a~~~~~~----------------  169 (396)
T 4eut_A          111 ESEFLIVLRD-VVGGMNHLRENGIVHRNIKP----GNIMRVIGEDGQSVYKLTDFGAARELEDD----------------  169 (396)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEEEECTTSCEEEEECCGGGCEECCCG----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCEEECCcCH----HHEEEeecCCCceeEEEecCCCceEccCC----------------
Confidence            3334444444 78899999999999999999    89998544445578999999999853211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-------CCCCCccchhhHHHHHHHH
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-------TEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-------~~y~~~~DvWS~G~il~el  162 (481)
                                 ....                      ...+|+.|+|||++.+.       ..|+.++||||+||++|||
T Consensus       170 -----------~~~~----------------------~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el  216 (396)
T 4eut_A          170 -----------EQFV----------------------SLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA  216 (396)
T ss_dssp             -----------GGSS----------------------CSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred             -----------Cccc----------------------cccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence                       0000                      11239999999998751       3488999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         163 VTGLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      ++|+.||.+........+.+.+.+...++..+....
T Consensus       217 ~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  252 (396)
T 4eut_A          217 ATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQ  252 (396)
T ss_dssp             HHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEE
T ss_pred             HHCCCCCCCCCcccchHHHHHHHhcCCCcccchhhe
Confidence            999999976433333344444444445555554443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.79  E-value=1.1e-20  Score=187.96  Aligned_cols=120  Identities=18%  Similarity=0.309  Sum_probs=70.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ........++.. .+.||+|||++|  |+||||||    +|||++..    |.+||+|||+|+........         
T Consensus       133 ~~~~~~~~i~~q-i~~~l~~LH~~~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~~~---------  194 (337)
T 3ll6_A          133 LSCDTVLKIFYQ-TCRAVQHMHRQKPPIIHRDLKV----ENLLLSNQ----GTIKLCDFGSATTISHYPDY---------  194 (337)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHTSSSCCBCCCCCG----GGCEECTT----SCEEBCCCTTCBCCSSCC-----------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCCCEEEccCCc----ccEEECCC----CCEEEecCccceeccccCcc---------
Confidence            344444555555 788999999999  99999999    89999876    79999999999854321100         


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc--CCCCCCCccchhhHHHHHHHHH
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL--GSTEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~--~~~~y~~~~DvWS~G~il~ell  163 (481)
                                     .......            ..........+|+.|+|||++.  ....++.++||||+||++|||+
T Consensus       195 ---------------~~~~~~~------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~  247 (337)
T 3ll6_A          195 ---------------SWSAQRR------------ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC  247 (337)
T ss_dssp             --------------------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHH
T ss_pred             ---------------ccccccc------------ccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHH
Confidence                           0000000            0000001122499999999984  3344899999999999999999


Q ss_pred             hCCCCCCCc
Q psy3074         164 TGLPTFPGV  172 (481)
Q Consensus       164 tg~~PF~g~  172 (481)
                      +|+.||.+.
T Consensus       248 ~g~~p~~~~  256 (337)
T 3ll6_A          248 FRQHPFEDG  256 (337)
T ss_dssp             HSSCCC---
T ss_pred             hCCCCCcch
Confidence            999999764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.79  E-value=1.2e-20  Score=183.82  Aligned_cols=111  Identities=25%  Similarity=0.437  Sum_probs=85.3

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.....                  
T Consensus       115 ~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~Dfg~~~~~~~~------------------  167 (284)
T 2vgo_A          115 RSATFMEE-LADALHYCHERKVIHRDIKP----ENLLMGYK----GELKIADFGWSVHAPSL------------------  167 (284)
T ss_dssp             HHHHHHHH-HHHHHHHHHTTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECSSS------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCceecCCCH----HHEEEcCC----CCEEEecccccccCccc------------------
Confidence            33444444 78899999999999999999    89999866    79999999999742110                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                ......                      +|+.|+|||++.+.. ++.++|+||+||++|||++|..||.+
T Consensus       168 ----------~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          168 ----------RRRTMC----------------------GTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             ----------CBCCCC----------------------SCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             ----------cccccc----------------------CCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCC
Confidence                      000112                      389999999998765 89999999999999999999999987


Q ss_pred             chhhHHHHHHHH
Q psy3074         172 VREVYDQLDKIF  183 (481)
Q Consensus       172 ~~~~~~~l~~i~  183 (481)
                      ... .+....+.
T Consensus       215 ~~~-~~~~~~~~  225 (284)
T 2vgo_A          215 PSH-TETHRRIV  225 (284)
T ss_dssp             SSH-HHHHHHHH
T ss_pred             CCH-hHHHHHHh
Confidence            533 23444443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.79  E-value=6.8e-21  Score=185.67  Aligned_cols=108  Identities=19%  Similarity=0.335  Sum_probs=81.9

Q ss_pred             HHHhhhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ......++.. .+.||+|||++|  |+||||||    +|||++... .....+||+|||+|+.....             
T Consensus       121 ~~~~~~~~~~-l~~~l~~lH~~~~~ivH~dikp----~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-------------  182 (287)
T 4f0f_A          121 WSVKLRLMLD-IALGIEYMQNQNPPIVHRDLRS----PNIFLQSLDENAPVCAKVADFGLSQQSVHS-------------  182 (287)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHTSSSCCBCSCCSG----GGEEESCCCTTCSCCEEECCCTTCBCCSSC-------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCCCeecCCCCc----ceEEEeccCCCCceeEEeCCCCcccccccc-------------
Confidence            3334445555 788999999999  99999999    899998663 12234999999999732110             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC-CCCCCCccchhhHHHHHHHHHhC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG-STEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~-~~~y~~~~DvWS~G~il~elltg  165 (481)
                                      .....                      +|+.|+|||++.+ ...|+.++||||+||++|||++|
T Consensus       183 ----------------~~~~~----------------------g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g  224 (287)
T 4f0f_A          183 ----------------VSGLL----------------------GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG  224 (287)
T ss_dssp             ----------------EECCC----------------------CCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHS
T ss_pred             ----------------ccccC----------------------CCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcC
Confidence                            01112                      3999999999853 33488999999999999999999


Q ss_pred             CCCCCCch
Q psy3074         166 LPTFPGVR  173 (481)
Q Consensus       166 ~~PF~g~~  173 (481)
                      +.||.+..
T Consensus       225 ~~pf~~~~  232 (287)
T 4f0f_A          225 EGPFDEYS  232 (287)
T ss_dssp             SCTTTTCC
T ss_pred             CCCCcccc
Confidence            99998754

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.79  E-value=8.5e-21  Score=189.56  Aligned_cols=119  Identities=20%  Similarity=0.406  Sum_probs=87.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       156 ~~~~~~i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~Dfg~~~~~~~~~---------------  211 (334)
T 2pvf_A          156 FKDLVSCTYQ-LARGMEYLASQKCIHRDLAA----RNVLVTEN----NVMKIADFGLARDINNID---------------  211 (334)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECTTTS---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeeCCCCcc----ceEEEcCC----CCEEEccccccccccccc---------------
Confidence            3334444554 78899999999999999999    89999865    799999999998532110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .+..                    .....+|+.|+|||++.+.. ++.++||||+||++|||++ |..|
T Consensus       212 -----------~~~~--------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          212 -----------YYKK--------------------TTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             -----------SEEC--------------------CSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -----------cccc--------------------cCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCC
Confidence                       0000                    00012378899999998765 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+.. ..+....+...
T Consensus       260 ~~~~~-~~~~~~~~~~~  275 (334)
T 2pvf_A          260 YPGIP-VEELFKLLKEG  275 (334)
T ss_dssp             STTCC-HHHHHHHHHHT
T ss_pred             cCcCC-HHHHHHHHhcC
Confidence            98853 32444444443

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.79  E-value=4.3e-20  Score=179.11  Aligned_cols=106  Identities=22%  Similarity=0.362  Sum_probs=67.0

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......              
T Consensus       110 ~~~~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~Nili~~~----~~~kl~dfg~~~~~~~~~--------------  166 (278)
T 3cok_A          110 SENEARHFMHQ-IITGMLYLHSHGILHRDLTL----SNLLLTRN----MNIKIADFGLATQLKMPH--------------  166 (278)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSSCCG----GGEEECTT----CCEEECCCTTCEECC-----------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCeecCCCCH----HHEEEcCC----CCEEEEeecceeeccCCC--------------
Confidence            34444555555 78899999999999999999    89999866    799999999997432110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                  .......                      +|+.|+|||++.+.. ++.++|+||+||++|||++|++|
T Consensus       167 ------------~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  211 (278)
T 3cok_A          167 ------------EKHYTLC----------------------GTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPP  211 (278)
T ss_dssp             ------------------------------------------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred             ------------Ccceecc----------------------CCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCC
Confidence                        0001112                      389999999998765 89999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       212 ~~~~  215 (278)
T 3cok_A          212 FDTD  215 (278)
T ss_dssp             SCCC
T ss_pred             CCCh
Confidence            9874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.78  E-value=2.5e-20  Score=181.88  Aligned_cols=103  Identities=21%  Similarity=0.391  Sum_probs=79.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++.. +..+.+||+|||+|+....                     
T Consensus       127 ~~i~~q-i~~~L~~LH~~~ivH~dikp----~NIl~~~~-~~~~~~kl~Dfg~a~~~~~---------------------  179 (285)
T 3is5_A          127 AELMKQ-MMNALAYFHSQHVVHKDLKP----ENILFQDT-SPHSPIKIIDFGLAELFKS---------------------  179 (285)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCCCCSG----GGEEESSS-STTCCEEECCCCCCCC------------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCEEECCCCH----HHEEEecC-CCCCCEEEEeeecceecCC---------------------
Confidence            344444 78899999999999999999    89999643 2347899999999974321                     


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                            +......                      .+|+.|+|||++.+  .++.++||||+||++|||++|+.||.+..
T Consensus       180 ------~~~~~~~----------------------~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          180 ------DEHSTNA----------------------AGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             -----------------------------------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ------cccCcCc----------------------ccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence                  1111111                      23999999999864  48999999999999999999999998853

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.78  E-value=2.6e-20  Score=185.04  Aligned_cols=104  Identities=21%  Similarity=0.344  Sum_probs=82.0

Q ss_pred             HHHhhhhccCcccccHHHHHHh---hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEET---RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~---~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ......++.. .+.||+|||++   ||+||||||    +|||++..    +.+||+|||+|+.....             
T Consensus       130 ~~~~~~i~~~-i~~~l~~lH~~~~~~ivH~Dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~-------------  187 (326)
T 3uim_A          130 WPKRQRIALG-SARGLAYLHDHCDPKIIHRDVKA----ANILLDEE----FEAVVGDFGLAKLMDYK-------------  187 (326)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHSSSSCEECCCCSG----GGEEECTT----CCEEECCCSSCEECCSS-------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCCCCeEeCCCch----hhEEECCC----CCEEeccCccccccCcc-------------
Confidence            3344445555 67899999999   999999999    89999866    79999999999853211             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  ........                      .+|+.|+|||++.+.. ++.++||||+||++|||++|+
T Consensus       188 ------------~~~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~  232 (326)
T 3uim_A          188 ------------DTHVTTAV----------------------RGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQ  232 (326)
T ss_dssp             ------------SSCEECCC----------------------CSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCC
T ss_pred             ------------cccccccc----------------------cCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCC
Confidence                        00111111                      2399999999998766 999999999999999999999


Q ss_pred             CCCC
Q psy3074         167 PTFP  170 (481)
Q Consensus       167 ~PF~  170 (481)
                      +||.
T Consensus       233 ~pf~  236 (326)
T 3uim_A          233 RAFD  236 (326)
T ss_dssp             CSBC
T ss_pred             Cccc
Confidence            9996

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.78  E-value=3.3e-20  Score=179.44  Aligned_cols=120  Identities=18%  Similarity=0.263  Sum_probs=88.5

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +||+++..    |.+||+|||+++.......             
T Consensus       103 ~~~~~~~~~~~-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~~~-------------  160 (276)
T 2yex_A          103 PEPDAQRFFHQ-LMAGVVYLHGIGITHRDIKP----ENLLLDER----DNLKISDFGLATVFRYNNR-------------  160 (276)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECEETTE-------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeeccCCCh----HHEEEccC----CCEEEeeCCCccccCCCcc-------------
Confidence            33444445555 78899999999999999999    89999865    7999999999974321100             


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                 ....                      ....+|+.|+|||++.+...++.++||||+||++|||++|+.|
T Consensus       161 -----------~~~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  207 (276)
T 2yex_A          161 -----------ERLL----------------------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (276)
T ss_dssp             -----------ECCB----------------------CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             -----------hhcc----------------------cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence                       0000                      0112389999999998876558899999999999999999999


Q ss_pred             CCCchhhHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIF  183 (481)
Q Consensus       169 F~g~~~~~~~l~~i~  183 (481)
                      |.+..+....+..+.
T Consensus       208 ~~~~~~~~~~~~~~~  222 (276)
T 2yex_A          208 WDQPSDSCQEYSDWK  222 (276)
T ss_dssp             CSCSCTTSHHHHHHH
T ss_pred             CCCCchHHHHHHHhh
Confidence            987654433444433

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.78  E-value=1.4e-20  Score=187.13  Aligned_cols=100  Identities=27%  Similarity=0.303  Sum_probs=79.9

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+.....                     
T Consensus       153 ~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~~---~~~kL~Dfg~~~~~~~~---------------------  203 (320)
T 3a99_A          153 SFFWQ-VLEAVRHCHNCGVLHRDIKD----ENILIDLNR---GELKLIDFGSGALLKDT---------------------  203 (320)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEETTT---TEEEECCCTTCEECCSS---------------------
T ss_pred             HHHHH-HHHHHHHHHHCCcEeCCCCH----HHEEEeCCC---CCEEEeeCccccccccc---------------------
Confidence            34444 78899999999999999999    899997332   79999999999843210                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                            . ....                      .+|+.|+|||++.+...++.++||||+||++|||++|+.||.+.
T Consensus       204 ------~-~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          204 ------V-YTDF----------------------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             ------C-BCCC----------------------CSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ------c-ccCC----------------------CCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence                  0 0011                      13999999999987775688999999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.78  E-value=1.2e-20  Score=205.68  Aligned_cols=120  Identities=21%  Similarity=0.345  Sum_probs=88.8

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                  
T Consensus       492 ~~~~i~~q-i~~aL~~LH~~givHrDikp----~NILl~~~----~~vkL~DFG~a~~~~~~------------------  544 (656)
T 2j0j_A          492 SLILYAYQ-LSTALAYLESKRFVHRDIAA----RNVLVSSN----DCVKLGDFGLSRYMEDS------------------  544 (656)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECCCCCCCSCCC-------------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCccccccch----HhEEEeCC----CCEEEEecCCCeecCCC------------------
Confidence            33444444 78899999999999999999    89999876    79999999999853211                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               ......                    ...+|+.|||||++.+.. |+.++||||+||++|||++ |.+||.
T Consensus       545 ---------~~~~~~--------------------~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt~g~~Pf~  594 (656)
T 2j0j_A          545 ---------TYYKAS--------------------KGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQ  594 (656)
T ss_dssp             --------------------------------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ---------cceecc--------------------CCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHHcCCCCCC
Confidence                     000000                    011378999999998765 9999999999999999997 999999


Q ss_pred             CchhhHHHHHHHHHHhCCC
Q psy3074         171 GVREVYDQLDKIFKILGTP  189 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p  189 (481)
                      +... .+.+..+......+
T Consensus       595 ~~~~-~~~~~~i~~~~~~~  612 (656)
T 2j0j_A          595 GVKN-NDVIGRIENGERLP  612 (656)
T ss_dssp             TCCH-HHHHHHHHHTCCCC
T ss_pred             CCCH-HHHHHHHHcCCCCC
Confidence            8543 35566665544433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.78  E-value=2.8e-20  Score=195.43  Aligned_cols=116  Identities=17%  Similarity=0.285  Sum_probs=84.8

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++.. +..+.+||+|||+|+........            
T Consensus       101 ~~~~~~~i~~q-i~~aL~yLH~~gIvHrDIKP----~NILl~~~-~~~~~vkL~DFGla~~~~~~~~~------------  162 (483)
T 3sv0_A          101 SLKTVLMLADQ-MINRVEFVHSKSFLHRDIKP----DNFLMGLG-RRANQVYIIDFGLAKKYRDTSTH------------  162 (483)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECCG-GGTTCEEECCCTTCEECBCTTTC------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCEeecccCc----ceEEEecC-CCCCeEEEEeCCcceeccCCccc------------
Confidence            33444445555 78899999999999999999    89999521 12379999999999854321100            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                  . ...+.                ......+|+.|+|||++.+.. |+.++|||||||++|||++|+.|
T Consensus       163 ------------~-~~~~~----------------~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          163 ------------Q-HIPYR----------------ENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             ------------C-BCCCC----------------CCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------c-ccccc----------------cccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCC
Confidence                        0 00000                001122499999999998876 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       213 f~~~  216 (483)
T 3sv0_A          213 WQGL  216 (483)
T ss_dssp             TSSC
T ss_pred             Cccc
Confidence            9874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.78  E-value=9.2e-21  Score=184.68  Aligned_cols=106  Identities=23%  Similarity=0.470  Sum_probs=82.5

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                
T Consensus       110 ~~~~~~i~~~-i~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~~l~Dfg~~~~~~~~----------------  164 (288)
T 3kfa_A          110 AVVLLYMATQ-ISSAMEYLEKKNFIHRDLAA----RNCLVGEN----HLVKVADFGLSRLMTGD----------------  164 (288)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHHTCCCSCCSG----GGEEECGG----GCEEECCCCGGGTSCSS----------------
T ss_pred             HhHHHHHHHH-HHHHHHHHHHCCccCCCCCc----ceEEEcCC----CCEEEccCccceeccCC----------------
Confidence            3333444444 78899999999999999999    89999876    69999999999843211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .. ....+                   ..+|+.|+|||++.+.. ++.++||||+||++|||++ |.+|
T Consensus       165 -----------~~-~~~~~-------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p  212 (288)
T 3kfa_A          165 -----------TY-TAHAG-------------------AKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP  212 (288)
T ss_dssp             -----------SS-EEETT-------------------EEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -----------cc-ccccC-------------------CccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCC
Confidence                       00 00000                   11278899999998765 9999999999999999999 9999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       213 ~~~~  216 (288)
T 3kfa_A          213 YPGI  216 (288)
T ss_dssp             STTC
T ss_pred             CCCC
Confidence            9885

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.78  E-value=1.6e-20  Score=185.40  Aligned_cols=116  Identities=21%  Similarity=0.340  Sum_probs=83.2

Q ss_pred             HhhhhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          12 RQISVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ....++.. .+.||+|||+. ||+||||||    +|||++..    +.+||+|||+++.....                 
T Consensus       125 ~~~~~~~~-i~~~l~~lH~~~~i~H~dlkp----~Nil~~~~----~~~kl~dfg~~~~~~~~-----------------  178 (318)
T 2dyl_A          125 ILGKMTVA-IVKALYYLKEKHGVIHRDVKP----SNILLDER----GQIKLCDFGISGRLVDD-----------------  178 (318)
T ss_dssp             HHHHHHHH-HHHHHHHHHHHHCCCCCCCCG----GGEEECTT----SCEEECCCTTC-----------------------
T ss_pred             HHHHHHHH-HHHHHHHHHhhCCEEeCCCCH----HHEEECCC----CCEEEEECCCchhccCC-----------------
Confidence            33444444 78899999995 999999999    89999866    79999999999743210                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC----CCCCCCccchhhHHHHHHHHHhCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG----STEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~----~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                ......                      .+|+.|+|||++.+    ...++.++||||+||++|||++|+
T Consensus       179 ----------~~~~~~----------------------~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~  226 (318)
T 2dyl_A          179 ----------KAKDRS----------------------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ  226 (318)
T ss_dssp             ----------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred             ----------cccccc----------------------CCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence                      000111                      13999999999962    345899999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~  185 (481)
                      .||.+.....+.+..+...
T Consensus       227 ~pf~~~~~~~~~~~~~~~~  245 (318)
T 2dyl_A          227 FPYKNCKTDFEVLTKVLQE  245 (318)
T ss_dssp             CTTTTCCSHHHHHHHHHHS
T ss_pred             CCCCCCCccHHHHHHHhcc
Confidence            9998765555666665553

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.78  E-value=2.1e-20  Score=186.97  Aligned_cols=115  Identities=28%  Similarity=0.406  Sum_probs=86.9

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                
T Consensus       141 ~~~~~i~~q-i~~aL~~LH~~~ivH~dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~----------------  195 (335)
T 2owb_A          141 PEARYYLRQ-IVLGCQYLHRNRVIHRDLKL----GNLFLNED----LEVKIGDFGLATKVEYDG----------------  195 (335)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCCTTCEECCSTT----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCCEecCCCc----hhEEEcCC----CCEEEeeccCceecccCc----------------
Confidence            334444555 78899999999999999999    89999866    799999999998532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                ......                      .+|+.|+|||++.+.. ++.++||||+||++|||++|+.||.
T Consensus       196 ----------~~~~~~----------------------~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~  242 (335)
T 2owb_A          196 ----------ERKKVL----------------------CGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE  242 (335)
T ss_dssp             ----------CCBCCC----------------------CSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ----------cccccc----------------------CCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCC
Confidence                      000111                      2399999999998765 8999999999999999999999998


Q ss_pred             CchhhHHHHHHHHH
Q psy3074         171 GVREVYDQLDKIFK  184 (481)
Q Consensus       171 g~~~~~~~l~~i~~  184 (481)
                      +... .+.+..+..
T Consensus       243 ~~~~-~~~~~~~~~  255 (335)
T 2owb_A          243 TSCL-KETYLRIKK  255 (335)
T ss_dssp             CSSH-HHHHHHHHH
T ss_pred             CCCH-HHHHHHHhc
Confidence            7532 233444433

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.78  E-value=4.3e-20  Score=191.59  Aligned_cols=108  Identities=18%  Similarity=0.364  Sum_probs=79.5

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC---------CCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA---------TPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~---------~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ++.. .+.||+|||++||+||||||    +|||++...         ...+.+||+|||+|+......            
T Consensus       120 i~~q-i~~aL~~LH~~~ivHrDLkp----~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~------------  182 (434)
T 2rio_A          120 LLRQ-IASGVAHLHSLKIIHRDLKP----QNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ------------  182 (434)
T ss_dssp             HHHH-HHHHHHHHHHTTEECCCCSG----GGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------
T ss_pred             HHHH-HHHHHHHHHHCCccccCCCh----HhEEEecCcccccccccCCCceEEEEcccccceecCCCC------------
Confidence            4444 78899999999999999999    899997542         234689999999998532110            


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC------CCCCCCccchhhHHHHHH
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG------STEYSTSLDMWGVGCILI  160 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~------~~~y~~~~DvWS~G~il~  160 (481)
                                   ..+...                   .....+|+.|+|||++.+      ...++.++||||+||++|
T Consensus       183 -------------~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~  230 (434)
T 2rio_A          183 -------------SSFRTN-------------------LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY  230 (434)
T ss_dssp             --------------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred             -------------ccceee-------------------ecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence                         000000                   001124999999999976      245999999999999999


Q ss_pred             HHHh-CCCCCCCc
Q psy3074         161 EMVT-GLPTFPGV  172 (481)
Q Consensus       161 ellt-g~~PF~g~  172 (481)
                      ||++ |++||.+.
T Consensus       231 ellt~g~~Pf~~~  243 (434)
T 2rio_A          231 YILSKGKHPFGDK  243 (434)
T ss_dssp             HHHTTSCCTTCST
T ss_pred             HHHhCCCCCCCCc
Confidence            9999 99999764

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.78  E-value=1.7e-20  Score=186.30  Aligned_cols=118  Identities=27%  Similarity=0.409  Sum_probs=85.5

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+...                    
T Consensus       115 ~~~~~~~q-i~~~l~~lH~~~ivH~dlkp----~NIl~~~~~-~~~~~kl~Dfg~~~~~~--------------------  168 (322)
T 2ycf_A          115 TCKLYFYQ-MLLAVQYLHENGIIHRDLKP----ENVLLSSQE-EDCLIKITDFGHSKILG--------------------  168 (322)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESSSS-SSCCEEECCCTTCEECC--------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeeccCCCH----HHEEEecCC-CCCeEEEccCccceecc--------------------
Confidence            33344444 78899999999999999999    899998652 22469999999997421                    


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc--CCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL--GSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~--~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                             ......                      ...+|+.|+|||++.  +...|+.++||||+||++|||++|.+||
T Consensus       169 -------~~~~~~----------------------~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  219 (322)
T 2ycf_A          169 -------ETSLMR----------------------TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF  219 (322)
T ss_dssp             -------CCHHHH----------------------HHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -------cccccc----------------------cccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence                   111000                      012499999999984  3455999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFK  184 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~  184 (481)
                      .+..........+..
T Consensus       220 ~~~~~~~~~~~~~~~  234 (322)
T 2ycf_A          220 SEHRTQVSLKDQITS  234 (322)
T ss_dssp             CSTTCSSCHHHHHHH
T ss_pred             cccchHHHHHHHHHh
Confidence            875443233334433

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.78  E-value=2.9e-20  Score=184.92  Aligned_cols=105  Identities=22%  Similarity=0.264  Sum_probs=80.6

Q ss_pred             hhhhccCcccccHHHHHHh----------hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCC
Q psy3074          13 QISVSSDSKLLDADIAEET----------RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGD   82 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~----------~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~   82 (481)
                      ...++.. .+.||+|||+.          +|+||||||    +|||++..    +.+||+|||+|+........      
T Consensus       123 ~~~i~~q-i~~al~~LH~~~~~l~~~~~~~ivH~Dlkp----~Nill~~~----~~~kL~DFg~a~~~~~~~~~------  187 (322)
T 3soc_A          123 LCHIAET-MARGLAYLHEDIPGLKDGHKPAISHRDIKS----KNVLLKNN----LTACIADFGLALKFEAGKSA------  187 (322)
T ss_dssp             HHHHHHH-HHHHHHHHTCCEEEETTEEECEEECSCCSG----GGEEECTT----CCEEECCCTTCEEECTTSCC------
T ss_pred             HHHHHHH-HHHHHHHHHhhccccccccCCCEEeCCCCh----HhEEECCC----CeEEEccCCcccccccccCc------
Confidence            3444444 67899999999          999999999    89999866    79999999999754221100      


Q ss_pred             CCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC----CCCCCccchhhHHHH
Q psy3074          83 SPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS----TEYSTSLDMWGVGCI  158 (481)
Q Consensus        83 ~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~----~~y~~~~DvWS~G~i  158 (481)
                                        ..                      .....+|+.|+|||++.+.    ..++.++||||+||+
T Consensus       188 ------------------~~----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i  227 (322)
T 3soc_A          188 ------------------GD----------------------THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV  227 (322)
T ss_dssp             ------------------CC----------------------CTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred             ------------------cc----------------------cccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence                              00                      0011249999999999874    336678899999999


Q ss_pred             HHHHHhCCCCCCCc
Q psy3074         159 LIEMVTGLPTFPGV  172 (481)
Q Consensus       159 l~elltg~~PF~g~  172 (481)
                      +|||++|++||.+.
T Consensus       228 l~el~tg~~pf~~~  241 (322)
T 3soc_A          228 LWELASRCTAADGP  241 (322)
T ss_dssp             HHHHHTTBTTSSSC
T ss_pred             HHHHHhCCCCCCCC
Confidence            99999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.78  E-value=2.4e-20  Score=183.23  Aligned_cols=118  Identities=19%  Similarity=0.317  Sum_probs=86.5

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                
T Consensus       109 ~~~~~~~~q-i~~al~~LH~~~i~H~dlkp----~NIl~~~~----~~~kl~dfg~~~~~~~~~----------------  163 (305)
T 2wtk_C          109 CQAHGYFCQ-LIDGLEYLHSQGIVHKDIKP----GNLLLTTG----GTLKISALGVAEALHPFA----------------  163 (305)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECCTTC----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCeeecCCCc----ccEEEcCC----CcEEeeccccccccCccc----------------
Confidence            333444444 78899999999999999999    89999866    799999999997532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC-CCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST-EYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~-~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                              ........                      .+|+.|+|||++.+.. .++.++||||+||++|||++|+.||
T Consensus       164 --------~~~~~~~~----------------------~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  213 (305)
T 2wtk_C          164 --------ADDTCRTS----------------------QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF  213 (305)
T ss_dssp             --------SSCEECCC----------------------CSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             --------cccccccC----------------------CCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence                    00000111                      2399999999998643 2478999999999999999999999


Q ss_pred             CCchhhHHHHHHHHH
Q psy3074         170 PGVREVYDQLDKIFK  184 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~  184 (481)
                      .+.+ ..+.++.+..
T Consensus       214 ~~~~-~~~~~~~i~~  227 (305)
T 2wtk_C          214 EGDN-IYKLFENIGK  227 (305)
T ss_dssp             CCSS-HHHHHHHHHH
T ss_pred             CCch-HHHHHHHHhc
Confidence            8843 3344444443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.78  E-value=6.8e-21  Score=186.30  Aligned_cols=109  Identities=19%  Similarity=0.357  Sum_probs=83.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......               
T Consensus       116 ~~~~~~i~~q-i~~~l~~LH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~---------------  171 (291)
T 1xbb_A          116 DKNIIELVHQ-VSMGMKYLEESNFVHRDLAA----RNVLLVTQ----HYAKISDFGLSKALRADE---------------  171 (291)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEET----TEEEECCCTTCEECCTTC---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCeEcCCCCc----ceEEEeCC----CcEEEccCCcceeeccCC---------------
Confidence            3334445555 78899999999999999999    89999876    799999999998532110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                .......                    ...+|+.|+|||++.+.. ++.++||||+||++|||++ |+.|
T Consensus       172 ----------~~~~~~~--------------------~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p  220 (291)
T 1xbb_A          172 ----------NYYKAQT--------------------HGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKP  220 (291)
T ss_dssp             ----------SEEEC------------------------CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ----------Ccccccc--------------------cCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCC
Confidence                      0000000                    011278899999998765 8999999999999999999 9999


Q ss_pred             CCCch
Q psy3074         169 FPGVR  173 (481)
Q Consensus       169 F~g~~  173 (481)
                      |.+..
T Consensus       221 ~~~~~  225 (291)
T 1xbb_A          221 YRGMK  225 (291)
T ss_dssp             STTCC
T ss_pred             CCCCC
Confidence            98854

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.78  E-value=2.5e-20  Score=182.52  Aligned_cols=125  Identities=20%  Similarity=0.312  Sum_probs=91.5

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.....                  
T Consensus       125 ~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~------------------  177 (298)
T 1phk_A          125 ETRKIMRA-LLEVICALHKLNIVHRDLKP----ENILLDDD----MNIKLTDFGFSCQLDPG------------------  177 (298)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECCTT------------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCcccCCCCc----ceEEEcCC----CcEEEecccchhhcCCC------------------
Confidence            33444444 78899999999999999999    89999866    79999999999743211                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc-----CCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL-----GSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~-----~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                               ......                      .+|+.|+|||++.     ....++.++||||+||++|||++|.
T Consensus       178 ---------~~~~~~----------------------~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  226 (298)
T 1phk_A          178 ---------EKLREV----------------------CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS  226 (298)
T ss_dssp             ---------CCBCCC----------------------CSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ---------cccccc----------------------cCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence                     000011                      2389999999986     2445899999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      .||.+.+. .+.+..+......++.+.++
T Consensus       227 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  254 (298)
T 1phk_A          227 PPFWHRKQ-MLMLRMIMSGNYQFGSPEWD  254 (298)
T ss_dssp             CSSCCSSH-HHHHHHHHHTCCCCCTTTGG
T ss_pred             CCCcCccH-HHHHHHHhcCCcccCccccc
Confidence            99988543 35555565554444433333

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.78  E-value=1.6e-20  Score=185.55  Aligned_cols=100  Identities=26%  Similarity=0.326  Sum_probs=76.2

Q ss_pred             HhhhhccCcccccHHHHHH---hhhhcccCCCCCCCcchhccccCCCCCc-eeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074          12 RQISVSSDSKLLDADIAEE---TRVLLRNRKPPRPKSEVFLNKYATPPRE-LKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~---~~i~hrdlkp~~~~~nill~~~~~~~g~-~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.++.. .+.||+|||+   +||+||||||    +|||++..    |. +||+|||+|+.....              
T Consensus       103 ~~~~~~~q-i~~~l~~LH~~~~~~ivH~dlkp----~NIll~~~----~~~~kl~Dfg~~~~~~~~--------------  159 (307)
T 2eva_A          103 HAMSWCLQ-CSQGVAYLHSMQPKALIHRDLKP----PNLLLVAG----GTVLKICDFGTACDIQTH--------------  159 (307)
T ss_dssp             HHHHHHHH-HHHHHHHHHTCSSSCCCCCCCSG----GGEEEETT----TTEEEECCCCC---------------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCCCCeecCCCCh----hHEEEeCC----CCEEEEcccccccccccc--------------
Confidence            33444444 6789999999   8999999999    89999865    44 899999999742110              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                     .....                      +|+.|+|||++.+.. ++.++||||+||++|||++|+.
T Consensus       160 ---------------~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~  201 (307)
T 2eva_A          160 ---------------MTNNK----------------------GSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVITRRK  201 (307)
T ss_dssp             ------------------------------------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHHHHHTCC
T ss_pred             ---------------cccCC----------------------CCCceEChhhhCCCC-CCcHHHHHHHHHHHHHHHHCCC
Confidence                           00111                      399999999998765 9999999999999999999999


Q ss_pred             CCCCc
Q psy3074         168 TFPGV  172 (481)
Q Consensus       168 PF~g~  172 (481)
                      ||.+.
T Consensus       202 p~~~~  206 (307)
T 2eva_A          202 PFDEI  206 (307)
T ss_dssp             TTTTT
T ss_pred             Cchhh
Confidence            99864

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.78  E-value=1.4e-20  Score=181.07  Aligned_cols=117  Identities=18%  Similarity=0.318  Sum_probs=87.1

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+++.....                
T Consensus       103 ~~~~~~~~~~-i~~~l~~lH~~~i~H~dl~p----~Nili~~~----~~~kl~dfg~~~~~~~~----------------  157 (267)
T 3t9t_A          103 AETLLGMCLD-VCEGMAYLEEACVIHRDLAA----RNCLVGEN----QVIKVSDFGMTRFVLDD----------------  157 (267)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSSCCG----GGEEECGG----GCEEECCTTGGGGBCCH----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCcccCCCch----heEEECCC----CCEEEcccccccccccc----------------
Confidence            3344445555 78899999999999999999    89999876    79999999999743110                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                 .                    ........+|+.|+|||++.+.. ++.++|+||+||++|||++ |++|
T Consensus       158 -----------~--------------------~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p  205 (267)
T 3t9t_A          158 -----------Q--------------------YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIP  205 (267)
T ss_dssp             -----------H--------------------HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             -----------c--------------------ccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCC
Confidence                       0                    00001112378899999998665 9999999999999999999 9999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+... .+.+..+..
T Consensus       206 ~~~~~~-~~~~~~i~~  220 (267)
T 3t9t_A          206 YENRSN-SEVVEDIST  220 (267)
T ss_dssp             TTTCCH-HHHHHHHHT
T ss_pred             CCCCCH-HHHHHHHhc
Confidence            987532 244444443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.78  E-value=8.5e-20  Score=189.29  Aligned_cols=103  Identities=17%  Similarity=0.279  Sum_probs=75.3

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      .+.||+|||++||+||||||    +|||++... +....+||+|||+|+........                       
T Consensus       127 i~~aL~~LH~~~ivHrDlKp----~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~-----------------------  179 (432)
T 3p23_A          127 TTSGLAHLHSLNIVHRDLKP----HNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-----------------------  179 (432)
T ss_dssp             HHHHHHHHHHTTCCCCCCST----TSEEECCCBTTTBCCEEECCTTEEECC-----------------------------
T ss_pred             HHHHHHHHHHCcCEeCCCCH----HHEEEecCCCCCceeEEEecccceeeccCCCcc-----------------------
Confidence            67899999999999999999    899996432 22346789999999853211000                       


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--CCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVT-GLPTFPGV  172 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--~~~y~~~~DvWS~G~il~ellt-g~~PF~g~  172 (481)
                      ......                      ..+|+.|+|||++.+  ...++.++||||+||++|||++ |.+||...
T Consensus       180 ~~~~~~----------------------~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~  233 (432)
T 3p23_A          180 FSRRSG----------------------VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS  233 (432)
T ss_dssp             ----------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred             eeeccc----------------------cCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence            000011                      224999999999985  3457889999999999999999 99999653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.78  E-value=1e-20  Score=183.58  Aligned_cols=119  Identities=22%  Similarity=0.436  Sum_probs=88.3

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+++......             
T Consensus       106 ~~~~~~~~i~~q-i~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-------------  163 (279)
T 1qpc_A          106 LTINKLLDMAAQ-IAEGMAFIEERNYIHRDLRA----ANILVSDT----LSCKIADFGLARLIEDNE-------------  163 (279)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----SCEEECCCTTCEECSSSC-------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCeeccCCCH----hhEEEcCC----CCEEECCCcccccccCcc-------------
Confidence            334444555555 78899999999999999999    89999865    799999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                    .. ..                   ....+|+.|+|||++.+.. ++.++||||+||++|||++ |+
T Consensus       164 --------------~~-~~-------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~  208 (279)
T 1qpc_A          164 --------------YT-AR-------------------EGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGR  208 (279)
T ss_dssp             --------------EE-CC-------------------TTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTC
T ss_pred             --------------cc-cc-------------------cCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCC
Confidence                          00 00                   0011377899999998665 8999999999999999999 99


Q ss_pred             CCCCCchhhHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~  184 (481)
                      +||.+... .+.+..+.+
T Consensus       209 ~p~~~~~~-~~~~~~~~~  225 (279)
T 1qpc_A          209 IPYPGMTN-PEVIQNLER  225 (279)
T ss_dssp             CSSTTCCH-HHHHHHHHT
T ss_pred             CCCcccCH-HHHHHHHhc
Confidence            99988533 244444433

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.78  E-value=1e-20  Score=183.65  Aligned_cols=98  Identities=23%  Similarity=0.426  Sum_probs=76.2

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.....                    
T Consensus       120 ~~~~~~-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~~l~Dfg~~~~~~~~--------------------  170 (278)
T 1byg_A          120 LKFSLD-VCEAMEYLEGNNFVHRDLAA----RNVLVSED----NVAKVSDFGLTKEASST--------------------  170 (278)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----SCEEECCCCC---------------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCccccCCCc----ceEEEeCC----CcEEEeecccccccccc--------------------
Confidence            344444 78899999999999999999    89999865    79999999999742110                    


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCc
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGV  172 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~g~  172 (481)
                               .....                      +|+.|+|||++.+.. ++.++||||+||++|||++ |++||.+.
T Consensus       171 ---------~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          171 ---------QDTGK----------------------LPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             ------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             ---------ccCCC----------------------ccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence                     00011                      278899999998665 9999999999999999998 99999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.78  E-value=2.1e-20  Score=183.72  Aligned_cols=106  Identities=25%  Similarity=0.391  Sum_probs=83.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......               
T Consensus       118 ~~~~~~~~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~Dfg~~~~~~~~~---------------  173 (303)
T 3a7i_A          118 ETQIATILRE-ILKGLDYLHSEKKIHRDIKA----ANVLLSEH----GEVKLADFGVAGQLTDTQ---------------  173 (303)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECBTTB---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCCccCCCCh----heEEECCC----CCEEEeecccceecCccc---------------
Confidence            3344445555 78899999999999999999    89999866    799999999997432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 .....                      ..+|+.|+|||++.+.. ++.++||||+||++|||++|++||
T Consensus       174 -----------~~~~~----------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          174 -----------IKRNT----------------------FVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             -----------CCBCC----------------------CCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             -----------cccCc----------------------cCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCC
Confidence                       00001                      12389999999998765 999999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+..
T Consensus       220 ~~~~  223 (303)
T 3a7i_A          220 SELH  223 (303)
T ss_dssp             TTSC
T ss_pred             CCcC
Confidence            8753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.77  E-value=1.7e-20  Score=182.01  Aligned_cols=104  Identities=13%  Similarity=0.124  Sum_probs=80.0

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC---------------CCCCceeeecccccccccCCCCC
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA---------------TPPRELKLADFGLARAKSVPSHT   76 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~---------------~~~g~~Kl~DFGla~~~~~~~~~   76 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++...               ...+.+||+|||+|+......  
T Consensus       116 ~~~~i~~q-i~~al~~lH~~~ivH~Dikp----~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~--  188 (289)
T 1x8b_A          116 ELKDLLLQ-VGRGLRYIHSMSLVHMDIKP----SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ--  188 (289)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEC--------------------CCCEEECCCTTCEETTCSC--
T ss_pred             HHHHHHHH-HHHHHHHHHhCCEeecCCCH----HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc--
Confidence            33444444 78899999999999999999    899998542               133589999999998532110  


Q ss_pred             cCCCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHH
Q psy3074          77 YSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVG  156 (481)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G  156 (481)
                                                  ..                      .+|+.|+|||++.+...++.++||||+|
T Consensus       189 ----------------------------~~----------------------~gt~~y~aPE~~~~~~~~~~~~Di~slG  218 (289)
T 1x8b_A          189 ----------------------------VE----------------------EGDSRFLANEVLQENYTHLPKADIFALA  218 (289)
T ss_dssp             ----------------------------CC----------------------CCCGGGCCHHHHTTCCTTHHHHHHHHHH
T ss_pred             ----------------------------cc----------------------CCCccccChhHhcCCCCCCchhhHHHHH
Confidence                                        00                      1389999999999876688899999999


Q ss_pred             HHHHHHHhCCCCCCCc
Q psy3074         157 CILIEMVTGLPTFPGV  172 (481)
Q Consensus       157 ~il~elltg~~PF~g~  172 (481)
                      |++|||++|.+|+...
T Consensus       219 ~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          219 LTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             HHHHHHTTCCCCCSSS
T ss_pred             HHHHHHhcCCCCCcch
Confidence            9999999999888654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.77  E-value=2.2e-20  Score=185.46  Aligned_cols=104  Identities=24%  Similarity=0.418  Sum_probs=77.4

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                   
T Consensus       132 ~~i~~q-i~~~l~~lH~~~ivH~dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~-------------------  183 (326)
T 2x7f_A          132 AYICRE-ILRGLSHLHQHKVIHRDIKG----QNVLLTEN----AEVKLVDFGVSAQLDRTV-------------------  183 (326)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCCCCSG----GGEEECTT----CCEEECCCTTTC-------------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCccccCCcH----HHEEEcCC----CCEEEeeCcCceecCcCc-------------------
Confidence            334444 78899999999999999999    89999765    799999999997432100                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC----CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG----STEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~----~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                             .......                      +|+.|+|||++.+    ...++.++||||+||++|||++|.+||
T Consensus       184 -------~~~~~~~----------------------~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~  234 (326)
T 2x7f_A          184 -------GRRNTFI----------------------GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL  234 (326)
T ss_dssp             ------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             -------ccccccc----------------------CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC
Confidence                   0001112                      3999999999973    334999999999999999999999999


Q ss_pred             CCchh
Q psy3074         170 PGVRE  174 (481)
Q Consensus       170 ~g~~~  174 (481)
                      .+...
T Consensus       235 ~~~~~  239 (326)
T 2x7f_A          235 CDMHP  239 (326)
T ss_dssp             TTSCH
T ss_pred             CCCcH
Confidence            87543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.77  E-value=3.4e-20  Score=181.50  Aligned_cols=105  Identities=29%  Similarity=0.443  Sum_probs=82.9

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                
T Consensus       115 ~~~~~i~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~~----------------  169 (294)
T 2rku_A          115 PEARYYLRQ-IVLGCQYLHRNRVIHRDLKL----GNLFLNED----LEVKIGDFGLATKVEYDG----------------  169 (294)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECCSTT----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHCCccccCCCh----HhEEEcCC----CCEEEEeccCceecccCc----------------
Confidence            333444444 78899999999999999999    89999866    799999999998532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                ......                      .+|+.|+|||++.+.. ++.++|+||+||++|||++|+.||.
T Consensus       170 ----------~~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~  216 (294)
T 2rku_A          170 ----------ERKKVL----------------------CGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFE  216 (294)
T ss_dssp             ----------CCBCCC----------------------CSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             ----------cccccc----------------------cCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCC
Confidence                      000111                      2389999999998765 8999999999999999999999998


Q ss_pred             Cch
Q psy3074         171 GVR  173 (481)
Q Consensus       171 g~~  173 (481)
                      +..
T Consensus       217 ~~~  219 (294)
T 2rku_A          217 TSC  219 (294)
T ss_dssp             CSS
T ss_pred             CCC
Confidence            753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.77  E-value=3.4e-20  Score=181.68  Aligned_cols=115  Identities=17%  Similarity=0.269  Sum_probs=84.3

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.......            
T Consensus       118 ~~~~~~~~i~~q-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~~~------------  176 (303)
T 2vwi_A          118 LDESTIATILRE-VLEGLEYLHKNGQIHRDVKA----GNILLGED----GSVQIADFGVSAFLATGGD------------  176 (303)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTCCCCCCSG----GGEEECTT----CCEEECCCHHHHHCC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCCCCCCCCh----hhEEEcCC----CCEEEEeccchheeccCCC------------
Confidence            334444455555 78899999999999999999    89999866    7999999999975321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                               .........                      ..+|+.|+|||++.+...++.++||||+||++|||++|+.
T Consensus       177 ---------~~~~~~~~~----------------------~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  225 (303)
T 2vwi_A          177 ---------ITRNKVRKT----------------------FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA  225 (303)
T ss_dssp             ------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ---------ccchhhhcc----------------------cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCC
Confidence                     000000111                      1249999999999875559999999999999999999999


Q ss_pred             CCCCchh
Q psy3074         168 TFPGVRE  174 (481)
Q Consensus       168 PF~g~~~  174 (481)
                      ||.+...
T Consensus       226 pf~~~~~  232 (303)
T 2vwi_A          226 PYHKYPP  232 (303)
T ss_dssp             TTTTSCG
T ss_pred             CCccCch
Confidence            9987544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.77  E-value=3e-20  Score=183.62  Aligned_cols=112  Identities=21%  Similarity=0.356  Sum_probs=78.0

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+++........                 
T Consensus       114 ~~i~~q-i~~~l~~lH~~~ivH~dlkp----~Nil~~~~~-~~~~~kl~Dfg~~~~~~~~~~~-----------------  170 (316)
T 2ac3_A          114 SVVVQD-VASALDFLHNKGIAHRDLKP----ENILCEHPN-QVSPVKICDFDLGSGIKLNGDC-----------------  170 (316)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEESCSS-SSCSEEECCTTCCC-------------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCceeCCCCH----HHEEEccCC-CcCceEEEEccCccccccCCcc-----------------
Confidence            334444 78899999999999999999    899998652 1234999999999853211000                 


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC----CCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG----STEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~----~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                             .  .. ..              .......+|+.|+|||++.+    ...|+.++||||+||++|||++|++||
T Consensus       171 -------~--~~-~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf  226 (316)
T 2ac3_A          171 -------S--PI-ST--------------PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF  226 (316)
T ss_dssp             -----------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             -------c--cc-cc--------------cccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence                   0  00 00              00001124999999999975    123899999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       227 ~~~  229 (316)
T 2ac3_A          227 VGR  229 (316)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.77  E-value=1.7e-19  Score=176.07  Aligned_cols=107  Identities=21%  Similarity=0.349  Sum_probs=82.6

Q ss_pred             hhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          14 ISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..++.. .+.||+|||+++  |+||||||    +|||++..   .|.+||+|||+|+....                   
T Consensus       132 ~~~~~q-i~~~l~~lH~~~~~i~H~dikp----~Nil~~~~---~~~~kl~Dfg~~~~~~~-------------------  184 (290)
T 1t4h_A          132 RSWCRQ-ILKGLQFLHTRTPPIIHRDLKC----DNIFITGP---TGSVKIGDLGLATLKRA-------------------  184 (290)
T ss_dssp             HHHHHH-HHHHHHHHHTSSSCCCCSCCCG----GGEEESST---TSCEEECCTTGGGGCCT-------------------
T ss_pred             HHHHHH-HHHHHHHHHcCCCCEEECCCCH----HHEEEECC---CCCEEEeeCCCcccccc-------------------
Confidence            334444 788999999999  99999999    89999732   27999999999973211                   


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               .......|                      |+.|+|||++.+  .++.++||||+||++|||++|+.||.+
T Consensus       185 ---------~~~~~~~~----------------------t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          185 ---------SFAKAVIG----------------------TPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             ---------TSBEESCS----------------------SCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ---------cccccccC----------------------CcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence                     11122223                      999999999874  399999999999999999999999988


Q ss_pred             chhhHHHHH
Q psy3074         172 VREVYDQLD  180 (481)
Q Consensus       172 ~~~~~~~l~  180 (481)
                      ..+......
T Consensus       232 ~~~~~~~~~  240 (290)
T 1t4h_A          232 CQNAAQIYR  240 (290)
T ss_dssp             CSSHHHHHH
T ss_pred             cCcHHHHHH
Confidence            655433333

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.77  E-value=7.5e-20  Score=181.91  Aligned_cols=104  Identities=23%  Similarity=0.371  Sum_probs=66.3

Q ss_pred             hhhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          14 ISVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ..++.. .+.||.|||+. ||+||||||    +|||++..    |.+||+|||+|+.....                   
T Consensus       128 ~~i~~~-i~~~l~~lH~~~~ivH~dlkp----~NIll~~~----~~~kl~Dfg~~~~~~~~-------------------  179 (327)
T 3aln_A          128 GKITLA-TVKALNHLKENLKIIHRDIKP----SNILLDRS----GNIKLCDFGISGQLVDS-------------------  179 (327)
T ss_dssp             HHHHHH-HHHHHHHHHHHHSCCCSCCCG----GGEEEETT----TEEEECCCSSSCC-----------------------
T ss_pred             HHHHHH-HHHHHHHHhccCCEeECCCCH----HHEEEcCC----CCEEEccCCCceecccc-------------------
Confidence            344444 68899999999 999999999    89999866    79999999999743210                   


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL---GSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~---~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                              ......                      .+|+.|+|||++.   ....|+.++||||+||++|||++|+.||
T Consensus       180 --------~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  229 (327)
T 3aln_A          180 --------IAKTRD----------------------AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY  229 (327)
T ss_dssp             --------------------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCS
T ss_pred             --------cccccC----------------------CCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence                    000111                      2399999999994   2344999999999999999999999999


Q ss_pred             CCchhh
Q psy3074         170 PGVREV  175 (481)
Q Consensus       170 ~g~~~~  175 (481)
                      .+..+.
T Consensus       230 ~~~~~~  235 (327)
T 3aln_A          230 PKWNSV  235 (327)
T ss_dssp             SCC---
T ss_pred             CCcchH
Confidence            875443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.77  E-value=9.6e-21  Score=184.69  Aligned_cols=116  Identities=25%  Similarity=0.346  Sum_probs=85.1

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+++......                 
T Consensus       122 ~~~~~~~~-i~~~l~~lH~~~i~H~dikp----~Nili~~~----~~~kl~Dfg~~~~~~~~~-----------------  175 (291)
T 1u46_A          122 TLSRYAVQ-VAEGMGYLESKRFIHRDLAA----RNLLLATR----DLVKIGDFGLMRALPQND-----------------  175 (291)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEEEET----TEEEECCCTTCEECCC-C-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCcccCCCch----heEEEcCC----CCEEEccccccccccccc-----------------
Confidence            33444444 78899999999999999999    89999876    799999999998532110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFP  170 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~PF~  170 (481)
                               . .....                  ....+|+.|+|||++.+.. ++.++||||+||++|||++ |++||.
T Consensus       176 ---------~-~~~~~------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~  226 (291)
T 1u46_A          176 ---------D-HYVMQ------------------EHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWI  226 (291)
T ss_dssp             ---------C-EEEC-----------------------CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             ---------c-chhhh------------------ccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcc
Confidence                     0 00000                  0011378899999998765 8999999999999999999 999998


Q ss_pred             CchhhHHHHHHHH
Q psy3074         171 GVREVYDQLDKIF  183 (481)
Q Consensus       171 g~~~~~~~l~~i~  183 (481)
                      +.+. .+.+..+.
T Consensus       227 ~~~~-~~~~~~~~  238 (291)
T 1u46_A          227 GLNG-SQILHKID  238 (291)
T ss_dssp             TCCH-HHHHHHHH
T ss_pred             cCCH-HHHHHHHH
Confidence            8543 24444443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.77  E-value=2.4e-20  Score=181.76  Aligned_cols=106  Identities=17%  Similarity=0.292  Sum_probs=79.5

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCC----CCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYAT----PPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~----~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++....    ..+.+||+|||+|+....             
T Consensus       112 ~~~~~~i~~q-i~~~L~~LH~~~ivH~Dlkp----~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------------  173 (289)
T 4fvq_A          112 ILWKLEVAKQ-LAAAMHFLEENTLIHGNVCA----KNILLIREEDRKTGNPPFIKLSDPGISITVLP-------------  173 (289)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEEEECCBGGGTBCCEEEECCCCSCTTTSC-------------
T ss_pred             HHHHHHHHHH-HHHHHHHHhhCCeECCCcCc----ceEEEecCCcccccccceeeeccCcccccccC-------------
Confidence            3334445555 78899999999999999999    8999987631    112399999999973210             


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                    ..   .                      ..+|+.|+|||++.+...++.++||||+||++|||++|
T Consensus       174 --------------~~---~----------------------~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g  214 (289)
T 4fvq_A          174 --------------KD---I----------------------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG  214 (289)
T ss_dssp             --------------HH---H----------------------HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTT
T ss_pred             --------------cc---c----------------------cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcC
Confidence                          00   0                      01388899999999856699999999999999999995


Q ss_pred             -CCCCCCc
Q psy3074         166 -LPTFPGV  172 (481)
Q Consensus       166 -~~PF~g~  172 (481)
                       .+||.+.
T Consensus       215 ~~~~~~~~  222 (289)
T 4fvq_A          215 GDKPLSAL  222 (289)
T ss_dssp             TCCTTTTS
T ss_pred             CCCCcccc
Confidence             5566553

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.77  E-value=2.4e-20  Score=185.95  Aligned_cols=107  Identities=18%  Similarity=0.225  Sum_probs=76.9

Q ss_pred             hhhccCcccccHHHHHHh---------hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074          14 ISVSSDSKLLDADIAEET---------RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~---------~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      ..++.. .+.||+|||+.         ||+||||||    +|||++..    |.+||+|||+|+........        
T Consensus       114 ~~i~~q-i~~~L~~LH~~~~~~~~~~~~ivH~Dikp----~Nill~~~----~~~kL~DFG~a~~~~~~~~~--------  176 (336)
T 3g2f_A          114 CRLAHS-VTRGLAYLHTELPRGDHYKPAISHRDLNS----RNVLVKND----GTCVISDFGLSMRLTGNRLV--------  176 (336)
T ss_dssp             HHHHHH-HHHHHHHHHCCBCCGGGCBCCEECSSCSG----GGEEECTT----SCEEECCCTTCEECSSSSCC--------
T ss_pred             HHHHHH-HHHHHHHHHhhhccccccccceeeccccc----ceEEEcCC----CcEEEeeccceeeccccccc--------
Confidence            344444 68899999999         999999999    89999866    79999999999854221100        


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC------CCCCCccchhhHHHH
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS------TEYSTSLDMWGVGCI  158 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~------~~y~~~~DvWS~G~i  158 (481)
                                   ..+....                   ......+|+.|+|||++.+.      ..++.++||||+||+
T Consensus       177 -------------~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~i  224 (336)
T 3g2f_A          177 -------------RPGEEDN-------------------AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI  224 (336)
T ss_dssp             -----------------------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHH
T ss_pred             -------------Ccccccc-------------------ccccCCCccceeCchhhcCCcccccccccccccchHHHHHH
Confidence                         0000000                   00112349999999999873      236788999999999


Q ss_pred             HHHHHhCCCCC
Q psy3074         159 LIEMVTGLPTF  169 (481)
Q Consensus       159 l~elltg~~PF  169 (481)
                      +|||++|..||
T Consensus       225 l~ell~g~~p~  235 (336)
T 3g2f_A          225 YWEIFMRCTDL  235 (336)
T ss_dssp             HHHHHTTBGGG
T ss_pred             HHHHHhcCCcC
Confidence            99999996554

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.77  E-value=1.5e-20  Score=185.99  Aligned_cols=112  Identities=16%  Similarity=0.232  Sum_probs=80.3

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++.     |.+||+|||+|+........            
T Consensus       128 ~~~~~~~i~~q-i~~al~~lH~~~i~H~dlkp----~NIl~~~-----~~~~l~Dfg~~~~~~~~~~~------------  185 (319)
T 2y4i_B          128 DVNKTRQIAQE-IVKGMGYLHAKGILHKDLKS----KNVFYDN-----GKVVITDFGLFSISGVLQAG------------  185 (319)
T ss_dssp             CSHHHHHHHHH-HHHHHHHHHHTTCCCCCCCS----TTEEEC-------CCEECCCSCCC--------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCccccCCCh----hhEEEeC-----CCEEEeecCCcccccccccc------------
Confidence            33444455555 78899999999999999999    8999972     68999999999743210000            


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC--------CCCCCCccchhhHHHHHH
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG--------STEYSTSLDMWGVGCILI  160 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~--------~~~y~~~~DvWS~G~il~  160 (481)
                               ....                      ......+|+.|+|||++.+        ...|+.++||||+||++|
T Consensus       186 ---------~~~~----------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~  234 (319)
T 2y4i_B          186 ---------RRED----------------------KLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY  234 (319)
T ss_dssp             -----------CC----------------------SCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred             ---------cccc----------------------ccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence                     0000                      0011224899999999985        334899999999999999


Q ss_pred             HHHhCCCCCCCch
Q psy3074         161 EMVTGLPTFPGVR  173 (481)
Q Consensus       161 elltg~~PF~g~~  173 (481)
                      ||++|+.||.+..
T Consensus       235 el~~g~~p~~~~~  247 (319)
T 2y4i_B          235 ELHAREWPFKTQP  247 (319)
T ss_dssp             HHHHSSCSSSSCC
T ss_pred             HHHhCCCCCCCCC
Confidence            9999999998753

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.77  E-value=3e-20  Score=183.22  Aligned_cols=103  Identities=27%  Similarity=0.422  Sum_probs=74.0

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                  
T Consensus       138 ~~~i~~q-i~~~l~~LH~~~i~H~dl~p----~NIl~~~~----~~~kl~Dfg~~~~~~~~~------------------  190 (310)
T 2wqm_A          138 VWKYFVQ-LCSALEHMHSRRVMHRDIKP----ANVFITAT----GVVKLGDLGLGRFFSSKT------------------  190 (310)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCC----------------------------
T ss_pred             HHHHHHH-HHHHHHHHhhCCeeCCCCcH----HHEEEcCC----CCEEEEeccceeeecCCC------------------
Confidence            3344444 78899999999999999999    89999865    799999999997432100                  


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                              .......                      +|+.|+|||++.+.. ++.++||||+||++|||++|..||.+.
T Consensus       191 --------~~~~~~~----------------------~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          191 --------TAAHSLV----------------------GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             --------------------------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             --------ccccccC----------------------CCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCccc
Confidence                    0001112                      389999999998765 999999999999999999999999875


Q ss_pred             h
Q psy3074         173 R  173 (481)
Q Consensus       173 ~  173 (481)
                      .
T Consensus       240 ~  240 (310)
T 2wqm_A          240 K  240 (310)
T ss_dssp             -
T ss_pred             c
Confidence            3

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.77  E-value=2e-19  Score=177.73  Aligned_cols=107  Identities=23%  Similarity=0.343  Sum_probs=76.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......               
T Consensus       133 ~~~~~~i~~q-i~~~l~~lH~~~i~H~dlkp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~---------------  188 (309)
T 2h34_A          133 PPRAVAIVRQ-IGSALDAAHAAGATHRDVKP----ENILVSAD----DFAYLVDFGIASATTDEK---------------  188 (309)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECSCCC-----------------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCcCCcCCCCh----HHEEEcCC----CCEEEecCccCccccccc---------------
Confidence            3344445555 78899999999999999999    89999876    799999999997432100               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                ......                      ..+|+.|+|||++.+.. ++.++||||+||++|||++|+.||
T Consensus       189 ----------~~~~~~----------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf  235 (309)
T 2h34_A          189 ----------LTQLGN----------------------TVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPY  235 (309)
T ss_dssp             ----------------------------------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred             ----------cccccc----------------------cCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHHCCCCC
Confidence                      000001                      12389999999998765 999999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+.+
T Consensus       236 ~~~~  239 (309)
T 2h34_A          236 QGDQ  239 (309)
T ss_dssp             CSCH
T ss_pred             CCch
Confidence            9854

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.77  E-value=9.7e-21  Score=183.64  Aligned_cols=116  Identities=29%  Similarity=0.487  Sum_probs=85.6

Q ss_pred             HHhhhhccCcccccHHHHHHhh-----hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074          11 QRQISVSSDSKLLDADIAEETR-----VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~-----i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      .....++.. .+.||+|||+.+     |+||||||    +|||++..    |.+||+|||+++......           
T Consensus       111 ~~~~~i~~~-i~~~l~~lH~~~~~~~~ivH~dl~p----~NIl~~~~----~~~kl~dfg~~~~~~~~~-----------  170 (279)
T 2w5a_A          111 EFVLRVMTQ-LTLALKECHRRSDGGHTVLHRDLKP----ANVFLDGK----QNVKLGDFGLARILNHDT-----------  170 (279)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHHC------CCCCCSG----GGEEECSS----SCEEECCCCHHHHC---C-----------
T ss_pred             HHHHHHHHH-HHHHHHHHhcccCCCCeeEEeccch----hhEEEcCC----CCEEEecCchheeecccc-----------
Confidence            334445555 788999999999     99999999    89999866    799999999997421100           


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                     ...                      ....+|+.|+|||++.+.. ++.++||||+||++|||++|
T Consensus       171 ---------------~~~----------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g  212 (279)
T 2w5a_A          171 ---------------SFA----------------------KTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCAL  212 (279)
T ss_dssp             ---------------HHH----------------------HHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHS
T ss_pred             ---------------ccc----------------------cccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHC
Confidence                           000                      0112489999999998775 99999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~  185 (481)
                      ++||.+.+. .+....+...
T Consensus       213 ~~p~~~~~~-~~~~~~i~~~  231 (279)
T 2w5a_A          213 MPPFTAFSQ-KELAGKIREG  231 (279)
T ss_dssp             SCSSCCSSH-HHHHHHHHHT
T ss_pred             CCCCcccCH-HHHHHHHhhc
Confidence            999988533 2444444443

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.77  E-value=2e-19  Score=179.00  Aligned_cols=106  Identities=20%  Similarity=0.218  Sum_probs=77.7

Q ss_pred             HhhhhccCcccccHHHHHHh--------hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCC
Q psy3074          12 RQISVSSDSKLLDADIAEET--------RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDS   83 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~--------~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~   83 (481)
                      ....++.. .+.||+|||++        ||+||||||    +|||++..    |.+||+|||+|+........       
T Consensus       135 ~~~~i~~~-i~~~l~~lH~~~~~~~~~~~ivH~Dikp----~Nill~~~----~~~kl~Dfg~a~~~~~~~~~-------  198 (337)
T 3mdy_A          135 SMLKLAYS-SVSGLCHLHTEIFSTQGKPAIAHRDLKS----KNILVKKN----GTCCIADLGLAVKFISDTNE-------  198 (337)
T ss_dssp             HHHHHHHH-HHHHHHHHHSCBCSTTCBCCEECSCCCG----GGEEECTT----SCEEECCCTTCEECC------------
T ss_pred             HHHHHHHH-HHHHHHHHHHhhhhhccCCCEEecccch----HHEEECCC----CCEEEEeCCCceeecccccc-------
Confidence            33444444 68899999999        999999999    89999866    79999999999753211100       


Q ss_pred             CCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCc------cchhhHHH
Q psy3074          84 PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTS------LDMWGVGC  157 (481)
Q Consensus        84 ~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~------~DvWS~G~  157 (481)
                                          ...                 ......+|+.|+|||++.+.. ++..      +||||+||
T Consensus       199 --------------------~~~-----------------~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~  240 (337)
T 3mdy_A          199 --------------------VDI-----------------PPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGL  240 (337)
T ss_dssp             -----------------------------------------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHH
T ss_pred             --------------------ccC-----------------CCCCCccCcceeChhhccccc-CCccccCccccchHHHHH
Confidence                                000                 000112499999999998765 4444      99999999


Q ss_pred             HHHHHHhC----------CCCCCC
Q psy3074         158 ILIEMVTG----------LPTFPG  171 (481)
Q Consensus       158 il~elltg----------~~PF~g  171 (481)
                      ++|||++|          ..||.+
T Consensus       241 il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          241 ILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             HHHHHHhccCcccccccccccHhh
Confidence            99999999          777765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.76  E-value=3.4e-20  Score=183.96  Aligned_cols=109  Identities=22%  Similarity=0.370  Sum_probs=78.3

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      ++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.........                  
T Consensus       169 i~~q-i~~aL~~LH~~~ivH~Dlkp----~NIll~~~----~~~kL~DfG~a~~~~~~~~~~------------------  221 (332)
T 3qd2_B          169 IFIQ-IAEAVEFLHSKGLMHRDLKP----SNIFFTMD----DVVKVGDFGLVTAMDQDEEEQ------------------  221 (332)
T ss_dssp             HHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECSCC----------------------
T ss_pred             HHHH-HHHHHHHHHhCCeeecCCCc----ccEEEeCC----CCEEEeecCcccccccchhhc------------------
Confidence            3444 67899999999999999999    89999866    799999999998543211000                  


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                           .   ...          ............+|+.|+|||++.+.. |+.++||||+||++|||++|..|+.
T Consensus       222 -----~---~~~----------~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          222 -----T---VLT----------PMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             ----------------------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             -----c---ccc----------cccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChh
Confidence                 0   000          000000111223599999999998775 9999999999999999999988763

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.76  E-value=8.3e-20  Score=182.83  Aligned_cols=107  Identities=25%  Similarity=0.408  Sum_probs=68.4

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+|+.....               
T Consensus       126 ~~~~~~~i~~q-l~~~l~~LH~~~ivH~dlkp----~NIll~~~~-~~~~~kl~Dfg~~~~~~~~---------------  184 (336)
T 3fhr_A          126 TEREAAEIMRD-IGTAIQFLHSHNIAHRDVKP----ENLLYTSKE-KDAVLKLTDFGFAKETTQN---------------  184 (336)
T ss_dssp             BHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEESCSS-TTCCEEECCCTTCEEC------------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHhCCeecCCCCH----HHEEEEecC-CCceEEEeccccceecccc---------------
Confidence            33444445554 78899999999999999999    899997542 2367999999999742110               


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                   ......                      +|+.|+|||++.+.. |+.++||||+||++|||++|++|
T Consensus       185 -------------~~~~~~----------------------~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p  228 (336)
T 3fhr_A          185 -------------ALQTPC----------------------YTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPP  228 (336)
T ss_dssp             ------------------------------------------------------CH-HHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             -------------ccccCC----------------------CCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCC
Confidence                         001112                      399999999997665 99999999999999999999999


Q ss_pred             CCCc
Q psy3074         169 FPGV  172 (481)
Q Consensus       169 F~g~  172 (481)
                      |.+.
T Consensus       229 f~~~  232 (336)
T 3fhr_A          229 FYSN  232 (336)
T ss_dssp             C---
T ss_pred             CCCc
Confidence            9775

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.76  E-value=1.1e-19  Score=178.84  Aligned_cols=107  Identities=24%  Similarity=0.392  Sum_probs=82.1

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......               
T Consensus       132 ~~~~~~i~~~-i~~~l~~lH~~~i~H~dlkp----~Nili~~~----~~~kl~Dfg~~~~~~~~~---------------  187 (307)
T 2nru_A          132 WHMRCKIAQG-AANGINFLHENHHIHRDIKS----ANILLDEA----FTAKISDFGLARASEKFA---------------  187 (307)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCCTTCEECCSCS---------------
T ss_pred             HHHHHHHHHH-HHHHHHHHhcCCeecCCCCH----HHEEEcCC----CcEEEeeccccccccccc---------------
Confidence            3334445554 78899999999999999999    89999765    799999999998432110               


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                               .....                      ....+|+.|+|||++.+.  ++.++||||+||++|||++|.+||
T Consensus       188 ---------~~~~~----------------------~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~g~~p~  234 (307)
T 2nru_A          188 ---------QTVMT----------------------SRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAV  234 (307)
T ss_dssp             ---------SCEEC----------------------SSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred             ---------ccccc----------------------cccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHHCCCCc
Confidence                     00000                      011249999999998763  899999999999999999999999


Q ss_pred             CCch
Q psy3074         170 PGVR  173 (481)
Q Consensus       170 ~g~~  173 (481)
                      .+..
T Consensus       235 ~~~~  238 (307)
T 2nru_A          235 DEHR  238 (307)
T ss_dssp             CTTB
T ss_pred             ccCc
Confidence            8753

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.76  E-value=2.7e-20  Score=185.27  Aligned_cols=121  Identities=21%  Similarity=0.371  Sum_probs=86.8

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+++.......              
T Consensus       139 ~~~~~~i~~q-i~~al~~LH~~~i~H~dlkp----~NIli~~~~-~~~~~kl~Dfg~~~~~~~~~~--------------  198 (327)
T 2yfx_A          139 MLDLLHVARD-IACGCQYLEENHFIHRDIAA----RNCLLTCPG-PGRVAKIGDFGMARDIYRASY--------------  198 (327)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESCSS-TTCCEEECCCHHHHHHHC-----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHhhCCeecCcCCH----hHEEEecCC-CcceEEECccccccccccccc--------------
Confidence            3344445555 78899999999999999999    899998542 224799999999974321100              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                   ..                   ......+|+.|+|||++.+.. ++.++||||+||++|||++ |.+|
T Consensus       199 -------------~~-------------------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p  245 (327)
T 2yfx_A          199 -------------YR-------------------KGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMP  245 (327)
T ss_dssp             -----------------------------------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -------------cc-------------------cCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCC
Confidence                         00                   000112388999999998765 9999999999999999998 9999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+... .+.+..+..
T Consensus       246 ~~~~~~-~~~~~~~~~  260 (327)
T 2yfx_A          246 YPSKSN-QEVLEFVTS  260 (327)
T ss_dssp             STTCCH-HHHHHHHHT
T ss_pred             CCCcCH-HHHHHHHhc
Confidence            987532 244444443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.76  E-value=2.8e-20  Score=182.53  Aligned_cols=107  Identities=19%  Similarity=0.363  Sum_probs=81.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......              
T Consensus       125 ~~~~~~~~~~-i~~~l~~lH~~~i~H~dikp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~~--------------  181 (302)
T 4e5w_A          125 LKQQLKYAVQ-ICKGMDYLGSRQYVHRDLAA----RNVLVESE----HQVKIGDFGLTKAIETDKE--------------  181 (302)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEET----TEEEECCCTTCEECCTTCC--------------
T ss_pred             HHHHHHHHHH-HHHHHHHhhcCCcccCCCch----heEEEcCC----CCEEECcccccccccCCCc--------------
Confidence            3344445555 78899999999999999999    89999876    7999999999985321110              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                   .....                  ....+|+.|+|||++.+.. ++.++||||+||++|||++|..|+
T Consensus       182 -------------~~~~~------------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~  229 (302)
T 4e5w_A          182 -------------YYTVK------------------DDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSD  229 (302)
T ss_dssp             -------------EEECC------------------CCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             -------------ceecc------------------CCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCC
Confidence                         00000                  0112388899999998766 899999999999999999999986


Q ss_pred             CC
Q psy3074         170 PG  171 (481)
Q Consensus       170 ~g  171 (481)
                      ..
T Consensus       230 ~~  231 (302)
T 4e5w_A          230 SS  231 (302)
T ss_dssp             GS
T ss_pred             cc
Confidence            43

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.76  E-value=4.1e-20  Score=182.69  Aligned_cols=115  Identities=23%  Similarity=0.372  Sum_probs=82.6

Q ss_pred             hhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          13 QISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        13 ~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ...++.. .+.||+|||++||+||||||    +|||++.     |.+||+|||+|+.......                 
T Consensus       129 ~~~i~~q-i~~aL~~LH~~~ivH~dlkp----~NIl~~~-----~~~kL~Dfg~~~~~~~~~~-----------------  181 (313)
T 3cek_A          129 RKSYWKN-MLEAVHTIHQHGIVHSDLKP----ANFLIVD-----GMLKLIDFGIANQMQPDTT-----------------  181 (313)
T ss_dssp             HHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEEET-----TEEEECCCSSSCC-----------------------
T ss_pred             HHHHHHH-HHHHHHHHHHCCceecCCCc----ccEEEEC-----CeEEEeeccccccccCccc-----------------
Confidence            3344444 78899999999999999999    8999953     6899999999984321100                 


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC----------CCCCCccchhhHHHHHHHH
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS----------TEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~----------~~y~~~~DvWS~G~il~el  162 (481)
                             .......                      .+|+.|+|||++.+.          ..++.++||||+||++|||
T Consensus       182 -------~~~~~~~----------------------~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el  232 (313)
T 3cek_A          182 -------SVVKDSQ----------------------VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM  232 (313)
T ss_dssp             -------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred             -------cccccCC----------------------CCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence                   0000111                      239999999999762          3589999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHH
Q psy3074         163 VTGLPTFPGVREVYDQLDKIF  183 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~  183 (481)
                      ++|+.||.+..+....+..+.
T Consensus       233 ~~g~~pf~~~~~~~~~~~~~~  253 (313)
T 3cek_A          233 TYGKTPFQQIINQISKLHAII  253 (313)
T ss_dssp             HHSSCTTTTCCSHHHHHHHHH
T ss_pred             HhCCCchhhHHHHHHHHHHHH
Confidence            999999987644434444433

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.76  E-value=1.1e-20  Score=188.18  Aligned_cols=108  Identities=20%  Similarity=0.315  Sum_probs=83.0

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......              
T Consensus       126 ~~~~~~i~~q-i~~al~~lH~~~ivH~Dikp----~NIl~~~~----~~~kl~Dfg~~~~~~~~~~--------------  182 (327)
T 3lxl_A          126 ASRLLLYSSQ-ICKGMEYLGSRRCVHRDLAA----RNILVESE----AHVKIADFGLAKLLPLDKD--------------  182 (327)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEET----TEEEECCGGGCEECCTTCS--------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCccCCCCCh----hhEEECCC----CCEEEcccccceecccCCc--------------
Confidence            3344444444 78899999999999999999    89999876    7999999999985321110              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                   .. ...                 ....+|+.|+|||++.+.. ++.++||||+||++|||++|+.||
T Consensus       183 -------------~~-~~~-----------------~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~  230 (327)
T 3lxl_A          183 -------------YY-VVR-----------------EPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKS  230 (327)
T ss_dssp             -------------EE-ECS-----------------SCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred             -------------cc-eee-----------------ccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCC
Confidence                         00 000                 0112388899999998765 899999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       231 ~~~  233 (327)
T 3lxl_A          231 CSP  233 (327)
T ss_dssp             GSH
T ss_pred             ccc
Confidence            764

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.76  E-value=4.8e-20  Score=177.46  Aligned_cols=104  Identities=13%  Similarity=0.186  Sum_probs=81.0

Q ss_pred             HHHHhhhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      .......++.. .+.||+|||+++  |+||||||    +|||++..    |.+||+|||++......             
T Consensus       109 ~~~~~~~i~~q-i~~~l~~lH~~~~~i~H~dikp----~Nil~~~~----~~~~l~~~~~~~~~~~~-------------  166 (271)
T 3kmu_A          109 DQSQAVKFALD-MARGMAFLHTLEPLIPRHALNS----RSVMIDED----MTARISMADVKFSFQSP-------------  166 (271)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHTTSSSCCTTCCCSG----GGEEECTT----SCEEEEGGGSCCTTSCT-------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHhcCCCceecCCCcc----ceEEEcCC----cceeEEeccceeeeccc-------------
Confidence            34444555555 788999999999  99999999    89999866    78999999987632100             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC--CCCCccchhhHHHHHHHHHh
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST--EYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~--~y~~~~DvWS~G~il~ellt  164 (481)
                                                              ...+|+.|+|||++.+..  .++.++||||+||++|||++
T Consensus       167 ----------------------------------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  206 (271)
T 3kmu_A          167 ----------------------------------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT  206 (271)
T ss_dssp             ----------------------------------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence                                                    011389999999998754  13337999999999999999


Q ss_pred             CCCCCCCchh
Q psy3074         165 GLPTFPGVRE  174 (481)
Q Consensus       165 g~~PF~g~~~  174 (481)
                      |+.||.+.+.
T Consensus       207 g~~p~~~~~~  216 (271)
T 3kmu_A          207 REVPFADLSN  216 (271)
T ss_dssp             CSCTTTTSCH
T ss_pred             CCCCccccCh
Confidence            9999988544

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.76  E-value=8.6e-20  Score=177.09  Aligned_cols=101  Identities=24%  Similarity=0.363  Sum_probs=80.8

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......                 
T Consensus       123 ~~~~i~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~~-----------------  176 (284)
T 2a19_B          123 LALELFEQ-ITKGVDYIHSKKLINRDLKP----SNIFLVDT----KQVKIGDFGLVTSLKNDG-----------------  176 (284)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEET----TEEEECCCTTCEESSCCS-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCeeeccCCH----HHEEEcCC----CCEEECcchhheeccccc-----------------
Confidence            33445545 78899999999999999999    89999876    799999999998532110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                .....                      .+|+.|+|||++.+.. ++.++||||+||++|||++|..||..
T Consensus       177 ----------~~~~~----------------------~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~  223 (284)
T 2a19_B          177 ----------KRTRS----------------------KGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFE  223 (284)
T ss_dssp             ----------CCCCC----------------------CSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred             ----------ccccc----------------------CCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchh
Confidence                      00011                      1399999999998765 99999999999999999999999854

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.76  E-value=2.3e-20  Score=184.62  Aligned_cols=116  Identities=18%  Similarity=0.318  Sum_probs=83.7

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+++....               
T Consensus       131 ~~~~~~~~i~~q-i~~~L~~LH~~~ivH~dlkp----~NIl~~~~----~~~kl~dfg~~~~~~~---------------  186 (317)
T 2buj_A          131 LTEDQILWLLLG-ICRGLEAIHAKGYAHRDLKP----TNILLGDE----GQPVLMDLGSMNQACI---------------  186 (317)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----SCEEECCCSSCEESCE---------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCcccCCCCH----HHEEEcCC----CCEEEEecCcchhccc---------------
Confidence            344444555555 78899999999999999999    89999766    7999999999974210               


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC--CCCCccchhhHHHHHHHHHhC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST--EYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~--~y~~~~DvWS~G~il~elltg  165 (481)
                                       ...+    .....   .........+|+.|+|||++.+..  .++.++||||+||++|||++|
T Consensus       187 -----------------~~~~----~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g  242 (317)
T 2buj_A          187 -----------------HVEG----SRQAL---TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG  242 (317)
T ss_dssp             -----------------EEES----HHHHH---HHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHS
T ss_pred             -----------------cccc----ccccc---cccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhC
Confidence                             0000    00000   000011223499999999997653  278999999999999999999


Q ss_pred             CCCCCC
Q psy3074         166 LPTFPG  171 (481)
Q Consensus       166 ~~PF~g  171 (481)
                      +.||.+
T Consensus       243 ~~p~~~  248 (317)
T 2buj_A          243 EGPYDM  248 (317)
T ss_dssp             SCTTHH
T ss_pred             CCChhh
Confidence            999965

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.76  E-value=4.8e-20  Score=181.97  Aligned_cols=105  Identities=21%  Similarity=0.265  Sum_probs=81.6

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ......++.. .+.||+|||++||+||||||    +|||++..   .|.+||+|||+|+.....                
T Consensus       138 ~~~~~~~~~q-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~---~~~~kl~dfg~~~~~~~~----------------  193 (312)
T 2iwi_A          138 EGPSRCFFGQ-VVAAIQHCHSRGVVHRDIKD----ENILIDLR---RGCAKLIDFGSGALLHDE----------------  193 (312)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHHTEECCCCSG----GGEEEETT---TTEEEECCCSSCEECCSS----------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHHCCeeecCCCh----hhEEEeCC---CCeEEEEEcchhhhcccC----------------
Confidence            3334445555 78899999999999999999    89999832   279999999999843210                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 .. ...                      .+|+.|+|||++.+...++.++||||+||++|||++|+.||
T Consensus       194 -----------~~-~~~----------------------~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf  239 (312)
T 2iwi_A          194 -----------PY-TDF----------------------DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF  239 (312)
T ss_dssp             -----------CB-CCC----------------------CSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             -----------cc-ccc----------------------CCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCC
Confidence                       00 011                      13899999999987764566999999999999999999999


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      .+.
T Consensus       240 ~~~  242 (312)
T 2iwi_A          240 ERD  242 (312)
T ss_dssp             CSH
T ss_pred             CCh
Confidence            874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.76  E-value=2.7e-19  Score=175.50  Aligned_cols=150  Identities=22%  Similarity=0.250  Sum_probs=96.8

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++.....                  
T Consensus       118 ~~~~~~~~-i~~~l~~lH~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~~------------------  170 (302)
T 2j7t_A          118 QIQVVCRQ-MLEALNFLHSKRIIHRDLKA----GNVLMTLE----GDIRLADFGVSAKNLKT------------------  170 (302)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCCCCSG----GGEEECTT----SCEEECCCHHHHHHHHH------------------
T ss_pred             HHHHHHHH-HHHHHHHHhcCCcccCCCCH----HHEEECCC----CCEEEEECCCCcccccc------------------
Confidence            33444444 78899999999999999999    89999866    79999999998632100                  


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCcccc----CCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLL----GSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~----~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                              .......                      .+|+.|+|||++.    ....++.++||||+||++|||++|.+
T Consensus       171 --------~~~~~~~----------------------~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~  220 (302)
T 2j7t_A          171 --------LQKRDSF----------------------IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP  220 (302)
T ss_dssp             --------HHC---------------------------CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred             --------ccccccc----------------------cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence                    0000111                      2399999999985    34459999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCC--CccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTP--TEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      ||.+.+.. +.+..+.......  .+..++..-......|+...|..|++..++
T Consensus       221 p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  273 (302)
T 2j7t_A          221 PHHELNPM-RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL  273 (302)
T ss_dssp             TTTTSCHH-HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCccCCHH-HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHH
Confidence            99875432 3444443322111  111121111111224555566666665544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.76  E-value=1.8e-19  Score=177.92  Aligned_cols=105  Identities=24%  Similarity=0.376  Sum_probs=82.8

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+++......                 
T Consensus       126 ~~~~i~~~-i~~~l~~lH~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~~-----------------  179 (314)
T 3com_A          126 EIATILQS-TLKGLEYLHFMRKIHRDIKA----GNILLNTE----GHAKLADFGVAGQLTDTM-----------------  179 (314)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECBTTB-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHhCCCcCCCcCH----HHEEECCC----CCEEEeecccchhhhhhc-----------------
Confidence            33444444 78899999999999999999    89999876    799999999997432110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                               .....                      ..+|+.|+|||++.+.. ++.++||||+||++|||++|..||.+
T Consensus       180 ---------~~~~~----------------------~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          180 ---------AKRNT----------------------VIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             ---------SCBCC----------------------CCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ---------cccCc----------------------cCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCC
Confidence                     00001                      12389999999998765 99999999999999999999999987


Q ss_pred             chh
Q psy3074         172 VRE  174 (481)
Q Consensus       172 ~~~  174 (481)
                      ...
T Consensus       228 ~~~  230 (314)
T 3com_A          228 IHP  230 (314)
T ss_dssp             SCH
T ss_pred             CCh
Confidence            543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.76  E-value=5.2e-20  Score=184.42  Aligned_cols=119  Identities=19%  Similarity=0.297  Sum_probs=91.1

Q ss_pred             chhHHHHhhhhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      +.........++.. .+.||+|||+ +||+||||||    +|||++..    |.+||+|||+++.....           
T Consensus       146 ~~~~~~~~~~i~~q-i~~~l~~lH~~~~i~H~dl~p----~Nil~~~~----~~~kl~dfg~~~~~~~~-----------  205 (348)
T 2pml_X          146 CFIPIQVIKCIIKS-VLNSFSYIHNEKNICHRDVKP----SNILMDKN----GRVKLSDFGESEYMVDK-----------  205 (348)
T ss_dssp             CCCCHHHHHHHHHH-HHHHHHHHHHTSCEECCCCCG----GGEEECTT----SCEEECCCTTCEECBTT-----------
T ss_pred             cCCCHHHHHHHHHH-HHHHHHHHhccCCEeecCCCh----HhEEEcCC----CcEEEeccccccccccc-----------
Confidence            33444455555555 7889999999 9999999999    89999866    79999999999843110           


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCC-ccchhhHHHHHHHHH
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYST-SLDMWGVGCILIEMV  163 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~-~~DvWS~G~il~ell  163 (481)
                                       ..                      ....+|+.|+|||++.+...|+. ++||||+||++|||+
T Consensus       206 -----------------~~----------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          206 -----------------KI----------------------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             -----------------EE----------------------CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred             -----------------cc----------------------cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence                             00                      01123899999999998755777 999999999999999


Q ss_pred             hCCCCCCCchhhHHHHHHHH
Q psy3074         164 TGLPTFPGVREVYDQLDKIF  183 (481)
Q Consensus       164 tg~~PF~g~~~~~~~l~~i~  183 (481)
                      +|++||.+..+..+.+..+.
T Consensus       247 ~g~~pf~~~~~~~~~~~~i~  266 (348)
T 2pml_X          247 YNVVPFSLKISLVELFNNIR  266 (348)
T ss_dssp             HSSCSSCCSSCSHHHHHHHT
T ss_pred             hCCCCCCCCCcHHHHHHHHh
Confidence            99999998655445555443

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.75  E-value=1e-19  Score=183.44  Aligned_cols=99  Identities=32%  Similarity=0.497  Sum_probs=79.5

Q ss_pred             hhccCcccccHHHHHHh-hhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          15 SVSSDSKLLDADIAEET-RVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~-~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      .++.. .+.||+|||+. ||+||||||    +|||++..    |.+||+|||+|+....                     
T Consensus       135 ~i~~~-i~~~l~~lh~~~~i~H~dlkp----~Nil~~~~----~~~kl~Dfg~~~~~~~---------------------  184 (360)
T 3eqc_A          135 KVSIA-VIKGLTYLREKHKIMHRDVKP----SNILVNSR----GEIKLCDFGVSGQLID---------------------  184 (360)
T ss_dssp             HHHHH-HHHHHHHHHHHHCCCCSCCSG----GGEEECTT----CCEEECCCCCCHHHHH---------------------
T ss_pred             HHHHH-HHHHHHHHHHhCCEEcCCccH----HHEEECCC----CCEEEEECCCCccccc---------------------
Confidence            34444 68899999986 999999999    89999876    7999999999974210                     


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .....+.                      +|+.|+|||++.+.. |+.++||||+||++|||++|+.||.+.+
T Consensus       185 -------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          185 -------SMANSFV----------------------GTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             -------HC----C----------------------CCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             -------ccccCCC----------------------CCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                   0011122                      399999999998765 9999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.75  E-value=5.8e-20  Score=179.46  Aligned_cols=99  Identities=28%  Similarity=0.518  Sum_probs=78.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++...   |.+||+|||+++......                          
T Consensus       131 i~~~l~~lH~~~i~H~dl~p----~Nil~~~~~---~~~kl~Dfg~~~~~~~~~--------------------------  177 (295)
T 2clq_A          131 ILEGLKYLHDNQIVHRDIKG----DNVLINTYS---GVLKISDFGTSKRLAGIN--------------------------  177 (295)
T ss_dssp             HHHHHHHHHHTTEECCCCSG----GGEEEETTT---CCEEECCTTTCEESCC----------------------------
T ss_pred             HHHHHHHHHhCCEEccCCCh----hhEEEECCC---CCEEEeecccccccCCCC--------------------------
Confidence            78899999999999999999    899998632   799999999997432100                          


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS-TEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~-~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                      .....                      ..+|+.|+|||++.+. ..++.++||||+||++|||++|+.||.+..+
T Consensus       178 ~~~~~----------------------~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          178 PCTET----------------------FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             ---CC----------------------CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             Ccccc----------------------cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            00001                      1238999999999764 3489999999999999999999999976543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.75  E-value=3.3e-19  Score=173.91  Aligned_cols=116  Identities=25%  Similarity=0.452  Sum_probs=86.4

Q ss_pred             HhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          12 RQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ....++.. .+.||+|||++||+||||||    +|||++... ..+.+||+|||+++......                 
T Consensus       122 ~~~~i~~q-i~~~l~~LH~~~i~H~dl~p----~NIlv~~~~-~~~~~kL~Dfg~~~~~~~~~-----------------  178 (287)
T 2wei_A          122 DAARIIKQ-VFSGITYMHKHNIVHRDLKP----ENILLESKE-KDCDIKIIDFGLSTCFQQNT-----------------  178 (287)
T ss_dssp             HHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESCSS-TTCCEEECSTTGGGTBCCCS-----------------
T ss_pred             HHHHHHHH-HHHHHHHHHHCCeeccCCCh----hhEEEecCC-CcccEEEeccCcceeecCCC-----------------
Confidence            33444444 78899999999999999999    899997542 23579999999998432110                 


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                                ....                      ..+|+.|+|||++.+.  ++.++||||+||++|||++|.+||.+
T Consensus       179 ----------~~~~----------------------~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          179 ----------KMKD----------------------RIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             ----------SCSC----------------------HHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             ----------cccc----------------------ccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCC
Confidence                      0000                      1138899999998764  89999999999999999999999988


Q ss_pred             chhhHHHHHHHHHH
Q psy3074         172 VREVYDQLDKIFKI  185 (481)
Q Consensus       172 ~~~~~~~l~~i~~~  185 (481)
                      .+. .+.+..+...
T Consensus       225 ~~~-~~~~~~~~~~  237 (287)
T 2wei_A          225 KNE-YDILKRVETG  237 (287)
T ss_dssp             SSH-HHHHHHHHHC
T ss_pred             CCH-HHHHHHHHcC
Confidence            543 3455555443

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.75  E-value=1.9e-19  Score=176.05  Aligned_cols=124  Identities=23%  Similarity=0.357  Sum_probs=80.3

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.............            
T Consensus       119 ~~i~~q-i~~~l~~LH~~~i~H~dlkp----~Nil~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~------------  177 (303)
T 1zy4_A          119 WRLFRQ-ILEALSYIHSQGIIHRDLKP----MNIFIDES----RNVKIGDFGLAKNVHRSLDILKLDS------------  177 (303)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECCCCCCSCTTC---------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCeecccCCH----HhEEEcCC----CCEEEeeCcchhhcccccchhcccc------------
Confidence            344444 78899999999999999999    89999766    7999999999985321110000000            


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                      ....+....                      .....+|+.|+|||++.+...++.++||||+||++|||++   ||....
T Consensus       178 ~~~~~~~~~----------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          178 QNLPGSSDN----------------------LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             --------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             ccccccccc----------------------cccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            000000000                      0112349999999999877669999999999999999998   665544


Q ss_pred             hhHHHHHHHH
Q psy3074         174 EVYDQLDKIF  183 (481)
Q Consensus       174 ~~~~~l~~i~  183 (481)
                      +..+.+..+.
T Consensus       233 ~~~~~~~~~~  242 (303)
T 1zy4_A          233 ERVNILKKLR  242 (303)
T ss_dssp             HHHHHHHHHH
T ss_pred             hHHHHHHhcc
Confidence            4434444443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.75  E-value=2.8e-20  Score=184.63  Aligned_cols=107  Identities=20%  Similarity=0.337  Sum_probs=82.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....++.. .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......                
T Consensus       134 ~~~~~i~~~-l~~~l~~LH~~~ivH~Dikp----~Nil~~~~----~~~kl~Dfg~a~~~~~~~----------------  188 (318)
T 3lxp_A          134 AQLLLFAQQ-ICEGMAYLHAQHYIHRDLAA----RNVLLDND----RLVKIGDFGLAKAVPEGH----------------  188 (318)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCGGGCEECCTTC----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCccCCCCch----heEEEcCC----CCEEECCccccccccccc----------------
Confidence            334445555 78899999999999999999    89999866    799999999998532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                .... .                  .....+|+.|+|||++.+.. ++.++||||+||++|||++|..||.
T Consensus       189 ----------~~~~-~------------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~  238 (318)
T 3lxp_A          189 ----------EYYR-V------------------REDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQ  238 (318)
T ss_dssp             ----------SEEE-C---------------------CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             ----------cccc-c------------------ccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCccc
Confidence                      0000 0                  00112388899999998765 8999999999999999999999997


Q ss_pred             Cc
Q psy3074         171 GV  172 (481)
Q Consensus       171 g~  172 (481)
                      ..
T Consensus       239 ~~  240 (318)
T 3lxp_A          239 SP  240 (318)
T ss_dssp             SH
T ss_pred             cc
Confidence            64

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.73  E-value=5.6e-20  Score=182.96  Aligned_cols=108  Identities=19%  Similarity=0.350  Sum_probs=82.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.. .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......              
T Consensus       144 ~~~~~~i~~q-i~~aL~~LH~~~ivH~dikp----~NIli~~~----~~~kL~Dfg~~~~~~~~~~--------------  200 (326)
T 2w1i_A          144 HIKLLQYTSQ-ICKGMEYLGTKRYIHRDLAT----RNILVENE----NRVKIGDFGLTKVLPQDKE--------------  200 (326)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEEEET----TEEEECCCTTCEECCSSCS--------------
T ss_pred             HHHHHHHHHH-HHHHHHHHHhCCEeccCCCc----ceEEEcCC----CcEEEecCcchhhcccccc--------------
Confidence            3344445555 78899999999999999999    89999876    7999999999985321110              


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                  .. . .                 .....+|+.|+|||++.+.. ++.++||||+||++|||++|..||
T Consensus       201 ------------~~-~-~-----------------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~  248 (326)
T 2w1i_A          201 ------------YY-K-V-----------------KEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKS  248 (326)
T ss_dssp             ------------EE-E-C-----------------SSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGG
T ss_pred             ------------cc-c-c-----------------ccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCC
Confidence                        00 0 0                 00012378899999998765 899999999999999999999998


Q ss_pred             CCc
Q psy3074         170 PGV  172 (481)
Q Consensus       170 ~g~  172 (481)
                      ...
T Consensus       249 ~~~  251 (326)
T 2w1i_A          249 KSP  251 (326)
T ss_dssp             GSH
T ss_pred             CCC
Confidence            753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.72  E-value=4.1e-18  Score=184.04  Aligned_cols=102  Identities=26%  Similarity=0.407  Sum_probs=80.1

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++... ....+||+|||+|+.....                     
T Consensus       125 ~I~~Q-Ll~aL~yLHs~gIVHrDLKP----~NILl~~~g-~~~~vKL~DFG~a~~~~~~---------------------  177 (676)
T 3qa8_A          125 TLLSD-ISSALRYLHENRIIHRDLKP----ENIVLQPGP-QRLIHKIIDLGYAKELDQG---------------------  177 (676)
T ss_dssp             HHHHH-HHHHHHHHHHTTBCCCCCCS----TTEEEECCS-SSCEEEECSCCCCCBTTSC---------------------
T ss_pred             HHHHH-HHHHHHHHHHCCCccCCCCH----HHeEeecCC-CceeEEEcccccccccccc---------------------
Confidence            34444 68899999999999999999    899998652 1235899999999853211                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                            .......                      +|+.|+|||++.+.. |+.++||||+||++|||++|..||.+.
T Consensus       178 ------~~~~~~~----------------------gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          178 ------ELCTEFV----------------------GTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             ------CCCCCCC----------------------SCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ------ccccccc----------------------CCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence                  1111112                      399999999998765 999999999999999999999999764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.72  E-value=2.1e-18  Score=172.19  Aligned_cols=109  Identities=17%  Similarity=0.226  Sum_probs=80.6

Q ss_pred             HHhhhhccCcccccHHHHH--------HhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCC
Q psy3074          11 QRQISVSSDSKLLDADIAE--------ETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGD   82 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh--------~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~   82 (481)
                      ...+.++.. .+.||+|||        +.+|+||||||    +|||++..    |.+||+|||+|+.......       
T Consensus       139 ~~~~~i~~~-i~~~l~~lH~~~~~~~~~~~ivH~Dlkp----~NIll~~~----~~~kL~Dfg~~~~~~~~~~-------  202 (342)
T 1b6c_B          139 EGMIKLALS-TASGLAHLHMEIVGTQGKPAIAHRDLKS----KNILVKKN----GTCCIADLGLAVRHDSATD-------  202 (342)
T ss_dssp             HHHHHHHHH-HHHHHHHHHCCBCSTTCBCEEECSCCSG----GGEEECTT----SCEEECCCTTCEEEETTTT-------
T ss_pred             HHHHHHHHH-HHHHHHHHHHHHhhhcccCCeeeCCCCH----HHEEECCC----CCEEEEECCCceecccccc-------
Confidence            334445554 788999999        99999999999    89999876    7999999999975321110       


Q ss_pred             CCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCC-----CCCccchhhHHH
Q psy3074          83 SPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTE-----YSTSLDMWGVGC  157 (481)
Q Consensus        83 ~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~-----y~~~~DvWS~G~  157 (481)
                                        ...  ..                 .....+|+.|+|||++.+...     ++.++||||+||
T Consensus       203 ------------------~~~--~~-----------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~  245 (342)
T 1b6c_B          203 ------------------TID--IA-----------------PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL  245 (342)
T ss_dssp             ------------------EEE--EC-----------------CCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHH
T ss_pred             ------------------ccc--cc-----------------cccCCcCcccCCHhhhcccccccccccCCcccHHHHHH
Confidence                              000  00                 001124999999999987632     336899999999


Q ss_pred             HHHHHHhC----------CCCCCCc
Q psy3074         158 ILIEMVTG----------LPTFPGV  172 (481)
Q Consensus       158 il~elltg----------~~PF~g~  172 (481)
                      ++|||++|          ..||.+.
T Consensus       246 il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          246 VFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             HHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             HHHHHHhccCcCCcccccccCcccc
Confidence            99999999          7888764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.70  E-value=2e-18  Score=172.44  Aligned_cols=100  Identities=15%  Similarity=0.132  Sum_probs=78.1

Q ss_pred             HhhhhccCcccccHHHHH-HhhhhcccCCCCCCCcchhccccCC----------------CCCceeeecccccccccCCC
Q psy3074          12 RQISVSSDSKLLDADIAE-ETRVLLRNRKPPRPKSEVFLNKYAT----------------PPRELKLADFGLARAKSVPS   74 (481)
Q Consensus        12 ~~~~~~~~~~~~~~~~lh-~~~i~hrdlkp~~~~~nill~~~~~----------------~~g~~Kl~DFGla~~~~~~~   74 (481)
                      ....+... .+.||+||| ++||+||||||    +|||++....                ....+||+|||+|+...   
T Consensus       162 ~~~~i~~q-i~~aL~~lH~~~~ivHrDlKp----~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~---  233 (336)
T 2vuw_A          162 TAKSILHQ-LTASLAVAEASLRFEHRDLHW----GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER---  233 (336)
T ss_dssp             HHHHHHHH-HHHHHHHHHHHHCCBCSCCCG----GGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE---
T ss_pred             HHHHHHHH-HHHHHHHHHHhCCEeECCCCH----HHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC---
Confidence            33344444 788999999 99999999999    8999987621                11289999999998431   


Q ss_pred             CCcCCCCCCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhh
Q psy3074          75 HTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWG  154 (481)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS  154 (481)
                                              .+    ...|                      |+.|||||++.+..  +.++||||
T Consensus       234 ------------------------~~----~~~g----------------------t~~y~aPE~~~g~~--~~~~Diws  261 (336)
T 2vuw_A          234 ------------------------DG----IVVF----------------------CDVSMDEDLFTGDG--DYQFDIYR  261 (336)
T ss_dssp             ------------------------TT----EEEC----------------------CCCTTCSGGGCCCS--SHHHHHHH
T ss_pred             ------------------------CC----cEEE----------------------eecccChhhhcCCC--ccceehhh
Confidence                                    11    1233                      99999999998764  88999999


Q ss_pred             HHHH-HHHHHhCCCCCCC
Q psy3074         155 VGCI-LIEMVTGLPTFPG  171 (481)
Q Consensus       155 ~G~i-l~elltg~~PF~g  171 (481)
                      ++++ .+++++|..||.+
T Consensus       262 l~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          262 LMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             HHHHHHTTCTTSCCTHHH
T ss_pred             hhCCCCcccccccCCCcc
Confidence            8777 8889999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.67  E-value=1e-17  Score=183.50  Aligned_cols=123  Identities=20%  Similarity=0.283  Sum_probs=92.3

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .....+.++.. .+.||+|||++||+||||||    +|||++.     +.+||+|||+|+.....               
T Consensus       180 ~~~~~~~~~~q-i~~aL~~lH~~giiHrDlkp----~NIll~~-----~~~kl~DFG~a~~~~~~---------------  234 (681)
T 2pzi_A          180 PVAEAIAYLLE-ILPALSYLHSIGLVYNDLKP----ENIMLTE-----EQLKLIDLGAVSRINSF---------------  234 (681)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECS-----SCEEECCCTTCEETTCC---------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCCeecccCh----HHeEEeC-----CcEEEEecccchhcccC---------------
Confidence            33444455555 78899999999999999999    8999975     38999999999843110               


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                     ...                      .+|+.|||||++.+.  ++.++||||+||++|||++|.+|
T Consensus       235 ---------------~~~----------------------~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~  275 (681)
T 2pzi_A          235 ---------------GYL----------------------YGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPT  275 (681)
T ss_dssp             ---------------SCC----------------------CCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCE
T ss_pred             ---------------Ccc----------------------CCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCC
Confidence                           011                      239999999999764  58999999999999999999999


Q ss_pred             CCCch-----------hhHHHHHHHHHHhCCCCccCcc
Q psy3074         169 FPGVR-----------EVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       169 F~g~~-----------~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      |.+..           .....+..++..+-.+++...+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~  313 (681)
T 2pzi_A          276 RNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF  313 (681)
T ss_dssp             ETTEECSSCCTTCHHHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred             CcccccccccccccccccCHHHHHHHhhhccCChhhCC
Confidence            87631           1123466677777766665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.67  E-value=1.4e-18  Score=184.94  Aligned_cols=95  Identities=15%  Similarity=0.192  Sum_probs=81.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++||||+++..++...+..|||||||+ ++|.+++..         +..++.|++.||.|||+++|+||
T Consensus       385 ~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHr  455 (540)
T 3en9_A          385 RTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHN  455 (540)
T ss_dssp             HHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECT
T ss_pred             HHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccC
Confidence            46789999999999999955444456667899999998 678777643         56889999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||||+|||++.    ++|++|||+|+.+.
T Consensus       456 DiKp~NILl~~----~~kL~DFGla~~~~  480 (540)
T 3en9_A          456 DLTTSNFIFDK----DLYIIDFGLGKISN  480 (540)
T ss_dssp             TCCTTSEEESS----SEEECCCTTCEECC
T ss_pred             CCCHHHEEECC----eEEEEECccCEECC
Confidence            99999999987    49999999998665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	481
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-23
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-09
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	8e-06
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	9e-06
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-23
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-09
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-06
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-06
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-23
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-06
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-06
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-05
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-22
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-08
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-06
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-04
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-08
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-06
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-05
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-22
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-05
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-05
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-05
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-21
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-08
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-05
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	0.002
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-21
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-09
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-07
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-06
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-20
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-07
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-05
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-05
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	6e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-14
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-05
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-04
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-20
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-16
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-06
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-05
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-19
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-08
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-07
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	9e-05
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-19
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-06
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-19
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-06
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-04
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-04
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-19
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	0.003
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-18
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-13
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-06
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-04
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-18
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	9e-04
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	0.001
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-06
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-18
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-09
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-06
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-06
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-05
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	0.001
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-18
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-05
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-04
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	0.002
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-17
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-06
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-05
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-17
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-07
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-05
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-17
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-11
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-06
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	0.001
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-17
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	0.002
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-17
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-04
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-04
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	0.004
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-17
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-08
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-05
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	0.003
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-17
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-16
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-05
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	0.002
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-05
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-04
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-17
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	0.002
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-08
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-06
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-05
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-16
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-12
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-05
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-16
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-04
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-16
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-04
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	0.002
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-16
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-14
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-04
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-16
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	0.003
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-16
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-07
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-06
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	0.003
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-16
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-04
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-04
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	0.002
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-16
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-06
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-05
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-16
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-09
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-07
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-16
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-07
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-05
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-10
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-05
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	0.001
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-15
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-07
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-05
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-15
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	9e-05
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	0.002
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-15
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-05
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-04
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-14
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-06
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-05
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-14
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-14
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	0.004
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	9e-07
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	0.002
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-12
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-06
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	9e-14
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-13
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-05
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-13
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-08
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-07
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-12
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	0.002
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-11
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-06
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-11
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-11
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-05
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-04
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-05

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 24/114 (21%), Positives = 51/114 (44%), Gaps = 1/114 (0%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
           T  +E   +  L+H  +V LHD     + +  ++E++   +L + +      +       
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE 128

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRR 381
           +M Q+ +GL + H    +H D+KP+N++ +    + ++L  F L   L      
Sbjct: 129 YMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 2/67 (2%)

Query: 132 LWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTE 191
             +  P+V  G        DMW VG +   +++GL  F G     + L  +        +
Sbjct: 189 AEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGG-ENDDETLRNVKSCDWNMDD 246

Query: 192 ETWEGVS 198
             + G+S
Sbjct: 247 SAFSGIS 253

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 45.5 bits (107), Expect = 8e-06
 Identities = 9/37 (24%), Positives = 19/37 (51%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           T  +E   +  L+H  +V LHD     + +  ++E++
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 45.5 bits (107), Expect = 9e-06
 Identities = 10/47 (21%), Positives = 17/47 (36%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYR 135
           D Y   ++LG G++  V +     T    A K +    E       +
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK 72

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 98.6 bits (245), Expect = 3e-23
 Identities = 24/110 (21%), Positives = 51/110 (46%), Gaps = 1/110 (0%)

Query: 268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIR 326
           +T   E S++ +L H  ++ LHD    +  +  + E++   +L   +      +    + 
Sbjct: 71  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 130

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            +M Q   GL + H   I+H D+KP+N++       ++++  F L   L+
Sbjct: 131 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 14/68 (20%), Positives = 29/68 (42%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  +  P+++          DMW +G +   +++GL  F G  +  + L  + +      
Sbjct: 191 TAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAG-EDDLETLQNVKRCDWEFD 248

Query: 191 EETWEGVS 198
           E+ +  VS
Sbjct: 249 EDAFSSVS 256

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 9/38 (23%), Positives = 20/38 (52%)

Query: 439 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           +T   E S++ +L H  ++ LHD    +  +  + E++
Sbjct: 71  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 45.8 bits (108), Expect = 7e-06
 Identities = 11/40 (27%), Positives = 17/40 (42%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           D Y  L++LG G++  V +     T +V   K I      
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL 68

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.2 bits (239), Expect = 6e-23
 Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + E  +L    H NIV L D  +  + L  + E+     +   M      L    I++  
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
            Q L  L+Y H  +I+HRD+K  N+L + 
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTL 145

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (109), Expect = 4e-06
 Identities = 12/47 (25%), Positives = 25/47 (53%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYR 135
           D +  + +LG+G++  V+K  +  T+ + A K I  + EE +  +  
Sbjct: 12  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV 58

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.7 bits (108), Expect = 6e-06
 Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 10/73 (13%)

Query: 132 LWYRPPDVLLGST----EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL- 186
            ++  P+V++  T     Y    D+W +G  LIEM    P         + +  + KI  
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKIAK 229

Query: 187 -GTPTEETWEGVS 198
              PT       S
Sbjct: 230 SEPPTLAQPSRWS 242

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (99), Expect = 6e-05
 Identities = 10/35 (28%), Positives = 16/35 (45%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           + E  +L    H NIV L D  +  + L  + E+ 
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 1e-22
 Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 2/124 (1%)

Query: 265 GAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHN 324
             P    +E  + K L H N+V  +      +      EY              G+   +
Sbjct: 45  DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD 104

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
            + F  QL+ G+ Y H   I HRD+KP+NLL+   +  N+++  F L     Y +R R+L
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLL 162

Query: 385 HRDV 388
           ++  
Sbjct: 163 NKMC 166

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (123), Expect = 6e-08
 Identities = 15/68 (22%), Positives = 28/68 (41%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           TL Y  P++L     ++  +D+W  G +L  M+ G   +    +   Q    +K   T  
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-CQEYSDWKEKKTYL 226

Query: 191 EETWEGVS 198
              W+ + 
Sbjct: 227 NP-WKKID 233

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (106), Expect = 8e-06
 Identities = 12/47 (25%), Positives = 23/47 (48%), Gaps = 2/47 (4%)

Query: 84  PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           PF   + +  +  LGEG+Y  V    + +T + VA+K + ++     
Sbjct: 2   PF--VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC 46

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.4 bits (94), Expect = 2e-04
 Identities = 9/42 (21%), Positives = 14/42 (33%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
              P    +E  + K L H N+V  +      +      EY 
Sbjct: 44  VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.5 bits (237), Expect = 2e-22
 Identities = 28/117 (23%), Positives = 54/117 (46%), Gaps = 1/117 (0%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
             +E S+L   +H NI+ LH+   +   L  +FE++   D+ + +   +  L+   I  +
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILH 385
           + Q+   L + H   I H D++P+N++        I++  F   R L      R+L 
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 16/68 (23%), Positives = 30/68 (44%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
              Y  P+V       ST+ DMW +G ++  +++G+  F         ++ I     T  
Sbjct: 166 APEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLA-ETNQQIIENIMNAEYTFD 223

Query: 191 EETWEGVS 198
           EE ++ +S
Sbjct: 224 EEAFKEIS 231

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.8 bits (108), Expect = 7e-06
 Identities = 6/40 (15%), Positives = 18/40 (45%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + Y+  + LG G +  V +     + +    K ++++  +
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD 44

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (100), Expect = 5e-05
 Identities = 11/36 (30%), Positives = 20/36 (55%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
             +E S+L   +H NI+ LH+   +   L  +FE++
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 94.7 bits (235), Expect = 3e-22
 Identities = 29/89 (32%), Positives = 41/89 (46%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            I+E   L++L+H N +          T   V EY     S  +E H   L    I    
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
              L+GL+Y H   ++HRDVK  N+L+SE
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSE 150

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.0 bits (106), Expect = 1e-05
 Identities = 14/56 (25%), Positives = 25/56 (44%), Gaps = 3/56 (5%)

Query: 131 TLWYRPPDVLLGSTE--YSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFK 184
           T ++  P+V+L   E  Y   +D+W +G   IE+    P    +  +   L  I +
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ 228

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 9/39 (23%), Positives = 21/39 (53%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           +  L ++G GS+  V+       ++VVA+K++    ++ 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.8 bits (103), Expect = 2e-05
 Identities = 10/36 (27%), Positives = 15/36 (41%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
            I+E   L++L+H N +          T   V EY 
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (225), Expect = 3e-21
 Identities = 30/105 (28%), Positives = 47/105 (44%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K G      RE  +   L+H NI+ L+   H  + +  + EY          +     D 
Sbjct: 46  KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE 105

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                ++ +L   LSYCH +R++HRD+KP+NLL+       I  F
Sbjct: 106 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 150

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.1 bits (122), Expect = 7e-08
 Identities = 17/67 (25%), Positives = 31/67 (46%), Gaps = 2/67 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           TL Y PP+++ G   +   +D+W +G +  E + G P F       +   +I ++  T  
Sbjct: 167 TLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISRVEFTFP 224

Query: 191 EETWEGV 197
           +   EG 
Sbjct: 225 DFVTEGA 231

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.3 bits (99), Expect = 6e-05
 Identities = 8/40 (20%), Positives = 18/40 (45%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + +     LG+G +  V+      +  ++ALK +   + E
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE 45

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (87), Expect = 0.002
 Identities = 11/42 (26%), Positives = 18/42 (42%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
            G      RE  +   L+H NI+ L+   H  + +  + EY 
Sbjct: 47  AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYA 88

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.7 bits (227), Expect = 5e-21
 Identities = 23/106 (21%), Positives = 47/106 (44%), Gaps = 1/106 (0%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
           K       IRE  +L E     IV  +   ++   ++   E++       + + +G +  
Sbjct: 44  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE 103

Query: 323 HNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISEIDHHNIRLF 367
             +      +++GL+Y   + +I+HRDVKP N+L++      +  F
Sbjct: 104 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDF 149

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.2 bits (135), Expect = 2e-09
 Identities = 18/65 (27%), Positives = 26/65 (40%), Gaps = 1/65 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  Y  P+ L G+  YS   D+W +G  L+EM  G    P       +L    ++ G   
Sbjct: 166 TRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 191 EETWE 195
           E    
Sbjct: 225 ETPPR 229

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 15/44 (34%), Positives = 23/44 (52%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           K D + K+ +LG G+   VFK     +  V+A K I L+ +  I
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI 47

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 9/42 (21%), Positives = 17/42 (40%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           P      IRE  +L E     IV  +   ++   ++   E++
Sbjct: 45  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 86

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (219), Expect = 3e-20
 Identities = 28/97 (28%), Positives = 42/97 (43%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
            RE  ++  L H   V L+        L F   Y          R  G  D    R +  
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           +++  L Y H + I+HRD+KP+N+L++E  H  I  F
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 19/64 (29%), Positives = 29/64 (45%), Gaps = 2/64 (3%)

Query: 132 LWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTE 191
             Y  P++L        S D+W +GCI+ ++V GLP F      Y    KI K+     E
Sbjct: 174 AQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIKLEYDFPE 231

Query: 192 ETWE 195
           + + 
Sbjct: 232 KFFP 235

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (104), Expect = 1e-05
 Identities = 14/57 (24%), Positives = 27/57 (47%), Gaps = 3/57 (5%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR---LQEEEGITLWYRPPDVL 140
           + + +     LGEGS++TV       T++  A+K +    + +E  +    R  DV+
Sbjct: 6   RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (98), Expect = 9e-05
 Identities = 9/35 (25%), Positives = 12/35 (34%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
            RE  ++  L H   V L+        L F   Y 
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYA 90

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 87.6 bits (216), Expect = 6e-20
 Identities = 50/99 (50%), Positives = 69/99 (69%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
           T IRE S+LKELKH+NIV L+D++HT+  L  VFE++  DL + ++   GGL+    + F
Sbjct: 46  TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF 105

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           + QLL G++YCH RR+LHRD+KPQNLLI+      I  F
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADF 144

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 71.8 bits (175), Expect = 2e-14
 Identities = 44/73 (60%), Positives = 54/73 (73%), Gaps = 1/73 (1%)

Query: 132 LWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTE 191
           LWYR PDVL+GS +YST++D+W VGCI  EMV G P FPGV E  DQL +IF+ILGTP  
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNS 222

Query: 192 ETWEGVSLLPGYN 204
           + W  V+ LP Y+
Sbjct: 223 KNWPNVTELPKYD 235

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 16/40 (40%), Positives = 28/40 (70%), Gaps = 1/40 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           + Y  L+++GEG+Y  V+K  +N   +  ALK+IRL++E+
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED 40

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 39.9 bits (92), Expect = 4e-04
 Identities = 24/49 (48%), Positives = 33/49 (67%)

Query: 428 LSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           +       G P T IRE S+LKELKH+NIV L+D++HT+  L  VFE++
Sbjct: 34  IRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 9e-20
 Identities = 42/112 (37%), Positives = 64/112 (57%)

Query: 256 KEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMER 315
               +  K+G   TA+RE  LL+EL H NI+ L D    +S ++ VF+++ TDL   ++ 
Sbjct: 33  LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD 92

Query: 316 HSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           +S  L   +I+ +M   L+GL Y H+  ILHRD+KP NLL+ E     +  F
Sbjct: 93  NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADF 144

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (186), Expect = 6e-16
 Identities = 37/80 (46%), Positives = 48/80 (60%), Gaps = 1/80 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P++L G+  Y   +DMW VGCIL E++  +P  PG     DQL +IF+ LGTPT
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG-DSDLDQLTRIFETLGTPT 221

Query: 191 EETWEGVSLLPGYNVHRDAP 210
           EE W  +  LP Y   +  P
Sbjct: 222 EEQWPDMCSLPDYVTFKSFP 241

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (107), Expect = 7e-06
 Identities = 19/36 (52%), Positives = 25/36 (69%)

Query: 93  KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           KLD LGEG +ATV+K     TNQ+VA+K+I+L    
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS 37

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 16/37 (43%), Positives = 25/37 (67%)

Query: 440 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           TA+RE  LL+EL H NI+ L D    +S ++ VF+++
Sbjct: 46  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.4 bits (211), Expect = 3e-19
 Identities = 26/112 (23%), Positives = 48/112 (42%), Gaps = 3/112 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           I E  +++E K+ NIV   D       L  V EY+       +      +D   I     
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCR 123

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
           + L+ L + H  +++HRD+K  N+L+      +++L  F     ++    +R
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGM--DGSVKLTDFGFCAQITPEQSKR 173

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.1 bits (127), Expect = 3e-08
 Identities = 19/68 (27%), Positives = 32/68 (47%), Gaps = 3/68 (4%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T ++  P+V+     Y   +D+W +G + IEM+ G P +     +   L  I    GTP 
Sbjct: 179 TPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATN-GTPE 235

Query: 191 EETWEGVS 198
            +  E +S
Sbjct: 236 LQNPEKLS 243

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (116), Expect = 5e-07
 Identities = 12/45 (26%), Positives = 25/45 (55%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYR 135
           Y + +++G+G+  TV+      T Q VA++++ LQ++    L   
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (98), Expect = 9e-05
 Identities = 12/35 (34%), Positives = 17/35 (48%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           I E  +++E K+ NIV   D       L  V EY+
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.0 bits (210), Expect = 4e-19
 Identities = 25/143 (17%), Positives = 51/143 (35%), Gaps = 4/143 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
             E  +L++ +H NI+       T   L  V ++   + L  ++       +   +    
Sbjct: 52  KNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
            Q  +G+ Y H + I+HRD+K  N+ + E     +++  F L    S         +   
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHE--DLTVKIGDFGLATVKSRWSGSHQFEQLSG 168

Query: 390 PQNLLISEIVFTNLSGVVVSTVD 412
               +  E++            D
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSD 191

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 11/61 (18%), Positives = 27/61 (44%), Gaps = 2/61 (3%)

Query: 131 TLWYRPPDVLLG--STEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGT 188
           ++ +  P+V+       YS   D++  G +L E++TG   +  +      +  + +   +
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228

Query: 189 P 189
           P
Sbjct: 229 P 229

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 86.3 bits (213), Expect = 5e-19
 Identities = 24/99 (24%), Positives = 44/99 (44%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
               SL+       IV +    HT   L+F+ + ++     Y     G     ++R +  
Sbjct: 55  RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA 114

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           +++ GL + H R +++RD+KP N+L+ E  H  I     
Sbjct: 115 EIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 153

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  Y  P+VL     Y +S D + +GC+L +++ G   F           +I ++  T  
Sbjct: 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ--HKTKDKHEIDRMTLTMA 225

Query: 191 EETWEGVS 198
            E  +  S
Sbjct: 226 VELPDSFS 233

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 41.6 bits (97), Expect = 1e-04
 Identities = 6/38 (15%), Positives = 16/38 (42%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           + +     +G G +  V+      T ++ A+K +  + 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR 41

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.5 bits (94), Expect = 4e-04
 Identities = 8/35 (22%), Positives = 14/35 (40%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
               SL+       IV +    HT   L+F+ + +
Sbjct: 55  RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 89

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.0 bits (207), Expect = 9e-19
 Identities = 22/98 (22%), Positives = 44/98 (44%), Gaps = 2/98 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           +REA ++ +L +  IV L  +    + L  V E      L +++      +   N+   +
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            Q+  G+ Y   +  +HRD+  +N+L+    +  I  F
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 153

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (85), Expect = 0.003
 Identities = 10/35 (28%), Positives = 17/35 (48%), Gaps = 1/35 (2%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           +REA ++ +L +  IV L  +    + L  V E  
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMA 90

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.8 bits (206), Expect = 1e-18
 Identities = 49/97 (50%), Positives = 68/97 (70%), Gaps = 1/97 (1%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYME-RHSGGLDHHNIRL 327
           TAIRE SLLKEL H NIV L D++HT + L  VFE++H DL ++M+     G+    I+ 
Sbjct: 47  TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKS 106

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           ++FQLL+GL++CH  R+LHRD+KPQNLLI+      +
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKL 143

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.4 bits (166), Expect = 2e-13
 Identities = 39/73 (53%), Positives = 50/73 (68%), Gaps = 1/73 (1%)

Query: 132 LWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTE 191
           LWYR P++LLG   YST++D+W +GCI  EMVT    FPG  E+ DQL +IF+ LGTP E
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDE 224

Query: 192 ETWEGVSLLPGYN 204
             W GV+ +P Y 
Sbjct: 225 VVWPGVTSMPDYK 237

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (111), Expect = 2e-06
 Identities = 18/39 (46%), Positives = 29/39 (74%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
           + + K++++GEG+Y  V+K  + LT +VVALK+IRL  E
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE 40

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 4e-04
 Identities = 25/49 (51%), Positives = 31/49 (63%)

Query: 428 LSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           +       G P TAIRE SLLKEL H NIV L D++HT + L  VFE++
Sbjct: 35  IRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.2 bits (205), Expect = 1e-18
 Identities = 24/96 (25%), Positives = 48/96 (50%), Gaps = 3/96 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGG--LDHHNIRLF 328
           + EA+L+K+L+H  +V L+  V T+  +  + EY+         +   G  L  + +   
Sbjct: 56  LAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
             Q+  G+++   R  +HRD++  N+L+S+     I
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKI 150

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (90), Expect = 9e-04
 Identities = 12/35 (34%), Positives = 23/35 (65%), Gaps = 1/35 (2%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           + EA+L+K+L+H  +V L+  V T+  +  + EY+
Sbjct: 56  LAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYM 89

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.1 bits (88), Expect = 0.001
 Identities = 10/40 (25%), Positives = 20/40 (50%), Gaps = 1/40 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           +    +++LG G +  V+ GY N  +  VA+K ++     
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS 51

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.7 bits (203), Expect = 4e-18
 Identities = 52/105 (49%), Positives = 70/105 (66%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDH 322
             G P +A+RE  LLKELKH NIV LHD++H+   LT VFE+   DL +Y +  +G LD 
Sbjct: 41  DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP 100

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
             ++ F+FQLL+GL +CH R +LHRD+KPQNLLI+      +  F
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANF 145

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.4 bits (171), Expect = 5e-14
 Identities = 47/94 (50%), Positives = 59/94 (62%), Gaps = 2/94 (2%)

Query: 120 KEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-LPTFPGVREVYDQ 178
             +R    E +TLWYRPPDVL G+  YSTS+DMW  GCI  E+     P FPG  +V DQ
Sbjct: 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQ 211

Query: 179 LDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYT 212
           L +IF++LGTPTEE W  ++ LP Y  +   P T
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (110), Expect = 2e-06
 Identities = 18/38 (47%), Positives = 30/38 (78%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y KL+++GEG+Y TVFK  +  T+++VALK +RL +++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD 41

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 82.8 bits (204), Expect = 4e-18
 Identities = 33/121 (27%), Positives = 53/121 (43%), Gaps = 3/121 (2%)

Query: 264 NGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDH 322
            G   +   E ++L ++KH NIV L DI  +   L  + + V   +L   +    G    
Sbjct: 48  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTE 106

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHH-NIRLFMFQLLRGLSYCHRR 381
            +    +FQ+L  + Y H   I+HRD+KP+NLL   +D    I +  F L +        
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166

Query: 382 R 382
            
Sbjct: 167 S 167

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.8 bits (134), Expect = 3e-09
 Identities = 18/68 (26%), Positives = 29/68 (42%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  Y  P+VL     YS ++D W +G I   ++ G P F    +     ++I K      
Sbjct: 172 TPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDA-KLFEQILKAEYEFD 229

Query: 191 EETWEGVS 198
              W+ +S
Sbjct: 230 SPYWDDIS 237

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 14/41 (34%), Positives = 21/41 (51%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
           D Y   D LG G+++ V       T ++VA+K I  +  EG
Sbjct: 9   DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 49

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 13/42 (30%), Positives = 21/42 (50%)

Query: 435 PGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
            G   +   E ++L ++KH NIV L DI  +   L  + + V
Sbjct: 48  EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 82.9 bits (204), Expect = 5e-18
 Identities = 26/100 (26%), Positives = 43/100 (43%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            + E  +L+ +    +V L       S L  V EYV         R  G     + R + 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            Q++    Y H   +++RD+KP+NLLI +  +  +  F F
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 44.8 bits (105), Expect = 1e-05
 Identities = 9/38 (23%), Positives = 17/38 (44%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           D + ++  LG GS+  V       +    A+K +  Q+
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK 78

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 2/90 (2%)

Query: 106 FKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG 165
            +GY  +T+   A +          T     P+++L    Y+ ++D W +G ++ EM  G
Sbjct: 176 QQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAG 234

Query: 166 LPTFPGVREVYDQLDKIFKILGTPTEETWE 195
            P F    +     +KI             
Sbjct: 235 YPPFFA-DQPIQIYEKIVSGKVRFPSHFSS 263

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.1 bits (202), Expect = 7e-18
 Identities = 21/99 (21%), Positives = 43/99 (43%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
             E  +L  + H  I+ +         +  + +Y+       + R S    +   + +  
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 111

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           ++   L Y H + I++RD+KP+N+L+ +  H  I  F F
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 150

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 42.4 bits (99), Expect = 6e-05
 Identities = 9/35 (25%), Positives = 16/35 (45%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           +  L  LG GS+  V    S    +  A+K ++ +
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKE 40

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 14/52 (26%), Positives = 22/52 (42%), Gaps = 2/52 (3%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFK 184
            Y  P+V+     Y+ S+D W  G ++ EM+ G   F          +KI  
Sbjct: 166 DYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILN 215

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 37.4 bits (86), Expect = 0.002
 Identities = 5/35 (14%), Positives = 13/35 (37%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
             E  +L  + H  I+ +         +  + +Y+
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYI 86

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.4 bits (200), Expect = 1e-17
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 1/94 (1%)

Query: 272 REASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
            E+ + K ++    I T+            V E +   L       S       + L   
Sbjct: 51  IESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLAD 110

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
           Q++  + Y H +  +HRDVKP N L+      N+
Sbjct: 111 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.1 bits (111), Expect = 2e-06
 Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 6/72 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI----L 186
           T  Y   +  LG  E S   D+  +G +L+    G   + G++    +  K  +I    +
Sbjct: 176 TARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKM 233

Query: 187 GTPTEETWEGVS 198
            TP E   +G  
Sbjct: 234 STPIEVLCKGYP 245

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 8/41 (19%), Positives = 19/41 (46%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
            + Y    ++G GS+  ++ G      + VA+K   ++ + 
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH 46

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 80.9 bits (199), Expect = 1e-17
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 3/102 (2%)

Query: 270 AIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRL 327
            ++E  +L+++  H NI+ L D   T +    VF+ +   +L  Y+      L     R 
Sbjct: 56  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRK 114

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
            M  LL  +   H+  I+HRD+KP+N+L+ +  +  +  F F
Sbjct: 115 IMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 156

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 50.8 bits (121), Expect = 1e-07
 Identities = 18/73 (24%), Positives = 27/73 (36%), Gaps = 6/73 (8%)

Query: 131 TLWYRPPDVLLGSTE-----YSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI 185
           T  Y  P+++  S       Y   +DMW  G I+  ++ G P F   R+    L  I   
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSG 230

Query: 186 LGTPTEETWEGVS 198
                   W+  S
Sbjct: 231 NYQFGSPEWDDYS 243

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 44.3 bits (104), Expect = 2e-05
 Identities = 9/37 (24%), Positives = 16/37 (43%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           + Y   + LG G  + V +     T +  A+K I + 
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVT 39

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 1e-17
 Identities = 38/170 (22%), Positives = 70/170 (41%), Gaps = 15/170 (8%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRST-----LTFVFEYVHTDLSQYMERHSGGLDHHN 324
            +RE  +L   +H NI+ ++DI+   +      +  V   +  DL + +   +  L + +
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDH 110

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRIL 384
           I  F++Q+LRGL Y H   +LHRD+KP NLL++     ++++  F L R     H     
Sbjct: 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT--TCDLKICDFGLARVADPDHDHTGF 168

Query: 385 HRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSFHYLP 434
             +        +  +  N      S   + S   W        +  +   
Sbjct: 169 LTEYVATRWYRAPEIMLN------SKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.5 bits (151), Expect = 3e-11
 Identities = 33/79 (41%), Positives = 48/79 (60%), Gaps = 1/79 (1%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           WYR P+++L S  Y+ S+D+W VGCIL EM++  P FPG +   DQL+ I  ILG+P++E
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG-KHYLDQLNHILGILGSPSQE 235

Query: 193 TWEGVSLLPGYNVHRDAPY 211
               +  L   N     P+
Sbjct: 236 DLNCIINLKARNYLLSLPH 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (111), Expect = 2e-06
 Identities = 14/42 (33%), Positives = 20/42 (47%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEG 129
              Y  L  +GEG+Y  V   Y N+    VA+K+I   E + 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT 48

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (89), Expect = 0.001
 Identities = 9/38 (23%), Positives = 19/38 (50%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLF 478
            +RE  +L   +H NI+ ++DI+   +       Y++ 
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT 90

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 80.6 bits (198), Expect = 2e-17
 Identities = 21/107 (19%), Positives = 51/107 (47%), Gaps = 3/107 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++ +  H N++ L  +V   + +  + E++ +  L  ++ ++ G      +   +
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             +  G+ Y      +HRD+  +N+L++   +   ++  F L R L 
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNS--NLVCKVSDFGLSRFLE 179

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 37.4 bits (86), Expect = 0.002
 Identities = 8/35 (22%), Positives = 20/35 (57%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           + EAS++ +  H N++ L  +V   + +  + E++
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.7 bits (196), Expect = 2e-17
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 3/91 (3%)

Query: 271 IREASLLKELKHNNIVTLHD-IVHTRSTLTFVFEYV-HTDLSQYMERHSGG-LDHHNIRL 327
           + EAS++ +L+H+N+V L   IV  +  L  V EY+    L  Y+       L    +  
Sbjct: 48  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107

Query: 328 FMFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
           F   +   + Y      +HRD+  +N+L+SE
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 138

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (96), Expect = 1e-04
 Identities = 11/54 (20%), Positives = 24/54 (44%), Gaps = 1/54 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFK 184
            + +  P+ L    ++ST  D+W  G +L E+ +          + D + ++ K
Sbjct: 163 PVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (92), Expect = 5e-04
 Identities = 14/36 (38%), Positives = 23/36 (63%), Gaps = 1/36 (2%)

Query: 442 IREASLLKELKHNNIVTLHD-IVHTRSTLTFVFEYV 476
           + EAS++ +L+H+N+V L   IV  +  L  V EY+
Sbjct: 48  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.004
 Identities = 9/40 (22%), Positives = 14/40 (35%), Gaps = 2/40 (5%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
                L  +G+G +  V  G        VA+K I+     
Sbjct: 7   KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATA 44

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 79.8 bits (196), Expect = 2e-17
 Identities = 26/103 (25%), Positives = 42/103 (40%), Gaps = 4/103 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRST----LTFVFEYVHTDLSQYMERHSGGLDHHNIR 326
            REA     L H  IV ++D     +        V EYV     + +    G +      
Sbjct: 55  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 114

Query: 327 LFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
             +    + L++ H+  I+HRDVKP N++IS  +   +  F  
Sbjct: 115 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 157

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 53.6 bits (128), Expect = 1e-08
 Identities = 18/68 (26%), Positives = 28/68 (41%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  Y  P+   G        D++ +GC+L E++TG P F G         +  +    P 
Sbjct: 177 TAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTG-DSPVSVAYQHVREDPIPP 234

Query: 191 EETWEGVS 198
               EG+S
Sbjct: 235 SARHEGLS 242

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 44.3 bits (104), Expect = 1e-05
 Identities = 10/41 (24%), Positives = 17/41 (41%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           +D Y   + LG G  + V        ++ VA+K +R     
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR 46

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 37.4 bits (86), Expect = 0.003
 Identities = 12/39 (30%), Positives = 15/39 (38%), Gaps = 4/39 (10%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRST----LTFVFEYV 476
            REA     L H  IV ++D     +        V EYV
Sbjct: 55  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 3e-17
 Identities = 43/122 (35%), Positives = 63/122 (51%), Gaps = 10/122 (8%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRS--------TLTFVFEYVHTDLSQYME 314
           K G P TA+RE  +L+ LKH N+V L +I  T++        ++  VF++   DL+  + 
Sbjct: 49  KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS 108

Query: 315 RHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                     I+  M  LL GL Y HR +ILHRD+K  N+LI+      ++L  F L R 
Sbjct: 109 NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITR--DGVLKLADFGLARA 166

Query: 375 LS 376
            S
Sbjct: 167 FS 168

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.4 bits (192), Expect = 1e-16
 Identities = 47/182 (25%), Positives = 65/182 (35%), Gaps = 45/182 (24%)

Query: 58  ELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVV 117
            LKLADFGLARA S+  ++  ++  +                                  
Sbjct: 155 VLKLADFGLARAFSLAKNSQPNRYTNRVV------------------------------- 183

Query: 118 ALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD 177
                        TLWYRPP++LLG  +Y   +D+WG GCI+ EM T  P   G  E   
Sbjct: 184 -------------TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-H 229

Query: 178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFL 237
           QL  I ++ G+ T E W  V     Y           K+          P    +    L
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289

Query: 238 QV 239
            +
Sbjct: 290 VL 291

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 1e-05
 Identities = 15/38 (39%), Positives = 25/38 (65%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y KL ++G+G++  VFK     T Q VALK++ ++ E+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK 49

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.002
 Identities = 15/51 (29%), Positives = 27/51 (52%)

Query: 428 LSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVLF 478
           +       G P TA+RE  +L+ LKH N+V L +I  T+++     +  ++
Sbjct: 43  VLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.0 bits (194), Expect = 4e-17
 Identities = 22/91 (24%), Positives = 46/91 (50%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA  +++  H +IV L  ++        +      +L  +++     LD  ++ L+ +
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDH 361
           QL   L+Y   +R +HRD+  +N+L+S  D 
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVSSNDC 146

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.1 bits (197), Expect = 4e-17
 Identities = 25/102 (24%), Positives = 39/102 (38%), Gaps = 7/102 (6%)

Query: 270 AIREAS-LLKELKHNNIVTLHDIVHT----RSTLTFVFEYV-HTDLSQYMERHSG-GLDH 322
           A RE     +  +  +IV + D+       R  L  V E +   +L   ++         
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
                 M  +   + Y H   I HRDVKP+NLL +    + I
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 152

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 16/56 (28%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKIL 186
           T +Y  P+VL    +Y  S DMW +G I+  ++ G P F     +        +I 
Sbjct: 176 TPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 230

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (95), Expect = 2e-04
 Identities = 8/37 (21%), Positives = 16/37 (43%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
            +    LG G    V + ++  T +  ALK ++   +
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK 50

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.8 bits (196), Expect = 4e-17
 Identities = 23/132 (17%), Positives = 53/132 (40%), Gaps = 2/132 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           + EA ++  + + ++  L  I  T +            L  Y+  H   +    +  +  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKP 390
           Q+ +G++Y   RR++HRD+  +N+L+      ++++  F L + L    +         P
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKT--PQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176

Query: 391 QNLLISEIVFTN 402
              +  E +   
Sbjct: 177 IKWMALESILHR 188

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (87), Expect = 0.002
 Identities = 14/46 (30%), Positives = 22/46 (47%), Gaps = 4/46 (8%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQV----VALKEIRLQEEE 128
           K   + K+  LG G++ TV+KG      +     VA+KE+R     
Sbjct: 7   KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP 52

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.0 bits (194), Expect = 6e-17
 Identities = 29/113 (25%), Positives = 57/113 (50%), Gaps = 2/113 (1%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQ 331
           RE S+LKE++H N++TLH++   ++ +  + E V              L       F+ Q
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121

Query: 332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFM--FQLLRGLSYCHRRR 382
           +L G+ Y H  +I H D+KP+N+++ + +    R+ +  F L   + + +  +
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 174

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.2 bits (127), Expect = 2e-08
 Identities = 13/68 (19%), Positives = 27/68 (39%), Gaps = 2/68 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  +  P+++          DMW +G I   +++G   F G  +  + L  +  +     
Sbjct: 179 TPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNYEFE 236

Query: 191 EETWEGVS 198
           +E +   S
Sbjct: 237 DEYFSNTS 244

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.5 bits (107), Expect = 7e-06
 Identities = 12/37 (32%), Positives = 17/37 (45%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           D Y   ++LG G +A V K     T    A K I+ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKR 46

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (106), Expect = 1e-05
 Identities = 13/34 (38%), Positives = 24/34 (70%)

Query: 443 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           RE S+LKE++H N++TLH++   ++ +  + E V
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELV 95

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 1e-16
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 9/101 (8%)

Query: 272 REASLLKELKHNNIVTLHDIVHTRST------LTFVFEYVHTDLSQYMERHS---GGLDH 322
           RE  ++++L H NIV L    ++         L  V +YV   + +    +S     L  
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 323 HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHN 363
             ++L+M+QL R L+Y H   I HRD+KPQNLL+       
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL 162

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (156), Expect = 7e-12
 Identities = 29/66 (43%), Positives = 46/66 (69%), Gaps = 1/66 (1%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           +YR P+++ G+T+Y++S+D+W  GC+L E++ G P FPG     DQL +I K+LGTPT E
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG-DSGVDQLVEIIKVLGTPTRE 245

Query: 193 TWEGVS 198
               ++
Sbjct: 246 QIREMN 251

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (100), Expect = 5e-05
 Identities = 8/38 (21%), Positives = 19/38 (50%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y     +G GS+  V++     + ++VA+K++   +  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF 59

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 21/104 (20%), Positives = 45/104 (43%), Gaps = 3/104 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++  L H  +V L+ +   +  +  + EY+ +  L  Y+           +    
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
             +   + Y   ++ LHRD+  +N L+++     +++  F L R
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVND--QGVVKVSDFGLSR 148

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (92), Expect = 4e-04
 Identities = 9/35 (25%), Positives = 18/35 (51%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           I EA ++  L H  +V L+ +   +  +  + EY+
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.1 bits (189), Expect = 2e-16
 Identities = 29/120 (24%), Positives = 54/120 (45%), Gaps = 4/120 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           IRE + +  L H N++ L+ +V T   +  V E      L   + +H G      +  + 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
            Q+  G+ Y   +R +HRD+  +NLL++      +++  F L+R L       ++    K
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLA--TRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.1 bits (93), Expect = 4e-04
 Identities = 19/63 (30%), Positives = 27/63 (42%), Gaps = 3/63 (4%)

Query: 123 RLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGVREVYDQLDK 181
            +QE   +   +  P+ L   T +S + D W  G  L EM T G   + G+      L K
Sbjct: 169 VMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILHK 226

Query: 182 IFK 184
           I K
Sbjct: 227 IDK 229

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (87), Expect = 0.002
 Identities = 11/35 (31%), Positives = 18/35 (51%), Gaps = 1/35 (2%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           IRE + +  L H N++ L+ +V T   +  V E  
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELA 92

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.6 bits (190), Expect = 2e-16
 Identities = 41/114 (35%), Positives = 62/114 (54%), Gaps = 9/114 (7%)

Query: 263 KNGAPFTAIREASLLKELK---HNNIVTLHDIVHTRST-----LTFVFEYVHTD-LSQYM 313
           + G P + IRE ++L+ L+   H N+V L D+     T     LT VFE+V  D  +   
Sbjct: 47  EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLD 106

Query: 314 ERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
           +    G+    I+  MFQLLRGL + H  R++HRD+KPQN+L++      +  F
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 5e-14
 Identities = 38/86 (44%), Positives = 46/86 (53%), Gaps = 2/86 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           TLWYR P+VLL S  Y+T +D+W VGCI  EM    P F G  +V DQL KI  ++G P 
Sbjct: 178 TLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPG 235

Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKL 216
           EE W     LP    H  +     K 
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKF 261

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 15/39 (38%), Positives = 22/39 (56%), Gaps = 1/39 (2%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLT-NQVVALKEIRLQEEE 128
           Y  + ++GEG+Y  VFK        + VALK +R+Q  E
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE 47

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (190), Expect = 2e-16
 Identities = 24/113 (21%), Positives = 45/113 (39%), Gaps = 19/113 (16%)

Query: 271 IREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH------------ 316
           + E  +L  L  H NIV L            + EY  + DL  ++ R             
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 317 -----SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNI 364
                   LD  ++  F +Q+ +G+++   +  +HRD+  +N+L++      I
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.003
 Identities = 10/36 (27%), Positives = 13/36 (36%), Gaps = 1/36 (2%)

Query: 442 IREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYV 476
           + E  +L  L  H NIV L            + EY 
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYC 109

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 42/118 (35%), Positives = 60/118 (50%), Gaps = 13/118 (11%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYV-HTDLSQYMERHS---GGLDHH 323
            + E +LL+ELKH NIV  +D +  R+  TL  V EY    DL+  + + +     LD  
Sbjct: 50  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 109

Query: 324 NIRLFMFQLLRGLSYCHRR-----RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
            +   M QL   L  CHRR      +LHRD+KP N+ +      N++L  F L R L+
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--KQNVKLGDFGLARILN 165

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 5/68 (7%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T +Y  P+ +     Y+   D+W +GC+L E+   +P F      + Q +   KI     
Sbjct: 177 TPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKF 231

Query: 191 EETWEGVS 198
                  S
Sbjct: 232 RRIPYRYS 239

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.1 bits (109), Expect = 3e-06
 Identities = 10/40 (25%), Positives = 17/40 (42%)

Query: 87  KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           +A+ Y  L  +G GSY    K       +++  KE+    
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS 41

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 2/51 (3%)

Query: 428 LSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDIVHTRS--TLTFVFEYV 476
           L +  +        + E +LL+ELKH NIV  +D +  R+  TL  V EY 
Sbjct: 37  LDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 87

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.6 bits (188), Expect = 3e-16
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           I EA ++ +L H  +V L+ +   ++ +  VFE++ H  LS Y+    G      +    
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G++Y     ++HRD+  +N L+ E
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGE 136

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (92), Expect = 4e-04
 Identities = 10/35 (28%), Positives = 21/35 (60%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           I EA ++ +L H  +V L+ +   ++ +  VFE++
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.3 bits (91), Expect = 5e-04
 Identities = 11/52 (21%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKI 182
            + +  P+V   S  YS+  D+W  G ++ E+ +        R   + ++ I
Sbjct: 165 PVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 11/35 (31%), Positives = 16/35 (45%), Gaps = 1/35 (2%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR 123
                + ++G G +  V  GY  L    VA+K IR
Sbjct: 5   SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIR 38

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.1 bits (189), Expect = 4e-16
 Identities = 23/129 (17%), Positives = 48/129 (37%), Gaps = 19/129 (14%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++ +L  H NIV L         +  +FEY  + DL  Y+           I   
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
             + L      +                  +   ++  F +Q+ +G+ +   +  +HRD+
Sbjct: 148 NQKRLEEEEDLNV-----------------LTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190

Query: 389 KPQNLLISE 397
             +N+L++ 
Sbjct: 191 AARNVLVTH 199

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (188), Expect = 4e-16
 Identities = 24/106 (22%), Positives = 47/106 (44%), Gaps = 2/106 (1%)

Query: 263 KNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLD 321
            +    T + +  L    +H  +  +     T+  L FV EY+   DL  +++      D
Sbjct: 43  DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFD 101

Query: 322 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                 +  +++ GL + H + I++RD+K  N+L+ +  H  I  F
Sbjct: 102 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADF 147

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.3 bits (109), Expect = 4e-06
 Identities = 17/41 (41%), Positives = 24/41 (58%), Gaps = 1/41 (2%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG 171
           T  Y  P++LLG  +Y+ S+D W  G +L EM+ G   F G
Sbjct: 166 TPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHG 205

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 3e-05
 Identities = 12/35 (34%), Positives = 19/35 (54%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIR 123
           + +I    LG+GS+  VF      TNQ  A+K ++
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALK 36

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.5 bits (185), Expect = 7e-16
 Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 1/99 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           + EA+++++L +  IV +   +    +   V E           + +  +   NI   + 
Sbjct: 56  LAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           Q+  G+ Y      +HRD+  +N+L+    +  I  F  
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 76.4 bits (187), Expect = 7e-16
 Identities = 41/111 (36%), Positives = 61/111 (54%), Gaps = 9/111 (8%)

Query: 270 AIREASLLKELK-HNNIVTLHDIVHTRS--TLTFVFEYV-HTDLSQYMERHSGGLDHHNI 325
             RE  +L+ L+   NI+TL DIV      T   VFE+V +TD  Q  +     L  ++I
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDI 131

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
           R +M+++L+ L YCH   I+HRDVKP N++I   +H  +RL  + L     
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-EHRKLRLIDWGLAEFYH 181

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 57.5 bits (138), Expect = 1e-09
 Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 5/111 (4%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           + +++ P++L+    Y  SLDMW +GC+L  M+     F    + YDQL +I K+LGT  
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251

Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
              +     +  YN+  D  +       +  R       E+      +  D
Sbjct: 252 LYDY-----IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 48.3 bits (114), Expect = 8e-07
 Identities = 13/47 (27%), Positives = 26/47 (55%)

Query: 84  PFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
            +G  D Y  + +LG G Y+ VF+  +   N+ V +K ++  +++ I
Sbjct: 30  EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI 76

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 75.6 bits (185), Expect = 8e-16
 Identities = 18/118 (15%), Positives = 41/118 (34%), Gaps = 4/118 (3%)

Query: 272 REASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
            E    K L     I  ++           V + +   L   ++          + +   
Sbjct: 49  DEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAK 108

Query: 331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHH---NIRLFMFQLLRGLSYCHRRRILH 385
           Q+L  +   H + +++RD+KP N LI   +      I +  F +++       ++ + 
Sbjct: 109 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 50.6 bits (120), Expect = 1e-07
 Identities = 16/72 (22%), Positives = 26/72 (36%), Gaps = 6/72 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILG--- 187
           T  Y   +  LG  E S   D+  +G + +  + G   + G++       K  +I     
Sbjct: 176 TARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQ 233

Query: 188 -TPTEETWEGVS 198
            TP  E   G  
Sbjct: 234 STPLRELCAGFP 245

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 13/38 (34%), Positives = 22/38 (57%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           Y    ++GEGS+  +F+G + L NQ VA+K    + + 
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA 44

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.0 bits (186), Expect = 1e-15
 Identities = 36/104 (34%), Positives = 54/104 (51%), Gaps = 8/104 (7%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  LLK ++H N++ L D+     TL        V  ++ TDL + M+     L   
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGED 121

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
            I+  ++Q+L+GL Y H   I+HRD+KP NL ++E     I  F
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 165

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.9 bits (139), Expect = 9e-10
 Identities = 31/83 (37%), Positives = 45/83 (54%), Gaps = 1/83 (1%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPTEE 192
           WYR P+V+L    Y+ ++D+W VGCI+ EM+TG   F G  +  DQL +I K+ GTP  E
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG-SDHLDQLKEIMKVTGTPPAE 241

Query: 193 TWEGVSLLPGYNVHRDAPYTGNK 215
             + +      N  +  P    K
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKK 264

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 2e-05
 Identities = 10/52 (19%), Positives = 18/52 (34%)

Query: 76  TYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEE 127
                  + +     Y  L  +G G+Y  V       T   VA+K++    +
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 56

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (89), Expect = 0.001
 Identities = 13/37 (35%), Positives = 20/37 (54%)

Query: 441 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVL 477
           A RE  LLK ++H N++ L D+     TL    ++ L
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYL 100

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.5 bits (180), Expect = 3e-15
 Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 6/98 (6%)

Query: 271 IREASLLKELKHNNIVTLHDI----VHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIR 326
             EA +LK L+H NIV  +D     V  +  +  V E + +   +   +    +    +R
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 115

Query: 327 LFMFQLLRGLSYCHRR--RILHRDVKPQNLLISEIDHH 362
            +  Q+L+GL + H R   I+HRD+K  N+ I+     
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS 153

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (115), Expect = 7e-07
 Identities = 9/52 (17%), Positives = 22/52 (42%), Gaps = 2/52 (3%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKI 182
           T  +  P++     +Y  S+D++  G  ++EM T    +   +       ++
Sbjct: 176 TPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 16/47 (34%), Positives = 27/47 (57%), Gaps = 4/47 (8%)

Query: 81  GDSPFGKADAYIKLD-QLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           G S  G+   ++K D ++G GS+ TV+KG    T   VA  E++ ++
Sbjct: 3   GMSNDGR---FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 46

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 73.6 bits (180), Expect = 3e-15
 Identities = 24/108 (22%), Positives = 52/108 (48%), Gaps = 4/108 (3%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH--TDLSQYMERHSGGLDHHNIRLF 328
           ++EA+++KE+KH N+V L  +         + E++     L    E +   +    +   
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLS 376
             Q+   + Y  ++  +HRD+  +N L+ E  +H +++  F L R ++
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGE--NHLVKVADFGLSRLMT 166

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 42.0 bits (98), Expect = 9e-05
 Identities = 10/40 (25%), Positives = 17/40 (42%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
                  +LG G Y  V++G     +  VA+K ++    E
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 56

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 37.8 bits (87), Expect = 0.002
 Identities = 10/35 (28%), Positives = 21/35 (60%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV 476
           ++EA+++KE+KH N+V L  +         + E++
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.3 bits (179), Expect = 7e-15
 Identities = 23/113 (20%), Positives = 47/113 (41%), Gaps = 2/113 (1%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFM 329
            + E+ +L+  +H  +  L     T   L FV EY +     +             R + 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRR 382
            +++  L Y H R +++RD+K +NL++ +    +I++  F L +         
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGATM 162

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (101), Expect = 5e-05
 Identities = 9/37 (24%), Positives = 18/37 (48%)

Query: 89  DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           + +  L  LG+G++  V       T +  A+K +R +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKE 41

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (95), Expect = 2e-04
 Identities = 16/68 (23%), Positives = 32/68 (47%), Gaps = 6/68 (8%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T  Y  P+VL  + +Y  ++D WG+G ++ EM+ G   F          +++F+++    
Sbjct: 168 TPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYN-----QDHERLFELILMEE 221

Query: 191 EETWEGVS 198
                 +S
Sbjct: 222 IRFPRTLS 229

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 6/108 (5%)

Query: 270 AIREASLLKELK--HNNIVTLHDIVHTRSTLTFVFEYVH--TDLSQYMERHSGGLDHHNI 325
              E  LLK++    + ++ L D      +   + E      DL  ++    G L     
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELA 112

Query: 326 RLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
           R F +Q+L  + +CH   +LHRD+K +N+LI   +   ++L  F    
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-NRGELKLIDFGSGA 159

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (111), Expect = 2e-06
 Identities = 13/45 (28%), Positives = 21/45 (46%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV 175
           T  Y PP+ +     +  S  +W +G +L +MV G   F    E+
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.0 bits (98), Expect = 8e-05
 Identities = 10/35 (28%), Positives = 15/35 (42%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQ 125
           Y     LG G + +V+ G     N  VA+K +   
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 40

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.5 bits (177), Expect = 1e-14
 Identities = 28/128 (21%), Positives = 53/128 (41%), Gaps = 19/128 (14%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERH------------ 316
             E  +L +L  H NI+ L      R  L    EY  H +L  ++ +             
Sbjct: 58  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117

Query: 317 ---SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
              +  L    +  F   + RG+ Y  +++ +HRD+  +N+L+ E  ++  ++  F L R
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE--NYVAKIADFGLSR 175

Query: 374 GLSYCHRR 381
           G     ++
Sbjct: 176 GQEVYVKK 183

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 2e-14
 Identities = 16/89 (17%), Positives = 40/89 (44%), Gaps = 1/89 (1%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDL-SQYMERHSGGLDHHNIRLFM 329
           + EA ++ +  H+NI+ L  ++     +  + EY+      +++    G      +   +
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             +  G+ Y      +HRD+  +N+L++ 
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNS 145

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.7 bits (84), Expect = 0.004
 Identities = 8/34 (23%), Positives = 18/34 (52%)

Query: 442 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEY 475
           + EA ++ +  H+NI+ L  ++     +  + EY
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEY 90

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (174), Expect = 2e-14
 Identities = 20/101 (19%), Positives = 47/101 (46%), Gaps = 1/101 (0%)

Query: 270 AIREASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLF 328
              E  +L+ ++    +VTLH    T + L  + +Y++                H ++++
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           + +++  L + H+  I++RD+K +N+L+    H  +  F  
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 175

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.3 bits (114), Expect = 9e-07
 Identities = 19/94 (20%), Positives = 39/94 (41%), Gaps = 1/94 (1%)

Query: 105 VFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT 164
           V      L+ + VA +  R  +  G   +  P  V  G + +  ++D W +G ++ E++T
Sbjct: 168 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227

Query: 165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVS 198
           G   F    E  +   +I + +        + +S
Sbjct: 228 GASPFTVDGEK-NSQAEISRRILKSEPPYPQEMS 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 3/41 (7%)

Query: 89  DAYIKLDQLGEGSYATVFKGY---SNLTNQVVALKEIRLQE 126
           + +  L  LG G+Y  VF       + T ++ A+K ++   
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKAT 64

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.5 bits (174), Expect = 3e-14
 Identities = 30/105 (28%), Positives = 51/105 (48%), Gaps = 6/105 (5%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT-----FVFEYVHTDLSQYMERHSGGLDHHN 324
             RE  LLK +KH N++ L D+     +L      ++  ++       + +    L   +
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDH 122

Query: 325 IRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMF 369
           ++  ++Q+LRGL Y H   I+HRD+KP NL ++E     I  F  
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 167

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 3e-12
 Identities = 29/80 (36%), Positives = 46/80 (57%), Gaps = 1/80 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T WYR P+++L    Y+ ++D+W VGCI+ E++TG   FPG  +  DQL  I +++GTP 
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG-TDHIDQLKLILRLVGTPG 239

Query: 191 EETWEGVSLLPGYNVHRDAP 210
            E  + +S     N  +   
Sbjct: 240 AELLKKISSESARNYIQSLT 259

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.8 bits (110), Expect = 3e-06
 Identities = 12/58 (20%), Positives = 24/58 (41%)

Query: 73  PSHTYSHQGDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGI 130
           P+        + +   + Y  L  +G G+Y +V   +   T   VA+K++    +  I
Sbjct: 2   PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.8 bits (170), Expect = 9e-14
 Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 271 IREASLLKELKHNNIVTLHDI-VHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           + E  ++K+  H N+++L  I + +  +   V  Y+ H DL  ++   +      ++  F
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 358
             Q+ +G+ +   ++ +HRD+  +N ++ E
Sbjct: 136 GLQVAKGMKFLASKKFVHRDLAARNCMLDE 165

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.6 bits (167), Expect = 2e-13
 Identities = 24/104 (23%), Positives = 49/104 (47%), Gaps = 3/104 (2%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMF 330
           ++EA ++K+L+H  +V L+ +V                L  +++  +G        + M 
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 119

Query: 331 -QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLR 373
            Q+  G++Y  R   +HRD++  N+L+ E  +   ++  F L R
Sbjct: 120 AQIASGMAYVERMNYVHRDLRAANILVGE--NLVCKVADFGLAR 161

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (100), Expect = 5e-05
 Identities = 11/64 (17%), Positives = 23/64 (35%), Gaps = 1/64 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
            + +  P+  L    ++   D+W  G +L E+ T            + LD++ +    P 
Sbjct: 177 PIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235

Query: 191 EETW 194
               
Sbjct: 236 PPEC 239

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.3 bits (163), Expect = 9e-13
 Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 9/131 (6%)

Query: 270 AIREASLLKELKHNNIVTLHDIVHTRSTLT------FVFEYVHTDLSQYMERHSGGLDHH 323
           A RE  L+K + H NI++L ++   + TL        V E +  +L Q ++      DH 
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHE 119

Query: 324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRI 383
            +   ++Q+L G+ + H   I+HRD+KP N+++       I  F      G S+     +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 384 LHRDVKPQNLL 394
           + R  +   ++
Sbjct: 180 VTRYYRAPEVI 190

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 54.6 bits (130), Expect = 1e-08
 Identities = 38/111 (34%), Positives = 52/111 (46%), Gaps = 2/111 (1%)

Query: 131 TLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKILGTPT 190
           T +YR P+V+LG   Y  ++D+W VGCI+ EMV     FPG R+  DQ +K+ + LGTP 
Sbjct: 181 TRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPG-RDYIDQWNKVIEQLGTPC 238

Query: 191 EETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRD 241
            E  + +       V     Y G      FP      + E       Q RD
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (115), Expect = 6e-07
 Identities = 15/56 (26%), Positives = 26/56 (46%), Gaps = 1/56 (1%)

Query: 74  SHTYSHQ-GDSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           +  YS + GDS F     Y  L  +G G+   V   Y  + ++ VA+K++    + 
Sbjct: 1   NQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN 56

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 66.0 bits (160), Expect = 2e-12
 Identities = 26/128 (20%), Positives = 49/128 (38%), Gaps = 17/128 (13%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
            REA+L+ E  + NIV L  +      +  +FEY+ + DL++++   S            
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS------------ 111

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
                          L    +  +     +          Q+  G++Y   R+ +HRD+ 
Sbjct: 112 ----PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167

Query: 390 PQNLLISE 397
            +N L+ E
Sbjct: 168 TRNCLVGE 175

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.9 bits (87), Expect = 0.002
 Identities = 15/71 (21%), Positives = 28/71 (39%), Gaps = 6/71 (8%)

Query: 129 GITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPTFPGVREVYDQLDKIFKILG 187
            I + + PP+ +     Y+T  D+W  G +L E+ + GL  + G        + I+ +  
Sbjct: 203 AIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG----MAHEEVIYYVRD 257

Query: 188 TPTEETWEGVS 198
                  E   
Sbjct: 258 GNILACPENCP 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.9 bits (157), Expect = 3e-12
 Identities = 26/151 (17%), Positives = 56/151 (37%), Gaps = 26/151 (17%)

Query: 271 IREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLF 328
           I E  ++K + KH NI+ L         L  + EY    +L +Y++              
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQ-------------- 111

Query: 329 MFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDV 388
                       R   L     P +    ++   ++    +Q+ RG+ Y   ++ +HRD+
Sbjct: 112 ----------ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161

Query: 389 KPQNLLISEIVFTNLSGVVVSTVDSGSGGWW 419
             +N+L++E     ++   ++        + 
Sbjct: 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 61.0 bits (147), Expect = 2e-11
 Identities = 26/142 (18%), Positives = 49/142 (34%), Gaps = 14/142 (9%)

Query: 248 MEHVHNCEKEGGNGPKNGAPFTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHT 307
            + V      G       A  +A  E   L++L+   +  ++           + E +  
Sbjct: 39  FKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDA 94

Query: 308 DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLF 367
                +          N    +  +L  ++  + R I+H D+   N+L+SE     I + 
Sbjct: 95  KELYRV-------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWII 144

Query: 368 MFQLLRGLSYCHRRRILHRDVK 389
            F     +     R IL RDV+
Sbjct: 145 DFPQSVEVGEEGWREILERDVR 166

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 44.0 bits (103), Expect = 9e-06
 Identities = 10/37 (27%), Positives = 19/37 (51%)

Query: 361 HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
             N    +  +L  ++  + R I+H D+   N+L+SE
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE 138

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.6 bits (151), Expect = 2e-11
 Identities = 25/122 (20%), Positives = 49/122 (40%), Gaps = 19/122 (15%)

Query: 272 REASLLKELKHNNIVTLHDIV-HTRSTLTFVFEYV-HTDLSQYMERH------------- 316
               L+    H N+V L          L  + E+    +LS Y+                
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 317 --SGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRG 374
                L   ++  + FQ+ +G+ +   R+ +HRD+  +N+L+SE   + +++  F L R 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE--KNVVKICDFGLARD 183

Query: 375 LS 376
           + 
Sbjct: 184 IY 185

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.6 bits (151), Expect = 2e-11
 Identities = 23/104 (22%), Positives = 41/104 (39%), Gaps = 15/104 (14%)

Query: 268 FTAIREASLLKELKHNNIVTLHDIVH----TRSTLTFVFEYV-HTDLSQYMERHSGGLDH 322
           +    E      L+H NI+      +    T + L  V +Y  H  L  Y+ R+   +  
Sbjct: 42  WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTV 99

Query: 323 HNIRLFMFQLLRGLSYCH--------RRRILHRDVKPQNLLISE 358
             +         GL++ H        +  I HRD+K +N+L+ +
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK 143

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 8e-05
 Identities = 10/41 (24%), Positives = 20/41 (48%), Gaps = 2/41 (4%)

Query: 88  ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEE 128
           A   +  + +G+G +  V++G      + VA+K    +EE 
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREER 40

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 6e-04
 Identities = 15/78 (19%), Positives = 24/78 (30%), Gaps = 7/78 (8%)

Query: 131 TLWYRPPDVLLGS-----TEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLDKIFKI 185
           T  Y  P+VL  S      E     D++ +G +  E+           +   QL     +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--YQLPYYDLV 232

Query: 186 LGTPTEETWEGVSLLPGY 203
              P+ E    V      
Sbjct: 233 PSDPSVEEMRKVVCEQKL 250

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.2 bits (137), Expect = 1e-09
 Identities = 19/128 (14%), Positives = 47/128 (36%), Gaps = 31/128 (24%)

Query: 271 IREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYV-HTDLSQYMERHSGGLDHHNIRLFM 329
           + EAS++KE   +++V L  +V        + E +   DL  Y+      + ++ +    
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL--- 127

Query: 330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVK 389
                                      +      +     ++  G++Y +  + +HRD+ 
Sbjct: 128 ---------------------------APPSLSKMIQMAGEIADGMAYLNANKFVHRDLA 160

Query: 390 PQNLLISE 397
            +N +++E
Sbjct: 161 ARNCMVAE 168

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 29/150 (19%), Positives = 53/150 (35%), Gaps = 21/150 (14%)

Query: 269 TAIREASLLKELKHNNIVTLHDIVHTR-STLTFVFEYVHTD---------------LSQY 312
            A  E  LL+ +   +      +       L   F +   +               L+  
Sbjct: 55  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALI 114

Query: 313 MERHSGGLDHHNIRLFMFQLLRGLSYCHRRR-ILHRDVKPQNLLISEIDHH----NIRLF 367
            +    G+    ++    QLL GL Y HRR  I+H D+KP+N+L+  +D       I++ 
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIA 174

Query: 368 MFQLLRGLSYCHRRRILHRDVKPQNLLISE 397
                      +   I  R+ +   +L+  
Sbjct: 175 DLGNACWYDEHYTNSIQTREYRSPEVLLGA 204

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 50.8 bits (120), Expect = 2e-07
 Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 11/109 (10%)

Query: 133 WYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG-----VREVYDQLDKIFKILG 187
            YR P+VLLG+  +    D+W   C++ E++TG   F         +  D + +I ++LG
Sbjct: 194 EYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 188 TPTEETWEGVSLLPGYNVHRDAPYTGNKLGL-----TFPRLYDIPEGES 231
                          +   R      +KL            Y   + E+
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 12/36 (33%), Positives = 21/36 (58%)

Query: 91  YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQE 126
           YI + +LG G ++TV+     + N  VA+K +R  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK 50

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	481
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.97
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.96
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.95
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.95
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.94
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.94
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.94
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.94
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	99.94
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.93
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.93
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.93
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.93
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.93
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	99.93
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	99.93
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.93
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	99.93
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	99.92
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.92
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.92
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	99.92
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	99.92
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.92
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.92
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.92
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.92
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.92
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.92
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.92
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.92
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.92
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.92
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.92
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.91
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.91
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.91
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.91
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.91
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.91
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.91
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.91
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.91
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.91
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.9
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.9
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.9
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.9
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.9
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.9
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.89
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.89
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.89
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.89
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.89
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.89
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.89
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.89
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.88
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.88
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.87
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.87
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.87
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.87
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.87
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.87
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.86
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.86
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.84
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.82
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.82
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.64
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	95.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	89.03

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-35  Score=286.33  Aligned_cols=147  Identities=21%  Similarity=0.303  Sum_probs=122.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|+.++|||||+++++|.+++.+|||||||+ |+|.+++..  +.+++..++.++.|++.||+|||++||+||
T Consensus        63 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHr  140 (293)
T d1yhwa1          63 LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHR  140 (293)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence            46789999999999999999999999999999999999 567665543  569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.....                                         .....+
T Consensus       141 DiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~-----------------------------------------~~~~~~  177 (293)
T d1yhwa1         141 DIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-----------------------------------------KRSTMV  177 (293)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECCSTTC-----------------------------------------CBCCCC
T ss_pred             CCcHHHeEECCCCc--Eeeccchhheeeccccc-----------------------------------------cccccc
Confidence            99999999998877  99999999875431100                                         001134


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +.++|+||+|+++|+|++|..||..
T Consensus       178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~  218 (293)
T d1yhwa1         178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN  218 (293)
T ss_dssp             SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence            56666666        5678999999999999999977643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-35  Score=287.66  Aligned_cols=150  Identities=25%  Similarity=0.397  Sum_probs=125.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.+++.+|||||||+ |+|.+++.. .+.+++..++.++.|++.||+|||++||+||
T Consensus        49 ~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHr  127 (271)
T d1nvra_          49 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHR  127 (271)
T ss_dssp             CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            35689999999999999999999999999999999998 578877754 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.......                                       .....+
T Consensus       128 DiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~---------------------------------------~~~~~~  166 (271)
T d1nvra_         128 DIKPENLLLDERDN--LKISDFGLATVFRYNNRER---------------------------------------LLNKMC  166 (271)
T ss_dssp             CCCGGGEEECTTCC--EEECCCTTCEECEETTEEC---------------------------------------CBCCCC
T ss_pred             cccHHHEEECCCCC--EEEccchhheeeccCCccc---------------------------------------ccccee
Confidence            99999999998877  9999999997654221100                                       011256


Q ss_pred             ceeccCCC---------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|+||         +.++|+||+|+++++|++|..|+..
T Consensus       167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~  208 (271)
T d1nvra_         167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  208 (271)
T ss_dssp             SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence            78888887         2346999999999999999976643

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=280.87  Aligned_cols=146  Identities=23%  Similarity=0.417  Sum_probs=124.8

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+++|+.++|||||++++++.+++.+|+|||||+ |+|.+.+.. .+.+++..++.++.|++.||+|||+++|+|
T Consensus        51 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivH  129 (263)
T d2j4za1          51 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIH  129 (263)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            346789999999999999999999999999999999999 678777765 457999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||+|+......                                           ....
T Consensus       130 rDiKp~Nill~~~~~--~kl~DFG~a~~~~~~~-------------------------------------------~~~~  164 (263)
T d2j4za1         130 RDIKPENLLLGSAGE--LKIADFGWSVHAPSSR-------------------------------------------RTTL  164 (263)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCCSCSCCCCCC-------------------------------------------CEET
T ss_pred             eeeccccceecCCCC--EeecccceeeecCCCc-------------------------------------------cccc
Confidence            999999999998877  9999999886432110                                           0113


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +||+.|++|        +.++|+||+|+++++|++|..||.
T Consensus       165 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  205 (263)
T d2j4za1         165 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE  205 (263)
T ss_dssp             TEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCC
Confidence            477777777        678899999999999999997764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-35  Score=290.45  Aligned_cols=154  Identities=20%  Similarity=0.271  Sum_probs=124.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC-ceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR-RILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~-~iiH  346 (481)
                      .+.||+.+|++++|||||+++++|.+++.+|||||||+ |+|.+++.+ .+.+++..++.++.|++.||.|||++ +|+|
T Consensus        50 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiH  128 (322)
T d1s9ja_          50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMH  128 (322)
T ss_dssp             HHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            46789999999999999999999999999999999999 578777765 45799999999999999999999974 8999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc-cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH-RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~-~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||||+|||+++++.  +|++|||+|+.+.... ...+.++.|.|||++.+..                           
T Consensus       129 RDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~---------------------------  179 (322)
T d1s9ja_         129 RDVKPSNILVNSRGE--IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH---------------------------  179 (322)
T ss_dssp             SCCSGGGEEECTTCC--EEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSC---------------------------
T ss_pred             cccCHHHeeECCCCC--EEEeeCCCccccCCCccccccCCccccCchHHcCCC---------------------------
Confidence            999999999998887  9999999998654221 1223344444444332110                           


Q ss_pred             ccceeccCCCCCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         426 INLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       426 ~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                               -+.++|+||+|++++||.+|..||...
T Consensus       180 ---------y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         180 ---------YSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             ---------CCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             ---------CCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                     056789999999999999999887654

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-35  Score=287.87  Aligned_cols=184  Identities=18%  Similarity=0.146  Sum_probs=144.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.+++.+|+|||||+ |+|.+++....+.+++..++.++.|++.||.|||+++|+||
T Consensus        55 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHr  134 (288)
T d2jfla1          55 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR  134 (288)
T ss_dssp             GTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEe
Confidence            35689999999999999999999999999999999998 57777777666679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccc---------cccccccCCCeeEEEeecCC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLI---------SEIVFTNLSGVVVSTVDSGS  415 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~---------~~~~~~~s~g~~~~~~~~g~  415 (481)
                      ||||+|||++.++.  +|++|||+|+.+...   ......+..|.|||++.         +...|.||.||++++|.+|.
T Consensus       135 DiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~  212 (288)
T d2jfla1         135 DLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE  212 (288)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSS
T ss_pred             ecChhheeECCCCC--EEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCC
Confidence            99999999998887  999999998755422   22345677899999884         34567899999999999999


Q ss_pred             CCccccccCccc-----ceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         416 GGWWFESKSNIN-----LSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       416 ~~~~~~~~~~~~-----~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      .||...+...+.     +.+... +..+.-.-.+..++..|+..+
T Consensus       213 ~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~d  256 (288)
T d2jfla1         213 PPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKN  256 (288)
T ss_dssp             CTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSS
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHHHHHHHHHccCC
Confidence            999865432211     111111 111111234567777777765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5e-35  Score=288.26  Aligned_cols=145  Identities=23%  Similarity=0.308  Sum_probs=121.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+|++|+|||||++++++.+++.+|+|||||.|+....+....+.+++..++.++.||+.||.|||++||+|||
T Consensus        61 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrD  140 (309)
T d1u5ra_          61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD  140 (309)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred             HHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccC
Confidence            46689999999999999999999999999999999999776666656667899999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||+++++.  +|++|||+|+...... .                                            .+|
T Consensus       141 iKp~NILl~~~~~--~Kl~DFG~a~~~~~~~-~--------------------------------------------~~G  173 (309)
T d1u5ra_         141 VKAGNILLSEPGL--VKLGDFGSASIMAPAN-S--------------------------------------------FVG  173 (309)
T ss_dssp             CSGGGEEEETTTE--EEECCCTTCBSSSSBC-C--------------------------------------------CCS
T ss_pred             CCcceEEECCCCC--EEEeecccccccCCCC-c--------------------------------------------ccc
Confidence            9999999998877  9999999986443211 1                                            234


Q ss_pred             eeccCCC-----------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP-----------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p-----------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|+||           +.++|+||+|++++||.+|..|+..
T Consensus       174 T~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~  216 (309)
T d1u5ra_         174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (309)
T ss_dssp             CGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence            4555554           3357999999999999999977654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-35  Score=283.58  Aligned_cols=150  Identities=23%  Similarity=0.352  Sum_probs=124.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||+++++|.+++.+|+|||||+ |+|.+++.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        54 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHr  132 (288)
T d1uu3a_          54 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHR  132 (288)
T ss_dssp             HHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcC
Confidence            46789999999999999999999999999999999999 578777665 4679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.......                                       .....+
T Consensus       133 DiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~---------------------------------------~~~~~~  171 (288)
T d1uu3a_         133 DLKPENILLNEDMH--IQITDFGTAKVLSPESKQA---------------------------------------RANSFV  171 (288)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECC-------------------------------------------------CC
T ss_pred             cCCccccccCCCce--EEecccccceecccCCccc---------------------------------------cccccc
Confidence            99999999998887  9999999997654211100                                       011245


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|+||        +..+|+||+|+++|+|++|..||..
T Consensus       172 GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (288)
T d1uu3a_         172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA  212 (288)
T ss_dssp             CCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence            67777777        5567999999999999999977654

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-34  Score=286.02  Aligned_cols=150  Identities=21%  Similarity=0.322  Sum_probs=125.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|+.++|||||+++++|++++.+|+|||||+ |+|..++.. .+.+++..++.++.|++.||+|||+++|+||
T Consensus        51 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHR  129 (337)
T d1o6la_          51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR  129 (337)
T ss_dssp             HHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCcccc
Confidence            46789999999999999999999999999999999999 567776655 4679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.....                                         .....+
T Consensus       130 DlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~-----------------------------------------~~~~~~  166 (337)
T d1o6la_         130 DIKLENLMLDKDGH--IKITDFGLCKEGISDGA-----------------------------------------TMKTFC  166 (337)
T ss_dssp             CCCGGGEEECTTSC--EEECCCTTCBCSCCTTC-----------------------------------------CBCCCE
T ss_pred             ccCHHHeEecCCCC--EEEeecccccccccCCc-----------------------------------------ccccce
Confidence            99999999998887  99999999874331110                                         011245


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ||+.|++|        +..+|+||+|+++|||++|..||....
T Consensus       167 GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             ECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence            66666666        677899999999999999997776543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=7.7e-34  Score=280.60  Aligned_cols=146  Identities=16%  Similarity=0.267  Sum_probs=121.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      .+.+|+.+|+.++|||||++++++.+++.+|+|||||.|+....+......+++..++.++.|++.||+|||+++|+|||
T Consensus        50 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrD  129 (316)
T d1fota_          50 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRD  129 (316)
T ss_dssp             HHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             HHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccc
Confidence            46789999999999999999999999999999999999654444444556789999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++.  +|++|||+|+.+......                                            .+|
T Consensus       130 iKp~NILl~~~g~--vkL~DFG~a~~~~~~~~~--------------------------------------------~~G  163 (316)
T d1fota_         130 LKPENILLDKNGH--IKITDFGFAKYVPDVTYT--------------------------------------------LCG  163 (316)
T ss_dssp             CCGGGEEECTTSC--EEECCCSSCEECSSCBCC--------------------------------------------CCS
T ss_pred             cCchheeEcCCCC--EEEecCccceEecccccc--------------------------------------------ccC
Confidence            9999999998887  999999998755422222                                            345


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      |+.|++|        +.++|+||+|+++|+|++|..||..
T Consensus       164 t~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~  203 (316)
T d1fota_         164 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD  203 (316)
T ss_dssp             CTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             cccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence            5555555        5677999999999999999877654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=4.1e-34  Score=286.41  Aligned_cols=150  Identities=19%  Similarity=0.272  Sum_probs=124.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||+++++|.+++.+|||||||+ |+|.+.+....+.+++..++.++.||+.||.|||++||+||
T Consensus        69 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHr  148 (350)
T d1koaa2          69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL  148 (350)
T ss_dssp             HHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeee
Confidence            35689999999999999999999999999999999998 68888886666679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.+....+|++|||+|+.+......                                          ...+
T Consensus       149 DiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~------------------------------------------~~~~  186 (350)
T d1koaa2         149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV------------------------------------------KVTT  186 (350)
T ss_dssp             CCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE------------------------------------------EEEC
T ss_pred             eechhHeeeccCCCCeEEEeecchheeccccccc------------------------------------------ceec
Confidence            9999999997544445999999998755422110                                          0123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|+++++|++|..||..
T Consensus       187 gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             SCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence            55566666        4567999999999999999977643

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=4.7e-34  Score=286.17  Aligned_cols=150  Identities=19%  Similarity=0.269  Sum_probs=122.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||+++++|.+++.+|||||||+ |+|.+.+......+++..++.++.||+.||.|||++||+||
T Consensus        72 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHR  151 (352)
T d1koba_          72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL  151 (352)
T ss_dssp             HHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence            35689999999999999999999999999999999999 67878776666679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++......+|++|||+|+.+......                                          ....
T Consensus       152 DiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~------------------------------------------~~~~  189 (352)
T d1koba_         152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIV------------------------------------------KVTT  189 (352)
T ss_dssp             CCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE------------------------------------------EEEC
T ss_pred             ccccccccccccCCCeEEEeecccceecCCCCce------------------------------------------eecc
Confidence            9999999998544445999999999765421110                                          0122


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +.++|+||+|+++|+|++|..||..
T Consensus       190 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             SSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred             CcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence            34444444        4567999999999999999876643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.4e-34  Score=280.99  Aligned_cols=150  Identities=21%  Similarity=0.324  Sum_probs=123.5

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++|+.++|||||+++++|++++.+|||||||+ |+|.+.+......+++..++.++.||+.||+|||++||+|||
T Consensus        48 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrD  127 (321)
T d1tkia_          48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFD  127 (321)
T ss_dssp             HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCccc
Confidence            4579999999999999999999999999999999999 589888876555799999999999999999999999999999


Q ss_pred             CCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcccc
Q psy3074         349 VKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINL  428 (481)
Q Consensus       349 lKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~  428 (481)
                      |||+|||++.++...+|++|||+++........                                          ....+
T Consensus       128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~------------------------------------------~~~~~  165 (321)
T d1tkia_         128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF------------------------------------------RLLFT  165 (321)
T ss_dssp             CCGGGEEESSSSCCCEEECCCTTCEECCTTCEE------------------------------------------EEEES
T ss_pred             ccccceeecCCCceEEEEcccchhhccccCCcc------------------------------------------ccccc
Confidence            999999998776667999999988754311100                                          01224


Q ss_pred             eeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         429 SFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       429 t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |+.|++|        +.++|+||+|+++|+|++|..||..+
T Consensus       166 t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~  206 (321)
T d1tkia_         166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE  206 (321)
T ss_dssp             CGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence            4445554        55679999999999999998776543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-34  Score=278.53  Aligned_cols=182  Identities=25%  Similarity=0.287  Sum_probs=133.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec--CCeEEEEEeccC-CCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT--RSTLTFVFEYVH-TDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~--~~~~~iv~E~~~-g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+++|++++|||||++++++.+  .+.+|||||||+ |+|.+++..   ....+++..++.++.|++.||.|||++
T Consensus        49 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~  128 (269)
T d2java1          49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR  128 (269)
T ss_dssp             HHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            35689999999999999999999865  457999999998 688888754   235699999999999999999999987


Q ss_pred             c-----eeeccCCCccccccccchhhHHHHHHHHHhhcccc---ccCceeccccCCCcccc----cccccccCCCeeEEE
Q psy3074         343 R-----ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYC---HRRRILHRDVKPQNLLI----SEIVFTNLSGVVVST  410 (481)
Q Consensus       343 ~-----iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~---~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~  410 (481)
                      +     |+||||||+|||++.++.  +|++|||+|+.+...   ......+..|.|||++.    +...|.||.|+++++
T Consensus       129 ~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilye  206 (269)
T d2java1         129 SDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE  206 (269)
T ss_dssp             CC---------CCGGGEEECTTSC--EEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHH
Confidence            6     999999999999998877  999999999977532   22345677899999884    445567999999999


Q ss_pred             eecCCCCccccccCcc-----cceeccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         411 VDSGSGGWWFESKSNI-----NLSFHYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       411 ~~~g~~~~~~~~~~~~-----~~t~~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      |++|..||...+...+     .+.+.-++...+   ..+..++..|+..+
T Consensus       207 l~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s---~~l~~li~~~L~~d  253 (269)
T d2java1         207 LCALMPPFTAFSQKELAGKIREGKFRRIPYRYS---DELNEIITRMLNLK  253 (269)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSC---HHHHHHHHHHTCSS
T ss_pred             HhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccC---HHHHHHHHHHcCCC
Confidence            9999999986543221     122222222222   34567778887776

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.5e-33  Score=277.44  Aligned_cols=149  Identities=23%  Similarity=0.309  Sum_probs=113.8

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+.+|+.++|||||++++++.+++.+|||||||+ |+|.+++.. .+.+++..+..++.|++.||+|||+++|+|||
T Consensus        54 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrD  132 (307)
T d1a06a_          54 MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRD  132 (307)
T ss_dssp             -CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEE
Confidence            4479999999999999999999999999999999998 688888765 46799999999999999999999999999999


Q ss_pred             CCCcccccccc-chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         349 VKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       349 lKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      |||+|||+... ....+|++|||+|+.......                                          ....+
T Consensus       133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~------------------------------------------~~~~~  170 (307)
T d1a06a_         133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV------------------------------------------LSTAC  170 (307)
T ss_dssp             CCGGGEEESSSSTTCCEEECCC----------------------------------------------------------
T ss_pred             ecccceeecccCCCceEEEeccceeEEccCCCe------------------------------------------eeeee
Confidence            99999999642 223499999999975431110                                          01133


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|+||        +.++|+||+|+++|+|.+|..||...
T Consensus       171 GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         171 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             --CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence            55555555        56789999999999999999776543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.2e-33  Score=273.31  Aligned_cols=151  Identities=25%  Similarity=0.412  Sum_probs=124.2

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      +.+.+|+++|++++|||||+++++|.+++.+|||||||+ |+|.+++... +.+++..++.++.|++.||.|||+++|+|
T Consensus        58 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivH  136 (293)
T d1jksa_          58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAH  136 (293)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceee
Confidence            456789999999999999999999999999999999999 6788877654 57999999999999999999999999999


Q ss_pred             ccCCCccccccccch--hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         347 RDVKPQNLLISEIDH--HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       347 rDlKp~NiLl~~~~~--~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      |||||+|||++.++.  ..+|++|||+|+.+......                                          .
T Consensus       137 rDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~------------------------------------------~  174 (293)
T d1jksa_         137 FDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF------------------------------------------K  174 (293)
T ss_dssp             CCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBC------------------------------------------S
T ss_pred             cccccceEEEecCCCcccceEecchhhhhhcCCCccc------------------------------------------c
Confidence            999999999987653  24899999988754422110                                          1


Q ss_pred             cccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ...||+.|+||        +.++|+||+|+++++|++|..||..+
T Consensus       175 ~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  219 (293)
T d1jksa_         175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD  219 (293)
T ss_dssp             CCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC
Confidence            12345555555        66789999999999999999776543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3e-33  Score=272.73  Aligned_cols=153  Identities=18%  Similarity=0.313  Sum_probs=124.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+++|++++|||||++++++.+++.+|||||||+ |++..++... ...+++..+..++.|++.||+|||+++|+|
T Consensus        59 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH  138 (287)
T d1opja_          59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH  138 (287)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            46789999999999999999999999999999999999 6788887653 346899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||+|+.+......                                        .....
T Consensus       139 rDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~----------------------------------------~~~~~  176 (287)
T d1opja_         139 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT----------------------------------------AHAGA  176 (287)
T ss_dssp             SCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE----------------------------------------EETTE
T ss_pred             CccccCeEEECCCCc--EEEccccceeecCCCCce----------------------------------------eeccc
Confidence            999999999998877  999999998754311000                                        00012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                      .||+.|++|        +.++|+||+|++++||.++..|++.+..
T Consensus       177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~  221 (287)
T d1opja_         177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID  221 (287)
T ss_dssp             EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch
Confidence            345556665        5568999999999999997777776554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-33  Score=269.88  Aligned_cols=146  Identities=22%  Similarity=0.324  Sum_probs=118.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++|++++|||||++++++.+    +..+|+|||||+ |+|.+++... +.+++..++.++.|++.||+|||+++
T Consensus        54 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~  132 (270)
T d1t4ha_          54 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT  132 (270)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            45689999999999999999999875    456899999998 5787777653 57999999999999999999999998


Q ss_pred             --eeeccCCCccccccc-cchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         344 --ILHRDVKPQNLLISE-IDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       344 --iiHrDlKp~NiLl~~-~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                        |+||||||+|||+++ ++.  +|++|||+|+.......                                        
T Consensus       133 ~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~~~~~----------------------------------------  170 (270)
T d1t4ha_         133 PPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRASFA----------------------------------------  170 (270)
T ss_dssp             SCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTTSB----------------------------------------
T ss_pred             CCEEeCCcChhhceeeCCCCC--EEEeecCcceeccCCcc----------------------------------------
Confidence              999999999999964 555  99999999974321110                                        


Q ss_pred             cccCcccceeccCCC-------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPP-------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p-------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                         ...+||+.|++|       +.++|+||+|+++++|.+|..||..
T Consensus       171 ---~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         171 ---KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             ---EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ---CCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence               012345555555       6678999999999999999977643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.5e-33  Score=279.68  Aligned_cols=153  Identities=19%  Similarity=0.265  Sum_probs=121.5

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|+.++|||||++++++.+...+++||||+. |++...+.. .+.+++..++.++.||+.||.|||+++|+||
T Consensus        87 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHR  165 (350)
T d1rdqe_          87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYR  165 (350)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            46789999999999999999999999999999999998 567777655 4579999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +||+|||+|+.+.........+..|.|||++.+..+                            
T Consensus       166 DIKP~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~----------------------------  215 (350)
T d1rdqe_         166 DLKPENLLIDQQGY--IQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGY----------------------------  215 (350)
T ss_dssp             CCSGGGEEECTTSC--EEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCB----------------------------
T ss_pred             cCCHHHcccCCCCC--EEeeeceeeeecccccccccCccccCCHHHHcCCCC----------------------------
Confidence            99999999998877  999999999765433222233333333333321100                            


Q ss_pred             ceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                              +..+|+||+|+++|+|++|..||..
T Consensus       216 --------~~~~DiwSlGvilyemltG~~Pf~~  240 (350)
T d1rdqe_         216 --------NKAVDWWALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             --------CTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             --------CccccccchhHHHHHHHhCCCCCCC
Confidence                    4556888888888888888866644

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.5e-33  Score=270.91  Aligned_cols=149  Identities=39%  Similarity=0.639  Sum_probs=123.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+++|++++|||||+++++|.+++.+|+|||||.|++...+... .+.+++..++.++.|++.||+|||+++|+|
T Consensus        46 ~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiH  125 (298)
T d1gz8a_          46 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH  125 (298)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEc
Confidence            3567899999999999999999999999999999999998877776543 456999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+|+.........                                         ...
T Consensus       126 rDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~-----------------------------------------~~~  162 (298)
T d1gz8a_         126 RDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY-----------------------------------------THE  162 (298)
T ss_dssp             SCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT-----------------------------------------TCC
T ss_pred             cccCchheeecccCc--ceeccCCcceeccCCcccc-----------------------------------------eee
Confidence            999999999988776  8999999998654211100                                         012


Q ss_pred             cceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      +||+.|++|         +.++|+||+|+++++|.+|..||.
T Consensus       163 ~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~  204 (298)
T d1gz8a_         163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP  204 (298)
T ss_dssp             BCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence            234444444         556899999999999999997764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.4e-33  Score=272.35  Aligned_cols=154  Identities=32%  Similarity=0.497  Sum_probs=122.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+.+|+.+|++++|||||++++++.+++.+|||||||.|++...+......+++..++.++.||+.||+|||+++|+||
T Consensus        45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHr  124 (299)
T d1ua2a_          45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHR  124 (299)
T ss_dssp             THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecc
Confidence            35778999999999999999999999999999999999988877777666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccc---cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH---RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~---~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||+++++.  +|++|||+|+.+....   ...+.+..|.|||++.....+                        
T Consensus       125 DiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~------------------------  178 (299)
T d1ua2a_         125 DLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY------------------------  178 (299)
T ss_dssp             CCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCC------------------------
T ss_pred             cCCcceEEecCCCc--cccccCccccccCCCcccccceecChhhccHHHHccCCCC------------------------
Confidence            99999999998877  9999999997654221   122334445555444321100                        


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                                 +..+|+||+|++++||.+|..||
T Consensus       179 -----------~~~~DiwSlGvil~el~~g~~pf  201 (299)
T d1ua2a_         179 -----------GVGVDMWAVGCILAELLLRVPFL  201 (299)
T ss_dssp             -----------CHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -----------ChhhhhhhcchHHHHHHhCcCCC
Confidence                       33457788888888888776544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7e-33  Score=268.56  Aligned_cols=150  Identities=18%  Similarity=0.223  Sum_probs=120.3

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|++++|||||++++++.. +.+++|||||+ |+|.+++......+++..+..++.|++.||+|||+++|+|
T Consensus        49 ~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivH  127 (276)
T d1uwha_          49 QAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIH  127 (276)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEec
Confidence            356789999999999999999998754 56899999999 7899988776677999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+|+.+........                                       ....
T Consensus       128 rDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~~---------------------------------------~~~~  166 (276)
T d1uwha_         128 RDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQ---------------------------------------FEQL  166 (276)
T ss_dssp             SCCCGGGEEEETTSS--EEECCCCCSCC---------------------------------------------------C
T ss_pred             cccCHHHEEEcCCCC--EEEccccceeeccccCCccc---------------------------------------cccc
Confidence            999999999998877  99999999875432111000                                       0123


Q ss_pred             cceeccCCC-----------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         427 NLSFHYLPP-----------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       427 ~~t~~y~~p-----------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .||+.|+||           +..+|+||+|++++||.+|..|+.
T Consensus       167 ~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~  210 (276)
T d1uwha_         167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS  210 (276)
T ss_dssp             CCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             ccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC
Confidence            466666666           234699999999999999997654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=2.5e-32  Score=267.65  Aligned_cols=154  Identities=16%  Similarity=0.258  Sum_probs=117.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.+++.+|+|||||+ |+|.+++....+.+++..+..++.||+.||.|||+++|+||
T Consensus        73 ~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHr  152 (299)
T d1jpaa_          73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHR  152 (299)
T ss_dssp             HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccC
Confidence            46789999999999999999999999999999999999 57877777766779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.........                                    .+.....
T Consensus       153 DlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~------------------------------------~~~~~~~  194 (299)
T d1jpaa_         153 DLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTY------------------------------------TSALGGK  194 (299)
T ss_dssp             CCCGGGEEECTTCC--EEECCC----------------------------------------------------------
T ss_pred             ccccceEEECCCCc--EEECCcccceEccCCCCccee------------------------------------eeccccc
Confidence            99999999998877  999999999865422110000                                    0001123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~  460 (481)
                      +|+.|++|        +..+|+||+|++++||.. |..|+..
T Consensus       195 ~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             -CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             CCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence            56667776        445799999999999996 7766543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=8.8e-33  Score=267.94  Aligned_cols=185  Identities=22%  Similarity=0.321  Sum_probs=149.4

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|++++ |||||++++++.+++.+|||||||+ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+|
T Consensus        55 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivH  133 (277)
T d1phka_          55 ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVH  133 (277)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            4678999999997 9999999999999999999999998 688888865 467999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCccccc----------ccccccCCCeeEEEeecC
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLIS----------EIVFTNLSGVVVSTVDSG  414 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~----------~~~~~~s~g~~~~~~~~g  414 (481)
                      |||||+|||++.++.  +|++|||+|+.+....  ...+.+..+.+|+++.+          ...|.||.|+++++|++|
T Consensus       134 rDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g  211 (277)
T d1phka_         134 RDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG  211 (277)
T ss_dssp             SCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             cccccceEEEcCCCC--eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC
Confidence            999999999998887  9999999998765322  23345667888888753          346789999999999999


Q ss_pred             CCCccccccCc-----ccceeccCCCCCChhhhhhHHHHHHhhCCCc
Q psy3074         415 SGGWWFESKSN-----INLSFHYLPPGAPFTAIREASLLKELKHNNI  456 (481)
Q Consensus       415 ~~~~~~~~~~~-----~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~  456 (481)
                      ..||...+...     ..+.+.+..|..+.-.-.+..++..|+..++
T Consensus       212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p  258 (277)
T d1phka_         212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP  258 (277)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSG
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCCh
Confidence            99998664221     2233444443333333466778888888873

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-32  Score=261.97  Aligned_cols=151  Identities=19%  Similarity=0.329  Sum_probs=117.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|++++++++|||||++++++.+++..|+|||||+ |+|.+++......+++..+..++.|++.||.|||+++|+||
T Consensus        46 ~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr  125 (263)
T d1sm2a_          46 DFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR  125 (263)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred             HHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeec
Confidence            46789999999999999999999999999999999998 77888887766778999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.......                                        .....
T Consensus       126 DlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~----------------------------------------~~~~~  163 (263)
T d1sm2a_         126 DLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTS----------------------------------------STGTK  163 (263)
T ss_dssp             TCSGGGEEECGGGC--EEECSCC---------------------------------------------------------
T ss_pred             ccchhheeecCCCC--eEecccchheeccCCCcee----------------------------------------eccee
Confidence            99999999998877  9999999997554211000                                        00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ||+.|++|        +..+|+||+|++++||.++..|++..
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~  205 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN  205 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence            45555555        44579999999999999854465544

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=2.2e-32  Score=275.25  Aligned_cols=144  Identities=22%  Similarity=0.329  Sum_probs=120.2

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccCC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDVK  350 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDlK  350 (481)
                      +|+++++.++|||||+++++|.+++.+|+|||||+ |+|.+++... ..+++..++.++.||+.||.|||+++|+|||||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK  134 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  134 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence            46788888899999999999999999999999999 6788877654 578999999999999999999999999999999


Q ss_pred             CccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccccee
Q psy3074         351 PQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNINLSF  430 (481)
Q Consensus       351 p~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~~t~  430 (481)
                      |+|||++.++.  +|++|||+|+.+.....                                           ...+||+
T Consensus       135 P~NILl~~~g~--iKl~DFGla~~~~~~~~-------------------------------------------~~~~GT~  169 (364)
T d1omwa3         135 PANILLDEHGH--VRISDLGLACDFSKKKP-------------------------------------------HASVGTH  169 (364)
T ss_dssp             GGGEEECSSSC--EEECCCTTCEECSSSCC-------------------------------------------CSCCSCG
T ss_pred             cceeEEcCCCc--EEEeeeceeeecCCCcc-------------------------------------------ccccccc
Confidence            99999998887  99999999875432110                                           0123555


Q ss_pred             ccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         431 HYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       431 ~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      .|+||         +.++|+||+|+++|+|++|..||...
T Consensus       170 ~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             GGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             ccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence            55555         55679999999999999999776543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.7e-32  Score=267.06  Aligned_cols=148  Identities=20%  Similarity=0.304  Sum_probs=121.6

Q ss_pred             hHHHHHHHHh-hcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLK-ELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~-~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|..++. .++|||||++++++.+++.+|||||||+ |+|.+++.. .+.+++..++.++.||+.||+|||+++|+|
T Consensus        48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiH  126 (320)
T d1xjda_          48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVY  126 (320)
T ss_dssp             HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3456777765 6899999999999999999999999999 578877765 457999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++.+.  +|++|||+|+.+......                                         ....
T Consensus       127 rDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~-----------------------------------------~~~~  163 (320)
T d1xjda_         127 RDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK-----------------------------------------TNTF  163 (320)
T ss_dssp             CCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC-----------------------------------------BCCC
T ss_pred             ccCcccceeecCCCc--eeccccchhhhccccccc-----------------------------------------cccc
Confidence            999999999998887  999999998754311100                                         1123


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      +||+.|++|        +.++|+||+|+++++|++|..||..
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~  205 (320)
T d1xjda_         164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG  205 (320)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCC
Confidence            466666666        6678999999999999999877654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=266.14  Aligned_cols=150  Identities=21%  Similarity=0.357  Sum_probs=122.5

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc----------------------CCCChH
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS----------------------GGLDHH  323 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~----------------------~~l~~~  323 (481)
                      ..+.+|+.+|+++ +|||||++++++.+.+.+|+|||||+ |+|.+++....                      ..+++.
T Consensus        85 ~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  164 (325)
T d1rjba_          85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE  164 (325)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred             HHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHH
Confidence            4567899999998 89999999999999999999999998 78998886543                      247888


Q ss_pred             HHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccC
Q psy3074         324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNL  403 (481)
Q Consensus       324 ~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s  403 (481)
                      .+..++.|++.||.|||+++|+||||||+|||++.++.  +|++|||+|+..........                    
T Consensus       165 ~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~--------------------  222 (325)
T d1rjba_         165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVV--------------------  222 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEE--------------------
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCe--EEEeeccccccccCCCceee--------------------
Confidence            99999999999999999999999999999999998877  99999999976542211100                    


Q ss_pred             CCeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         404 SGVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       404 ~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                                         .....||+.|++|        +.++|+||+|++++||++ |..||
T Consensus       223 -------------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         223 -------------------RGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             -------------------ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             -------------------eccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCC
Confidence                               0113456667776        556799999999999996 77554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.5e-32  Score=268.37  Aligned_cols=150  Identities=20%  Similarity=0.248  Sum_probs=119.5

Q ss_pred             HHHHHHHHhh-cCCCCeeEEeeeeec----CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         270 AIREASLLKE-LKHNNIVTLHDIVHT----RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       270 ~~rE~~il~~-l~HpnIV~l~~~~~~----~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      +.+|+.++.+ ++|||||+++++|++    +..+|||||||+ |+|.+++.... ..+++..++.++.|++.||+|||++
T Consensus        51 ~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~  130 (335)
T d2ozaa1          51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI  130 (335)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc
Confidence            4579998765 589999999999976    467999999998 68999887643 4699999999999999999999999


Q ss_pred             ceeeccCCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccc
Q psy3074         343 RILHRDVKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFE  421 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~  421 (481)
                      +|+||||||+|||+++.. ...+|++|||+|+.+.....                                         
T Consensus       131 ~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~-----------------------------------------  169 (335)
T d2ozaa1         131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-----------------------------------------  169 (335)
T ss_dssp             TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC-----------------------------------------
T ss_pred             CCccccccccccccccccccccccccccceeeeccCCCc-----------------------------------------
Confidence            999999999999998643 33589999999875431110                                         


Q ss_pred             ccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         422 SKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       422 ~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                       ....+||+.|+||        +.++|+||+|+++|+|++|..||...
T Consensus       170 -~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         170 -LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             -CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             -cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence             0113356666666        45679999999999999999777544

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=2.1e-31  Score=259.23  Aligned_cols=155  Identities=35%  Similarity=0.594  Sum_probs=123.9

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      ..+.+|+.+|++++|||||+++++|.+++..+++||++.+++...+....+.+++..++.++.|++.||+|||+++|+||
T Consensus        45 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHr  124 (286)
T d1ob3a_          45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHR  124 (286)
T ss_dssp             HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEec
Confidence            35778999999999999999999999999999999999988888887777889999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||++.++.  +|++|||+|........   ..+.+..+.+|+++...                           
T Consensus       125 DiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~---------------------------  175 (286)
T d1ob3a_         125 DLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS---------------------------  175 (286)
T ss_dssp             CCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCHHHHTTC---------------------------
T ss_pred             CCCCceeeEcCCCC--EEecccccceecccCccccceecccchhhhHHHHhCC---------------------------
Confidence            99999999998877  99999999986542211   11111222222222110                           


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                              ..-+..+|+||+|++++||.+|..||-
T Consensus       176 --------~~~~~~~DiwslGv~l~el~~G~~pf~  202 (286)
T d1ob3a_         176 --------KKYSTTIDIWSVGCIFAEMVNGTPLFP  202 (286)
T ss_dssp             --------CSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             --------CCCCcceeehhcCcHHHHHHHCCCCCC
Confidence                    001456799999999999999996653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.7e-31  Score=259.86  Aligned_cols=150  Identities=17%  Similarity=0.274  Sum_probs=122.3

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.++ .+|||||||+ |+|.+++......+++..+..++.|++.||+|||+++|+||
T Consensus        55 ~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHr  133 (285)
T d1u59a_          55 EMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR  133 (285)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            467899999999999999999998754 5899999999 67888876666679999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.......                                      .......
T Consensus       134 DlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~--------------------------------------~~~~~~~  173 (285)
T d1u59a_         134 DLAARNVLLVNRHY--AKISDFGLSKALGADDSYY--------------------------------------TARSAGK  173 (285)
T ss_dssp             CCSGGGEEEEETTE--EEECCCTTCEECTTCSCEE--------------------------------------CCCCSSC
T ss_pred             cCchhheeeccCCc--eeeccchhhhccccccccc--------------------------------------ccccccc
Confidence            99999999998777  9999999997654211000                                      0011134


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      ||+.|++|        +..+|+||+|++++||++ |..|+-
T Consensus       174 gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~  214 (285)
T d1u59a_         174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK  214 (285)
T ss_dssp             CCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred             cCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence            66677777        567799999999999986 786654

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.4e-31  Score=258.73  Aligned_cols=150  Identities=20%  Similarity=0.346  Sum_probs=119.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|++++|||||++++++.+ +.+|+|||||+ |+|.+.+.... ..+++..+..++.||+.||.|||+++|+|
T Consensus        54 ~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH  132 (272)
T d1qpca_          54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH  132 (272)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            46789999999999999999998755 56799999999 67777654332 35899999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||+|+.+......                                        .....
T Consensus       133 rDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~----------------------------------------~~~~~  170 (272)
T d1qpca_         133 RDLRAANILVSDTLS--CKIADFGLARLIEDNEYT----------------------------------------AREGA  170 (272)
T ss_dssp             SCCSGGGEEECTTSC--EEECCCTTCEECSSSCEE----------------------------------------CCTTC
T ss_pred             Cccchhheeeecccc--eeeccccceEEccCCccc----------------------------------------ccccc
Confidence            999999999998877  999999999754311000                                        00113


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      .||+.|++|        +.++|+||+|++++||+++..|++..
T Consensus       171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~  213 (272)
T d1qpca_         171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG  213 (272)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred             CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence            355666666        56679999999999999865566554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.8e-32  Score=260.02  Aligned_cols=146  Identities=25%  Similarity=0.397  Sum_probs=117.9

Q ss_pred             HHHHHHHHhhcC--CCCeeEEeeeeecCCeEEEEEeccCC--CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         270 AIREASLLKELK--HNNIVTLHDIVHTRSTLTFVFEYVHT--DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       270 ~~rE~~il~~l~--HpnIV~l~~~~~~~~~~~iv~E~~~g--~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      +.+|+.+|++++  |||||+++++|.+++..|+||||+.|  ++...+.. .+.+++..++.++.|++.||+|||+++|+
T Consensus        54 ~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ii  132 (273)
T d1xwsa_          54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVL  132 (273)
T ss_dssp             EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            347999999997  89999999999999999999999974  45555554 46799999999999999999999999999


Q ss_pred             eccCCCcccccccc-chhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         346 HRDVKPQNLLISEI-DHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       346 HrDlKp~NiLl~~~-~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||||+|||++.+ +.  +|++|||+|+......                                           ..
T Consensus       133 HrDiKp~NIll~~~~~~--vkl~DFG~a~~~~~~~-------------------------------------------~~  167 (273)
T d1xwsa_         133 HRDIKDENILIDLNRGE--LKLIDFGSGALLKDTV-------------------------------------------YT  167 (273)
T ss_dssp             CSCCSGGGEEEETTTTE--EEECCCTTCEECCSSC-------------------------------------------BC
T ss_pred             cccCcccceEEecCCCe--EEECccccceeccccc-------------------------------------------cc
Confidence            99999999999754 44  9999999886432110                                           01


Q ss_pred             cccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         425 NINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       425 ~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      ..+||+.|++|         +.++|+||+|+++++|++|..||..+
T Consensus       168 ~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             ccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence            13456666666         23469999999999999999777654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.96  E-value=9.5e-32  Score=260.58  Aligned_cols=151  Identities=23%  Similarity=0.324  Sum_probs=115.9

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+.+|+++|+.++|||||++++++...+    .+|+|||||+ |+|...+.. .+.+++..++.++.|++.||+|||++|
T Consensus        53 ~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~  131 (277)
T d1o6ya_          53 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNG  131 (277)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4668999999999999999999998654    4899999999 567666654 467999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  ++++|||++..+......                                      ....
T Consensus       132 iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~--------------------------------------~~~~  171 (277)
T d1o6ya_         132 IIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNS--------------------------------------VTQT  171 (277)
T ss_dssp             EECCCCSGGGEEEETTSC--EEECCCTTCEECC-----------------------------------------------
T ss_pred             ccCccccCcccccCcccc--ceeehhhhhhhhcccccc--------------------------------------cccc
Confidence            999999999999988777  788888876543211100                                      0001


Q ss_pred             CcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         424 SNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       424 ~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ...+||+.|++|        +..+|+||+|+++++|++|..||-.
T Consensus       172 ~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             -------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence            224577777777        5567999999999999999977643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.6e-31  Score=253.14  Aligned_cols=148  Identities=17%  Similarity=0.281  Sum_probs=123.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.++++++|||||++++++.+++.+++|||||+ |++..++......+++..+..++.|++.||.|||+++|+||
T Consensus        45 ~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~  124 (258)
T d1k2pa_          45 EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR  124 (258)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCS
T ss_pred             HHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence            46789999999999999999999999999999999998 67888877766779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||+++++.  +|++|||+|+.+.......                                        .....
T Consensus       125 dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~----------------------------------------~~~~~  162 (258)
T d1k2pa_         125 DLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTS----------------------------------------SVGSK  162 (258)
T ss_dssp             CCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCC----------------------------------------CCCSC
T ss_pred             cccceeEEEcCCCc--EEECcchhheeccCCCcee----------------------------------------ecccC
Confidence            99999999998777  9999999987543211100                                        00123


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      +|+.|++|        +.++|+||+|++++||.+ |..|+
T Consensus       163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf  202 (258)
T d1k2pa_         163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY  202 (258)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCC
Confidence            56666666        567899999999999997 77554

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.4e-31  Score=257.56  Aligned_cols=154  Identities=16%  Similarity=0.275  Sum_probs=120.4

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+++|++++|||||++++++.+.+.+++|||||. |++...+......+++..+..++.|++.||+|||+++|+||
T Consensus        55 ~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHr  134 (283)
T d1mqba_          55 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR  134 (283)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             HHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccC
Confidence            46789999999999999999999999999999999998 55666666666779999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.......                                      .......
T Consensus       135 DlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~--------------------------------------~~~~~~~  174 (283)
T d1mqba_         135 DLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAT--------------------------------------YTTSGGK  174 (283)
T ss_dssp             CCCGGGEEECTTCC--EEECCCCC-------------------------------------------------------C
T ss_pred             ccccceEEECCCCe--EEEcccchhhcccCCCccc--------------------------------------eEeccCC
Confidence            99999999998877  9999999998654211100                                      0011133


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ||+.|+||        +..+|+||+|++++||.++..|++.+.
T Consensus       175 gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~  217 (283)
T d1mqba_         175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL  217 (283)
T ss_dssp             CCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             CCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC
Confidence            56666766        456799999999999998666766543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=257.07  Aligned_cols=153  Identities=16%  Similarity=0.275  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      +.+.+|+.+|++++|||||++++++.+++ .+++||++. |++.+.+......+++..+..++.||+.||.|||+++|+|
T Consensus        56 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiH  134 (317)
T d1xkka_          56 KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH  134 (317)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence            45778999999999999999999998764 567777776 7898888887778999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+|+.+........                                       ....
T Consensus       135 rDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~~---------------------------------------~~~~  173 (317)
T d1xkka_         135 RDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYH---------------------------------------AEGG  173 (317)
T ss_dssp             SCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC----------------------------------------------
T ss_pred             CcchhhcceeCCCCC--eEeeccccceeccccccccc---------------------------------------cccc
Confidence            999999999998877  99999999987642211100                                       0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      .||+.|++|        +.++|+||+|++++||.++..++|.+.
T Consensus       174 ~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~  217 (317)
T d1xkka_         174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI  217 (317)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             ccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC
Confidence            355666666        566899999999999997333555544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.2e-31  Score=264.12  Aligned_cols=152  Identities=24%  Similarity=0.434  Sum_probs=122.2

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC------eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS------TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~------~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+++|+.++|||||+++++|...+      .+|+|||||++++...+..  +.+++..++.++.|++.||.|||++
T Consensus        63 ~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~  140 (346)
T d1cm8a_          63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAA  140 (346)
T ss_dssp             HHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhC
Confidence            4678999999999999999999998654      5799999997777666543  5699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||||||+|||++.++.  +|++|||+|+.........+.++.|.||+++.+..                        
T Consensus       141 ~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~------------------------  194 (346)
T d1cm8a_         141 GIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM------------------------  194 (346)
T ss_dssp             TEECCCCCGGGEEECTTCC--EEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTT------------------------
T ss_pred             CCcccccCcchhhcccccc--cccccccceeccCCccccccccccccCHHHHcCCC------------------------
Confidence            9999999999999998887  99999999986654444444555555555443210                        


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                 ..+.++|+||+|+++++|++|..|+.
T Consensus       195 -----------~~~~~~DiwSlGvil~ell~g~~pf~  220 (346)
T d1cm8a_         195 -----------RYTQTVDIWSVGCIMAEMITGKTLFK  220 (346)
T ss_dssp             -----------CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -----------CCCccchhhcchHHHHHHHHCcCCCC
Confidence                       01456789999999999999986653

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.5e-31  Score=255.84  Aligned_cols=149  Identities=17%  Similarity=0.279  Sum_probs=119.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .+.+|+.+|++++|||||++++++.++ ..+||||||+ |+|.+++.. ...+++..+..++.||+.||+|||+++|+||
T Consensus        54 ~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr  131 (277)
T d1xbba_          54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHR  131 (277)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence            467899999999999999999999754 5789999999 678777664 4569999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+.......                                      .......
T Consensus       132 DlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~--------------------------------------~~~~~~~  171 (277)
T d1xbba_         132 DLAARNVLLVTQHY--AKISDFGLSKALRADENYY--------------------------------------KAQTHGK  171 (277)
T ss_dssp             CCSGGGEEEEETTE--EEECCCTTCEECCTTCSEE--------------------------------------EC----C
T ss_pred             CCcchhhcccccCc--ccccchhhhhhcccccccc--------------------------------------ccccccC
Confidence            99999999998877  9999999987544211000                                      0011234


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhC-CCcccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTL  459 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~  459 (481)
                      ||+.|++|        +..+|+||+|++++||++ |.+|+-
T Consensus       172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~  212 (277)
T d1xbba_         172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR  212 (277)
T ss_dssp             CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence            66777777        557799999999999986 775553

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.8e-30  Score=251.09  Aligned_cols=151  Identities=21%  Similarity=0.347  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|++++|||||++++++. ++.+|+|||||+ |++..++....+.+++..+..++.|++.||.|||+++|+|
T Consensus        53 ~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH  131 (273)
T d1mp8a_          53 EKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH  131 (273)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeec
Confidence            35678999999999999999999996 467899999999 6787777776677999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+||++++++.  +|++|||+|+.+.......                                        ....
T Consensus       132 rDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~~~----------------------------------------~~~~  169 (273)
T d1mp8a_         132 RDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYK----------------------------------------ASKG  169 (273)
T ss_dssp             SCCSGGGEEEEETTE--EEECC----------------------------------------------------------
T ss_pred             cccchhheeecCCCc--EEEccchhheeccCCccee----------------------------------------ccce
Confidence            999999999998877  9999999998654221100                                        0012


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVTLHDI  462 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~~~~~  462 (481)
                      .||+.|++|        +.++|+||+|++++||++ |. +++.+.
T Consensus       170 ~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~-~P~~~~  213 (273)
T d1mp8a_         170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-KPFQGV  213 (273)
T ss_dssp             -CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC-CTTTTC
T ss_pred             ecCcccchhhHhccCCCCCccccccchHHHHHHHhcCC-CCCCCC
Confidence            355566666        556799999999999987 66 444443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-30  Score=261.54  Aligned_cols=153  Identities=26%  Similarity=0.373  Sum_probs=114.2

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeec------CCeEEEEEeccCCCHHHHHHH---hcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         272 REASLLKELKHNNIVTLHDIVHT------RSTLTFVFEYVHTDLSQYMER---HSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~------~~~~~iv~E~~~g~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ||+++|++++|||||+++++|..      ..++|||||||++++...+..   ....+++..++.++.|++.||+|||++
T Consensus        62 ~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~  141 (350)
T d1q5ka_          62 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF  141 (350)
T ss_dssp             HHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence            69999999999999999999854      346899999999877666542   345699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||+||||||+|||++.++ ..+|++|||+|+.+....  ...+.+..+.+|+++..                        
T Consensus       142 ~IiHrDiKp~NILl~~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~------------------------  196 (350)
T d1q5ka_         142 GICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG------------------------  196 (350)
T ss_dssp             TEECCCCCGGGEEECTTT-CCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT------------------------
T ss_pred             CCcccCCCcceEEEecCC-CceeEecccchhhccCCcccccccccccccChHHhhc------------------------
Confidence            999999999999998654 138999999987553211  11111222222221111                        


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                              ..   ..+.++|+||+|++++||.+|..||..
T Consensus       197 --------~~---~~~~~~DIwSlG~il~el~~g~~pf~~  225 (350)
T d1q5ka_         197 --------AT---DYTSSIDVWSAGCVLAELLLGQPIFPG  225 (350)
T ss_dssp             --------CS---SCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             --------cc---CCCcceeecccceEEEehhhCCCCCCC
Confidence                    00   015667999999999999999866643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2e-30  Score=256.07  Aligned_cols=153  Identities=31%  Similarity=0.512  Sum_probs=121.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeec--------CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHh
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHT--------RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYC  339 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~--------~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~yl  339 (481)
                      .++.+|+.+|+.++||||+++++++..        ++.+|+|||||.+++..........+++..++.++.|++.||.||
T Consensus        54 ~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~l  133 (318)
T d3blha1          54 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI  133 (318)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHh
Confidence            456789999999999999999999865        346899999999888777766667899999999999999999999


Q ss_pred             hcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcc
Q psy3074         340 HRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWW  419 (481)
Q Consensus       340 H~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~  419 (481)
                      |+++|+||||||+|||++.++.  +|++|||+|+.+.......                                     
T Consensus       134 H~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~-------------------------------------  174 (318)
T d3blha1         134 HRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQ-------------------------------------  174 (318)
T ss_dssp             HHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC------------------------------------------
T ss_pred             ccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccc-------------------------------------
Confidence            9999999999999999998877  9999999987544111000                                     


Q ss_pred             ccccCcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         420 FESKSNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       420 ~~~~~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      .......+||+.|++|         +.++|+||+|++++||..|..||.
T Consensus       175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~  223 (318)
T d3blha1         175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ  223 (318)
T ss_dssp             CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence            0001113456666666         456799999999999999986654

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-30  Score=255.24  Aligned_cols=147  Identities=33%  Similarity=0.588  Sum_probs=116.5

Q ss_pred             HHHHHHHHhhc---CCCCeeEEeeeeec-----CCeEEEEEeccCCCHHHHHH-HhcCCCChHHHHHHHHHHHHHHHHhh
Q psy3074         270 AIREASLLKEL---KHNNIVTLHDIVHT-----RSTLTFVFEYVHTDLSQYME-RHSGGLDHHNIRLFMFQLLRGLSYCH  340 (481)
Q Consensus       270 ~~rE~~il~~l---~HpnIV~l~~~~~~-----~~~~~iv~E~~~g~l~~~l~-~~~~~l~~~~~~~~~~qi~~~l~ylH  340 (481)
                      +.||+.+|+.|   +|||||+++++|..     ...++++||||.|++..... .....+++..++.++.|++.||+|||
T Consensus        54 ~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH  133 (305)
T d1blxa_          54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH  133 (305)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            55788887776   79999999999853     35789999999987665543 34456999999999999999999999


Q ss_pred             cCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         341 RRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       341 ~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      +++|+||||||+|||+++.+.  +|++|||+++.......                                        
T Consensus       134 ~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~----------------------------------------  171 (305)
T d1blxa_         134 SHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA----------------------------------------  171 (305)
T ss_dssp             HTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGG----------------------------------------
T ss_pred             hCCEEecCCCccEEEEcCCCC--eeecchhhhhhhccccc----------------------------------------
Confidence            999999999999999998877  99999998764321110                                        


Q ss_pred             cccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         421 ESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                        ....+||+.|+||        +.++|+||+|++++||++|..||..
T Consensus       172 --~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~  217 (305)
T d1blxa_         172 --LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG  217 (305)
T ss_dssp             --GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             --CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCC
Confidence              0112355555555        6678999999999999999977643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.2e-30  Score=251.08  Aligned_cols=158  Identities=37%  Similarity=0.631  Sum_probs=123.5

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      .++.+|+.+|+.++|||||++++++.+.+..+++||++.|+....+....+.+++..++.++.|++.||+|||+++|+||
T Consensus        46 ~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHr  125 (292)
T d1unla_          46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHR  125 (292)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeee
Confidence            35678999999999999999999999999999999999977666666667789999999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhcccccc---CceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccC
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHR---RRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKS  424 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~---~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~  424 (481)
                      ||||+|||++..+.  +|++|||.|+.......   ....+..+.||+++....                          
T Consensus       126 DiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--------------------------  177 (292)
T d1unla_         126 DLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK--------------------------  177 (292)
T ss_dssp             CCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS--------------------------
T ss_pred             cccCcccccccCCc--eeeeecchhhcccCCCccceeeccccchhhhhHhccCC--------------------------
Confidence            99999999998776  99999999876542211   111112222222221100                          


Q ss_pred             cccceeccCCCCCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         425 NINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       425 ~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                               .-+.++|+||+|++++||+.|..|++...
T Consensus       178 ---------~~~~~~DiwSlG~il~ell~g~~p~~~~~  206 (292)
T d1unla_         178 ---------LYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_dssp             ---------CCCTHHHHHHHHHHHHHHTTTSCCSCCCS
T ss_pred             ---------CCCchhhccccchHHHHHhhCCCCCCCCC
Confidence                     01455799999999999999988876543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.3e-30  Score=256.02  Aligned_cols=149  Identities=26%  Similarity=0.453  Sum_probs=117.6

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCC-----eEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRS-----TLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~-----~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      .+++|+.+|++++|||||++++++....     .+|++|+++.|+|.+++..  +.+++..++.++.|++.||+|||++|
T Consensus        52 ~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~  129 (345)
T d1pmea_          52 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN  129 (345)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4678999999999999999999997653     4677777777899988864  46999999999999999999999999


Q ss_pred             eeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCcccccc
Q psy3074         344 ILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESK  423 (481)
Q Consensus       344 iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~  423 (481)
                      |+||||||+|||++.++.  +|++|||+|+...........                                      .
T Consensus       130 iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~--------------------------------------~  169 (345)
T d1pmea_         130 VLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGF--------------------------------------L  169 (345)
T ss_dssp             EECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCT--------------------------------------T
T ss_pred             CcCCCCCcceEEECCCCC--EEEcccCceeeccCCCcccee--------------------------------------e
Confidence            999999999999998877  999999999765433211100                                      0


Q ss_pred             CcccceeccCCC---------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         424 SNINLSFHYLPP---------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       424 ~~~~~t~~y~~p---------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ...+||+.|++|         +.++|+||+|+++++|+.|..||.
T Consensus       170 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~  214 (345)
T d1pmea_         170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFP  214 (345)
T ss_dssp             CCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCC
Confidence            011233333333         456799999999999999986653

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.6e-30  Score=249.63  Aligned_cols=152  Identities=22%  Similarity=0.340  Sum_probs=117.7

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh-cCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH-SGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      .+.+|+.+|++++|||||++++++.+ +.+|+|||||+ |++..++... ...+++..+..++.||+.||+|||+++|+|
T Consensus        58 ~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH  136 (285)
T d1fmka3          58 AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVH  136 (285)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheec
Confidence            46789999999999999999999865 56899999999 5677666543 356999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||+++++.  +|++|||+|+.+......                                        .....
T Consensus       137 ~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~----------------------------------------~~~~~  174 (285)
T d1fmka3         137 RDLRAANILVGENLV--CKVADFGLARLIEDNEYT----------------------------------------ARQGA  174 (285)
T ss_dssp             SCCSGGGEEECGGGC--EEECCCCTTC-----------------------------------------------------
T ss_pred             ccccceEEEECCCCc--EEEcccchhhhccCCCce----------------------------------------eeccc
Confidence            999999999998877  999999998754311100                                        00112


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                      .||+.|++|        +.++|+||+|++++||.++..|++.+..
T Consensus       175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~  219 (285)
T d1fmka3         175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV  219 (285)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC
Confidence            355666665        5567999999999999986666666543

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=4.8e-30  Score=251.51  Aligned_cols=155  Identities=22%  Similarity=0.349  Sum_probs=124.9

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------------CCCChH
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------------GGLDHH  323 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------------~~l~~~  323 (481)
                      ..+.+|+++|++++||||+++++++.+.+..+++||||+ |+|.+++....                       ..+++.
T Consensus        61 ~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  140 (301)
T d1lufa_          61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA  140 (301)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHH
T ss_pred             HHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHH
Confidence            346789999999999999999999999999999999998 78888875422                       237888


Q ss_pred             HHHHHHHHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccC
Q psy3074         324 NIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNL  403 (481)
Q Consensus       324 ~~~~~~~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s  403 (481)
                      .+..++.|++.||+|||+++++||||||+|||++.++.  +|++|||+|+.+........                    
T Consensus       141 ~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~~~~--------------------  198 (301)
T d1lufa_         141 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKA--------------------  198 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC---------------------
T ss_pred             HHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCccccc--------------------
Confidence            99999999999999999999999999999999998777  99999999986643221110                    


Q ss_pred             CCeeEEEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         404 SGVVVSTVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       404 ~g~~~~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                                         .....+|+.|++|        +.++|+||+|++++||+++..|++.+..
T Consensus       199 -------------------~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         199 -------------------DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             ----------------------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             -------------------cCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence                               0113355566666        5567999999999999998766665543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-29  Score=247.66  Aligned_cols=153  Identities=21%  Similarity=0.356  Sum_probs=114.9

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecC-CeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTR-STLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMF  330 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~-~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~  330 (481)
                      .+.+|..++.++ +|+|||.+++++..+ ..+++|||||+ |+|.+++....               ..+++..+..++.
T Consensus        62 ~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (299)
T d1ywna1          62 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF  141 (299)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHH
Confidence            345677777776 588999999987654 57999999999 78888886532               2478999999999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEE
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVST  410 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~  410 (481)
                      ||+.||.|||+++|+||||||+|||+++++.  +|++|||+|+.+.......                            
T Consensus       142 qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~----------------------------  191 (299)
T d1ywna1         142 QVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYV----------------------------  191 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTTSC----------------------------
T ss_pred             HHHHHHHHHHhCCCcCCcCCccceeECCCCc--EEEccCcchhhcccccccc----------------------------
Confidence            9999999999999999999999999998877  9999999997543211100                            


Q ss_pred             eecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         411 VDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       411 ~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                                 ......||+.|++|        +.++|+||+|++++||+++..++|.+.
T Consensus       192 -----------~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         192 -----------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             -----------CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             -----------ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence                       01124577777777        567799999999999998765666544

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=7.5e-30  Score=246.65  Aligned_cols=150  Identities=22%  Similarity=0.353  Sum_probs=120.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILH  346 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiH  346 (481)
                      ..+.+|+.+|++++|||||++++++.++ .+++|||||+ |++.+.+....+.+++..+..++.|++.||.|||+++|+|
T Consensus        56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiH  134 (273)
T d1u46a_          56 DDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH  134 (273)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEee
Confidence            3567899999999999999999999764 6789999998 7788887777777999999999999999999999999999


Q ss_pred             ccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCcc
Q psy3074         347 RDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNI  426 (481)
Q Consensus       347 rDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~  426 (481)
                      |||||+|||++.++.  +|++|||+++.+.........+                                      ...
T Consensus       135 rDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~~~~~~--------------------------------------~~~  174 (273)
T d1u46a_         135 RDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQ--------------------------------------EHR  174 (273)
T ss_dssp             SCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC------------------------------------------
T ss_pred             eeecHHHhccccccc--eeeccchhhhhcccCCCcceec--------------------------------------Ccc
Confidence            999999999998776  9999999988654322111100                                      112


Q ss_pred             cceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         427 NLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       427 ~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                      .+++.|++|        +..+|+||+|++++||.. |..|+
T Consensus       175 ~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf  215 (273)
T d1u46a_         175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW  215 (273)
T ss_dssp             -CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence            344455555        455799999999999996 77554

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.1e-29  Score=247.79  Aligned_cols=150  Identities=21%  Similarity=0.327  Sum_probs=121.7

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHh---------------cCCCChHHHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERH---------------SGGLDHHNIRLFMFQ  331 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~---------------~~~l~~~~~~~~~~q  331 (481)
                      .+.+|+++|+++ +|||||++++++.+++.+|+|||||+ |+|.+++...               ...+++..+..++.|
T Consensus        56 ~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  135 (309)
T d1fvra_          56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD  135 (309)
T ss_dssp             HHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHH
Confidence            577899999998 69999999999999999999999999 7888887643               246899999999999


Q ss_pred             HHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEe
Q psy3074         332 LLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTV  411 (481)
Q Consensus       332 i~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~  411 (481)
                      |+.||.|+|+++|+||||||+|||++.++.  +|++|||+|+........                              
T Consensus       136 ia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~~~~------------------------------  183 (309)
T d1fvra_         136 VARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYVKK------------------------------  183 (309)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEECCC------------------------------
T ss_pred             HHHHHHhhhcCCccccccccceEEEcCCCc--eEEccccccccccccccc------------------------------
Confidence            999999999999999999999999998776  999999998654321110                              


Q ss_pred             ecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         412 DSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       412 ~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                                  ....||+.|++|        +..+|+||+|++++||+++..|++.+.
T Consensus       184 ------------~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         184 ------------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             ----------------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ------------cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence                        012244455555        556799999999999999765666543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=3.6e-29  Score=244.37  Aligned_cols=156  Identities=13%  Similarity=0.138  Sum_probs=126.8

Q ss_pred             HHHHHHHHhhcCC-CCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~H-pnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++++.++| +||+.+++++......++|||||.|+|.+.+......+++..+..++.|++.||+|||++||+|||
T Consensus        47 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrD  126 (293)
T d1csna_          47 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD  126 (293)
T ss_dssp             HHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred             HHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceecc
Confidence            4568999999986 899999999999999999999999999998877667799999999999999999999999999999


Q ss_pred             CCCccccccccc---hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         349 VKPQNLLISEID---HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       349 lKp~NiLl~~~~---~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      |||+|||++...   ...+|++|||+|+.+........                                  ........
T Consensus       127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~----------------------------------~~~~~~~~  172 (293)
T d1csna_         127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH----------------------------------IPYREKKN  172 (293)
T ss_dssp             CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCB----------------------------------CCCCCCCC
T ss_pred             CCccceeecCcccccCCceEEcccceeEEcccCccccc----------------------------------eeecccCc
Confidence            999999997532   23599999999976542211100                                  00011223


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                      ++||+.|++|        +..+|+||+|++++||+.|..|+-
T Consensus       173 ~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~  214 (293)
T d1csna_         173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ  214 (293)
T ss_dssp             CCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             eEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence            6788899988        556699999999999999997764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=3.3e-29  Score=245.13  Aligned_cols=157  Identities=16%  Similarity=0.170  Sum_probs=124.3

Q ss_pred             HHHHHHHHhhcCCCC-eeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeecc
Q psy3074         270 AIREASLLKELKHNN-IVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRD  348 (481)
Q Consensus       270 ~~rE~~il~~l~Hpn-IV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrD  348 (481)
                      +.+|+++++.++|+| |+.+.+++.+.+..++|||||+|++...+....+.+++..+..++.|++.||+|||+++|+|||
T Consensus        49 ~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrD  128 (299)
T d1ckia_          49 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD  128 (299)
T ss_dssp             HHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             HHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence            457999999998776 5566677788889999999999999888877777899999999999999999999999999999


Q ss_pred             CCCccccccccc-hhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         349 VKPQNLLISEID-HHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       349 lKp~NiLl~~~~-~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      |||+|||++..+ ...+|++|||+|+.+.......                                  ..........+
T Consensus       129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~----------------------------------~~~~~~~~~~~  174 (299)
T d1ckia_         129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ----------------------------------HIPYRENKNLT  174 (299)
T ss_dssp             CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC----------------------------------BCCCCBCCSCC
T ss_pred             CCHhhccccccCCCceeeeeccCcceecccccccc----------------------------------ceeccccCCcC
Confidence            999999986543 3459999999987654221100                                  00011122356


Q ss_pred             ceeccCCC--------CCChhhhhhHHHHHHhhCCCccccc
Q psy3074         428 LSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLH  460 (481)
Q Consensus       428 ~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~  460 (481)
                      ||+.|++|        +..+|+||+|++++||.+|..|+..
T Consensus       175 gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             CCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence            88888887        5667999999999999999977644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=4.3e-29  Score=247.50  Aligned_cols=153  Identities=30%  Similarity=0.461  Sum_probs=113.1

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecC--CeEEEEEeccCC-CHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTR--STLTFVFEYVHT-DLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~--~~~~iv~E~~~g-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      .+.+|+++|+.++ ||||++++++|...  ..+++|||||.+ +|...    .+.+++..++.++.||+.||+|||++||
T Consensus        75 ~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gI  150 (328)
T d3bqca1          75 KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGI  150 (328)
T ss_dssp             HHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhccc
Confidence            3567999999996 99999999999754  579999999995 45432    3469999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      +||||||+|||++.++. .+|++|||+|+.+....  ...+.+..+.+|+++.+..                        
T Consensus       151 vHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~------------------------  205 (328)
T d3bqca1         151 MHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ------------------------  205 (328)
T ss_dssp             ECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCC------------------------
T ss_pred             ccccccccceEEcCCCC-eeeecccccceeccCCCcccccccCccccCcccccCCC------------------------
Confidence            99999999999986432 38999999987543211  1111122222222221100                        


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                                 .-+.++|+||+|+++++|..|..|+...
T Consensus       206 -----------~~~~~~DiwslG~~l~e~~~g~~pf~~~  233 (328)
T d3bqca1         206 -----------MYDYSLDMWSLGCMLASMIFRKEPFFHG  233 (328)
T ss_dssp             -----------CCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             -----------CCCcccchhhhhhhhHHhccCCCCCCCC
Confidence                       0045579999999999999998777654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.9e-29  Score=251.93  Aligned_cols=152  Identities=24%  Similarity=0.403  Sum_probs=114.0

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecC------CeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTR------STLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~------~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.||+++|++++|||||++++++...      ...+++++++.|+|.+++..  +.+++..++.++.|++.||+|||++
T Consensus        63 ~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~  140 (348)
T d2gfsa1          63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA  140 (348)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhC
Confidence            456899999999999999999998643      23555555555788887743  5699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFES  422 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~  422 (481)
                      ||+||||||+|||++.++.  +|++|||+|............+..+.+|+++....                        
T Consensus       141 giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~------------------------  194 (348)
T d2gfsa1         141 DIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWM------------------------  194 (348)
T ss_dssp             TCCCCCCCGGGEEECTTCC--EEECCC----CCTGGGSSSCHHHHTSCHHHHTTCS------------------------
T ss_pred             CCcccccCCcccccccccc--ccccccchhcccCcccccccccccccCchhhcCCc------------------------
Confidence            9999999999999998887  89999999876654444444444444444432210                        


Q ss_pred             cCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         423 KSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       423 ~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                 ..+.++|+||+|+++++|+.|..||.
T Consensus       195 -----------~~~~~~DiwSlGv~l~~ll~g~~pF~  220 (348)
T d2gfsa1         195 -----------HYNQTVDIWSVGCIMAELLTGRTLFP  220 (348)
T ss_dssp             -----------CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             -----------cCCcccchhhhhHHHHHHHhCCCCCC
Confidence                       01556799999999999999986653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.7e-29  Score=248.48  Aligned_cols=149  Identities=20%  Similarity=0.338  Sum_probs=118.7

Q ss_pred             HHHHHHHHhhcCC-CCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeec
Q psy3074         270 AIREASLLKELKH-NNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHR  347 (481)
Q Consensus       270 ~~rE~~il~~l~H-pnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHr  347 (481)
                      +.+|+++|++++| |||+++++++.+...++++||||. |+|.+.+... +.+++..+..++.|++.||+|||+++|+||
T Consensus        75 ~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHr  153 (322)
T d1vzoa_          75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYR  153 (322)
T ss_dssp             CCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEec
Confidence            3469999999987 899999999999999999999999 6787777654 568899999999999999999999999999


Q ss_pred             cCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCccc
Q psy3074         348 DVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSNIN  427 (481)
Q Consensus       348 DlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~~~  427 (481)
                      ||||+|||++.++.  +|++|||+|+.+........                                        ....
T Consensus       154 DiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~~~~----------------------------------------~~~~  191 (322)
T d1vzoa_         154 DIKLENILLDSNGH--VVLTDFGLSKEFVADETERA----------------------------------------YDFC  191 (322)
T ss_dssp             CCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGG----------------------------------------CGGG
T ss_pred             cCCccceeecCCCC--EEEeeccchhhhcccccccc----------------------------------------cccc
Confidence            99999999998877  99999999876542211100                                        0012


Q ss_pred             ceeccCCC----------CCChhhhhhHHHHHHhhCCCcccccc
Q psy3074         428 LSFHYLPP----------GAPFTAIREASLLKELKHNNIVTLHD  461 (481)
Q Consensus       428 ~t~~y~~p----------~~p~~~~s~~~~l~~l~~~~~~~~~~  461 (481)
                      |++.|++|          +.++|+||+|++|++|+.|..||...
T Consensus       192 g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             SCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred             cccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            23333333          44679999999999999999776544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.8e-29  Score=250.76  Aligned_cols=150  Identities=22%  Similarity=0.395  Sum_probs=113.1

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeec------CCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHT------RSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~------~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      .+.+|+.+|++++|||||+++++|..      ...+|+|||||.|++.+.+.   ..+++..++.++.|++.||.|||++
T Consensus        62 ~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~  138 (355)
T d2b1pa1          62 RAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA  138 (355)
T ss_dssp             HHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhc
Confidence            45689999999999999999999964      46899999999998877663   4699999999999999999999999


Q ss_pred             ceeeccCCCccccccccchhhHHHHHHHHHhhccccc--cCceeccccCCCcccccccccccCCCeeEEEeecCCCCccc
Q psy3074         343 RILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCH--RRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWF  420 (481)
Q Consensus       343 ~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~--~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~  420 (481)
                      ||+||||||+|||++.++.  +|++|||+++......  ...+.++.+.|||++.+.                       
T Consensus       139 giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-----------------------  193 (355)
T d2b1pa1         139 GIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-----------------------  193 (355)
T ss_dssp             TCCCSCCCGGGEEECTTCC--EEECCCCC---------------CCTTCCHHHHTTC-----------------------
T ss_pred             ccccccCCccccccccccc--eeeechhhhhccccccccccccccccccChhhhcCC-----------------------
Confidence            9999999999999998877  8899998776544221  111222233333322110                       


Q ss_pred             cccCcccceeccCCCCCChhhhhhHHHHHHhhCCCcccc
Q psy3074         421 ESKSNINLSFHYLPPGAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       421 ~~~~~~~~t~~y~~p~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                   ..+.++|+||+|+++++|+.|.+||.
T Consensus       194 -------------~~~~~~DiwSlG~~l~ell~g~~pF~  219 (355)
T d2b1pa1         194 -------------GYKENVDIWSVGCIMGEMVRHKILFP  219 (355)
T ss_dssp             -------------CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred             -------------CCCCCcccccccchHHHHhhCCCCCC
Confidence                         01567899999999999999996653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=1.1e-29  Score=243.95  Aligned_cols=186  Identities=19%  Similarity=0.222  Sum_probs=134.0

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhc-CCCChHHHHHHHHHHHHHHHHhhcCce
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHS-GGLDHHNIRLFMFQLLRGLSYCHRRRI  344 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~ylH~~~i  344 (481)
                      +.+.+|+++|++++|||||++++++.+ ++.+|+|||||+ |+|.+++.... ..+++..+..++.||+.||.|||+.+|
T Consensus        45 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~i  124 (262)
T d1byga_          45 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF  124 (262)
T ss_dssp             HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCce
Confidence            346789999999999999999998854 567899999998 78888886543 348999999999999999999999999


Q ss_pred             eeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccc----cccccccCCCeeEEEeec-CCCCcc
Q psy3074         345 LHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLI----SEIVFTNLSGVVVSTVDS-GSGGWW  419 (481)
Q Consensus       345 iHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~----~~~~~~~s~g~~~~~~~~-g~~~~~  419 (481)
                      +||||||+|||++.++.  +|++|||+++...........+..+.|||++.    +...|.||+|++++++.+ |.+||.
T Consensus       125 vH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~  202 (262)
T d1byga_         125 VHRDLAARNVLVSEDNV--AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP  202 (262)
T ss_dssp             CCSCCSGGGEEECTTSC--EEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred             eccccchHhheecCCCC--EeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence            99999999999998887  99999999997765555555666788888874    444567999999999997 788887


Q ss_pred             ccccCccccee--ccCCCCCChhhhhhHHHHHHhhCCC
Q psy3074         420 FESKSNINLSF--HYLPPGAPFTAIREASLLKELKHNN  455 (481)
Q Consensus       420 ~~~~~~~~~t~--~y~~p~~p~~~~s~~~~l~~l~~~~  455 (481)
                      ..+...+....  .+.++-++...-.+..++..+...+
T Consensus       203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~d  240 (262)
T d1byga_         203 RIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD  240 (262)
T ss_dssp             TSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccC
Confidence            65443321111  1222211212234556777777765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=8.9e-29  Score=243.57  Aligned_cols=153  Identities=22%  Similarity=0.330  Sum_probs=123.6

Q ss_pred             hHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc-----------------CCCChHHHHHHH
Q psy3074         269 TAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS-----------------GGLDHHNIRLFM  329 (481)
Q Consensus       269 ~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~-----------------~~l~~~~~~~~~  329 (481)
                      .+.+|+.+++.+ +|||||++++++.+++.+|+|||||+ |++..++....                 ..+++..+..++
T Consensus        72 ~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  151 (311)
T d1t46a_          72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS  151 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHH
Confidence            467899999999 69999999999999999999999998 67888776532                 248899999999


Q ss_pred             HHHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEE
Q psy3074         330 FQLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVS  409 (481)
Q Consensus       330 ~qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~  409 (481)
                      .||+.||.|||+++++||||||+|||++..+.  +|++|||+++.+........                          
T Consensus       152 ~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~~~--------------------------  203 (311)
T d1t46a_         152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVV--------------------------  203 (311)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEE--------------------------
T ss_pred             HHHHHHHHHHHhCCeeecccccccccccccCc--ccccccchheeccCCCcceE--------------------------
Confidence            99999999999999999999999999988777  99999999875542211100                          


Q ss_pred             EeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         410 TVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       410 ~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                                   ....+||+.|++|        +..+|+||+|++++||+++..|++...
T Consensus       204 -------------~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         204 -------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             -------------CSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             -------------eeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence                         0113466777777        566799999999999998544665543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=7.4e-29  Score=243.79  Aligned_cols=154  Identities=17%  Similarity=0.242  Sum_probs=123.8

Q ss_pred             hHHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------CCCChHHHHHHHHHHHHHHHH
Q psy3074         269 TAIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------GGLDHHNIRLFMFQLLRGLSY  338 (481)
Q Consensus       269 ~~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~y  338 (481)
                      .+.+|+.++++++|||||++++++..++..++|||||+ |++..++....         ..+++..+..++.|++.||.|
T Consensus        69 ~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~  148 (308)
T d1p4oa_          69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY  148 (308)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999999999999998 78888776432         236788899999999999999


Q ss_pred             hhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCc
Q psy3074         339 CHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       339 lH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                      ||+++|+||||||+|||+++++.  +|++|||+|+.+.........                                  
T Consensus       149 LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~~~~----------------------------------  192 (308)
T d1p4oa_         149 LNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKG----------------------------------  192 (308)
T ss_dssp             HHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGG----------------------------------
T ss_pred             HhhCCeeeceEcCCceeecCCce--EEEeecccceeccCCcceeec----------------------------------
Confidence            99999999999999999998877  999999998765432211100                                  


Q ss_pred             cccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccccccc
Q psy3074         419 WFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDIV  463 (481)
Q Consensus       419 ~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~~  463 (481)
                           ....+|+.|++|        ...+|+||+|++++||..+..+++.+..
T Consensus       193 -----~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~  240 (308)
T d1p4oa_         193 -----GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  240 (308)
T ss_dssp             -----GSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             -----cceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC
Confidence                 112356666666        4466999999999999988656665543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.1e-28  Score=237.32  Aligned_cols=132  Identities=40%  Similarity=0.742  Sum_probs=107.7

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......                   
T Consensus       104 ~~~~q-il~aL~~lH~~~iiHrDiKp----~NIli~~~----~~~KL~DFG~a~~~~~~~~-------------------  155 (299)
T d1ua2a_         104 AYMLM-TLQGLEYLHQHWILHRDLKP----NNLLLDEN----GVLKLADFGLAKSFGSPNR-------------------  155 (299)
T ss_dssp             HHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECCCGGGSTTTSCCC-------------------
T ss_pred             HHHHH-HHHHHHHhhccceecccCCc----ceEEecCC----CccccccCccccccCCCcc-------------------
Confidence            33444 68899999999999999999    89999876    7999999999985322110                   


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                             ....                      .++|+.|||||++.+...|+.++||||+||++|||++|.+||.+.. 
T Consensus       156 -------~~~~----------------------~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-  205 (299)
T d1ua2a_         156 -------AYTH----------------------QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-  205 (299)
T ss_dssp             -------CCCC----------------------SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-
T ss_pred             -------cccc----------------------eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-
Confidence                   0001                      1249999999999988779999999999999999999999999854 


Q ss_pred             hHHHHHHHHHHhCCCCccCcccccCCCCCC
Q psy3074         175 VYDQLDKIFKILGTPTEETWEGVSLLPGYN  204 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~  204 (481)
                      ..+++.+|.+.+++|..+.|+.........
T Consensus       206 ~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         206 DLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             HHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             HHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            458999999999999999998876655443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.4e-28  Score=237.25  Aligned_cols=150  Identities=22%  Similarity=0.368  Sum_probs=121.6

Q ss_pred             hhHHHHHHHHhhc-CCCCeeEEeeeeecCCeEEEEEeccC-CCHHHHHHHhc---------------CCCChHHHHHHHH
Q psy3074         268 FTAIREASLLKEL-KHNNIVTLHDIVHTRSTLTFVFEYVH-TDLSQYMERHS---------------GGLDHHNIRLFMF  330 (481)
Q Consensus       268 ~~~~rE~~il~~l-~HpnIV~l~~~~~~~~~~~iv~E~~~-g~l~~~l~~~~---------------~~l~~~~~~~~~~  330 (481)
                      ..+.+|+.++.++ +|||||++++++.+++.+++|||||+ |++.+++....               ..+++..+..++.
T Consensus        63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  142 (299)
T d1fgka_          63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  142 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence            3466799999888 79999999999999999999999998 77888886442               3489999999999


Q ss_pred             HHHHHHHHhhcCceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEE
Q psy3074         331 QLLRGLSYCHRRRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVST  410 (481)
Q Consensus       331 qi~~~l~ylH~~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~  410 (481)
                      |++.||+|||+++|+||||||+|||++.++.  +|++|||+++.+.........                          
T Consensus       143 qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~~~~--------------------------  194 (299)
T d1fgka_         143 QVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT--------------------------  194 (299)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTTCCC--------------------------
T ss_pred             HHHHHHHHhhhCCEEeeeecccceeecCCCC--eEeccchhhcccccccccccc--------------------------
Confidence            9999999999999999999999999998887  999999998866532211110                          


Q ss_pred             eecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhC-CCccc
Q psy3074         411 VDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKH-NNIVT  458 (481)
Q Consensus       411 ~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~-~~~~~  458 (481)
                                   ....+|+.|++|        +.++|+||+|++++||++ |.+|+
T Consensus       195 -------------~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         195 -------------TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             -------------TTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             -------------ccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence                         113355556665        567799999999999997 66444

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=4.4e-28  Score=238.50  Aligned_cols=156  Identities=18%  Similarity=0.314  Sum_probs=123.7

Q ss_pred             hhHHHHHHHHhhcCCCCeeEEeeeeec-CCeEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCcee
Q psy3074         268 FTAIREASLLKELKHNNIVTLHDIVHT-RSTLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRIL  345 (481)
Q Consensus       268 ~~~~rE~~il~~l~HpnIV~l~~~~~~-~~~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~ii  345 (481)
                      .++.+|+++|++++|||||++++++.+ ++..++|||||+ |++.+++......+++..+..++.|++.||.|+|+.+|+
T Consensus        73 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~ii  152 (311)
T d1r0pa_          73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV  152 (311)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcc
Confidence            356789999999999999999999765 568999999999 677777776666678888999999999999999999999


Q ss_pred             eccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCccccccCc
Q psy3074         346 HRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGWWFESKSN  425 (481)
Q Consensus       346 HrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~~~~~~~~  425 (481)
                      ||||||+|||+++++.  +|++|||+++.+........                                     .....
T Consensus       153 HrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~-------------------------------------~~~~~  193 (311)
T d1r0pa_         153 HRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSV-------------------------------------HNKTG  193 (311)
T ss_dssp             CSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCT-------------------------------------TCTTC
T ss_pred             cCCccHHhEeECCCCC--EEEecccchhhccccccccc-------------------------------------eeccc
Confidence            9999999999998877  99999999986543211100                                     00011


Q ss_pred             ccceeccCCC--------CCChhhhhhHHHHHHhhCCCccccccc
Q psy3074         426 INLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTLHDI  462 (481)
Q Consensus       426 ~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~~~~  462 (481)
                      ..||+.|++|        +..+|+||+|++++||.++..|++.+.
T Consensus       194 ~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~  238 (311)
T d1r0pa_         194 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV  238 (311)
T ss_dssp             SSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred             ccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence            2356666666        556699999999999999777777654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.2e-28  Score=233.80  Aligned_cols=117  Identities=27%  Similarity=0.441  Sum_probs=91.9

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +..+.....+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....              
T Consensus       102 ~l~e~~~~~i~~q-i~~al~~lH~~~ivHrDiKp----~Nill~~~----~~~kl~DFG~a~~~~~--------------  158 (263)
T d2j4za1         102 KFDEQRTATYITE-LANALSYCHSKRVIHRDIKP----ENLLLGSA----GELKIADFGWSVHAPS--------------  158 (263)
T ss_dssp             SCCHHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEECCCCSCSCCCC--------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHCCeeeeeecc----ccceecCC----CCEeecccceeeecCC--------------
Confidence            4445555555555 88999999999999999999    89999876    7999999999974321              


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                    +......                      ||+.|||||++.+.. |+.++||||+||++|||++|+
T Consensus       159 --------------~~~~~~~----------------------Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~  201 (263)
T d2j4za1         159 --------------SRRTTLC----------------------GTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGK  201 (263)
T ss_dssp             --------------CCCEETT----------------------EEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSS
T ss_pred             --------------CcccccC----------------------CCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCC
Confidence                          1112223                      399999999999865 999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~  184 (481)
                      +||.+. +..+.+.+|.+
T Consensus       202 ~Pf~~~-~~~~~~~~i~~  218 (263)
T d2j4za1         202 PPFEAN-TYQETYKRISR  218 (263)
T ss_dssp             CTTCCS-SHHHHHHHHHT
T ss_pred             CCCCCC-CHHHHHHHHHc
Confidence            999884 33355555543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.5e-27  Score=233.69  Aligned_cols=128  Identities=41%  Similarity=0.700  Sum_probs=104.8

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      +... .+.||+|||+++|+||||||    +|||++..    |.+||+|||+++....                       
T Consensus       121 ~~~q-i~~aL~yLH~~~ivHrDiKp----~NILi~~~----~~~kl~dfg~~~~~~~-----------------------  168 (305)
T d1blxa_         121 MMFQ-LLRGLDFLHSHRVVHRDLKP----QNILVTSS----GQIKLADFGLARIYSF-----------------------  168 (305)
T ss_dssp             HHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECSCCSCCCCCG-----------------------
T ss_pred             HHHH-HHHHHHHHHhCCEEecCCCc----cEEEEcCC----CCeeecchhhhhhhcc-----------------------
Confidence            4444 68899999999999999999    89999876    7999999999974211                       


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhh
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREV  175 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~  175 (481)
                          +.....                      ..+|+.|||||++.+.. |+.++||||+||++|||++|++||.+.+ .
T Consensus       169 ----~~~~~~----------------------~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~-~  220 (305)
T d1blxa_         169 ----QMALTS----------------------VVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSS-D  220 (305)
T ss_dssp             ----GGGGCC----------------------CCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSS-H
T ss_pred             ----cccCCC----------------------cccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCC-H
Confidence                011111                      23499999999998876 9999999999999999999999999854 4


Q ss_pred             HHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         176 YDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       176 ~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      .+++.+|.+.++.|....|+.....+..
T Consensus       221 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~  248 (305)
T d1blxa_         221 VDQLGKILDVIGLPGEEDWPRDVALPRQ  248 (305)
T ss_dssp             HHHHHHHHHHHCCCCGGGSCTTCSSCGG
T ss_pred             HHHHHHHHHhhCCCchhcccccccchhh
Confidence            5899999999999999888876554433

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.93  E-value=4.9e-27  Score=234.75  Aligned_cols=134  Identities=19%  Similarity=0.291  Sum_probs=103.9

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++..+..-..+... .+.||+|||++|||||||||    +||||+..  ..|.+||+|||+|+..               
T Consensus       122 ~~l~e~~~~~i~~q-i~~aL~ylH~~~iiHRDiKp----~NILl~~~--~~~~vkL~DFGla~~~---------------  179 (352)
T d1koba_         122 YKMSEAEVINYMRQ-ACEGLKHMHEHSIVHLDIKP----ENIMCETK--KASSVKIIDFGLATKL---------------  179 (352)
T ss_dssp             CCBCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESST--TCCCEEECCCTTCEEC---------------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHHCCeeeccccc----cccccccc--CCCeEEEeecccceec---------------
Confidence            34555555666666 88999999999999999999    89999743  2379999999999853               


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                  ..+.......|                      |+.|||||++.+.. |+.++||||+||++|||++|
T Consensus       180 ------------~~~~~~~~~~g----------------------t~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG  224 (352)
T d1koba_         180 ------------NPDEIVKVTTA----------------------TAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSG  224 (352)
T ss_dssp             ------------CTTSCEEEECS----------------------SGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHS
T ss_pred             ------------CCCCceeeccC----------------------cccccCHHHHcCCC-CCCccchHHHHHHHHHHHhC
Confidence                        22233344444                      99999999998776 99999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      ++||.+.+ ..+.+..|.+....++...++.+
T Consensus       225 ~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~  255 (352)
T d1koba_         225 LSPFAGED-DLETLQNVKRCDWEFDEDAFSSV  255 (352)
T ss_dssp             CCSSCCSS-HHHHHHHHHHCCCCCCSSTTTTS
T ss_pred             CCCCCCCC-HHHHHHHHHhCCCCCCcccccCC
Confidence            99999854 44777777776555555444433

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=7.8e-28  Score=232.72  Aligned_cols=158  Identities=17%  Similarity=0.201  Sum_probs=105.1

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++......+.++.+ .+.||+|||+++||||||||    +||||+..    +.+||+|||+|+.......          
T Consensus        99 ~~~~~~~~~~i~~q-i~~gl~yLH~~~ivHrDlKp----~NiLl~~~----~~~Kl~DFGla~~~~~~~~----------  159 (276)
T d1uwha_          99 TKFEMIKLIDIARQ-TAQGMDYLHAKSIIHRDLKS----NNIFLHED----LTVKIGDFGLATVKSRWSG----------  159 (276)
T ss_dssp             CCCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEETT----SSEEECCCCCSCC----------------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHhcCCEeccccCH----HHEEEcCC----CCEEEccccceeeccccCC----------
Confidence            44555666677777 88999999999999999999    89999876    7999999999985321100          


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC--CCCCCccchhhHHHHHHHHH
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~--~~y~~~~DvWS~G~il~ell  163 (481)
                                    ......                      ..+|+.|||||++.+.  ..|+.++|||||||++|||+
T Consensus       160 --------------~~~~~~----------------------~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~  203 (276)
T d1uwha_         160 --------------SHQFEQ----------------------LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM  203 (276)
T ss_dssp             ------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             --------------cccccc----------------------cccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence                          000111                      1249999999999753  34899999999999999999


Q ss_pred             hCCCCCCCchhhHHHHHHHHHHhCCCCccCc-cccc---CCCCCCccCCCCccCCCcCc
Q psy3074         164 TGLPTFPGVREVYDQLDKIFKILGTPTEETW-EGVS---LLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       164 tg~~PF~g~~~~~~~l~~i~~~~~~p~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ||+.||.+.+........+.+....|..... +..+   ......|+...|..|+++.+
T Consensus       204 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~  262 (276)
T d1uwha_         204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ  262 (276)
T ss_dssp             HSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            9999999865543333334343444432221 1111   11123456655666656543

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1e-27  Score=235.06  Aligned_cols=146  Identities=17%  Similarity=0.160  Sum_probs=113.1

Q ss_pred             HHHHHHhhcCCCCeeEEeeeeecCC----eEEEEEeccC-CCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhc-----
Q psy3074         272 REASLLKELKHNNIVTLHDIVHTRS----TLTFVFEYVH-TDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHR-----  341 (481)
Q Consensus       272 rE~~il~~l~HpnIV~l~~~~~~~~----~~~iv~E~~~-g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~-----  341 (481)
                      +|+..+++++|||||++++++.+++    .+|+|||||+ |+|..++..  ..+++.....++.|++.||.|+|+     
T Consensus        46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~  123 (303)
T d1vjya_          46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGT  123 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence            3666667889999999999997654    6899999998 688888865  358999999999999999999996     


Q ss_pred             ---CceeeccCCCccccccccchhhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeEEEeecCCCCc
Q psy3074         342 ---RRILHRDVKPQNLLISEIDHHNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVVSTVDSGSGGW  418 (481)
Q Consensus       342 ---~~iiHrDlKp~NiLl~~~~~~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~~~~~~g~~~~  418 (481)
                         ++|+||||||+|||++.++.  +|++|||+++.+.......                                    
T Consensus       124 ~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~------------------------------------  165 (303)
T d1vjya_         124 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTI------------------------------------  165 (303)
T ss_dssp             TCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEE------------------------------------
T ss_pred             ccCCCeeccccCccceEEcCCCC--eEEEecCccccccCCCcce------------------------------------
Confidence               59999999999999998877  9999999987553211000                                    


Q ss_pred             cccccCcccceeccCCC--------------CCChhhhhhHHHHHHhhCCCccc
Q psy3074         419 WFESKSNINLSFHYLPP--------------GAPFTAIREASLLKELKHNNIVT  458 (481)
Q Consensus       419 ~~~~~~~~~~t~~y~~p--------------~~p~~~~s~~~~l~~l~~~~~~~  458 (481)
                       ........||+.|++|              +.++|+||+|++|+||.+|..|+
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~  218 (303)
T d1vjya_         166 -DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG  218 (303)
T ss_dssp             -CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBT
T ss_pred             -eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCC
Confidence             0001123466666666              12469999999999999997554

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.93  E-value=6e-28  Score=241.34  Aligned_cols=119  Identities=19%  Similarity=0.355  Sum_probs=94.0

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      .....+... .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+.....                 
T Consensus       141 ~~~~~i~~q-i~~aL~yLH~~~iiHRDIKP----~NILl~~~----g~ikL~DFG~a~~~~~~-----------------  194 (350)
T d1rdqe_         141 PHARFYAAQ-IVLTFEYLHSLDLIYRDLKP----ENLLIDQQ----GYIQVTDFGFAKRVKGR-----------------  194 (350)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECSSC-----------------
T ss_pred             HHHHHHHHH-HHHHHHHHHhCCEecCcCCH----HHcccCCC----CCEEeeeceeeeecccc-----------------
Confidence            333344444 78999999999999999999    89999876    79999999999853210                 


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFP  170 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~  170 (481)
                                  .....|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.
T Consensus       195 ------------~~~~~G----------------------t~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~  239 (350)
T d1rdqe_         195 ------------TWTLCG----------------------TPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFF  239 (350)
T ss_dssp             ------------BCCCEE----------------------CGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ------------cccccC----------------------ccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCC
Confidence                        112234                      99999999999765 9999999999999999999999999


Q ss_pred             CchhhHHHHHHHHHHhCCCCc
Q psy3074         171 GVREVYDQLDKIFKILGTPTE  191 (481)
Q Consensus       171 g~~~~~~~l~~i~~~~~~p~~  191 (481)
                      +. +....+.+|......++.
T Consensus       240 ~~-~~~~~~~~i~~~~~~~p~  259 (350)
T d1rdqe_         240 AD-QPIQIYEKIVSGKVRFPS  259 (350)
T ss_dssp             CS-SHHHHHHHHHHCCCCCCT
T ss_pred             Cc-CHHHHHHHHhcCCCCCCc
Confidence            85 445677777765544433

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.2e-28  Score=233.93  Aligned_cols=120  Identities=27%  Similarity=0.466  Sum_probs=90.3

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .+.....++.. .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+......              
T Consensus       106 ~e~~~~~~~~q-i~~al~ylH~~~iiHrDiKp----~NIll~~~----~~vkl~DFG~a~~~~~~~--------------  162 (288)
T d1uu3a_         106 DETCTRFYTAE-IVSALEYLHGKGIIHRDLKP----ENILLNED----MHIQITDFGTAKVLSPES--------------  162 (288)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----SCEEECCCTTCEECC-----------------
T ss_pred             CHHHHHHHHHH-HHHHHHhhccccEEcCcCCc----cccccCCC----ceEEecccccceecccCC--------------
Confidence            33333444444 78899999999999999999    89999876    799999999998542110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                ........+                      ||+.|||||++.+.. |+.++||||+||++|||++|++|
T Consensus       163 ----------~~~~~~~~~----------------------GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~P  209 (288)
T d1uu3a_         163 ----------KQARANSFV----------------------GTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPP  209 (288)
T ss_dssp             -----------------CC----------------------CCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ----------ccccccccc----------------------CCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCC
Confidence                      111112223                      499999999998876 99999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFKI  185 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~  185 (481)
                      |.+.+ ..+.+++|.+.
T Consensus       210 f~~~~-~~~~~~~i~~~  225 (288)
T d1uu3a_         210 FRAGN-EYLIFQKIIKL  225 (288)
T ss_dssp             SCCSS-HHHHHHHHHTT
T ss_pred             CCCcC-HHHHHHHHHcC
Confidence            99853 34566666543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.2e-27  Score=235.89  Aligned_cols=107  Identities=26%  Similarity=0.465  Sum_probs=87.0

Q ss_pred             cccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCC
Q psy3074          20 SKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGE   99 (481)
Q Consensus        20 ~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~   99 (481)
                      ..+.||+|||++|||||||||    +|||++.+    |.+||+|||+|+....                          .
T Consensus       113 qil~al~ylH~~~iiHRDlKP----~NILl~~~----g~vkl~DFG~a~~~~~--------------------------~  158 (337)
T d1o6la_         113 EIVSALEYLHSRDVVYRDIKL----ENLMLDKD----GHIKITDFGLCKEGIS--------------------------D  158 (337)
T ss_dssp             HHHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCSCC--------------------------T
T ss_pred             HHhhhhhhhhhcCccccccCH----HHeEecCC----CCEEEeeccccccccc--------------------------C
Confidence            378999999999999999999    89999876    8999999999984321                          1


Q ss_pred             CceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         100 GSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       100 g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      +.....++|                      |+.|||||++.+.. |+.++||||+||++|||++|++||.+.+ ..+.+
T Consensus       159 ~~~~~~~~G----------------------T~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~  214 (337)
T d1o6la_         159 GATMKTFCG----------------------TPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLF  214 (337)
T ss_dssp             TCCBCCCEE----------------------CGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHH
T ss_pred             Cccccccee----------------------CHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcC-HHHHH
Confidence            112223444                      99999999998876 9999999999999999999999999854 33555


Q ss_pred             HHHHH
Q psy3074         180 DKIFK  184 (481)
Q Consensus       180 ~~i~~  184 (481)
                      +++..
T Consensus       215 ~~i~~  219 (337)
T d1o6la_         215 ELILM  219 (337)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            55544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.5e-27  Score=235.90  Aligned_cols=116  Identities=29%  Similarity=0.395  Sum_probs=86.1

Q ss_pred             hhhccCcccccHHHHHH-hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccce
Q psy3074          14 ISVSSDSKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYI   92 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~   92 (481)
                      ..+... .+.||+|||+ +||+||||||    +|||++..    |.+||+|||+|+....                    
T Consensus       107 ~~~~~q-il~aL~yLH~~~~IiHRDiKP----~NILl~~~----~~vkl~DFGla~~~~~--------------------  157 (322)
T d1s9ja_         107 GKVSIA-VIKGLTYLREKHKIMHRDVKP----SNILVNSR----GEIKLCDFGVSGQLID--------------------  157 (322)
T ss_dssp             HHHHHH-HHHHHHHHHHHHCCCCSCCSG----GGEEECTT----CCEEECCCCCCHHHHH--------------------
T ss_pred             HHHHHH-HHHHHHHHHHhCCEEccccCH----HHeeECCC----CCEEEeeCCCccccCC--------------------
Confidence            344444 7889999997 5899999999    89999876    7999999999984311                    


Q ss_pred             ecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          93 KLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        93 ~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                              +....++                      ||++|||||++.+.. |+.++||||+||++|||++|+.||.+.
T Consensus       158 --------~~~~~~~----------------------GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         158 --------SMANSFV----------------------GTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             --------HTC---C----------------------CSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             --------Ccccccc----------------------CCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                    0111233                      499999999999876 999999999999999999999999987


Q ss_pred             hhhHHHHHHHHHHhCCC
Q psy3074         173 REVYDQLDKIFKILGTP  189 (481)
Q Consensus       173 ~~~~~~l~~i~~~~~~p  189 (481)
                      +....++..+....+.+
T Consensus       207 ~~~~~~~~~~~~~~~~~  223 (322)
T d1s9ja_         207 DAKELELMFGCQVEGDA  223 (322)
T ss_dssp             CTTHHHHHC--------
T ss_pred             CHHHHHHHHHHHhcCCc
Confidence            65545555444444443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3.2e-27  Score=227.68  Aligned_cols=120  Identities=18%  Similarity=0.253  Sum_probs=91.3

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++..+.....+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.......          
T Consensus        98 ~~l~e~~~~~i~~q-i~~al~ylH~~~IiHrDiKp----~NILl~~~----~~~KL~DFG~a~~~~~~~~----------  158 (271)
T d1nvra_          98 IGMPEPDAQRFFHQ-LMAGVVYLHGIGITHRDIKP----ENLLLDER----DNLKISDFGLATVFRYNNR----------  158 (271)
T ss_dssp             TBCCHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECTT----CCEEECCCTTCEECEETTE----------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHHHHcCCccCcccH----HHEEECCC----CCEEEccchhheeeccCCc----------
Confidence            34445555556666 89999999999999999999    89999876    7999999999985321100          


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                    ......                      .+||+.|||||++.+...++.++||||+||++|||++|
T Consensus       159 --------------~~~~~~----------------------~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         159 --------------ERLLNK----------------------MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             --------------ECCBCC----------------------CCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             --------------cccccc----------------------eeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence                          000111                      23499999999999877567899999999999999999


Q ss_pred             CCCCCCchhhHHHHH
Q psy3074         166 LPTFPGVREVYDQLD  180 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~  180 (481)
                      ++||.+..+....+.
T Consensus       203 ~~pf~~~~~~~~~~~  217 (271)
T d1nvra_         203 ELPWDQPSDSCQEYS  217 (271)
T ss_dssp             SCSCSSSSTTSHHHH
T ss_pred             CCCCCCCChHHHHHH
Confidence            999987655433333

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1e-26  Score=226.67  Aligned_cols=117  Identities=22%  Similarity=0.397  Sum_probs=90.5

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .+..-..+... .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+......              
T Consensus       114 ~~~~~~~i~~q-i~~aL~yLH~~~iiHrDiKp----~NILl~~~----~~vkl~DFG~a~~~~~~~--------------  170 (293)
T d1yhwa1         114 DEGQIAAVCRE-CLQALEFLHSNQVIHRDIKS----DNILLGMD----GSVKLTDFGFCAQITPEQ--------------  170 (293)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECCSTT--------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHCCCcccCCcH----HHeEECCC----CcEeeccchhheeecccc--------------
Confidence            34444445555 78999999999999999999    89999866    799999999998532110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                  ......+                      +|+.|||||++.+.. |+.++||||+||++|||++|++|
T Consensus       171 ------------~~~~~~~----------------------gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~P  215 (293)
T d1yhwa1         171 ------------SKRSTMV----------------------GTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPP  215 (293)
T ss_dssp             ------------CCBCCCC----------------------SCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             ------------ccccccc----------------------cCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCC
Confidence                        1111122                      499999999999865 99999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHH
Q psy3074         169 FPGVREVYDQLDKIFK  184 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~  184 (481)
                      |.+.+.. +.+..+..
T Consensus       216 f~~~~~~-~~~~~~~~  230 (293)
T d1yhwa1         216 YLNENPL-RALYLIAT  230 (293)
T ss_dssp             TTTSCHH-HHHHHHHH
T ss_pred             CCCCCHH-HHHHHHHh
Confidence            9885433 55555544

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.92  E-value=1.2e-26  Score=231.74  Aligned_cols=134  Identities=22%  Similarity=0.323  Sum_probs=103.8

Q ss_pred             cchhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCC
Q psy3074           5 ENKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSP   84 (481)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~   84 (481)
                      .++..+.....+... .+.||+|||++|||||||||    +|||++...  .|.+||+|||+|+..              
T Consensus       118 ~~~l~e~~~~~i~~q-i~~aL~ylH~~~iiHrDiKp----~NIll~~~~--~~~vkL~DFG~a~~~--------------  176 (350)
T d1koaa2         118 HNKMSEDEAVEYMRQ-VCKGLCHMHENNYVHLDLKP----ENIMFTTKR--SNELKLIDFGLTAHL--------------  176 (350)
T ss_dssp             TSCBCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESSTT--SCCEEECCCTTCEEC--------------
T ss_pred             cCCCCHHHHHHHHHH-HHHHHHHHHhcCCeeeeech----hHeeeccCC--CCeEEEeecchheec--------------
Confidence            345556555666666 89999999999999999999    899996532  378999999999853              


Q ss_pred             CCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh
Q psy3074          85 FGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        85 ~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt  164 (481)
                                   +......+..|                      |+.|||||++.+.. |+.++||||+||++|||++
T Consensus       177 -------------~~~~~~~~~~g----------------------T~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~  220 (350)
T d1koaa2         177 -------------DPKQSVKVTTG----------------------TAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLS  220 (350)
T ss_dssp             -------------CTTSCEEEECS----------------------CTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHH
T ss_pred             -------------ccccccceecC----------------------cccccCHHHHcCCC-CChhHhhhhhhHHHHHHHh
Confidence                         22223344555                      99999999999876 9999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHHHHhCCCCccCccc
Q psy3074         165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      |++||.+. +..+.+..|......++...++.
T Consensus       221 G~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~  251 (350)
T d1koaa2         221 GLSPFGGE-NDDETLRNVKSCDWNMDDSAFSG  251 (350)
T ss_dssp             SSCSSCCS-SHHHHHHHHHHTCCCSCCGGGGG
T ss_pred             CCCCCCCC-CHHHHHHHHHhCCCCCCcccccC
Confidence            99999985 44477777776655555444443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.9e-28  Score=238.18  Aligned_cols=121  Identities=20%  Similarity=0.358  Sum_probs=92.1

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.+ .+.||+|||+++||||||||    +|||++..    |.+||+|||+|+......             
T Consensus       161 l~~~~~~~i~~q-i~~gl~yLH~~~IiHRDlKp----~Nill~~~----~~~Kl~DFGla~~~~~~~-------------  218 (325)
T d1rjba_         161 LTFEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAA----RNVLVTHG----KVVKICDFGLARDIMSDS-------------  218 (325)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEEETTCSG----GGEEEETT----TEEEECCCGGGSCGGGCT-------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCeeeccCch----hccccccC----CeEEEeeccccccccCCC-------------
Confidence            444555566666 78899999999999999999    89999876    799999999998542211             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                 .........                      +|+.|||||++.+.. |+.++|||||||++|||+| |+
T Consensus       219 -----------~~~~~~~~~----------------------gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~  264 (325)
T d1rjba_         219 -----------NYVVRGNAR----------------------LPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV  264 (325)
T ss_dssp             -----------TSEEETTEE----------------------ECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSC
T ss_pred             -----------ceeeecccc----------------------CCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCC
Confidence                       000001112                      399999999998766 9999999999999999998 89


Q ss_pred             CCCCCchhhHHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~  185 (481)
                      +||.+.+.. +.+.++.+.
T Consensus       265 ~Pf~~~~~~-~~~~~~~~~  282 (325)
T d1rjba_         265 NPYPGIPVD-ANFYKLIQN  282 (325)
T ss_dssp             CSSTTCCCS-HHHHHHHHT
T ss_pred             CCCCCCCHH-HHHHHHHhc
Confidence            999986443 444555443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.4e-27  Score=229.98  Aligned_cols=116  Identities=30%  Similarity=0.504  Sum_probs=82.4

Q ss_pred             HHhhhhccCcccccHHHHHHhh-----hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074          11 QRQISVSSDSKLLDADIAEETR-----VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~-----i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      .....+... .+.||+|||+.+     ||||||||    +|||++..    |.+||+|||+|+.....            
T Consensus       109 ~~~~~i~~q-i~~al~ylH~~~~~~~~IiHrDiKp----~NIll~~~----~~vkl~DFG~a~~~~~~------------  167 (269)
T d2java1         109 EFVLRVMTQ-LTLALKECHRRSDGGHTVLHRDLKP----ANVFLDGK----QNVKLGDFGLARILNHD------------  167 (269)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHHCC---------CCG----GGEEECTT----SCEEECCHHHHHHC---------------
T ss_pred             HHHHHHHHH-HHHHHHHHHHhcCCCCCEEeCcCch----hhcCcCCC----CcEEEeeccceeecccC------------
Confidence            334444555 788999999976     99999999    89999876    79999999999853211            


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                    ........                      +|+.|||||++.+.. |+.++||||+||++|||++|
T Consensus       168 --------------~~~~~~~~----------------------gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg  210 (269)
T d2java1         168 --------------TSFAKAFV----------------------GTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCAL  210 (269)
T ss_dssp             --------------------------------------------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred             --------------CCccccCC----------------------CCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhC
Confidence                          01112233                      399999999998765 99999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~  185 (481)
                      ++||.+.+ ..+.+.+|...
T Consensus       211 ~~Pf~~~~-~~~~~~~i~~~  229 (269)
T d2java1         211 MPPFTAFS-QKELAGKIREG  229 (269)
T ss_dssp             SCSCCCSS-HHHHHHHHHHT
T ss_pred             CCCCCCCC-HHHHHHHHHcC
Confidence            99999853 33555655543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.92  E-value=2.5e-27  Score=233.53  Aligned_cols=108  Identities=24%  Similarity=0.413  Sum_probs=88.0

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+.....                           
T Consensus       113 i~~al~~lH~~~iiHrDiKp----~NILl~~~----g~vkL~DFG~a~~~~~~---------------------------  157 (316)
T d1fota_         113 VCLALEYLHSKDIIYRDLKP----ENILLDKN----GHIKITDFGFAKYVPDV---------------------------  157 (316)
T ss_dssp             HHHHHHHHHTTTEECCCCCG----GGEEECTT----SCEEECCCSSCEECSSC---------------------------
T ss_pred             HHHhhhhhccCcEEccccCc----hheeEcCC----CCEEEecCccceEeccc---------------------------
Confidence            68899999999999999999    89999876    79999999999853210                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                        ....+                      ||+.|||||++.+.. |+.++||||+||++|||++|++||.+. +..+.+.
T Consensus       158 --~~~~~----------------------Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~  211 (316)
T d1fota_         158 --TYTLC----------------------GTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYE  211 (316)
T ss_dssp             --BCCCC----------------------SCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCS-SHHHHHH
T ss_pred             --ccccc----------------------CcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCc-CHHHHHH
Confidence              01123                      399999999998766 999999999999999999999999985 3446667


Q ss_pred             HHHHHhCCC
Q psy3074         181 KIFKILGTP  189 (481)
Q Consensus       181 ~i~~~~~~p  189 (481)
                      +|...-...
T Consensus       212 ~i~~~~~~~  220 (316)
T d1fota_         212 KILNAELRF  220 (316)
T ss_dssp             HHHHCCCCC
T ss_pred             HHHcCCCCC
Confidence            776654333

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.92  E-value=4.2e-26  Score=221.36  Aligned_cols=140  Identities=47%  Similarity=0.799  Sum_probs=111.2

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++..+..-..++.. .+.||+|||+++||||||||    +|||++.+    |.+||+|||+|.......           
T Consensus        95 ~~l~~~~~~~i~~q-i~~~L~~LH~~~IvHrDiKp----~NIll~~~----~~~kl~DfG~a~~~~~~~-----------  154 (286)
T d1ob3a_          95 GGLESVTAKSFLLQ-LLNGIAYCHDRRVLHRDLKP----QNLLINRE----GELKIADFGLARAFGIPV-----------  154 (286)
T ss_dssp             TCCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECCTTHHHHHCC-------------
T ss_pred             CCcchhhhHHHHHH-HHHHHHHhccCcEEecCCCC----ceeeEcCC----CCEEecccccceecccCc-----------
Confidence            34444444555555 78899999999999999999    89999876    799999999997532110           


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG  165 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg  165 (481)
                                     ......                      ++|+.|+|||++.+...++.++|+||+||++|||++|
T Consensus       155 ---------------~~~~~~----------------------~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G  197 (286)
T d1ob3a_         155 ---------------RKYTHE----------------------IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG  197 (286)
T ss_dssp             --------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred             ---------------ccccee----------------------cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC
Confidence                           001111                      2389999999999888799999999999999999999


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      ++||.+.+ ..+++.++.+.++.|....|+........
T Consensus       198 ~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         198 TPLFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             SCSCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCCCCCC-HHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence            99999854 45889999999999999999888766554

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.9e-27  Score=227.01  Aligned_cols=109  Identities=21%  Similarity=0.361  Sum_probs=85.6

Q ss_pred             hhhccCcccccHHHHHHhh--hhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccc
Q psy3074          14 ISVSSDSKLLDADIAEETR--VLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAY   91 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~--i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~   91 (481)
                      ..++.. .+.||+|||+++  |+||||||    +|||++..   .|.+||+|||+|+...                    
T Consensus       115 ~~~~~q-i~~gl~yLH~~~~~IiHrDiKp----~NILl~~~---~~~~Kl~DFGla~~~~--------------------  166 (270)
T d1t4ha_         115 RSWCRQ-ILKGLQFLHTRTPPIIHRDLKC----DNIFITGP---TGSVKIGDLGLATLKR--------------------  166 (270)
T ss_dssp             HHHHHH-HHHHHHHHHTSSSCCCCSCCCG----GGEEESST---TSCEEECCTTGGGGCC--------------------
T ss_pred             HHHHHH-HHHHHHHHHHCCCCEEeCCcCh----hhceeeCC---CCCEEEeecCcceecc--------------------
Confidence            344444 788999999999  99999999    89999643   2799999999997421                    


Q ss_pred             eecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q psy3074          92 IKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPG  171 (481)
Q Consensus        92 ~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g  171 (481)
                              .+.....+|                      |+.|||||++.+  .|+.++||||+||++|||++|++||.+
T Consensus       167 --------~~~~~~~~G----------------------T~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         167 --------ASFAKAVIG----------------------TPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             --------TTSBEESCS----------------------SCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             --------CCccCCccc----------------------CccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence                    122233344                      999999999975  399999999999999999999999987


Q ss_pred             chhhHHHHHHH
Q psy3074         172 VREVYDQLDKI  182 (481)
Q Consensus       172 ~~~~~~~l~~i  182 (481)
                      ..+..+..+.+
T Consensus       215 ~~~~~~~~~~i  225 (270)
T d1t4ha_         215 CQNAAQIYRRV  225 (270)
T ss_dssp             CSSHHHHHHHH
T ss_pred             cccHHHHHHHH
Confidence            65554444443

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=2.1e-27  Score=233.33  Aligned_cols=117  Identities=22%  Similarity=0.349  Sum_probs=91.8

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +..+.....++.+ .+.||+|||++||+||||||    +|||++..    |.+||+|||+|+....              
T Consensus       111 ~l~e~~~~~i~~q-i~~aL~yLH~~~iiHrDiKp----~NILl~~~----~~~Kl~DFG~a~~~~~--------------  167 (309)
T d1u5ra_         111 PLQEVEIAAVTHG-ALQGLAYLHSHNMIHRDVKA----GNILLSEP----GLVKLGDFGSASIMAP--------------  167 (309)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCBCCCCSG----GGEEEETT----TEEEECCCTTCBSSSS--------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCEeccCCCc----ceEEECCC----CCEEEeecccccccCC--------------
Confidence            3445555556666 78999999999999999999    89999876    7999999999984211              


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCC--CCCCCccchhhHHHHHHHHHh
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGS--TEYSTSLDMWGVGCILIEMVT  164 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~--~~y~~~~DvWS~G~il~ellt  164 (481)
                                      ...+.                      ||+.|||||++.+.  ..|+.++||||+||++|||++
T Consensus       168 ----------------~~~~~----------------------GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~  209 (309)
T d1u5ra_         168 ----------------ANSFV----------------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (309)
T ss_dssp             ----------------BCCCC----------------------SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             ----------------CCccc----------------------cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence                            01122                      39999999999753  359999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHHHH
Q psy3074         165 GLPTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~  185 (481)
                      |++||.+.+. .+.+..+...
T Consensus       210 g~~Pf~~~~~-~~~~~~i~~~  229 (309)
T d1u5ra_         210 RKPPLFNMNA-MSALYHIAQN  229 (309)
T ss_dssp             SSCTTTTSCH-HHHHHHHHHS
T ss_pred             CCCCCCCCCH-HHHHHHHHhC
Confidence            9999988543 3555555543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.92  E-value=2.4e-27  Score=231.90  Aligned_cols=158  Identities=14%  Similarity=0.229  Sum_probs=102.0

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      .......+.++.+ .+.||+|||+++|+||||||    +||||+.+    +.+||+|||+|+.......           
T Consensus       124 ~l~~~~~~~i~~q-ia~gl~yLH~~~iiHrDlKp----~NILl~~~----~~~Kl~DFGla~~~~~~~~-----------  183 (299)
T d1jpaa_         124 QFTVIQLVGMLRG-IAAGMKYLADMNYVHRDLAA----RNILVNSN----LVCKVSDFGLSRFLEDDTS-----------  183 (299)
T ss_dssp             CSCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCC----------------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHhhCCCccCcccc----ceEEECCC----CcEEECCcccceEccCCCC-----------
Confidence            4455555666666 78999999999999999999    89999876    7999999999985421110           


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                      ...+.+                .....+|+.|||||++.+.. |+.++|||||||++|||+| |
T Consensus       184 ----------------~~~~~~----------------~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g  230 (299)
T d1jpaa_         184 ----------------DPTYTS----------------ALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYG  230 (299)
T ss_dssp             --------------------------------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred             ----------------cceeee----------------cccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCC
Confidence                            000000                00012389999999998765 9999999999999999998 8


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ++||.+... .+.+..+.+....|.+..++..-......|+...|..|+++.+
T Consensus       231 ~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e  282 (299)
T d1jpaa_         231 ERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ  282 (299)
T ss_dssp             CCTTTTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999998543 3566666665555554444332222233455555555555443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=1.4e-26  Score=227.15  Aligned_cols=127  Identities=22%  Similarity=0.357  Sum_probs=87.3

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ...+.....+... .+.||+|||++||+||||||    +|||+... +..|.+||+|||+|+...               
T Consensus       103 ~l~e~~~~~~~~q-i~~al~ylH~~~iiHrDiKp----~Nil~~~~-~~~~~vkl~DFG~a~~~~---------------  161 (307)
T d1a06a_         103 FYTERDASRLIFQ-VLDAVKYLHDLGIVHRDLKP----ENLLYYSL-DEDSKIMISDFGLSKMED---------------  161 (307)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEESSS-STTCCEEECCC----------------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHhhhhceeeeEEecc----cceeeccc-CCCceEEEeccceeEEcc---------------
Confidence            3444444555555 88999999999999999999    89999643 234799999999998421               


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  .+......+|                      |+.|||||++.+.. |+.++||||+||++|||++|+
T Consensus       162 ------------~~~~~~~~~G----------------------T~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~  206 (307)
T d1a06a_         162 ------------PGSVLSTACG----------------------TPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGY  206 (307)
T ss_dssp             ---------------------------------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSS
T ss_pred             ------------CCCeeeeeee----------------------CccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCC
Confidence                        1122222334                      99999999998765 999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCC
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPT  190 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~  190 (481)
                      +||.+... .+....|.+.-..++
T Consensus       207 ~Pf~~~~~-~~~~~~i~~~~~~~~  229 (307)
T d1a06a_         207 PPFYDEND-AKLFEQILKAEYEFD  229 (307)
T ss_dssp             CSCCCSSH-HHHHHHHHTTCCCCC
T ss_pred             CCCCCCCH-HHHHHHHhccCCCCC
Confidence            99998543 355666655443333

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=1.2e-26  Score=228.58  Aligned_cols=173  Identities=31%  Similarity=0.500  Sum_probs=118.1

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.|+.|||++||+||||||    +|||++.+    |.+||+|||+|+........                      ..
T Consensus       126 il~~l~~lH~~~ivHrDlKp----~NILl~~~----~~~kl~dfg~~~~~~~~~~~----------------------~~  175 (318)
T d3blha1         126 LLNGLYYIHRNKILHRDMKA----ANVLITRD----GVLKLADFGLARAFSLAKNS----------------------QP  175 (318)
T ss_dssp             HHHHHHHHHHTTEECCCCCG----GGEEECTT----SCEEECCCTTCEECCC---------------------------C
T ss_pred             HHHHHHHhccCCEEecCcCc----hheeecCC----CcEEeeecceeeeccccccc----------------------cc
Confidence            68999999999999999999    99999876    79999999999854321100                      00


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      ....                      ..++|++|+|||++.+...|+.++||||+||++|||++|++||.+.. ..+.+.
T Consensus       176 ~~~~----------------------~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~-~~~~~~  232 (318)
T d3blha1         176 NRYT----------------------NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT-EQHQLA  232 (318)
T ss_dssp             CCCC----------------------SCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHH
T ss_pred             cccc----------------------ceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC-HHHHHH
Confidence            0001                      12349999999999988779999999999999999999999999854 458889


Q ss_pred             HHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcchhHHHHHHhhhhhhhcCCccccc
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGESMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      .+.+.++.++++.+..................+..+...++....      .......+.++...+|.++..
T Consensus       233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~dLl~~mL~~dP~~R~s  298 (318)
T d3blha1         233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVR------DPYALDLIDKLLVLDPAQRID  298 (318)
T ss_dssp             HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHC------CHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccC------CHHHHHHHHHHCcCChhHCcC
Confidence            999999999998888776554443333222222221111111000      011233566777778877654

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.7e-27  Score=231.49  Aligned_cols=121  Identities=19%  Similarity=0.359  Sum_probs=84.2

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ........++.+ .+.||+|||+++||||||||    +||||+..    |.+||+|||+|+........           
T Consensus       131 l~~~~~~~~~~q-i~~gl~ylH~~~ivHrDlKp----~NILl~~~----~~~Kl~DFGla~~~~~~~~~-----------  190 (299)
T d1ywna1         131 LTLEHLICYSFQ-VAKGMEFLASRKCIHRDLAA----RNILLSEK----NVVKICDFGLARDIYKDPDY-----------  190 (299)
T ss_dssp             BCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECGG----GCEEECC------CCSCTTS-----------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCCcCCcCCc----cceeECCC----CcEEEccCcchhhccccccc-----------
Confidence            334445555656 78999999999999999999    89999877    79999999999853211100           


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-C
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-L  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-~  166 (481)
                                   ...                      +...+|+.|||||++.+.. |+.++||||+||++|||+|| .
T Consensus       191 -------------~~~----------------------~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~  234 (299)
T d1ywna1         191 -------------VRK----------------------GDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGA  234 (299)
T ss_dssp             -------------CCT----------------------TSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------ccc----------------------CceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCC
Confidence                         000                      0112499999999999866 99999999999999999986 6


Q ss_pred             CCCCCchhhHHHHHHHHH
Q psy3074         167 PTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~  184 (481)
                      +||.+..........+.+
T Consensus       235 ~p~~~~~~~~~~~~~~~~  252 (299)
T d1ywna1         235 SPYPGVKIDEEFCRRLKE  252 (299)
T ss_dssp             CSSTTCCCSHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHhc
Confidence            789876444333333333

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=5.6e-27  Score=227.48  Aligned_cols=157  Identities=15%  Similarity=0.176  Sum_probs=103.5

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      .......+.++.+ .+.|++|||+++|+||||||    +||||+.+    +.+||+|||+|+......            
T Consensus       106 ~~~~~~~~~i~~~-i~~gl~~lH~~~iiHrDlKp----~NILl~~~----~~~Kl~DFGla~~~~~~~------------  164 (283)
T d1mqba_         106 EFSVLQLVGMLRG-IAAGMKYLANMNYVHRDLAA----RNILVNSN----LVCKVSDFGLSRVLEDDP------------  164 (283)
T ss_dssp             CSCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCCCC--------------------
T ss_pred             cccHHHHHHHHHH-HHHhhhhccccccccCcccc----ceEEECCC----CeEEEcccchhhcccCCC------------
Confidence            3445555667777 78899999999999999999    99999876    799999999998532110            


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  ...+..                     ....+|+.|||||++.+.. |+.++|||||||++|||++|.
T Consensus       165 ------------~~~~~~---------------------~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~  210 (283)
T d1mqba_         165 ------------EATYTT---------------------SGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYG  210 (283)
T ss_dssp             ------------------------------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred             ------------ccceEe---------------------ccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCC
Confidence                        000000                     0112499999999998775 999999999999999999965


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .||.......+.++.+......|.+..++..-......|+...|..|+++.+
T Consensus       211 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e  262 (283)
T d1mqba_         211 ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD  262 (283)
T ss_dssp             CCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence            5444433444556666655555555544432222334566666666666543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.4e-27  Score=229.38  Aligned_cols=155  Identities=14%  Similarity=0.135  Sum_probs=107.2

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.+ .+.||+|||+++||||||||    +||||+..    |.+||+|||+|+........           
T Consensus       104 l~~~~~~~i~~q-i~~gl~ylH~~~iiHrDlKp----~Nill~~~----~~~kl~DFGla~~~~~~~~~-----------  163 (277)
T d1xbba_         104 VKDKNIIELVHQ-VSMGMKYLEESNFVHRDLAA----RNVLLVTQ----HYAKISDFGLSKALRADENY-----------  163 (277)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEEET----TEEEECCCTTCEECCTTCSE-----------
T ss_pred             CCHHHHHHHHHH-HHHHHhhHHhCCcccCCCcc----hhhccccc----Ccccccchhhhhhccccccc-----------
Confidence            444555666666 78999999999999999999    89999877    79999999999854211100           


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                  ......                      ..+|+.|||||++.+.. |+.++|||||||++|||+| |+
T Consensus       164 ------------~~~~~~----------------------~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~  208 (277)
T d1xbba_         164 ------------YKAQTH----------------------GKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQ  208 (277)
T ss_dssp             ------------EEC--------------------------CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTC
T ss_pred             ------------cccccc----------------------cCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCC
Confidence                        000011                      12499999999998776 9999999999999999998 89


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      +||.+.+. .+....|.+....+.+..++..-......|+...|..|+++++
T Consensus       209 ~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~  259 (277)
T d1xbba_         209 KPYRGMKG-SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA  259 (277)
T ss_dssp             CSSTTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred             CCCCCCCH-HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            99998543 2445555444444444433332222233566666666666543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=8.9e-27  Score=226.56  Aligned_cols=119  Identities=24%  Similarity=0.365  Sum_probs=90.5

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.....+... .+.||+|||++||+||||||    +|||++.+    |.+||+|||+|+.....              
T Consensus       107 l~e~~~~~i~~q-i~~gL~ylH~~~ivHrDiKp----~NIll~~~----~~~Kl~DFG~a~~~~~~--------------  163 (288)
T d2jfla1         107 LTESQIQVVCKQ-TLDALNYLHDNKIIHRDLKA----GNILFTLD----GDIKLADFGVSAKNTRT--------------  163 (288)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEECTT----SCEEECCCTTCEECHHH--------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHCCEEEeecCh----hheeECCC----CCEEEEechhhhccCCC--------------
Confidence            444444555555 78999999999999999999    99999876    79999999999742100              


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC----CCCCCCccchhhHHHHHHHHH
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG----STEYSTSLDMWGVGCILIEMV  163 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~----~~~y~~~~DvWS~G~il~ell  163 (481)
                                                        ........+|+.|||||++..    ...|+.++||||+||++|||+
T Consensus       164 ----------------------------------~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyeml  209 (288)
T d2jfla1         164 ----------------------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA  209 (288)
T ss_dssp             ----------------------------------HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHH
T ss_pred             ----------------------------------cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHh
Confidence                                              000112235999999999953    345899999999999999999


Q ss_pred             hCCCCCCCchhhHHHHHHHHH
Q psy3074         164 TGLPTFPGVREVYDQLDKIFK  184 (481)
Q Consensus       164 tg~~PF~g~~~~~~~l~~i~~  184 (481)
                      +|++||.+.+. .+.+.++..
T Consensus       210 tg~~Pf~~~~~-~~~~~~i~~  229 (288)
T d2jfla1         210 EIEPPHHELNP-MRVLLKIAK  229 (288)
T ss_dssp             HSSCTTTTSCG-GGHHHHHHH
T ss_pred             hCCCCCCCCCH-HHHHHHHHc
Confidence            99999988543 355555554

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=3.2e-27  Score=229.38  Aligned_cols=156  Identities=13%  Similarity=0.127  Sum_probs=108.4

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........++.+ .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+........          
T Consensus       105 ~l~~~~~~~i~~q-i~~gL~ylH~~~iiHrDlKp----~Nill~~~----~~~Kl~DFGla~~~~~~~~~----------  165 (285)
T d1u59a_         105 EIPVSNVAELLHQ-VSMGMKYLEEKNFVHRDLAA----RNVLLVNR----HYAKISDFGLSKALGADDSY----------  165 (285)
T ss_dssp             TSCHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEEET----TEEEECCCTTCEECTTCSCE----------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCeecCcCch----hheeeccC----Cceeeccchhhhcccccccc----------
Confidence            4455555666666 78999999999999999999    89999876    79999999999854221100          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                       .  ..                .....+|+.|||||++.+.. |+.++|||||||++|||+| |
T Consensus       166 -----------------~--~~----------------~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G  209 (285)
T d1u59a_         166 -----------------Y--TA----------------RSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYG  209 (285)
T ss_dssp             -----------------E--CC----------------CCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred             -----------------c--cc----------------ccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCC
Confidence                             0  00                00112489999999998775 9999999999999999998 9


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ++||.+.+. .+.+..|.+....+.++.++..-.-....||...|..||++.+
T Consensus       210 ~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~  261 (285)
T d1u59a_         210 QKPYKKMKG-PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT  261 (285)
T ss_dssp             CCTTTTCCT-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCCCCCCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999998643 3555555554444433333322212233566666666666543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.91  E-value=4.9e-27  Score=228.35  Aligned_cols=154  Identities=15%  Similarity=0.150  Sum_probs=101.3

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||++||+||||||    +||||+..    |.+||+|||+|+......             
T Consensus       112 ~~~~~~~~i~~q-i~~gL~yLH~~~iiHrDlKp----~NILl~~~----~~~Kl~DFG~a~~~~~~~-------------  169 (287)
T d1opja_         112 VSAVVLLYMATQ-ISSAMEYLEKKNFIHRDLAA----RNCLVGEN----HLVKVADFGLSRLMTGDT-------------  169 (287)
T ss_dssp             SCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCCCTTTCCSSS-------------
T ss_pred             hHHHHHHHHHHH-HHHHHHHHHHCCcccCcccc----CeEEECCC----CcEEEccccceeecCCCC-------------
Confidence            344445556666 78899999999999999999    89999877    799999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                     .....+                   ..+|+.|||||++.+.. |+.++||||+||++|||++|..
T Consensus       170 ---------------~~~~~~-------------------~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~  214 (287)
T d1opja_         170 ---------------YTAHAG-------------------AKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGM  214 (287)
T ss_dssp             ---------------SEEETT-------------------EEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSC
T ss_pred             ---------------ceeecc-------------------ccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCC
Confidence                           011111                   11388999999998776 9999999999999999999665


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ||....+..+..+.+......+.++.++..-......|+...|..|+++.+
T Consensus       215 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e  265 (287)
T d1opja_         215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAE  265 (287)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHH
Confidence            554434443434444333333333333222111223456555555566443

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.91  E-value=5.5e-26  Score=228.11  Aligned_cols=98  Identities=24%  Similarity=0.440  Sum_probs=81.8

Q ss_pred             hccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecc
Q psy3074          16 VSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLD   95 (481)
Q Consensus        16 ~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~   95 (481)
                      +... .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+......                     
T Consensus       112 ~~~q-i~~aL~ylH~~~iiHrDlKP----~NILl~~~----g~iKl~DFGla~~~~~~~---------------------  161 (364)
T d1omwa3         112 YAAE-IILGLEHMHNRFVVYRDLKP----ANILLDEH----GHVRISDLGLACDFSKKK---------------------  161 (364)
T ss_dssp             HHHH-HHHHHHHHHHTTEECCCCSG----GGEEECSS----SCEEECCCTTCEECSSSC---------------------
T ss_pred             HHHH-HHHHHHHHHHCCccceeecc----ceeEEcCC----CcEEEeeeceeeecCCCc---------------------
Confidence            3344 78999999999999999999    89999876    799999999998532110                     


Q ss_pred             cCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          96 QLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        96 ~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             ....+                      ||+.|||||++.+...|+.++||||+||++|||++|++||.+.
T Consensus       162 -------~~~~~----------------------GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         162 -------PHASV----------------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             -------CCSCC----------------------SCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             -------ccccc----------------------cccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence                   00112                      3999999999987767999999999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1e-25  Score=220.12  Aligned_cols=138  Identities=44%  Similarity=0.750  Sum_probs=110.1

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+..-..+... .+.||+|||++|||||||||    +|||++.+    +.+||+|||+|+.......            
T Consensus        99 l~e~~~~~~~~q-il~~L~yLH~~~IiHrDiKp----eNIl~~~~----~~~kl~DFG~a~~~~~~~~------------  157 (298)
T d1gz8a_          99 IPLPLIKSYLFQ-LLQGLAFCHSHRVLHRDLKP----QNLLINTE----GAIKLADFGLARAFGVPVR------------  157 (298)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEECTT----SCEEECSTTHHHHHCCCSB------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHhhcCCEEccccCc----hheeeccc----CcceeccCCcceeccCCcc------------
Confidence            344444445555 78999999999999999999    89999866    7999999999985422110            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                    ..                      ...++|+.|+|||++.....++.++|+||+||++|||++|++
T Consensus       158 --------------~~----------------------~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~  201 (298)
T d1gz8a_         158 --------------TY----------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  201 (298)
T ss_dssp             --------------CT----------------------TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             --------------cc----------------------eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence                          00                      011249999999999988878999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      ||.+.+ ..+++.++++..+.|....|+.....+..
T Consensus       202 Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         202 LFPGDS-EIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             SCCCSS-HHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCCCC-HHHHHHHHHHhcCCCchhhcccccccccc
Confidence            999854 45889999999999999988877655443

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.7e-26  Score=221.63  Aligned_cols=153  Identities=15%  Similarity=0.194  Sum_probs=100.0

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||+++|+||||||    +|||++..    +.+||+|||+|+.......            
T Consensus        98 ~~~~~~~~i~~q-ia~gl~~lH~~~iiHrDlKp----~Nill~~~----~~~Kl~DFGla~~~~~~~~------------  156 (263)
T d1sm2a_          98 FAAETLLGMCLD-VCEGMAYLEEACVIHRDLAA----RNCLVGEN----QVIKVSDFGMTRFVLDDQY------------  156 (263)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCTTCSG----GGEEECGG----GCEEECSCC----------------------
T ss_pred             CCHHHHHHHHHH-HHHHHHhhhccceeecccch----hheeecCC----CCeEecccchheeccCCCc------------
Confidence            344555666666 78899999999999999999    89999987    6999999999985321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GL  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~  166 (481)
                                   ......                      .+|+.|||||++.+.. |+.++|||||||++|||+| |.
T Consensus       157 -------------~~~~~~----------------------~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~  200 (263)
T d1sm2a_         157 -------------TSSTGT----------------------KFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGK  200 (263)
T ss_dssp             -------------------------------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSC
T ss_pred             -------------eeecce----------------------ecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCC
Confidence                         000011                      2389999999998876 9999999999999999999 57


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      +||.+. +..+.++.+......+.+...+..-......|+...|..|+++++
T Consensus       201 ~~~~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~  251 (263)
T d1sm2a_         201 IPYENR-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSR  251 (263)
T ss_dssp             CTTCSC-CHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCC-CHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHH
Confidence            777663 444566666665444444333222111223456656666666544

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.3e-26  Score=228.47  Aligned_cols=153  Identities=16%  Similarity=0.178  Sum_probs=106.0

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .......++.+ .+.||+|||+++||||||||    +|||++..    +.+||+|||+|+.......             
T Consensus       109 ~~~~~~~i~~q-i~~gl~yLH~~~iiHrDlKp----~NIll~~~----~~~kl~DFGla~~~~~~~~-------------  166 (317)
T d1xkka_         109 GSQYLLNWCVQ-IAKGMNYLEDRRLVHRDLAA----RNVLVKTP----QHVKITDFGLAKLLGAEEK-------------  166 (317)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCSCCCG----GGEEEEET----TEEEECCCSHHHHTTTTCC-------------
T ss_pred             CHHHHHHHHHH-HHHHHHHHHHcCcccCcchh----hcceeCCC----CCeEeeccccceecccccc-------------
Confidence            34444555656 78899999999999999999    89999877    7999999999985421110             


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLP  167 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~  167 (481)
                                 .......                      .+|+.|||||++.+.. |+.++|||||||++|||+| |.+
T Consensus       167 -----------~~~~~~~----------------------~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~  212 (317)
T d1xkka_         167 -----------EYHAEGG----------------------KVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSK  212 (317)
T ss_dssp             -----------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             -----------ccccccc----------------------ccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCC
Confidence                       0001111                      2399999999998876 9999999999999999998 899


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ||.+.+. .+....+.+....|.++.++..-......|+...|..|+++.+
T Consensus       213 p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e  262 (317)
T d1xkka_         213 PYDGIPA-SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRE  262 (317)
T ss_dssp             TTTTSCG-GGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCH-HHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHH
Confidence            9988533 2344444444444544444432222233566666666666544

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=7.2e-27  Score=225.40  Aligned_cols=152  Identities=17%  Similarity=0.289  Sum_probs=104.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.. .+.||+|||+++|+||||||    +||||+..    +.+||+|||+|+......             
T Consensus       106 l~~~~~~~i~~q-i~~gl~~lH~~~ivHrDiKp----~NIll~~~----~~~Kl~DFGla~~~~~~~-------------  163 (272)
T d1qpca_         106 LTINKLLDMAAQ-IAEGMAFIEERNYIHRDLRA----ANILVSDT----LSCKIADFGLARLIEDNE-------------  163 (272)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----SCEEECCCTTCEECSSSC-------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCcccCccch----hheeeecc----cceeeccccceEEccCCc-------------
Confidence            445556667777 78899999999999999999    89999876    799999999998532110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-C
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-L  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-~  166 (481)
                                    .. .                   .....+|+.|||||++.+.. |+.++|||||||++|||+|| .
T Consensus       164 --------------~~-~-------------------~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~  208 (272)
T d1qpca_         164 --------------YT-A-------------------REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGR  208 (272)
T ss_dssp             --------------EE-C-------------------CTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTC
T ss_pred             --------------cc-c-------------------ccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCC
Confidence                          00 0                   00112489999999998765 99999999999999999995 5


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcC
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLG  217 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  217 (481)
                      +||.+ .+..+.++.+......+.++.++..-......|+...|..|+++.
T Consensus       209 ~~~~~-~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~  258 (272)
T d1qpca_         209 IPYPG-MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFD  258 (272)
T ss_dssp             CSSTT-CCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCC-CCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHH
Confidence            55655 444466666655544444443332211122345555555555543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.7e-25  Score=223.43  Aligned_cols=121  Identities=33%  Similarity=0.622  Sum_probs=100.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++.+.   ..+||+|||+|+.....                           
T Consensus       131 il~aL~yLH~~~IiHrDiKp----~NILl~~~~---~~~kl~DFG~a~~~~~~---------------------------  176 (350)
T d1q5ka_         131 LFRSLAYIHSFGICHRDIKP----QNLLLDPDT---AVLKLCDFGSAKQLVRG---------------------------  176 (350)
T ss_dssp             HHHHHHHHHTTTEECCCCCG----GGEEECTTT---CCEEECCCTTCEECCTT---------------------------
T ss_pred             HHHHHHHHHhcCCcccCCCc----ceEEEecCC---CceeEecccchhhccCC---------------------------
Confidence            78999999999999999999    899998652   48999999999853211                           


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                      .....+.                      +|+.|+|||++.+...|+.++||||+||++|||++|++||.+.+ ..+++.
T Consensus       177 ~~~~~~~----------------------gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~-~~~~l~  233 (350)
T d1q5ka_         177 EPNVSYI----------------------CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS-GVDQLV  233 (350)
T ss_dssp             SCCCSCC----------------------SCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHH
T ss_pred             ccccccc----------------------ccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC-HHHHHH
Confidence            1111112                      39999999999988789999999999999999999999999854 458999


Q ss_pred             HHHHHhCCCCccCccccc
Q psy3074         181 KIFKILGTPTEETWEGVS  198 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~  198 (481)
                      +|.+.+|+|..+.|....
T Consensus       234 ~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         234 EIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             HHHHHHCCCCHHHHHHHC
T ss_pred             HHHHHhCCChHHhhhhhc
Confidence            999999999988776543

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3e-26  Score=223.41  Aligned_cols=131  Identities=18%  Similarity=0.234  Sum_probs=97.8

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      +.....+... .+.||+|||+++|+||||||    +|||++......+.+||+|||+|+.....                
T Consensus       112 ~~~~~~~~~q-i~~al~yLH~~~ivHrDiKp----~Nill~~~~~~~~~vkl~DfG~a~~~~~~----------------  170 (293)
T d1jksa_         112 EEEATEFLKQ-ILNGVYYLHSLQIAHFDLKP----ENIMLLDRNVPKPRIKIIDFGLAHKIDFG----------------  170 (293)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESCSSSSSCCEEECCCTTCEECTTS----------------
T ss_pred             hhHHHHHHHH-HHHHHHhhhhcceeeccccc----ceEEEecCCCcccceEecchhhhhhcCCC----------------
Confidence            3333444444 78999999999999999999    89999877555567999999999853211                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 ......                      .+|+.|||||++.+.. |+.++||||+||++|||++|++||
T Consensus       171 -----------~~~~~~----------------------~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf  216 (293)
T d1jksa_         171 -----------NEFKNI----------------------FGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPF  216 (293)
T ss_dssp             -----------CBCSCC----------------------CCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             -----------cccccc----------------------CCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHcCCCCC
Confidence                       111111                      2399999999998765 999999999999999999999999


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCccc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      .+.+ ..+.+..|......++...++.
T Consensus       217 ~~~~-~~~~~~~i~~~~~~~~~~~~~~  242 (293)
T d1jksa_         217 LGDT-KQETLANVSAVNYEFEDEYFSN  242 (293)
T ss_dssp             CCSS-HHHHHHHHHTTCCCCCHHHHTT
T ss_pred             CCCC-HHHHHHHHHhcCCCCCchhcCC
Confidence            9853 4466677766554444444433

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2e-26  Score=222.38  Aligned_cols=154  Identities=17%  Similarity=0.219  Sum_probs=98.8

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +......+.++.. .+.||+|||+++||||||||    +||+++..    +.+||+|||+|+.......           
T Consensus       104 ~l~~~~~~~~~~q-i~~gl~ylH~~~iiHrDlKp----~NIll~~~----~~~Kl~DfG~a~~~~~~~~-----------  163 (273)
T d1mp8a_         104 SLDLASLILYAYQ-LSTALAYLESKRFVHRDIAA----RNVLVSSN----DCVKLGDFGLSRYMEDSTY-----------  163 (273)
T ss_dssp             TSCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEEET----TEEEECC-----------------------
T ss_pred             CCCHHHHHHHHHH-HHHHhhhhcccCeeccccch----hheeecCC----CcEEEccchhheeccCCcc-----------
Confidence            3445555556666 78899999999999999999    89999887    7999999999985321100           


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                    .....                      ..+|+.|||||++.+.. |+.++|||||||++|||++ |
T Consensus       164 --------------~~~~~----------------------~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g  206 (273)
T d1mp8a_         164 --------------YKASK----------------------GKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHG  206 (273)
T ss_dssp             -------------------------------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTS
T ss_pred             --------------eeccc----------------------eecCcccchhhHhccCC-CCCccccccchHHHHHHHhcC
Confidence                          00011                      12389999999998766 9999999999999999998 8


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .+||.+.+. .+.+.++......|.+..++..-......|+...|..|+++.+
T Consensus       207 ~~P~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~e  258 (273)
T d1mp8a_         207 VKPFQGVKN-NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTE  258 (273)
T ss_dssp             CCTTTTCCG-GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            999988543 3556666554444443333322111223455555555555443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=1.7e-26  Score=221.07  Aligned_cols=155  Identities=17%  Similarity=0.274  Sum_probs=111.2

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++......+.++.+ .+.|++|||++||+||||||    +|||++..    +.+||+|||+|+........         
T Consensus        95 ~~~~~~~~~~i~~q-i~~gl~~LH~~~iiH~dlk~----~Nill~~~----~~~kl~DfG~a~~~~~~~~~---------  156 (258)
T d1k2pa_          95 HRFQTQQLLEMCKD-VCEAMEYLESKQFLHRDLAA----RNCLVNDQ----GVVKVSDFGLSRYVLDDEYT---------  156 (258)
T ss_dssp             GCCCHHHHHHHHHH-HHHHHHHHHHTTBCCSCCSG----GGEEECTT----CCEEECCCSSCCBCSSSSCC---------
T ss_pred             cCCcHHHHHHHHHH-HHHHHHHHhhcCcccccccc----eeEEEcCC----CcEEECcchhheeccCCCce---------
Confidence            34445566677777 88999999999999999999    99999876    79999999999854221100         


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-  164 (481)
                                      ...                      ...+|+.|||||++.+.. |+.++|||||||++|||+| 
T Consensus       157 ----------------~~~----------------------~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~  197 (258)
T d1k2pa_         157 ----------------SSV----------------------GSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL  197 (258)
T ss_dssp             ----------------CCC----------------------CSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTT
T ss_pred             ----------------eec----------------------ccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhc
Confidence                            000                      012399999999999776 9999999999999999998 


Q ss_pred             CCCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         165 GLPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      |+.||.+.+. .+...+|......+.++..+..-......||...|..|+++++
T Consensus       198 g~~Pf~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e  250 (258)
T d1k2pa_         198 GKMPYERFTN-SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI  250 (258)
T ss_dssp             SCCTTTTSCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred             CCCCCCCCCH-HHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHH
Confidence            8999998643 3566666665555555444332222233566666666666544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5e-26  Score=219.58  Aligned_cols=100  Identities=27%  Similarity=0.304  Sum_probs=81.2

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .++.. .+.||+|||++||+||||||    +|||++.+.   +.+||+|||+|+.....                     
T Consensus       114 ~~~~q-i~~al~~lH~~~iiHrDiKp----~NIll~~~~---~~vkl~DFG~a~~~~~~---------------------  164 (273)
T d1xwsa_         114 SFFWQ-VLEAVRHCHNCGVLHRDIKD----ENILIDLNR---GELKLIDFGSGALLKDT---------------------  164 (273)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECSCCSG----GGEEEETTT---TEEEECCCTTCEECCSS---------------------
T ss_pred             HHHHH-HHHHHHHHHHCCCccccCcc----cceEEecCC---CeEEECccccceecccc---------------------
Confidence            34444 78899999999999999999    899998543   68999999999742210                     


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCc
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGV  172 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~  172 (481)
                             ....+.                      ||+.|||||++.+...++.++||||+||++|||++|++||.+.
T Consensus       165 -------~~~~~~----------------------GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (273)
T d1xwsa_         165 -------VYTDFD----------------------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  213 (273)
T ss_dssp             -------CBCCCC----------------------SCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             -------cccccc----------------------cCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence                   011122                      3999999999988776678899999999999999999999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=1.1e-25  Score=222.01  Aligned_cols=112  Identities=26%  Similarity=0.474  Sum_probs=88.1

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..++.. .+.||+|||+++|+||||||    +|||++..    |.+||+|||+|+......                   
T Consensus       106 ~~~~~q-i~~al~ylH~~~iiHrDikp----~NiL~~~~----~~~kl~DFG~a~~~~~~~-------------------  157 (320)
T d1xjda_         106 TFYAAE-IILGLQFLHSKGIVYRDLKL----DNILLDKD----GHIKIADFGMCKENMLGD-------------------  157 (320)
T ss_dssp             HHHHHH-HHHHHHHHHHTTCBCCCCCG----GGEEECTT----SCEEECCCTTCBCCCCTT-------------------
T ss_pred             HHHHHH-HHHHHHHHHhCCeeeccCcc----cceeecCC----Cceeccccchhhhccccc-------------------
Confidence            334444 78999999999999999999    89999876    799999999998432110                   


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                             .......                      ||+.|||||++.+.. |+.++||||+||++|||++|++||.+.+
T Consensus       158 -------~~~~~~~----------------------gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         158 -------AKTNTFC----------------------GTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             -------CCBCCCC----------------------SCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             -------ccccccC----------------------CCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence                   0111122                      499999999999876 9999999999999999999999999854


Q ss_pred             hhHHHHHHHHH
Q psy3074         174 EVYDQLDKIFK  184 (481)
Q Consensus       174 ~~~~~l~~i~~  184 (481)
                       ..+.+.+|..
T Consensus       208 -~~~~~~~i~~  217 (320)
T d1xjda_         208 -EEELFHSIRM  217 (320)
T ss_dssp             -HHHHHHHHHH
T ss_pred             -HHHHHHHHHc
Confidence             3355666543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=5e-25  Score=219.59  Aligned_cols=129  Identities=34%  Similarity=0.591  Sum_probs=104.4

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .+..-..+... .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+......              
T Consensus       119 ~~~~~~~~~~q-i~~aL~~LH~~~IiHrDiKp----~NIL~~~~----~~~kl~Dfg~a~~~~~~~--------------  175 (346)
T d1cm8a_         119 GEDRIQFLVYQ-MLKGLRYIHAAGIIHRDLKP----GNLAVNED----CELKILDFGLARQADSEM--------------  175 (346)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECCSSC--------------
T ss_pred             cHHHHHHHHHH-HHHHHHHHHhCCCcccccCc----chhhcccc----cccccccccceeccCCcc--------------
Confidence            33333444444 78999999999999999999    89999876    799999999998532110              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                                           +...+|+.|||||++.+...++.++||||+||++|||++|++|
T Consensus       176 -------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p  218 (346)
T d1cm8a_         176 -------------------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  218 (346)
T ss_dssp             -------------------------------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             -------------------------------------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence                                                 0112399999999999877789999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      |.+. +..+++..+....+.|+.+.++...
T Consensus       219 f~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         219 FKGS-DHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             SCCS-SHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             CCCC-ChHHHHHHHHhccCCCcHHHHhhhc
Confidence            9995 4458899999999999887665543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.90  E-value=5.5e-25  Score=212.53  Aligned_cols=127  Identities=24%  Similarity=0.392  Sum_probs=89.9

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.....+... .+.||+|||++||+||||||    +|||++..    +.+||+|||+++......             
T Consensus       108 l~~~~~~~i~~q-i~~al~~lH~~~iiHrDiKP----~NIll~~~----~~~~l~d~~~~~~~~~~~-------------  165 (277)
T d1o6ya_         108 MTPKRAIEVIAD-ACQALNFSHQNGIIHRDVKP----ANIMISAT----NAVKVMDFGIARAIADSG-------------  165 (277)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEETT----SCEEECCCTTCEECC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHhCCccCccccC----cccccCcc----ccceeehhhhhhhhcccc-------------
Confidence            344444555555 78999999999999999999    89999877    799999999997532111             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLP  167 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~  167 (481)
                                .........                      ++|+.|||||++.+.. |+.++||||+||++|||+||++
T Consensus       166 ----------~~~~~~~~~----------------------~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~  212 (277)
T d1o6ya_         166 ----------NSVTQTAAV----------------------IGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEP  212 (277)
T ss_dssp             ---------------------------------------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ----------ccccccccc----------------------cCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCC
Confidence                      000111122                      3499999999998765 9999999999999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHhCCCC
Q psy3074         168 TFPGVREVYDQLDKIFKILGTPT  190 (481)
Q Consensus       168 PF~g~~~~~~~l~~i~~~~~~p~  190 (481)
                      ||.+.+. .+.+.++.+.-..|+
T Consensus       213 Pf~~~~~-~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         213 PFTGDSP-VSVAYQHVREDPIPP  234 (277)
T ss_dssp             SCCCSSH-HHHHHHHHHCCCCCG
T ss_pred             CCCCcCH-HHHHHHHHhcCCCCC
Confidence            9998543 355555555443333

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=3.5e-25  Score=219.82  Aligned_cols=111  Identities=25%  Similarity=0.389  Sum_probs=86.9

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +..+..-..+... .+.||+|||++||+||||||    +|||++.. ...+.+||+|||+|+.....             
T Consensus       107 ~l~e~~~~~i~~q-i~~al~ylH~~~iiHRDiKp----~NIll~~~-~~~~~~Kl~DFG~a~~~~~~-------------  167 (335)
T d2ozaa1         107 AFTEREASEIMKS-IGEAIQYLHSINIAHRDVKP----ENLLYTSK-RPNAILKLTDFGFAKETTSH-------------  167 (335)
T ss_dssp             CEEHHHHHHHHHH-HHHHHHHHHHTTEECCCCSG----GGEEESCS-STTCCEEECCCTTCEECCCC-------------
T ss_pred             CcCHHHHHHHHHH-HHHHHHHHHHcCCccccccc----cccccccc-cccccccccccceeeeccCC-------------
Confidence            3444444455555 78999999999999999999    89999864 23478999999999853211             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                    ......+                      +|+.|||||++.+.. |+.++||||+||++|||+||+
T Consensus       168 --------------~~~~~~~----------------------gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~  210 (335)
T d2ozaa1         168 --------------NSLTTPC----------------------YTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGY  210 (335)
T ss_dssp             --------------CCCCCCS----------------------CCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSS
T ss_pred             --------------Ccccccc----------------------CCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCC
Confidence                          1111122                      399999999998766 999999999999999999999


Q ss_pred             CCCCCch
Q psy3074         167 PTFPGVR  173 (481)
Q Consensus       167 ~PF~g~~  173 (481)
                      +||.+.+
T Consensus       211 ~Pf~~~~  217 (335)
T d2ozaa1         211 PPFYSNH  217 (335)
T ss_dssp             CSCEETT
T ss_pred             CCCCCCC
Confidence            9998753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.90  E-value=4.1e-25  Score=213.52  Aligned_cols=125  Identities=21%  Similarity=0.315  Sum_probs=94.4

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ..+.+-..+... .+.||+|||++||+||||||    +|||++.+    |.+||+|||+|+...                
T Consensus       107 l~e~~~~~~~~q-i~~al~~lH~~~ivHrDlkp----~Nill~~~----~~~kl~DFG~a~~~~----------------  161 (277)
T d1phka_         107 LSEKETRKIMRA-LLEVICALHKLNIVHRDLKP----ENILLDDD----MNIKLTDFGFSCQLD----------------  161 (277)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECTT----CCEEECCCTTCEECC----------------
T ss_pred             CCHHHHHHHHHH-HHHHHHHHHHcCCccccccc----ceEEEcCC----CCeEEccchheeEcc----------------
Confidence            334444444444 78999999999999999999    99999866    799999999998532                


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccC-----CCCCCCccchhhHHHHHHHH
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLG-----STEYSTSLDMWGVGCILIEM  162 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~-----~~~y~~~~DvWS~G~il~el  162 (481)
                                 .+.....+.|                      |+.|+|||++.+     ...|+.++||||+||++|||
T Consensus       162 -----------~~~~~~~~~g----------------------t~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         162 -----------PGEKLREVCG----------------------TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             -----------TTCCBCCCCS----------------------CGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             -----------CCCceeeeec----------------------cCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence                       1111122233                      999999999973     44589999999999999999


Q ss_pred             HhCCCCCCCchhhHHHHHHHHHHhCCCCc
Q psy3074         163 VTGLPTFPGVREVYDQLDKIFKILGTPTE  191 (481)
Q Consensus       163 ltg~~PF~g~~~~~~~l~~i~~~~~~p~~  191 (481)
                      ++|++||.+.++ .+.++.|...-..++.
T Consensus       209 l~g~~Pf~~~~~-~~~~~~i~~~~~~~~~  236 (277)
T d1phka_         209 LAGSPPFWHRKQ-MLMLRMIMSGNYQFGS  236 (277)
T ss_dssp             HHSSCSSCCSSH-HHHHHHHHHTCCCCCT
T ss_pred             ccCCCCCCCCCH-HHHHHHHHhCCCCCCC
Confidence            999999998543 4666667665443333

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.89  E-value=9e-26  Score=220.82  Aligned_cols=154  Identities=16%  Similarity=0.175  Sum_probs=106.6

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.+ .+.|++|||+++||||||||    +||||+..    +.+||+|||+|+.......            
T Consensus       137 l~~~~~~~i~~q-i~~gl~ylH~~~ivHrDlKp----~NILld~~----~~~Kl~DFGls~~~~~~~~------------  195 (301)
T d1lufa_         137 LSCAEQLCIARQ-VAAGMAYLSERKFVHRDLAT----RNCLVGEN----MVVKIADFGLSRNIYSADY------------  195 (301)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCSCHHHHTGGGC------------
T ss_pred             CCHHHHHHHHHH-HHHHhhhcccCCeEeeEEcc----cceEECCC----CcEEEccchhheeccCCcc------------
Confidence            445566777777 88999999999999999999    89999876    7999999999985321100            


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-C
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-L  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-~  166 (481)
                                  .......                      .+|+.|||||++.+.. |+.++|||||||++|||++| .
T Consensus       196 ------------~~~~~~~----------------------~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~  240 (301)
T d1lufa_         196 ------------YKADGND----------------------AIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGL  240 (301)
T ss_dssp             ------------BC----C----------------------CBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ------------ccccCCC----------------------CcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCC
Confidence                        0001111                      2389999999999776 99999999999999999998 5


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      +||.+.+ ..+.+..+.+....+.++..+..-......||...|..|+++.+
T Consensus       241 ~p~~~~~-~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~e  291 (301)
T d1lufa_         241 QPYYGMA-HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS  291 (301)
T ss_dssp             CTTTTSC-HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCC-HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            7888754 33666666555444433333322112233556655555566543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.3e-24  Score=214.51  Aligned_cols=134  Identities=18%  Similarity=0.281  Sum_probs=102.9

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +..+..-..+... .+.||+|||++||+||||||    +|||++..  ..+.+||+|||+|+..                
T Consensus        98 ~l~e~~~~~i~~q-i~~al~yLH~~~iiHrDlKp----~NIll~~~--~~~~ikl~DFG~~~~~----------------  154 (321)
T d1tkia_          98 ELNEREIVSYVHQ-VCEALQFLHSHNIGHFDIRP----ENIIYQTR--RSSTIKIIEFGQARQL----------------  154 (321)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEESSS--SCCCEEECCCTTCEEC----------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHHcCCCcccccc----cceeecCC--CceEEEEcccchhhcc----------------
Confidence            3445444555555 89999999999999999999    89999754  2358999999999843                


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                 ..+.......|                      |+.|+|||++.+.. |+.++||||+||++|||++|.
T Consensus       155 -----------~~~~~~~~~~~----------------------t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~  200 (321)
T d1tkia_         155 -----------KPGDNFRLLFT----------------------APEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             -----------CTTCEEEEEES----------------------CGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSS
T ss_pred             -----------ccCCccccccc----------------------ccccccchhccCCC-CCchhhcccHHHHHHHHHhCC
Confidence                       22222333444                      99999999998776 999999999999999999999


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCccccc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVS  198 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~  198 (481)
                      +||.+.+ ..+.+.+|.+....++.+.|+.++
T Consensus       201 ~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s  231 (321)
T d1tkia_         201 NPFLAET-NQQIIENIMNAEYTFDEEAFKEIS  231 (321)
T ss_dssp             CTTCCSS-HHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             CCCCCCC-HHHHHHHHHhCCCCCChhhccCCC
Confidence            9999854 447778887766666655555443

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.5e-25  Score=217.37  Aligned_cols=153  Identities=16%  Similarity=0.230  Sum_probs=105.1

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCc
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGK   87 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~   87 (481)
                      ......+.++.+ .+.||+|||+++|+||||||    +||||+.+    |.+||+|||+|+......             
T Consensus       110 l~~~~~~~i~~~-i~~gl~~LH~~~ivH~DlKp----~NIll~~~----~~~kl~DfGla~~~~~~~-------------  167 (285)
T d1fmka3         110 LRLPQLVDMAAQ-IASGMAYVERMNYVHRDLRA----ANILVGEN----LVCKVADFGLARLIEDNE-------------  167 (285)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECGG----GCEEECCCCTTC-------------------
T ss_pred             chHHHHHHHHHH-HHHHHHHHhhhheecccccc----eEEEECCC----CcEEEcccchhhhccCCC-------------
Confidence            344555666666 89999999999999999999    89999877    799999999998432110             


Q ss_pred             cccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC-
Q psy3074          88 ADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL-  166 (481)
Q Consensus        88 ~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~-  166 (481)
                                  ......                      ..+|+.|||||++.+.. |+.++|||||||++|||++|. 
T Consensus       168 ------------~~~~~~----------------------~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~  212 (285)
T d1fmka3         168 ------------YTARQG----------------------AKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGR  212 (285)
T ss_dssp             ------------------------------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTC
T ss_pred             ------------ceeecc----------------------ccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCC
Confidence                        000011                      12399999999998766 999999999999999999954 


Q ss_pred             CCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         167 PTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       167 ~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      +||.+ ....+.+..+.+....|.+..++.........|+...|..|+++.+
T Consensus       213 p~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~  263 (285)
T d1fmka3         213 VPYPG-MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEY  263 (285)
T ss_dssp             CSSTT-CCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCC-CCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHH
Confidence            55555 4555667777666655555544432222233566666666665443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=4.8e-24  Score=206.94  Aligned_cols=127  Identities=46%  Similarity=0.829  Sum_probs=104.6

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.||+|||++||+||||||    +|||++..    +.+||+|||+|+........                        
T Consensus       110 ~~~aL~~lH~~~IvHrDiKP----~NIli~~~----~~~kl~DFG~a~~~~~~~~~------------------------  157 (292)
T d1unla_         110 LLKGLGFCHSRNVLHRDLKP----QNLLINRN----GELKLANFGLARAFGIPVRC------------------------  157 (292)
T ss_dssp             HHHHHHHHHHTTEECCCCSG----GGEEECTT----CCEEECCCTTCEECCSCCSC------------------------
T ss_pred             HHHHHHHhhcCCEeeecccC----cccccccC----CceeeeecchhhcccCCCcc------------------------
Confidence            68899999999999999999    99999876    69999999999854321100                        


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQLD  180 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l~  180 (481)
                        .                      ....+++.|+|||++.+...++.++||||+||++|||++|+.||....+..+++.
T Consensus       158 --~----------------------~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~  213 (292)
T d1unla_         158 --Y----------------------SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK  213 (292)
T ss_dssp             --C----------------------CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred             --c----------------------eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH
Confidence              0                      0112388999999999888789999999999999999999988766677778999


Q ss_pred             HHHHHhCCCCccCcccccCCCCC
Q psy3074         181 KIFKILGTPTEETWEGVSLLPGY  203 (481)
Q Consensus       181 ~i~~~~~~p~~~~~~~~~~~~~~  203 (481)
                      ++....+.|.+..|+........
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         214 RIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             HHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             HHHhhcCCCChhhhhhhhhcccc
Confidence            99999999999888877655444

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=9e-26  Score=217.75  Aligned_cols=157  Identities=19%  Similarity=0.183  Sum_probs=106.3

Q ss_pred             chhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCC
Q psy3074           6 NKATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPF   85 (481)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~   85 (481)
                      ++......+.++.. .+.|++|||+++|+||||||    +||||+..    +.+||+|||+|+......           
T Consensus       106 ~~l~~~~~~~~~~q-i~~gl~ylH~~~iiHrDikp----~NIll~~~----~~vkl~DfGl~~~~~~~~-----------  165 (273)
T d1u46a_         106 GHFLLGTLSRYAVQ-VAEGMGYLESKRFIHRDLAA----RNLLLATR----DLVKIGDFGLMRALPQND-----------  165 (273)
T ss_dssp             GGSCHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEEEET----TEEEECCCTTCEECCC-C-----------
T ss_pred             CCCCHHHHHHHHHH-HHHHHHHhhhCCEeeeeecH----HHhccccc----cceeeccchhhhhcccCC-----------
Confidence            34445555566666 78899999999999999999    89999886    699999999998542111           


Q ss_pred             CccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-
Q psy3074          86 GKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-  164 (481)
Q Consensus        86 ~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-  164 (481)
                                   .......                     ...+|+.|+|||++.+.. |+.++|||||||++|||+| 
T Consensus       166 -------------~~~~~~~---------------------~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~  210 (273)
T d1u46a_         166 -------------DHYVMQE---------------------HRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTY  210 (273)
T ss_dssp             -------------CEEEC--------------------------CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTT
T ss_pred             -------------CcceecC---------------------ccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhC
Confidence                         0000000                     112388999999999876 9999999999999999998 


Q ss_pred             CCCCCCCchhhHHHHHHHHHHhCCC-CccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         165 GLPTFPGVREVYDQLDKIFKILGTP-TEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       165 g~~PF~g~~~~~~~l~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      |++||.+.+. .+.+.++.+....| .++.++..-......||...|..|+++.+
T Consensus       211 G~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~e  264 (273)
T d1u46a_         211 GQEPWIGLNG-SQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA  264 (273)
T ss_dssp             SCCTTTTCCH-HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCcCH-HHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            8999998543 35666665543222 22223222111233456666666666543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=1.1e-24  Score=218.07  Aligned_cols=176  Identities=28%  Similarity=0.471  Sum_probs=117.1

Q ss_pred             cCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccC
Q psy3074          18 SDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQL   97 (481)
Q Consensus        18 ~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (481)
                      ....+.||+|||++||+||||||    +|||++..    +.+|++|||+++...                          
T Consensus       125 ~~qil~gl~~LH~~giiHrDlKP----~Nil~~~~----~~~kl~df~~~~~~~--------------------------  170 (355)
T d2b1pa1         125 LYQMLCGIKHLHSAGIIHRDLKP----SNIVVKSD----CTLKILDFGLARTAG--------------------------  170 (355)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCG----GGEEECTT----CCEEECCCCC-------------------------------
T ss_pred             HHHHHHHHHHhhhcccccccCCc----cccccccc----cceeeechhhhhccc--------------------------
Confidence            33478999999999999999999    89999876    789999999998432                          


Q ss_pred             CCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchhhHH
Q psy3074          98 GEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVREVYD  177 (481)
Q Consensus        98 g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~  177 (481)
                       .+.....+.                      +|+.|||||++.+.. |+.++||||+||++|||++|++||.+. +...
T Consensus       171 -~~~~~~~~~----------------------~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~g~~pF~~~-~~~~  225 (355)
T d2b1pa1         171 -TSFMMTPYV----------------------VTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGR-DYID  225 (355)
T ss_dssp             ---------------------------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCS-SHHH
T ss_pred             -ccccccccc----------------------ccccccChhhhcCCC-CCCCcccccccchHHHHhhCCCCCCCC-CHHH
Confidence             111222223                      399999999998865 999999999999999999999999985 4458


Q ss_pred             HHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcCCCCccCCCcch----hHHHHHHhhhhhhhcCCccccc
Q psy3074         178 QLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLTFPRLYDIPEGE----SMASAFLQVRDAAILNPMEHVH  252 (481)
Q Consensus       178 ~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~----~~a~~ll~v~~~~~~~~~~~~~  252 (481)
                      ++.++.+.++.|.++.|..........+...+..........++.........    ........++++...+|.++..
T Consensus       226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t  304 (355)
T d2b1pa1         226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS  304 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred             HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence            89999999999998888765432211112222222222222222221111111    1222455677888888877654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.89  E-value=8.9e-25  Score=217.78  Aligned_cols=128  Identities=38%  Similarity=0.683  Sum_probs=99.1

Q ss_pred             hhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccccee
Q psy3074          14 ISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIK   93 (481)
Q Consensus        14 ~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~   93 (481)
                      ..+... .+.||+|||++|||||||||    +|||++..    |.+||+|||+|+........                 
T Consensus       112 ~~i~~q-il~al~yLH~~~iiHRDIKp----~NILl~~~----~~~kl~DfG~a~~~~~~~~~-----------------  165 (345)
T d1pmea_         112 CYFLYQ-ILRGLKYIHSANVLHRDLKP----SNLLLNTT----CDLKICDFGLARVADPDHDH-----------------  165 (345)
T ss_dssp             HHHHHH-HHHHHHHHHHTTEECCCCCG----GGEEECTT----CCEEECCCTTCEECCGGGCB-----------------
T ss_pred             HHHHHH-HHHHHHHHHHCCCcCCCCCc----ceEEECCC----CCEEEcccCceeeccCCCcc-----------------
Confidence            334444 78899999999999999999    89999866    79999999999853211000                 


Q ss_pred             cccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch
Q psy3074          94 LDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR  173 (481)
Q Consensus        94 ~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~  173 (481)
                            ....                      ...++|+.|+|||++.....|+.++||||+||++|||++|++||.+. 
T Consensus       166 ------~~~~----------------------~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~-  216 (345)
T d1pmea_         166 ------TGFL----------------------TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK-  216 (345)
T ss_dssp             ------CCTT----------------------CCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS-
T ss_pred             ------ceee----------------------ccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC-
Confidence                  0000                      11234999999999988777999999999999999999999999985 


Q ss_pred             hhHHHHHHHHHHhCCCCccCccc
Q psy3074         174 EVYDQLDKIFKILGTPTEETWEG  196 (481)
Q Consensus       174 ~~~~~l~~i~~~~~~p~~~~~~~  196 (481)
                      +..++...+...+..|.......
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         217 HYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             SHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CHHHHHHHHhhhccCCChhhhhh
Confidence            44578888888888887664433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.89  E-value=1.5e-24  Score=214.41  Aligned_cols=124  Identities=29%  Similarity=0.464  Sum_probs=100.1

Q ss_pred             hhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceec
Q psy3074          15 SVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKL   94 (481)
Q Consensus        15 ~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~   94 (481)
                      .+... .+.||+|||++||+||||||    +|||++...   +.+||+|||+|+......                    
T Consensus       133 ~i~~q-il~aL~~LH~~gIvHrDiKp----~NILi~~~~---~~vkl~DFG~a~~~~~~~--------------------  184 (328)
T d3bqca1         133 FYMYE-ILKALDYCHSMGIMHRDVKP----HNVMIDHEH---RKLRLIDWGLAEFYHPGQ--------------------  184 (328)
T ss_dssp             HHHHH-HHHHHHHHHHTTEECCCCSG----GGEEEETTT---TEEEECCGGGCEECCTTC--------------------
T ss_pred             HHHHH-HHHHHHHHhhcccccccccc----cceEEcCCC---CeeeecccccceeccCCC--------------------
Confidence            34444 78999999999999999999    899998652   479999999998532111                    


Q ss_pred             ccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCchh
Q psy3074          95 DQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVRE  174 (481)
Q Consensus        95 ~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~~  174 (481)
                             ....                      ..+|+.|+|||++.+...|+.++||||+||++|||++|+.||....+
T Consensus       185 -------~~~~----------------------~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         185 -------EYNV----------------------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             -------CCCS----------------------CCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             -------cccc----------------------cccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence                   0111                      12399999999999888899999999999999999999999998777


Q ss_pred             hHHHHHHHHHHhCCCCccCcc
Q psy3074         175 VYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       175 ~~~~l~~i~~~~~~p~~~~~~  195 (481)
                      ..++...+.+.++.|....+.
T Consensus       236 ~~~~~~~i~~~~g~~~~~~~~  256 (328)
T d3bqca1         236 NYDQLVRIAKVLGTEDLYDYI  256 (328)
T ss_dssp             HHHHHHHHHHHHCHHHHHHHH
T ss_pred             hHHHHHHHHHHHCCchhhhhh
Confidence            778888888888877655443

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=5.5e-25  Score=214.98  Aligned_cols=122  Identities=20%  Similarity=0.342  Sum_probs=91.9

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........++.+ .+.||+|||+++||||||||    +|||++..    |.+||+|||+++......            
T Consensus       131 ~l~~~~~~~~~~q-i~~al~ylH~~~ivHrDiKp----~NiLl~~~----~~~kl~dfg~~~~~~~~~------------  189 (299)
T d1fgka_         131 QLSSKDLVSCAYQ-VARGMEYLASKKCIHRDLAA----RNVLVTED----NVMKIADFGLARDIHHID------------  189 (299)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----CCEEECSTTCCCCGGGCC------------
T ss_pred             cCCHHHHHHHHHH-HHHHHHHhhhCCEEeeeecc----cceeecCC----CCeEeccchhhccccccc------------
Confidence            3455555666666 88999999999999999999    89999877    799999999998543211            


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                  ....+..                      ..+|+.|||||++.+.. |+.++|||||||++|||++ |
T Consensus       190 ------------~~~~~~~----------------------~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g  234 (299)
T d1fgka_         190 ------------YYKKTTN----------------------GRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLG  234 (299)
T ss_dssp             ------------TTCCCTT----------------------SCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTS
T ss_pred             ------------ccccccc----------------------CCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCC
Confidence                        0000111                      12389999999998765 9999999999999999998 7


Q ss_pred             CCCCCCchhhHHHHHHHHHH
Q psy3074         166 LPTFPGVREVYDQLDKIFKI  185 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~  185 (481)
                      .+||.+.+. .+.++.+...
T Consensus       235 ~~p~~~~~~-~~~~~~i~~~  253 (299)
T d1fgka_         235 GSPYPGVPV-EELFKLLKEG  253 (299)
T ss_dssp             CCSSTTCCH-HHHHHHHHTT
T ss_pred             CCCCCCCCH-HHHHHHHHcC
Confidence            999987433 2444444443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.88  E-value=1.3e-24  Score=213.49  Aligned_cols=155  Identities=14%  Similarity=0.120  Sum_probs=104.7

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.+ .+.||.|||+.+|+||||||    +||||+..    +.+||+|||+|+..........           
T Consensus       129 ~~~~~~i~~q-ia~gL~~lH~~~iiHrDLK~----~NILl~~~----~~~kL~DFG~~~~~~~~~~~~~-----------  188 (311)
T d1r0pa_         129 VKDLIGFGLQ-VAKGMKFLASKKFVHRDLAA----RNCMLDEK----FTVKVADFGLARDMYDKEFDSV-----------  188 (311)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----CCEEECSSGGGCCTTTTTCCCT-----------
T ss_pred             HHHHHHHHHH-HHHhhhhhcccCcccCCccH----HhEeECCC----CCEEEecccchhhccccccccc-----------
Confidence            3445566666 78899999999999999999    99999876    7999999999985432110000           


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTF  169 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF  169 (481)
                                 .                      ......+|+.|+|||++.... |+.++|||||||++|||+||..||
T Consensus       189 -----------~----------------------~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~  234 (311)
T d1r0pa_         189 -----------H----------------------NKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPP  234 (311)
T ss_dssp             -----------T----------------------CTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -----------e----------------------ecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCC
Confidence                       0                      000112499999999998766 999999999999999999987777


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      ....+..+....+......+.++.++..-......|+...|..|+++.+
T Consensus       235 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~e  283 (311)
T d1r0pa_         235 YPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSE  283 (311)
T ss_dssp             CC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHH
Confidence            7655555556666555444444433322222233567666666666544

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.87  E-value=9.5e-24  Score=205.52  Aligned_cols=118  Identities=17%  Similarity=0.232  Sum_probs=87.7

Q ss_pred             hHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccC-CCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           8 ATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYA-TPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~-~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ......+.++.. .+.||+|||++|||||||||    +|||++... ...+.+||+|||+|+........          
T Consensus        98 ~~~~~~~~i~~q-~~~~l~~lH~~giiHrDiKp----~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~----------  162 (293)
T d1csna_          98 FSVKTVAMAAKQ-MLARVQSIHEKSLVYRDIKP----DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK----------  162 (293)
T ss_dssp             CCHHHHHHHHHH-HHHHHHHHHTTTEECCCCCG----GGEEECCSSSTTTTCEEECCCTTCEESBCTTTC----------
T ss_pred             hhhHHHHHHHHH-HHHHHHHHHHCCceeccCCc----cceeecCcccccCCceEEcccceeEEcccCccc----------
Confidence            344444555555 67899999999999999999    899998643 24578999999999864321100          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                               ...........                      +||+.|||||++.+.. |+.++||||+||++|||++|+
T Consensus       163 ---------~~~~~~~~~~~----------------------~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~  210 (293)
T d1csna_         163 ---------QHIPYREKKNL----------------------SGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGS  210 (293)
T ss_dssp             ---------CBCCCCCCCCC----------------------CSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             ---------cceeecccCce----------------------EEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCC
Confidence                     00000001112                      3499999999998765 999999999999999999999


Q ss_pred             CCCCCc
Q psy3074         167 PTFPGV  172 (481)
Q Consensus       167 ~PF~g~  172 (481)
                      .||.+.
T Consensus       211 ~Pf~~~  216 (293)
T d1csna_         211 LPWQGL  216 (293)
T ss_dssp             CTTSSC
T ss_pred             CcCCCc
Confidence            999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.6e-24  Score=214.33  Aligned_cols=128  Identities=34%  Similarity=0.599  Sum_probs=98.6

Q ss_pred             HHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcc
Q psy3074           9 TVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKA   88 (481)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~   88 (481)
                      .+..-..+... .+.||+|||++||+||||||    +|||++..    |.+|++|||+|.......              
T Consensus       119 ~e~~~~~i~~q-il~aL~~LH~~giiHrDiKp----~NILi~~~----~~~kl~dfg~a~~~~~~~--------------  175 (348)
T d2gfsa1         119 TDDHVQFLIYQ-ILRGLKYIHSADIIHRDLKP----SNLAVNED----CELKILDFGLARHTDDEM--------------  175 (348)
T ss_dssp             CHHHHHHHHHH-HHHHHHHHHHTTCCCCCCCG----GGEEECTT----CCEEECCC----CCTGGG--------------
T ss_pred             cHHHHHHHHHH-HHHHHHHHHhCCCcccccCC----cccccccc----ccccccccchhcccCccc--------------
Confidence            33333444444 78999999999999999999    89999876    799999999997421100              


Q ss_pred             ccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q psy3074          89 DAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPT  168 (481)
Q Consensus        89 ~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~P  168 (481)
                                                           ....+|+.|+|||++.+...++.++||||+||++|||++|++|
T Consensus       176 -------------------------------------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p  218 (348)
T d2gfsa1         176 -------------------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  218 (348)
T ss_dssp             -------------------------------------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             -------------------------------------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence                                                 0112499999999999887789999999999999999999999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCcccc
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGV  197 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~  197 (481)
                      |.+. +.......|.+..+.++.+.+...
T Consensus       219 F~~~-~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         219 FPGT-DHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             CCCS-SHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             CCCC-CHHHHHHHHHHhcCCCChHHhhhc
Confidence            9995 445888899999998887655443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.5e-24  Score=211.39  Aligned_cols=155  Identities=17%  Similarity=0.245  Sum_probs=106.3

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +........++.+ .+.|+.|||+++||||||||    +|||++..    +.+|++|||+|+.......           
T Consensus       141 ~l~~~~~~~~~~q-i~~gl~~LH~~~ivHrDLKp----~NIl~~~~----~~~ki~DfG~~~~~~~~~~-----------  200 (311)
T d1t46a_         141 ALDLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAA----RNILLTHG----RITKICDFGLARDIKNDSN-----------  200 (311)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEEETT----TEEEECCCGGGSCTTSCTT-----------
T ss_pred             CCCHHHHHHHHHH-HHHHHHHHHhCCeeeccccc----cccccccc----CcccccccchheeccCCCc-----------
Confidence            4455566667777 88999999999999999999    89999876    7999999999985421110           


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-C
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-G  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g  165 (481)
                                   ......                      ..+|+.|||||++.+.. |+.++|||||||++|||+| |
T Consensus       201 -------------~~~~~~----------------------~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         201 -------------YVVKGN----------------------ARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             -------------SEECSS----------------------SEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTT
T ss_pred             -------------ceEeee----------------------cccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCC
Confidence                         000001                      12499999999998765 9999999999999999998 6


Q ss_pred             CCCCCCchhhHHHHHHHHHH-hCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         166 LPTFPGVREVYDQLDKIFKI-LGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .+||.+.+.. +.+.++.+. ...+.++.++..-.-....|+...|..|+++++
T Consensus       245 ~p~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~  297 (311)
T d1t46a_         245 SSPYPGMPVD-SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQ  297 (311)
T ss_dssp             CCSSTTCCSS-HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCCHH-HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHH
Confidence            7777775443 455555544 433343444332211223456555555566543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=1.6e-24  Score=212.63  Aligned_cols=152  Identities=18%  Similarity=0.265  Sum_probs=104.7

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      ++.......++.+ .+.|+.|||+++|+||||||    +|||++..    +.+||+|||+|+.....             
T Consensus       123 ~l~~~~~~~~~~q-ia~gl~~lH~~~iiHrDlkp----~NIL~~~~----~~~kl~DfG~a~~~~~~-------------  180 (309)
T d1fvra_         123 TLSSQQLLHFAAD-VARGMDYLSQKQFIHRDLAA----RNILVGEN----YVAKIADFGLSRGQEVY-------------  180 (309)
T ss_dssp             SSCHHHHHHHHHH-HHHHHHHHHHTTEECSCCSG----GGEEECGG----GCEEECCTTCEESSCEE-------------
T ss_pred             CCCHHHHHHHHHH-HHHHHHhhhcCCcccccccc----ceEEEcCC----CceEEcccccccccccc-------------
Confidence            3444555666666 78899999999999999999    89999887    69999999999843210             


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-  165 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-  165 (481)
                                    .......                      +|+.|+|||++.+.. |+.++|||||||++|||++| 
T Consensus       181 --------------~~~~~~~----------------------gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~  223 (309)
T d1fvra_         181 --------------VKKTMGR----------------------LPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLG  223 (309)
T ss_dssp             --------------CCC--------------------------CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTS
T ss_pred             --------------cccccee----------------------cCCcccchHHhccCC-CCccceeehhHHHHHHHHhcC
Confidence                          0011112                      389999999998776 99999999999999999996 


Q ss_pred             CCCCCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         166 LPTFPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       166 ~~PF~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      .+||.+. +..+.++.+.+....+.+..++..-......|+...|..|+++.+
T Consensus       224 ~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  275 (309)
T d1fvra_         224 GTPYCGM-TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ  275 (309)
T ss_dssp             CCTTTTC-CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCC-CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            5678774 333555555444333333333322111223566666666666544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.87  E-value=2.4e-24  Score=206.33  Aligned_cols=147  Identities=18%  Similarity=0.226  Sum_probs=98.4

Q ss_pred             HHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccc
Q psy3074          10 VQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKAD   89 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~   89 (481)
                      ....+.++.+ .+.|+.|||+++|+||||||    +|||++..    |.+||+|||+++.....                
T Consensus       102 ~~~~~~i~~~-i~~al~ylH~~~ivH~dlkp----~Nil~~~~----~~~kl~dfg~s~~~~~~----------------  156 (262)
T d1byga_         102 GDCLLKFSLD-VCEAMEYLEGNNFVHRDLAA----RNVLVSED----NVAKVSDFGLTKEASST----------------  156 (262)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHHTTCCCSCCSG----GGEEECTT----SCEEECCCCC-----------------------
T ss_pred             HHHHHHHHHH-HHhhccccccCceeccccch----HhheecCC----CCEeecccccceecCCC----------------
Confidence            3344556666 88899999999999999999    89999876    79999999999843210                


Q ss_pred             cceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHh-CCCC
Q psy3074          90 AYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVT-GLPT  168 (481)
Q Consensus        90 ~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~ellt-g~~P  168 (481)
                                   .....                      +|+.|||||++.+.. |+.++|||||||++|||+| |++|
T Consensus       157 -------------~~~~~----------------------~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p  200 (262)
T d1byga_         157 -------------QDTGK----------------------LPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVP  200 (262)
T ss_dssp             ----------------------------------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             -------------Ccccc----------------------ccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCC
Confidence                         01112                      288999999998765 9999999999999999998 7999


Q ss_pred             CCCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCc
Q psy3074         169 FPGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGL  218 (481)
Q Consensus       169 F~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (481)
                      |.+. +..+.+..|......+.++.++..-......|+...|..|+++.+
T Consensus       201 ~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~  249 (262)
T d1byga_         201 YPRI-PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQ  249 (262)
T ss_dssp             CTTS-CGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCC-CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHH
Confidence            8874 333455555444433333333222111223456655665666543

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.87  E-value=1.1e-23  Score=205.36  Aligned_cols=118  Identities=17%  Similarity=0.237  Sum_probs=86.9

Q ss_pred             hhHHHHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCC
Q psy3074           7 KATVQRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFG   86 (481)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~   86 (481)
                      +.....-+.++.. .+.||+|||++|||||||||    +|||++... ....+||+|||+|+........          
T Consensus        99 ~~~~~~~~~~~~q-i~~~l~~lH~~~iiHrDiKp----~NIl~~~~~-~~~~vkl~DFG~a~~~~~~~~~----------  162 (299)
T d1ckia_          99 KFSLKTVLLLADQ-MISRIEYIHSKNFIHRDVKP----DNFLMGLGK-KGNLVYIIDFGLAKKYRDARTH----------  162 (299)
T ss_dssp             CCCHHHHHHHHHH-HHHHHHHHHHTTEECSCCCG----GGEEECCGG-GTTCEEECCCSSCEECBCTTTC----------
T ss_pred             CCcHHHHHHHHHH-HHHHHHHHHHCCeeeccCCH----hhccccccC-CCceeeeeccCcceeccccccc----------
Confidence            3444444555555 78999999999999999999    899986542 2357999999999864321100          


Q ss_pred             ccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCC
Q psy3074          87 KADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGL  166 (481)
Q Consensus        87 ~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~  166 (481)
                                  ...   .+                .......+|+.|||||++.+.. |+.++||||+||++|||++|+
T Consensus       163 ------------~~~---~~----------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~  210 (299)
T d1ckia_         163 ------------QHI---PY----------------RENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGS  210 (299)
T ss_dssp             ------------CBC---CC----------------CBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred             ------------cce---ec----------------cccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCC
Confidence                        000   00                0001123499999999999876 999999999999999999999


Q ss_pred             CCCCCc
Q psy3074         167 PTFPGV  172 (481)
Q Consensus       167 ~PF~g~  172 (481)
                      +||.+.
T Consensus       211 ~P~~~~  216 (299)
T d1ckia_         211 LPWQGL  216 (299)
T ss_dssp             CTTCCC
T ss_pred             Cccccc
Confidence            999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=3.4e-24  Score=210.22  Aligned_cols=152  Identities=14%  Similarity=0.172  Sum_probs=107.1

Q ss_pred             HHhhhhccCcccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCcccc
Q psy3074          11 QRQISVSSDSKLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADA   90 (481)
Q Consensus        11 ~~~~~~~~~~~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~   90 (481)
                      ...+.++.. .+.|++|||+++|+||||||    +|||++..    +.+||+|||+|+......                
T Consensus       133 ~~~~~i~~~-ia~gl~~LH~~~ivHrDlk~----~NiLld~~----~~~Kl~DFGla~~~~~~~----------------  187 (308)
T d1p4oa_         133 SKMIQMAGE-IADGMAYLNANKFVHRDLAA----RNCMVAED----FTVKIGDFGMTRDIYETD----------------  187 (308)
T ss_dssp             HHHHHHHHH-HHHHHHHHHHTTCBCSCCSG----GGEEECTT----CCEEECCTTCCCGGGGGG----------------
T ss_pred             HHHHHHHHH-HHHHHHHHhhCCeeeceEcC----CceeecCC----ceEEEeecccceeccCCc----------------
Confidence            344556666 78899999999999999999    99999876    799999999998532110                


Q ss_pred             ceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhC-CCCC
Q psy3074          91 YIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTG-LPTF  169 (481)
Q Consensus        91 ~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg-~~PF  169 (481)
                              .     ...+                 ....+|+.|||||++.+.. |+.++|||||||++|||+|| .+||
T Consensus       188 --------~-----~~~~-----------------~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~  236 (308)
T d1p4oa_         188 --------Y-----YRKG-----------------GKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPY  236 (308)
T ss_dssp             --------C-----EEGG-----------------GSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             --------c-----eeec-----------------cceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCC
Confidence                    0     0000                 1112499999999998776 99999999999999999997 5888


Q ss_pred             CCchhhHHHHHHHHHHhCCCCccCcccccCCCCCCccCCCCccCCCcCcC
Q psy3074         170 PGVREVYDQLDKIFKILGTPTEETWEGVSLLPGYNVHRDAPYTGNKLGLT  219 (481)
Q Consensus       170 ~g~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (481)
                      .+. +..+.+..+.+....+.+...+..-......|+...|..|+++.++
T Consensus       237 ~~~-~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i  285 (308)
T d1p4oa_         237 QGL-SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI  285 (308)
T ss_dssp             TTS-CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCC-CHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence            874 3335666666655444444443322222345677666667775543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.86  E-value=2.8e-23  Score=204.79  Aligned_cols=108  Identities=22%  Similarity=0.385  Sum_probs=81.9

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCCCCCCCccccceecccCCCC
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQLGEG  100 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~g  100 (481)
                      .+.|++|||+++|+||||||    +|||++..    |.+||+|||+|+......                         .
T Consensus       138 i~~al~~lH~~~ivHrDiKp----~Nill~~~----~~vkL~DFG~a~~~~~~~-------------------------~  184 (322)
T d1vzoa_         138 IVLALEHLHKLGIIYRDIKL----ENILLDSN----GHVVLTDFGLSKEFVADE-------------------------T  184 (322)
T ss_dssp             HHHHHHHHHHTTCCCCCCCG----GGEEECTT----SCEEESCSSEEEECCGGG-------------------------G
T ss_pred             HHHHHHHhhcCCEEeccCCc----cceeecCC----CCEEEeeccchhhhcccc-------------------------c
Confidence            68899999999999999999    99999876    799999999998532110                         0


Q ss_pred             ceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCchhhHHHH
Q psy3074         101 SYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST-EYSTSLDMWGVGCILIEMVTGLPTFPGVREVYDQL  179 (481)
Q Consensus       101 ~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~-~y~~~~DvWS~G~il~elltg~~PF~g~~~~~~~l  179 (481)
                      +...                      ...+|+.|+|||++.+.. .|+.++||||+||++|||++|+.||.+.+.. +..
T Consensus       185 ~~~~----------------------~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~-~~~  241 (322)
T d1vzoa_         185 ERAY----------------------DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK-NSQ  241 (322)
T ss_dssp             GGGC----------------------GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC-CCH
T ss_pred             cccc----------------------ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence            0000                      112499999999998754 4788999999999999999999999885322 334


Q ss_pred             HHHHH
Q psy3074         180 DKIFK  184 (481)
Q Consensus       180 ~~i~~  184 (481)
                      ..+.+
T Consensus       242 ~~i~~  246 (322)
T d1vzoa_         242 AEISR  246 (322)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            44443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.84  E-value=6e-22  Score=197.86  Aligned_cols=146  Identities=24%  Similarity=0.307  Sum_probs=105.4

Q ss_pred             HHHHHHHHhhcC-----------CCCeeEEeeeeec--CCeEEEEEeccC--CCHHHHH-HHhcCCCChHHHHHHHHHHH
Q psy3074         270 AIREASLLKELK-----------HNNIVTLHDIVHT--RSTLTFVFEYVH--TDLSQYM-ERHSGGLDHHNIRLFMFQLL  333 (481)
Q Consensus       270 ~~rE~~il~~l~-----------HpnIV~l~~~~~~--~~~~~iv~E~~~--g~l~~~l-~~~~~~l~~~~~~~~~~qi~  333 (481)
                      +.+|+.+++.++           |+|||++++++..  ....+++|+++.  ++..... ......+++..++.++.|++
T Consensus        56 ~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil  135 (362)
T d1q8ya_          56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL  135 (362)
T ss_dssp             HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHH
Confidence            345777776664           6889999998864  456777777765  3333332 23345688999999999999


Q ss_pred             HHHHHhhc-CceeeccCCCccccccccch----hhHHHHHHHHHhhccccccCceeccccCCCcccccccccccCCCeeE
Q psy3074         334 RGLSYCHR-RRILHRDVKPQNLLISEIDH----HNIRLFMFQLLRGLSYCHRRRILHRDVKPQNLLISEIVFTNLSGVVV  408 (481)
Q Consensus       334 ~~l~ylH~-~~iiHrDlKp~NiLl~~~~~----~~ikl~dfgla~~~~~~~~~~i~~~d~~~~~il~~~~~~~~s~g~~~  408 (481)
                      .||.|||+ .||+||||||+|||++.++.    ..++++|||.|.........                           
T Consensus       136 ~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~---------------------------  188 (362)
T d1q8ya_         136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN---------------------------  188 (362)
T ss_dssp             HHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCS---------------------------
T ss_pred             HHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccccccc---------------------------
Confidence            99999997 89999999999999986553    23677777776544332222                           


Q ss_pred             EEeecCCCCccccccCcccceeccCCC--------CCChhhhhhHHHHHHhhCCCcccc
Q psy3074         409 STVDSGSGGWWFESKSNINLSFHYLPP--------GAPFTAIREASLLKELKHNNIVTL  459 (481)
Q Consensus       409 ~~~~~g~~~~~~~~~~~~~~t~~y~~p--------~~p~~~~s~~~~l~~l~~~~~~~~  459 (481)
                                       .+||+.|++|        +..+|+||+|+++++|..|..||-
T Consensus       189 -----------------~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         189 -----------------SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             -----------------CCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             -----------------ccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence                             3345555555        566899999999999999987754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.82  E-value=2.8e-22  Score=195.88  Aligned_cols=109  Identities=19%  Similarity=0.180  Sum_probs=81.2

Q ss_pred             HHHhhhhccCcccccHHHHHH--------hhhhcccCCCCCCCcchhccccCCCCCceeeecccccccccCCCCCcCCCC
Q psy3074          10 VQRQISVSSDSKLLDADIAEE--------TRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAKSVPSHTYSHQG   81 (481)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~lh~--------~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~~~~~~~~~~~~   81 (481)
                      ....+.++.+ .+.|++|||+        +||+||||||    +||||+.+    |.+||||||+|+.......+..   
T Consensus        99 ~~~~~~~~~~-ia~gl~~lH~~~~~~~~~~~IvHrDlKp----~NILl~~~----~~~Kl~DFGl~~~~~~~~~~~~---  166 (303)
T d1vjya_          99 VEGMIKLALS-TASGLAHLHMEIVGTQGKPAIAHRDLKS----KNILVKKN----GTCCIADLGLAVRHDSATDTID---  166 (303)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHCCBCSTTCBCEEECSCCCG----GGEEECTT----SCEEECCCTTCEEEETTTTEEC---
T ss_pred             HHHHHHHHHH-HHHHHHHHHHhhhhhccCCCeeccccCc----cceEEcCC----CCeEEEecCccccccCCCccee---
Confidence            3444566666 6789999996        5999999999    99999866    7999999999985432111000   


Q ss_pred             CCCCCccccceecccCCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCC-----CCCCccchhhHH
Q psy3074          82 DSPFGKADAYIKLDQLGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGST-----EYSTSLDMWGVG  156 (481)
Q Consensus        82 ~~~~~~~~~~~~~~~~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~-----~y~~~~DvWS~G  156 (481)
                                         .....                      ..+|+.|||||++.+..     .|+.++||||||
T Consensus       167 -------------------~~~~~----------------------~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G  205 (303)
T d1vjya_         167 -------------------IAPNH----------------------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG  205 (303)
T ss_dssp             -------------------C--------------------------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred             -------------------ccccc----------------------eecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence                               00011                      23499999999987643     267789999999


Q ss_pred             HHHHHHHhCCCCCCC
Q psy3074         157 CILIEMVTGLPTFPG  171 (481)
Q Consensus       157 ~il~elltg~~PF~g  171 (481)
                      |++|||+||.+||..
T Consensus       206 vvl~el~tg~~~~~~  220 (303)
T d1vjya_         206 LVFWEIARRCSIGGI  220 (303)
T ss_dssp             HHHHHHHHTBCBTTB
T ss_pred             HHHHHHhhCCCCCCc
Confidence            999999999988854

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.82  E-value=1e-21  Score=196.22  Aligned_cols=120  Identities=26%  Similarity=0.403  Sum_probs=91.0

Q ss_pred             cccccHHHHHH-hhhhcccCCCCCCCcchhccccCC--CCCceeeecccccccccCCCCCcCCCCCCCCCccccceeccc
Q psy3074          20 SKLLDADIAEE-TRVLLRNRKPPRPKSEVFLNKYAT--PPRELKLADFGLARAKSVPSHTYSHQGDSPFGKADAYIKLDQ   96 (481)
Q Consensus        20 ~~~~~~~~lh~-~~i~hrdlkp~~~~~nill~~~~~--~~g~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   96 (481)
                      ..+.|++|||+ .||+||||||    +|||++....  ....+|++|||.|+......                      
T Consensus       133 qil~al~~lh~~~~IvHrDlKp----~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~----------------------  186 (362)
T d1q8ya_         133 QLLLGLDYMHRRCGIIHTDIKP----ENVLMEIVDSPENLIQIKIADLGNACWYDEHY----------------------  186 (362)
T ss_dssp             HHHHHHHHHHHTTCEECSCCSG----GGEEEEEEETTTTEEEEEECCCTTCEETTBCC----------------------
T ss_pred             HHHHHHHHHhhhcCcccccCCh----hHeeeeccCcccccceeeEeeccccccccccc----------------------
Confidence            36889999998 8999999999    8999987531  11248999999997432110                      


Q ss_pred             CCCCceeEEEecccCcchhhhhhhhhhhccccCceeeeeCCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCch---
Q psy3074          97 LGEGSYATVFKGYSNLTNQVVALKEIRLQEEEGITLWYRPPDVLLGSTEYSTSLDMWGVGCILIEMVTGLPTFPGVR---  173 (481)
Q Consensus        97 ~g~g~~~~~~~g~~~~~~~~~~~k~~~~~~~~~~t~~Y~APEvl~~~~~y~~~~DvWS~G~il~elltg~~PF~g~~---  173 (481)
                             ..                      ..+|+.|||||++.+.. |+.++|+||+||+++||++|+.||.+..   
T Consensus       187 -------~~----------------------~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~  236 (362)
T d1q8ya_         187 -------TN----------------------SIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHS  236 (362)
T ss_dssp             -------CS----------------------CCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             -------cc----------------------ccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCcccc
Confidence                   00                      12399999999999765 9999999999999999999999997642   


Q ss_pred             --hhHHHHHHHHHHhCCCCccCcc
Q psy3074         174 --EVYDQLDKIFKILGTPTEETWE  195 (481)
Q Consensus       174 --~~~~~l~~i~~~~~~p~~~~~~  195 (481)
                        ...+.+..+...+|.++.+.+.
T Consensus       237 ~~~~~~~~~~~~~~lg~~~~~~~~  260 (362)
T d1q8ya_         237 YTKDDDHIAQIIELLGELPSYLLR  260 (362)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhCCCCHHHhh
Confidence              2345677788888988776554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.64  E-value=1.5e-18  Score=157.51  Aligned_cols=93  Identities=18%  Similarity=0.159  Sum_probs=77.0

Q ss_pred             HHHHHHHHhhcCCCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCceeeccC
Q psy3074         270 AIREASLLKELKHNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRRILHRDV  349 (481)
Q Consensus       270 ~~rE~~il~~l~HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~iiHrDl  349 (481)
                      +.+|..++.++.|++++..+++..    .+++|||+++...       ..++...+..++.|++.++.|||++||+||||
T Consensus        61 ~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDi  129 (191)
T d1zara2          61 ARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDL  129 (191)
T ss_dssp             HHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccC
Confidence            457999999999999998876532    2799999996532       12566667889999999999999999999999


Q ss_pred             CCccccccccchhhHHHHHHHHHhhcc
Q psy3074         350 KPQNLLISEIDHHNIRLFMFQLLRGLS  376 (481)
Q Consensus       350 Kp~NiLl~~~~~~~ikl~dfgla~~~~  376 (481)
                      ||+|||+++.+   ++++|||+|....
T Consensus       130 KP~NILv~~~~---~~liDFG~a~~~~  153 (191)
T d1zara2         130 SQYNVLVSEEG---IWIIDFPQSVEVG  153 (191)
T ss_dssp             STTSEEEETTE---EEECCCTTCEETT
T ss_pred             ChhheeeeCCC---EEEEECCCcccCC
Confidence            99999998644   7889999987654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.93  E-value=2.5e-11  Score=108.96  Aligned_cols=41  Identities=10%  Similarity=0.064  Sum_probs=36.5

Q ss_pred             ccccHHHHHHhhhhcccCCCCCCCcchhccccCCCCCceeeecccccccc
Q psy3074          21 KLLDADIAEETRVLLRNRKPPRPKSEVFLNKYATPPRELKLADFGLARAK   70 (481)
Q Consensus        21 ~~~~~~~lh~~~i~hrdlkp~~~~~nill~~~~~~~g~~Kl~DFGla~~~   70 (481)
                      .+.+++|||++||+||||||    +|||++..     .++|+|||+|+..
T Consensus       112 l~~~l~~lH~~giiHrDiKP----~NILv~~~-----~~~liDFG~a~~~  152 (191)
T d1zara2         112 ILEEVAKFYHRGIVHGDLSQ----YNVLVSEE-----GIWIIDFPQSVEV  152 (191)
T ss_dssp             HHHHHHHHHHTTEECSCCST----TSEEEETT-----EEEECCCTTCEET
T ss_pred             HHHHHHHHhhCCEEEccCCh----hheeeeCC-----CEEEEECCCcccC
Confidence            67899999999999999999    89999853     5899999999753

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=95.12  E-value=0.0049  Score=55.60  Aligned_cols=70  Identities=9%  Similarity=0.000  Sum_probs=46.7

Q ss_pred             hHHHHHHHHhhcC-CCCeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcCc
Q psy3074         269 TAIREASLLKELK-HNNIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRRR  343 (481)
Q Consensus       269 ~~~rE~~il~~l~-HpnIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~~  343 (481)
                      ...+|..++..+. +--+-+++.+..+++..++||++++|.......     .+......+..++...+..+|+..
T Consensus        55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~-----~~~~~~~~~~~~l~~~l~~lH~~~  125 (263)
T d1j7la_          55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT-----TTCSCHHHHHHHHHHHHHHHHTSC
T ss_pred             hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc-----cccccHHHHHHHHHHHHHHHhccC
Confidence            4678999988775 323556677777888999999999986443211     122223445677777788888654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.99  E-value=0.013  Score=52.34  Aligned_cols=66  Identities=15%  Similarity=0.011  Sum_probs=42.1

Q ss_pred             hHHHHHHHHhhcCCC--CeeEEeeeeecCCeEEEEEeccCCCHHHHHHHhcCCCChHHHHHHHHHHHHHHHHhhcC
Q psy3074         269 TAIREASLLKELKHN--NIVTLHDIVHTRSTLTFVFEYVHTDLSQYMERHSGGLDHHNIRLFMFQLLRGLSYCHRR  342 (481)
Q Consensus       269 ~~~rE~~il~~l~Hp--nIV~l~~~~~~~~~~~iv~E~~~g~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~ylH~~  342 (481)
                      ...+|...|+.+...  .+.+++.+..+++..++||++++|....     .......   ....++...|.-||+.
T Consensus        50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~-----~~~~~~~---~~~~~l~~~la~LH~~  117 (255)
T d1nd4a_          50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-----SSHLAPA---EKVSIMADAMRRLHTL  117 (255)
T ss_dssp             CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-----TSCCCHH---HHHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc-----cccccHH---HHHHHHHHHHHHHccC
Confidence            356788888877643  2456677777888899999999874321     1112222   2345566667777754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=89.03  E-value=0.048  Score=52.45  Aligned_cols=38  Identities=18%  Similarity=0.035  Sum_probs=24.4

Q ss_pred             hhHHHHHHHHhhcC-C--CCeeEEeeeeecCCeEEEEEeccCC
Q psy3074         268 FTAIREASLLKELK-H--NNIVTLHDIVHTRSTLTFVFEYVHT  307 (481)
Q Consensus       268 ~~~~rE~~il~~l~-H--pnIV~l~~~~~~~~~~~iv~E~~~g  307 (481)
                      .+..+|.++|+.+. +  ..+.+++.+  +++.-++|||++++
T Consensus        75 ~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~~  115 (392)
T d2pula1          75 DRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSH  115 (392)
T ss_dssp             THHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTT
T ss_pred             HHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccCC
Confidence            34567988888764 2  234555543  34455789999975